PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Yu, S; Li, SJ; Henke, A; Muse, ED; Cheng, B; Welzel, G; Chatterjee, AK; Wang, DL; Roland, J; Glass, CK; Tremblay, M				Yu, Shan; Li, Sijia; Henke, Adam; Muse, Evan D.; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Glass, Christopher K.; Tremblay, Matthew			Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases	FASEB JOURNAL			English	Article						LXR; traumatic brain injury; ulcerative colitis; drug discovery	ELEMENT-BINDING PROTEIN-1C; LIPID-METABOLISM; LXR AGONIST; GENE; MICE; OXYSTEROLS; PATHWAYS; TRANSREPRESSION; INTEGRATION; LIPOGENESIS	Liver X receptor (LXR), a nuclear hormone receptor, is an essential regulator of immune responses. Activation of LXR-mediated transcription by synthetic agonists, such as T0901317 and GW3965, attenuates progression of inflammatory disease in animal models. However, the adverse effects of these conventional LXR agonists in elevating liver lipids have impeded exploitation of this intriguing mechanism for chronic therapy. Here, we explore the ability of a series of sterol-based LXR agonists to alleviate inflammatory conditions in mice without hepatotoxicity. We show that oral treatment with sterol-based LXR agonists in mice significantly reduces dextran sulfate sodium colitis-induced body weight loss, which is accompanied by reduced expression of inflammatory markers in the large intestine. The anti-inflammatory property of these agonists is recapitulated in vitro in mouse lamina propria mononuclear cells, human colonic epithelial cells, and human peripheral blood mononuclear cells. In addition, treatment with LXR agonists dramatically suppresses inflammatory cytokine expression in a model of traumatic brain injury. Importantly, in both disease models, the sterol-based agonists do not affect the liver, and the conventional agonist T0901317 results in significant liver lipid accumulation and injury. Overall, these results provide evidence for the development of sterol-based LXR agonists as novel therapeutics for chronic inflammatory diseases.	[Yu, Shan; Li, Sijia; Henke, Adam; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Tremblay, Matthew] Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA; [Muse, Evan D.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Muse, Evan D.] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA	Tremblay, M (corresponding author), Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA.; Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, GPL Rm 217,9500 Gilman Dr,Mail Code 0651, La Jolla, CA 92093 USA.	cglass@ucsd.edu; mtremblay@calibr.org	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	Crohn's and Colitis Foundation of America Research Fellowship Award [368561]; U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award [UL1-TR001114]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK063491] Funding Source: NIH RePORTER	This work was supported by a Crohn's and Colitis Foundation of America Research Fellowship Award (368561; to S.Y.), and by a U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award (UL1-TR001114; to Scripps Translational Science Institute).	Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Cheng O, 2010, NEUROSCIENCE, V166, P1101, DOI 10.1016/j.neuroscience.2010.01.024; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hu BH, 2010, J MED CHEM, V53, P3296, DOI 10.1021/jm100034x; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakobsson T, 2014, MUCOSAL IMMUNOL, V7, P1416, DOI 10.1038/mi.2014.31; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Katz A, 2009, J CLIN PHARMACOL, V49, P643, DOI 10.1177/0091270009335768; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lim RKV, 2015, BIOCONJUGATE CHEM, V26, P2216, DOI 10.1021/acs.bioconjchem.5b00203; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Quinet EM, 2009, J LIPID RES, V50, P2358, DOI 10.1194/jlr.M900037-JLR200; Quinet EM, 2004, J LIPID RES, V45, P1929, DOI 10.1194/jlr.M400257-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Temml V, 2014, J CHEM INF MODEL, V54, P367, DOI 10.1021/ci400682b; Tice CM, 2014, J MED CHEM, V57, P7182, DOI 10.1021/jm500442z; Traversari C, 2014, EUR J IMMUNOL, V44, P1896, DOI 10.1002/eji.201344292; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	33	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2570	2579		10.1096/fj.201600244R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	WOS:000379249500012	27025962	Green Published			2021-06-18	
J	Zhou, Z; Jiang, BH; Cao, LB; Zhu, F; Mao, HJ; Yang, KH				Zhou, Zhou; Jiang, Binhui; Cao, Libo; Zhu, Feng; Mao, Haojie; Yang, King H.			Numerical simulations of the 10-year-old head response in drop impacts and compression tests	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						Pediatric head finite element model; Child cadaver test; Fall accident reconstruction; Skull fracture; Brain injury	FINITE-ELEMENT MODEL; DIFFUSE AXONAL INJURY; REAL-WORLD TRAUMA; CRANIAL BONE; DYNAMIC-RESPONSE; BRAIN-INJURIES; CHILD; AGE; VALIDATION; CRITERIA	Background and objective: Studies on traumatic injuries of children indicate that impact to the head is a major cause of severe injury and high mortality. However, regulatory and ethical concerns very much limit development and validation of computer models representing the pediatric head. The purpose of this study was to develop a child head finite element model with high-biofidelity to be used for studying pediatric head injury mechanisms. Methods: A newly developed 10-year-old (YO) pediatric finite element head model was limitedly validated for kinematic and kinetic responses against data from quasi-static compressions and drop tests obtained from an experimental study involving a child-cadaver specimen. The validated model was subsequently used for a fall accident reconstruction and associated injury analysis. Results: The model predicted the same shape of acceleration-time histories as was found in drop tests with the largest discrepancy of -8.2% in the peak acceleration at a drop height of 15 cm. Force-deflection responses predicted by the model for compression loading had a maximum discrepancy of 7.5% at a strain rate of 0.3 s(-1). The model-predicted maximum von Mises stress (sigma(v)) and principal strain (epsilon(p)) in the skull, intracranial pressure (ICP), maximum sigma(v) and maximum epsilon(p) in the brain, head injury criterion (HIC), brain injury criterion (BrIC), and head impact power (HIP) were used for analyzing risks of injury in the accident reconstruction. Conclusions: Based on the results of the injury analyses, the following conclusions can be drawn: (1) ICP cannot be used to accurately predict the locations of brain injury, but it may reflect the overall energy level of the impact event. (2) The brain regions predicted by the model to have high sigma(v) coincide with the locations of subdural hematoma with transtentorial herniation and the impact position of an actual injury. (3) The brain regions with high epsilon(p) predicted by the model coincide with locations commonly found where diffuse axonal injuries (DAI) due to blunt-impact and rapid acceleration have taken place. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Zhou, Zhou; Jiang, Binhui; Cao, Libo; Zhu, Feng] Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China; [Jiang, Binhui; Mao, Haojie; Yang, King H.] Wayne State Univ, Bioengn Ctr, Detroit, MI 48201 USA; [Zhu, Feng] Embry Riddle Aeronaut Univ, Dept Mech Engn, Daytona Beach, FL 32114 USA	Jiang, BH (corresponding author), Hunan Univ, State Key Lab Adv Design & Mfg Vehicle Body, Changsha 410082, Hunan, Peoples R China.	jjhhzz123@163.com	Mao, Haojie/Q-7514-2018; Jiang, Binhui/V-9272-2019	Mao, Haojie/0000-0002-7563-9234; Jiang, Binhui/0000-0001-9255-5780; zhou, zhou/0000-0002-3910-0418	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11172099]; National Science Foundational for Young Scientists of China [51405148]; Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body [51475001, 3135001]	The authors would like to thank the National Natural Science Foundation of China (No. 11172099) and The National Science Foundational for Young Scientists of China (No. 51405148) for the financial support. The project was also supported by the Fund of State Key Laboratory of Advanced Design and Manufacturing for Vehicle Body No. 51475001 and 3135001. The authors would also like to thank Ms. Barbara R. Presley from Wayne State University for her careful proofreading of this paper.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Altair Engineering Inc, 2009, HYPERVIEW US GUID; Cai Y., 2013, ASME 2013 SUMM BIOEN; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; CLAESSENS M, 1997, P 41 STAPP CAR CRASH, P315, DOI DOI 10.4271/973338; Curry JD, 1975, J BONE JOINT SURG AM, V57, P810; Davis MT, 2012, J BIOMECH, V45, P2493, DOI 10.1016/j.jbiomech.2012.07.001; DEKABAN AS, 1977, ANN NEUROL, V2, P485, DOI 10.1002/ana.410020607; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Dong LQ, 2013, ANN BIOMED ENG, V41, P2538, DOI 10.1007/s10439-013-0858-7; Eppinger R. H., 1984, SAE GOV IND M EXP WA; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Fournier E., 2000, IRCOBI INT RES COUNC, V2000, P223; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; Irwin Annette L, 2002, Stapp Car Crash J, V46, P297; James HE, 1999, ACT NEUR S, V73, P85; Jiang BH, 2014, COMPUT METHOD BIOMEC, V17, P1185, DOI 10.1080/10255842.2012.739164; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; Loyd A. M., 2011, THESIS DUKE U; Mao HJ, 2014, ANN BIOMED ENG, V42, P2143, DOI 10.1007/s10439-014-1078-5; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Mertz H., 1989, SP782 AUTOMOTIVE FRO, P133; Mertz H. J., 1997, STAPP CAR CRASH J, V41, P261; MILLER RT, 1998, P 42 STAPP CAR CRASH, P155; Mizuno Koji, 2005, Traffic Inj Prev, V6, P361, DOI 10.1080/15389580500255922; Nahum A. M., 1977, P 21 STAPP CAR CRASH, P339; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Ren LH, 2015, INT J CRASHWORTHINES, V20, P602, DOI 10.1080/13588265.2015.1073132; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Ruan J., 2013, P FISITA 2012 WORLD, P207; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Sevagan G, 2013, P I MECH ENG H, V227, P778, DOI 10.1177/0954411913483430; Shen M., 2015, INT RES COUNC BIOM I, P672; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Takhounts E. G., 2011, 22 INT TECHN C ENH S, P1; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Trosseille X., 1992, P 36 STAPP CAR CRASH, DOI 10.4271/922527; TSAI FY, 1980, AM J NEURORADIOL, V1, P23; Ward C., 1980, P 24 STAPP CAR CRASH, P163; WEBER W, 1984, Z RECHTSMED, V92, P87, DOI 10.1007/BF02116216; Weber W, 1985, 7 RECHTSMED, V94, P93; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2016, ANN BIOMED ENG, V44, P258, DOI 10.1007/s10439-015-1372-x	65	14	14	1	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUL	2016	131						13	25		10.1016/j.cmpb.2016.04.013			13	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Computer Science; Engineering; Medical Informatics	DN8AA	WOS:000377300100003	27265045				2021-06-18	
J	Brock, JH; Graham, L; Staufenberg, E; Collyer, E; Koffler, J; Tuszynski, MH				Brock, John H.; Graham, Lori; Staufenberg, Eileen; Collyer, Eileen; Koffler, Jacob; Tuszynski, Mark H.			Bone Marrow Stromal Cell Intraspinal Transplants Fail to Improve Motor Outcomes in a Severe Model of Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						bone marrow stromal cells; brain-derived neurotrophic factor; neuroprotection; severe spinal cord compression	MESENCHYMAL STEM-CELLS; PROMOTE FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; IMMUNE RECONSTITUTION; HINDLIMB FUNCTION; CEREBROSPINAL-FLUID; GROWTH-FACTOR; BRAIN; RAT; BDNF	Bone marrow stromal cells (BMSCs) have been reported to exert potential neuroprotective properties in models of neurotrauma, although precise mechanisms underlying their benefits are poorly understood. Despite this lack of knowledge, several clinical trials have been initiated using these cells. To determine whether local mechanisms mediate BMSC neuroprotective actions, we grafted allogeneic BMSCs to sites of severe, compressive spinal cord injury (SCI) in Sprague-Dawley rats. Cells were administered 48 h after the original injury. Additional animals received allogeneic MSCs that were genetically modified to secrete brain-derived neurotrophic factor (BDNF) to further determine whether a locally administered neurotrophic factor provides or extends neuroprotection. When assessed 2 months post-injury in a clinically relevant model of severe SCI, BMSC grafts with or without BDNF secretion failed to improve motor outcomes. Thus, allogeneic grafts of BMSCs do not appear to act through local mechanisms, and future clinical trials that acutely deliver BMSCs to actual sites of injury within days are unlikely to be beneficial. Additional studies should address whether systemic administration of BMSCs alter outcomes from neurotrauma.	[Brock, John H.; Graham, Lori; Staufenberg, Eileen; Collyer, Eileen; Koffler, Jacob; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, 0626 Univ Calif, La Jolla, CA 92093 USA; [Brock, John H.; Tuszynski, Mark H.] Vet Adm San Diego Healthcare Syst, La Jolla, CA USA	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, 0626 Univ Calif, La Jolla, CA 92093 USA.	mtuszynski@ucsd.edu		koffler, jacob/0000-0002-8415-2938	Department of Defense Congressionally Directed Medical Research Program: Spinal Cord Injury Research Program (CDMRP-SCIRP); Veterans AdministrationUS Department of Veterans Affairs; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS42291]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Bernard and Anne Spitzer Charitable Trust	We thank Nicole Armstrong for technical assistance. This study was supported by the Department of Defense Congressionally Directed Medical Research Program: Spinal Cord Injury Research Program (CDMRP-SCIRP), the Veterans Administration, the NIH (NS42291), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and the Bernard and Anne Spitzer Charitable Trust.	Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Conner JM, 1996, J NEUROSCI METH, V65, P93, DOI 10.1016/0165-0270(95)00151-4; Cui XY, 2013, BIOSCI TRENDS, V7, P202, DOI 10.5582/bst.2013.v7.5.202; Dasari Venkata Ramesh, 2014, World J Stem Cells, V6, P120, DOI 10.4252/wjsc.v6.i2.120; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Fouad K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00187; Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Gransee HM, 2015, J NEUROTRAUM, V32, P185, DOI 10.1089/neu.2014.3464; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Jin W, 2014, J TRAUMA ACUTE CARE, V76, P1228, DOI 10.1097/TA.0000000000000211; Kalwak K, 2002, BRIT J HAEMATOL, V118, P74, DOI 10.1046/j.1365-2141.2002.03560.x; Karamouzian S, 2012, CLIN NEUROL NEUROSUR, V114, P935, DOI 10.1016/j.clineuro.2012.02.003; Kim DH, 1996, NEUROREPORT, V7, P2221, DOI 10.1097/00001756-199609020-00033; Koskinen E, 2013, J NEUROTRAUM, V30, P1587, DOI 10.1089/neu.2013.2943; Kwon BK, 2013, EXP NEUROL, V248, P30, DOI 10.1016/j.expneurol.2013.05.012; Lee B.A., 2014, J SPINAL CORD MED; Li JM, 2004, BIOL BLOOD MARROW TR, V10, P540, DOI 10.1016/j.bbmt.2004.05.007; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; McTigue DM, 1998, J NEUROSCI, V18, P5354; Mitsui T, 2005, EXP NEUROL, V194, P410, DOI 10.1016/j.expneurol.2005.02.022; Mofidi A, 2011, MINI-REV MED CHEM, V11, P763, DOI 10.2174/138955711796355267; Nandoe RDS, 2006, CELL TRANSPLANT, V15, P563, DOI 10.3727/000000006783981602; Novitzky N, 2001, CYTOTHERAPY, V3, P211, DOI 10.1080/146532401753174043; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Ritfeld G.J., 2015, CELL TRANSPLANT; Saito F, 2012, RESTOR NEUROL NEUROS, V30, P127, DOI 10.3233/RNN-2011-0629; Sandner B., 2015, CELL TRANSPLANT; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Steffenhagen C, 2012, STEM CELLS DEV, V21, P1838, DOI 10.1089/scd.2011.0137; Stroncek DF, 2014, TISSUE ENG PART B-RE, V20, P200, DOI [10.1089/ten.teb.2013.0529, 10.1089/ten.TEB.2013.0529]; Swanger SA, 2005, CELL TRANSPLANT, V14, P775, DOI 10.3727/000000005783982594; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Vanelderen P, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.09.006; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Vawda R, 2013, CURR STEM CELL RES T, V8, P25, DOI 10.2174/1574888X11308010005; Williams KM, 2008, BEST PRACT RES CL HA, V21, P579, DOI 10.1016/j.beha.2008.06.003; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Zariffa J, 2011, SPINAL CORD, V49, P463, DOI 10.1038/sc.2010.140	61	14	14	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2016	33	12					1103	1114		10.1089/neu.2015.4009			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN9WT	WOS:000377432100001	26414795	Green Published			2021-06-18	
J	Adjorlolo, S; Egbenya, DL				Adjorlolo, Samuel; Egbenya, Daniel Lawer			Executive functioning profiles of adult and juvenile male sexual offenders: A systematic review	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						Executive functioning; neurocognitive functioning; sexual offenders; juvenile sexual offenders; adult sexual offenders	TRAUMATIC BRAIN-INJURY; NONPEDOPHILIC CHILD MOLESTERS; PRISON PSYCHIATRIC-TREATMENT; OF-THE-LITERATURE; FRONTAL LOBES; NEUROPSYCHOLOGICAL MEASURES; COGNITIVE REHABILITATION; INDIVIDUAL-DIFFERENCES; ANTISOCIAL-BEHAVIOR; INTEGRATED THEORY	Evidence regarding biological correlates of sexual offending, which might enhance the understanding, research, and treatment of these offenders, is rather emerging or in the embryonic stage. In this study, our main objective is to identify specific executive functioning (EF) processes that are commonly impaired in sexual offenders, and to further determine whether these differ as a function of offender subtypes. A search is conducted in ProQuest, Criminal Justice Abstract, EBSCOhost, and Social Science Citation Index electronic journal databases for studies published spanning the period 1990-2015. Google Scholar and Google search engines were also searched and the reference lists of the retrieved papers were searched for additional papers. A total of 1303 papers were retained for consideration. After removing duplicates, and subjecting the retrieved papers to inclusion and exclusion criteria, 24 papers (19 published and 5 unpublished) were deemed appropriate for the review. While several EF processes have been investigated, the available evidence implicates deficits in cognitive flexibility and inhibition of interference as commonly reported among adult male sexual offenders. This finding may be due to the sensitivity of tests of cognitive flexibility (e.g. the Wisconsin Card Sorting Test) and inhibition of interference (e.g. the Stroop Test) to frontal lobe lesions, and also because these tests are among the most frequently administered EF tests as revealed by this study. Juvenile sexual offenders, however, exhibit no distinct EF profiles. The findings of the study, implications for treatment, and recommendations for future studies are succinctly discussed.	[Adjorlolo, Samuel] City Univ Hong Kong, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China; [Egbenya, Daniel Lawer] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Mol Med,Div Anat, Oslo, Norway	Adjorlolo, S (corresponding author), City Univ Hong Kong, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China.	sadjorlol2-c@my.cityu.edu.hk	Adjorlolo, Samuel/AAL-1009-2020; Egbenya, Daniel Lawer/AAV-2279-2020	Egbenya, Daniel Lawer/0000-0002-3223-8510			Abracen J., 1991, J FORENSIC PSYCHIATR, V2, P167, DOI [10.1080/09585189108407646, DOI 10.1080/09585189108407646]; Adjorlolo S, 2015, APPL NEUROPSYCH-ADUL, V22, P388, DOI 10.1080/23279095.2014.949718; Adjorlolo S, 2015, J FORENSIC PSYCHOL P, V15, P185, DOI 10.1080/15228932.2015.1015363; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; ANDREWS DA, 1990, CRIM JUSTICE BEHAV, V17, P19, DOI 10.1177/0093854890017001004; Becerra-Garcia JA, 2014, PSYCHIAT PSYCHOL LAW, V21, P585, DOI 10.1080/13218719.2013.873974; Bauman Johnson WL, 2010, ARCH CLIN NEUROPSYCH, V25, P601, DOI 10.1093/arclin/acq049; Blanchard R, 2003, ARCH SEX BEHAV, V32, P573, DOI 10.1023/A:1026093612434; Blanchard R, 2002, ARCH SEX BEHAV, V31, P511, DOI 10.1023/A:1020659331965; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chan HC, 2016, J INTERPERS VIOLENCE, V31, P2259, DOI 10.1177/0886260515575606; Chan HC, 2011, INT J OFFENDER THER, V55, P228, DOI 10.1177/0306624X10361317; Chan HC, 2009, TRAUMA VIOLENCE ABUS, V10, P31, DOI 10.1177/1524838008326478; Chen CY, 2008, BEHAV BRAIN RES, V187, P483, DOI 10.1016/j.bbr.2007.10.011; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen LJ, 2010, J PSYCHIATR PRACT, V16, P405, DOI 10.1097/01.pra.0000390759.04581.7c; Cohen LJ, 2002, PSYCHIAT QUART, V73, P313, DOI 10.1023/A:1020416101092; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deuthser M., 2004, THESIS SWINBURNE U T; Eastvold A, 2011, J INT NEUROPSYCH SOC, V17, P295, DOI 10.1017/S1355617710001669; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2007, J CLIN PSYCHIAT, V68, P588, DOI 10.4088/JCP.v68n0415; Fazel S, 2007, INT J GERIATR PSYCH, V22, P87, DOI 10.1002/gps.1648; Fishbein D, 2009, LAW HUMAN BEHAV, V33, P419, DOI 10.1007/s10979-008-9163-7; Flor-Henry P., 1987, VARIANT SEXUALITY RE, P49; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gillespie N. K., 2000, J SEX AGGRESS, V5, P21, DOI [10.1080/13552600008413293, DOI 10.1080/13552600008413293]; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Joyal CC, 2007, SEX ABUSE-J RES TR, V19, P155, DOI 10.1177/107906320701900206; Joyal CC, 2014, SEX ABUSE-J RES TR, V26, P149, DOI 10.1177/1079063213482842; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kelly T, 2002, CHILD NEUROPSYCHOL, V8, P138, DOI 10.1076/chin.8.2.138.8722; Kruger THC, 2011, J SEX MED, V8, P1650, DOI 10.1111/j.1743-6109.2009.01564.x; Levenson JS, 2015, SEX ABUSE-J RES TR, V27, P258, DOI 10.1177/1079063214544332; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lord A, 2014, J FORENSIC PRACT, V16, P94, DOI 10.1108/JFP-02-2013-0012; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maes JHR, 2011, J CLIN EXP NEUROPSYC, V33, P366, DOI 10.1080/13803395.2010.524149; Martin J E., 1998, THESIS ADLER SCH PRO; McLeod DA, 2015, J CHILD SEX ABUS, V24, P97, DOI 10.1080/10538712.2015.978925; MILLER AD, 1997, THESIS ADLER SCH PRO; Miyaguchi K, 2014, J INTELLECT DEV DIS, V39, P253, DOI 10.3109/13668250.2014.925103; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Morais HB, 2016, SEX ABUSE-J RES TR, V28, P741, DOI 10.1177/1079063215569545; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Patrick CJ, 2009, DEV PSYCHOPATHOL, V21, P913, DOI 10.1017/S0954579409000492; Pflugradt DM, 2010, J CHILD SEX ABUS, V19, P434, DOI 10.1080/10538712.2010.495701; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rimmer L. M., 1998, THESIS CALIFORNIA SC; Rocha NBF, 2014, J FORENSIC PSYCHI PS, V25, P224, DOI 10.1080/14789949.2014.884617; Rodriguez M., 2014, THESIS U SYDNEY AUST; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross E., 2012, THESIS U W ONTARIO O; Ross EH, 2010, CRIM JUSTICE BEHAV, V37, P656, DOI 10.1177/0093854810363104; Schiffer B, 2007, J PSYCHIATR RES, V41, P753, DOI 10.1016/j.jpsychires.2006.06.003; Schiffer B, 2011, J SEX MED, V8, P1975, DOI 10.1111/j.1743-6109.2010.02140.x; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sigre-Leiros V, 2015, CHILD ABUSE NEGLECT, V40, P81, DOI 10.1016/j.chiabu.2014.10.003; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Spinella M., 2006, INT J FORENSIC PSYCH, V1, P62; Stone M. H., 2001, J INDIV PSYCHOL, V57, P51; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Suchy Y, 2009, J INT NEUROPSYCH SOC, V15, P248, DOI 10.1017/S1355617709090353; Veneziano C, 2004, PERCEPT MOTOR SKILL, V98, P661; Ward T, 2006, AGGRESS VIOLENT BEH, V11, P44, DOI 10.1016/j.avb.2005.05.002; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Young MH, 2012, INT J OFFENDER THER, V56, P1103, DOI 10.1177/0306624X11417361; Young MH, 2010, INT J OFFENDER THER, V54, P92, DOI 10.1177/0306624X08322373	79	14	14	0	28	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.	JUN	2016	27	3					349	375		10.1080/14789949.2016.1141431			27	Criminology & Penology; Psychiatry	Criminology & Penology; Psychiatry	DL8GH	WOS:000375878700003					2021-06-18	
J	Bahado-Singh, RO; Graham, SF; Han, B; Turkoglu, O; Ziadeh, J; Mandal, R; Er, A; Wishart, DS; Stahel, PL				Bahado-Singh, Ray O.; Graham, Stewart F.; Han, BeomSoo; Turkoglu, Onur; Ziadeh, James; Mandal, Rupasri; Er, Anil; Wishart, David S.; Stahel, Philip L.			Serum metabolomic markers for traumatic brain injury: a mouse model	METABOLOMICS			English	Article						Traumatic brain injury; Metabolomics; Serum; Biomarkers; Mouse model	METABOANALYST; GLUTATHIONE; PREVALENCE; SERVER	Introduction Traumatic brain injury (TBI) is physical injury to brain tissue that temporarily or permanently impairs brain function. Objectives Evaluate the use of metabolomics for the development of biomarkers of TBI for the diagnosis and timing of injury onset. Methods A validated model of closed injury TBI was employed using 10 TBI mice and 8 sham operated controls. Quantitative LC-MS/MS metabolomic analysis was performed on the serum. Results Thirty-six (24.0 %) of 150 metabolites were altered with TBI. Principal component analysis (PCA) and Partial least squares discriminant analysis (PLS-DA) analyses revealed clear segregation between TBI versus control sera. The combination of methionine sulfoxide and the lipid PC aa C34:4 accurately diagnosed TBI, AUC (95 % CI) 0.85 (0.644-1.0). A combination of metabolite markers were highly accurate in distinguishing early (4 h post TBI) from late (24 h) TBI: AUC (95 % CI) 1.0 (1.0-1.0). Spermidine, which is known to have an antioxidant effect and which is known to be metabolically disrupted in TBI, was the most discriminating biomarker based on the variable importance ranking in projection (VIP) plot. Several important metabolic pathways were found to be disrupted including: pathways for arginine, proline, glutathione, cysteine, and sphingolipid metabolism. Conclusion Using serum metabolomic analysis we were able to identify novel putative serum biomarkers of TBI. They were accurate for detecting and determining the timing of TBI. In addition, pathway analysis provided important insights into the biochemical mechanisms of brain injury. Potential clinical implications for diagnosis, timing, and monitoring brain injury are discussed.	[Bahado-Singh, Ray O.] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Graham, Stewart F.; Turkoglu, Onur] Beaumont Hlth, Dept Obstet & Gynecol, 3811 West 13 Mile Rd, Royal Oak, MI 48073 USA; [Han, BeomSoo; Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Biol & Comp Sci, Edmonton, AB, Canada; [Ziadeh, James] Oakland Univ, William Beaumont Sch Med, Dept Emergency Med, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Er, Anil] Dokuz Eylul Univ, Dept Pediat Emergency Med, Sch Med, TR-35340 Izmir, Turkey; [Stahel, Philip L.] Univ Colorado, Sch Med, Dept Neurosurg, Denver Hlth Med Ctr, Denver, CO USA; [Stahel, Philip L.] Univ Colorado, Sch Med, Dept Orthoped, Denver Hlth Med Ctr, Denver, CO USA	Graham, SF (corresponding author), Beaumont Hlth, Dept Obstet & Gynecol, 3811 West 13 Mile Rd, Royal Oak, MI 48073 USA.	stewart.graham@beaumont.edu	Graham, Stewart/AAE-9772-2020; Wishart, David Scott/ABI-3181-2020	Graham, Stewart/0000-0003-1001-0002			Altura BM, 2002, BRAIN RES BULL, V58, P271, DOI 10.1016/S0361-9230(02)00772-4; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0957-1; Bahado-Singh RO, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.056; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Faul M, 2006, TRAUMATIC BRAIN INJU; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Graham SF, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0986-9; Graham SF, 2014, METABOLOMICS, V10, P744, DOI 10.1007/s11306-013-0610-1; Graham SF, 2013, METABOLOMICS, V9, P974, DOI 10.1007/s11306-013-0516-y; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hastie T., 2001, ELEMENTS STAT LEARNI, DOI [DOI 10.1007/B94608, 10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mondello Stefania, 2015, Handb Clin Neurol, V127, P245, DOI 10.1016/B978-0-444-52892-6.00016-7; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pan XB, 2016, NEUROBIOL AGING, V38, P151, DOI 10.1016/j.neurobiolaging.2015.11.014; Park YM, 2015, CYTOTHERAPY, V17, P25, DOI 10.1016/j.jcyt.2014.08.006; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Wishart DS, 2010, METHODS MOL BIOL, V593, P283, DOI 10.1007/978-1-60327-194-3_14; Wu GY, 2004, J NUTR, V134, P489; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	36	14	14	1	26	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	JUN	2016	12	6							100	10.1007/s11306-016-1044-3			12	Endocrinology & Metabolism	Endocrinology & Metabolism	DP8MS	WOS:000378752900005					2021-06-18	
J	de Holanda, LF; Pereira, BJA; Holanda, RR; Neto, JT; de Holanda, CVM; Giudicissi, M; de Oliveira, NRC; de Oliveira, JG				de Holanda, Luciano Ferreira; Pereira, Benedito Jamilson A.; Holanda, Rafael Rodrigues; Neto, Jose Targino; de Holanda, Carlos Vanderlei M.; Giudicissi Filho, Miguel; Cunha de Oliveira, Nathalia Ribeiro; de Oliveira, Jean G.			Neurosurgical Management of Nonmissile Penetrating Cranial Lesions	WORLD NEUROSURGERY			English	Article						Neurosurgical management; Nonmissile penetrating injury; Penetrating lesion; Trauma; Traumatic brain injury	OF-THE-LITERATURE; INTRACRANIAL WOOD; FOREIGN-BODIES; STAB WOUNDS; HEAD-INJURY; BRAIN; TOMOGRAPHY	OBJECTIVE: The objective of this study is to present a case series of nonmissile penetrating (NMP) injuries and to establish a workflow for an uncommon mechanism of traumatic head injury through the analysis of each case, classification of the type of lesion, management, and outcome score at follow-up. METHODS: From January 1991 to December 2008, 36,000 patients presenting with traumatic brain injury (TBI) were admitted in the Department of Neurosurgery, Hospital Antonio Targino, Campina Grande-PB, Brazil. From these patients, 11 presenting with lesions caused by NMP objects were selected. RESULTS: Among the 11 patients, 9 were men and 2 were women. Their ages ranged from 7 to 74 years old (mean age +/- SD, 29.1 +/- 22.99 years). All patients underwent neuro-radiologic evaluation. The entry point was classified as natural (orbit) or artificial (skull transfixation), and we also divided the patients presenting with secondary parenchymal or vascular damage from those presenting with only lesions caused by the primary penetration into the cranium and meninges. All patients were neurosurgically treated with removal of the foreign body through craniotomy, except the patient whose object (pen) was removed without craniotomy with local anesthesia. Glasgow Coma Scale (GCS) score on admission was a statistically significant factor on prognosis, and any patient who presented with a GCS score of 15 evolved satisfactorily, and there were no deaths in this group of patients (P = 0.04). CONCLUSIONS: TBIs caused by NMP objects are unusual and caused by aggression, self-inflicted harm (in the case of psychiatric patients), and accident. The foreign body may enter into the skull through a natural hole (orbit, nose, mouth, or ear) or crosses the skull, causing a fracture and creating an artificial hole. Preoperative neuro-radiologic assessment is paramount for the correct neurosurgical approach. The main prognostic factor for these patients is the GCS score at admission.	[de Holanda, Luciano Ferreira; Pereira, Benedito Jamilson A.; Holanda, Rafael Rodrigues; Neto, Jose Targino] Hosp Antonio Targino, Dept Neurosurg, Campina Grande, PB, Brazil; [de Holanda, Luciano Ferreira] Univ Fed Campina Grande, Dept Neurol & Neurosurg, Campina Grande, PB, Brazil; [Pereira, Benedito Jamilson A.; de Holanda, Carlos Vanderlei M.; Giudicissi Filho, Miguel; de Oliveira, Jean G.] Hosp Beneficencia Portuguesa, Ctr Neurol & Neurosurg Associates, Dept Neurosurg, Sao Paulo, SP, Brazil; [Cunha de Oliveira, Nathalia Ribeiro] Hosp Beneficencia Portuguesa, Ctr Neurol & Neurosurg Associates, Dept Dent, Sao Paulo, SP, Brazil	Pereira, BJA (corresponding author), Hosp Antonio Targino, Dept Neurosurg, Campina Grande, PB, Brazil.	benedito.jamilson@hotmail.com	de Oliveira, Nathalia R. C./R-7239-2016; de Oliveira, Jean G./H-2896-2012	de Oliveira, Jean G./0000-0002-7274-7715			Alafaci C, 2010, CLIN NEUROL NEUROSUR, V112, P813, DOI 10.1016/j.clineuro.2010.06.008; Cemil B, 2009, ULUS TRAVMA ACIL CER, V15, P624; Chibbaro S, 2006, ACTA NEUROCHIR, V148, P937, DOI 10.1007/s00701-006-0794-5; Davis GA, 2000, J CLIN NEUROSCI, V7, P545, DOI 10.1054/jocn.2000.0692; Deb S, 2000, J TRAUMA, V48, P1159, DOI 10.1097/00005373-200006000-00026; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; GLATT HJ, 1990, OPHTHALMIC PLAST REC, V6, P108, DOI 10.1097/00002341-199006000-00005; GREEN BF, 1990, OPHTHALMOLOGY, V97, P608; Gutierrez-Gonzalez R, 2008, CLIN NEUROL NEUROSUR, V110, P207, DOI 10.1016/j.clineuro.2007.09.014; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; Khoshyomn S, 2004, J TRAUMA, V56, P1131, DOI 10.1097/01.TA.0000071299.31349.D6; Large M, 2012, AM J FOREN MED PATH, V33, P13, DOI 10.1097/PAF.0b013e3181dd5b47; Lopez F, 2000, CHILD NERV SYST, V16, P117, DOI 10.1007/s003810050025; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; MILLER CF, 1977, SURG NEUROL, V7, P95; Ratiu P, 2004, J NEUROTRAUM, V21, P637, DOI 10.1089/089771504774129964; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; TEASDALE G, 1974, LANCET, V2, P81; Yamashita M, 1998, Arq Neuropsiquiatr, V56, P317, DOI 10.1590/S0004-282X1998000200026	21	14	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2016	90						420	429		10.1016/j.wneu.2016.03.015			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DS1MS	WOS:000380360500053	26987636				2021-06-18	
J	Ellis, MU; Marion, SD; McArthur, DL; Babikian, T; Giza, C; Kernan, CL; Newman, N; Moran, L; Akarakian, R; Houshiarnejad, A; Mink, R; Johnson, J; Babbitt, CJ; Olsen, A; Asarnow, RF				Ellis, Monica U.; Marion, Sarah DeBoard; McArthur, David L.; Babikian, Talin; Giza, Christopher; Kernan, Claudia L.; Newman, Nina; Moran, Lisa; Akarakian, Roy; Houshiarnejad, Asal; Mink, Richard; Johnson, Jeffrey; Babbitt, Christopher J.; Olsen, Alexander; Asarnow, Robert F.			The UCLA Study of Children with Moderate-to-Severe Traumatic Brain Injury: Event-Related Potential Measure of Interhemispheric Transfer Time	JOURNAL OF NEUROTRAUMA			English	Article						corpus callosum; event-related potential; interhemispheric transfer time; neurocognitive functioning; pediatric traumatic brain injury	POSTERIOR CALLOSAL SECTION; CLOSED-HEAD-INJURY; CORPUS-CALLOSUM; EVOKED-POTENTIALS; TRANSMISSION TIME; PARENT EDUCATION; VISUAL PROCESSES; PEDIATRIC TBI; INFORMATION; AGENESIS	Traumatic brain injury (TBI) frequently results in diffuse axonal injury and other white matter damage. The corpus callosum (CC) is particularly vulnerable to injury following TBI. Damage to this white matter tract has been associated with impaired neurocognitive functioning in children with TBI. Event-related potentials can identify stimulus-locked neural activity with high temporal resolution. They were used in this study to measure interhemispheric transfer time (IHTT) as an indicator of CC integrity in 44 children with moderate/severe TBI at 3-5 months post-injury, compared with 39 healthy control children. Neurocognitive performance also was examined in these groups. Nearly half of the children with TBI had IHTTs that were outside the range of the healthy control group children. This subgroup of TBI children with slow IHTT also had significantly poorer neurocognitive functioning than healthy controlseven after correction for premorbid intellectual functioning. We discuss alternative models for the relationship between IHTT and neurocognitive functioning following TBI. Slow IHTT may be a biomarker that identifies children at risk for poor cognitive functioning following moderate/severe TBI.	[Ellis, Monica U.; Babikian, Talin; Kernan, Claudia L.; Newman, Nina; Moran, Lisa; Houshiarnejad, Asal; Olsen, Alexander; Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 48-240 Semel Inst,760 Westwood Plaza, Los Angeles, CA 90024 USA; [McArthur, David L.; Giza, Christopher] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA; [Babikian, Talin; Kernan, Claudia L.; Moran, Lisa] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA 90024 USA; [Giza, Christopher; Mink, Richard] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Ellis, Monica U.; Marion, Sarah DeBoard] Fuller Grad Sch Psychol, Pasadena, CA USA; [Akarakian, Roy] Wayne State Univ, Sch Med, Detroit, MI USA; [Mink, Richard] Harbor Univ Calif, Los Angeles Med Ctr, Torrance, CA USA; [Johnson, Jeffrey] Univ So Calif, Dept Clin Pediat, Los Angeles, CA USA; [Johnson, Jeffrey] Los Angeles Cty USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Babbitt, Christopher J.] Miller Childrens Hosp, Dept Pediat, Long Beach, CA USA; [Olsen, Alexander] Norwegian Univ Sci & Technol, Alexander Olsen Dept Psychol, N-7034 Trondheim, Norway; [Olsen, Alexander] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway	Asarnow, RF (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 48-240 Semel Inst,760 Westwood Plaza, Los Angeles, CA 90024 USA.	rasarnow@mednet.ucla.edu	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD061504]	This research was supported by National Institute of Child Health and Human Development Grant #HD061504. We thank Alma Martinez and Alma Ramirez for their assistance in data collection and the children and their parents who participated in this research.	ANDREASSI JL, 1975, PSYCHOPHYSIOLOGY, V12, P541, DOI 10.1111/j.1469-8986.1975.tb00043.x; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BANICH MT, 1990, CORTEX, V26, P77, DOI 10.1016/S0010-9452(13)80076-7; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Brown WS, 1999, NEUROPSYCHOLOGIA, V37, P1165, DOI 10.1016/S0028-3932(99)00011-1; BROWN WS, 1993, NEUROPSYCHOLOGIA, V31, P1267, DOI 10.1016/0028-3932(93)90097-J; Buckhalt JA, 2009, CHILD DEV, V80, P875, DOI 10.1111/j.1467-8624.2009.01303.x; DAMASIO AR, 1980, J NEUROL NEUROSUR PS, V43, P351, DOI 10.1136/jnnp.43.4.351; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; Delis D, 1994, CALIFORNIA VERBAL LE; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; GAZZANIGA MS, 1973, NEUROLOGY, V23, P1126, DOI 10.1212/WNL.23.10.1126; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Larson EB, 1997, NEUROPSYCHOLOGIA, V35, P573; LASSONDE M, 1988, BEHAV BRAIN RES, V30, P165, DOI 10.1016/0166-4328(88)90146-5; LEDLOW A, 1978, ANN NEUROL, V3, P525, DOI 10.1002/ana.410030613; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; RUGG MD, 1985, J NEUROL NEUROSUR PS, V48, P367, DOI 10.1136/jnnp.48.4.367; SARON CD, 1989, BEHAV NEUROSCI, V103, P1115, DOI 10.1037/0735-7044.103.5.1115; SAUERWEIN H, 1983, NEUROPSYCHOLOGIA, V21, P167, DOI 10.1016/0028-3932(83)90084-2; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; SUGISHITA M, 1987, NEUROPSYCHOLOGIA, V25, P329, DOI 10.1016/0028-3932(87)90022-4; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Verger K, 2001, BRAIN INJURY, V15, P211; VUILLEUMIER P, 1995, CLIN NEUROL NEUROSUR, V97, P39, DOI 10.1016/0303-8467(94)00056-C; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	43	14	14	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					990	996		10.1089/neu.2015.4023			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600002	26153851	Green Published			2021-06-18	
J	Hifumi, T; Kuroda, Y; Kawakita, K; Yamashita, S; Oda, Y; Dohi, K; Maekawa, T				Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya; Yamashita, Susumu; Oda, Yasutaka; Dohi, Kenji; Maekawa, Tsuyoshi		Brain Hypothermia B-HYPO Study Grp	Fever Control Management Is Preferable to Mild Therapeutic Hypothermia in Traumatic Brain Injury Patients with Abbreviated Injury Scale 3-4: A Multi-Center, Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						Abbreviated Injury Scale; heterogeneous pathophysiology; multi-center randomized controlled trial; therapeutic hypothermia; traumatic brain injury	GLASGOW COMA SCALE; INTRACRANIAL-PRESSURE; TEMPERATURE; MORTALITY; SEVERITY; BLOOD	In our prospective, multi-center, randomized controlled trial (RCT)the Brain Hypothermia (B-HYPO) studywe could not show any difference on neurological outcomes in patients probably because of the heterogeneity in the severity of their traumatic condition. We therefore aimed to clarify and compare the effectiveness of the two therapeutic temperature management regimens in severe (Abbreviated Injury Scale [AIS] 3-4) or critical trauma patients (AIS 5). In the present post hoc B-HYPO study, we re-evaluated data based on the severity of trauma as AIS 3-4 or AIS 5 and compared Glasgow Outcome Scale score and mortality at 6 months by per-protocol analyses. Consequently, 135 patients were enrolled. Finally, 129 patients, that is, 47 and 31 patients with AIS 3-4 and 36 and 15 patients with AIS 5 were allocated to the mild therapeutic hypothermia (MTH) and fever control groups, respectively. No significant intergroup differences were observed with regard to age, gender, scores on head computed tomography (CT) scans, and surgical operation for traumatic brain injury (TBI), except for Injury Severity Score (ISS) in AIS 5. The fever control group demonstrated a significant reduction of TBI-related mortality compared with the MTH group (9.7% vs. 34.0%, p=0.02) and an increase of favorable neurological outcomes (64.5% vs. 51.1%, p=0.26) in patients with AIS 3-4, although the latter was not statistically significant. There was no difference in mortality or favorable outcome in patients with AIS 5. Fever control may be considered instead of MTH in patients with TBI (AIS 3-4).	[Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya] Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Miki, Kagawa, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Dept Emergency Med, Yamaguchi, Japan; [Oda, Yasutaka] Yamaguchi Univ, Sch Med, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan; [Dohi, Kenji] Jikei Univ, Sch Med, Dept Emergency Med, Tokyo, Japan; [Maekawa, Tsuyoshi] Yamaguchi Prefectural Grand Med Ctr, Yamaguchi, Japan	Hifumi, T (corresponding author), Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hifumitoru@gmail.com		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462821] Funding Source: KAKEN	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001) and by the Japanese Human Science Association, 2002-2004.	CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fox JL, 2010, CAN J EMERG MED, V12, P355; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Medicine T. A. f. t. A. o. A., 2015, ABBR INJ SCAL PHIL; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Oda Y, 2009, RESUSCITATION, V80, P189, DOI 10.1016/j.resuscitation.2008.10.001; Saxena M, 2014, COCHRANE DB SYST REV, V8; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; The Japan Society of Neurotraumatology, 2001, GUID MAN SEV HEAD IN; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80	26	14	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1047	1053		10.1089/neu.2015.4033			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600008	26413933	Green Published			2021-06-18	
J	Hirst, JJ; Cumberland, AL; Shaw, JC; Bennett, GA; Kelleher, MA; Walker, DW; Palliser, HK				Hirst, Jonathan J.; Cumberland, Angela L.; Shaw, Julia C.; Bennett, Greer A.; Kelleher, Meredith A.; Walker, David W.; Palliser, Hannah K.			Loss of neurosteroid-mediated protection following stress during fetal life	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article; Proceedings Paper	8th International Meeting on Steroids and Nervous System	2015	Torino, ITALY			Preterm birth; Pregnancy compromise; Perinatal brain injury; Allopregnanolone; Fetus; Neonate; Placenta	PITUITARY-ADRENAL AXIS; TRAUMATIC BRAIN-INJURY; GABA(A) RECEPTORS; PRENATAL STRESS; PRETERM BIRTH; GUINEA-PIG; RAT-BRAIN; 5-ALPHA-PREGNANE STEROIDS; NEUROACTIVE STEROIDS; GROWTH RESTRICTION	Elevated levels of neurosteroids during late gestation protect the fetal brain from hypoxia/ischaemia and promote neurodevelopment. Suppression of allopregnanolone production during pregnancy leads to the onset of seizure-like activity and potentiates hypoxia-induced brain injury. Markers of myelination are reduced and astrocyte activation is increased. The placenta has a key role in maintaining allopregnanolone concentrations in the fetal circulation and brain during gestation and levels decline markedly after both normal and preterm birth. This leads to the preterm neonate developing in a neurosteroid deficient environment between delivery and term equivalence. The expression of 5 alpha-reductases is also lower in the fetus prior to term. These deficiencies in neurosteroid exposure may contribute to the increase in incidence of the adverse patterns of behaviour seen in children that are born preterm. Repeated exposure to glucocorticoid stimulation suppresses 5 alpha-reductase expression and allopregnanolone levels in the fetus and results in reduced myelination. Both fetal growth restriction and prenatal maternal stress lead to increased cortisol concentrations in the maternal and fetal circulation. Prenatal stress results in reduced expression of key GABA(A) receptor subunits that normally heighten neurosteroid sensitivity. These stressors also result in altered placental allopregnanolone metabolism pathways. These findings suggest that reduced neurosteroid production and action in the perinatal period may contribute to some of the adverse neurodevelopmental and behavioural outcomes that result from these pregnancy compromises. Studies examining perinatal steroid supplementation therapy with non-metabolisable neurosteroid analogues to improve these outcomes are warranted. (C) 2015 Elsevier Ltd. All rights reserved.	[Hirst, Jonathan J.; Cumberland, Angela L.; Shaw, Julia C.; Bennett, Greer A.; Palliser, Hannah K.] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia; [Kelleher, Meredith A.] Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Walker, David W.] Monash Univ, Dept Obstet & Gynaecol, Ritchie Ctr Baby Hlth Res, Clayton, Vic 3800, Australia	Hirst, JJ (corresponding author), Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia.	Jon.Hirst@newcastle.edu.au	Cumberland, Angela/AAM-3052-2020; Kelleher, Meredith Anne/L-2317-2019; Hirst, Jonathan/G-7822-2013	Kelleher, Meredith Anne/0000-0002-5313-004X; Cumberland, Angela/0000-0003-4463-9378; Hirst, Jonathan/0000-0002-9362-5303			Aneja S, 2013, INDIAN PEDIATR, V50, P1033, DOI 10.1007/s13312-013-0284-9; Austin MP, 2005, EARLY HUM DEV, V81, P917, DOI 10.1016/j.earlhumdev.2005.07.005; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Baram TZ, 2003, ANN NEUROL, V54, P701, DOI 10.1002/ana.10833; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Ben-Ari Y, 2011, EPILEPSIA, V52, P1544, DOI 10.1111/j.1528-1167.2011.03132.x; Bennett GA, 2013, DEV NEUROSCI-BASEL, V35, P416, DOI 10.1159/000354176; Bennett P.H., 2014, J PAEDIATR CHILD H, V50, pA339; Billiards S.S., 2002, FETAL NEONATAL PHYSL, V29, pA32; Coleman H., 2013, FETAL NEONATAL PHYSL, P40; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Crossley KJ, 2000, NEUROPHARMACOLOGY, V39, P1514, DOI 10.1016/S0028-3908(99)00222-1; Cumberland A.L., 2015, 8 INT C STER NERV SY, V8, pA24; Dalziel SR, 2005, BMJ-BRIT MED J, V331, P665, DOI 10.1136/bmj.38576.494363.E0; Dean JM, 2006, NEUROPHARMACOLOGY, V50, P491, DOI 10.1016/j.neuropharm.2005.10.017; DOLLING M, 1979, Journal of Developmental Physiology (Eynsham), V1, P399; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Elgen S.K., 2014, EUR CHILD ADOLES PSY, V24, P263; Grassi S, 2007, EUR J NEUROSCI, V26, P23, DOI 10.1111/j.1460-9568.2007.05645.x; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Hill M, 2007, J STEROID BIOCHEM, V105, P166, DOI 10.1016/j.jsbmb.2006.10.010; Hill M, 2010, J STEROID BIOCHEM, V122, P114, DOI 10.1016/j.jsbmb.2010.05.007; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Keirse MJNC, 2004, BIRTH-ISS PERINAT C, V31, P230, DOI 10.1111/j.0730-7659.2004.00315.x; Kelleher MA, 2013, REPROD SCI, V20, P1365, DOI 10.1177/1933719113485295; Kelleher MA, 2011, J ENDOCRINOL, V208, P301, DOI 10.1677/JOE-10-0248; King S, 2005, STRESS, V8, P35, DOI 10.1080/10253890500108391; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Matthews SG, 2007, J NEUROENDOCRINOL, V19, P73, DOI 10.1111/j.1365-2826.2006.01504.x; McKendry AA, 2010, J NEUROENDOCRINOL, V22, P166, DOI 10.1111/j.1365-2826.2009.01949.x; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Nappi RE, 2001, OBSTET GYNECOL, V97, P77, DOI 10.1016/S0029-7844(00)01112-1; Newnham JP, 2008, LANCET, V372, P2094, DOI 10.1016/S0140-6736(08)61903-0; Newnham JP, 2009, SEMIN FETAL NEONAT M, V14, P157, DOI 10.1016/j.siny.2008.11.005; Nguyen PN, 2004, J PHYSIOL-LONDON, V560, P593, DOI 10.1113/jphysiol.2004.069336; Nguyen PN, 2003, PEDIATR RES, V54, P840, DOI 10.1203/01.PDR.0000088066.47755.36; Nguyen PN, 2003, PEDIATR RES, V53, P956, DOI 10.1203/01.PDR.0000064905.64688.10; Nicol MB, 2001, NEUROSCI LETT, V306, P13, DOI 10.1016/S0304-3940(01)01861-4; Nicol MB, 1999, NEUROPHARMACOLOGY, V38, P49, DOI 10.1016/S0028-3908(98)00166-X; NORMAN TR, 1991, FERTIL STERIL, V56, P1034; Norwitz Errol R, 2011, Rev Obstet Gynecol, V4, P60; Palliser HK, 2015, J DEV ORIG HLTH DIS, V6, P350, DOI 10.1017/S2040174415001075; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Poletti A, 1998, ENDOCRINOLOGY, V139, P2171, DOI 10.1210/en.139.4.2171; Rivera C, 1999, NATURE, V397, P251; Roberts G, 2009, J PEDIATR-US, V154, P829, DOI 10.1016/j.jpeds.2008.12.036; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Shaw JC, 2015, J DEV ORIG HLTH DIS, V6, P250, DOI 10.1017/S2040174415000069; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Smith SS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00135; Snead OC, 1998, ANN NEUROL, V44, P688, DOI 10.1002/ana.410440417; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Trotter A, 2000, ANN MED, V32, P608, DOI 10.3109/07853890009002031; Turner AJ, 2009, PLACENTA, V30, P236, DOI 10.1016/j.placenta.2008.11.023; Tyzio R, 2008, EUR J NEUROSCI, V27, P2515, DOI 10.1111/j.1460-9568.2008.06234.x; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Vu TT, 2009, REPROD FERT DEVELOP, V21, P599, DOI 10.1071/RD08224; Wang JM, 2008, BRAIN RES REV, V57, P398, DOI 10.1016/j.brainresrev.2007.08.010; Williams MT, 1999, NEUROTOXICOL TERATOL, V21, P403, DOI 10.1016/S0892-0362(98)00060-9; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001; Yawno T, 2007, NEUROSCIENCE, V146, P1726, DOI 10.1016/j.neuroscience.2007.03.023; Yawno T, 2011, STRESS, V14, P13, DOI 10.3109/10253890.2010.504789; Zimmerberg B, 1998, PHARMACOL BIOCHEM BE, V59, P819, DOI 10.1016/S0091-3057(97)00540-6; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	77	14	14	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	JUN	2016	160				SI		181	188		10.1016/j.jsbmb.2015.09.012			8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	DN1QM	WOS:000376840500022	26365557				2021-06-18	
J	Horswill, MS				Horswill, Mark S.			Improving Fitness to Drive: The Case for Hazard Perception Training	AUSTRALIAN PSYCHOLOGIST			English	Article						driving skill; hazard perception; rehabilitation; road safety; training	TRAUMATIC BRAIN-INJURY; OLDER DRIVERS; NOVICE DRIVERS; RISK AWARENESS; WILL REDUCE; PERFORMANCE; ROAD; ABILITY; INTERVENTION; SIMULATOR	On one hand, individuals who are unfit to drive should not be allowed behind the wheel. On the other hand, being unable to drive can have significant negative consequences for some individuals, including an increased mortality risk. One potential solution to this dilemma is to use training interventions to improve fitness-to-drive. The problem is that, in general, post-licensing driver training and education has a disappointing track record in terms of improving road safety. However, one type of intervention that may have the potential to buck this trend is hazard perception training. Hazard perception, which is the driver's ability to anticipate dangerous situations on the road ahead, has been found to predict both crash risk and on-road driving performance, and can account for variance in both of these criteria that other key fitness-to-drive measures cannot. Crucially, there is evidence that hazard perception competence can be improved by brief computer-based interventions, even for driver groups who are more likely to face fitness-to-drive challenges, such as individuals aged over 65 years or adults with attention deficit hyperactivity disorder. This article puts the case for potentially using such interventions to help individuals with fitness-to-drive difficulties.	[Horswill, Mark S.] Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia	Horswill, MS (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia.	m.horswill@psy.uq.edu.au	Horswill, Mark/J-9029-2019	Horswill, Mark/0000-0002-0286-6292			Anstey K. J., 2009, AUSTR ROAD SAF RES P; Austroads, 2012, ASS FITN DRIV; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Beanland V, 2013, SAFETY SCI, V51, P127, DOI 10.1016/j.ssci.2012.06.021; Borowsky A., 2014, P HUM FACT ERG SOC A; Borowsky A., 2009, TRANSPORTATION RES F; Borowsky A, 2015, TRAFFIC INJ PREV, V16, P133, DOI 10.1080/15389588.2014.909593; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Boufous S, 2011, TRAFFIC INJ PREV, V12, P475, DOI 10.1080/15389588.2011.591856; Brown P.C., 2014, MAKE IT STICK; Chapman P., 2002, TRANSP RES PART F TR, V5, P157, DOI DOI 10.1016/S1369-8478(02)00014-1; Chatham RE, 2009, DEVELOPMENT OF PROFESSIONAL EXPERTISE: TOWARD MEASUREMENT OF EXPERT PERFORMANCE AND DESIGN OF OPTIMAL LEARNING ENVIRONMENTS, P27, DOI 10.1017/CBO9780511609817.003; Cheng ASK, 2011, ACCIDENT ANAL PREV, V43, P1464, DOI 10.1016/j.aap.2011.02.024; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Congdon P., 1999, VICROADS HAZARD PERC; Crundall D, 2010, ACCIDENT ANAL PREV, V42, P2117, DOI 10.1016/j.aap.2010.07.001; Darby P, 2009, SAFETY SCI, V47, P436, DOI 10.1016/j.ssci.2008.05.004; Deery HA, 1996, ADDICTION, V91, P815, DOI 10.1046/j.1360-0443.1996.9168158.x; Devos H, 2010, NEUROREHAB NEURAL RE, V24, P843, DOI 10.1177/1545968310368687; Devos H, 2009, NEUROREHAB NEURAL RE, V23, P699, DOI 10.1177/1545968309334208; Dickerson AE, 2014, OCCUP THER HEALTH CA, V28, P82, DOI 10.3109/07380577.2014.904535; Dogan E, 2012, ACCIDENT ANAL PREV, V45, P522, DOI 10.1016/j.aap.2011.09.004; Edwards JD, 2009, J GERONTOL A-BIOL, V64, P1290, DOI 10.1093/gerona/glp114; Edwards JD, 2009, GERONTOLOGIST, V49, P485, DOI 10.1093/geront/gnp042; Ericsson KA, 2007, CURR DIR PSYCHOL SCI, V16, P346, DOI 10.1111/j.1467-8721.2007.00533.x; Evans, 1991, TRAFFIC SAFETY DRIVE; Fisher DL, 2006, INJURY PREV, V12, P25, DOI 10.1136/ip.2006.012021; Fisher DL, 2002, HUM FACTORS, V44, P287, DOI 10.1518/0018720024497853; Grayson G.B., 2003, RISK HAZARD PERCEPTI; Groeger JA, 2007, ERGONOMICS, V50, P1250, DOI 10.1080/00140130701318723; Hamid M., 2014, TRANSP RES BOARD 93; Horswill M.S., 2004, COGNITIVE APPROACH S, P155; Horswill MS, 2008, J GERONTOL B-PSYCHOL, V63, pP212, DOI 10.1093/geronb/63.4.P212; Horswill MS, 2015, PSYCHOL AGING, V30, P62, DOI 10.1037/a0038671; Horswill MS, 2013, ACCIDENT ANAL PREV, V52, P100, DOI 10.1016/j.aap.2012.12.014; Horswill MS, 2013, ACCIDENT ANAL PREV, V50, P130, DOI 10.1016/j.aap.2012.04.001; Horswill MS, 2011, ACCIDENT ANAL PREV, V43, P2121, DOI 10.1016/j.aap.2011.05.035; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Horswill MS, 2010, PSYCHOL AGING, V25, P464, DOI 10.1037/a0017306; Horswill MS, 2004, J APPL SOC PSYCHOL, V34, P177, DOI 10.1111/j.1559-1816.2004.tb02543.x; Horswill MS, 1999, BRIT J PSYCHOL, V90, P189, DOI 10.1348/000712699161341; Isler RB, 2011, ACCIDENT ANAL PREV, V43, P1818, DOI 10.1016/j.aap.2011.04.017; Isler RB, 2009, ACCIDENT ANAL PREV, V41, P445, DOI 10.1016/j.aap.2008.12.016; JACOBY LL, 1978, J VERB LEARN VERB BE, V17, P649, DOI 10.1016/S0022-5371(78)90393-6; Korner-Bitensky N, 2009, J SAFETY RES, V40, P105, DOI 10.1016/j.jsr.2009.02.002; Liddle J, 2012, AUST OCCUP THER J, V59, P384, DOI 10.1111/j.1440-1630.2011.00956.x; Marottoli RA, 2007, J GEN INTERN MED, V22, P590, DOI 10.1007/s11606-007-0134-3; Mayhew DR, 1998, J PUBLIC HEALTH POL, V19, P51, DOI 10.2307/3343089; McKenna F, 1997, DEV HAZARD PERCEPTIO; McKenna F.P., 1999, IATSS RES, V23, P26; McKenna FP, 2006, J EXP PSYCHOL-APPL, V12, P1, DOI 10.1037/1076-898X.12.1.1; McKenna FP., 1991, HAZARD PERCEPTION DR; Meir A., 2010, 3 INT C APPL HUM FAC; Meir A, 2014, TRAFFIC INJ PREV, V15, P172, DOI 10.1080/15389588.2013.802775; Nasvadi GE, 2007, ACCIDENT ANAL PREV, V39, P1073, DOI 10.1016/j.aap.2007.02.005; Peltz D.C., 1974, ACCIDENT ANAL PREV, V6, P45, DOI [10.1016/0001-4575(74)90015-3, DOI 10.1016/0001-4575(74)90015-3]; Petzoldt T, 2013, ACCIDENT ANAL PREV, V50, P1185, DOI 10.1016/j.aap.2012.09.016; Pollatsek A, 2006, HUM FACTORS, V48, P447, DOI 10.1518/001872006778606787; Poulsen AA, 2010, AUST NZ J PSYCHIAT, V44, P528, DOI 10.3109/00048671003596048; Pradhan AK, 2009, ERGONOMICS, V52, P657, DOI 10.1080/00140130802550232; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Quimby A.R., 1986, PERCEPTUAL ABILITIES; Quimby A.R., 1981, HUMAN FACTORS DRIVIN; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Regan MA, 2000, ROAD SAF RES POL ED; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Rosenbloom T, 2011, ACCIDENT ANAL PREV, V43, P601, DOI 10.1016/j.aap.2010.08.005; Ross R. W, 2013, 7 INT DRIV S HUM FAC; Savage SW, 2013, TRANSPORT RES F-TRAF, V17, P52, DOI 10.1016/j.trf.2012.10.002; Schmidt R.A., 2005, MOTOR CONTROL LEARNI, V4, 89-122; Scialfa CT, 2012, ACCIDENT ANAL PREV, V45, P547, DOI 10.1016/j.aap.2011.09.005; Scialfa CT, 2011, ACCIDENT ANAL PREV, V43, P204, DOI 10.1016/j.aap.2010.08.010; Shinar D., 2007, TRAFFIC SAFETY HUMAN; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Starkey, 2013, AUSTR ROAD SAF RES P; Taylor T, 2013, ACCIDENT ANAL PREV, V58, P175, DOI 10.1016/j.aap.2013.02.008; Taylor T. G., 2011, P INT DRIV S HUM FAC; Transport and Road Research Laboratory, 1979, HAZ PERC TEST DRIV; Vlakveld W, 2011, TRANSPORT RES REC, P153, DOI 10.3141/2265-17; Wallis TSA, 2007, ACCIDENT ANAL PREV, V39, P1177, DOI 10.1016/j.aap.2007.03.003; Wang YB, 2010, TRAFFIC INJ PREV, V11, P483, DOI 10.1080/15389588.2010.489242; Waylen AE, 2004, TRANSPORT RES F-TRAF, V7, P323, DOI 10.1016/j.trf.2004.09.009; Wells P, 2008, COHORT 2 STUDY LEARN; WEST R, 1993, ADDICTION, V88, P527, DOI 10.1111/j.1360-0443.1993.tb02059.x; Wetton MA, 2010, ACCIDENT ANAL PREV, V42, P1232, DOI 10.1016/j.aap.2010.01.017; Wetton MA, 2013, ACCIDENT ANAL PREV, V54, P57, DOI 10.1016/j.aap.2013.02.013; Wetton MA, 2011, ACCIDENT ANAL PREV, V43, P1759, DOI 10.1016/j.aap.2011.04.007; Wood JM, 2013, ACCIDENT ANAL PREV, V50, P1161, DOI 10.1016/j.aap.2012.09.009; Zafian T., 2014, TRANSP RES BOARD 93	91	14	15	0	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	JUN	2016	51	3					173	181		10.1111/ap.12132			9	Psychology, Multidisciplinary	Psychology	DR6XF	WOS:000380043900001					2021-06-18	
J	Jonas, WB; Bellanti, DM; Paat, CF; Boyd, CC; Duncan, A; Price, A; Zhang, WM; French, LM; Chae, H				Jonas, Wayne B.; Bellanti, Dawn M.; Paat, Charmagne F.; Boyd, Courtney C.; Duncan, Alaine; Price, Ashley; Zhang, Weimin; French, Louis M.; Chae, Heechin			A Randomized Exploratory Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated with Traumatic Brain Injury	MEDICAL ACUPUNCTURE			English	Article						Traumatic Brian Injury; Headache; Pain Management; Acupuncture	POSTTRAUMATIC-STRESS-DISORDER; TRIAL; DEPRESSION	Background: Headaches are prevalent among Service members with traumatic brain injury (TBI); 80% report chronic or recurrent headache. Evidence for nonpharmacologic treatments, such as acupuncture, are needed. Objective: The aim of this research was to determine if two types of acupuncture (auricular acupuncture [AA] and traditional Chinese acupuncture [TCA]) were feasible and more effective than usual care (UC) alone for TBI-related headache. Materials and Methods: Design: This was a three-armed, parallel, randomized exploratory study. Setting: The research took place at three military treatment facilities in the Washington, DC, metropolitan area. Patients: The subjects were previously deployed Service members (18-69 years old) with mild-to-moderate TBI and headaches. Intervention: The interventions explored were UC alone or with the addition of AA or TCA. Outcome Measures: The primary outcome was the Headache Impact Test (HIT). Secondary outcomes were the Numerical Rating Scale (NRS), Pittsburgh Sleep Quality Index, Post-Traumatic Stress Checklist, Symptom Checklist-90-R, Medical Outcome Study Quality of Life (QoL), Beck Depression Inventory, State-Trait Anxiety Inventory, the Automated Neuropsychological Assessment Metrics, and expectancy of outcome and acupuncture efficacy. Results: Mean HIT scores decreased in the AA and TCA groups but increased slightly in the UC-only group from baseline to week 6 [AA, -10.2%(-6.4 points); TCA, -4.6% (-2.9 points); UC, +0.8%(+0.6 points)]. Both acupuncture groups had sizable decreases in NRS (Pain Best), compared to UC (TCA versus UC: P=0.0008, d=1.70; AA versus UC: P=0.0127, d=1.6). No statistically significant results were found for any other secondary outcome measures. Conclusions: Both AA and TCA improved headache-related QoLmore than UC did in Servicemembers with TBI.	[Jonas, Wayne B.; Bellanti, Dawn M.; Paat, Charmagne F.; Boyd, Courtney C.; Price, Ashley; Zhang, Weimin] Samueli Inst, 1737 King St,Suite 600, Alexandria, VA 22314 USA; [Duncan, Alaine] Integrat Healing LLC, Hyattsville, MD USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Chae, Heechin] Ft Belvoir Community Hosp, Def & Vet Brain Injury Ctr Clin, Ft Belvoir, VA USA	Jonas, WB (corresponding author), Samueli Inst, 1737 King St,Suite 600, Alexandria, VA 22314 USA.	wjonas@samueliinstitute.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0212] Funding Source: Medline		Barker R, 2006, ACAD EMERG MED, V13, P19, DOI 10.1197/j.aem.2005.07.014; Bayliss MS, 2002, HIT 6 USERS GUIDE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cao WS, 2001, MODERN REHABILITATIO, V5, P110; Chan YY, 2015, J AFFECT DISORDERS, V176, P106, DOI 10.1016/j.jad.2015.01.048; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010; Coeytaux RR, 2005, HEADACHE, V45, P1113, DOI 10.1111/j.1526-4610.2005.00235.x; Da Silva AN, 2015, HEADACHE, V55, P470, DOI 10.1111/head.12525; Dasgupta A, 2010, AM J HEALTH-SYST PH, V67, P1337, DOI 10.2146/ajhp090507; Defense and Veterans Brain Injury Center, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, UPD MILD TRAUM BRAIN; Department of Veterans Affairs (VA) Department of Defense (DoD), 2009, VA DOD CLIN PRACT GU; Domingo C, 2001, Rev Enferm, V24, P50; Engel CC, 2014, MED CARE, V52, pS57, DOI 10.1097/MLR.0000000000000237; FERRAZ MB, 1990, J RHEUMATOL, V17, P1022; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollifield M, 2007, J NERV MENT DIS, V195, P504, DOI 10.1097/NMD.0b013e31803044f8; Jonas WB, 2011, MED ACUPUNCT, V23, P249, DOI 10.1089/acu.2011.0840; Kadel RP, 2012, ANN SOUTHEAST SAS US; Kalavapalli Ramprasad, 2007, Complement Ther Clin Pract, V13, P184, DOI 10.1016/j.ctcp.2007.01.001; Khusid MA, 2015, MIL MED, V180, P132, DOI 10.7205/MILMED-D-14-00195; Lee C, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-46; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Lindel K, 2009, CANCER INVEST, V27, P781, DOI 10.1080/07357900802653456; Liu L, 2015, EVID-BASED COMPL ALT, V2015, P18; Manber R, 2004, J AFFECT DISORDERS, V83, P89, DOI 10.1016/j.jad.2004.05.009; Niemtzow RC, 2006, J ALTERN COMPLEM MED, V12, P597, DOI 10.1089/acm.2006.597; Pilkington Karen, 2007, Acupunct Med, V25, P1; Shen J, 2001, J ALTERN COMPLEM MED, V7, pS121; Smith C. A., 2005, COCHRANE DB SYST REV, V2; Sniezek DP, 2013, MED ACUPUNCT, V25, P164, DOI 10.1089/acu.2012.0900; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wasserstein RL, 2016, AM STAT         0307; Wheway Jayne, 2012, Int J Risk Saf Med, V24, P163, DOI 10.3233/JRS-2012-0569	37	14	14	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1933-6586	1933-6594		MED ACUPUNCT	Med. Acupunct.	JUN	2016	28	3					113	130		10.1089/acu.2016.1183			18	Integrative & Complementary Medicine	Integrative & Complementary Medicine	EB7MF	WOS:000387571000002	27458496	Other Gold, Green Published			2021-06-18	
J	Loncarevic-Vasiljkovic, N; Milanovic, D; Pesic, V; Tesic, V; Brkic, M; Lazic, D; Avramovic, V; Kanazir, S				Loncarevic-Vasiljkovic, Natasa; Milanovic, Desanka; Pesic, Vesna; Tesic, Vesna; Brkic, Marjana; Lazic, Divna; Avramovic, Vladimir; Kanazir, Selma			Dietary restriction suppresses apoptotic cell death, promotes Bcl-2 and Bcl-xl mRNA expression and increases the Bcl-2/Bax protein ratio in the rat cortex after cortical injury	NEUROCHEMISTRY INTERNATIONAL			English	Article						Dietary restriction; Cortical stab injury; Neuroapoptosis; Intrinsic apoptotic pathway	TRAUMATIC BRAIN-INJURY; FOOD RESTRICTION; GENE-EXPRESSION; TRANSGENIC MICE; BAX; OVEREXPRESSION; MECHANISMS; MEMORY; DAMAGE	Traumatic brain injury (TBI) is one of the leading causes of death and disability in humans. Subsequent pathological events occurring in the brain after TBI, referred to as secondary injury, continue to damage surrounding tissue resulting in substantial neuronal loss. Using an animal model of TBI we examined the effect of dietary restriction (DR) on the neuroapoptosis and Bcl-2 family genes as the main regulators of the intrinsic apoptotic pathway. Bcl-2, Bcl-xl and Bax mRNA and protein expression in the ipsilateral cortex of adult Wistar rats exposed to DR before TBI were studied from 2 to 28 days post injury. Our results showed that DR suppressed neuroapoptosis and promoted significant upregulation of antiapoptotic Bcl-2 and Bcl-xl mRNAs in the ipsilateral cortex following injury. Expression of the proapoptotic Bax gene increased in ad libitum (AL) fed rats but remained unchanged in rats exposed to DR. Although the expression of Bcl-2, Bcl-xl and Bax proteins was changed in a similar manner in both experimental groups, DR promoted a continuous increase in the Bcl-2:Bax protein ratio throughout the recovery period. Together with our previous finding that DR mediates inhibition of the extrinsic apoptotic pathway the present work reveals that modulation of the intrinsic pathway contributes to the beneficial effect of DR in brain injury. These findings provide new insight into the effects of DR on pro-survival signaling after injury, lending further support to its neuroprotective effect. (C) 2016 Elsevier Ltd. All rights reserved.	[Loncarevic-Vasiljkovic, Natasa; Milanovic, Desanka; Pesic, Vesna; Tesic, Vesna; Brkic, Marjana; Lazic, Divna; Avramovic, Vladimir; Kanazir, Selma] Univ Belgrade, Inst Biol Res, Dept Neurobiol, Bulevor Despota Stefana 142, Belgrade 11060, Serbia	Kanazir, S (corresponding author), Univ Belgrade, Inst Biol Res, Dept Neurobiol, Bulevor Despota Stefana 142, Belgrade 11060, Serbia.	selkan@ibiss.bg.ac.rs	; Kanazir, Selma/E-5495-2015	Pesic, Vesna/0000-0002-1415-5834; Kanazir, Selma/0000-0002-7229-5296; Loncarevic-Vasiljkovic, Natasa/0000-0002-8350-1390; Avramovic, Vladimir/0000-0002-3579-837X	Ministry of Education, Science and Technological Development, Republic of Serbia [ON173056]; Fogarty International Research Award, NIH [R03AG046216]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R03AG046216] Funding Source: NIH RePORTER	We would like to thank Dr Nevena Grdovic and Dr Sanja Ivkovic for the critical reading and helpful comments regarding the manuscript. This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (grant ON173056) and the Fogarty International Research Award, NIH (R03AG046216).	Bar-Am O., 2005, FASEB J, V3, P252; Bruce-Keller AJ, 1999, ANN NEUROL, V45, P8, DOI 10.1002/1531-8249(199901)45:1<8::AID-ART4>3.0.CO;2-V; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Clark RSB, 1997, J NEUROSCI, V17, P9172; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Ge Y, 2004, MOL BRAIN RES, V129, P124, DOI 10.1016/j.molbrainres.2004.06.034; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Jeong MA, 2011, J NEUROTRAUM, V28, P479, DOI 10.1089/neu.2010.1609; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Loncarevic-Vasiljkovic N, 2009, EXP NEUROL, V220, P198, DOI 10.1016/j.expneurol.2009.08.024; Manzanero Silvia, 2011, Exp Transl Stroke Med, V3, P8, DOI 10.1186/2040-7378-3-8; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raghupathi R., 1997, J CEREB BLOOD FLOW M, V20, P421; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sharma S, 2005, BRAIN RES BULL, V67, P482, DOI 10.1016/j.brainresbull.2005.07.015; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Stumm G, 1999, FASEB J, V13, P1065; Veenith Tonny, 2009, World J Emerg Surg, V4, P7, DOI 10.1186/1749-7922-4-7; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wiessner C, 1999, NEUROSCI LETT, V268, P119, DOI 10.1016/S0304-3940(99)00392-4; WONG H, 1994, ANAL BIOCHEM, V223, P251, DOI 10.1006/abio.1994.1581; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Zhang X., 2005, CRIT CARE, V9	35	14	14	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN	2016	96						69	76		10.1016/j.neuint.2016.02.017			8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	DN1DO	WOS:000376806700008	26939764				2021-06-18	
J	McLean, ACL; McLean, AL; Kalff, R; Walter, J				McLean, Anna C. Lawson; McLean, Aaron Lawson; Kalff, Rolf; Walter, Jan			Google Search Queries About Neurosurgical Topics: Are They a Suitable Guide for Neurosurgeons?	WORLD NEUROSURGERY			English	Article						Google trends; Internet; Neurosurgery; Patient guidance; Search queries	NATIONAL TRENDS SURVEY; INFORMATION; INTERNET; CANCER; QUALITY; EDUCATION	OBJECTIVE: Google is the most popular search engine, with about 100 billion searches per month. Google Trends is an integrated tool that allows users to obtain Google's search popularity statistics from the last decade. Our aim was to evaluate whether Google Trends is a useful tool to assess the public's interest in specific neurosurgical topics. METHODS: We evaluated Google Trends statistics for the neurosurgical search topic areas "hydrocephalus," "spinal stenosis," "concussion," "vestibular schwannoma," and "cerebral arteriovenous malformation. "We compared these with bibliometric data from PubMed and epidemiologic data from the German Federal Monitoring Agency. In addition, we assessed Google users' search behavior for the search terms "glioblastoma" and "meningioma." RESULTS: Over the last 10 years, there has been an increasing interest in the topic "concussion" from Internet users in general and scientists. "Spinal stenosis," "concussion," and "vestibular schwannoma" are topics that are of special interest in high-income countries (eg, Germany), whereas "hydrocephalus" is a popular topic in low- and middle-income countries. The Google-defined top searches within these topic areas revealed more detail about people's interests (eg, "normal pressure hydrocephalus" or "football concussion"ranked among the most popular search queries within the corresponding topics). There was a similar volume of queries for "glioblastoma" and "meningioma." CONCLUSIONS: Google Trends is a useful source to elicit information about general trends in peoples' health interests and the role of different diseases across the world. The Internet presence of neurosurgical units and surgeons can be guided by online users' interests to achieve high-quality, professional-endorsed patient education.	[McLean, Anna C. Lawson; McLean, Aaron Lawson; Kalff, Rolf; Walter, Jan] Univ Jena, Jena Univ Hosp, Dept Neurosurg, Jena, Germany	Walter, J (corresponding author), Univ Jena, Jena Univ Hosp, Dept Neurosurg, Jena, Germany.	jan.walter@med.uni-jena.de	McLean, Aaron Lawson/D-6830-2013; Walter, Jan/AAE-4536-2021	McLean, Aaron Lawson/0000-0001-5528-6905; 			Alotaibi NM, 2016, WORLD NEUROSURG, V88, P619, DOI 10.1016/j.wneu.2015.11.011; Baldi I, 2014, NEUROCHIRURGIE; Berg GM, 2014, JAAPA-J AM ACAD PHYS, V27, DOI 10.1097/01.JAA.0000442712.05009.b1; Best J, 2015, EUR ARCH OTO-RHINO-L, V272, P3499, DOI 10.1007/s00405-014-3349-z; Brodbelt A, 2015, EUR J CANCER, V51, P533, DOI 10.1016/j.ejca.2014.12.014; Car J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007092.pub2; Carlsson T, 2015, INTERACT J MED RES, V4, P66, DOI 10.2196/ijmr.3819; Chou WYS, 2011, J CANCER SURVIV, V5, P263, DOI 10.1007/s11764-011-0179-5; Epstein D., 2011, SPORT ILLUS; Garcia GH, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01228; Ghobrial GM, 2014, CLIN NEUROL NEUROSUR, V118, P59, DOI 10.1016/j.clineuro.2013.12.013; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glynn RW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-442; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lee K, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4345; Madden T, 2015, AM J OBSTET GYNECOL; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Mohan R, 2015, J ARTHROPLASTY, V30, P803, DOI 10.1016/j.arth.2014.12.022; Murray G, 2016, BRIT J ORAL MAX SURG, V54, P163, DOI 10.1016/j.bjoms.2015.12.005; Ohaegbulam SC, 2001, NEUROSURGERY, V49, P226; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Prestin A, 2015, J HEALTH COMMUN, V20, P790, DOI 10.1080/10810730.2015.1018590; Rossignol L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076020; Sobota A, 2015, INT J GYNECOL CANCER, V25, P537, DOI 10.1097/IGC.0000000000000362; Sullivan TB, 2014, CLIN ORTHOP RELAT R, V472, P1597, DOI 10.1007/s11999-013-3425-5	25	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2016	90						179	185		10.1016/j.wneu.2016.02.045			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DS1MS	WOS:000380360500024	26898496				2021-06-18	
J	Schmidt, B; Reinhard, M; Lezaic, V; McLeod, DD; Weinhold, M; Mattes, H; Klingelhofer, J				Schmidt, Bernhard; Reinhard, Matthias; Lezaic, Vesna; McLeod, Damian D.; Weinhold, Marco; Mattes, Heinz; Klingelhoefer, Juergen			Autoregulation monitoring and outcome prediction in neurocritical care patients: Does one index fit all?	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Cerebral autoregulation; Cerebrovascular pressure reactivity; Modified Rankin Scale; Cerebral blood flow; Traumatic brain injury; Stroke	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; VOLUME INDEX; HEAD-INJURY; CEREBROVASCULAR REACTIVITY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CRANIECTOMY; VELOCITY	Indexes PRx and Mx have been formerly introduced to assess cerebral autoregulation and have been shown to be associated with 3-month clinical outcome. In a mixed cohort of neurocritical care patients, we retrospectively investigated the impact of selected clinical characteristics on this association. Forty-one patients (18-77 years) with severe traumatic (TBI, N = 20) and non-traumatic (N = 21) brain injuries were studied. Cerebral blood flow velocity, arterial blood pressure and intracranial pressure were repeatedly recorded during 1-h periods. Calculated PRx and Mx were correlated with 3-month clinical outcome score of modified Rankin Scale (mRS) in different subgroups with specific clinical characteristics. Both PRx and Mx correlated significantly with outcome (PRx: r = 0.38, p < 0.05; AUC = 0.64, n.s./Mx: r = 0.48, p < 0.005; AUC = 0.80, p < 0.005) in the overall group, and in patients with hemicraniectomy (N = 17; PRx: r = 0.73, p < 0.001; AUC = 0.89, p < 0.01/Mx: r = 0.69, p < 0.005; AUC = 0.87, p < 0.05). Mx, not PRx, correlated significantly with mRS in patients with heart failure (N = 17; r = 0.69, p < 0.005; AUC = 0.92, p < 0.005), and in non-traumatic patients (r = 0.49, p < 0.05; AUC = 0.79, p < 0.05). PRx, not Mx, correlated significantly with mRS in TBI patients (r = 0.63, p < 0.01; AUC = 0.89, p < 0.01). Both indexes did not correlate with mRS in diabetes patients (N = 15), PRx failed in hypocapnic patients (N = 26). Both PRx and Mx were significantly associated with 3-month clinical outcome, even in patients with hemicraniectomy. PRx was more appropriate for TBI patients, while Mx was better suited for non-traumatic patients and patients with heart failure. Prognostic values of indexes were affected by diabetes (both Mx and PRx) and hypocapnia (PRx only).	[Schmidt, Bernhard; Lezaic, Vesna; Weinhold, Marco; Klingelhoefer, Juergen] Chemnitz Med Ctr, Dept Neurol, Dresdner Str 178, D-09131 Chemnitz, Germany; [Reinhard, Matthias] Univ Freiburg, Dept Neurol, Breisacher Str 64, D-79106 Freiburg, Germany; [McLeod, Damian D.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Mattes, Heinz] Univ Erlangen Nurnberg, Dept Elect Elect & Commun Engn, D-91052 Erlangen, Germany	Schmidt, B (corresponding author), Chemnitz Med Ctr, Dept Neurol, Dresdner Str 178, D-09131 Chemnitz, Germany.	B.Schmidt@skc.de	MCLEOD, DAMIAN/G-7704-2013	MCLEOD, DAMIAN/0000-0002-1297-8984			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diedler J, 2014, CRIT CARE, V18, DOI 10.1186/cc13796; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; LASSEN NA, 1974, CIRC RES, V34, P749, DOI 10.1161/01.RES.34.6.749; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MUDHOLKAR GS, 1992, BIOMETRIKA, V79, P850, DOI 10.1093/biomet/79.4.850; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 2014, IJCNMH S1, V1, pS18; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257	29	14	14	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	JUN	2016	30	3					367	375		10.1007/s10877-015-9726-3			9	Anesthesiology	Anesthesiology	DL6YV	WOS:000375786900014	26085437	Green Published, Other Gold			2021-06-18	
J	Singh, R; Savitz, J; Teague, TK; Polanski, DW; Mayer, AR; Bellgowan, PSF; Meier, TB				Singh, Rashmi; Savitz, Jonathan; Teague, T. Kent; Polanski, David W.; Mayer, Andrew R.; Bellgowan, Patrick S. F.; Meier, Timothy B.			Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSIVE DISORDER; PROFESSIONAL FOOTBALL PLAYERS; LIFE COGNITIVE IMPAIRMENT; QUINOLINIC ACID; RECURRENT CONCUSSION; HIGH-SCHOOL; HIPPOCAMPAL; RAT; ANTAGONISTS	Objective An imbalance of neuroactive kynurenine pathway metabolites has been proposed as one mechanism behind the neuropsychiatric sequelae of certain neurological disorders. We hypothesized that concussed football players would have elevated plasma levels of neurotoxic kynurenine metabolites and reduced levels of neuroprotective metabolites relative to healthy football players and that altered kynurenine levels would correlate with post-concussion mood symptoms. Methods Mood scales and plasma concentrations of kynurenine metabolites were assessed in concussed (N=18; 1.61 days post-injury) and healthy football players (N=18). A subset of football players returned at 1-week (N=14; 9.29 days) and 1-month post-concussion (N=14, 30.93 days). Results Concussed athletes had significantly elevated levels of quinolinic acid (QUIN) and significantly lower ratios of kynurenic acid (KYNA) to QUIN at all time points compared with healthy athletes (p's<0.05), with no longitudinal evidence of normalization of KYNA or KYNA/QUIN. At 1-day post-injury, concussed athletes with lower levels of the putatively neuroprotective KYNA/QUIN ratio reported significantly worse depressive symptoms (p=0.04), and a trend toward worse anxiety symptoms (p=0.06), while at 1-month higher QUIN levels were associated with worse mood symptoms (p's<0.01). Finally, concussed athletes with worse concussion outcome, defined as number of days until return-to-play, had higher QUIN and lower KYNA/QUIN at 1-month post-injury (p's<0.05). Conclusions These results converge with existing kynurenine literature on psychiatric patients and provide the first evidence of altered peripheral levels of kynurenine metabolites following sports-related concussion.	[Singh, Rashmi; Savitz, Jonathan; Meier, Timothy B.] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Polanski, David W.] Univ Tulsa, Dept Athlet, Tulsa, OK 74104 USA; [Mayer, Andrew R.; Meier, Timothy B.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Bellgowan, Patrick S. F.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Meier, TB (corresponding author), Lovelace Biomed & Environm Res Inst, Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	timothybmeier@gmail.com	Savitz, Jonathan/C-3088-2009; Teague, T. Kent/A-2527-2008	Savitz, Jonathan/0000-0001-8143-182X; Teague, T. Kent/0000-0002-4680-5440	Laureate Institute for Brain Research; William K Warren Foundation	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K Warren Foundation.	Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2014, J SCI MED SPORT; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Savitz J, 2015, BRAIN BEHAV IMMUN, V46, P55, DOI 10.1016/j.bbi.2015.02.007; Savitz J, 2015, PSYCHONEUROENDOCRINO, V52, P200, DOI 10.1016/j.psyneuen.2014.11.015; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; SMITH DH, 1993, J NEUROSCI, V13, P5383; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745	32	14	14	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2016	87	6					670	675		10.1136/jnnp-2015-311369			6	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	DM9KX	WOS:000376686100015	26269650				2021-06-18	
J	Thomas, DB; Newman-Toker, DE				Thomas, Dana B.; Newman-Toker, David E.			Diagnosis is a team sport - partnering with allied health professionals to reduce diagnostic errors	DIAGNOSIS			English	Article						Diagnosis; diagnostic errors; dizziness; misdiagnosis; physical therapy specialty; vertigo	PAROXYSMAL POSITIONAL VERTIGO; VESTIBULAR REHABILITATION THERAPY; EMERGENCY PHYSICIANS; PATIENT SAFETY; DIZZINESS PRESENTATIONS; DIZZY PATIENTS; INTERNATIONAL SURVEY; CLINICAL-PRACTICE; MEDICAL-STUDENTS; SYMPTOM QUALITY	Background: Diagnostic errors are the most common, most costly, and most catastrophic of medical errors. Interdisciplinary teamwork has been shown to reduce harm from therapeutic errors, but sociocultural barriers may impact the engagement of allied health professionals (AHPs) in the diagnostic process. Methods: A qualitative case study of the experience at a single institution around involvement of an AHP in the diagnostic process for acute dizziness and vertigo. We detail five diagnostic error cases in which the input of a physical therapist was central to correct diagnosis. We further describe evolution of the sociocultural milieu at the institution as relates to AHP engagement in diagnosis. Results: Five patients with acute vestibular symptoms were initially misdiagnosed by physicians and then correctly diagnosed based on input from a vestibular physical therapist. These included missed labyrinthine concussion and post-traumatic benign paroxysmal positional vertigo (BPPV); BPPV called gastroenteritis; BPPV called stroke; stroke called BPPV; and multiple sclerosis called BPPV. As a consequence of surfacing these diagnostic errors, initial resistance to physical therapy input to aid medical diagnosis has gradually declined, creating a more collaborative environment for 'team diagnosis' of patients with dizziness and vertigo at the institution. Conclusions: Barriers to AHP engagement in 'team diagnosis' include sociocultural norms that establish medical diagnosis as something reserved only for physicians. Drawing attention to the valuable diagnostic contributions of AHPs may help facilitate cultural change. Future studies should seek to measure diagnostic safety culture and then implement proven strategies to breakdown sociocultural barriers that inhibit effective teamwork and transdisciplinary diagnosis.	[Newman-Toker, David E.] Johns Hopkins Univ, Sch Med, Dept Neurol & Otolaryngol, CRB-2,Room 2M-03 North 1550 Orleans St, Baltimore, MD 21231 USA; [Thomas, Dana B.] WakeMed Hlth & Hosp, Raleigh Campus, Raleigh, NC USA	Newman-Toker, DE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol & Otolaryngol, CRB-2,Room 2M-03 North 1550 Orleans St, Baltimore, MD 21231 USA.	toker@jhu.edu					[Anonymous], 2015, PROFESSIONAL ED C TR; [Anonymous], 2000, AUDIOLOGIC GUIDELINE; [Anonymous], 2015, IMPROVING DIAGNOSIS; Bashir K, 2015, EMERG MED AUSTRALAS, V27, P179, DOI 10.1111/1742-6723.12362; Benbassat J, 2012, ACTA OPHTHALMOL, V90, P503, DOI 10.1111/j.1755-3768.2011.02221.x; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Bruce BB, 2011, NEW ENGL J MED, V364, P387, DOI 10.1056/NEJMc1009733; Cohen HS, 2011, J VESTIBUL RES-EQUIL, V21, P243, DOI 10.3233/VES-2011-0424; Cohen HS, 2009, J VESTIBUL RES-EQUIL, V19, P15, DOI 10.3233/VES-2009-0339; Cohen HS, 2004, OTOL NEUROTOL, V25, P130, DOI 10.1097/00129492-200403000-00008; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Geser Rebekka, 2012, Front Neurol, V3, P169, DOI 10.3389/fneur.2012.00169; Hautz WE, 2015, JAMA-J AM MED ASSOC, V313, P303, DOI 10.1001/jama.2014.15770; HERDMAN SJ, 1990, PHYS THER, V70, P381, DOI 10.1093/ptj/70.6.381; Herdman SJ, 1997, PHYS THER, V77, P602, DOI 10.1093/ptj/77.6.602; Kattah JC, 2009, STROKE, V40, P3504, DOI 10.1161/STROKEAHA.109.551234; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; Kerber KA, 2015, NEUROL CLIN, V33, P565, DOI 10.1016/j.ncl.2015.04.009; Kerber KA, 2013, OTOLARYNG HEAD NECK, V148, P425, DOI 10.1177/0194599812471633; Kerber KA, 2011, ACAD EMERG MED, V18, P619, DOI 10.1111/j.1553-2712.2011.01093.x; Kreda SH., 2009, DIAGNOSIS MANAGEMENT; Manser T, 2009, ACTA ANAESTH SCAND, V53, P143, DOI 10.1111/j.1399-6576.2008.01717.x; McDonald KM, 2014, DIAGNOSIS, V1, P55, DOI 10.1515/dx-2013-0023; McDonald KM, 2013, ANN INTERN MED, V158, P381, DOI 10.7326/0003-4819-158-5-201303051-00004; Morrison R, 2006, J VASC NURS, V24, P82, DOI 10.1016/j.jvn.2006.05.002; Nemr NK, 2013, CODAS, V25, P297, DOI 10.1590/S2317-17822013000300017; Newman-Toker DE, 2008, ACTA OTO-LARYNGOL, V128, P601, DOI 10.1080/00016480701596096; Newman-Toker DE, 2007, ANN EMERG MED, V50, P204, DOI 10.1016/j.annemergmed.2007.03.037; Newman-Toker DE, 2016, ANN NEUROL, V79, P27, DOI 10.1002/ana.24532; Newman-Toker DE, 2015, SEMIN NEUROL, V35, P506, DOI 10.1055/s-0035-1564298; Newman-Toker DE, 2015, NEUROL CLIN, V33, P577, DOI 10.1016/j.ncl.2015.04.011; Newman-Toker DE, 2014, DIAGNOSIS, V1, P155, DOI 10.1515/dx-2013-0038; Newman-Toker DE, 2014, ACAD EMERG MED, V21, P348, DOI 10.1111/acem.12338; Newman-Toker DE, 2013, ACAD EMERG MED, V20, P986, DOI 10.1111/acem.12223; Newman-Toker DE, 2009, ACAD EMERG MED, V16, P970, DOI 10.1111/j.1553-2712.2009.00523.x; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Newman-Toker DE., 2015, MOD HEALTHC ANN PAT; Romig Mark, 2010, Hosp Pract (1995), V38, P114, DOI 10.3810/hp.2010.11.348; Royl G, 2011, EUR NEUROL, V66, P256, DOI 10.1159/000331046; Sakr M, 1999, LANCET, V354, P1321, DOI 10.1016/S0140-6736(99)02447-2; Savitz SI, 2007, ACAD EMERG MED, V14, P63, DOI 10.1197/j.aem.2006.06.060; Schiff GD, 2005, DIAGNOSING DIAGNOSIS, P255; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627; SLOANE PD, 1989, J FAM PRACTICE, V29, P33; Stanton VA, 2007, MAYO CLIN PROC, V82, P1319, DOI 10.4065/82.11.1319; STEMBER M, 1991, SOC SCI J, V28, P1, DOI 10.1016/0362-3319(91)90040-B; Tarnutzer AA, 2011, CAN MED ASSOC J, V183, P1025, DOI 10.1503/cmaj.100174; Tehrani ASS, 2013, ACAD EMERG MED, V20, P689, DOI 10.1111/acem.12168; Tehrani ASS, 2013, BMJ QUAL SAF, V22, P672, DOI 10.1136/bmjqs-2012-001550; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116	52	14	14	0	9	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	2194-8011	2194-802X		DIAGNOSIS	Diagnosis	JUN	2016	3	2					49	59		10.1515/dx-2016-0009			11	Medicine, General & Internal	General & Internal Medicine	DN7FU	WOS:000377241500003	29536891	Green Accepted			2021-06-18	
J	Lee, NK; Yang, J; Chang, EH; Park, SE; Lee, J; Choi, SJ; Oh, W; Chang, JW; Na, DL				Lee, Na Kyung; Yang, Jehoon; Chang, Eun Hyuk; Park, Sang Eon; Lee, Jeongmin; Choi, Soo Jin; Oh, Wonil; Chang, Jong Wook; Na, Duk L.			Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer's Disease Mouse Model	PLOS ONE			English	Article							MARROW MONONUCLEAR-CELLS; TRANSGENIC MOUSE; BLOOD; BARRIER; RATS; INFUSION; TRANSPLANTATION; MANNITOL; ISCHEMIA; STROKE	Mesenchymal stem cells (MSCs) have a promising role as a therapeutic agent for neurodegenerative diseases such as Alzheimer's disease (AD). Prior studies suggested that intraarterially administered MSCs are engrafted into the brain in stroke or traumatic brain injury (TBI) animal models. However, a controversial standpoint exists in terms of the integrity of the blood brain barrier (BBB) in transgenic AD mice. The primary goal of this study was to explore the feasibility of delivering human umbilical cord-blood derived mesenchymal stem cells (hUCB-MSCs) into the brains of non-transgenic WT (C3H/C57) and transgenic AD (APP/PS1) mice through the intra-arterial (IA) route. Through two experiments, mice were infused with hUCB-MSCs via the right internal carotid artery and were sacrificed at two different time points: 6 hours (experiment 1) or 5 minutes (experiment 2) after infusion. In both experiments, no cells were detected in the brain parenchyma while MSCs were detected in the cerebrovasculature in experiment 2. The results from this study highlight that intra-arterial delivery of MSCs is not the most favorable route to be implemented as a potential therapeutic approach for AD.	[Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Chang, Jong Wook] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Na, Duk L.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea; [Lee, Na Kyung; Park, Sang Eon; Lee, Jeongmin; Chang, Jong Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea; [Yang, Jehoon] Samsung Biomed Res Inst, Lab Anim Res Ctr, Seoul, South Korea; [Chang, Eun Hyuk] Samsung Elect Co Ltd, Samsung Adv Inst Technol SAIT, Samsung Biomed Res Inst, Seoul 135710, South Korea; [Choi, Soo Jin; Oh, Wonil] MEDIPOST Co Ltd, Biomed Res Inst, Gyeonggi Do 463400, South Korea	Chang, JW (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Na, DL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.; Na, DL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea.; Chang, JW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Stem Cell & Regenerat Med Inst, Seoul, South Korea.	kjistlife@hanmail.net; dukna@naver.com		Lee, Na Kyung/0000-0001-6116-2562	Korean Health Technology R&D Project, Ministry of Health and Welfare [HI12C1821]; Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [HI14C3484]	This study was supported by grants received from the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI12C1821), and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, (HI14C3484), Republic of Korea. Three of the co-authors, EHC, SJC, and WIO, are currently employed by the following commercial companies: Samsung Electronics Co., Ltd and MEDIPOST Co., Ltd, respectively. The funders provided support in the form of salaries for authors [EHC, SJC, and WIO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Casey David A, 2010, P T, V35, P208; Chhabra Lovely, 2012, Indian Pacing Electrophysiol J, V12, P32; Choi JJ, 2008, ULTRASONIC IMAGING, V30, P189, DOI 10.1177/016173460803000304; COSOLO WC, 1989, AM J PHYSIOL, V256, pR443; Cui LL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt544; Do TM, 2014, NEUROPHARMACOLOGY, V81, P311, DOI 10.1016/j.neuropharm.2014.02.010; Guo L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt327; Kean TJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/732742; Khabbal J, 2015, CELL TRANSPLANT, V24, P819, DOI 10.3727/096368914X679336; Kim DH, 2015, STEM CELLS DEV, V24, P2378, DOI 10.1089/scd.2014.0487; Kim Hee Jin, 2015, Alzheimers Dement (N Y), V1, P95, DOI 10.1016/j.trci.2015.06.007; Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140; Kim Ju-Yeon, 2012, World J Stem Cells, V4, P110, DOI 10.4252/wjsc.v4.i11.110; Kim JS, 2012, NANOMEDICINE-UK, V7, P219, DOI [10.2217/NNM.11.94, 10.2217/nnm.11.94]; Kristen D, 2008, MULTISCALE MODEL SIM, V7, P888; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee PH, 2012, ANN NEUROL, V72, P32, DOI 10.1002/ana.23612; Lin H, 2011, CELL MOL IMMUNOL, V8, P19, DOI 10.1038/cmi.2010.57; Mitkari B, 2013, EXP NEUROL, V239, P158, DOI 10.1016/j.expneurol.2012.09.018; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Park HJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0180-4; Park KS, 2010, NANOMED-NANOTECHNOL, V6, P263, DOI 10.1016/j.nano.2009.07.005; Park SE, 2016, NEUROREPORT, V27, P235, DOI 10.1097/WNR.0000000000000526; Poduslo JF, 2001, NEUROBIOL DIS, V8, P555, DOI 10.1006/nbdi.2001.0402; Rosado-de-Castro PH, 2013, REGEN MED, V8, P145, DOI [10.2217/RME.13.2, 10.2217/rme.13.2]; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Wagner B, 2013, ADV BIOCHEM ENG BIOT, V130, P19, DOI 10.1007/10_2012_155; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Yamamoto R, 1985, J JAPANESE SOC CLIN, V24, P150; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yavagal DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093735	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2016	11	5							e0155912	10.1371/journal.pone.0155912			13	Multidisciplinary Sciences	Science & Technology - Other Topics	DM4BV	WOS:000376291500029	27203695	DOAJ Gold, Green Published			2021-06-18	
J	Lian, D; He, DK; Wu, J; Liu, Y; Zhu, MJ; Sun, JM; Chen, F; Li, L				Lian, Di; He, Dake; Wu, Jing; Liu, Ying; Zhu, Mingjie; Sun, Jiaming; Chen, Feng; Li, Ling			Exogenous BDNF increases neurogenesis in the hippocampus in experimental Streptococcus pneumoniae meningitis	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Streptococcus pneumoniae meningitis; Brain-derived neurotrophic factor; Neural stem cells; Endogenous neurogenesis	NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; NEUROTROPHIC FACTOR BDNF; BACTERIAL-MENINGITIS; DENTATE GYRUS; RESTRICTED PROGENITORS; FOREBRAIN NEUROGENESIS; COGNITIVE IMPAIRMENT; ANTIBIOTIC-TREATMENT	Background: Despite the effective use of antibiotics, occurrences of mortality and neurological sequelae following Streptococcus pneumoniae meningitis remain high. Methods: We investigated the neurogenesis of endogenous neural stem cells (NSCs) after inoculation with exogenous brain-derived neurotrophic factor (BDNF) in the hippocampus dentate gyrus following experimental S. pneumoniae meningitis using a double-labeling immunofluorescence analysis with 5-bromo-2'-deoxyuridine (BrdU), Nestin, DCX and NeuN. Results: Our results showed that 7 days after inoculation, the number of BrdU & Nestin co-labeled cells increased in the hippocampus in meningitis rats compared with control rats (p < 0.05). But the number of DCX-positive cells decreased in the dentate gyrus of infected rats treated with saline (p < 0.05). However, these cell numbers returned to close to normal-control levels in infected rats treated with BDNF (p > 0.05). After treatment with exogenous BDNF, the number of BrdU & Nestin co-labeled cells increased in the hippocampus in both the meningitis rats and normal control rats (p < 0.05), but this increase was more significant in the former (p < 0.05). We found that the percentage of BrdU & DCX/BrdU co-labeled cells increased in infected rats treated with BDNF both 7 days and 14 days after inoculation in a greater proportion compared to other groups (p < 0.05). No significant differences were found in the percentage of BrdU & NeuN/BrdU 28 days after inoculation among all of the groups (p > 0.05). Conclusion: Our findings suggest that S. pneumoniae meningitis activates the proliferation of endogenous NSCs, but impairs their early differentiation. Administration of exogenous BDNF might improve the neurogenesis of endogenous NSCs in the hippocampus and may provide a promising therapy after bacterial meningitis. (C) 2016 Elsevier B.V. All rights reserved.	[Lian, Di; He, Dake; Wu, Jing; Li, Ling] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurol, Shanghai, Peoples R China; [Liu, Ying; Chen, Feng] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Zhu, Mingjie; Sun, Jiaming] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pathol, Shanghai, Peoples R China	Li, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Pediat Neurol, Shanghai, Peoples R China.	linglidoctor@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171630, 81271337]	The work of the authors is supported by grants from the National Natural Science Foundation of China (no.81171630; and no.81271337).	Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Barichello T., 2014, MOL NEUROBIOL, P1; Barichello T, 2015, J NEURAL TRANSM, V122, P643, DOI 10.1007/s00702-014-1302-3; Barichello T, 2015, J NEUROIMMUNOL, V278, P262, DOI 10.1016/j.jneuroim.2014.11.015; Barichello T, 2014, EXP BIOL MED, V239, P1360, DOI 10.1177/1535370214535896; Barichello T, 2010, J NEUROIMMUNOL, V223, P73, DOI 10.1016/j.jneuroim.2010.04.004; Bifrare YD, 2005, J INFECT DIS, V191, P40, DOI 10.1086/426399; Bingham B, 2005, BRAIN RES, V1058, P167, DOI 10.1016/j.brainres.2005.07.075; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gerber J, 2003, J NEUROSCI RES, V73, P441, DOI 10.1002/jnr.10682; Gerber J, 2010, CURR OPIN NEUROL, V23, P312, DOI 10.1097/WCO.0b013e32833950dd; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gounder P. P., 2015, J INFECT; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; Hattiangady B, 2007, STEM CELLS, V25, P2104, DOI 10.1634/stemcells.2006-0726; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hofer S, 2011, J NEUROPATH EXP NEUR, V70, P890, DOI 10.1097/NEN.0b013e3182303f31; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Jit M, 2010, J INFECTION, V61, P114, DOI 10.1016/j.jinf.2010.04.008; Kalyani AJ, 1999, J NEUROBIOL, V38, P207, DOI 10.1002/(SICI)1097-4695(19990205)38:2<207::AID-NEU4>3.3.CO;2-7; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Kuhn HG, 2007, CURR PHARM BIOTECHNO, V8, P127; Leib SL, 2001, BRAIN, V124, P1734, DOI 10.1093/brain/124.9.1734; Li L, 2003, J CHILD NEUROL, V18, P828, DOI 10.1177/088307380301801202; Li L, 2007, PEDIATR NEUROL, V36, P324, DOI 10.1016/j.pediatrneurol.2007.01.007; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liechti FD, 2015, FUTURE MICROBIOL, V10, P1195, DOI 10.2217/fmb.15.43; Liu JL, 1998, J NEUROSCI, V18, P7768; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Magavi SS, 2000, NATURE, V405, P951; Muralidharan R, 2014, EUR J NEUROL, V21, P447, DOI 10.1111/ene.12328; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Song XQ, 2014, NEUROL SCI, V35, P1915, DOI 10.1007/s10072-014-1862-x; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vukovic J, 2013, J NEUROSCI, V33, P6603, DOI 10.1523/JNEUROSCI.3064-12.2013; Wellmer A, 2000, NEUROSCI LETT, V296, P137, DOI 10.1016/S0304-3940(00)01645-1; Woehrl B, 2011, EXPERT REV ANTI-INFE, V9, P1053, DOI [10.1586/ERI.11.129, 10.1586/eri.11.129]; Zhu JM, 2011, J INT MED RES, V39, P488, DOI 10.1177/147323001103900216	52	14	14	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	MAY 15	2016	294						46	55		10.1016/j.jneuroim.2016.03.014			10	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	DM7MQ	WOS:000376545100008	27138098				2021-06-18	
J	Ravin, R; Blank, PS; Busse, B; Ravin, N; Vira, S; Bezrukov, L; Waters, H; Guerrero-Cazares, H; Quinones-Hinojosa, A; Lee, PR; Fields, RD; Bezrukov, SM; Zimmerberg, J				Ravin, Rea; Blank, Paul S.; Busse, Brad; Ravin, Nitay; Vira, Shaleen; Bezrukov, Ludmila; Waters, Hang; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Lee, Philip R.; Fields, R. Douglas; Bezrukov, Sergey M.; Zimmerberg, Joshua			Blast shockwaves propagate Ca2+ activity via purinergic astrocyte networks in human central nervous system cells	SCIENTIFIC REPORTS			English	Article							STRETCH-INDUCED INJURY; EXTRACELLULAR ATP; BRAIN-INJURY; MODEL; ANTAGONIST; ACTIVATION; EXPRESSION; RECEPTORS; MECHANISM; NEURONS	In a recent study of the pathophysiology of mild, blast-induced traumatic brain injury (bTBI) the exposure of dissociated, central nervous system (CNS) cells to simulated blast resulted in propagating waves of elevated intracellular Ca2+. Here we show, in dissociated human CNS cultures, that these calcium waves primarily propagate through astrocyte-dependent, purinergic signaling pathways that are blocked by P2 antagonists. Human, compared to rat, astrocytes had an increased calcium response and prolonged calcium wave propagation kinetics, suggesting that in our model system rat CNS cells are less responsive to simulated blast. Furthermore, in response to simulated blast, human CNS cells have increased expressions of a reactive astrocyte marker, glial fibrillary acidic protein (GFAP) and a protease, matrix metallopeptidase 9 (MMP-9). The conjoint increased expression of GFAP and MMP-9 and a purinergic ATP (P2) receptor antagonist reduction in calcium response identifies both potential mechanisms for sustained changes in brain function following primary bTBI and therapeutic strategies targeting abnormal astrocyte activity.	[Ravin, Rea; Blank, Paul S.; Busse, Brad; Ravin, Nitay; Vira, Shaleen; Bezrukov, Ludmila; Waters, Hang; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, NIH, Bethesda, MD 20892 USA; [Ravin, Rea; Ravin, Nitay] Celoptics Inc, Rockville, MD 20852 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA; [Lee, Philip R.; Fields, R. Douglas] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Nervous Syst Dev & Plast, NIH, Bethesda, MD 20892 USA; [Bezrukov, Sergey M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Transport, NIH, Bethesda, MD 20892 USA	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, NIH, Bethesda, MD 20892 USA.	zimmerbj@mail.nih.gov	Blank, Paul/Q-9673-2019	Guerrero-Cazares, Hugo/0000-0003-1307-719X	Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS070024]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD001409, ZIAHD000713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS070024] Funding Source: NIH RePORTER	We thank Dr. Sachiko Murase NINDS, NIH, for a generous gift of rat CNS cortex tissue. This work was supported by the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) of the National Institutes of Health (NIH) and under NIH award number R01NS070024 (A.Q.H.).	Alvarez-Maubecin V, 2000, J NEUROSCI, V20, P4091; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cleries R, 2012, COMPUT BIOL MED, V42, P438, DOI 10.1016/j.compbiomed.2011.12.012; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; De Neve J, 2013, STAT APPL GENET MOL, V12, P333, DOI 10.1515/sagmb-2012-0003; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Gordon GRJ, 2011, EXP PHYSIOL, V96, P393, DOI 10.1113/expphysiol.2010.053132; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kennedy C, 2000, MOL PHARMACOL, V57, P926; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Malik N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096139; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murase S, 2006, J NEUROSCI, V26, P9750, DOI 10.1523/JNEUROSCI.2745-06.2006; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Paemeleire K, 2000, J NEUROTRAUM, V17, P345, DOI 10.1089/neu.2000.17.345; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Ravin R., 2015, United States Patent, Patent No. [US 9,217,698, 9217698]; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wanner IB, 2012, METHODS MOL BIOL, V814, P189, DOI 10.1007/978-1-61779-452-0_14; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x	55	14	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 10	2016	6								25713	10.1038/srep25713			14	Multidisciplinary Sciences	Science & Technology - Other Topics	DL2UD	WOS:000375489800003	27162174	DOAJ Gold, Green Published			2021-06-18	
J	Besnard, J; Richard, P; Banville, F; Nolin, P; Aubin, G; Le Gall, D; Richard, I; Allain, P				Besnard, Jeremy; Richard, Paul; Banville, Frederic; Nolin, Pierre; Aubin, Ghislaine; Le Gall, Didier; Richard, Isabelle; Allain, Phillippe			Virtual reality and neuropsychological assessment: The reliability of a virtual kitchen to assess daily-life activities in victims of traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						instrumental activities of daily living (IADL); executive functions; ecological validity; virtual reality; activities of daily living (ADL); neuropsychological assessment; Action; traumatic brain injury	EXECUTIVE FUNCTION; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HEAD-INJURY; REHABILITATION; DEFICITS; VALIDITY; TASK; ENVIRONMENTS; DYSFUNCTION	Traumatic brain injury (TBI) causes impairments affecting instrumental activities of daily living (IADL). However, few studies have considered virtual reality as an ecologically valid tool for the assessment of IADL in patients who have sustained a TBI. The main objective of the present study was to examine the use of the Nonimmersive Virtual Coffee Task (NI-VCT) for IADL assessment in patients with TBI. We analyzed the performance of 19 adults suffering from TBI and 19 healthy controls (HCs) in the real and virtual tasks of making coffee with a coffee machine, as well as in global IQ and executive functions. Patients performed worse than HCs on both real and virtual tasks and on all tests of executive functions. Correlation analyses revealed that NI-VCT scores were related to scores on the real task. Moreover, regression analyses demonstrated that performance on NI-VCT matched real-task performance. Our results support the idea that the virtual kitchen is a valid tool for IADL assessment in patients who have sustained a TBI.	[Besnard, Jeremy] Univ Angers, Lab Psychol Pays Loire EA 4638, LUNAM Univ, Angers, France; [Richard, Paul] Univ Angers, Lab Angevin Rech Ingn Syst EA 7315, LUNAM Univ, Angers, France; [Banville, Frederic] Univ Quebec Rimousky, Dept Nursing, Rimousky, PQ, Canada; [Nolin, Pierre] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ GA9 5H7, Canada; [Aubin, Ghislaine; Richard, Isabelle] Reg Ctr Funct Rehabil, Angers, France; [Le Gall, Didier; Allain, Phillippe] Univ Angers, Lab Psychol Pays Loire EA 4638, LUNAM Univ, Angers, France; [Le Gall, Didier; Allain, Phillippe] Univ Hosp Angers, Dept Neurol, Neuropsychol Unit, 4 Rue Larrey, F-49033 Angers 01, France	Allain, P (corresponding author), Univ Hosp Angers, Dept Neurol, Neuropsychol Unit, 4 Rue Larrey, F-49033 Angers 01, France.	philippe.allain@univ-angers.fr		ALLAIN, Philiooe/0000-0003-0668-0986; Besnard, Jeremy/0000-0001-7127-7558			Allain P, 2004, REV NEUROPSYCHOL, V14, P285; Allain P, 2014, J INT NEUROPSYCH SOC, V20, P468, DOI 10.1017/S1355617714000344; Allain P, 2012, CORTEX, V48, P1155, DOI 10.1016/j.cortex.2011.05.016; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Burgess PW, 2009, RESTOR NEUROL NEUROS, V27, P493, DOI 10.3233/RNN-2009-0511; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Canty AL, 2014, NEUROPSYCHOL REHABIL, V24, P238, DOI 10.1080/09602011.2014.881746; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Dickinson A, 2007, BEHAV INFORM TECHNOL, V26, P343, DOI 10.1080/01449290601176948; Edwards J, 2014, APPL NEUROPSYCH-ADUL, V21, P220, DOI 10.1080/09084282.2013.796554; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Giovannetti T, 2008, DEMENT GERIATR COGN, V25, P359, DOI 10.1159/000121005; Giovannetti T, 2008, NEUROPSYCHOLOGY, V22, P235, DOI 10.1037/0894-4105.22.2.235; Giovannetti T, 2007, J CLIN EXP NEUROPSYC, V29, P690, DOI 10.1080/13803390600932286; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1989, INTEGRATING THEORY P, P93; Harris Kristen, 2005, Can J Occup Ther, V72, P21; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Josman N, 2008, INT J DISABIL HUM DE, V7, P49; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P171, DOI 10.1080/09084282.2011.643955; Lee JH, 2003, CYBERPSYCHOL BEHAV, V6, P383, DOI 10.1089/109493103322278763; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Ward T., 1994, TEST EVERYDAY ATTENT; Westbrook A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068210; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Wood E, 2005, J APPL GERONTOL, V24, P419, DOI 10.1177/0733464805278378; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	53	14	16	1	39	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 3	2016	23	3					223	235		10.1080/23279095.2015.1048514			13	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DH6KJ	WOS:000372899100010	26569498				2021-06-18	
J	Azouvi, P; Vallat-Azouvi, C; Joseph, PA; Meulemans, T; Bertola, C; Le Gall, D; Bellmann, A; Roussel, M; Coyette, F; Krier, M; Franconie, C; Bindschadler, C; Diouf, M; Godefroy, O				Azouvi, Philippe; Vallat-Azouvi, Claire; Joseph, Pierre-Alain; Meulemans, Thierry; Bertola, Celine; Le Gall, Didier; Bellmann, Anne; Roussel, Martine; Coyette, Francoise; Krier, Marianne; Franconie, Catherine; Bindschadler, Claire; Diouf, Momar; Godefroy, Olivier		GREFEX Study Grp Grp Reflexion	Executive Functions Deficits After Severe Traumatic Brain Injury: The GREFEX Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; behavior; cognition; executive functions; rehabilitation; traumatic brain injury	CLOSED-HEAD INJURY; DYSEXECUTIVE SYNDROME; ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DIVIDED ATTENTION; WORKING-MEMORY; NORMATIVE DATA; REHABILITATION; DYSFUNCTION; COMA	Objective: To assess the sensitivity of traditional neuropsychological tests and of a behavioral inventory of executive disorders in a large sample of patients with chronic severe traumatic brain injury. Methods: A total of 112 patients were compared with 780 healthy controls from a larger database. The GREFEX battery included 7 widely used tests and the Behavioral Dysexecutive Syndrome Inventory (proxy rating). A previously described statistical methodology was used, controlling for age, education, and gender. Summary scores were computed and performance was dichotomized on the basis of 5th percentile cutoffs from controls' z scores. Results: The frequency of cognitive impairment was high (55.4%) but lower than that of behavioral changes (81.5%). Double dissociations were observed between cognitive and behavioral assessments. Behavioral changes exhibited larger effect-sizes as compared with cognitive impairments. Logistic regression analysis showed that 3 cognitive tests (verbal fluency, Stroop reading, and Trail Making Test-B) and 3 behavior z scores (hypoactivity, anticipation, and hyperactivity) best discriminated patients from controls. Conclusion: Behavioral changes were more frequent and severe than cognitive deficits, at least as assessed with traditional testing. The present results also suggest that a shortened battery may provide a rapid screening method with reasonable sensitivity to detect deficits of executive functions in patients with severe traumatic brain injury.	[Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Azouvi, Philippe; Vallat-Azouvi, Claire] Univ Versailles St Quentin, EA HANDIReSP 4047, Garches, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, UGECAMIDF, Antenne UEROS & SAMSAH92, Garches, France; [Joseph, Pierre-Alain] Univ Bordeaux, EA 4136, Liege, Belgium; [Meulemans, Thierry] Univ Liege, Neuropsychol Unit, Liege, Belgium; [Bertola, Celine] Fdn Hopale, CRF Calve, Berck Sur Mer, France; [Le Gall, Didier] CHU, EA 4638, LPPL, Angers, France; [Le Gall, Didier] CHU, Unite Neuropsychol, Angers, France; [Le Gall, Didier] Univ Angers, Angers, France; [Bellmann, Anne] Clin Romande Readaptat, Sion, Switzerland; [Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Dept Neurol, Amiens, France; [Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Lab Funct Neurosci, EA 4559, Amiens, France; [Coyette, Francoise] St Luc Univ, Hosp Bruxelles, Brussels, Belgium; [Krier, Marianne] Inst Reg Med Phys & Readaptat, Nancy, France; [Franconie, Catherine] Univ Hosp, Nimes, France; [Bindschadler, Claire] Univ Lausanne Hosp, Lausanne, Switzerland; [Diouf, Momar] Univ Hosp Amiens, Dept Biostat, Amiens, France	Azouvi, P (corresponding author), Hop Raymond Poincare, Dept Phys Med & Rehabil, F-92380 Garches, France.	philippe.azouvi@rpc.aphp.fr		Godefroy, Olivier/0000-0001-6789-6620			Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Cazalis F, 2001, J INT NEUROPSYCH SOC, V7, P795, DOI 10.1017/S1355617701777028; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Crawford JR, 2008, CHILD NEUROPSYCHOL, V14, P99, DOI 10.1080/09297040801894709; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Glantz SA., 2000, PRIMER APPL REGRESSI; Godefroy O, 2014, J ALZHEIMERS DIS, V42, P1203, DOI 10.3233/JAD-140585; Godefroy O, 2014, CORTEX, V54, P51, DOI 10.1016/j.cortex.2014.01.016; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robertson I, 1996, PHILOS T ROY SOC B, V351, P1411; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Spikman JM, 2000, J CLIN EXP NEUROPSYC, V22, P325, DOI 10.1076/1380-3395(200006)22:3;1-V;FT325; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; TEASDALE G, 1974, LANCET, V2, P81; Tressoldi PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056180; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wang Y., 2014, UNDERSTANDING TRAUMA, P99; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson BA, 1996, BEHAV ASSESSMENT DYS	65	14	14	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E10	E20		10.1097/HTR.0000000000000169			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800002	26394296				2021-06-18	
J	Lopez-Rodriguez, AB; Mela, V; Acaz-Fonseca, E; Garcia-Segura, LM; Viveros, MP				Belen Lopez-Rodriguez, Ana; Mela, Virginia; Acaz-Fonseca, Estefania; Miguel Garcia-Segura, Luis; Viveros, Maria-Paz			CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; CB2 cannabinoid receptor antagonist; Leptin; Neuroinflammation; Mice	AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD INJURY; ENDOCANNABINOID SYSTEM; SICKNESS BEHAVIOR; IMMUNE-RESPONSE; GENE-EXPRESSION; D-AMPHETAMINE; FOOD-INTAKE; CELL-DEATH; MICE	Background and purpose: The rates for traumatic brain injury (TBI) have risen in the last decade. Studies in animal models and clinical trials have not yet resulted in an effective treatment for TBI. Leptin, a 16 kDa peptidic hormone is mainly known as a regulator of energy balance and has been shown to exert neuroprotective effects in different models of brain pathology. In this study, we have assessed whether leptin exerts protective actions in a TBI mouse model. In addition, the possible implication of CB2 cannabinoid receptor in leptin actions has been explored, since it is known that the endocannabinoid system interacts with leptin and actively participates in brain recovery after lesions. Methods: Swiss (CD1) male mice were subjected to weigh-drop model for TBI. Prior to the lesion, mice were injected with an antagonist of CB2 receptor (AM630) or the vehicle and immediately after TBI, they received leptin or vehicle treatment. Data were analyzed using a two-way ANOVA or the non-parametric test Kruskal-Wallis when appropriate. For correlation analyses, Spearman's rho test, followed by linear regression test, was used. Results: TBI induced a neurological deficit, which was improved by leptin treatment. Leptin recovered several parameters affected by TBI, including the expression of cannabinoid receptors, axonal injury marker and neuroinflammatory components. The effects of leptin were prevented or reduced when it was administered in combination with the CB2 receptor antagonist, AM630. Conclusions and implications: Since some of the beneficial effects of leptin were not evident in the presence of AM630, our results suggest that CB2 receptor might be involved in the full expression of the neuroprotective effects of the hormone. These findings open new avenues for the study of leptin as a therapeutic treatment for TBI and enhance the importance of CB2 receptor in TBI pathophysiology and recovery. (C) 2016 Published by Elsevier Inc.	[Belen Lopez-Rodriguez, Ana; Mela, Virginia; Viveros, Maria-Paz] Univ Complutense, Fac Biol, Dept Fisiol, Fisiol Anim 2, E-28040 Madrid, Spain; [Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, E-28002 Madrid, Spain	Lopez-Rodriguez, AB (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	lranabelen@gmail.com	Mela, Virginia/N-4664-2017; Garcia-Segura, Luis M/U-3711-2017; Lopez-Rodriguez, Ana Belen/H-3631-2017; Acaz-Fonseca, Estefania/S-5884-2016; Viveros, Maria-Paz/S-6855-2016	Mela, Virginia/0000-0001-7702-0972; Garcia-Segura, Luis M/0000-0002-2450-2916; Lopez-Rodriguez, Ana Belen/0000-0002-0747-7966; Acaz-Fonseca, Estefania/0000-0003-2549-6420; Viveros, Maria-Paz/0000-0002-4119-4636	Ministerio de Economia y Competitividad, Spain [BFU2011-30217-C03-01, BFU2012-38144]; Redes tematicas de Investigacion Cooperativa en Salud; Red de Trastornos AdictivosInstituto de Salud Carlos III [RD2012/0028/0021-FEDER]; GRUPO UCM [951579]; Precipita-FECYT Crowd funding program	We acknowledge financial support from the Ministerio de Economia y Competitividad, Spain (BFU2011-30217-C03-01 and BFU2012-38144), Redes tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos (RD2012/0028/0021-FEDER), GRUPO UCM (951579) and Precipita-FECYT Crowd funding program.	Adriani W, 2003, BEHAV NEUROSCI, V117, P695, DOI 10.1037/0735-7044.117.4.695; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Agrawal S, 2011, J CLIN IMMUNOL, V31, P89, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Aguilar-Valles A, 2015, NEUROPHARMACOLOGY, V96, P124, DOI 10.1016/j.neuropharm.2014.12.023; Arain M, 2015, ANN CLIN TRANSL NEUR, V2, P289, DOI 10.1002/acn3.163; Avraham Y, 2010, CURR NEUROVASC RES, V7, P136, DOI 10.2174/156720210791184943; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Bosier B, 2013, MOL METAB, V2, P393, DOI 10.1016/j.molmet.2013.08.001; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garcia-Caceres C, 2011, ENDOCRINOLOGY, V152, P1809, DOI 10.1210/en.2010-1252; Gertsch J, 2004, FEBS LETT, V577, P563, DOI 10.1016/j.febslet.2004.10.064; Guo M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.126; Guo M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.9; Han KH, 2009, CARDIOVASC RES, V84, P378, DOI 10.1093/cvr/cvp240; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harvey J, 2007, J NEUROCHEM, V100, P307, DOI 10.1111/j.1471-4159.2006.04205.x; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Liu J, 2010, PSYCHOPHARMACOLOGY, V207, P535, DOI 10.1007/s00213-009-1684-3; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Loffreda S, 1998, FASEB J, V12, P57; De Jesus ML, 2010, NEUROCHEM INT, V56, P829, DOI 10.1016/j.neuint.2010.03.007; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lu JN, 2006, NEUROSCI LETT, V407, P240, DOI 10.1016/j.neulet.2006.08.053; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Fernandez-Martos CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035594; Marwarha G, 2014, BBA-MOL BASIS DIS, V1842, P1587, DOI 10.1016/j.bbadis.2014.05.015; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Palomba L, 2015, J BIOL CHEM, V290, P13669, DOI 10.1074/jbc.M115.646885; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Pinteaux E, 2007, J NEUROCHEM, V102, P826, DOI 10.1111/j.1471-4159.2007.04559.x; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Siegl D, 2014, ANESTHESIOLOGY, V121, P98, DOI 10.1097/ALN.0000000000000192; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Sonia Villapol T. T. L, 2013, TRENDS CELL SIGNALIN; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Suarez J, 2009, HIPPOCAMPUS, V19, P623, DOI 10.1002/hipo.20537; Tang BL, 2008, BIOCHEM BIOPH RES CO, V368, P181, DOI 10.1016/j.bbrc.2008.01.063; TANG H, 2015, BRAIN INJURY, P1; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Viveros MP, 2012, J PSYCHOPHARMACOL, V26, P164, DOI 10.1177/0269881111408956; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Whiteside GT, 2005, EUR J PHARMACOL, V528, P65, DOI 10.1016/j.ejphar.2005.10.043; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xiao EN, 2003, ENDOCRINOLOGY, V144, P4350, DOI 10.1210/en.2003-0532; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zhang JY, 2013, J CEREBR BLOOD F MET, V33, P567, DOI 10.1038/jcbfm.2012.202	87	14	16	1	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						274	282		10.1016/j.expneurol.2016.03.018			9	Neurosciences	Neurosciences & Neurology	DK0OU	WOS:000374612900024	27006282				2021-06-18	
J	Chen, SY; Shi, QK; Zheng, SY; Luo, LS; Yuan, ST; Wang, X; Cheng, ZH; Zhang, WH				Chen, Shangyu; Shi, Qiankun; Zheng, Shuyun; Luo, Liangshen; Yuan, Shoutao; Wang, Xiang; Cheng, Zihao; Zhang, Wenhao			Role of alpha-II-spectrin breakdown products in the prediction of the severity and clinical outcome of acute traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						acute traumatic brain injury; alpha-II-spectrin breakdown products; prediction of the severity of injury; clinical outcome	SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; CELL-DEATH; CALPAIN; MECHANISMS; APOPTOSIS; RATS; ACCUMULATION; DEGRADATION; PROTEOLYSIS	alpha II-spectrin breakdown products are regarded as potential biomarkers for traumatic brain injury (TBI). The aim of the present study was to further evaluate these biomarkers by assessing their clinical utility in predicting the severity of injury and clinical outcome of patients with TBI. Eligible patients with acute TBI (n=17), defined by a Glasgow Coma Scale (GCS) score of <= 8, were enrolled. Ventricular cerebrospinal fluid (CSF) was sampled from each patient at 24, 72 and 120 h following TBI. An immunoblot assay was used to determine the concentrations of SBDPs in the CSF samples. The concentrations of SBDPs combined with the GCS score at 24 h after injury and the Glasgow Outcome Score (GOS) at 30 days after injury were compared and analyzed. The levels of SBDPs in CSF were markedly increased following acute TBI in comparison with those in the control group. In the early period after TBI, the levels of SBDPs were closely associated with GCS score. Comparisons of the SBDP levels with the severity of injury revealed significant differences between patients with the most severe brain injury and patients with severe brain injury in the first 24 h post-injury (P<0.05). The levels and dynamic changes of SBDPs in CSF exhibited a close association with GOS at 30 days after injury. The levels of SBDPs differed significantly between patients grouped according to prognosis (P<0.05). These results suggest that in the early period after TBI, the levels and dynamic changes of SBDPs in CSF can be useful in the prediction of the severity of injury and clinical outcome of patients.	[Chen, Shangyu; Shi, Qiankun; Zheng, Shuyun; Yuan, Shoutao; Wang, Xiang; Cheng, Zihao; Zhang, Wenhao] Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China; [Luo, Liangshen] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurosurg, Nanjing 210006, Jiangsu, Peoples R China	Zheng, SY (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Crit Care Med, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	syzheng915@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171786]	The present study was supported by the National Natural Science Foundation of China (grant no. 81171786).	Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cardali S, 2006, J Neurosurg Sci, V50, P25; Castillo MR, 1998, NEUROSCIENCE, V86, P1133, DOI 10.1016/S0306-4522(98)00070-0; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Kmietowicz Z, 2007, BRIT MED J, V335, P1182, DOI 10.1136/bmj.39415.528623.AD; MAJNO G, 1995, AM J PATHOL, V146, P3; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	27	14	15	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAY	2016	11	5					2049	2053		10.3892/etm.2016.3153			5	Medicine, Research & Experimental	Research & Experimental Medicine	DH3TR	WOS:000372710200082	27168849	Bronze, Green Published			2021-06-18	
J	Dennis, EL; Hua, X; Villalon-Reina, J; Moran, LM; Kernan, C; Babikian, T; Mink, R; Babbitt, C; Johnson, J; Giza, CC; Thompson, PM; Asarnow, RF				Dennis, Emily L.; Hua, Xue; Villalon-Reina, Julio; Moran, Lisa M.; Kernan, Claudia; Babikian, Talin; Mink, Richard; Babbitt, Christopher; Johnson, Jeffrey; Giza, Christopher C.; Thompson, Paul M.; Asarnow, Robert F.			Tensor-Based Morphometry Reveals Volumetric Deficits in Moderate/Severe Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						MRI; pediatric; tensor based morphometry; traumatic brain injury	CORPUS-CALLOSUM; CHILDREN; MRI; ATROPHY; CHILDHOOD; OUTCOMES; GROWTH; TBI	Traumatic brain injury (TBI) can cause widespread and prolonged brain degeneration. TBI can affect cognitive function and brain integrity for many years after injury, often with lasting effects in children, whose brains are still immature. Although TBI varies in how it affects different individuals, image analysis methods such as tensor-based morphometry (TBM) can reveal common areas of brain atrophy on magnetic resonance imaging (MRI), secondary effects of the initial injury, which will differ between subjects. Here we studied 36 pediatric moderate to severe TBI (msTBI) participants in the post-acute phase (1-6 months post-injury) and 18 msTBI participants who returned for their chronic assessment, along with well-matched controls at both time-points. Participants completed a battery of cognitive tests that we used to create a global cognitive performance score. Using TBM, we created three-dimensional (3D) maps of individual and group differences in regional brain volumes. At both the post-acute and chronic time-points, the greatest group differences were expansion of the lateral ventricles and reduction of the lingual gyrus in the TBI group. We found a number of smaller clusters of volume reduction in the cingulate gyrus, thalamus, and fusiform gyrus, and throughout the frontal, temporal, and parietal cortices. Additionally, we found extensive associations between our cognitive performance measure and regional brain volume. Our results indicate a pattern of atrophy still detectable 1-year post-injury, which may partially underlie the cognitive deficits frequently found in TBI.	[Dennis, Emily L.; Hua, Xue; Villalon-Reina, Julio; Thompson, Paul M.] USC, Keck Sch Med, Imaging Genet Ctr, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Engn, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Marina Del Rey, CA USA; [Moran, Lisa M.; Kernan, Claudia; Babikian, Talin; Asarnow, Robert F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Mink, Richard] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Mink, Richard] Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA USA; [Babbitt, Christopher] Miller Childrens Hosp, Long Beach, CA USA; [Johnson, Jeffrey] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Brain Injury Res Ctr, Div Pediat Neurol, Los Angeles, CA USA	Dennis, EL (corresponding author), Univ So Calif, Keck Sch Med, 2001 N Soto St, Los Angeles, CA 90033 USA.	emily.dennis@ini.usc.edu	Dennis, Emily/AAD-5223-2021; Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB008432, U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS080655, K99NS096116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG040060] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54 EB020403, R01 EB008432] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99 NS096116, R01 NS080655] Funding Source: Medline		[Anonymous], 2015, CONCUSSION MANAGEMEN; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Delis D, 1994, CALIFORNIA VERBAL LE; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dennis Emily L, 2013, Dialogues Clin Neurosci, V15, P359; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hua X, 2009, HUM BRAIN MAPP, V30, P209, DOI 10.1002/hbm.20498; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Langers DRM, 2007, NEUROIMAGE, V38, P43, DOI 10.1016/j.neuroimage.2007.07.031; Leow A, 2005, LECT NOTES COMPUT SC, V3565, P493; Lepore N, 2007, LECT NOTES COMPUT SC, V4792, P826; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; REKATE HL, 1995, NEUROSURGERY, V37, P399; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Verger K, 2001, BRAIN INJURY, V15, P211; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D., 2003, WECHSLER INTELLIGENC; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	35	14	14	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					840	852		10.1089/neu.2015.4012			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800006	26393494	Green Published, Other Gold			2021-06-18	
J	Griffin, JH; Fernandez, JA; Lyden, PD; Zlokovic, BV				Griffin, John H.; Fernandez, Jose A.; Lyden, Patrick D.; Zlokovic, Berislav V.			Activated protein C promotes neuroprotection: mechanisms and translation to the clinic	THROMBOSIS RESEARCH			English	Article						activated protein C (APC); stroke; neuroprotection; neurogenesis; traumatic brain injury	REDUCED ANTICOAGULANT ACTIVITY; TISSUE-PLASMINOGEN ACTIVATOR; FOCAL ISCHEMIC-STROKE; GLUTAMATE EXCITOTOXICITY; RECEPTOR 1; HIPPOCAMPAL-NEURONS; THERAPEUTIC WINDOW; ENDOTHELIAL-CELLS; MICE; DEFICIENCY	Activated protein C (APC) is a plasma serine protease that is capable of antithrombotic, anti-inflammatory, anti-apoptotic, and cell-signaling activities. Animal injury studies show that recombinant APC and some of its mutants are remarkably therapeutic for a wide range of injuries. In particular, for neurologic injuries, APC reduces damage caused by ischemia/reperfusion in the brain, by acute brain trauma, and by chronic neurodegenerative conditions. For these neuroprotective effects, APC requires endothelial cell protein C receptor. APC activates cell signaling networks with alterations in gene expression profiles by activating protease activated receptors 1 and 3. To minimize APC-induced bleeding risk, APC variants were engineered to lack > 90% anticoagulant activity but retain normal cell signaling. The neuroprotective APC mutant, 3K3A-APC which has Lys191-193 mutated to Ala191-193, is very neuroprotective and it is currently in clinical trials for ischemic stroke. (C) 2016 Elsevier Ltd. All rights reserved.	[Griffin, John H.; Fernandez, Jose A.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Griffin, John H.] Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA; [Lyden, Patrick D.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Griffin, JH (corresponding author), Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA.	jgriffin@scripps.edu	Fernandez, Jose A/A-3211-2008	Fernandez, Jose A/0000-0002-0804-1865; Griffin, John/0000-0002-4302-2547	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL052246, R01HL021544, P01HL031950, R37HL052246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090904, U01NS088312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005142] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R37 HL052246, P01 HL031950, R01 HL021544, R01 HL052246] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005142] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS090904, U01 NS088312] Funding Source: Medline		Amar AP, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00344; Bock F, 2014, THROMB HAEMOSTASIS, V111, P610, DOI 10.1160/TH13-11-0967; BRANSON HE, 1983, LANCET, V2, P1165; Burnier L, 2013, BLOOD, V122, P807, DOI 10.1182/blood-2013-03-488957; Chalmers E, 2011, ARCH DIS CHILD, V96, P1066, DOI 10.1136/adc.2010.199919; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cheng T, 2006, NAT MED, V12, P1278, DOI 10.1038/nm1498; DREYFUS M, 1995, SEMIN THROMB HEMOST, V21, P371, DOI 10.1055/s-2007-1000658; Esmon CT, 2012, SEMIN IMMUNOPATHOL, V34, P127, DOI 10.1007/s00281-011-0284-6; Fernandez JA, 2003, BLOOD CELL MOL DIS, V30, P271, DOI 10.1016/S1079-9796(03)00034-2; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Gorbacheva L, 2010, NEUROSCIENCE, V165, P1138, DOI 10.1016/j.neuroscience.2009.11.027; Gorbacheva LR, 2008, BIOCHEMISTRY-MOSCOW+, V73, P717, DOI 10.1134/S0006297908060138; Gorbacheva L, 2013, NEUROCHEM INT, V63, P101, DOI 10.1016/j.neuint.2013.05.008; Gorbacheva LR, 2007, THROMB HAEMOSTASIS, V98, P1150, DOI 10.1160/TH07-03-0228; Gorbacheva L, 2009, J NEUROCHEM, V111, P967, DOI 10.1111/j.1471-4159.2009.06380.x; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Guo H, 2004, NEURON, V41, P563, DOI 10.1016/S0896-6273(04)00019-4; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Guo H, 2009, EUR J NEUROSCI, V29, P1119, DOI 10.1111/j.1460-9568.2009.06664.x; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Jalbert LR, 1998, J CLIN INVEST, V102, P1481, DOI 10.1172/JCI3011; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Lay AJ, 2005, J CLIN INVEST, V115, P1552, DOI 10.1172/JCI24030; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; Macko RF, 1996, STROKE, V27, P2005, DOI 10.1161/01.STR.27.11.2005; Macko RF, 1999, STROKE, V30, P542, DOI 10.1161/01.STR.30.3.542; McKelvey Kelly, 2014, World J Biol Chem, V5, P169, DOI 10.4331/wjbc.v5.i2.169; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2014, THROMB HAEMOSTASIS, V112, P883, DOI 10.1160/TH14-05-0448; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Ohga S, 2013, HAEMOPHILIA, V19, P378, DOI 10.1111/hae.12097; PETRAGLIA AL, 2010, NEUROSURGERY, V66, P71; Petraglia AL, 2010, NEUROSURGERY, V66, P165, DOI 10.1227/01.NEU.0000363148.49779.68; Quinn LM, 2015, BIOCHEM SOC T, V43, P691, DOI 10.1042/BST20140312; Rezaie AR, 2014, THROMB HAEMOSTASIS, V112, P876, DOI 10.1160/TH14-02-0167; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Shibata M, 2001, CIRCULATION, V103, P1799, DOI 10.1161/01.CIR.103.13.1799; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Walker CT, 2010, BRAIN RES, V1347, P125, DOI 10.1016/j.brainres.2010.05.075; Wang YM, 2013, STROKE, V44, P3529, DOI 10.1161/STROKEAHA.113.003350; Wang YM, 2013, BLOOD CELL MOL DIS, V51, P104, DOI 10.1016/j.bcmd.2013.02.009; Wang YM, 2013, BRAIN RES, V1507, P97, DOI 10.1016/j.brainres.2013.02.023; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Wang YM, 2009, STROKE, V40, P1864, DOI 10.1161/STROKEAHA.108.536680; Wildhagen KCAA, 2011, THROMB HAEMOSTASIS, V106, P1034, DOI 10.1160/TH11-08-0522; Williams PD, 2012, CURR PHARM DESIGN, V18, P4215; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	55	14	14	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	MAY	2016	141			2			S62	S64					3	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	DM2TR	WOS:000376201100017	27207428	Green Accepted			2021-06-18	
J	Momosaki, R; Yasunaga, H; Matsui, H; Horiguchi, H; Fushimi, K; Abo, M				Momosaki, Ryo; Yasunaga, Hideo; Matsui, Hiroki; Horiguchi, Hiromasa; Fushimi, Kiyohide; Abo, Masahiro			Predictive factors for oral intake after aspiration pneumonia in older adults	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						aspiration pneumonia; dysphagia; elderly; oral intake	ACUTE ISCHEMIC-STROKE; TRAUMATIC BRAIN-INJURY; HOSPITALIZED-PATIENTS; SINGLE-CENTER; DYSPHAGIA; RISK; DATABASE; SYSTEM	Aim: The purpose of the present study was to clarify the predictive factors for achieving oral intake after aspiration pneumonia in elderly patients. Methods: This retrospective observational study used data from the Japanese Diagnosis Procedure Combination inpatient database. We identified patients who were admitted to acute-care hospitals with aspiration pneumonia. The outcome was time to achieve total oral intake. We carried out Cox regression analysis to identify predictors for the early initiation of total oral intake. Results: Of 66 611 elderly patients with aspiration pneumonia, 59% achieved total oral intake within 30 days. Cox regression analysis showed that early initiation of total oral intake was associated with female sex and higher Barthel Index. Delayed initiation of total oral intake was associated with underweight, higher scores of pneumonia severity and comorbidities. Conclusion: We clarified prognostic factors for total oral intake in elderly aspiration pneumonia patients. Our findings will be helpful in nutritional care planning for elderly aspiration pneumonia patients.	[Momosaki, Ryo; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo 1058461, Japan; [Momosaki, Ryo; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan	Momosaki, R (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	momosakiryo@gmail.com	Momosaki, Ryo/H-6486-2018	Momosaki, Ryo/0000-0003-3274-3952; Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labor and Welfare, JapanMinistry of Health, Labour and Welfare, Japan [H26-Policy-011]	This study was funded by a grant from the Ministry of Health, Labor and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011).	Chang CY, 2013, STROKE, V44, P1182, DOI 10.1161/STROKEAHA.111.000663; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; Kohno S, 2011, INTERNAL MED, V50, P1183, DOI 10.2169/internalmedicine.50.4651; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Maeshima S, 2013, J STROKE CEREBROVASC, V22, P926, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.003; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Matsuda S, 2008, EUROHEALTH, V14, P27; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Nakajima M, 2014, J REHABIL MED, V46, P200, DOI 10.2340/16501977-1260; Nakajima M, 2012, J NEUROL SCI, V323, P56, DOI 10.1016/j.jns.2012.08.006; Nakajima M, 2012, INTERNAL MED, V51, P45, DOI 10.2169/internalmedicine.51.5593; Nakajima M, 2010, DYSPHAGIA, V25, P192, DOI 10.1007/s00455-009-9242-z; Park YH, 2013, GERIATR NURS, V34, P212, DOI 10.1016/j.gerinurse.2013.02.014; Sainsbury A, 2005, AGE AGEING, V34, P228, DOI 10.1093/ageing/afi063; Sasaki T, 2012, DIGEST ENDOSC, V24, P226, DOI 10.1111/j.1443-1661.2011.01208.x; Serra-Prat M, 2012, AGE AGEING, V41, P376, DOI 10.1093/ageing/afs006; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Takahata H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-6; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; van der Maarel-Wierink CD, 2011, J DENT RES, V90, P1398, DOI 10.1177/0022034511422909; Warnecke T, 2008, J NEUROL NEUROSUR PS, V79, P312, DOI 10.1136/jnnp.2007.134551	25	14	15	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAY	2016	16	5					556	560		10.1111/ggi.12506			5	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	DK5MS	WOS:000374964600004	25953259				2021-06-18	
J	Sander, AM; Maestas, KL; Pappadis, MR; Hammond, FM; Hanks, RA				Sander, Angelle M.; Maestas, Kacey Little; Pappadis, Monique R.; Hammond, Flora M.; Hanks, Robin A.		NIDILRR Traumatic Brain Injury Mod	Multicenter Study of Sexual Functioning in Spouses/Partners of Persons With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							INDEPENDENCE MEASURE; HEAD-INJURY; REHABILITATION; SATISFACTION; ADJUSTMENT; STABILITY; DISTRESS; TBI; ADENOCARCINOMA; PARTICIPATION	Objective: To investigate sexual functioning and its predictors in spouses/partners of persons with traumatic brain injury (TBI). Design: Inception cohort survey. Setting: Community. Participants: Persons (N=70) with complicated mild to severe TBI admitted to 1 of 6 participating TBI Model Systems inpatient rehabilitation units and their spouses/partners who were both living in the community and assessed 1 year after injury. Interventions: Not applicable. Main Outcome Measures: Derogatis Interview for Sexual Functioning Self-Report; Global Sexual Satisfaction Index. Results: Twenty percent of spouses/partners of persons with TBI reported sexual dysfunction, and 44% reported dissatisfaction with sexual functioning. Sixty-two percent of spouses/partners reported a decrease in sexual activity during the year postinjury, 34% reported a decrease in sexual drive or desire, and 34% indicated that sexuality was less important in comparison to preinjury. The sexual functioning of spouses/partners of persons with TBI was highly associated with the sexual functioning of the person with TBI. Age of spouses/partners and sexual functioning in persons with the TBI were significant predictors of spouses'/partners' sexual functioning, even after controlling for sex of partners and the physical, cognitive, participation, and sexual functioning of the persons with injury. Conclusions: Greater sexual dysfunction in spouses/partners was associated with older age and with poorer sexual functioning in the person with injury. Rehabilitation professionals should provide education on the potential impact of TBI on sexual functioning for both persons with TBI and their spouses/partners, and integrate the assessment of sexual functioning into their clinical assessment, making appropriate referrals for therapy. (C) 2016 by the American Congress of Rehabilitation Medicine	[Sander, Angelle M.; Maestas, Kacey Little] Baylor Coll Med, Harris Hlth Syst, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.; Maestas, Kacey Little; Pappadis, Monique R.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Pappadis, Monique R.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Hammond, Flora M.] Carolinas Hlth Care Syst, Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Hanks, Robin A.] Rehabil Inst Michigan, Detroit, MI USA	Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	asander@bcm.edu	Pappadis, Monique/Q-8639-2016	Pappadis, Monique/0000-0003-4742-4380; Ripley, David/0000-0002-5349-1830	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0028, H133A070043, 90RT5007, H133A080044, H133A070042, 90DP0036]	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant nos. 90DP0028, H133A070043, 90RT5007, H133A080044, H133A070042, 90DP0036). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/h0080313; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; [Anonymous], 1997, GUIDE UNIFORM DATA S; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Cameron RP, 2011, REHABIL PSYCHOL, V56, P289, DOI 10.1037/a0025513; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Derogatis L, 1987, DEROGATIS INTERVIEW; Derogatis L. R., 1975, DEROGATIS SEXUAL FUN; Derogatis LR, 1997, J SEX MARITAL THER, V23, P291; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gosling J, 1999, BRAIN INJURY, V13, P785; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hall KM., 1993, J HEAD TRAUMA REHAB, V8, DOI [DOI 10.1097/00001199-199308020-00008, 10.1097/00001199-199308020-00008]; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee DM, 2016, ARCH SEX BEHAV, V45, P133, DOI 10.1007/s10508-014-0465-1; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Nicolosi A, 2006, J SEX MARITAL THER, V32, P331, DOI 10.1080/00926230600666469; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2014.02.006, 10.1016/j.apmr.2013.06.004]; TEASDALE G, 1974, LANCET, V2, P81; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P729, DOI 10.1016/0360-3016(90)90503-C; ZINREICH ES, 1990, INT J RADIAT ONCOL, V19, P1001, DOI 10.1016/0360-3016(90)90025-F	44	14	14	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2016	97	5					753	759		10.1016/j.apmr.2016.01.009			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DL4UM	WOS:000375633300014	26845190				2021-06-18	
J	Schmidt, JD; Pierce, AF; Guskiewicz, KM; Register-Mihalik, JK; Pamukoff, DN; Mihalik, JP				Schmidt, Julianne D.; Pierce, Alice F.; Guskiewicz, Kevin M.; Register-Mihalik, Johna K.; Pamukoff, Derek N.; Mihalik, Jason P.			Safe-Play Knowledge, Aggression, and Head-Impact Biomechanics in Adolescent Ice Hockey Players	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; mild traumatic brain injuries; head trauma; adolescent sports	BODY-CHECKING; YOUTH; CONCUSSION; INJURY; EPIDEMIOLOGY; FOOTBALL; POSITION; RULES; SPORT; RISK	Context: Addressing safe-play knowledge and player aggression could potentially improve ice hockey sport safety. Objectives: To compare (1) safe-play knowledge and aggression between male and female adolescent ice hockey players and (2) head-impact frequency and severity between players with high and low levels of safe-play knowledge and aggression during practices and games. Design: Cohort study. Setting: On field. Patients or Other Participants: Forty-one male (n = 29) and female (n = 12) adolescent ice hockey players. Intervention(s): Players completed the Safe Play Questionnaire (0 = less knowledge, 7 = most knowledge) and Competitive Aggressiveness and Anger Scale (12 = less aggressive, 60 = most aggressive) at midseason. Aggressive penalty minutes were recorded throughout the season. The Head Impact Telemetry System was used to capture headimpact frequency and severity (linear acceleration [g], rotational acceleration [rad/s(2)], Head Impact Technology severity profile) at practices and games. Main Outcome Measure(s): One-way analyses of variance were used to compare safe play knowledge and aggression between sexes. Players were categorized as having high or low safe-play knowledge and aggression using a median split. A 23 2 mixed-model analysis of variance was used to compare headimpact frequency, and random-intercept general linear models were used to compare head-impact severity between groups (high, low) and event types (practice, game). Results: Boys (5.8 of 7 total; 95% confidence interval [CI] = 5.3, 6.3) had a trend toward better safe-play knowledge compared with girls (4.9 of 7 total; 95% CI = 3.9, 5.9; F-1,F-36 = 3.40, P =.073). Less aggressive male players sustained significantly lower head rotational accelerations during practices (1512.8 rad/s(2), 95% CI = 1397.3, 1637.6 rad/s(2)) versus games (1754.8 rad/s(2), 95% CI = 1623.9, 1896.2 rad/s(2)) and versus high-aggression players during practices (1773.5 rad/s(2), 95% CI = 1607.9, 1956.3 rad/s(2); F-1,F-26 = 6.04, P = .021). Conclusions: Coaches and sports medicine professionals should ensure that athletes of all levels, ages, and sexes have full knowledge of safe play and should consider aggression interventions for reducing head-impact severity among aggressive players during practice.	[Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol & Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA; [Pierce, Alice F.] Carolina Family Practice & Sports Med, Cary, NC USA; [Guskiewicz, Kevin M.; Register-Mihalik, Johna K.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Register-Mihalik, Johna K.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Pamukoff, Derek N.] Calif State Univ Fullerton, Dept Kinesiol, Fullerton, CA 92634 USA	Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol & Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Pamukoff, Derek/AAL-9296-2021				Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano Michael D, 2011, Open Med, V5, pe57; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Gee CJ, 2007, PSYCHOL SPORT EXERC, V8, P567, DOI 10.1016/j.psychsport.2006.06.006; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kukaswadia A, 2010, PEDIATRICS, V125, P735, DOI 10.1542/peds.2009-2083; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Malenfant S, 2012, J SCI MED SPORT, V15, P463, DOI 10.1016/j.jsams.2012.03.003; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Maxwell JP, 2007, PSYCHOL SPORT EXERC, V8, P179, DOI 10.1016/j.psychsport.2006.03.002; Mihalik JP, 2008, P I MECH ENG P-J SPO, V222, P45, DOI 10.1243/17543371JSET4; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Paul RJ, 2013, INT J SPORT FINANC, V8, P21; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Smith AM, 2013, CURR SPORT MED REP, V12, P356, DOI 10.1249/JSR.0000000000000004; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Swartz EE, 2009, J ATHL TRAINING, V44, P306, DOI 10.4085/1062-6050-44.3.306; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	30	14	14	1	12	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2016	51	5					366	372		10.4085/1062-6050-51.5.04			7	Sport Sciences	Sport Sciences	EI9VD	WOS:000392856500001	27111585	Green Published, Bronze			2021-06-18	
J	Vangansewinkel, T; Geurts, N; Quanten, K; Nelissen, S; Lemmens, S; Geboes, L; Dooley, D; Vidal, PM; Pejler, G; Hendrix, S				Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Pejler, Gunnar; Hendrix, Sven			Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6	FASEB JOURNAL			English	Article						CNS trauma; mMCP6; ECM remodeling; gene expression; improved outcome	CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCANS; AXONAL REGENERATION; GLIAL SCAR; BETA-TRYPTASE; ABC PROMOTES; MATRIX; INFLAMMATION; BRAIN; MICE	An important barrier for axon regeneration and recovery after traumatic spinal cord injury (SCI) is attributed to the scar that is formed at the lesion site. Here, we investigated the effect of mouse mast cell protease (mMCP) 6, a mast cell (MC)-specific tryptase, on scarring and functional recovery after a spinal cord hemisection injury. Functional recovery was significantly impaired in both MC-deficient and mMCP6-knockout (mMCP6(-/-)) mice after SCI compared with wild-type control mice. This decrease in locomotor performance was associated with an increased lesion size and excessive scarring at the injury site. Axon growth-inhibitory chondroitin sulfate proteoglycans and the extracellular matrix components fibronectin, laminin, and collagen IV were significantly up-regulated in MC-deficient and mMCP6(-/-) mice, with an increase in scar volume between 23 and 32%. A degradation assay revealed that mMCP6 directly cleaves fibronectin and collagen IV in vitro. In addition, gene expression levels of the scar components fibronectin, aggrecan, and collagen IV were increased up to 6.8-fold in mMCP6(-/-) mice in the subacute phase after injury. These data indicate that endogenous mMCP6 has scar-suppressing properties after SCI via indirect cleavage of axon growth-inhibitory scar components and alteration of the gene expression profile of these factors.-Vangansewinkel, T., Geurts, N., Quanten, K., Nelissen, S., Lemmens, S., Geboes, L., Dooley, D., Vidal, P. M., Pejler, G., Hendrix, S. Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6. www.fasebj.org	[Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Hendrix, Sven] Hasselt Univ, Biomed Res Inst, Dept Morphol, Diepenbeek, Belgium; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Vidal, Pia M.] Univ Hlth Network, Div Genet & Dev, Krembil Neurosci Ctr, Toronto, ON, Canada	Hendrix, S (corresponding author), Martelarenlaan 42, B-3500 Hasselt, Belgium.	sven.hendrix@uhasselt.be	Vangansewinkel, Tim/N-4308-2017; Hendrix, Sven/F-4059-2010; Vidal, Pia M./U-8401-2019	Hendrix, Sven/0000-0003-2344-7369; Vidal, Pia M./0000-0001-9885-3076; Dooley, Dearbhaile/0000-0001-5337-1831	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SPP1394]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)FWO [G.0389.12, G0A5813, G.0834.11N, G0A58113, 1.2.917.14N]; Agentschap voor Innovatie door Wetenschap en Technologie [101517]; COST Action Mast Cells and Basophils-Targets for Innovative Therapies [BM1007]	The authors thank Dr. David Lee (Novartis Pharma, Basel, Switzerland) and Dr. Peter Nigrovic (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for providing the mMCP6<SUP>-/-</SUP> mice, and Dr. Leen Timmermans (Hasselt University) for her help with the qPCR analysis and immunohistochemistry. This study was supported in part by grants from Deutsche Forschungsgemeinschaft (SPP1394), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO; G.0389.12, G0A5813, G.0834.11N, and G0A58113 to S.H., and 1.2.917.14N to N.G.), and from Agentschap voor Innovatie door Wetenschap en Technologie (101517 to T.V.). This work has also benefited from the support of the COST Action BM1007 Mast Cells and Basophils-Targets for Innovative Therapies.	Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Didangelos A, 2014, J NEUROSCI, V34, P16424, DOI 10.1523/JNEUROSCI.2927-14.2014; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Douaiher J, 2014, ADV IMMUNOL, V122, P211, DOI 10.1016/B978-0-12-800267-4.00006-7; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Fajardo I, 2003, J IMMUNOL, V171, P1493, DOI 10.4049/jimmunol.171.3.1493; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Hermanns S, 2006, ADV EXP MED BIOL, V557, P177; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Liu XB, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/627831; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Loske P, 2012, J NEUROCHEM, V120, P1084, DOI 10.1111/j.1471-4159.2012.07657.x; Lundequist A, 2006, BIOL CHEM, V387, P1513, DOI 10.1515/BC.2006.189; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033; Mullan CS, 2008, AM J RESP CELL MOL, V38, P600, DOI 10.1165/rcmb.2007-0082OC; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Nelissen S, 2013, ACTA NEUROPATHOL, V125, P637, DOI 10.1007/s00401-013-1092-y; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Polajeva J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025222; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Ribatti D, 2015, EXP CELL RES, V332, P157, DOI 10.1016/j.yexcr.2014.11.014; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Schwab ME, 1996, PHYSIOL REV, V76, P319; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal PM, 2013, CYTOKINE GROWTH F R, V24, P1, DOI 10.1016/j.cytogfr.2012.08.008; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Yang XP, 2010, LEUKEMIA LYMPHOMA, V51, P1550, DOI 10.3109/10428194.2010.496013; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu YJ, 2015, J NEUROTRAUM, V32, P1158, DOI 10.1089/neu.2014.3703	74	14	15	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2040	2057		10.1096/fj.201500114R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	WOS:000374879400030	26917739				2021-06-18	
J	Warren, AM; Rainey, EE; Weddle, RJ; Bennett, M; Roden-Foreman, K; Foreman, ML				Warren, Ann Marie; Rainey, Evan Elizabeth; Weddle, Rebecca Joanne; Bennett, Monica; Roden-Foreman, Kenleigh; Foreman, Michael L.			The Intensive Care Unit Experience: Psychological Impact on Family Members of Patients With and Without Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						intensive care unit; traumatic brain injury; family caregiver	POSTTRAUMATIC-STRESS; CRITICAL ILLNESS; DEPRESSION; CAREGIVERS; SYMPTOMS; PREDICTORS; ANXIETY; SCREEN	Purpose/Objective: The intensive care unit (ICU) has been identified as a possible contributor to emotional distress. This study seeks to identify whether families of traumatic brain injury (TBI) patients in the ICU experience psychological differences as compared with non-TBI patients' family members. Method: Eighty-two family members in a trauma/critical care ICU were assessed at baseline and again at 3 months. The Patient Health Questionnaire 8-Item measured depression, the Primary Care PTSD Screen measured symptoms of posttraumatic stress (PTS). Results: Forty of these individuals were the family members of ICU patients who had sustained a TBI; 42 of the individuals were the family members of non-TBI patients in the ICU. At baseline, 39% (33% non-TBI, 45% TBI, p = .28) of the total sample screened positive for depressive symptoms and 24.3% (26% non-TBI, 23% TBI, p = .69) screened positive for PTS symptoms. However, differences emerged between the groups at 3 months, with family members in the non-TBI group showing a significant decrease in both baseline depression and PTS symptoms. Conclusions/Implications: This study, to our knowledge, is the first of its kind to examine psychological differences in the ICU in those whose family members either have or do not have a TBI. Results suggest the TBI group endorsed more symptoms of depression and PTS symptoms at 3 months. Although it is unclear whether symptoms were directly related to the ICU experience or the injury itself, future research should explore the possible additive effect of postintensive care syndrome-family symptoms.	[Warren, Ann Marie; Foreman, Michael L.] Baylor Univ, Med Ctr, Div Trauma Crit Care & Acute Care Surg, 3409 Worth St,Suite C2-500, Dallas, TX 75246 USA; [Rainey, Evan Elizabeth; Weddle, Rebecca Joanne] Baylor Res Inst, Dallas, TX USA; [Bennett, Monica] Baylor Scott & White Hlth, Dallas, TX USA; [Roden-Foreman, Kenleigh] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA	Warren, AM (corresponding author), Baylor Univ, Med Ctr, Div Trauma Crit Care & Acute Care Surg, 3409 Worth St,Suite C2-500, Dallas, TX 75246 USA.; Warren, AM (corresponding author), Baylor Univ, Med Ctr, Div Trauma Crit Care & Acute Care Surg, Trauma Res, 3409 Worth St,Suite C2-500, Dallas, TX 75246 USA.	annmarie.warren@BSWHealth.org		Warren, Ann Marie/0000-0002-3753-5573; McShan, Evan Elizabeth/0000-0002-9250-3240; McMinn, PhD, Kenleigh/0000-0002-4623-8634			Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Baumhover NC, 2013, AACN ADV CRIT CARE, V24, P130, DOI 10.1097/NCI.0b013e318286489e; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Davidson JE, 2012, CRIT CARE MED, V40, P618, DOI 10.1097/CCM.0b013e318236ebf9; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Gonzalez O., 2010, Morbidity and Mortality Weekly Report, V59, P1229; Hanley J, 2013, J TRAUMA ACUTE CARE, V75, P722, DOI 10.1097/TA.0b013e3182a53a5f; Institute for Patient-and Family-Centered Care, 2015, FREQ ASK QUEST WHAT; Jones C, 2004, INTENS CARE MED, V30, P456, DOI 10.1007/s00134-003-2149-5; Jutte JE, 2015, SEMIN RESP CRIT CARE, V36, P943, DOI 10.1055/s-0035-1566002; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefkowitz DS, 2010, J CLIN PSYCHOL MED S, V17, P230, DOI 10.1007/s10880-010-9202-7; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; National Center for PTSD, 2015, HOW COMM IS PTSD; National Quality Forum, 2012, END SUMM PULM CRIT C; Ouimette P, 2008, J ANXIETY DISORD, V22, P337, DOI 10.1016/j.janxdis.2007.02.010; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Rainey EE, 2014, AM J SURG, V208, P517, DOI 10.1016/j.amjsurg.2014.05.016; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Schmidt M, 2012, CURR OPIN CRIT CARE, V18, P540, DOI 10.1097/MCC.0b013e328357f141; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Society of Critical Care Medicine, 2011, POSTINT CAR SYNDR PI; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; Ulman A. J., 2014, COCHRANE DB SYST REV, P12; Warren AM, 2014, J TRAUMA NURS, V21, P139, DOI 10.1097/TA.0b013e3182858ab9	31	14	14	0	9	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2016	61	2					179	185		10.1037/rep0000080			7	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	DN2XS	WOS:000376926900008	27196860				2021-06-18	
J	Brooks, BL; Iverson, GL; Atkins, JE; Zafonte, R; Berkner, PD				Brooks, Brian L.; Iverson, Grant L.; Atkins, Joseph E.; Zafonte, Ross; Berkner, Paul D.			Sex Differences and Self-Reported Attention Problems During Baseline Concussion Testing	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						adolescents; baseline; children; gender; return to play; TBI	SPORTS-RELATED CONCUSSION; DEFICIT HYPERACTIVITY DISORDER; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; SYMPTOMS; RECOVERY; AGE; PLAYERS	Amateur athletic programs often use computerized cognitive testing as part of their concussion management programs. There is evidence that athletes with preexisting attention problems will have worse cognitive performance and more symptoms at baseline testing. The purpose of this study was to examine whether attention problems affect assessments differently for male and female athletes. Participants were drawn from a database that included 6,840 adolescents from Maine who completed Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) at baseline (primary outcome measure). The final sample included 249 boys and 100 girls with self-reported attention problems. Each participant was individually matched for sex, age, number of past concussions, and sport to a control participant (249 boys, 100 girls). Boys with attention problems had worse reaction time than boys without attention problems. Girls with attention problems had worse visual-motor speed than girls without attention problems. Boys with attention problems reported more total symptoms, including more cognitive-sensory and sleep-arousal symptoms, compared with boys without attention problems. Girls with attention problems reported more cognitive-sensory, sleep-arousal, and affective symptoms than girls without attention problems. When considering the assessment, management, and outcome from concussions in adolescent athletes, it is important to consider both sex and preinjury attention problems regarding cognitive test results and symptom reporting.	[Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program Brain Injury & Rehabil, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.] Univ Calgary, Dept Pediat, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Iverson, Grant L.] Harvard Univ, Spaulding Rehabil Hosp, Sch Med, Dept Phys Med & Rehabil,MassGen Hosp Children Spo, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.; Zafonte, Ross] Massachusetts Gen Hosp Home Base Program, Boston, MA USA; [Atkins, Joseph E.] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Zafonte, Ross] Harvard Univ, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp,Sch Med,Dept Phys Med & Re, Boston, MA 02115 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA	Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca		Iverson, Grant/0000-0001-7348-9570	Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members; Mooney-Reed Charitable Foundation	This work was funded in part by the Goldfarb Center for Public Policy and Civic Engagement/Colby College and the Bill and Joan Alfond Foundation. RZ was supported in part by the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. GLI and RZ acknowledge support from the Mooney-Reed Charitable Foundation.	Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P498; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; IBM Corp, 2010, IBM SPSS STAT WIND V; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Kirkwood MW, 2012, CLIN J SPORT MED, V22, P383, DOI 10.1097/JSM.0b013e31826396fc; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wasserman T, 2012, APPL NEUROPSYCH-CHIL, V1, P90, DOI 10.1080/21622965.2012.702025; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	44	14	14	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	APR 2	2016	5	2					119	126		10.1080/21622965.2014.1003066			8	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DJ1BG	WOS:000373937500005	25923339				2021-06-18	
J	Heyer, GL; Young, JA; Rose, SC; McNally, KA; Fischer, AN				Heyer, Geoffrey L.; Young, Julie A.; Rose, Sean C.; McNally, Kelly A.; Fischer, Anastasia N.			Post-traumatic headaches correlate with migraine symptoms in youth with concussion	CEPHALALGIA			English	Article						Concussion; post-traumatic headache; migraine; pediatric; adolescent; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TENSION-TYPE HEADACHE; NECK PAIN; RECOVERY; ATTACKS; PREVALENCE; VALIDITY; SPORT	Objective The term post-traumatic migraine (PTM) has been used to describe post-traumatic headaches (PTHs) that have associated migraine features, but studies of this relationship are lacking. The objective of the present study was to determine whether PTH correlates strongly with migraine symptoms among youth with concussion. Methods Twenty-three symptoms were analyzed from a retrospective cohort of 1953 pediatric patients with concussion. A principal component analysis (PCA) with oblique Promax rotation was conducted to explore underlying symptom relationships in the full cohort and in subcohorts stratified by the presence (n=414) or absence (n=1526) of premorbid headache. Results The mean patient age was 14.1 years; 63% were male. Headache was the most common postconcussion symptom, acknowledged by 69.4% of patients. When considering the full cohort, the PCA demonstrated clustering of headache with photophobia, phonophobia, nausea, dizziness, and neck pain. Similar clustering was present among patients without premorbid headaches. Repeating the analysis in the patients with preconcussion headaches led to elimination of neck pain from the cluster. Conclusions PTH correlates strongly with other migraine symptoms among youth with concussion, regardless of premorbid headaches. This clustering of migraine symptoms supports the existence of PTM as a distinct clinical entity in some patients.	[Heyer, Geoffrey L.; Rose, Sean C.] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Neurol, Columbus, OH 43205 USA; [Heyer, Geoffrey L.; Rose, Sean C.] Ohio State Univ, Dept Neurol, Columbus, OH 43205 USA; [Young, Julie A.; Fischer, Anastasia N.] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH 43205 USA; [McNally, Kelly A.] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Psychol & Neuropsychol, Columbus, OH 43205 USA; [McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA	Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Neurol, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Ohio State Univ, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org		McNally, Kelly/0000-0001-9278-9413; Heyer, Geoffrey/0000-0001-9334-3739; Rose, Sean/0000-0001-5177-7715			Aaltonen K, 2000, CEPHALALGIA, V20, P580, DOI 10.1046/j.1468-2982.2000.00089.x; Ashina S, 2015, CEPHALALGIA, V35, P211, DOI 10.1177/0333102414535110; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Blaschek A, 2014, CEPHALALGIA, V34, P895, DOI 10.1177/0333102414523338; BURKE EC, 1956, AMA J DIS CHILD, V92, P330, DOI 10.1001/archpedi.1956.02060030324002; Calhoun AH, 2011, HEADACHE, V51, P1388, DOI 10.1111/j.1526-4610.2011.01970.x; ESPIR MLE, 1972, BRIT MED J, V3, P352, DOI 10.1136/bmj.3.5822.352; Florencio LL, 2014, HEADACHE, V54, P1203, DOI 10.1111/head.12393; HAAS DC, 1969, J NEUROL NEUROSUR PS, V32, P548, DOI 10.1136/jnnp.32.6.548; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Jolliffe I.T., 1986, PRINCIPAL COMPONENT; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McIntosh T K, 1986, NIDA Res Monogr, V75, P527; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; MICHAEL MI, 1952, J PEDIATR-US, V41, P18, DOI 10.1016/S0022-3476(52)80024-1; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Radanov BP, 2001, EUR SPINE J, V10, P403, DOI 10.1007/s005860000227; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	40	14	14	0	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	APR	2016	36	4					309	316		10.1177/0333102415590240			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DJ2DS	WOS:000374014500002	26054363				2021-06-18	
J	Khalin, I; Jamari, NLA; Razak, NBA; Hasain, ZB; Nor, MAB; Zainudin, MHB; Omar, AB; Alyautdin, R				Khalin, Igor; Jamari, Nor Laili Azua; Razak, Nadiawati Bt Abdul; Hasain, Zubaidah Bt; Nor, Mohd Asri bin Mohd; Zainudin, Mohd Hakimi bin Ahmad; Omar, Ainsah Bt; Alyautdin, Renad			A mouse model of weight-drop closed head injury: emphasis on cognitive and neurological deficiency	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; neurological severity score; passive avoidance; weight-drop injury model; C57BL/6 mice; neural regeneration	TRAUMATIC BRAIN-INJURY; NEURONAL CELL LOSS; ANIMAL-MODELS; MICE; RECOVERY; MOTOR	Traumatic brain injury (TBI) is a leading cause of death and disability in individuals worldwide. Producing a clinically relevant TBI model in small-sized animals remains fairly challenging. For good screening of potential therapeutics, which are effective in the treatment of TBI, animal models of TBI should be established and standardized. In this study, we established mouse models of closed head injury using the Shohami weight-drop method with some modifications concerning cognitive deficiency assessment and provided a detailed description of the severe TBI animal model. We found that 250 g falling weight from 2 cm height produced severe closed head injury in C57BL/6 male mice. Cognitive disorders in mice with severe closed head injury could be detected using passive avoidance test on day 7 after injury. Findings from this study indicate that weight-drop injury animal models are suitable for further screening of brain neuroprotectants and potentially are similar to those seen in human TBI.	[Khalin, Igor; Razak, Nadiawati Bt Abdul; Hasain, Zubaidah Bt; Omar, Ainsah Bt] Natl Def Univ Malaysia, Fac Med & Def Hlth, Kuala Lumpur, Malaysia; [Jamari, Nor Laili Azua] Natl Def Univ Malaysia, Dept Chem, Ctr Def Fdn Studies, Kuala Lumpur, Malaysia; [Nor, Mohd Asri bin Mohd] Natl Def Univ Malaysia, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Zainudin, Mohd Hakimi bin Ahmad] Natl Def Univ Malaysia, Ctr Res & Innovat Management, Kuala Lumpur, Malaysia; [Alyautdin, Renad] Sci Ctr Expertise Med Applicat Prod, Petrovsky Blvd, Moscow, Russia	Khalin, I (corresponding author), Natl Def Univ Malaysia, Fac Med & Def Hlth, Kuala Lumpur, Malaysia.	igor@upnm.edu.my	Alyautdin, Renad N/L-9261-2014	Alyautdin, Renad N/0000-0002-4647-977X; AHMAD ZAINUDIN, MOHD HAKIMI/0000-0002-1211-2937; Khalin, Igor/0000-0003-1041-5747	Ministry of Higher Education of MalaysiaMinistry of Education, Malaysia [RAGS/2013/UPNM/SKK/01/2]	The study was supported by a grant from the Ministry of Higher Education of Malaysia, No. RAGS/2013/UPNM/SKK/01/2.	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Meybodi KT, 2005, BEHAV PHARMACOL, V16, P139, DOI 10.1097/00008877-200505000-00002; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Walker EA, 2010, ADV EXP MED BIOL, V678, P138; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449	25	14	14	0	14	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2016	11	4					630	635		10.4103/1673-5374.180749			6	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	DO1XF	WOS:000377572700028	27212925	DOAJ Gold, Green Published			2021-06-18	
J	Kriz, PK; Stein, C; Kent, J; Ruggieri, D; Dolan, E; O'Brien, M; Meehan, WP				Kriz, Peter K.; Stein, Cynthia; Kent, Janet; Ruggieri, Danielle; Dolan, Emilie; O'Brien, Michael; Meehan, William P., III			Physical Maturity and Concussion Symptom Duration among Adolescent Ice Hockey Players	JOURNAL OF PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; HIGH-SCHOOL FOOTBALL; RISK-FACTORS; SELF-REPORT; PUBERTAL DEVELOPMENT; SEXUAL-MATURATION; YOUTH FOOTBALL; BODY CHECKING; INJURY RATES; RECOVERY	Objective To investigate the association between physical maturity and risk of prolonged concussion symptoms in adolescent ice hockey players. Study design Prospective cohort study of 145 patients ages 13-18 years with concussion referred to 3 hospital-affiliated sports medicine clinics between September 1, 2012 and March 31, 2015. Concussion evaluations included Post Concussive Symptom Score, neurologic examination, and postinjury computerized neurocognitive testing. Pubertal development at initial visit was assessed by the Pubertal Developmental Scale. Duration of concussion symptoms (days) was the main outcome. Statistical comparisons were conducted using Student t test, Wilcoxon rank sum, and logistic regression. Results Mean symptom duration was 44.5 +/- 48.7 days. Nearly one-half (48.3%) of all players enrolled had prolonged concussion symptoms (>= 28 days); most (86.9%) had symptom resolution by 90 days. Among males, less physically mature adolescents took longer to recover than more physically mature players (54.5 days vs 33.4 days; P=.004). " Early" Pubertal Category Score was the strongest predictor of prolonged symptoms (OR=4.29, 95% CI 1.24-14.85; P=.021) among males. Among females, heavier weight increased the odds of experiencing prolonged symptoms (OR 1.07, 95% CI 1.00-1.14; P=.039). Conclusions Among adolescent ice hockey players, early-pubertal stage is independently associated with longer recovery from concussion in males, and heavier weight is associated with longer concussion recovery in females. Until further studies determine valid physical maturity indicators, peripubertal collision sport athletes should compete in leagues grouped by relative age and be discouraged from "playing up" on varsity teams.	[Kriz, Peter K.; Ruggieri, Danielle; Dolan, Emilie] Brown Univ, Warren Alpert Med Sch, Div Sports Med, Dept Orthoped, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Kriz, Peter K.; Ruggieri, Danielle; Dolan, Emilie] Brown Univ, Warren Alpert Med Sch, Div Sports Med, Dept Pediat, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Kriz, Peter K.; Ruggieri, Danielle; Dolan, Emilie] Hasbro Childrens Hosp, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Stein, Cynthia; O'Brien, Michael; Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Div Sports Med, Dept Orthoped, Boston, MA USA; [Kent, Janet] South Shore Hosp, Youth Sports Concuss Clin, Weymouth, MA USA; [O'Brien, Michael; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA	Kriz, PK (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Sports Med, Dept Orthoped, 2 Dudley St,Suite 200, Providence, RI 02905 USA.; Kriz, PK (corresponding author), Hasbro Childrens Hosp, 2 Dudley St,Suite 200, Providence, RI 02905 USA.	Peter_Kriz@brown.edu			Rhode Island Foundation [20113642]; National Federation of State High School Associations Foundation [701-5917]; National Football League Players Association	Funded in part by Rhode Island Foundation (20113642) and the National Federation of State High School Associations Foundation (701-5917). The content of this report is solely the responsibility of the authors and does not necessarily reflect the official views of the funders. W.M. receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A guide for coaches and parents, and royalties from Wolters Kluwer for working as an author for UpToDate; he is under contract with ABC-Clio publishing for a future book, Concussions, and with Springer International publishing for a future book, Head and Neck Injuries in Young Athletes; and his research is funded, in part, by the National Football League Players Association and philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. The other authors declare no conflicts of interest.	Aspen Institute, 2012, PLAYING SAF FUT YOUT; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bond L, 2006, J ADOLESCENCE, V29, P709, DOI 10.1016/j.adolescence.2005.10.001; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; BROOKSGUNN J, 1987, CHILD DEV, V58, P829, DOI 10.1111/j.1467-8624.1987.tb01423.x; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Coleman L, 2002, J ADOLESCENCE, V25, P535, DOI 10.1006/jado.2002.0494; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Crockett LJ, 1988, PUBERTAL DEV S UNPUB; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; DUKE PM, 1980, PEDIATRICS, V66, P918; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graham R., 2014, SPORTS RELATED CONCU; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Le Gall F, 2007, SCAND J MED SCI SPOR, V17, P564, DOI 10.1111/j.1600-0838.2006.00594.x; LINDER MM, 1995, CLIN J SPORT MED, V5, P167, DOI 10.1097/00042752-199507000-00006; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; National Federation of High School Associations, 2012 13 HIGH SCH ATH; PALLANT J, 2010, SPSS SURVIVAL MANUAL; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Scherr R., RECENT SURGE POPULAR; SCHLOSSBERGER NM, 1992, J ADOLESCENT HEALTH, V13, P109, DOI 10.1016/1054-139X(92)90075-M; Schmitz KE, 2004, J EARLY ADOLESCENCE, V24, P357, DOI 10.1177/0272431604268531; Straus B., GETTING INVOLVED LAT; USA Hockey, US HOCK OFF PLAYING; Wiggins W., 1999, THESIS LAKEHEAD U TH; Zimmer DM, 2015, TIS SEASON W MILFORD	40	14	14	1	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2016	171						234	+		10.1016/j.jpeds.2015.12.006			8	Pediatrics	Pediatrics	DH4KC	WOS:000372753600048	26781190				2021-06-18	
J	Serri, K; El Rayes, M; Giraldeau, G; Williamson, D; Bernard, F				Serri, Karim; El Rayes, Malak; Giraldeau, Genevieve; Williamson, David; Bernard, Francis			Traumatic brain injury is not associated with significant myocardial dysfunction: an observational pilot study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Myocardial dysfunction; Echocardiography; Left ventricular ejection fraction	NEUROCARDIOGENIC INJURY; EUROPEAN-ASSOCIATION; TROPONIN ELEVATION; AMERICAN-SOCIETY; WALL-MOTION; ECHOCARDIOGRAPHY; CLASSIFICATION; PREDICTORS; HEMORRHAGE; GUIDELINES	Background: Myocardial dysfunction has been well described with catastrophic neurological events, such as subarachnoid hemorrhage and brain death. There is very limited data describing myocardial function in the context of traumatic brain injury (TBI), as no prospective study has yet examined this association. The objective of our study was to evaluate cardiac function using echocardiography in patients with clinically important TBI. Methods: We conducted a prospective observational study of consecutive TBI patients admitted to the intensive care unit. All patients older than 16 years with moderate to severe TBI according to the Glascow Coma Scale (GCS) were eligible for the study. Only patients with a prior history of heart disease or cardiomyopathy or evidence of brain death on admission were excluded. A complete transthoracic echocardiogram was performed within 4 days of admission. Results: Forty-nine patients (67 % males, median age 34 years) were included in the study. Forty-one patients had severe TBI (84 %) with a median GCS of six, 44 patients (90 %) required mechanical ventilation and 36 (74 %) intracranial pressure monitoring. Hospital mortality was 18 %. No patients had global left ventricular dysfunction as defined by a left ventricular ejection fraction (LVEF) below 50 % (95 % CI, 0-0.07). Average LVEF was 65 +/- 4 %. Four patients (8 %) had regional wall motion abnormalities with preserved LVEF. Discussion: The main finding of this study is the absence of clinically significant myocardial dysfunction in patients with moderate or severe TBI. Although myocardial dysfunction has been well described in a variety of neurological settings, it is possible that the young age of TBI patients and the absence of cardiovascular risk factors are protective against significant myocardial injury from catecholamine excess. Conclusions: In a group of patients with clinically important TBI, we did not identify any significant cardiac dysfunction.	[Serri, Karim; El Rayes, Malak; Williamson, David; Bernard, Francis] Univ Montreal, Serv Intensifs, Hop Sacre Coeur Montreal, Dept Med, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada; [Serri, Karim; Williamson, David; Bernard, Francis] Univ Montreal, Res Ctr, Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Giraldeau, Genevieve] Univ Montreal, Inst Cardiol Montreal, Montreal, PQ, Canada	Serri, K (corresponding author), Univ Montreal, Serv Intensifs, Hop Sacre Coeur Montreal, Dept Med, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada.; Serri, K (corresponding author), Univ Montreal, Res Ctr, Hop Sacre Coeur Montreal, Montreal, PQ, Canada.	karim.serri@umontreal.ca					Banki NM, 2005, CIRCULATION, V112, P3314, DOI 10.1161/CIRCULATIONAHA.105.558239; Borbely XI, 2015, NEUROCRIT CARE, V23, P66, DOI 10.1007/s12028-014-0101-x; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; DOSHI R, 1977, J NEUROL NEUROSUR PS, V40, P821, DOI 10.1136/jnnp.40.8.821; Dujardin KS, 2001, J HEART LUNG TRANSPL, V20, P350, DOI 10.1016/S1053-2498(00)00193-5; HAWKINS WE, 1971, CARDIOVASC RES, V5, P524, DOI 10.1093/cvr/5.4.524; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Huttemann E, 2002, INTENS CARE MED, V28, P1084, DOI 10.1007/s00134-002-1355-x; JACOB WA, 1972, J MOL CELL CARDIOL, V4, P287, DOI 10.1016/0022-2828(72)90076-4; KARCH SB, 1986, HUM PATHOL, V17, P9, DOI 10.1016/S0046-8177(86)80150-2; Kothavale A, 2006, NEUROCRIT CARE, V4, P199, DOI 10.1385/NCC:4:3:199; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee VH, 2006, NEUROCRIT CARE, V5, P243, DOI 10.1385/NCC:5:3:243; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Najafipour Hamid, 2014, Iranian Biomedical Journal, V18, P225, DOI 10.6091/ibj.13222.2014; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Salem R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0558-1; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Urbaniak K, 2007, SURG NEUROL, V67, P21, DOI 10.1016/j.surneu.2006.08.065; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	30	14	14	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 16	2016	24								31	10.1186/s13049-016-0217-4			5	Emergency Medicine	Emergency Medicine	DH4ZT	WOS:000372795200001	26983752	DOAJ Gold, Green Published			2021-06-18	
J	Cristofori, I; Zhong, WT; Mandoske, V; Chau, A; Krueger, F; Strenziok, M; Grafman, J				Cristofori, Irene; Zhong, Wanting; Mandoske, Valerie; Chau, Aileen; Krueger, Frank; Strenziok, Maren; Grafman, Jordan			Brain Regions Influencing Implicit Violent Attitudes: A Lesion-Mapping Study	JOURNAL OF NEUROSCIENCE			English	Article						aggression; implicit attitudes; traumatic brain injury	VENTROMEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; INTIMATE PARTNER VIOLENCE; VOXEL-BASED LESION; ASSOCIATION TEST; HEAD-INJURY; AGGRESSIVE-BEHAVIOR; TEMPORAL CORTEX; GENDER; VETERANS	Increased aggression is common after traumatic brain injuries and may persist after cognitive recovery. Maladaptive aggression and violence are associated with dysfunction in the prefrontal and temporal cortex, but such dysfunctional behaviors are typically measured by explicit scales and history. However, it is well known that answers on explicit scales on sensitive topics-such as aggressive thoughts and behaviors-may not reveal true tendencies. Here, we investigated the neural basis of implicit attitudes toward aggression in humans using a modified version of the Implicit Association Task (IAT) with a unique sample of 112 Vietnam War veterans who suffered penetrating brain injury and 33 healthy controls who also served in combat in Vietnam but had no history of brain injury. We hypothesized that dorsolateral prefrontal cortex (dlPFC) lesions, due to the crucial role of the dlPFC in response inhibition, could influence performance on the IAT. In addition, we investigated the causal contribution of specific brain areas to implicit attitudes toward violence. We found a more positive implicit attitude toward aggression among individuals with lesions to the dlPFC and inferior posterior temporal cortex (ipTC). Furthermore, executive functions were critically involved in regulating implicit attitudes toward violence and aggression. Our findings complement existing evidence on the neural basis of explicit aggression centered on the ventromedial prefrontal cortex. These findings highlight that dlPFC and ipTC play a causal role in modulating implicit attitudes about violence and are crucially involved in the pathogenesis of aggressive behavior.	[Cristofori, Irene; Zhong, Wanting; Mandoske, Valerie; Chau, Aileen; Grafman, Jordan] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Cristofori, Irene; Zhong, Wanting; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank; Strenziok, Maren] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Cristofori, I; Grafman, J (corresponding author), Rehabil Inst Chicago, Brain Injury Res Program, Cognit Neurosci Lab, 345 E Super St, Chicago, IL 60611 USA.	irene.cristofori@gmail.com; jgrafman@northwestern.edu		Grafman, Jordan H./0000-0001-8645-4457; Zhong, Wanting/0000-0002-6025-1739; Cristofori, Irene/0000-0003-2339-1457			Amodio DM, 2014, NAT REV NEUROSCI, V15, P670, DOI 10.1038/nrn3800; Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Banse R, 2014, AGGRESS BEH IN PRESS; Barbey AK, 2014, BRAIN, V137, P2823, DOI 10.1093/brain/awu207; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bradley M. M., 1999, C1 U FLOR CTR RES PS; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Buss A.H., 2000, AGGRESSION QUESTIONN; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dal Monte O, 2013, SOC COGN AFFECT NEUR, V8, P632, DOI 10.1093/scan/nss041; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Eckhardt CI, 2012, J INTERPERS VIOLENCE, V27, P471, DOI 10.1177/0886260511421677; Finley EP, 2010, J FAM VIOLENCE, V25, P737, DOI 10.1007/s10896-010-9331-7; Forbes CE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00320; Forbes CE, 2012, CEREB CORTEX, V22, P2602, DOI 10.1093/cercor/bhr337; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Gray NS, 2003, NATURE, V423, P497, DOI 10.1038/423497a; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hare TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00050; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hayes A.F., 2018, INTRO MEDIATION MODE, V2nd ed.; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hoptman MJ, 2002, BIOL PSYCHIAT, V52, P9, DOI 10.1016/S0006-3223(02)01311-2; HYER L, 1991, J CLIN PSYCHOL, V47, P510, DOI 10.1002/1097-4679(199107)47:4<510::AID-JCLP2270470407>3.0.CO;2-F; Kaplan E., 1983, BOSTON NAMING TEST; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Landenberger N.A., 2005, J EXP CRIMINOL, V1, P451, DOI [https://doi.org/10.1007/s11292-005-3541-7, DOI 10.1007/S11292-005-3541-7]; Lang P. J, 2008, A8 U FLOR; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; de Almeida RMM, 2015, PHYSIOL BEHAV, V143, P121, DOI 10.1016/j.physbeh.2015.02.053; McCollister KE, 2010, DRUG ALCOHOL DEPEN, V108, P98, DOI 10.1016/j.drugalcdep.2009.12.002; McNeil M. M., 1994, REVISED TOKEN TEST; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Quadflieg S, 2009, J COGNITIVE NEUROSCI, V21, P1560, DOI 10.1162/jocn.2009.21091; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Robertson K, 2007, J INTERPERS VIOLENCE, V22, P639, DOI 10.1177/0886260506298835; Rudman LA, 2001, PERS SOC PSYCHOL B, V27, P1164, DOI 10.1177/0146167201279009; Seidenwurm D, 1997, AM J NEURORADIOL, V18, P625; Shapiro J. P., 2000, ATTITUDES GUNS VIOLE; Silver E, 2005, AM J PUBLIC HEALTH, V95, P2015, DOI 10.2105/AJPH.2003.021436; Silver Jonathan M., 1994, P313; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger C., 1988, MANUAL STATE TRAIT A; Spielberger C. D., 1994, USE PSYCHOL TESTING, P292, DOI DOI 10.1002/9780470479216.CORPSY0943; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Truman J., 2010, CRIMINAL VICTIMIZATI; Tsuchida A, 2012, CEREB CORTEX, V22, P2904, DOI 10.1093/cercor/bhr370; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; United States Department of Defense, 1960, ARM FORC QUAL TEST A; Warrington E., 1991, VISUAL OBJECT SPACE; Woermann FG, 2000, J NEUROL NEUROSUR PS, V68, P162, DOI 10.1136/jnnp.68.2.162; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104	74	14	14	0	38	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	MAR 2	2016	36	9					2757	2768		10.1523/JNEUROSCI.2975-15.2016			12	Neurosciences	Neurosciences & Neurology	DF2BV	WOS:000371145400018	26937013	Bronze, Green Published			2021-06-18	
J	Boychuk, JA; Butler, CR; Halmos, KC; Smith, BN				Boychuk, Jeffery A.; Butler, Corwin R.; Halmos, Katalin Cs; Smith, Bret N.			Enduring changes in tonic GABA(A) receptor signaling in dentate granule cells after controlled cortical impact brain injury in mice	EXPERIMENTAL NEUROLOGY			English	Article						GABA(A) receptors; Tonic GABA current; Controlled cortical impact; Traumatic brain injury; Post-traumatic epilepsy	DELTA-SUBUNIT; RAT MODEL; PHARMACOLOGICAL CHARACTERIZATION; POSTTRAUMATIC EPILEPSY; PHASIC INHIBITION; OVARIAN CYCLE; MOUSE MODEL; EXPRESSION; ACTIVATION; GYRUS	Changes in functional GABA(A)R signaling in hippocampus have previously been evaluated using pre-clinical animal models of either diffuse brain injury or extreme focal brain injury that precludes measurement of cells located ipsilateral to injury. As a result, there is little information about the status of functional GABA(A)R signaling in dentate granule cells (DGCs) located ipsilateral to focal brain injury, where significant cellular changes have been documented. We used whole-cell patch-clamp recordings from hippocampal slices to measure changes in GABA(A)Rs in dentate granule cells (DGCs) at 1-2,3-5, and 8-13 weeks after controlled cortical impact (CCI) brain injury. Synaptic and tonic GABA(A)R currents (I-TronicGABA) were measured in DGCs at baseline conditions and during application of the GABA(A)R agonist 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-3-ol hydrochloride (THIP) to assess in the function of 8 subunit-containing GABA(A)Rs. DGCs ipsilateral to CCI exhibited no changes in the amplitude of resting I-TonicGABA relative to DGCs after sham-injury or contralateral to CCI. In contrast, there was a significant reduction in the THIP-evoked I-TronicGABA in DGCs ipsilateral to CCI at both time-points. Tonic GABAergic inhibition of DGCs ipsilateral to injury also exhibited reduced responsiveness to the neurosteroid THDOC. I-TonicGABA in DGCs ipsilateral to CCI did not exhibit a change in sensitivity to L655,708, an inverse agonist with selectivity for alpha(5) subunit-containing GABA(A)Rs, suggesting a lack of functional change in GABA(A)Rs containing this subunit. At the 8-13 week time-point, gene expression of GABA(A)R subunits expected to contribute to I-TronicGABA (i.e., alpha(4), alpha(5) and delta) was not significantly altered by CCI injury in isolated dentate gyrus. Collectively, these results demonstrate enduring functional changes in I-TonicGABA in DGCs ipsilateral to focal brain injury that occur independent of altered gene expression. (C) 2016 Elsevier Inc All rights reserved.	[Boychuk, Jeffery A.; Butler, Corwin R.; Halmos, Katalin Cs; Smith, Bret N.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Epilepsy Ctr, Lexington, KY 40536 USA; [Boychuk, Jeffery A.] Univ Kentucky, Ctr Adv Translat Stroke Sci, Lexington, KY 40536 USA; [Smith, Bret N.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA	Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA.	bret.smith@uky.edu		Butler, Corwin/0000-0001-5134-4151; Boychuk, Jeffery A/0000-0002-7003-1553	Department of Defense (USAMRMC) Grant [W81XWH-11-1-0502]; American Epilepsy Society; Lennox and Lombroso Trust for Epilepsy Research and Training	Supported by Department of Defense (USAMRMC) Grant W81XWH-11-1-0502 (BNS) and a Fellowship from the American Epilepsy Society and Lennox and Lombroso Trust for Epilepsy Research and Training (JAB).	Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P171, DOI 10.1113/jphysiol.1986.sp016246; Barnard EA, 1998, PHARMACOL REV, V50, P291; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Bonin RP, 2007, J NEUROPHYSIOL, V98, P2244, DOI 10.1152/jn.00482.2007; Boychuk CR, 2015, J NEUROPHYSIOL, V114, P698, DOI 10.1152/jn.00209.2015; Bright DP, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00193; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chang YC, 1996, J NEUROSCI, V16, P5415; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; Cossart R, 2001, NAT NEUROSCI, V4, P52; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRAGUHN A, 1990, NEURON, V5, P781, DOI 10.1016/0896-6273(90)90337-F; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; EBERT B, 1994, MOL PHARMACOL, V46, P957; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hagihara Hideo, 2009, J Vis Exp, DOI 10.3791/1543; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hoestgaard-Jensen K, 2014, J NEUROSCI, V34, P16256, DOI 10.1523/JNEUROSCI.1495-14.2014; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kapur J, 1997, J NEUROSCI, V17, P7532, DOI 10.1523/jneurosci.17-19-07532.1997; Kapur J, 1999, MOL PHARMACOL, V55, P444; Kharlamov EA, 2008, BRAIN RES, V1210, P29, DOI 10.1016/j.brainres.2008.02.070; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; KUSAMA T, 1993, BRIT J PHARMACOL, V109, P200, DOI 10.1111/j.1476-5381.1993.tb13554.x; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Leroy C, 2004, J PHYSIOL-LONDON, V557, P473, DOI 10.1113/jphysiol.2003.059246; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LUDDENS H, 1991, TRENDS PHARMACOL SCI, V12, P49, DOI 10.1016/0165-6147(91)90495-E; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mtchedlishvili Z, 2006, MOL PHARMACOL, V69, P564, DOI 10.1124/mol.105.016683; Mtchedlishvili Z, 2001, J PHYSIOL-LONDON, V537, P453, DOI 10.1111/j.1469-7793.2001.00453.x; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Nakamura Y, 2015, ADV PHARMACOL, V72, P97, DOI 10.1016/bs.apha.2014.11.008; Nusser Z, 1998, J NEUROSCI, V18, P1693; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Pavlov I, 2009, J NEUROSCI, V29, P15341, DOI 10.1523/JNEUROSCI.2747-09.2009; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Quirk K, 1996, NEUROPHARMACOLOGY, V35, P1331, DOI 10.1016/S0028-3908(96)00061-5; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Redecker C, 2002, J CEREBR BLOOD F MET, V22, P1463, DOI 10.1097/01.WCB.0000034149.72481.BD; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEGAL M, 1984, J NEUROPHYSIOL, V52, P469; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Spigelman I, 2002, EPILEPSIA, V43, P3, DOI 10.1046/j.1528-1157.43.s.5.8.x; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Storustovu SI, 2006, J PHARMACOL EXP THER, V316, P1351, DOI 10.1124/jpet.105.092403; Sun CS, 2007, J NEUROSCI, V27, P12641, DOI 10.1523/JNEUROSCI.4141-07.2007; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tao WC, 2013, J NEUROSCI, V33, P3738, DOI 10.1523/JNEUROSCI.4829-12.2013; vandenPol AN, 1996, J NEUROSCI, V16, P4283; VERDOORN TA, 1990, NEURON, V4, P919, DOI 10.1016/0896-6273(90)90145-6; Wei WZ, 2003, J NEUROSCI, V23, P10650; WEISS DS, 1988, J NEUROPHYSIOL, V59, P495; WEISS DS, 1988, J NEUROPHYSIOL, V59, P514; Whiting PJ, 1999, ANN NY ACAD SCI, V868, P645, DOI 10.1111/j.1749-6632.1999.tb11341.x; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Wood CE, 2003, J PHYSIOL-LONDON, V549, P573, DOI 10.1113/jphysiol.2002.038398; YOON KW, 1994, J NEUROPHYSIOL, V71, P2151; Zhan RZ, 2009, J NEUROPHYSIOL, V102, P670, DOI 10.1152/jn.00147.2009; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007; Zhang W, 2012, J NEUROSCI, V32, P1183, DOI 10.1523/JNEUROSCI.5342-11.2012	92	14	15	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2016	277						178	189		10.1016/j.expneurol.2016.01.005			12	Neurosciences	Neurosciences & Neurology	DF2ST	WOS:000371194800019	26772635	Bronze			2021-06-18	
J	Cobb, BR; Zadnik, AM; Rowson, S				Cobb, Bryan R.; Zadnik, Abigail M.; Rowson, Steven			Comparative analysis of helmeted impact response of Hybrid III and National Operating Committee on Standards for Athletic Equipment headforms	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Concussion; brain injury; helmet testing; biomechanics; linear acceleration; rotational acceleration	ICE HOCKEY HELMETS; HEAD IMPACT; PROFESSIONAL FOOTBALL; BIOMECHANICAL PERFORMANCE; BRAIN-INJURY; CONCUSSION; ACCELERATION; EXPOSURE; KINEMATICS; RISK	As advanced helmet testing methodologies are developed, the effect headform selection may have on the biomechanical impact response must be considered. This study sought to assess response differences between two of the most commonly used headforms, the Hybrid III and National Operating Committee on Standards for Athletic Equipment headforms, through a series of helmeted impact tests. A total of 180 pendulum impact tests were conducted with three impactor velocities and six impact locations. Test condition-specific significant differences were found between the two headforms for peak linear and angular accelerations (=0.05), although differences tended to be small. On average, the National Operating Committee on Standards for Athletic Equipment headform experienced higher peak linear (3.7 +/- 7.8%) and angular (12.0 +/- 21.6%) accelerations, with some of the largest differences associated with impacts to the facemask. Without the facemask impacts, the average differences in linear (1.8 +/- 6.0%) and angular (9.6 +/- 15.9%) acceleration would be lower. No significant differences were found in coefficient of variation values for linear (Hybrid III: 2.6 +/- 2.3%, National Operating Committee on Standards for Athletic Equipment: 2.0 +/- 1.4%) or angular (Hybrid III: 4.9 +/- 4.0%; National Operating Committee on Standards for Athletic Equipment: 5.2 +/- 5.8%) acceleration. These data have application toward development and validation of future helmet evaluation protocols and standards.	[Cobb, Bryan R.; Zadnik, Abigail M.; Rowson, Steven] Virginia Tech, Ctr Injury Biomech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA	Cobb, BR (corresponding author), Virginia Tech, Ctr Injury Biomech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	cobb84@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596			Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Gadd CW., 1966, 660793 SAE; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hirsch AE, 1970, 700899 SAE; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; King A.I., 2003, P INT RES C BIOM IMP; MacAlister Anna, 2014, Biomed Sci Instrum, V50, P242; McLeod D. G., 1974, 741193 SAE; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2006, STAND LIN IMP TEST M; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2011, STAND PERF SPEC NEWL; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NOCSAE (National Operating Committee on Standards for Athletic Equipment), 2011, STAND TEST METH EQ U; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; Ouckama R, 2012, P I MECH ENG P-J SPO, V226, P185, DOI 10.1177/1754337111435625; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, J NEUROSURG, V119, P805, DOI 10.3171/2013.3.JNS121735; Rowson S, 2013, P I MECH ENG P-J SPO, V227, P12, DOI 10.1177/1754337112442620; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Versace J., 1971, 710881 SAE; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	45	14	14	1	10	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	MAR	2016	230	1			SI		50	60		10.1177/1754337115599133			11	Engineering, Mechanical; Sport Sciences	Engineering; Sport Sciences	DG8AN	WOS:000372304900007					2021-06-18	
J	Lawrence, DW; Comper, P; Hutchison, MG				Lawrence, David W.; Comper, Paul; Hutchison, Michael G.			Influence of Extrinsic Risk Factors on National Football League Injury Rates	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						National Football League; NFL; concussion; injury prevention; temperature; epidemiology	SYNTHETIC PLAYING SURFACES; UPPER EXTREMITY INJURIES; HAMSTRING INJURIES; SPORTS INJURIES; PREVENTION; TEMPERATURE; CONCUSSION; PLAYERS; ANKLE; KNEE	Background: The risk of injury associated with American football is significant, with recent reports indicating that football has one of the highest rates of all-cause injury, including concussion, of all major sports. There are limited studies examining risk factors for injuries in the National Football League (NFL). Purpose: To identify risk factors for NFL concussions and musculoskeletal injuries. Study Design: Case-control study; Level of evidence, 3. Methods: Injury report data were collected prospectively for each week over the 2012-2013 and 2013-2014 regular seasons for all 32 teams. Poisson regression models were used to identify the relationship between predetermined variables and the risk of the 5 most frequent injuries (knee, ankle, hamstring, shoulder, and concussion). Results: A total of 480 games or 960 team games (TGs) from the 2012-2013 and 2013-2014 regular seasons were included in this study. A trend to an increasing risk of concussion and TG ankle injury with decreasing mean game-day temperature was observed. The risk of TG concussion (incidence rate ratio [IRR], 2.16; 95% CI, 1.35-3.45; P = .001) and TG ankle injury (IRR, 1.48; 95% CI, 1.10-1.98; P = .01) was significantly greater for TGs played at a mean game-day temperature of 9.7 degrees C (49.5 degrees F) compared with a mean game-day temperature of 21.0 degrees C (69.8 degrees F). The risk of TG shoulder injury was significantly increased for TGs played on grass surfaces (IRR, 1.36; 95% CI, 1.02-1.81; P = .038) compared with synthetic surfaces. The risk of TG injury was not associated with time in season, altitude, time zone change prior to game, or distance traveled to a game. Conclusion: This study evaluated extrinsic risk factors for injury in the NFL. A hazardous association was identified for risk of concussion and ankle injury with colder game-day temperature. Further research should be conducted to substantiate this relationship and its potential implication for injury prevention initiatives.	[Lawrence, David W.; Comper, Paul; Hutchison, Michael G.] Univ Toronto, Toronto, ON M5B 1W8, Canada	Lawrence, DW (corresponding author), Univ Toronto, St Michaels Hosp, Dept Family & Community Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	dw.lawrence@mail.utoronto.ca					[Anonymous], STAR TRIBUNE; [Anonymous], ASS PRESS; [Anonymous], NFL INJ; Archer T, ROMO TORE RIB CARTIL; Balazs GC, 2015, AM J SPORT MED, V43, P1798, DOI 10.1177/0363546514545864; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowen M., 2016, ESPN; Carlisle JC, 2008, AM J SPORT MED, V36, P1945, DOI 10.1177/0363546508318198; Dewhurst S, 2005, EUR J APPL PHYSIOL, V94, P491, DOI 10.1007/s00421-005-1384-6; Ekstrand J, 2004, BRIT J SPORT MED, V38, P493, DOI 10.1136/bjsm.2003.009134; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Florio M., NFL RESUMES QUIET PU; Florio M. M, MORE COUNTRIES COULD; Fuller CW, 2015, BRIT J SPORT MED, V49, P458, DOI 10.1136/bjsports-2014-094369; Gever J., NFL STEPS WARNINGS P; Hershman EB, 2012, AM J SPORT MED, V40, P2200, DOI 10.1177/0363546512458888; HESS GP, 1989, SPORTS MED, V8, P371, DOI 10.2165/00007256-198908060-00005; Krause BA, 2000, J SPORT REHABIL, V9, P253, DOI 10.1123/jsr.9.3.253; Kujala UM, 1997, SPORTS MED, V23, P397, DOI 10.2165/00007256-199723060-00005; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; Lynch TS, 2013, AM J SPORT MED, V41, P2904, DOI 10.1177/0363546513504284; Mair SD, 1996, AM J SPORT MED, V24, P137, DOI 10.1177/036354659602400203; Mall NA, 2008, AM J SPORT MED, V36, P1938, DOI 10.1177/0363546508318197; Mazer B, 2010, CLIN J SPORT MED, V20, P249, DOI 10.1097/JSM.0b013e3181e0b913; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Newton D., 2016, ESPN; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Orchard J, 2002, SPORTS MED, V32, P419, DOI 10.2165/00007256-200232070-00002; Orchard JW, 2013, OPEN ACCESS J SPORTS, V4, P251, DOI 10.2147/OAJSM.S52417; Orchard JW, 2003, MED SCI SPORT EXER, V35, P1118, DOI 10.1249/01.MSS.0000074563.61975.9B; Petersen J, 2005, BRIT J SPORT MED, V39, P319, DOI 10.1136/bjsm.2005.018549; Radil K, INFLUENCE TEMPERATUR; Ruedl G, 2012, SCAND J MED SCI SPOR, V22, P185, DOI 10.1111/j.1600-0838.2011.01286.x; Schwellnus MP, 2012, BRIT J SPORT MED, V46, P816, DOI 10.1136/bjsports-2012-091395; Sessler M., R GOODELL SAYS INJUR; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188; Taylor SA, 2012, PHYSICIAN SPORTSMED, V40, P66, DOI 10.3810/psm.2012.11.1989; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Triplett M, PAYTON CRITICAL EXTR; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Zarvosky GS., 2014, ORTHOP J SPORTS MED, V2; Zavorsky GS, 2014, J ORTHOP SPORT PHYS, V44, P458, DOI 10.2519/jospt.2014.0201	44	14	14	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	MAR	2016	4	3							2325967116639222	10.1177/2325967116639222			9	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	DJ8VV	WOS:000374492200010	27088102	DOAJ Gold, Green Published			2021-06-18	
J	Lo Giudice, D; Smith, K; Fenner, S; Hyde, Z; Atkinson, D; Skeaf, L; Malay, R; Flicker, L				Lo Giudice, Dina; Smith, Kate; Fenner, Stephen; Hyde, Zoe; Atkinson, David; Skeaf, Linda; Malay, Roslyn; Flicker, Leon			Incidence and predictors of cognitive impairment and dementia in Aboriginal Australians: A follow-up study of 5 years	ALZHEIMERS & DEMENTIA			English	Article						Indigenous; Dementia; Cognition; Cohort study; Older people	STRAIT ISLANDER PEOPLES; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; RISK-FACTORS; PREVALENCE; BURDEN; OLDER; TRENDS; PAIN	Introduction: Aboriginal Australians are reported to develop dementia earlier than the general population. The causes remain unknown. Methods: This was a longitudinal study of 363 participants aged >= 45 years. Consensus diagnoses were established for cognitive impairment or dementia. Results: At follow-up, 189 people (mean +/- standard deviation age, 65.4 +/- 10.3 years) participated, as 109 (30%) had died and 65 (18%) were unavailable. The incidence of cognitive impairment or dementia was 52.6 (95% confidence interval 33.9, 81.5) per 1000 person-years (380.3 total person-years) and for dementia was 21.0 (10.5, 42.1) per 1000 person-years (380.3 person-years total) over the age 60 years. Longitudinal risk factors associated with a decline from normal cognition to impairment were age and head injury. Other associations with cognitive decline were stroke, head injury, nonaspirin analgesics, lower BMI, and higher systolic BP. Discussion: Dementia incidence in Aboriginal Australians is among the highest in the world, and is associated with age and head injury. (C) 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.	[Lo Giudice, Dina] Melbourne Hlth, Aged Care, Melbourne, Vic, Australia; [Lo Giudice, Dina; Smith, Kate; Hyde, Zoe; Skeaf, Linda; Malay, Roslyn; Flicker, Leon] WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia; [Fenner, Stephen] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Hyde, Zoe; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Atkinson, David] Univ Western Australia, Rural Clin Sch WA, Perth, WA 6009, Australia; [Atkinson, David] Kimberley Aboriginal Med Serv, Broome, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia	Lo Giudice, D (corresponding author), Melbourne Hlth, Aged Care, Melbourne, Vic, Australia.; Lo Giudice, D (corresponding author), WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia.	dina.logiudice@mhorg.au	Hyde, Zoe/B-6411-2009	Hyde, Zoe/0000-0002-5985-1729; Smith, Kate/0000-0003-4077-1996; Atkinson, David/0000-0001-7069-5555; Flicker, Leon/0000-0002-3650-0475	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [634486]	This research was supported by National Health and Medical Research Council (NHMRC) Project Grant ID 634486.	Avila-Funes JA, 2012, J AM GERIATR SOC, V60, P1708, DOI 10.1111/j.1532-5415.2012.04142.x; Australian Institute of Health and Welfare, 2011, LIF EXP MORT AB TORR; Australian Institute of Health and Welfare (AIHW) , 2011, HLTH WELF AUSTR AB T; Bowirrat A, 2002, J NEUROL SCI, V203, P73, DOI 10.1016/S0022-510X(02)00269-1; Catindig JAS, 2012, J NEUROL SCI, V321, P11, DOI 10.1016/j.jns.2012.07.023; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Flicker L, 2010, CLIN GERIATR MED, V26, P17, DOI 10.1016/j.cger.2009.12.005; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Hendrie H C, 1993, Int Psychogeriatr, V5, P5, DOI 10.1017/S1041610293001358; Jacklin KM, 2013, CAN J PUBLIC HEALTH, V104, pE39, DOI 10.1007/BF03405652; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Li SQ, 2014, MED J AUSTRALIA, V200, P465, DOI 10.5694/mja13.11052; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; LoGiudice DC, 2012, INTERN MED J, V42, pE102, DOI 10.1111/j.1445-5994.2010.02332.x; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Radford K, 2015, ALZHEIMERS DEMENT, V11, P271, DOI 10.1016/j.jalz.2014.03.007; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Russ TC, 2012, INT J EPIDEMIOL, V41, P1012, DOI 10.1093/ije/dys103; Smith K, 2008, NEUROLOGY, V71, P1470, DOI 10.1212/01.wnl.0000320508.11013.4f; Smith K, 2010, AUST NZ J PSYCHIAT, V44, P888, DOI 10.3109/00048674.2010.491816; Thrift AG, 2007, INT J STROKE, V2, P57, DOI 10.1111/j.1747-4949.2007.00090.x; Vindigni Dein, 2003, Aust J Rural Health, V11, P187, DOI 10.1046/j.1440-1584.2003.00503.x; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wang ZM, 2006, EUR J CARDIOV PREV R, V13, P438, DOI 10.1097/00149831-200606000-00021; Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051	30	14	14	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAR	2016	12	3					252	261		10.1016/j.jalz.2015.01.009			10	Clinical Neurology	Neurosciences & Neurology	DH3VP	WOS:000372715200006	25998515				2021-06-18	
J	Simpson, GK; Daher, M; Hodgkinson, A; Strettles, B				Simpson, Grahame K.; Daher, Maysaa; Hodgkinson, Adeline; Strettles, Barbara			Comparing the Injury Profile, Service Use, Outcomes, and Comorbidities of People With Severe TBI Across Urban, Regional, and Remote Populations in New South Wales: A Multicentre Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						rehabilitation; traumatic brain injury; rural; service utilization	TRAUMATIC BRAIN-INJURY; COMMUNITY-DWELLING ADULTS; CHALLENGING BEHAVIORS; CARE; REHABILITATION; SCALE; PARTICIPATION; PREVALENCE; CAREGIVERS; CLIENTS	Objective: To compare the demographic/injury profile, outcomes, service utilization, and unmet service needs of individuals with severe traumatic brain injury across urban, regional, and remote areas of New South Wales. Setting: The 11 community-based rehabilitation teams of the New South Wales Brain Injury Rehabilitation Program. Participants: Active clients (N = 503) with severe traumatic brain injury. Design: A prospective cross-sectional multicenter study. Main Measures: Overt Behaviour Scale, Health of the Nation Outcome Scale-Acquired Brain Injury, Disability Rating Scale, Sydney Psychosocial Reintegration Scale-2, Care and Needs Scale, data protocol on service utilization, and unmet needs. Results: There were no differences in injury severity or functional outcomes across the 3 locations. However, clients in regional and remote areas had significantly higher levels of premorbid and postinjury comorbidities and lower levels of participation in comparison to urban clients. Although accessing the same number of services as their urban counterparts, clients in regional and remote areas had significantly higher levels of unmet needs suggesting problems with under-servicing. Conclusions: Geographical location had a significant impact on service access and outcomes.	[Simpson, Grahame K.; Hodgkinson, Adeline] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, Sydney Sch Med, John Walsh Ctr Rehabil Res, Sydney, NSW 2006, Australia; [Simpson, Grahame K.; Daher, Maysaa] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Strettles, Barbara] Agcy Clin Innovat, Sydney, NSW, Australia	Simpson, GK (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool Brain Injury Rehabil Unit, POB 7279, Liverpool Bc, NSW 1871, Australia.	grahame.simpson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060	New South Wales Agency for Clinical Innovation (ACI)	The New South Wales Agency for Clinical Innovation (ACI) funded the project. Thanks to Dr Mark Sabaz, Dr Jeff Rogers, Inika Gillis, the project steering committee, and the participating BIRP clinicians.	Access Economics Pty Ltd, 2009, EC COST SPIN CORD IN; Anderson S, 2004, J COGNITIVE REHABILI, V22, P6; Australian Bureau of Statistics, 2010, YB AUSTR 2009 10; Australian Bureau of Statistics, 2014, REG POP GROWTH AUSTR; Australian Bureau of Statistics, 2011, AUSTR SOC TRENDS MAR; Australian Bureau of Statistics, 2006, STAT GEOGR; Australian Bureau of Statistics, 2004, YB AUSTR 2004; Australian Bureau of Statistics, 2008, AUSTR SOC TRENDS ART; Brain Injury Rehabilitation Directorate, 2014, 2011 2012 ANN REP; Brain Injury Rehabilitation Directorate, 2014, NSW BRAIN INJ REH PR; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Coetzer B R, 2002, Aust J Rural Health, V10, P229, DOI 10.1046/j.1440-1584.2002.00425.x; Coetzer R., 2001, PSYCHIAT B, V25, P421, DOI DOI 10.1192/pb.25.11.421; Curtin M, 2011, BRAIN INJURY, V25, P266, DOI 10.3109/02699052.2010.542793; Department of Economic and Social Affairs, 2013, 2012 DEM YB; Ducharme JM, 2001, BRAIN INJURY, V15, P333, DOI 10.1080/02699050010005869; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Fleminger S, 2005, PSYCHIATR BULL, V29, P53, DOI 10.1192/pb.29.2.53; Foster M, 2000, BRAIN INJURY, V14, P1035; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Gontkovsky ST, 2006, BRAIN INJURY, V20, P701, DOI 10.1080/02699050600744103; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Jackson H, 2001, NEUROREHABILITATION, V16, P27; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Miller S., 2011, RURAL REMOT IN PRESS; Mitsch V, 2014, BRAIN INJURY, V28, P1504, DOI 10.3109/02699052.2014.938120; Murphy J, 2004, TOPICS EMERGENCY MED, V26, P231; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sabaz M., 2010, NSW BRAIN INJURY REH; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sample PL, 2007, SUBST USE MISUSE, V42, P705, DOI 10.1080/10826080701202536; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Schootman M, 1999, BRAIN INJURY, V13, P995; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Stucki, 2015, HDB VOCATIONAL REHAB, P263; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408, DOI 10.1375/BRIM.5.1.81.35408]; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; US Department of Commerce, 2009, STAT ABSTR US 2010	52	14	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		E26	E38		10.1097/HTR.0000000000000160			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DH7NQ	WOS:000372981300003	26098264				2021-06-18	
J	Vargo, MM; Vargo, KG; Gunzler, D; Fox, KW				Vargo, Mary M.; Vargo, Kevin G.; Gunzler, Douglas; Fox, Kermit W.			Interdisciplinary Rehabilitation Referrals in a Concussion Clinic Cohort: An Exploratory Analysis	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; COMORBIDITY SURVEY REPLICATION; SPORT-RELATED CONCUSSION; HEAD-INJURY; MILD; PREVALENCE; STATEMENT; RECOVERY; SYMPTOMS; NEED	Objective: To assess the frequency and spectrum of referrals to rehabilitation disciplines in a concussion clinic population and factors associated with need for referral. Design: Retrospective study. Setting: Concussion clinic within the Physical Medicine and Rehabilitation Department of an academic medical center. Participants: Patients receiving physiatric management for concussion care. Main Outcome Measures: Referral to physical therapy (PT), occupational therapy, speech therapy (ST), neuropsychology, or any referral (Any), and reasons for referral. Interventions: Demographic and clinical variables were analyzed for possible association with referral to rehabilitation disciplines. These independent variables included mechanism of injury, referral source, age, gender, provider, days since injury, presenting Sports Concussion Assessment Tool 2 (SCAT2) symptom score, insurance type, clinical risk factors, whether the injury was work related and whether the patient had been hospitalized. Results: Among 262 patients meeting inclusion criteria, the most commonly prescribed individual therapy was physical therapy (74 patients; 28%), followed by speech therapy (60 patients, 23%), neuropsychology (27 patients, 10.3%), and occupational therapy (19 patients, 7.2%). In all, 121 (46%) of patients were referred to one or more disciplines. The most common reasons for referral were cognitive strategies (54 patients, 21%), balance/vestibular therapy (50 patients, 19%), and neck pain (32 patients, 12%). Per multivariate logistic regression analysis, covariates associated with PT: age, SCAT2 symptom score, gender, provider, and (inversely) cognitive/learning disorder; ST: time elapsed since injury, gender, and referral source of internal clinic; Any: SCAT2 symptom score. Referrals did not significantly vary by mechanism of injury (sports, fall, vehicular, etc), whether work-related, or whether the patient had been hospitalized. Insurance factors were significant for PT and Any on the univariate analysis but not logistic regression. Conclusions: Relatively little has been described about the typical rehabilitation requirements of individuals recovering from concussion. Although rest and guided return to usual activities have been emphasized as mainstays of management, a large number of patients in this concussion cohort were determined to require additional rehabilitation services to assist in recovery.	[Vargo, Mary M.; Fox, Kermit W.] Case Western Reserve Univ, Phys Med & Rehabil, Metrohlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44019 USA; [Vargo, Kevin G.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Pittsburgh, PA USA; [Gunzler, Douglas] Case Western Reserve Univ, Ctr Hlth Care Res & Policy, Metrohlth Med Ctr, Cleveland, OH 44019 USA	Vargo, MM (corresponding author), Case Western Reserve Univ, Phys Med & Rehabil, Metrohlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44019 USA.	mvargo@metrohealth.org					Alexander Hamish, 2007, N Z Med J, V120, pU2420; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Anderson T, 2006, PRACT NEUROL, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, CDCS C TRAUM BRAIN I; Centers for Disease Control and Prevention, 2015, ATTENTION DEFICIT HY; DeMarco AP, 2015, J CHILD NEUROL, V30, P468; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2007, BRAIN INJURY MED PRI, P333; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rose JM, 2005, BRAIN INJURY, V19, P29, DOI 10.1080/02699050310001617361; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	30	14	14	2	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	MAR	2016	8	3					241	248		10.1016/j.pmrj.2015.07.006			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DG9WQ	WOS:000372434900007	26226207				2021-06-18	
J	Gagnon, A; Lin, J; Stergiou-Kita, M				Gagnon, Alicia; Lin, Jenny; Stergiou-Kita, Mary			Family members facilitating community re-integration and return to productivity following traumatic brain injury - motivations, roles and challenges	DISABILITY AND REHABILITATION			English	Article							REHABILITATION; WORK; INTERVENTION; MODERATE; OUTCOMES		[Gagnon, Alicia; Lin, Jenny; Stergiou-Kita, Mary] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Stergiou-Kita, Mary] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada	Gagnon, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada.	alicia.gagnon@mail.utoronto.ca					Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Chan J, 2009, ADV MENT HEALTH, V8, P155, DOI 10.5172/jamh.8.2.155; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; KENDALL E, 2003, J VOCAT REHABIL, V19, P31; Kolakowsky-Hayner SA, 2001, NEUROREHABILITATION, V16, P41; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; Macaden AS, 2010, DISABIL REHABIL, V32, P1140, DOI 10.3109/09638280903311594; Portney LG, 2009, FDN CLIN RES APPL PR; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Smith Michele S, 2002, Rehabil Nurs, V27, P209; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stergiou-Kita M, 2009, CAN J OCCUP THER, V76, P276, DOI 10.1177/000841740907600406; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	22	14	14	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	FEB 27	2016	38	5					433	441		10.3109/09638288.2015.1044035			9	Rehabilitation	Rehabilitation	DA5HS	WOS:000367834600004	25974226				2021-06-18	
J	White, TE; Surles-Zeigler, MC; Ford, GD; Gates, AS; Davids, B; Distel, T; LaPlaca, MC; Ford, BD				White, Todd E.; Surles-Zeigler, Monique C.; Ford, Gregory D.; Gates, Alicia S.; Davids, Benem; Distel, Timothy; LaPlaca, Michelle C.; Ford, Byron D.			Bilateral gene interaction hierarchy analysis of the cell death gene response emphasizes the significance of cell cycle genes following unilateral traumatic brain injury	BMC GENOMICS			English	Article						Traumatic brain injury; Cell death; Microarray; Bioinformatics; Gene interaction hierarchy	LONG-TERM DISABILITY; RAT CEREBRAL-CORTEX; SPINAL-CORD-INJURY; DEPENDENT KINASES; UNITED-STATES; IN-VITRO; PROVIDES NEUROPROTECTION; PROTEIN-KINASES; CORTICAL IMPACT; CDK INHIBITOR	Background: Delayed or secondary cell death that is caused by a cascade of cellular and molecular processes initiated by traumatic brain injury (TBI) may be reduced or prevented if an effective neuroprotective strategy is employed. Microarray and subsequent bioinformatic analyses were used to determine which genes, pathways and networks were significantly altered 24 h after unilateral TBI in the rat. Ipsilateral hemi-brain, the corresponding contralateral hemi-brain, and naive (control) brain tissue were used for microarray analysis. Results: Ingenuity Pathway Analysis showed cell death and survival (CD) to be a top molecular and cellular function associated with TBI on both sides of the brain. One major finding was that the overall gene expression pattern suggested an increase in CD genes in ipsilateral brain tissue and suppression of CD genes contralateral to the injury which may indicate an endogenous protective mechanism. We created networks of genes of interest (GOI) and ranked the genes by the number of direct connections each had in the GOI networks, creating gene interaction hierarchies (GIHs). Cell cycle was determined from the resultant GIHs to be a significant molecular and cellular function in post-TBI CD gene response. Conclusions: Cell cycle and apoptosis signalling genes that were highly ranked in the GIHs and exhibited either the inverse ipsilateral/contralateral expression pattern or contralateral suppression were identified and included STAT3, CCND1, CCND2, and BAX. Additional exploration into the remote suppression of CD genes may provide insight into neuroprotective mechanisms that could be used to develop therapies to prevent cell death following TBI.	[White, Todd E.; Surles-Zeigler, Monique C.; Gates, Alicia S.; Davids, Benem; Distel, Timothy; Ford, Byron D.] Morehouse Sch Med, Inst Neurosci, Dept Neurobiol, 720 Westview Dr SW, Atlanta, GA 30310 USA; [Ford, Gregory D.] Georgia Highlands Coll, Div Nat Sci & Phys Educ, 5441 Highway 20 NE, Cartersville, GA 30121 USA; [LaPlaca, Michelle C.] Georgia Inst Technol, Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA; [Distel, Timothy; Ford, Byron D.] Univ Calif Riverside, Sch Med, 900 Univ Ave, Riverside, CA 92521 USA	Ford, BD (corresponding author), Morehouse Sch Med, Inst Neurosci, Dept Neurobiol, 720 Westview Dr SW, Atlanta, GA 30310 USA.; Ford, BD (corresponding author), Univ Calif Riverside, Sch Med, 900 Univ Ave, Riverside, CA 92521 USA.	byron.ford@ucr.edu		Surles-Zeigler, Monique/0000-0002-2308-8813	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS 057993, U54 NS060659]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0055]; W.M. Keck FoundationW.M. Keck Foundation; BRIC NIH [5P20M006131-02]; Howard Hughes Medical InstituteHoward Hughes Medical Institute [52006306]; PHS Grant from Clinical and Translational Science Award program, NIH, National Center for Research Resources (NCRR) [UL1 RR025008, KL2 RR025009, TL1 RR025010]; Morehouse School of Medicine Grants from NCRR [U54 RR026137, G12RR003034, S21MD000101]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454, KL2TR000455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [G12RR003034, TL1RR025010, U54RR026137, KL2RR025009, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS060659, U01NS057993] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [S21MD000101] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007056] Funding Source: NIH RePORTER	The authors would like to thank Brock Wester, Kaelin Brewster, and Samantha Simon for their technical assistance. This work was supported by National Institutes of Health (NIH) grants U01 NS 057993 (BDF), U54 NS060659 (BDF), Department of Defense Contract #W81XWH-10-2-0055 (BDF), the W.M. Keck Foundation (BDF); BRIC NIH grant #5P20M006131-02 (GDF), Howard Hughes Medical Institute grant #52006306 (GDF) and PHS Grant (UL1 RR025008, KL2 RR025009 or TL1 RR025010) from the Clinical and Translational Science Award program, NIH, National Center for Research Resources (NCRR) (MCL). The project described was supported by Morehouse School of Medicine Grants Number U54 RR026137, G12RR003034 and S21MD000101 from the NCRR, a component of NIH, and its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.	Affymetrix, 2010, GENECHIP 3 IVT EXPR; Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032; Arifin Muhammad Zafrullah, 2011, Asian J Neurosurg, V6, P72, DOI 10.4103/1793-5482.92160; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chang YW, 2009, J NEUROTRAUM, V26, P979, DOI [10.1089/neu.2008.0762, 10.1089/neu.2008-0762]; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; DeGracia DJ, 1996, J NEUROCHEM, V67, P2005; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Dressler Jan, 2009, Leg Med (Tokyo), V11 Suppl 1, pS54, DOI 10.1016/j.legalmed.2009.02.024; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; IPA&REG;, 2015, FAQS STAT CALC; IPA&REG;, 2013, IPA NETW GEN; IPA&REG;, 2013, IPA CAN PATHW OV; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Ji YH, 2008, MOL CELL BIOCHEM, V309, P49, DOI 10.1007/s11010-007-9642-z; Jones LL, 2000, J COMP NEUROL, V426, P468, DOI 10.1002/1096-9861(20001023)426:3<468::AID-CNE9>3.0.CO;2-I; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Li YG, 2012, TOXICOL APPL PHARM, V262, P194, DOI 10.1016/j.taap.2012.05.001; Li YG, 2011, TOXICOL APPL PHARM, V253, P261, DOI 10.1016/j.taap.2011.03.026; Liu Y, 2003, BRAIN RES, V972, P142, DOI 10.1016/S0006-8993(03)02519-8; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Meikrantz W, 1996, J BIOL CHEM, V271, P10205, DOI 10.1074/jbc.271.17.10205; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; O'Hare M, 2002, PHARMACOL THERAPEUT, V93, P135, DOI 10.1016/S0163-7258(02)00183-3; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Saha RN, 2009, J IMMUNOL, V183, P2068, DOI 10.4049/jimmunol.0801892; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; SHARP JW, 1990, EXP NEUROL, V109, P323, DOI 10.1016/S0014-4886(05)80023-8; Shi JQ, 2009, FEBS LETT, V583, P971, DOI 10.1016/j.febslet.2009.02.028; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Stenzel-Poore MP, 2004, STROKE, V35, P2683, DOI 10.1161/01.STR.0000143735.89281.bb; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Thomsen GM, 2014, STEM CELL RES, V13, P48, DOI 10.1016/j.scr.2014.04.013; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wainwright MS, 2003, DEV BRAIN RES, V146, P79, DOI 10.1016/j.devbrainres.2003.09.012; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; White TE, 2015, BRAIN NEUROTRAUMA MO, P378; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	88	14	14	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	FEB 24	2016	17								130	10.1186/s12864-016-2412-0			29	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	DF8FS	WOS:000371593400001	26912237	DOAJ Gold, Green Published			2021-06-18	
J	Maruta, J; Palacios, EM; Zimmerman, RD; Ghajar, J; Mukherjee, P				Maruta, Jun; Palacios, Eva M.; Zimmerman, Robert D.; Ghajar, Jamshid; Mukherjee, Pratik			Chronic Post-Concussion Neurocognitive Deficits. I. Relationship with White Matter Integrity	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						eye movement; diffusion tensor imaging; mild traumatic brain injury; neuroimaging; neuropsychology; post-concussion syndrome	TRAUMATIC BRAIN-INJURY; SUBJECT DIFFUSION DATA; SPATIAL STATISTICS; VOXELWISE ANALYSIS; SYMPTOMS; TRENDS; SYNCHRONIZATION; SPECIFICITY; VALIDITY; SPORTS	We previously identified visual tracking deficits and associated degradation of integrity in specific white matter tracts as characteristics of concussion. We re-explored these characteristics in adult patients with persistent post-concussive symptoms using independent new data acquired during 2009-2012. Thirty-two patients and 126 normal controls underwent cognitive assessments and MR-DTI. After data collection, a subset of control subjects was selected to be individually paired with patients based on gender and age. We identified patients' cognitive deficits through pairwise comparisons between patients and matched control subjects. Within the remaining 94 normal subjects, we identified white matter tracts whose integrity correlated with metrics that indicated performance degradation in patients. We then tested for reduced integrity in these white matter tracts in patients relative to matched controls. Most patients showed no abnormality in MR images unlike the previous study. Patients' visual tracking was generally normal. Patients' response times in an attention task were slowed, but could not be explained as reduced integrity of white matter tracts relating to normal response timing. In the present patient cohort, we did not observe behavioral or anatomical deficits that we previously identified as characteristic of concussion. The recent cohort likely represented those with milder injury compared to the earlier cohort. The discrepancy may be explained by a change in the patient recruitment pool circa 2007 associated with an increase in public awareness of concussion.	[Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Palacios, Eva M.; Mukherjee, Pratik] Univ Calif San Francisco, Sch Med, Dept Radiol & Biomed Imaging, San Francisco, CA USA; [Zimmerman, Robert D.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Ghajar, Jamshid] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA	Maruta, J (corresponding author), Brain Trauma Fdn, New York, NY USA.; Mukherjee, P (corresponding author), Univ Calif San Francisco, Sch Med, Dept Radiol & Biomed Imaging, San Francisco, CA USA.	jmaruta@braintrauma.org; pratik@radiology.ucsf.edu	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	U.S. Department of Defense Congressionally Directed Medical Research Programs through an Advanced Technology Award [W81XWH-08-1-0646]	We thank the staff of Brain Trauma Foundation's clinical research team and the Citigroup Biomedical Imaging Center for assistance with data collection and maintenance. Frank Ezekiel preprocessed the DTI data. This work was supported by U.S. Department of Defense Congressionally Directed Medical Research Programs through an Advanced Technology Award (W81XWH-08-1-0646) to JG.	Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; CDC, 2013, HEADS 10 YEARS ANN V; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellenbogen RG, 2010, WORLD NEUROSURG, V74, P560, DOI 10.1016/j.wneu.2010.11.016; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Ghosh SS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00004; Gong GL, 2005, NEUROREPORT, V16, P1701, DOI 10.1097/01.wnr.0000183327.98370.6a; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Inano S, 2011, AM J NEURORADIOL, V32, P2103, DOI 10.3174/ajnr.A2785; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00045; Maruta J, 2014, MIL MED, V179, P619, DOI 10.7205/MILMED-D-13-00420; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2012, PROC SPIE, V8371, DOI 10.1117/12.927790; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Niven Daniel J, 2012, Clin Epidemiol, V4, P99, DOI 10.2147/CLEP.S30816; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Temme L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00041; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	46	14	15	0	19	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	FEB 10	2016	10								35	10.3389/fnhum.2016.00035			8	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	DD3VJ	WOS:000369850900001	26903842	DOAJ Gold, Green Published			2021-06-18	
J	Ghodadra, A; Alhilali, L; Fakhran, S				Ghodadra, A.; Alhilali, L.; Fakhran, S.			Principal Component Analysis of Diffusion Tensor Images to Determine White Matter Injury Patterns Underlying Postconcussive Headache	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPATIAL STATISTICS; IMAGING FINDINGS; CORPUS-CALLOSUM; MIGRAINE; DYSFUNCTION; IMPAIRMENT; INTEGRITY; SYMPTOMS; ADULTS	BACKGROUND AND PURPOSE: Principal component analysis, a data-reduction algorithm, generates a set of principal components that are independent, linear combinations of the original dataset. Our study sought to use principal component analysis of fractional anisotropy maps to identify white matter injury patterns that correlate with posttraumatic headache after mild traumatic brain injury. MATERIALS AND METHODS: Diffusion tensor imaging and neurocognitive testing with the Immediate Post-Concussion Assessment and Cognitive Test were performed in 40 patients with mild traumatic brain injury and 24 without posttraumatic headache. Principal component analysis of coregistered fractional anisotropy maps was performed. Regression analysis of the major principal components was used to identify those correlated with posttraumatic headache. Finally, each principal component that correlated with posttraumatic headache was screened against other postconcussive symptoms and demographic factors. RESULTS: Principal component 4 (mean, 7.1 10.3) correlated with the presence of posttraumatic headache in mild traumatic brain injury (odds ratio per SD, 2.32; 95% CI, 1.29-4.67; P = .01). Decreasing principal component 4 corresponded with decreased fractional anisotropy in the midsplenium and increased fractional anisotropy in the genu of the corpus callosum. Principal component 4 identified patients with posttraumatic headache with an area under the receiver operating characteristic curve of 0.73 and uniquely correlated with posttraumatic headache and no other postconcussive symptom or demographic factors. CONCLUSIONS: Principal component analysis can be an effective data-mining method to identify white matter injury patterns on DTI that correlate with clinically relevant symptoms in mild traumatic brain injury. A pattern of reduced fractional anisotropy in the splenium and increased fractional anisotropy in the genu of the corpus callosum identified by principal component analysis can help identify patients at risk for posttraumatic headache after mild traumatic brain injury.	[Ghodadra, A.; Alhilali, L.; Fakhran, S.] Univ Pittsburgh, Dept Radiol, Med Ctr, 200 Lothrop St,Suite 201 East Wing, Pittsburgh, PA 15213 USA	Ghodadra, A (corresponding author), Univ Pittsburgh, Dept Radiol, Med Ctr, 200 Lothrop St,Suite 201 East Wing, Pittsburgh, PA 15213 USA.	ghodadraag@upmc.edu		Alhilali, Lea/0000-0002-9059-2454			Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BOHNEN N, 1992, NEUROSURGERY, V30, P692; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jolliffe I., 2014, WILEY STATSREF STAT; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim SN, 2012, PROG NEURO-PSYCHOPH, V37, P50, DOI 10.1016/j.pnpbp.2011.11.015; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Li XL, 2011, HEADACHE, V51, P237, DOI 10.1111/j.1526-4610.2010.01774.x; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Schulte T, 2013, NEUROIMAGE, V77, P195, DOI 10.1016/j.neuroimage.2013.03.056; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xydis V, 2006, PEDIATR RADIOL, V36, P934, DOI 10.1007/s00247-006-0235-x; Yaeger K, 2014, AM J ROENTGENOL, V202, P614, DOI 10.2214/AJR.13.11091; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yu DH, 2013, CEPHALALGIA, V33, P34, DOI 10.1177/0333102412466964; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	31	14	14	0	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	2016	37	2					274	278		10.3174/ajnr.A4505			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DC3HU	WOS:000369111200019	26405087	Other Gold, Green Published			2021-06-18	
J	Jefferson, SC; Clayton, ER; Donlan, NA; Kozlowski, DA; Jones, TA; Adkins, DL				Jefferson, Stephanie C.; Clayton, Elyse Renee; Donlan, Nicole A.; Kozlowski, Dorothy Annette; Jones, Theresa A.; Adkins, DeAnna Lynn			Cortical Stimulation Concurrent With Skilled Motor Training Improves Forelimb Function and Enhances Motor Cortical Reorganization Following Controlled Cortical Impact	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						motor cortex; motor map; TBI; recovery; plasticity; ICMS; CCI	SENSORIMOTOR CORTEX; RECOVERY; PLASTICITY; INFARCT; RATS	Background. Electrical and magnetic brain stimulation can improve motor function following stroke in humans, rats, and nonhuman primates, especially when paired with rehabilitative training (RT). Previously, we found in rodent stroke models that epidural electrical cortical stimulation (CS) of the ipsilesional motor cortex (MC) combined with motor RT enhances motor function and motor cortical plasticity. It was unknown whether CS following experimental traumatic brain injury (TBI) would have similar effects. Objective. To test the effects of CS combined with motor training after moderate/severe TBI on behavioral outcome and motor cortical organization. Methods. Following unilateral controlled cortical impact (CCI) over the caudal forelimb area of the MC in adult male rats, forelimb reach training was administered daily for 9 weeks concurrently with subthreshold, 100-Hz monopolar CS or no-stimulation control procedures. The rate and magnitude of behavioral improvements and changes in forelimb movement representations in the injured MC as revealed by intracortical microstimulation were measured. Results. CCI resulted in severe motor impairments persisting throughout the 9 weeks of training in both groups, but CS-treated animals had significantly greater behavioral improvements. CS also increased wrist motor cortical representation, one of the main movements used in the training task, when compared with RT alone. However, the overall recovery level was modest, leaving animals still extremely impaired. Conclusions. These data suggest that CS may be useful for improving rehabilitation efficacy after TBI but also raise the possibility that the CS parameters that are highly effective following stroke are suboptimal after moderate/severe TBI.	[Jefferson, Stephanie C.; Donlan, Nicole A.; Jones, Theresa A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Clayton, Elyse Renee; Adkins, DeAnna Lynn] Med Univ S Carolina, Dept Neurosci, 173 Ashley Ave,CRI404D,MSC510, Charleston, SC 29425 USA; [Kozlowski, Dorothy Annette] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Jones, Theresa A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Adkins, DeAnna Lynn] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Adkins, DeAnna Lynn] Med Univ S Carolina, Ctr Biomed Imaging, Charleston, SC 29425 USA	Adkins, DL (corresponding author), Med Univ S Carolina, Dept Neurosci, 173 Ashley Ave,CRI404D,MSC510, Charleston, SC 29425 USA.	adkinsdl@musc.edu	Jones, Theresa A/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Adkins, DeAnna L/0000-0002-3063-5731	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065866]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065866] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This material is the result of work supported by NINDS NS065866 (DLA, TAJ, DAK).	Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Boychuk JA, 2011, NEUROREHAB NEURAL RE, V25, P88, DOI 10.1177/1545968310385126; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; O'Bryant AJ, 2016, NEUROREHAB NEURAL RE, V30, P143, DOI 10.1177/1545968314562112; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871	10	14	14	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	FEB	2016	30	2			SI		155	158		10.1177/1545968315600274			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DC2VO	WOS:000369076400006	26248599	Green Accepted			2021-06-18	
J	Malec, JF; Whiteneck, GG; Bogner, JA				Malec, James F.; Whiteneck, Gale G.; Bogner, Jennifer A.			Another Look at the PART-O Using the Traumatic Brain Injury Model Systems National Database: Scoring to Optimize Psychometrics	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Community participation; Outcome assessment (health care); Rehabilitation	PARTICIPATION ASSESSMENT; OUTCOMES MEASUREMENT; ISSUES	Objective: To integrate previous approaches to scoring the Participation Assessment with Recombined Tools-Objective (PART-O) in a unidimensional scale. Design: Retrospective analysis of PART-O data from the Traumatic Brain Injury Model Systems. Setting: Community. Participants: Data from individuals (N=469) selected randomly from participants who completed 1-year follow-up in the Traumatic Brain Injury Model Systems were used in Rasch model development. The model was subsequently tested on data from additional random samples of similar size at 1-, 2-, 5-, 10-, and >15-year follow-ups. Interventions: Not applicable. Main Outcome Measure: PART-O. Results: After combining items for productivity and social interaction, the initial analysis at 1-year follow-up indicated relatively good fit to the Rasch model (person reliability=.80) but also suggested item misfit and that the 0-to-5 scale used for most items did not consistently show clear separation between rating levels. Reducing item rating scales to 3 levels (except combined and dichotomous items) resolved these issues and demonstrated good item level discrimination, fit, and person reliability (.81), with no evidence of multidimensionality. These results replicated in analyses at each additional follow-up period. Conclusions: Modifications to item scoring for the PART-O resulted in a unidimensional parametric equivalent measure that addresses previous concerns about competing item relations, and it fit the Rasch model consistently across follow-up periods. The person-item map shows a progression toward greater community participation from solitary and dyadic activities, such as leaving the house and having a friend through social and productivity activities, to group activities with others who share interests or beliefs. (C) 2016 by the American Congress of Rehabilitation Medicine	[Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Malec, James F.] Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Whiteneck, Gale G.] Craig Hosp, Englewood, CO USA; [Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA	Malec, JF (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.; Malec, JF (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [USDE-90DP0036-01-00]; Rocky Mountain Regional Brain Injury System at Craig Hospital, Englewood, CO [USDE-90DP0034-01-00]; Ohio Regional Traumatic Brain Injury Model System at Ohio State University, Columbus, OH [USDE-90DP0040-01-00]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000040, U48DP000034, U48DP000036] Funding Source: NIH RePORTER	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) for the Indiana University/Rehabilitation Hospital of Indiana Traumatic Brain Injury Model System (grant no. USDE-90DP0036-01-00); Rocky Mountain Regional Brain Injury System at Craig Hospital, Englewood, CO (grant no. USDE-90DP0034-01-00); and the Ohio Regional Traumatic Brain Injury Model System at Ohio State University, Columbus, OH (grant no. USDE-90DP0040-01-00). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this report do not necessarily represent the policy of NIDILRR, ACL, and HHS, and you should not assume endorsement by the federal government.	Alonso J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-210; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bond T.G., 2007, APPL RASCH MODEL FUN; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Dijkers M, 2009, ARCH PHYS MED REHAB, V90, pe39, DOI DOI 10.1016/j.apmr.2009.08.123; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS72, DOI 10.1016/j.apmr.2009.11.031; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS1, DOI 10.1016/j.apmr.2011.07.202; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; *WHO, 1997, ICIDH 2 INT CLASS IM; World Health Organization, 1993, INT CLASS IMP DIS HA; World Health Organization, 2001, INT CLASS FUNCT DIS	16	14	14	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2					211	217		10.1016/j.apmr.2015.09.001			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DC4RH	WOS:000369207500005	26381059				2021-06-18	
J	Mao, XR; Kaufman, DM; Crowder, CM				Mao, X. R.; Kaufman, D. M.; Crowder, C. M.			Nicotinamide mononucleotide adenylyltransferase promotes hypoxic survival by activating the mitochondrial unfolded protein response	CELL DEATH & DISEASE			English	Article							WALLERIAN DEGENERATION; C-ELEGANS; AXONAL DEGENERATION; ENZYMATIC-ACTIVITY; NAD BIOSYNTHESIS; LIFE-SPAN; WLD(S); STRESS; MECHANISMS; PROTECTION	Gain-of-function mutations in the mouse nicotinamide mononucleotide adenylyltransferase type 1 (Nmnat1) produce two remarkable phenotypes: protection against traumatic axonal degeneration and reduced hypoxic brain injury. Despite intensive efforts, the mechanism of Nmnat1 cytoprotection remains elusive. To develop a new model to define this mechanism, we heterologously expressed a mouse Nmnat1 non-nuclear-localized gain-of-function mutant gene (m-nonN-Nmnat1) in the nematode Caenorhabditis elegans and show that it provides protection from both hypoxia-induced animal death and taxol-induced axonal pathology. Additionally, we find that m-nonN-Nmnat1 significantly lengthens C. elegans lifespan. Using the hypoxia-protective phenotype in C. elegans, we performed a candidate screen for genetic suppressors of m-nonN-Nmnat1 cytoprotection. Loss of function in two genes, haf-1 and dve-1, encoding mitochondrial unfolded protein response (mitoUPR) factors were identified as suppressors. M-nonN-Nmnat1 induced a transcriptional reporter of the mitoUPR gene hsp-6 and provided protection from the mitochondrial proteostasis toxin ethidium bromide. M-nonN-Nmnat1 was also protective against axonal degeneration in C. elegans induced by the chemotherapy drug taxol. Taxol markedly reduced basal expression of a mitoUPR reporter; the expression was restored by m-nonN-Nmnat1. Taken together, these data implicate the mitoUPR as a mechanism whereby Nmnat1 protects from hypoxic and axonal injury.	[Mao, X. R.; Kaufman, D. M.; Crowder, C. M.] Washington Univ, Dept Anesthesiol, Sch Med, 660 South Euclid Ave, St Louis, MO 63110 USA; [Kaufman, D. M.] Washington Univ, Med Scientist Training Program, Sch Med, 660 South Euclid Ave, St Louis, MO 63110 USA; [Kaufman, D. M.; Crowder, C. M.] Univ Washington, Dept Anesthesiol & Pain Med, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Crowder, C. M.] Univ Washington, Dept Genome Sci, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Mao, X. R.] Univ Washington, Dept Genet, Sch Med, Seattle, WA 98195 USA	Crowder, CM (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	cmc53@uw.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045905, 5R21NS084360-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045905, R21NS084360] Funding Source: NIH RePORTER	We thank members in Crowder laboratory for help and insightful discussions. We thank Michael Nonet and his lab members and Jeffery Milbrandt and Yo Sasaki for reagents, advice and help with technique development. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We also thank National BioResource Project, Japan for strains. This work was supported by funding from the National Institute of Neurological Disorders and Stroke (R01 NS045905 and 5R21NS084360-02).	Ali YO, 2011, J BIOL CHEM, V286, P19089, DOI 10.1074/jbc.M111.219295; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Badiola N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.31; Bennett GJ, 2011, EUR J NEUROSCI, V33, P1667, DOI 10.1111/j.1460-9568.2011.07652.x; Bhattacharya MRC, 2012, J NEUROSCI, V32, P5054, DOI 10.1523/JNEUROSCI.4951-11.2012; BRENNER S, 1974, GENETICS, V77, P71; Butler JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046140; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calixto A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003141; Chen LZ, 2011, TRENDS CELL BIOL, V21, P577, DOI 10.1016/j.tcb.2011.08.003; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Evans T.C., 2006, TRANSFORMATION MICRO, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1]; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; Fawcett EM, 2012, JOVE-J VIS EXP, DOI 10.3791/4088; Fay DS, 2013, CLASSICAL GENETIC ME; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hill S, 2014, REDOX BIOL, V2, P936, DOI 10.1016/j.redox.2014.07.005; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Larue BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016790; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mabon ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007937; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Mao XR, 2010, MOL CELL BIOL, V30, P5033, DOI 10.1128/MCB.00922-10; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; SAHENK Z, 1994, ARCH NEUROL-CHICAGO, V51, P726, DOI 10.1001/archneur.1994.00540190110024; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Scott B, 2013, J EXP BIOL, V216, P2283, DOI 10.1242/jeb.082263; Verdin E, 2014, NAT MED, V20, P25, DOI 10.1038/nm.3447; Verghese PB, 2011, P NATL ACAD SCI USA, V108, P19054, DOI 10.1073/pnas.1107325108; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	53	14	14	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	FEB	2016	7								e2113	10.1038/cddis.2016.5			10	Cell Biology	Cell Biology	DG5FU	WOS:000372102400018	26913604	DOAJ Gold, Green Published			2021-06-18	
J	Sung, CW; Chen, KY; Chiang, YH; Chiu, WT; Ou, JC; Lee, HC; Tsai, SH; Lin, JW; Yang, CM; Tsai, YR; Liao, KH; Chen, GS; Li, WJ; Wang, JY				Sung, Chih-Wei; Chen, Kai-Yun; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Ou, Ju-Chi; Lee, Hsin-Chien; Tsai, Shin-Han; Lin, Jia-Wei; Yang, Che-Ming; Tsai, Yan-Rou; Liao, Kuo-Hsing; Chen, Gunng-Shinng; Li, Wei-Jiun; Wang, Jia-Yi			Heart rate variability and serum level of insulin-like growth factor-1 are correlated with symptoms of emotional disorders in patients suffering a mild traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Mild traumatic brain injury (mTBI); Autonomic nervous system (ANS); Heart rate variability (HRV); Insulin-like growth factor-1 (IGF-1); Emotional disorder	MAJOR DEPRESSIVE DISORDER; COGNITIVE DYSFUNCTION; CIRCADIAN-RHYTHM; INVENTORY-II; CORTISOL; RISK; ANXIETY; BIOMARKER; MELATONIN; RELEASE	Objective: Patients who have experienced a mild traumatic brain injury (mTBI) are susceptible to symptoms of anxiety or depression. To explore the potential biomarkers for emotional disorders in mTBI patients, we analyzed the frequency domain of heart rate variability (HRV) and serum concentrations of four neurohormones. Methods: We assessed mTBI patients on their first visit and follow-up. Symptoms were evaluated by the Beck Anxiety Inventory and the Beck Depression Inventory, respectively. Serum levels of adrenocorticotropic hormone (ACTH), melatonin, cortisol, and insulin-like growth factor (IGF)-1 and HRV follow-ups were measured and compared. Results: mTBI patients were more vulnerable to symptoms of anxiety or depression than healthy controls. Reduced HRV was noted in mTBI patients compared to healthy controls. The mTBI patients demonstrated higher serum levels of ACTH, lower IGF-1 compared to healthy controls. In correlation analysis, only IGF-1 was positively correlated with HRV in mTBI patients. Both HRV and IGF-1 were correlated with symptom of depression while only HRV was correlated with symptom of anxiety in mTBI patients. Conclusions: We infer that HRV may be more significantly correlated with emotional disorders than is IGF-1 in mTBI patients. Significance: The study is relevant for specific diagnostic markers in mTBI patients. (C) 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Sung, Chih-Wei; Chen, Gunng-Shinng; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Sung, Chih-Wei; Li, Wei-Jiun; Wang, Jia-Yi] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei 110, Taiwan; [Chen, Kai-Yun; Chiang, Yung-Hsiao; Tsai, Yan-Rou] Taipei Med Univ, Grad Program Neuroregenerat, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chiu, Wen-Ta; Tsai, Shin-Han] Taipei Med Univ, Grad Inst Injury & Prevent, Coll Publ Hlth, Taipei 110, Taiwan; [Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency, New Taipei 235, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, New Taipei 235, Taiwan; [Lin, Jia-Wei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei 235, Taiwan; [Yang, Che-Ming] Taipei Med Univ, Shuang Ho Hosp, Dept Nucl Med, New Taipei 235, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 116, Taiwan	Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Xing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw		Sung, Chih-Wei/0000-0003-3312-2752; Wang, Jia-Yi/0000-0002-9106-3351; lee, hsin-chien/0000-0002-7557-8259	Ministry of Science and Technology [MOST-103-2321-B-038-002, MOST-104-2320-B-038-057-MY3, MOST-103-2815-C-038-016-B]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC 98-2321-B-038-003-MY3]	This work was supported in part by grants from the Ministry of Science and Technology (MOST-103-2321-B-038-002 and MOST-104-2320-B-038-057-MY3) to JYW; and from National Science Council (NSC 98-2321-B-038-003-MY3) to WTC; and from the Ministry of Science and Technology (MOST-103-2815-C-038-016-B) to CWS, Taiwan.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Akdemir A, 2001, COMPR PSYCHIAT, V42, P161, DOI 10.1053/comp.2001.19756; Altrocchi PH, 1996, NEUROLOGY, V46, P278; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BECK AT, 1991, AM J PSYCHIAT, V148, P1195; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boyce WT, 2001, BRIT J PSYCHIAT, V179, P144, DOI 10.1192/bjp.179.2.144; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Camm AJ, 1996, EUR HEART J, V17, P354; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Cox BJ, 1996, BEHAV RES THER, V34, P949, DOI 10.1016/S0005-7967(96)00037-X; Cox BJ, 1996, BEHAV RES THER, V34, P55; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Evans S, 2013, J PAIN RES, V6, P449, DOI 10.2147/JPR.S43849; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hansen MV, 2014, BREAST CANCER RES TR, V145, P683, DOI 10.1007/s10549-014-2962-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Laborde S, 2015, PHYSIOL BEHAV, V139, P430, DOI 10.1016/j.physbeh.2014.11.036; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lemoine P, 2007, J SLEEP RES, V16, P372, DOI 10.1111/j.1365-2869.2007.00613.x; Lemoine P, 2012, EXPERT OPIN PHARMACO, V13, P895, DOI 10.1517/14656566.2012.667076; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lerma C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3513; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Llompart-Pou JA, 2010, J ENDOCRINOL INVEST, V33, P368, DOI 10.1007/BF03346605; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Malhi GS, 2013, ACTA PSYCHIAT SCAND, V128, P2, DOI 10.1111/acps.12173; Mirzaie B, 2013, ARCH MED SCI, V9, P68, DOI 10.5114/aoms.2012.30833; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Osman A, 1997, J CLIN PSYCHOL, V53, P7, DOI 10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pandi-Perumal SR, 2009, PROG NEUROBIOL, V88, P264, DOI 10.1016/j.pneurobio.2009.04.007; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Posener JA, 2000, ARCH GEN PSYCHIAT, V57, P755, DOI 10.1001/archpsyc.57.8.755; RABINS PV, 1985, J AFFECT DISORDERS, V9, P165, DOI 10.1016/0165-0327(85)90096-5; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Serra-Nedelec AD, 2012, P NATL ACAD SCI USA, V109, P4257, DOI 10.1073/pnas.1119803109; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Sosin DM, 1996, BRAIN INJURY, V10, P47; Srinivasan V, 2009, PSYCHIAT RES, V165, P201, DOI 10.1016/j.psychres.2007.11.020; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Tang SC, 2015, J NEUROL NEUROSUR PS, V86, P95, DOI 10.1136/jnnp-2014-308389; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; Vogele C, 2009, PHYSIOL BEHAV, V98, P229, DOI 10.1016/j.physbeh.2009.05.018; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zebrowski JJ, 2015, PHYSIOL MEAS, V36, P163, DOI 10.1088/0967-3334/36/1/163; Zheng A, 2008, J NUTR SCI VITAMINOL, V54, P148, DOI 10.3177/jnsv.54.148	81	14	14	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	2016	127	2					1629	1638		10.1016/j.clinph.2015.08.006			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DB3UW	WOS:000368439100087	26350409				2021-06-18	
J	Geddes, RI; Peterson, BL; Stein, DG; Sayeed, I				Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal			Progesterone Treatment Shows Benefit in Female Rats in a Pediatric Model of Controlled Cortical Impact Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; WATER-MAZE; GENDER-DIFFERENCES; IMPROVED OUTCOMES; PREGNANT-WOMEN; CLINICAL-TRIAL; IMMATURE RATS; RECOVERY; NEUROPROTECTION	Purpose We recently showed that progesterone treatment can reduce lesion size and behavioral deficits after moderate-to-severe bilateral injury to the medial prefrontal cortex in immature male rats. Whether there are important sex differences in response to injury and progesterone treatment in very young subjects has not been given sufficient attention. Here we investigated progesterone's effects in the same model of brain injury but with pre-pubescent females. Methods Twenty-eight-day-old female Sprague-Dawley rats received sham (n = 14) or controlled cortical impact (CCI) (n = 21) injury, were given progesterone (8 mg/kg body weight) or vehicle injections on post-injury days (PID) 1-7, and underwent behavioral testing from PID 9-27. Brains were evaluated for lesion size at PID 28. Results Lesion size in vehicle-treated female rats with CCI injury was smaller than that previously reported for similarly treated age-matched male rats. Treatment with progesterone reduced the effect of CCI on extent of damage and behavioral deficits. Conclusion Pre-pubescent female rats with midline CCI injury to the frontal cortex have reduced morphological and functional deficits following progesterone treatment. While gender differences in susceptibility to this injury were observed, progesterone treatment produced beneficial effects in young rats of both sexes following CCI.	[Geddes, Rastafa I.; Peterson, Bethany L.; Stein, Donald G.; Sayeed, Iqbal] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020	Geddes, Rastafa/0000-0002-7313-761X	Emory Center for Injury Control, National Institutes of Health [R49CE001494-04]; Emory University Summer Undergraduate Research Experience (SURE) program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R49CE001494-04]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001494] Funding Source: NIH RePORTER	This work was supported by the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, the Emory University Summer Undergraduate Research Experience (SURE) program, and by unrestricted gifts to the Brain Research Laboratory from BHR Pharma and Allen and Company. There were no employer/employee relationships with either of the companies although DGS had a consulting agreement with BHR to provide pre-clinical information on the use of progesterone for the treatment of TBI. None of the authors currently participate in any licensing agreement or receive any royalties from BHR Pharma. Allen and Company is an investment firm with no commercial interests in pharmacology or any other matter relating to the authors' research. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of this or any other manuscript.; This work was supported by unrestricted gifts in support of research from BHR Pharma, Allen and Company, the Emory Center for Injury Control, National Institutes of Health grant no. R49CE001494-04 to DGS, and the Emory University Summer Undergraduate Research Experience (SURE) program. The authors would like to acknowledge the contributions of our undergraduate research trainees (William Godwin, Maydda Qureshi, Leea Richardson, and Noah Rosen) towards the completion of this work.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 2000, J NEUROTRAUM, V17, P929; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berry C, 2012, AM J SURG, V204, P558, DOI 10.1016/j.amjsurg.2011.07.012; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coughlan T, 2009, INT J NEUROSCI, V119, P1718, DOI 10.1080/00207450903116430; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Dableh Liliane J, 2011, J Pain Res, V4, P91, DOI 10.2147/JPR.S17009; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Frye CA, 2011, J PSYCHOPHARMACOL, V25, P421, DOI 10.1177/0269881109349836; Geddes RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087252; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Haider AH, 2007, ARCH SURG-CHICAGO, V142, P875, DOI 10.1001/archsurg.142.9.875; Halliwell C, 2009, DEV NEUROREHABIL, V12, P269, DOI 10.3109/17518420903087715; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; HOLMES GL, 1984, DEV BRAIN RES, V16, P45, DOI 10.1016/0165-3806(84)90061-0; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; HULL EM, 1981, PHYSIOL BEHAV, V26, P401, DOI 10.1016/0031-9384(81)90166-9; Kallai J, 2005, BEHAV BRAIN RES, V159, P187, DOI 10.1016/j.bbr.2004.10.015; Kaore SN, 2012, J PHARM PHARMACOL, V64, P1040, DOI 10.1111/j.2042-7158.2012.01464.x; Kolb B, 2000, NEUROPHARMACOLOGY, V39, P756, DOI 10.1016/S0028-3908(99)00260-9; Kolb B, 2013, PROG BRAIN RES, V207, P35, DOI 10.1016/B978-0-444-63327-9.00005-9; Kolb B, 2011, DEV MED CHILD NEUROL, V53, P4, DOI 10.1111/j.1469-8749.2011.04054.x; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084336; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luoma JI, 2012, J STEROID BIOCHEM, V131, P30, DOI 10.1016/j.jsbmb.2011.11.002; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Mannix R, 2014, J NEUROSURG, V121, P1337, DOI 10.3171/2014.8.JNS14715; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mueller SC, 2009, J CHILD PSYCHOL PSYC, V50, P1227, DOI 10.1111/j.1469-7610.2009.02112.x; Newhouse P, 2007, BEHAV BRAIN RES, V183, P1, DOI 10.1016/j.bbr.2007.05.011; PARKER V, 1986, NEUROPHARMACOLOGY, V25, P663, DOI 10.1016/0028-3908(86)90224-8; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Peterson BL, 2015, BEHAV BRAIN RES, V286, P152, DOI 10.1016/j.bbr.2015.03.005; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reddy DS, 2010, NEUROPHARMACOLOGY, V59, P573, DOI 10.1016/j.neuropharm.2010.08.017; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Robertson CL, 2014, J BIOENERG BIOMEMBR; Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Schieb LJ, 2013, MMWR-MORBID MORTAL W, V62, P721; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Singh M, 2005, ANN NY ACAD SCI, V1052, P145, DOI 10.1196/annals.1347.010; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Tsuji M, 2012, EXP NEUROL, V233, P214, DOI 10.1016/j.expneurol.2011.10.004; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wong R, 2013, J CEREBR BLOOD F MET, V33, P1362, DOI 10.1038/jcbfm.2013.120; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2012, AM J SURG, V204, P803, DOI 10.1016/j.amjsurg.2011.05.002; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46	81	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2016	11	1							e0146419	10.1371/journal.pone.0146419			17	Multidisciplinary Sciences	Science & Technology - Other Topics	DB6WB	WOS:000368655300020	26799561	DOAJ Gold, Green Published			2021-06-18	
J	Lau, EY; Berkowitz, ML; Schwegler, E				Lau, Edmond Y.; Berkowitz, Max L.; Schwegler, Eric			Shock Wave-Induced Damage of a Protein by Void Collapse	BIOPHYSICAL JOURNAL			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TRAUMATIC BRAIN-INJURY; GATED ION CHANNELS; FORCE-FIELD; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE; DENATURED STATES; SODIUM-CHANNELS; LIPID-BILAYERS; K+ CHANNEL	In this study, we report on a series of molecular dynamics simulations that were used to examine the effects of shock waves on a membrane-bound ion channel. A planar shock wave was found to compress the ion channel upon impact, but the protein geometry resembles the crystal structure as soon as the solvent density begins to dissipate. When a void was placed in close proximity to the membrane, the shock wave proved to be more destructive to the protein due to formation of a nanojet that results from the asymmetric collapse of the void. The nanojet was able to cause significant structural changes to the protein even at low piston velocities that are not able to directly cause poration of the membrane.	[Lau, Edmond Y.; Schwegler, Eric] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Berkowitz, Max L.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA	Lau, EY (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	lau12@llnl.gov		Berkowitz, Max/0000-0002-9116-0362	Office of Naval ResearchOffice of Naval Research [N00014151P00020]; U.S. Department of Energy by Lawrence Livermore National LaboratoryUnited States Department of Energy (DOE) [DE-AC52-07NA27344]	This work was funded by a grant from the Office of Naval Research (N00014151P00020) and was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. Computing support for this work came from the Lawrence Livermore National Laboratory (LLNL) Institutional Computing Grand Challenge program.	ABRAHAM FF, 1977, J CHEM PHYS, V67, P2384, DOI 10.1063/1.435080; Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Anderson CAF, 2002, STRUCTURE, V10, P175, DOI 10.1016/S0969-2126(02)00700-1; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Brujan EA, 2005, PHYS MED BIOL, V50, P4797, DOI 10.1088/0031-9155/50/20/004; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; CONTI F, 1982, J MEMBRANE BIOL, V69, P23, DOI 10.1007/BF01871238; Cooper EC, 1999, P NATL ACAD SCI USA, V96, P4759, DOI 10.1073/pnas.96.9.4759; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Devaraneni PK, 2011, BIOCHEMISTRY-US, V50, P10442, DOI 10.1021/bi2012965; Dima RI, 2004, J PHYS CHEM B, V108, P6564, DOI 10.1021/jp037128y; Espinosa S, 2014, MICROFLUID NANOFLUID, V16, P613, DOI 10.1007/s10404-013-1258-x; Fu HH, 2015, J PHYS CHEM LETT, V6, P413, DOI 10.1021/jz502513w; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Ganzenmuller GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051989; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; HEINEMANN SH, 1987, J GEN PHYSIOL, V90, P765, DOI 10.1085/jgp.90.6.765; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarecki BW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01040; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamatari YO, 2004, METHODS, V34, P133, DOI 10.1016/j.ymeth.2004.03.010; Karp G., 2013, CELL MOL BIOL CONCEP, P121; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Koshiyama K, 2008, BBA-BIOMEMBRANES, V1778, P1423, DOI 10.1016/j.bbamem.2008.03.010; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; McAteer JA, 2008, SEMIN NEPHROL, V28, P200, DOI 10.1016/j.semnephrol.2008.01.003; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; RYBAKOV AP, 1995, EUR J MECH B-FLUID, V14, P323; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; Schiffer A, 2012, P ROY SOC A-MATH PHY, V468, P2807, DOI 10.1098/rspa.2012.0076; Schmidt M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03849; Shieh CC, 2000, PHARMACOL REV, V52, P557; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Steinhauser MO, 2014, SOFT MATTER, V10, P4778, DOI 10.1039/c4sm00407h; Tanielian T, 2008, INVISIBLE WOUNDS WAR; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; van der Spoel D., 2010, GROMACS USER MANUAL; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zhou Y, 2012, J CONTROL RELEASE, V157, P103, DOI 10.1016/j.jconrel.2011.09.068	62	14	14	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	JAN 5	2016	110	1					147	156		10.1016/j.bpj.2015.11.030			10	Biophysics	Biophysics	DA4QD	WOS:000367783900008	26745418	Green Published, Bronze			2021-06-18	
J	Zhao, HX; Liao, Y; Xu, D; Wang, QP; Gan, Q; You, C; Yang, CH				Zhao, He-xiang; Liao, Yi; Xu, Ding; Wang, Qiang-ping; Gan, Qi; You, Chao; Yang, Chao-hua			Prospective randomized evaluation of therapeutic decompressive craniectomy in severe traumatic brain injury with mass lesions (PRECIS): study protocol for a controlled trial	BMC NEUROLOGY			English	Article						Decompressive craniectomy; Traumatic brain injury; Subdural mass lesions; Early surgery; Intracranial pressure	ACUTE SUBDURAL HEMATOMAS; HEAD-INJURY; INTRACRANIAL HYPERTENSION; SURGICAL COMPLICATIONS; MANAGEMENT; CRANIOPLASTY; MULTICENTER; CRANIOTOMY; EVACUATION; EXPERIENCE	Background: For cases of severe traumatic brain injury, during primary operation, neurosurgeons usually face a dilemma of whether or not to remove the bone flap after mass lesion evacuation. Decompressive craniectomy, which involves expansion of fixed cranial cavity, is used to treat intra-operative brain swelling and post-operative malignant intracranial hypertension. However, due to indefinite indication, the decision to perform this procedure heavily relies on personal experiences. In addition, decompressive craniectomy is associated with various complications, and the procedure lacks strong evidence of better outcomes. In the present study, we designed a prospective, randomized, controlled trial to clarify the effect of decompressive craniectomy in severe traumatic brain injury patients with mass lesions. Methods: PRECIS is a prospective, randomized, assessor-blind, single center clinical trial. In this trial, 336 patients with traumatic mass lesions will be randomly allocated to a therapeutic decompressive craniectomy group or a prophylactic decompressive craniectomy group. In the therapeutic decompressive craniectomy group, the bone flap will be removed or replaced depending on the emergence of brain swelling. In the prophylactic decompressive craniectomy group, the bone flap will be removed after mass lesion evacuation. A stepwise management of intracranial pressure will be provided according to the Brain Trauma Foundation guidelines. Salvage decompressive craniectomy will be performed for craniotomy patients once there is evidence of imaging deterioration and post-operative malignant intracranial hypertension. Participants will be assessed at 1, 6 and 12 months after randomization. The primary endpoint is favorable outcome according to the Extended Glasgow Outcome Score (5-8) at 12 months. The secondary endpoints include quality of life measured by EQ-5D, mortality, complications, intracranial pressure and cerebral perfusion pressure control and incidence of salvage craniectomy in craniotomy patients at each investigation time point. Discussion: This study will provide evidence to optimize primary decompressive craniectomy application and assess outcomes and risks for mass lesions in severe traumatic brain injury.	[Zhao, He-xiang; Xu, Ding; Wang, Qiang-ping; Gan, Qi; You, Chao; Yang, Chao-hua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Liao, Yi] Sichuan Univ, West China Hosp, Dept Neurointens Care Unit, Chengdu 610041, Sichuan, Peoples R China	Yang, CH (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China.	PRECISCD120@hotmail.com			Scientific Research and Innovation Foundation of West China Hospital [141100522]	This study is supported by the Scientific Research and Innovation Foundation of West China Hospital (No. 141100522).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cianchi Giovanni, 2012, J Trauma Manag Outcomes, V6, P8, DOI 10.1186/1752-2897-6-8; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; Ellenberg J. H., 1996, DRUG INF J, V30, P535, DOI DOI 10.1177/009286159603000229; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2011, ACTA NEUROCHIR, V153, P1105, DOI 10.1007/s00701-011-0974-9; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jasielski Piotr, 2013, Acta Neurochir Suppl, V118, P125, DOI 10.1007/978-3-7091-1434-6_22; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Marion DW, 2006, NEUROSURGERY, V58, P655; Matthew B.Potts, 2012, SCHMIDEK SWEET OPERA, P1551, DOI [10.1016/B978-1-4160-6839-6.10135-2., DOI 10.1016/B978-1-4160-6839-6.10135-2]; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Munch E, 2000, NEUROSURGERY, V47, P315; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; RANSOHOFF J, 1971, J NEUROL NEUROSUR PS, V34, P106, DOI 10.1136/jnnp.34.1.106-a; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schneider GH, 2002, ACT NEUR S, V81, P77; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Servadei F, 2015, WORLD NEUROSURG, V83, P133, DOI 10.1016/j.wneu.2014.08.031; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214; WHITFIELD P, 1995, STROKE, V26, P1125; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yang CH, 2012, CHIN J TRAUMATOL, V15, P158, DOI 10.3760/cma.j.issn.1008-1275.2012.03.006; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yuji O, 2013, INT LESSONS ROAD SAF; Zhao HX, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0100-7	54	14	14	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JAN 5	2016	16								1	10.1186/s12883-015-0524-9			8	Clinical Neurology	Neurosciences & Neurology	DA1QX	WOS:000367571700001	26727957	DOAJ Gold, Green Published			2021-06-18	
J	Kubu, CS; Ready, RE; Festa, JR; Roper, BL; Pliskin, NH				Kubu, Cynthia S.; Ready, Rebecca E.; Festa, Joanne R.; Roper, Brad L.; Pliskin, Neil H.			The Times They Are a Changin': Neuropsychology and Integrated Care Teams	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychology; Professional Issues; Integrated Care; Health care Teams.	DEEP BRAIN-STIMULATION; CLINICAL NEUROPSYCHOLOGY; POSITION STATEMENT; CNS TUMORS; CONCUSSION; MANAGEMENT; ISSUES; SPORT	Objective: To gather illustrative data from clinical neuropsychologists who are working in integrated care settings in order to provide an initial blueprint for moving forward in this new era of health care. Method: A survey was designed to illustrate the ways in which neuropsychologists are participating in integrated care teams and distributed on major neuropsychology listservs. The survey evaluated the settings, roles, services provided, practice issues, remuneration, and impact of neuropsychologists' participation in integrated care teams with respect to patient care and health outcomes. Frequencies were used to summarize the findings as well as qualitative coding of narrative responses. Results: There were 412 respondents to the survey and 261 of those indicated that they worked in at least one integrated care setting. Neuropsychologists work in a variety of integrated care settings and provide diverse services which contribute to improved patient care and outcomes. Conclusions: Three primary themes emerge from the findings with regard to the engagement and teams: advocacy, collaboration, and communication. We argue for the need for more easily accessible outcome studies illustrating the clinical benefits and cost-savings associated with inclusion of neuropsychologists in integrated care teams. In addition, educational and training initiatives are needed to better equip current and future clinical neuropsychologists to function effectively in integrated care settings.	[Kubu, Cynthia S.] Ctr Neurol Restorat, Dept Psychiat & Psychol, Cleveland, OH USA; [Ready, Rebecca E.] Univ Massachusetts, Psychol & Brain Sci, Amherst, MA 01003 USA; [Festa, Joanne R.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Roper, Brad L.] Affairs Med Ctr, Psychol Sect, Memphis, TN USA; [Roper, Brad L.] Univ Tennessee, Coll Med, Memphis, TN USA; [Pliskin, Neil H.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA	Kubu, CS (corresponding author), Cleveland Clin Fdn, Ctr Neurol Restorat, Dept Psychiat & Psychol, P57,9500 Euclid Ave, Cleveland, OH 44195 USA.	kubuc@ccf.org					Azmi H., 2008, AM ASS STER FUNCT NE; Belar CD, 2014, TRAIN EDUC PROF PSYC, V8, P3, DOI 10.1037/tep0000027; Braun M, 2011, COGN BEHAV NEUROL, V24, P107, DOI 10.1097/WNN.0b013e3182351289; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bull KS, 2013, HAND CLINIC, V112, P967, DOI 10.1016/B978-0-444-52910-7.00017-9; Burrell JR, 2015, J NEUROL NEUROSUR PS, V86, P1216, DOI 10.1136/jnnp-2013-307483; Deuschl G, 2006, MOVEMENT DISORD, V21, pS219, DOI 10.1002/mds.20957; Dyrbye LN, 2011, JAMA-J AM MED ASSOC, V305, P2009, DOI 10.1001/jama.2011.652; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Ford PJ, 2006, J MED ETHICS, V32, P106, DOI 10.1136/jme.200X.013151; *I MED, 2001, CROSS QUAL CHASM NEW; Lang AE, 2006, MOVEMENT DISORD, V21, pS171, DOI 10.1002/mds.20955; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meyers CA, 2006, J CLIN ONCOL, V24, P1305, DOI 10.1200/JCO.2005.04.6086; Michels TC, 2010, AM FAM PHYSICIAN, V82, P495; Mink JW, 2006, MOVEMENT DISORD, V21, P1831, DOI 10.1002/mds.21039; Novotney A, 2010, MONITOR, V41; Nuttin B, 2014, J NEUROL NEUROSUR PS, V85, P1003, DOI 10.1136/jnnp-2013-306580; Okun MS, 2007, CLIN NEUROPSYCHOL, V21, P162, DOI 10.1080/13825580601025940; Pilitsis JG, 2005, STEREOT FUNCT NEUROS, V83, P67, DOI 10.1159/000086676; Pliskin N, 2015, NEUROBLAST; PRIGATANO GP, 2003, CLIN NEUROPSYCHOLOGY; Rey-Casserly C, 2012, PROF PSYCHOL-RES PR, V43, P422, DOI 10.1037/a0028721; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rozensky RH, 2014, TRAIN EDUC PROF PSYC, V8, P83, DOI 10.1037/tep0000021; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; Warren AM, 2014, J TRAUMA NURS, V21, P139, DOI 10.1097/TA.0b013e3182858ab9; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Wilson SJ, 2015, EPILEPSIA, V56, P674, DOI 10.1111/epi.12962	29	14	14	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2016	30	1					51	65		10.1080/13854046.2015.1134670			15	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DH4CM	WOS:000372733100004	26839169				2021-06-18	
J	Abe, K; Shimada, R; Okada, Y; Kibayashi, K				Abe, Keiichi; Shimada, Ryo; Okada, Yoshikazu; Kibayashi, Kazuhiko			Traumatic brain injury decreases serotonin transporter expression in the rat cerebrum	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; Depression; Serotonin transporter; SSRI	RANDOMIZED CONTROLLED-TRIAL; DEPRESSION; SERTRALINE; RECEPTOR; AXONS; MODEL	Objectives: An association has been postulated between traumatic brain injury (TBI) and depression. The serotonin transporter (SERT) regulates the concentration of serotonin in the synaptic cleft and represents a molecular target for antidepressants. We hypothesized that SERT expression in the brain changes following TBI. Methods: We performed immunohistochemistry, real-time polymerase chain reaction analysis for mRNA and western blot analysis for protein to examine the time-dependent changes in SERT expression in the cerebrum during the first 14 days after TBI, using a controlled cortical impact model in rats. Results: SERT immunoreactivity in neuronal fibres within the area adjacent to the cortical contusion decreased 1 to 14 days after injury. Significantly decreased SERT mRNA and protein expression were noted in the area adjacent to the cortical contusion 7 days after injury. There were no significant changes in SERT expression in the cingulum of the injured brain. Discussion: The findings of this study indicate that TBI decreases SERT expression in the cerebral cortex. The decreased levels of SERT expression after TBI may result in decreased serotonin neurotransmission in the brain and indicate a possible relationship with depression following TBI.	[Abe, Keiichi; Okada, Yoshikazu] Tokyo Womens Med Univ, Sch Med, Dept Neurosurg, Tokyo 1628666, Japan; [Shimada, Ryo; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Tokyo 1628666, Japan	Shimada, R (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	shimada@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26293164]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [26293164] Funding Source: KAKEN	This work was supported by Grant-in-Aid for Scientific Research (B) to K.K. from the Japan Society for the Promotion of Science [No. 26293164].	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Austin MC, 2002, NEUROSCIENCE, V114, P807, DOI 10.1016/S0306-4522(02)00289-0; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Banos JH, 2010, J HEAD TRAUMA REHAB, V25, P357, DOI 10.1097/HTR.0b013e3181d6c715; Croft HA, 2014, J CLIN PSYCHIAT, V75, pE1291, DOI 10.4088/JCP.14m08992; Dam H, 2007, NEUROL RES, V29, P717, DOI 10.1179/016164107X208059; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FUJITA M, 1993, NEUROSCI LETT, V162, P59, DOI 10.1016/0304-3940(93)90559-4; Horschitz S, 2001, BIOCHEM SOC T, V29, P728, DOI 10.1042/BST0290728; Inoue T, 2002, CNS NEUROL DISORD-DR, V1, P519, DOI 10.2174/1568007023338987; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Masuzawa Hideaki, 2003, No To Shinkei, V55, P933; Penna Aubin, 2007, J Vis Exp, P264, DOI 10.3791/264; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Sakai N, 2000, SEIKAGAKU, V72, P1215; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shimada R, 2012, J CLIN NEUROSCI, V19, P447, DOI 10.1016/j.jocn.2011.06.033; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sur C, 1996, NEUROSCIENCE, V73, P217, DOI 10.1016/0306-4522(96)00030-9; Zhou FC, 1998, BRAIN RES, V805, P241, DOI 10.1016/S0006-8993(98)00691-X	23	14	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	4					358	363		10.1080/01616412.2015.1110402			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DM4TK	WOS:000376339400012	27082144				2021-06-18	
J	Adams, D; Dahdah, M				Adams, Deana; Dahdah, Marie			Coping and adaptive strategies of traumatic brain injury survivors and primary caregivers	NEUROREHABILITATION			English	Article						Coping skills; anger; social support; brain injuries; caregivers; mental health	SOCIAL SUPPORT; FAMILY; ADJUSTMENT; QUALITY; PEOPLE; STYLE	BACKGROUND: Qualitative research methods allowed the investigator to contribute to the development of new theories and to examine change in processes over time, which added rich detail to existing knowledge of the use of coping and adaptive strategies by traumatic brain injury survivors and their primary caregivers (Ponsford, Sloan, & Snow, 2013). The advantages of phenomenological study were that it allows flexibility to explore and understand meanings attached by people to well-studied concepts such as coping, resiliency, and adaptation or compensation. Phenomenological study was sensitive to contextual factors. It also permitted the study of in-depth dynamics of coping and adaptive strategies of TBI survivors and primary caregivers, while understanding the social and psychological implications of the phenomenon. OBJECTIVE: To explore the needs and deficits of adult traumatic brain injury (TBI) survivors and primary caregivers; and to identify their self-initiated coping and adaptive strategies. Significant to this study was the development of coping and adaptive strategies by the participants after their discharge from inpatient and rehabilitation treatment. The compensatory skills taught in treatment settings did not transfer to the home environment. Therefore, these strategies developed independently from previous treatment recommendations contributed to the development of theory related to rehabilitation and counseling. Distinctive to this study was the similarity of coping and adaptive strategies developed from both mild and severe traumatic brain injury survivors. METHODS: This study consisted of eleven with TBI and six primary caregivers (N = 17), who participated in a series of semi-structured interviews aimed at discovering the coping and adaptive strategies utilized in dealing with the effects of brain injury. A Qualitative Phenomenological design was employed. RESULTS: Patience and understanding, support, and professional help were identified by TBI survivors and caregivers as being their most relevant needs. Self-reported deficits included short-term memory loss (STM), fatigue, anger, and personality changes, and the strategies that TBI survivors and caregivers identified tended to address their problems with these specific day-to-day deficits. Problem focused, emotion focused, and avoidant coping were utilized to some degree in their adjustment to home life and activities of daily living. Participants offered suggestions for mental health professionals addressing how to more effectively work with brain injury survivors and their primary caregivers. CONCLUSION: TBI survivors and caregivers had multiple self-reported unaddressed needs following their discharge from facility-based treatment. They reported spontaneously engaging in various coping and adaptive strategies to address their needs and deficits. However, further education regarding potential post-TBI challenges and strategies for addressing them are needed, including a need for community and mental health resources.	[Adams, Deana] Hope Brain Injury, POB 136816, Ft Worth, TX 76136 USA; [Adams, Deana] Ctr Counseling & Enrichment, Arlington, TX USA; [Dahdah, Marie] Baylor Inst Rehabil, Dallas, TX USA; [Dahdah, Marie] Baylor Reg Med Ctr Plano, Plano, TX USA	Adams, D (corresponding author), Hope Brain Injury, POB 136816, Ft Worth, TX 76136 USA.	admin@hopeafterbraininjury.org					Brain Injury Association of America, 2011, BIAA AD NEW TBI DEF; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US E; Chester S. K., 2014, EFFECTIVE PSYCHOTHER; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Connors S. H., 2010, CARE MANAGEMENT, V16, P7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Gronwall D., 2002, HEAD INJURY FACTS; Haglin C, 1996, J REHABIL, V62, P37; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Jennett B, 1975, Ciba Found Symp, P309; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/0090-5550.39.4.215; Lazarus R.S., 1984, STRESS APPRAISAL COP; Lewis J., 2010, QUALITATIVE STUDY PR; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; National Institutes of Health, 1998, REH PERS TRAUM BRAIN; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponterotto J., 2008, SAGE HDB QUALITATIVE, P455; QSR International, 2010, NVIVO SOFTW VERS 9; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; STOLER DR, 1998, COPING MILD TRAUMATI; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; WHO, 2004, REH PERS TRAUM BRAIN	29	14	14	0	17	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	2					223	237		10.3233/NRE-161353			15	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DT7HD	WOS:000381656800005	27372358				2021-06-18	
J	Adhikari, U; Goliaei, A; Berkowitz, ML				Adhikari, Upendra; Goliaei, Ardeshir; Berkowitz, Max L.			Nanobubbles, cavitation, shock waves and traumatic brain injury	PHYSICAL CHEMISTRY CHEMICAL PHYSICS			English	Article							ULTRASOUND-INDUCED CAVITATION; INTENSITY FOCUSED ULTRASOUND; ATOMIC-FORCE MICROSCOPY; MOLECULAR-DYNAMICS; BARRIER DISRUPTION; DRUG-DELIVERY; GENE DELIVERY; FOLDING SIMULATIONS; PRIMARY BLAST; CANCER-CELLS	Collapse of bubbles, microscopic or nanoscopic, due to their interaction with the impinging pressure wave produces a jet of particles moving in the direction of the wave. If there is a surface nearby, the high-speed jet particles hit it, and as a result damage to the surface is produced. This cavitation effect is well known and intensely studied in case of microscopic sized bubbles. It can be quite damaging to materials, including biological tissues, but it can also be beneficial when controlled, like in case of sonoporation of biological membranes for the purpose of drug delivery. Here we consider recent simulation work performed to study collapse of nanobubbles exposed to shock waves, in order to understand the detailed mechanism of the cavitation induced damage to soft materials, such as biological membranes. We also discuss the connection of the cavitation effect with the traumatic brain injury caused by blasts. Specifically, we consider possible damage to model membranes containing lipid bilayers, bilayers with embedded ion channel proteins like the ones found in neural cells and also protein assemblies found in the tight junction of the blood brain barrier.	[Adhikari, Upendra; Berkowitz, Max L.] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC 27599 USA; [Goliaei, Ardeshir] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Goliaei, Ardeshir] Univ North Carolina Chapel Hill, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA	Berkowitz, ML (corresponding author), Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC 27599 USA.	maxb@unc.edu		Berkowitz, Max/0000-0002-9116-0362	Office of Naval ResearchOffice of Naval Research [N00014-14-1-0241]	The support by a grant N00014-14-1-0241 from the Office of Naval Research is gratefully acknowledged. MLB wants to thank Dr T Bentley who introduced him to the fascinating subject of cavitation and also for his constant encouragement and support. The authors express their gratitude to their collaborators, Dr E. Lau and E. Schwegler from the Lawrence Livermore National Laboratory and are also grateful to Dr Santo, a former member of the group, who performed initial simulations and who constantly helped with valuable advice after he left the group. We also thank Professors Wei Han and Yun-Dong Wu for providing us the PACE force-field parameters.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adhikari U, 2015, J PHYS CHEM B, V119, P6225, DOI 10.1021/acs.jpcb.5b02218; Amabile PG, 2001, J AM COLL CARDIOL, V37, P1975, DOI 10.1016/S0735-1097(01)01253-0; Aryal M, 2014, ADV DRUG DELIVER REV, V72, P94, DOI 10.1016/j.addr.2014.01.008; Ball P, 2012, CHEMPHYSCHEM, V13, P2173, DOI 10.1002/cphc.201200119; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bazan-Peregrino M, 2012, J CONTROL RELEASE, V157, P235, DOI 10.1016/j.jconrel.2011.09.086; Bellmann C, 2014, ANTIOXID REDOX SIGN, V20, P855, DOI 10.1089/ars.2013.5288; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BOURNE NK, 1992, J FLUID MECH, V244, P225, DOI 10.1017/S0022112092003045; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Brennen CE, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0022; Bunkin NF, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739530; Bunkin NF, 2016, J PHYS CHEM B, V120, P1291, DOI 10.1021/acs.jpcb.5b11103; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Choubey A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3518472; Clement GT, 2004, ULTRASONICS, V42, P1087, DOI 10.1016/j.ultras.2004.04.003; Coussios C. C., 2009, INT J HYPERTHER, V23, P105; Craig VSJ, 2011, SOFT MATTER, V7, P40, DOI 10.1039/c0sm00558d; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; DEAR JP, 1988, J FLUID MECH, V190, P409, DOI 10.1017/S0022112088001387; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Ferrara KW, 2008, ADV DRUG DELIVER REV, V60, P1097, DOI 10.1016/j.addr.2008.03.002; Flannigan DJ, 2005, NATURE, V434, P52, DOI 10.1038/nature03361; Fu HH, 2015, J PHYS CHEM LETT, V6, P413, DOI 10.1021/jz502513w; Giesecke T, 2003, ULTRASOUND MED BIOL, V29, P1359, DOI 10.1016/S0301-5629(03)00980-3; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goiaei A, 2015, ACS CHEM NEUROSCI, V6, P1296, DOI 10.1021/acschemneuro.5b00116; Gong CL, 1998, J ACOUST SOC AM, V104, P2675, DOI 10.1121/1.423851; Han W, 2012, J CHEM THEORY COMPUT, V8, P4413, DOI 10.1021/ct300696c; Han W, 2010, J CHEM THEORY COMPUT, V6, P3373, DOI 10.1021/ct1003127; Han W, 2010, J CHEM THEORY COMPUT, V6, P3390, DOI 10.1021/ct100313a; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoekstra A, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0377; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hosseinkhah N, 2015, IEEE T BIO-MED ENG, V62, P1293, DOI 10.1109/TBME.2014.2385651; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2003, ACT NEUR S, V86, P555; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Ibsen S, 2013, DRUG DES DEV THER, V7, P375, DOI 10.2147/DDDT.S31564; Ishida N, 2000, LANGMUIR, V16, P6377, DOI 10.1021/la000219r; Junge L, 2003, ULTRASOUND MED BIOL, V29, P1769, DOI 10.1016/j.ultrasmedbio.2003.08.010; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Konofagou EE, 2012, CURR PHARM BIOTECHNO, V13, P1332; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Larina IV, 2005, TECHNOL CANCER RES T, V4, P217, DOI 10.1177/153303460500400211; Larina IV, 2005, ANTICANCER RES, V25, P149; Lau EY, 2016, BIOPHYS J, V110, P147, DOI 10.1016/j.bpj.2015.11.030; Lauer E, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4719142; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Liu YW, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4896937; Lohse D, 2015, REV MOD PHYS, V87, P981, DOI 10.1103/RevModPhys.87.981; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lou ST, 2000, J VAC SCI TECHNOL B, V18, P2573, DOI 10.1116/1.1289925; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2013, CHEM SOC REV, V42, P6801, DOI 10.1039/c3cs60093a; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P203, DOI 10.1016/j.jconrel.2005.01.011; Mesiwala AH, 2002, ULTRASOUND MED BIOL, V28, P389, DOI 10.1016/S0301-5629(01)00521-X; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nielsen SO, 2010, PHYS CHEM CHEM PHYS, V12, P12401, DOI 10.1039/c004111d; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Ohgaki K, 2010, CHEM ENG SCI, V65, P1296, DOI 10.1016/j.ces.2009.10.003; Ohl CD, 2003, BBA-GEN SUBJECTS, V1624, P131, DOI 10.1016/j.bbagen.2003.10.005; Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI [10.1529/biophysj.105.075366, 10.1529/biophysj.106.075366]; Ohl SW, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0019; Paliwal Sumit, 2006, Expert Opin Drug Deliv, V3, P713, DOI 10.1517/17425247.3.6.713; Pan G, 2016, LANGMUIR, V32, P11133, DOI 10.1021/acs.langmuir.6b01483; Pardridge William M, 2005, NeuroRx, V2, P3; PARKER JL, 1994, J PHYS CHEM-US, V98, P8468, DOI 10.1021/j100085a029; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peng H, 2015, ADV COLLOID INTERFAC, V222, P573, DOI 10.1016/j.cis.2014.09.004; Peshkovsky SL, 2008, ULTRASON SONOCHEM, V15, P618, DOI 10.1016/j.ultsonch.2007.07.006; Praprotnik M, 2008, ANNU REV PHYS CHEM, V59, P545, DOI 10.1146/annurev.physchem.59.032607.093707; Rae J, 2005, ULTRASON SONOCHEM, V12, P325, DOI 10.1016/j.ultsonch.2004.06.007; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYBAKOV AP, 1995, EUR J MECH B-FLUID, V14, P323; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Santo KP, 2015, J PHYS CHEM B, V119, P8879, DOI 10.1021/jp505720d; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Steinhauser MO, 2014, SOFT MATTER, V10, P4778, DOI 10.1039/c4sm00407h; Sun DD, 2016, J PHYS CHEM C, V120, P18803, DOI 10.1021/acs.jpcc.6b04086; Sun YJ, 2016, COLLOID SURFACE A, V495, P176, DOI 10.1016/j.colsurfa.2016.01.050; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Treat LH, 2009, AIP CONF PROC, V1113, P443; Tung YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580763; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Uchida T, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6020031; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vedadi M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.014503; Vogel A, 1996, J ACOUST SOC AM, V100, P148, DOI 10.1121/1.415878; Vykhodtseva N, 2008, ULTRASONICS, V48, P279, DOI 10.1016/j.ultras.2008.04.004; Wan CK, 2012, J CHEM THEORY COMPUT, V8, P300, DOI 10.1021/ct2004275; Wang S, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/18/184007; Weijs JH, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.054501; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zhang XH, 2013, LANGMUIR, V29, P1017, DOI 10.1021/la303837c; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	113	14	14	5	42	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1463-9076	1463-9084		PHYS CHEM CHEM PHYS	Phys. Chem. Chem. Phys.		2016	18	48					32638	32652		10.1039/c6cp06704b			15	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	EF6IY	WOS:000390435800001	27883130				2021-06-18	
J	Afshar, M; Netzer, G; Salisbury-Afshar, E; Murthi, S; Smith, GS				Afshar, Majid; Netzer, Giora; Salisbury-Afshar, Elizabeth; Murthi, Sarah; Smith, Gordon S.			Injured patients with very high blood alcohol concentrations	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury; Injury prevention; Blood alcohol level; Ethanol; Trauma recidivism; Alcohol consumption; Alcohol use disorder; Blunt trauma; Forensic toxicology; Alcohol poisoning	TRAUMA CENTER PATIENTS; GLASGOW COMA SCALE; INTOXICATION; SEVERITY; ETHANOL; DEATHS; SCORE; VALIDATION; DRIVER; ABUSE	Objective: Most data regarding high blood alcohol concentrations (BAC) >= 400 mg/dL have been from alcohol poisoning deaths. Few studies have described this group and reported their alcohol consumption patterns or outcomes compared to other trauma patients. We hypothesised trauma patients with very high BACs arrived to the trauma centre with less severe injuries than their sober counterparts. Method: Historical cohort of 46,222 patients admitted to a major trauma centre between January 1, 2002 and October 31, 2011. BAC was categorised into ordinal groups by 100 mg/dL intervals. Alcohol questionnaire data on frequency and quantity was captured in the BAC >= 400 mg/dL group. The primary analysis was for BAC >= 400 mg/dL. Results: BAC was recorded in 44,502 (96.3%) patients. Those with a BAC >= 400 mg/dL accounted for 1.1% (147) of BAC positive cases. These patients had the lowest proportion of severe trauma and in-hospital death in comparison with the other alcohol groups (p < 0.001). In adjusted analysis, the risk for severe injury increased with the BAC groups between 1 and 199 mg/dL and was not different or decreased for groups above 200 mg/dL in reference to the BAC negative group (test for trend p = 0.001). BAC >= 400 group encountered more injuries caused by blunt trauma in comparison with the other alcohol groups (p < 0.001), and the group comprised mainly of falls. Admission Glasgow Coma Scale was a poor predictor for traumatic brain injury in the high BAC group. Readmission occurred in 22.4% (33) of patients the BAC >= 400 group. The majority of these patients reported drinking alcohol 4 or more days per week (81, 67.5%) and five or more drinks per day (79, 65.8%), evident of risky alcohol use. Conclusions: Most traumas admitted with BAC >= 400 mg/dL survived and their injuries were less severe than their less intoxicated and sober counterparts. They also had evidence for risky alcohol use and nearly one-quarter returned to the trauma centre with another injury over the study period. Recognition of this highest BAC group presents an opportunity to provide focused care for their risky alcohol use. (C) 2015 Elsevier Ltd. All rights reserved.	[Afshar, Majid] Loyola Univ Hlth Sci, Div Pulm & Crit Care Med, Maywood, IL USA; [Afshar, Majid] Loyola Univ, Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Netzer, Giora] Univ Maryland, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Netzer, Giora; Smith, Gordon S.] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Salisbury-Afshar, Elizabeth] Heartland Hlth Outreach, Chicago, IL USA; [Murthi, Sarah] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Program Trauma, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA	Afshar, M (corresponding author), 2160 South First Ave,Bldg 54, Maywood, IL 60153 USA.	majid_afshar@luhs.org	Salisbury-Afshar, Elizabeth M/AAK-4180-2020; Afshar, Majid/AAD-8365-2019	Afshar, Majid/0000-0002-6368-4652; Smith, Gordon/0000-0002-2911-3071	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1AA018313];  [F32AA022553-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018313, F32AA022553] Funding Source: NIH RePORTER	This research was supported in part by National Institute of Health grants 1RO1AA018313 (Gordon Smith) and F32AA022553-01 (Majid Afshar).	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Afshar M, 2014, J TRAUMA ACUTE CARE, V76, P1447, DOI 10.1097/TA.0000000000000238; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Fleming M, 2009, ALCOHOL CLIN EXP RES, V33, P1777, DOI 10.1111/j.1530-0277.2009.01016.x; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Friedman LS, 2012, ALCOHOL, V46, P769, DOI 10.1016/j.alcohol.2012.08.006; Friedmann PD, 2001, J STUD ALCOHOL, V62, P234, DOI 10.15288/jsa.2001.62.234; Friedmann PD, 2013, NEW ENGL J MED, V368, P365, DOI 10.1056/NEJMcp1204714; Garriott J, 2008, GARRIOTS MEDICOLEGAL; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Graham JDP, 1962, DIAGNOSIS TREATMENT; HEATLEY MK, 1990, MED SCI LAW, V30, P101, DOI 10.1177/002580249003000203; Jones AW, 2003, J FORENSIC SCI, V48, P874; Jones AW, 1999, J STUD ALCOHOL, V60, P400, DOI 10.15288/jsa.1999.60.400; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Kanny D, 2015, MMWR-MORBID MORTAL W, V63, P1238; KNIGHT B, 1991, FORENSIC PATHOLOGY; MacLeod JBA, 2011, INJURY, V42, P922, DOI 10.1016/j.injury.2010.01.098; PERPER JA, 1986, J FORENSIC SCI, V31, P212; Purssell RA, 2001, ANN EMERG MED, V38, P653, DOI 10.1067/mem.2001.119455; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Simpson K, 1952, FORENSIC MED; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; Soderstrom CA, 1997, ACCIDENT ANAL PREV, V29, P715, DOI 10.1016/S0001-4575(97)00040-7; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stahre M, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130293; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TAYLOR HL, 1977, J FORENSIC SCI, V22, P639; TEASDALE G, 1974, LANCET, V2, P81; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WINEK CL, 1976, CLIN CHEM, V22, P832	36	14	14	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					83	88		10.1016/j.injury.2015.10.063			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900016	26556488	Green Accepted			2021-06-18	
J	Armistead-Jehle, P; Cooper, DB; Vanderploeg, RD				Armistead-Jehle, Patrick; Cooper, Douglas B.; Vanderploeg, Rodney D.			The role of performance validity tests in the assessment of cognitive functioning after military concussion: A replication and extension	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Concussion; mild traumatic brain injury; military; neuropsychological testing; performance validity; symptom validity testing; testing	TRAUMATIC BRAIN-INJURY; MEMORY COMPLAINTS INVENTORY; NEUROPSYCHOLOGICAL PERFORMANCE; POSTCONCUSSIVE COMPLAINTS; REPEATABLE BATTERY; EVALUATION CONTEXT; OEF/OIF VETERANS; EFFORT INDEX; SYMPTOMS; SYMPTOMATOLOGY	The current investigation is a replication and extension of a previously published study by Cooper, Vanderploeg, Armistead-Jehle, Lewis, and Bowles (2014) demonstrating that performance validity test scores accounted for more variance in cognitive testing among service members with a history of concussion than did demographic variables, etiology of and time since injury, and symptom severity. The present study included a sample of 142 active-duty service members evaluated following a suspected or confirmed history of mild traumatic brain injury. Participants completed a battery of neuropsychological measures that included scales of performance and symptom validity (specifically the Medical Symptom Validity Test, Nonverbal Medical Symptom Validity Test, and Personality Assessment Inventory). Among the factors considered in the current study, performance validity test results accounted for the most variance in cognitive test scores, above demographic, concussion history, symptom validity, and psychological distress variables. Performance validity test results were modestly related to symptom validity as measured by the Personality Assessment Inventory Negative Impression Management scale. In sum, the current results replicated the original Cooper et al. study and highlight the importance of including performance validity tests as part of neurocognitive evaluation, even in clinical contexts, within this population.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Ft Leavenworth, KS USA; [Cooper, Douglas B.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, Ft Sam Houston, TX USA; [Vanderploeg, Rodney D.] James A Haley VAMC, Mental Hlth & Behav Sci Psychol Serv, Tampa, FL USA; [Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol & Psychiat, Tampa, FL USA	Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Dept Behav Hlth, 550 Pope Ave, Ft Leavenworth, KS 66027 USA.	patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P725, DOI 10.1093/arclin/acs071; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone Dominic A, 2009, Appl Neuropsychol, V16, P309, DOI 10.1080/09084280903297883; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Edinger JD, 2003, J SLEEP RES, V12, P43, DOI 10.1046/j.1365-2869.2003.00335.x; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Green, 2004, GREENS MED SYMPTOM V; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2008, MANUAL NONVERBAL MED; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Hart Robert P, 2003, Curr Pain Headache Rep, V7, P116, DOI 10.1007/s11916-003-0021-5; Heaton RK, 2004, REVISED COMPREHENSIV; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kurtz JE, 2007, J PERS ASSESS, V88, P1, DOI 10.1080/00223890709336828; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Lewis R.F., 1995, DIGIT VIGILANCE TEST; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Morey L. C., 1991, PERSONALITY ASSESSME; Morey L. C., 2003, ESSENTIALS PAI ASSES; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Randolph C, 1998, REPEATABLE BATTERY A; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Wager John G, 2010, Appl Neuropsychol, V17, P305, DOI 10.1080/09084282.2010.525093; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Wolfson D., 1993, HALSTEAD REITAN NEUR; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015	54	14	14	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	4					264	273		10.1080/23279095.2015.1055564			10	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DQ7XA	WOS:000379420300003	26569384				2021-06-18	
J	Bressan, S; Takagi, M; Anderson, V; Davis, GA; Oakley, E; Dunne, K; Clarke, C; Doyle, M; Hearps, S; Ignjatovic, V; Seal, M; Babl, FE				Bressan, Silvia; Takagi, Michael; Anderson, Vicki; Davis, Gavin A.; Oakley, Ed; Dunne, Kevin; Clarke, Cathriona; Doyle, Melissa; Hearps, Stephen; Ignjatovic, Vera; Seal, Marc; Babl, Franz E.			Protocol for a prospective, longitudinal, cohort study of postconcussive symptoms in children: the Take CARe (Concussion Assessment and Recovery Research) study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; UNITED-STATES; SPORT; EPIDEMIOLOGY; IMPAIRMENT; RECOMMENDATIONS; ADOLESCENTS; RELIABILITY; PERFORMANCE	Introduction: A substantial minority of children who sustain a concussion suffer prolonged postconcussive symptoms. These symptoms can persist for more than 1 month postinjury and include physical, cognitive, behavioural and emotional changes. Those affected can develop significant disability, diminishing their quality of life. The precise prevalence of postconcussive symptoms following child concussion is unclear, with heterogeneous and at times conflicting results published regarding factors that predict children at risk for developing long-lasting postconcussive symptoms. The aim of the Take C.A. Re (Concussion Assessment and Recovery Research) study is to provide an in-depth multidimensional description of the postconcussive recovery trajectories from a physical, neurocognitive and psychosocial perspective in the 3 months following concussion, with a focus on the early postconcussive period, and identification of factors associated with prolonged recovery. Methods and analysis: Take C.A. Re is a prospective, longitudinal study at a tertiary children's hospital, recruiting and assessing patients aged 5-<18 years who present to the emergency department with a concussion and following them at 1-4 days, 2 weeks, 1 month and 3 months postinjury. Multiple domains are assessed: postconcussive symptoms, balance and coordination, neurocognition, behaviour, quality of life, fatigue, post-traumatic stress symptoms, parental distress and family burden. 'Delayed recovery' is operationalised as the presence of >= 3 symptoms on the Post Concussive Symptoms Inventory rated as worse compared with baseline. Main analyses comprise analysis of variance (recovery trajectories, delayed vs normal recovery groups) and regression analyses of predictors of recovery (preinjury, acute and family factors). Ethics and dissemination: Ethical approval has been obtained through the Royal Children's Hospital Melbourne Human Research Ethics Committee (33122). We aim to disseminate the findings through	[Bressan, Silvia; Takagi, Michael; Anderson, Vicki; Davis, Gavin A.; Oakley, Ed; Dunne, Kevin; Clarke, Cathriona; Doyle, Melissa; Hearps, Stephen; Ignjatovic, Vera; Seal, Marc; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Takagi, Michael; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Vicki; Oakley, Ed; Dunne, Kevin; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp Melbourne, Emergency Dept, Melbourne, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia	Anderson, V (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Anderson, V (corresponding author), Univ Melbourne, Sch Psychol Sci, Melbourne, Vic 3010, Australia.; Anderson, V (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia.; Anderson, V (corresponding author), Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia.	Vicki.anderson@rch.org.au	Meijer, Anna/K-5118-2016; Seal, Marc L/J-9290-2019; Hearps, Stephen/L-6853-2016	Seal, Marc L/0000-0002-8396-140X; Visser, Melissa/0000-0002-5313-3347; Ignjatovic, Vera/0000-0002-5548-5813	Royal Children's Hospital Foundation, Melbourne, Australia [2014-370, 2014-400]; Australian National Health and Medical Research Council Centre of Research Excellence for Paediatric Emergency MedicineNational Health and Medical Research Council of Australia [GNT 1058560]; NHMRCNational Health and Medical Research Council of Australia	The study is funded by a project grant from Royal Children's Hospital Foundation, Melbourne, Australia (2014-370). The study is part funded by an Australian National Health and Medical Research Council Centre of Research Excellence for Paediatric Emergency Medicine grant (GNT 1058560) and received infrastructure support from the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB is part funded by a Royal Children's Hospital Foundation grant, Melbourne, Australia (2014-400). VA is part-funded by NHMRC Senior Practitioner fellowship.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Haran H. P., 2015, J SCI MED SPORT; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kassam-Adams N, 2011, J TRAUMA STRESS, V24, P252, DOI 10.1002/jts.20640; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mollica CM, 2005, CHILD NEUROPSYCHOL, V11, P303, DOI 10.1080/092970490911306; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Peden M., 2008, WORLD REPORT CHILD I; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Wiebe DJ, 2012, PEDIATR EMERG CARE, V28, P498, DOI 10.1097/PEC.0b013e3182586f76; Williams J, 2014, APP NEUROPSYCHOL CHI, P1; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	50	14	14	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	1							e009427	10.1136/bmjopen-2015-009427			9	Medicine, General & Internal	General & Internal Medicine	DD5VX	WOS:000369993900091	26758260	DOAJ Gold, Green Published			2021-06-18	
J	Connery, AK; Peterson, RL; Baker, DA; Kirkwood, MW				Connery, Amy K.; Peterson, Robin L.; Baker, David A.; Kirkwood, Michael W.			The impact of pediatric neuropsychological consultation in mild traumatic brain injury: a model for providing feedback after invalid performance	CLINICAL NEUROPSYCHOLOGIST			English	Article						Validity testing; pediatric neuropsychological assessment; noncredible effort	POSTCONCUSSIVE SYMPTOMS; RECOGNITION TRIAL; CHILDREN; STATEMENT; ACADEMY; SCORES; PAIN; TOMM; TBI	Objective: In recent years, pediatric practitioners have increasingly recognized the importance of objectively measuring performance validity during clinical assessments. Yet, no studies have examined the impact of neuropsychological consultation when invalid performance has been identified in pediatric populations and little published guidance exists for clinical management. Here we provide a conceptual model for providing feedback after noncredible performance has been detected. In a pilot study, we examine caregiver satisfaction and postconcussive symptoms following provision of this feedback for patients seen through our concussion program. Methods: Participants (N=70) were 8-17-year-olds with a history of mild traumatic brain injury who underwent an abbreviated neuropsychological evaluation between 2 and 12months post-injury. We examined postconcussive symptom reduction and caregiver satisfaction after neuropsychological evaluation between groups of patients who were determined to have provided noncredible effort (n=9) and those for whom no validity concerns were present (n=61). Results: We found similarly high levels of caregiver satisfaction between groups and greater reduction in self-reported symptoms after feedback was provided using the model with children with noncredible presentations compared to those with credible presentations. Conclusion: The current study lends preliminary support to the idea that the identification and communication of invalid performance can be a beneficial clinical intervention that promotes high levels of caregiver satisfaction and a reduction in self-reported and caregiver-reported symptoms.	[Connery, Amy K.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; Childrens Hosp Colorado, Aurora, CO USA	Connery, AK (corresponding author), Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA.	amy.connery@childrenscolorado.org					Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Baker D. A., 2015, VALIDITY TESTING CHI, P125; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bodin D, 2007, CLIN NEUROPSYCHOL, V21, P884, DOI 10.1080/13854040600888784; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Breaux K. C., 2009, TECHNICAL MANAUL WEC; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; BUSH SS, 2009, NEUROPSYCHOLOGY MALI, P530; Carone DA, 2010, CLIN NEUROPSYCHOL, V24, P759, DOI 10.1080/13854041003712951; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Connery A, 2015, VALIDITY TESTING CHI, P145; Delis D, 1994, CALIFORNIA VERBAL LE; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J., 2011, CASEBOOK CLIN NEUROP, P183; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Green CM, 2014, J CLIN EXP NEUROPSYC, V36, P261, DOI 10.1080/13803395.2013.879096; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2004, MANUAL MED SYMPTOM V; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2007, CLIN NEUROPSYCHOL, V21, P532, DOI 10.1080/13854040600611392; Kirkwood M. W., 2015, VALIDITY TESTING CHI, P79; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; REITAN R, 1969, MANUAL ADM NEU UNPUB; Sherman E. M. S., 2015, VALIDITY TESTING CHI, P22; Slick D.J., 2012, PEDIAT FORENSIC NEUR, P113; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED	48	14	14	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	4					579	598		10.1080/13854046.2016.1177596			20	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	DO6YO	WOS:000377929600007	27142647				2021-06-18	
J	Cuesta, M; Hannon, MJ; Crowley, RK; Behan, LA; Tormey, W; Rawluk, D; Delargy, M; Agha, A; Thompson, CJ				Cuesta, Martin; Hannon, Mark J.; Crowley, Rachel K.; Behan, Lucy Ann; Tormey, William; Rawluk, Daniel; Delargy, Mark; Agha, Amar; Thompson, Christopher J.			Symptoms of gonadal dysfunction are more predictive of hypopituitarism than nonspecific symptoms in screening for pituitary dysfunction following moderate or severe traumatic brain injury	CLINICAL ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; LONG-TERM; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; PREVALENCE; DEPRESSION; PATIENT; FATIGUE; ADULTS; RISK	Objective The economic and logistic burden of screening for hypopituitarism following moderate/severe traumatic brain injury (TBI) is considerable. A key recommendation in published guidelines is to prioritize for screening those patients with symptoms suggestive of pituitary dysfunction. The purpose of this study was to evaluate the utility of targeted screening for hypopituitarism in long-term survivors after moderate/severe TBI using referrals on the basis of symptoms. Design In group 1 (G1), consecutive, unselected patients were screened from the Irish National Neurosurgery Centre, whereas in group 2 (G2) patients were targeted based on the presence of symptoms suggestive of pituitary dysfunction. Patients A total of 137 patients (113 male) were systematically screened (G1) and compared to 112 patients (77 male) referred for pituitary evaluation on the basis of suggestive symptoms (G2). Main outcome measures The rate of GH, ACTH, gonadotrophin (GT), TSH and ADH deficiency was compared among groups. Results Patients referred with menstrual dysfunction had more GH (50% vs 11%, P = 0.001), ACTH (60% vs 14%, P < 0.0001), GT (90% vs 16%, P < 0.0001) deficiency and any pituitary hormone deficit (80% vs 33%, P = 0.003) than G1. Men with symptoms of hypogonadism had more GH (33% vs 11%, P = 0.003), GT (58% vs 16%, P < 0.0001) and TSH (16% vs 1%, P = 0.03) deficiency than G1. Patients with nonspecific symptoms were no more likely to have hypopituitarism than those consecutively screened. Conclusions Symptoms of hypogonadism are sufficiently predictive of hypopituitarism to justify screening for hypopituitarism after moderate/severe TBI. Nonspecific symptoms of hypopituitarism are no more predictive than unselected screening.	[Cuesta, Martin; Hannon, Mark J.; Crowley, Rachel K.; Behan, Lucy Ann; Agha, Amar; Thompson, Christopher J.] Beaumont Hosp, RCSI Med Sch, Acad Dept Endocrinol, Dublin 9, Dublin, Ireland; [Tormey, William] Beaumont Hosp, RCSI Med Sch, Dept Chem Pathol, Dublin 9, Ireland; [Rawluk, Daniel] Beaumont Hosp, RCSI Med Sch, Natl Neurosurg Unit, Dublin 9, Ireland; [Delargy, Mark] Beaumont Hosp, RCSI Med Sch, Natl Rehabil Unit, Dublin 9, Ireland	Thompson, CJ (corresponding author), Beaumont Hosp, RCSI Med Sch, Acad Dept Endocrinol, Beaumont Rd, Dublin 9, Dublin, Ireland.	christhompson@beaumont.ie		Crowley, Rachel/0000-0003-1472-4117	Pfizer PharmaceuticalsPfizer; Novo Nordisk PharmaceuticalsNovo Nordisk	The work in this study was supported by unrestricted grants from Pfizer Pharmaceuticals and Novo Nordisk Pharmaceuticals.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2007, NAT CLIN PRACT ENDOC, V3, P318, DOI 10.1038/ncpendmet0460; Carroll P.V., 2008, J CLIN ENDOCRINOLOGY, V83, P382; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gleeson HK, 2003, J CLIN ENDOCR METAB, V88, P2106, DOI 10.1210/jc.2002-020969; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Kelly D.F., 2004, J NEUROSURG, V93, P743; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2015, EUR J ENDOCRINOL, V172, P753, DOI 10.1530/EJE-14-1069; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; PAVORD SR, 1992, CLIN ENDOCRINOL, V36, P135, DOI 10.1111/j.1365-2265.1992.tb00947.x; Personnier C, 2014, J CLIN ENDOCR METAB, V99, P2052, DOI 10.1210/jc.2013-4129; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430	33	14	14	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	JAN	2016	84	1					92	98		10.1111/cen.12874			7	Endocrinology & Metabolism	Endocrinology & Metabolism	DB2NB	WOS:000368344600013	26252757				2021-06-18	
J	Currie, DW; Fields, SK; Patterson, MJ; Comstock, RD				Currie, Dustin W.; Fields, Sarah K.; Patterson, Michael J.; Comstock, R. Dawn			Cheerleading Injuries in United States High Schools	PEDIATRICS			English	Article							EPIDEMIOLOGY; PREVENTION; FREQUENCY	BACKGROUND AND OBJECTIVES: Approximately 400 000 students participate in US high school abstract cheerleading annually, including 123 386 involved in competitive spirit squads. The degree of athleticism and the difficulty of cheerleading skills have increased in recent decades, renewing safety concerns. This study describes the epidemiology of high school cheerleading injuries and compares cheerleading injury rates and patterns relative to other sports. METHODS: Data collected by the longitudinal, National High School Sports-Related Injury Surveillance Study from 2009/2010 through 2013/2014 were analyzed. RESULTS: Injury rates in cheerleading ranked 18th of 22 sports, with an overall injury rate of 0.71 per 1000 athlete-exposures (AEs). Competition (0.85) and practice (0.76) injury rates were similar, whereas performance rates were lower (0.49). Although 96.8% of injured cheerleaders were girls, the overall injury rate was higher in boys (1.33 vs 0.69, rate ratio [RR]: 1.93, 95% confidence interval [CI]: 1.30-2.88). Although concussions were the most common cheerleading injury (31.1% of injuries), concussion rates were significantly lower in cheerleading (2.21 per 10 000 athlete-exposures) than all other sports combined (3.78; RR: 0.58, 95% CI: 0.51-0.66) and all other girls' sports (2.70; RR: 0.82, 95% CI: 0.72-0.93). Over half of all injuries occurred during stunts (53.2%). CONCLUSIONS: Although safety remains a concern among cheerleaders, overall injury rates are lower than most other high school sports. Although overall injury rates are relatively low, cheerleading injuries may be more severe when they do occur. A detailed knowledge of cheerleading injury patterns relative to other sports is needed to drive targeted, evidence-based prevention efforts.	[Currie, Dustin W.; Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Mail Stop B119,13001 East 17th Pl, Aurora, CO 80045 USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Fields, Sarah K.] Univ Colorado, Dept Commun, Denver, CO 80202 USA; [Patterson, Michael J.] Lemak Sports Med, Birmingham, AL USA	Currie, DW (corresponding author), Colorado Sch Publ Hlth, Dept Epidemiol, Mail Stop B119,13001 East 17th Pl, Aurora, CO 80045 USA.	dustin.currie@ucdenver.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000674, R49CE001172] Funding Source: NIH RePORTER	The content of this report was supported in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01. We also acknowledge the generous research funding contributions of the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack.	American Association of Cheerleading Coaches and Administrators, 2006, AM ASS CHEERL COACH; American Sports Data Inc, 2004, SUP SPORTS PART, VII; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Cantu RC, 2013, 27 ANN REP FALL 1982; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Giannone L., 2006, AM ASS CHEERLEADING, P1; Hutchinson MR, 1997, PHYSICIAN SPORTSMED, V25, P83, DOI 10.3810/psm.1997.09.1508; Jacobson BH, 2005, BRIT J SPORT MED, V39, P237, DOI 10.1136/bjsm.2004.014605; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; LaBella CR, 2012, PEDIATRICS, V130, P966, DOI 10.1542/peds.2012-2480; Mueller FO, 2009, J ATHL TRAINING, V44, P565, DOI 10.4085/1062-6050-44.6.565; National Federation of State High School Associations, 2013 2014 HIGH SCH A; National Federation of State High School Associations, 2014, 2014 2015 SPIR RUL B; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Schulz MR, 2002, ATHLETIC INJURIES N; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shields BJ, 2009, J ATHL TRAINING, V44, P567, DOI 10.4085/1062-6050-44.6.567	21	14	14	1	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	JAN	2016	137	1							e20152447	10.1542/peds.2015-2447			9	Pediatrics	Pediatrics	DF5KJ	WOS:000371390300033	26729538				2021-06-18	
J	Darkazalli, A; Ismail, AAO; Abad, N; Grant, SC; Levenson, CW				Darkazalli, Ali; Ismail, Abdol Aziz Ould; Abad, Nastaren; Grant, Samuel C.; Levenson, Cathy W.			Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; mesenchymal stem cells; subventricular zone; X-ray irradiation; depression	BONE-MARROW; HEAD-INJURY; ADULT RATS; DEPRESSION; TRANSPLANTATION; PROLIFERATION	Purpose: Major depression and related mood disorders are the most common long-term outcomes associated with traumatic brain injury (TBI). Given the potentially debilitating consequences of depression, and the fact that TBI patients are frequently refractory to antidepressant drugs, new therapies are clearly needed. We hypothesized that human bone marrow-derived mesenchymal stem cells (hMSC), delivered intravenously, can effectively treat TBI-induced depression and other behavioral deficits associated with TBI. Methods: Rats (n= 8 per group) were subjected to experimental TBI or control sham operation. Six hours post TBI, rats were treated with 1 x 10(6) hMSC or vehicle control Immediately after TBI and prior to hMSC or control treatment, rats were subjected to either targeted precision x-ray irradiation to eliminate subventricular zone (SVZ) proliferation or sham irradiation. One week after TBI, SVZ irradiation, and hMSC treatment, rats were evaluated for the depression -like behavior, anhedonia, using the two-bottle saccharin preference paradigm; and for working memory using the novel object recognition test. Results: TBI resulted in a 54% (p < 0.05) decrease in saccharin preference scores while treatment of TBI with hMSC fully prevented this anhedonic behavior. TBI was also found to produce a 73% (p < 0.05) decrease in novel object interaction time, indicating impaired working memory, and was similarly improved by treatment with hMSC. The ability of hMSC to prevent TBI-associated depression and working memory impairment was eliminated when SVZ proliferation was inhibited by irradiation. Conclusions: This work has identified a possible role for hMSC in the treatment of TBI-induced depression and other behaviors and suggests a mechanistic role for proliferative cells of the SVZ proliferation in hMSC efficacy.	[Darkazalli, Ali; Levenson, Cathy W.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Darkazalli, Ali; Levenson, Cathy W.] Florida State Univ, Coll Med, Program Neurosci, Tallahassee, FL 32306 USA; [Ismail, Abdol Aziz Ould; Abad, Nastaren; Grant, Samuel C.] FAMU FSU Coll Engn, Dept Chem & Biomed Engn, Tallahassee, FL USA; [Ismail, Abdol Aziz Ould; Abad, Nastaren; Grant, Samuel C.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	Levenson, CW (corresponding author), Coll Med, Res Bldg,MSR 2350-E,1115W Call St, Tallahassee, FL 32306 USA.	cathy.levenson@med.fsu.edu	Abad, Nastaren/AAI-3961-2021; Grant, Samuel/D-8744-2013	Grant, Samuel/0000-0001-7738-168X; Abad, Nastaren/0000-0002-7020-0492; Levenson, Cathy W/0000-0003-4463-3136	National Science FoundationNational Science Foundation (NSF) [DMR-1157490]; State of Florida; NHMFL user collaboration grant program; Department of DefenseUnited States Department of Defense	The authors would like to thank Dr. Thomas J. Morgan Jr. for assistance with stem cell culture and delivery. The authors would also like to thank Dr. Jens Rosenberg for his expertise and support of the imaging portion of this work was performed at the National High Magnetic Field Laboratory (NHMFL) and the FAMU-FSU College of Engineering. The NHMFL is supported by National Science Foundation (DMR-1157490) and the State of Florida. Funding was also provided by NHMFL user collaboration grant program and the Department of Defense.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kebriaei P, 2009, BIOL BLOOD MARROW TR, V15, P804, DOI 10.1016/j.bbmt.2008.03.012; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Lazic SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113855; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Nagai R, 2000, SURG NEUROL, V53, P503, DOI 10.1016/S0090-3019(00)00214-7; Nowrangi MA, 2014, PSYCHOSOMATICS, V55, P430, DOI 10.1016/j.psym.2013.11.006; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Shinohara C, 1997, CANCER RES, V57, P2694; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Tassabehji NM, 2008, PHYSIOL BEHAV, V95, P365, DOI 10.1016/j.physbeh.2008.06.017; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Wan M, 2012, STEM CELLS, V30, P2498, DOI 10.1002/stem.1208; WILLIS P, 1976, NEUROPATH APPL NEURO, V2, P377, DOI 10.1111/j.1365-2990.1976.tb00511.x; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	34	14	15	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	3					433	441		10.3233/RNN-150628			9	Neurosciences	Neurosciences & Neurology	DQ1EY	WOS:000378945500007	27080073				2021-06-18	
J	Ehrhart, J; Darlington, D; Kuzmin-Nichols, N; Sanberg, CD; Sawmiller, DR; Sanberg, PR; Tan, J				Ehrhart, Jared; Darlington, Donna; Kuzmin-Nichols, Nicole; Sanberg, Cyndy D.; Sawmiller, Darrell R.; Sanberg, Paul R.; Tan, Jun			Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer's Disease-Like Murine Model	CELL TRANSPLANTATION			English	Article						Human umbilical cord blood cells (HUCBCs); Biodistribution; Polymerase chain reaction (PCR); Mice; Rats; Neurodegenerative diseases	TRANSPLANTATION; THERAPY; STROKE	Human umbilical cord blood cells (HUCBCs), a prolific source of non-embryonic or adult stem cells, have emerged as effective and relatively safe immunomodulators and neuroprotectors, reducing behavioral impairment in animal models of Alzheimer's disease (AD), Parkinson's disease, amyotrophic lateral sclerosis, traumatic brain injury, spinal cord injury, and stroke. In this report, we followed the bioavailability of HUCBCs in AD-like transgenic PSAPP mice and nontransgenic Sprague Dawley rats. HUCBCs were injected into tail veins of mice or rats at a single dose of 1 x 10(6) or 2.2 x 10(6) cells, respectively, prior to harvesting of tissues at 24 h, 7 days, and 30 days after injection. For determination of HUCBC distribution, tissues from both species were subjected to total DNA isolation and polymerase chain reaction (PCR) amplification of the gene for human glycerol-3-phosphate dehydrogenase. Our results show a relatively similar biodistribution and retention of HUCBCs in both mouse and rat organs. HUCBCs were broadly detected both in the brain and several peripheral organs, including the liver, kidney, and bone marrow, of both species, starting within 7 days and continuing up to 30 days posttransplantation. No HUCBCs were recovered in the peripheral circulation, even at 24 h posttransplantation. Therefore, HUCBCs reach several tissues including the brain following a single intravenous treatment, suggesting that this route can be a viable method of administration of these cells for the treatment of neurodegenerative diseases.	[Ehrhart, Jared; Kuzmin-Nichols, Nicole; Sanberg, Cyndy D.] Saneron CCEL Therapeut Inc, 13014 N Dale Mabry Highway,Suite 266, Tampa, FL 33618 USA; [Darlington, Donna; Sawmiller, Darrell R.; Tan, Jun] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsani Coll Med, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr, Tampa, FL USA; [Sanberg, Paul R.; Tan, Jun] Univ S Florida, Dept Neurosurg & Brain Repair, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL USA	Ehrhart, J (corresponding author), Saneron CCEL Therapeut Inc, 13014 N Dale Mabry Highway,Suite 266, Tampa, FL 33618 USA.	jce@saneron-ccel.com	Sawmiller, Darrell/AAQ-9722-2021	Sawmiller, Darrell/0000-0003-3599-6859	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R42 AG031586-03]; Florida Hi Tech Corridor Matching Grant Program [FHT 11-12, FHT 12-01, FHT 13-07]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG032432, R42AG031586] Funding Source: NIH RePORTER	This research was supported by an NIH grant (No. 5R42 AG031586-03) and the Florida Hi Tech Corridor Matching Grant Program (FHT 11-12, FHT 12-01, and FHT 13-07). J.T. is a consultant for Saneron CCEL Therapeutics, Inc. and is an inventor on a patent application submitted by USE. P.R.S. is a cofounder of Saneron CCEL Therapeutics, Inc.	Broxmeyer HE, 1995, ANN NY ACAD SCI, V770, P105, DOI 10.1111/j.1749-6632.1995.tb31048.x; Cairns Kevin, 2003, Phys Med Rehabil Clin N Am, V14, pS135, DOI 10.1016/S1047-9651(02)00059-1; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Darlington D, 2013, STEM CELLS DEV, V22, P412, DOI 10.1089/scd.2012.0345; El-Badri NS, 2006, STEM CELLS DEV, V15, P497, DOI 10.1089/scd.2006.15.497; ENDE N, 1995, CLIN IMMUNOL IMMUNOP, V75, P190, DOI 10.1006/clin.1995.1070; Ende N, 2004, BIOCHEM BIOPH RES CO, V321, P168, DOI 10.1016/j.bbrc.2004.06.121; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P173; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P181; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P241; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Henning RJ, 2006, CELL TRANSPLANT, V15, P647, DOI 10.3727/000000006783981611; Lee JK, 2010, CURR ALZHEIMER RES, V7, P540; Lemere CA, 2003, NEUROCHEM RES, V28, P1017, DOI 10.1023/A:1023203122036; Lewis ID, 2002, INTERN MED J, V32, P601, DOI 10.1046/j.1445-5994.2002.00276.x; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Newman MB, 2003, NEUROTOX RES, V5, P355, DOI 10.1007/BF03033155; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; PATTERSON MB, 1992, ALZ DIS ASSOC DIS, V6, P145, DOI 10.1097/00002093-199206030-00003; Potkin SG, 2002, INT PSYCHOGERIATR, V14, P7, DOI 10.1017/S1041610203008640; Sanberg P. R., 2005, ANN NY ACAD SCI, V10, P855; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Steiner H, 1999, BIOCHEM SOC T, V27, P234, DOI 10.1042/bst0270234; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; van de Ven C, 2007, EXP HEMATOL, V35, P1753, DOI 10.1016/j.exphem.2007.08.017; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011	31	14	14	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2016	25	1					195	199		10.3727/096368915X689604			5	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	DC9QV	WOS:000369557000013	26414627	Green Accepted, Bronze			2021-06-18	
J	Geng, FY; Ma, YH; Xing, T; Zhuang, XB; Zhu, JX; Yao, LS				Geng, Fengyang; Ma, Yinghua; Xing, Tao; Zhuang, Xianbo; Zhu, Jianxin; Yao, Lusu			Effects of Hyperbaric Oxygen Therapy on Inflammasome Signaling after Traumatic Brain Injury	NEUROIMMUNOMODULATION			English	Article						Traumatic brain injury; Hyperbaric oxygen therapy; Inflammasomes; High-mobility group box 1	SPINAL-CORD-INJURY; CEREBRAL-CORTEX; CELL-DEATH; EXPRESSION; HMGB1; HMGB1/NF-KAPPA-B; ACTIVATION; PROTEIN; MODEL; MICE	Objective: Neuroinflammation plays an important role in secondary tissue damage after traumatic brain injury (TBI). Recently, the inflammasome-mediated inflammatory pathway has been observed in the inflammatory response of TBI. In this study, we investigated the influence of hyperbaric oxygen therapy (HBOT) on inflammasome activation after TBI. Methods: The experimental mice were randomly divided into 4 groups as follows: sham-operated normobaric air (21% O-2 at one absolute atmosphere), HBOT only, TBI + normobaric air and TBI + HBOT. Following the evaluation of motor deficits and brain edema, the expression of inflammasome components and effectors was measured by qRT-PCR and Western blotting. Moreover, alterations in IL-1 beta, IL-18 and high-mobility group box 1 (HMGB1) were calculated by enzyme-linked immunosorbent assay at each time point after injury. Results: HBOT improved motor score and reduced brain edema. Furthermore, it suppressed protein expression of inflammasome components and reduced the levels of IL-1 beta and IL-18, accompanied by the reduction of HMGB1 in brain tissues and serum. Conclusion: These results suggest that HBOT may alleviate the inflammatory response after TBI by inhibiting the activation of inflammasome signaling. (C) 2016 S. Karger AG, Basel	[Geng, Fengyang; Ma, Yinghua; Xing, Tao; Zhuang, Xianbo; Zhu, Jianxin; Yao, Lusu] Liaocheng Peoples Hosp, Dept Neurosurg, 67 West Dongchang Rd, Liaocheng 252000, Shandong, Peoples R China	Ma, YH (corresponding author), Liaocheng Peoples Hosp, Dept Neurosurg, 67 West Dongchang Rd, Liaocheng 252000, Shandong, Peoples R China.	yinghuamalc@sina.com					Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Guedes VA, 2016, EXPERT REV NEUROTHER, V16, P61, DOI 10.1586/14737175.2016.1126180; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; He Q, 2012, ASIAN PAC J CANCER P, V13, P1365, DOI 10.7314/APJCP.2012.13.4.1365; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Kang N, 2015, INT J CLIN EXP PATHO, V8, P1141; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Liang F, 2013, EUR REV MED PHARMACO, V17, P2010; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vande Walle L, 2011, VIRULENCE, V2, P162, DOI 10.4161/viru.2.2.15480; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Yang J, 2013, SPINE, V38, pE1641, DOI 10.1097/BRS.0000000000000005; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zeng XN, 2012, CNS NEUROSCI THER, V18, P388, DOI 10.1111/j.1755-5949.2012.00308.x; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	28	14	21	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2016	23	2					122	129		10.1159/000445689			8	Endocrinology & Metabolism; Immunology; Neurosciences	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	DN6NU	WOS:000377192800007	27216735				2021-06-18	
J	Guo, J; Yang, CX; Yang, JJ; Yao, Y				Guo, Jie; Yang, Chunxiao; Yang, Jiajia; Yao, Yang			Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Glycyrrhizic acid; neuroprotection; oxidative damage; vascular dementia; voltage-dependent sodium channels	18-BETA-GLYCYRRHETINIC ACID; ISCHEMIA-REPERFUSION; CEREBRAL-ISCHEMIA; HYDROGEN-PEROXIDE; SPINAL-CORD; BRAIN; INJURY; NEURONS; HMGB1; EXCITABILITY	Vascular dementia (VD) is the second most common cause of cognitive impairment in the elderly population. Our study aims to investigate the neuroprotective effects of glycyrrhizic acid (GA), a major active constituent of Glycyrrhiza glabra root, in a VD rat model induced by permanent occlusion of the bilateral common carotid arteries. Spatial cognitive function was examined by the Morris water maze test and synaptic plasticity was explored by assessing long-term potentiation. The results showed that GA (20 mg/kg for 5 days) significantly improved the performance of learning and memory of VD rats in the Morris water maze test and attenuated induction of long-term potentiation. Histopathological studies showed that GA significantly attenuated cell damage in VD rats. Malondialdehyde levels and superoxide dismutase activity were analyzed in the hippocampus and cortex to investigate anti-oxidant status. The results showed that GA decreased the level of lipid peroxidation and increased the activity of superoxide dismutase in VD rats. Lastly, whole-cell patch-clamp analysis was used to examine the effect of GA on voltage-gated sodium channels (VGSCs) in hippocampal CA1 pyramidal neurons. GA (10, 20 and 50 mu M) inhibited the current amplitude of the VGSCs. These results suggest that the neuroprotective effects of GA in VD rats relate to the reduction of oxidative stress and inhibition of VGSCs. Our study provides experimental evidence for the application of GA in the treatment of cognitive deficits induced by Alzheimer's disease, stroke, or traumatic brain injury.	[Guo, Jie; Yao, Yang] Tianjin First Ctr Hosp, Dept Neurol, Tianjin 300192, Peoples R China; [Yang, Chunxiao] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Yang, Jiajia] Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China	Yao, Y (corresponding author), Tianjin First Ctr Hosp, Dept Neurol, Tianjin 300192, Peoples R China.; Yang, JJ (corresponding author), Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China.	jiajia.yang@tju.edu.cn; nkyaoyang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31300923, 31500865]; Tianjin Municipal Health Bureau Foundation [2014KY14, 14KG22]	The study was supported by grants from the National Natural Science Foundation of China (31300923, 31500865) and Tianjin Municipal Health Bureau Foundation (2014KY14, 14KG22). We thank Xiaoyuan SUO for assistance with preparation of the manuscript.	Akman T, 2015, INFLAMMATION, V38, P1581, DOI 10.1007/s10753-015-0133-1; Alagona G, 2004, NEUROSCI LETT, V362, P95, DOI 10.1016/j.neulet.2004.03.006; An L, 2013, NEUROBIOL LEARN MEM, V100, P18, DOI 10.1016/j.nlm.2012.12.003; Ates O, 2007, NEUROL RES, V29, P317, DOI 10.1179/016164107X159225; Barakat W, 2014, EUR J PHARMACOL, V724, P43, DOI 10.1016/j.ejphar.2013.12.032; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; Brahma MK, 2009, J NEUROSCI RES, V87, P1400, DOI 10.1002/jnr.21960; Cherng JM, 2006, EUR J PHARMACOL, V547, P10, DOI 10.1016/j.ejphar.2006.06.080; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Kao TC, 2009, J AGR FOOD CHEM, V57, P754, DOI 10.1021/jf802864k; Kim KW, 2008, J GERIATR PSYCH NEUR, V21, P12, DOI [10.1177/08988707311028, 10.1177/0891988707311028]; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Kim SW, 2011, ANAT CELL BIOL, V44, P304, DOI 10.5115/acb.2011.44.4.304; Lee Ae Young, 2011, Chonnam Med J, V47, P66, DOI 10.4068/cmj.2011.47.2.66; Li XL, 2011, INT J MOL SCI, V12, P905, DOI 10.3390/ijms12020905; Lin CSY, 2002, J PHYSIOL-LONDON, V538, P435, DOI 10.1113/jphysiol.2001.012478; Liu C, 2007, PHARMACOL BIOCHEM BE, V86, P423, DOI 10.1016/j.pbb.2006.11.005; Ma JH, 2005, ACTA PHARMACOL SIN, V26, P828, DOI 10.1111/j.1745-7254.2005.00154.x; Martinez-Sanchez M, 2004, NEUROSCIENCE, V128, P729, DOI 10.1016/j.neuroscience.2004.06.074; Mongin Alexander A, 2007, Pathophysiology, V14, P183, DOI 10.1016/j.pathophys.2007.09.009; Ni B, 2013, INT J NEUROSCI, V123, P745, DOI 10.3109/00207454.2013.796551; Ogiku M, 2011, J PHARMACOL EXP THER, V339, P93, DOI 10.1124/jpet.111.182592; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047; Rackova L, 2007, NAT PROD RES, V21, P1234, DOI 10.1080/14786410701371280; Raley-Susman KM, 2001, J NEUROPHYSIOL, V86, P2715; Roger S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00152; Roman GC, 2002, J NEUROL SCI, V203, P7, DOI 10.1016/S0022-510X(02)00252-6; Smolarczyk R, 2012, ARCH IMMUNOL THER EX, V60, P391, DOI 10.1007/s00005-012-0183-0; Song JH, 2013, MOLECULES, V18, P15788, DOI 10.3390/molecules181215788; Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; XiYang YB, 2016, MOL NEUROBIOL, V53, P955, DOI 10.1007/s12035-014-9048-3; Yang JJ, 2014, NEUROMOL MED, V16, P376, DOI 10.1007/s12017-013-8284-4; Yanpallewar S, 2005, LIFE SCI, V76, P1325, DOI 10.1016/j.lfs.2004.06.029; Yao Y, 2010, PHYTOTHER RES, V24, P136, DOI 10.1002/ptr.2902; Yao Y, 2012, AM J PHYSIOL-REG I, V302, pR815, DOI 10.1152/ajpregu.00452.2011; Zaghloul N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108168; Zhu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046286	45	14	16	0	17	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2016	15	8					1001	1008		10.2174/1871527315666160527163526			8	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	EB1OG	WOS:000387121800016	27238153				2021-06-18	
J	Keller, CJ; Chen, EC; Brodsky, K; Yoon, JH				Keller, Corey J.; Chen, Evan C.; Brodsky, Kimberly; Yoon, Jong H.			A case of butane hash oil (marijuana wax)-induced psychosis	SUBSTANCE ABUSE			English	Article						Butane hash oil; cannabis; marijuana; psychosis; THC; wax	TRAUMATIC BRAIN-INJURY; HIGH-POTENCY CANNABIS; DISORDER	Background: Marijuana is one of the most widely used controlled substances in the United States. Despite extensive research on smoked marijuana, little is known regarding the potential psychotropic effects of marijuana wax, a high-potency form of marijuana that is gaining in popularity. Case: The authors present a case of Mr. B, a 34-year-old veteran who presented with profound psychosis in the setting of recent initiation of heavy, daily marijuana wax use. He exhibited incoherent speech and odd behaviors and appeared to be in a dream-like state with perseverating thoughts about his combat experience. His condition persisted despite treatment with risperidone 4mg twice a day (BID), but improved dramatically on day 8 of hospitalization with the return of baseline mental function. Following discharge, Mr. B discontinued all marijuana use and did not exhibit the return of any psychotic symptoms. Discussion: This study highlights the need for future research regarding the potential medical and psychiatric effects of new, high-potency forms of marijuana. Could cannabis have a dose-dependent impact on psychosis? What other potential psychiatric effects could emerge heretofore unseen in lower potency formulations? Given the recent legalization of marijuana, these questions merit timely exploration.	[Keller, Corey J.; Chen, Evan C.; Brodsky, Kimberly; Yoon, Jong H.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA; [Keller, Corey J.; Chen, Evan C.; Brodsky, Kimberly; Yoon, Jong H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	Keller, CJ (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd, Stanford, CA 94305 USA.	coreyjkeller@gmail.com					Copeland J, 2009, INT REV PSYCHIATR, V21, P96, DOI 10.1080/09540260902782745; D'Souza DC, 2004, NEUROPSYCHOPHARMACOL, V29, P1558, DOI 10.1038/sj.npp.1300496; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Di Forti M, 2015, LANCET PSYCHIAT, V2, P233, DOI 10.1016/S2215-0366(14)00117-5; Di Forti M, 2009, BRIT J PSYCHIAT, V195, P488, DOI 10.1192/bjp.bp.109.064220; Doan C, KCRA NEWS; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Loflin M, 2014, ADDICT BEHAV, V39, P1430, DOI 10.1016/j.addbeh.2014.05.013; Mehmedic Z, 2010, J FORENSIC SCI, V55, P1209, DOI 10.1111/j.1556-4029.2010.01441.x; Morrison PD, 2009, PSYCHOL MED, V39, P1607, DOI 10.1017/S0033291709005522; Murphy CR, ABC NEWS; Paparelli A, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00001; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stogner JM, 2015, SUBST ABUS; Substance Abuse and Mental Health Services Administration, 2014, NSDUH SER H; Substance Abuse and Mental Health Services Administration (SAMHS)., 2014, NSDUH SER; What You Should Know About Marijuana Concentrates, WHAT YOU SHOULD KNOW; Zuurman L, 2010, J PSYCHOPHARMACOL, V24, P1689, DOI 10.1177/0269881109106913	18	14	14	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0889-7077	1547-0164		SUBST ABUS	Subst. Abus.		2016	37	3					384	386		10.1080/08897077.2016.1141153			3	Substance Abuse	Substance Abuse	DV2RW	WOS:000382769800003	26820171				2021-06-18	
J	Lecky, F; Russell, W; Fuller, G; McClelland, G; Pennington, E; Goodacre, S; Han, K; Curran, A; Holliman, D; Freeman, J; Chapman, N; Stevenson, M; Byers, S; Mason, S; Potter, H; Coats, T; Mackway-Jones, K; Peters, M; Shewan, J; Strong, M				Lecky, Fiona; Russell, Wanda; Fuller, Gordon; McClelland, Graham; Pennington, Elspeth; Goodacre, Steve; Han, Kyee; Curran, Andrew; Holliman, Damien; Freeman, Jennifer; Chapman, Nathan; Stevenson, Matt; Byers, Sonia; Mason, Suzanne; Potter, Hugh; Coats, Tim; Mackway-Jones, Kevin; Peters, Mary; Shewan, Jane; Strong, Mark			The Head Injury Transportation Straight to Neurosurgery (HITS-NS) randomised trial: a feasibility study	HEALTH TECHNOLOGY ASSESSMENT			English	Article							TRAUMATIC BRAIN-INJURY; HEALTH TECHNOLOGY-ASSESSMENT; PARTIAL EXPECTED VALUE; COST-EFFECTIVENESS; HYPERTONIC RESUSCITATION; PARAMEDIC PRACTITIONERS; EXTRADURAL HEMATOMA; PERFECT INFORMATION; OUTCOME PREDICTION; DECISION-MAKING	Background: Reconfiguration of trauma services, with direct transport of traumatic brain injury (TBI) patients to neuroscience centres (NCs), bypassing non-specialist acute hospitals (NSAHs), could potentially improve outcomes. However, delays in stabilisation of airway, breathing and circulation (ABC) and the difficulties in reliably identifying TBI at scene may make this practice deleterious compared with selective secondary transfer from nearest NSAH to NC. National Institute for Health and Care Excellence guidance and systematic reviews suggested equipoise and poor-quality evidence - with regard to 'early neurosurgery' in this cohort - which we sought to address. Methods: Pilot cluster randomised controlled trial of bypass to NC conducted in two ambulance services with the ambulance station (n = 74) as unit of cluster [Lancashire/Cumbria in the North West Ambulance Service (NWAS) and the North East Ambulance Service (NEAS)]. Adult patients with signs of isolated TBI [Glasgow Coma Scale (GCS) score of < 13 in NWAS, GCS score of < 14 in NEAS] and stable ABC, injured nearest to a NSAH were transported either to that hospital (control clusters) or bypassed to the nearest NC (intervention clusters). Primary outcomes: recruitment rate, protocol compliance, selection bias as a result of non-compliance, accuracy of paramedic TBI identification (overtriage of study inclusion criteria) and pathway acceptability to patients, families and staff. 'Open-label' secondary outcomes: 30-day mortality, 6-month Extended Glasgow Outcome Scale (GOSE) and European Quality of Life-5 Dimensions. Results: Overall, 56 clusters recruited 293 (169 intervention, 124 control) patients in 12 months, demonstrating cluster randomised pre-hospital trials as viable for heath service evaluations. Overall compliance was 62%, but 90% was achieved in the control arm and when face-to-face paramedic training was possible. Non-compliance appeared to be driven by proximity of the nearest hospital and perceptions of injury severity and so occurred more frequently in the intervention arm, in which the perceived time to the NC was greater and severity of injury was lower. Fewer than 25% of recruited patients had TBI on computed tomography scan (n = 70), with 7% (n = 20) requiring neurosurgery (craniotomy, craniectomy or intracranial pressure monitoring) but a further 18 requiring admission to an intensive care unit. An intention-to-treat analysis revealed the two trial arms to be equivalent in terms of age, GCS and severity of injury. No significant 30-day mortality differences were found (8.8% vs. 9.1/%; p > 0.05) in the 273 (159/113) patients with data available. There were no apparent differences in staff and patient preferences for either pathway, with satisfaction high with both. Very low responses to invitations to consent for follow-up in the large number of mild head injury-enrolled patients meant that only 20% of patients had 6-month outcomes. The trial-based economic evaluation could not focus on early neurosurgery because of these low numbers but instead investigated the comparative cost-effectiveness of bypass compared with selective secondary transfer for eligible patients at the scene of injury. Conclusions: Current NHS England practice of bypassing patients with suspected TBI to neuroscience centres gives overtriage ratios of 13 : 1 for neurosurgery and 4 : 1 for TBI. This important finding makes studying the impact of bypass to facilitate early neurosurgery not plausible using this study design. Future research should explore an efficient comparative effectiveness design for evaluating 'early neurosurgery through bypass' and address the challenge of reliable TBI diagnosis at the scene of injury.	[Lecky, Fiona; Fuller, Gordon; Goodacre, Steve; Freeman, Jennifer; Chapman, Nathan; Stevenson, Matt; Mason, Suzanne; Strong, Mark] Univ Sheffield, Sch Hlth & Related Res SCHaRR, Hlth Serv Res, EMRiS Grp, Sheffield, S Yorkshire, England; [Russell, Wanda] Univ Manchester, Inst Populat, Ctr Occupat & Environm Hlth, Trauma Audit & Res Network, Manchester, Lancs, England; [McClelland, Graham; Han, Kyee; Byers, Sonia] North East Ambulance Serv NHS Fdn Trust, Res & Dev Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Pennington, Elspeth; Curran, Andrew; Mackway-Jones, Kevin; Peters, Mary] North West Ambulance Serv, Res & Dev Dept, Carlisle, Cumbria, England; [Holliman, Damien] Newcastle Tyne Hosp NHS Fdn Trust, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Potter, Hugh] Potter Rees Serious Injury Solicitors LLP, Manchester, Lancs, England; [Coats, Tim] Univ Leicester, Univ Hosp Leicester NHS Trust, Dept Cardiovasc Sci, Leicester, Leics, England; [Shewan, Jane] Yorkshire Ambulance Serv NHS Trust, Res & Dev Dept, Wakefield, England	Lecky, F (corresponding author), Univ Sheffield, Sch Hlth & Related Res SCHaRR, Hlth Serv Res, EMRiS Grp, Sheffield, S Yorkshire, England.	f.e.lecky@sheffield.ac.uk	; Strong, Mark/A-4638-2010; Russell, Wanda/O-9051-2014	Pennington, Elspeth/0000-0002-9187-0524; McClelland, Graham/0000-0002-4502-5821; Fuller, Gordon Ward/0000-0001-8532-3500; Chapman, Nathan/0000-0002-5600-5439; Mason, Suzanne/0000-0002-1701-0577; Coats, Timothy/0000-0003-2736-2784; Strong, Mark/0000-0003-1486-8233; Russell, Wanda/0000-0003-2671-1938	National Institute for Health Research (NIHR) Health Technology Assessment programmeNational Institute for Health Research (NIHR); National Institute for Health ResearchNational Institute for Health Research (NIHR) [DRF-2011-04-050, 08/116/85, PDF-2012-05-258] Funding Source: researchfish	This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 20, No. 1. See the NIHR Journals Library website for further project information.	Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Allen Donner, 2000, DESIGN ANAL CLUSTER; Allison P.D., 2001, MISSING DATA; [Anonymous], 2007, REP NAT CONF ENQ PAT; Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Ara R, 2012, VALUE HEALTH, V15, P971, DOI 10.1016/j.jval.2012.05.003; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL AIS 20; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Beecham J, 2009, BRAIN INJURY, V23, P30, DOI 10.1080/02699050802590338; Benger JR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002467; Bennett C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-168; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brennan A, 2007, MED DECIS MAKING, V27, P448, DOI 10.1177/0272989X07302555; Briggs A., 2006, DECISION MODELLING H; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Callaham M, 1997, ANN EMERG MED, V30, P785, DOI 10.1016/S0196-0644(97)70049-0; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Centre for Bayesian Statistics in Health Economics (CHEBS) School of Health and Related Research University of Sheffield, EXCEL MACROS FOR SAM; Cheung R, 2013, EMERG MED J, V30, P476, DOI 10.1136/emermed-2012-201324; Chilcott J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14250; Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K., 2013, 81 CHE U YORK; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; Culyer Anthony, 2007, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; DEBOOR C, 1974, PRACTICAL GUIDE SPLI; *DEP HLTH, HOSP EP STAT; Department of Health, 2008, HIGH QUAL WORKF NHS; Department of Health, 2007, FRAM ACT; Department of Health, 2008, NHS REF COSTS 2007 2; Department of Health, 2007, OUR NHS OUR FUT; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dixon S, 2009, EMERG MED J, V26, P446, DOI 10.1136/emj.2008.061424; Donner A, 2004, AM J PUBLIC HEALTH, V94, P416, DOI 10.2105/AJPH.94.3.416; Durham R, 2006, ANN SURG, V243, P775, DOI 10.1097/01.sla.0000219644.52926.f1; Eckermann S, 2007, HEALTH ECON, V16, P195, DOI 10.1002/hec.1161; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Forsyth RJ, 2001, COCHRANE DB SYST REV, V3; Fuller G, 2011, J INTENSIVE CARE SOC, V12, P1; Fuller G, 2015, EUR J EMERG MED, V22, P42, DOI 10.1097/MEJ.0000000000000117; Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Ganapathy K, 2002, SURG NEUROL, V58, P388, DOI 10.1016/S0090-3019(02)00924-2; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gomes E, 2010, RESUSCITATION, V81, P440, DOI 10.1016/j.resuscitation.2009.12.014; Greenhalgh T., 2010, READ PAPER BASICS EV, V4th ed.; Hall AR., 2005, ADV TEXTS ECONOMETRI; Hannan EL, 2000, J TRAUMA, V48, P76, DOI 10.1097/00005373-200001000-00013; Hargreaves K, 2014, EMERG MED J, V31, P499, DOI 10.1136/emermed-2013-202346; Harrison DA, 2013, HLTH TECHNOL ASSESS, V17; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; Hastie T, 1995, STAT METHODS MED RES, V4, P87; Hayes RJ, 2009, INTERD STAT, P3; Health and Social Care Information Centre, AMB SERV ENGL 2006 0; Holmes M, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18160; Jennings PA, 2012, ANN EMERG MED, V59, P497, DOI 10.1016/j.annemergmed.2011.11.012; Kaltenthaler E, 2011, 13 NICE DSU; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kober A, 2002, MAYO CLIN PROC, V77, P35, DOI 10.4065/77.1.35; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Leaviss J., 2014, HLTH TECHNOL ASSESS, V18; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lendrum RA, 2013, ANAESTHESIA, V68, P30, DOI 10.1111/anae.12049; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Mason S, 2007, BRIT MED J, V335, P919, DOI 10.1136/bmj.39343.649097.55; McCartan DP, 2008, BRAIN INJURY, V22, P305, DOI 10.1080/02699050801995124; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Meadow C, 2011, JICS, V12, P88; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; National Audit Office (NAO), 2010, MAJ TRAUM CAR ENGL; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2007, HEAD INJ TRIAG ASS I; National Institute for Health and Care Excellence, 2013, HEAD INJ TRIAG ASS I, V176; Neuroanaesthesia Society of Great Britain and Ireland (NASGBI), NEUR CAR CAP DEM REP; Nicholl J, 2011, COST EFFECTIVENESS R; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petsas A, 2010, J NEUROSURG ANESTH, V22, P354, DOI 10.1097/ANA.0b013e3181f0da95; Philips Z, 2006, PHARMACOECONOMICS, V24, P355, DOI 10.2165/00019053-200624040-00006; Pickering A, 2014, COMP DIRECT TRANSFER; Pickering A, 2012, EMERG MED J, V29, P451, DOI 10.1136/emj.2010.094755; R Development Core Team, 2013, R LANG ENV STAT COMP; Robinson S, 2008, J OPER RES SOC, V59, P278, DOI 10.1057/palgrave.jors.2602368; Robson C., 2011, REAL WORLD RES; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Royal College of Surgeons of Edinburgh, 2012, TRAUM CAR SCOTL; Ruff LM, 2013, BRIT J NEUROSURG, V27, P19, DOI 10.3109/02688697.2012.709555; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schiferer A, 2007, ANESTH ANALG, V105, P1852, DOI 10.1213/01.ane.0000287676.39323.9e; Schmidt TA, 2009, PREHOSP EMERG CARE, V13, P160, DOI 10.1080/10903120802708852; Seguin J, 1999, J TRAUMA, V47, pS99; Shiel A, 2004, BRIT J NEUROSURG, V18, P5, DOI 10.1080/02688690410001660625; Sleat G, 2011, INJURY, V42, P838, DOI 10.1016/j.injury.2011.05.014; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Snooks H, 2004, EMERG MED J, V21, P105, DOI 10.1136/emj.2003.009050; Snooks H, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-2; Soares MO, 2012, HLTH TECHNOL ASSESS, V16; Stevenson MD, 2001, INJURY, V32, P267, DOI 10.1016/S0020-1383(00)00191-1; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; Strong M, 2013, TRIALS SUPPL 1, V14, pO25; Strong M, 2013, EFFICIENT METHOD COM; Strong M, 2014, MED DECIS MAKING, V34, P311, DOI 10.1177/0272989X13505910; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Trauma Audit & Research Network (TARN), WEBS PUBL STAND CAR; Turner J, 2000, HEALTH TECHNOL ASSES, V4; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x; University of Sheffield, 2010, BUILD EV BAS PREH UR; Vondy A, 2011, EMERG MED J, V28, P250, DOI 10.1136/emj.2010.101022; Wang HE, 2011, ANN EMERG MED, V57, P232, DOI 10.1016/j.annemergmed.2010.11.034; Watson DLB, 2012, ANN EMERG MED, V60, P641, DOI 10.1016/j.annemergmed.2011.12.002; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wood S., 2017, GEN ADDITIVE MODELS, V2nd ed.; Woollard M, 2004, EMERG MED J, V21, P362, DOI 10.1136/emj.2004.014324; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	143	14	14	0	5	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	JAN	2016	20	1					1	+		10.3310/hta20010			200	Health Care Sciences & Services	Health Care Sciences & Services	DC3EA	WOS:000369101000001	26753808	DOAJ Gold, Green Accepted, Green Published			2021-06-18	
J	Linnstaedt, SD; Bortsov, AV; Soward, AC; Swor, R; Peak, DA; Jones, J; Rathlev, N; Lee, DC; Domeier, R; Hendry, PL; McLean, SA				Linnstaedt, Sarah D.; Bortsov, Andrey V.; Soward, April C.; Swor, Robert; Peak, David A.; Jones, Jeffrey; Rathlev, Niels; Lee, David C.; Domeier, Robert; Hendry, Phyllis L.; McLean, Samuel A.			CRHBP polymorphisms predict chronic pain development following motor vehicle collision	PAIN			English	Article						Genetic variant; CRHBP; HPA axis; Musculoskeletal pain; Stress-induced hyperalgesia; Motor vehicle collision	HPA AXIS GENES; GLUCOCORTICOID-RECEPTOR; MUSCULOSKELETAL PAIN; IMMUNOPHILIN FKBP51; STRESS; ASSOCIATION; SYMPTOMS; BRAIN; RISK; EXPRESSION	Musculoskeletal pain (MSP) is a common sequela of traumatic stress exposure. While biological factors contributing to chronic MSP after motor vehicle collision (MVC) have traditionally focused on tissue injury, increasing evidence suggests that neuro/stress/immune processes mediated by stress system activation may play a more dominant role. In a previous study, we found that genetic variants in the hypothalamic-pituitary-adrenal (HPA) axis-related gene FKBP5 influence vulnerability to persistent MSP 6 weeks after MVC. In the present cohort study (n5855), we evaluated whether genetic variants in several other important HPA axis-related genes, including the glucocorticoid receptor (NR3C1), corticotropin-releasing hormone receptor R1 (CRHR1), and corticotropin-releasing hormone-binding protein (CRHBP), influence risk of chronic MSP over time after MVC. Genetic polymorphism rs7718461 in the CRHBP gene showed significant association (P = 0.0012) with overall pain severity during the year after MVC in regression models controlling for multiple comparisons. Two additional CRHBP alleles in high linkage disequilibrium with rs7718461 also showed trend-level significance. In secondary analyses, a significant interaction between this CRHBP locus (minor allele frequency = 0.33) and time was observed (P = 0.015), with increasing effect observed over time following trauma. A significant CRHBP x FKBP5 interaction was also observed, with substantially increased MSP after MVC in those with a risk allele in both genes compared with either gene alone. The results of this study indicate that genetic variants in 2 different HPA axis genes predict chronic MSP severity following MVC and support the hypothesis that the HPA axis is involved in chronic post-MVC MSP pathogenesis.	[Linnstaedt, Sarah D.; Bortsov, Andrey V.; Soward, April C.; McLean, Samuel A.] Univ N Carolina, TRYUMPH Res Program, Chapel Hill, NC USA; [Linnstaedt, Sarah D.; Bortsov, Andrey V.; Soward, April C.; McLean, Samuel A.] Univ N Carolina, Anesthesiol, Chapel Hill, NC USA; [Swor, Robert] William Beaumont Hosp, Emergency Med, Royal Oak, MI 48072 USA; [Peak, David A.] Massachusetts Gen Hosp, Emergency Med, Boston, MA 02114 USA; [Jones, Jeffrey] Spectrum Hlth Syst, Emergency Med, Grand Rapids, MI USA; [Rathlev, Niels] Baystate Med Ctr, Emergency Med, Springfield, MA USA; [Lee, David C.] N Shore Univ Hosp, Emergency Med, Manhasset, NY USA; [Domeier, Robert] St Joseph Mercy Hlth Syst, Emergency Med, Ypsilanti, MI USA; [Hendry, Phyllis L.] Univ Florida, Coll Med, Emergency Med, Jacksonville, FL USA; [McLean, Samuel A.] Univ N Carolina, Emergency Med, Chapel Hill, NC USA	McLean, SA (corresponding author), Univ N Carolina, Sch Med, Emergency Med, Wing C CB 7010, Chapel Hill, NC 27599 USA.	smclean@aims.unc.edu			National Institute of Arthritis and Musculoskeletal and Skin diseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR056328]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR056328] Funding Source: NIH RePORTER	The project described was supported by Award Number R01AR056328 from the National Institute of Arthritis and Musculoskeletal and Skin diseases.	[Anonymous], P 12 IASP R IN PRESS; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bijur PE, 2003, ACAD EMERG MED, V10, P390, DOI 10.1197/aemj.10.4.390; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI [10.1016/j.psyneuen.2008.08.018, 10.1016/j.psyneuen.2009.05.021]; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bortsov AV, 2014, NEUROMOL MED, V16, P83, DOI 10.1007/s12017-013-8255-9; Bortsov AV, 2013, PAIN, V154, P1419, DOI 10.1016/j.pain.2013.04.037; Bromer C, 2013, DEV PSYCHOBIOL, V55, P673, DOI 10.1002/dev.21061; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; De Luca V, 2010, J PSYCHOPHARMACOL, V24, P677, DOI 10.1177/0269881108097817; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; El-Hage W, 2013, MOL PSYCHIATR, V18, P174, DOI 10.1038/mp.2011.145; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Ferreira S H, 1993, Drugs, V46 Suppl 1, P1; FUKUOKA H, 1994, BRAIN RES, V657, P133, DOI 10.1016/0006-8993(94)90960-1; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Hartling L, 2001, SPINE, V26, P36, DOI 10.1097/00007632-200101010-00008; Holliday KL, 2010, ANN RHEUM DIS, V69, P556, DOI 10.1136/ard.2009.116137; Holm LW, 2008, SPINE, V33, pS52, DOI 10.1097/BRS.0b013e3181643ece; Khasar SG, 2008, J NEUROSCI, V28, P5721, DOI 10.1523/JNEUROSCI.0256-08.2008; Tran L, 2012, AM J PHYSIOL-GASTR L, V302, pG1301, DOI 10.1152/ajpgi.00501.2011; Levran O, 2014, ANN HUM GENET, V78, P290, DOI 10.1111/ahg.12064; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; Linnstaedt SD, 2015, J PAIN, V16, P637, DOI 10.1016/j.jpain.2015.03.011; Mahon PB, 2013, PSYCHOPHARMACOLOGY, V227, P231, DOI 10.1007/s00213-012-2956-x; MAIER SF, 1993, BRAIN RES, V623, P321, DOI 10.1016/0006-8993(93)91446-Y; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; McLean SA, 2011, SPINE, V36, pS226, DOI 10.1097/BRS.0b013e3182387fb4; Musey PI, 2014, ACAD EMERG MED, V21, P1421, DOI 10.1111/acem.12529; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Pesole G, 1997, GENE, V205, P95, DOI 10.1016/S0378-1119(97)00407-1; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; Platts-Mills TF, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-14; Ribbe K, 2011, ARCH GEN PSYCHIAT, V68, P1247, DOI 10.1001/archgenpsychiatry.2011.100; Roy A, 2012, J PSYCHIATR RES, V46, P72, DOI 10.1016/j.jpsychires.2011.09.009; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Seasholtz AF, 2001, PEPTIDES, V22, P743, DOI 10.1016/S0196-9781(01)00387-4; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Suissa S, 2001, EUR SPINE J, V10, P44, DOI 10.1007/s005860000220; Ulirsch JC, 2014, PAIN; *US CENS BUR, 2011, STAT ABSTR US 2012; Walton DM, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/876871; Wang SX, 2004, J NEUROSCI, V24, P8595, DOI 10.1523/JNEUROSCI.3058-04.2004; WATKINS LR, 1995, BRAIN RES, V692, P244, DOI 10.1016/0006-8993(95)00715-3; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7; WATKINS LR, 1994, BRAIN RES, V654, P15, DOI 10.1016/0006-8993(94)91566-0; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Westphal NJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1878, DOI 10.2741/1931; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	59	14	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0304-3959	1872-6623		PAIN	Pain	JAN	2016	157	1					273	279		10.1097/j.pain.0000000000000374			7	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	DN5KD	WOS:000377104800028	26447706	Green Accepted			2021-06-18	
J	Lu, W; Krellman, JW; Dijkers, MP				Lu, William; Krellman, Jason W.; Dijkers, Marcel P.			Can Cognitive Behavioral Therapy for Insomnia also treat fatigue, pain, and mood symptoms in individuals with traumatic brain injury? - A multiple case report	NEUROREHABILITATION			English	Article						Insomnia; traumatic brain injury; cognitive behavioral therapy; case study	SLEEP QUALITY INDEX; HOSPITAL ANXIETY; MULTIDIMENSIONAL ASSESSMENT; IMPORTANT DIFFERENCE; DEPRESSION SCALE; SEVERITY INDEX; OF-LIFE; DISTURBANCES; VALIDITY; POPULATION	BACKGROUND: Individuals with traumatic brain injury (TBI) often develop sleep disorders post-injury. The most common one is insomnia, which can exacerbate other post-injury symptoms, including fatigue, impaired cognition, depression, anxiety, and pain. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a manualized treatment that effectively treats insomnia with secondary effects on cognition, mood, and pain in various populations. OBJECTIVE: This paper reviews the use of CBT-I for three participants with TBI of different severities. METHODS: Pre- and post-treatment assessments of insomnia, fatigue, depression, anxiety, and pain were conducted. Mood was further assessed at follow-up. Minimal clinically important difference (MCID) scores derived from the research literature were used to establish clinically meaningful symptom improvement on self-report questionnaires. RESULTS: The reduction in insomnia severity scores for all three participants were not large enough to be considered a clinically significant improvement following CBT-I, although trends toward improvement were observed. However, all participants showed clinically significant reductions in anxiety at post-treatment; the effects persisted for 2 participants at follow-up. Reductions in depression symptoms were observed for 2 participants at post-treatment, and treatment effects persisted for 1 participant at follow-up. One participant endorsed clinically significant improvements in fatigue and pain severity. CONCLUSIONS: We conclude that CBT-I may provide secondary benefits for symptoms commonly experienced by individuals with TBI, especially mood disturbances.	[Lu, William] NYU, Langone Med Ctr, Rusk Rehabil, New York, NY 10003 USA; [Krellman, Jason W.; Dijkers, Marcel P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA	Lu, W (corresponding author), NYU, Langone Med Ctr, Rusk Rehabil, New York, NY 10003 USA.	william.lu@nyumc.org			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5U49CE002092-02]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002092] Funding Source: NIH RePORTER	Supported by the Centers for Disease Control and Prevention (grant no. 5U49CE002092-02). No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	American Psychiatric Association & American Psychiatric Association. Task Force on DSM-V, 2013, DIAGNOSTIC AND STATI; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BELZA BL, 1995, J RHEUMATOL, V22, P639; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Daley M, 2009, SLEEP, V32, P55; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Fairbrother N, 2008, PSYCHOL ASSESSMENT, V20, P150, DOI 10.1037/1040-3590.20.2.150; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Given B, 2008, J PAIN SYMPTOM MANAG, V35, P126, DOI 10.1016/j.jpainsymman.2007.03.012; Goligher EC, 2008, J RHEUMATOL, V35, P635; Harvey AG, 2002, BEHAV RES THER, V40, P869, DOI 10.1016/S0005-7967(01)00061-4; Hughes CM, 2009, ACUPUNCT MED, V27, P163, DOI 10.1136/aim.2009.000760; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Lequerica A, 2012, J HEAD TRAUMA REHAB, V27, pE28, DOI 10.1097/HTR.0b013e31826fe574; Lu W, 2015, BRAIN INJURY, V29, P1342, DOI 10.3109/02699052.2015.1043947; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mathias Susan D, 2011, J Support Oncol, V9, P72; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Martinez MP, 2014, J BEHAV MED, V37, P683, DOI 10.1007/s10865-013-9520-y; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Savard J, 2005, J CLIN ONCOL, V23, P6083, DOI 10.1200/JCO.2005.09.548; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; SPIELMAN AJ, 1987, SLEEP, V10, P45; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Yang M, 2009, CURR MED RES OPIN, V25, P2487, DOI 10.1185/03007990903167415; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	50	14	15	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	1					59	69		10.3233/NRE-151296			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DE6CC	WOS:000370719800008	26889799				2021-06-18	
J	Marsh, NV; Ludbrook, MR; Gaffaney, LC				Marsh, Nigel V.; Ludbrook, Maria R.; Gaffaney, Lauren C.			Cognitive functioning following traumatic brain injury: A five-year follow-up	NEUROREHABILITATION			English	Article						Traumatic brain injury; cognitive functioning; neuropsychological assessment; long-term outcome	COMPLEX FIGURE TEST; HEAD-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; PRACTICAL SCALE; WORKING-MEMORY; VERBAL FLUENCY; TBI; PERFORMANCE; MODERATE; AGE	OBJECTIVE: To describe the long-term prevalence and severity of cognitive deficits following significant (i.e., ventilation required for >24 hours) traumatic brain injury. To assess a comprehensive range of cognitive functions using psychometric measures with established normative, reliability, and validity data. METHODS: A group of 71 adults was assessed at approximately five years (mean = 66 months) following injury. Assessment of cognitive functioning covered the domains of intelligence, attention, verbal and visual memory, visual-spatial construction, and executive functions. RESULTS: Impairment was evident across all domains but prevalence varied both within and between domains. Across aspects of intelligence clinical impairment ranged from 8-25%, attention 39-62%, verbal memory 16-46%, visual memory 23-51%, visual-spatial construction 38%, and executive functions (verbal fluency) 13%. In addition, 3-23% of performances across the measures were in the borderline range, suggesting a high prevalence of subclinical deficit. CONCLUSIONS: Although the prevalence of impairment may vary across cognitive domains, long-term follow-up documented deficits in all six domains. These findings provide further evidence that while improvement of cognitive functioning following significant traumatic brain injury may be possible, recovery of function is unlikely.	[Marsh, Nigel V.] Sunway Univ, Dept Psychol, Bandar Sunway, Selangor, Malaysia; [Ludbrook, Maria R.; Gaffaney, Lauren C.] Univ Waikato, Dept Psychol, Hamilton, New Zealand	Marsh, NV (corresponding author), Sunway Univ, Dept Psychol, 5 Jalan Univ, Bandar Sunway 47500, Selangor Darul, Malaysia.	nigelm@sunway.edu.my	Marsh, Nigel V./F-5433-2019	Marsh, Nigel V./0000-0002-4060-6432	Neurological Foundation of New Zealand [NF 98/17PG]	This study was supported by grant number NF 98/17PG from the Neurological Foundation of New Zealand.	Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Havill JH, 1998, NEW ZEAL MED J, V111, P161; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; JENNETT B, 1975, LANCET, V1, P480; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Marsh NV, 2005, J CLIN EXP NEUROPSYC, V27, P352, DOI 10.1080/13803390490515685; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; Meyers J., 1995, REY COMPLEX FIGURE T; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mitrushina M., 2005, HDB NORMATIVE DATA N; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schmidt M., 1996, REY AUDITORY VERBAL; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Smith A., 1982, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	36	14	15	0	23	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	1					71	78		10.3233/NRE-151297			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DE6CC	WOS:000370719800009	26889800	Green Accepted			2021-06-18	
J	Pappu, S; Lerma, J; Khraishi, T				Pappu, Suguna; Lerma, Jesus; Khraishi, Tariq			Brain CT to Assess Intracranial Pressure in Patients with Traumatic Brain Injury	JOURNAL OF NEUROIMAGING			English	Article						Cerebrospinal fluid; computed tomography; image analysis; intracranial monitor; intracranial pressure	HEAD-INJURY; IMPACT	INTRODUCTIONMorphologic features of computed tomography (CT) scans of the brain can be used to estimate intracranial pressure (ICP) via an image-processing algorithm. Clinically, such estimations can be used to prognosticate outcomes and avoid placement of invasive intracranial monitors in certain patients with severe traumatic brain injury. Features on a CT scan that may correlate with measurements of low ICP are sought. METHODSA measure is proposed that is a function of the distribution of cerebrospinal fluid (CSF) in and around the brain. In our method, we present an algorithm that semiautomatically segments brain parenchyma from CSF, and apply standard image processing calculations. The ratio of CSF volume to the size of the intracranial vault (ICV) or volume inside the skull, csf(v)/icv(v) is calculated and then plotted against the actual recorded ICP, yielding a relationship between the image features and ICP. RESULTSWe analyzed a total of 45 scans from 20 patients with severe traumatic brain injury (TBI). We showed that a ratio csf(v)/icv(v) > .034 correlates with an ICP < 20 mmHg (P = .0046). For csf(v)/icv(v) .034, a distinction between low and high ICP cannot be effectively estimated by this univariate measure. CONCLUSIONThis method permits a noninvasive means of identifying patients who are low risk for having elevated ICP; by following Brain Trauma Foundation guidelines strictly such a patient may be subjected to an unnecessary, invasive procedure. This work is a promising pilot study that will need to be analyzed for a larger population.	Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Lerma, Jesus; Khraishi, Tariq] Univ New Mexico, Dept Mech Engn, Albuquerque, NM 87131 USA; [Pappu, Suguna] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA	Pappu, S (corresponding author), Univ New Mexico, Dept Neurosurg, MSC10 5615, Albuquerque, NM 87131 USA.	spappu@salud.unm.edu					Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen WA, 2010, IEEE INT C BIOINFORM, P510, DOI 10.1109/BIBM.2010.5706619; Faul M., 2002, TRAUMATIC BRAIN INJU; Glowacki M, 2010, ACTA NEUROCHIR SUPPL, V106, P199, DOI 10.1007/978-3-211-98811-4_37; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Lauric A, SOFT SEGMENTATION CT; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Ross IB, 2003, AM J NEURORADIOL, V24, P1528; Zeng T, 2010, CHIN J TRAUMATOL, V13, P146, DOI 10.3760/cma.j.issn.1008-1275.2010.03.003	17	14	14	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	JAN-FEB	2016	26	1					37	40		10.1111/jon.12289			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DA7VI	WOS:000368012400004	26752449				2021-06-18	
J	Parys, M; Nelson, N; Koehl, K; Miller, R; Kaneene, JB; Kruger, JM; Yuzbasiyan-Gurkan, V				Parys, M.; Nelson, N.; Koehl, K.; Miller, R.; Kaneene, J. B.; Kruger, J. M.; Yuzbasiyan-Gurkan, V.			Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						Feline; Inflammatory disease; Regenerative medicine; Route of injection	TRAUMATIC BRAIN-INJURY; CHRONIC KIDNEY-DISEASE; HUMAN BONE-MARROW; STROMAL CELLS; TNF-ALPHA; INDOLEAMINE 2,3-DIOXYGENASE; INTRAVENOUS-INFUSION; HUMAN BLOOD; CORD BLOOD; IFN-GAMMA	Background: Chronic inflammatory diseases are common in cats and mesenchymal stem cells (MSC) are a promising therapeutic approach for management of these disorders. The purpose of this study was to evaluate the safety of intraperitoneal injection of MSC in cats. Hypothesis: Intrapertioneal injection of autologous MSC in cats is safe. Animals: Ten healthy adult purpose-bred cats. Methods: Mesenchymal stem cells were isolated from subcutaneous adipose tissue collected during ovariohysterectomy and characterized for expression of CD90, CD105 and CD44 and trilineage differentiation. Three weeks postoperatively a complete blood count, serum chemistry profile, urinalysis, and abdominal ultrasound were performed. Five cats then received 1 9 10 6 of autologous MSC/kg of body weight intraperitoneally with ultrasound guidance; 5 additional cats were sham injected. Cats were monitored for 6 weeks with daily physical examinations and weekly clinicopathological evaluations. Abdominal ultrasonography was repeated at weeks 1 and 5 after injection. Results: Serious adverse effects were not observed in any MSC-injected cat. Two animals developed transient lethargy and decreased activity. Jejunal lymph node size was increased in MSC-injected cats compared to controls at weeks 1 (1.38 +/- 0.25 versus 0.88 +/- 0.25 cm(2); P =.036) and 5 (1.75 +/- 0.82 versus 0.79 +/- 0.12 cm(2); P = .047). A hyperechoic renal segmental cortical lesion was observed in 1 MSC-injected cat. Conclusions and Clinical Relevance: Intraperitoneal MSC injection was well tolerated with only mild, self-limiting adverse effects being observed in 2 cats. This route provides a safe means of administration for cell-based treatment in cats.	[Parys, M.; Nelson, N.; Koehl, K.; Kruger, J. M.; Yuzbasiyan-Gurkan, V.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Miller, R.; Kaneene, J. B.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Miller, R.; Kaneene, J. B.] Michigan State Univ, Coll Vet Med, Ctr Populat, E Lansing, MI 48824 USA	Kruger, JM (corresponding author), Ctr Vet Med, Dept Small Anim Clin Sci, 736 Wilson Rd,Room D208, E Lansing, MI 48824 USA.	krugerj@cvm.msu.edu	Yuzbasiyan-Gurkan, Vilma/AAF-8459-2020; Parys, Maciej/AAF-7081-2021	Parys, Maciej/0000-0003-4456-3369	Morris Animal Foundation Fellowship Award [D13FE-405]; Michigan State University Center for Feline Health and Well-Being; Michigan State University, College of Veterinary Medicine Endowed Research Funds	This study was supported by Morris Animal Foundation Fellowship Award (D13FE-405), and grants from the Michigan State University Center for Feline Health and Well-Being and the Michigan State University, College of Veterinary Medicine Endowed Research Funds.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Aroch I, 2010, J FELINE MED SURG, V12, P466, DOI 10.1016/j.jfms.2010.01.010; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Brown JM, 2011, CLIN EXP ALLERGY, V41, P526, DOI 10.1111/j.1365-2222.2010.03685.x; Carrade DD, 2011, CYTOTHERAPY, V13, P419, DOI 10.3109/14653249.2010.536213; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Flemming A, 2011, J CLIN IMMUNOL, V31, P1143, DOI 10.1007/s10875-011-9581-z; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ghionzoli M, 2010, PEDIATR SURG INT, V26, P79, DOI 10.1007/s00383-009-2504-x; Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hickey MC, 2014, J VET INTERN MED, V28, P319, DOI 10.1111/jvim.12314; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Liu LS, 2014, AM J PATHOL, V184, P3344, DOI 10.1016/j.ajpath.2014.08.010; Liu W, 2013, THEOR APPL MECH LETT, V3, DOI [10.1186/2045-9912-3-3, 10.1063/2.1306201]; Luz-Crawford P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045272; Mader EK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-20; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Moll G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085040; Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111; Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Najar M, 2013, INT IMMUNOPHARMACOL, V15, P693, DOI 10.1016/j.intimp.2013.02.020; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Paepe D, 2013, J FELINE MED SURG, V15, P849, DOI 10.1177/1098612X13477415; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Porada CD, 2011, EXP HEMATOL, V39, P1124, DOI 10.1016/j.exphem.2011.09.001; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Quimby JM, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt198; Quimby JM, 2011, J FELINE MED SURG, V13, P418, DOI 10.1016/j.jfms.2011.01.005; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Semon JA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt391; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spriet M, 2015, VET RADIOL ULTRASOUN, V56, P327, DOI 10.1111/vru.12243; Tang S, 2004, CLIN EXP IMMUNOL, V136, P85, DOI 10.1111/j.1365-2249.2004.02407.x; Trzil JE, 2014, CLIN EXP ALLERGY, V44, P1546, DOI 10.1111/cea.12411; Wang PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043408; Webb TL, 2012, J FELINE MED SURG, V14, P165, DOI 10.1177/1098612X11429224; Zhang AB, 2010, J CELL BIOCHEM, V111, P469, DOI 10.1002/jcb.22729; Zhao YS, 2012, STEM CELL TRANSL MED, V1, P685, DOI 10.5966/sctm.2012-0027	52	14	15	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-1676			J VET INTERN MED	J. Vet. Intern. Med.	JAN-FEB	2016	30	1					157	163		10.1111/jvim.13655			7	Veterinary Sciences	Veterinary Sciences	DB9AR	WOS:000368808800022	26512713	DOAJ Gold, Green Published			2021-06-18	
J	de Sousa, MVP; Ferraresi, C; Kawakubo, M; Kaippert, B; Yoshimura, EM; Hamblin, MR				Pires de Sousa, Marcelo Victor; Ferraresi, Cleber; Kawakubo, Masayoshi; Kaippert, Beatriz; Yoshimura, Elisabeth Mateus; Hamblin, Michael R.			Transcranial low-level laser therapy (810 nm) temporarily inhibits peripheral nociception: photoneuromodulation of glutamate receptors, prostatic acid phophatase, and adenosine triphosphate	NEUROPHOTONICS			English	Article						transcranial low-level laser therapy; photobiomodulation; pain threshold; nociception; Von Frey filaments; tail flick test; cold plate test; formalin injection; adenosine triphosphate; prostatic acid phosphatase; metabotropic glutamate receptor	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; LIGHT THERAPY; CHRONIC PAIN; IRRADIATION; MECHANISMS; MODELS; PHOSPHATASE; RELIEF	Photobiomodulation or low-level light therapy has been shown to attenuate both acute and chronic pain, but the mechanism of action is not well understood. In most cases, the light is applied to the painful area, but in the present study we applied light to the head. We found that transcranial laser therapy (TLT) applied to mouse head with specific parameters (810 nm laser, 300 mW/cm(2), 7.2 or 36 J/cm(2)) decreased the reaction to pain in the foot evoked either by pressure (von Frey filaments), cold, or inflammation (formalin injection) or in the tail (evoked by heat). The pain threshold increasing is maximum around 2 h after TLT, remains up to 6 h, and is finished 24 h after TLT. The mechanisms were investigated by quantification of adenosine triphosphate (ATP), immunofluorescence, and hematoxylin and eosin (H&E) staining of brain tissues. TLT increased ATP and prostatic acid phosphatase (an endogenous analgesic) and reduced the amount of glutamate receptor (mediating a neurotransmitter responsible for conducting nociceptive information). There was no change in the concentration of tubulin, a constituent of the cytoskeleton, and the H&E staining revealed no tissue damage. (C) 2016 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Pires de Sousa, Marcelo Victor; Ferraresi, Cleber; Kawakubo, Masayoshi; Kaippert, Beatriz; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA; [Pires de Sousa, Marcelo Victor; Yoshimura, Elisabeth Mateus] Univ Sao Paulo, Inst Phys, Lab Radiat Dosimetry & Med Phys, Rua Matao,Travessa R,187,Cidade Univ, Sao Paulo, Brazil; [Pires de Sousa, Marcelo Victor] Bright Photomed Ltd, CIETEC Bldg,2242 Lineu Prestes, BR-05508000 Sao Paulo, Brazil; [Ferraresi, Cleber] Univ Fed Sao Carlos, Dept Phys Therapy, Lab Electrothermophototherapy, St Washington Luis,Km 235, BR-13565905 Sao Paulo, Brazil; [Ferraresi, Cleber] Univ Fed Sao Carlos, Postgrad Program Biotechnol, St Washington Luis,Km 235, BR-13560000 Sao Paulo, Brazil; [Ferraresi, Cleber] Univ Sao Paulo, Opt Grp, Phys Inst Sao Carlos, St Miguel Petroni,146 Jardim Bandeirantes, BR-13560970 Sao Paulo, Brazil; [Kaippert, Beatriz] Univ Fed Rio de Janeiro, 373 Cidade Univ, BR-21941170 Rio De Janeiro, RJ, Brazil; [Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, 50 Staniford St 807, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave,E25-518, Cambridge, MA 02139 USA	de Sousa, MVP; Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, BAR414,40 Blossom St, Boston, MA 02114 USA.; de Sousa, MVP (corresponding author), Univ Sao Paulo, Inst Phys, Lab Radiat Dosimetry & Med Phys, Rua Matao,Travessa R,187,Cidade Univ, Sao Paulo, Brazil.; de Sousa, MVP (corresponding author), Bright Photomed Ltd, CIETEC Bldg,2242 Lineu Prestes, BR-05508000 Sao Paulo, Brazil.; Hamblin, MR (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, 50 Staniford St 807, Boston, MA 02114 USA.; Hamblin, MR (corresponding author), Harvard MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave,E25-518, Cambridge, MA 02139 USA.	marcelo230786@gmail.com; hamblin@helix.mgh.harvard.edu	Ferraresi, Cleber/B-2458-2014; Yoshimura, Elisabeth M/E-8848-2012; Hamblin, Michael R/H-2758-2019	Ferraresi, Cleber/0000-0002-1361-8390; Hamblin, Michael R/0000-0001-6431-4605; Yoshimura, Elisabeth/0000-0003-4778-1230	NIAID NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01 AI050875] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875] Funding Source: NIH RePORTER		Abr`amoff M.D., 2005, BIOPHOTONICS INT, V11, P36, DOI [10.1117/1.3589100, DOI 10.1117/1.3589100]; Alayat MSM, 2014, LASER MED SCI, V29, P1065, DOI 10.1007/s10103-013-1472-5; Alves ACA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4296; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bjordal JM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-75; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; Cambier D, 2000, LASER MED SCI, V15, P195, DOI 10.1007/PL00011317; Chow R, 2015, LASERS IN DENTISTRY: GUIDE FOR CLINICAL PRACTICE, P34; Chow RT, 2007, J PERIPHER NERV SYST, V12, P28, DOI 10.1111/j.1529-8027.2007.00114.x; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Gonzalez-Lima F, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00036; Goodman L.S., 1996, GOODMAN GILMANS PHAR, V1549; Hamblin M., 2011, LOW LEVEL LIGHT THER; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Hurt JK, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-28; Jimbo K, 1998, NEUROSCI LETT, V240, P93, DOI 10.1016/S0304-3940(97)00935-X; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2273411; Kington JA, 2014, SPRINGERBR ENV SECUR, V19, P5, DOI 10.1007/978-3-319-07704-8_2; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Lampl Y., 2007, EXPERT REV NEUROTHER, V8; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2012, EXPERT REV MED DEVIC, V9, P71, DOI 10.1586/ERD.11.64; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Le Bars D, 2001, PHARMACOL REV, V53, P597; Masoumipoor M, 2014, ARCH NEUROSCI, V1, P76, DOI 10.5812/archneurosci.13740; Moges H, 2009, LASER SURG MED, V41, P52, DOI 10.1002/lsm.20732; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Navratil L., 1997, Laser Therapy, V9, P33; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Pallotta RC, 2012, LASER MED SCI, V27, P71, DOI 10.1007/s10103-011-0906-1; de Sousa MVP, 2014, J NEUROSCI METH, V232, P1, DOI 10.1016/j.jneumeth.2014.04.017; Pitcher GM, 1999, J NEUROSCI METH, V87, P185, DOI 10.1016/S0165-0270(99)00004-7; Rickards L.D., 2006, INT J OSTEOPATH MED, V9, P120, DOI DOI 10.1016/J.IJ0SM.2006.07.007; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sousa MVP, 2012, PROC SPIE, V8427, DOI 10.1117/12.912616; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Tao YX, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-30; Trimmer PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-26; WALKER J, 1983, NEUROSCI LETT, V43, P339, DOI 10.1016/0304-3940(83)90211-2; Yousefi-Nooraie R., 2008, LOW LEVEL LASER THER; Zhang H, 2012, CELL SIGNAL, V24, P224, DOI 10.1016/j.cellsig.2011.09.004; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	44	14	14	0	4	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	2329-423X	2329-4248		NEUROPHOTONICS	Neurophotonics	JAN-MAR	2016	3	1							015003	10.1117/1.NPh.3.1.015003			9	Neurosciences; Optics	Neurosciences & Neurology; Optics	DI8SJ	WOS:000373771200007	26835486	Green Published, Bronze			2021-06-18	
S	Semple, BD; Carlson, J; Noble-Haeusslein, LJ		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Semple, Bridgette D.; Carlson, Jaclyn; Noble-Haeusslein, Linda J.			Pediatric Rodent Models of Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Pediatric; Juvenile; Children; Behavior; Mice; Rodents	GLUTATHIONE-PEROXIDASE ACTIVITY; FLUID-PERCUSSION MODEL; IMMATURE RAT; DENTATE GYRUS; SEX-DIFFERENCES; YOUNG-RATS; ADULT RATS; BARRIER PERMEABILITY; COGNITIVE DEFICITS; CELL-PROLIFERATION	Due to a high incidence of traumatic brain injury (TBI) in children and adolescents, age-specific studies are necessary to fully understand the long-term consequences of injuries to the immature brain. Preclinical and translational research can help elucidate the vulnerabilities of the developing brain to insult, and provide model systems to formulate and evaluate potential treatments aimed at minimizing the adverse effects of TBI. Several experimental TBI models have therefore been scaled down from adult rodents for use in juvenile animals. The following chapter discusses these adapted models for pediatric TBI, and the importance of age equivalence across species during model development and interpretation. Many neurodevelopmental processes are ongoing throughout childhood and adolescence, such that neuropathological mechanisms secondary to a brain insult, including oxidative stress, metabolic dysfunction and inflammation, may be influenced by the age at the time of insult. The long-term evaluation of clinically relevant functional outcomes is imperative to better understand the persistence and evolution of behavioral deficits over time after injury to the developing brain. Strategies to modify or protect against the chronic consequences of pediatric TBI, by supporting the trajectory of normal brain development, have the potential to improve quality of life for brain-injured children.	[Semple, Bridgette D.; Carlson, Jaclyn] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Sch Med, Dept Phys Therapy & Rehabil Sci, San Francisco, CA USA	Semple, BD (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077767, R01NS050159] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS077767, R01 NS050159] Funding Source: Medline		Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chabout J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029401; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Choe MC, 2016, J CHILD NEUROL, V31, P109, DOI 10.1177/0883073815572685; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Covey MV, 2010, DEV NEUROSCI-BASEL, V32, P488, DOI 10.1159/000321607; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ellis TW, 2014, EXP NEUROL, V261, P434, DOI 10.1016/j.expneurol.2014.06.008; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Guevara R, 2011, EXP GERONTOL, V46, P923, DOI 10.1016/j.exger.2011.08.003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Herschkowitz N, 1997, NEUROPEDIATRICS, V28, P296, DOI 10.1055/s-2007-973720; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, V48, P2473, DOI DOI 10.3791/2473; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kercmar J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00337; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Langlois JA, 2000, TRAUMATIC BRAIN INJU; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; MCWILLIAMS JR, 1983, SCIENCE, V221, P572; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; NEHLIG A, 1991, NEUROSCIENCE, V40, P871, DOI 10.1016/0306-4522(91)90018-J; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Osier N. D., 2015, BRAIN NEUROTRAUMA MO, P421; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2016, J CHILD NEUROL, V31, P28, DOI 10.1177/0883073814549244; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Robertson Charlene M T, 2002, Pediatr Crit Care Med, V3, P345, DOI 10.1097/00130478-200210000-00003; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; SCHEFF SW, 1980, BRAIN RES, V199, P21, DOI 10.1016/0006-8993(80)90227-9; SCHENK F, 1985, BEHAV NEURAL BIOL, V43, P69, DOI 10.1016/S0163-1047(85)91510-9; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Terranova ML, 2005, CURR PROTOC TOXICOL, V13, P101; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Venna VR, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.128; Verger K, 2001, BRAIN INJURY, V15, P211; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003	112	14	14	1	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						325	343		10.1007/978-1-4939-3816-2_18	10.1007/978-1-4939-3816-2		19	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500020	27604726				2021-06-18	
J	Theadom, A; Rowland, V; Levack, W; Starkey, N; Wilkinson-Meyers, L; McPherson, K				Theadom, Alice; Rowland, Vickie; Levack, William; Starkey, Nicola; Wilkinson-Meyers, Laura; McPherson, Kathryn		TBI Experiences Grp	Exploring the experience of sleep and fatigue in male and female adults over the 2 years following traumatic brain injury: a qualitative descriptive study	BMJ OPEN			English	Article							PREVALENCE; DISORDERS; INSOMNIA	Objectives: To explore the experience of fatigue and sleep difficulties over the first 2 years after traumatic brain injury (TBI). Design: Longitudinal qualitative descriptive analysis of interviews completed as part of a larger longitudinal study of recovery following TBI. Data relating to the experience of fatigue and/or sleep were extracted and coded by two independent researchers. Setting: Community-based study in the Hamilton and Auckland regions of New Zealand. Participants: 30 adult participants who had experienced mild, moderate or severe brain injury within the past 6 months (>16 years of age). 15 participants also nominated significant others to take part. Interviews were completed at 6, 12 and 24 months postinjury. Results: Participants described feeling unprepared for the intensity, impact and persistent nature of fatigue and sleep difficulties after injury. They struggled to learn how to manage their difficulties by themselves and to adapt strategies in response to changing circumstances over time. Four themes were identified: (1) Making sense of fatigue and sleep after TBI; (2) accepting the need for rest; (3) learning how to rest and; (4) need for rest impacts on ability to engage in life. Conclusions: Targeted support to understand, accept and manage the sleep and fatigue difficulties experienced may be crucial to improve recovery and facilitate engagement in everyday life. Advice needs to be timely and revised for relevance over the course of recovery.	[Theadom, Alice; Rowland, Vickie; McPherson, Kathryn] Auckland Univ Technol, Person Centred Res Ctr, Auckland, New Zealand; [Theadom, Alice; Rowland, Vickie] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Levack, William] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Wilkinson-Meyers, Laura] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [McPherson, Kathryn] Hlth Res Council New Zealand, Auckland, New Zealand	Theadom, A (corresponding author), Auckland Univ Technol, Person Centred Res Ctr, Auckland, New Zealand.; Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand.	alice.theadom@aut.ac.nz	Levack, William Mark Magnus/F-9607-2018; Starkey, Nicola/AAJ-3795-2020	Levack, William Mark Magnus/0000-0001-6631-908X; Starkey, Nicola/0000-0002-4370-8186; Wilkinson-Meyers, Laura/0000-0001-9807-7361; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New ZealandHealth Research Council of New Zealand [10/471]	The parent study informing this work was supported by the Health Research Council of New Zealand, grant number 10/471.	Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Crotty M., 1998, FDN SOCIAL RES MEANI; Dhand R, 2006, CURR OPIN PULM MED, V12, P379; Eilertsen G, 2013, J ADV NURS, V69, P514, DOI 10.1111/jan.12002; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kirkevold M, 2012, DISABIL REHABIL, V34, P665, DOI 10.3109/09638288.2011.615373; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ponsford J, 2004, BRAIN INJURY, V18, P1065; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821	25	14	14	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	4							e010453	10.1136/bmjopen-2015-010453			9	Medicine, General & Internal	General & Internal Medicine	DM5LV	WOS:000376391400072	27059468	DOAJ Gold, Green Published			2021-06-18	
J	Willemse, RB; Hillebrand, A; Ronner, HE; Vandertop, WP; Stam, CJ				Willemse, Ronald B.; Hillebrand, Arjan; Ronner, Hanneke E.; Vandertop, W. Peter; Stam, Cornelis J.			Magnetoencephalographic study of hand and foot sensorimotor organization in 325 consecutive patients evaluated for tumor or epilepsy surgery	NEUROIMAGE-CLINICAL			English	Article						Brain mapping; Brain neoplasms; Cortical reorganization; Epilepsy; Magnetoencephalography	PRIMARY SOMATOSENSORY CORTEX; TIBIAL NERVE-STIMULATION; SPATIALLY FILTERED MAGNETOENCEPHALOGRAPHY; TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; VOLUNTARY MOVEMENTS; INTERHEMISPHERIC INTERACTIONS; CEREBRAL ACTIVATION; TACTILE INFORMATION; EXPERIMENTAL-DESIGN	Objectives: The presence of intracranial lesions or epilepsy may lead to functional reorganization and hemispheric lateralization. We applied a clinical magnetoencephalography (MEG) protocol for the localization of the contralateral and ipsilateral S1 and M1 of the foot and hand in patients with non-lesional epilepsy, stroke, developmental brain injury, traumatic brain injury and brain tumors. We investigated whether differences in activation patterns could be related to underlying pathology. Methods: Using dipole fitting, we localized the sources underlying sensory and motor evoked magnetic fields (SEFs and MEFs) of both hands and feet following unilateral stimulation of the median nerve (MN) and posterior tibial nerve (PTN) in 325 consecutive patients. The primary motor cortex was localized using beamforming following a self-paced repetitive motor task for each hand and foot. Results: The success rate for motor and sensory localization for the feet was significantly lower than for the hands (motor_hand 94.6% versus motor_feet 81.8%, p < 0.001; sensory_hand 95.3% versus sensory_feet 76.0%, p < 0.001). MN and PTN stimulation activated 86.6% in the contralateral S1, with ipsilateral activation < 0.5%. Motor cortex activation localized contralaterally in 76.1% (5.2% ipsilateral, 7.6% bilateral and 11.1% failures) of all motor MEG recordings. The ipsilateral motor responses were found in 43 (14%) out of 308 patients with motor recordings (range: 8.3-50%, depending on the underlying pathology), and had a higher occurrence in the foot than in the hand (motor_foot 44.8% versus motor_hand 29.6%, p = 0.031). Ipsilateral motor responses tended to be more frequent in patients with a history of stroke, traumatic brain injury (TBI) or developmental brain lesions (p = 0.063). Conclusions: MEG localization of sensorimotor cortex activation was more successful for the hand compared to the foot. In patients with neural lesions, there were signs of brain reorganization as measured by more frequent ipsilateral motor cortical activation of the foot in addition to the traditional sensory and motor activation patterns in the contralateral hemisphere. The presence of ipsilateral neural reorganization, especially around the foot motor area, suggests that careful mapping of the hand and foot in both contralateral and ipsilateral hemispheres prior to surgery might minimize postoperative deficits. (C) 2015 The Authors. Published by Elsevier Inc.	[Willemse, Ronald B.; Vandertop, W. Peter] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Hillebrand, Arjan; Ronner, Hanneke E.; Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Hillebrand, Arjan; Ronner, Hanneke E.; Stam, Cornelis J.] Vrije Univ Amsterdam Med Ctr, MEG Ctr, Amsterdam, Netherlands	Willemse, RB (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Neurosurg, 2F 01,de Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	r.willemse@vumc.nl; a.hillebrand@vumc.nl; he.ronner@vumc.nl; wp.vandertop@vumc.nl; cj.stam@vumc.nl	Vandertop, William P./K-9288-2018	Hillebrand, Arjan/0000-0002-8508-3532; Vandertop, William/0000-0001-5417-0265			Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Anderson CT, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0446-8; Bradnam LV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00184; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Caciagli L, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00411; Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; Carpentier AC, 2001, J NEUROSURG, V94, P946, DOI 10.3171/jns.2001.94.6.0946; Castillo EM, 2004, NEUROIMAGE, V21, P973, DOI 10.1016/j.neuroimage.2003.10.020; Chen ACN, 2012, BRAIN TOPOGR, V25, P228, DOI 10.1007/s10548-011-0209-7; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Chlebus P, 2004, NEUROCASE, V10, P326, DOI 10.1080/13554790490507669; Ciccarelli O, 2005, EXP BRAIN RES, V166, P31, DOI 10.1007/s00221-005-2335-5; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Ganslandt O, 1999, Neurosurg Focus, V6, pe3; Guzzetta A, 2007, CLIN NEUROPHYSIOL, V118, P1110, DOI 10.1016/j.clinph.2007.02.014; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; Hari R, 1996, NEUROIMAGE, V4, P111, DOI 10.1006/nimg.1996.0035; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hillebrand A, 2003, NEUROIMAGE, V20, P2302, DOI 10.1016/j.neuroimage.2003.07.031; Hillebrand A, 2013, CLIN NEUROPHYSIOL, V124, P107, DOI 10.1016/j.clinph.2012.06.013; Hillebrand A, 2002, NEUROIMAGE, V16, P638, DOI 10.1006/nimg.2002.1102; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; Huang MX, 2004, HUM BRAIN MAPP, V23, P26, DOI 10.1002/hbm.20038; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; KAKIGI R, 1995, ELECTROEN CLIN NEURO, V95, P127, DOI 10.1016/0013-4694(95)00053-2; Kakigi R, 2000, PROG NEUROBIOL, V61, P495, DOI 10.1016/S0301-0082(99)00063-5; Kanno A, 2003, NEUROIMAGE, V18, P169, DOI 10.1006/nimg.2002.1283; Knowlton Robert C, 2008, Epilepsy Curr, V8, P1, DOI 10.1111/j.1535-7511.2007.00215.x; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Korvenoja A, 1995, NEUROREPORT, V6, P2589, DOI 10.1097/00001756-199512150-00033; Korvenoja A, 1999, HUM BRAIN MAPP, V8, P13, DOI 10.1002/(SICI)1097-0193(1999)8:1<13::AID-HBM2>3.0.CO;2-B; Korvenoja A, 2006, RADIOLOGY, V241, P213, DOI 10.1148/radiol.2411050796; KRISTEVA R, 1991, ELECTROEN CLIN NEURO, V81, P284, DOI 10.1016/0168-5597(91)90015-P; Lee HW, 2009, J NEUROL NEUROSUR PS, V80, P285, DOI 10.1136/jnnp.2008.156067; Liuzzi G, 2010, CEREB CORTEX, V20, P1323, DOI 10.1093/cercor/bhp196; MacIntosh BJ, 2004, NEUROIMAGE, V22, P1619, DOI 10.1016/j.neuroimage.2004.03.035; Maegaki Y, 1995, NEUROLOGY, V45, P2255, DOI 10.1212/WNL.45.12.2255; Makela JP, 2001, HUM BRAIN MAPP, V12, P180, DOI 10.1002/1097-0193(200103)12:3<180::AID-HBM1014>3.0.CO;2-N; Makela JP, 2013, BRAIN STIMUL, V6, P286, DOI 10.1016/j.brs.2012.04.012; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Nagarajan S, 2008, J NEUROSURG, V109, P228, DOI 10.3171/JNS/2008/109/8/0228; Nakamura A, 1998, NEUROIMAGE, V7, P377, DOI 10.1006/nimg.1998.0332; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pittaccio S, 2013, IEEE ENG MED BIO, P6353, DOI 10.1109/EMBC.2013.6611007; Pittaccio S, 2011, HUM BRAIN MAPP, V32, P60, DOI 10.1002/hbm.20998; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Schiffbauer H, 2002, J NEUROSURG, V97, P1333, DOI 10.3171/jns.2002.97.6.1333; SCHNITZLER A, 1995, NEUROSCI LETT, V200, P25, DOI 10.1016/0304-3940(95)12065-C; Sekihara K, 2004, IEEE T BIO-MED ENG, V51, P1726, DOI 10.1109/TBME.2004.827926; Solodkin A, 2001, EUR J NEUROL, V8, P425, DOI 10.1046/j.1468-1331.2001.00242.x; Staudt M, 2010, J ANAT, V217, P469, DOI 10.1111/j.1469-7580.2010.01262.x; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Stoeckel MC, 2010, EXP NEUROL, V221, P13, DOI 10.1016/j.expneurol.2009.10.021; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Takeuchi N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/823285; Taniguchi M, 2000, NEUROIMAGE, V12, P298, DOI 10.1006/nimg.2000.0611; Taniguchi M, 2004, J NEUROL NEUROSUR PS, V75, P466, DOI 10.1136/jnnp.2002.001834; Tarapore PE, 2012, J NEUROSURG, V117, P354, DOI 10.3171/2012.5.JNS112124; Tozakidou M, 2013, NEUROIMAGE-CLIN, V2, P221, DOI 10.1016/j.nicl.2013.01.002; van Wijk BCM, 2012, EUR J NEUROSCI, V36, P2088, DOI 10.1111/j.1460-9568.2012.08122.x; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Whalen C, 2008, HUM BRAIN MAPP, V29, P1288, DOI 10.1002/hbm.20465; Wilke M, 2009, HUM BRAIN MAPP, V30, P776, DOI 10.1002/hbm.20545; Willemse R.B., 2007, NEUROSURGERY, V61, P1209; Willemse Ronald B, 2010, Open Neuroimag J, V4, P93, DOI 10.2174/1874440001004010093; Willernse RB, 2007, NEUROSURGERY, V61, P1209, DOI 10.1227/01.NEU.0000280159.49731.B5; Zhu Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-21; Ziemann U, 1999, J PHYSIOL-LONDON, V518, P895, DOI 10.1111/j.1469-7793.1999.0895p.x	71	14	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	10						46	53		10.1016/j.nicl.2015.11.002			8	Neuroimaging	Neurosciences & Neurology	DI0LX	WOS:000373189000005	26693401	DOAJ Gold, Green Published			2021-06-18	
J	Yengo-Kahn, AM; Zuckerman, SL; Stotts, J; Zalneraitis, BH; Gardner, RM; Kerr, ZY; Solomon, GS				Yengo-Kahn, Aaron M.; Zuckerman, Scott L.; Stotts, Jeff; Zalneraitis, Brian H.; Gardner, Ryan M.; Kerr, Zachary Y.; Solomon, Gary S.			Performance following a first professional concussion among National Basketball Association players	PHYSICIAN AND SPORTSMEDICINE			English	Article						Mild traumatic brain injury; concussion; National Basketball Association; performance; athletes; sport-related concussion; player impact estimate; post-concussive performance	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; EPIDEMIOLOGY; INJURIES; FOOTBALL; OUTCOMES; INFORMATION; RECOVERY; RETURN	Objectives: Basketball is a physical game played on a hardwood floor among high-jumping athletes at risk for injury. It is currently unknown how sport-related concussion (SRC) affects player performance after injury among professional basketball players. The objective of this study was to explore the impact of SRC on basketball performance among National Basketball Association (NBA) players.Methods: A retrospective, archival cohort study was performed that compared NBA player performance following concussion to pre-concussive performance. A comprehensive NBA injury database, compiled from publically available sources, was queried for NBA players who suffered concussion from 2005-06 to 2014-15 (10 seasons). Intra-and inter-player analyses were performed against a matched control group of players who missed playing time for personal reasons.Results: Following application of inclusion/exclusion criteria and a matching process, 51 concussed players and 51 control players were included in analysis. There were no statistically significant decrements in baseline to post-concussion performance metrics in intra-player or player vs. controls after 5 return games.Conclusions: Our findings suggest that at the NBA level, an athlete's performance in the initial 5 games following injury does not suffer from the after-effects of concussive injury. These results may be useful in counseling professional athletes following a concussion.	[Yengo-Kahn, Aaron M.; Zuckerman, Scott L.; Zalneraitis, Brian H.; Gardner, Ryan M.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Sci, Med Ctr North T-4224, Nashville, TN 37212 USA; [Stotts, Jeff] St Vincent Hlth Syst, Dept Athlet Training, Little Rock, AR USA; [Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA	Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Sci, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Yengo-Kahn, Aaron/AAV-7647-2020; Solomon, Gary/K-9011-2019	Yengo-Kahn, Aaron/0000-0002-5989-3064; Kerr, Zachary/0000-0003-1423-1259			Amin NH, 2013, AM J SPORT MED, V41, P1864, DOI 10.1177/0363546513490659; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bonfield CM, 2014, PROG NEUROL SURG, V28, P161, DOI 10.1159/000358777; Busfield BT, 2009, ARTHROSCOPY, V25, P825, DOI 10.1016/j.arthro.2009.02.021; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Classe J G, 1997, J Am Optom Assoc, V68, P43; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; de Oliveira RF, 2007, EXP PSYCHOL, V54, P180, DOI 10.1027/1618-3169.54.3.180; Dick R, 2007, J ATHL TRAINING, V42, P194; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Dubin J., 2015, ADV STATS GUIDE 2015; De Oliveira RF, 2006, J SPORT SCI, V24, P933, DOI 10.1080/02640410500357101; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harris JD, 2013, SPORTS HEALTH, V5, P562, DOI 10.1177/1941738113495788; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kioumourtzoglou E, 1998, PERCEPT MOTOR SKILL, V86, P771, DOI 10.2466/pms.1998.86.3.771; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Media FSI, 2015, FOX SPORTS; Namdari S, 2009, AM J SPORT MED, V37, P943, DOI 10.1177/0363546508330150; Nba, 2015, NBA; Orchard J, 2002, BRIT J SPORT MED, V36, P16, DOI 10.1136/bjsm.36.1.16; Padaki AS, 2016, AM J SPORTS MED; Podlog L, 2015, J SCI MED SPORT, V18, P278, DOI 10.1016/j.jsams.2014.05.005; Samson K, 2012, WHY CONCUSSION RULES, p[1, 13]; SOUTHARD D, 1993, RES Q EXERCISE SPORT, V64, P284, DOI 10.1080/02701367.1993.10608812; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Yeh PC, 2012, AM J SPORT MED, V40, P589, DOI 10.1177/0363546511428601; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313	34	14	14	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2016	44	3					297	303		10.1080/00913847.2016.1200956			7	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	DW3AW	WOS:000383515400016	27294806				2021-06-18	
J	Van Beek, L; Vanderauwera, J; Ghesquiere, P; Lagae, L; De Smedt, B				Van Beek, Leen; Vanderauwera, Jolijn; Ghesquiere, Pol; Lagae, Lieven; De Smedt, Bert			Longitudinal changes in mathematical abilities and white matter following paediatric mild traumatic brain injury	BRAIN INJURY			English	Article							WORKING-MEMORY; FUNCTIONAL RECOVERY; INDIVIDUAL-DIFFERENCES; ACADEMIC-ACHIEVEMENT; EXECUTIVE FUNCTIONS; CORPUS-CALLOSUM; YOUNG-CHILDREN; SHORT-TERM; DIFFUSION; OUTCOMES		[Van Beek, Leen; Vanderauwera, Jolijn; Ghesquiere, Pol; De Smedt, Bert] Univ Leuven, Fac Psychol & Educ Sci, Parenting & Special Educ, Leuven, Belgium; [Vanderauwera, Jolijn] Univ Leuven, Dept Neurosci, Res Grp ExpORL, Leuven, Belgium; [Lagae, Lieven] Univ Leuven, Dept Dev & Regenerat, Biomed Sci Grp, Leuven, Belgium	De Smedt, B (corresponding author), Parenting & Special Educ Res Unit, Leopold Vanderkelenstr 32 Box 3765, B-3000 Leuven, Belgium.	bert.desmedt@ppw.kuleuven.be	De Smedt, Bert/G-4729-2010; De Smedt, Bert/Q-7020-2019; Ghesquiere, Pol/B-9226-2009; De Smedt, Bert/U-6124-2019	De Smedt, Bert/0000-0002-3313-3278; De Smedt, Bert/0000-0002-3313-3278; Ghesquiere, Pol/0000-0001-9056-7550; 	'Research Foundation Flanders' FWOFWO [G.A113.11N]	This research was supported by the 'Research Foundation Flanders' FWO (grant number G.A113.11N). We thank the children and their families for their time and contribution to this study.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Beaulieu C, 1998, MAGN RESON IMAGING, V16, P1201, DOI 10.1016/S0730-725X(98)00151-9; BERGERGROSS P, 1985, PERCEPT MOTOR SKILL, V61, P254, DOI 10.2466/pms.1985.61.1.254; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P186, DOI 10.1016/j.jecp.2009.01.004; Dowker A, 2008, DEVELOPMENTAL SCI, V11, P650, DOI 10.1111/j.1467-7687.2008.00713.x; Dudal P., 2000, LEERLINGVOLGSYSTEEM; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Gathercole S. E., 2006, WORKING MEMORY ED, P219, DOI DOI 10.1016/B978-012554465-8/50010-7; Gathercole S. E, 2001, WORKING MEMORY BATTE; Gathercole S. E., 2008, WORKING MEMORY LEARN; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2008, LEARN INDIVID DIFFER, V18, P214, DOI 10.1016/j.lindif.2007.10.003; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hubber PJ, 2014, Q J EXP PSYCHOL, V67, P936, DOI 10.1080/17470218.2013.838590; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kort W., 2005, WISC 3 NL WECHSLER I; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Leemans A., 2009, P INT SOC MAG RESON, V17, P3537, DOI DOI 10.1093/occmed/kqr069; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matejko AA, 2015, NEUROSCI BIOBEHAV R, V48, P35, DOI 10.1016/j.neubiorev.2014.11.006; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sattler J.M., 2001, ASSESSMENT CHILDREN, V4th edn; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slater E. J., 1989, J ADOLESCENT RES, V4, P371; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Trick LM, 2008, PERCEPT PSYCHOPHYS, V70, P743, DOI 10.3758/PP.70.5.743; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang R, 2007, P INT SOC MAG RESON, V15, P3720; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2003, HDB REY OSTERRIETH C, P83	78	14	14	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1701	1710		10.3109/02699052.2015.1075172			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800023	26479021				2021-06-18	
J	Walker, WC; Franke, LM; McDonald, SD; Sima, AP; Keyser-Marcus, L				Walker, W. C.; Franke, L. M.; McDonald, S. D.; Sima, A. P.; Keyser-Marcus, L.			Prevalence of mental health conditions after military blast exposure, their co- occurrence, and their relation to mild traumatic brain injury	BRAIN INJURY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CONCUSSION SYMPTOMS QUESTIONNAIRE; SPORTS-RELATED CONCUSSION; NATIONAL-GUARD SOLDIERS; OEF/OIF VETERANS; NEUROPSYCHOLOGICAL OUTCOMES; PSYCHIATRIC DIAGNOSES; COMBAT DUTY; US VETERANS; HEAD-INJURY		[Walker, W. C.; Franke, L. M.; McDonald, S. D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, Richmond, VA 23298 USA; [Walker, W. C.; Franke, L. M.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Walker, W. C.; Franke, L. M.; McDonald, S. D.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [McDonald, S. D.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23298 USA; [Sima, A. P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Keyser-Marcus, L.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23298 USA	Walker, WC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Sch Med, MCV Stn, Box 677, Richmond, VA 23298 USA.	wwalker@mcvh-vcu.edu	; Franke, Lude/P-7036-2016	Sima, Adam/0000-0001-8426-9987; Franke, Lude/0000-0002-5159-8802	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and Rehabilitation Research and Development Career Development Award-2 [1IK2RX000703-01]	This material is in part based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and Rehabilitation Research and Development Career Development Award-2 (1IK2RX000703-01; S.M.). The views expressed are those of the authors and do not necessarily represent or reflect the policy or position of the Department of the Army, Department of Defense, the US Government, the Department of Veterans Affairs or any of the institutions with which the authors are affiliated.	Adler AB, 2008, J TRAUMA STRESS, V21, P301, DOI 10.1002/jts.20336; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bolzenius JD, 2015, APPL NEUROPSYCH-ADUL, V22, P79, DOI 10.1080/23279095.2013.845823; Booth-Kewley S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-130; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Meyer KS, 2010, PSYCHIAT CLIN N AM, V33, P783, DOI 10.1016/j.psc.2010.08.007; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Orsillo SM, 1996, J TRAUMA STRESS, V9, P235, DOI 10.1007/BF02110658; Orsillo SM, 1996, J NERV MENT DIS, V184, P307, DOI 10.1097/00005053-199605000-00007; Polusny MA, 2009, MIL MED, V174, P353, DOI 10.7205/MILMED-D-01-1608; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith TC, 2014, J ADDICT MED, V8, P271, DOI 10.1097/ADM.0000000000000050; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Walker WC, 2014, J REHABIL RES DEV, V51, P1203, DOI 10.1682/JRRD.2013.12.0271; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	35	14	15	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1581	1588		10.3109/02699052.2015.1075151			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800008	26479126				2021-06-18	
J	Karuppagounder, SS; Kumar, A; Shao, DS; Zille, M; Bourassa, MW; Caulfield, JT; Alim, I; Ratan, RR				Karuppagounder, Saravanan S.; Kumar, Arnit; Shao, Diana S.; Zille, Marietta; Bourassa, Megan W.; Caulfield, Joseph T.; Alim, Ishraq; Ratan, Rajiv R.			Metabolism and epigenetics in the nervous system: Creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenases	BRAIN RESEARCH			English	Article						Stroke; Brain; Epigenetics; Metabolism; 2-Oxoglutarate-dependent dioxygenases; Neuroprotection	HIF PROLYL-HYDROXYLASE; HISTONE DEACETYLASE INHIBITORS; INDUCIBLE FACTOR-I; SUBEROYLANILIDE HYDROXAMIC ACID; SPINAL MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; VALPROIC ACID; SODIUM-BUTYRATE; HUNTINGTONS-DISEASE; TET PROTEINS	Modern definitions of epigenetics incorporate models for transient but biologically important changes in gene expression that are unrelated to DNA code but responsive to environmental changes such as injury-induced stress. In this scheme, changes in oxygen levels (hypoxia) and/or metabolic co-factors (iron deficiency or diminished 2-oxoglutarate levels) are transduced into broad genetic programs that return the cell and the organism to a homeostatic set point. Over the past two decades, exciting studies have identified a superfamily of iron-, oxygen-, and 2-oxoglutarate-dependent dioxygenases that sit in the nucleus as modulators of transcription factor stability, co-activator function, histone demethylases, and DNA demethylases. These studies have provided a concrete molecular scheme for how changes in metabolism observed in a host of neurological conditions, including stroke, traumatic brain injury, and Alzheimer's disease, could be transduced into adaptive gene expression to protect the nervous system. We will discuss these enzymes in this short review, focusing primarily on the ten eleven translocation (TET) DNA demethylases, the jumonji (JmJc) histone demethylases, and the oxygen-sensing prolyl hydroxylase domain enzymes (HIP PHDs). This article is part of a Special Issue entitled SI: Neuroprotection. (C) 2015 Elsevier B.V. All rights reserved.	[Karuppagounder, Saravanan S.; Kumar, Arnit; Shao, Diana S.; Zille, Marietta; Bourassa, Megan W.; Caulfield, Joseph T.; Alim, Ishraq; Ratan, Rajiv R.] Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; [Karuppagounder, Saravanan S.; Kumar, Arnit; Shao, Diana S.; Zille, Marietta; Bourassa, Megan W.; Caulfield, Joseph T.; Alim, Ishraq; Ratan, Rajiv R.] Cornell Univ, Dept Neurol, Weill Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10021 USA	Ratan, RR (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, Burke Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	rrr2001@med.cornell.edu	Zille, Marietta/P-1700-2018; Kumar, Amit/L-7132-2017	Zille, Marietta/0000-0002-0609-8956; Kumar, Amit/0000-0001-5017-9887	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01 NIA AG014930]; Dr. Miriam and Sheldon G. Adelson Program in Neurorehabilitation and Neural Repair; Sperling Center for Hemorrhagic Stroke Recovery at the Burke Medical Research Institute; New York State Department of Health Center for Research Excellence in Spinal Cord Injury [DOHC019772]; Clinical and Translational Science Center at Weill Cornell Medical College [TL1TR000459]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG014930] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health (P01 NIA AG014930, Project 1 to R.R.R.), the Dr. Miriam and Sheldon G. Adelson Program in Neurorehabilitation and Neural Repair, the Sperling Center for Hemorrhagic Stroke Recovery at the Burke Medical Research Institute and New York State Department of Health Center for Research Excellence in Spinal Cord Injury (Grant no. DOHC019772). This work was also supported by Grant TL1TR000459 of the Clinical and Translational Science Center at Weill Cornell Medical College.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Aleyasin H, 2015, ANTIOXID REDOX SIGN, V22, P121, DOI 10.1089/ars.2013.5595; Aminova LR, 2008, ANTIOXID REDOX SIGN, V10, P1989, DOI 10.1089/ars.2008.2039; Aminova LR, 2005, J BIOL CHEM, V280, P3996, DOI 10.1074/jbc.M409223200; Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.3.CO;2-#; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Castelo-Branco G, 2014, NEUROBIOL DIS, V71, P220, DOI 10.1016/j.nbd.2014.08.019; Castro AA, 2012, BEHAV BRAIN RES, V229, P208, DOI 10.1016/j.bbr.2012.01.016; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Chang X, 2015, EXP CELL RES, V334, P136, DOI 10.1016/j.yexcr.2015.04.004; Cherng CH, 2014, J FORMOS MED ASSOC, V113, P513, DOI 10.1016/j.jfma.2013.04.007; Chiu CT, 2011, NEUROPSYCHOPHARMACOL, V36, P2406, DOI 10.1038/npp.2011.128; Chou AH, 2011, NEUROBIOL DIS, V41, P481, DOI 10.1016/j.nbd.2010.10.019; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Denk F, 2013, PAIN, V154, P1668, DOI 10.1016/j.pain.2013.05.021; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fleiss B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-70; Gardian G, 2004, NEUROMOL MED, V5, P235, DOI 10.1385/NMM:5:3:235; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Ge ZZ, 2013, EXP NEUROL, V241, P56, DOI 10.1016/j.expneurol.2012.12.006; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; Hancock R.L., 2015, EPIGENOMICS, P1; Hao HH, 2013, NEUROSCI BULL, V29, P484, DOI 10.1007/s12264-013-1355-6; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Isles AR, 2015, GENES BRAIN BEHAV, V14, P64, DOI 10.1111/gbb.12184; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karuppagounder SS, 2013, J NEUROSCI RES, V91, P1066, DOI 10.1002/jnr.23204; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Kidd SK, 2011, NEUROSCIENCE, V194, P189, DOI 10.1016/j.neuroscience.2011.08.010; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Klein C, 2015, NEUROBIOL AGING, V36, P832, DOI 10.1016/j.neurobiolaging.2014.10.003; Ko M, 2015, IMMUNOL REV, V263, P6, DOI 10.1111/imr.12239; Kuiper C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00359; Kukkar A, 2014, J FORMOS MED ASSOC, V113, P921, DOI 10.1016/j.jfma.2013.05.013; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Lee HY, 2014, MOL CELLS, V37, P43, DOI 10.14348/molcells.2014.2250; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Li T, 2015, MOL NEUROBIOL, V51, P142, DOI 10.1007/s12035-014-8734-5; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lu WH, 2013, J NEUROSCI RES, V91, P694, DOI 10.1002/jnr.23200; Lv L, 2012, EXP NEUROL, V233, P783, DOI 10.1016/j.expneurol.2011.11.042; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Matsushita Y, 2013, BRIT J PHARMACOL, V170, P991, DOI 10.1111/bph.12366; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; MONTI B, 2012, HOAJ BIOL, V1; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Narver HL, 2008, ANN NEUROL, V64, P465, DOI 10.1002/ana.21449; Niatsetskaya Z, 2010, ANTIOXID REDOX SIGN, V12, P435, DOI 10.1089/ars.2009.2800; Noh H, 2014, NEUROSCIENCE, V266, P255, DOI 10.1016/j.neuroscience.2014.02.012; Olson DE, 2015, CHEM BIOL, V22, P439, DOI 10.1016/j.chembiol.2015.03.014; Ono K, 2009, PARKINSONISM RELAT D, V15, P649, DOI 10.1016/j.parkreldis.2009.03.002; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shmakova A, 2014, BIOCHEM J, V462, P385, DOI 10.1042/BJ20140754; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Sleiman S., 2014, J NEUROSCI; Smith SMC, 2014, ASN NEURO, V6, DOI 10.1042/AN20130050; Speer RE, 2013, FREE RADICAL BIO MED, V62, P26, DOI 10.1016/j.freeradbiomed.2013.01.026; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugai F, 2004, EUR J NEUROSCI, V20, P3179, DOI 10.1111/j.1460-9568.2004.03765.x; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thirstrup K, 2011, PHARMACOL RES, V64, P268, DOI 10.1016/j.phrs.2011.03.017; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Tsai LK, 2006, NEUROBIOL DIS, V24, P286, DOI 10.1016/j.nbd.2006.07.004; Vangeison G, 2008, J NEUROSCI, V28, P1988, DOI 10.1523/JNEUROSCI.5323-07.2008; Wang B, 2012, FREE RADICAL BIO MED, V52, P928, DOI 10.1016/j.freeradbiomed.2011.12.006; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wiley JC, 2011, AGING CELL, V10, P418, DOI 10.1111/j.1474-9726.2011.00680.x; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Xuan AG, 2012, LIFE SCI, V90, P463, DOI 10.1016/j.lfs.2012.01.001; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Yoo YE, 2011, EXP NEUROL, V231, P147, DOI 10.1016/j.expneurol.2011.06.003; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yu HM, 2015, NAT NEUROSCI, V18, P836, DOI 10.1038/nn.4008; Yu SH, 2012, J KOREAN NEUROSURG S, V51, P191, DOI 10.3340/jkns.2012.51.4.191; Zadori D, 2009, PHARMACOL BIOCHEM BE, V94, P148, DOI 10.1016/j.pbb.2009.08.001; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029	114	14	15	1	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 2	2015	1628				SI		273	287		10.1016/j.brainres.2015.07.030			15	Neurosciences	Neurosciences & Neurology	CZ9IW	WOS:000367412300005	26232572	Green Accepted			2021-06-18	
J	Bodley-Scott, SEM; Riley, GA				Bodley-Scott, Sarah E. M.; Riley, Gerard A.			How Partners Experience Personality Change After Traumatic Brain Injury - Its Impact on Their Emotions and their Relationship	BRAIN IMPAIRMENT			English	Article						neurobehavioural changes; personality changes; couple relationship	FAMILY CAREGIVERS; HEAD-INJURY; ADJUSTMENT; TBI; REHABILITATION; SATISFACTION; DEPRESSION; DISTRESS; RECOVERY; STRESS	Objective: The aim of this qualitative study was to explore how spouses/partners experience social, emotional and behavioural changes in persons following traumatic brain injury (TBI), with a particular focus on their emotional impact and the effect on the couple relationship. Method: Interpretative phenomenological analysis (IPA) of interview data explored five women's experiences of these changes in their partners following TBI. Results: Themes describe the direct emotional impact of living with the changes as well as the emotional impact of attempts to manage and make sense of the changes (identity change, managing the changes and making sense of the changes). The impact on the couple relationship is described under the themes of feeling love and receiving love. Changes led three of the participants to experience their partner as having been replaced by a new person; they actively disliked this new person; they felt unable to love the new person in the same way as the old person; and their love was defined in terms of a caring relationship, rather than a spousal relationship. Conclusions: The study provides insight into why social, emotional and behavioural changes might be so consistently associated with reduced emotional wellbeing and lower levels of relationship quality and satisfaction.	[Bodley-Scott, Sarah E. M.; Riley, Gerard A.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	Riley, GA (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	G.A.Riley@bham.ac.uk	Riley, Gerard Anthony/J-1646-2012; riley, gerard/AAP-1439-2020	Riley, Gerard Anthony/0000-0002-1167-8023; 			Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bowen C., 2010, RELATIONAL APPROACH; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Brocki JM, 2006, PSYCHOL HEALTH, V21, P87, DOI 10.1080/14768320500230185; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; CHESLA C, 1994, FAM RELAT, V43, P3, DOI 10.2307/585135; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Gosling J, 1999, BRAIN INJURY, V13, P785; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; MCDONALD S, 2003, BRAIN IMPAIR, V4, P36, DOI DOI 10.1375/brim.4.1.36.27032; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Minnes P, 2000, BRAIN INJURY, V14, P737; Murray J, 1998, AGEING SOC, V18, P659, DOI 10.1017/S0144686X98007120; ODDY M, 1995, TRAUMATIC BRAIN INJU, P167; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Polkinghorne DE, 2005, J COUNS PSYCHOL, V52, P137, DOI 10.1037/0022-0167.52.2.137; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Riley GA, 2013, INT PSYCHOGERIATR, V25, P263, DOI 10.1017/S1041610212001743; Ruston A., 2007, SOCIAL SCI, V2, P159; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Smith J.A., 2009, INTERPRETATIVE PHENO; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Walters AH., 2010, DEMENTIA LONDON, V9, P169, DOI [10.1177/1471301209354027, DOI 10.1177/1471301209354027]; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Willig C., 2008, INTRO QUALITATIVE RE; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 2005, PSYCHOLOGIST, V18, P138; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532	43	14	14	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2015	16	3					205	220		10.1017/BrImp.2015.22			16	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DD4KV	WOS:000369892700005		Green Published			2021-06-18	
J	Drijkoningen, D; Leunissen, I; Caeyenberghs, K; Hoogkamer, W; Sunaert, S; Duysens, J; Swinnen, SP				Drijkoningen, David; Leunissen, Inge; Caeyenberghs, Karen; Hoogkamer, Wouter; Sunaert, Stefan; Duysens, Jacques; Swinnen, Stephan P.			Regional Volumes in Brain Stem and Cerebellum Are Associated With Postural Impairments in Young Brain-Injured Patients	HUMAN BRAIN MAPPING			English	Article						traumatic brain injury; voxel-based morphometry; cerebellum; brain stem; postural control; grey matter; white matter; spatially unbiased infratentorial template; volumetric analysis	DIFFUSE AXONAL INJURY; VOXEL-BASED MORPHOMETRY; TRAUMATIC HEAD-INJURY; DECEREBRATE CAT; WHITE-MATTER; 1ST TRIAL; TELL US; BALANCE; CHILDREN; GAIT	Many patients with traumatic brain injury (TBI) suffer from postural control impairments that can profoundly affect daily life. The cerebellum and brain stem are crucial for the neural control of posture and have been shown to be vulnerable to primary and secondary structural consequences of TBI. The aim of this study was to investigate whether morphometric differences in the brain stem and cerebellum can account for impairments in static and dynamic postural control in TBI. TBI patients (n=18) and healthy controls (n=30) completed three challenging postural control tasks on the EquiTestV (R) system (Neurocom). Infratentorial grey matter (GM) and white matter (WM) volumes were analyzed with cerebellum-optimized voxel-based morphometry using the spatially unbiased infratentorial toolbox. Volume loss in TBI patients was revealed in global cerebellar GM, global infratentorial WM, middle cerebellar peduncles, pons and midbrain. In the TBI group and across both groups, lower postural control performance was associated with reduced GM volume in the vermal/paravermal regions of lobules I-IV, V and VI. Moreover, across all participants, worse postural control performance was associated with lower WM volume in the pons, medulla, midbrain, superior and middle cerebellar peduncles and cerebellum. This is the first study in TBI patients to demonstrate an association between postural impairments and reduced volume in specific infratentorial brain areas. Volumetric measures of the brain stem and cerebellum may be valuable prognostic markers of the chronic neural pathology, which complicates rehabilitation of postural control in TBI. (C) 2015 Wiley Periodicals, Inc.	[Drijkoningen, David; Leunissen, Inge; Hoogkamer, Wouter; Duysens, Jacques; Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Grp Biomed Sci, Leuven, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia; [Sunaert, Stefan] Katholieke Univ Leuven, Univ Hosp, Dept Radiol, Leuven, Belgium; [Swinnen, Stephan P.] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium	Swinnen, SP (corresponding author), Movement Control & Neuroplast Res Grp, Tervuursevest 101, B-3001 Leuven, Belgium.	stephan.swinnen@faber.kuleuven.be	Hoogkamer, Wouter/I-8670-2019	Hoogkamer, Wouter/0000-0003-0524-0196; Leunissen, Inge/0000-0002-3977-3620; Caeyenberghs, Karen/0000-0001-7009-6843; Duysens, Jacques/0000-0002-0043-8817	Research Program of the Research Foundation - Flanders (FWO)FWO [G.A114.11, G.0721.12, G.0708.14]; Research Fund KU LeuvenKU Leuven [OT/11/071]; Interuniversity Attraction Poles program of the Belgian Federal GovernmentBelgian Federal Science Policy Office [P7/11]	Contract grant sponsor: Research Program of the Research Foundation - Flanders (FWO); Contract grant numbers: G.A114.11, G.0721.12, G.0708.14; Contract grant sponsor: Research Fund KU Leuven; Contract grant number: OT/11/071; Contract grant sponsor: Interuniversity Attraction Poles program of the Belgian Federal Government; Contract grant number: P7/11	Ai JL, 2007, EXP BRAIN RES, V177, P95, DOI 10.1007/s00221-006-0654-9; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Brandauer B, 2008, CLIN NEUROPHYSIOL, V119, P2528, DOI 10.1016/j.clinph.2008.07.280; Bruininks RH, 2005, BOT2 BRUININKS OSERE; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2014, BRAIN CONNECT, DOI [10.1089/brain.2014.0293, DOI 10.1089/BRAIN.2014.0293]; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Campbell AD, 2013, J NEUROPHYSIOL, V110, P2236, DOI 10.1152/jn.00766.2012; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Duysens J, 2015, CLIN NEUROPHYSIOL, V126, P5, DOI 10.1016/j.clinph.2014.05.024; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Ferraye MU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091183; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Honeycutt CF, 2010, J NEUROPHYSIOL, V103, P3266, DOI 10.1152/jn.00764.2009; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Hoogkamer W, 2015, GAIT POSTURE, V41, P592, DOI 10.1016/j.gaitpost.2015.01.004; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Ilg W, 2013, MOVEMENT DISORD, V28, P1566, DOI 10.1002/mds.25558; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mori S., 2005, MRI ATLAS HUMAN WHIT; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Nijhuis LBO, 2010, J NEUROPHYSIOL, V104, P2704, DOI 10.1152/jn.01080.2009; Nonnekes J, 2015, NEUROSCI BIOBEHAV R, V53, P131, DOI 10.1016/j.neubiorev.2015.04.002; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prosperini L, 2013, RADIOLOGY, V268, P181, DOI 10.1148/radiol.13121695; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schoch B, 2010, CEREBELLUM, V9, P324, DOI 10.1007/s12311-010-0165-x; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Slobounov S, 2006, MOTOR CONTROL, V10, P69, DOI 10.1123/mcj.10.1.69; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Spraker MB, 2012, NEUROIMAGE, V59, P1647, DOI 10.1016/j.neuroimage.2011.09.019; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P94, DOI 10.1136/jnnp.74.1.94; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Talairach J., 1988, COPLANAR STEREOTAXIC; Taube W, 2015, CORTEX, V64, P102, DOI 10.1016/j.cortex.2014.09.022; Taylor DL, 2006, BRAIN PATHOL, V16, P195, DOI 10.1111/j.1750-3639.2006.00017.x; Timmann D, 2008, CEREBELLUM, V7, P602, DOI 10.1007/s12311-008-0066-4; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wen L, 2014, NEURAL REGEN RES, V9, P1902, DOI 10.4103/1673-5374.145358	87	14	14	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	DEC	2015	36	12					4897	4909		10.1002/hbm.22958			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DB1QF	WOS:000368283100012	26441014	Green Published			2021-06-18	
J	Gavaskar, AS; Tummala, NC				Gavaskar, Ashok S.; Tummala, Naveen C.			Ganz Surgical Dislocation of the Hip Is a Safe Technique for Operative Treatment of Pipkin Fractures. Results of a Prospective Trial	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						femoral head fracture; hip dislocation; pipkin; surgical dislocation; Ganz	FEMORAL-HEAD	Objectives:The primary objective was to study the incidence of femoral head osteonecrosis after Ganz approach for Pipkin fracture dislocations. Clinico-radiological and functional outcomes were also studied.Design:Prospective, nonrandomised.Setting:Tertiary care trauma center.Patients:Twenty-eight patients with type I/II Pipkin fracture dislocation reduced within 6 hours of injury.Intervention:The displaced head fracture was addressed through safe surgical dislocation after urgent closed reduction of the hip.Outcome Measurements:Incidence of osteonecrosis using radiographs and functional outcome using modified Merle d'Aubigne and Oxford scores were studied.Results:Twenty-six fractures were fixed, and 2 type I fractures were excised. Twenty-six of 28 patients were followed up for a mean of 36 months. There was no osteonecrosis. All fractures and osteotomies had united. The mean modified Merle d'Aubigne score was 16.5 (14-18), and the mean Oxford score was 42.65 (38-48).Conclusions:Safe surgical dislocation provides satisfactory results in Pipkin fracture dislocations. The incidence of osteonecrosis is not increased in patients undergoing early joint reduction.Level of Evidence:Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.	[Gavaskar, Ashok S.] Parvathy Hosp, Dept Orthoped & Trauma, Hip Unit, Madras 600094, Tamil Nadu, India; [Tummala, Naveen C.] Dhruv Clin, Madras, Tamil Nadu, India	Gavaskar, AS (corresponding author), Parvathy Hosp, Dept Orthoped & Trauma, Hip Unit, 63A-44 Gandhi Rd, Madras 600094, Tamil Nadu, India.	gavaskar.ortho@gmail.com					BUTLER JE, 1981, J BONE JOINT SURG AM, V63, P1292, DOI 10.2106/00004623-198163080-00011; Chen ZW, 2011, INT ORTHOP, V35, P1077, DOI 10.1007/s00264-010-1087-4; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gardner MJ, 2005, J ORTHOP TRAUMA, V19, P334; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; Henle P, 2007, INJURY, V38, P478, DOI 10.1016/j.injury.2007.01.023; HOUGAARD K, 1988, J BONE JOINT SURG AM, V70A, P233, DOI 10.2106/00004623-198870020-00011; Kloen P., 2002, EUROPEAN J TRAUMA, V28, P221, DOI [10.1007/s00068-002-1173-4, DOI 10.1007/S00068-002-1173-4]; Konrath GA, 1999, J ORTHOP TRAUMA, V13, P407, DOI 10.1097/00005131-199908000-00003; McMurtry IA, 2001, INJURY, V32, P162, DOI 10.1016/S0020-1383(00)00152-2; ROEDER LF, 1980, CLIN ORTHOP RELAT R, P121; Ross JR, 2012, CURR REV MUSCULOSKE, V5, P199, DOI 10.1007/s12178-012-9129-8; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Solberg BD, 2009, CLIN ORTHOP RELAT R, V467, P929, DOI 10.1007/s11999-008-0505-z; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008	17	14	17	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	DEC	2015	29	12					544	548		10.1097/BOT.0000000000000399			5	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CX2FC	WOS:000365510200004	26595593				2021-06-18	
J	Johansson, B; Bjuhr, H; Karlsson, M; Karlsson, JO; Ronnback, L				Johansson, Birgitta; Bjuhr, Helena; Karlsson, Magdalena; Karlsson, Jan-Olof; Ronnback, Lars			Mindfulness-Based Stress Reduction (MBSR) Delivered Live on the Internet to Individuals Suffering from Mental Fatigue After an Acquired Brain Injury	MINDFULNESS			English	Article						Mindfulness; Internet; Mental fatigue; Attention; TBI; Stroke	CONTROLLED-TRIAL; DEPRESSION; SYMPTOMS; MEDITATION; DISORDERS; PROGRAM; STROKE; SCALE; MILD; MOOD	An acquired brain injury often leads to long-lasting mental fatigue, which can have a considerable effect on work and social interactions. Fortunately, the Mindfulness-Based Stress Reduction (MBSR) program has been found to alleviate mental fatigue. The purpose of this feasibility study was to evaluate the success of an interactive MBSR program delivered live online to individuals who have experienced a traumatic brain injury or stroke. We included the following three groups in our study: an Internet group, a face-to-face MBSR group, and an active control group who took weekly walks in natural environments. Thirty-four participants completed the study, and all were suffering from long-lasting mental fatigue after either a traumatic brain injury (16 participants) or a stroke (18 participants). However, seven did not accept to attend an Internet MBSR, and Internet was the only choice for others. We found that, according to the Mental Fatigue Scale (MFS), the program leads to significantly reduced mental fatigue in the Internet group compared with the face-to-face and the control group. Individuals in the MBSR groups also exhibited an improved ability to process two temporally close targets (attentional blink task), while this was not detected in the control group. In conclusion, we believe that it is possible for individuals suffering from mental fatigue after an acquired brain injury to obtain positive results through enrollment in a live, interactive, online MBSR program. This is promising, as the Internet is accessible to many individuals, irrespective of where they live. Further randomized control studies comparing are warranted.	[Johansson, Birgitta; Bjuhr, Helena; Karlsson, Magdalena; Ronnback, Lars] Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Dubbsgatan 14,1Tr, S-41345 Gothenburg, Sweden; [Karlsson, Jan-Olof] Univ West, Dept Econ & Informat, Trollhattan, Sweden	Johansson, B (corresponding author), Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Dubbsgatan 14,1Tr, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se			Health & Medical Care Committee of the Vastra Gotaland Region; Swedish Stroke Association; Swedish Association for Survivors of Accident and Injury	This work was supported by grants from The Health & Medical Care Committee of the Vastra Gotaland Region, The Swedish Stroke Association, and The Swedish Association for Survivors of Accident and Injury.	Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Boettcher J, 2014, BEHAV THER, V45, P241, DOI 10.1016/j.beth.2013.11.003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Carlson LE, 2005, INT J BEHAV MED, V12, P278, DOI 10.1207/s15327558ijbm1204_9; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Detry MA, 2014, JAMA-J AM MED ASSOC, V312, P85, DOI 10.1001/jama.2014.7523; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Gluck TM, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-175; Goldstein J., 2014, SHAMBHALA SUN, P36; Hansson E, 2004, NEUROCHEM RES, V29, P989, DOI 10.1023/B:NERE.0000021243.86287.43; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kabat-Zinn J., 2001, FULL FULL CATASTROPH; Kilpatrick LA, 2011, NEUROIMAGE, V56, P290, DOI 10.1016/j.neuroimage.2011.02.034; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Krusche A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000803; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; Ljotsson B, 2010, BEHAV RES THER, V48, P531, DOI 10.1016/j.brat.2010.03.003; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; McCown D, 2010, TEACHING MINDFULNESS: A PRACTICAL GUIDE FOR CLINICIANS AND EDUCATORS, P1, DOI 10.1007/978-0-387-09484-7; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morledge TJ, 2013, ANN BEHAV MED, V46, P137, DOI 10.1007/s12160-013-9490-x; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Raes F, 2011, CLIN PSYCHOL PSYCHOT, V18, P250, DOI 10.1002/cpp.702; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Ronnback L., 2012, INT SCHOLARLY RES NE, V2012, DOI [10.5402/2012/686425, DOI 10.5402/2012/686425]; Ronnback L., 2012, LONG LASTING MENTAL; Ronnback L, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-22; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; SNAITH RP, 1986, BRIT J PSYCHIAT, V148, P599, DOI 10.1192/bjp.148.5.599; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Surawy C, 2005, BEHAV COGN PSYCHOTH, V33, P103, DOI 10.1017/S135246580400181X; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Wechsler D., 2003, WECHSLER ADULT INTEL; Winward C, 2009, STROKE, V40, P757, DOI 10.1161/STROKEAHA.108.527101	41	14	15	2	38	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1868-8527	1868-8535		MINDFULNESS	Mindfulness	DEC	2015	6	6					1356	1365		10.1007/s12671-015-0406-7			10	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	DB7IZ	WOS:000368689600014					2021-06-18	
J	Parks, AC; Moore, RD; Wu, CT; Broglio, SP; Covassin, T; Hillman, CH; Pontifex, MB				Parks, Andrew C.; Moore, Robert D.; Wu, Chien-Ting; Broglio, Steven P.; Covassin, Tracey; Hillman, Charles H.; Pontifex, Matthew B.			The association between a history of concussion and variability in behavioral and neuroelectric indices of cognition	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						mTBI; Intra-individual variability; ERPs; P3	TRAUMATIC BRAIN-INJURY; INTRAINDIVIDUAL VARIABILITY; REACTION-TIME; PERFORMANCE; RECOVERY; ATTENTION; SPORTS; ABNORMALITIES; TRACKING; DECLINE	Associations between a history of concussion and variability in behavioral and neuroelectric indices of cognition were assessed in college-aged adults with a history of concussion and a healthy control group, in response to a stimulus discrimination task and a more attentionally demanding flanker task. Greater intra-individual variability was observed only for behavioral indices of reaction time in response to the flanker task for those with a history of concussion. An association was also observed between the number of concussions resulting in a loss of consciousness and greater variability of reaction time regardless of the type of task. Relative to neuroelectric measures, a concussive history was associated with smaller P3 amplitude only in response to the flanker task; with no differences between groups observed in response to the oddball task or for intra-individual variability measures. Thus, increased variability associated with a history of concussion appears to be behavior and process specific. The behavioral metrics and functions assessed are important considerations for identifying subtle, yet persistent influences of concussion on cognitive performance. Further, factors such as loss of consciousness associated with a concussive injury may moderate the extent to which these increases in behavioral variability manifest. Thus, the identification of persistent cognitive impairment following concussive injuries necessitates the utilization of appropriate tasks and may be facilitated by going beyond behavioral measures of central tendency. (C) 2015 Elsevier B.V. All rights reserved.	[Parks, Andrew C.; Covassin, Tracey; Pontifex, Matthew B.] Michigan State Univ, E Lansing, MI 48824 USA; [Moore, Robert D.; Wu, Chien-Ting; Hillman, Charles H.] Univ Illinois, Champaign, IL USA; [Broglio, Steven P.] Univ Michigan, Ann Arbor, MI 48109 USA	Pontifex, MB (corresponding author), Michigan State Univ, Dept Kinesiol, 27P IM Sports Circle, E Lansing, MI 48824 USA.	pontifex@msu.edu	Parks, Andrew/O-9038-2017; Parks, Andrew/T-3480-2019; Pontifex, Matthew B/A-4474-2009; Hillman, Charles/AAD-4828-2019	Parks, Andrew/0000-0001-5864-7921; Pontifex, Matthew B/0000-0001-9819-9625; Hillman, Charles/0000-0002-3722-5612	Summer Research Development Fellowship through College of Education; Summer Research Development Fellowship through Graduate School at Michigan State University	Support for our research and the preparation of this manuscript was provided by the National Athletic Trainer's Association Research and Education Fund, the Mary Jane Neer Fund for Disability Research, the Research Board at the University of Illinois, and a Summer Research Development Fellowship awarded to A. Parks through the College of Education and the Graduate School at Michigan State University.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; BRITTON TC, 1991, J NEUROL NEUROSUR PS, V54, P505, DOI 10.1136/jnnp.54.6.505; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bunce D, 2007, NEUROPSYCHOLOGIA, V45, P2009, DOI 10.1016/j.neuropsychologia.2007.02.006; BUNCE DJ, 1993, PSYCHOL AGING, V8, P26, DOI 10.1037/0882-7974.8.1.26; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Compumedics Neuroscan, 2003, SCAN 4 3, VII; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Fjell AM, 2009, NEUROBIOL AGING, V30, P2065, DOI 10.1016/j.neurobiolaging.2008.01.015; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gamaldo AA, 2012, NEUROPSYCHOLOGY, V26, P534, DOI 10.1037/a0028686; Gamer M, 2010, PSYCHOPHYSIOLOGY, V47, P355, DOI 10.1111/j.1469-8986.2009.00933.x; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2012, J NEUROTRAUM, V29, P2625, DOI 10.1089/neu.2012.2312; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Karr JE, 2014, J CLIN EXP NEUROPSYC, V36, P15, DOI 10.1080/13803395.2013.863833; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Lovden M, 2007, NEUROPSYCHOLOGIA, V45, P2827, DOI 10.1016/j.neuropsychologia.2007.05.005; Lovden M, 2013, NEUROIMAGE, V64, P209, DOI 10.1016/j.neuroimage.2012.09.039; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2009, J ATHL TRAINING, P36; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Moore RD, 2015, BIOL PSYCHOL, V109, P93, DOI 10.1016/j.biopsycho.2015.04.008; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Moore RD, 2014, J ATHL TRAINING, V49, P36, DOI 10.4085/1062-6050-49.1.02; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Walhovd KB, 2007, NEUROPSYCHOLOGIA, V45, P2277, DOI 10.1016/j.neuropsychologia.2007.02.022; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	64	14	14	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	DEC	2015	98	3	1				426	434		10.1016/j.ijpsycho.2015.08.006			9	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	DA0NH	WOS:000367493600005	26327621				2021-06-18	
J	Bijttebier, S; Caeyenberghs, K; van den Ameele, H; Achten, E; Rujescu, D; Titeca, K; van Heeringen, C				Bijttebier, Stijn; Caeyenberghs, Karen; van den Ameele, Hans; Achten, Eric; Rujescu, Dan; Titeca, Koen; van Heeringen, Cornelis			The Vulnerability to Suicidal Behavior is Associated with Reduced Connectivity Strength	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						suicidal behavior; predisposition; connectivity strength; network based analysis; 5-HTTLPR; MAOA; whole brain tractography	TRAUMATIC BRAIN-INJURY; TENSOR IMAGING TRACTOGRAPHY; CORPUS-CALLOSUM; INTERHEMISPHERIC INTERACTION; VISUAL INFORMATION; FIBER TRACTOGRAPHY; COGNITIVE CONTROL; DIFFUSION MRI; RATING-SCALE; DEPRESSION	Suicidal behavior constitutes a major public health problem. Based on the stress diathesis model, biological correlates of a diathesis might help to predict risk after stressor-exposure. Structural changes in cortical and subcortical areas and their connections have increasingly been linked with the diathesis. The current study identified structural network changes associated with a diathesis using a whole-brain approach by examining the structural connectivity between regions in euthymic suicide attempters (SA). In addition, the association between connectivity measures, clinical and genetic characteristics was investigated. We hypothesized that SA showed lower connectivity strength, associated with an increased severity of general clinical characteristics and an elevated expression of short alleles in serotonin polymorphisms. Thirteen euthymic SA were compared with fifteen euthymic non-attempters and seventeen healthy controls (HC). Clinical characteristics and three serotonin-related genetic polymorphisms were assessed. Diffusion MRI together with anatomical scans were administered. Preprocessing was performed using Explore DTI. Whole brain tractography of the diffusion-weighted images was followed by a number of streamlines-weighted network analysis using NBS. The network analysis revealed decreased connectivity strength in SA in the connections between the left olfactory cortex and left anterior cingulate gyrus. Furthermore, SA had increased suicidal ideation, hopelessness and self-reported depression, but did not show any differences for the genetic polymorphisms. Finally, lower connectivity strength between the right calcarine fissure and the left middle occipital gyrus was associated with increased trait anxiety severity (r(s) = -0.78, p < 0.01) and hopelessness (r(s) = -0.76, p < 0.01). SA showed differences in white matter network connectivity strength associated with clinical characteristics. Together, these variables could play an important role in predicting suicidal behavior.	[Bijttebier, Stijn; van Heeringen, Cornelis] Univ Ghent, Dept Psychiat & Med Psychol, Unit Suicide Res, B-9000 Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia; [van den Ameele, Hans] AZ Sint Jan Brugge Oostende AV, Dept Psychiat, Brugge, Belgium; [Achten, Eric] Univ Ghent, Dept Radiol & Nucl Med, B-9000 Ghent, Belgium; [Achten, Eric] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Rujescu, Dan] Univ Halle Wittenberg, Univ Klin & Poliklin Psychiat Psychotherapie & Ps, D-06108 Halle, Germany; [Titeca, Koen] AZ Groeninge, Dept Psychiat, Kortrijk, Belgium	Bijttebier, S (corresponding author), Univ Ghent, Dept Psychiat & Med Psychol, Unit Suicide Res, B-9000 Ghent, Belgium.	stijn.bijttebier@ugent.be	van Heeringen, Kees/H-2384-2013	van Heeringen, Kees/0000-0001-5801-194X; Caeyenberghs, Karen/0000-0001-7009-6843; Bijttebier, Stijn/0000-0001-7931-2901			Antypa N, 2013, EUR NEUROPSYCHOPHARM, V23, P1125, DOI 10.1016/j.euroneuro.2013.03.013; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Banich MT, 1998, BRAIN COGNITION, V36, P128, DOI 10.1006/brcg.1997.0950; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Beck A., 1988, MANUAL BECK HOPELESS; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; BERLUCCHI G, 1967, ARCH ITAL BIOL, V105, P583; Caeyenberghs K, 2015, NEUROIMAGE-CLIN, V7, P98, DOI 10.1016/j.nicl.2014.11.018; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cyprien F, 2011, BIOL PSYCHIAT, V70, P320, DOI 10.1016/j.biopsych.2011.02.035; Desmyter S, 2013, CNS NEUROL DISORD-DR, V12, P921, DOI 10.2174/18715273113129990093; Dougherty RF, 2005, P NATL ACAD SCI USA, V102, P7350, DOI 10.1073/pnas.0500003102; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; First M., 1994, STRUCTURED CLIN INTE; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Franken IHA, 2005, J PSYCHOPATHOL BEHAV, V27, P25, DOI 10.1007/s10862-005-3262-2; Germana C, 2010, ACTA PSYCHIAT SCAND, V122, P481, DOI 10.1111/j.1600-0447.2010.01582.x; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jia ZY, 2014, J PSYCHIATR NEUROSCI, V39, P170, DOI 10.1503/jpn.130023; Jia ZY, 2010, AM J PSYCHIAT, V167, P1381, DOI 10.1176/appi.ajp.2010.09101513; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Khalsa S, 2014, NEUROIMAGE, V102, P118, DOI 10.1016/j.neuroimage.2013.12.022; Kim B, 2015, J AFFECT DISORDERS, V175, P139, DOI 10.1016/j.jad.2015.01.001; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Leemans A., 2009, 17 ANN M INT SOC MAG; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lo CP, 2007, EUR J NEUROL, V14, P777, DOI 10.1111/j.1468-1331.2007.01854.x; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Mahon K, 2012, BIPOLAR DISORD, V14, P80, DOI 10.1111/j.1399-5618.2012.00984.x; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Olvet DM, 2014, J PSYCHIATR RES, V51, P60, DOI 10.1016/j.jpsychires.2014.01.002; Overbeek T., 1999, MINIINTERNATIONAL NE; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Poudel GR, 2014, NEUROBIOL DIS, V65, P180, DOI 10.1016/j.nbd.2014.01.013; PTITO M, 1981, REV CAN BIOL EXPTL, V40, P61; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Schmand B., 1992, NEUROPSYCHOLOGISCHE; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Ploeg H.M., 2000, HANDLEIDING BIJ ZELF; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; van Heeringen K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00824; Vernon AC, 2012, BIOL PSYCHIAT, V71, P855, DOI 10.1016/j.biopsych.2011.12.004; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Welcome SE, 2008, BRAIN COGNITION, V67, P69, DOI 10.1016/j.bandc.2007.11.005; Westlye LT, 2011, ARCH GEN PSYCHIAT, V68, P369, DOI 10.1001/archgenpsychiatry.2011.24; World Health Organization, 2014, PREVENTING SUICIDE G; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	68	14	14	1	18	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 30	2015	9								632	10.3389/fnhum.2015.00632			11	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CY7DZ	WOS:000366569700001	26648857	DOAJ Gold, Green Published			2021-06-18	
J	Quan, W; Zhang, ZF; Tian, QL; Wen, XL; Yu, P; Wang, D; Cui, WY; Zhou, L; Park, E; Baker, AJ; Zhang, JM; Jiang, RC				Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Cui, Weiyun; Zhou, Lei; Park, Eugene; Baker, Andrew J.; Zhang, Jianning; Jiang, Rongcai			A rat model of chronic subdural hematoma: Insight into mechanisms of revascularization and inflammation	BRAIN RESEARCH			English	Article						Angiogenesis; Behavior; Chronic subdural hematoma; Histology; Inflammation; Pathology; Rat model	REGULATORY T-CELLS; ENDOTHELIAL PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; ATRIAL-FIBRILLATION; SURGICAL-TREATMENT; RISK-FACTORS; RECURRENCE; STROKE; GROWTH; PHYSIOPATHOGENESIS	Chronic subdural hematoma (CSDH) is a common neurological occurrence in the elderly population with significant impact on the quality of life and work. Studies have attempted to determine the risk factors and pathophysiological mechanisms of CSDH using models in numerous mammalian species. To date, these animal models have only been able to reproduce limited durations of hematoma which does not accurately reflect the chronic state of CSDH. To address some of these challenges we modified a rat model of CSDH using two consecutive injections of autologous blood resulting in a hematoma of more than three weeks. We observed inflammatory and angiogenic changes related to the development and recovery of CSDH. In this study the technique for producing a CSDH in a small animal model had a success rate of 78.13%. The hematoma was sustainable up to 24 days. Hematoma resolution was associated with a gradual decrease in local pro-inflammatory factors and gradual increase in anti-inflammatory factors as well as proliferation and subsequent maturation of newly formed vessels. These events were also associated with improved behavioral outcome. Expression of anti-inflammatory cytoldnes also paralleled reabsorption of the hematoma. Reduction in hem. atoma size was also associated with neurological recovery. These data suggest that vessel maturation and anti-inflammatory pathways may contribute to the resolution of CSDH and neurological recovery. The regulation of the two mechanisms is a potential target for the treatment of CSDH. The modified model of rat CSDH demonstrated a high level of reproducibility in our hands and may be useful in future CSDH studies. (C) 2015 Elsevier B.V. All rights reserved.	[Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Cui, Weiyun; Zhou, Lei; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Quan, Wei; Zhang, Zhifei; Tian, Qilong; Wen, Xiaolong; Yu, Peng; Wang, Dong; Zhang, Jianning; Jiang, Rongcai] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Park, Eugene] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Inst Med Sci, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Inst Med Sci, Dept Surg, Toronto, ON, Canada	Zhang, JM (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhangtj@gmail.com; rongcaijiang@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301629, 81271359]; Ontario-China Research and Innovation Fund (OCRIF) [2011DFG33430]	We acknowledge Li Liu, Weiyun Cui, Fanglian Chen and Lei Zhou for their technical assistance of experiments and data interpretation. The work was supported by the National Natural Science Foundation of China (Grant nos. 81301629, and 81271359), the Ontario-China Research and Innovation Fund (OCRIF, 2011DFG33430).	AIKAWA H, 1987, J NEUROSURG, V67, P710, DOI 10.3171/jns.1987.67.5.0710; APFELBAUM RI, 1974, J NEUROSURG, V40, P336, DOI 10.3171/jns.1974.40.3.0336; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Brand C, 2014, BRIT J NEUROSURG, V28, P68, DOI 10.3109/02688697.2013.815314; Brea D, 2014, J CELL MOL MED, V18, P1571, DOI 10.1111/jcmm.12304; Chen JC, 2005, STROKE, V36, P2665, DOI 10.1161/01.STR.0000189992.06654.ab; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; D'Abbondanza JA, 2014, NEUROL RES, V36, P176, DOI 10.1179/1743132813Y.0000000279; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Eijkenboom M, 2004, NEUROSCIENCE, V124, P523, DOI 10.1016/j.neuroscience.2003.11.019; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; GLOVER D, 1976, J NEUROSURG, V45, P393, DOI 10.3171/jns.1976.45.4.0393; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Hong HJ, 2009, SURG NEUROL, V71, P161, DOI 10.1016/j.surneu.2008.01.023; HUBSCHMANN OR, 1980, NEUROSURGERY, V6, P233; Jussen D, 2008, CRIT CARE MED, V36, P543, DOI 10.1097/01.CCM.0B013E3181620A0F; Kalamatianos T, 2013, J NEUROSURG, V118, P353, DOI 10.3171/2012.10.JNS12327; Karabiyikoglu M, 2005, NEUROSURGERY, V57, P565, DOI 10.1227/01.NEU.0000170435.47739.AE; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; LABADIE EL, 1976, J NEUROSURG, V45, P382, DOI 10.3171/jns.1976.45.4.0382; Li T, 2014, J NEUROL SCI, V341, P88, DOI 10.1016/j.jns.2014.04.009; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Mark S. G., 2010, HDB NEUROSURGERY, pP897; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mori K, 1998, NEUROL MED-CHIR, V38, P697, DOI 10.2176/nmc.38.697; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Na SY, 2015, STROKE, V46, P212, DOI 10.1161/STROKEAHA.114.007756; Nordstrom A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001151; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; OHSHIMA T, 1982, Neurologia Medico-Chirurgica, V22, P696, DOI 10.2176/nmc.22.696; Pericolini E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111163; Prasain Nutan, 2012, J Vis Exp, DOI 10.3791/3872; Pripp AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090149; Rabe H, 2014, IMMUNOLOGY, V141, P467, DOI 10.1111/imm.12209; RAPAPORT FT, 1972, TRANSPL P, V4, P537; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Sahara M, 2014, CELL RES, V24, P820, DOI 10.1038/cr.2014.59; Schebesch KM, 2008, ZBL NEUROCHIR, V69, P61, DOI 10.1055/s-2007-1004582; Shehadah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086621; Siddiq I, 2012, J NEUROTRAUM, V29, P2647, DOI 10.1089/neu.2012.2444; Stanisic M, 2012, INFLAMM RES, V61, P845, DOI 10.1007/s00011-012-0476-0; Stanisic M, 2012, ACTA NEUROCHIR, V154, P113, DOI 10.1007/s00701-011-1203-2; Suzuki M, 1998, ACTA NEUROCHIR, V140, P51, DOI 10.1007/s007010050057; Tokmak M, 2007, J NEUROSURG, V107, P290, DOI 10.3171/JNS-07/08/0290; Wang D, 2010, J NEUROTRAUM, V27, P1489, DOI 10.1089/neu.2009.1057; WATANABE S, 1972, J NEUROSURG, V37, P552, DOI 10.3171/jns.1972.37.5.0552; Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217	55	14	15	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 2	2015	1625						84	96		10.1016/j.brainres.2015.08.017			13	Neurosciences	Neurosciences & Neurology	CW5QQ	WOS:000365052000009	26315377				2021-06-18	
J	Colantonio, A; Hsueh, J; Petgrave, J; Hirdes, JP; Berg, K				Colantonio, Angela; Hsueh, Jayden; Petgrave, Josian; Hirdes, John P.; Berg, Katherine			A Profile of Patients With Traumatic Brain Injury Within Home Care, Long-Term Care, Complex Continuing Care, and Institutional Mental Health Settings in a Publicly Insured Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare settings; patient profile; traumatic brain injury	RESIDENTS	Objective: To describe the sociodemographic and clinical profile of people with traumatic brain injury (TBI) in home care, nursing homes, and complex continuing care settings in a national sample. Methods: Cross-sectional study using available Resident Assessment Instrument (RAI 2.0 and RAI Home Care [HC]) national databases in Canada from 1996 to 2011. The profile of people with TBI was compared with patients with and without prespecified neurological conditions within each setting. Participants: Adults 18 years and older identified with TBI (n = 10 878) and adult patients with other neurological (n = 422 300) and nonneurological (n = 571 567) conditions. Main Measures: Demographic and clinical characteristics, functional characteristics, mood and behavior, and treatment and medication variables. Data from Canadian home care (RAI-HC), mental health (RAI-MH), nursing home, and complex continuing care facilities (RAI Minimum Data Set 2.0). Results: Patients with TBI were significantly different on almost all items. They were among the youngest in care settings, and psychotropic drug use by this population was among the highest in at least 2 settings. Conclusion: These data can inform the planning for appropriate care and resources for patients with TBI in a range of settings.	[Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Colantonio, Angela; Petgrave, Josian] Univ Waterloo, Dept Occupat Sci & Occupat Therapy, Waterloo, ON N2L 3G1, Canada; [Berg, Katherine] Univ Waterloo, Dept Phys Therapy, Waterloo, ON N2L 3G1, Canada; [Colantonio, Angela; Hsueh, Jayden; Berg, Katherine] Univ Waterloo, Grad Dept Rehabil Sci, Waterloo, ON N2L 3G1, Canada; [Hirdes, John P.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada	Colantonio, A (corresponding author), Univ Toronto, Occupat Sci & Occupat Therapy, Rehabil Sci Bldg,160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Public Health Agency of Canada; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute; CIHR Research Chair in Gender Work and Health at the University of TorontoCanadian Institutes of Health Research (CIHR) [CGW-126580]; Ontario Home Care Research and Knowledge Exchange Chair by the Ontario Ministry of Health and Long Term Care	Funding for the study was provided by the Public Health Agency of Canada and funding from the Ontario Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute. Dr Colantonio was supported by the Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute and a CIHR Research Chair in Gender Work and Health at the University of Toronto (CGW-126580). Dr Hirdes was supported by the Ontario Home Care Research and Knowledge Exchange Chair by the Ontario Ministry of Health and Long Term Care.	Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Bronskill S, 2011, HLTH SYSTEM USE FRAI, P91; Buchanan RJ, 2003, BRAIN INJURY, V17, P507, DOI 10.1080/0269905031000070215; *CAN I HLTH INF, 2006, FAC BAS CONT CAR CAN; Canadian Cancer Care Society's Steering Committee on Cancer, 2011, CAN CANC STAT 2011; Canadian Institute for Health Information, 2007, BURD NEUR DIS DIS IN; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; Cooper C, 2006, AM J GERIAT PSYCHIAT, V14, P489, DOI 10.1097/01.JGP.0000192498.18316.b6; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Finkelstein E, 2003, INCIDENCE EC BURDEN; Frisina PG, 2010, REHABIL NURS, V35, P141, DOI 10.1002/j.2048-7940.2010.tb00039.x; Gabella BA, 2007, J HEAD TRAUMA REHAB, V22, P368, DOI 10.1097/01.HTR.0000300232.98242.ce; Henry-Sanchez JT, 2012, AM J PHYS MED REHAB, V91, P601, DOI 10.1097/PHM.0b013e31825596af; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; KELLY G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; Multiple Sclerosis International Federation, 2008, ATL MULT SCLER DAT; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; O'Reilly Kate, 2002, Aust Health Rev, V25, P46; Seeley H, 2012, BRIT J NEUROSURG, V26, P730, DOI 10.3109/02688697.2012.693647; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wodchis WP, 2008, MED CARE, V46, P882, DOI 10.1097/MLR.0b013e3181789471	26	14	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					E18	E29		10.1097/HTR.0000000000000112			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300003	25699620				2021-06-18	
J	Larrabee, GJ				Larrabee, Glenn J.			The Multiple Validities of Neuropsychological Assessment	AMERICAN PSYCHOLOGIST			English	Article						test and assessment validity; evidence-based; core battery	MILD COGNITIVE IMPAIRMENT; FALSE-POSITIVE ERROR; BIAS SCALE RBS; PERFORMANCE VALIDITY; RESPONSE BIAS; CONSTRUCT-VALIDITY; ALZHEIMERS-DISEASE; CROSS-VALIDATION; SYMPTOM VALIDITY; FINANCIAL CAPACITY	This article discusses construct and criterion validity of neuropsychological tests, as well as assessment validity, which allows determination of whether an individual examinee is producing valid test results. Factor analyses identify 6 domains of abilities. Tests of learning and memory and processing speed are most sensitive to presence of brain dysfunction in both traumatic brain injury (TBI) and Alzheimer's disease (AD). Tests of processing speed, working memory, verbal symbolic functions, and visuoperceptual and visuospatial judgment and problem solving are sensitive to the severity of TBI and AD, as well as to the functional consequences of these disorders, including ability to work, financial and medical decision-making capacities, and driving ability. Unilateral hemisphere stroke allows study of impairment in sensorimotor skills and lateralized neuropsychological abilities, as well as the moderating effects of aphasia and neglect on test performance. Assessment validity is determined by performance validity tests, measuring whether an examinee is providing an accurate measure of their actual level of ability, and symptom validity tests, measuring whether an examinee is providing an accurate report of their actual symptom experience. A core neuropsychological battery is described that includes tests with established construct and criterion validity, and assessment validity, for comprehensive evidence-based evaluation.		Larrabee, GJ (corresponding author), 2650 Bahia Vista St,Suite 308, Sarasota, FL 34239 USA.	glarrabee@aol.com					Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bauer RM, 2000, CLIN GUIDE NEUROPSYC, P419; Ben-Porath Y.S., 2012, INTERPRETING MMPI 2; BENTON A, 1991, Neuropsychology Review, V2, P267, DOI 10.1007/BF01108848; Benton A. L., 1994, CONTRIBUTIONS NEUROP; Benton A. L., 1991, NEUROBEHAVIORAL ASPE, P3; Bianchini KJ, 2014, CLIN NEUROPSYCHOL, V28, P1376, DOI 10.1080/13854046.2014.986199; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Borenstein M., 2009, INTRO METAANALYSIS; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carroll J. B., 1993, HUMAN COGNITIVE ABIL; Crook TH, 1988, NEUROPSYCHOLOGY, V2, P1, DOI 10.1037//0894-4105.2.1.1; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1224, DOI 10.1080/13854046.2014.987167; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Frazier TW, 2004, J INT NEUROPSYCH SOC, V10, P578, DOI 10.1017/S1355617704104049; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greenaway MC, 2009, CLIN NEUROPSYCHOL, V23, P7, DOI 10.1080/13854040801891686; Greiffenstein MF, 2003, CLIN NEUROPSYCHOL, V17, P561, DOI 10.1076/clin.17.4.561.27937; Griffith HR, 2006, J INT NEUROPSYCH SOC, V12, P166, DOI 10.1017/S1355617706060267; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heilman KM, 2012, CLIN NEUROPSYCHOLOGY; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; KANE RL, 1985, J CLIN EXP NEUROPSYC, V7, P211, DOI 10.1080/01688638508401254; Keifer E, 2013, J CLIN EXP NEUROPSYC, V35, P1048, DOI 10.1080/13803395.2013.854319; Larrabee G. J., 1992, J CLIN EXPT NEUROPSY, V14, P65; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; LARRABEE GJ, 1992, ARCH CLIN NEUROPSYCH, V7, P395, DOI 10.1016/0887-6177(92)90152-D; LARRABEE GJ, 1986, INT J NEUROSCI, V29, P141, DOI 10.3109/00207458608985644; LARRABEE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P275, DOI 10.1080/01688638608401318; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Leonberger F. T., 1992, NEUROPSYCHOLOGY, V6, P239, DOI DOI 10.1037/0894-4105.6.3.239; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Loring DW, 2008, CLIN NEUROPSYCHOL, V22, P524, DOI 10.1080/13854040701425445; Loring DW, 2006, CLIN NEUROPSYCHOL, V20, P221, DOI 10.1080/13854040590947443; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Miller JB, 2010, CLIN NEUROPSYCHOL, V24, P678, DOI 10.1080/13854041003601493; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Rohling ML, 2011, PSYCHOL BULL, V137, P708, DOI 10.1037/a0023327; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2010, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-375035-8.10008-4; SHERER M, 1994, ARCH CLIN NEUROPSYCH, V9, P427, DOI 10.1016/0887-6177(94)90005-1; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Smith G. E., 1992, PSYCHOL ASSESSMENT, V4, P382, DOI DOI 10.1037/1040-3590.4.3.382; SMITH GE, 1993, PSYCHOL ASSESSMENT J, V5, P121, DOI DOI 10.1037/1040-3590.5.1.121; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; SPREEN O, 1965, J NERV MENT DIS, V140, P323, DOI 10.1097/00005053-196505000-00002; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Trahan DE, 1997, ARCH CLIN NEUROPSYCH, V12, P57, DOI 10.1016/S0887-6177(96)00025-X; TRAHAN DE, 1989, CLIN NEUROPSYCHOL, V3, P169, DOI DOI 10.1080/13854048908403290; VEGA A, 1967, J CONSULT PSYCHOL, V31, P619, DOI 10.1037/h0025112; Wechsler D., 2009, WMS 4 TECHNICAL INTE; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; WILLIAMS JM, 1987, J CONSULT CLIN PSYCH, V55, P595, DOI 10.1037/0022-006X.55.4.595; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wolfson D., 1993, HALSTEAD REITAN NEUR; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	82	14	14	0	26	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0003-066X	1935-990X		AM PSYCHOL	Am. Psychol.	NOV	2015	70	8					779	788		10.1037/a0039835			11	Psychology, Multidisciplinary	Psychology	CX4WM	WOS:000365701100023	26618971				2021-06-18	
J	Li, WT; Zhang, SY; Zhou, YF; Zhang, BF; Liang, ZQ; Liu, YH; Wei, Y; Li, CK; Meng, XJ; Xia, M; Dan, Y; Song, JN				Li, Wen-Tao; Zhang, Su-Yuan; Zhou, Yue-Fei; Zhang, Bin-Fei; Liang, Zhen-Qiang; Liu, Yong-Hong; Wei, Yan; Li, Chuan-Kun; Meng, Xi-Jun; Xia, Ming; Dan, Yong; Song, Jin-Ning			Carvacrol attenuates traumatic neuronal injury through store-operated Ca2+ entry-independent regulation of intracellular Ca2+ homeostasis	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; TRPM7; Calcium homeostasis; nNOS	IN-VITRO MODEL; BRAIN-INJURY; DOWN-REGULATION; TRPM7 CHANNELS; ISCHEMIA; DEATH; MECHANISMS; TRPC1	Searching for effective pharmacological agents for traumatic brain injury (TBI) treatment has largely been unsuccessful. The transient receptor potential melastatin 7 (TRPM7), a TRP channel that is essential for embryonic development, has been shown to mediate ischemic neuronal injury in vivo and in vitro, but global deletion of TRPM7 in mice is lethal. Here, carvacrol was used to investigate the protective effect of TRPM7 inhibition in an in vitro traumatic neuronal injury model. Carvacrol (0.5 and 1 mM) reduced lactate dehydrogenase (LDH) release, apoptosis and caspase-3 activation after traumatic injury in cortical neurons. These neuroprotective effects were accompanied by alleviated cytoplasmic calcium levels as measured by calcium imaging. In contrast, the thapsigargin (TG) induced store-operated calcium entry (SOCE) and the expression of SOCE related proteins in neurons were not altered by carvacrol treatment. The involvement of TRPM7 sensitive calcium influx in our in vitro model was confirmed by the results that bradykinin induced calcium influx was prevented by carvacrol in neurons. Furthermore, carvacrol significantly inhibited the induction of neuronal nitric oxide synthase (nNOS) after traumatic injury, and treatment with carvacrol and the nNOS inhibitor NLPA together had no extra effect on calcium concentration and neuronal injury. Thus, inhibition of TRPM7 function by carvacrol protects against traumatic neuronal injury, and might be a potential drug development strategy for the treatment of TBI. (C) 2015 Elsevier Ltd. All rights reserved.	[Li, Wen-Tao; Zhang, Bin-Fei; Wei, Yan; Li, Chuan-Kun; Meng, Xi-Jun; Xia, Ming; Dan, Yong; Song, Jin-Ning] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China; [Zhang, Su-Yuan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Lib, Xian 710061, Shaanxi, Peoples R China; [Zhou, Yue-Fei] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Liang, Zhen-Qiang] Dingxi First Peoples Hosp, Dept Neurosurg, Dingxi 743000, Gansu, Peoples R China; [Liu, Yong-Hong] Northwest Civil Aviat Hosp, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China	Song, JN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Neurosurg, Xian 710061, Shaanxi, Peoples R China.	songjinning_xjtu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870844, 30471774]; Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" [2008ZDKG-66]; New Century Excellent Talents Program of Ministry of EducationProgram for New Century Excellent Talents in University (NCET) [NCET-05-0831]; Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education [20110201110060]; Natural Science Foundation of Shaanxi Province of ChinaNatural Science Foundation of Shaanxi Province [2003C1-16]	This work was financially supported by the National Natural Science Foundation of China (No. 30870844 and NO. 30471774), the Key Scientific and Technological Innovation Special Projects of Shaanxi "13115" (Grant No. 2008ZDKG-66), the New Century Excellent Talents Program of Ministry of Education (No.NCET-05-0831), the Special Research Fund for the Doctoral Disciplinary Points in Universities of Ministry of Education (Grant No. 20110201110060), and the Natural Science Foundation of Shaanxi Province of China (No. 2003C1-16).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts MM, 2005, NEUROSCIENTIST, V11, P116, DOI 10.1177/1073858404272966; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bae CYJ, 2011, ACTA PHARMACOL SIN, V32, P725, DOI 10.1038/aps.2011.60; Bianchetti E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.237; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Chen T, 2013, CELL SIGNAL, V25, P2863, DOI 10.1016/j.cellsig.2013.09.004; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; DeWitt D S, 1995, New Horiz, V3, P376; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033584; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhao L, 2007, LIFE SCI, V81, P1211, DOI 10.1016/j.lfs.2007.08.034	28	14	15	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2015	90						107	113		10.1016/j.neuint.2015.07.020			7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CX0DH	WOS:000365366600013	26220904				2021-06-18	
J	Mayer, AR; Hanlon, FM; Dodd, AB; Ling, JM; Klimaj, SD; Meier, TB				Mayer, Andrew R.; Hanlon, Faith M.; Dodd, Andrew B.; Ling, Josef M.; Klimaj, Stefan D.; Meier, Timothy B.			A functional magnetic resonance imaging study of cognitive control and neurosensory deficits in mild traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						cognitive control; multisensory; auditory; visual; functional magnetic resonance imaging	POSTERIOR PARIETAL CORTEX; DUAL SENSORY IMPAIRMENT; CROSS-MODAL DISTRACTION; HEAD-INJURY; ACTIVATION; ATTENTION; MRI; BLAST; INTEGRATION; CONCUSSION	Mild traumatic brain injury patients (mTBI) frequently report symptoms of increased distractability and sensory disturbances during mutisensory stimulation. These common post-concussive symptoms could putatively result from dysfunction within the cognitive control network (CCN; top-down) or from unisensory cortex (bottom-up) itself. Functional magnetic resonance imaging (fMRI) and high-resolution structural data were therefore prospectively collected during a multisensory (audio-visual) cognitive control task from 46 mTBI patients within 3 weeks of injury and 46 matched healthy controls (HC), with a subset of participants returning at 4 months. Multisensory stimuli were presented at two frequencies to manipulate cognitive and perceptual load. Patients self-reported more cognitive, emotional, somatic, vestibular and visual symptoms relative to HC, which improved, but did not entirely resolve, over the 4 month follow-up period. There were no group differences in behavior or functional activation during cognitive control (incongruent - congruent trials). In contrast, patients exhibited abnormal activation within different regions of visual cortex that depended on whether attention was focused on auditory or visual information streams. Patients also exhibited increased activation within bilateral inferior parietal lobules during higher cognitive/perceptual loads, suggesting a compensatory mechanism to achieve similar levels of behavioral performance. Functional abnormalities within the visual cortex and inferior parietal lobules were only partially resolved at 4 months post-injury, suggesting that neural abnormalities may take longer to resolve than behavioral measures used in most clinical settings. In summary, current results indicate that abnormalities within unisensory cortex (particularly visual areas) following mTBI, which likely contribute to deficits commonly reported during multisensory stimulation. Hum Brain Mapp 36:4394-4406, 2015. (c) 2015 Wiley Periodicals, Inc.	[Mayer, Andrew R.; Hanlon, Faith M.; Dodd, Andrew B.; Ling, Josef M.; Klimaj, Stefan D.; Meier, Timothy B.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Klimaj, Stefan/AAV-4060-2020		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24-HD050836, R21-NS064464-01A1, R21-NS064464-01S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD050836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS064464] Funding Source: NIH RePORTER	Contract grant sponsor: National Institutes of Health; Contract grant numbers: R24-HD050836, R21-NS064464-01A1, R21-NS064464-01S1 (to A.M.).	Arciniegas D, 2000, J NEUROPSYCH CLIN N, V12, P77, DOI 10.1176/jnp.12.1.77; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; Baier B, 2006, J NEUROSCI, V26, P12260, DOI 10.1523/JNEUROSCI.1457-06.2006; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; HUBEL DH, 1959, SCIENCE, V129, P1279, DOI 10.1126/science.129.3358.1279; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; Mayer AR, 2009, CEREB CORTEX, V19, P993, DOI 10.1093/cercor/bhn148; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2012, HUM BRAIN MAPP, V33, P2843, DOI 10.1002/hbm.21405; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Nachev P, 2006, CORTEX, V42, P766, DOI 10.1016/S0010-9452(08)70415-5; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Talairach J., 1988, COPLANAR STEREOTAXIC; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zmigrod S, 2014, MULTISENS RES, V27, P161, DOI 10.1163/22134808-00002449	57	14	15	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	NOV	2015	36	11					4394	4406		10.1002/hbm.22930			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CV4EQ	WOS:000364219500013	26493161	Green Published, Green Accepted			2021-06-18	
J	Mendenhall, SK; Sivaganesan, A; Mistry, A; Sivasubramaniam, P; McGirt, MJ; Devin, CJ				Mendenhall, Stephen K.; Sivaganesan, Ahilan; Mistry, Akshitkumar; Sivasubramaniam, Priya; McGirt, Matthew J.; Devin, Clinton J.			Traumatic atlantooccipital dislocation: comprehensive assessment of mortality, neurologic improvement, and patient-reported outcomes at a Level 1 trauma center over 15 years	SPINE JOURNAL			English	Article						Trauma; Cervical spine; Outcomes; Diagnosis; Treatment; Craniocervical junction	ATLANTO-OCCIPITAL DISLOCATION; CERVICAL-SPINE INJURIES; OCCIPITOVERTEBRAL RELATIONSHIPS; OCCIPITOATLANTAL DISLOCATION; RADIOLOGIC-DIAGNOSIS; LATERAL RADIOGRAPHS; SUPINE SUBJECTS; BRAIN-INJURY; SURVIVAL; DISSOCIATION	BACKGROUND CONTEXT: Only Level 3 evidence exists for the diagnosis and treatment of atlantooccipital dislocation (AOD) with few studies examining mortality, neurologic improvement, and patient-reported outcomes (PROs). PURPOSE: First, the aim was to determine: the incidence of AOD, 90-day surgical morbidity and mortality after AOD, patient factors that may be associated with delayed or missed diagnosis, and factors that were associated with mortality and neurologic improvement after AOD. Secondly, the aim was to quantify the pain, disability, and quality of life experienced by patients surviving AOD. STUDY DESIGN/SETTING: This was a retrospective cohort study. PATIENT SAMPLE: A total of 5,337 consecutive spine computed tomography traumagrams from 1997 to 2012 were included. OUTCOME MEASURES: Mortality, neurologic improvement, complications, EuroQol five dimensions (EQ-5D), Neck Disability Index (NDI), Numeric Rating Scale (NRS)-neck, NRS-arm, and return-to-work were the outcome measures. METHODS: Patients were considered to have AOD if they met one of the following radiographic criteria: basion-dens interval greater than 10 mm; basion-axial interval: anterior displacement greater than 12 mm or posterior displacement greater than 4 mm between the basion and posterior C2 line; and condyle to C1 interval greater than 1.4 mm. Linear regression analysis was performed to identify factors associated with 90-day mortality, neurologic improvement, and missed diagnosis. Patient-reported outcomes were assessed via phone interview. RESULTS: Thirty-one patients met radiographic criteria for AOD; an incidence of 0.6% over 15 years. Twenty-one (68%) patients were treated with occipital cervical fusion. At 90 days postoperatively, there were no new neurologic deficits or reoperations. Eight (26%) patients died within 90 days. All patients who died had no documented AOD diagnosis and were not treated surgically. Missed AOD diagnosis was the strongest predictor of mortality. Younger age, lower Glasgow Coma Score, lower Injury Severity Score (ISS) score, and worse initial American Spinal Injury Association (ASIA) score were significantly associated with greater neurologic improvement. Higher ISS score and better ASIA score were significantly associated with missed AOD diagnosis. The average PROs metrics at time of telephone follow-up were as follows: EQ-5D=0.73 +/- 0.19, NDI=30.89 +/- 18.57, NRS-neck=2.33 +/- 2.21, NRS-arm=2.00 +/- 2.54. Of the patients with follow-up data, four were employed full-time, and five were receiving disability. CONCLUSIONS: Our work suggests that failure to diagnose AOD is a powerful predictor of mortality. Higher ISS scores and better neurologic presentation were significantly associated with missed diagnosis. Craniocervical arthrodesis preserved neurologic function with low complication rate and unexpectedly high PROs and return-to-work. These results must be carefully interpreted because it is unclear whether missed AOD diagnosis accompanies another death-causing injury (eg, traumatic brain injury) or if failure to treat AOD contributes to mortality in a multifactorial manner. (C) 2015 Elsevier Inc. All rights reserved.	[Mendenhall, Stephen K.; Sivaganesan, Ahilan; Mistry, Akshitkumar; McGirt, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA; [Sivasubramaniam, Priya; Devin, Clinton J.] Vanderbilt Univ, Med Ctr, Dept Orthoped Surg, Nashville, TN 37232 USA; [McGirt, Matthew J.] Carolina Neurosurg & Spine Associates, Charlotte, NC 28204 USA	Devin, CJ (corresponding author), Vanderbilt Spine Ctr, Vanderbilt Dept Orthopaed Surg, Med Ctr East, South Tower,Suite 4200, Nashville, TN 37232 USA.	clintondevin@gmail.com		Mistry, Akshitkumar/0000-0002-7918-5153	National Institute of Arthritis and Musculoskeletal diseaseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	SKM: Nothing to disclose. AS: Nothing to disclose. AM: Nothing to disclose. PS: Nothing to disclose. MJM: Consulting: Depuy and Stryker (C and A, respectively). CJD: Grants: National Institute of Arthritis and Musculoskeletal disease (F).	ALKER GJ, 1975, RADIOLOGY, V114, P611; ANTONELLI M, 1994, CHEST, V105, P224, DOI 10.1378/chest.105.1.224; Bellabarba C, 2006, J NEUROSURG-SPINE, V4, P429, DOI 10.3171/spi.2006.4.6.429; Blackwood NJ, 1908, ANN SURG, V47, P654, DOI 10.1097/00000658-190805000-00003; BOHLMAN HH, 1979, J BONE JOINT SURG AM, V61, P1119, DOI 10.2106/00004623-197961080-00001; BOOLS JC, 1986, AM J NEURORADIOL, V7, P901; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; BUCHOLZ RW, 1979, J BONE JOINT SURG AM, V61, P248, DOI 10.2106/00004623-197961020-00014; Cavalcanti M, 2006, CRIT CARE MED, V34, P1067, DOI 10.1097/01.CCM.0000206471.44161.A0; CHAN RNW, 1980, J TRAUMA, V20, P684, DOI 10.1097/00005373-198008000-00009; Chaput CD, 2011, J TRAUMA, V71, P393, DOI 10.1097/TA.0b013e3181eb6a31; Como JJ, 2009, J TRAUMA, V67, P651, DOI 10.1097/TA.0b013e3181ae583b; Cooper Z, 2010, J SURG RES, V160, P3, DOI 10.1016/j.jss.2009.04.004; DAVIS D, 1971, J NEUROSURG, V34, P603, DOI 10.3171/jns.1971.34.5.0603; DAVIS JW, 1993, J TRAUMA, V34, P342, DOI 10.1097/00005373-199303000-00006; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DEBEER JD, 1988, J BONE JOINT SURG BR, V70, P652; Diaz JJ, 2003, J TRAUMA, V55, P658, DOI 10.1097/01.TA.0000088120.99247.4A; DIBENEDETTO T, 1990, SPINE, V15, P595, DOI 10.1097/00007632-199006000-00031; DICKMAN CA, 1993, J SPINAL DISORD, V6, P300, DOI 10.1097/00002517-199306040-00004; DUBLIN AB, 1980, J NEUROSURG, V52, P541, DOI 10.3171/jns.1980.52.4.0541; Dziurzynski K, 2005, SPINE, V30, P1427, DOI 10.1097/01.brs.0000166524.88394.b3; EVARTS CM, 1970, J BONE JOINT SURG AM, VA 52, P1653, DOI 10.2106/00004623-197052080-00017; FARTHING J W, 1948, N C Med J, V9, P34; FINNEY HL, 1978, J NEUROSURG, V48, P636, DOI 10.3171/jns.1978.48.4.0636; Fisher CG, 2001, CAN J SURG, V44, P412; FRUIN AH, 1977, J NEUROSURG, V46, P663, DOI 10.3171/jns.1977.46.5.0663; GABRIELS.TO, 1966, AMER J ROENTGENOL RA, V97, P624, DOI 10.2214/ajr.97.3.624; GERRELTS BD, 1991, J TRAUMA, V31, P1622, DOI 10.1097/00005373-199112000-00010; Govender S, 2003, J BONE JOINT SURG BR, V85B, P875, DOI 10.1302/0301-620X.85B6.14092; Guigui P, 1995, Eur Spine J, V4, P242, DOI 10.1007/BF00303419; Hadley MN, 2002, NEUROSURGERY, V50, pS105; HARRIS JH, 1994, AM J ROENTGENOL, V162, P881, DOI 10.2214/ajr.162.4.8141012; HARRIS JH, 1994, AM J ROENTGENOL, V162, P887, DOI 10.2214/ajr.162.4.8141013; Horn EM, 2007, J NEUROSURG-SPINE, V6, P113, DOI 10.3171/spi.2007.6.2.113; HOSONO N, 1993, SPINE, V18, P786, DOI 10.1097/00007632-199305000-00023; Jansson KA, 2011, ACTA ORTHOP, V82, P82, DOI 10.3109/17453674.2010.548026; JONSSON H, 1991, J SPINAL DISORD, V4, P251, DOI 10.1097/00002517-199109000-00001; Kool DR, 2007, EMERG RADIOL, V14, P135, DOI 10.1007/s10140-007-0633-x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MATAVA MJ, 1993, SPINE, V18, P1897, DOI 10.1097/00007632-199310000-00030; MONTANE I, 1991, SPINE, V16, P112, DOI 10.1097/00007632-199102000-00002; Mueller FJ, 2013, EUR SPINE J, V22, P65, DOI 10.1007/s00586-012-2543-1; Nunley PD, 2009, SPINE J, V9, P121, DOI 10.1016/j.spinee.2007.11.009; PAGE CP, 1973, J NEUROSURG, V39, P394, DOI 10.3171/jns.1973.39.3.0394; Pang D, 2007, NEUROSURGERY, V61, P995, DOI 10.1227/01.neu.0000303196.87672.78; POWERS B, 1979, NEUROSURGERY, V4, P12, DOI 10.1097/00006123-197901000-00004; Rojas CA, 2007, AM J NEURORADIOL, V28, P1819, DOI 10.3174/ajnr.A0660; Theodore N, 2013, NEUROSURGERY S, V72, P114; TRAYNELIS VC, 1986, J NEUROSURG, V65, P863, DOI 10.3171/jns.1986.65.6.0863; VANDENBOUT AH, 1986, SPINE, V11, P174, DOI 10.1097/00007632-198603000-00017; Vender John R, 2004, Neurosurg Focus, V16, pE9; Wafaisade A, 2011, CRIT CARE MED, V39, P621, DOI 10.1097/CCM.0b013e318206d3df; WOODRING JH, 1981, AM J ROENTGENOL, V137, P21, DOI 10.2214/ajr.137.1.21; Yuksel KZ, 2008, SPINE, V33, P2066, DOI 10.1097/BRS.0b013e31817e2cfc; ZIGLE JE, 1986, SPINE, V11, P645, DOI 10.1097/00007632-198607000-00026	56	14	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	NOV 1	2015	15	11					2385	2395		10.1016/j.spinee.2015.07.003			11	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CV3QO	WOS:000364173900033	26165481				2021-06-18	
J	Van Beek, L; Ghesquiere, P; Lagae, L; De Smedt, B				Van Beek, Leen; Ghesquiere, Pol; Lagae, Lieven; De Smedt, Bert			Mathematical Difficulties and White Matter Abnormalities in Subacute Pediatric Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						corpus callosum; diffusion tensor imaging; mathematical difficulties; mild traumatic brain injury; pediatrics	TENSOR IMAGING DETECTS; DIFFUSE AXONAL INJURY; WORKING-MEMORY; CORPUS-CALLOSUM; INDIVIDUAL-DIFFERENCES; SHORT-TERM; COGNITIVE DYSFUNCTION; ACADEMIC-ACHIEVEMENT; EXECUTIVE FUNCTIONS; WATER DIFFUSION	Mathematical difficulties have been documented following pediatric mild traumatic brain injury (mTBI), yet a precise characterization of these impairments and their neural correlates is currently unavailable. We aimed to characterize these impairments by comparing behavioral and neuroimaging (i.e., diffusion tensor imaging [DTI]) outcomes from children with subacute mTBI to typically-developing controls. Twenty subacute pediatric mTBI patients and 20 well-matched controls underwent cognitive assessment and DTI examination. DTI tractography was used to detect white matter abnormalities in the corpus callosum (CC) and superior and inferior longitudinal fasciculi; these tracts are involved in mathematical performance and they are often damaged after mTBI. Behavioral results revealed that children with mTBI performed significantly more poorly on rapid apprehension of small numbers of objects (or subitizing), processing of non-symbolic numerosities, and procedural problem solving. These group differences were explained by differences in visuospatial working memory, which suggests that the observed mathematical difficulties may be a consequence of impairments in visuospatial abilities. DTI analysis revealed subtle group differences in the CC genu and splenium (i.e., higher fractional anisotropy and lower mean and radial diffusivity in children with mTBI) but the observed white matter abnormalities of the CC were not significantly associated with the observed mathematical difficulties in the mTBI patients.	[Van Beek, Leen; Ghesquiere, Pol; De Smedt, Bert] Univ Leuven, Parenting & Special Educ Res Unit, Leuven, Belgium; [Lagae, Lieven] Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium	De Smedt, B (corresponding author), Parenting & Special Educ Res Unit, Leopold Vanderkelenstr 32,Box 3765, B-3000 Leuven, Belgium.	Bert.DeSmedt@ppw.kuleuven.be	De Smedt, Bert/U-6124-2019; De Smedt, Bert/G-4729-2010; Ghesquiere, Pol/B-9226-2009; De Smedt, Bert/Q-7020-2019	De Smedt, Bert/0000-0002-3313-3278; Ghesquiere, Pol/0000-0001-9056-7550; De Smedt, Bert/0000-0002-3313-3278	"Research Foundation Flanders" FWOFWO [G.0359.10]	This research was supported by the "Research Foundation Flanders" FWO (grant number G.0359.10). We thank the children and their families for their time and contribution to this study.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Barnea-Goraly N, 2005, COGNITIVE BRAIN RES, V25, P735, DOI 10.1016/j.cogbrainres.2005.09.013; Barnes M. A., 2010, PEDIAT NEUROPSYCHOLO, P297; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Berch DB, 2005, J LEARN DISABIL-US, V38, P333, DOI 10.1177/00222194050380040901; BERGERGROSS P, 1985, PERCEPT MOTOR SKILL, V61, P254, DOI 10.2466/pms.1985.61.1.254; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Booth R., 2000, J MATH BEHAV, V18, P169, DOI DOI 10.1016/S0732-3123(99)00027-9; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; Cantlon JF, 2011, LEARN INDIVID DIFFER, V21, P672, DOI 10.1016/j.lindif.2011.09.003; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Concha L., 2008, P 16 ANN M INT SOC M, P566; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2009, DEV DISABIL RES REV, V15, P4, DOI 10.1002/ddrr.44; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P186, DOI 10.1016/j.jecp.2009.01.004; Dowker A, 2008, DEVELOPMENTAL SCI, V11, P650, DOI 10.1111/j.1467-7687.2008.00713.x; Dudal P., 2000, LEERLINGVOLGSYSTEEM; Dumontheil I, 2012, CEREB CORTEX, V22, P1078, DOI 10.1093/cercor/bhr175; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gathercole S. E, 2001, WORKING MEMORY BATTE; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Gerardi K, 2013, P NATL ACAD SCI USA, V110, P11267, DOI 10.1073/pnas.1220568110; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Gray SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094428; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hellgren K, 2013, DEV MED CHILD NEUROL, V55, P1109, DOI 10.1111/dmcn.12206; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hubber PJ, 2014, Q J EXP PSYCHOL, V67, P936, DOI 10.1080/17470218.2013.838590; Huisman TAGM, 2001, RADIOLOGE, V41, P1038, DOI 10.1007/s001170170003; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jarvis H. L., 2003, EDUC CHILD PSYCHOL, V20, P123; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kort W., 2005, WISC 3 NL WECHSLER I; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2010, ALCOHOL CLIN EXP RES, V34, P354, DOI 10.1111/j.1530-0277.2009.01097.x; Leemans A., 2009, P INT SOC MAG RESON, V17, P3537, DOI DOI 10.1093/occmed/kqr069; LeFevre JA, 1996, J EXP PSYCHOL GEN, V125, P284, DOI 10.1037/0096-3445.125.3.284; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Matejko AA, 2013, NEUROIMAGE, V66, P604, DOI 10.1016/j.neuroimage.2012.10.045; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; MAYBERY MT, 2003, ED CHILD PSYCHOL, V20, P77; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S., 2007, INTRO DIFFUSION TENS; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Hearn K, 2011, VIS COGN, V19, P289, DOI 10.1080/13506285.2010.535994; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reuhkala Minna, 2001, ED PSYCHOL, V21, P387, DOI DOI 10.1080/01443410120090786; Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Rotzer S, 2008, NEUROIMAGE, V39, P417, DOI 10.1016/j.neuroimage.2007.08.045; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Rykhlevskaia E, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.051.2009; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Sattler J.M., 2001, ASSESSMENT CHILDREN, V4th edn; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Schwartz ED, 2005, NEUROREPORT, V16, P73, DOI 10.1097/00001756-200501190-00017; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Short SJ, 2013, NEUROIMAGE, V64, P156, DOI 10.1016/j.neuroimage.2012.09.021; Slater E. J., 1989, J ADOLESCENT RES, V4, P371; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Takahashi M, 2002, P NATL ACAD SCI USA, V99, P16192, DOI 10.1073/pnas.252249999; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Till C, 2011, NEUROREPORT, V22, P1005, DOI 10.1097/WNR.0b013e32834dc301; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Treit S, 2014, NEUROSCIENCE, V276, P87, DOI 10.1016/j.neuroscience.2013.12.019; Trick LM, 2008, PERCEPT PSYCHOPHYS, V70, P743, DOI 10.3758/PP.70.5.743; Tsang JM, 2009, P NATL ACAD SCI USA, V106, P22546, DOI 10.1073/pnas.0906094106; van Dijck JP, 2009, COGNITION, V113, P248, DOI 10.1016/j.cognition.2009.08.005; van Eimeren L, 2010, NEUROIMAGE, V52, P358, DOI 10.1016/j.neuroimage.2010.04.001; van Eimeren L, 2008, NEUROREPORT, V19, P1117, DOI 10.1097/WNR.0b013e328307f5c1; Vandermosten M, 2013, NEUROPSYCHOLOGIA, V51, P2087, DOI 10.1016/j.neuropsychologia.2013.07.008; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang R, 2007, P INT SOC MAG RESON, V15, P3720; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2003, HDB REY OSTERRIETH C, P83; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	148	14	14	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1567	1578		10.1089/neu.2014.3809			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500004	25915107				2021-06-18	
J	Mansouri, MT; Khodayar, MJ; Tabatabaee, A; Ghorbanzadeh, B; Naghizadeh, B				Mansouri, Mohammad Taghi; Khodayar, Mohammad Javad; Tabatabaee, Arnirhossein; Ghorbanzadeh, Behnam; Naghizadeh, Bahareh			Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Simvastatin; Antinociception; Tolerance; Physical dependence; Hot-plate test; Mice	NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; COA REDUCTASE INHIBITORS; D-2 RECEPTOR EXPRESSION; TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE; SPINAL-CORD; PREFRONTAL CORTEX; OPIOID TOLERANCE; UP-REGULATION	Statins, 3-hydroxy-3-methylglutaryl co-enzyme A (HMG-CoA) reductase inhibitors, are widely used in the management of different diseases beyond their primary indication for lowering cholesterol. Previous studies have demonstrated the neuroprotective effects of simvastatin in different animal models. In the present study, we examined the effects of simvastatin (30, 60, 100 and 300 mg/kg, p.o.) on the development and expression of morphine-induced tolerance and dependence in mice. For the induction of morphine tolerance and dependence, mice were twice daily treated with morphine (10 mg/kg, s.c.) for 5 consecutive days. Tolerance was evaluated by the hot-plate test and physical dependence by naloxone challenge, on the sixth day. The results showed that oral administration of simvastatin produced antinociceptive activity in a dose-dependent way. Co-administration of simvastatin with morphine did not affect the acute morphine-induced analgesia (10 mg/kg, s.c.). However, repeated co-administration of simvastatin with morphine significantly attenuated the development of tolerance to the analgesic effect of morphine and inhibited the naloxone (5 mg/kg, s.c.)-precipitated withdrawal signs (jumping and body weight loss). Also, simvastatin at doses of 100 and 300 mg/kg attenuated the expression of morphine-induced tolerance and dependence. These data indicated that, while simvastatin can alleviate both development and expression of morphine-induced tolerance, it cannot enhance morphine-induced antinociception. Taken together, simvastatin may be used as an adjutant therapeutic agent in combination with morphine and or other opioids in patients with severe chronic pain. (C) 2015 Elsevier Inc All rights reserved.	[Mansouri, Mohammad Taghi; Naghizadeh, Bahareh] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Pharmacol, Ahwaz, Iran; [Khodayar, Mohammad Javad; Tabatabaee, Arnirhossein] Ahvaz Jundishapur Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Ahwaz, Iran; [Ghorbanzadeh, Behnam] Dezful Univ Med Sci, Sch Med, Dept Pharmacol, Dezful, Iran	Mansouri, MT (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Pharmacol, Ahwaz, Iran.	mansouri_smt@yahoo.com	Khodayar, Mohammad Javad/D-2779-2018; Mansouri, Seyed Mohammad Taghi/F-3847-2014; Ghorbanzadeh, Behnam/D-3580-2017	Khodayar, Mohammad Javad/0000-0001-9518-1286; Mansouri, Seyed Mohammad Taghi/0000-0002-7549-0708; Ghorbanzadeh, Behnam/0000-0002-0409-0416	Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran [PRC-115]	This paper is issued from Pharm.D. thesis of (Seyed Amirhossein Tabatabaee) and financial support was provided by the Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (PRC-115), Ahvaz, Iran. Funding sources have no involvement in the study design, in the data collection, analysis and interpretation, in the manuscript writing and in the decision to submit the manuscript for publication.	Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Cao JL, 2005, PHARMACOL BIOCHEM BE, V80, P493, DOI 10.1016/j.pbb.2005.01.009; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Dambisya YM, 1996, BRIT J PHARMACOL, V117, P914, DOI 10.1111/j.1476-5381.1996.tb15280.x; Di Napoli P, 2001, CARDIOVASC RES, V51, P283, DOI 10.1016/S0008-6363(01)00306-6; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Garcia-Sevilla JA, 2004, NEUROPHARMACOLOGY, V46, P519, DOI 10.1016/j.neuropharm.2003.10.006; Garzon J, 2001, EUR J NEUROSCI, V13, P801, DOI 10.1046/j.0953-816x.2000.01444.x; Gholami MR, 2008, EUR J PHARMACOL, V590, P111, DOI 10.1016/j.ejphar.2008.05.050; Gintzler AR, 2000, MOL NEUROBIOL, V21, P21, DOI 10.1385/MN:21:1-2:021; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GRUNDY SM, 1988, NEW ENGL J MED, V319, P24; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Hernandez L, 2009, BRAIN RES, V1248, P31, DOI 10.1016/j.brainres.2008.10.065; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu JG, 2001, BRAIN RES REV, V38, P1, DOI 10.1016/S0165-0173(01)00057-1; Machelska H, 1997, NEUROREPORT, V8, P2743, DOI 10.1097/00001756-199708180-00020; Mansouri MT, 2014, EUR J PHARMACOL, V741, P272, DOI 10.1016/j.ejphar.2014.08.024; Mao JR, 1999, BRAIN RES REV, V30, P289, DOI 10.1016/S0165-0173(99)00020-X; Marie-Claire C, 2004, NEUROPSYCHOPHARMACOL, V29, P2208, DOI 10.1038/sj.npp.1300513; Miranda HF, 2011, BASIC CLIN PHARMACOL, V109, P438, DOI 10.1111/j.1742-7843.2011.00746.x; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; Nakagawa T, 2005, NEUROSCIENCE, V134, P9, DOI 10.1016/j.neuroscience.2005.03.029; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Ohsawa M, 2012, J PHARMACOL SCI, V119, P102, DOI 10.1254/jphs.12007SC; Ren X, 2004, BEHAV BRAIN RES, V152, P243, DOI 10.1016/j.bbr.2003.10.013; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Saito T, 2011, ANESTH ANALG, V113, P565, DOI 10.1213/ANE.0b013e318224ac35; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Shi XQ, 2011, PAIN, V152, P1033, DOI 10.1016/j.pain.2011.01.006; Starowicz K, 2003, BRAIN RES, V990, P113, DOI 10.1016/S0006-8993(03)03444-9; Stoller DC, 2007, BRAIN RES, V1142, P28, DOI 10.1016/j.brainres.2007.01.028; Stuve O, 2003, CURR OPIN NEUROL, V16, P393, DOI 10.1097/01.wco.0000073942.19076.d1; Takai Y, 2001, PHYSIOL REV, V81, P153; Taylor DA, 2001, J PHARMACOL EXP THER, V297, P11; Tokuyama S, 2000, BRAIN RES BULL, V52, P363, DOI 10.1016/S0361-9230(00)00273-2; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Walters CL, 2000, NEUROPSYCHOPHARMACOL, V23, P307, DOI 10.1016/S0893-133X(00)00113-5; Wang Q, 2005, BRAIN RES, V1045, P229, DOI 10.1016/j.brainres.2005.03.016; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; Wang Q, 2009, EXP NEUROL, V216, P132, DOI 10.1016/j.expneurol.2008.11.016; WAY EL, 1969, J PHARMACOL EXP THER, V167, P1; Williams JT, 2001, PHYSIOL REV, V81, P299; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yin R, 2007, J THORAC CARDIOV SUR, V134, P780, DOI 10.1016/j.jtcvs.2007.05.001; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zhang GH, 2008, BRAIN RES, V1199, P82, DOI 10.1016/j.brainres.2007.12.043	52	14	14	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	OCT	2015	137						38	43		10.1016/j.pbb.2015.08.002			6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	CS5SB	WOS:000362137200006	26255154				2021-06-18	
J	Moss, JA; Moore, RL; Selleck, CS				Moss, Jacqueline A.; Moore, Randy L.; Selleck, Cynthia S.			Veteran Competencies for Undergraduate Nursing Education	ADVANCES IN NURSING SCIENCE			English	Article						competencies; curricula; Nursing Education; Veterans; Veterans Health		Military Veterans comprise approximately 10% of the US population. Most Veterans do not receive their health care through Veterans Affairs facilities, are seen across the health care system, and their prior military service and associated health issues often go unrecognized. In this study, a modified Delphi design was used to develop a set of 10 Veteran Care Competencies and associated knowledge, skills, and attitudes for Undergraduate Nursing Education: Military and Veteran Culture, Post Traumatic Stress Disorder, Amputation and Assistive Devices, Environmental/Chemical Exposures, Substance Use Disorder, Military Sexual Trauma, Traumatic Brain Injury, Suicide, Homelessness, and Serious Illness Especially at the End of Life.	[Moss, Jacqueline A.] Dept Acute Chron & Continuing Care, Birmingham, AL USA; [Moore, Randy L.] Univ Alabama Birmingham, Sch Nursing, 1720 2nd Ave S, Birmingham, AL 35294 USA; [Moore, Randy L.] Birmingham Vet Affairs Med Ctr, VA Nursing Acad Partnership, Birmingham, AL USA; [Selleck, Cynthia S.] Univ Alabama Birmingham, Sch Nursing, Clin & Global Partnerships, Birmingham, AL 35294 USA	Moss, JA (corresponding author), Univ Alabama Birmingham, Sch Nursing, 1720 2nd Ave S, Birmingham, AL 35294 USA.	mossja@uab.edu			Office of Academic Affiliations through the Veterans Affairs Nursing Academy	This publication was supported in part by the Office of Academic Affiliations through the Veterans Affairs Nursing Academy, a partnership between the Birmingham Veterans Affairs Medical Center and the University of Alabama at Birmingham School of Nursing.	American Nurses Association, 2010, NURS SCOP STAND PRAC; Brown R, 2010, TEACH LEARN NURS, V5, P115, DOI 10.1016/j.teln.2010.02.005; Charan R, 2007, 6 PERSONALITY TRAITS; Cronenwett L, 2007, NURS OUTLOOK, V55, P122, DOI 10.1016/j.outlook.2007.02.006; Institute of Medicine, 2003, HLTH PROFESSIONS ED; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; National Council of State Boards of Nursing, 1996, ASS COMP REG RESP; Pijl-Zieber EM, 2014, NURS EDUC TODAY, V34, P676, DOI 10.1016/j.nedt.2013.09.007; US Department of Veterans Affairs, TRENDS UT VA PROGR S; US Department of Veterans Affairs Office of the Actuary, PROJ VET POP 2013 20	10	14	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0161-9268	1550-5014		ADV NURS SCI	Adv. Nurs. Sci.	OCT-DEC	2015	38	4					306	316		10.1097/ANS.0000000000000092			11	Nursing	Nursing	DD2AT	WOS:000369725500008	26517342				2021-06-18	
J	Zhang, J; Ge, W; Yuan, Z				Zhang, Jian; Ge, Wei; Yuan, Zhen			In vivo three-dimensional characterization of the adult zebrafish brain using a 1325 nm spectral-domain optical coherence tomography system with the 27 frame/s video rate	BIOMEDICAL OPTICS EXPRESS			English	Article							LIGHT-SHEET MICROSCOPY; RECONSTRUCTION; DYNAMICS; PROLIFERATION; NEUROGENESIS	In this study, a spectral-domain optical coherence tomography (SD-OCT) system was used for noninvasive imaging of the adult zebrafish brain. Based on a 1325 nm light source and two high-speed galvo mirrors, our SD-OCT system can offer a large field of view of brain morphology with high resolution (12 mu m axial and 13 mu m lateral) at video rate (27 frame/s). In vivo imaging of both the control and injured brain was performed using adult zebrafish model. The recovered results revealed that olfactory bulb, optic commissure, telencephalon, tectum opticum, cerebellum, medulla, preglomerular complex and posterior tuberculum could be clearly identified in the cross-sectional SD-OCT images of the adult zebrafish brain. The reconstructed results also suggested that SD-OCT can be used for diagnosis and monitoring of traumatic brain injury. In particular, we found the reconstructed volumetric SD-OCT images enable a comprehensive three-dimensional characterization of the control or injured brain in the intact zebrafish. (C)2015 Optical Society of America	[Zhang, Jian; Ge, Wei; Yuan, Zhen] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	Zhang, J (corresponding author), Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China.	zhenyuan@umac.mo	Yuan, zhen/ABG-3111-2020; , 镜海真人（袁振）/ABG-2380-2020		University of Macau in Macau; FDCT grant from Macao government [026/2014/A1];  [SRG2013-00035-FHS];  [MYRG2014-00093-FHS];  [MYRG2015-00036-FHS]	Authors would like to thank Dr. Weiting Chen and Yuqin Fan for their help of raising zebrafish. This study was supported from University of Macau in Macau, SRG2013-00035-FHS Grant, MYRG2014-00093-FHS Grant, MYRG2015-00036-FHS grant and FDCT grant 026/2014/A1 from Macao government.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; An L, 2011, BIOMED OPT EXPRESS, V2, P2770, DOI 10.1364/BOE.2.002770; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hariri S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106013; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Kagemann L, 2008, MOL VIS, V14, P2157; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lin YS, 2013, J BIOPHOTONICS, V6, P668, DOI 10.1002/jbio.201200069; Ma ZH, 2010, BIOMED OPT EXPRESS, V1, P798, DOI 10.1364/BOE.1.000798; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Mueller T, 2008, J COMP NEUROL, V507, P1245, DOI 10.1002/cne.21604; Mueller T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00064; Rao KD, 2009, J BIOPHOTONICS, V2, P288, DOI 10.1002/jbio.200910032; Ronneberger O, 2012, NAT METHODS, V9, P735, DOI [10.1038/NMETH.2076, 10.1038/nmeth.2076]; Siebel AM, 2011, BRAIN RES BULL, V86, P385, DOI 10.1016/j.brainresbull.2011.08.017; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Wullimann MF, 2004, J COMP NEUROL, V475, P143, DOI 10.1002/cne.20183; Yuan Z, 2014, BIOMED OPT EXPRESS, V5, P3011, DOI 10.1364/BOE.5.003011; Yuan Z, 2013, BIOMED OPT EXPRESS, V4, P2629, DOI 10.1364/BOE.4.002629; Yun SH, 2003, OPT EXPRESS, V11, P3598, DOI 10.1364/OE.11.003598; Zhang Q., 2014, J INNOV OPT HEAL SCI, V8; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256	26	14	15	1	15	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	OCT 1	2015	6	10					3932	3940		10.1364/BOE.6.003932			9	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CS7AT	WOS:000362236600025	26504643	DOAJ Gold, Green Published			2021-06-18	
J	Nogueira, ML; Moreira, JD; Baronzio, GF; Dubois, B; Steyaert, JM; Schwartz, L				Nogueira, Marcel Levy; Moreira, Jorgelindo da Veiga; Baronzio, Gian Franco; Dubois, Bruno; Steyaert, Jean-Marc; Schwartz, Laurent			Mechanical stress as the common denominator between chronic inflammation, cancer, and alzheimer's disease	FRONTIERS IN ONCOLOGY			English	Article						cancer; inflammation; fibrosis; pressure; Alzheimer's disease; mechanical stress	TRAUMATIC BRAIN-INJURY; NORMAL-PRESSURE HYDROCEPHALUS; MAGNETIC-RESONANCE ELASTOGRAPHY; PULSE-WAVE ENCEPHALOPATHY; A-BETA PEPTIDE; AMYLOID-BETA; CEREBROSPINAL-FLUID; TAU PATHOLOGY; CELL-DEATH; INTRACRANIAL-PRESSURE	The pathogenesis of common diseases, such as Alzheimer's disease (AD) and cancer, are currently poorly understood. Inflammation is a common risk factor for cancer and AD. Recent data, provided by our group and from others, demonstrate that increased pressure and inflammation are synonymous. There is a continuous increase in pressure from inflammation to fibrosis and then cancer. This is in line with the numerous papers reporting high interstitial pressure in cancer. But most authors focus on the role of pressure in the lack of delivery of chemotherapy in the center of the tumor. Pressure may also be a key factor in carcinogenesis. Increased pressure is responsible for oncogene activation and cytokine secretion. Accumulation of mechanical stress plays a key role in the development of diseases of old age, such as cardiomyopathy, atherosclerosis, and osteoarthritis. Growing evidence suggest also a possible link between mechanical stress in the pathogenesis of AD. The aim of this review is to describe environmental and endogenous mechanical factors possibly playing a pivotal role in the mechanism of chronic inflammation, AD, and cancer.	[Nogueira, Marcel Levy; Dubois, Bruno] Hop La Pitie Salpetriere, AP HP, Dept Neurol, IM2A, Paris, France; [Nogueira, Marcel Levy; Dubois, Bruno] Inst Cerveau & Moelle Epiniere ICM, Inst Neurosci Translat Paris IHU A ICM, Paris, France; [Nogueira, Marcel Levy; Moreira, Jorgelindo da Veiga; Steyaert, Jean-Marc; Schwartz, Laurent] Univ Paris Saclay, Ecole Polytech, Lab Informat LIX, UMR 7161, Palaiseau, France; [Baronzio, Gian Franco] Kines Med Ctr, Integrat Oncol, Milan, Italy; [Dubois, Bruno] Inst Cerveau & Moelle Epiniere ICM, INSERM, CNRS, UMR S975, Paris, France	Schwartz, L (corresponding author), Ecole Polytech, Lab Informat LIX, F-91128 Palaiseau, France.	laurent.schwartz@polytechnique.edu					Abolhassani M, 2008, INFLAMM RES, V57, P419, DOI 10.1007/s00011-007-7213-0; Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Aoyama Y, 2006, J NEUROSURG, V104, P332, DOI 10.3171/ped.2006.104.5.332; Barz H, 2013, MED HYPOTHESES, V81, P768, DOI 10.1016/j.mehy.2013.07.049; Bateman GA, 2004, MED HYPOTHESES, V63, P980, DOI 10.1016/j.mehy.2004.04.019; Bateman GA, 2004, MED HYPOTHESES, V62, P182, DOI 10.1016/S0306-9877(03)00330-X; Bateman GA, 2008, NEURORADIOLOGY, V50, P491, DOI 10.1007/s00234-008-0374-x; Bech RA, 1999, ACTA NEUROCHIR, V141, P633, DOI 10.1007/s007010050353; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Brinckmann P, 2013, MUSCULOSKELETAL BIOM; Cabral Danielle, 2011, Alzheimers Dement, V7, P509, DOI 10.1016/j.jalz.2010.12.008; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carnevale D, 2011, BIOCHEM SOC T, V39, P939, DOI 10.1042/BST0390939; Chakravarty A, 2004, MED HYPOTHESES, V63, P827, DOI 10.1016/j.mehy.2004.03.029; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chetelat G, 2013, NAT REV NEUROL, V9, P123, DOI [10.1038/nrneurol.2013.21, 10.1038/nrneurol.2013.21-c2]; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; DeVita VT, 2011, ROSENBERGS CANC PRIN; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; El Sankari S, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-12; Eyckmans J, 2011, DEV CELL, V21, P35, DOI 10.1016/j.devcel.2011.06.015; Fleury V, 2003, FRACTALS, V11, P397, DOI 10.1142/S0218348X0300204X; Gatson JW, 2013, J NEUROSURG, V118, P1336, DOI 10.3171/2013.2.JNS121771; Golomb J, 2000, J NEUROL NEUROSUR PS, V68, P778, DOI 10.1136/jnnp.68.6.778; Greig NH, 2004, ANN NY ACAD SCI, V1035, P290, DOI 10.1196/annals.1332.018; Grimble RF, 2003, CURR OPIN CLIN NUTR, V6, P21, DOI 10.1097/00075197-200301000-00005; Hachiya NS, 2008, MED HYPOTHESES, V70, P1034, DOI 10.1016/j.mehy.2007.06.043; Hamill OP, 2001, PHYSIOL REV, V81, P685; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Heo KS, 2014, MOL CELLS, V37, P435, DOI [10.14348/molcells.2014.0078, 10.14348/molcells.2014.0108]; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hughes TM, 2013, NEUROLOGY, V81, P1711, DOI 10.1212/01.wnl.0000435301.64776.37; Hutchison JS, 2001, J NEUROTRAUM, V18, P1333, DOI 10.1089/08977150152725632; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jacobs CR, 2013, INTRODUCTION TO CELL MECHANICS AND MECHANOBIOLOGY, P1; Johnson FE, 2000, INT J ONCOL, V16, P617; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Klinge PM, 2006, NEUROREPORT, V17, P657, DOI 10.1097/00001756-200604240-00020; Kristen AV, 2010, CARDIOVASC PATHOL, V19, P228, DOI 10.1016/j.carpath.2009.04.005; Kucewicz JC, 2007, ULTRASOUND MED BIOL, V33, P681, DOI 10.1016/j.ultrasmedbio.2006.11.008; Kurata T, 2014, J STROKE CEREBROVASC, V23, P2580, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.023; LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Lee SJ, 2009, MED HYPOTHESES, V72, P199, DOI 10.1016/j.mehy.2008.09.044; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Locke D, 1998, J PATHOL, V186, P343; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Michael R, 2008, VISION RES, V48, P626, DOI 10.1016/j.visres.2007.12.005; Modesto K, 2014, PROG CARDIOVASC DIS, V57, P111, DOI 10.1016/j.pcad.2014.03.003; Mori F, 2002, NEUROPATHOLOGY, V22, P186, DOI 10.1046/j.1440-1789.2002.00445.x; Murphy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081668; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Nagai K, 2004, J AM GERIATR SOC, V52, P1037, DOI 10.1111/j.1532-5415.2004.52277_15.x; Niggemeyer O, 2012, RHEUMATOL INT, V32, P2645, DOI 10.1007/s00296-011-2005-9; Nogueira ML, 2016, ALZHEIMERS DEMENT, V12, P11, DOI 10.1016/j.jalz.2015.03.005; Nonaka Y, 2008, J NEUROS-PEDIATR, V1, P68, DOI 10.3171/PED-08/01/068; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Peters WS, 1996, ANN BOT-LONDON, V77, P657, DOI 10.1006/anbo.1996.0082; Pierce JES, 1996, J NEUROSCI, V16, P1083; Podolsky DIK, 1994, ALCOHOL RELATED DIS, P1483; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Robicsek F, 2002, ACTA CHIR BELG, V102, P1; Rothwell Peter M, 2013, Recent Results Cancer Res, V191, P121, DOI 10.1007/978-3-642-30331-9_7; Rubenstein E, 1998, LANCET, V351, P283, DOI 10.1016/S0140-6736(97)09234-9; Safar ME, 2012, CURR HYPERTENS REP, V14, P339, DOI 10.1007/s11906-012-0272-9; Savolainen S, 1999, ACTA NEUROCHIR, V141, P849, DOI 10.1007/s007010050386; Schreiber S, 2014, J ALZHEIMERS DIS, V42, pS205, DOI 10.3233/JAD-132618; Schwartz L, 2002, MED HYPOTHESES, V58, P340, DOI 10.1054/mehy.2001.1539; SCHWARTZ L, 2004, CANC GLYCOLYSIS PHYS; Schwartz L, 2008, AM J PHYSIOL-GASTR L, V295, pG934, DOI 10.1152/ajpgi.90296.2008; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Silverberg Gerald, 2006, Cerebrospinal Fluid Res, V3, P7; Silverberg GD, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-2; Silverberg GD, 2010, BRAIN RES, V1317, P286, DOI 10.1016/j.brainres.2009.12.065; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Solar M, 2013, J MECH BEHAV BIOMED, V19, P43, DOI 10.1016/j.jmbbm.2012.10.007; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Thompson D. W., 1942, GROWTH FORM; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Varongchayakul N, 2013, ACS NANO, V7, P7734, DOI 10.1021/nn402322k; Visser AW, 2015, ANN RHEUM DIS, V74, P1842, DOI 10.1136/annrheumdis-2013-205012; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Wostyn P, 2004, MED HYPOTHESES, V62, P925, DOI 10.1016/j.mehy.2004.01.013; WOSTYN P, 1994, MED HYPOTHESES, V43, P219, DOI 10.1016/0306-9877(94)90069-8; Wostyn P, 2008, CLIN NEUROL NEUROSUR, V110, P101, DOI 10.1016/j.clineuro.2007.10.011; Wostyn P, 2010, MED HYPOTHESES, V74, P973, DOI 10.1016/j.mehy.2009.12.019; Xu ZP, 2010, BIOPHYS J, V98, P2053, DOI 10.1016/j.bpj.2009.12.4317; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zhong WJ, 2014, ALZ DIS ASSOC DIS, V28, P44, DOI 10.1097/WAD.0b013e3182949f06	112	14	14	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2234-943X			FRONT ONCOL	Front. Oncol.	SEP 17	2015	5								197	10.3389/fonc.2015.00197			8	Oncology	Oncology	CW6UI	WOS:000365133100001	26442209	DOAJ Gold, Green Published			2021-06-18	
J	Hendriksen, JGM; Peijnenborgh, JCAW; Aldenkamp, AP; Vles, JSH				Hendriksen, J. G. M.; Peijnenborgh, J. C. A. W.; Aldenkamp, A. P.; Vles, J. S. H.			Diagnostic overshadowing in a population of children with neurological disabilities: A cross sectional descriptive study on acquired ADHD	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						ADHD; Neurology; Neuropsychology; Learning disabilities	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; DUCHENNE MUSCULAR-DYSTROPHY; TRAUMATIC BRAIN-INJURY; ADOLESCENTS; DISTURBANCE; TYPE-1	Aim: Diagnostic overshadowing refers to the underdiagnosis of comorbid conditions in children with known neurological diagnoses. To demonstrate diagnostic overshadowing we determined the prevalence of attention deficit-hyperactivity disorders (ADHD) in a cohort of children with a wide range of neurological disabilities. Method: The study cohort consisted of 685 children (mean age 10.3 years, SD: 3.1; 425 boys and 260 girls) who visited a tertiary outpatient multidisciplinary clinic for neurological learning disabilities. Patients with ADHD were identified by retrospective chart review using DSM-IV criteria. Results: The prevalence of ADHD in this cohort was 38.8% (266 children); of these children only 28.2% (75 children) were diagnosed with ADHD before referral. Interpretation: ADHD is a common problem in children with neurological disabilities and may be underdiagnosed due to overshadowing of somatic, physical or syndromal features of the disability. In our heterogeneous population ADHD was overshadowed in 71.8% of the cases. This finding may have important implications for diagnosis and treatment of mental health needs in children with neurological disabilities. (C) 2015 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Hendriksen, J. G. M.; Peijnenborgh, J. C. A. W.; Vles, J. S. H.] Kempenhaeghe, Dept Neurol Learning Disabil, NL-5590 AB Heeze, Netherlands; [Hendriksen, J. G. M.; Peijnenborgh, J. C. A. W.; Aldenkamp, A. P.] Kernpenhaeghe Epilepsy Ctr, Dept Behav Sci, NL-5590 AB Heeze, Netherlands; [Hendriksen, J. G. M.; Aldenkamp, A. P.; Vles, J. S. H.] Maastricht Univ, Med Ctr, Dept Neurol, NL-6202 AZ Maastricht, Netherlands; [Peijnenborgh, J. C. A. W.; Aldenkamp, A. P.; Vles, J. S. H.] Maastricht Univ, Sch Mental Hlth & Neurosci, NL-6229 ER Maastricht, Netherlands; [Aldenkamp, A. P.] Univ Technol, Dept Elect Engn, NL-5600 MB Eindhoven, Netherlands	Hendriksen, JGM (corresponding author), Kempenhaeghe, Ctr Neurol Learning Disabil, POB 61, NL-5590 AB Heeze, Netherlands.	Hendriksenj@kempenhaeghe.nl; Peijnenborghj@kempenhaeghe.nl; Aldenkampb@kempenhaege.nl; Jsh.vles@mumc.nl					Bjorgaas HM, 2012, RES DEV DISABIL, V33, P1287, DOI 10.1016/j.ridd.2012.02.024; Ewen Joshua B, 2005, Semin Pediatr Neurol, V12, P229, DOI 10.1016/j.spen.2005.12.005; Garg S, 2013, DEV MED CHILD NEUROL, V55, P139, DOI 10.1111/dmcn.12043; Goldman LS, 1998, JAMA-J AM MED ASSOC, V279, P1100, DOI 10.1001/jama.279.14.1100; GRAHAM P, 1968, BRIT MED J, V3, P695, DOI 10.1136/bmj.3.5620.695; Johnson H, 2005, DEV MED CHILD NEUROL, V47, P237, DOI 10.1017/S0012162205000460; Lion-Francois L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0142-4; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; Polanczyk G., 2007, AM J PSYCHIAT; REISS S, 1982, AM J MENT DEF, V86, P567; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179	14	14	14	1	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	SEP	2015	19	5					521	524		10.1016/j.ejpn.2015.04.004			4	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CQ7IU	WOS:000360777000004	25976065				2021-06-18	
J	Kasmaei, VM; Asadi, P; Zohrevandi, B; Raouf, MT				Kasmaei, Vahid Monsef; Asadi, Payman; Zohrevandi, Behzad; Raouf, Mohammad Taghi			An Epidemiologic Study of Traumatic Brain Injuries in Emergency Department	EMERGENCY			English	Article						Brain injuries; head injuries; epidemiology; mortality; risk factors	IMPACT; LEGISLATION; OUTCOMES	Introduction: Traumatic brain injuries (TBI) are one of the most important causes of death in patients under the age of 25 years and is responsible for one third of total deaths caused by trauma. Therefore, knowing its epidemiologic pattern in different populations seems vital. Therefore, this study aims to examine the epidemiologic pattern of TBI in emergency department. Methods: In this cross-sectional study, the profiles of 1000 patients affected by TBI were selected using simple random sampling. The examined variables in this study included demographic, season, mechanism of injury, accompanying injuries, level of consciousness, hospitalization duration, computed tomography (CT) scan results, needing surgery, admission to intensive care unit, and outcome of the patient. In the end, independent risk factors for the death of patients were determined. Results: 1000 patients suffering from were studied (81.8% male; mean age 38.5 +/- 21.7 years). The frequency of their referral to hospital in spring (31.4%) was more (p<0.01). 45.9% of the patients had a level of consciousness less than 9 based on the Glasgow Coma Scale (GCS). Subdural (45.9%) and epidural bleeding (23.7%) were the most common findings in CT scans in this study (p<0.001). Finally, 233 (23.3%) of the patients were dead. Over 60 years of age, falling and motorcycle accidents, intracranial hemorrhage accompanied by brain contusion, subdural bleeding, a GCS of less than 9, and the need to be admitted to intensive care unit were independent risk factors of death in TBI. Conclusion: Age Over 60 years, falling and motorcycle accidents, intracranial hemorrhage accompanied by brain contusion, subdural bleeding, a GCS of less than 9, and need to be admitted to intensive care unit were independent risk factors for the death in TBI patients.	[Kasmaei, Vahid Monsef; Asadi, Payman; Zohrevandi, Behzad; Raouf, Mohammad Taghi] Guilan Univ Med Sci, Rd Trauma Res Ctr, Rasht, Iran	Asadi, P (corresponding author), Guilan Univ Med Sci, Rd Trauma Res Ctr, Rasht, Iran.	payman.asadi@yahoo.com	Zohrevandi, Behzad/AAH-7283-2021; Raouf, Mohammad Taghi/AAH-7883-2021	Raouf, Mohammad Taghi/0000-0001-8579-3115			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Asadi P, 2014, IRAN J EMERG MED, V1, P28; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Fakharian E, 2007, FEYZ J KASHAN UNI ME, V11, P21; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Greenwald BD, 2010, ARCH PHYS MED REHAB, V91, P3; Hijar M, 2012, REV PANAM SALUD PUBL, V32, P70, DOI 10.1590/S1020-49892012000700011; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Park E, 2010, CMAJ, V178, P1163; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saadat S, 2015, EMERGENCY, V3, P16; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; World Health Organization, 2008, VIOL INJ DIS BIENN 2; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	22	14	14	0	0	SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED	TEHRAN	SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN	2345-4571			EMERGENCY	Emergency	FAL	2015	3	4					141	145					5	Emergency Medicine	Emergency Medicine	V9Z6K	WOS:000409498900003	26495403	DOAJ Gold			2021-06-18	
J	Zhou, XB; Song, H; Hu, M; Li, XL; Cai, Y; Huang, GP; Li, J; Kang, L; Li, J				Zhou, Xiaobo; Song, Hui; Hu, Min; Li, Xiaolin; Cai, Ying; Huang, Guoping; Li, Jun; Kang, Lin; Li, Jing			Risk factors of severity of post-traumatic stress disorder among survivors with physical disabilities one year after the Wenchuan earthquake	PSYCHIATRY RESEARCH			English	Article						Disaster; Trauma; China; Disability	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; GENERAL-POPULATION; ADULT SURVIVORS; PTSD; CHINA; IMPACT; SYMPTOMS; EXPOSURE; ADOLESCENTS	On May 12,2008, a devastating earthquake measuring 8.0 on the Richter scale struck Wenchuan County and surrounding areas in China. This study aimed to assess post-traumatic stress disorder (PTSD) in the aftermath of the earthquake, and to evaluate factors of severity of PTSD symptoms among survivors with physical disabilities. We conducted a population-based cross-sectional survey and recruited 817 survivors with physical disabilities in three stricken areas. Assessment measures included the PTSD Checklist-Civilian Version (PCL-C) and the 12-item General Health Questionnaire (GHQ-12). Our study showed that 27.42% of the survivors with physical disabilities had PTSD symptoms one year after the Wenchuan earthquake. In the regression model, geographic location, female, suffering from paralysis following the earthquake, and going into a coma in the earthquake were associated with severe PTSD symptoms. Our findings suggest that a substantial proportion of physically disabled survivors of a big earthquake may have severe PTSD symptoms. The associated factors of PTSD identified in our study could inform the implementation of preventive programs for this population and give hint on the way to cope with this kind of disaster in the future. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Zhou, Xiaobo; Li, Xiaolin; Cai, Ying; Kang, Lin; Li, Jing] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu 610041, Sichuan, Peoples R China; [Song, Hui; Huang, Guoping] Third Peoples Hosp Mianyang City, Dept Psychiat, Mianyang City 621000, Sichuan, Peoples R China; [Hu, Min] Fourth Peoples Hosp Chengdu City, Dept Psychiat, Chengdu 610000, Sichuan, Peoples R China; [Li, Jun] Demobilized Vet Hosp Sichuan Prov, Dept Psychiat, Chongzhou City 611200, Sichuan, Peoples R China	Li, J (corresponding author), 28 Dianxinnan St, Chengdu 610041, Sichuan, Peoples R China.	joana028@163.com			863 National Project [2008 AA 022 605]	This work was funded by the 863 National Project (No. 2008 AA 022 605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno Ron, 2007, Am J Public Health, V97 Suppl 1, pS103, DOI 10.2105/AJPH.2006.087007; Agar E, 2006, BEHAV COGN PSYCHOTH, V34, P437, DOI 10.1017/S1352465806002943; Amital D, 2012, ISR MED ASSOC J, V14, P281; [Anonymous], 2008, SOHU NEWS; Bhuvaneswar Chaya G, 2007, Prim Care Companion J Clin Psychiatry, V9, P303; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Broberg AG, 2005, J CHILD PSYCHOL PSYC, V46, P1279, DOI 10.1111/j.1469-7610.2005.01439.x; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Chen ZX, 2009, SEX ROLES, V60, P765, DOI 10.1007/s11199-009-9585-9; Cheng HG, 2012, PSYCHIAT RES, V199, P212, DOI 10.1016/j.psychres.2012.03.019; Cheng YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096644; China Disabled Person's Federation, 2012, TOT POP DIS PEOPL TY; Chiu KB, 2011, ACAD EMERG MED, V18, P1156, DOI 10.1111/j.1553-2712.2011.01206.x; DiGrande L, 2008, J TRAUMA STRESS, V21, P264, DOI 10.1002/jts.20345; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Goldberg D., 1992, GEN HLTH QUESTIONNAI; Grubaugh AL, 2007, DEPRESS ANXIETY, V24, P124, DOI 10.1002/da.20226; Hatcher MB, 2009, BRIT J HEALTH PSYCH, V14, P541, DOI 10.1348/135910708X373445; Hussain A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-232; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Jia ZB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-172; Jones R., 2012, SCI SCOPE, V36, P54; Khamis V, 2012, SOC SCI MED, V74, P2005, DOI 10.1016/j.socscimed.2012.02.025; Klein MB, 2007, J BURN CARE RES, V28, P84, DOI 10.1097/BCR.0b013E31802C888E; Koenen KC, 2002, J NERV MENT DIS, V190, P209, DOI 10.1097/00005053-200204000-00001; Koren D, 2006, CNS SPECTRUMS, V11, P616, DOI 10.1017/S1092852900013675; LI A, 1994, CHIN J REHABIL MED, V10, P96; Li Wenxue, 2013, Shanghai Arch Psychiatry, V25, P306, DOI 10.3969/j.issn.1002-0829.2013.05.006; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Liu ZY, 2012, ASIA-PAC J PUBLIC HE, V24, P21, DOI 10.1177/1010539510373945; Niederkrotenthaler T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083038; Ongecha-Owuor F A, 2004, East Afr Med J, V81, P362; Otis Catherine, 2012, Top Spinal Cord Inj Rehabil, V18, P253, DOI 10.1310/sci1803-253; Peng K., 2010, CHINESE HLTH EC, V29, P33; Pevalin DJ, 2000, SOC PSYCH PSYCH EPID, V35, P508, DOI 10.1007/s001270050272; Roberge Marie-Anne, 2010, Can J Cardiol, V26, pe170; Salazar AM, 2013, SOC PSYCH PSYCH EPID, V48, P545, DOI 10.1007/s00127-012-0563-0; Sareen J, 2014, CAN J PSYCHIAT, V59, P460, DOI 10.1177/070674371405900902; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Tian YL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1073; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Wu ZB, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-126; Xu J, 2005, J INTELL DISABIL RES, V49, P745, DOI 10.1111/j.1365-2788.2005.00744.x; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Ying L, 2014, SUICIDE LIFE THREAT; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhang ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046449, 10.1371/journal.pone.0029651]; Zheng QL, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-25; Zhuoying T.B.Z.Y.Q., 2007, CHIN J SPEC ED, V8, P011	55	14	15	0	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	AUG 30	2015	228	3					468	474		10.1016/j.psychres.2015.05.062			7	Psychiatry	Psychiatry	CP9YI	WOS:000360251400035	26163729				2021-06-18	
J	Zhang, JL; Feng, GJ; Bao, GF; Xu, GH; Sun, YY; Li, WD; Wang, LL; Chen, JJ; Jin, HRC; Cui, ZM				Zhang, Jinlong; Feng, Guijuan; Bao, Guofeng; Xu, Guanhua; Sun, Yuyu; Li, Weidong; Wang, Lingling; Chen, Jiajia; Jin, Huricha; Cui, Zhiming			Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and beta-catenin pathway after spinal cord injury	CELL CYCLE			English	Article						astrocyte proliferation; -catenin; p27; PKM2; spinal cord injury	CELL-CYCLE; PYRUVATE-KINASE; EXPRESSION; REGENERATION; APOPTOSIS; RECOVERY; TARGET; BRAIN; DEATH; M2	Aberrant functionality of the cell cycle has been implicated in the pathology of traumatic SCI. Although it has been reported that the expressions of various cell cycle related proteins were altered significantly following SCI, detailed information on the subject remains largely unclear. The embryonic pyruvate kinase M2 (PKM2) is an important metabolic kinase in aerobic glycolysis or the warburg effect, however, its functions in central nervous system (CNS) injury remains elusive. Here we demonstrate that PKM2 was not only significantly upregulated by western blot and immunohistochemistry but certain traumatic stimuli also induced translocation of PKM2 into the nucleus in astrocytes following spinal cord injury (SCI). Furthermore, the expression levels and localization of p--catenin, p27, cyclin D1 and PCNA were correlated with PKM2 after SCI. In vitro, we also found that PKM2 co-immunoprecipitation with p--catenin and p27 respectively. Knockdown of PKM2 apparently decreased the level of PCNA, cyclinD1, p27 in primary astrocyte cells. Taken together, our findings indicate that nuclear translocation of PKM2 promotes astrocytes proliferation after SCI through modulating cell cycle signaling. These discoveries firstly uncovered the role of PKM2 in spinal cord injury and provided a potential therapeutic target for CNS injury and repair.	[Zhang, Jinlong; Bao, Guofeng; Xu, Guanhua; Sun, Yuyu; Li, Weidong; Wang, Lingling; Chen, Jiajia; Jin, Huricha; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China; [Feng, Guijuan] Nantong Univ, Affiliated Hosp, Dept Stomatol, Nantong 226001, Jiangsu, Peoples R China	Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China.	cuizhiming2012@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271367]	This work was supported by the National Natural Science Foundation of China (No. 81271367).	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Cheng P, 2014, NEUROPHARMACOLOGY, V85, P408, DOI 10.1016/j.neuropharm.2014.06.004; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Cui ZM, 2014, J MOL NEUROSCI, V54, P252, DOI 10.1007/s12031-014-0282-y; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fan FT, 2014, ASIAN PAC J CANCER P, V15, P1961, DOI 10.7314/APJCP.2014.15.5.1961; Fillies T, 2007, ONCOL REP, V17, P355; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu W, 2015, ONCOTARGET, V6, P6570, DOI 10.18632/oncotarget.3262; Huang Y, 2009, CELL MOL NEUROBIOL, V29, P403, DOI 10.1007/s10571-008-9332-8; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Li W, 2009, P NATL ACAD SCI USA, V106, P486, DOI 10.1073/pnas.0804177106; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Park J, 2014, NEURAL REGEN RES, V9, P677, DOI 10.4103/1673-5374.131564; Rivadeneira DB, 2010, GASTROENTEROLOGY, V138, P1920, DOI 10.1053/j.gastro.2010.01.007; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Shen AU, 2008, NEUROCHEM INT, V52, P1266, DOI 10.1016/j.neuint.2008.01.011; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tang L, 2013, CELL CYCLE, V12, P2665, DOI 10.4161/cc.25728; Tator CH, 2002, INJURY PREV, V8, pIV33, DOI 10.1136/ip.8.suppl_4.iv33; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; Wu JF, 2012, CELL CYCLE, V11, P1782, DOI 10.4161/cc.20153; Xia MS, 2014, J NEUROSCI RES, V92, P1078, DOI 10.1002/jnr.23384; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhang JL, 2013, J MOL NEUROSCI, V49, P417, DOI 10.1007/s12031-012-9914-2; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371; Zhao JA, 2011, NEUROCHEM RES, V36, P549, DOI 10.1007/s11064-010-0377-y	46	14	15	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4101	1551-4005		CELL CYCLE	Cell Cycle	AUG 18	2015	14	16					2609	2618		10.1080/15384101.2015.1064203			10	Cell Biology	Cell Biology	CQ0OG	WOS:000360295400020	26151495	Green Published, Bronze			2021-06-18	
J	Brenner, LA; Betthauser, LM; Bahraini, N; Lusk, JL; Terrio, H; Scher, AI; Schwab, KA				Brenner, Lisa A.; Betthauser, Lisa M.; Bahraini, Nazanin; Lusk, Jaimie L.; Terrio, Heidi; Scher, Ann I.; Schwab, Karen A.			Soldiers Returning From Deployment: A Qualitative Study Regarding Exposure, Coping, and Reintegration	REHABILITATION PSYCHOLOGY			English	Article						Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF); posttraumatic stress disorder (PTSD); traumatic brain injury (TBI); qualitative; military	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SYMPTOMS; AFGHANISTAN; VETERANS; IRAQ; CARE; TBI; WAR	Purpose/Objective: The purpose of this study was to qualitatively explore exposure to deployment-related physical and/or emotional trauma and associated symptoms among Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) soldiers. Interviews also focused on in-theater- and reintegration-related experiences. Research Method/Design: OEF/OIF soldiers (N = 103) participated in semistructured interviews, and a qualitative descriptive methodology was used to analyze the data. Results: Themes were identified regarding (a) common experiences related to emotional and physical traumas and associated symptoms and strategies for coping and making meaning of experiences and (b) how combat and reintegration experiences affected soldiers' senses of self, relationships with others, and functioning. Conclusions/Implications: Themes identified support a rethinking of deployment-related mild traumatic brain injury and posttraumatic stress disorder as discrete conditions. Dimensional versus categorical models should be considered. The findings also highlight experiences and potentially meaningful constructs (e.g., moral injury, moral repair) that can be used to inform research and clinical efforts aimed at improving the lives of those who have served.	[Brenner, Lisa A.; Betthauser, Lisa M.; Bahraini, Nazanin; Lusk, Jaimie L.] Mental Illness Res Educ & Clin Ctr, Vet Integrated Serv Network 19, Denver, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin] Univ Colorado Denver, Dept Psychiat, Denver, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Neurol, Denver, CO USA; [Brenner, Lisa A.; Bahraini, Nazanin] Univ Colorado Denver, Dept Phys Med & Rehabil, Denver, CO USA; [Betthauser, Lisa M.] Univ Colorado Denver, Dept Psychol, Denver, CO USA; [Lusk, Jaimie L.] Univ Denver, Grad Sch Profess Psychol, Denver, CO 80208 USA; [Terrio, Heidi] Def & Vet Brain Injury Ctr, Ft Carson, CO USA; [Terrio, Heidi] Evans Army Community Hosp, Colorado Springs, CO USA; [Scher, Ann I.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Schwab, Karen A.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Schwab, Karen A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA	Brenner, LA (corresponding author), Eastern Colorado Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Vet Integrated Serv Network 19, Denver, CO 80220 USA.	lisa.brenner@va.gov	Brenner, Lisa A./AAG-2442-2019	Scher, Ann/0000-0003-4599-9834	U.S. Army Medical Research and Congressionally Directed Medical Research Programs Award [W81XWH-08-2-0105]; Veterans Integrated Service Network 19 Mental Illness Research Education and Clinical Center, located at the Denver VA Medical Center; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The authors have no conflicts of interest to report. This article conforms to applicable governmental regulations and discipline-appropriate ethical standards. Per governmental regulations and the ethical standards described previously, the authors confirm that "In the conduct of research where humans....". "In the conduct of research where humans are the subjects, the investigator(s) adhered to the policies regarding the protection of human subjects as prescribed by Code of Federal Regulations (CFR) Title 45, Vol. 1, Pt. 46; Title 32, chap. 1, Pt. 219; and Title 21, chap. 1, Pt. 50 (Protection of Human Subjects)." Writing of this article was supported by U.S. Army Medical Research and Congressionally Directed Medical Research Programs Award W81XWH-08-2-0105 and the Veterans Integrated Service Network 19 Mental Illness Research Education and Clinical Center, located at the Denver VA Medical Center. The views, opinions, and findings contained in this article are those of the authors and should not be construed as official Department of Defense or Department of Veterans Affairs positions, policies, or decisions unless so designated by other documentation. We thank those who facilitated and conducted interviews (Denise Strasser, Maria Devore, Parri Hinton, Colleen Costello, and Joseph Huggins). We appreciate the support of the Defense and Veterans Brain Injury Center. Kathleen Chwalisz provided invaluable feedback regarding initial drafts of the manuscript. We also thank the soldiers who participated, and are grateful for their willingness to describe their lived experiences.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Bahraini N, 2013, J HEAD TRAUMA REHAB, V28, P223, DOI 10.1097/HTR.0b013e318291dab7; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Brenner L.A., 2008, J MENT HLTH COUNS, V30, P211; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Denzin N. K., 1978, RES ACT THEORETICAL; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Diekelmann NL, 1989, NLN CRITERIA APPRAIS; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iversen A, 2007, CLIN PSYCHOL REV, V27, P842, DOI 10.1016/j.cpr.2007.07.006; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Jolly R., 1996, CHANGING STEP; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Maguen S, 2009, J TRAUMA STRESS, V22, P435, DOI 10.1002/jts.20451; Miles Huberman, 1994, QUALITATIVE DATA ANA; Moustakas C., 1994, PHENOMENOLOGICAL RES; Nazem S, 2014, J CLIN PSYCHIAT, V75, pE947, DOI 10.4088/JCP.14com09450; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Patton MQ., 1990, QUALITATIVE EVALUATI; Sampson R., 1997, ADV CRIMINOLOGICAL T, V7, P133; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Weathers F. W., 1993, ANN M INT SOC TRAUM	30	14	14	0	32	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2015	60	3					277	285		10.1037/rep0000048			9	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	CR0UB	WOS:000361037600008	26147237	Bronze			2021-06-18	
J	Griesdale, DE; Sekhon, MS; Menon, DK; Lavinio, A; Donnelly, J; Robba, C; Sekhon, IS; Taylor, A; Henderson, WR; Turgeon, AF; Gupta, AK				Griesdale, Donald E.; Sekhon, Mypinder S.; Menon, David K.; Lavinio, Andrea; Donnelly, Joseph; Robba, Chiara; Sekhon, Indeep S.; Taylor, Andrew; Henderson, William R.; Turgeon, Alexis F.; Gupta, Arun K.			Hemoglobin Area and Time Index Above 90 g/L are Associated with Improved 6-Month Functional Outcomes in Patients with Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Anemia; Brain injuries; Blood transfusion; Glasgow Outcome Scale; Neurocritical care; Area under curve	BLOOD-CELL TRANSFUSION; CRITICALLY-ILL; CLINICAL-PRACTICE; ANEMIA; INCREASES; MORTALITY; INFECTION; EVENTS	There is conflicting data on the relationship between anemia and outcomes in patients with traumatic brain injuries (TBI). The objective of this study was to determine if the proportion of time and area under the hemoglobin-time curve of a parts per thousand yen90 g/L are independently associated with 6-month functional outcomes. Retrospective cohort study of 116 patients with a severe TBI who underwent invasive neuromonitoring between June 2006 and December 2013. Hemoglobin area (HAI) and time (HTI) indices were calculated by dividing the total area, or time, under the hemoglobin-time curve at 90 g/L or above by the total duration of monitoring. Multivariable log-binomial regression was used to model the association between HAI or HTI and 6 month favorable neurologic outcome (Glasgow Outcome Score 4 or 5). Patients had a mean age of 38 years (SD 16) with a median admission Glasgow Coma Scale of 6 (IQR 4-7). There were 1523 hemoglobin measurements and 523 monitoring days. Patients had a hemoglobin a parts per thousand yen90 g/L for a median of 70 % (IQR 37-100) of the time. Each 10 g/L increase in HAI (RR 1.23, 95 %CI 1.04-1.44, P = 0.011), and 10 % increase in HTI (1.10, 95 %CI 1.04-1.16, P < 0.001) were associated with improved neurologic outcome. Thirty-one patients (27 %) received a transfusion with the median pre-transfusion hemoglobin being 81 g/L (IQR 76-87). In patients with severe TBI, increased area under the curve and percentage of time that the hemoglobin concentration was a parts per thousand yen90 g/L, were associated with improved neurologic outcomes.	[Griesdale, Donald E.; Sekhon, Mypinder S.; Sekhon, Indeep S.; Henderson, William R.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Menon, David K.; Lavinio, Andrea; Donnelly, Joseph; Robba, Chiara; Taylor, Andrew; Gupta, Arun K.] Univ Cambridge, Addenbrookes Hosp, Cambridge Univ Hosp Trust, Neurocrit Care Unit, Cambridge CB2 2QQ, England; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care, Quebec City, PQ, Canada; [Turgeon, Alexis F.] Univ Laval, CHU Quebec Res Ctr, Populat Hlth & Optimal Hlth Practices Unit, Quebec City, PQ, Canada	Griesdale, DE (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Room 2438,Jim Pattison Pavil,2nd Floor, Vancouver, BC V5Z 1M9, Canada.	donald.griesdale@vch.ca	Donnelly, Joseph/N-6803-2019; Lavinio, Andrea/M-1778-2016; Donnelly, Joseph/E-9235-2018; Robba, Chiara/AAS-7421-2020	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Griesdale, Donald/0000-0001-5985-8624	VGH & UBC Hospital Foundation Best of Health Fund; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	Dr. Griesdale is funded by the VGH & UBC Hospital Foundation Best of Health Fund.	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Claridge JA, 2002, AM SURGEON, V68, P566; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Griesdale DEG, 2015, J CRIT CARE, V30, P111, DOI 10.1016/j.jcrc.2014.07.026; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; Hill GE, 2003, J TRAUMA, V54, P908, DOI 10.1097/01.TA.0000022460.21283.53; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mackenzie IMJ, 2011, INTENS CARE MED, V37, P435, DOI 10.1007/s00134-010-2103-2; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Roberts DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11489; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sekhon MS, 2011, J CRIT CARE, V26, P357, DOI 10.1016/j.jcrc.2010.12.001; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vogelzang M, 2004, CRIT CARE, V8, pR122, DOI 10.1186/cc2840; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	33	14	14	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2015	23	1					78	84		10.1007/s12028-014-0096-3			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	CN8FJ	WOS:000358674600012	25510896				2021-06-18	
J	Karagyaur, M; Dyikanov, D; Makarevich, P; Semina, E; Stambolsky, D; Plekhanova, O; Kalinina, N; Tkachuk, V				Karagyaur, M.; Dyikanov, D.; Makarevich, P.; Semina, E.; Stambolsky, D.; Plekhanova, O.; Kalinina, N.; Tkachuk, V.			Non-viral transfer of BDNF and uPA stimulates peripheral nerve regeneration	BIOMEDICINE & PHARMACOTHERAPY			English	Article						BDNF; Urokinase; Nerve regeneration	PLASMINOGEN-ACTIVATOR; SCIATIC-NERVE; NEUROTROPHIC FACTORS; INJURY; ANGIOGENESIS; SKELETAL; PROTECTS; MUSCLE	Peripheral nerves connect brain and spinal cord with the extremities and inner organs, and nerves injury can lead the disability and social exclusion. Growth factors and other natural stimulators of regeneration processes look very promising as future medicines. In our study, we tested the influence of genetic constructions that contain genes of brain-derived neurotrophic factor and urokinase plasminogen activator on nerve's structure and function after traumatic and ischemic injuries. Injection of pVax1-hBDNF and pVax1-muPA after traumatic injury led to better restoration of nerve's structure and function compared to similar parameters of control group mice. In ischemic injury model pVax1-hBDNF and pVax1-muPA slowed and reduced the damage progression and stimulated nerve regeneration as well. However, the treatment with pVax1-muPA was less effective after the traumatic injury. As we chose a non-viral method of gene delivery during our study the optimal conditions of plasmid intramuscular delivery were also determined. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Karagyaur, M.; Makarevich, P.; Semina, E.; Stambolsky, D.; Plekhanova, O.; Tkachuk, V.] Russian Cardiol Res & Prod Complex, Inst Expt Cardiol, Moscow 121552, Russia; [Dyikanov, D.; Kalinina, N.; Tkachuk, V.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biol & Med Chem, Moscow 119192, Russia	Kalinina, N (corresponding author), Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biol & Med Chem, Lomonosovsky Prospekt 31-5, Moscow 119192, Russia.	n_i_kalinina@mail.ru	Stambolsky, Dmitry/A-8358-2014; Semina, Ekaterina V/A-8184-2014; Tkachuk, Vsevolod A/J-9357-2012; Kalinina, Natalia/AAN-6763-2020; Plekhanova, Olga/B-9945-2014; Kalinina, Natalia I./L-6475-2013; Semina, Ekaterina/AAB-4817-2020; Makarevich, Pavel/A-8157-2014; Karagyaur, Maxim N/A-8385-2014	Stambolsky, Dmitry/0000-0001-6983-9697; Kalinina, Natalia/0000-0003-3497-9619; Plekhanova, Olga/0000-0002-4693-295X; Kalinina, Natalia I./0000-0003-3497-9619; Semina, Ekaterina/0000-0002-3927-9286; Makarevich, Pavel/0000-0001-8869-5190; Karagyaur, Maxim N/0000-0003-4289-3428; Tkachuk, Vsevolod/0000-0002-7492-747X	Russian Scientific Foundation (project RNF)Russian Science Foundation (RSF) [14-24-00086]	This study was supported by Russian Scientific Foundation (project RNF No 14-24-00086).	Adams RA, 2004, MOL INTERV, V4, P163; Adams WE, 1943, J ANAT, V77, P243; Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157; Balezina O. P., 2004, Uspekhi Fiziologicheskikh Nauk, V35, P37; Balezina OP, 2005, B EXP BIOL MED+, V139, P4, DOI 10.1007/s10517-005-0196-3; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Burnett MG, 2004, NEUROSURG FOCUS, V16, pE1; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Cho E, 2012, NEUROBIOL DIS, V46, P215, DOI 10.1016/j.nbd.2012.01.010; Jang HS, 2004, MOL THER, V9, P464, DOI 10.1016/j.ymthe.2003.12.002; Kadiyala RK, 2005, J BONE JOINT SURG BR, V87B, P337, DOI 10.1302/0301-620X.87B3.15694; Li ST, 2014, CNS NEUROSCI THER, V20, P154, DOI 10.1111/cns.12182; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Makarevich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038776; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Tkachuk VA, 2009, CAN J PHYSIOL PHARM, V87, P231, DOI 10.1139/Y08-113; Traktuev DO, 2007, MOL THER, V15, P1939, DOI 10.1038/sj.mt.6300262; Vard'ya I V, 2000, Dokl Biol Sci, V371, P112; Wong KH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/neq062; Zeder M, 2005, SOFTWARE FOR BIOL	22	14	20	2	9	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	AUG	2015	74						63	70		10.1016/j.biopha.2015.07.002			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	CR2TD	WOS:000361182600009	26349964				2021-06-18	
J	Lee, JY; Lee, CY; Kim, HR; Lee, CH; Kim, HW; Kim, JH				Lee, Jae Yoon; Lee, Cheol Young; Kim, Hong Rye; Lee, Chang-Hyun; Kim, Hyun Woo; Kim, Jong Hyun			A Role of Serum-Based Neuronal and Glial Markers as Potential Predictors for Distinguishing Severity and Related Outcomes in Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Brain injuries; Biological markers; S100 Calcium Binding Protein beta Subunit; Glial fibrillary acidic protein; Ubiquitin thiolesterase	FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE; KINASE-BB ISOENZYME; CREATINE-KINASE; CEREBROSPINAL-FLUID; S-100 PROTEIN; ENOLASE; BLOOD; S100B; INFARCTION	Objective : Optimal treatment decision and estimation of the prognosis in traumatic brain injury (TBI) is currently based on demographic and clinical predictors. But sometimes, there are limitations in these factors. In this study, we analyzed three central nervous system biomarkers in TBI patients, will discuss the roles and clinical applications of biomarkers in TBI. Methods : From July on 2013 to August on 2014, a total of 45 patients were included. The serum was obtained at the time of hospital admission, and biomarkers were extracted with centrifugal process. It was analyzed for the level of S-100 beta (S100B), glial fibrillary acidic protein (GFAP), and ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1). Results : This study included 33 males and 12 females with a mean age of 58.5 (19-84) years. TBI patients were classified into two groups. Group A was severe TBI with Glasgow Coma Scale (GCS) score 3-5 and Group B was mild TBI with GCS score 13-15. The median serum concentration of S100B, GFAP, and UCH-L1 in severe TBI were raised 5.1 fold, 5.5 fold, and 439.1 fold compared to mild injury, respectively. The serum levels of these markers correlated significantly with the injury severity and clinical outcome (p<0.001). Increased level of markers was strongly predicted poor outcomes. Conclusion : S100B, GFAP, and UCH-L1 serum level of were significantly increased in TBI according to severity and associated clinical outcomes. Biomarkers have potential utility as diagnostic, prognostic, and therapeutic adjuncts in the setting of TBI.	[Lee, Jae Yoon; Lee, Cheol Young; Kim, Hong Rye; Lee, Chang-Hyun; Kim, Hyun Woo; Kim, Jong Hyun] Konyang Univ Hosp, Dept Neurosurg, Taejon 35365, South Korea; [Lee, Cheol Young] Kyung Hee Univ, Grad Sch Med, Seoul, South Korea; [Lee, Cheol Young] Konyang Univ, Myunggok Med Res Inst, Taejon, South Korea	Lee, CY (corresponding author), Konyang Univ Hosp, Dept Neurosurg, 158 Gwanjeodong Ro, Taejon 35365, South Korea.	leecy009@hanmail.net		Lee, Chang-Hyun/0000-0003-0134-2101	Konyang University Myunggok Research Fund	This work was supported (in part) by Konyang University Myunggok Research Fund of 2013.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-71; HAMM CW, 1995, CURR OPIN CARDIOL, V10, P355, DOI 10.1097/00001573-199507000-00003; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; HANS P, 1987, J NEUROSURG, V66, P714, DOI 10.3171/jns.1987.66.5.0714; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kleiman NS, 2002, J AM COLL CARDIOL, V40, P1044, DOI 10.1016/S0735-1097(02)02119-8; KRUSE A, 1991, ACTA NEUROCHIR, V110, P106, DOI 10.1007/BF01400675; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mishra A, 2012, J PEDIATR NEUROSCI, V7, P71, DOI 10.4103/1817-1745.97633; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Park JE, 2009, J KOREAN NEUROSURG S, V45, P90, DOI 10.3340/jkns.2009.45.2.90; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; USUI A, 1989, CLIN CHEM, V35, P1942; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yoon KH, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-71; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	36	14	15	0	3	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	AUG	2015	58	2					93	100		10.3340/jkns.2015.58.2.93			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CX1ZT	WOS:000365495300001	26361523	DOAJ Gold, Green Published			2021-06-18	
J	Ning, YL; Yang, N; Chen, X; Zhao, ZA; Zhang, XZ; Chen, XY; Li, P; Zhao, Y; Zhou, YG				Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Zhang, Xiu-Zhu; Chen, Xing-Yun; Li, Ping; Zhao, Yan; Zhou, Yuan-Guo			Chronic caffeine exposure attenuates blast-induced memory deficit in mice	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Brain injuries; Caffeine; Memory disorders; Blast injuries		Objective: To investigate the effects of three different ways of chronic caffeine administration on blast-induced memory dysfunction and to explore the underlying mechanisms. Methods: Adult male C57BL/6 mice were used and randomly divided into five groups: control: without blast exposure, con-water: administrated with water continuously before and after blast-induced traumatic brain injury (bTBI), con-caffeine: administrated with caffeine continuously for 1 month before and after bTBI, pre-caffeine: chronically administrated with caffeine for 1 month before bTBI and withdrawal after bTBI, post-caffeine: chronically administrated with caffeine after bTBI. After being subjected to moderate intensity of blast injury, mice were recorded for learning and memory performance using Morris water maze (MWM) paradigms at 1, 4, and 8 weeks post-blast injury. Neurological deficit scoring, glutamate concentration, proinflammatory cytokines production, and neuropathological changes at 24 h, 1, 4, and 8 weeks post-bTBI were examined to evaluate the brain injury in early and prolonged stages. Adenosine A1 receptor expression was detected using qPCR. Results: All of the three ways of chronic caffeine exposure ameliorated blast-induced memory deficit, which is correlated with the neuroprotective effects against excitotoxicity, inflammation, astrogliosis and neuronal loss at different stages of injury. Continuous caffeine treatment played positive roles in both early and prolonged stages of bTBI; pre-bTBI and post-bTBI treatment of caffeine tended to exert neuroprotective effects at early and prolonged stages of bTBI respectively. Up-regulation of adenosine A1 receptor expression might contribute to the favorable effects of chronic caffeine consumption. Conclusion: Since caffeinated beverages are widely consumed in both civilian and military personnel and are convenient to get, the results may provide a promising prophylactic strategy for blast-induced neurotrauma and the consequent cognitive impairment. (C) 2015 Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.	[Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Chen, Xing-Yun; Li, Ping; Zhao, Yan; Zhou, Yuan-Guo] Third Mil Med Univ, Mol Biol Ctr, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing, Peoples R China; [Ning, Ya-Lei; Yang, Nan; Chen, Xing; Zhao, Zi-Ai; Zhang, Xiu-Zhu; Chen, Xing-Yun; Li, Ping; Zhao, Yan; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Zhang, Xiu-Zhu] Third Mil Med Univ, Dept 4, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing, Peoples R China	Zhou, YG (corresponding author), Third Mil Med Univ, Mol Biol Ctr, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing, Peoples R China.	yuanguo.zhou@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201461]; Key Project of Medicine and Health of PLA [08G098]; Natural Science Foundation of Chongqing, ChinaNatural Science Foundation of Chongqing [CSTC2012jjA10107]	We gratefully acknowledge Prof. Zhi-Yong Yin, senior engineers Xiao-Yan Li and Xin Ning for their technical support on the BST-I bio-shock tube. We thank Academician Zheng-Guo Wang for critically reading and editing the manuscript. This work was supported by the grants from National Natural Science Foundation of China (No. 81201461), Key Project of Medicine and Health of PLA (No. 08G098) and the Natural Science Foundation of Chongqing, China (No. CSTC2012jjA10107).	Arendash GW, 2009, J ALZHEIMERS DIS, V17, P661, DOI 10.3233/JAD-2009-1087; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; BENOWITZ NL, 1990, ANNU REV MED, V41, P277, DOI 10.1146/annurev.me.41.020190.001425; Boison Detlev, 2011, Handb Exp Pharmacol, P251, DOI 10.1007/978-3-642-13443-2_9; Bura SA, 2008, PAIN, V140, P95, DOI 10.1016/j.pain.2008.07.012; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Cunha RA, 2008, CURR PHARM DESIGN, V14, P1512, DOI 10.2174/138161208784480090; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROCHEM, V113, P1536, DOI 10.1111/j.1471-4159.2010.06716.x; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Espinosa J, 2013, J ALZHEIMERS DIS, V34, P509, DOI 10.3233/JAD-111982; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Fredholm Bertil B, 2004, Lakartidningen, V101, P2552; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002; Gui L, 2009, BRAIN RES, V1297, P185, DOI 10.1016/j.brainres.2009.08.050; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Hoge CW, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Jacobson KA, 1996, TRENDS PHARMACOL SCI, V17, P108, DOI 10.1016/0165-6147(96)10002-X; Johansson B, 1997, BRAIN RES, V762, P153, DOI 10.1016/S0006-8993(97)00378-8; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li W, 2009, EXP NEUROL, V215, P69, DOI 10.1016/j.expneurol.2008.09.012; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Liu MD, 2014, CHIN J TRAUMATOL, V17, P317, DOI 10.3760/cma.j.issn.1008-1275.2014.06.003; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ning YL, 2013, J CEREBR BLOOD F MET, V33, P1789, DOI 10.1038/jcbfm.2013.127; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Sachse KT, 2008, J CEREBR BLOOD F MET, V28, P395, DOI 10.1038/sj.jcbfm.9600539; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Scott HA, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.008; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Thong FSL, 2002, J APPL PHYSIOL, V92, P2347, DOI 10.1152/japplphysiol.01229.2001; Vijayanathan V, 2011, BEHAV BRAIN RES, V225, P491, DOI 10.1016/j.bbr.2011.08.006; Wei CJ, 2011, LEARN MEMORY, V18, P459, DOI 10.1101/lm.2136011; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhou SJ, 2009, BRAIN RES, V1303, P74, DOI 10.1016/j.brainres.2009.09.082	43	14	14	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2015	18	4					204	211		10.1016/j.cjtee.2015.10.003			8	Orthopedics	Orthopedics	VF1NE	WOS:000442089500004	26764541	DOAJ Gold			2021-06-18	
J	Schatz, P; Ybarra, V; Leitner, D				Schatz, Philip; Ybarra, Vincent; Leitner, Donald			Validating the Accuracy of Reaction Time Assessment on Computer-Based Tablet Devices	ASSESSMENT			English	Article						computer-based assessment; timing accuracy; reaction time	NEUROPSYCHOLOGICAL ASSESSMENT; IPAD VERSION; MILLITIMER; CONCUSSION; MACINTOSH; PAPER	Computer-based assessment has evolved to tablet-based devices. Despite the availability of tablets and apps, there is limited research validating their use. We documented timing delays between stimulus presentation and (simulated) touch response on iOS devices (3rd- and 4th-generation Apple iPads) and Android devices (Kindle Fire, Google Nexus, Samsung Galaxy) at response intervals of 100, 250, 500, and 1,000 milliseconds (ms). Results showed significantly greater timing error on Google Nexus and Samsung tablets (81-97 ms), than Kindle Fire and Apple iPads (27-33 ms). Within Apple devices, iOS 7 obtained significantly lower timing error than iOS 6. Simple reaction time (RT) trials (250 ms) on tablet devices represent 12% to 40% error (30-100 ms), depending on the device, which decreases considerably for choice RT trials (3-5% error at 1,000 ms). Results raise implications for using the same device for serial clinical assessment of RT using tablets, as well as the need for calibration of software and hardware.	[Schatz, Philip; Ybarra, Vincent; Leitner, Donald] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA	Schatz, P (corresponding author), St Josephs Univ, Psychol, 222 Post Hall,5600 City Ave, Philadelphia, PA 19131 USA.	schatzSJU@gmail.com					American Psychological Association (APA), 1986, GUID COMP BAS TESTS; Apple, 2014, NEW GAM PLAN CONC; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Bertucco M, 2014, J CHILD NEUROL, V29, P1460, DOI 10.1177/0883073813494265; Black JM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002730; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Clionsky M, 2014, CLIN NEUROPSYCHOL, V28, P747, DOI 10.1080/13854046.2014.913686; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; De Clercq A, 2003, BEHAV RES METH INS C, V35, P109, DOI 10.3758/BF03195502; Dorr M, 2013, INVEST OPHTH VIS SCI, V54, P7266, DOI 10.1167/iovs.13-11743; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; MacInnes WJ, 2001, BEHAV RES METH INS C, V33, P174, DOI 10.3758/BF03195363; McKinney CJ, 1999, BEHAV RES METH INS C, V31, P129, DOI 10.3758/BF03207703; Onoda K, 2013, CLIN INTERV AGING, V8, P353, DOI 10.2147/CIA.S42342; Pearson, 2013, Q INT GROUNDBR MOB S; Pew, 2014, INT PROJ OMN SURV; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Seashore SH, 1941, J EXP PSYCHOL, V29, P342, DOI 10.1037/h0061571; Turpin A, 2014, J VISION, V14, DOI 10.1167/14.3.16; Van Tasell DJ, 2013, OTOL NEUROTOL, V34, P9, DOI 10.1097/MAO.0b013e318278c05d; WESTALL R, 1986, BEHAV RES METH INSTR, V18, P307, DOI 10.3758/BF03204405; WESTALL RF, 1989, BEHAV RES METH INSTR, V21, P540, DOI 10.3758/BF03202886; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	25	14	14	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	AUG	2015	22	4					405	410		10.1177/1073191114566622			6	Psychology, Clinical	Psychology	CN0DD	WOS:000358082100002	25612627				2021-06-18	
J	Seel, RT; Corrigan, JD; Dijkers, MP; Barrett, RS; Bogner, J; Smout, RJ; Garmoe, W; Horn, SD				Seel, Ronald T.; Corrigan, John D.; Dijkers, Marcel P.; Barrett, Ryan S.; Bogner, Jennifer; Smout, Randall J.; Garmoe, William; Horn, Susan D.			Patient Effort in Traumatic Brain Injury Inpatient Rehabilitation: Course and Associations With Age, Brain Injury Severity, and Time Postinjury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Amnesia; anterograde; Craniocerebral trauma; Psychomotor agitation; Rehabilitation	FUNCTIONAL INDEPENDENCE MEASURE; AGITATED BEHAVIOR SCALE; PSYCHOMETRIC PROPERTIES; GALVESTON ORIENTATION; RATING-SCALE; AMNESIA TEST; HEAD-INJURY; RELIABILITY; VALIDITY; PARTICIPATION	Objective: To describe patients' level of effort in occupational, physical, and speech therapy sessions during traumatic brain injury (TBI) inpatient rehabilitation and to evaluate how age, injury severity, cognitive impairment, and time are associated with effort. Design: Prospective, multicenter, longitudinal cohort study. Setting: Acute TBI rehabilitation programs. Participants: Patients (N=1946) receiving 138,555 therapy sessions. Interventions: Not applicable. Main Outcome Measures: Effort in rehabilitation sessions rated on the Rehabilitation Intensity of Therapy Scale, FIM, Comprehensive Severity Index brain injury severity score, posttraumatic amnesia (PTA), and Agitated Behavior Scale (ABS). Results: The Rehabilitation Intensity of Therapy Scale effort ratings in individual therapy sessions closely conformed to a normative distribution for all 3 disciplines. Mean Rehabilitation Intensity of Therapy Scale ratings for patients' therapy sessions were higher in the discharge week than in the admission week (P<.001). For patients who completed 2, 3, or 4 weeks of rehabilitation, differences in effort ratings (P<.001) were observed between 5 subgroups stratified by admission FIM cognitive scores and over time. In linear mixed-effects modeling, age and Comprehensive Severity Index brain injury severity score at admission, days from injury to rehabilitation admission, days from admission, and daily ratings of PTA and ABS score were predictors of level of effort (P<.0001). Conclusions: Patients' level of effort can be observed and reliably rated in the TBI inpatient rehabilitation setting using the Rehabilitation Intensity of Therapy Scale. Patients who sustain TBI show varying levels of effort in rehabilitation therapy sessions, with effort tending to increase over the stay. PTA and agitated behavior are primary risk factors that substantially reduce patient effort in therapies. (C) 2015 by the American Congress of Rehabilitation Medicine	[Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA 30309 USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Dijkers, Marcel P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Barrett, Ryan S.; Smout, Randall J.; Horn, Susan D.] Int Sever Informat Syst, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Garmoe, William] Medstar Natl Rehabil Hosp, Washington, DC USA	Seel, RT (corresponding author), Shepherd Ctr, Crawford Res Inst, 6th Fl,2020 Peachtree Rd, Atlanta, GA 30309 USA.	ron_seel@shepherd.org			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01), and the National Institute on Disability and Rehabilitation Research (grant no. H133A080023); Publication of this article was supported by the American Congress of Rehabilitation Medicine	Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Christensen AL, 1998, J HEAD TRAUMA REHAB, V13, P79, DOI 10.1097/00001199-199810000-00009; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Department of Biostatistics Vanderbilt University, STAT PROBL DOC AV; Dijkers MP, 2012, J SPINAL CORD MED, V35, P624, DOI 10.1179/2045772312Y.0000000065; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Institute of Medicine, 2007, FUTURE DISABILITY AM; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Lequerica AH, 2006, REHABIL PSYCHOL, V51, P331, DOI 10.1037/0090-5550.51.4.331; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lu L, 2007, P N E SAS US GROUP C; Maclean N, 2000, SOC SCI MED, V50, P495; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Seel R, 2002, REHABILITATION INTEN; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS97, DOI 10.1016/j.apmr.2012.04.008; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Steyerberg EW., 2009, CLIN PREDICTION MODE; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; 2004, AM HERITAGE COLL DIC	36	14	14	0	22	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S235	S244		10.1016/j.apmr.2014.10.027			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100006	26212400	Green Accepted			2021-06-18	
J	Sima, AP; Wehman, PH; Chan, F; West, MD; Leucking, RG				Sima, Adam P.; Wehman, Paul H.; Chan, Fong; West, Michael D.; Leucking, Richard G.			An Evaluation of Risk Factors Related to Employment Outcomes for Youth With Disabilities	CAREER DEVELOPMENT AND TRANSITION FOR EXCEPTIONAL INDIVIDUALS			English	Article						disabilities; youth; transition; employment; classification tree; NLTS2	TRAUMATIC BRAIN-INJURY; VOCATIONAL-REHABILITATION; WORK PARTICIPATION; TREE ANALYSIS; YOUNG-ADULTS; CLASSIFICATION; PREDICTORS; TRANSITION; ADOLESCENTS; EDUCATION	This study explores non-modifiable risk factors associated with poor post-school competitive employment outcomes for students with disabilities. A classification tree analysis was used with a sample of 2,900 students who were in the second National Longitudinal Transition Study-2 (NLTS2) up to 6 years following school exit to identify groups of youth with poor employment outcomes based on characteristics that are unable to be modified through an intervention. Post-school employment was related to the disability characteristics of the student (disability type, ability to understand what is being said, general health status), family characteristics (yearly income, community setting), and youth characteristics (race). The classification tree analysis identified four groups of students who were at greatest risk for poor outcomes. Future research will be directed toward modifiable variables that mitigate risks for those groups that may potentially lead to school-and home-based interventions.	[Sima, Adam P.; Wehman, Paul H.; Chan, Fong; West, Michael D.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Leucking, Richard G.] TransCen Inc, Rockville, MD USA	West, MD (corresponding author), Virginia Commonwealth Univ, Rehabil Res & Training Ctr, POB 842011, Richmond, VA 23284 USA.	mdwest@vcu.edu		Sima, Adam/0000-0001-8426-9987			Achterberg TJ, 2009, J OCCUP REHABIL, V19, P129, DOI 10.1007/s10926-009-9169-0; Achterberg TJ, 2012, DISABIL REHABIL, V34, P1519, DOI 10.3109/09638288.2011.650311; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Camp NJ, 2002, CANCER CAUSE CONTROL, V13, P813, DOI 10.1023/A:1020611416907; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Carter EW, 2011, J SPEC EDUC, V45, P89, DOI 10.1177/0022466909353204; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chan F, 2006, DISABIL REHABIL, V28, P257, DOI 10.1080/09638280500158307; Chan F., 2005, J APPL REHABILITATIO, V36, P3; Chan JYC, 2011, REHABIL RES POL EDUC, V25, P135, DOI 10.1891/216866511805001019; Chang LY, 2013, SAFETY SCI, V51, P17, DOI 10.1016/j.ssci.2012.06.017; DeVivo Michael J, 2002, J Spinal Cord Med, V25, P335; Doren B, 1998, J SPEC EDUC, V31, P425, DOI 10.1177/002246699803100402; Gan XM, 2011, J NEUROL SCI, V306, P108, DOI 10.1016/j.jns.2011.03.032; Grobman WA, 2006, AM J OBSTET GYNECOL, V194, P888, DOI 10.1016/j.ajog.2005.09.002; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Hand D., 2001, ADAP COMP MACH LEARN; Hasnain R, 2009, J VOCAT REHABIL, V31, P175, DOI 10.3233/JVR-2009-0487; Hastie T., 2009, ELEMENTS STAT LEARNI; Kohler PA, 2003, J SPEC EDUC, V37, P174, DOI 10.1177/00224669030370030701; Kolakowsky-Hayner SA, 2010, BRAIN INJURY, V24, P1428, DOI 10.3109/02699052.2010.523039; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Lindsay R, 2007, BONE, V40, pS32, DOI 10.1016/j.bone.2007.03.004; Lindsay S, 2011, DISABIL REHABIL, V33, P843, DOI 10.3109/09638288.2010.514018; McMahon BT, 2008, J OCCUP REHABIL, V18, P133, DOI 10.1007/s10926-008-9136-1; Michon H, 2005, SOC PSYCH PSYCH EPID, V40, P408, DOI 10.1007/s00127-005-0910-5; Newman L., 2011, 20113005 NCSER; Olshen RA, 1984, CLASSIFICATION REGRE; Rabren K., 2002, CAREER DEV EXCEPTION, V25, P25, DOI [10.1177/088572880202500103, DOI 10.1177/088572880202500103]; Reker DM, 2005, J REHABIL RES DEV, V42, P77, DOI 10.1682/JRRD.2003.11.0164; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Wagner M, 2005, J EMOT BEHAV DISORD, V13, P25, DOI 10.1177/10634266050130010301; Wehman P., 2013, PREDICTORS TRA UNPUB; West M., 2008, MONOGRAPH WORKPLACE, P191	34	14	14	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2165-1434	2165-1442		CAREER DEV TRANSIT E	Career Dev. Transit. Except. Individ.	AUG	2015	38	2					89	100		10.1177/2165143414534887			12	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	CQ1WP	WOS:000360391200004					2021-06-18	
J	Rajtmajer, SM; Roy, A; Albert, R; Molenaar, PCM; Hillary, FG				Rajtmajer, Sarah M.; Roy, Arnab; Albert, Reka; Molenaar, Peter C. M.; Hillary, Frank G.			A voxelwise approach to determine consensus regions-of-interest for the study of brain network plasticity	FRONTIERS IN NEUROANATOMY			English	Article						fMRI; ROI selection; plasticity; modularity; label propagation; traumatic brain injury; hyperconnectivity	HUMAN CEREBRAL-CORTEX; FUNCTIONAL MRI DATA; CONNECTIVITY; PARCELLATION; ORGANIZATION; MODULARITY; REGRESSION; PATTERNS; RECOVERY; DEFICITS	Despite exciting advances in the functional imaging of the brain, it remains a challenge to define regions of interest (ROIs) that do not require investigator supervision and permit examination of change in networks over time (or plasticity). Plasticity is most readily examined by maintaining ROIs constant via seed-based and anatomical-atlas based techniques, but these approaches are not data-driven, requiring definition based on prior experience (e.g., choice of seed-region, anatomical landmarks). These approaches are limiting especially when functional connectivity may evolve over time in areas that are finer than known anatomical landmarks or in areas outside predetermined seeded regions. An ideal method would permit investigators to study network plasticity due to learning, maturation effects, or clinical recovery via multiple time point data that can be compared to one another in the same ROI while also preserving the voxel-level data in those ROIs at each time point. Data-driven approaches (e.g., whole-brain voxelwise approaches) ameliorate concerns regarding investigator bias, but the fundamental problem of comparing the results between distinct data sets remains. In this paper we propose an approach, aggregate-initialized label propagation (AILP), which allows for data at separate time points to be compared for examining developmental processes resulting in network change (plasticity). To do so, we use a whole-brain modularity approach to parcellate the brain into anatomically constrained functional modules at separate time points and then apply the AILP algorithm to form a consensus set of ROIs for examining change over time. To demonstrate its utility, we make use of a known dataset of individuals with traumatic brain injury sampled at two time points during the first year of recovery and show how the AILP procedure can be applied to select regions of interest to be used in a graph theoretical analysis of plasticity.	[Rajtmajer, Sarah M.] Penn State Univ, Dept Math, University Pk, PA 16802 USA; [Roy, Arnab; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Albert, Reka] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Molenaar, Peter C. M.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Hillary, Frank G.] Penn State Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 313 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Albert, Reka/E-2195-2011; Hillary, Frank/AAN-8622-2021	Albert, Reka/0000-0002-9485-0828; 	New Jersey Commission for Brain Injury Research [09.001.BIR1]; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania	This work was funded in part by the New Jersey Commission for Brain Injury Research (09.001.BIR1) and the Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Nicholas Gilbert for his ingenuity and dedication in creating the plots for images.	Ahn YY, 2006, PHYSICA A, V367, P531, DOI 10.1016/j.physa.2005.12.013; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Babadi B, 2014, IEEE T BIO-MED ENG, V61, P1555, DOI 10.1109/TBME.2014.2311996; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brier MR, 2014, NEUROBIOL AGING, V35, P757, DOI 10.1016/j.neurobiolaging.2013.10.081; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Elston GN, 2005, ANAT REC PART A, V285A, P610, DOI 10.1002/ar.a.20198; Elston GN, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-18-j0002.2000; Elston GN, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00002; Gamboa OL, 2014, NEUROIMAGE, V94, P385, DOI 10.1016/j.neuroimage.2013.12.008; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Honnorat N, 2015, NEUROIMAGE, V106, P207, DOI 10.1016/j.neuroimage.2014.11.008; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; LUND JS, 1993, CEREB CORTEX, V3, P148, DOI 10.1093/cercor/3.2.148; Mazaika P K., 2009, HUM BRAIN MAPP C FLO; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; ROCKLAND K S, 1985, Society for Neuroscience Abstracts, V11, P17; Rockland KS, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00061; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Sorensen T, 1948, BIOL SKAR, V5, P1; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; TEASDALE G, 1974, LANCET, V2, P81; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yu QB, 2012, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00103, 10.3389/fnsys.2011.00007]	55	14	14	2	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5129			FRONT NEUROANAT	Front. Neuroanat.	JUL 28	2015	9								97	10.3389/fnana.7015.00097			13	Anatomy & Morphology; Neurosciences	Anatomy & Morphology; Neurosciences & Neurology	CQ2LL	WOS:000360431800001	26283928	DOAJ Gold			2021-06-18	
J	Dretsch, M; Parish, R; Kelly, M; Coldren, R; Russell, M				Dretsch, Michael; Parish, Robert; Kelly, Mark; Coldren, Rodney; Russell, Michael			Eight-Day Temporal Stability of the Automated Neuropsychological Assessment Metric (ANAM) in a Deployment Environment	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						ANAM; military; neurocognitive; test-retest reliability	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; US ARMY SOLDIERS; MILITARY PERSONNEL; TEST-PERFORMANCE; REACTION-TIME; SYMPTOM-FREE; SPECIFICITY; BATTERY	Automated neurocognitive tests are commonly used by military providers for making clinical decisions about the recovery of postconcussive cognitive sequelae. This practice often utilizes baseline assessments that precede the concussive injury. As such, investigating and establishing the psychometrics of an instrument is necessary to minimize confounds for interpreting assessment scores. Test-retest reliability (TRR) values for an 8.3 +/- 2-day retest window for the Automated Neuropsychological Assessment Metrics-Version 4 (ANAM) were calculated in 86 healthy U.S. Army soldiers deployed to Iraq. After removal of outliers, all but 1 subtest, Simple Reaction Time, had adequate or greater TRR values (intraclass correlation coefficient=0.72-0.86). The findings suggest that overall, the ANAM has good temporal stability when the retesting intertrial interval is less than 11 days while in a deployed environment.	[Dretsch, Michael] Natl Intrepid Ctr Excellence, Res, Bethesda, MD 20889 USA; [Parish, Robert] Irwin Army Community Hosp, Behav Hlth, Ft Riley, KS USA; [Kelly, Mark] Walter Reed Natl Mil Med Ctr, Psychol, Bethesda, MD USA; [Coldren, Rodney] Uniformed Serv Univ Hlth Sci, Preventat Med & Biometr, Bethesda, MD 20814 USA; [Russell, Michael] Vet Hlth Adm, VISN Ctr Excellence Res Returning War Vet 17, Waco, TX USA	Dretsch, M (corresponding author), Natl Intrepid Ctr Excellence, Res, 4860 South Palmer Rd, Bethesda, MD 20889 USA.	dr.dretsch1@yahoo.com			U.S. Army Medical Research Acquisition Activity [W81XWIH-09-2-0057]	This work was supported by the U.S. Army Medical Research Acquisition Activity [Grant Number W81XWIH-09-2-0057].	Anastasi A., 1998, PSYCHOL TESTING; Barr W., 2008, TXB CLIN NEUROPSYCHO, P660; Barth JT., 1989, MILD HEAD INJURY, P257; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Bey T, 2009, WEST J EMERG MED, V10, P6; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Coldren R., 2011, THE ANAM STOPLIGHT; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Dretsch MN, 2013, APPL NEUROPSYCH-ADUL, V20, P272, DOI 10.1080/09084282.2012.715110; Dretsch MN, 2012, MIL MED, V177, P1011, DOI 10.7205/MILMED-D-12-00129; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Epstein D., 2013, THE SPORTS GENE; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jackson ML, 2013, ACCIDENT ANAL PREV, V50, P438, DOI 10.1016/j.aap.2012.05.020; Kaida K, 2014, NEUROPSYCH DIS TREAT, V10, P19, DOI 10.2147/NDT.S53633; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Krusemark EA, 2011, J NEUROSCI, V31, P3429, DOI 10.1523/JNEUROSCI.4394-10.2011; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marczinski CA, 2012, EXP CLIN PSYCHOPHARM, V20, P129, DOI 10.1037/a0026136; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McKeon JMM, 2013, J ATHL TRAINING, V48, P836, DOI 10.4085/1062-6050-48.6.17; McNeil J., 2010, MILITARY NEUROPSYCHO, P361; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; ORR JM, 1991, PERS PSYCHOL, V44, P473; Osborne J. W, 2004, PRACTICAL ASSESSMENT, V9, P1, DOI DOI 10.1017/CBO9781107415324.004; Portney L. G., 1993, FDN CLIN RES APPL PR, P557; Randolph C, 2005, J ATHL TRAINING, V40, P139; Riccio CA, 2001, ANN NY ACAD SCI, V931, P113; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Strigo IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015093; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	51	14	14	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JUL 4	2015	22	4					304	310		10.1080/23279095.2014.926454			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	CL5SF	WOS:000357020100009	25531697				2021-06-18	
J	Godwin, EE; Lukow, HR; Lichiello, S				Godwin, Emilie E.; Lukow, Herman R., II; Lichiello, Stephanie			Promoting Resilience Following Traumatic Brain Injury: Application of an Interdisciplinary, Evidence-Based Model for Intervention	FAMILY RELATIONS			English	Article						resilience; resilience after traumatic brain injury; resilience and adjustment intervention; resilience promotion; therapeutic couples intervention; traumatic brain injury	FAMILY INTERVENTION; NEUROBEHAVIORAL INTERVENTION; POSITIVE EMOTIONS; MARITAL STABILITY; TBI; REHABILITATION; INDIVIDUALS; SKILLS; LONG; PERSPECTIVES	With an increasing instance of traumatic brain injury and little advancement over recent decades in the rehabilitation of brain injury survivors and their family members, focus has shifted toward the establishment of effective whole-family resilience promotion interventions. Using the Brain Injury Family Intervention as a model, clinicians constructed two curriculum-based interventions grounded in resilience theory and drawing from the interdisciplinary approaches of neuropsychology and marriage and family therapy: (a) the Resilience and Adjustment Intervention, for individual survivors of traumatic brain jury, and (b) the Therapeutic Couples Intervention, designed to increase relational satisfaction in couples following a traumatic brain injury. The present study outlines the need for the integration of resilience tenets into rehabilitation techniques, summarizes the empirical justification for the use of an interdisciplinary approach, and offers an overview with implementation specifics regarding these two newly designed interventions.	[Godwin, Emilie E.; Lukow, Herman R., II; Lichiello, Stephanie] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA	Godwin, EE (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, POB 980206, Richmond, VA 23298 USA.	eegodwin@vcu.edu			National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, Department of Education, Washington, DC [H133A120031, H133P090013]	This work was supported by Grants H133A120031 and H133P090013 from the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, Department of Education, Washington, DC.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Asoodeh MH, 2010, PROCD SOC BEHV, V5, P2042, DOI 10.1016/j.sbspro.2010.07.410; Benzies K, 2009, CHILD FAM SOC WORK, V14, P103, DOI 10.1111/j.1365-2206.2008.00586.x; Black K, 2008, J FAM NURS, V14, P33, DOI 10.1177/1074840707312237; Boswell JF, 2015, PSYCHOTHER RES, V25, P6, DOI 10.1080/10503307.2013.817696; Brain Injury Association of Queensland, 2010, GET FACTS ACQ BRAIN; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Butzer B, 2008, PERS RELATIONSHIP, V15, P141, DOI 10.1111/j.1475-6811.2007.00189.x; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Centers for Disease Control and Prevention, 2014, INJ PREV CONTR TRAUM; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Creamer M, 2008, PSYCHIATRY, V71, P319, DOI 10.1521/psyc.2008.71.4.319; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Demery J, 2011, 119 ANN CONV AM PSYC, DOI [10.1037/e662792011-001, DOI 10.1037/E662792011-001]; Dowrick C, 2008, HEALTH-LONDON, V12, P439, DOI 10.1177/1363459308094419; Edward K.-L., 2005, J AM PSYCHIAT NURSES, V11, P101, DOI [10.1177/1078390305277526, DOI 10.1177/1078390305277526]; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gan C., 2012, ACQ BRAIN INJ NETW C; Gan C., 2008, ACQ BRAIN INJ NETW C; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Green RJ, 2004, J FAM PSYCHOL, V18, P290, DOI 10.1037/0893-3200.18.2.290; Hall P, 2001, MED EDUC, V35, P867, DOI 10.1046/j.1365-2923.2001.00919.x; HANNUM J W, 1991, Journal of Psychosocial Oncology, V9, P1, DOI 10.1300/J077v09n02_01; Hawley DR, 2000, AM J FAM THER, V28, P101, DOI 10.1080/019261800261699; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoofien D, 2001, BRAIN INJURY, V15, P189; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer J, 2012, GETTING BETTER BETTE; Kreutzer J. S., 2000, SERVICE OBSTACLES SC; Kreutzer J. S., 2012, TRAUMATIC BRAIN INJU; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2010, J HEAD TRAUMA REHAB, V25, P113, DOI 10.1097/HTR.0b013e3181cf0712; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; Lefebvre H., 2012, RESILIENCE INDIVIDUA; Lefebvre H., 2006, ILLNESS CRISIS LOSS, V14, P337, DOI DOI 10.1177/105413730601400403; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Model Systems Knowledge Translation Center, 2013, TBI FACTSH BOOKL RES; Mohan N., 2010, THESIS FLINDERS U AD; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Niemeier J., 2004, 1 STEPS NEUROBEHAVIO; Niemeier JP, 2010, J VOCAT REHABIL, V33, P167, DOI 10.3233/JVR-2010-0525; Niemeier JP, 2011, BRAIN INJURY, V25, P680, DOI 10.3109/02699052.2011.573520; Niemeier JP, 2005, NEUROPSYCHOL REHABIL, V15, P129, DOI 10.1080/09602010443000083; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Rajkumar AP, 2008, SOC SCI MED, V67, P844, DOI 10.1016/j.socscimed.2008.05.014; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Silliman B., 1994, RATIONALE RESILIENT; Silver JM., 2011, TXB TRAUMATIC BRAIN, V2nd ed.; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tedeschi RG, 2005, PROF PSYCHOL-RES PR, V36, P230, DOI 10.1037/0735-7028.36.3.230; Tegner I, 2009, J POETRY THER, V22, P121, DOI 10.1080/08893670903198383; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Vanderbilt-Adriance E, 2008, CLIN CHILD FAM PSYCH, V11, P30, DOI 10.1007/s10567-008-0031-2; Walsh F, 2003, FAM PROCESS, V42, P1, DOI 10.1111/j.1545-5300.2003.00001.x; Walsh F, 1996, FAM PROCESS, V35, P261, DOI 10.1111/j.1545-5300.1996.00261.x; Walsh F., 2011, STRENGTHENING FAMILY; Watt N F, 1995, J Prim Prev, V15, P209, DOI 10.1007/BF02197473; Wemer E. E., 1990, HDB EARLY CHILDHOOD, V2, P115; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Zasler ND, 2012, BRAIN INJURY MED PRI	88	14	14	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-6664	1741-3729		FAM RELAT	Fam. Relat.	JUL	2015	64	3					347	362		10.1111/fare.12122			16	Family Studies; Social Work	Family Studies; Social Work	CJ9QP	WOS:000355837600001					2021-06-18	
J	Kratz, AL; Chadd, E; Jensen, MP; Kehn, M; Kroll, T				Kratz, Anna L.; Chadd, Edmund; Jensen, Mark P.; Kehn, Matthew; Kroll, Thilo			An examination of the psychometric properties of the community integration questionnaire (CIQ) in spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injury; Community Integration Questionnaire; Factor analysis; Validity; Reliability	CRAIG HANDICAP ASSESSMENT; TRAUMATIC BRAIN-INJURY; REPORTING TECHNIQUE; LIFE SATISFACTION; FIT INDEXES; INDIVIDUALS; PARTICIPATION; RELIABILITY; DISABILITY; VALIDITY	Objective: To examine the psychometric properties of the Community Integration Questionnaire (CIQ) in large samples of individuals with spinal cord injury (SCI). Design: Longitudinal 12-month survey study. Setting: Nation-wide, community dwelling. Participants: Adults with SCI: 627 at Time 1, 494 at Time 2. Interventions: Not applicable. Outcome measures: The CIQ is a 15-item measure developed to measure three domains of community integration in individuals with traumatic brain injury: home integration, social integration, and productive activity. SCI consumer input suggested the need for two additional items assessing socializing at home and internet/email activity. Results: Exploratory factor analyses at Time 1 indicated three factors. Time 2 confirmatory factor analysis did not show a good fit of the 3-factor model. CIQ scores were normally distributed and only the Productive subscale demonstrated problems with high (25%) ceiling effects. Internal reliability was acceptable for the Total and Home scales, but low for the Social and Productive activity scales. Validity of the CIQ is suggested by significant differences by sex, age, and wheelchair use. Conclusions: The factor structure of the CIQ was not stable over time. The CIQ may be most useful for assessing home integration, as this is the subscale with the most scale stability and internal reliability. The CIQ may be improved for use in SCI by including items that reflect higher levels of productive functioning, integration across the life span, and home-and internet-based social functioning.	[Kratz, Anna L.; Chadd, Edmund] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Jensen, Mark P.] Univ Washington, Seattle, WA 98195 USA; [Kehn, Matthew] Math Policy Res, Washington, DC USA; [Kroll, Thilo] Univ Dundee & St Andrews, Social Dimens Hlth Inst, Dundee, Scotland	Kratz, AL (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy,Suite 300, Ann Arbor, MI 48108 USA.	alkratz@umich.edu		Kroll, Thilo/0000-0003-2082-5117	National Institute on Disability and Rehabilitation Research (NIDRR) [H133B031114]; NRH Rehabilitation Research and Training Center on SCI: Promoting Health and Preventing Complications Through Exercise; Department of Education, NIDRR [H133B080024]	This study was funded by National Institute on Disability and Rehabilitation Research (NIDRR) grant H133B031114, the NRH Rehabilitation Research and Training Center on SCI: Promoting Health and Preventing Complications Through Exercise. Manuscript development was also supported by a grant from the Department of Education, NIDRR grant number H133B080024.	Allen K, 1996, JAMA-J AM MED ASSOC, V275, P1001, DOI 10.1001/jama.275.13.1001; BENTLER PM, 1990, MULTIVAR BEHAV RES, V25, P163, DOI 10.1207/s15327906mbr2502_3; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Comas-Herrera A, 2006, AGEING SOC, V26, P285, DOI 10.1017/S0144686X05004289; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers Marcel., 1998, TOP SPINAL CORD INJ, V4, P1, DOI [10.1310/BJJA-2018-45KL-0VTL, DOI 10.1310/BJJA-2018-45KL-0VTL]; Drainoni ML, 2004, ARCH PHYS MED REHAB, V85, P1872, DOI 10.1016/j.apmr.2004.07.350; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Gontkovsky ST, 2009, NEUROREHABILITATION, V24, P185, DOI 10.3233/NRE-2009-0467; Hall KM, 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Houlihan BV, 2003, DISABIL REHABIL, V25, P422, DOI 10.1080/0963828031000071750; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Kroll T, 2012, AM J PHYS MED REHAB, V91, P640, DOI 10.1097/PHM.0b013e31825a12cd; Masedo AI, 2005, AM J PHYS MED REHAB, V84, P167, DOI 10.1097/01.PHM.0000154898.25609.4A; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Noonan VK, 2009, SPINAL CORD, V47, P435, DOI 10.1038/sc.2008.171; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Streiner DL, 1989, HLTH MEASUREMENT SCA; Tozato F, 2005, TOHOKU J EXP MED, V205, P357, DOI 10.1620/tjem.205.357; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van der Slot WMA, 2007, DISABIL REHABIL, V29, P179, DOI 10.1080/09638280600747686; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whiteneck GG, 1992, GUIDE US CHART CRAIG; *WHO, 1997, INT CLASS IMP ACT PA; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 1980, INT CLASS IMP DIS HA; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	35	14	15	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL	2015	38	4					446	455		10.1179/2045772313Y.0000000182			10	Clinical Neurology	Neurosciences & Neurology	CL4RS	WOS:000356941800007	24621050	Green Published			2021-06-18	
J	Li, Q; Cheng, YM; Bi, MJ; Lin, HY; Chen, YF; Zou, Y; Liu, YY; Kang, H; Guo, YL				Li, Qin; Cheng, Yongmei; Bi, MingJun; Lin, Hongyang; Chen, Yufei; Zou, Yong; Liu, Yuanyuan; Kang, Hai; Guo, Yunliang			Effects of N-butylphthalide on the activation of Keap1/Nrf-2 signal pathway in rats after carbon monoxide poisoning	ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY			English	Article						CO poisoning; N-Butylphthalide; Apoptosis-associated gene; MMP; Keapl; Nrf-2; NQO-1	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; NRF2/ARE PATHWAY; NEONATAL-RATS; DISEASE; EXPRESSION; APOPTOSIS; QUINONE; CELLS; HO-1	Carbon monoxide (CO) is the leading cause of death by poisoning all over the world and may result in neuropathologic changes and cognitive and neurologic sequelae, yet little is known regarding its outcomes. The present study aimed to evaluate the neuroprotective effects of N-butylphthalide (NBP) against brain damage after acute CO poisoning. The animal model of CO poisoning was established by exposed to 1000 ppm CO in air for 40 min and then to 3000 ppm for another 20 min. RT-PCR was used to assess the expressions of apoptosis-associated genes Bcl-2 mRNA and Bax mRNA. Mitochondrial membrane potential (MMP) was detected by fluorescent probe JC-1. Immunohistochemistry stain and Western blot assay were used to evaluate the expression levels of Kelch-like ECH-associated protein 1 (Keapl), nuclear factor erythroid 2-related factor 2 (Nrf-2) and NAD(P)H: quinone oxidoreductase 1(NQO-1). CO poisoning could increase the levels of Bcl-2 mRNA and Bax mRNA expressions, and obviously decrease the MMP of cells. NBP treatment could maintain the high MMP, significantly up-regulate Bcl-2 mRNA and down-regulate Bax mRNA expression, and the ratio of Bcl-2 mRNA/Bax mRNA expressions was higher than that in the CO poisoning group (P < 0.05). CO poisoning could start oxidative stress response. The expressions of Keap1, Nrf-2 and NQO-1 proteins significantly increased at 1, 3 and 7 day after NBP administration as compared with the CO poisoning group (P < 0.01). These findings suggest that N-butylphthalide may protect mitochondrial function, balance the expressions of anti-apoptosis genes and pro-apoptosis genes, be in part associated with activation of Keap1-Nrf-2/antioxidant response element (ARE) signaling pathway, and play a neuroprotective role in brain damage after acute CO poisoning. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Qin; Cheng, Yongmei; Bi, MingJun; Lin, Hongyang; Chen, Yufei; Liu, Yuanyuan; Kang, Hai] Qingdao Univ, Coll Med, Yantai Yuhuangding Hosp Affiliated Hosp, Emergency Ctr, Yantai, Yudong, Peoples R China; [Zou, Yong] Qingdao Univ, Coll Med, Yantai Yuhuangding Hosp Affiliated Hosp, Dept Clin Med, Yantai, Yudong, Peoples R China; [Guo, Yunliang] Qingdao Univ, Coll Med, Inst Cerebrovasc Dis, Affiliated Hosp, Qingdao 266071, Jiangsu, Peoples R China	Bi, MJ (corresponding author), Qingdao Univ, Coll Med, Yantai Yuhuangding Hosp Affiliated Hosp, Emergency Ctr, 20 Rd, Yantai, Yudong, Peoples R China.	chengym1967@163.com; bimingjun00@163.com			Yantai Science and Technology Project [2014WS013]; Medical and Health Development Project in Shandong [2014WS0248]	This work was supported by Yantai Science and Technology Project Grants in 2014 (2014WS013) and Medical and Health Development Project in Shandong (2014WS0248).	Biswas C, 2014, J BIOL CHEM, V289, P26882, DOI 10.1074/jbc.M114.567685; Cervellati C, 2014, J NEUROL SCI, V337, P156, DOI 10.1016/j.jns.2013.11.041; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Geraldo AF, 2014, J RADIOL CASE REP, V8, P1, DOI 10.3941/jrcr.v8i5.1721; Ghosh N, 2011, FREE RADICAL RES, V45, P888, DOI 10.3109/10715762.2011.574290; Guratowska Monika, 2010, Przegl Lek, V67, P566; Hampson NB, 2007, UNDERSEA HYPERBAR M, V34, P163; Han ST, 2007, TOXICOL LETT, V170, P111, DOI 10.1016/j.toxlet.2007.02.006; Hu JY, 2014, CELL BIOCHEM BIOPHYS, V69, P363, DOI 10.1007/s12013-013-9808-0; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069030; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; LI Q, 2014, ENV TOXICOL; Mauriz E, 2013, NUTR HOSP, V28, P2229, DOI [10.3305/nh.2013.28.6.6983, 10.3305/nutr hosp.v28in06.6983]; Milani P, 2013, NEUROBIOL DIS, V60, P51, DOI 10.1016/j.nbd.2013.08.005; Morris G, 2014, METAB BRAIN DIS, V29, P19, DOI 10.1007/s11011-013-9435-x; Muller Aaron J, 2014, Neoreviews, V15, pe177; Neil B., 2009, CRIT CARE MED, V37, P1941; Pangeni R, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/48/485102; Qin L., 2015, ENV TOXICOL PHARM; Qu Y, 2014, NEUROBIOL DIS, V63, P184, DOI 10.1016/j.nbd.2013.11.023; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Shrader WD, 2012, BIOORG MED CHEM LETT, V22, P391, DOI 10.1016/j.bmcl.2011.10.117; Tofighi R, 2006, BRAIN RES, V1098, P1, DOI 10.1016/j.brainres.2006.04.095; Wang XL, 2014, LIFE SCI, V114, P77, DOI 10.1016/j.lfs.2014.08.004; Wang XL, 2014, BRAIN RES, V1560, P18, DOI 10.1016/j.brainres.2014.02.019; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yuan H., 2010, ACTA PHARMACOL SIN, V31, P1421; Zhang B, 2015, ENVIRON TOXICOL PHAR, V39, P237, DOI 10.1016/j.etap.2014.11.013; Zovein A, 2004, AM J PHYSIOL-REG I, V286, pR273, DOI 10.1152/ajpregu.00160.2003	30	14	22	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1382-6689	1872-7077		ENVIRON TOXICOL PHAR	Environ. Toxicol. Pharmacol.	JUL	2015	40	1					22	29		10.1016/j.etap.2015.05.009			8	Environmental Sciences; Pharmacology & Pharmacy; Toxicology	Environmental Sciences & Ecology; Pharmacology & Pharmacy; Toxicology	CO5BQ	WOS:000359175000004	26056974				2021-06-18	
J	Sandhaug, M; Andelic, N; Langhammer, B; Mygland, A				Sandhaug, Maria; Andelic, Nada; Langhammer, Birgitta; Mygland, Aase			Community integration 2 years after moderate and severe traumatic brain injury	BRAIN INJURY			English	Article						Community integration; rehabilitation; traumatic brain injury	QUALITY-OF-LIFE; LONG-TERM OUTCOMES; REHABILITATION; QUESTIONNAIRE; PARTICIPATION; PERSPECTIVES; PREDICTION; DISABILITY; SWEDEN	Objective: The aim of this study was to examine community integration by the Community Integration Questionnaire (CIQ) 2 years after injury in a divided TBI sample of moderately and severely injured patients. The second aim was to identify social-demographic, injury-related and rehabilitation associated predictors of CIQ Design: A cohort study. Setting: Outpatient follow-up. Participants: Fifty-seven patients with moderate (n = 21) or severe (n = 36) TBI were examined with the Community Integration Questionnaire (CIQ)) at 2 years after injury. Possible predictors were analysed in a regression model using CIQ total score at 2 years as the outcome measure. Main outcome measures: The Community Integration Questionnaire. Results: At 2 years follow-up, there was significant difference between the moderately and severely injured patients in the productivity scores (p < 0.003), while difference in the total CIQ scores approached the significance level (p = 0.074). Significant predictors of a higher CIQ score were living with a spouse, higher Glasgow Coma Scale (GCS) in the acute phase, shorter Post-Traumatic Amnesia (PTA), longer rehabilitation stay (LOS) and use of rehabilitation service. Use of rehabilitation service (B = 7.766) and living with a spouse (B = 4.251) had the largest influence. This means that living with a spouse, better score on the GCS scale, shorter PTA, longer LOS and use of rehabilitation service after discharge equated to better community integration 2 years after TBI Conclusions: Two years after TBI the moderately injured patients have a higher productivity level than the severely injured patients. Marital status, injury severity and rehabilitation after injury were associated with community integration 2 years after TBI.	[Sandhaug, Maria; Langhammer, Birgitta] Oslo & Akershus Univ Coll, Inst Physiotherapy, Oslo, Norway; [Sandhaug, Maria] Statped, Head Off, Oslo, Norway; [Sandhaug, Maria] Statped, Dept Acquired Brain Injury, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Andelic, Nada] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Langhammer, Birgitta] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Mygland, Aase] Sorlandet Hosp, Dept Habilitat, Kristiansand, Norway; [Mygland, Aase] Sorlandet Hosp, Dept Neurol, Kristiansand, Norway; [Mygland, Aase] Univ Bergen, Dept Clin Med, Bergen, Norway	Sandhaug, M (corresponding author), Statped Head Off, Acquired Brain Injury, Postbox 2814, N-0204 Oslo, Norway.	maria.sandhaug@statped.no	Langhammer, Birgitta/P-1765-2019	Langhammer, Birgitta/0000-0002-9639-0570; Andelic, Nada/0000-0002-3719-4406	Norwegian Foundation for Health and Rehabilitation	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study has been financed with the aid of EXTRA funds from the Norwegian Foundation for Health and Rehabilitation.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Fleming J, 1999, BRAIN INJURY, V13, P417; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Millis S R, 1994, Int J Neurosci, V79, P165; Pallant J, 2005, SPSS SURVIVAL MANUAL; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B, 1994, BRAIN INJURY REHABIL, P355; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; World Health Organization, 2001, INT CLASS FUNCT DIS	33	14	14	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					915	920		10.3109/02699052.2015.1022880			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800017	25962927				2021-06-18	
J	Wijayatilake, DS; Talati, C; Panchatsharam, S				Wijayatilake, Dhuleep S.; Talati, Chiraag; Panchatsharam, Selvakumar			The Monitoring and Management of Severe Traumatic Brain Injury in the United Kingdom: Is there a Consensus?: A National Survey	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						trauma; head injury; intensive care	INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; INTENSIVE-CARE; PERFUSION	Background: To survey the current practice of monitoring and management of severe traumatic brain injury (TBI) patients in the critical care units across the United Kingdom. Methods: A structured telephone interview was conducted with senior medical or nursing staff of all the adult neurocritical care units. Thirty-one neurocritical care units that managed adult patients with severe TBI were identified from the Risk Adjustment in Neurocritical Care (RAIN) study and the Society of British Neurological Surgeons. Results: Intracranial pressure (ICP) monitoring was used in all the 31 institutions. Cerebral perfusion pressure was used in 30 of the 31 units and a Cerebral perfusion pressure target of 60 to 70mm Hg was the most widely used target (25 of 31 units). Transcranial Doppler was used in 12 units (39%); brain tissue oxygen (PbtO(2)) was used in 8 (26%); cerebral microdialysis was used in 4 (13%); jugular bulb oximetry in 1 unit; and near-infrared spectrometry was not used in any unit. Continuous capnometry was used in 28 (91%) units for mechanically ventilated patients. Mannitol was the most commonly used agent for osmotherapy to treat intracranial hypertension. Conclusions: We identified that there was no clear consensus and considerable variation in practice in the management of TBI patients in UK neurocritical care units. A protocol-based management has been shown to improve outcome in sepsis patients. Given the magnitude of the problem, we conclude that there is an urgent need for international consensus guidelines for management of TBI patients in critical care units.	[Wijayatilake, Dhuleep S.] Barking Havering & Redbridge Hosp NHS Trust, Queens Hosp, Dept Neurocrit Care, Romford RM7 0AG, Essex, England; [Talati, Chiraag] London Chest Hosp, Barts Hlth NHS Trust, Dept Anaesthesia, London E2 9JX, England; [Panchatsharam, Selvakumar] Univ Hosp Leicester NHS Trust, Dept Anaesthesia & Crit Care, Leicester, Leics, England	Wijayatilake, DS (corresponding author), Barking Havering & Redbridge Hosp NHS Trust, Queens Hosp, Dept Neurocrit Care, Romford RM7 0AG, Essex, England.	sanjay.wijayatilake@bhrhospitals.nhs.uk	Wijayatilake, Sanjay/AAQ-2164-2020				Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Bratton S, 2007, J NEUROTRAUM, V24, P7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Dunham CM, 2006, CRIT CARE, V10, DOI 10.1186/cc5097; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Haydel MJ, ASSESSMENT ACUTE TRA; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Kowoll CM, 2014, NEUROCRIT CARE, V20, P176, DOI 10.1007/s12028-013-9893-3; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Lecky F, 2014, HEAD INJURY TRIAGE A; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Olson DM, 2014, NEUROCRIT CARE, V20, P15, DOI 10.1007/s12028-013-9847-9; Olson DM, 2009, NEUROCRIT CARE, V11, P20, DOI 10.1007/s12028-008-9184-6; Pattinson K, 2005, BJA EDUC, V5, P130, DOI 10.1093/bjaceaccp/mki035; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Reilly P, 1997, HEAD INJURY PHYSL MA; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; SEBEL PS, 1983, BRIT J ANAESTH, V55, P1265, DOI 10.1093/bja/55.12.1265; Tisdall MM, 2006, BRIT J ANAESTH, V97, P18, DOI 10.1093/bja/ael109; Wijayatilake DS, 2012, CURR OPIN ANESTHESIO, V25, P540, DOI 10.1097/ACO.0b013e328357960a	28	14	16	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2015	27	3					241	245					5	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	DD0FW	WOS:000369596800007	25493928				2021-06-18	
J	de Guise, E; Alturki, AY; Lague-Beauvais, M; LeBlanc, J; Champoux, MC; Couturier, C; Anderson, K; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M; Frasnelli, J				de Guise, E.; Alturki, A. Y.; Lague-Beauvais, M.; LeBlanc, J.; Champoux, M. C.; Couturier, C.; Anderson, K.; Lamoureux, J.; Marcoux, J.; Maleki, M.; Feyz, M.; Frasnelli, J.			Olfactory and executive dysfunctions following orbito-basal lesions in traumatic brain injury	BRAIN INJURY			English	Article						Anosmia; cognition; olfaction; orbito-frontal lesion; traumatic brain injury	GLASGOW OUTCOME SCALE; POSTTRAUMATIC ANOSMIA; HEAD-INJURY; ODOR IDENTIFICATION; DISCRIMINATION; PERFORMANCE; IMPAIRMENT; DISABILITY; DEFICITS; TESTS	Objective: To study the acute relationship between olfactory function and traumatic brain injury (TBI), cognitive functions and outcome. Methods: Sixty-two patients with TBI were evaluated within the first 2 weeks following TBI. The Sniffin'Sticks identification test was used to assess olfaction. A neuropsychological evaluation was carried out to assess attention, verbal fluency, naming, memory, problem-solving and mental flexibility. The extended Glasgow Outcome Scale (GOSE) and the Disability Rating Scale (DRS) were rated at discharge from acute care. Results: Traumatic lesions located in the basal frontal area resulted in odour identification scores that were significantly lower than when lesions were elsewhere (p<0.001). A significant positive correlation was shown between odour identification scores and mental flexibility scores (p=0.004) and patients with hyposmia had worse performances on executive tests measuring problem-solving, verbal fluency and mental flexibility (p<0.01). Moreover, the odour identification score and the DRS total score were related (p=0.019). Conclusions: These findings add information regarding acute olfactory status following TBI and provide evidence on the importance of assessing olfaction very early post-TBI in order to plan intervention and determine what accident prevention advice will be required for home or work re-integration.	[de Guise, E.; Alturki, A. Y.; Marcoux, J.; Maleki, M.] McGill Univ, Dept Neurol & Neurosurg, Ctr Hlth, Montreal, PQ, Canada; [de Guise, E.; Anderson, K.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Alturki, A. Y.] King Fahad Med City, Natl Neurosci Inst, Dept Neurosurg, Riyadh, Saudi Arabia; [Lague-Beauvais, M.; LeBlanc, J.; Champoux, M. C.; Couturier, C.; Anderson, K.; Feyz, M.] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ, Canada; [Lamoureux, J.] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ H3C 3J7, Canada; [Frasnelli, J.] Univ Quebec Trois Rivieres, Anat Dept, Trois Rivieres, PQ GA9 5H7, Canada; [Frasnelli, J.] Hop Sacre Coeur, Ctr Avance Etud Sommeil, Montreal, PQ H4J 1C5, Canada	de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Pavillon Marie Victorin,CP 6128 Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	elaine.de.guise@umontreal.ca		Frasnelli, Johannes/0000-0002-8863-3982	Research Institute of the McGill University Health Center	We thank the Research Institute of the McGill University Health Center for their support.	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bersani G, 2013, PSYCHIAT RES, V210, P208, DOI 10.1016/j.psychres.2013.05.032; Buron E, 2013, PSYCHOPATHOLOGY, V46, P63, DOI 10.1159/000338717; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Caminiti F, 2013, BRAIN INJURY, V27, P1715, DOI 10.3109/02699052.2013.823667; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chapados C, 2013, BRAIN, V136, P2966, DOI 10.1093/brain/awt228; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Hoover E, 2014, J ACOUST SOC AM, V135, P2166, DOI DOI 10.1121/1.4877039; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Magone T, 2013, US NEUROLOGY, V9, P61; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Novack TA, 2000, BRAIN INJURY, V14, P987; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; Signoret JL, 1989, 96 BEC FOND IPSEN; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Tao KK, 2012, J EMERG MED, V42, P180, DOI 10.1016/j.jemermed.2009.08.063; Tranel D, 2012, J CLIN EXP NEUROPSYC, V34, P117, DOI 10.1080/13803395.2011.633897; Uittenhove K, 2013, ACTA PSYCHOL, V143, P113, DOI 10.1016/j.actpsy.2013.02.007; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Wechsler D, 2008, WMS 3 MANUAL; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238	38	14	15	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					730	738		10.3109/02699052.2015.1004748			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700008	25826471				2021-06-18	
J	Fraas, MR; Coughlan, GF; Hart, EC; McCarthy, C				Fraas, M. R.; Coughlan, G. F.; Hart, E. C.; McCarthy, C.			Concussion knowledge and management practices among coaches and medical staff in Irish professional rugby teams	IRISH JOURNAL OF MEDICAL SCIENCE			English	Article						Concussion; Rugby; Coaches knowledge; Medical management; Ireland	INJURIES; PLAYERS	Self-reported concussion rates among U-20 and elite rugby union players in Ireland are 45-48 %. Half of these injuries go unreported. Accurate knowledge of concussion signs and symptoms and appropriate management practices among coaches and medical staff is important to improve the welfare of players. Examine concussion knowledge among coaches, and management techniques among medical staff of professional Irish rugby teams. Surveys were administered to 11 coaches and 12 medical staff at the end of the 2010-2011 season. Coaches demonstrated an accurate knowledge of concussion with a good understanding of concussion-related symptoms. Medical staff reported using a variety of methods for assessing concussion and making return-to-play decisions. Reliance on subjective clinical methods was evident, with less reliance on objective postural stability performance. Overall, the coaches in this investigation have accurate knowledge of concussion and medical staff use effective techniques for managing this injury. On-going education is needed to assist coaches in identifying concussion signs and symptoms. It is recommended that medical staff increase their reliance on objective methods for assessment and return-to-play decision making.	[Fraas, M. R.] Western Washington Univ, Dept Commun Sci & Disorders, Bellingham, WA 98225 USA; [Fraas, M. R.; Hart, E. C.] Elmhurst Coll, Dept Commun Arts & Sci, Chicago, IL USA; [Coughlan, G. F.; McCarthy, C.] Irish Rugby Football Union, Dept Med, Dublin, Ireland; [Hart, E. C.] Chicago Sch Profess Psychol, Dept Psychol, Chicago, IL USA	Fraas, MR (corresponding author), Western Washington Univ, Dept Commun Sci & Disorders, 516 High St, Bellingham, WA 98225 USA.	Michael.fraas@wwu.edu					Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Council for International Organizations of Medical Sciences World Health Organization, 2002, INT ETH GUID BIOM RE; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Holtzhausen LJ, 2006, SAMJ S AFR MED J, V96, P1260; International Rugby Board, 2010, LAWS GAM RUGB UN 201; International Rugby Board, 2011, PUTT PLAYERS FIRST I; IRFU, 2011, 20102011 IRFU; Irish Rugby Football Union, 2013, STAND APPR FIELD EM; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; McLeod TV, 2009, J FAM PRACTICE, V58, P512; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; O'Donoghue EM., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Tommasone BA, 2006, J ATHL TRAINING, V41, P470	22	14	14	0	30	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0021-1265	1863-4362		IRISH J MED SCI	Irish J. Med. Sci.	JUN	2015	184	2					425	430		10.1007/s11845-014-1137-9			6	Medicine, General & Internal	General & Internal Medicine	CG3EL	WOS:000353160800028	24852661				2021-06-18	
J	Fredricks, TR; Nakazawa, M				Fredricks, Todd Robert; Nakazawa, Masato			Perceptions of Physicians in Civilian Medical Practice on Veterans' Issues Related to Health Care	JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION			English	Article								Context: The percentage of total US residents in the military is lower than ever before. Many civilians, including civilian physicians, have little knowledge of US military actions or the day-to-day experiences and working environments of veterans. Objective: To assess civilian physician knowledge of veterans' issues using a survey. Methods: A 10-item survey was distributed to physicians at 2 primary care-focused medical conferences in Ohio to determine self-reported levels of comfort and familiarity with veteran-oriented topics. Results: Of 350 surveys that were distributed, 141 surveys were returned. Of the 141 respondents, 101 practiced primary care, 19 practiced internal medicine, 16 practiced other specialties, and 5 did not report a specialty affiliation and were excluded from final analysis. A single respondent reported pediatrics as a specialty but indicated "not applicable" for all answers. This individual was excluded from final analysis. Overall, physicians reported feeling moderately comfortable with military terminology and uncomfortable with the diagnosis and management of traumatic brain injury. More than half of the respondents indicated that they were not comfortable discussing health-related exposures and associated risks that veterans might experience and that they were unfamiliar with referral and consultation services for veterans. The data collected had a high degree of reliability (Cronbach alpha-0.88). Respondents of both primary care and internal medicine specialties scored statistically significantly higher than the other respondents in questions on veterans' medical conditions, military terminology, and military health risks (P<.05), although these 2 groups scored similarly (P>.05). Specialty orientation did not affect responses for questions on other topics (P>.05) Conclusion: The data indicated an overall moderate level of familiarity among civilian physicians with veterans' issues. The results did not reveal an overall high level of comfort with any issues included in the survey. More research is needed to determine reasons behind the findings and methods to improve civilian physician comfort with various veterans' issues.	[Fredricks, Todd Robert] Ohio Univ, Heritage Coll Osteopath Med, Dept Family Med, 251 Grosvenor Hall, Athens, OH 45701 USA; [Nakazawa, Masato] Ohio Univ, Heritage Coll Osteopath Med, Off Res & Grants, Athens, OH 45701 USA	Fredricks, TR (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Family Med, 251 Grosvenor Hall, Athens, OH 45701 USA.	fredrick@ohio.edu					Agency for Healthcare Research and Quality, NUMB PRACT PRIM CAR; [Anonymous], WORLD WAR 2 VET; [Anonymous], STAT COUNT QUICKFACT; [Anonymous], 1900, HIST NAT POP EST JUL; [Anonymous], PROJ VET POP 2013 20; Au DH, 2012, CHEST, V141, P726, DOI 10.1378/chest.11-0362; Eikenberry KW, 2013, NY TIMES; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fan VS, 2005, J GEN INTERN MED, V20, P226, DOI 10.1111/j.1525-1497.2005.40135.x; Green LV, 2013, HEALTH AFFAIR, V32, P11, DOI 10.1377/hlthaff.2012.1086; Henry SG, 2012, PATIENT EDUC COUNS, V86, P297, DOI 10.1016/j.pec.2011.07.006; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Jeffreys MD, 2010, MIL MED, V175, P719, DOI 10.7205/MILMED-D-10-00054; Joos SK, 1996, J GEN INTERN MED, V11, P147, DOI 10.1007/BF02600266; Katz DA, 2014, J GEN INTERN MED, V29, P682, DOI 10.1007/s11606-013-2633-8; LaVela SL, 2012, PATIENT EDUC COUNS, V88, P420, DOI 10.1016/j.pec.2012.06.004; Lee YY, 2009, HEALTH CARE ANAL, V17, P244, DOI 10.1007/s10728-008-0100-1; Liang CY, 2013, BRIT J GEN PRACT, V63, pE354, DOI 10.3399/bjgp13X667222; Matthias MS, 2010, PAIN MED, V11, P1688, DOI 10.1111/j.1526-4637.2010.00980.x; Nichols L O, 1998, Tenn Med, V91, P94; Skelton I., 2013, JOINT FORCE Q, V64, P60; Street RL, 2005, MED CARE, V43, P960, DOI 10.1097/01.mlr.0000178172.40344.70; Suarez-Almazor ME, 2004, CURR OPIN RHEUMATOL, V16, P91, DOI 10.1097/00002281-200403000-00003; Tulsky JA, 2005, J PALLIAT MED, V8, P95, DOI DOI 10.1089/JPM.2005.8.S-95; Varney SM, 2012, SOUTH MED J, V105, P538, DOI 10.1097/SMJ.0b013e318268cd18; Wagner GJ, 2010, J PAIN SYMPTOM MANAG, V39, P527, DOI 10.1016/j.jpainsymman.2009.07.012; Weiner SJ, 2005, ANN INTERN MED, V142, P709, DOI 10.7326/0003-4819-142-8-200504190-00039	28	14	14	0	0	AMER OSTEOPATHIC ASSN	CHICAGO	142 EAST ONTARIO STREET, CHICAGO, IL 60611-2864 USA	0098-6151	1945-1997		J AM OSTEOPATH ASSOC	J. Am. Osteopath. Assoc.	JUN	2015	115	6					360	368		10.7556/jaoa.2015.076			9	Medicine, General & Internal	General & Internal Medicine	V05YC	WOS:000213906900006	26024329				2021-06-18	
J	Laksari, K; Assari, S; Seibold, B; Sadeghipour, K; Darvish, K				Laksari, Kaveh; Assari, Soroush; Seibold, Benjamin; Sadeghipour, Keya; Darvish, Kurosh			Computational simulation of the mechanical response of brain tissue under blast loading	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain tissue; Quasilinear viscoelasticity; Hyperelasticity; Blast loading; Discontinuous Galerkin method; Injury biomechanics	INJURY; MODEL; HEAD; WAVE	In the present study, numerical simulations of nonlinear wave propagation and shock formation in brain tissue have been presented and a new mechanism of injury for blast-induced neurotrauma (BINT) is proposed. A quasilinear viscoelastic (QLV) constitutive material model was used that encompasses the nonlinearity as well as the rate dependence of the tissue relevant to BINT modeling. A one-dimensional model was implemented using the discontinuous Galerkin finite element method and studied with displacement- and pressure-input boundary conditions. The model was validated against LS-DYNA finite element code and theoretical results for specific conditions that resulted in shock wave formation. It was shown that a continuous wave can become a shock wave as it propagates in the QLV brain tissue when the initial changes in acceleration are beyond a certain limit. The high spatial gradient of stress and strain at the shock front cause large relative motions at the cellular scale at high temporal rates even when the maximum stresses and strains are relatively low. This gradient-induced local deformation may occur away from the boundary and is proposed as a contributing factor to the diffuse nature of BINT.	[Laksari, Kaveh; Assari, Soroush; Sadeghipour, Keya; Darvish, Kurosh] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA; [Seibold, Benjamin] Temple Univ, Dept Math, Philadelphia, PA 19122 USA	Darvish, K (corresponding author), Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA.	kdarvish@temple.edu		Darvish, Kurosh/0000-0002-6674-266X	American Heart AssociationAmerican Heart Association [11PRE7690042]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K25 HL086512-05]; NSFNational Science Foundation (NSF) [DMS-1318709]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K25HL086512] Funding Source: NIH RePORTER; Direct For Mathematical & Physical ScienNational Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS) [1318641] Funding Source: National Science Foundation	The authors acknowledge funding for this work from American Heart Association pre-doctoral fellowship under Grant Number 11PRE7690042 (K.L.), NHLBI under Grant Number K25 HL086512-05 (K.D.), and NSF under Grant Number DMS-1318709 (B.S.).	BEAR MF, 2007, NEUROSCIENCE; Blinkov S. M., 1968, HUMAN BRAIN FIGURES; CDC, 2011, TRAUM BRAIN INJ FACT; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cockburn B., 2001, Journal of Scientific Computing, V16, P173, DOI 10.1023/A:1012873910884; Cockburn B, 1998, J COMPUT PHYS, V141, P199, DOI 10.1006/jcph.1998.5892; Coleman B. D., 1965, ARCH RATIONAL MECH A, V19, P239, DOI 10.1007/BF00250213; COLEMAN BD, 1966, ARCH RATION MECH AN, V22, P333, DOI 10.1007/BF00266558; Coleman BD, 1965, ARCH RATIONAL MECH A, V19, P317; Coleman BD, 1964, ARCH RATION MECH AN, V19, P1; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Evans L.C, 2010, PARTIAL DIFFERENTIAL, Vsecond; Feng Y, 2013, J BIOMECH, V46, P863, DOI [10.1016/j.jbiomech.2012.12.024, DOI 10.1016/J.JBI0MECH.2012.12.024]; Hallquist, 2006, LS DYNA THEORY MANUA; Hesthaven JS, 2008, TEXTS APPL MATH, V54, P1; Hoberecht RW, 2009, THESIS U WASHINGTON; Humphrey JD, 2003, P ROY SOC A-MATH PHY, V459, P3, DOI 10.1098/rspa.2002.1060; Karniadakis G.E., 1999, SPECTRAL HP ELEMENT; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Logan JD, 2010, INTRO NONLINEAR PART, V93; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Noh WF, 1976, N77 NASA STIRECON, V77, P26430; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Takhounts EG, 2008, STAPP CAR C, V52, P1; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; VONNEUMANN J, 1950, J APPL PHYS, V21, P232, DOI 10.1063/1.1699639; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	35	14	14	0	26	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2015	14	3					459	472		10.1007/s10237-014-0616-2			14	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CI0ED	WOS:000354408100003	25205088	Green Accepted			2021-06-18	
J	Qiu, JL; Zhu, WL; Lu, YJ; Bai, ZF; Liu, ZG; Zhao, P; Sun, C; Zhang, YB; Li, H; Liu, W				Qiu, Jun-Ling; Zhu, Wen-Li; Lu, Yu-Jie; Bai, Zheng-Fa; Liu, Zhi-Gang; Zhao, Pei; Sun, Chao; Zhang, Ya-Bin; Li, Hua; Liu, Wei			The selective mGluR5 agonist CHPG attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-kappa B pathway in BV2 microglial cells	NEUROCHEMISTRY INTERNATIONAL			English	Article						SO2; Microglia; Inflammation; mGluR5; TSG-6; NF-kappa B	METABOTROPIC GLUTAMATE RECEPTORS; TRAUMATIC BRAIN-INJURY; SULFUR-DIOXIDE; RAT HIPPOCAMPUS; IN-VITRO; ACTIVATION; NEUROTOXICITY; APOPTOSIS; TSG-6; EXPRESSION	Sulfur dioxide (SO2) is a common air pollutant and can cause harmful insults on neurons. Microglial activation has been implicated in the signaling cascades that contribute to neuronal cell death in various neurological disorders. In the present study, we found that SO2 derivatives decreased cell viability via inducing oxidative stress, inflammatory responses and apoptotic cell death in BV2 microglial cells. Pretreatment with (RS)-2-chloro-5-hydroxyphenylglycine (CHPG), an mGluR5 agonist, significantly attenuated the SO2-induced cytotoxicity, which was fully prevented by the mGluR5 antagonist MPEP. CHPG increased the expression of TNF-alpha stimulated gene/protein 6 (TSG-6), but decreased the activation of nuclear factor-kappa B (NF-kappa B) after SO2 derivatives treatment in BV2 cells. In addition, knockdown of TSG-6 expression by specific targeted short interfering RNA (siRNA) partially reversed the protection induced by CHPG. Therefore, our findings reveal a mechanistic basis for exploring the association between SO2 exposure and neurological disorders, and also for opening up therapeutic approaches of ameliorating neuronal injury resulting from exposure in atmospheric polluting environment. (C) 2015 Elsevier Ltd. All rights reserved.	[Qiu, Jun-Ling; Lu, Yu-Jie; Bai, Zheng-Fa; Sun, Chao; Zhang, Ya-Bin; Liu, Wei] Shannxi Fourth Peoples Hosp, Basic Med Sci Res Ctr, Xian 710043, Shannxi, Peoples R China; [Zhu, Wen-Li; Zhao, Pei] Shannxi Fourth Peoples Hosp, Dept Neurol, Xian 710043, Shannxi, Peoples R China; [Liu, Zhi-Gang; Li, Hua] Shannxi Fourth Peoples Hosp, Dept Neurosurg, Xian 710043, Shannxi, Peoples R China	Li, H (corresponding author), Shannxi Fourth Peoples Hosp, Dept Neurosurg, Xian 710043, Shannxi, Peoples R China.	lihua_sx4y@126.com; liuwei_sx4y@126.com					Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Bisseret P, 2013, ORG BIOMOL CHEM, V11, P5393, DOI 10.1039/c3ob40997j; Bordi F, 1999, PROG NEUROBIOL, V59, P55, DOI 10.1016/S0301-0082(98)00095-1; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Cai C, 2008, CLIN EXP ALLERGY, V38, P1680, DOI 10.1111/j.1365-2222.2008.03053.x; Cape JN, 2003, ENVIRON INT, V29, P201, DOI 10.1016/S0160-4120(02)00180-0; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; DESANTIS V, 1986, ENVIRON RES, V41, P130, DOI 10.1016/S0013-9351(86)80175-X; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Rencuzogullari E, 2001, MUTAT RES-GEN TOX EN, V490, P107, DOI 10.1016/S1383-5718(00)00142-X; Sang N, 2009, ECOTOX ENVIRON SAFE, V72, P879, DOI 10.1016/j.ecoenv.2008.07.007; Sang N, 2011, TOXICOL SCI, V124, P400, DOI 10.1093/toxsci/kfr224; Sang N, 2010, TOXICOL SCI, V114, P226, DOI 10.1093/toxsci/kfq010; Wang XB, 2014, LIFE SCI, V98, P63, DOI 10.1016/j.lfs.2013.12.027; Winder DG, 1996, J NEUROSCI RES, V46, P131, DOI 10.1002/(SICI)1097-4547(19961015)46:2<131::AID-JNR1>3.0.CO;2-I; Yun Y, 2010, INHAL TOXICOL, V22, P919, DOI 10.3109/08958378.2010.494694; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	27	14	14	0	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JUN-JUL	2015	85-86						46	52		10.1016/j.neuint.2015.04.007			7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CK4QT	WOS:000356209000006	25953665				2021-06-18	
J	Sun, B; Hu, C; Fang, H; Zhu, LN; Gao, N; Zhu, JC				Sun, Bo; Hu, Chen; Fang, Huan; Zhu, Lina; Gao, Ning; Zhu, Jingci			The Effects of Lactobacillus acidophilus on the Intestinal Smooth Muscle Contraction through PKC/MLCK/MLC Signaling Pathway in TBI Mouse Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN KINASE; INTERSTITIAL-CELLS; PHOSPHORYLATION; RELAXATION; CPI-17; GROWTH; SUPPLEMENTATION; SENSITIZATION	Clinical studies have shown that probiotics influence gastrointestinal motility. However, the molecular mechanisms by which probiotic Lactobacillus modulates intestinal motility in traumatic brain injury (TBI) mouse model have not been explored. In the present study, we provided evidence showing that treatment of TBI mice with Lactobacillus acidophilus significantly improved the terminal ileum villus morphology, restored the impaired interstitial cells of Cajal (ICC) and the disrupted ICC networks after TBI, and prevented TBI-mediated inhibition of contractile activity in intestinal smooth muscle. Mechanistically, the decreased concentration of MLCK, phospho-MLC20 and phospho-MYPT1 and increased concentration of MLCP and PKC were observed after TBI, and these events mediated by TBI were efficiently prevented by Lactobacillus acidophilus application. These findings may provide a novel mechanistic basis for the application of Lactobacillus acidophilus in the treatment of TBI.	[Sun, Bo; Hu, Chen; Fang, Huan; Zhu, Lina; Zhu, Jingci] Third Mil Med Univ, Sch Nursing, Chongqing 400038, Peoples R China; [Gao, Ning] Third Mil Med Univ, Coll Pharm, Chongqing 400038, Peoples R China	Gao, N (corresponding author), Third Mil Med Univ, Coll Pharm, Chongqing 400038, Peoples R China.	gaoning59@163.com; zhujingci2009@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272079]	This study was funded by the National Natural Science Foundation of China, grant number 81272079, URL: http://www.nsfc.gov.cn/, received by JCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayman S, 2003, BRIT J PHARMACOL, V139, P1532, DOI 10.1038/sj.bjp.0705394; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; BATEUP JM, 1995, APPL ENVIRON MICROB, V61, P1147, DOI 10.1128/AEM.61.3.1147-1149.1995; Biancani P, 1997, AM J MED, V103, p23S, DOI 10.1016/S0002-9343(97)00316-1; Borthakur A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075664; Botes M, 2008, ARCH MICROBIOL, V190, P573, DOI 10.1007/s00203-008-0408-0; Bowen Denise M, 2013, J Dent Hyg, V87, P5; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Duan HB, 2013, J SURG RES, V184, P1006, DOI 10.1016/j.jss.2013.03.096; Dumonceaux TJ, 2006, APPL ENVIRON MICROB, V72, P2815, DOI 10.1128/AEM.72.4.2815-2823.2006; Ehrmann MA, 2002, J APPL MICROBIOL, V92, P966, DOI 10.1046/j.1365-2672.2002.01608.x; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229; Gomes AMP, 1999, TRENDS FOOD SCI TECH, V10, P139, DOI 10.1016/S0924-2244(99)00033-3; Hersch E, 2004, AM J PHYSIOL-CELL PH, V287, pC1209, DOI 10.1152/ajpcell.00198.2004; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; IKEBE M, 1985, J BIOL CHEM, V260, P4547; Kitazawa T, 2003, J PHYSIOL-LONDON, V546, P879, DOI 10.1113/jphysiol.2002.029306; Lipp P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004556; Liu S, 2013, NEURAL REGEN RES, V8, P3334, DOI 10.3969/j.issn.1673-5374.2013.35.008; Liu ZH, 2014, MOL BIOL REP, V41, P8037, DOI 10.1007/s11033-014-3701-9; Lorincz A, 2008, GASTROENTEROLOGY, V134, P1083, DOI 10.1053/j.gastro.2008.01.036; Mahavadi S, 2014, CELL BIOCHEM BIOPHYS, V68, P1, DOI 10.1007/s12013-013-9677-6; Massi M, 2006, WORLD J GASTROENTERO, V12, P5987, DOI 10.3748/wjg.v12.i37.5987; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Nalli AD, 2014, J PHARMACOL EXP THER, V350, P89, DOI 10.1124/jpet.113.212522; Nazzaro F, 2012, ANAEROBE, V18, P280, DOI 10.1016/j.anaerobe.2012.03.002; Ojetti V, 2014, J GASTROINTEST LIVER, V23, P387, DOI 10.15403/jgld.2014.1121.234.elr; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Pan Hong, 2014, Fa Yi Xue Za Zhi, V30, P169; Porcher C, 2002, AM J GASTROENTEROL, V97, P118; Rauch S, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.002; Savard P, 2011, INT J FOOD MICROBIOL, V149, P50, DOI 10.1016/j.ijfoodmicro.2010.12.026; Singhi SC, 2008, INDIAN J PEDIATR, V75, P621, DOI 10.1007/s12098-008-0119-1; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Tan M, 2011, BRIT J NEUROSURG, V25, P2, DOI 10.3109/02688697.2010.522745; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Weber LP, 2000, BIOCHEM J, V352, P573, DOI 10.1042/0264-6021:3520573; Ye J, 2006, J CELL MOL MED, V10, P687, DOI 10.1111/j.1582-4934.2006.tb00428.x; Yu QH, 2013, HUM VACC IMMUNOTHER, V9, P805, DOI 10.4161/hv.23302	43	14	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2015	10	6							e0128214	10.1371/journal.pone.0128214			17	Multidisciplinary Sciences	Science & Technology - Other Topics	CL0KF	WOS:000356630900127	26030918	DOAJ Gold, Green Published			2021-06-18	
J	van Ierssel, SH; Conraads, VM; Van Craenenbroeck, EM; Liu, Y; Maas, AIR; Parizel, PM; Hoymans, VY; Vrints, CJ; Jorens, PG				van Ierssel, Sabrina H.; Conraads, Viviane M.; Van Craenenbroeck, Emeline M.; Liu, Yin; Maas, Andrew I. R.; Parizel, Paul M.; Hoymans, Vicky Y.; Vrints, Christiaan J.; Jorens, Philippe G.			Endothelial Dysfunction in Acute Brain Injury and the Development of Cerebral Ischemia	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						endothelial dysfunction; subarachnoid hemorrhage; cerebral ischemia; traumatic brain injury	ANEURYSMAL SUBARACHNOID HEMORRHAGE; PROGENITOR CELLS; VASOSPASM; MICROPARTICLES; MECHANISMS; INFARCTION; DEFICITS	Cerebral ischemia (CeI) is a major complicating event after acute brain injury (ABI) in which endothelial dysfunction is a key player. This study evaluates cellular markers of endothelial function and in vivo reactive hyperemia in patients with ABI and their relationship to the development of cerebral ischemia. We studied cellular markers of endothelial dysfunction and the peripheral reactive hyperemia index (RHI) in 26 patients with ABI at admission and after 6 and 12 days, and compared these with those of healthy volunteers (n=15). CeI was determined clinically or by computer tomography. In patients with ABI, RHI at admission was significantly reduced compared with healthy subjects (P=0.003), coinciding with a decrease in circulating endothelial progenitor cells (EPC; P=0.002). The RHI recovered in eight patients without development of CeI, but failed to fully recover by day 12 in three of four patients who developed CeI. Despite recovery of the RHI within 12 days in these patients (P=0.003), EPC count remained significantly lower after 12 days in patients with ABI (P=0.022). CD31(+) T cells and endothelial microparticles were not different between controls and patients. No differences were noted in cellular markers of endothelial dysfunction in patients developing CeI and those not. In conclusion, patients with ABI exhibit impaired microvascular endothelial function measured as RHI and a decreased circulating level of EPC. (c) 2015 Wiley Periodicals, Inc.	[van Ierssel, Sabrina H.; Jorens, Philippe G.] Univ Antwerp, Univ Antwerp Hosp, Dept Crit Care Med, Edegem, Belgium; [van Ierssel, Sabrina H.; Conraads, Viviane M.; Van Craenenbroeck, Emeline M.; Hoymans, Vicky Y.; Vrints, Christiaan J.] Univ Antwerp, Univ Antwerp Hosp, Lab Cellular & Mol Cardiol, Edegem, Belgium; [van Ierssel, Sabrina H.] Univ Antwerp, Univ Antwerp Hosp, Dept Internal Med, Edegem, Belgium; [Conraads, Viviane M.; Van Craenenbroeck, Emeline M.; Hoymans, Vicky Y.; Vrints, Christiaan J.] Univ Antwerp, Univ Antwerp Hosp, Dept Cardiol, Edegem, Belgium; [Liu, Yin; Parizel, Paul M.] Univ Antwerp, Univ Antwerp Hosp, Dept Radiol, Edegem, Belgium; [Liu, Yin] Cent S Univ, Xiangya Hosp 3, Dept Radiol, Changsha, Hunan, Peoples R China; [Maas, Andrew I. R.] Univ Antwerp, Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium	van Ierssel, SH (corresponding author), Univ Antwerp Hosp, Wilrijkstr 10, B-2650 Edegem, Belgium.	sabrina.vanierssel@uantwerpen.be	Van Craenenbroeck, Emeline/AAG-4540-2020	van Ierssel, Sabrina H./0000-0003-2955-4130; Parizel, Paul M./0000-0002-0221-2854	Research Foundation-Flanders, BelgiumFWO; Agency for Innovation by Science and Technology	Contract grant sponsor: The Research Foundation-Flanders, Belgium (to S.H.v.I., V.M.C.); Contract grant sponsor: The Agency for Innovation by Science and Technology.	Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; Bergstrom A, 2014, BRIT J ANAESTH, V112, P311, DOI 10.1093/bja/aet331; Brown RJ, 2013, NEUROSURGERY, V72, P702, DOI 10.1227/NEU.0b013e318285c3db; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; de Rooij NK, 2013, STROKE, V44, P1288, DOI 10.1161/STROKEAHA.113.001125; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fan HK, 2012, INFLAMMATION, V35, P130, DOI 10.1007/s10753-011-9297-5; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Kolias AG, 2009, J NEUROSCI RES, V87, P1, DOI 10.1002/jnr.21823; Kozniewska E, 2006, J PHYSIOL PHARMACOL, V57, P145; Lackner P, 2010, STROKE, V41, P2353, DOI 10.1161/STROKEAHA.110.584995; Lacroix R, 2010, J THROMB HAEMOST, V8, P2571, DOI 10.1111/j.1538-7836.2010.04047.x; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Sanborn MR, 2012, J NEUROSURG, V117, P579, DOI 10.3171/2012.6.JNS111163; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Van Craenenbroeck EMF, 2008, J IMMUNOL METHODS, V332, P31, DOI 10.1016/j.jim.2007.12.006; van Ierssel SH, 2010, THROMB RES, V125, P332, DOI 10.1016/j.thromres.2009.12.019; vansIerssel SH, 2013, PLOS ONE, V8; vansIerssel SH, 2012, PLOS ONE, V7; Vergouwen MDI, 2008, J CEREBR BLOOD F MET, V28, P1761, DOI 10.1038/jcbfm.2008.74; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vergouwen MDI, 2009, J CEREBR BLOOD F MET, V29, P1734, DOI 10.1038/jcbfm.2009.88; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wei HJ, 2011, NEUROSCI LETT, V498, P114, DOI 10.1016/j.neulet.2011.04.061; Wei HJ, 2011, J NEUROSCI RES, V89, P1822, DOI 10.1002/jnr.22696	34	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2015	93	6					866	872		10.1002/jnr.23566			7	Neurosciences	Neurosciences & Neurology	CF9TN	WOS:000352909800004	25677574				2021-06-18	
J	Tang, AD; Makowiecki, K; Bartlett, C; Rodger, J				Tang, Alexander D.; Makowiecki, Kalina; Bartlett, Carole; Rodger, Jennifer			Low Intensity Repetitive Transcranial Magnetic Stimulation Does Not Induce Cell Survival or Regeneration in a Mouse Optic Nerve Crush Model	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ALTERNATING-CURRENT STIMULATION; THETA-BURST STIMULATION; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; RAT MODEL; BDNF; RTMS; INJURY; TRANSECTION	Low intensity repetitive Transcranial Magnetic Stimulation (LI-rTMS), a non-invasive form of brain stimulation, has been shown to induce structural and functional brain plasticity, including short distance axonal sprouting. However, the potential for LI-rTMS to promote axonal regeneration following neurotrauma has not been investigated. This study examined the effect of LI-rTMS on retinal ganglion cell (RGC) survival, axon regeneration and levels of BDNF in an optic nerve crush neurotrauma model. Adult C57Bl/6J mice received a unilateral intraorbital optic nerve crush. Mice received 10 minutes of sham (handling control without stimulation) (n=6) or LI-rTMS (n = 8) daily stimulation for 14 days to the operated eye. Immunohistochemistry was used to assess RGC survival (beta-3 Tubulin) and axon regeneration across the injury (GAP43). Additionally, BDNF expression was quantified in a separate cohort by ELISA in the retina and optic nerve of injured (optic nerve crush) (sham n = 5, LIrTMS n = 5) and non-injured mice (sham n = 5, LI-rTMS n = 5) that received daily stimulation as above for 7 days. Following 14 days of LI-rTMS there was no significant difference in mean RGC survival between sham and treated animals (p > 0.05). Also, neither sham nor LIrTMS animals showed GAP43 positive labelling in the optic nerve, indicating that regeneration did not occur. At 1 week, there was no significant difference in BDNF levels in the retina or optic nerves between sham and LI-rTMS in injured or non-injured mice (p > 0.05). Although LI-rTMS has been shown to induce structural and molecular plasticity in the visual system and cerebellum, our results suggest LI-rTMS does not induce neuroprotection or regeneration following a complete optic nerve crush. These results help define the therapeutic capacity and limitations of LI-rTMS in the treatment of neurotrauma.	[Tang, Alexander D.; Makowiecki, Kalina; Bartlett, Carole; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Dept Expt & Regenerat Neurosci, Perth, WA 6009, Australia	Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Dept Expt & Regenerat Neurosci, Perth, WA 6009, Australia.	jennifer.rodger@uwa.edu.au	Rodger, Jennifer/H-5735-2014; Tang, Alexander D/S-5258-2018	Rodger, Jennifer/0000-0003-3413-4229; Makowiecki, Kalina/0000-0003-4550-3819; Tang, alexander/0000-0002-3832-847X	National Health and Medical Research Council Neurotrauma Research ProgramNational Health and Medical Research Council of Australia [634386, APP1002258]; State Government of Western Australia; Australian Research CouncilAustralian Research Council [LP110100201]	This work was supported by the National Health and Medical Research Council (634386, APP1002258; http://www.nhmrc.gov.au/) Neurotrauma Research Program, State Government of Western Australia (no grant number available, http://www.nrp.org.au/), and the Australian Research Council (LP110100201; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Bates KA, 2012, BRAIN RES, V1458, P76, DOI 10.1016/j.brainres.2012.04.006; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Bortolomasi M, 2007, PSYCHIAT RES, V150, P181, DOI 10.1016/j.psychres.2006.04.010; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Di Lazzaro V, 2013, BRAIN STIMUL, V6, P469, DOI 10.1016/j.brs.2013.01.004; Dixon KJ, 2006, EXP NEUROL, V202, P44, DOI 10.1016/j.expneurol.2006.05.010; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Grehl S, 2015, BRAIN STIMUL, V8, P114, DOI 10.1016/j.brs.2014.09.012; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Henrich-Noack P, 2013, BRAIN RES BULL, V95, P7, DOI 10.1016/j.brainresbull.2013.02.008; Henrich-Noack P, 2013, NEUROSCI LETT, V543, P1, DOI 10.1016/j.neulet.2013.03.013; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hou JM, 2014, J NEUROTRAUM, V31, P1088, DOI 10.1089/neu.2013.3096; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Khedr EM, 2010, ACTA NEUROL SCAND, V121, P30, DOI 10.1111/j.1600-0404.2009.01195.x; Kleinjung T, 2005, OTOLARYNG HEAD NECK, V132, P566, DOI 10.1016/j.otohns.2004.09.134; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; Lenz M, 2014, BRAIN STRUCT FUNCT, P1; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Macharadze T, 2009, NEUROREPORT, V20, P301, DOI 10.1097/WNR.0b013e32832027e6; Makowiecki K, 2014, J NEUROSCI, V34, P10780, DOI 10.1523/JNEUROSCI.0723-14.2014; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Morellini N, 2015, CEREBELLUM, V14, P23, DOI 10.1007/s12311-014-0617-9; Morimoto T, 2005, INVEST OPHTH VIS SCI, V46, P2147, DOI 10.1167/iovs.04-1339; Morimoto T, 2002, NEUROREPORT, V13, P227, DOI 10.1097/00001756-200202110-00011; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Panagis L, 2005, EUR J NEUROSCI, V21, P2305, DOI 10.1111/j.1460-9568.2005.04046.x; Coimbra JP, 2009, J COMP NEUROL, V514, P66, DOI 10.1002/cne.21992; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Prilloff S, 2012, INVEST OPHTH VIS SCI, V53, P1460, DOI 10.1167/iovs.11-8306; Rodger J, 2012, FASEB J, V26, P1593, DOI 10.1096/fj.11-194878; Sergeeva EG, 2012, J NEUROPHYSIOL, V108, P2494, DOI 10.1152/jn.00341.2012; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Templeton JP, 2012, MOL VIS, V18, P2147; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Volz LJ, 2013, BRAIN STIMUL, V6, P598, DOI 10.1016/j.brs.2013.01.008; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; WEIBEL D, 1995, BRAIN RES, V679, P249, DOI 10.1016/0006-8993(95)00238-L; WEISSMAN JD, 1992, ELECTROEN CLIN NEURO, V85, P215, DOI 10.1016/0168-5597(92)90135-X; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2; Zanardini R, 2006, J AFFECT DISORDERS, V91, P83, DOI 10.1016/j.jad.2005.12.029	52	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126949	10.1371/journal.pone.0126949			13	Multidisciplinary Sciences	Science & Technology - Other Topics	CI7CV	WOS:000354921400085	25993112	DOAJ Gold, Green Published			2021-06-18	
J	Sierra-Mercado, D; McAllister, LM; Lee, CCH; Milad, MR; Eskandar, EN; Whalen, MJ				Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Milad, Mohammed R.; Eskandar, Emad N.; Whalen, Michael J.			Controlled cortical impact before or after fear conditioning does not affect fear extinction in mice	BRAIN RESEARCH			English	Article						Traumatic brain injury; Fear learning; Extinction; Anxiety disorder; Dorsal hippocampus; Learning and memory; Rodent	TRAUMATIC BRAIN-INJURY; VENTROMEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; VENTRAL HIPPOCAMPUS; DORSAL HIPPOCAMPUS; AMYGDALA; LESIONS; MILD; EXPRESSION; ANXIETY	Post-traumatic stress disorder (PTSD) is characterized in part by impaired extinction of conditioned fear. Traumatic brain injury (TBI) is thought to be a risk factor for development of PTSD. We tested the hypothesis that controlled cortical impact (CCI) would impair extinction of fear learned by Pavlovian conditioning, in mice. To mimic the scenarios in which TBI occurs prior to or after exposure to an aversive event, severe CCI was delivered to the left parietal cortex at one of two time points: (1) Prior to fear conditioning, or (2) after conditioning. Delay auditory conditioning was achieved by pairing a tone with a foot shock in "context A". Extinction training involved the presentation of tones in a different context (context B) in the absence of foot shock. Test for extinction memory was achieved by presentation of additional tones alone in context B over the following two days. In pre- or post-injury paradigms, CCI did not influence fear learning and extinction. Furthermore, CCI did not affect locomotor activity or elevated plus maze testing. Our results demonstrate that, within the time frame studied, CCI does not impair the acquisition and expression of conditioned fear or extinction memory. (C) 2015 Elsevier B.V. All rights reserved.	[Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Whalen, Michael J.] Massachusetts Gen Hosp, Neurosci Ctr, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio; McAllister, Lauren M.; Lee, Christopher C. H.; Milad, Mohammed R.; Eskandar, Emad N.; Whalen, Michael J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio; Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Milad, Mohammed R.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sierra-Mercado, Demetrio] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA	Sierra-Mercado, D (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA.	demetrio.sierra@upr.edu; LMCALLISTER1@mgh.harvard.edu; lee.chris.ch@gmail.com; milad@nmr.mgh.harvard.edu; eeskandar@mgh.harvard.edu; mwhalen@partners.org	Milad, Mohammed R/O-4553-2018		RCMI [8G12MD007600]; Brain & Behavior Research Foundation (NARSAD) [MH097964, MH097880, MH086400, NS086422]; DOD/CIMIT [W81XWH-07-2-0011]; Behavioral Core Facility [P01NS5510406];  [DA026297]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH097964, P50MH086400, R01MH097880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS055104, R01NS086422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA026297] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [G12MD007600] Funding Source: NIH RePORTER	We thank Jimmy Zhang for technical assistance. This study was supported in part by RCMI 8G12MD007600, a supplement from DA026297 and a Young Investigator Grant from the Brain & Behavior Research Foundation (NARSAD) to DS-M, MH097964 and MH097880 to MRM, MH086400 and NS086422 to ENE, DOD/CIMIT W81XWH-07-2-0011 to MJW, and Behavioral Core Facility (P01NS5510406).	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Devan BD, 1999, J NEUROSCI, V19, P2789; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Farinelli M, 2006, LEARN MEMORY, V13, P329, DOI 10.1101/lm.204806; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Hefner K, 2008, J NEUROSCI, V28, P8074, DOI 10.1523/JNEUROSCI.4904-07.2008; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hogg S, 1998, BEHAV BRAIN RES, V93, P157, DOI 10.1016/S0166-4328(97)00145-9; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Milad MR, 2012, ANNU REV PSYCHOL, V63, P129, DOI 10.1146/annurev.psych.121208.131631; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Pavlov I. P., 1927, CONDITIONED REFLEXES; PELLOW S, 1985, NEUROSCI BIOBEHAV R, V9, P55, DOI 10.1016/0149-7634(85)90032-6; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Quinn JJ, 2008, HIPPOCAMPUS, V18, P640, DOI 10.1002/hipo.20424; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Rougemont-Bucking A, 2011, CNS NEUROSCI THER, V17, P227, DOI 10.1111/j.1755-5949.2010.00152.x; Runyan JD, 2004, J NEUROSCI, V24, P1288, DOI 10.1523/JNEUROSCI.4880-03.2004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229	55	14	14	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 5	2015	1606						133	141		10.1016/j.brainres.2015.02.031			9	Neurosciences	Neurosciences & Neurology	CH0XR	WOS:000353746200014	25721797	Green Accepted			2021-06-18	
J	Bruce, ED; Konda, S; Dean, DD; Wang, EW; Huang, JH; Little, DM				Bruce, Erica D.; Konda, Sneha; Dean, Dana D.; Wang, Ernest W.; Huang, Jason H.; Little, Deborah M.			Neuroimaging and traumatic brain injury: State of the field and voids in translational knowledge	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Traumatic brain injury (TBI); Neuroimaging; Biomarkers; Magnetic resonance imaging (MRI)	MILD-COGNITIVE-IMPAIRMENT; CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; WHITE-MATTER INTEGRITY; TENSOR IMAGING DETECTS; ALZHEIMERS-DISEASE; MOUSE MODEL; WORKING-MEMORY	Traumatic brain injury (TBI) is a leading cause of death and disability in every developed country in the world and is believed to be a risk factor in the later development of depression, anxiety disorders and neurodegenerative diseases including chronic traumatic encephalopathy (CTE), Alzheimer's Disease (AD), Parkinson's Disease (PD), and amyotrophic lateral sclerosis (ALS). One challenge faced by those who conduct research into TBI is the lack of a verified and validated biomarker that can be used to diagnose TBI or for use as a prognostic variable which can identify those at risk for poor recovery following injury or at risk for neurodegeneration later in life. Neuroimaging continues to hold promise as a TBI biomarker but is limited by a lack of clear relationship between the neuropathology of injury/recovery and the quantitative and image based data that is obtained. Specifically lacking is the data on biochemical and biologic changes that lead to alterations in neuroimaging markers. There are multiple routes towards developing, the knowledge required to more definitively link pathology to imaging but the most efficient approach is expanded leveraging of in vivo human blood, serum, and imaging biomarkers with both in vivo and ex vivo animal findings. This review describes the current use and limitations of imaging in TBI including a discussion of currently used animal injury models and the available animal imaging data and extracted markers that hold the greatest promise for helping translate alterations in imaging back to injury pathology. Further, it reviews both the human and animal TBI literature supporting current standards, identifies the remaining voids in the literature, and briefly highlights recent advances in molecular imaging. This article is part of a Special Issue entitled 'Traumatic Brain Injury'. (C) 2015 Elsevier Inc. All rights reserved.	[Bruce, Erica D.] Baylor Univ, Dept Environm Sci, Inst Biomed Studies, Inst Ecol Earth & Environm Sci, Waco, TX 76798 USA; [Konda, Sneha; Little, Deborah M.] Texas A&M Hlth Sci Ctr, Coll Med, Inst Neurosci, Temple, TX 76508 USA; [Dean, Dana D.; Wang, Ernest W.; Huang, Jason H.; Little, Deborah M.] Baylor Scott & White Healthcare, Inst Neurosci, Temple, TX 76508 USA	Little, DM (corresponding author), Baylor Scott & White Hlth, Inst Neurosci, Sect Vet Biomed Res, 5701 Airport Rd,Mailbox MS AR D120, Temple, TX 76502 USA.	deborahmlittle@gmail.com	Huang, Jason H/J-4739-2019; Guenat, Heather/H-6528-2014; Bruce, Erica D./H-2194-2015	Huang, Jason H/0000-0002-4426-0168; Bruce, Erica D./0000-0002-4900-0496			Ackl N, 2005, NEUROSCI LETT, V384, P23, DOI 10.1016/j.neulet.2005.04.035; Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Arfanakis K, 2002, MAGNET RESON MED, V47, P354, DOI 10.1002/mrm.10046; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Centers for Disease Control and Prevention (CDC) The National Institutes of Health (NIH) The Department of Defense (DoD) The Department of Veterans Affairs (VA) Leadership Panel, 2013, REP C TRAUM BRAIN IN; Cernak I., J CEREB BLOOD FLOW M, V30, P255; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Choi JJ, 2007, PHYS MED BIOL, V52, P5509, DOI 10.1088/0031-9155/52/18/004; Crandall M, 2011, ARCH SURG-CHICAGO, V146, P442, DOI 10.1001/archsurg.2011.34; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Dankbaar JW, 2009, J NEURORADIOLOGY, V36, P219, DOI 10.1016/j.neurad.2009.01.001; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellis CM, 2001, NEUROLOGY, V57, P1571, DOI 10.1212/WNL.57.9.1571; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Falini A, 2005, NEUROIMAGE, V26, P1159, DOI 10.1016/j.neuroimage.2005.03.005; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fellgiebel A, 2006, PSYCHIAT RES-NEUROIM, V146, P283, DOI 10.1016/j.pscychresns.2006.01.006; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Foley LM, 2013, J CEREBR BLOOD F MET, V33, P129, DOI 10.1038/jcbfm.2012.145; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Fujita Y, 2014, CHILD NERV SYST, V30, P1201, DOI 10.1007/s00381-014-2353-3; Gallagher C, 2013, J INT NEUROPSYCH SOC, V19, P349, DOI 10.1017/S1355617712001373; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; HILL A, 1981, ANN NEUROL, V10, P109, DOI 10.1002/ana.410100202; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Ibarretxe-Bilbao N, 2012, MOVEMENT DISORD, V27, P1746, DOI 10.1002/mds.25240; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jones RS, 2004, NEUROL RES, V26, P488, DOI 10.1179/016164104225017640; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kantarci K, 2002, DEMENT GERIATR COGN, V14, P198, DOI 10.1159/000066021; Kantarci K, 2002, J INT NEUROPSYCH SOC, V8, P934, DOI 10.1017/S1355617702870084; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Lin AJ, 2011, ANN BIOMED ENG, V39, P1349, DOI 10.1007/s10439-011-0269-6; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maegele M, 2007, INFLAMM RES, V56, P318, DOI 10.1007/s00011-007-6141-3; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall SA, 2012, MIL MED, V177, P76, DOI 10.7205/MILMED-D-12-00142; Mayer A., 2014, CONCUSSIONS ATHLETIC, P249; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Modrego Pedro J., 2006, Current Alzheimer Research, V3, P161, DOI 10.2174/156720506776383103; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Planetta PJ, 2013, AM J NEURORADIOL, V34, P74, DOI 10.3174/ajnr.A3178; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Prince DA, 2012, JASPERS BASIC MECH E; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Prodoehl J, 2013, MOVEMENT DISORD, V28, P1816, DOI 10.1002/mds.25491; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reimao S, 2011, NEURORADIOL J, V24, P177, DOI 10.1177/197140091102400203; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Sandry J, 2015, J NEUROL, V262, P59, DOI 10.1007/s00415-014-7523-4; Santos JMG, 2008, DEMENT GERIATR COGN, V26, P15, DOI 10.1159/000140624; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Selnes P, 2013, J ALZHEIMERS DIS, V33, P723, DOI 10.3233/JAD-2012-121603; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stebbins GT, 2009, BEHAV NEUROL, V21, P39, DOI [10.3233/BEN-2009-0234, 10.1155/2009/915041]; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; TAYLOR GA, 1994, PEDIATR RADIOL, V24, P111, DOI 10.1007/BF02020166; Teipel SJ, 2010, J ALZHEIMERS DIS, V22, P507, DOI 10.3233/JAD-2010-100234; Tisserand DJ, 2006, BRAIN COGNITION, V60, P216; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; University of Michigan Functional MRI Laboratory, 2007, ART SPIN LAB; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; van Bruggen T, 2012, PSYCHIAT RES-NEUROIM, V203, P184, DOI 10.1016/j.pscychresns.2011.12.003; van Laar PJ, 2008, RADIOLOGY, V246, P198, DOI 10.1148/radiol.2453061932; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wee CY, 2011, LECT NOTES COMPUT SC, V6892, P277, DOI 10.1007/978-3-642-23629-7_34; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068	146	14	14	3	24	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAY	2015	66		B		SI		103	113		10.1016/j.mcn.2015.03.017			11	Neurosciences	Neurosciences & Neurology	CK7FT	WOS:000356398900006	25827094				2021-06-18	
J	Hughes, AJ; Beier, M; Hartoonian, N; Turner, AP; Amtmann, D; Ehde, DM				Hughes, Abbey J.; Beier, Meghan; Hartoonian, Narineh; Turner, Aaron P.; Amtmann, Dagmar; Ehde, Dawn M.			Self-Efficacy as a Longitudinal Predictor of Perceived Cognitive Impairment in Individuals With Multiple Sclerosis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Cognition; Executive function; Longitudinal studies; Multiple sclerosis; Rehabilitation; Self efficacy; Self report	QUALITY-OF-LIFE; DISABILITY STATUS SCALE; TRAUMATIC BRAIN-INJURY; PHYSICAL-ACTIVITY; HEALTH-STATUS; DEPRESSION; ADJUSTMENT; MANAGEMENT; DISORDERS; ADHERENCE	Objectives: To determine whether self-efficacy longitudinally predicts 2 types of perceived cognitive impairment (PCI) in multiple sclerosis (MS): general cognitive functioning and executive functioning; and secondarily to assess whether self-efficacy mediates the relationships between depression, fatigue, and PCI. Design: Longitudinal analysis of self-report survey data collected over 3 years. Hierarchical regression analyses examined the relationship between self-efficacy and PCI, adjusting for depression and fatigue. Additional analyses tested self-efficacy as a mediator between depression, fatigue, and PCI. Setting: Community. Participants: Community-dwelling individuals with MS (N=233; age range, 22-83y) were recruited from a larger longitudinal survey study of individuals with MS (N=562). Interventions: Not applicable. Main Outcome Measures: Primary outcome measures were the Applied Cognition General Concerns and the Applied Cognition Executive Function domains of the Quality of Life in Neurological Disorders (NeuroQoL) measures. Results: Self-efficacy was significantly correlated with PCI at baseline (r=.40.53) and 3 years later (r=.36.44). In multivariate regression analyses, self-efficacy was a significant longitudinal predictor of PCI, both for general cognitive functioning (13=20, P<.01) and executive functioning (13=.16, P<.05). Self-efficacy partially mediated the relationships between depression, fatigue, and PCI. Conclusions: Self-efficacy may influence how individuals with MS perceive their cognitive functioning over time. Interventions that target self-efficacy, particularly early in the disease course, may lead to improvements in PCI, as well as improvements in fatigue and depression. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hughes, Abbey J.; Beier, Meghan; Turner, Aaron P.; Amtmann, Dagmar; Ehde, Dawn M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Hughes, Abbey J.; Hartoonian, Narineh; Turner, Aaron P.] Vet Affairs Puget Sound Hlth Care Syst, Multiple Sclerosis Ctr Excellence West, Seattle, WA USA	Hughes, AJ (corresponding author), Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA.	ajhughes@uw.edu	Hughes, Abbey/K-8861-2015; Ehde, Dawn/K-1883-2016; Turner, Aaron/A-7902-2009	Hughes, Abbey/0000-0002-7612-6887; Turner, Aaron/0000-0001-6897-8003; Ehde, Dawn/0000-0002-9555-2347	Department of Education, National Institute on Disability and Rehabilitation Research [H133B031129, H133B080025]; National Institutes of Health (NIH) through the NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01AR052171-03]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [MB 0026]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U01AR052171] Funding Source: NIH RePORTER	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research (grant nos. H133B031129, H133B080025); the National Institutes of Health (NIH) through the NIH Roadmap for Medical Research (grant no. 5U01AR052171-03); and the National Multiple Sclerosis Society (grant no. MB 0026). The contents of this article do not necessarily represent the policy of the Department of Education and should not assume endorsement by the Federal Government.	Aalto AM, 1997, PATIENT EDUC COUNS, V30, P215, DOI 10.1016/S0738-3991(96)00963-9; Aljasem LI, 2001, DIABETES EDUCATOR, V27, P393, DOI 10.1177/014572170102700309; Amtmann D, 2012, ARCH PHYS MED REHAB, V93, P1757, DOI 10.1016/j.apmr.2012.05.001; Bamer AM, 2008, MULT SCLER J, V14, P1127, DOI 10.1177/1352458508092807; Bamer AM, 2007, MULT SCLER J, V13, P1033, DOI 10.1177/1352458507077624; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barlow JH, 2002, PATIENT EDUC COUNS, V46, P11, DOI 10.1016/S0738-3991(01)00146-X; Barnwell AM, 1997, SOC SCI MED, V45, P411, DOI 10.1016/S0277-9536(96)00356-5; Benito-Leon J, 2003, DISABIL REHABIL, V25, P1291, DOI 10.1080/09638280310001608591; Bowen J, 2001, MULT SCLER, V7, P201, DOI 10.1191/135245801678438447; Buckelew SP, 1996, ARTHRIT CARE RES, V9, P97, DOI 10.1002/1529-0131(199604)9:2<97::AID-ANR1790090205>3.0.CO;2-F; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Denney DR, 2005, ARCH CLIN NEUROPSYCH, V20, P967, DOI 10.1016/j.acn.2005.04.012; Dilorio C, 1992, West J Nurs Res, V14, P292; Dilorio C, 1992, WESTERN J NURS RES, V14, P303; Garfield AC, 2012, DISABIL REHABIL, V34, P2047, DOI 10.3109/09638288.2012.667503; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; HOLDEN G, 1991, SOC WORK HEALTH CARE, V16, P53; JENSEN MP, 1991, PAIN, V47, P249, DOI 10.1016/0304-3959(91)90216-K; Jongen PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096444; Julian L, 2007, MULT SCLER J, V13, P81, DOI 10.1177/1352458506070255; Kasser SL, 2012, DISABIL HEALTH J, V5, P261, DOI 10.1016/j.dhjo.2012.07.001; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lackner JM, 1996, J CONSULT CLIN PSYCH, V64, P212, DOI 10.1037/0022-006X.64.1.212; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Marks R, 2005, HEALTH PROMOT PRACT, V6, P148, DOI 10.1177/1524839904266792; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Motl RW, 2009, INT J REHABIL RES, V32, P260, DOI 10.1097/MRR.0b013e328325a5ed; Ng A, 2013, DISABIL REHABIL, V35, P1039, DOI 10.3109/09638288.2012.717586; Pakenham KI, 1999, HEALTH PSYCHOL, V18, P383, DOI 10.1037/0278-6133.18.4.383; Plow M, 2012, DISABIL HEALTH J, V5, P284, DOI 10.1016/j.dhjo.2012.05.007; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rae-Grant AD, 2011, J REHABIL RES DEV, V48, P1087, DOI 10.1682/JRRD.2010.08.0159; Saunders C, 2010, J NEUROSCI NURS, V42, pS10, DOI 10.1097/JNN.0b013e3181ee122b; Schmitt MM, 2014, REHABIL PSYCHOL, V59, P27, DOI 10.1037/a0035288; Schoenthaler A, 2009, HEALTH EDUC BEHAV, V36, P127, DOI 10.1177/1090198107309459; Senders A, 2014, MULT SCLER J, V20, P1102, DOI 10.1177/1352458513517279; Shnek ZM, 1997, ANN BEHAV MED, V19, P287, DOI 10.1007/BF02892293; Stuifbergen AK, 2000, NURS RES, V49, P122, DOI 10.1097/00006199-200005000-00002; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; Suh Y, 2011, BEHAV MED, V37, P87, DOI 10.1080/08964289.2011.603768; Trojan DA, 2007, MULT SCLER J, V13, P985, DOI 10.1177/1352458507077175; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Wegener ST, 2009, ARCH PHYS MED REHAB, V90, P373, DOI 10.1016/j.apmr.2008.08.222; Wollin Judy Ann, 2013, Int J MS Care, V15, P90, DOI 10.7224/1537-2073.2012-032; ZELDOW PB, 1984, J NERV MENT DIS, V172, P80, DOI 10.1097/00005053-198402000-00003	51	14	14	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2015	96	5					913	919		10.1016/j.apmr.2015.01.008			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CH6JL	WOS:000354142800019	25597915	Green Accepted			2021-06-18	
J	Joseph, B; Pandit, V; Khalil, M; Kulvatunyou, N; Aziz, H; Tang, A; O'Keeffe, T; Hays, D; Gries, L; Lemole, M; Friese, RS; Rhee, P				Joseph, Bellal; Pandit, Viraj; Khalil, Mazhar; Kulvatunyou, Narong; Aziz, Hassan; Tang, Andrew; O'Keeffe, Terence; Hays, Daniel; Gries, Lynn; Lemole, Michael; Friese, Randall S.; Rhee, Peter			Use of Prothrombin Complex Concentrate as an Adjunct to Fresh Frozen Plasma Shortens Time to Craniotomy in Traumatic Brain Injury Patients	NEUROSURGERY			English	Article						Fresh frozen plasma; Prothrombin complex concentrate; Time to craniotomy; Traumatic brain injury	RECOMBINANT FACTOR VIIA; INTRACRANIAL HEMORRHAGE; COAGULOPATHY; REVERSAL; THERAPY; TESTS	BACKGROUND:The use of prothrombin complex concentrate (PCC) to reverse acquired (coagulopathy of trauma) and induced coagulopathy (preinjury warfarin use) is well defined.OBJECTIVE:To compare outcomes in patients with traumatic brain injury without warfarin therapy receiving PCC as an adjunct to fresh frozen plasma (FFP) therapy compared with patients receiving FFP therapy alone.METHODS:All patients with traumatic brain injury coagulopathy without warfarin therapy who received PCC (25 IU/kg) in conjunction with FFP or FFP alone at our Level I trauma center were reviewed. Coagulopathy was defined as an international normalized ratio >1.5. The groups (PCC + FFP vs FFP alone) were matched using propensity score matching on a 1:2 ratio for age, sex, Glasgow Coma Scale score, Injury Severity Score, head Abbreviated Injury Scale score, and international normalized ratio (INR) on presentation. The primary outcome measure was time to craniotomy. Secondary outcome measures were blood product requirements, cost of therapy, and mortality.RESULTS:A total of 1641 patients were reviewed, 222 of whom were included (PCC + FFP, 74; FFP, 148). The mean standard deviation age was 46.4 21.7 years, the median (range) Glasgow Coma Scale score was 8 (3-12), and the mean standard deviation INR on presentation was 1.92 0.6. PCC + FFP therapy was associated with an accelerated correction of INR (P = .001) and decrease in overall pack red blood cell (P = .035) and FFP (P = .041) administration requirement. Craniotomy was performed in 26.1% of patients (n = 58). Patients who received PCC + FFP therapy had faster time to craniotomy (P = .028) compared with patients who received FFP therapy alone.CONCLUSION:PCC as an adjunct to FFP decreases the time to craniotomy with faster correction of INR and concomitant decrease in the need for blood product requirement in patients with traumatic brain injury exclusive of prehospital warfarin therapy.ABBREVIATIONS:AIS, Abbreviated Injury ScaleFFP, fresh frozen plasmaINR, international normalized ratioPCC, prothrombin complex concentraterFVIIa, recombinant factor VIIaRHCT, repeat head computed tomography scanSD, standard deviationTBI, traumatic brain injury	[Joseph, Bellal; Pandit, Viraj; Khalil, Mazhar; Kulvatunyou, Narong; Aziz, Hassan; Tang, Andrew; O'Keeffe, Terence; Hays, Daniel; Gries, Lynn; Lemole, Michael; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, Tucson, AZ 85724 USA	Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu					Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brown CVR, 2012, AM SURGEON, V78, P57; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; May AK, 1997, AM SURGEON, V63, P233; Pabinger-Fasching I, 2008, THROMB RES, V122, pS19, DOI 10.1016/S0049-3848(08)70005-7; Roitberg B, 2005, NEUROSURGERY, V57, P832, DOI 10.1227/01.NEU.0000180816.80626.C2; Safaoui MN, 2009, AM J SURG, V197, P785, DOI 10.1016/j.amjsurg.2008.04.003; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a	20	14	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2015	76	5					601	607		10.1227/NEU.0000000000000685			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG3VY	WOS:000353208900012	25886249				2021-06-18	
J	Larson, JCG; Flaro, L; Peterson, RL; Connery, AK; Baker, DA; Kirkwood, MW				Larson, Jennifer C. Gidley; Flaro, Lloyd; Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.			The Medical Symptom Validity Test Measures Effort Not Ability in Children: A Comparison Between Mild TBI and Fetal Alcohol Spectrum Disorder Samples	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity testing; Performance validity testing; MSVT; Traumatic brain injury; Children	NONCREDIBLE EFFORT; TEST FAILURE; PERFORMANCE; INDICATORS; STATEMENT; CAPACITY; ACADEMY; ADULTS; EXAM	Inadequate effort during neuropsychological examination results in inaccurate representations of an individual's true abilities and difficulties. As such, performance validity tests (PVTs) are strongly recommended as standard practice during adult-based evaluations. One concern with using PVTs with children is that failure reflects immature cognitive ability rather than non-credible effort. The current study examined performance on the Medical Symptom Validity Test (MSVT) in two large pediatric clinical samples with strikingly different neuropsychological profiles: (1) mild traumatic brain injury (mTBI; n = 510) and (2) fetal alcohol spectrum disorder (FASD; n = 120). Despite higher IQ scores and reading ability, the mTBI group performed significantly worse than the FASD group on all effort indices. Sixteen percent of the mTBI group failed the MSVT, whereas only 5% of the FASD group did. Our findings support the idea that the MSVT measures effort, not ability, in most cases and help to justify incorporating PVTs into pediatric neuropsychological batteries.	[Larson, Jennifer C. Gidley] Kennedy Krieger Inst, Dept Neuropsychol, Baltimore, MD USA; [Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Peterson, Robin L.; Connery, Amy K.; Baker, David A.; Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO 80045 USA	Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Concuss Program, B285,13123 E 16th Ave, Aurora, CO 80045 USA.	michael.kirkwood@childrenscolorado.org					Adams W., 1998, TEST ACAD PERFORMANC; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Flanagan DP., 2009, ESSENTIALS WISC 4 AS; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Green CM, 2014, J CLIN EXP NEUROPSYC, V36, P261, DOI 10.1080/13803395.2013.879096; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2004, MANUAL MED SYMPTOM V; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry G. K., 2005, FORENSIC NEUROPSYCHO, P205; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Kirk JW, 2014, ASSESSMENT, V21, P562, DOI 10.1177/1073191114520626; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; Mattson S. N., 2010, PEDIAT NEUROPSYCHOLO, P265; McCaffrey R. J., 2009, NEUROPSYCHOLOGY MALI, P377; Salekin R. T., 2008, CLIN ASSESSMENT MALI; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D, 2003, MANUAL WECHSLER INTE; Wechsler D., 1991, MANUAL WECHSLER INTE; Wilkenson G.S., 2006, WIDE RANGE ACHIEVEME; Woodcock R.W., 2001, WOODCOCKJOHNSON 3 TE	39	14	14	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2015	30	3					192	199		10.1093/arclin/acv012			8	Psychology, Clinical; Psychology	Psychology	CH1ZO	WOS:000353822600003	25787156	Green Published			2021-06-18	
J	Lin, C; Zhao, X; Sun, HC				Lin, Chao; Zhao, Xin; Sun, Haichen			Analysis on the risk factors of intracranial infection secondary to traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Traumatic brain injury; Complication; Intracranial infection; Risky factor		Objective: To discuss the characteristics and risk factors for intracranial infection post traumatic brain injury to prevent and better the clinical care. Methods: Retrospective study of 520 patients with traumatic brain injury were included, 308 male and 212 female. The risky factors of intracranial infection were identified. Results: Thirty two cases (6.54%, 32/520) of intracranial infection were diagnosed. Intracranial infection most likely happened 4-10 days after injury. Cerebrospinal fluid leakage, drainage, multiple craniotomies were significant related to intracranial infection. Logistic regression predicted cerebrospinal fluid leakage and drainage as independent factors. Conclusion: Intracranial infection is a serious complication after traumatic brain injury. Patients with drainage or cerebrospinal fluid leakage are more risky for intracranial infection. Aggressive precaution should be taken to better outcome. (C) 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.	[Lin, Chao; Zhao, Xin; Sun, Haichen] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Sun, HC (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	sun_haichen@aliyun.com					Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/NEU.2013.2904, 10.1089/neu.2013.2904]; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Bellamy JL, 2013, PLAST RECONSTR SURG, V132, P154, DOI 10.1097/PRS.0b013e3182910b9b; Boque M C, 2000, Semin Respir Infect, V15, P280; Bota DP, 2005, J NEUROSURG, V103, P468, DOI 10.3171/jns.2005.103.3.0468; Briggs S, 2004, SCAND J INFECT DIS, V36, P165, DOI 10.1080/00365540410027193; BROWN EM, 1994, LANCET, V344, P1547; GAMBARDELLA G, 1993, CHILD NERV SYST, V9, P470, DOI 10.1007/BF00393552; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Grimwood K, 2000, ARCH DIS CHILD, V83, P111, DOI 10.1136/adc.83.2.111; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kourbeti IS, 2007, NEUROSURGERY, V60, P317, DOI 10.1227/01.NEU.0000249266.26322.25; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; Morton R, 2012, NEUROSURGERY, V71, pE193, DOI 10.1227/NEU.0b013e318232e250; Park M, 2006, ANN ALLERG ASTHMA IM, V97, P681, DOI 10.1016/S1081-1206(10)61100-3; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Pitout JDD, 1997, AM J MED, V103, P51, DOI 10.1016/S0002-9343(97)00044-2; Prasad K, 2012, CURR INFECT DIS REP, V14, P445, DOI 10.1007/s11908-012-0271-7; Shapiro S, 1996, SURG NEUROL, V45, P278, DOI 10.1016/0090-3019(95)00359-2	25	14	22	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	APR	2015	18	2					81	83		10.1016/j.cjtee.2014.10.007			3	Orthopedics	Orthopedics	VF1MH	WOS:000442085200004	26511298	DOAJ Gold			2021-06-18	
J	Daniels, DJ; Clarke, MJ; Puffer, R; Luo, TD; McIntosh, AL; Wetjen, NM				Daniels, David J.; Clarke, Michelle J.; Puffer, Ross; Luo, T. David; McIntosh, Amy L.; Wetjen, Nicolas M.			High occurrence of head and spine injuries in the pediatric population following motocross accidents	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						motocross; motorcycle; pediatric; sports injury; trauma	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; EPIDEMIOLOGY; SPORTS; IMPACT; CONCUSSION; CHILDREN; TRENDS; COST	OBJECT Off-road motorcycling is a very popular sport practiced by countless people worldwide. Despite its popularity, not much has been published on the severity and distribution of central nervous system related injuries associated with this activity in the pediatric population. The purpose of this study was to confirm, characterize, and document the rate of head and spine injuries associated with off-road motorcycling in this population. METHODS All patients aged 18 years or less who were treated for a motorbike injury at the authors' institution (a Level 1 regional trauma center) between 2000 and 2007 were identified through in-house surgical and trauma registries. Type, mechanism, and severity of CNS-related injuries were assessed, including: incidence of traumatic brain injury (TBI), loss of consciousness (LOC), Glasgow Coma Scale (GCS) score, head CT findings, neurological deficits, spinal fractures, cervical strain, and use of protective gear, including helmet. RESULTS During the 8-year period of study, 298 accidents were evaluated in 248 patients. The patients' mean age at the time of injury was 14.2 +/- 2.7 years. Head injury or TBI was identified in 60 (20.1%) of 298 cases (involving 58 of 248 patients). Fifty-seven cases were associated with LOC, and abnormalities were identified on head CT in 10 patients; these abnormalities included skull fractures and epidural, subdural, subarachnoid, and intraparenchymal hemorrhages. The GCS score was abnormal in 11 cases and ranged from 3 to 15, with an overall mean of 14.5. No patients required cranial surgery. Helmet use was confirmed in 43(71.6%) of the cases involving TBI. Spine fractures were identified in 13 patients (4.3%) and 5 required surgical fixation for their injury. CONCLUSIONS The authors found a high occurrence of head injuries following pediatric off-road motorcycle riding or motocross accidents despite the use of helmets. Additionally, this study severely underestimates the rate of mild TBIs in this patient population. Our data indicate that motocross is a high-risk sport despite the use of protective gear. Riders and parents should be counseled accordingly about the risks prior to participation.	[Daniels, David J.; Clarke, Michelle J.; Puffer, Ross; Wetjen, Nicolas M.] Mayo Clin, Coll Med, Dept Neurosurg, Rochester, MN 55905 USA; [Luo, T. David; McIntosh, Amy L.] Mayo Clin, Coll Med, Dept Orthopaed Surg, Rochester, MN 55905 USA	Clarke, MJ (corresponding author), Mayo Clin, Dept Neurol Surg, 200 First St SW, Rochester, MN 55905 USA.	clarke.michelle@mayo.edu		McIntosh, Amy/0000-0002-3660-4901			American Academy of Pediatrics Committee on Accident and Poison Prevention, 1987, PEDIATRICS, V79, P306; American Motorcyclist Association, 2008 RUL GOV PROAM S; Brandt MM, 2002, J TRAUMA, V53, P469, DOI 10.1097/00005373-200209000-00012; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conn J. M., 2006, Morbidity and Mortality Weekly Report, V55, P621; Consumer Product Safety Commission, 2010, 2008 ANN REP ATV REL; Cordell H. K., 2005, OFF HIGHWAY VEHICLE; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P266, DOI 10.3171/2014.9.PEDS14153; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gobbi A, 2004, KNEE SURG SPORT TR A, V12, P574, DOI 10.1007/s00167-004-0510-z; Gorski TF, 2003, AM SURGEON, V69, P895; Grange JT, 2009, CURR SPORT MED REP, V8, P125, DOI 10.1249/JSR.0b013e3181a61e95; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Hooten Kristopher G, 2012, Clin Neurosurg, V59, P126; Kennedy RD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001848; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Lace JK, 2005, PEDIATRICS, V115, P1085, DOI 10.1542/peds.2005-0181; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Luo TD, 2015, J NEUROSURG-PEDIATR, V15, P255, DOI 10.3171/2014.11.PEDS14127; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mattei TA, 2012, J NEUROSURG-PEDIATR, V10, P490, DOI 10.3171/2012.8.PEDS12116; Max W, 1998, J TRAUMA, V45, P550, DOI 10.1097/00005373-199809000-00023; Missouri Center for Health Information Management and Epidemiology, 1993, CRASH OUTC DAT EV SY; Pomerantz WJ, 2005, PEDIATRICS, V115, P704, DOI 10.1542/peds.2004-1304; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sills AK, 2013, NEUROSURGERY, V73, pE1091, DOI 10.1227/NEU.0000000000000152; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Vane DW, 2005, PEDIATRICS, V115, P1087, DOI 10.1542/peds.2005-0061	34	14	14	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2015	15	3					261	265		10.3171/2014.9.PEDS14149			5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CC3RL	WOS:000350266900006	25555116	Bronze			2021-06-18	
J	Feldman, A; Hart, KW; Lindsell, CJ; McMullan, JT				Feldman, Amanda; Hart, Kimberly W.; Lindsell, Christopher J.; McMullan, Jason T.			Randomized Controlled Trial of a Scoring Aid to Improve Glasgow Coma Scale Scoring by Emergency Medical Services Providers	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; INTERRATER RELIABILITY; MOTOR SCORE; PREDICTION; VALIDATION	Study objective: Emergency medical services (EMS) personnel frequently use the Glasgow Coma Scale (GCS) to assess injured and critically ill patients. This study assesses the accuracy of EMS providers' GCS scoring, as well as the improvement in GCS score assessment with the use of a scoring aid. Methods: This randomized, controlled study was conducted in the emergency department (ED) of an urban academic trauma center. Emergency medical technicians or paramedics who transported a patient to the ED were randomly assigned one of 9 written scenarios, either with or without a GCS scoring aid. Scenarios were created by consensus of expert attending emergency medicine, EMS, and neurocritical care physicians, with universal consensus agreement on GCS scores. chi(2) And Student's t tests were used to compare groups. Results: Of 180 participants, 178 completed the study. Overall, 73 of 178 participants (41%) gave a GCS score that matched the expert consensus score. GCS score was correct in 22 of 88 (25%) cases without the scoring aid. GCS was correct in 51 of 90 (57%) cases with the scoring aid. Most (69%) of the total GCS scores fell within 1 point of the expert consensus GCS score. Differences in accuracy were most pronounced in scenarios with a correct GCS score of 12 or below. Subcomponent accuracy was eye 62%, verbal 70%, and motor 51%. Conclusion: In this study, 60% of EMS participants provided inaccurate GCS score estimates. Use of a GCS scoring aid improved accuracy of EMS GCS score assessments.	[Feldman, Amanda] Northeast Ohio Med Univ, Akron, OH USA; [Feldman, Amanda; Hart, Kimberly W.; Lindsell, Christopher J.; McMullan, Jason T.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA	McMullan, JT (corresponding author), Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45220 USA.	jason.mcmullan@uc.edu	McMullan, Jason/ABB-9691-2020	McMullan, Jason/0000-0002-7656-7447	Institutional Clinical and Translational Science Award, NIH/NCRR grant [5UL1RR026314-03]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist and provided the following details: This project was supported in part by an Institutional Clinical and Translational Science Award, NIH/NCRR grant 5UL1RR026314-03.	Baez AA, 2007, PREHOSP DISASTER MED, V22, P230, DOI 10.1017/S1049023X00004726; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Caroline NL., 1991, STUDY GUIDE EMERGENC, P94; Dalton A, 1999, MOSSBYS PARAMEDIC RE, P295; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heim C, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-39; Hsieh A, 2008, PARAMEDIC COMPANION, P240; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Lane Peter L, 2002, Prehosp Disaster Med, V17, P142; Takahashi C, 2011, AM J EMERG MED, V29, P196, DOI 10.1016/j.ajem.2009.09.018; TEASDALE G, 1974, LANCET, V2, P81; Thompson DO, 2011, ANN EMERG MED, V58, P417, DOI 10.1016/j.annemergmed.2011.05.033; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	20	14	14	0	8	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	MAR	2015	65	3					325	329		10.1016/j.annemergmed.2014.07.454			5	Emergency Medicine	Emergency Medicine	CC9QN	WOS:000350705800018	25199613	Green Accepted			2021-06-18	
J	Luo, TD; Clarke, MJ; Zimmerman, AK; Quinn, M; Daniels, DJ; McIntosh, AL				Luo, T. David; Clarke, Michelle J.; Zimmerman, Amy K.; Quinn, Michael; Daniels, David J.; McIntosh, Amy L.			Concussion symptoms in youth motocross riders: a prospective, observational study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; symptoms; motocross; pediatric; return to play; trauma	SPORT-RELATED CONCUSSION; 2ND IMPACT SYNDROME; ADOLESCENT SPORT; INJURY; CHILDREN; POPULATION; MANAGEMENT	OBJECT Action motorsports, including motocross, have been gaining popularity among children and adolescents, raising concerns for increased risk of concussions in participating youth. The authors undertook this study to test the following hypotheses: 1) that there is a high rate of concussion symptoms associated with a number of preventable or adjustable risk factors, and 2) that a high percentage of these symptoms are not be reported to adults and medical personnel. METHODS The authors identified all motocross riders under the age of 18 at a regional racetrack during the riding season between May and October 2010. The participants completed questionnaires pertaining to demographic characteristics and variables associated with motocross. The questionnaire results were compared with the incidence of self-reported concussion symptoms. RESULTS Two hundred two riders were identified who met the criteria for participation in the study, and 139 of them completed the study questionnaire. Of these 139 riders, 67 (48%) reported at least 1 concussion symptom during the season. The majority of riders (98%) reported "always" wearing a helmet, and 72% received professional help with fitting of their helmets. Proper helmet fitting was associated with a 41% decreased risk of concussion symptoms (RR 0.59, 95% CI 0.44-0.81, p < 0.01). Sixty-six riders (47%) reported having received sponsor support for motocross participation. Sponsor support conferred a relative risk for concussion symptoms of 1.48 (95% CI 1.05-2.08, p = 0.02). CONCLUSIONS Nearly half of all motocross competitors under the age of 18 reported concussion symptoms. Preventive measures are necessary to limit the negative impact from concussions. The risk of concussive injury can be decreased for pediatric motocross riders if they receive professional help with proper helmet fitting and through implementation of stricter guidelines regarding sponsorship.	[Luo, T. David; Zimmerman, Amy K.; McIntosh, Amy L.] Mayo Clin, Mayo Clin Coll Med, Dept Orthoped Surg, Rochester, MN 55905 USA; [Clarke, Michelle J.; Daniels, David J.] Mayo Clin, Mayo Clin Coll Med, Dept Neurosurg, Rochester, MN 55905 USA; [Quinn, Michael] Mayo Clin, Mayo Clin Coll Med, Dept Anesthesia, Rochester, MN 55905 USA	Clarke, MJ (corresponding author), Mayo Clin, Dept Neurol Surg, 200 1st St SW, Rochester, MN 55905 USA.	clarke.michelle@mayo.edu		McIntosh, Amy/0000-0002-3660-4901			Abernethy L, 2007, BRIT J SPORT MED, V41, P627, DOI 10.1136/bjsm.2007.035691; American Academy of Pediatrics Committee on Accident and Poison Prevention, 1987, PEDIATRICS, V79, P306; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Daniels DJ, 2015, J NEUROSURG PEDIAT, DOI [10.3171/2014.9.PEDS14153, DOI 10.3171/2014.9.PEDS14153]]; Daniels DJ, 2015, J NEUROSURG PEDIAT, DOI [10.3171/2014.9.PEDS14149, DOI 10.3171/2014.9.PEDS14149]]; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Grace MT, 2013, J PEDIATR HEALTH CAR, V27, P377, DOI 10.1016/j.pedhc.2012.10.004; Grange JT, 2009, CURR SPORT MED REP, V8, P125, DOI 10.1249/JSR.0b013e3181a61e95; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kennedy RD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001848; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; MX Sports Pro Racing, 2014, COMP B 20141 IMPACT; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343	27	14	14	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2015	15	3					255	260		10.3171/2014.11.PEDS14127			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	CC3RL	WOS:000350266900005	25555121	Bronze			2021-06-18	
J	Salunke, P; Garg, R; Kapoor, A; Chhabra, R; Mukherjee, KK				Salunke, Pravin; Garg, Ravi; Kapoor, Ankur; Chhabra, Rajesh; Mukherjee, Kanchan K.			Symptomatic contralateral subdural hygromas after decompressive craniectomy: plausible causes and management protocols	JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; contralateral subdural collections; cranioplasty; trauma	TRAUMATIC BRAIN-INJURY; EFFUSION SECONDARY; COMPLICATIONS	OBJECT Contra lateral subdural hygromas are occasionally observed after decompressive craniectomies (DCs). Some of these hygromas are symptomatic, and the etiology and management of these symptomatic contralateral subdural collections (CLDCs) present surgical challenges. The authors share their experience with managing symptomatic CLSDCs after a DC. METHODS During a 10-month period, 306 patients underwent a DC. Of these patients, 266 had a head injury, 25 a middle cerebral artery infarction (that is, a thrombotic stroke), and 15 an infarction due to a vasospasm (resulting from an aneurysmal subarachnoid hemorrhage [SAH]). Seventeen patients (15 with a head injury and 2 with an SAH) developed a CLSDC, and 7 of these patients showed overt symptoms of the fluid collection. These patients were treated with a trial intervention consisting of bur hole drainage followed by cranioplasty. If required, a ventriculo- or thecoperitoneal shunt was inserted at a later time. RESULTS Seven patients developed a symptomatic CLSDC after a DC, 6 of whom-had a head injury and 1 had an SAH. The average length of time between the DC and CLSDC formation was 24 days. Fluid drainage via a bur hole was attempted in the first 5 patients. However, symptoms in these patients improved only temporarily. All 7 patients (including the 5 in whom the bur hole drainage had failed and 2 directly after the DC) underwent a cranioplasty, and the CLSDC resolved in all of these patients. The average time it took for the CLSDC to resolve after the cranioplasty was 34 days. Three patients developed hydrocephalus after the cranioplasty, requiring a diversion procedure, and 1 patient contracted meningitis and died. CONCLUSIONS Arachnoid tears and blockage of arachnoid villi appear to be the underlying causes of a CLSDC. The absence of sufficient fluid pressure required for CSF absorption after a DC further aggravates such fluid collections. Un-derlying hydrocephalus may appear as subdural collections in some patients after the DC. Bur hole drainage appears to be only a temporary measure and leads to recurrence of a CLSDC. Therefore, cranioplasty is the definitive treatment for such collections and, if performed early, may even avert CLSDC formation. A temporary ventriculostomy or an external lumbar drainage may be added to aid the cranioplasty and may be removed postoperatively. Ventriculoperitoneal or thecoperitoneal shunting may be required for patients in whom a hydrocephalus manifests after cranioplasty and underlies the CLSDC.	[Salunke, Pravin; Garg, Ravi; Kapoor, Ankur; Chhabra, Rajesh; Mukherjee, Kanchan K.] Postgrad Inst Med Educ & Res, Dept Neurosurg, Chandigarh 160012, India	Salunke, P (corresponding author), PGIMER, Dept Neurosurg, Sect 12, Chandigarh 160012, India.	drpravin_salunke@yahoo.co.uk					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Kilincer C, 2010, MED PRIN PRACT, V19, P499, DOI 10.1159/000320313; Paredes Igor, 2011, Surg Neurol Int, V2, P88, DOI 10.4103/2152-7806.82370; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Salunke P, 2012, NEUROL INDIA, V60, P254, DOI 10.4103/0028-3886.96433; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su FW, 2008, J CLIN NEUROSCI, V15, P305, DOI 10.1016/j.jocn.2006.08.019; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Wang HK, 2012, INJURY, V43, P594, DOI 10.1016/j.injury.2010.06.004; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	16	14	19	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2015	122	3					602	609		10.3171/2014.10.JNS14780			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CC3RJ	WOS:000350266600016	25495740				2021-06-18	
J	Shukla, DR; Pillai, G; McAnany, S; Hausman, M; Parsons, BO				Shukla, Dave R.; Pillai, Gita; McAnany, Steven; Hausman, Michael; Parsons, Bradford O.			Heterotopic ossification formation after fracture-dislocations of the elbow	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Elbow; heterotopic ossification; fracture-dislocation; terrible triad; coronoid; radial head	RISK-FACTORS; RADIAL HEAD; BONE	Background: Heterotopic ossification (HO) is a serious complication of traumatic elbow injuries, particularly fracture-dislocations. Limited data exist in the literature regarding the risk factors associated with HO formation in these injuries. The purpose of this study was to review the incidence of HO after fracture-dislocation of the elbow and to identify potential risk factors associated with its formation. Methods: Twenty-seven patients (28 elbows) were surgically treated for elbow fracture-dislocations during 8 years, with an average follow-up of 14 months. Records were reviewed with attention paid to several factors: demographic data, comorbidities, time interval from injury to surgical intervention, number of closed reductions attempted before surgery, surgical approach, management of the radial head, treatment of the anterior capsular injury, and coronoid fixation. Results: Of the 28 elbows, 12 (43%) developed HO postoperatively; 9 of 28 elbows underwent multiple attempted closed reductions before definitive surgical stabilization, with HO formation in 7 of the 9 (77%). Time to surgery, age, gender, radial head fixation or replacement, coronoid open reduction and internal fixation, capsular repair, and medical comorbidities were not found to influence HO formation, although the performance of multiple reductions was identified as a risk factor. Discussion: HO developed in 77% of patients with multiple attempted closed reductions. We found a 43% incidence of HO in patients surgically treated for elbow fracture-dislocations. Neither time to surgery after the injury nor demographic or other factors relating to the manner in which associated osseous or soft tissue injuries were managed influenced the formation of HO. (C) 2015 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Shukla, Dave R.; Pillai, Gita; McAnany, Steven; Hausman, Michael; Parsons, Bradford O.] Icahn Sch Med Mt Sinai, Leni & Peter May Dept Orthopaed Surg, New York, NY 10029 USA	Shukla, DR (corresponding author), Icahn Sch Med Mt Sinai, Leni & Peter May Dept Orthopaed Surg, 5 East 98th St, New York, NY 10029 USA.	dshukla@gmail.com		McAnany, Steven/0000-0002-1157-3790			Abrams GD, 2012, J SHOULDER ELB SURG, V21, P1550, DOI 10.1016/j.jse.2012.05.040; Bauer AS, 2012, J HAND SURG-AM, V37A, P1422, DOI 10.1016/j.jhsa.2012.03.013; BROBERG MA, 1987, CLIN ORTHOP RELAT R, P109; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629; Douglas K, 2012, ORTHOPEDICS, V35, pE815, DOI 10.3928/01477447-20120525-18; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1991, CLIN ORTHOPAEDICS, V263, P13; GASTON SR, 1949, AM J SURG, V78, P631, DOI 10.1016/0002-9610(49)90300-1; Ilahi OA, 1998, ORTHOPEDICS, V21, P265; Lee EK, 2013, J SHOULDER ELB SURG, V22, P716, DOI 10.1016/j.jse.2012.11.020; McLaughlin HL, 1955, SURG CLIN N AM, P553; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; PUZAS JE, 1989, CLIN ORTHOP RELAT R, P269; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Smith FM, 1949, AM J SURG, V78, P47; Thompson H C 3rd, 1967, Clin Orthop Relat Res, V50, P129	16	14	20	0	9	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	MAR	2015	24	3					333	338		10.1016/j.jse.2014.11.037			6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CB6SR	WOS:000349757500004	25601384				2021-06-18	
J	Eum, RS; Seel, RT; Goldstein, R; Brown, AW; Watanabe, TK; Zasler, ND; Roth, EJ; Zafonte, RD; Glenn, MB				Eum, Regina S.; Seel, Ronald T.; Goldstein, Richard; Brown, Allen W.; Watanabe, Thomas K.; Zasler, Nathan D.; Roth, Elliot J.; Zafonte, Ross D.; Glenn, Mel B.			Predicting Institutionalization after Traumatic Brain Injury Inpatient Rehabilitation	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; traumatic brain injury; outcome measures; rehabilitation; predictive modeling	NURSING-HOME PLACEMENT; LONG-TERM DISABILITY; GALVESTON ORIENTATION; UNITED-STATES; AMNESIA TEST; HOSPITALIZATION; MODEL; POPULATION; REPRESENTATIVENESS; DISPOSITION	Risk factors contributing to institutionalization after inpatient rehabilitation for people with traumatic brain injury (TBI) have not been well studied and need to be better understood to guide clinicians during rehabilitation. We aimed to develop a prognostic model that could be used at admission to inpatient rehabilitation facilities to predict discharge disposition. The model could be used to provide the interdisciplinary team with information regarding aspects of patients' functioning and/or their living situation that need particular attention during inpatient rehabilitation if institutionalization is to be avoided. The study population included 7219 patients with moderate-severe TBI in the Traumatic Brain Injury Model Systems (TBIMS) National Database enrolled from 2002-2012 who had not been institutionalized prior to injury. Based on institutionalization predictors in other populations, we hypothesized that among people who had lived at a private residence prior to injury, greater dependence in locomotion, bed-chair-wheelchair transfers, bladder and bowel continence, feeding, and comprehension at admission to inpatient rehabilitation programs would predict institutionalization at discharge. Logistic regression was used, with adjustment for demographic factors, proxy measures for TBI severity, and acute-care length-of-stay. C-statistic and predictiveness curves validated a five-variable model. Higher levels of independence in bladder management (adjusted odds ratio [OR], 0.88; 95% CI 0.83, 0.93), bed-chair-wheelchair transfers (OR, 0.81 [95% CI, 0.83-0.93]), and comprehension (OR, 0.78 [95% CI, 0.68, 0.89]) at admission were associated with lower risks of institutionalization on discharge. For every 10-year increment in age was associated with a 1.38 times higher risk for institutionalization (95% CI, 1.29, 1.48) and living alone was associated with a 2.34 times higher risk (95% CI, 1.86, 2.94). The c-statistic was 0.780. We conclude that this simple model can predict risk of institutionalization after inpatient rehabilitation for patients with TBI.	[Eum, Regina S.] Pioneer Spine & Sports Phys, West Springfield, MA USA; [Seel, Ronald T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA; [Goldstein, Richard; Zafonte, Ross D.; Glenn, Mel B.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Watanabe, Thomas K.] Moss Rehab, Dept Phys Med & Rehabil, Philadelphia, PA USA; [Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Tree Life Serv, Richmond, VA USA; [Roth, Elliot J.] Northwestern Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL USA	Eum, RS (corresponding author), West Haven Med Grp, 689 Campbell Ave, West Haven, CT 06516 USA.	regina.eum@gmail.com		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research; Office of Special Education Services; Department of Education to Spaulding Rehabilitation Hospital [H133A120085]; Shepherd Center-Georgia Model Brain Injury System [H133A110006]; Mayo Clinic [H133-A120026]; MossRehab [H133A120037]; Virginia Commonwealth University [H133A120031]; Rehabilitation Institute of Chicago [H133A080045]; Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital/Harvard Medical School	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, Office of Special Education Services, Department of Education to Spaulding Rehabilitation Hospital (H133A120085), Shepherd Center-Georgia Model Brain Injury System (H133A110006), Mayo Clinic (H133-A120026), MossRehab (H133A120037), Virginia Commonwealth University (H133A120031), and Rehabilitation Institute of Chicago (H133A080045). However, the contents of this manuscript do not necessarily represent the policy of the Department of Education and endorsement by the federal government should not be assumed. This work also was supported in part by a grant from the Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital/Harvard Medical School.	Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Black T M, 1999, Rehabil Nurs, V24, P109; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Buhr GT, 2006, GERONTOLOGIST, V46, P52, DOI 10.1093/geront/46.1.52; Cai Q, 2009, SOC WORK HEALTH CARE, V48, P154, DOI 10.1080/00981380802580588; Cameron AC, 2011, HDB EMPIRICAL EC; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Goodwin JS, 2011, J GERONTOL A-BIOL, V66, P1321, DOI 10.1093/gerona/glr171; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grunkemeier GL, 2004, ANN THORAC SURG, V77, P1142, DOI 10.1016/j.athoracsur.2004.01.005; Harrell Frank E., 2001, REGRESSION MODELING; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; Medicare Payment Advisory Commission, 2013, REP C MED PAYM POL; Medicare Payment Advisory Commission, 2013, REH FAC INP PAYM SYS; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Rozzini L, 2006, J AM MED DIR ASSOC, V7, P345, DOI 10.1016/j.jamda.2005.11.008; Schlegel D, 2004, ARCH NEUROL-CHICAGO, V61, P1061, DOI 10.1001/archneur.61.7.1061; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2009, TRAUM BRAIN INJ MOD; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	41	14	14	1	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2015	32	4					280	286		10.1089/neu.2014.3351			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	CB0KN	WOS:000349314900009	25203001	Green Published			2021-06-18	
J	Choe, MC; Giza, CC				Choe, Meeryo C.; Giza, Christopher C.			Diagnosis and Management of Acute Concussion	SEMINARS IN NEUROLOGY			English	Article						mild traumatic brain injury; concussion; diagnosis; return-to-play	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; OPERATION IRAQI FREEDOM; TEST-RETEST RELIABILITY; MAGNETIC-RESONANCE SPECTROSCOPY; COLLEGIATE FOOTBALL PLAYERS; VISUAL SCREENING TOOL; BLUNT HEAD TRAUMA; BASE-LINE; NEUROPSYCHOLOGICAL ASSESSMENT	Mild traumatic brain injury (mTBI), or concussion, constitutes a significant percentage of the millions of TBIs sustained in the United States each year. Symptoms are typically short-lived, and may correlate to physiologic changes in the acute period after injury. There are many available tools that can be utilized on the sideline as well as in the clinical setting for assessment and diagnosis of concussion. It is important to use validated tests in conjunction with a thorough history and physical examination. Neurocognitive testing may be helpful in the subacute period. Management should begin with removal from risk if a concussion is suspected, and once diagnosis is made, education and reassurance should be provided. Once symptoms have resolved, a graded return-to-play protocol can be implemented with close supervision and observation for return of symptoms. Management should be tailored to the individual, and if symptoms are prolonged, further diagnostic evaluation may be necessary.	[Choe, Meeryo C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA	Choe, MC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Neurol, Mattel Childrens Hosp, 22-474 MDCC,10833 LeConte Ave, Los Angeles, CA 90095 USA.	mchoe@mednet.ucla.edu					Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], NEUROSURGERY; [Anonymous], 2003, J AM COLL SURGEONS; [Anonymous], HEART LUNG; [Anonymous], NEUROSURGERY; [Anonymous], NEUROSURGERY; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Barnes GR, 2008, PROG BRAIN RES, V171, P441, DOI 10.1016/S0079-6123(08)00665-1; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Baugh CM, 2014, AM J SPORTS MED; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brenner DJ, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130629; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Broglio SP, NEUROSURGERY, P1057; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2002, ANN THORAC SURG, V73, P2005, DOI 10.1016/S0003-4975(01)03375-6; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cortesi F, 2012, J SLEEP RES, V21, P700, DOI 10.1111/j.1365-2869.2012.01021.x; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Del Rossi G, 2014, J ATHL TRAINING, V49, P356, DOI 10.4085/1062-6059-49.2.04; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2015, APPL NEUROPSYCH-CHIL, V4, P266, DOI 10.1080/21622965.2014.911094; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horslen BC, 2011, EXP BRAIN RES, V215, P27, DOI 10.1007/s00221-011-2867-9; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; HOVDA DA, 1990, ACT NEUR S, V51, P331; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Irick E, 2013, 2013 14 NCAA SPORTS; Iverson GL, 2014, BRAIN INJURY, P1; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; KANE RL, 1992, NEUROPSYCHOL REV, V3, P1, DOI 10.1007/BF01108787; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Kerr ME, 1996, HEART LUNG, V25, P200, DOI 10.1016/S0147-9563(96)80030-6; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Klossner D, 2013, 2013 14 NCAA SPORTS, P56; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lewis MS, 2011, NEUROUROL URODYNAM, V30, P183, DOI 10.1002/nau.20963; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lingsma HF, 2014, J NEUROTRAUMA; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maki BE, 1996, J VESTIBUL RES-EQUIL, V6, P53; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrea M, NEUROSURGERY, P882; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Nassiri JD, 2002, MIL MED, V167, P873; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Office of the US Army Surgeon General, 2009, 09068 OTSG MEDCOM OF; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Patel AV, 2007, J ATHL TRAINING, V42, P66; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Sher L, 2009, EXPERT REV NEUROTHER, V9, P921, DOI [10.1586/ern.09.61, 10.1586/ERN.09.61]; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Simpson TL, 2007, J TRAUMA STRESS, V20, P239, DOI 10.1002/jts.20209; Sosin DM, 1996, PEDIATRICS, V98, P868; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Thomas Emily, 2013, Pediatr Nurs, V39, P299; Thurman DA, 1999, TRAUMATIC BRAIN INJU; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; United States Department of Defense, 2010, DTM09033 US DEP DEF; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Wada M, 2001, NEUROSCI LETT, V302, P157, DOI 10.1016/S0304-3940(01)01662-7; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	193	14	14	0	13	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					29	41		10.1055/s-0035-1544243			13	Clinical Neurology	Neurosciences & Neurology	CC4AP	WOS:000350293300006	25714865	Bronze			2021-06-18	
J	Schorr, B; Schlee, W; Arndt, M; Lule, D; Kolassa, IT; Lopez-Rolon, A; Bender, A				Schorr, Barbara; Schlee, Winfried; Arndt, Marion; Lule, Dorothee; Kolassa, Iris-Tatjana; Lopez-Rolon, Alexander; Bender, Andreas			Stability of auditory event-related potentials in coma research	JOURNAL OF NEUROLOGY			English	Article						Disorders of consciousness; Minimally conscious state; Unresponsive wakefulness syndrome; P300; ERPs; EEG	MINIMALLY CONSCIOUS STATES; VEGETATIVE STATE; RETEST RELIABILITY; BRAIN-INJURY; DISORDERS; RECOVERY; P300; PSYCHOPHYSIOLOGY; REHABILITATION; ERPS	Patients with unresponsive wakefulness syndrome (UWS) or in minimally conscious state (MCS) after brain injury show significant fluctuations in their behavioural abilities over time. As the importance of event-related potentials (ERPs) in the detection of traces of consciousness increases, we investigated the retest reliability of ERPs with repeated tests at four different time points. Twelve healthy controls and 12 inpatients (8 UWS, 4 MCS; 6 traumatic, 6 non-traumatic) were tested twice a day (morning, afternoon) for 2 days with an auditory oddball task. ERPs were recorded with a 256-channel-EEG system, and correlated with behavioural test scores in the Coma Recovery Scale-revised (CRS-R). The number of identifiable P300 responses varied between zero and four in both groups. Reliabilities varied between Krippendorff's alpha = 0.43 for within-day comparison, and alpha = 0.25 for between-day comparison in the patient group. Retest reliability was strong for the CRS-R scores for all comparisons (alpha = 0.83-0.95). The stability of auditory information processing in patients with disorders of consciousness is the basis for other, even more demanding tasks and cognitive potentials. The relatively low ERP-retest reliability suggests that it is necessary to perform repeated tests, especially when probing for consciousness with ERPs. A single negative ERP test result may be mistaken for proof that a UWS patient truly is unresponsive.	[Schorr, Barbara; Arndt, Marion; Bender, Andreas] Therapiezentrum Burgau, D-89331 Burgau, Germany; [Schorr, Barbara; Kolassa, Iris-Tatjana] Univ Ulm, Inst Psychol & Educ, D-89069 Ulm, Germany; [Schlee, Winfried] Univ Regensburg, Inst Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Lule, Dorothee] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany; [Lopez-Rolon, Alexander; Bender, Andreas] Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany	Schorr, B (corresponding author), Univ Ulm, Inst Psychol & Educ, Albert Einstein Allee 47, D-89069 Ulm, Germany.	barbara.schorr@uni-ulm.de	Kolassa, Iris Tatjana/Y-3032-2018	Bender, Andreas/0000-0002-6328-7104; Lopez-Rolon, Alex/0000-0002-6366-2015			Bekinschtein TA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00005; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bekinschtein TA, 2009, BRAIN INJURY, V23, P915, DOI 10.1080/02699050903283197; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Cavinato M, 2011, CLIN NEUROPHYSIOL, V122, P719, DOI 10.1016/j.clinph.2010.08.024; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Donchin E, 1986, PSYCHOPHYSIOLOGY SYS, P244; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grill E, 2013, ARCH PHYS MED REHAB, V94, P1870, DOI 10.1016/j.apmr.2012.10.040; Guldenmund P, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/624724; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Krippendorff K., 2011, Computing Krippendorff's Alpha-Reliability; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Lule D, 2013, CLIN NEUROPHYSIOL, V124, P101, DOI 10.1016/j.clinph.2012.04.030; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pinheiro J., 2019, R PACKAGE; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9	34	14	15	0	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	FEB	2015	262	2					307	315		10.1007/s00415-014-7561-y			9	Clinical Neurology	Neurosciences & Neurology	CB8OI	WOS:000349889200007	25381459				2021-06-18	
J	Zhumadilov, A; Gilman, CP; Viderman, D				Zhumadilov, Agzam; Gilman, Charles P.; Viderman, Dmitriy			Management of super-refractory status epilepticus with isoflurane and hypothermia	FRONTIERS IN NEUROLOGY			English	Article						SRSE; epilepsy; hypothermia; isoflurane; neurotrauma; neurocritical care	PROPYLENE-GLYCOL TOXICITY; TEMPERATURE	Super-refractory status epilepticus (SRSE) is defined as status epilepticus that continues 24 h or more after the onset of anesthesia, and includes those cases in which epilepsy is recurrent upon treatment reduction. We describe the presentation and successful management of a male patient with SRSE using the inhaled anesthetic isoflurane, and mild hypothermia (HT). The potential utility of combined HT and volatile anesthesia is discussed.	[Zhumadilov, Agzam; Viderman, Dmitriy] Republican Res Ctr Emergency Care, Astana 010000, Kazakhstan; [Gilman, Charles P.] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan; [Viderman, Dmitriy] Nazarbayev Univ, Sch Med, Astana, Kazakhstan	Zhumadilov, A (corresponding author), Republican Res Ctr Emergency Care, Dept Anesthesiol & Crit Med, 3 Kerey,Zhanibek Khanov St, Astana 010000, Kazakhstan.	agzamzh@gmail.com	Viderman, Dmitriy/P-7902-2019				Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Corry JJ, 2008, NEUROCRIT CARE, V9, P189, DOI 10.1007/s12028-008-9092-9; Dabir Shideh, 2015, Asian Cardiovasc Thorac Ann, V23, P292, DOI 10.1177/0218492314551972; Fugate JE, 2010, ANESTH ANALG, V111, P1520, DOI 10.1213/ANE.0b013e3181f6da34; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Hofer CK, 2005, J THORAC CARDIOV SUR, V129, P838, DOI 10.1016/j.jtcvs.2004.07.002; Ikeda T, 1998, ANESTHESIOLOGY, V88, P866, DOI 10.1097/00000542-199804000-00004; Kimberger O, 2008, BEST PRACT RES-CLIN, V22, P729, DOI 10.1016/j.bpa.2007.11.002; Loh GW, 2010, CURR OPIN CRIT CARE, V16, P128, DOI 10.1097/MCC.0b013e3283374e3c; Maze M, 1994, ANESTHESIA; Mirsattari SM, 2004, ARCH NEUROL-CHICAGO, V61, P1254, DOI 10.1001/archneur.61.8.1254; Motamedi GK, 2013, EPILEPSIA, V54, P959, DOI 10.1111/epi.12144; Neligan A, 2010, ARCH NEUROL-CHICAGO, V67, P931, DOI 10.1001/archneurol.2010.169; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Penberthy LT, 2005, SEIZURE-EUR J EPILEP, V14, P46, DOI 10.1016/j.seizure.2004.06.001; Pillai U, 2014, AM J THER, V21, pE106, DOI 10.1097/MJT.0b013e31824c407d; Rosenow F, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2007.01359.x; Rossetti AO, 2011, EPILEPSIA, V52, P64, DOI 10.1111/j.1528-1167.2011.03241.x; Shorvon S, 2012, BRAIN, V135, P2314, DOI 10.1093/brain/aws091; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Wilson KC, 2005, CHEST, V128, P1674, DOI 10.1378/chest.128.3.1674	21	14	14	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 28	2015	5								286	10.3389/fneur.2014.00286			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CU7TG	WOS:000363743900001	25674075	DOAJ Gold, Green Published			2021-06-18	
J	Chen, YH; Huang, EYK; Kuo, TT; Ma, HI; Hoffer, BJ; Tsui, PF; Tsai, JJ; Chou, YC; Chiang, YH				Chen, Yuan-Hao; Huang, Eagle Yi-Kung; Kuo, Tung-Tai; Ma, Hsin-I; Hoffer, Barry J.; Tsui, Pi-Fen; Tsai, Jing-Jr; Chou, Yu-Ching; Chiang, Yung-Hsiao			Dopamine Release Impairment in Striatum After Different Levels of Cerebral Cortical Fluid Percussion Injury	CELL TRANSPLANTATION			English	Article						Fluid percussion injury; Dopamine; Fast-scan cyclic voltammetry (FSCV); Novel object recognition (NOR) test; Dopamine reuptake	TRAUMATIC BRAIN-INJURY; RAT FRONTAL-CORTEX; TYROSINE-HYDROXYLASE; COMPENSATORY RESPONSE; EXPRESSION; IMPACT; MODEL; NEURONS; MEMORY; TRANSMISSION	To investigate the role of dopamine release in cognitive impairment and motor learning deficits after brain injury, different levels of traumatic brain injury (TBI) were made in rats by using fluid percussion at two different atmospheres (2 Psi and 6 Psi). Tonic and phasic bursting dopamine release and behavior tests followed at several time points. We used in vitro fast-scan cyclic voltammetry to survey dopamine release in the striatum and analyzed the rats' behavior using novel object recognition (NOR) and rotarod tests. Both tonic and bursting dopamine release were greatly depressed in the severely (6 Psi) injured group, which persisted up to 8 weeks later. However, in the 2 Psi-injured group, the suppression of bursting dopamine release occurred at 1 similar to 2 weeks after injury, but there were no significant differences after 4 weeks. Tonic dopamine release was also diminished significantly at 1 similar to 2 weeks after the injury; partial recovery could then be seen 4 weeks after injury. A significant deficiency in the fixed speed rotarod test and NOR test were noted in both 2 Psi and 6 Psi groups initially; however, the changes recovered in the 2 Psi group 2 weeks after injury while persisting in the 6 Psi group. In conclusion, striatal evoked dopamine release was affected by fluid percussion injury, with behavioral deficits showing differences as a function of injury severity. The severe fluid percussion injury (6 Psi) group showed more dopamine release defects, as well as cognitive and motor deficiencies. Recovery of dopamine release and improvement in behavioral impairment were better in the mild TBI group.	[Chen, Yuan-Hao; Ma, Hsin-I; Tsai, Jing-Jr] Tri Serv Gen Hosp, Dept Neurol Surg, Natl Def Med Ctr, Taipei 114, Taiwan; [Huang, Eagle Yi-Kung; Tsui, Pi-Fen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei 106, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Program Neuroregenerat, Taipei, Taiwan	Chen, YH (corresponding author), Tri Serv Gen Hosp, Dept Neurol Surg, Natl Def Med Ctr, 4F,325,2nd Sec,Cheng Kung Rd, Taipei 114, Taiwan.	chenyh178@gmail.com	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council of TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2314-B-016-008]; USPHSUnited States Department of Health & Human ServicesUnited States Public Health Service [NS070825]; Medical Research Project from the Tri-Service General Hospital of Taiwan [TSGH-C101-084, TSGH-C100-033]	This work was supported by the National Science Council of Taiwan under grant NSC 101-2314-B-016-008, USPHS grant NS070825, and by Medical Research Project grants TSGH-C101-084, and TSGH-C100-033 from the Tri-Service General Hospital of Taiwan. The authors declare no conflicts of interest.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Beeler JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00170; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BLANCHARD V, 1995, J NEUROCHEM, V64, P1669; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, J NEUROTRAUM, V14, P43, DOI 10.1089/neu.1997.14.43; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Grace AA, 2000, ADDICTION, V95, pS119; GRACE AA, 1983, NEUROSCIENCE, V10, P333, DOI 10.1016/0306-4522(83)90137-9; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Hauber W, 2010, PHARMACOPSYCHIATRY, V43, pS32, DOI 10.1055/s-0030-1248300; Huang EYK, 2003, N-S ARCH PHARMACOL, V368, P386, DOI 10.1007/s00210-003-0803-7; KATZMAN R, 1971, BRAIN RES, V25, P579, DOI 10.1016/0006-8993(71)90462-8; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KMIECIAKKOLADA K, 1987, POL J PHARMACOL PHAR, V39, P47; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lindgren N, 2000, J NEUROCHEM, V74, P2470, DOI 10.1046/j.1471-4159.2000.0742470.x; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; PASINETTI GM, 1991, BRAIN RES, V567, P253, DOI 10.1016/0006-8993(91)90803-4; Rachmany L., 2012, AGE DORDR, V35, P1621; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wilson MS, 2005, J NEUROSCI RES, V80, P85, DOI 10.1002/jnr.20419; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zhang LF, 2009, MOL PHARMACOL, V76, P396, DOI 10.1124/mol.109.056317; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	48	14	14	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2015	24	10					2113	2128		10.3727/096368914X683584			16	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Cell Biology; Research & Experimental Medicine; Transplantation	CT5PB	WOS:000362861200015	25198499	Bronze			2021-06-18	
J	Lam, C; Lin, MR; Chu, SF; Tsai, SH; Bai, CH; Chiu, WT				Lam, Carlos; Lin, Mau-Roung; Chu, Shu-Fen; Tsai, Shin-Han; Bai, Chyi-Huey; Chiu, Wen-Ta			The Effect of Various Types of Motorcycle Helmets on Cervical Spine Injury in Head Injury Patients: A Multicenter Study in Taiwan	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; RISK; PATTERNS; NECK	Introduction. The relationship between cervical spine injury (CSI) and helmet in head injury (HI) patients following motorcycle crashes is crucial. Controversy still exists; therefore we evaluated the effect of various types of helmets on CSI in HI patients following motorcycle crashes and researched the mechanism of this effect. Patients and Methods. A total of 5225 patients of motorcycle crashes between 2000 and 2009 were extracted from the Head Injury Registry in Taiwan. These patients were divided into case and control groups according to the presence of concomitant CSI. Helmet use and types were separately compared between the two groups and the odds ratio of CSI was obtained by using multiple logistic regression analysis. Results. We observed that 173 (3.3%) of the HI patients were associated with CSI. The HI patients using a helmet (odds ratio (OR) = 0.31, 95% confidence interval (CI) = 0.19-0.49), full-coverage helmet (0.19, 0.10-0.36), and partial-coverage helmet (0.35, 0.21-0.56) exhibited a significantly decreased rate of CSI compared with those without a helmet. Conclusion. Wearing full-coverage and partial-coverage helmets significantly reduced the risk of CSI among HI patients following motorcycle crashes. This effect may be due to the smooth surface and hard padding materials of helmet.	[Lam, Carlos] Taipei Med Univ, Wan Fang Hosp, Dept Crit & Emergency Med, Taipei 116, Taiwan; [Lam, Carlos; Lin, Mau-Roung; Tsai, Shin-Han; Chiu, Wen-Ta] Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan; [Chu, Shu-Fen] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei 235, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Dept Emergency Med, Coll Med, Taipei 110, Taiwan; [Tsai, Shin-Han] Taipei Med Univ, Shuang Ho Hosp, Taipei 110, Taiwan; [Bai, Chyi-Huey] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei 110, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 116, Taiwan	Chiu, WT (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Grad Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	wtchiu@tmu.edu.tw		Lam, Carlos/0000-0002-8051-7485	Department of Health, Executive Yuan [DOH100-TD-B-111-003]; National Health Research InstituteNational Health Research Institutes - Taiwan [NHRI-EX100-9707PI]	This study was financially supported by the Department of Health, Executive Yuan (Grant No. DOH100-TD-B-111-003) and National Health Research Institute (Grant No. NHRI-EX100-9707PI). The authors would like to thank Ta-Chien Chan and Chia-Kun Chang for providing assistance with this study. They are grateful for the assistance provided by the following 25 hospitals: National Taiwan University Hospital, Taipei Veterans General Hospital, Taipei Cathay General Hospital, Taipei City Hospital Renai Branch, Chung-Shan Hospital, Country Hospital, West Garden Hospital, Pojen General Hospital, Central Clinic Hospital, Taipei Mackay Memorial Hospital, Taipei City Hospital Heping Branch, Taipei City Hospital Yang-Ming Branch, Taipei City Hospital Zhongxing Branch, Songshan Armed Forces General Hospital, Taipei City Hospital Zhongxiao Branch, Taipei Jen-Chi Hospital, Taipei Medical University Hospital, TMU-Wan Fang Hospital, TMU-Shuang Ho Hospital, Tri-Service General Hospital, Shin Kong Wu Ho-Su Memorial Hospital, Buddhist Tzu Chi General Hospital (Hualien), Mennonite Cherish Hospital, Hua-Lien Hospital, and Hualien Armed Forces General Hospital.	Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; BACHULIS BL, 1988, AM J SURG, V155, P708, DOI 10.1016/S0002-9610(88)80151-X; Camacho DLA, 1999, J BIOMECH, V32, P293, DOI 10.1016/S0021-9290(98)00178-X; Camacho DLA, 2001, J BIOMECH ENG-T ASME, V123, P432, DOI 10.1115/1.1389086; Chen YH, 2011, PSYCHOL MED, V41, P1271, DOI 10.1017/S0033291710001819; Chiang MF, 2006, SURG NEUROL, V66, pS14, DOI 10.1016/j.surneu.2006.08.029; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Chu D, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-137; Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Goslar PW, 2008, J TRAUMA, V64, P190, DOI 10.1097/TA.0b013e3180f62eec; Health Promotion Administration and Ministry of Health and Welfare; (Republic of China), 2014, NATL HLTH INT SURV; Hitosugi M, 2004, AM J FOREN MED PATH, V25, P125, DOI 10.1097/01.paf.0000127397.67081.f5; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Japan Automobile Manufacturers Association and INC, 2013, MOT IND JAP 2011; Kung WM, 2011, INJURY, V42, P940, DOI 10.1016/j.injury.2010.09.019; Lam C, 2011, ASIA-PAC J PUBLIC HE, V23, P957, DOI 10.1177/1010539510364669; Lee HY, 2010, AM J PUBLIC HEALTH, V100, P165, DOI 10.2105/AJPH.2008.159004; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; Lin MR, 2004, NEUROEPIDEMIOLOGY, V23, P269, DOI 10.1159/000080091; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Ministry of Transportation and Communications of the Republic of China, 2014, STAT TRANSP COMM COU; Moskal A, 2008, INJURY PREV, V14, P238, DOI 10.1136/ip.2007.018093; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Nightingale RW, 1997, SPINE, V22, P2380, DOI 10.1097/00007632-199710150-00012; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; Piatt JH, 2006, J NEUROSURG-SPINE, V5, P210, DOI 10.3171/spi.2006.5.3.210; Robertson A, 2002, J TRAUMA, V53, P5, DOI 10.1097/00005373-200207000-00002; SINHA AK, 1995, INJURY, V26, P543, DOI 10.1016/0020-1383(95)00078-N; Sun JC, 2012, TRAFFIC INJ PREV, V13, P519, DOI 10.1080/15389588.2012.656857; Tian HL, 2009, J TRAUMA, V67, P1305, DOI 10.1097/TA.0b013e31819db57c; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; TSAI YJ, 1995, AM J EPIDEMIOL, V142, P974, DOI 10.1093/oxfordjournals.aje.a117746; Van Camp L A, 1998, Eur J Emerg Med, V5, P207; YEO JD, 1979, MED J AUSTRALIA, V2, P381, DOI 10.5694/j.1326-5377.1979.tb104193.x	37	14	15	0	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2015	2015								487985	10.1155/2015/487985			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CB5VE	WOS:000349694900001	25705663	DOAJ Gold, Green Published			2021-06-18	
J	Mbakile-Mahlanza, L; Manderson, L; Ponsford, J				Mbakile-Mahlanza, Lingani; Manderson, Lenore; Ponsford, Jennie			The experience of traumatic brain injury in Botswana	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Botswana; Caregivers; Healthcare workers; Experiences; Coping; Qualitative	ETHNIC DISPARITIES; OUTCOMES; HEALTH; ASSOCIATION; FAMILIES; AFRICA; RACE	Whilst the consequences of traumatic brain injury (TBI) are understood in Western countries, it is not known how cultural background and beliefs affect response and outcome following TBI in low and middle income countries. This study aimed to explore the experiences of TBI in Botswana. Participants included 21 individuals with moderate to severe TBI (68% males, mean age 35.2 years), 18 caregivers and 25 healthcare workers. Qualitative semi-structured interviews were transcribed, translated and thematically coded. Thematic analysis indicated several themes: Injury-related changes, attributions and beliefs about the cause of the injury, family reactions, attitudes, and resources. Participants described the common injury-related effects of TBI. Many participants attributed their injury to supernatural causes. Immediate family members of participants with TBI expressed a sense of love and devotion towards the injured person. Communication was characterised by inadequate information given to those injured and their caregivers. Provision of care was impeded by insufficient staff, limited supplies and lack of training of nurses. The current healthcare system would therefore appear to be ill-equipped to meet the needs of TBI survivors in Botswana. This study will improve understanding of cultural responses and approaches to brain injuries in Botswana which may, in turn, inform improved practice.	[Mbakile-Mahlanza, Lingani; Manderson, Lenore; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Manderson, Lenore] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia	Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu		Manderson, Lenore/0000-0002-7883-1790	Australian Psychological Society (APS); Epworth Healthcare	We are grateful to the participants for their time and willingness to share their experiences. This work was supported by Australian Psychological Society (APS) Grant for Intercultural/International Projects and a travel grant from Epworth Healthcare.	Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Brodin J, 2000, INT J REHABIL RES, V23, P163, DOI 10.1097/00004356-200023030-00004; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Central Statistics Office, 2013, BOTSW AIDS IMP SURV; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Creswell J., 2011, DESIGNING CONDUCTING; Creswell J. W., 2017, DESIGNING CONDUCTING; Dahodwala N, 2007, NEUROLOGY, V68, pE15, DOI 10.1212/01.wnl.0000257827.43171.23; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Denzin N., 2002, QUALITATIVE INQUIRY; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hanche-Olsen TP, 2012, WORLD J SURG, V36, P2371, DOI 10.1007/s00268-012-1659-0; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Helps Y., 2008, HOSP SEPARATIONS DUE; Ingstad B., 1997, COMMUNITY BASED REHA, V7; Ingstad Benedicte, 2007, DISABILITY LOCAL GLO, P237; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kleinman A., 1980, PATIENTS HEALERS CON, V3; Livingston J., 2012, IMPROVISING MED AFRI; Lopez-Jimenez H., 2011, BEHAV MODERATE UNPUB; Manderson L., 2010, CHRONIC CONDITIONS F; Mkhize N., 2014, MEDITERRANEAN J SOCI, V5, P2413; Mokhosi MT, 2004, S AFR J PSYCHOL, V34, P301, DOI 10.1177/008124630403400208; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Nsamenang AB, 2010, CONTEMP ISS EARLY CH, V11, P20, DOI 10.2304/ciec.2010.11.1.20; ODEK AW, 2007, E AFRICA SOCIAL SCI, V23, P1; Ponsford J, 2012, TRAUMATIC BRAIN INJU; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Republic of Botswana, 2002, HOUS INC EXP SURV; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Silver JM, 2005, TXB TRAUMATIC BRAIN; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Thebe, 2006, CULTURE CUSTOMS BOTS; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x; Unantenne N, 2013, J RELIG HEALTH, V52, P1147, DOI 10.1007/s10943-011-9554-9; Walsh K., 2005, NEUROPSYCHOLOGY CLIN; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271	41	14	14	1	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2015	25	6					936	958		10.1080/09602011.2014.999000			23	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	DP1TC	WOS:000378271300008	25558888				2021-06-18	
J	Oliver, J; Abbas, K; Lightfoot, JT; Baskin, K; Collins, B; Wier, D; Bramhall, JP; Huang, J; Puschett, JB				Oliver, Joel; Abbas, Kamran; Lightfoot, J. Timothy; Baskin, Kelly; Collins, Blaise; Wier, David; Bramhall, Joe P.; Huang, Jason; Puschett, Jules B.			Comparison of Neurocognitive Testing and the Measurement of Marinobufagenin in Mild Traumatic Brain Injury: A Preliminary Report	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						athletic brain trauma; concussion; bufodienolides; marinobufagenin; neurocognitive testing		The evaluation of concussed athletes, including testing to determine if and when they may return to play, has become an important task of athletic trainers and team physicians. Currently, concussion protocols are in place, which depend largely upon assessments based upon neurocognitive testing (NCT). The authors have evaluated the use of a biomarker of brain trauma, marinobufagenin (MBG), and compared its application in concussed athletes with the performance of NTC. We found a disparity between these two testing procedures. In this communication, the findings of these comparative data are presented. We noted that athletes whose NCT evaluations had returned to baseline and who were allowed to again participate in play then showed a recurrence of elevated urinary MBG excretion. These observations raise concern as to the processes currently in effect with regard to the decision as to returning athletes to the full activity. They suggest a need for further evaluation.	[Oliver, Joel; Abbas, Kamran; Puschett, Jules B.] Texas A&M Univ, Coll Vet Med & Biosci, Dept Pathobiol, College Stn, TX 77843 USA; [Lightfoot, J. Timothy; Baskin, Kelly; Collins, Blaise] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Wier, David; Bramhall, Joe P.] Texas A&M Univ, Dept Athlet, College Stn, TX USA; [Huang, Jason] Baylor Scott & White Healthcare, Coll Med, Dept Neurosurg, Temple, TX USA; [Huang, Jason] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA	Puschett, JB (corresponding author), Texas A&M Univ, Coll Vet Med & Biosci, Dept Pathobiol, College Stn, TX 77843 USA.	jbpuschett@aol.com	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168; Collins, Patrick/0000-0001-8711-1296	MD Research Endowment; Huffhines Institute; Texas A&M University School of Veterinary Medicine	These studies were funded (in part) by the Jules B. Puschett, MD Research Endowment, by a grant from the Huffhines Institute, and by the Texas A&M University School of Veterinary Medicine. The authors confirm that the funder had no influence over the study design, content of the article, or selection of this journal.	Abi-Ghanem D, 2011, J IMMUNOASS IMMUNOCH, V32, P31, DOI 10.1080/15321819.2010.538107; Agunanne E, 2011, AM J PERINAT, V28, P509, DOI 10.1055/s-0031-1272965; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Farjo B, 2014, J INVEST MED, V62, P544; Ferris C, 2014, ARCH CLIN NEUROPSYCH, V29; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasan KM, 2014, MAGN RESON IMAGING, V32, P405, DOI 10.1016/j.mri.2014.01.014; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Horvat D, 2010, HYPERTENS PREGNANCY, V29, P1, DOI 10.3109/10641950802629709; Ianosi-Irimie M, 2005, CLIN EXP HYPERTENS, V27, P605, DOI 10.1080/10641960500298608; Ing NH, 2014, AM J PHYSIOL-REG I, V306, pR918, DOI 10.1152/ajpregu.00499.2013; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kamali A, 2014, MAGN RESON IMAGING, V32, P796, DOI 10.1016/j.mri.2014.04.002; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mitchell BM, 2007, AM J HYPERTENS, V20, P1297, DOI 10.1016/j.amjhyper.2007.08.007; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Puschett JB, 2012, AM J PERINAT, V29, P777, DOI 10.1055/s-0032-1316447; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schoner W, 2002, EUR J BIOCHEM, V269, P2440, DOI 10.1046/j.1432-1033.2002.02911.x; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Shapiro L, 2011, ANN M BOOKL, V78, P2011; Singh R, 2004, JAMA-J AM MED ASSOC, V311, P1883; Thoma RJ, 2015, BRAIN INJURY, V19, P1; Uddin MN, 2009, AM J NEPHROL, V30, P26, DOI 10.1159/000193220; Uddin MN, 2009, AM J PHYSIOL-REG I, V296, pR1726, DOI 10.1152/ajpregu.90963.2008; Uddin MN, 2012, HYPERTENS PREGNANCY, V31, P70, DOI 10.3109/10641955.2010.525275; Vu H, 2006, EXP BIOL MED, V231, P215; Vu HV, 2005, AM J NEPHROL, V25, P520, DOI 10.1159/000088461; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507	42	14	14	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.		2015	9						67	72		10.4137/JEN.S27921			6	Neurosciences	Neurosciences & Neurology	V30WQ	WOS:000215593100009	26351409	DOAJ Gold, Green Published			2021-06-18	
J	Pedersen, K; Fahlstedt, M; Jacobsson, A; Kleiven, S; von Holst, H				Pedersen, Kyrre; Fahlstedt, Madelen; Jacobsson, Anders; Kleiven, Svein; von Holst, Hans			A National Survey of Traumatic Brain Injuries Admitted to Hospitals in Sweden from 1987 to 2010	NEUROEPIDEMIOLOGY			English	Article						Traumatic brain injury; Epidemiology; Age; Gender; Primary prevention	EPIDEMIOLOGY; POPULATION; TRENDS; SEVERITY	Background: With an increasing and aging population, there is a global demand for improving the primary prevention strategies aimed at reducing traumatic brain injuries (TBIs). The objective of the present epidemiological study was to evaluate the pattern of TBI in Sweden over a 24 years period (1987-2010). Methods: The Swedish Hospital Discharge Register was used, where in-patient care with a main diagnosis of TBI according to ICD9/10 was included. External factors, age and gender distribution was evaluated. Results: A decreasing number of annual incidence was observed, that is, from 230 to 156 per 100,000 inhabitants. A steady decrease of concussion was observed while other intracranial injuries increased especially traumatic subdural hemorrhage and subarachnoid hemorrhage. The study identified 3 groups of patients young, adults and elderly. The highest incidence and the largest increase of incidence were seen in the oldest age group (85+ years) while the population under 65 years had a decreasing incidence of TBI. The most frequent etiology was fall accidents (57%) with a relative constant trend over the study period. Conclusions: More effort should be focused on different strategies for different age groups, especially the elderly group. A well-planned strategy for primary prevention guidelines for different age groups will have the chance to further reduce not only the health-care costs but also complications among elderly care. (C) 2015 S. Karger AG, Basel	[Pedersen, Kyrre; von Holst, Hans] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Fahlstedt, Madelen; Kleiven, Svein; von Holst, Hans] KTH Royal Inst Technol, Dept Neuron Engn, Stockholm, Sweden; [Jacobsson, Anders] Natl Board Hlth & Welf, Dept Epidemiol, Stockholm, Sweden	Fahlstedt, M (corresponding author), Royal Inst Technol, STH, Dept Neuron Engn, Alfred Nobels Alle 10, SE-14152 Huddinge, Sweden.	madelen.fahlstedt@sth.kth.se			Swedish VINNOVAVinnova [IHF 2013 - 05118]	The present study was sponsored by the Swedish VINNOVA, IHF 2013 - 05118.	Alaranta H, 2000, Wien Med Wochenschr, V150, P444; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; [Anonymous], 2010, SAMH KOSTN FALL; Bonander C, 2014, J SAFETY RES, V51, P15, DOI 10.1016/j.jsr.2014.07.001; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Ekman R, 2001, ACCIDENT ANAL PREV, V33, P793, DOI 10.1016/S0001-4575(00)00093-2; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Firsching R, 2001, WORLD J SURG, V25, P1221; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Pearl Chung FK, 2013, J NEUROL NEUROPHYSIO, V5, P1; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Servadei F, 2002, J Neurosurg Sci, V46, P111; Socialstyrelsen, 2008, KODN PAT SLUT; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430	22	14	14	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2015	45	1					20	27		10.1159/000381780			8	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	CP4VX	WOS:000359881800003	26201267				2021-06-18	
J	Requejo, PS; Furumasu, J; Mulroy, SJ				Requejo, Philip S.; Furumasu, Jan; Mulroy, Sara J.			Evidence-Based Strategies for Preserving Mobility for Elderly and Aging Manual Wheelchair Users	TOPICS IN GERIATRIC REHABILITATION			English	Article						elderly and aging; evidenced-based practice; functional mobility; manual wheelchair; pain and dysfunction; quality of life; seating and positioning	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; SHOULDER JOINT KINETICS; TRAUMATIC BRAIN-INJURY; ARM DRIVE WHEELCHAIRS; UPPER EXTREMITY PAIN; UPPER-LIMB FUNCTION; PHYSICAL-ACTIVITY; INTERNATIONAL-CLASSIFICATION; MECHANICAL EFFICIENCY	Elderly and aging manual wheelchair users have an increased risk for accelerated loss of function and mobility that greatly limits independence and affects quality of life. This review addresses important issues for preserving function and mobility among elderly and aging individuals who use a manual wheelchair by presenting the current available evidence and recommendations. These include recommendations for maximizing function by decreasing pain, improving the ability to self-propel, and prolonging mobility and endurance through ergonomics, individualized wheelchair selection and configuration, and adaptations for increasing the capacity to handle the daily mobility demands through training, strengthening, and exercise. Each recommendation is supported by current research in each relevant area.	[Requejo, Philip S.; Furumasu, Jan; Mulroy, Sara J.] Rancho Los Amigos Natl Rehabil Ctr, Phys Therapy Dept, Downey, CA 90242 USA; [Requejo, Philip S.] Rancho Los Amigos Natl Rehabil Ctr, Rehabil Engn Program, Downey, CA 90242 USA; [Requejo, Philip S.; Mulroy, Sara J.] Rancho Los Amigos Natl Rehabil Ctr, Pathokinesiol Lab, Downey, CA 90242 USA	Requejo, PS (corresponding author), Rancho Los Amigos Natl Rehabil Ctr, Rehabil Engn Program, Downey, CA 90242 USA.	prequejo@dhs.lacounty.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD049774] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD049774] Funding Source: Medline		Ahmed Mohamed S, 2005, Phys Med Rehabil Clin N Am, V16, P19, DOI 10.1016/j.pmr.2004.06.017; Aissaoui R, 2002, AM J PHYS MED REHAB, V81, P94, DOI 10.1097/00002060-200202000-00004; Aissaoui R, 2001, ARCH PHYS MED REHAB, V82, P274, DOI 10.1053/apmr.2001.19473; Algood SD, 2004, ARCH PHYS MED REHAB, V85, P1865, DOI 10.1016/j.apmr.2004.04.043; Allam AM, 2013, PM&R, V5, P957, DOI 10.1016/j.pmrj.2013.05.015; Allen R, 2002, CLIN REHABIL, V16, P329, DOI 10.1191/0269215502cr499oa; Allison GT, 1996, DISABIL REHABIL, V18, P35, DOI 10.3109/09638289609167087; Alm M, 2008, J REHABIL MED, V40, P277, DOI 10.2340/16501977-0173; Ambrosio F, 2005, J SPINAL CORD MED, V28, P407, DOI 10.1080/10790268.2005.11753840; Ambrosio F, 2007, J REHABIL RES DEV, V44, P693, DOI 10.1682/JRRD.2006.02.0016; Andersen JH, 2002, SPINE, V27, P660; [Anonymous], 2011, ECONOMIST; Arva J, 2001, MED ENG PHYS, V23, P699, DOI 10.1016/S1350-4533(01)00054-6; ASATO KT, 1993, IEEE T BIO-MED ENG, V40, P1320, DOI 10.1109/10.250587; Ataoglu E, 2013, SPINAL CORD, V51, P23, DOI 10.1038/sc.2012.51; Ballinger DA, 2000, ARCH PHYS MED REHAB, V81, P1575, DOI 10.1053/apmr.2000.18216; BAR CA, 1991, PROSTHET ORTHOT INT, V15, P232; Bashton D, 2012, DISABIL REHABIL-ASSI, V7, P75, DOI 10.3109/17483107.2011.574247; Bauer SM, 2011, DISABIL REHABIL-ASSI, V6, P243, DOI 10.3109/17483107.2010.529631; BAYLEY JC, 1987, J BONE JOINT SURG AM, V69A, P676, DOI 10.2106/00004623-198769050-00006; Beekman CE, 1999, PHYS THER, V79, P146, DOI 10.1093/ptj/79.2.146; Ben Mortenson W, 2012, J AM GERIATR SOC, V60, P1310, DOI 10.1111/j.1532-5415.2012.04038.x; Berven S, 2002, SEMIN NEUROL, V22, P167, DOI 10.1055/s-2002-36540; Bolin I, 2000, SPINAL CORD, V38, P425, DOI 10.1038/sj.sc.3101031; Bombardier CH, 2010, PHYS MED REH CLIN N, V21, P281, DOI 10.1016/j.pmr.2009.12.005; Boninger Michael L, 2013, Arch Phys Med Rehabil, V94, P2579, DOI 10.1016/j.apmr.2013.04.007; Boninger ML, 1997, AM J PHYS MED REHAB, V76, P420, DOI 10.1097/00002060-199709000-00013; Boninger ML, 2000, ARCH PHYS MED REHAB, V81, P608, DOI 10.1016/S0003-9993(00)90043-1; Boninger ML, 1998, ARCH PHYS MED REHAB, V79, P1577, DOI 10.1016/S0003-9993(98)90424-5; Brault M. W, 2010, AM DISABILITIES 2010; Brault MW, 2012, CURRENT POPULATION R, P70; Brienza D, 2010, J AM GERIATR SOC, V58, P2308, DOI 10.1111/j.1532-5415.2010.03168.x; Brienza DM, 1996, IEEE T REHABIL ENG, V4, P320, DOI 10.1109/86.547933; Brubaker C E, 1986, J Rehabil Res Dev, V23, P55; Buchholz AC, 2003, OBES RES, V11, P563, DOI 10.1038/oby.2003.79; Buchholz AC, 2009, APPL PHYSIOL NUTR ME, V34, P640, DOI 10.1139/H09-050; Burns SP, 1999, ARCH PHYS MED REHAB, V80, P566, DOI 10.1016/S0003-9993(99)90201-0; Byrne DW, 1996, SPINAL CORD, V34, P255, DOI 10.1038/sc.1996.46; Capoor Jaishree, 2005, Phys Med Rehabil Clin N Am, V16, P129, DOI 10.1016/j.pmr.2004.06.016; Chang FH, 2012, ARCH PHYS MED REHAB, V93, P2264, DOI 10.1016/j.apmr.2012.06.008; Charbonneau R, 2013, ARCH PHYS MED REHAB, V94, P1707, DOI 10.1016/j.apmr.2013.03.001; Charlifue S, 2010, PHYS MED REH CLIN N, V21, P383, DOI 10.1016/j.pmr.2009.12.002; Chen YY, 2005, ARCH PHYS MED REHAB, V86, P1208, DOI 10.1016/j.apmr.2004.12.023; Chow JW, 2009, ARCH PHYS MED REHAB, V90, P271, DOI 10.1016/j.apmr.2008.07.019; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Cohen RB, 1998, CLIN ORTHOP RELAT R, P95; Consumer Affairs Victoria, 2005, CONS CRED REV ISS PA, P01; Cooper RA, 1997, ARCH PHYS MED REHAB, V78, P1138, DOI 10.1016/S0003-9993(97)90141-6; Cooper RA, 1999, AM J PHYS MED REHAB, V78, P435, DOI 10.1097/00002060-199909000-00006; Cooper RA, 2001, ARCH PHYS MED REHAB, V82, P702, DOI 10.1053/apmr.2001.20836; Cooper RA, 1999, ARCH PHYS MED REHAB, V80, P462, DOI 10.1016/S0003-9993(99)90287-3; Cooper RA, 1996, J REHABIL RES DEV, V33, P45; Cowan R., 2007, MANUAL WHEELCHAIR PR; Cowan RE, 2009, ARCH PHYS MED REHAB, V90, P1076, DOI 10.1016/j.apmr.2008.10.034; Crawford A, 2008, DISABIL HEALTH J, V1, P7, DOI 10.1016/j.dhjo.2007.11.004; CRIMMINS EM, 1994, DEMOGRAPHY, V31, P159, DOI 10.2307/2061913; CRON L, 1993, AM J OCCUP THER, V47, P141, DOI 10.5014/ajot.47.2.141; CURTIS KA, 1995, PARAPLEGIA, V33, P290, DOI 10.1038/sc.1995.65; Curtis KA, 1999, ARCH PHYS MED REHAB, V80, P453, DOI 10.1016/S0003-9993(99)90285-X; Dallmeijer AJ, 2005, J REHABIL RES DEV, V42, P55, DOI 10.1682/JRRD.2004.08.0081; Dallmeijer AJ, 2004, SPINAL CORD, V42, P91, DOI 10.1038/sj.sc.3101566; Dalyan M, 1999, SPINAL CORD, V37, P191, DOI 10.1038/sj.sc.3100802; Davis JL, 1998, J REHABIL RES DEV, V35, P61; de Groot S, 2008, CLIN BIOMECH, V23, P434, DOI 10.1016/j.clinbiomech.2007.11.001; de Groot S, 2004, AM J PHYS MED REHAB, V83, P640, DOI 10.1097/01.phm.0000133437.58810.c6; de Groot S, 2002, MED SCI SPORT EXER, V34, P756, DOI 10.1097/00005768-200205000-00005; de Groot S, 2013, MED ENG PHYS, V35, P1476, DOI 10.1016/j.medengphy.2013.03.019; Desroches G, 2008, ARCH PHYS MED REHAB, V89, P1155, DOI 10.1016/j.apmr.2007.10.040; Dyson-Hudson TA, 2004, J SPINAL CORD MED, V27, P4, DOI 10.1080/10790268.2004.11753724; Fay BT, 2002, MED ENG PHYS, V24, P375, DOI 10.1016/S1350-4533(02)00037-1; Finlayson M, 2001, AM J OCCUP THER, V55, P545, DOI 10.5014/ajot.55.5.545; Finley MA, 2005, CLIN BIOMECH, V20, P32, DOI 10.1016/j.clinbiomech.2004.06.011; Fitzgerald SG, 2001, ARCH PHYS MED REHAB, V82, P1484, DOI 10.1053/apmr.2001.26139; Fliess-Douer O, 2012, ARCH PHYS MED REHAB, V93, P629, DOI 10.1016/j.apmr.2011.11.017; Forslund EB, 2007, SPINAL CORD, V45, P41, DOI 10.1038/sj.sc.3101935; Frost P, 2002, AM J IND MED, V41, P11, DOI 10.1002/ajim.10019; Gagnon D, 2005, SPINAL CORD, V43, P74, DOI 10.1038/sj.sc.3101660; Gagnon D, 2003, CLIN BIOMECH, V18, P319, DOI 10.1016/S0268-0033(03)00016-0; Gagnon D, 2008, J BIOMECH, V41, P1104, DOI 10.1016/j.jbiomech.2007.11.021; Gagnon D, 2009, J ELECTROMYOGR KINES, V19, P509, DOI 10.1016/j.jelekin.2007.12.005; Ganesh S, 2007, ARCH PHYS MED REHAB, V88, P434, DOI 10.1016/j.apmr.2006.12.045; GARBER SL, 1984, ARCH PHYS MED REHAB, V65, P579; GARG A, 1991, ERGONOMICS, V34, P289, DOI 10.1080/00140139108967314; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Gebrosky B, 2013, J REHABIL RES DEV, V50, P1373, DOI 10.1682/JRRD.2012.08.0155; Gefen A, 2014, OSTOMY WOUND MANAG, V60, P34; GELLMAN H, 1988, CLIN ORTHOP RELAT R, P132; GERHART KA, 1993, ARCH PHYS MED REHAB, V74, P1030, DOI 10.1016/0003-9993(93)90057-H; Ginis KAM, 2010, SPINAL CORD, V48, P65, DOI 10.1038/sc.2009.87; Ginn KA, 1997, PHYS THER, V77, P802, DOI 10.1093/ptj/77.8.802; Ginn KA, 2004, ARCH PHYS MED REHAB, V85, P1231, DOI 10.1016/j.apmr.2003.09.013; Goldstein B, 2004, PHYS MED REH CLIN N, V15, P699, DOI DOI 10.1016/J.PMR.2003.12.005; Groah SL, 2002, ARCH PHYS MED REHAB, V83, pS82, DOI 10.1053/apmr.2002.32182; Groah SL, 2012, AM J PHYS MED REHAB, V91, P80, DOI 10.1097/PHM.0b013e31821f70bc; Gronley JK, 2000, J REHABIL RES DEV, V37, P423; Gutierrez DD, 2005, J SPINAL CORD MED, V28, P222, DOI 10.1080/10790268.2005.11753816; Gutierrez DD, 2007, J SPINAL CORD MED, V30, P251, DOI 10.1080/10790268.2007.11753933; Harms M, 1990, PHYSIOTHERAPY, V76, P266; Harvey LA, 2000, ARCH PHYS MED REHAB, V81, P500, DOI 10.1053/mr.2000.3788; Hastings Jennifer, 2004, Phys Med Rehabil Clin N Am, V15, P699; Haubert L.L., 2005, TOP SPINAL CORD INJ, V11, P64; HILBERS PA, 1987, PHYS THER, V67, P1355, DOI 10.1093/ptj/67.9.1355; Hoenig H, 2003, AM J PUBLIC HEALTH, V93, P330, DOI 10.2105/AJPH.93.2.330; HOENIG H, 2004, ANN LONG TERM CARE, V12, P12; HOLDEN JM, 1988, APPL ERGON, V19, P281, DOI 10.1016/0003-6870(88)90075-0; Hosseini SM, 2012, ARCH PHYS MED REHAB, V93, P2237, DOI 10.1016/j.apmr.2012.05.021; Hsieh CC, 2011, ASSIST TECHNOL, V23, P1, DOI 10.1080/10400435.2010.541404; ITOI E, 1992, CLIN ORTHOP RELAT R, P165; JANSSEN TWJ, 1994, MED SCI SPORT EXER, V26, P661, DOI 10.1249/00005768-199406000-00002; Janssen-Potten YJM, 2000, ARCH PHYS MED REHAB, V81, P401, DOI 10.1053/mr.2000.3859; Karmarkar AM, 2012, ASSIST TECHNOL, V24, P155, DOI 10.1080/10400435.2012.659795; Kataoka M, 2012, SPINAL CORD, V50, P440, DOI 10.1038/sc.2011.170; KAYE HS, 2002, WHEELCHAIR USE US, P1; Kemp B., 2001, TOP SPINAL CORD INJU, V6, P116; Kemp B. J., 2004, AGING DISABILITY WHA; Kemp BJ, 2005, PHYS MED REH CLIN N, V16, pvii; Kemp Bryan J, 2005, Phys Med Rehabil Clin N Am, V16, P1, DOI 10.1016/j.pmr.2004.06.009; Kernozek TW, 1998, ARCH PHYS MED REHAB, V79, P313, DOI 10.1016/S0003-9993(98)90012-0; Kilkens OJE, 2003, CLIN REHABIL, V17, P418, DOI 10.1191/0269215503cr633oa; Kirby RL, 2002, ARCH PHYS MED REHAB, V83, P10, DOI 10.1053/apmr.2002.26823; Koontz A, 2012, DISABIL REHABIL-ASSI, V7, P20, DOI 10.3109/17483107.2011.553983; Koontz AM, 2011, J REHABIL RES DEV, V48, P1015, DOI 10.1682/JRRD.2010.09.0169; Koontz AM, 2009, ARCH PHYS MED REHAB, V90, P1916, DOI 10.1016/j.apmr.2009.05.022; Koontz AM, 2005, J REHABIL RES DEV, V42, P447, DOI 10.1682/JRRD.2004.08.0106; Koontz AM, 2002, J REHABIL RES DEV, V39, P635; Kotajarvi BR, 2004, J REHABIL RES DEV, V41, P403, DOI 10.1682/JRRD.2003.01.0008; Kulig K, 1998, CLIN ORTHOP RELAT R, P132, DOI 10.1097/00003086-199809000-00016; Kulig K, 2001, CLIN BIOMECH, V16, P744, DOI 10.1016/S0268-0033(01)00066-3; Kwarciak AM, 2012, DISABIL REHABIL-ASSI, V7, P459, DOI 10.3109/17483107.2011.650781; Lalumiere M, 2013, J ELECTROMYOGR KINES, V23, P1434, DOI 10.1016/j.jelekin.2013.06.009; Lammertse DP, 2001, TOP SPINAL CORD INJ, V6, P1; Lee Y, 2008, INT J GERIATR PSYCH, V23, P249, DOI 10.1002/gps.1870; Levy CE, 2004, ARCH PHYS MED REHAB, V85, P104, DOI 10.1016/S0003-9993(03)00426-X; Liu HY, 2010, J REHABIL RES DEV, V47, P441, DOI 10.1682/JRRD.2009.08.0137; Liu HY, 2008, J REHABIL RES DEV, V45, P1251, DOI 10.1682/JRRD.2007.12.0204; Louis N, 2010, CLIN BIOMECH, V25, P879, DOI 10.1016/j.clinbiomech.2010.07.002; Lukersmith S, 2013, AUST OCCUP THER J, V60, P378, DOI 10.1111/1440-1630.12077; LUNDQVIST C, 1991, SPINE, V16, P78, DOI 10.1097/00007632-199101000-00014; Mandy A, 2014, DISABIL REHABIL-ASSI, V9, P242, DOI 10.3109/17483107.2013.782575; Mandy A, 2007, DISABIL REHABIL-ASSI, V2, P255, DOI 10.1080/17483100701343624; Mao HF, 2006, ARCH PHYS MED REHAB, V87, P764, DOI 10.1016/j.apmr.2006.02.029; Margolis DJ, 2002, ANN EPIDEMIOL, V12, P321, DOI 10.1016/S1047-2797(01)00255-1; MASSE LC, 1992, J REHABIL RES DEV, V29, P12, DOI 10.1682/JRRD.1992.07.0012; McCarthy RE, 1999, ORTHOP CLIN N AM, V30, P435, DOI 10.1016/S0030-5898(05)70096-1; McCasland LD, 2006, JCR-J CLIN RHEUMATOL, V12, P179, DOI 10.1097/01.rhu.0000230532.54403.25; McClure PW, 2004, PHYS THER, V84, P832, DOI 10.1093/ptj/84.9.832; McGlinchey-Berroth R, 1995, J Spinal Cord Med, V18, P183; McKinley WO, 1999, ARCH PHYS MED REHAB, V80, P1402, DOI 10.1016/S0003-9993(99)90251-4; MCLAURIN CA, 1991, PROSTHET ORTHOT INT, V15, P24; McVeigh SA, 2009, J SPINAL CORD MED, V32, P115, DOI 10.1080/10790268.2009.11760762; MENTER RR, 1991, PARAPLEGIA, V29, P613, DOI 10.1038/sc.1991.90; Miller L, 2000, J GERONTOL NURS, V26, P46; Mortenson WB, 2007, DISABIL REHABIL-ASSI, V2, P275, DOI 10.1080/17483100701475863; Mortenson WB, 2008, ARCH PHYS MED REHAB, V89, P1177, DOI 10.1016/j.apmr.2008.01.010; Mulroy SJ, 2011, PHYS THER, V91, P1766, DOI 10.2522/ptj.20110024; Mulroy SJ, 2004, ARCH PHYS MED REHAB, V85, P925, DOI 10.1016/j.apmr.2003.08.090; Mulroy SJ, 1996, ARCH PHYS MED REHAB, V77, P187, DOI 10.1016/S0003-9993(96)90166-5; Nash MS, 2008, ARCH PHYS MED REHAB, V89, P2080, DOI 10.1016/j.apmr.2008.05.018; Nawoczenski DA, 2012, ARCH PHYS MED REHAB, V93, P1421, DOI 10.1016/j.apmr.2012.02.034; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Newsam CJ, 2003, J SPINAL CORD MED, V26, P59, DOI 10.1080/10790268.2003.11753662; Newsam CJ, 1999, GAIT POSTURE, V10, P223, DOI 10.1016/S0966-6362(99)00034-X; NIESING R, 1990, MED BIOL ENG COMPUT, V28, P329, DOI 10.1007/BF02446151; Noonan VK, 2009, DISABIL REHABIL, V31, P1883, DOI 10.1080/09638280902846947; Paralyzed Veterans of America Consortium for Spinal Cord Medicine, 2005, J Spinal Cord Med, V28, P434; Patel J, 2011, CLIN ORTHOP RELAT R, V469, P1302, DOI 10.1007/s11999-010-1687-8; Payne LZ, 1997, AM J SPORT MED, V25, P801, DOI 10.1177/036354659702500612; PENTLAND W, 1995, PARAPLEGIA, V33, P367, DOI 10.1038/sc.1995.84; PENTLAND WE, 1994, PARAPLEGIA, V32, P219, DOI 10.1038/sc.1994.41; PERKS BA, 1994, J REHABIL RES DEV, V31, P297; Perry J, 1996, ARCH PHYS MED REHAB, V77, P350, DOI 10.1016/S0003-9993(96)90083-0; Phillips AA, 2011, SPINAL CORD, V49, P702, DOI 10.1038/sc.2010.193; Putzke JD, 2002, PAIN, V100, P231, DOI 10.1016/S0304-3959(02)00069-6; Rader J, 2000, J Gerontol Nurs, V26, P24; Rae MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000822; Ragnarsson KT, 2012, AM J PHYS MED REHAB, V91, P231, DOI 10.1097/PHM.0b013e3182489f5e; Rao S S, 1996, IEEE Trans Rehabil Eng, V4, P152, DOI 10.1109/86.536770; REDFORD JB, 1993, ARCH PHYS MED REHAB, V74, P877, DOI 10.1016/0003-9993(93)90016-4; Rejeski WJ, 2008, GERIATR GERONTOL INT, V8, P48, DOI 10.1111/j.1447-0594.2008.00446.x; Requejo P., 2008, TOPICS SPINAL CORD I, V13, P86; Requejo PS, 2007, J SPIN CORD MED TAMP; REYES ML, 1995, ARCH PHYS MED REHAB, V76, P433, DOI 10.1016/S0003-9993(95)80572-9; Rice LA, 2014, ARCH PHYS MED REHAB, V95, P10, DOI 10.1016/j.apmr.2013.06.028; Rice LA, 2013, ARCH PHYS MED REHAB, V94, P1230, DOI 10.1016/j.apmr.2013.03.008; Richter WM, 2007, ARCH PHYS MED REHAB, V88, P76, DOI 10.1016/j.apmr.2006.09.015; RODGERS MM, 1994, ARCH PHYS MED REHAB, V75, P85; Rodgers MM, 2003, J REHABIL RES DEV, V40, P27, DOI 10.1682/JRRD.2003.01.0027; RODRIGUEZ GP, 1989, ARCH PHYS MED REHAB, V70, P442, DOI 10.1016/0003-9993(89)90003-8; RODRIGUEZ GP, 1986, ARCH PHYS MED REHAB, V67, P177, DOI 10.1016/0003-9993(86)90073-0; Rousseau-Harrison K, 2009, DISABIL REHABIL-ASSI, V4, P344, DOI 10.1080/17483100903038550; Rushton PW, 2010, SPINAL CORD, V48, P691, DOI 10.1038/sc.2009.197; Sakakibara BM, 2013, ARCH PHYS MED REHAB, V94, P1031, DOI 10.1016/j.apmr.2013.01.016; Salisbury SK, 2006, SPINAL CORD, V44, P723, DOI 10.1038/sj.sc.3101908; SANDERSON DJ, 1985, J BIOMECH, V18, P423, DOI 10.1016/0021-9290(85)90277-5; Sawatzky BJ, 2004, ERGONOMICS, V47, P1475, DOI 10.1080/00140130412331290862; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; SHARKEY NA, 1995, AM J SPORT MED, V23, P270, DOI 10.1177/036354659502300303; Shields Margot, 2004, Health Rep, V15, P37; SIE IH, 1992, ARCH PHYS MED REHAB, V73, P44; Souza A, 2010, J REHABIL RES DEV, V47, P213, DOI 10.1682/JRRD.2009.07.0096; Steel EJ, 2012, AM J PHYS MED REHAB, V91, pS55, DOI 10.1097/PHM.0b013e31823d4ee6; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599; Szlachcic Y, 2007, J SPINAL CORD MED, V30, P473, DOI 10.1080/10790268.2007.11754580; Tam EW, 2003, ARCH PHYS MED REHAB, V84, P1466, DOI 10.1016/S0003-9993(03)00269-7; Thompson L, 1999, ASSIST TECHNOL, V11, P123, DOI 10.1080/10400435.1999.10131996; THOMPSON WG, 1990, RHEUM DIS CLIN N AM, V16, P803; Trefler E, 2004, ASSIST TECHNOL, V16, P18, DOI 10.1080/10400435.2004.10132071; Ulin S S, 1997, SCI Nurs, V14, P19; US Department of Health and Human Services Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO, pC; van der Woude L H, 1989, J Rehabil Res Dev, V26, P31; van der Woude LHV, 2009, J REHABIL MED, V41, P143, DOI 10.2340/16501977-0296; van Drongelen S, 2005, ARCH PHYS MED REHAB, V86, P1214, DOI 10.1016/j.apmr.2004.09.023; VANDERWOUDE LHV, 1995, J MED ENG TECHNOL, V19, P123, DOI 10.3109/03091909509012418; Varcin-Coad L, 1998, AAOHN J, V46, P530; VIDAL J, 1991, PARAPLEGIA, V29, P261, DOI 10.1038/sc.1991.37; Vissers M, 2008, J REHABIL MED, V40, P461, DOI 10.2340/16501977-0191; Walter JS, 2002, J REHABIL RES DEV, V39, P53; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Warms CA, 2008, DISABIL HEALTH J, V1, P236, DOI 10.1016/j.dhjo.2008.07.002; WATERS RL, 1985, J BONE JOINT SURG AM, V67A, P1245, DOI 10.2106/00004623-198567080-00016; World Health Organization, 2001, INT CLASS FUNCT DIS, P229; Wu HW, 1998, J BIOMECH ENG-T ASME, V120, P533, DOI 10.1115/1.2798024; Wu S., 2000, PROJECTION CHRONIC I; Yassi A, 2001, SPINE, V26, P1739, DOI 10.1097/00007632-200108150-00002	226	14	14	0	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0882-7524	1550-2414		TOP GERIATR REHABIL	Top. Geriatr. Rehabil.	JAN-MAR	2015	31	1					26	41		10.1097/TGR.0000000000000042			16	Gerontology; Rehabilitation	Geriatrics & Gerontology; Rehabilitation	AZ0SK	WOS:000347954700005	26366040	Green Accepted			2021-06-18	
J	Risen, SR; Barber, AD; Mostofsky, SH; Suskauer, SJ				Risen, S. R.; Barber, A. D.; Mostofsky, S. H.; Suskauer, S. J.			Altered functional connectivity in children with mild to moderate TBI relates to motor control	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						TBI; pediatric; resting-state networks; fMRI		PURPOSE: Functionally relevant alterations in resting state fMRI (rs-fMRI) connectivity have been identified in adults with traumatic brain injury (TBI). We evaluated rs-fMRI connectivity in children with TBI and explored the relationship between altered connectivity and measures of neurological function. METHODS: Rs-fMRI was obtained in 14 children after TBI and 14 controls matched for age, sex, and handedness. Whole-brain connectivity was evaluated separately for the default mode network (DMN) and dorsal attention network (DAN); Between-group contrasts identified regions with altered connectivity between TBI and control cohorts. In children with TBI, the relationships between regions of altered connectivity and performance on relevant functional measures were examined. RESULTS: Compared to controls, children with TBI showed significantly greater connectivity between DMN and right dorsal premotor cortex (RdPM) and between DAN and bilateral sensorimotor cortex (SM1). In children with TBI, greater DMN-RdPM connectivity was associated with worse motor performance whereas greater DAN-LSM1 connectivity was associated with better motor performance; furthermore, DMN-RdPM and DAN-LSM1 connectivity were negatively correlated. CONCLUSION: Rs-fMRI reveals significant altered connectivity in children with TBI compared to controls. After TBI in children, patterns of altered connectivity appear divergent, with increased DMN-motor network connectivity associated with worse motor control whereas increased DAN-motor network connectivity appears compensatory.	[Risen, S. R.; Barber, A. D.; Mostofsky, S. H.; Suskauer, S. J.] Kennedy Krieger Inst, Baltimore, MD USA; [Risen, S. R.; Barber, A. D.; Mostofsky, S. H.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Risen, S. R.; Mostofsky, S. H.; Suskauer, S. J.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Suskauer, S. J.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA	Suskauer, SJ (corresponding author), Kennedy Krieger Inst, Dept Phys Med & Rehabil, 707 N Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org	Barber, Anita D/P-7010-2016	Barber, Anita D/0000-0001-8766-3103	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD061611, R01MH078160, R01MH085328]; NIH/NCRR CTSA ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [UL1TR001079-01];  [RC2DA029475]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414, K23HD061611, U54HD079123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH085328, R01MH078160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [RC2DA029475] Funding Source: NIH RePORTER	S.R. Risen received funding from NIH grant T32HD 007414-20. S.H. Mostofsky received funding from RC2DA029475 and remains funded by NIH R01MH078160 and R01MH085328. S.J. Suskauer was funded by NIH K23HD061611 and received research support from NIH/NCRR CTSA Program UL1TR001079-01.	Addamo PK, 2007, BRAIN RES REV, V54, P189, DOI 10.1016/j.brainresrev.2007.01.004; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barber AD, 2013, NEUROPSYCHOLOGIA, V51, P156, DOI 10.1016/j.neuropsychologia.2012.11.011; Barber AD, 2012, CEREB CORTEX, V22, P51, DOI 10.1093/cercor/bhr062; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borich M, 2014, J NEUROTRAUMA; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Faul M., 2010, TRAUMATIC BRAIN INJU, P1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Herjanic, 1997, DIAGNOSTIC INTERVIEW; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Jantzen KJ, 2004, P NATL ACAD SCI USA, V101, P6815, DOI 10.1073/pnas.0401300101; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Mahone EM, 2006, J INT NEUROPSYCH SOC, V12, P622, DOI 10.1017/S1355617706060814; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Shannon BJ, 2011, P NATL ACAD SCI USA, V108, P11241, DOI 10.1073/pnas.1108241108; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Venkatesan UM, 2014, J NEUROTRAUMA; WATSON RT, 1978, ANN NEUROL, V3, P505, DOI 10.1002/ana.410030609; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	44	14	14	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					309	319		10.3233/PRM-150349			11	Pediatrics	Pediatrics	VG7LK	WOS:000448290900005	26684071	Green Accepted			2021-06-18	
J	Souvenir, R; Doycheva, D; Zhang, JH; Tang, JP				Souvenir, Rhonda; Doycheva, Desislava; Zhang, John H.; Tang, Jiping			Erythropoietin in Stroke Therapy: Friend or Foe	CURRENT MEDICINAL CHEMISTRY			English	Article						Erythropoietin signaling; janus kinase 2; signal transducers and activators of transcription 3	RECOMBINANT-HUMAN-ERYTHROPOIETIN; FOCAL CEREBRAL-ISCHEMIA; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; NEONATAL HYPOXIA-ISCHEMIA; HIGH-DOSE ERYTHROPOIETIN; NEURAL PROGENITOR CELLS; NITRIC-OXIDE FORMATION; IN-VITRO MODEL	Recombinant human erythropoietin (rhEPO), over the past decade, was hailed as an auspicious therapeutic strategy for various types of brain injuries. The promising results from experiments conducted in animal models of stroke led to a hurried clinical trial that was swiftly aborted in Phase II. The multiple neuroprotective modalities of rhEPO failed to translate smoothly to human adult ischemic brain injury and provided limited aid to neonates. In light of the antithetical results, several questions were raised as to why and how this clinical trial failed. There was bolstering evidence from the preliminary studies that pointed to a bright future. Therefore, the objective of this review is to address these questions by discussing the signaling pathways of rhEPO that are reported to mediate the neuroprotective effect in various animal models of brain injury. Major biomedical bibliographical databases (MEDLINE, ISI, PubMed, and Cochrane Library) were searched with the use of keywords such as erythropoietin, stroke, neonatal hypoxia ischemia, intracerebral hemorrhage, etc. This article will discuss the confounding factors that influence the efficacy of rhEPO treatment hence challenging its clinical translatability. Lastly, rhEPO may still be a promising therapeutic candidate for neonates in spite of its shortcoming in clinical trial if caution is taken with the dose and duration of its administration.	[Souvenir, Rhonda] Loma Linda Univ, Sch Med, Dept Mol Genet & Microbiol, Loma Linda, CA 92350 USA; [Souvenir, Rhonda; Doycheva, Desislava; Zhang, John H.; Tang, Jiping] Loma Linda Univ, Dept Physiol & Pharmacol, Sch Med, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA 92350 USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92350 USA	Tang, JP (corresponding author), Loma Linda Univ, Dept Physiol & Pharmacol, Sch Med, Loma Linda, CA 92350 USA.	jtang@llu.edu		Doycheva, Desislava/0000-0001-7795-5989; Souvenir, Rhonda/0000-0002-8880-2483	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060936, NS053407]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060936, R01NS053407] Funding Source: NIH RePORTER	This review was supported by NIH NS060936 to Tang and NIH NS053407 to Zhang.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Benders MJ, 2014, J PEDIATR-US, V164, P481, DOI 10.1016/j.jpeds.2013.10.084; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bugno M, 1995, NUCLEIC ACIDS RES, V23, P5041, DOI 10.1093/nar/23.24.5041; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Cao Yiting, 2010, Genes Cancer, V1, P50; Caro J, 1988, Contrib Nephrol, V66, P54; Casals-Pascual C, 2009, TRENDS PARASITOL, V25, P30, DOI 10.1016/j.pt.2008.10.002; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chau M, 2011, ACTA NEUROCHIR SUPPL, V111, P299, DOI 10.1007/978-3-7091-0693-8_50; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Cheng XA, 2011, NEUROSCI LETT, V493, P18, DOI 10.1016/j.neulet.2011.02.006; Chi OZ, 2008, PHARMACOLOGY, V82, P38, DOI 10.1159/000127839; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; Dame C, 2004, J BIOL CHEM, V279, P2955, DOI 10.1074/jbc.M310404200; DEARDEN NM, 1985, LANCET, V2, P255; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fan Q, 2006, EXP HEMATOL, V34, P1303, DOI 10.1016/j.exphem.2006.05.012; Fan XY, 2011, PEDIATR RES, V69, P56, DOI 10.1203/PDR.0b013e3181fcbef3; Fauchere JC, 2008, PEDIATRICS, V122, P375, DOI 10.1542/peds.2007-2591; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; Gonzalez FF, 2009, DEV NEUROSCI-BASEL, V31, P403, DOI 10.1159/000232558; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; Grasso G, 2002, J NEUROSURG, V96, P565, DOI 10.3171/jns.2002.96.3.0565; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; He Jin-Shui, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P586; Helbok R, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-32; Ihle J N, 1995, Semin Immunol, V7, P247, DOI 10.1006/smim.1995.0029; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Juul SE, 2008, PEDIATRICS, V122, P383, DOI 10.1542/peds.2007-2711; Kadri Z, 2000, CELL GROWTH DIFFER, V11, P573; Kanaan NM, 2006, BRAIN RES, V1068, P221, DOI 10.1016/j.brainres.2005.10.078; Kaplan N, 1996, ARCH BIOCHEM BIOPHYS, V326, P271, DOI 10.1006/abbi.1996.0076; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Kobayashi T, 2002, BIOCHEM BIOPH RES CO, V296, P145, DOI 10.1016/S0006-291X(02)00832-X; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Kumral A, 2004, BIOL NEONATE, V85, P51, DOI 10.1159/000074958; Kumral A, 2003, BIOL NEONATE, V84, P325, DOI 10.1159/000073642; Lacombe C, 1999, NEPHROL DIAL TRANSPL, V14, P22, DOI 10.1093/ndt/14.suppl_2.22; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Li Y, 2007, NEUROCHEM RES, V32, P2132, DOI 10.1007/s11064-007-9387-9; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu C, 1997, J BIOL CHEM, V272, P32395, DOI 10.1074/jbc.272.51.32395; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Magnanti M, 2001, BLOOD, V98, P2872, DOI 10.1182/blood.V98.9.2872; Masuda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE1038; McPherson RJ, 2010, CURR OPIN PEDIATR, V22, P139, DOI 10.1097/MOP.0b013e328336eb57; Meyer MP, 2003, ARCH DIS CHILD-FETAL, V88, P41; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Rhee JS, 2004, CANCER RES, V64, P952, DOI 10.1158/0008-5472.CAN-03-2445; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Santhanam AVR, 2005, STROKE, V36, P2731, DOI 10.1161/01.STR.0000190021.85035.5b; Sattler MB, 2004, CELL DEATH DIFFER, V11, pS181, DOI 10.1038/sj.cdd.4401504; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SHUAI K, 1992, SCIENCE, V258, P1808, DOI 10.1126/science.1281555; SIESJO BK, 1985, J TOXICOL-CLIN TOXIC, V23, P267, DOI 10.3109/15563658508990634; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Sola A, 2005, PEDIATR RES, V57, P481, DOI 10.1203/01.PDR.0000155760.88664.06; Souvenir R, 2014, TRANSL STROKE RES, V5, P118, DOI 10.1007/s12975-013-0312-z; Souvenir R, 2011, NEUROBIOL DIS, V44, P28, DOI 10.1016/j.nbd.2011.05.020; Springborg JB, 2003, BRAIN RES, V984, P143, DOI 10.1016/S0006-8993(03)03124-X; Studer L, 2000, J NEUROSCI, V20, P7377; Sun Y, 2005, STROKE, V36, P1672, DOI 10.1161/01.STR.0000173406.04891.8c; Sun Y, 2004, J CEREBR BLOOD F MET, V24, P259, DOI 10.1097/01.WCB.0000110049.43905.AC; TAYLOR JE, 1994, CLIN NEPHROL, V41, P297; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tseng MY, 2010, J NEUROSURG, V112, P1235, DOI 10.3171/2009.10.JNS09954; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Worthmann H, 2013, STROKE, V44, P2128, DOI 10.1161/STROKEAHA.113.001145; Wu H, 1999, DEVELOPMENT, V126, P3597; Wu XC, 1999, EXP PHYSIOL, V84, P917; Wu XC, 1999, CLIN SCI, V97, P413, DOI 10.1042/CS19990055; Xiong T, 2011, INT J DEV NEUROSCI, V29, P583, DOI 10.1016/j.ijdevneu.2010.12.007; Yeo EJ, 2008, ANN HEMATOL, V87, P11, DOI 10.1007/s00277-007-0359-6; Yu XB, 2002, DEVELOPMENT, V129, P505; Yu XB, 2001, BLOOD, V98, P475, DOI 10.1182/blood.V98.2.475; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816; Zhang L, 2010, PLOS ONE, V5	105	14	15	0	9	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2015	22	10					1205	1213		10.2174/0929867322666150114152134			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CD5WW	WOS:000351160400006	25620101	Green Accepted			2021-06-18	
J	Strizzi, J; Landa, LO; Pappadis, M; Olivera, SL; Tangarife, ERV; Agis, IF; Perrin, PB; Arango-Lasprilla, JC				Strizzi, Jenna; Landa, Laiene Olabarrieta; Pappadis, Monique; Leonor Olivera, Silvia; Valdivia Tangarife, Edgar Ricardo; Agis, Inmaculada Fernandez; Perrin, Paul B.; Carlos Arango-Lasprilla, Juan			Sexual Functioning, Desire, and Satisfaction in Women with TBI and Healthy Controls	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; FUNCTION INDEX FSFI; QUALITY-OF-LIFE; PSYCHOMETRIC VALIDATION; VERSION; MEN; QUESTIONNAIRE; INVENTORY; DYSFUNCTION; PREVALENCE	Traumatic brain injury (TBI) can substantially alter many areas of a person's life and there has been little research published regarding sexual functioning in women with TBI. Methods. A total of 58 women (29 with TBI and 29 healthy controls) from Neiva, Colombia, participated. There were no statistically significant differences between groups in sociodemographic characteristics. All 58 women completed the Sexual Quality of Life Questionnaire (SQoL), Female Sexual Functioning Index (FSFI), Sexual Desire Inventory (SDI), and the Sexual Satisfaction Index (ISS). Results. Women with TBI scored statistically significantly lower on the SQoL (p < 0.001), FSFI subscales of desire (p < 0.05), arousal (p < 0.05), lubrication (p < 0.05), orgasm (p < 0.05), and satisfaction (p < 0.05), and the ISS (p < 0.001) than healthy controls. Multiple linear regressions revealed that age was negatively associated with some sexuality measures, while months since the TBI incident were positively associated with these variables. Conclusion. These results disclose that women with TBI do not fare as well as controls in these measures of sexual functioning and were less sexually satisfied. Future research is required to further understand the impact of TBI on sexual function and satisfaction to inform for rehabilitation programs.	[Strizzi, Jenna; Agis, Inmaculada Fernandez] Univ Almeria, Dept Psychol, Almeria, Spain; [Landa, Laiene Olabarrieta; Carlos Arango-Lasprilla, Juan] Univ Deusto, Dept Psychol, Bilbao, Spain; [Pappadis, Monique] Univ Texas Med Branch, Sch Hlth Profess, Div Rehabil Sci, Galveston, TX 77555 USA; [Pappadis, Monique] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Leonor Olivera, Silvia; Valdivia Tangarife, Edgar Ricardo] Univ Surcolombiana, Fac Salud, Grp Invest Carlos Finlay, Neiva, Colombia; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci Ikerbasque, Bilbao, Spain	Arango-Lasprilla, JC (corresponding author), Univ Deusto, Dept Psychol, Bilbao, Spain.	jcarango@deusto.es	Landa, Laiene Olabarrieta/V-6207-2017; Pappadis, Monique/Q-8639-2016; Perrin, Paul/L-5373-2015	Landa, Laiene Olabarrieta/0000-0002-8305-8720; Pappadis, Monique/0000-0003-4742-4380; Perrin, Paul/0000-0003-2070-215X; Fernandez Agis, Inmaculada/0000-0002-3160-5569			Abraham L, 2008, J SEX MED, V5, P595, DOI 10.1111/j.1743-6109.2007.00749.x; Abraham L, 2009, J SEX MED, V6, P2244, DOI 10.1111/j.1743-6109.2009.01336.x; Aloni A, 2003, SEXUAL DIFFICULTIES; Carrobles JA, 2011, AN PSICOL-SPAIN, V27, P27; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Bellamkonda E, 2014, BRAIN INJURY, V28, P1063, DOI 10.3109/02699052.2014.896473; Blümel M Juan Enrique, 2004, Rev. chil. obstet. ginecol., V69, P118; Burri A, 2010, J SEX MED, V7, P3929, DOI 10.1111/j.1743-6109.2010.01970.x; Christopher FS, 2000, J MARRIAGE FAM, V62, P999, DOI 10.1111/j.1741-3737.2000.00999.x; Crowe SF, 1999, BRAIN INJURY, V13, P347; DAVIS CM, 1998, HDB SEXUALITY RELATE; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; Goldin Y, 2014, J HEAD TRAUMA REHAB, V29, P418, DOI 10.1097/HTR.0b013e31829cf76d; Gutierrez P, 2009, J SEX MED, V6, P2698, DOI 10.1111/j.1743-6109.2009.01315.x; Guzick DS, 2011, FERTIL STERIL, V95, P1568, DOI 10.1016/j.fertnstert.2011.01.027; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Iglesias P. S., 2009, INT J PSYCHOL PSYCHO, V9, P259, DOI DOI 10.1080/00224499.2013.816261; King BE, 2000, PSYCHOL REP, V86, P347, DOI 10.2466/pr0.2000.86.1.347; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Larson JH, 1998, J SEX MARITAL THER, V24, P193, DOI 10.1080/00926239808404933; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Masel B.S., 2015, J NEUROTRAUMA; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ortega V, 2006, PSYCHOL REP, V99, P147, DOI 10.2466/PR0.99.1.147-165; Pacagnella RD, 2009, CAD SAUDE PUBLICA, V25, P2333; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Sandel ME, 2007, BRAIN INJURY MED PRI, P637; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sidi H, 2007, J SEX MED, V4, P1642, DOI 10.1111/j.1743-6109.2007.00476.x; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Sun XG, 2011, J SEX MED, V8, P1101, DOI 10.1111/j.1743-6109.2010.02171.x; Symonds T, 2005, J SEX MARITAL THER, V31, P385, DOI 10.1080/00926230591006502; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; Wielinski CL, 2010, J SEX MED, V7, P1438, DOI 10.1111/j.1743-6109.2009.01408.x	43	14	14	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								247479	10.1155/2015/247479			7	Clinical Neurology	Neurosciences & Neurology	CW0MT	WOS:000364684300001	26556951	DOAJ Gold, Green Published			2021-06-18	
J	Woodacre, T; Waydia, SE; Wienand-Barnett, S				Woodacre, Timothy; Waydia, Shree Eesh; Wienand-Barnett, Sophie			Aetiology of injuries and the need for protective equipment for surfers in the UK	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Surfing injuries; Trauma; Accident prevention; Emergency medical services; UK	SURFING INJURIES; RIDERS	Background: Surfing is a popular UK water-sport. Previous studies investigating surfing injuries have been principally based on trauma from large waves and reef breaks in the US and Australia. Subsequent conclusions and recommendations for the use of protective equipment in surfing may therefore not be relevant in the UK. Aims: This study examines the aetiology of surfing injuries in the UK. Methods: Data was collected in 2012 using a web-based survey distributed to UK surfing clubs. Surfers recorded time/experience as a surfer, number of episodes spent surfing per month, different breaks surfed and type, frequency and method of any injuries sustained whilst surfing in the UK, including treatment received. Results: Completed surveys were obtained from 130 individuals, M:F division 85: 45, median age 28 (range 17-65). 122 surfers reported a total of 335 injuries. Head injuries were the most common (24%) followed by ankle (19%), knee (13%), back (10%), hand/wrist (9%), elbow/shoulder (7%), trunk (7%), neck (4%), hip (4%) and genitalia (3%) injuries. Surfers collided most often with their own boards (31%). The other collisions were with rocks/coral (15%), the sea (11%), other surf boards (10%) the sea bed (7%), other water vessels (2%) and by paddle-boards (1%). Of 327 injuries, cuts/lacerations (31%) were the commonest type of injury, followed by bruises/peri-orbital ecchymoses (24%), joint/ligament sprains (15%), muscle or tendon tears/ruptures (9%), concussion (5%), fractures (3%) and teeth injuries (1%). The remaining 8 injuries were not categorized. 65% of the surfers never required professional medical treatment for their differing injuries. There were no skull fractures and no head injuries required neurosurgical intervention. Conclusion: Surfing injuries in the UK are common. They appear of a similar aetiology to those reported in the literature in countries with a high surfing population, but generally of a lower severity, with few requiring professional treatment, hospital admission or operative intervention. Concussion appears rare and in this study there were no head injuries that required neurosurgical intervention. Surfing helmets aim to prevent such serious head injuries; whilst they should be considered for injury prevention their routine use is unlikely to be warranted whilst surfing in the UK. (C) 2014 Elsevier Ltd. All rights reserved.	[Woodacre, Timothy; Waydia, Shree Eesh; Wienand-Barnett, Sophie] Royal Cornwall Hosp, Truro TR1 3LJ, Cornwall, England	Woodacre, T (corresponding author), Royal Cornwall Hosp, Dept Trauma & Orthopaed, Truro TR1 3LJ, Cornwall, England.	timwoodacre@yahoo.co.uk					ALLEN RH, 1977, JAMA-J AM MED ASSOC, V237, P668, DOI 10.1001/jama.237.7.668; British Marine Federation, 2007, BMF WAT SPORT LEIS P; Fitzjones O, 1998, STORMRIDER GUIDE EUR, P2; Hay CSM, 2009, WILD ENVIRON MED, V20, P335, DOI 10.1580/1080-6032-020.004.0335; LOWDON BJ, 1983, MED J AUSTRALIA, V2, P613, DOI 10.5694/j.1326-5377.1983.tb122722.x; Nathanson A, 2002, AM J EMERG MED, V20, P155, DOI 10.1053/ajem.2002.32650; Nathanson A, 2007, AM J SPORT MED, V35, P113, DOI 10.1177/0363546506293702; Pikora TJ, 2012, MED SPORT SCI, V58, P80, DOI 10.1159/000338583; Royal Life Saving Society Australia, 2012, NAT DROWN REP; Taylor DM, 2005, WILD ENVIRON MED, V16, P75, DOI 10.1580/1080-6032(2005)16[75:POSRRT]2.0.CO;2; Taylor DM, 2004, J SCI MED SPORT, V7, P429, DOI 10.1016/S1440-2440(04)80260-3	11	14	15	0	21	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2015	46	1					162	165		10.1016/j.injury.2014.07.019			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AX1YJ	WOS:000346739600030	25173670				2021-06-18	
J	Douglas, JM; Knox, L; De Maio, C; Bridge, H				Douglas, Jacinta M.; Knox, Lucy; De Maio, Carren; Bridge, Helen			Improving Communication-specific Coping after Traumatic Brain Injury: Evaluation of a New Treatment using Single-case Experimental Design	BRAIN IMPAIRMENT			English	Article						brain injury; rehabilitation; communication; coping; treatment; evaluation	SOCIAL INTEGRATION; FACIAL EXPRESSION; N-OF-1 TRIALS; RATING-SCALE; FOLLOW-UP; QUESTIONNAIRE; DISCOURSE; OUTCOMES; ABILITY; SKILLS	Background and aims: Impaired communication is a well-documented and enduring consequence of traumatic brain injury (TBI). As a result of this impairment, people with TBI frequently experience communication breakdown and associated stress. Typically, we use communication-specific coping strategies in situations characterised by communication breakdown. Productive strategies enhance message transfer; non-productive strategies do little to resolve problems and frequently result in negative social interaction. This research aimed to evaluate the effectiveness of a new treatment, Communication-specific Coping Intervention (CommCope-I), which specifically targets coping in the context of communication breakdown. Method: Single-case experimental design (A-B-A with follow-up using multiple probes) across two participants was used. Participants were Samantha, a 30-year-old woman who had sustained severe TBI 8 years previously, and Thomas, a 34-year-old man who had sustained severe TBI when he was 29 years old. CommCope-I is a 6-week programme which targets personally relevant productive coping strategies identified collaboratively with the client. Productive coping scripts are developed and practised through a series of graded scenarios that are evaluated with the aid of video recording. Results: Percentage of non-overlapping corrected data (PNCD) was used to analyse the results. PNCD involves a data-correction procedure to remove baseline trend from the data series prior to calculating the change produced as a result of intervention. A large treatment effect was demonstrated in both participants (PNCD: end of treatment Samantha = 100%, Thomas = 100%, 3-month follow-up Samantha = 100%, Thomas = 100%). These results are consistent with highly effective treatment. Conclusions: This study provides sound phase-1 evidence for the effectiveness of CommCope-I.	[Douglas, Jacinta M.; Knox, Lucy; De Maio, Carren; Bridge, Helen] La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic 3086, Australia; [Douglas, Jacinta M.] Summer Fdn, Melbourne, Vic, Australia; [De Maio, Carren] Scope, Box Hill, Vic, Australia; [Bridge, Helen] Beachside & South Eastern Suburbs Speech Pathol S, Melbourne, Vic, Australia	Douglas, JM (corresponding author), La Trobe Univ, Dept Human Commun Sci, Bundoora, Vic 3086, Australia.	J.Douglas@latrobe.edu.au	Knox, Lucy/E-8642-2013	Knox, Lucy/0000-0001-8331-6032; Douglas, Jacinta/0000-0003-0940-6624	Victoria Neurotrauma Initiative of the Transport Accident Commission, Victoria, Australia [D071]	This research was funded by the Victoria Neurotrauma Initiative of the Transport Accident Commission, Victoria, Australia (grant no. D071).	Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-1021, 10.3233/WOR-2010-01021]; Bracy C. A., 2005, BRAIN IMPAIR, V6, P1, DOI [10.1375/brim.6.1.1.65476., DOI 10.1375/BRIM.6.1.1.65476, DOI 10.1375/brim.6.1.1.65476]; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Crice P., 1975, STUDIES SYNTAX SEMAN, V3, P41; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DOUGLAS J, 2004, EVIDENCE BASED PRACT; Douglas J., 2012, BRAIN IMPAIR, V13, P170; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Friedman A., 2005, BRAIN INJURY S, V19, P50; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Manolov R, 2009, BEHAV RES METHODS, V41, P1262, DOI 10.3758/BRM.41.4.1262; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Mellick D., 2000, CRAIG HANDICAP ASSES; Mitchell C., 2011, BRAIN IMPAIRMENT S, V41; Muir A., 2007, BRAIN IMPAIR, V8, P83; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Scruggs TE, 1998, BEHAV MODIF, V22, P221, DOI 10.1177/01454455980223001; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P235; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	44	14	14	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2014	15	3					190	201		10.1017/BrImp.2014.25			12	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CC2NV	WOS:000350182800003					2021-06-18	
J	Gardizi, E; Hanks, RA; Millis, SR; Figueroa, MJ				Gardizi, Elmar; Hanks, Robin A.; Millis, Scott R.; Figueroa, Maritza J.			Comorbidity and Insurance as Predictors of Disability After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Comorbidity; Insurance; Rehabilitation; Traumatic brain injury	PHYSICAL-ACTIVITY; RATING-SCALE; HEAD-INJURY; REHABILITATION; COMPLICATIONS; OUTCOMES; TRACHEOTOMY; HYPOTHERMIA; DISORDERS; DISEASE	Objective: To examine the unique contribution of self-reported medical comorbidity and insurance type on disability after traumatic brain injury (TBI). Design: Inception cohort design at 1-year follow up. Setting: A university affiliated rehabilitation hospital. Participants: Adults with mild-complicated to severe TBI (N=70). Intervention: Not applicable. Main Outcome Measures: Self-reported medical comorbidities were measured using the Modified Cumulative Illness Rating Scale, while insurance type was classified as commercial or government-funded; disability was measured using the Disability Rating Scale. Results: Two models were run using multiple linear regression, and the best-fitting model was selected on the basis of Bayesian information criterion. The full model, which included self-reported medical comorbidity and insurance type, was significantly better fitting than the reduced model. Participants with a longer duration of posttraumatic amnesia, more self-reported medical comorbidities, and government insurance were more likely to have higher levels of disability. Meanwhile, individual organ systems were not predictive of disability. Conclusions: The cumulative effect of self-reported medical comorbidities and type of insurance coverage predict disability above and beyond well-known prognostic variables. Early assessment of medical complications and improving services provided by government-funded insurance may enhance quality of life and reduce long-term health care costs. (C) 2014 by the American Congress of Rehabilitation Medicine	[Gardizi, Elmar] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; [Hanks, Robin A.; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Figueroa, Maritza J.] Nexus Hlth Syst, Touchstone Neurorecovery Ctr, Conroe, TX USA	Gardizi, E (corresponding author), Univ Windsor, Dept Psychol, Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	gardizi@uwindsor.ca			US Department of Education-National Institute of Disability Research and RehabilitationUS Department of Education [H133A020515]	Supported by the US Department of Education-National Institute of Disability Research and Rehabilitation (grant no. H133A020515).	Adelmann PK, 2003, ADM POLICY MENT HLTH, V31, P111, DOI 10.1023/B:APIH.0000003017.78877.56; [Anonymous], 2012, CHOIC OLD DIS PERS W; Bassuk SS, 2005, J APPL PHYSIOL, V99, P1193, DOI 10.1152/japplphysiol.00160.2005; Benumof J, 2007, BENUMOFS AIRWAY MANA; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bihari M, 2010, HMOS VS PPOS WHAT AR; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Chan L, 2000, ARCH PHYS MED REHAB, V81, P715, DOI 10.1016/S0003-9993(00)90098-4; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Corrigan JD, 2011, J HEAD TRAUMA REHAB, V26, P1; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Faul M, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Giaquinto S, 2001, DISABIL REHABIL, V23, P296; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Liou TH, 2005, NUTR REV, V63, P321, DOI [10.1111/j.1753-4887.2005.tb00110.x, 10.1301/nr.2005.oct.321.331]; Lucas JA, 2009, CLIN NEUROPSYCHOLOGY, P351; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Nirula R, 2009, J TRAUMA, V66, P255, DOI 10.1097/TA.0b013e31815ede46; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Orman JA, 2011, TXB TRAUMATIC BRAIN, V2nd, P3; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Raftery AE, 1996, BIOMETRIKA, V83, P251, DOI 10.1093/biomet/83.2.251; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Retchin SM, 1997, JAMA-J AM MED ASSOC, V278, P119; Richard I, 2005, ANN FR ANESTH, V24, P659, DOI 10.1016/j.annfar.2005.03.010; Rimmer James H, 2005, Phys Med Rehabil Clin N Am, V16, P41, DOI 10.1016/j.pmr.2004.06.013; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; Stevens J., 1986, APPL MULTIVARIATE ST; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tabachnick B.G., 1989, USING MULTIVARIATE S; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Zafonte RD, 2002, J HEAD TRAUMA REHAB, V17, P322, DOI 10.1097/00001199-200208000-00006	53	14	14	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2014	95	12					2396	2401		10.1016/j.apmr.2014.06.004			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AW0AY	WOS:000345954000022	24972339				2021-06-18	
J	Heinzelmann, M; Lee, H; Rak, H; Livingston, W; Barr, T; Baxter, T; Scattergood-Keepper, L; Mysliwiec, V; Gill, J				Heinzelmann, Morgan; Lee, Hyunhwa; Rak, Hannah; Livingston, Whitney; Barr, Taura; Baxter, Tristin; Scattergood-Keepper, Lindsay; Mysliwiec, Vincent; Gill, Jessica			Sleep restoration is associated with reduced plasma C-reactive protein and depression symptoms in military personnel with sleep disturbance after deployment	SLEEP MEDICINE			English	Article						CRP; Inflammation; Depression; HRQOL; Military; PTSD; IL-6	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; IMMUNE ACTIVATION; HEART-DISEASE; PTSD; INFLAMMATION; MORTALITY; BIOMARKERS; VETERANS; INCREASE	Background: Deployed military personnel are vulnerable to chronic sleep disturbance, which is highly comorbid with post-traumatic stress disorder (PTSD) and depression, as well as declines in health related quality of life (HRQOL). Inflammation is associated with HRQOL declines and sleep-related comorbidities; however, the impact of sleep changes on comorbid symptoms and inflammation in this population is unknown. Methods: In this observational study, we examined the relationship between reported sleep changes and concentrations of inflammatory biomarkers, interleukin 6 (IL-6), and C-reactive protein (CRP) in peripheral blood. The sample was dichotomized into two groups: (1) decrease in Pittsburgh Sleep Quality Index (PSQI; restorative sleep) and (2) no change or increase in PSQI (no change). Mixed between-within subjects analysis of variance tests were used to determine group differences on changes of inflammation and comorbid symptoms. Results: In our sample of 66 recently deployed military personnel with insomnia, 34 participants reported restorative sleep whereas 32 reported no sleep changes. The two groups did not differ in demographic or clinical characteristics, with the exception of PTSD diagnosis at baseline. The restorative sleep group had significant reductions in CRP concentrations and depression symptoms, as well as reduced fatigue and improvements in emotional well-being, social functioning, and physical functioning at follow-up. Conclusions: Military personnel who report sleep restoration after deployment have reduced CRP concentrations, decreased severity of depression, and improved HRQOL. These findings suggest that treatment for sleep disturbances may be associated with improvements in mental and physical health, thereby supporting continued study in this line of research. (C) 2014 Elsevier B.V. All rights reserved.	[Heinzelmann, Morgan; Rak, Hannah; Livingston, Whitney; Scattergood-Keepper, Lindsay; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Lee, Hyunhwa] Univ Nevada, Las Vegas, NV 89154 USA; [Barr, Taura] W Virginia Univ, Morgantown, WV 26506 USA; [Baxter, Tristin; Mysliwiec, Vincent] Madigan Army Med Ctr, Tacoma, WA 98431 USA	Lee, H (corresponding author), Univ Nevada, 4505 Maryland Pkwy,Box 453018, Las Vegas, NV 89154 USA.	hyunhwa.lee@unlv.edu	Gill, Gill M/Q-2020-2017	Heinzelmann, Morgan/0000-0002-4399-6229; Lee, Hyunhwa/0000-0002-5625-3141	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027] Funding Source: NIH RePORTER	This study was funded, in part, by the Center for Neuroscience and Regenerative Medicine (Grant 60855). Additionally, Taura Barr is a 2012 Robert Wood Johnson Foundation Nurse Faculty Scholar.	Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Aversa LH, 2013, QUAL LIFE RES, V22, P1381, DOI 10.1007/s11136-012-0280-x; Axelsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082291; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Boscarino JA, 2010, PSYCHOSOM MED, V72, P481, DOI 10.1097/PSY.0b013e3181d9a80c; Bot M, 2011, J PSYCHOSOM RES, V71, P13, DOI 10.1016/j.jpsychores.2010.11.006; Boyko EJ, 2010, DIABETES CARE, V33, P1771, DOI 10.2337/dc10-0296; Britt TW, 2007, MIL MED, V172, P157, DOI 10.7205/MILMED.172.2.157; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capuron L, 2001, PSYCHONEUROENDOCRINO, V26, P797, DOI 10.1016/S0306-4530(01)00030-0; Chennaoui M, 2011, CYTOKINE, V56, P318, DOI 10.1016/j.cyto.2011.06.002; Edwards RD, 2010, NATL BUREAU EC RES W; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; FERRER CF, 1995, AVIAT SPACE ENVIR MD, V66, P571; Germain A, 2012, J PSYCHOSOM RES, V72, P89, DOI 10.1016/j.jpsychores.2011.11.010; Gill J, 2010, BIOL PSYCHIAT, V68, P999, DOI 10.1016/j.biopsych.2010.07.033; Gill JM, 2013, J PSYCHOSOM RES, V74, P301, DOI 10.1016/j.jpsychores.2012.10.013; GILL JS, 2014, BJU INT S, V113, P2; Grandner MA, 2013, SLEEP, V36, P769, DOI 10.5665/sleep.2646; Hamer M, 2011, BRAIN BEHAV IMMUN, V25, P168, DOI 10.1016/j.bbi.2010.09.013; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Laugsand LE, 2012, PSYCHOSOM MED, V74, P543, DOI 10.1097/PSY.0b013e31825904eb; Lopresti AL, 2014, PROG NEURO-PSYCHOPH, V48, P102, DOI 10.1016/j.pnpbp.2013.09.017; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; Maes M, 2012, PROG NEURO-PSYCHOPH, V36, P169, DOI 10.1016/j.pnpbp.2011.09.006; Miller NL, 2010, SLEEP, V33, P1623, DOI 10.1093/sleep/33.12.1623; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Office of the Surgeon General United States Army Medical Command, 2011, JOINT MENT HLTH ADV; Paulus EJ, 2013, J TRAUMA STRESS, V26, P169, DOI 10.1002/jts.21785; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Phillips AC, 2009, PSYCHOSOM MED, V71, P395, DOI 10.1097/PSY.0b013e31819e6706; Pizzi C, 2009, CLIN PHARMACOL THER, V86, P527, DOI 10.1038/clpt.2009.121; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Rusiecki Jennifer A, 2013, Front Psychiatry, V4, P56, DOI 10.3389/fpsyt.2013.00056; Scherrer JF, 2010, AM HEART J, V159, P772, DOI 10.1016/j.ahj.2010.02.033; Shanahan L, 2014, PSYCHONEUROENDOCRINO, V40, P76, DOI 10.1016/j.psyneuen.2013.10.019; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wium-Andersen MK, 2013, JAMA PSYCHIAT, V70, P176, DOI 10.1001/2013.jamapsychiatry.102; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Xue Y, 2012, AM J CARDIOL, V109, P1215, DOI 10.1016/j.amjcard.2011.11.063; Zen AL, 2012, HEALTH PSYCHOL, V31, P194, DOI 10.1037/a0025989	48	14	16	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	DEC	2014	15	12					1565	1570		10.1016/j.sleep.2014.08.004			6	Clinical Neurology	Neurosciences & Neurology	AW1YG	WOS:000346084100020	25311836				2021-06-18	
J	Pasiali, V; LaGasse, AB; Penn, SL				Pasiali, Varvara; LaGasse, A. Blythe; Penn, Saundra L.			The Effect of Musical Attention Control Training (MACT) on Attention Skills of Adolescents with Neurodevelopmental Delays: A Pilot Study	JOURNAL OF MUSIC THERAPY			English	Article						attention; autism spectrum disorders; music therapy; neurodevelopmental disorder	TRAUMATIC BRAIN-INJURY; SPECTRUM DISORDERS; CHILDREN; AUTISM; PERFORMANCE; NETWORKS; DEFICITS; THERAPY; ADHD; RESPONSIVENESS	Background: Given the effect of musical training on the rate and accuracy of processing auditory information, therapeutic uses of music may potentially have remedial benefits for individuals with neurodevelopmental deficits. However, additional studies are needed to establish efficacy of music therapy interventions for attention skills in children/adolescents with neurodevelopmental disabilities including those with Autism Spectrum Disorders (ASD). Objective: To establish feasibility and preliminary efficacy of a group music therapy protocol to improve attention skills (sustained, selective, attentional control/switching) in adolescents diagnosed with autism and/or developmental delays. Methods: This single group pretest/posttest study took place in a private school for high functioning adolescents with neurodevelopmental delays. Nine students (4 males, 5 females), ages 13 to 20, participated in the study. Autism severity was assessed using the CARS2-HF and indicated the following distribution for study participants: severe (n = 3), mild (n = 4), or minimal/no (n = 2) symptoms. We assessed feasibility of implementing a 45-min Musical Attention Control Training (MACT) intervention delivered by a board-certified music therapist eight times over 6 weeks in a school setting. We also examined preliminary efficacy of the MACT to improve attention skills using the Test of Everyday Attention for Children (TEA-Ch). Results: Parental consent rate was 100%. All nine participants successfully completed testing measures and 6 weeks of the intervention. Average participation rate was 97%. Data analysis showed positive trends and improvements on measures of attentional control/switching and selective attention. Conclusions: The results showed that the intervention and testing measures were feasible to implement and acceptable to the participants who all completed the protocol. Data analysis demonstrated positive trends indicating that more research on the use of music therapy attention training in high-functioning adolescents with neurodevelopmental disabilities is warranted.	[Pasiali, Varvara; Penn, Saundra L.] Queens Univ Charlotte, Charlotte, NC 28274 USA; [LaGasse, A. Blythe] Colorado State Univ, Ft Collins, CO 80523 USA	Pasiali, V (corresponding author), Queens Univ Charlotte, 1900 Selwyn Ave, Charlotte, NC 28274 USA.	pasialiv@queens.edu	LaGasse, Blythe/AAB-9517-2021				Abikoff H, 1996, J LEARN DISABIL, V29, P238, DOI 10.1177/002221949602900302; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Ames C, 2010, DEV REV, V30, P52, DOI 10.1016/j.dr.2009.12.003; Belmonte M. K., 2000, AUTISM, V4, P269, DOI DOI 10.1177/1362361300004003004; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Brabender VA, 2004, ESSENTIALS GROUP THE; Carnahan C., 2009, ED TREATMENT CHILDRE, V32, P37, DOI [10.1353/etc.0.0047, DOI 10.1353/ETC.0.0047]; Ceccato E., 2006, NORD J MUSIC THER, V15, P110, DOI [10.1080/08098130609478158, DOI 10.1080/08098130609478158]; Ceccato E, 2012, AM J ALZHEIMERS DIS, V27, P301, DOI 10.1177/1533317512452038; DeBedout JK, 2006, J MUSIC THER, V43, P123, DOI 10.1093/jmt/43.2.123; Fan J, 2012, BRAIN BEHAV, V2, P647, DOI 10.1002/brb3.90; Finnigan E, 2010, AUTISM, V14, P321, DOI 10.1177/1362361309357747; Gagnon LG, 2012, NEUROPSYCHOL REHABIL, V22, P809, DOI 10.1080/09602011.2012.691044; Gardiner, 2005, RHYTHM MUSIC BRAIN, P179; Geist K., 2008, YOUNG CHILDREN, V63, P20; Geist K, 2012, MUSIC THER PERSPECT, V30, P141, DOI 10.1093/mtp/30.2.141; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; Ivanov I, 2012, BRAIN BEHAV, V2, P741, DOI 10.1002/brb3.80; Jeong E, 2011, J MUSIC THER, V48, P551, DOI 10.1093/jmt/48.4.551; Kalas A, 2012, J MUSIC THER, V49, P430, DOI 10.1093/jmt/49.4.430; Kim J, 2009, AUTISM, V13, P389, DOI 10.1177/1362361309105660; Kinnealey M, 2012, AM J OCCUP THER, V66, P511, DOI 10.5014/ajot.2012.004010; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Manly T., 1999, TEST EVERY DAY ATTEN; Montgomery J, 2011, INT J REHABIL RES, V34, P330, DOI 10.1097/MRR.0b013e32834a8fa8; Mueller C., 2013, THESIS COLORADO; Ouellet S., 2012, CANADIAN J MUSIC THE, V18, P79; Padmala S, 2011, J COGNITIVE NEUROSCI, V23, P3419, DOI 10.1162/jocn_a_00011; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ravizza SM, 2013, DEV PSYCHOPATHOL, V25, P773, DOI 10.1017/S0954579413000163; Reitman M., 2006, DISS ABSTR INT, V66; Robb SL, 2003, J MUSIC THER, V40, P266, DOI 10.1093/jmt/40.4.266; Sanders J, 2008, RES AUTISM SPECT DIS, V2, P1, DOI 10.1016/j.rasd.2007.03.005; Schopler E, 2010, CHILDHOOD AUTISM RAT; Shalev L, 2007, CHILD NEUROPSYCHOL, V13, P382, DOI 10.1080/09297040600770787; STANDLEY JM, 1996, MUSIC THERAPY PERSPE, V14, P87, DOI DOI 10.1093/MTP/14.2.87; Strait DL, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00113; Strait DL, 2010, HEARING RES, V261, P22, DOI 10.1016/j.heares.2009.12.021; Sussman JE, 2009, J MUSIC THER, V46, P53, DOI 10.1093/jmt/46.1.53; Thaut M., 2005, RHYTHM MUSIC BRAIN; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Wigram T, 2006, CHILD CARE HLTH DEV, V32, P535, DOI 10.1111/j.1365-2214.2006.00615.x; Wigram T., 2009, COMMUNICATIVE MUSICA, P423; Wolfe DE, 2009, J MUSIC THER, V46, P69, DOI 10.1093/jmt/46.1.69; [徐梦燕 Xu Mengyan], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P696	45	14	14	2	57	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	WIN	2014	51	4					333	354		10.1093/jmt/thu030			22	Music; Rehabilitation	Music; Rehabilitation	CA1SQ	WOS:000348692200003	25504177				2021-06-18	
J	Rowell, SE; Barbosa, RR; Lennox, TC; Fair, KA; Rao, AJ; Underwood, SJ; Schreiber, MA				Rowell, Susan E.; Barbosa, Ronald R.; Lennox, Tori C.; Fair, Kelly A.; Rao, Abigail J.; Underwood, Samantha J.; Schreiber, Martin A.			Moderate elevations in international normalized ratio should not lead to delays in neurosurgical intervention in patients with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	44th Annual Meeting of the Western-Trauma-Association	MAR 02-07, 2014	Steamboat Springs, CO	Western Trauma Assoc		Traumatic brain injury; thrombelastography; time to intervention; coagulopathy	FROZEN PLASMA TRANSFUSION; PROTHROMBIN TIME; COAGULATION; THROMBELASTOGRAPHY; COAGULOPATHY; TESTS	BACKGROUND: The management of severe traumatic brain injury (TBI) frequently involves invasive intracranial monitoring or cranial surgery. In our institution, intracranial procedures are often deferred until an international normalized ratio (INR) of less than 1.4 is achieved. There is no evidence that a moderately elevated INR is associated with increased risk of bleeding in patients undergoing neurosurgical intervention (NI). Thrombelastography (TEG) provides a functional assessment of clotting and has been shown to better predict clinically relevant coagulopathy compared with INR. We hypothesized that in patients with TBI, an elevated INR would result in increased time to NI and would not be associated with coagulation abnormalities based on TEG. METHODS: A secondary analysis of prospectively collected data was performed in trauma patients with intracranial hemorrhage that underwent NI (defined as cranial surgery or intracranial pressure monitoring) within 24 hours of arrival. Time from admission to NI was recorded. TEG and routine coagulation assays were obtained at admission. Patients were considered hypocoagulable based on INR if their admission INR was greater than 1.4 (high INR). Manufacturer-specified values were used to determine hypocoagulability for each TEG variable. RESULTS: Sixty-one patients (median head Abbreviated Injury Scale EATS] score, 5) met entry criteria, of whom 16% had high INR. Demographic, physiologic, and injury scoring data were similar between groups. The median time to NI was longer in patients with high INR (358 minutes vs. 184 minutes, p = 0.027). High-INR patients were transfused more plasma than patients with an INR of 1.4 or less (2 U vs. 0 U, p = 0.01). There was no association between an elevated INR and hypocoagulability based on TEG. CONCLUSION: TBI patients with an admission INR of greater than 1.4 had a longer time to NI. The use of plasma transfusion to decrease the INR may have contributed to this delay. A moderately elevated INR was not associated with coagulation abnormalities based on TEG. Routine plasma transfusion to correct a moderately elevated INR before NI should be reexamined. (Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Rowell, Susan E.; Lennox, Tori C.; Fair, Kelly A.; Underwood, Samantha J.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA; [Rao, Abigail J.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97239 USA; [Barbosa, Ronald R.] Legacy Emanuel Hosp & Hlth, Trauma Serv, Portland, OR USA	Rowell, SE (corresponding author), Oregon Hlth & Sci Univ, Dept Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rowells@ohsu.edu	Rowell, Susan/S-7480-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000128] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12 HL108974] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [5K12HLK108974-03] Funding Source: Medline		Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; Barton JS, 2013, HPB, V15, P865, DOI 10.1111/hpb.12051; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2006, NEUROSURGERY, V58, pS7, DOI 10.1227/01.NEU.0000210365.36914.E3; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Dzik WH, 2009, ROSSIS PRINCIPLES TR; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Holland L, 2006, CURR OPIN HEMATOL, V13, P447, DOI 10.1097/01.moh.0000245688.47333.b6; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Kim BS, 2008, NEUROSURGICAL EMERGE; Kumar M, 2013, CONSULTATIVE HEMOSTA; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; McCully SP, 2013, J TRAUMA ACUTE CARE, V75, P947, DOI 10.1097/TA.0b013e3182a9676c; National Institute for Health and Clinical Excellence, 2010, HEAD INJ QUICK REF; Osterud B, 1997, THROMB HAEMOSTASIS, V78, P755; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Schochl H, 2013, J TRAUMA ACUTE CARE, V74, P1587, DOI 10.1097/TA.0b013e31828c3171; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; West KL, 2011, J NEUROSURG, V114, P9, DOI 10.3171/2010.7.JNS091857; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53	30	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2014	77	6					846	850		10.1097/TA.0000000000000459			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AU8EE	WOS:000345828500010	25423533	Green Accepted			2021-06-18	
J	Salentijn, EG; Collin, JD; Boffano, P; Forouzanfar, T				Salentijn, Erik G.; Collin, John D.; Boffano, Paolo; Forouzanfar, Tymour			A ten year analysis of the traumatic maxillofacial and brain injury patient in Amsterdam: Complications and treatment	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Maxillofacial; Trauma; Brain; Injury; Complications; Treatment	FACIAL FRACTURES; MANAGEMENT; CHILDREN; REPAIR	Maxillofacial trauma is often associated with injuries to the cranium, especially in high-energy trauma. The management of such cases can be challenging and requires close cooperation between oral and maxillofacial surgery and neurosurgical teams. There are few reports in the current literature describing the complications that develop in patients with maxillofacial trauma and traumatic brain injury (TBI).Complications can be categorized as early or late and/or minor and major. The exact definition of complications and their categorization remains a matter of current debate. We present a 10 year retrospective study of complications and their subsequent management in patients receiving maxillofacial and neurosurgical treatment for maxillofacial trauma associated with TBI. The study population consisted of 47 people, excluded from a maxillofacial trauma population of 579 patients. The severity of the trauma was scored as mild, moderate or severe, using the Glasgow Coma Scale at presentation of the Emergency Department. In total 36 patients (76.6%) developed complications. Patients involved in road traffic collision were most likely to develop complications (92.3%). This was followed by falls (66.7%) as mechanism of the injury. Patients aged 60-69 years experienced the highest complication rate (5), followed by patients aged 20-29 years (4.1) and 30-39 years (3.5). The majority of complications were infection and inflammation (36.4%), followed by neurological deficit (24.0%), physiological dysregulation (11.6%) and facial bone deformity (8.3%). Patients who developed no complications, most often presented with mild TBI (72.7%). The most common treatment modality employed to manage complications was pharmacological, followed by antibiotic treatment, conservative treatment and decompression therapy. The mean hospital stay after the trauma for the patients with complications was 28 days. Thirteen patients (36.1%) were transferred to a rehabilitation centre, a nursing home, or a home for the elderly. Nine patients (25%) completely recovered from their complications and 4 patients (11.1%) died after the trauma. This report provides useful data concerning the rate and type of complications that occur, and the multidisciplinary treatment that is required in traumatic maxillofacial and brain injury patients. c 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Salentijn, Erik G.; Boffano, Paolo; Forouzanfar, Tymour] Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam, Dept Oral & Maxillofacial Surg Oral Pathol, NL-1007 MB Amsterdam, Netherlands; [Collin, John D.] Bristol Dent Hosp, Dept Oral & Maxillofacial Surg, Bristol BS2 1LY, Avon, England	Salentijn, EG (corresponding author), Vrije Univ Amsterdam Med Ctr, Acad Ctr Dent Amsterdam, Dept Oral & Maxillofacial Surg Oral Pathol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	e.salentijn@vumc.nl	Boffano, Paolo/J-1094-2016	Boffano, Paolo/0000-0002-0782-9933			Bogusiak K, 2010, J CRANIOFAC SURG, V21, P1018, DOI 10.1097/SCS.0b013e3181e62e47; BRANDT KE, 1991, J TRAUMA, V31, P15, DOI 10.1097/00005373-199101000-00003; Calderoni DR, 2010, J CRANIOMAXILLOFAC S, V39, P593; Cannon DE, 2012, AM J OTOLARYNG, V33, P615, DOI 10.1016/j.amjoto.2011.12.003; Clauser L, 2004, CHILD NERV SYST, V20, P168, DOI 10.1007/s00381-003-0868-0; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Fishman G, 2009, CHILD NERV SYST, V25, P915, DOI 10.1007/s00381-009-0887-6; Giuliani G., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P100; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Kanowitz SJ, 2006, INT J PEDIATR OTORHI, V70, P2087, DOI 10.1016/j.ijporl.2006.08.007; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; KAUFMAN MS, 1984, J ORAL MAXIL SURG, V42, P250, DOI 10.1016/0278-2391(84)90457-9; Lee TT, 1998, J TRAUMA, V44, P665, DOI 10.1097/00005373-199804000-00018; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Salentijn EG, 2012, J CRANIOMAXILLOFAC S, V41, P630; Salentijn EG, 2014, J CRANIO MAXILL SURG, V42, P705, DOI 10.1016/j.jcms.2013.12.008; Shibuya TY, 2007, J ORAL MAXIL SURG, V65, P1693, DOI 10.1016/j.joms.2006.06.309; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; van den Bergh B, 2012, J CRANIO MAXILL SURG, V40, pE165, DOI 10.1016/j.jcms.2011.08.006	21	14	14	0	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1717	1722		10.1016/j.jcms.2014.06.005			6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200031	25176495				2021-06-18	
J	Lee, YK; Lee, CW; Huang, MY; Hsu, CY; Su, YC				Lee, Yi-Kung; Lee, Chen-Wen; Huang, Ming-Yuan; Hsu, Chen-Yang; Su, Yung-Cheng			Increased risk of ischemic stroke in patients with mild traumatic brain injury: a nationwide cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Stroke; Traumatic brain injury; National health insurance	LOGISTIC-REGRESSION MODELS; PROPORTIONAL HAZARDS; OUTCOMES; EPIDEMIOLOGY; DISEASE; ADULTS	Background: It is known that the risk of stroke in patients with traumatic brain injury might be increased. However, the relationship between mild traumatic brain injury and ischemic stroke has never been established. We conducted a study of patients in Taiwan with mild traumatic brain injury to evaluate if they had a higher risk of stroke compared with the general population. Methods: We utilized a sampled National Health Insurance claims database containing one million beneficiaries. We followed all adult beneficiaries older than 18 years from January 1, 2007 to December 31, 2010 to determine if they were diagnosed with ischemic stroke. We further identified patients with mild traumatic brain injury and compared their risk of ischemic stroke with the general population. Results: We identified 24,905 patients with mild traumatic brain injury and 719,811 patients without mild traumatic brain injury. After controlling for age, gender, urbanization level, socioeconomic status, diabetes, hypertension, coronary artery disease, hyperlipidemia, history of alcohol intoxication, malignancies, heart failure, atrial fibrillation, smoking, obesity, epilepsy, peripheral artery disease and Charlson Comorbidity Index score, the adjusted hazard ratio for ischemic stroke was 1.46 (95% confidence interval, 1.33-1.62). Conclusion: Mild traumatic brain injury is an independent significant risk factor for ischemic stroke.	[Lee, Yi-Kung; Lee, Chen-Wen; Su, Yung-Cheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Emergency Dept, Dalin Township 622, Chiayi County, Taiwan; [Lee, Yi-Kung; Lee, Chen-Wen; Su, Yung-Cheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Ming-Yuan] Mackay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Hsu, Chen-Yang] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan	Su, YC (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Emergency Dept, 2 Minsheng Rd, Dalin Township 622, Chiayi County, Taiwan.	drsu119@gmail.com					Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; INGRAM DD, 1989, STAT MED, V8, P525, DOI 10.1002/sim.4780080502; Lazzarino AI, 2013, PSYCHOSOM MED, V75, P311, DOI 10.1097/PSY.0b013e3182898e6d; Lee YK, 2013, EMERG MED J, V30, P620, DOI 10.1136/emermed-2012-201440; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Liao CC, 2014, MAYO CLIN PROC, V89, P163, DOI 10.1016/j.mayocp.2013.09.019; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Rodriguez-Sainz Aida, 2013, Curr Treat Options Cardiovasc Med, V15, P322, DOI 10.1007/s11936-013-0236-7; Romero Jose Rafael, 2008, Ther Adv Cardiovasc Dis, V2, P287, DOI 10.1177/1753944708093847; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; van der Net JB, 2008, EUR J HUM GENET, V16, P1111, DOI 10.1038/ejhg.2008.59; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wright MJ, 2014, J CLIN EXP NEUROPSYC, V36, P268, DOI 10.1080/13803395.2014.884543; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	28	14	14	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	NOV 19	2014	22								66	10.1186/s13049-014-0066-y			7	Emergency Medicine	Emergency Medicine	AX3XX	WOS:000346870100001	25406859	DOAJ Gold, Green Published			2021-06-18	
J	Wang, CZ; Pahk, JB; Balaban, CD; Miller, MC; Wood, AR; Vipperman, JS				Wang, Chenzhi; Pahk, Jae Bum; Balaban, Carey D.; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.			Computational Study of Human Head Response to Primary Blast Waves of Five Levels from Three Directions	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PATHOLOGY; EXPOSURE	Human exposure to blast waves without any fragment impacts can still result in primary blast-induced traumatic brain injury (bTBI). To investigate the mechanical response of human brain to primary blast waves and to identify the injury mechanisms of bTBI, a three-dimensional finite element head model consisting of the scalp, skull, cerebrospinal fluid, nasal cavity, and brain was developed from the imaging data set of a human female. The finite element head model was partially validated and was subjected to the blast waves of five blast intensities from the anterior, right lateral, and posterior directions at a stand-off distance of one meter from the detonation center. Simulation results show that the blast wave directly transmits into the head and causes a pressure wave propagating through the brain tissue. Intracranial pressure (ICP) is predicted to have the highest magnitude from a posterior blast wave in comparison with a blast wave from any of the other two directions with same blast intensity. The brain model predicts higher positive pressure at the site proximal to blast wave than that at the distal site. The intracranial pressure wave invariably travels into the posterior fossa and vertebral column, causing high pressures in these regions. The severities of cerebral contusions at different cerebral locations are estimated using an ICP based injury criterion. Von Mises stress prevails in the cortex with a much higher magnitude than in the internal parenchyma. According to an axonal injury criterion based on von Mises stress, axonal injury is not predicted to be a cause of primary brain injury from blasts.	[Wang, Chenzhi; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA; [Pahk, Jae Bum] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Balaban, Carey D.] Univ Pittsburgh, Pittsburgh, PA USA	Vipperman, JS (corresponding author), Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA.	jsv@pitt.edu	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Vipperman, Jeffrey/0000-0001-5585-954X	University of PittsburghUniversity of Pittsburgh; National Science Foundation (NSF)National Science Foundation (NSF); NSFNational Science Foundation (NSF) [1130289]; National Institute of Biomedical Imaging and BioEngineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	The authors gratefully acknowledge the University of Pittsburgh and National Science Foundation (NSF) for the funding support. This material is based upon work supported by the NSF under Grant No. 1130289. Thanks are also expressed for the MRI data obtained from The International Consortium for Brain Mapping (ICBM 2011). The ICBM project (Principal Investigator John Mazziotta, M.D, University of California, Los Angeles) is supported by the National Institute of Biomedical Imaging and BioEngineering. ICBM is the result of efforts of co-investigators from UCLA, Montreal Neurologic Institute, University of Texas at San Antonio, and the Institute of Medicine, Juelich/Heinrich Heine University - Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI 10.1089/neu.2009-0885; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cooper P., 1996, EXPLOSIVES ENG; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Friedlander FG, 1976, WAVE EQUATION CURVED; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hoffer ME, 2013, PSYCHIAT ANN, V43, P318, DOI 10.3928/00485713-20130703-06; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lee E., 1973, JWL EQUATION STATE C; Lee EL., 1968, ADIABATIC EXPANSION; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Nahum AM., 1977, P 21 STAPP CAR CRASH, P339, DOI [10.4271/770922., DOI 10.4271/770922]; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rogers GFC, 1980, THERMODYNAMIC TRANSP; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wang C, 2011, P IMECE 2011; Wang C, 2012, P IMECE 2012; Ward C, 1980, P 24 STAPP CAR CRASH; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	42	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113264	10.1371/journal.pone.0113264			24	Multidisciplinary Sciences	Science & Technology - Other Topics	AU3SG	WOS:000345533200085	25409326	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Nemeth, CL; Reddy, R; Bekhbat, M; Bailey, J; Neigh, GN				Nemeth, Christina L.; Reddy, Renuka; Bekhbat, Mandakh; Bailey, Jabari; Neigh, Gretchen N.			Microglial activation occurs in the absence of anxiety-like behavior following microembolic stroke in female, but not male, rats	JOURNAL OF NEUROINFLAMMATION			English	Article						Sex differences; Vascular ischemia; Animal model; Behavior; Microglia	TRAUMATIC BRAIN-INJURY; HYPOXIA-ISCHEMIA; SEX-DIFFERENCES; STRESS; GENDER; NEUROINFLAMMATION; RECOVERY; DISEASE; WOMEN; MODEL	Background: The incidence of depression and anxiety disorders is twice as high in women than men; however, females exhibit less neuronal damage following an equivalent ischemic event. Microembolic stroke increases anxiety- and depressive-like behaviors in male rats but the behavioral repercussions in females are unknown. Findings: Given the relative neuronal protection from stroke in ovary-intact females, female rats exposed to microembolic stroke may be behaviorally protected as compared to males. The data presented demonstrate that anxiety-like behavior is increased in males despite a comparable increase in microglial activation following microembolic stroke in both males and females. Conclusions: These data suggest that males may be more behaviorally susceptible to the effects of microembolic stroke and further illustrate a dissociation between neuroinflammation and behavior in females.	[Nemeth, Christina L.; Neigh, Gretchen N.] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Nemeth, Christina L.; Reddy, Renuka; Bekhbat, Mandakh; Bailey, Jabari; Neigh, Gretchen N.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Neigh, GN (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gretchen.neigh@emory.edu	Neigh, Gretchen/AAW-5691-2020	Neigh, Gretchen/0000-0003-0955-9161; Bekhbat, Mandakh/0000-0003-1093-5160	American Heart AssociationAmerican Heart Association; National Alliance for Research in Schizophrenia and Affective DisordersNARSAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008605] Funding Source: NIH RePORTER	American Heart Association, National Alliance for Research in Schizophrenia and Affective Disorders.	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Li J, 2011, J CEREBR BLOOD F MET, V31, P413, DOI 10.1038/jcbfm.2010.181; Manwani B, 2011, WOMENS HEALTH, V7, P319, DOI [10.2217/WHE.11.22, 10.2217/whe.11.22]; Moisse K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-29; Neigh GN, 2009, STROKE, V40, P3601, DOI 10.1161/STROKEAHA.109.564146; Nemeth CL, 2012, BEHAV BRAIN RES, V234, P259, DOI 10.1016/j.bbr.2012.06.014; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Pyter LM, 2013, BRAIN BEHAV IMMUN, V30, P88, DOI 10.1016/j.bbi.2013.01.075; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wendell CR, 2010, AM J GERIAT PSYCHIAT, V18, P940, DOI 10.1097/JGP.0b013e3181d57a2b; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Zhang LQ, 2004, J CLIN INVEST, V113, P85, DOI 10.1172/JCI200418336	17	14	14	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	NOV 6	2014	11								174	10.1186/s12974-014-0174-7			5	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	AW1CG	WOS:000346027700001	25374157	DOAJ Gold, Green Published			2021-06-18	
J	Ciuffreda, KJ; Ludlam, DP; Thiagarajan, P; Yadav, NK; Capo-Aponte, J				Ciuffreda, Kenneth J.; Ludlam, Diana P.; Thiagarajan, Preethi; Yadav, Naveen K.; Capo-Aponte, Jose			Proposed Objective Visual System Biomarkers for Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							OCULOMOTOR REHABILITATION; EVOKED POTENTIALS; PROTOCOL; MTBI; DYSFUNCTIONS; POPULATION; CONCUSSION; TRACKING; TBI; VEP	The challenge and search for objectively based biomarkers to assess for the presence of concussion/mild traumatic brain injury is a high priority for the military establishment. We present a documented overview of specific test areas and related targeted, high-yield, objectively based parameters that may be potential "vision biomarkers" for the detection of concussion/mild traumatic brain injury based on results from our laboratory and others, with emphasis on oculomotor aspects. These findings have military relevance with respect to the initial diagnosis in the battlefield and in the far-forward medical facilities, pre-/postdeployment issues, pre-/postvisual rehabilitation evaluation, fitness-for-duty assessment, and establishment of a return-to-duty timeline.	[Ciuffreda, Kenneth J.; Ludlam, Diana P.; Thiagarajan, Preethi; Yadav, Naveen K.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA; [Capo-Aponte, Jose] Womack Army Med Ctr, Dept Optometry, Ft Bragg, NC 28310 USA	Ciuffreda, KJ (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.				Department of Defense (DoD)United States Department of Defense [W81XWH-12-1-0240, W81XWH-10-1-0141]; Langeloth Foundation; College of Optometrists in Vision Development (COVD); William C. Ezell Fellowship	We thank LTC James Truong for his helpful comments during manuscript preparation. Our studies were supported from the following sources: Department of Defense (DoD grants (W81XWH-12-1-0240 and W81XWH-10-1-0141), Langeloth Foundation, College of Optometrists in Vision Development (COVD), and the William C. Ezell Fellowship.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2013, J SPINE S, VS4, DOI [10.4172/2165-7939.S4-004., DOI 10.4172/2165-7939.S4-004]; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Casto KL, 2012, A576370 DTIC; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2013, BRAIN INJURY, V27, P41, DOI 10.3109/02699052.2012.700088; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2013, PUPILLARY DYNAMICS L; Ciuffreda KJ, 1995, EYE MOVEMENT BASICS, P72; Deployment Health Clinical Center (DHCC), DEPL SUPP ENH POSTD; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; GUR S, 1992, ISRAEL J MED SCI, V28, P622; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Maroon Joseph C, 2011, Clin Neurosurg, V58, P51; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; PAPATHANASOPOULOS P, 1994, EUR NEUROL, V34, P268, DOI 10.1159/000117054; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; Scheiman M, 2001, VISUAL VESTIBULAR CO, P89; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Thiagarajan P., 2012, THESIS STATE U NEW Y; Thiagarajan P, 2014, J REHABIL RES DEV, V51, P175, DOI 10.1682/JRRD.2013.01.0027; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; VistaLifeSciences, BETT INF BETT HLTH A; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zasler N, 2007, BRAIN INJURY MED PRI	49	14	14	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11					1212	1217		10.7205/MILMED-D-14-00059			6	Medicine, General & Internal	General & Internal Medicine	CA7LK	WOS:000349098600012	25373043	Bronze			2021-06-18	
J	Gibbs, LM				Gibbs, Lisa M.			Understanding the Medical Markers of Elder Abuse and Neglect: Physical Examination Findings	CLINICS IN GERIATRIC MEDICINE			English	Article						Elder abuse; Elder neglect; Medical markers; Physical injury	BRAIN-INJURY; STRANGULATION; MECHANISMS; FREQUENCY; PATTERNS; VICTIMS; RISK	A specific foundation of knowledge is important for evaluating potential abuse from physical findings in the older adult. The standard physical examination is a foundation for detecting many types of abuse. An understanding of traumatic injuries, including patterns of injury, is important for health care providers, and the inclusion of elder abuse in the differential diagnosis of patient care is essential. One must possess the skills needed to piece the history, including functional capabilities, and physical findings together. Armed with this skill set, health care providers will develop the confidence needed to identify and intervene in cases of elder abuse.	Univ Calif Irvine, Dept Family Med, Div Geriatr Med & Gerontol, Orange, CA 92868 USA	Gibbs, LM (corresponding author), Univ Calif Irvine, Dept Family Med, Div Geriatr Med & Gerontol, 101 City Dr, Orange, CA 92868 USA.	lgibbs@uci.edu					Alexandrescu DT, 2010, WILLIAMS HEMATOLOGY; Association for the Advancement of Wound Care (AAWC), 2010, ASS ADV WOUND CAR GU; Atanasijevic TC, 2005, J FORENSIC SCI, V50, P608; Bates-Jensen BM, 2009, HAZZARDS GERIATRIC M; Bird PE, 1998, J BURN CARE REHABIL, V19, P522, DOI 10.1097/00004630-199811000-00011; Bliss M R, 1998, J Tissue Viability, V8, P4; Brandeis G H, 2001, Adv Skin Wound Care, V14, P245, DOI 10.1097/00129334-200109000-00011; Brandeis GH, 2001, ADV SKIN WOUND CARE, V14, P245; Brown Kathleen, 2004, Nurse Pract, V29, P22, DOI 10.1097/00006205-200408000-00004; Brown KL, 2012, PRINCIPLES PRACTICE; Burgess AW, 2005, CLIN GERIATR MED, V21, P399, DOI 10.1016/j.cger.2004.10.005; Burkhart CN, 2011, TINTINALLIS EMERGENC; Chatham N, 2012, WOUND CARE ADVISOR, V1, P1; Collins KA, 2007, AM J FOREN MED PATH, V28, P157, DOI 10.1097/PAF.0b013e31805c93eb; Dem ling RH, 2010, CURRENT DIAGNOSIS TR; Faugno D, 2013, ADV EMERG NURS J, V35, P314, DOI 10.1097/TME.0b013e3182aa05d3; Fowler DR, 2011, TINTINALLIS EMERGENC; Fowler DR, 2011, TINTINALLIS EMERGENC; Friedman LS, 2011, J AM GERIATR SOC, V59, P417, DOI 10.1111/j.1532-5415.2010.03313.x; GERSTEIN AD, 1993, DERMATOL CLIN, V11, P749, DOI 10.1016/S0733-8635(18)30227-4; Greenbaum AR, 2004, BURNS, V30, P628, DOI 10.1016/j.burns.2004.03.019; HARPER RD, 1995, BURNS, V21, P205, DOI 10.1016/0305-4179(95)80010-L; Hawley DA, 2001, J EMERG MED, V21, P317, DOI 10.1016/S0736-4679(01)00401-2; Holbrook DS, 2013, J FORENSIC NURS, V9, P140, DOI 10.1097/JFN.0b013e31829beb1e; ISERSON KV, 1984, ANN EMERG MED, V13, P179, DOI 10.1016/S0196-0644(84)80609-5; Janniger CK, 2005, AM FAM PHYSICIAN, V72, P833; Johnson SC, 2009, HAZZARDS GERIATRIC M; Karch D, 2011, J INTERPERS VIOLENCE, V26, P137, DOI 10.1177/0886260510362890; Knox D M, 1994, Adv Wound Care, V7, P48; Knox DM, 1994, ADV WOUND CARE, V7, P54; Krob M J, 1986, J Burn Care Rehabil, V7, P529, DOI 10.1097/00004630-198611000-00017; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Lyder C. H., 2002, JAMA-J AM MED ASSOC, V289, P223, DOI [10.1001/jama.289.2.223, DOI 10.1001/jama.289.2.223]; Ma O, 2011, TINTINALLIS EMERGENC; Mosqueda L, 2005, J AM GERIATR SOC, V53, P1339, DOI 10.1111/j.1532-5415.2005.53406.x; Muller MJ, 2001, BRIT J SURG, V88, P583, DOI 10.1046/j.1365-2168.2001.01726.x; Munter DW, 2010, ATLAS EMERGENCY MED; Murphy K, 2013, CAN ASSOC RADIOL J, V64, P10, DOI 10.1016/j.carj.2012.12.001; National Burn Repository, 2012, REP DAT 2002 2011; National Pressure Ulcer Advisory Panel (NPUAP), NPUAP PRESS ULC STAG; Palmer M, 2013, J AM ACAD DERMATOL, V68, pE37, DOI 10.1016/j.jaad.2011.03.016; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Peck MD, 2012, BURNS, V38, P630, DOI 10.1016/j.burns.2011.12.028; Plattner T, 2005, FORENSIC SCI INT, V153, P202, DOI 10.1016/j.forsciint.2004.09.106; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Ropper AH, 2014, ADAMS VICTORS PRINCI; Sartoretti C, 1997, J TRAUMA, V43, P570, DOI 10.1097/00005373-199710000-00002; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Stapczynski JS, 2010, EMERG MED REP, V31, P193; Usatine RP, 2013, COLOR ATLAS FAMILY M; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wiglesworth A, 2009, J AM GERIATR SOC, V57, P1191, DOI 10.1111/j.1532-5415.2009.02330.x; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; Wolff K., 2013, FITZPATRICKS COLOR A; Yaar M, 2001, CLIN GERIATR MED, V17, P617, DOI 10.1016/S0749-0690(05)70089-6; Zelken JA, 2014, J ORAL MAXIL SURG, V72, P352, DOI 10.1016/j.joms.2013.08.015; Ziminski CE, 2013, J FORENSIC NURS, V9, P84, DOI 10.1097/JFN.0b013e31827d51d0	57	14	15	1	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0690	1879-8853		CLIN GERIATR MED	Clin. Geriatr. Med.	NOV	2014	30	4					687	+		10.1016/j.cger.2014.08.002			27	Geriatrics & Gerontology	Geriatrics & Gerontology	AT8SX	WOS:000345203300004	25439636				2021-06-18	
J	Hanks, RA; Rapport, LJ; Waldron-Perrine, B; Millis, SR				Hanks, Robin A.; Rapport, Lisa J.; Waldron-Perrine, Brigid; Millis, Scott R.			Role of Character Strengths in Outcome After Mild Complicated to Severe Traumatic Brain Injury: A Positive Psychology Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Community integration; Comorbidity; Quality of life; Patient outcome assessment; Rehabilitation	RANDOMIZED CONTROLLED-TRIAL; OLDER CANCER-PATIENTS; COMMUNITY INTEGRATION; NEGATIVE AFFECT; RATING-SCALE; COMORBIDITY; VALIDATION; INTERVENTIONS; PANAS	Objective: To examine the effects of character strengths on psychosocial outcomes after mild complicated to severe traumatic brain injury (TBI). Design: Prospective study with consecutive enrollment. Setting: A Midwestern rehabilitation hospital. Participants: Persons with mild complicated to severe TBI (N= 65). Interventions: Not applicable. Main Outcome Measures: Community Integration Measure, Disability Rating Scale, Modified Cumulative Illness Rating Scale, Positive and Negative Affect Schedule, Satisfaction with Life Scale, Values in Action Inventory of Strengths, and Wechsler Test of Adult Reading. Results: Character virtues and strengths were moderately associated with subjective outcomes, such that there were fewer and less strong associations between character virtues/strengths and objective outcomes than subjective outcomes. Specifically, positive attributes were associated with greater life satisfaction and perceived community integration. Fewer and less strong associations were observed for objective well-being; however, character strengths and virtues showed unique value in predicting physical health and disability. Positive affectivity was not meaningfully related to objective outcomes, but it was significantly related to subjective outcomes. In contrast, negative affectivity was related to objective but not subjective outcomes. Conclusions: Given the strength of the associations between positive aspects of character or ways of perceiving the world and positive feelings about one's current life situation, treatments focused on facilitating these virtues and strengths in persons who have experienced TBI may result in better perceived outcomes and potentially subsequently lower comorbidities. (C) 2014 by the American Congress of Rehabilitation Medicine	[Hanks, Robin A.; Waldron-Perrine, Brigid; Millis, Scott R.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Rapport, Lisa J.] Wayne State Univ, Coll Liberal Arts & Sci, Dept Psychol, Detroit, MI USA	Hanks, RA (corresponding author), Rehabil Inst Michigan, 261 Mack Blvd,Ste 555, Detroit, MI 48201 USA.	rhanks@med.wayne.edu					Costa P., 1992, REVISED NEO PERSONAL; Dahlsgaard K, 2005, REV GEN PSYCHOL, V9, P203, DOI 10.1037/1089-2680.9.3.203; Di Libero F, 2001, ARCH GERONTOL GERIAT, V32, P15, DOI 10.1016/S0167-4943(00)00089-3; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Extermann M, 2000, CRIT REV ONCOL HEMAT, V35, P181, DOI 10.1016/S1040-8428(00)00090-1; Gable SL, 2005, REV GEN PSYCHOL, V9, P103, DOI 10.1037/1089-2680.9.2.103; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Holdnack H, 2001, WECHSLER TEST ADULT; Jones TG, 2003, CLIN NEUROPSYCHOL, V17, P3, DOI 10.1076/clin.17.1.3.15626; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kenny DA., 1998, HDB SOCIAL PSYCHOL, VVol. 1, P233; KERCHER K, 1992, RES AGING, V14, P131, DOI 10.1177/0164027592142001; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ogedegbe GO, 2012, ARCH INTERN MED, V172, P322, DOI 10.1001/archinternmed.2011.1307; Park N, 2004, J SOC CLIN PSYCHOL, V23, P603, DOI 10.1521/jscp.23.5.603.50748; PAVOT W, 1993, SOC INDIC RES, V28, P1, DOI 10.1007/BF01086714; Peterson C, 2006, MICH PSYCH ASS MARCH; Peterson C., 2006, J POSIT PSYCHOL, V1, P17, DOI [10.1080/17439760500372739, DOI 10.1080/17439760500372739]; Peterson C., 2004, CHARACTER STRENGTHS; Peterson C, 2008, J TRAUMA STRESS, V21, P214, DOI 10.1002/jts.20332; Peterson JC, 2012, ARCH INTERN MED, V172, P329, DOI 10.1001/archinternmed.2011.1311; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ryff CD, 2006, PSYCHOTHER PSYCHOSOM, V75, P85, DOI 10.1159/000090892; Seligman MEP, 2006, AM PSYCHOL, V61, P774, DOI 10.1037/0003-066X.61.8.774; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	35	14	14	0	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2014	95	11					2096	2102		10.1016/j.apmr.2014.06.017			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AS3XC	WOS:000344207500014	25010535				2021-06-18	
J	Kim, SP; Kang, DS; Cheong, JH; Kim, JH; Song, KY; Kong, MH				Kim, Seung Pil; Kang, Dong Soo; Cheong, Jin Hwan; Kim, Jung Hee; Song, Kwan Young; Kong, Min Ho			Clinical Analysis of Epidural Fluid Collection as a Complication after Cranioplasty	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Cranioplasty; Epidural fluid collection; Size of skull defect	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; DEFECT	Objective : The epidural fluid collection (EFC) as a complication of cranioplasty is not well-described in the literature. This study aimed to identify the predictive factors for the development of EFC as a complication of cranioplasty, and its outcomes. Methods : From January 2004 to December 2012, 117 cranioplasty were performed in our institution. One-hundred-and-six of these patients were classified as either having EFC, or not having EFC. The two groups were compared to identify risk factors for EFC. Statistical significance was tested using the t-test and chi-square test, and a logistic regression analysis. Results : Of the 117 patients undergoing cranioplasty, 59 (50.4%) suffered complications, and EFC occurred in 48 of the patients (41.0%). In the t-test and chi-test, risk factors for EFC were size of the skull defect (p=0.003) and postoperative air bubbles in the epidural space (p<0.001). In a logistic regression, the only statistically significant factor associated with development of EFC was the presence of postoperative air bubbles. The EFC disappeared or regressed over time in 30 of the 48 patients (62.5%), as shown by follow-up brain computed tomographic scan, but 17 patients (35.4%) required reoperation. Conclusion : EFC after cranioplasty is predicted by postoperative air bubbles in the epidural space. Most EFC can be treated conservatively. However, reoperation is necessary to resolve about a third of the cases. During cranioplasty, special attention is required when the skull defect is large, since EFC is then more likely.	[Kim, Seung Pil; Kang, Dong Soo; Kim, Jung Hee; Song, Kwan Young; Kong, Min Ho] Seoul Med Ctr, Dept Neurosurg, Seoul 131865, South Korea; [Cheong, Jin Hwan] Hanyang Univ, Guri Hosp, Dept Neurosurg, Guri, South Korea	Kang, DS (corresponding author), Seoul Med Ctr, Dept Neurosurg, 156 Sinnae Ro, Seoul 131865, South Korea.	kdsyjyw@hotmail.com					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cho KC, 2011, J KOREAN NEUROTRAUMA, V7, P74; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Lee JW, 2011, J KOREAN NEUROSURG S, V50, P231, DOI 10.3340/jkns.2011.50.3.231; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Oh CH, 2008, J KOREAN NEUROSURG S, V44, P211, DOI 10.3340/jkns.2008.44.4.211; Park JS, 2007, J KOREAN NEUROSURG S, V42, P89; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Simard JM, 2011, CURR TREAT OPTION NE, V13, P217, DOI 10.1007/s11940-010-0110-9; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Walcott BP, 2012, J NEUROTRAUM, V29, P1879, DOI 10.1089/neu.2012.2382; Wen L, 2007, J CRANIOFAC SURG, V18, P526; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053	21	14	18	0	5	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2014	56	5					410	418		10.3340/jkns.2014.56.5.410			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AW9AQ	WOS:000346550600008	25535519	DOAJ Gold, Green Published			2021-06-18	
J	Lee, J; Costantini, TW; D'Mello, R; Eliceiri, BP; Coimbra, R; Bansal, V				Lee, Jisook; Costantini, Todd W.; D'Mello, Ryan; Eliceiri, Brian P.; Coimbra, Raul; Bansal, Vishal			Altering leukocyte recruitment following traumatic brain injury with ghrelin therapy	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	31st Annual Symposium of the National-Neurotrauma-Society	AUG 04-07, 2013	Nashville, TN	Natl Neurotrauma Soc		Traumatic brain injury (TBI); ghrelin; leukocyte; monocyte; mice	PROINFLAMMATORY CYTOKINE EXPRESSION; CELL TRAFFICKING; INNATE IMMUNITY; IN-VITRO; MICROGLIA; BARRIER; ACTIVATION; RESPONSES; PROTECTS; DAMAGE	BACKGROUND: Traumatic brain injury (TBI)-induced cerebral inflammation involves several mediators including activation of resident microglia, infiltration of leukocytes, and release of proinflammatory cytokines and chemokines at the site of injury. Invading leukocytes, mainly neutrophil and inflammatory monocytes, contribute to ongoing post-TBI cerebral edema and neuronal injury. Based on the beneficial effect of ghrelin hormone treatment following TBI, we hypothesized that ghrelin may alter the infiltrating inflammatory cell profile. METHODS: A weight drop model was used to create severe TBI. C57 mice were divided into three groups: sham, no TBI or ghrelin treatment; TBI, TBI only; TBI/ghrelin, animals were treated with ghrelin 20 mu g (intraperitoneally) immediately following TBI and again 1 hour later. Seven days after injury, brain sections were immunostained with Iba-1 and CD11b to assess the recruitment and activation of resident microglia and infiltrated leukocytes. Alternatively, brain dissociates were isolated, and flow cytometry was used to gate for microglia (CD11b(+), CD45(low) cells), monocytes (CD11b(+), CD45(high), F4/80(+) cells), and neutrophils (CD11b(+), CD45(high), F4/80 cells) to measure their recruitment to injury site. RESULTS: TBI resulted in a rapid invasion (16-fold) of inflammatory leukocytes to the site of injury, which persisted for at least 1 week. Ghrelin treatment significantly reduced infiltration of peripheral leukocytes (2.8-fold). In particular, recruitment of CD11b(+)CD45(high) inflammatory monocytes (2.4-fold) and CD11b(+)CD45(high)F4/80(-) neutrophils (1.7-fold) was reduced following ghrelin treatment. There were no observed ghrelin-mediated changes in either the number of CD11b(+)CD45(low) resident microglia or its activation state. CONCLUSION: Together, our data demonstrate that ghrelin attenuated leukocyte recruitment, which correlates with improved histologic outcome following TBI. Copyright (C) 2014 by Lippincott Williams & Wilkins	[Lee, Jisook; Costantini, Todd W.; D'Mello, Ryan; Eliceiri, Brian P.; Coimbra, Raul; Bansal, Vishal] Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA	Bansal, V (corresponding author), 200 W Arbor Dr,8896, San Diego, CA USA.	v3bansal@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Costantini, Todd/0000-0002-0215-5327; Eliceiri, Brian/0000-0003-1811-1916			Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI 10.1089/neu.2008-0858; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Coisne C, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-7; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2009, BLOOD, V113, P5202, DOI 10.1182/blood-2008-09-181255; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim JY, 2013, NEUROBIOL DIS, V58, P289, DOI 10.1016/j.nbd.2013.06.012; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kwidzinski E, 2003, J NEURAL TRANSM-SUPP, P29, DOI 10.1007/978-3-7091-0643-3_2; Lampron A, 2013, NEURON, V78, P214, DOI 10.1016/j.neuron.2013.04.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Lopez NE, 2014, J SURG RES, V187, P230, DOI 10.1016/j.jss.2013.09.030; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Mejia ROS, 2001, NEUROSURGERY, V48, P1393; Molfino A, 2014, CURR OPIN CLIN NUTR; Qi L, 2014, ANN SURG, V260, P169, DOI 10.1097/SLA.0000000000000328; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Smrcka M, 2007, BRATISL MED J, V108, P144; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	35	14	17	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2014	77	5					709	715		10.1097/TA.0000000000000445			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AT1OB	WOS:000344702300012					2021-06-18	
J	Rosenbaum, BP; Kelly, ML; Kshettry, VR; Weil, RJ				Rosenbaum, Benjamin P.; Kelly, Michael L.; Kshettry, Varun R.; Weil, Robert J.			Neurologic disorders, in-hospital deaths, and years of potential life lost in the USA, 1988-2011	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Hospital mortality; Nationwide Inpatient Sample; Neurologic disease burden; Premature mortality; Public health; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; UNITED-STATES; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; INTRACEREBRAL HEMORRHAGE; GBD 2010; DISEASE; DISPARITIES; EXPECTANCY; MORTALITY	Premature mortality is a public health concern that can be quantified as years of potential life lost (YPLL). Studying premature mortality can help guide hospital initiatives and resource allocation. We investigated the categories of neurologic and neurosurgical conditions associated with in-hospital deaths that account for the highest YPLL and their trends over time. Using the Nationwide Inpatient Sample (NIS), we calculated YPLL for patients hospitalized in the USA from 1988 to 2011. Hospitalizations were categorized by related neurologic principal diagnoses. An estimated 2,355,673 in-hospital deaths accounted for an estimated 25,598,566 YPLL. The traumatic brain injury (TBI) category accounted for the highest annual mean YPLL at 361,748 (33.9% of total neurologic YPLL). Intracerebral hemorrhage, cerebral ischemia, subarachnoid hemorrhage, and anoxic brain damage completed the group of five diagnoses with the highest YPLL. TBI accounted for 12.1% of all inflation adjusted neurologic hospital charges and 22.4% of inflation adjusted charges among neurologic deaths. The in-hospital mortality rate has been stable or decreasing for all of these diagnoses except TBI, which rose from 5.1% in 1988 to 7.8% in 2011. Using YPLL, we provide a framework to compare the burden of premature in-hospital mortality on patients with neurologic disorders, which may prove useful for informing decisions related to allocation of health resources or research funding. Considering premature mortality alone, increased efforts should be focused on TBI, particularly in and related to the hospital setting. (C) 2014 Elsevier Ltd. All rights reserved.	[Rosenbaum, Benjamin P.; Kelly, Michael L.; Kshettry, Varun R.; Weil, Robert J.] Cleveland Clin, Neurol Inst, Dept Neurosurg, Cleveland, OH 44195 USA; [Rosenbaum, Benjamin P.] Oregon Hlth & Sci Univ, BICC, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Weil, Robert J.] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44195 USA; [Weil, Robert J.] Geisinger Hlth Syst, Dept Neurosurg, Danville, PA USA	Rosenbaum, BP (corresponding author), Cleveland Clin, Neurol Inst, Dept Neurosurg, S40,9500 Euclid Ave, Cleveland, OH 44195 USA.	rosenbb@ccf.org			Melvin Burkhardt Chair in Neurosurgical Oncology; Karen Colina Wilson Research Endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic	R.J.W. was supported in part by the Melvin Burkhardt Chair in Neurosurgical Oncology, and by the Karen Colina Wilson Research Endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic. The funders of this philanthropic support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Adeoye O, 2010, NEUROCRIT CARE, V13, P82, DOI 10.1007/s12028-010-9351-4; [Anonymous], 2013, LANCET NEUROL, V12, P1127, DOI 10.1016/S1474-4422(13)70266-7; Borse NN, 2013, J SAFETY RES, V45, P127, DOI 10.1016/j.jsr.2013.02.001; Borse Nagesh N., 2012, Morbidity and Mortality Weekly Report, V61, P830; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Centers for Disease Control and Prevention, 1986, MMWR S, V35, p1S, DOI 10.1037/e371472004-001; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Hoyert D, 2012, DEATHS PRELIMINARY D, P52; Institute of Medicine [IOM], 2013, US HLTH INT PERSP SH; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McDonnell S, 1998, PUBLIC HEALTH REP, V113, P55; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Meador KJ, 2011, NEUROLOGY, V77, P1305, DOI 10.1212/WNL.0b013e318230a18f; Moses H, 2013, JAMA-J AM MED ASSOC, V310, P1947, DOI 10.1001/jama.2013.281425; Murphy S, 2013, DEATHS FINAL DATA 20, P168; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62134-5; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; National Institutes of Health, 2013, EST FUND VAR RES CON; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Richmond TS, 2008, AM J PHYS MED REHAB, V87, P609, DOI 10.1097/PHM.0b013e31817fb496; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Shield KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051923; Shkolnikov VM, 2011, DEMOGRAPHY, V48, P211, DOI 10.1007/s13524-011-0015-6; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Statistics USBoL, 2012, INFL CALC BUR LAB ST; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Towfighi A, 2010, STROKE, V41, P499, DOI 10.1161/STROKEAHA.109.571828; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-8; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Young WB, 2012, NEUROLOGY, V78, P292, DOI 10.1212/WNL.0b013e3182475126	46	14	14	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2014	21	11					1874	1880		10.1016/j.jocn.2014.05.006			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AU4TK	WOS:000345604100006	25012487				2021-06-18	
J	Villasana, LE; Westbrook, GL; Schnell, E				Villasana, L. E.; Westbrook, G. L.; Schnell, E.			Neurologic impairment following closed head injury predicts post-traumatic neurogenesis	EXPERIMENTAL NEUROLOGY			English	Article						Closed head injury; Traumatic brain injury; Adult neurogenesis; Hippocampus; Neurologic severity score	TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; GLASGOW COMA SCALE; DENTATE GYRUS; GRANULE CELLS; NEURONAL DIFFERENTIATION; ABERRANT NEUROGENESIS; COGNITIVE RECOVERY; RATS; PROLIFERATION	In the mammalian hippocampus, neurogenesis persists into adulthood, and increased generation of newborn neurons could be of clinical benefit following concussive head injuries. Post-traumatic neurogenesis has been well documented using "open" traumatic brain injury (TBI) models in rodents: however, human TBI most commonly involves closed head injury. Here we used a closed head injury (CHI) model to examine post-traumatic hippocampal neurogenesis in mice. All mice were subjected to the same CHI protocol, and a gross-motor based injury severity score was used to characterize neurologic impairment 1 h after the injury. When analyzed 2 weeks later, post-traumatic neurogenesis was significantly increased only in mice with a high degree of transient neurologic impairment immediately after injury. This increase was associated with an early increase in c-fos activity, and subsequent reactive astrocytosis and microglial activation in the dentate gyrus. Our results demonstrate that the initial degree of neurologic impairment after closed head injury predicts the induction of secondary physiologic and pathophysiologic processes, and that animals with severe neurologic impairment early after injury manifest an increase in post-traumatic neurogenesis in the absence of gross anatomic pathology. Published by Elsevier Inc.	[Villasana, L. E.; Schnell, E.] OHSU, Dept Anesthesiol & Perioperat Med, Portland, OR 97239 USA; [Westbrook, G. L.] OHSU, Vollum Inst, Portland, OR 97239 USA; [Schnell, E.] Portland VA Med Ctr, Portland, OR 97239 USA	Schnell, E (corresponding author), Portland VA Med Ctr, 3710 SW US Vet Hosp Rd,P3ANES, Portland, OR 97239 USA.	schneler@ohsu.edu		Schnell, Eric/0000-0002-5623-5015	Department of Veteran's Affairs Career Development Award (CDA-2); National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM082770]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH046613]; National Institutes of Health for the OHSU Imaging Center [P30-NS061800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM082770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS061800, F32NS083109] Funding Source: NIH RePORTER	We would like to thank Nee lay Pandit for constructing the closed-head weight drop device and for assistance generating pilot data for this study, and to Dr. Stefanie Kaech-Petrie for assistance with imaging. Funding for the present work was provided by a Department of Veteran's Affairs Career Development Award (CDA-2) to Dr. Schnell, a National Institute of General Medical Sciences T32-GM082770 to Dr. Villasana, a National Institute of Mental Health R01-MH046613 to Dr. Westbrook, and a National Institutes of Health P30-NS061800 for the OHSU Imaging Center.	Albert-WeiSSenberger Christiane, 2012, Exp Transl Stroke Med, V4, P1, DOI 10.1186/2040-7378-4-1; [Anonymous], 2012, INJ PREV CONTR TRAUM; BARONE P, 1993, SYNAPSE, V14, P1, DOI 10.1002/syn.890140102; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Couillard-Despres S, 2011, EUR J NEUROSCI, V33, P1037, DOI 10.1111/j.1460-9568.2011.07601.x; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Ho NF, 2013, MOL PSYCHIATR, V18, P404, DOI 10.1038/mp.2013.8; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Ohira K, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-12; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; Parent JM, 1997, J NEUROSCI, V17, P3727; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schnell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048045; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; TEASDALE G, 1974, LANCET, V2, P81; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang F, 2010, J NEUROSCI RES, V88, P519, DOI 10.1002/jnr.22224; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	14	15	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2014	261						156	162		10.1016/j.expneurol.2014.05.016			7	Neurosciences	Neurosciences & Neurology	AR4AX	WOS:000343531500016	24861442	Green Accepted			2021-06-18	
J	Walsh, J; Eccleston, C; Keogh, E				Walsh, Joseph; Eccleston, Christopher; Keogh, Edmund			Pain communication through body posture: The development and validation of a stimulus set	PAIN			English	Article						Pain; Communication; Body posture; Nonverbal behaviour	TRAUMATIC BRAIN-INJURY; FACIAL EXPRESSION; NONVERBAL-COMMUNICATION; POSTOPERATIVE PAIN; GENDER-DIFFERENCES; RECOGNITION; EMOTION; RELIABILITY; CHILDREN; BEHAVIOR	Pain can be communicated nonverbally through facial expressions, vocalisations, and bodily movements. Most studies have focussed on the facial display of pain, whereas there is little research on postural display. Stimulus sets for facial and vocal expressions of pain have been developed, but there is no equivalent for body-based expressions. Reported here is the development of a new stimulus set of dynamic body postures that communicate pain and basic emotions. This stimulus set is designed to facilitate research into the bodily communication of pain. We report a 3-phase development and validation study. First 16 actors performed affective body postures for pain, as well as happiness, sadness, fear, disgust, surprise, anger, and neutral expressions. Second, 20 observers independently selected the best image stimuli based on the accuracy of emotion identification and valence/arousal ratings. Third, to establish reliability, this accuracy and valence rating procedure was repeated with a second independent group of 40 participants. A final set of 144 images with good reliability was established and is made available. Results demonstrate that pain, along with basic emotions, can be communicated through body posture. Cluster analysis demonstrates that pain and emotion are recognised with a high degree of specificity. In addition, pain was rated as the most unpleasant (negative valence) of the expressions, and was associated with a high level of arousal. For the first time, specific postures communicating pain are described. The stimulus set is provided as a tool to facilitate the study of nonverbal pain communication, and its possible uses are discussed. (C) 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.	[Walsh, Joseph; Eccleston, Christopher; Keogh, Edmund] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England	Walsh, J (corresponding author), Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England.	j.a.d.walsh@bath.ac.uk		Walsh, Joseph/0000-0002-3402-8402; Keogh, Edmund/0000-0002-1615-3699; Eccleston, Christopher/0000-0003-0698-1543	Graduate School Scholarship by University of Bath	This research was funded by a Graduate School Scholarship provided by the University of Bath. The authors thank Emma Fisher of the University of Bath for acting as the second coder for the Body Action Posture Coding System (BAP) results.	Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Aviezer H, 2012, SCIENCE, V338, P1225, DOI 10.1126/science.1224313; Bartlett MS, 2014, CURR BIOL, V24, P738, DOI 10.1016/j.cub.2014.02.009; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; BERMAN D, 1992, BRIT J CANCER, V66, pS84; BOUCHER JD, 1980, J CROSS CULT PSYCHOL, V11, P263, DOI 10.1177/0022022180113003; Burgoon JK, 2002, J COMMUN, V52, P657, DOI 10.1111/j.1460-2466.2002.tb02567.x; Clarke JE, 2009, EUR J PAIN, V13, P305, DOI 10.1016/j.ejpain.2008.04.009; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Coulson M, 2004, J NONVERBAL BEHAV, V28, P117, DOI 10.1023/B:JONB.0000023655.25550.be; Craig K.D., 1992, APS J, V1, P153, DOI 10.1016/1058-9139(92)90001-S; Craig KD, 2010, J PAIN, V11, P101, DOI 10.1016/j.jpain.2009.08.008; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; Dael N, 2012, J NONVERBAL BEHAV, V36, P97, DOI 10.1007/s10919-012-0130-0; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Dethier M, 2012, J CLIN EXP NEUROPSYC, V34, P936, DOI 10.1080/13803395.2012.702734; EKMAN P, 1965, J PERS SOC PSYCHOL, V2, P726, DOI 10.1037/h0022736; EKMAN P, 1967, PERCEPT MOTOR SKILL, V24, P711, DOI 10.2466/pms.1967.24.3.711; Ekman P., 2002, FACIAL ACTION CODING; Ekman P., 1976, PICTURE FACIAL AFFEC; Fillingim RB, 1995, PAIN FORUM, V4, P209, DOI 10.1016/S1082-3174(11)80022-X; Fleiss JL., 2004, STAT METHODS RATES P; GEISSER ME, 1994, PAIN, V59, P79, DOI 10.1016/0304-3959(94)90050-7; Hand I, 2010, INT J PEDIAT, V2010, P1; Harrigan J. A., 2005, NEW HDB METHODS NONV; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Jensen MP, 1996, PAIN, V67, P35, DOI 10.1016/0304-3959(96)03078-3; KEEFE FJ, 1982, BEHAV THER, V13, P363, DOI 10.1016/S0005-7894(82)80001-4; Keogh E, 2014, PAIN, V155, P1927, DOI 10.1016/j.pain.2014.06.024; Krahe C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00386; Kret ME, 2011, NEUROIMAGE, V54, P1755, DOI 10.1016/j.neuroimage.2010.08.012; LaFrance M., 1978, INT J INTERCULTURAL, V2, P71, DOI [10.1016/0147-1767(78)90029-9, DOI 10.1016/0147-1767(78)90029-9]; LaGuardia R, 1982, EFFECT SOCIAL SETTIN; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; MATSUMOTO D, 1990, MOTIV EMOTION, V14, P195, DOI 10.1007/BF00995569; MCGRATH PJ, 1985, ADV PAIN RES THER, V9, P395; Prkachin KM, 2008, PAIN, V139, P267, DOI 10.1016/j.pain.2008.04.010; Prkachin KM, 2007, CLIN J PAIN, V23, P270, DOI 10.1097/AJP.0b013e3180308d28; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Riedl V, 2011, NEUROIMAGE, V57, P206, DOI 10.1016/j.neuroimage.2011.04.011; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Sullivan MJL, 2004, PAIN, V107, P220, DOI 10.1016/j.pain.2003.11.003; Tabachnick BG, 2007, USING MULTIVARIATE S; TARBELL SE, 1992, PAIN, V50, P273, DOI 10.1016/0304-3959(92)90031-6; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Tsai PF, 2011, RES NURS HEALTH, V34, P218, DOI 10.1002/nur.20432; von Baeyer CL, 2007, PAIN, V127, P140, DOI 10.1016/j.pain.2006.08.014; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	52	14	14	1	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3959	1872-6623		PAIN	Pain	NOV	2014	155	11					2282	2290		10.1016/j.pain.2014.08.019			9	Anesthesiology; Clinical Neurology; Neurosciences	Anesthesiology; Neurosciences & Neurology	AU1YM	WOS:000345413400011	25168671	Green Accepted			2021-06-18	
J	Tabansky, I; Quinkert, AW; Rahman, N; Muller, SZ; Lofgren, J; Rudling, J; Goodman, A; Wang, YP; Pfaff, DW				Tabansky, Inna; Quinkert, Amy Wells; Rahman, Nadera; Muller, Salomon Zev; Lofgren, Jesper; Rudling, Johan; Goodman, Alyssa; Wang, Yingping; Pfaff, Donald W.			Temporally-patterned deep brain stimulation in a mouse model of multiple traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Deep brain stimulation; Traumatic brain injury; Generalized arousal; Mouse; Central thalamus	INFERIOR COLLICULUS; AUDITORY-CORTEX; CNS AROUSAL; INFORMATION; IMPROVES; NEURONS; CODES; MICE; REPRESENTATIONS; PLASTICITY	We report that mice with closed-head multiple traumatic brain injury (TBI) show a decrease in the motoric aspects of generalized arousal, as measured by automated, quantitative behavioral assays. Further, we found that temporally-patterned deep brain stimulation (DBS) can increase generalized arousal and spontaneous motor activity in this mouse model of TBI. This arousal increase is input-pattern-dependent, as changing the temporal pattern of DBS can modulate its effect on motor activity. Finally, an extensive examination of mouse behavioral capacities, looking for deficits in this model of TBI, suggest that the strongest effects of TBI in this model are found in the initiation of any kind of movement. (C) 2014 Elsevier B.V. All rights reserved.	[Tabansky, Inna; Quinkert, Amy Wells; Rahman, Nadera; Muller, Salomon Zev; Lofgren, Jesper; Rudling, Johan; Goodman, Alyssa; Wang, Yingping; Pfaff, Donald W.] Rockefeller Univ, Neurobiol & Behav Lab, New York, NY 10065 USA; [Lofgren, Jesper; Rudling, Johan] Linkoping Univ, Fac Hlth Sci, S-58183 Linkoping, Sweden	Tabansky, I (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave,Box 275, New York, NY 10065 USA.	itabansky@rockefeller.edu	Krammel, Vera/N-4826-2014	Krammel, Vera/0000-0002-8273-8396; Quinkert, Amy/0000-0002-0165-6197; Tabansky, Inna/0000-0001-6454-1816	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01 NS067249]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067249] Funding Source: NIH RePORTER	This research was funded by NIH 5R01 NS067249 to D. Pfaff with N. Schiff. Helpful discussions with Nicholas Schiff, Keith Purpura and Khatuna Gagnidze are gratefully acknowledged.	Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Bao T-H, 2014, J MOL NEUROSCI; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; COHEN JE, 1995, NATURE, V378, P610, DOI 10.1038/378610a0; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Di Lorenzo PM, 2009, BEHAV NEUROSCI, V123, P14, DOI 10.1037/a0014176; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; Gonzalez MMC, 2013, J NEUROTRAUM, V30, P119, DOI 10.1089/neu.2012.2499; Hascoet M, 2001, PROG NEURO-PSYCHOPH, V25, P141, DOI 10.1016/S0278-5846(00)00151-2; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Kimmel DL, 2007, J NEUROSCI, V27, P7619, DOI 10.1523/JNEUROSCI.0386-07.2007; Kozloski J, 2000, J NEUROSCI, V20, P2400; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Laurent G, 1996, J NEUROSCI, V16, P3837; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Litvin Y, 2013, GENES BRAIN BEHAV, V12, P479, DOI 10.1111/gbb.12045; Malone BJ, 2010, J NEUROSCI, V30, P767, DOI 10.1523/JNEUROSCI.4170-09.2010; Marsat G, 2005, J NEUROSCI, V25, P6137, DOI 10.1523/JNEUROSCI.0646-05.2005; Mechler F, 1998, J NEUROSCI, V18, P6583; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Pfaff D, 2007, BIOESSAYS, V29, P803, DOI 10.1002/bies.20611; Quinkert AW, 2012, BEHAV BRAIN RES, V229, P349, DOI 10.1016/j.bbr.2012.01.025; Quinkert AW, 2011, P NATL ACAD SCI USA, V108, P15617, DOI 10.1073/pnas.1101894108; Quinkert AW, 2010, BEHAV BRAIN RES, V214, P377, DOI 10.1016/j.bbr.2010.06.009; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Sanchez JT, 2007, J NEUROSCI, V27, P1954, DOI 10.1523/JNEUROSCI.2894-06.2007; Schiff ND, 2008, NATURE, V452, P120, DOI 10.1038/nature06818; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2009, ANN NY ACAD SCI, V1157, P101, DOI 10.1111/j.1749-6632.2008.04123.x; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; Wasserman G.S., 1992, NEUROSIGNALS, V1, P117; Wehr M, 1999, J NEUROSCI, V19, P381; Wenk G.L., 2001, CURR PROTOC NEUROSCI, V4, DOI [10.1002/0471142301.ns0805bs04, DOI 10.1002/0471142301.NS0805BS04]; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; Wu SH, 2004, J NEUROSCI, V24, P4625, DOI 10.1523/JNEUROSCI.0318-04.2004	47	14	14	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	OCT 14	2014	273						123	132		10.1016/j.bbr.2014.07.026			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	AP7KN	WOS:000342256300015	25072520	Green Accepted			2021-06-18	
J	Barmparas, G; Liou, DZ; Lamb, AW; Gangi, A; Chin, M; Ley, EJ; Salim, A; Bukur, M				Barmparas, Galinos; Liou, Douglas Z.; Lamb, Alexander W.; Gangi, Alexandra; Chin, Mike; Ley, Eric J.; Salim, Ali; Bukur, Marko			Prehospital hypertension is predictive of traumatic brain injury and is associated with higher mortality	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; hypertension; adrenergic hyperactivity; prediction; score	GLASGOW COMA SCALE; SYMPATHETIC HYPERACTIVITY; CEREBRAL PERFUSION; RESISTANT RULES; IMPACT; PROPRANOLOL; CATECHOLAMINES; PERFORMANCE; ALCOHOL; PATIENT	BACKGROUND: The purpose of the current study was to investigate the effect of early adrenergic hyperactivity as manifested by prehospital (emergency medical service [EMS]) hypertension on outcomes of traumatic brain injury (TBI) patients and to develop a prognostic model of the presence of TBI based on EMS and admission (emergency department [ED]) hypertension. METHODS: This study is a retrospective review of the 2007 to 2008 National Trauma Data Bank including blunt trauma patients 15 years or older with available EMS and ED vital signs. Patients with head Abbreviated Injury Scale (AIS) score of 3 or greater were selected, and mortality was examined within EMS systolic blood pressure (SBP) groups: lower than 100 mm Hg, 110 mm Hg to 150 mm Hg, 160 mm Hg to 180 mm Hg, and 190 mm Hg to 230 mm Hg. A forward logistic regression model including the EMS heart rate, EMS SBP, EMS Glasgow Coma Scale (GCS) score, ED heart rate, and ED SBP was used to identify predictors of a TBI in patients with ED GCS score of less than or equal to 8, 9 to 13, and 14 to 15. RESULTS: For the 5-year study period, 315,242 patients met inclusion criteria. Adjusted odds for mortality increased in a stepwise fashion with increasing EMS SBP compared with patients with normal EMS SBP (adjusted odds ratio [95% confidence interval], 1.33 [1.22-1.44], p < 0.001, for EMS SBP of 160-180 mm Hg and 1.97 [1.76-2.21], p < 0.001, for EMS SBP of 190-230 mm Hg). A 7-point scoring system was developed for each ED GCS score group to predict the presence of a TBI. EMS SBP of greater than 150 mm Hg and ED SBP of greater than 150 mm Hg were both predictive of the presence of a TBI in patients with ED GCS score of 8 or less and in patients with ED GCS score of 9 to 13 or 14 to 15, respectively. CONCLUSION: Prehospital hypertension in TBI is associated with a higher mortality risk. Early hypertension in the prehospital setting and at admission can be used to predict the presence of such injuries. These findings may have important early triage and treatment implications. Copyright (C) 2014 by Lippincott Williams & Wilkins)	[Barmparas, Galinos; Liou, Douglas Z.; Lamb, Alexander W.; Gangi, Alexandra; Chin, Mike; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA 90048 USA; [Salim, Ali] Brigham & Womens Hosp, Dept Surg, Div Acute Care Surg & Surg Crit Care, Boston, MA 02115 USA; [Bukur, Marko] Delray Med Ctr, Dept Surg, Div Trauma Surg & Surg Crit Care, Ft Lauderdale, FL USA; [Bukur, Marko] Broward Hlth Med Ctr, Dept Surg, Div Trauma Surg & Surg Crit Care, Ft Lauderdale, FL USA	Bukur, M (corresponding author), Delray Trauma Off, Delray Hlth Med Ctr, Fair Oaks Pavil,5352 Linton Blvd, Delray Beach, FL 33484 USA.	mbukur@browardhealth.org	Barmparas, Galinos/L-6530-2019	Gangi, Afshin/0000-0002-0952-7760; Bukur, Marko/0000-0002-1850-7147			Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Barmparas G, 2012, AM SURGEON, V78, P1166; CDC, TBI US REP TRAUM BRA; Choi HA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0370-3; FRAYN KN, 1985, CIRC SHOCK, V16, P229; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Kemp CD, 2008, AM SURGEON, V74, P866; Kornblith LZ, 2013, J TRAUMA ACUTE CARE, V74, P1548, DOI 10.1097/TA.0b013e31829215eb; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2012, J TRAUMA ACUTE CARE, V72, P943, DOI 10.1097/TA.0b013e3182465527; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Lu J, 2005, ACT NEUR S, V95, P281; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Morris GF, 1997, WESTERN J MED, V166, P415; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Rados A, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-48; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Shahin H, 2010, J TRAUMA, V69, P1176, DOI 10.1097/TA.0b013e3181edbd47; Sloan AE, 2003, SEMIN RADIAT ONCOL, V13, P309, DOI 10.1016/S1053-4296(03)00030-4; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6	39	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2014	77	4					592	598		10.1097/TA.0000000000000382			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AQ8ZN	WOS:000343129700013	25250599				2021-06-18	
J	Cruse, D; Norton, L; Gofton, T; Young, GB; Owen, AM				Cruse, Damian; Norton, Loretta; Gofton, Teneille; Young, G. Bryan; Owen, Adrian M.			Positive Prognostication from Median-Nerve Somatosensory Evoked Cortical Potentials	NEUROCRITICAL CARE			English	Article						Coma; Somatosensory evoked potentials; Prognosis	TRAUMATIC BRAIN-INJURY; POSTANOXIC COMA; PRACTICAL SCALE; CONSCIOUSNESS; PREDICTION; RESPONSES; LATENCY	The bilateral absence of the cortical N20 median-nerve somatosensory evoked potential (SSEP) is a strong predictor of poor outcome from coma. However, when N20s are present, accurate prognostication is challenging. Here, we investigated the potential for later SSEP components to help disambiguate outcome in these cases. In a retrospective review of data from two intensive care units, the amplitudes and latencies of the N20, P25, and N35 components of 28 patients in coma were quantified and related to outcome at discharge from primary care (average 1-month post-injury). Only patients who had survived primary care were included in order to avoid self-fulfilling prophecies, and to focus outcome prediction on those patients with relatively present SSEPs. The amplitudes of the N20 and N35 components (averaged across hemispheres) significantly predicted the range of outcomes beyond death. Abnormal amplitudes of the N20 and N35-as derived from a healthy control group-were significantly associated with poor outcome. The relative latencies of the cortical components were not related to outcome. While it is well documented that absent SSEPs are highly predictive of poor outcome, the current data indicate that the relative preservation (absolute amplitude) of "present" N20 and N35 SSEP components can also provide predictive value and thereby inform clinicians and families with decision-making in coma. Further prospective study will elucidate the relative contributions of etiology to the predictive power of these SSEP measures.	[Cruse, Damian; Norton, Loretta; Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON N6A 5B7, Canada; [Norton, Loretta; Gofton, Teneille; Young, G. Bryan] Univ Western Ontario, Dept Clin Neurol Sci, London, ON N6A 5B7, Canada	Cruse, D (corresponding author), Univ Western Ontario, Brain & Mind Inst, Nat Sci Ctr Room 237, London, ON N6A 5B7, Canada.	dcruse@uwo.ca	Williams, Jackie/B-3495-2015; Owen, Adrian M/B-4997-2015	Norton, Loretta/0000-0002-6651-1837	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canada Excellence Research Chair (CERC) programme	This research was conducted at Western University, London, ON, Canada. This research was funded by the Canadian Institutes of Health Research (CIHR)and the Canada Excellence Research Chair (CERC) programme.	ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; CHU NS, 1986, J NEUROL SCI, V76, P199, DOI 10.1016/0022-510X(86)90169-3; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; Houlden DA, 2010, CRIT CARE MED, V38, P167, DOI 10.1097/CCM.0b013e3181c031b3; JENNETT B, 1975, LANCET, V1, P480; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Neurophysiology AC, 1994, J CLIN NEUROPHYSIOL, V11, P40; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; TEASDALE G, 1974, LANCET, V2, P81; Zandbergen EGJ, 2006, NEUROLOGY, V67, P583, DOI 10.1212/01.wnl.0000230162.35249.7f; Zandbergen EGJ, 2006, NEUROLOGY, V66, P62, DOI 10.1212/01.wnl.0000191308.22233.88; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	16	14	16	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					238	244		10.1007/s12028-014-9982-y			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900010	24865267				2021-06-18	
J	Eskandari, R; Abdullah, O; Mason, C; Lloyd, KE; Oeschle, AN; McAllister, JP				Eskandari, Ramin; Abdullah, Osama; Mason, Cameron; Lloyd, Kelley E.; Oeschle, Amanda N.; McAllister, James P., II			Differential vulnerability of white matter structures to experimental infantile hydrocephalus detected by diffusion tensor imaging	CHILDS NERVOUS SYSTEM			English	Article						Infantile hydrocephalus; Diffusion tensor imaging; White matter	NORMAL-PRESSURE HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL OBSTRUCTIVE HYDROCEPHALUS; EXPERIMENTAL NEONATAL HYDROCEPHALUS; KAOLIN-INDUCED HYDROCEPHALUS; FRACTIONAL ANISOTROPY; ALZHEIMER-DISEASE; VENTRICULOPERITONEAL SHUNTS; CORTICOSPINAL TRACT; CLINICAL ARTICLE	The differential vulnerability of white matter (WM) to acute and chronic infantile hydrocephalus and the related effects of early and late reservoir treatment are unknown, but diffusion tensor imaging (DTI) could provide this information. Thus, we characterized WM integrity using DTI in a clinically relevant model. Obstructive hydrocephalus was induced in 2-week-old felines by intracisternal kaolin injection. Ventricular reservoirs were placed 1 (early) or 2 (late) weeks post-kaolin and tapped frequently based solely on neurological deficit. Hydrocephalic and age-matched control animals were sacrificed 12 weeks postreservoir. WM integrity was evaluated in the optic system, corpus callosum, and internal capsule prereservoir and every 3 weeks using DTI. Analyses were grouped as acute (< 6 weeks) or chronic (a parts per thousand yen6 weeks). In the corpus callosum during acute stages, fractional anisotropy (FA) decreased significantly with early and late reservoir placement (p = 0.0008 and 0.0008, respectively), and diffusivity increased significantly in early (axial, radial, and mean diffusivity, p = 0.0026, 0.0012, and 0.0002, respectively) and late (radial and mean diffusivity, p = 0.01 and 0.0038, respectively) groups. Chronically, the corpus callosum was thinned and not detectable by DTI. FA was significantly lower in the optic chiasm and tracts (p = 0.0496 and 0.0052, respectively) with late but not early reservoir placement. In the internal capsule, FA in both reservoir groups increased significantly with age (p < 0.05) but diffusivity remained unchanged. All hydrocephalic animals treated with intermittent ventricular reservoir tapping demonstrated progressive ventriculomegaly. Both reservoir groups demonstrated WM integrity loss, with the CC the most vulnerable and the optic system the most resilient.	[Eskandari, Ramin] Lucile Packard Childrens Hosp, Stanford Childrens Hlth, Palo Alto, CA USA; [Abdullah, Osama; McAllister, James P., II] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Mason, Cameron; Lloyd, Kelley E.; Oeschle, Amanda N.; McAllister, James P., II] Univ Utah, Primary Childrens Med Ctr, Dept Neurosurg, Div Pediat Neurosurg, Salt Lake City, UT USA	Eskandari, R (corresponding author), 96 Jonathon Lucas St,Suite 301 MSC 606, Charleston, SC 29425 USA.	eskandar@musc.edu	McAllister, James P./N-9657-2019		Mentored Young Investigator award from the Hydrocephalus Association; Department of Neurosurgery at the University of Utah	This work was supported in part by the Mentored Young Investigator award from the Hydrocephalus Association to Ramin Eskandari, MD, and James P. McAllister, PhD, and by the Department of Neurosurgery at the University of Utah. We thank Kristin Kraus, MSc, for her superb scientific editing skills; Marion L. Walker, MD, John R. W. Kestle, MD, and Jay Riva-Cambrin, MD for their inspiration and advice; Eric Burdett, DVM, Jack Taylor, DVM, Greg Burns, DVM, Ron Nielsen, DVM, Yunuen Coria, Liana Roberson, Reesha Dennis-Bishop, Jacqueline Brown, Brittani Delaney, Annette Rowberry, Misty Seppi, Kris Carlson, and Chase Bryan for their assistance with animal care and surgery. Implanted ventricular catheters and reservoirs were provided by Integra Scientific (Plainsboro, NJ, USA) and Medtronic (Medtronic Inc USA, Minneapolis, MN, USA).	Air EL, 2010, J NEUROSURG-PEDIATR, V5, P385, DOI 10.3171/2009.11.PEDS09343; Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Cancelliere A, 2013, AM J NEURORADIOL, V34, P1443, DOI 10.3174/ajnr.A3350; Castillo EM, 2009, NEUROREPORT, V20, P1188, DOI 10.1097/WNR.0b013e32832f0ca6; CHUMAS PD, 1994, J NEUROSURG, V80, P491, DOI 10.3171/jns.1994.80.3.0491; Ciumas C, 2014, BRAIN, V137, P1095, DOI 10.1093/brain/awu039; Del Bigio MR, 2012, J NEUROPATH EXP NEUR, V71, P274, DOI 10.1097/NEN.0b013e31824c1b44; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; Del Bigio MR, 2004, BRAIN PATHOL, V14, P317; Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453; Demura K, 2012, ACTA NEUROCHIR SUPPL, V113, P29, DOI 10.1007/978-3-7091-0923-6_6; Di Curzio DL, 2013, EXP NEUROL, V248, P112, DOI 10.1016/j.expneurol.2013.06.004; Eskandari R, 2004, J NEUROSURG, V101, P196, DOI 10.3171/ped.2004.101.2.0196; Eskandari R, 2012, CHILD NERV SYST, V28, P1849, DOI 10.1007/s00381-012-1848-z; Eskandari R, 2011, CHILD NERV SYST, V27, P2067, DOI 10.1007/s00381-011-1552-4; Feldman HM, 2012, DEV MED CHILD NEUROL, V54, P809, DOI 10.1111/j.1469-8749.2012.04378.x; George E, 2014, CHILD NERV SYST, V30, P1135, DOI 10.1007/s00381-013-2351-x; Griffith JL, 2012, PEDIATR RES, V71, P185, DOI 10.1038/pr.2011.33; Hasan KM, 2008, J NEUROSURG-PEDIATR, V2, P75, DOI 10.3171/PED/2008/2/7/075; Hattingen E, 2010, NEUROSURGERY, V66, P917, DOI 10.1227/01.NEU.0000367801.35654.EC; Hattori T, 2012, AM J NEURORADIOL, V33, P274, DOI 10.3174/ajnr.A2780; Hattori T, 2012, AM J NEURORADIOL, V33, P97, DOI 10.3174/ajnr.A2706; Hattori T, 2011, AM J NEURORADIOL, V32, P1681, DOI 10.3174/ajnr.A2570; Heemskerk AM, 2013, AM J NEURORADIOL, V34, P1496, DOI 10.3174/ajnr.A3465; HOCHWALD GM, 1969, EXP NEUROL, V25, P190, DOI 10.1016/0014-4886(69)90043-0; Ivkovic M, 2013, AM J NEURORADIOL, V34, P1168, DOI 10.3174/ajnr.A3368; Jang SH, 2011, NEUROREHABILITATION, V28, P345, DOI 10.3233/NRE-2011-0662; Jang SH, 2013, INT J NEUROSCI, V123, P420, DOI 10.3109/00207454.2012.763164; Jurcoane A, 2014, NEURORADIOLOGY, V56, P5, DOI 10.1007/s00234-013-1289-8; Kanno S, 2011, J NEUROL, V258, P1949, DOI 10.1007/s00415-011-6038-5; Kaur S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085807; KEONG NC, 2008, CLIN NEUROL NEUROSUR, V110, pS4; Khan OH, 2006, EXP NEUROL, V200, P311, DOI 10.1016/j.expneurol.2006.02.113; Kim MJ, 2011, AM J NEURORADIOL, V32, P1496, DOI 10.3174/ajnr.A2531; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Koyama T, 2013, NEUROL MED-CHIR, V53, P601; Koyama T, 2012, NEUROL MED-CHIR, V52, P68, DOI 10.2176/nmc.52.68; KRIEBEL RM, 1993, EXP NEUROL, V119, P89, DOI 10.1006/exnr.1993.1009; Kwon SH, 2014, CLIN PERINATOL, V41, P257, DOI 10.1016/j.clp.2013.10.003; Langevin LM, 2014, J PEDIATR-US, V164, P1157, DOI 10.1016/j.jpeds.2014.01.018; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Lepomaki V, 2012, PEDIATR RADIOL, V42, P692, DOI 10.1007/s00247-012-2352-z; Lepomaki VK, 2012, PEDIATR RADIOL, V42, P175, DOI 10.1007/s00247-011-2234-9; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; LOVELY TJ, 1989, J NEUROSCI METH, V29, P201, DOI 10.1016/0165-0270(89)90144-1; LOVELY TJ, 1989, NEUROSURGERY, V24, P43, DOI 10.1227/00006123-198901000-00007; Mahoney CJ, 2014, HUM BRAIN MAPP, V35, P4163, DOI 10.1002/hbm.22468; Marumoto K, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-20; Mathur AM, 2010, SEMIN PERINATOL, V34, P57, DOI 10.1053/j.semperi.2009.10.006; McAllister II JP, 2011, YOUMANS TXB NEUROLOG, P2002; McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004; MCALLISTER JP, 1991, NEUROSURGERY, V29, P329, DOI 10.1227/00006123-199109000-00001; McAllister JP, 1998, NEUROSURG CLIN N AM, V9, P73; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Nicot B, 2014, ACTA RADIOL, V55, P614, DOI 10.1177/0284185113504570; Osuka S, 2010, J NEUROSURG, V112, P832, DOI 10.3171/2009.7.JNS09550; Rajagopal A, 2013, AM J NEURORADIOL, V34, P2379, DOI 10.3174/ajnr.A3737; SAHAR A, 1969, ARCH NEUROL-CHICAGO, V21, P638, DOI 10.1001/archneur.1969.00480180094009; Scheel M, 2012, ACTA NEUROCHIR, V154, P1699, DOI 10.1007/s00701-012-1377-2; Song YJC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084825; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sun M, 2012, CHILD NERV SYST, V28, P199, DOI 10.1007/s00381-011-1651-2; Sun SW, 2014, J ALZHEIMERS DIS, V38, P93, DOI 10.3233/JAD-130236; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Teipel SJ, 2014, EUR ARCH PS IN PRESS; Teipel SJ, 2013, MED CLIN N AM, V97, P399, DOI 10.1016/j.mcna.2012.12.013; Thompson DK, 2014, CORTEX, V52, P60, DOI 10.1016/j.cortex.2013.11.010; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; WRIGHT LC, 1991, PEDIATR NEUROSURG, V16, P139; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan W, 2013, AM J NEURORADIOL, V34, P439, DOI 10.3174/ajnr.A3218; Yuan W, 2009, AM J NEURORADIOL, V30, P1792, DOI 10.3174/ajnr.A1663; Yuan W, 2009, CEREBROSPINAL FLUID, V6, pS14; Yuan W, 2013, J PEDIATR NEURORADIO, V2, P119, DOI 10.3233/PNR-13052; Yuan WH, 2012, CHILD NERV SYST, V28, P47, DOI 10.1007/s00381-011-1590-y; Yuan WH, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-19; Zhang X, 2013, J CLIN CELL IMMUNO S, V7; Zhang X, 2014, CHINESE MED J-PEKING, V127, P532, DOI 10.3760/cma.j.issn.0366-6999.20123147	91	14	14	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2014	30	10					1651	1661		10.1007/s00381-014-2500-x			11	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AP7US	WOS:000342283200004	25070594	Bronze			2021-06-18	
J	Kurki, T; Himanen, L; Vuorinen, E; Myllyniemi, A; Saarenketo, AR; Kauko, T; Brandstack, N; Tenovuo, O				Kurki, Timo; Himanen, Leena; Vuorinen, Elina; Myllyniemi, Anna; Saarenketo, Anna-Riitta; Kauko, Tommi; Brandstack, Nina; Tenovuo, Olli			Diffusion tensor tractography-based analysis of the cingulum: clinical utility and findings in traumatic brain injury with chronic sequels	NEURORADIOLOGY			English	Article						Traumatic brain injury; Traumatic axonal injury; Diffusion tensor imaging; Diffusion tensor tractography	WHITE-MATTER INJURY; AXONAL INJURY; COGNITIVE IMPAIRMENT; WORKING-MEMORY; VOLUME CHANGES; CONNECTIVITY; CHILDREN; TRACTS; MRI; REPRODUCIBILITY	Introduction To evaluate the clinical utility of quantitative diffusion tensor tractography (DTT) and tractography-based core analysis (TBCA) of the cingulum by defining the reproducibility, normal values, and findings in traumatic brain injury (TBI). Methods Eighty patients with TBI and normal routine MRI and 78 controls underwent MRI at 3T. To determine reproducibility, 12 subjects were scanned twice. Superior (SC) and inferior (IC) cingulum were analyzed separately by DTT (fractional anisotropy (FA) thresholds 0.15 and 0.30). TBCA was performed from volumes defined by tractography with gradually changed FA thresholds. FA values were correlated with clinical and neuropsychological data. Results The lowest coefficient of variation was obtained at DTT threshold 0.30 (2.0 and 2.4 % for SC and IC, respectively), but in proportion to standard deviations of normal controls, the reproducibility of TBCA was better in SC and similar to that of DTT in IC. In patients with TBI, volume reduction with loss of peripheral fibers was relatively common; mean FA was mostly normal in these tractograms. The frequency of FA reductions (>2 SD) was in DTT smaller than in TBCA, in which FA decrease was present in 42 (13.1 %) of the 320 measurements. Central FA values in SC predicted visuoperceptual ability, and those in left IC predicted cognitive speed, language, and communication ability (p<0.05). Conclusion Tractography-based measurements have sufficient reproducibility for demonstration of severe abnormalities of the cingulum. TBCA is preferential for clinical FA analysis, because it measures corresponding areas in patients and controls without inaccuracies due to trauma-induced structural changes.	[Kurki, Timo; Brandstack, Nina] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland; [Kurki, Timo] Terveystalo Pulssi Med Ctr, MRI Unit, Turku, Finland; [Himanen, Leena; Vuorinen, Elina; Myllyniemi, Anna; Saarenketo, Anna-Riitta] NeuTera Neuropsychologist Ctr, Turku, Finland; [Kauko, Tommi] Univ Turku, Dept Biostat, Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, FIN-20520 Turku, Finland; [Tenovuo, Olli] Univ Turku, Turku, Finland; [Brandstack, Nina] Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland	Kurki, T (corresponding author), Terveystalo Pulssi Med Ctr, MRI Unit, Turku, Finland.	kurti@suomi24.fi		Kurki, Timo/0000-0001-5532-3534; Himanen, Leena/0000-0001-7261-8027			Alegret M, 2012, J ALZHEIMERS DIS, V30, P109, DOI 10.3233/JAD-2012-111850; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Borich MR, 2012, NEUROIMAGE, V59, P2393, DOI 10.1016/j.neuroimage.2011.09.009; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Catani M., 2012, ATLAS HUMAN BRAIN CO; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2013, NEUROSCI LETT, V543, P47, DOI 10.1016/j.neulet.2013.02.058; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kurki TJI, 2013, J MAGN RESON IMAGING, V38, P46, DOI 10.1002/jmri.23901; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Nandigam RNK, 2007, J NEUROIMAGING, V17, P74, DOI 10.1111/j.1552-6569.2006.00069.x; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rudrauf D, 2008, CORTEX, V44, P1084, DOI 10.1016/j.cortex.2008.05.005; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sasson E, 2012, BRAIN STRUCT FUNCT, V217, P503, DOI 10.1007/s00429-011-0344-7; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Torta DM, 2011, NEUROIMAGE, V56, P2157, DOI 10.1016/j.neuroimage.2011.03.066; van Huijzen, 2008, HUMAN CENTRAL NERVOU; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang SM, 2005, ANN NY ACAD SCI, V1064, P61, DOI 10.1196/annals.1340.013; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	45	14	15	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	OCT	2014	56	10					833	841		10.1007/s00234-014-1410-7			9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AS5ZZ	WOS:000344346100004	25080234				2021-06-18	
J	Maia, PD; Kutz, JN				Maia, Pedro D.; Kutz, J. Nathan			Compromised axonal functionality after neurodegeneration, concussion and/or traumatic brain injury	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Neurodegenerative diseases; Traumatic brain injury; Concussion; Alzheimer; Parkinson; Axonal Swellings; Axonal Computation; Spike train metrics	ACTION-POTENTIAL PROPAGATION; MILD; ABNORMALITIES; MECHANISMS; TRANSPORT; PATHOLOGY; BREAKAGE; DEMENTIA; DYNAMICS	Axonal swellings are almost universal in neurodegenerative diseases of the central nervous system, including Alzheimer's and Parkinson's disease. Concussions and traumatic brain injuries can also produce cognitive and behavioral deficits by compromising neuronal morphology. Using a spike metric analysis, we characterize computationally the effects of such axonal varicosities on spike train propagation by comparing Poisson spike train classes before and after propagation through a prototypical axonal enlargement, or focused axonal swelling. Misclassification of spike train classes and low-pass filtering of firing rate activity increases with more pronounced axonal injury. We show that confusion matrices and a calculation of the loss of transmitted information provide a very practical way to characterize how injured neurons compromise the signal processing and faithful conductance of spike trains. The method demonstrates that (i) neural codes encoded with low firing rates are more robust to injury than those encoded with high firing rates, (ii) classification depends upon the length of the spike train used to encode information, and (iii) axonal injuries reduce the variance of spike trains within a given stimulus class. The work introduces a novel theoretical and computational framework to quantify the interplay between electrophysiological dynamics with focused axonal swellings generated by injury or other neurodegenerative processes. It further suggests how pharmacology and plasticity may play a role in recovery of neural computation. Ultimately, the work bridges vast experimental observations of in vitro morphological pathologies with post-traumatic cognitive and behavioral dysfunction.	[Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Maia, PD (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	pmaia@u.washington.edu; kutz@uw.edu		D. Maia, Pedro/0000-0002-3335-4257			Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Altenberger R, 2001, J NEUROSCI METH, V112, P101, DOI 10.1016/S0165-0270(01)00456-3; Antic S, 2000, J PHYSIOL-LONDON, V527, P55, DOI 10.1111/j.1469-7793.2000.00055.x; Aronov D., 2005, PHYS REV E, V69; Bakkum DJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3181; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001; Chen W.R., 2002, J NEUROPHYSIOL, V88; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Dayan P., 2001, THEORETICAL NEUROSCI; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Ermentrout G. B., 2010, MATH FDN NEUROSCIENC; Ermentrout GB, 1996, SIAM J APPL MATH, V56, P1107, DOI 10.1137/S0036139994276793; Fainaru-Wada M., 2013, CROWN ARCHETYPE; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Gerstner W., 2002, SPIKING NEURON MODEL; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich E. M., 2007, DYNAMICAL SYSTEMS NE, V1st; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Khodorov B.I., 1975, Progress Biophys Molec Biol, V30, P145; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Kutz J.N., 2013, DATA DRIVEN MODELING; Liberski PP, 1999, ACTA NEUROPATHOL, V97, P329, DOI 10.1007/s004010050995; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Magdesian MH, 2012, BIOPHYS J, V103, P405, DOI 10.1016/j.bpj.2012.07.003; Maia P.D., 2014, J COMPUTATIONAL NEUR, V36, P55; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; PARNAS I, 1972, J NEUROPHYSIOL, V35, P903; Parnas I., 1976, J NEUROPHYSIOLOGY, V39; Parnas I., 1979, NEUROSCIENCES, P499; RAMON F, 1975, FED PROC, V34, P1357; Rinzel J., 1990, ANN NEW YORK ACAD SC, V591; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scott A., 2002, NEUROSCIENCE MATH PR; Segev I, 1999, J PHYSIOLOGY-PARIS, V93, P263, DOI 10.1016/S0928-4257(00)80055-8; Shepherd G.M.G., 1998, J NEUROSCIENCE, V18; Smith DH, 1999, J NEUROSCI, V19, P4263; SMITH DO, 1980, J PHYSIOL-LONDON, V301, P243, DOI 10.1113/jphysiol.1980.sp013202; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Victor JD, 2005, CURR OPIN NEUROBIOL, V15, P585, DOI 10.1016/j.conb.2005.08.002; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; ZHOU Y, 1994, MATH BIOSCI, V119, P169, DOI 10.1016/0025-5564(94)90075-2	63	14	14	0	24	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	OCT	2014	37	2					317	332		10.1007/s10827-014-0504-x			16	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	AP4QG	WOS:000342062400010	24916135				2021-06-18	
J	Neuberger, EJ; Wahab, RA; Jayakumar, A; Pfister, BJ; Santhakumar, V				Neuberger, Eric J.; Wahab, Radia Abdul; Jayakumar, Archana; Pfister, Bryan J.; Santhakumar, Vijayalakshmi			Distinct Effect of Impact Rise Times on Immediate and Early Neuropathology After Brain Injury in Juvenile Rats	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; neuronal cell death; electrophysiology; dentate gyrus; neuroexcitation	FLUID PERCUSSION INJURY; WHITE-MATTER; BLAST INJURY; MOUSE MODEL; IN-VITRO; EPILEPSY; NEURONS; TISSUE; HYPEREXCITABILITY; MECHANISMS	Traumatic brain injury (TBI) can occur from physical trauma from a wide spectrum of insults ranging from explosions to falls. The biomechanics of the trauma can vary in key features, including the rate and magnitude of the insult. Although the effect of peak injury pressure on neurological outcome has been examined in the fluid percussion injury (FPI) model, it is unknown whether differences in rate of rise of the injury waveform modify cellular and physiological changes after TBI. Using a programmable FPI device, we examined juvenile rats subjected to a constant peak pressure at two rates of injury: a standard FPI rate of rise and a faster rate of rise to the same peak pressure. Immediate postinjury assessment identified fewer seizures and relatively brief loss of consciousness after fast-rise injuries than after standard-rise injuries at similar peak pressures. Compared with rats injured at standard rise, fewer silver-stained injured neuronal profiles and degenerating hilar neurons were observed 4-6 hr after fast-rise FPI. However, 1 week postinjury, both fast-and standard-rise FPI resulted in hilar cell loss and enhanced perforant path-evoked granule cell field excitability compared with sham controls. Notably, the extent of neuronal loss and increase in dentate excitability were not different between rats injured at fast and standard rates of rise to peak pressure. Our data indicate that reduced cellular damage and improved immediate neurological outcome after fast rising primary concussive injuries mask the severity of the subsequent cellular and neurophysiological pathology and may be unreliable as a predictor of prognosis. (C) 2014 Wiley Periodicals, Inc.	[Neuberger, Eric J.; Jayakumar, Archana; Santhakumar, Vijayalakshmi] Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Wahab, Radia Abdul; Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Santhakumar, Vijayalakshmi] Rutgers State Univ, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Santhakumar, V (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, MSB H-512,185 S Orange Ave, Newark, NJ 07103 USA.	santhavi@njms.rutgers.edu	Santhakumar, Viji/K-4856-2019	Santhakumar, Viji/0000-0001-6278-4187	NJCBIR [CBIR11PJT003, 09.003-BIR1]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069861]; F.M, Kirby Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861] Funding Source: NIH RePORTER	Contract grant sponsor: NJCBIR, contract grant numbers: CBIR11PJT003; 09.003-BIR1; Contract grant sponsor: NIH/NINDS, contract grant number: NS069861; Contract grant sponsor: F.M, Kirby Foundation (to V.S.).	Abdul-Wahab R, 2011, NORTHEAST BIOENGIN C; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; [Anonymous], 2002, STROKE; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chauhan NB, 2014, RESTOR NEUR IN PRESS; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; ENGEL J, 1998, EPILEPSY COMPREHENSI; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Huh JW, 2011, J NEUROTRAUM, V28, P245, DOI 10.1089/neu.2010.1639; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; JESTER JM, 1995, J PHYSIOL-LONDON, V484, P689, DOI 10.1113/jphysiol.1995.sp020696; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; MANEV H, 1989, MOL PHARMACOL, V36, P106; Morrison B., 2003, STAPP CAR CRASH J, V47, P93; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Santhakumar V, 2003, J NEUROSCI, V23, P5865; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Toth Z, 1997, J NEUROSCI, V17, P8106; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; VANDENPOL AN, 1990, J COMP NEUROL, V296, P654, DOI 10.1002/cne.902960410; Vappou J, 2007, MAGN RESON MATER PHY, V20, P273, DOI 10.1007/s10334-007-0098-7; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yu JD, 2013, J NEUROPHYSIOL, V109, P1746, DOI 10.1152/jn.00891.2012; Zhang Jiangyue, 2006, Annu Proc Assoc Adv Automot Med, V50, P1; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhang Jiangyue, 2009, Ann Adv Automot Med, V53, P249; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215	69	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2014	92	10					1350	1361		10.1002/jnr.23401			12	Neurosciences	Neurosciences & Neurology	AN3QX	WOS:000340504500012	24799156	Other Gold, Green Accepted			2021-06-18	
J	Ploplis, VA; Donahue, DL; Sandoval-Cooper, MJ; MorenoCaffaro, M; Sheets, P; Thomas, SG; Walsh, M; Castellino, FJ				Ploplis, Victoria A.; Donahue, Deborah L.; Sandoval-Cooper, Mayra J.; MorenoCaffaro, Maria; Sheets, Patrick; Thomas, Scott G.; Walsh, Mark; Castellino, Francis J.			Systemic Platelet Dysfunction Is the Result of Local Dysregulated Coagulation and Platelet Activation in the Brain in a Rat Model of Isolated Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; coagulopathy; platelet dysfunction	TISSUE FACTOR; COAGULOPATHY	Coagulopathy after severe traumatic brain injury (TBI) has been extensively reported. Clinical studies have identified a strong relationship between diminished platelet-rich thrombus formation, responsiveness to adenosine diphosphate agonism, and severity of TBI. The mechanisms that lead to platelet dysfunction in the acute response to TBI are poorly understood. The development of a rodent model of TBI that mimics the coagulopathy observed clinically has recently been reported. Using immunohistochemical techniques and thromboelastography platelet mapping, the current study demonstrated that the expression of coagulation (tissue factor and fibrin) and platelet activation (P-selectin) markers in the injured brain paralleled the alteration in systemic platelet responsiveness to the agonists, adenosine diphosphate and arachodonic acid. Results of this study demonstrate that local procoagulant changes in the injured brain have profound effects on systemic platelet function.	[Ploplis, Victoria A.; Donahue, Deborah L.; Sandoval-Cooper, Mayra J.; MorenoCaffaro, Maria; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Sheets, Patrick] Indiana Univ Sch Med South Bend, South Bend, IN USA; [Thomas, Scott G.; Walsh, Mark] Mem Hosp South Bend, South Bend, IN USA	Ploplis, VA (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA.	vploplis@nd.edu		Walsh, Mark/0000-0002-5795-1144	NIH NHLBI grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL019982]; Haemonetics Corporation (Braintree, MA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL019982] Funding Source: NIH RePORTER	This study was supported in parts from a NIH NHLBI grant (HL019982 to FJC) and a reagent grant from Haemonetics Corporation (Braintree, MA).	Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Utter GH, 2002, J TRAUMA, V52, P1071, DOI 10.1097/00005373-200206000-00008	17	14	14	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2014	31	19					1672	1675		10.1089/neu.2013.3302			4	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AP5VI	WOS:000342146400009	24605991	Green Published			2021-06-18	
J	Hwang, DW; Jin, Y; Lee, DH; Kim, HY; Cho, HN; Chung, HJ; Park, Y; Youn, H; Lee, SJ; Lee, HJ; Kim, SU; Wang, KC; Lee, DS				Hwang, Do Won; Jin, Yeona; Lee, Do Hun; Kim, Han Young; Cho, Han Na; Chung, Hye Jin; Park, Yunwoong; Youn, Hyewon; Lee, Seung Jin; Lee, Hong J.; Kim, Seung U.; Wang, Kyu-Chang; Lee, Dong Soo			In Vivo Bioluminescence Imaging for Prolonged Survival of Transplanted Human Neural Stem Cells Using 3D Biocompatible Scaffold in Corticectomized Rat Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; PROGENITOR CELLS; FIREFLY LUCIFERASE; MOTOR FUNCTION; SPINAL-CORD; TISSUE; DIFFERENTIATION; EXPRESSION	Stem cell-based treatment of traumatic brain injury has been limited in its capacity to bring about complete functional recovery, because of the poor survival rate of the implanted stem cells. It is known that biocompatible biomaterials play a critical role in enhancing survival and proliferation of transplanted stem cells via provision of mechanical support. In this study, we noninvasively monitored in vivo behavior of implanted neural stem cells embedded within poly-L-lactic acid (PLLA) scaffold, and showed that they survived over prolonged periods in corticectomized rat model. Corticectomized rat models were established by motor-cortex ablation of the rat. F3 cells expressing enhanced firefly luciferase (F3-effLuc) were established through retroviral infection. The F3-effLuc within PLLA was monitored using IVIS-100 imaging system 7 days after corticectomized surgery. F3-effLuc within PLLA robustly adhered, and gradually increased luciferase signals of F3-effLuc within PLLA were detected in a day dependent manner. The implantation of F3-effLuc cells/PLLA complex into corticectomized rats showed longer-lasting luciferase activity than F3-effLuc cells alone. The bioluminescence signals from the PLLA-encapsulated cells were maintained for 14 days, compared with 8 days for the non-encapsulated cells. Immunostaining results revealed expression of the early neuronal marker, Tuj-1, in PLLA-F3-effLuc cells in the motor-cortexablated area. We observed noninvasively that the mechanical support by PLLA scaffold increased the survival of implanted neural stem cells in the corticectomized rat. The image-guided approach easily proved that scaffolds could provide supportive effect to implanted cells, increasing their viability in terms of enhancing therapeutic efficacy of stem-cell therapy.	[Hwang, Do Won; Jin, Yeona; Kim, Han Young; Park, Yunwoong; Youn, Hyewon; Lee, Dong Soo] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Hwang, Do Won; Kim, Han Young; Lee, Dong Soo] Seoul Natl Univ, WCU Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Lee, Do Hun] Univ Miami, Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Cho, Han Na; Chung, Hye Jin; Lee, Seung Jin] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ, Canc Hosp, Canc Imaging Ctr, Seoul, South Korea; [Youn, Hyewon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Hong J.; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Wang, Kyu-Chang] Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea	Wang, KC (corresponding author), Seoul Natl Univ, Childrens Hosp, Div Pediat Neurosurg, Seoul, South Korea.	kcwang@sun.ac.kr; dsl@plaza.snu.ac.kr		Youn, Hyewon/0000-0003-1006-2689	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2008799]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1299]	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2008799), and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1299). The funders had no role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Biernaskie J, 2005, EUR J NEUROSCI, V21, P989, DOI 10.1111/j.1460-9568.2005.03899.x; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gonzalez CLR, 2004, EUR J NEUROSCI, V20, P3442, DOI 10.1111/j.1460-9568.2004.03751.x; Hermanns S, 2001, J NEUROSCI METH, V110, P141, DOI 10.1016/S0165-0270(01)00427-7; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Hwang DW, 2008, EUR J NUCL MED MOL I, V35, P1887, DOI 10.1007/s00259-008-0751-z; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jung MR, 2011, J CONTROL RELEASE, V152, P294, DOI 10.1016/j.jconrel.2011.03.002; Lee DH, 2009, CHILD NERV SYST, V25, P1547, DOI 10.1007/s00381-009-0973-9; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Payne RG, 2002, BIOMATERIALS, V23, P4373, DOI 10.1016/S0142-9612(02)00185-0; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rafuse VF, 2005, NEUROSCIENCE, V131, P899, DOI 10.1016/j.neuroscience.2004.11.048; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023; Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sitthinamsuwan Bunpot, 2013, Journal of the Medical Association of Thailand, V96, P121; Srouji S, 2006, REGEN MED, V1, P519, DOI 10.2217/17460751.1.4.519; Tabata Yasuhiko, 2004, Congenital Anomalies, V44, P111, DOI 10.1111/j.1741-4520.2004.00024.x; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Zhang X, 2013, SEIZURE, V9, P1059	41	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2014	9	9							e105129	10.1371/journal.pone.0105129			11	Multidisciplinary Sciences	Science & Technology - Other Topics	AO4JX	WOS:000341304700014	25198726	DOAJ Gold, Green Published			2021-06-18	
J	Arenivas, A; Diaz-Arrastia, R; Spence, J; Cullum, CM; Krishnan, K; Bosworth, C; Culver, C; Kennard, B; de la Plata, CM				Arenivas, Ana; Diaz-Arrastia, Ramon; Spence, Jeffrey; Cullum, C. Munro; Krishnan, Kamini; Bosworth, Christopher; Culver, Carlee; Kennard, Beth; de la Plata, Carlos Marquez			Three approaches to investigating functional compromise to the default mode network after traumatic axonal injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Default mode network; Functional connectivity; TBI; Biomarker; Outcome; Traumatic axonal injury	RESTING-STATE NETWORKS; DIFFUSION TENSOR; STRUCTURAL CONNECTIVITY; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; PREFRONTAL CORTEX; CINGULATE CORTEX; BRAIN ACTIVITY; EARLY-STAGE; SCHIZOPHRENIA	The default mode network (DMN) is a reliably elicited functional neural network with potential clinical implications. Its discriminant and prognostic utility following traumatic axonal injury (TAI) have not been previously investigated. The present study used three approaches to analyze DMN functional connectedness, including a whole-brain analysis [A1], network-specific analysis [A2], and between-node (edge) analysis [A3]. The purpose was to identify the utility of each method in distinguishing between healthy and brain-injured individuals, and determine whether observed differences have clinical significance. Resting-state fMRI was acquired from 25 patients with TAI and 17 healthy controls. Patients were scanned 6-11 months post-injury, and functional and neurocognitive outcomes were assessed the same day. Using all three approaches, TAI subjects revealed significantly weaker functional connectivity (FC) than controls, and binary logistic regressions demonstrated all three approaches have discriminant value. Clinical outcomes were not correlated with FC using any approach. Results suggest that compromise to the functional connectedness of the DMN after TAI can be identified using resting-state FC; however, the degree of functional compromise to this network, as measured in this study, may not have clinical implications in chronic TAI.	[Arenivas, Ana; Cullum, C. Munro; Krishnan, Kamini; Bosworth, Christopher; Kennard, Beth; de la Plata, Carlos Marquez] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon; Cullum, C. Munro] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Spence, Jeffrey] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Clin Sci, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA; [Culver, Carlee; de la Plata, Carlos Marquez] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75235 USA	de la Plata, CM (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 W Mockingbird Ln, Dallas, TX 75235 USA.	c.marquez@utdallas.edu	Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465; Diaz-Arrastia, Ramon/0000-0001-6051-3594	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS060827]; National Institutes of Health/National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD48179, U01 HD42652]; Department of EducationUS Department of Education [H133 A020526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS060827, ZIANS003138] Funding Source: NIH RePORTER	This research was supported by funding to C. Marquez de la Plata (National Institutes of Health/National Institute of Neurological Disorders and Stroke K23 NS060827) and R. Diaz-Arrastia (National Institutes of Health/National Institute of Child Health and Human Development R01 HD48179, U01 HD42652, and Department of Education H133 A020526).	Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Delis DC, 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Duong MVA, 2005, J CEREBR BLOOD F MET, V25, P1245, DOI 10.1038/sj.jcbfm.9600122; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Firbank MJ, 2007, NEUROIMAGE, V36, P1, DOI 10.1016/j.neuroimage.2007.02.027; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lowe MJ, 2010, MAGN RESON MATER PHY, V23, P279, DOI 10.1007/s10334-010-0230-y; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Spreen O., 1977, NEUROSENSORY CTR COM; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; Swanson N, 2011, HUM BRAIN MAPP, V32, P654, DOI 10.1002/hbm.21055; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	67	14	15	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2014	8	3			SI		407	419		10.1007/s11682-012-9191-2			13	Neuroimaging	Neurosciences & Neurology	AP9ZR	WOS:000342441400010	22847713				2021-06-18	
J	Pang, L; Wang, HL; Wang, ZH; Wu, Y; Dong, N; Xu, DH; Wang, DW; Xu, H; Zhang, N				Pang, Li; Wang, He-Lei; Wang, Zhi-Hao; Wu, Yang; Dong, Ning; Xu, Da-Hai; Wang, Da-Wei; Xu, Hong; Zhang, Nan			Plasma copeptin as a predictor of intoxication severity and delayed neurological sequelae in acute carbon monoxide poisoning	PEPTIDES			English	Article						Biomarker; Carbon monoxide poisoning; Copeptin; Delayed neurological sequelae; Severity	TRAUMATIC BRAIN-INJURY; VASOPRESSIN PRECURSOR; PROGNOSTIC BIOMARKER; EMERGENCY-DEPARTMENT; STABLE PEPTIDE; S100B PROTEIN; MORTALITY; HEMORRHAGE; MARKER	The present study was designed to assess the usefulness of measuring plasma levels of copeptin (a peptide co-released with the hypothalamic stress hormone vasopressin) as a biomarker for the severity of carbon monoxide (CO) poisoning and for predicting delayed neurological sequelae (DNS). Seventy-two patients with CO poisoning and 72 sex and age matched healthy individuals were recruited. Plasma copeptin levels were measured on admission from CO poisoning patients and for healthy individuals at study entry by using a sandwich immunoassay. The CO poisoning patients were divided into two groups according to severity (unconscious and conscious) and occurrence of DNS. The mean plasma copeptin levels (52.5 +/- 18.5 pmol/L) in the unconscious group were significantly higher than in the conscious group (26.3 +/- 12.7 pmol/L) (P < 0.001). Plasma copeptin levels of more than 39.0 pmol/L detected CO poisoning with severe neurological symptoms e.g. unconsciousness (sensitivity 84.6% and specificity 81.4%). The plasma copeptin levels were higher in patients with DNS compared to patients without DNS (52.2 +/- 20.6 pmol/L vs. 27.9 +/- 14.8 pmol/L, P < 0.001). Plasma copeptin levels higher than 40.5 pmol/L predicted the development of DNS (sensitivity 77.8%, specificity 82.1%). Plasma copeptin levels were identified as an independent predictor for intoxication severity [odds ratio (OR) 1.261,95% confidence interval (CI) 1.112-1.638,P = 0.002] and DNS (OR 1.313,95% CI 1.106-1.859,P = 0.001). Thus, plasma copeptin levels independently related to intoxication severity and were identified as a novel biomarker for predicting DNS after acute CO poisoning. (C) 2014 Elsevier Inc. All rights reserved.	[Pang, Li; Wang, Zhi-Hao; Wu, Yang; Dong, Ning; Xu, Da-Hai; Wang, Da-Wei; Zhang, Nan] Jilin Univ, Hosp 1, Dept Emergency, Changchun 130021, Peoples R China; [Wang, He-Lei; Xu, Hong] Jilin Univ, Hosp 1, Dept Surg Gastroenterol, Changchun 130021, Peoples R China	Xu, H (corresponding author), Jilin Univ, Hosp 1, Dept Surg Gastroenterol, 71 Xinmin Rd, Changchun 130021, Peoples R China.	187211618@qq.com; 466634002@qq.com	wang, helei/AAF-2533-2020		Youth Development Foundation of the First Hospital of Jilin University	This study was supported by research grants from the Youth Development Foundation of the First Hospital of Jilin University. We thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.	Brvar M, 2004, RESUSCITATION, V61, P357, DOI 10.1016/j.resuscitation.2004.01.009; Deschamps D, 2003, OCCUP ENVIRON MED, V60, P212, DOI 10.1136/oem.60.3.212; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Hu HJ, 2011, AM J EMERG MED, V29, P261, DOI 10.1016/j.ajem.2009.09.030; Kao HK, 2009, PULM PHARMACOL THER, V22, P473, DOI 10.1016/j.pupt.2009.04.006; Katan M, 2011, NEUROLOGY, V76, P563, DOI 10.1212/WNL.0b013e31820b75e6; Katan M, 2010, SWISS MED WKLY, V140, P11, DOI 10.4414/smw.2010.13101; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Nickel CH, 2011, ACAD EMERG MED, V18, P851, DOI 10.1111/j.1553-2712.2011.01126.x; Pang L, 2013, J BIOCHEM MOL TOXIC, V27, P266, DOI 10.1002/jbt.21484; Parkinson RB, 2002, NEUROLOGY, V58, P1525, DOI 10.1212/WNL.58.10.1525; Rasmussen LS, 2004, ACTA ANAESTH SCAND, V48, P469, DOI 10.1111/j.1399-6576.2004.00362.x; Raub JA, 2000, TOXICOLOGY, V145, P1, DOI 10.1016/S0300-483X(99)00217-6; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Stolz D, 2007, CHEST, V131, P1058, DOI 10.1378/chest.06-2336; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Yardan T, 2009, AM J EMERG MED, V27, P838, DOI 10.1016/j.ajem.2008.04.016; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Zhang X, 2012, PEPTIDES, V33, P336, DOI 10.1016/j.peptides.2012.01.011; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575	24	14	17	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	SEP	2014	59						89	93		10.1016/j.peptides.2014.07.007			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AO5ZT	WOS:000341427300014	25038511				2021-06-18	
J	Wang, YP; Hameed, MQ; Rakhade, SN; Iglesias, AH; Muller, PA; Mou, DL; Rotenberg, A				Wang, Yingpeng; Hameed, Mustafa Q.; Rakhade, Sanjay N.; Iglesias, Antonio H.; Muller, Paul A.; Mou, Dan-Lei; Rotenberg, Alexander			Hippocampal immediate early gene transcription in the rat fluid percussion traumatic brain injury model	NEUROREPORT			English	Article						glutamate; hippocampus; immediate early gene (IEG); MK801; N-methyl-D-aspartate; traumatic brain injury	NERVOUS-SYSTEM; EXPRESSION; APOPTOSIS; EPILEPSY; DENSITY; BDNF; FOS	Traumatic brain injury (TBI) is one of the leading causes of neurological disability and death in the USA across all age groups, ethnicities, and incomes. In addition to the short-term morbidity and mortality, TBI leads to epilepsy and severe neurocognitive symptoms, both of which are referenced to post-traumatic hippocampal dysfunction, although the mechanisms of such hippocampal dysfunction are incompletely understood. Here, we study the temporal profile of the transcription of three select immediate early gene (IEG) markers of neuronal hyperactivation, plasticity, and injury, c-fos, brain-derived neurotrophic factor (BDNF), and Bax, in the acute period following the epileptogenic lateral fluid percussion injury in a rodent TBI model. We found that lateral fluid percussion injury leads to enhanced expression of the selected IEGs within 24 h of TBI. Specifically, BDNF and c-fos increase maximally 1-6 h after TBI in the ipsilesional hippocampus, whereas Bax increases in the hippocampus bilaterally in this time window. Antagonism of the N-methyl-D-aspartate-type glutamate receptor by MK801 attenuates the increase in BDNF and Bax, which underscores a therapeutic role for N-methyl-D-aspartate-type glutamate receptor antagonism in the acute post-traumatic time period and suggests a value to a hippocampal IEG readout as an outcome after injury or acute therapeutic intervention. (c) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Wang, Yingpeng; Hameed, Mustafa Q.; Rakhade, Sanjay N.; Muller, Paul A.; Rotenberg, Alexander] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Hameed, Mustafa Q.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Iglesias, Antonio H.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Wang, Yingpeng] Beijing Aerosp Gen Hosp, Dept Neurol, Beijing, Peoples R China; [Mou, Dan-Lei] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China	Rotenberg, A (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	alexander.rotenberg@childrens.harvard.edu	Hameed, Mustafa/G-3677-2014	Hameed, Mustafa/0000-0003-4004-5564	Boston Children's Hospital; Department of DefenseUnited States Department of Defense [PT073873]	The authors thank Dr Roman Gersner for his advice related to statistical analysis. This work was supported by the Boston Children's Hospital Translational Research Program (A.R.) and the Department of Defense PT073873 (A.R.).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Barwood CHS, 2013, BRAIN INJURY, V27, P671, DOI 10.3109/02699052.2013.775500; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Colak T, 2012, INJURY, V43, P1264, DOI 10.1016/j.injury.2012.01.021; Conti AC, 1998, J NEUROSCI, V18, P5663; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; Han Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064894; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Luo Chun, 2002, Chin J Traumatol, V5, P24; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Miyazaki S, 1989, INTRACRANIAL PRESSUR, P651; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Wang HC, 2014, NEUROCRIT CARE, V20, P119, DOI 10.1007/s12028-013-9944-9	25	14	14	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 20	2014	25	12					954	959		10.1097/WNR.0000000000000219			6	Neurosciences	Neurosciences & Neurology	AM9DN	WOS:000340180400013	24978397				2021-06-18	
J	Kaufman, DR; Puckett, MJ; Smith, MJ; Wilson, KS; Cheema, R; Landers, MR				Kaufman, Denise R.; Puckett, Mallory J.; Smith, Mitchell J.; Wilson, Kyle S.; Cheema, Rebecca; Landers, Merrill R.			Test-retest reliability and responsiveness of gaze stability and dynamic visual acuity in high school and college football players	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Vestibulo-ocular reflex; Reliability; responsiveness	TRAUMATIC BRAIN-INJURY; VESTIBULAR DYSFUNCTION; VESTIBULOOCULAR REFLEX; POSTURAL STABILITY; STABILIZATION TEST; HEAD-INJURY; CONCUSSION; DEFICITS; DIZZINESS; PERFORMANCE	Objectives: The purpose of this study was to establish reliability and responsiveness of the dynamic visual acuity test (DVAT) at head speeds of 150-200 degrees per second (deg/s) and the gaze stabilization test (GST) in high school and college football players. Design: Reliability design. Participants: Fifty high school and college football athletes completed the DVAT and GST in both the yaw (horizontal) and pitch (vertical) planes twice within two weeks. Results: Test-retest reliability for the DVAT was good in yaw, Intraclass Correlation Coefficient (ICC) = 0.770, and moderate/good in pitch, ICC = 0.725. Minimal detectable change (MDC) was 0.16 logMAR for yaw and 0.21 logMAR for pitch. GST reliability was moderate in yaw, ICC = 0.634, and poor in pitch, ICC = 0.411. MDCs were 73.4 deg/s (yaw) and 81.2 deg/s (pitch). Conclusions: The DVAT is reliable at high head speeds in high school and college football athletes in both yaw and pitch. GST head speeds were higher than previously reported in the literature, but reliability of this tool for this population was poor to moderate. From a clinical perspective, DVAT may be reliably used in the assessment of high school and college football athletes; however, GST requires further evaluation. (C) 2013 Elsevier Ltd. All rights reserved.	[Kaufman, Denise R.; Puckett, Mallory J.; Smith, Mitchell J.; Landers, Merrill R.] Univ Nevada, Dept Phys Therapy, Las Vegas, NV 89154 USA; [Wilson, Kyle S.] Univ Nevada, Las Vegas, NV 89154 USA; [Cheema, Rebecca] Pima Med Inst, Phys Therapist Assistant Program, Las Vegas, NV USA	Landers, MR (corresponding author), Univ Nevada, Dept Phys Therapy, 4505 Maryland Pkwy,Box 453029, Las Vegas, NV 89154 USA.	merrill.landers@unlv.edu	Landers, Merrill/P-6359-2014	Landers, Merrill/0000-0002-4234-910X			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Crane BT, 1997, J NEUROPHYSIOL, V78, P2129; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hall TD, 2004, OTOL NEUROTOL, V25, P746, DOI 10.1097/00129492-200409000-00017; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Herdman SJ, 2001, ARCH OTOLARYNGOL, V127, P1205, DOI 10.1001/archotol.127.10.1205; Herdman SJ, 1998, AM J OTOL, V19, P790; Honaker JA, 2010, J VESTIBUL RES-EQUIL, V20, P357, DOI 10.3233/VES-2010-0365; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kisilevski V, 2001, Int Tinnitus J, V7, P118; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; LEIGH RJ, 1993, NEUROLOGY, V43, P1288, DOI 10.1212/WNL.43.7.1288; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mohammad MT, 2011, J VESTIBUL RES-EQUIL, V21, P277, DOI 10.3233/VES-2011-0430; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; NeuroCom a division of Natus, 2012, NEUR VOR IMP ASS; NeuroCom International Inc, 2008, INVISION SYST; Peterson MD, 2010, J HEAD TRAUMA REHAB, V25, P193, DOI 10.1097/HTR.0b013e3181dc82fa; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Quevedo-Junyent L, 2011, RES Q EXERCISE SPORT, V82, P644, DOI 10.1080/02701367.2011.10599801; Roberts RA, 2007, J AM ACAD AUDIOL, V18, P236, DOI 10.3766/jaaa.18.3.5; Roberts RA, 2006, ANN OTO RHINOL LARYN, V115, P658, DOI 10.1177/000348940611500902; Schneiders AG, 2010, PHYS THER SPORT, V11, P47, DOI 10.1016/j.ptsp.2010.01.001; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; U.S. General Services Administration, 2003, FAC STAND P100 EL EN; Ward BK, 2010, J VESTIBUL RES-EQUIL, V20, P363, DOI 10.3233/VES-2010-0371; Ward BK, 2010, OTOL NEUROTOL, V31, P168, DOI 10.1097/MAO.0b013e3181c4c3e2	39	14	14	0	11	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	AUG	2014	15	3					181	188		10.1016/j.ptsp.2013.10.002			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AL3NL	WOS:000339035300009	24295546	Green Published			2021-06-18	
J	Kumar, RG; Bracken, MB; Clark, AN; Nick, TG; Melguizo, MS; Sander, AM				Kumar, Raj G.; Bracken, Michael B.; Clark, Allison N.; Nick, Todd G.; Melguizo, Maria S.; Sander, Angelle M.			Relationship of Preinjury Depressive Symptoms to Outcomes 3 mos After Complicated and Uncomplicated Mild Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Preinjury Depression; Mild Traumatic Brain Injury; Complicated mTBI; Recovery	HEAD-INJURY; RISK-FACTORS; CES-D; NATURAL-HISTORY; SCALE; PREDICTORS; SENSITIVITY; DISORDER; RECOVERY; VALIDITY	Objective: This study examines the effect of preinjury depressive symptoms on outcomes 3 mos after complicated and uncomplicated cases of mild traumatic brain injury. Design: Preinjury depressive symptoms, experienced in the 30 days before injury, as measured by retrospective self-report, were assessed within the first 2 wks after injury. The outcome measures assessed at 3 mos after injury included affective/behavioral, cognitive, and physical problems and health-related quality-of-life. Results: There were 177 patients who completed both the baseline and 3-mo follow-up interviews. The sample was categorized by severity of depressive symptoms in the month before injury as normal, mild, or moderate-severe. Compared with those reporting no preinjury depressive symptoms, persons reporting moderate-severe depressive symptoms had significantly worse outcomes on the Affective and Behavioral and the Cognitive subscales of the Head Injury-Family Interview Problem Checklist and on the 36-item Short-Form Health Survey Mental Component Summary score. The group reporting mild preinjury depressive symptoms scored worse on a measure of cognitive symptoms compared with those with no preinjury depressive symptoms. There was no interaction between preinjury depressive symptoms and severity of the mild traumatic brain injury (complicated or uncomplicated) for any of the outcomes. Conclusion: Moderate to severe depressive symptoms in the month before injury seems to be a possible risk factor for poor affective/behavioral, cognitive, and mental health-related quality-of-life outcomes at 3 mos after mild traumatic brain injury. Clinicians and researchers should consider the impact of preinjury depression on the recovery process to provide at-risk patients adequate treatment soon after injury.	[Kumar, Raj G.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Publ Hlth, Yale Ctr Perinatal Pediat & Environm Epidemiol, New Haven, CT USA; [Bracken, Michael B.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Clark, Allison N.; Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Harris Hlth Syst & Brain Injury Res Ctr, TIRR Mem Hermann, Houston, TX 77030 USA; [Nick, Todd G.; Melguizo, Maria S.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Pediat, Little Rock, AR 72205 USA; [Nick, Todd G.; Melguizo, Maria S.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Biostat, Little Rock, AR 72205 USA	Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund, Houston, TX 77030 USA.				National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133B990014, H133B090023, H133A120020]	Supported, in part, by grants from the National Institute on Disability and Rehabilitation Research, United States Department of Education (grant nos. H133B990014, H133B090023, H133A120020).	[Anonymous], 1997, SURVEILLANCE TRAUMAT; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CDC Data & Statistics, FEAT EST 1 10 US AD; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Harrell F. E., 2009, RMS S FUNCTIONS BIOS; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kleinbaum D., 2013, APPL REGRESSION ANAL; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2008, MILD TRAUMATIC BRAIN; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; PARIKH RM, 1988, INT J PSYCHIAT MED, V18, P169, DOI 10.2190/BH75-EUYA-4FM1-J7QA; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; QuickStats, 2007, NAT HLTH NUTR EX SUR; R Core Team, 2013, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; SAS Institute, 2010, SAS 9 2 LANG REF CON; Sharp LK, 2002, AM FAM PHYSICIAN, V66, P1001; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; SHINAR D, 1986, STROKE, V17, P241, DOI 10.1161/01.STR.17.2.241; The Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ware JE., 2000, SF 36 HLTH SURVEY MA; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	53	14	14	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2014	93	8					687	698		10.1097/PHM.0000000000000077			12	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AL7PT	WOS:000339327600006	24743469				2021-06-18	
J	Kushner, DS; Alvarez, G				Kushner, David S.; Alvarez, Gemayaret			Dual Diagnosis Traumatic Brain Injury with Spinal Cord Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Dual diagnosis; Traumatic brain injury; Spinal cord trauma; Diagnosis; Prognosis; Complications; Rehabilitation	POSTTRAUMATIC HYDROCEPHALUS; SWALLOWING DISORDERS; RISK-FACTORS; MILD; REHABILITATION; TBI; HYPOPITUITARISM; MANAGEMENT; SPASTICITY; DYSPHAGIA	Spinal cord injury (SCI) patients should be assessed for a co-occurring traumatic brain injury (TBI) on admission to a rehabilitation program. Incidence of a dual diagnosis may approach 60% with certain risk factors. Diagnosis of mild-moderate severity TBIs may be missed during acute care hospitalizations of SCI. Neuropsychological symptoms of a missed TBI diagnosis may be perceived during rehabilitation as noncompliance, inability to learn, maladaptive reactions to SCI, and poor motivation. There are life-threatening and quality-of-life threatening complications of TBI that also may be missed if a dual diagnosis is not made.	[Kushner, David S.; Alvarez, Gemayaret] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Miami, FL 33101 USA	Kushner, DS (corresponding author), Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, POB 016960 D-461, Miami, FL 33101 USA.	dkushner@med.miami.edu	Kushner, David S./AAW-4951-2020	Kushner, David S./0000-0001-6090-6304			Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Aimaretti G, 2005, THESCIENTIFICWORLDJO, V5, P777, DOI 10.1100/tsw.2005.100; [Anonymous], 2011, Continuum (Minneap Minn), V17, P646, DOI 10.1212/01.CON.0000399079.30556.03; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; *ASIA, 1992, STAND NEUR FUNCT CLA; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Choi GS, 2012, ARCH NEUROL-CHICAGO, V69, P363, DOI 10.1001/archneurol.2011.1930; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Guyot LL, 2000, NEUROL RES, V22, P25; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; HINOKI M, 1985, ACTA OTO-LARYNGOL, P9; Hsieh JTC, 2007, TOP SPINAL CORD INJ, V13, P81; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kirshblum S, 1999, ARCH PHYS MED REHAB, V80, P1101, DOI 10.1016/S0003-9993(99)90068-0; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Kushner DS, 2013, AM J PHYS MED REHAB, V92, P486, DOI 10.1097/PHM.0b013e31828762ec; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; National Data and Statistical Center, TRAUM BRAIN INJ MOD; National Institute on Disabilities Rehabilitation and Research Spinal Cord Injury Model Systems, SPIN CORD INJ MOD SY; OTT DJ, 1993, AM J ROENTGENOL, V161, P507, DOI 10.2214/ajr.161.3.8352094; Roberts A, 2013, J CHILD ORTHOP, V7, P389, DOI 10.1007/s11832-013-0512-9; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Saout V., 2011, Annals of Physical and Rehabilitation Medicine, V54, P259, DOI 10.1016/j.rehab.2011.04.003; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Thompson AJ, 2005, J NEUROL NEUROSUR PS, V76, P459, DOI 10.1136/jnnp.2004.035972; Tian W, 2013, DYSPHAGIA, V28, P131, DOI 10.1007/s00455-012-9421-1; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WILSON PR, 1991, CLIN J PAIN, V7, P5, DOI 10.1097/00002508-199103000-00003; Zafonte R, 2004, J HEAD TRAUMA REHAB, V19, P89, DOI 10.1097/00001199-200403000-00002	50	14	16	1	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	AUG	2014	25	3					681	+		10.1016/j.pmr.2014.04.005			18	Rehabilitation	Rehabilitation	AN6UU	WOS:000340734700013	25064795				2021-06-18	
J	Chen, X; Zhao, ZL; Chai, Y; Luo, LL; Jiang, RC; Zhang, JN				Chen, Xin; Zhao, Zilong; Chai, Yan; Luo, Lanlan; Jiang, Rongcai; Zhang, Jianning			The incidence of critical-illness-related-corticosteroid-insufficiency is associated with severity of traumatic brain injury in adult rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Critical illness related corticosteroid insufficiency; Corticosteroid response; Blood-brain barrier; Brain edema	RANDOMIZED CONTROLLED-TRIAL; AQUAPORIN 4; CELL-DEATH; HYDROCORTISONE; EDEMA; EXPRESSION; BARRIER; MEMORY	Traumatic brain injury (TB!) causes deleterious critical-illness-related-corticosteroid-insufficiency (CIRCI), leading to high mortality and morbidity. However, the incidence of CIRCI following different TBI severities is not fully defined. This study was designed to investigate mechanistically the effects of injury severity on corticosteroid response and the development of CIRCI in a rat model of experimentally controlled TBI. Adult male Wistar rats were randomly assigned to sham, mild injury, moderate injury or severe injury groups. TBI was induced using a fluid percussion device at magnitudes of 12-1.4 atm (mild injury), 2.0-22 atm (moderate injury), and 3.2-3.5 atm (severe injury). We first assessed the effects of injury severity on the mortality and CIRCI occurrence using electrical stimulation test to assess corticosteroid response. We also investigated a series of pathological changes in the hypothalamus, especially in the paraventricular nuclei (PVN), among different injury group including: apoptosis detected by a TUNEL assay, blood-brain-barrier (BBB) permeability assessed by brain water content and Evans Blue extravasation into the cerebral parenchyma, and BBB integrity evaluated by CD31 and Claudin-5 expression and transmission electron microscopy. We made the following observations. First, 6.7% of mild-injured, 13.3% of moderate-injured, and 68.8% of severe-injured rats developed CIRCI, with a peak incidence on post-injury day 7. Second, TBI-induced CIRCI is closely correlated with injury severity. As the injury severity rises both the incidence of CIRCI and mortality surge; Third, increased level of injury severity reduces the expression of endothelial tight junction protein, aggravate BBB permeability and exacerbate the ensuing neural apoptosis in the PVN of hypothalamus. These findings indicate that increased severity of TBI aggravate the incidence of CIRCI by causing damage to tight junctions of vascular endothelial cells and increasing neuronal apoptosis in the PVN of hypothalamus. (C) 2014 Elsevier B.V. All rights reserved.	[Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Chen, Xin; Zhao, Zilong; Chai, Yan; Jiang, Rongcai; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Luo, Lanlan] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China	Chen, X (corresponding author), Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	xinchentianjin@me.com; zilongzhaotianjin@hotmail.com; chaiyankelly@163.com; luolan116@sohu.com; jianghope111@163.com; jianningzhang@hotmail.com	Zhao, Zilong/AAZ-2196-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000533, 81370029]; Project of Tianjin Applied Basic and Cutting-edge Technological Research [13JCQNJC10500]	This work was supported by grants from the National Natural Science Foundation of China (grant nos. 81000533 and 81370029), and the Project of Tianjin Applied Basic and Cutting-edge Technological Research (13JCQNJC10500).	Annane D, 2010, CRIT CARE MED, V38, P721, DOI 10.1097/CCM.0b013e3181c54620; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; Asehnoune K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-228; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Chantong B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-260; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Chen X, 2011, BRAIN RES, V1382, P298, DOI 10.1016/j.brainres.2011.01.045; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Cuesta JM, 2012, CRIT CARE MED, V40, P3283, DOI 10.1097/CCM.0b013e31826567eb; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; EDWARDS OM, 1986, MEDICINE, V65, P281; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; JAATTELA M, 1991, ENDOCRINOLOGY, V128, P623; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jung B, 2012, CRIT CARE, V16, DOI 10.1186/cc11871; Krugers HJ, 2010, NAT REV NEUROSCI, V11, P675, DOI 10.1038/nrn2913; Kwon YS, 2010, INTENS CARE MED, V36, P1845, DOI 10.1007/s00134-010-1971-9; Lampron A, 2013, NEURON, V78, P214, DOI 10.1016/j.neuron.2013.04.005; Laurer H.L., 2002, ENCY HUMAN BRAIN, P93; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Martin LG, 2011, VET CLIN N AM-SMALL, V41, P767, DOI 10.1016/j.cvsm.2011.03.021; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Peng YS, 2009, CRIT CARE, V13, DOI 10.1186/cc7978; RINK A, 1995, AM J PATHOL, V147, P1575; Roquilly A, 2013, CRIT CARE, V17, DOI 10.1186/cc13138; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Triantos CK, 2011, CLIN GASTROENTEROL H, V9, P595, DOI 10.1016/j.cgh.2011.03.033; van Herck H, 1998, LAB ANIM-UK, V32, P377, DOI 10.1258/002367798780599794; Walker ML, 2011, AM SURGEON, V77, P579; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhao YD, 2001, WORLD J SURG, V25, P1202; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002	48	14	15	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUL 15	2014	342	1-2					93	100		10.1016/j.jns.2014.04.032			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AK4SN	WOS:000338414500014	24819916				2021-06-18	
J	Basmajian, HG; Choi, PD; Huh, K; Sankar, WN; Wells, L; Arkader, A				Basmajian, Hrayr G.; Choi, Paul D.; Huh, Kenneth; Sankar, Wudbhav N.; Wells, Lawrence; Arkader, Alexandre			Radial neck fractures in children: experience from two level-1 trauma centers	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						elbow fracture; Judet; pediatric fractures; percutaneous reduction; radial head; radial neck	CLOSED REDUCTION; PERCUTANEOUS REDUCTION; HEAD; MANAGEMENT	The aim of this study was to compare different treatment modalities for different severities of pediatric radial neck fractures in a large cohort of patients and determine prognostic factors. A retrospective, comparative study was conducted of all children treated for different severities of radial neck fractures at two level-1 pediatric trauma centers between 1990 and 2007. Pertinent data were collected, and the outcome was measured by the Tibone criteria. Several variables were compared to determine the prognostic value. Seventy-eight children were identified, 35 male and 43 female, at an average age of 7.8 years (range 3-15 years). Twenty-nine of the 78 (37%) children had associated injuries. Fracture patterns varied in their severity. Nineteen patients needed casting alone; 16 required closed reduction; of the children requiring surgery, 26 responded to percutaneous reduction and 17 were severe enough to need open reduction. Complications occurred in 28/78 (36%) children, 24 of which were related to stiffness. Seventeen of the 19 (89%) fractures that were amenable to casting alone had excellent or good outcomes, as did 11/16 (69%) in the closed reduction group. Among children treated operatively, 19/26 (73%) patients who underwent percutaneous reduction had an excellent or good outcome. Only 6/17 (35%) of the severe cases who underwent open reduction had an excellent or good outcome. The treatment method, essentially dictated by the severity of the cases, did correlate with the outcome (P = 0.001). Compared with more severe fractures that required operative treatment, patients treated nonoperatively had a higher rate of excellent to good outcome (P = 0.018). In particular, patients who underwent percutaneous reduction alone had improved outcomes versus open reduction (P = 0.008). The outcome was not related to the presence of an associated injury (P= 0.302). Initial fracture severity, as graded by the Judet classification, correlated with the outcome (P = 0.004). Furthermore, age also expressed significance, as patients younger than 10 years of age tended to do better than those above 10 years of age (P = 0.025). Children with less severe radial neck fractures amenable to nonoperative treatment fare well. Operative treatment of these fractures, particularly in severe cases when an open (not percutaneous) reduction is needed, is associated with a higher risk of poor outcome. Children over 10 years of age, especially those with more severe initial angulation, tend to fare worse. The presence of associated injuries does not appear to increase the risk of a poor outcome after treatment. There is a high rate of complications (36%), stiffness being the most common (24). This large bi-center retrospective study from two level-1 pediatric trauma centers emphasizes that in severe cases of radial neck fractures, open treatment does not necessarily decrease the risk of a poor outcome. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Choi, Paul D.; Huh, Kenneth; Arkader, Alexandre] Childrens Hosp Los Angeles, Div Orthopaed Surg, Los Angeles, CA 90027 USA; [Basmajian, Hrayr G.] Loma Linda Univ, Med Ctr, Dept Orthopaed Surg, Loma Linda, CA 92354 USA; [Sankar, Wudbhav N.; Wells, Lawrence] Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA 19104 USA	Basmajian, HG (corresponding author), Loma Linda Univ, Med Ctr, Dept Orthopaed Surg, 11406 Loma Linda Dr,Suite 218, Loma Linda, CA 92354 USA.	basmajianmd@gmail.com					BERNSTEIN SM, 1993, J PEDIATR ORTHOPED, V13, P85, DOI 10.1097/01241398-199301000-00017; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Evans MC, 1999, J PEDIATR ORTHOP B, V8, P93; FERAY C, 1969, PRESSE MED, V77, P2155; Golden DW, 2007, J PEDIATR ORTHOP B, V16, P144, DOI 10.1097/BPB.0b013e328010fcf2; Herring J, 2002, TACHDJIANS PEDIAT OR; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JUDET J, 1962, Ann Chir, V16, P1377; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; Malmvik J, 2003, J PEDIATR ORTHOP B, V12, P63, DOI 10.1097/00009957-200301000-00012; MERCHAN ECR, 1994, J TRAUMA, V37, P812; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Monson R, 2009, J PEDIATR ORTHOPED, V29, P243, DOI 10.1097/BPO.0b013e3181990745; Morrey BF, 2009, ELBOW ITS DISORDERS; Neher CG, 2003, J PEDIATR ORTHOPED, V23, P626, DOI 10.1097/01241398-200309000-00009; Patterson RF, 1934, J BONE JOINT SURG, V16, P695; PESUDO JV, 1982, CLIN ORTHOP RELAT R, P215; Radomisli TE, 1998, CLIN ORTHOP RELAT R, P30; Rockwood CA, 2006, ROCKWOOD WILKINS FRA; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; Stiefel D, 2001, J BONE JOINT SURG BR, V83B, P536, DOI 10.1302/0301-620X.83B4.11060; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013	26	14	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2014	23	4					369	374		10.1097/BPB.0000000000000057			6	Orthopedics; Pediatrics	Orthopedics; Pediatrics	AI8DM	WOS:000337136400014	24811086				2021-06-18	
J	Gracies, JM; Bayle, N; Goldberg, S; Simpson, DM				Gracies, Jean-Michel; Bayle, Nicolas; Goldberg, Sarah; Simpson, David M.			Botulinum Toxin Type B in the Spastic Arm: A Randomized, Double-Blind, Placebo-Controlled, Preliminary Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Botulinum toxin; Controlled clinical trials, randomized; Rehabilitation; Stroke	UPPER-LIMB SPASTICITY; STROKE; HEMIPARESIS; NEUROTOXIN; THERAPY; PARESIS; TRIAL	Objective: To determine the efficacy and safety of 2 doses of botulinum toxin type B (rimabotulinumtoxinB, BoNT/B) in spastic upper limb muscles. Design: Randomized, double-blind, placebo-controlled trial with a 3-month follow-up. Setting: Tertiary care center. Participants: Referred sample of adult hemiparetic patients (N=24) with disabling elbow flexor overactivity after stroke or traumatic brain injury. Interventions: Injection of 10,00011 of rimabotulinumtoxinB (fixed 250011 dose into elbow flexors; n=8), 15,00011 (5000U into elbow flexors; n=8), or placebo (n=8) into overactive upper limb muscles selected as per investigator's discretion. Main Outcome Measures: At 1 month postinjection, active range of elbow extension (goniometry; primary outcome); active upper limb function (Modified Frenchay Scale [MFS]); subjective global self-assessment (GSA) of arm pain, stiffness, and function; rapid alternating elbow flexion-extension movement frequency over the maximal range; elbow flexor spasticity grade and angle (Tardieu), and tone (Ashworth). Results: No adverse effects were associated with either BoNT/B dose. Both doses improved active elbow extension versus placebo (+8.3 degrees; 95% confidence interval, 1.1 degrees-15.5 degrees; analysis of covariance, P=.028). The high dose of BoNT/B also improved subject-perceived stiffness (P=.005) and the composite pain, stiffness, and function GSA (P=.017), effects that persisted 3 months from injection. No MFS change was demonstrated, although subjects with a baseline MFS <70/100 seemed more likely to benefit from BoNT/B. Conclusions: In this short-term study, BoNT/B up to 15,000U into spastic upper limb muscles, including the elbow flexors, was well tolerated and improved active elbow extension and subject-perceived stiffness. (C) 2014 by the American Congress of Rehabilitation Medicine	[Gracies, Jean-Michel; Bayle, Nicolas; Goldberg, Sarah; Simpson, David M.] Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA	Gracies, JM (corresponding author), Hop Univ Henri Mondor, Serv Reeduc Neurolocomotrice, 51 Av Marechal De Lattre De Tassigny, F-94010 Creteil, France.	jean-michel.gracies@hmn.aphp.fr		nicolas, bayle/0000-0002-3726-2712	Solstice Neurosciences, LLC.	Supported by Solstice Neurosciences, LLC.	Arezzo JC, 2009, TOXICON, V54, P690, DOI 10.1016/j.toxicon.2009.03.009; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Brashear A, 2004, ARCH PHYS MED REHAB, V85, P705, DOI 10.1016/j.apmr.2003.08.077; Brashear A, 2003, ARCH PHYS MED REHAB, V84, P103, DOI 10.1053/apmr.2003.50070; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Chang CL, 2009, ARCH PHYS MED REHAB, V90, P1462, DOI 10.1016/j.apmr.2009.03.008; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2010, ARCH PHYS MED REHAB, V91, P421, DOI 10.1016/j.apmr.2009.11.017; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, P9, DOI 10.1016/j.apmr.2008.04.030; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Gracies JM, 2002, HDB BOTULINUM TOXIN, P221; Meythaler JM, 2009, ARCH PHYS MED REHAB, V90, P1453, DOI 10.1016/j.apmr.2009.02.026; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Pittock SJ, 2003, CEREBROVASC DIS, V15, P289, DOI 10.1159/000069495; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Simpson DM, 2009, J NEUROL NEUROSUR PS, V80, P380, DOI 10.1136/jnnp.2008.159657; Vinti M, 2012, MUSCLE NERVE, V46, P926, DOI 10.1002/mus.23427	18	14	15	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2014	95	7					1303	1311		10.1016/j.apmr.2014.03.016			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AK5QA	WOS:000338479700012	24709034				2021-06-18	
J	Jones, NS; Walter, KD; Caplinger, R; Wright, D; Raasch, WG; Young, C				Jones, Nathaniel S.; Walter, Kevin D.; Caplinger, Roger; Wright, Daniel; Raasch, William G.; Young, Craig			Effect of Education and Language on Baseline Concussion Screening Tests in Professional Baseball Players	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sociocultural; neuropsychological testing; concussion; baseball	SPORTS-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; FOOTBALL PLAYERS; IMPACT; INJURY; RELIABILITY; PERFORMANCE; ZURICH; ISSUES	Objective: The purpose of the present study was to investigate the possible effects of sociocultural influences, specifically pertaining to language and education, on baseline neuropsychological concussion testing as obtained via immediate postconcussion assessment and cognitive testing (ImPACT) of players from a professional baseball team. Design: A retrospective chart review. Setting: Baseline testing of a professional baseball organization. Participants: Four hundred five professional baseball players. Independent Variables: Age, languages spoken, hometown country location (United States/Canada vs overseas), and years of education. Main Outcome Measures: The 5 ImPACT composite scores (verbal memory, visual memory, visual motor speed, reaction time, impulse control) and ImPACT total symptom score from the initial baseline testing. Results: The result of t tests revealed significant differences (P < 0.05) when comparing native English to native Spanish speakers in many scores. Even when corrected for education, the significant differences (P < 0.05) remained in some scores. Conclusions: Sociocultural differences may result in differences in computer-based neuropsychological testing scores.	[Jones, Nathaniel S.] Loyola Univ, Med Ctr, Dept Family Med, Maywood, IL 60153 USA; [Jones, Nathaniel S.] Loyola Univ, Med Ctr, Dept Orthopaed Surg & Rehabil, Maywood, IL 60153 USA; [Walter, Kevin D.; Raasch, William G.; Young, Craig] Med Coll Wisconsin, Dept Orthopaed Surg, Milwaukee, WI 53226 USA; [Caplinger, Roger; Wright, Daniel] Milwaukee Brewers Baseball Club, Milwaukee, WI USA; [Young, Craig] Med Coll Wisconsin, Dept Family & Community Med, Milwaukee, WI 53226 USA	Jones, NS (corresponding author), Loyola Univ, Med Ctr, Dept Family Med, 2160 S First Ave,Bldg 54,Rm 253, Maywood, IL 60153 USA.	nsjonesy@gmail.com		Jones, Nathaniel/0000-0002-7618-9431			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Collie A, 2004, BRIT J SPORT MED, V38, P273, DOI 10.1136/bjsm.2003.000293; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Granito VJ., 2002, J SPORT BEHAV, V25, P243; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; IVERSON GL, 2002, IMMEDIATE POSTCONCUS; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P310; Lovell M., 2004, IMPACT VERSION 2 0 C; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039	28	14	14	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2014	24	4					284	288					5	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	AL3VW	WOS:000339060000003	24184854				2021-06-18	
J	McLay, R; Ram, V; Murphy, J; Spira, J; Wood, DP; Wiederhold, MD; Wiederhold, BK; Johnston, S; Reeves, D				McLay, Robert; Ram, Vasudha; Murphy, Jennifer; Spira, James; Wood, Dennis P.; Wiederhold, Mark D.; Wiederhold, Brenda K.; Johnston, Scott; Reeves, Dennis			Effect of Virtual Reality PTSD Treatment on Mood and Neurocognitive Outcomes	CYBERPSYCHOLOGY BEHAVIOR AND SOCIAL NETWORKING			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; EMOTIONAL STROOP TASK; EXPOSURE THERAPY; IRAQ; DEPLOYMENT; ANXIETY; DUTY; CARE; PERSPECTIVES	Virtual reality (VR) is an emerging tool to help treat posttraumatic stress disorder (PTSD). Previously published studies have shown that VR graded exposure therapy (VR-GET) treatment can result in improvements in PTSD symptoms. Less is known about the impact on depression, general anxiety, and neuropsychological functioning in patients with PTSD. This study examined changes in self-reports of PTSD, depression, and anxiety before and after treatment, and also examined neuropsychological functioning as assessed by a computerized test of simple reaction time, procedural reaction time, and performance on the congruent, incongruent, emotional, and neutral (match the color of the "nonsense word'') Stroop tests. Results showed that subjects treated with VR-GET showed significant reductions in PTSD and anxiety severity and significant improvements on the emotional Stroop test. Changes in depression and other measures of neuropsychological function were not significant. Change scores on the emotional Stroop test did not correlate with changes in self-report measures of PTSD. Overall, these findings support the use of VR-GET as a treatment for PTSD but indicate that benefits may be narrowly focused. Additional treatments may be needed after or alongside VR-GET for service members with neuropsychological impairments.	[McLay, Robert] Naval Med Ctr San Diego, Directorate Mental Hlth, San Diego, CA 92134 USA; [Ram, Vasudha; Murphy, Jennifer; Johnston, Scott] Naval Ctr Combat & Operat Stress Control, San Diego, CA USA; [Spira, James] Natl Ctr PTSD, Honolulu, HI USA; [Wood, Dennis P.; Wiederhold, Mark D.; Wiederhold, Brenda K.] Virtual Real Med Ctr, San Diego, CA USA	McLay, R (corresponding author), Naval Med Ctr San Diego, Directorate Mental Hlth, 34800 Bob Wilson Dr, San Diego, CA 92134 USA.	Robert.McLay@med.navy.mil	Wiederhold, Brenda K/Z-1993-2019	Wiederhold, Brenda K/0000-0002-3320-0303			Baldwin DS, 2010, CURR TOP BEHAV NEURO, V2, P453, DOI 10.1007/7854_2009_2; Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Cisler JM, 2011, CLIN PSYCHOL REV, V31, P817, DOI 10.1016/j.cpr.2011.03.007; Elsmore TF, 2007, ARCH CLIN NEUROPSYCH, V22, pS135, DOI 10.1016/j.acn.2006.10.009; Enns MW, 1998, J AFFECT DISORDERS, V47, P195, DOI 10.1016/S0165-0327(97)00103-1; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Foa EB, 2007, PROLONGED EXPOSURE T; Foa EB, 2011, DEPRESS ANXIETY, V28, P1043, DOI 10.1002/da.20907; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; McLay RN, 2011, CYBERPSYCH BEH SOC N, V14, P223, DOI 10.1089/cyber.2011.0003; MCNALLY RJ, 1990, J ABNORM PSYCHOL, V99, P398, DOI 10.1037/0021-843X.99.4.398; Miller MW, 2010, J TRAUMA STRESS, V23, P631, DOI 10.1002/jts.20559; Naudet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020811; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Rizzo AA, 2009, STUD HEALTH TECHNOL, V142, P277, DOI 10.3233/978-1-58603-964-6-277; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Schwab KA, 2006, NEUROLOGY, V66, pA235; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stein DJ, 2009, CNS SPECTRUMS, V14, P25; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Weathers F. W., 1993, ANN M INT SOC TRAUM; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wood DP, 2007, CYBERPSYCHOL BEHAV, V10, P309, DOI 10.1089/cpb.2006.9951; Wood DP, 2011, STUD HEALTH TECHNOL, V163, P696, DOI 10.3233/978-1-60750-706-2-696	39	14	14	1	25	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2152-2715	2152-2723		CYBERPSYCH BEH SOC N	Cyberpsychology Behav. Soc. Netw.	JUL	2014	17	7					439	446		10.1089/cyber.2013.0383			8	Psychology, Social	Psychology	AL2HN	WOS:000338946700003	24635120				2021-06-18	
J	Parma, C; Carney, D; Grim, R; Bell, T; Shoff, K; Ahuja, V				Parma, Carolyn; Carney, Daniel; Grim, Rod; Bell, Ted; Shoff, Kimberly; Ahuja, Vanita			Unnecessary Head Computed Tomography Scans: A Level 1 Trauma Teaching Experience	AMERICAN SURGEON			English	Article							NEW-ORLEANS CRITERIA; BRAIN-INJURY; EMERGENCY-DEPARTMENT; EXTERNAL VALIDATION; CT; RULE; GUIDELINES; MANAGEMENT	The Canadian CT Head Rule attempts to standardize the practice of obtaining head computed tomography (CT) scans in patients with minor head injury. Previous research indicates 10 to 35 per cent of CTscans performed do not meet these guidelines. The purpose of this study was to review our use of CTscans in the evaluation of mild traumatic brain injury and to identify 1) unnecessary head CTscans (UHCT); 2) variables associated with UHCT; and 3) associated costs. Using a trauma registry, inclusion criteria were age older than 18 years, Glasgow Coma Scale of 15, and at least one head CTscan. UHCTs were those without head injury, loss of consciousness, amnesia, or neurologic complaint. The proportion of patients meeting the criteria for UHCT was 24.2 per cent. Univariate analyses revealed ages 41 to 64 years, drug use, vehicular injury, and surgery within 24 hours were associated with UHCT (all P<0.05). UHCTs were associated with higher Injury Severity Scores (P = 0.008), ventilator days, and length of stay (all P<0.05). An average cost of $1,413 per CT equals $149,778 in extra costs. This study suggests that current practices at our Level I trauma center result in UHCT. Further investigation into best practices would benefit our center by reducing costs and providing quality patient care.	[Parma, Carolyn; Ahuja, Vanita] York Hosp, Dept Surg, York, PA 17405 USA; [Carney, Daniel; Shoff, Kimberly] York Hosp, Trauma Serv, York, PA 17405 USA; [Grim, Rod; Bell, Ted] York Hosp, Emig Res Ctr, York, PA 17405 USA	Parma, C (corresponding author), York Hosp, Dept Surg, 1001 South George St, York, PA 17405 USA.	cparma@wellspan.org					Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cook L S, 1994, Acad Emerg Med, V1, P227; Crowe L, 2010, ARCH DIS CHILD, V95, P1017, DOI 10.1136/adc.2009.174854; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Joseph B, 2014, AM SURGEON, V80, P43; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; REINUS WR, 1993, ANN EMERG MED, V22, P1148, DOI 10.1016/S0196-0644(05)80981-3; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stein SC, 2007, J TRAUMA, V62, P1309; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	26	14	14	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUL	2014	80	7					664	668					5	Surgery	Surgery	AK2WX	WOS:000338282000020	24987897				2021-06-18	
J	Qi, L; Cui, XX; Dong, WF; Barrera, R; Coppa, GF; Wang, P; Wu, RQ				Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Coppa, Gene F.; Wang, Ping; Wu, Rongqian			Ghrelin Protects Rats Against Traumatic Brain Injury and Hemorrhagic Shock Through Upregulation of UCP2	ANNALS OF SURGERY			English	Article						ghrelin; hemorrhage; traumatic brain injury; UCP2	VAGUS NERVE-STIMULATION; MESSENGER-RNA EXPRESSION; UNCOUPLING PROTEIN-2; SECRETAGOGUE RECEPTOR; INTESTINAL DYSFUNCTION; HEAD-INJURY; HORMONE; HYPOTENSION; STOMACH; SEPSIS	Objective: To determine the mechanism responsible for ghrelin's neuroprotective effects after traumatic brain injury (TBI) and hemorrhagic shock. Background: Ghrelin, a gastrointestinal hormone, has been demonstrated to possess multiple functions, including upregulation of uncoupling protein 2 (UCP2) and stimulation of the vagus nerve. Recent evidence has indicated that ghrelin is neuroprotective. We, therefore, hypothesized that ghrelin protects rats against TBI and hemorrhagic shock through upregulation of UCP2, involving stimulation of the vagus nerve. Methods: Brain injury was induced by dropping a 450 g of weight from 1.5 m onto a steel helmet attached to the skull of male adult rats. Immediately after TBI, a midline laparotomy was performed, and both lumbar veins were isolated and severed at the junction with the vena cava. The abdomen was kept open for 20 minutes. At 45 minutes after TBI and uncontrolled hemorrhage (UH), ghrelin (4, 8, or 16 nmol/rat) or 1 mL of normal saline (vehicle) was intravenously administered. The Neurological Severity Scale (NSS), morphological alterations and beta-amyloid precursor protein expression in the brain, systemic organ injury markers (ie, alanine aminotransferase, aspartate aminotransferase, and lactate), and UCP2 expression in the cortex were measured. To determine whether the protective effect of ghrelin is mediated through upregulation of UCP2, genipin, a specific UCP2 antagonist, was administered intravenously before the injection of ghrelin in animals with TBI and UH. The role of the vagus nerve was assessed by performing vagotomy immediately before ghrelin administration. Results: Ghrelin attenuated brain injury and facilitated functional recovery after TBI and UH. Ghrelin increased UCP2 expression in the cortex, and administration of genipin abolished ghrelin's protection after TBI and UH. Furthermore, vagotomy prevented the beneficial effects of ghrelin and eliminated ghrelin-induced UCP2 upregulation after TBI and UH. Conclusions: The protective effects of ghrelin after TBI and UH seem to be related to upregulation of UCP2 expression in the brain and requiring the intact vagus nerve.	[Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] N Shore Univ Hosp, Dept Surg, Manhasset, NY USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Barrera, Rafael; Coppa, Gene F.; Wang, Ping; Wu, Rongqian] Long Isl Jewish Med Ctr, Manhasset, NY USA; [Qi, Lei; Cui, Xiaoxuan; Dong, Weifeng; Wang, Ping; Wu, Rongqian] Feinstein Inst Med Res, Manhasset, NY USA; [Qi, Lei] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China; [Wu, Rongqian] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33612 USA	Wu, RQ (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 8, Tampa, FL 33612 USA.	rwu1@health.usf.edu	Wu, Rongqian/I-3614-2012	Wu, Rongqian/0000-0003-0993-4531; Wang, Ping/0000-0002-1557-0394	Department of Defense/Deployment Related Medical Research Program [DR080669]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS072608]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072608] Funding Source: NIH RePORTER	Supported by a Department of Defense/Deployment Related Medical Research Program grant DR080669 (R. Wu) and a National Institutes of Health grant R21 NS072608 (R. Wu). The authors declare no conflicts of interest.	Aarabi B, 2009, CURR OPIN CRIT CARE, V15, P548, DOI 10.1097/MCC.0b013e32833190da; Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Ardesch JJ, 2007, SEIZURE-EUR J EPILEP, V16, P579, DOI 10.1016/j.seizure.2007.04.005; Ay I, 2009, NEUROSCI LETT, V459, P147, DOI 10.1016/j.neulet.2009.05.018; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; CAPONE AC, 1995, J AM COLL SURGEONS, V180, P49; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cheyuo C, 2011, SHOCK, V35, P258, DOI 10.1097/SHK.0b013e3181f48a37; Cioffi F, 2009, BIOFACTORS, V35, P417, DOI 10.1002/biof.54; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Coduras A, 2010, J ALZHEIMERS DIS, V19, P601, DOI 10.3233/JAD-2010-1258; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Horimoto M, 2004, HEPATOLOGY, V39, P386, DOI 10.1002/hep.20047; Kim SH, 1997, J TRAUMA, V42, P213, DOI 10.1097/00005373-199702000-00006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lindqvist A, 2004, NUTR NEUROSCI, V7, P217, DOI 10.1080/10284150400011390; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Miyamoto O, 2003, NEUROREPORT, V14, P1971, DOI 10.1097/00001756-200310270-00018; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Richard D, 2001, BIOCHEM SOC T, V29, P812, DOI 10.1042/BST0290812; Sakata I, 2003, NEUROSCI LETT, V342, P183, DOI 10.1016/S0304-3940(03)00294-5; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Sato N, 2003, JPN J PHYSIOL, V53, P443, DOI 10.2170/jjphysiol.53.443; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Tsubone T, 2005, REGUL PEPTIDES, V130, P97, DOI 10.1016/j.regpep.2005.04.004; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wang GY, 2002, REGUL PEPTIDES, V105, P75, DOI 10.1016/S0167-0115(02)00012-5; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, CRIT CARE MED, V35, P912, DOI 10.1097/01.CCM.0000257327.61829.34; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2009, ANN SURG, V250, P126, DOI 10.1097/SLA.0b013e3181ad85d6; Wu RQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002026; Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011	63	14	18	1	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JUL	2014	260	1					169	178		10.1097/SLA.0000000000000328			10	Surgery	Surgery	AI9XD	WOS:000337297900027	24670857				2021-06-18	
J	Speicher, SM; Walter, KH; Chard, KM				Speicher, Sarah M.; Walter, Kristen H.; Chard, Kathleen M.			Interdisciplinary Residential Treatment of Posttraumatic Stress Disorder and Traumatic Brain Injury: Effects on Symptom Severity and Occupational Performance and Satisfaction	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activities of daily living; brain injuries; depression; outcome and process assessment (health care); residential treatment; stress disorders, post-traumatic; veterans	COGNITIVE PROCESSING THERAPY; SELF-IDENTIFIED GOALS; PSYCHOMETRIC PROPERTIES; ADULTS; ACHIEVEMENT; OUTCOMES	OBJECTIVE. This study examined outcomes of an 8-wk residential treatment program for veterans with posttraumatic stress disorder (PTSD) and a history of traumatic brain injury (TBI). METHOD. Twenty-six veterans completed the Canadian Occupational Performance Measure, Clinician-Administered PTSD Scale, Beck Depression Inventory-2nd Edition, and PTSD Checklist before and after treatment. RESULTS. Veterans demonstrated significant improvements in occupational performance and satisfaction with their performance, as well as in PTSD and depression symptom severity after residential PTSD/TBI treatment. Additionally, improvements in occupational performance and satisfaction were associated with decreases in depression symptom severity. CONCLUSION. Although preliminary, results suggest that veterans with PTSD and a history of TBI experienced significant decreases in PTSD and depression symptom severity and improvement in self-perception of performance and satisfaction in problematic occupational areas. Changes in occupational areas and depression symptom severity were related, highlighting the importance of interdisciplinary treatment.	[Speicher, Sarah M.] Cincinnati Vet Affairs Med Ctr, Trauma Recovery Ctr, Cincinnati, OH 45220 USA; [Walter, Kristen H.] Vet Med Res Fdn, San Diego, CA USA; [Walter, Kristen H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Chard, Kathleen M.] Cincinnati Vet Affairs Med Ctr, Trauma Recovery Ctr, Ft Thomas, KY 41075 USA; [Chard, Kathleen M.] Univ Cincinnati, Dept Psychiat, Sch Med, Cincinnati, OH USA	Speicher, SM (corresponding author), Cincinnati Vet Affairs Med Ctr, Trauma Recovery Ctr, Cincinnati, OH 45220 USA.	Kathleen.Chard@va.gov	Walter, Kristen H/S-1827-2019				American Occupational Therapy Association, 2008, AM J OCCUP THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bejerholm U, 2007, AM J OCCUP THER, V61, P21, DOI 10.5014/ajot.61.1.21; Blake D. D., 1990, BEHAV THER, V13, P187; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chard KM, 2009, COGNITIVE PROCESSING; Christiansen CH, 1999, AM J OCCUP THER, V53, P91, DOI 10.5014/ajot.53.1.91; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Eklund Mona, 2007, Can J Occup Ther, V74, P303; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; First M.B., 1996, STRUCTURED CLIN INTE; Hand CL, 2011, CAN J OCCUP THER, V78, P147, DOI 10.2182/cjot.2011.78.3.2; Iannelli S, 2007, AUST OCCUP THER J, V54, P285, DOI 10.1111/j.1440-1630.2006-00650.x; Law M, 1994, Can J Occup Ther, V61, P191; Law M., 2005, CANADIAN OCCUPATIONA, V4th ed; Lopez A, 2011, WORK, V38, P33, DOI 10.3233/WOR-2011-1102; McColl M A, 2000, Can J Occup Ther, V67, P22; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Resick PA, 2008, J CONSULT CLIN PSYCH, V76, P243, DOI 10.1037/0022-006X.76.2.243; Schell T.L., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/mg720-1ccf.12, DOI 10.7249/MG720-1CCF.12]; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Trombly CA, 1998, AM J OCCUP THER, V52, P810, DOI 10.5014/ajot.52.10.810; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Twamley E. W., 2008, COGNITIVE SYMP UNPUB; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Weathers F., 1994, PTSD RES Q, V5, P2, DOI DOI 10.1037/E572192010-003; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zanarini MC, 2000, J PERS DISORD, V14, P291, DOI 10.1521/pedi.2000.14.4.291	37	14	14	0	10	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2014	68	4					412	421		10.5014/ajot.2014.011304			10	Rehabilitation	Rehabilitation	AL4FR	WOS:000339088800006	25005504	Bronze, Green Published			2021-06-18	
J	Vandekerckhove, M; Plessers, M; Van Mieghem, A; Beeckmans, K; Van Acker, F; Maex, R; Markowitsch, H; Marien, P; Van Overwalle, F				Vandekerckhove, Marie; Plessers, Maarten; Van Mieghem, Arno; Beeckmans, Kurt; Van Acker, Frederik; Maex, Reinoud; Markowitsch, Hans; Marien, Peter; Van Overwalle, Frank			Impaired Facial Emotion Recognition in Patients With Ventromedial Prefrontal Hypoperfusion	NEUROPSYCHOLOGY			English	Article						emotion; emotion recognition; emotional facial expression; ventromedial prefrontal cortex	TRAUMATIC BRAIN-INJURY; EVENT-RELATED FMRI; FRONTAL-LOBE DAMAGE; SOCIAL-BEHAVIOR; CORTEX; EXPRESSIONS; METAANALYSIS; ACTIVATION; AMYGDALA; SELF	Empathy refers to our ability to recognize and share emotions by another human being. Impairment may underlie many of the emotional deficits commonly associated with a range of neuropsychiatric and neurological conditions. The prefrontal cortex (PFC) has long been implicated in these processes, but the specific contribution of subregions of the PFC remain unclear. Studies regarding the role of subregions of the prefrontal cortex such as the ventromedial prefrontal cortex (vmPFC)-in facial emotion recognition have yielded inconsistent results. The present study aimed to investigate the capacity to recognize nonverbal emotional facial expressions in a group of patients with the following: (a) perfusion deficits in the vmPFC (vmPFC group; N = 13), (b) hypoperfusions sparing the vmPFC (nonvmPFC group; N = 12), and in (c) a control group of healthy volunteers (control group; N = 17). Regions of hypoperfusion were identified by means of Single Photon Emission Computed Tomography (SPECT). Participants were asked to recognize facial expressions of the 7 basic emotions (happiness, fear, surprise, anger, disgust, sadness, or neutral). Detection of facial expressions of fear, disgust, and surprise was affected after functional disruption of the vmPFC. The present study confirms the role of the vmPFC in recognizing emotional facial expressions.	[Vandekerckhove, Marie] Vrije Univ Brussel, Res Grp Biol Psychol, B-1050 Brussels, Belgium; [Plessers, Maarten] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Van Mieghem, Arno] AZ Sint Lucas, AZ Sint Maarten, Dept Nucl Med, Mechelen, Malle, Belgium; [Beeckmans, Kurt] CEPOS, Duffel, Belgium; [Van Acker, Frederik] Open Univ Heerlen, Fac Psychol, Heerlen, Netherlands; [Maex, Reinoud] Ecole Normale Super, Grp Neural Theory & Computat Sci, F-75231 Paris, France; [Markowitsch, Hans] Univ Bielefeld, Res Grp Physiol Psychol, Bielefeld, Germany; [Marien, Peter] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Marien, Peter] ZNA Middelheim, Dept Neurol, Antwerp, Belgium; [Marien, Peter] ZNA Middelheim, Memory Clin, Antwerp, Belgium; [Van Overwalle, Frank] Vrije Univ Brussel, Res Grp Social Neurosci, B-1050 Brussels, Belgium	Vandekerckhove, M (corresponding author), Vrije Univ Brussel, Fac Psychol & Educ Sci, Dept Expt & Appl Psychol, Res Grp Biol Psychol, Pleinlaan 2, B-1050 Brussels, Belgium.	Marie.Vandekerckhove@vub.ac.be	Vandekerckhove, Marie/K-5775-2019	Maex, Reinoud/0000-0002-5543-8902	Bielefeld Cluster of Excellence (CITEC); Fund for Scientific Research Flanders (Belgium)FWO	The researchers would like to thank CEPOS for their cooperation. HJM was supported by a grant from the Bielefeld Cluster of Excellence (CITEC). MP was supported by a predoctoral Research Grant from the Fund for Scientific Research Flanders (Belgium).	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.0.CO;2-Z; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gunning-Dixon FM, 2003, NEUROBIOL AGING, V24, P285, DOI 10.1016/S0197-4580(02)00099-4; Harciarek M, 2009, J CLIN EXP NEUROPSYC, V31, P322, DOI 10.1080/13803390802119930; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Kucharska-Pietura K., 2000, EUROPEAN NEUROPSYCHO, V10, P358, DOI [10.1016/S0924-977X(00)80470-8, DOI 10.1016/S0924-977X(00)80470-8]; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Lipsman N, 2014, NEUROIMAGE, V85, P769, DOI 10.1016/j.neuroimage.2013.05.104; Ma N, 2012, SOC NEUROSCI-UK, V7, P591, DOI 10.1080/17470919.2012.686925; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610; O'Doherty J, 2001, NAT NEUROSCI, V4, P95; Ogai Masahiro, 2003, Neuroreport, V14, P559, DOI 10.1097/00001756-200303240-00006; Olszanowski M., 2008, WARSAW SET EMOTIONAL; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; ROGERS CR, 1957, J CONSULT PSYCHOL, V21, P95, DOI 10.1037/0022-006X.60.6.827; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rudebeck PH, 2008, COGN AFFECT BEHAV NE, V8, P485, DOI 10.3758/CABN.8.4.485; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Stuss D.T., 1986, FRONTAL LOBES; Tsuchida A, 2012, CEREB CORTEX, V22, P2904, DOI 10.1093/cercor/bhr370; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wang AT, 2004, J AM ACAD CHILD PSY, V43, P481, DOI 10.1097/00004583-200404000-00015; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; Willis ML, 2010, NEUROPSYCHOLOGIA, V48, P2182, DOI 10.1016/j.neuropsychologia.2010.04.010; Winecoff A, 2013, J NEUROSCI, V33, P11032, DOI 10.1523/JNEUROSCI.4317-12.2013	55	14	14	0	22	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2014	28	4					605	612		10.1037/neu0000057			8	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	AL8OF	WOS:000339398000014	24773416				2021-06-18	
J	Yap, YC; Dickson, TC; King, AE; Breadmore, MC; Guijt, RM				Yap, Yiing C.; Dickson, Tracey C.; King, Anna E.; Breadmore, Michael C.; Guijt, Rosanne M.			Microfluidic culture platform for studying neuronal response to mild to very mild axonal stretch injuryn	BIOMICROFLUIDICS			English	Article							TRAUMATIC BRAIN-INJURY; IN-VITRO; NEUROSCIENCE RESEARCH; SOFT LITHOGRAPHY; MODEL; TRANSPORT; AXOTOMY; RAT; POLY(DIMETHYLSILOXANE); DEGENERATION	A new model for studying localised axonal stretch injury is presented, using a microfluidic device to selectively culture axons on a thin, flexible poly (dimethylsiloxane) membrane which can be deflected upward to stretch the axons. A very mild (0.5% strain) or mild stretch injury (5% strain) was applied to primary cortical neurons after 7 days growth in vitro. The extent of distal degeneration was quantified using the degenerative index (DI, the ratio of fragmented axon area to total axon area) of axons fixed at 24 h and 72 h post injury (PI), and immunolabelled for the axon specific, microtubule associated protein-tau. At 24 h PI following very mild injuries (0.5%), the majority of the axons remained intact and healthy with no significant difference in DI when compared to the control, but at 72 h PI, the DI increased significantly (DI = 0.11+/-0.03). Remarkably, dendritic beading in the somal compartment was observed at 24 h PI, indicative of dying back degeneration. When the injury level was increased (5% stretch, mild injury), microtubule fragmentation along the injured axons was observed, with a significant increase in DI at 24 h PI (DI = 0.17+/-0.02) and 72 h PI (DI = 0.18+/-0.01), relative to uninjured axons. The responses observed for both mild and very mild injuries are similar to those observed in the in vivo models of traumatic brain injury, suggesting that this model can be used to study neuronal trauma and will provide new insights into the cellular and molecular alterations characterizing the neuronal response to discrete axonal injury. (C) 2014 AIP Publishing LLC.	[Yap, Yiing C.; Dickson, Tracey C.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Yap, Yiing C.; King, Anna E.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas 7000, Australia; [Yap, Yiing C.; Breadmore, Michael C.] Univ Tasmania, Sch Phys Sci, ACROSS, Hobart, Tas 7001, Australia; [Yap, Yiing C.; Guijt, Rosanne M.] Univ Tasmania, Pharm Sch Med, ACROSS, Hobart, Tas 7001, Australia	Guijt, RM (corresponding author), Univ Tasmania, Pharm Sch Med, ACROSS, Private Bag 26, Hobart, Tas 7001, Australia.	Rosanne.Guijt@utas.edu.au	Guijt, Rosanne Marieke/R-2428-2017; King, Anna/J-7927-2014; Breadmore, Michael/J-7628-2014	Guijt, Rosanne Marieke/0000-0003-0011-5708; King, Anna/0000-0003-1792-0965; Breadmore, Michael/0000-0001-5591-4326; Dickson, Tracey/0000-0002-9196-1661; YAP, YIING CHIING/0000-0002-0713-8884	Select Foundation; Wicking Dementia Research and Education Centre; University Tasmania for a Graduate Research Scholarship; UTAS Cross Theme Grant; QEII Fellowship [DP0984745]	The authors would like to thank Mr. Graeme McCormark, Mr. Justin Dittman, and Mr. John Davis for their technical assistance in completing this work. This research was supported by Select Foundation (Fellowship to T. C. D.), the Wicking Dementia Research and Education Centre (Fellowship to A. E. K.), the University Tasmania for a Graduate Research Scholarship (Y.C.Y.) and UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant. M. C. B. would like to thank the Australian Research Council for funding and provision of a QEII Fellowship (DP0984745).	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Dolle JP, 2013, LAB CHIP, V13, P432, DOI 10.1039/c2lc41063j; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GALLANT PE, 1992, J NEUROPATH EXP NEUR, V51, P220, DOI 10.1097/00005072-199203000-00011; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Hosie KA, 2012, ASN NEURO, V4, P47, DOI 10.1042/AN20110031; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Johns C, 2008, J CHROMATOGR A, V1182, P205, DOI 10.1016/j.chroma.2008.01.014; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kazarian AA, 2010, ANALYST, V135, P1970, DOI 10.1039/c0an00010h; Kim YT, 2009, LAB CHIP, V9, P2576, DOI 10.1039/b903720a; Laker S. R., 2011, PM&R, V3, pS354; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Majumdar D, 2011, J NEUROSCI METH, V196, P38, DOI 10.1016/j.jneumeth.2010.12.024; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Nakayama Y, 2001, J NEUROTRAUM, V18, P545, DOI 10.1089/089771501300227341; Park JW, 2013, LAB CHIP, V13, P509, DOI 10.1039/c2lc41081h; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Siddique R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0676; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	45	14	14	1	28	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	1932-1058			BIOMICROFLUIDICS	Biomicrofluidics	JUL	2014	8	4							044110	10.1063/1.4891098			12	Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology; Physics, Fluids & Plasmas	Biochemistry & Molecular Biology; Biophysics; Science & Technology - Other Topics; Physics	AS4EG	WOS:000344225400015	25379095	Green Published			2021-06-18	
J	Cavus, G; Altas, M; Aras, M; Ozgur, T; Serarslan, Y; Yilmaz, N; Sefil, F; Ulutas, KT				Cavus, G.; Altas, M.; Aras, M.; Ozgur, T.; Serarslan, Y.; Yilmaz, N.; Sefil, F.; Ulutas, K. T.			Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Medulla spinalis; Spinal trauma; Methylprednisolone; Montelukast; Superoxide dismutase; Malondialdehyde	TRAUMATIC BRAIN-INJURY; CYSTEINYL LEUKOTRIENE RECEPTOR-1; SUPEROXIDE-DISMUTASE; CEREBROSPINAL-FLUID; BB ISOENZYME; EXPRESSION; DAMAGE; SERUM; ASSAY; CSF	OBJECTIVE: The development of secondary brain injury after trauma is known to involve in many cellular mediators. The aim of the study was to evaluate and compare the effects of the use of both methylprednisolone and montelukast on serum and tissue concentrations of NO, malondialdehyde (MDA) levels, superoxide dismutase (SOD) activity, and tissue glutathione peroxidase (GSH-Px) activity in rats with spinal cord injury (SCI). MATERIALS AND METHODS: SCI was induced in Wistar albino rats by dropping a 10 g rod from a 5.0 cm height at T9-10. The 28 rats were randomly divided into four equal groups: montelukast, methylprednisolone, non-treatment and sham groups. Rats were neurologically tested at 24 hours after trauma and spinal cord tissue levels of MDA, SOD, GSH-PX, CAT levels and blood CK, CK-BB, LDH levels were measured. In addition, histopathological changes were also examined. RESULTS: There was a significant improvement in Tarlov scores in methylprednisolone and montelukast administered group compared to the trauma group (p = 0.001). When compared to trauma group, methylprednisolone and montelukast groups had significant differences in MDA (p < 0.05), SOD (p < 0.001), CK-BB (p < 0.001) and LDH (p < 0.05) levels. Histopathologically, no significant changes were observed. CONCLUSIONS: The present study shows effects of montelukast with biochemical and histopathological parameters and compares its effects with those of methylprednisolone for the first time. Our research has shown that montelukast and methylprednisolone have a neuroprotective effect on spinal cord injury.	[Cavus, G.] Aksaray State Hosp, Dept Neurosurg, Aksaray, Turkey; [Altas, M.; Aras, M.; Serarslan, Y.; Yilmaz, N.] Mustafa Kemal Univ, Tayfur Ata Sokmen Med Fac, Dept Neurosurg, Antakya, Turkey; [Ozgur, T.] Mustafa Kemal Univ, Tayfur Ata Sokmen Med Fac, Dept Pathol, Antakya, Turkey; [Sefil, F.] Mustafa Kemal Univ, Tayfur Ata Sokmen Med Fac, Dept Physiol, Antakya, Turkey; [Ulutas, K. T.] Kadirli State Hosp, Dept Clin Biochem, Osmaniye, Turkey	Cavus, G (corresponding author), Aksaray State Hosp, Dept Neurosurg, Aksaray, Turkey.	gokhanctf@yahoo.com	CAVUS, GOKHAN/C-7096-2018; Sefil, Fatih/AAR-6907-2020; Ozgur, Tumay/AAA-1530-2020; ULUTAS, KEMAL TURKER/I-3045-2019; Sefil, Fatih/C-3094-2011; Ulutas, Kemal Turker/N-8935-2013; Aras, Mustafa/ABC-4734-2020	CAVUS, GOKHAN/0000-0001-7078-2501; ULUTAS, KEMAL TURKER/0000-0003-2852-0449; Sefil, Fatih/0000-0001-5534-7448; Ulutas, Kemal Turker/0000-0003-2852-0449; 			AEBI H, 1974, METHOD ENZYMAT AN, P673; Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Akpek EA, 1999, SPINE, V24, P128, DOI 10.1097/00007632-199901150-00006; Alaygut E., 2007, THESIS; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; APPLE FS, 1994, J CLIN IMMUNOASSAY, V17, P24; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; DEPRAETER C, 1991, PEDIATRICS, V88, P1204; DURAK I, 1993, CLIN CHIM ACTA, V214, P103, DOI 10.1016/0009-8981(93)90307-P; Ekmekci H, 2007, THESIS; Erol FS, 2008, J CLIN NEUROSCI, V15, P784, DOI 10.1016/j.jocn.2007.06.009; FERNANDEZ F, 1987, ACTA PAEDIATR SCAND, V76, P914, DOI 10.1111/j.1651-2227.1987.tb17263.x; Genovese T, 2008, BRIT J PHARMACOL, V153, P568, DOI 10.1038/sj.bjp.0707577; Hildebrand J, 1973, Acta Neurol Belg, V73, P229; Kanter M, 2006, HUM EXP TOXICOL, V25, P127, DOI 10.1191/0960327106ht608oa; Kurt G, 2009, SURG NEUROL, V71, P332, DOI 10.1016/j.surneu.2008.01.038; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALINOVSKY JM, 1991, ANESTHESIOLOGY, V75, P91, DOI 10.1097/00000542-199107000-00015; MITSUHASHI T, 1994, PARAPLEGIA, V32, P524, DOI 10.1038/sc.1994.84; NISHIBE M, 1989, Hokkaido Journal of Medical Science, V64, P301; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PFEIFFER FE, 1983, ARCH NEUROL-CHICAGO, V40, P169, DOI 10.1001/archneur.1983.04050030063012; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; Sala A, 2001, BIOCHEM BIOPH RES CO, V283, P1003, DOI 10.1006/bbrc.2001.4865; Sener G, 2007, J PHARM PHARMACOL, V59, P837, DOI 10.1211/jpp.59.6.0009; Serarslan Y, 2010, J CLIN NEUROSCI, V17, P349, DOI 10.1016/j.jocn.2009.03.036; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; SUN Y, 1988, CLIN CHEM, V34, P497; Taoka Y, 1998, BRAIN RES, V799, P264, DOI 10.1016/S0006-8993(98)00459-4; TARLOV IM, 1972, J NEUROSURG, V36, P10, DOI 10.3171/jns.1972.36.1.0010; TSUNG SH, 1976, CLIN CHEM, V22, P173; YAKOVLEV AG, 1994, MOL CHEM NEUROPATHOL, V23, P179, DOI 10.1007/BF02815410; Yilmaz G., 2007, THESIS; Yu GL, 2005, PHARMACOLOGY, V73, P31, DOI 10.1159/000081072; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	36	14	16	1	5	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JUN	2014	18	12					1770	1777					8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AP3KV	WOS:000341975800018	24992621				2021-06-18	
J	Chiu, HY; Lo, WC; Chiang, YH; Tsai, PS				Chiu, Hsiao-Yean; Lo, Wen-Cheng; Chiang, Yung-Hsiao; Tsai, Pei-Shan			The effects of sleep on the relationship between brain injury severity and recovery of cognitive function: A prospective study	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						Cognitive function; Traumatic brain injury; Severity of brain injury; Sleep	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; DISTURBANCES; ACTIGRAPHY; METAANALYSIS; RELIABILITY; PARAMETERS; LESIONS	Background: Disturbed sleep pattern is a common symptom after head trauma and its prevalence in acute traumatic brain injury (TBI) is less discussed. Sleep has a profound impact on cognitive function recovery and the mediating effect of disturbed sleep on cognitive function recovery has not been examined after acute TBI. Objectives: To identify the prevalence of disturbed sleep in mild, moderate, and severe acute TBI patients, and to determine the mediating effects of sleep on the relationship between brain injury severity and the recovery of cognitive function. Design: A prospective study design. Setting: Neurosurgical wards in a medical center in northern Taiwan. Participants: Fifty-two acute TBI patients between the ages of 18 and 65 years who had received a diagnosis of TBI for the first time, and were admitted to the neurosurgical ward. Method: The severity of brain injury was initially determined using the Glasgow Coma Scale. Each patient wore an actigraphy instrument on a non-paralytic or non-dominated limb for 7 consecutive days. A 7-day sleep diary was used to facilitate data analysis. Cognitive function was assessed on the first and seventh day after admission based on the Rancho Los Amigos Levels of Cognitive Functioning. Results: The mild (n = 35), moderate (n = 7) and severe (n = 10) TBI patients exhibited poorer sleep efficiency, and longer total sleep time (TST) and waking time after sleep onset, compared with the normative values for the sleep-related variables (P<.05 for all). The severe and moderate TBI patients had longer daytime TST than the mild TB! patients (P<.001), and the severe TBI patients had longer 24-h TST than the mild TBI patients (P = .001). The relationship between the severity of brain injury and the recovery of cognition function was mediated by daytime TST (t = -2.65, P = .004). Conclusions: Poor sleep efficiency, prolonged periods of daytime sleep, and a high prevalence of hypersomnia are common symptoms in acute TBI patients. The duration of daytime sleep mediates the relationship between the severity of brain injury and the recovery of cognition function. (C) 2013 Elsevier Ltd. All rights reserved.	[Chiu, Hsiao-Yean; Tsai, Pei-Shan] Taipei Med Univ, Grad Inst Nursing, Coll Nursing, Taipei, Taiwan; [Lo, Wen-Cheng; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Lo, Wen-Cheng; Chiang, Yung-Hsiao] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ Hosp, Sleep Sci Ctr, Taipei, Taiwan; [Tsai, Pei-Shan] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan	Tsai, PS (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	ptsai@tmu.edu.tw			National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 102-2628-B-038-004-MY3, NSC 102-2811-B-038-028]	P.S. Tsai was supported, in part, by a grant (NSC 102-2628-B-038-004-MY3) from National Science Council, Taiwan. H.Y. Chiu was supported by the postdoctoral fellowship funding (NSC 102-2811-B-038-028) from the National Science Council, Taiwan.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dowling G A, 1985, J Neurosurg Nurs, V17, P129; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Flannery J, 1998, Rehabil Nurs, V23, P88; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Hagen C, 1998, LEVELS COGNITIVE FUN; Hagen C., 1979, LEVELS COGNITIVE FUN; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Jang IS., 2001, J PHYSL 3, V534; Kenny D. A., 2012, MEDIATION; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; MALKMUS D, 1980, REHABILITATION HEAD; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Overeem S., 2010, SLEEP DISORDER NEURO; Pandharipande P, 2006, CRIT CARE CLIN, V22, P313, DOI 10.1016/j.ccc.2006.02.010; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; TEASDALE G, 1974, LANCET, V2, P81; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	43	14	15	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	JUN	2014	51	6					892	899		10.1016/j.ijnurstu.2013.10.020			8	Nursing	Nursing	AH7ZL	WOS:000336353800008	24246095				2021-06-18	
J	Dhandapani, S; Sharma, A; Sharma, K; Das, L				Dhandapani, Sivashanmugam; Sharma, Anurag; Sharma, Karamchand; Das, Lakshman			Comparative evaluation of MRS and SPECT in prognostication of patients with mild to moderate head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Head injury; Hypoperfusion; MRS; NAA/Cr ratio; Outcome; SPECT	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; PHOTON EMISSION CT; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; DAMAGE; EPIDEMIOLOGY; PERFORMANCE	Magnetic resonance spectroscopy (MRS) and single-photon emission computed tomography (SPECT) have only been individually studied in patients with head injury. This study aimed to comparatively assess both in patients with mild to moderate head injury. Patients with a Glasgow Coma Scale (GCS) score of 9-14 who underwent MRS and/or SPECT were evaluated in relation to various clinical factors and neurological outcome at 3 months. There were 56 SPECT (Tc99m-ethylcysteinate dimer [ECD]) studies and 41 single voxel proton MRS performed in 53 patients, with 41 patients having both. Of the 41 who underwent MRS, 13 had a lower N-acetyl-aspartate/creatine (NAA/Cr) ratio, 14 had a higher choline (Cho)/Cr ratio, 19 were normal, and nine had bilateral MRS abnormalities. Of the 56 who underwent SPECT, 22 and 19 had severe and moderate hypoperfusion, respectively. Among those in Traumatic Coma Data Bank CT scan category 1 and 2, 50% had MRS abnormalities, whereas 64% had SPECT hypoperfusion, suggesting greater incremental validity of SPECT over MRS. In univariate analyses, GCS, moderate/severe hypoperfusion and bilateral SPECT changes were found to have significant association with unfavorable outcome (odds ratio 13.2, 15.9, and 4.4, and p values <0.01, 0.01, and 0.05, respectively). Patients with lower NAA/Cr ratio in MRS had more unfavorable outcomes, however this was not significant. In multivariate analysis employing binary logistic regression, GCS and severe hypoperfusion on SPECT were noted to have significant association with unfavorable outcome, independent of age, CT scan category, and MRS abnormalities (p values = 0.02 and 0.04, respectively). To conclude, ECD-SPECT seems to have greater sensitivity, incremental validity and prognostic value than single voxel proton MRS in select patients with head injury, with only severe hypoperfusion in SPECT significantly associated with unfavorable outcome independent of other confounding factors. (C) 2013 Elsevier Ltd. All rights reserved.	[Sharma, Anurag] Safdarjang Hosp, Dept Neurosurg, New Delhi, India; PGIMER, Chandigarh, India	Dhandapani, S (corresponding author), Safdarjang Hosp, Dept Neurosurg, New Delhi, India.	ssdhandapani.neurosurg@gmail.com	Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255			Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arnold DL, 1996, MR SPECTROSCOPY CLIN, P139; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Devous Michael D Sr, 2005, NeuroRx, V2, P237, DOI 10.1602/neurorx.2.2.237; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P107, DOI 10.1016/S0973-0508(10)80024-3; Dhandapani SS, 2010, INDIAN J NEUROTRAUM, V7, P23, DOI 10.1016/S0973-0508(10)80007-3; Du YL, 2011, NEUROL INDIA, V59, P31, DOI 10.4103/0028-3886.86540; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; ICHISE M, 1994, J NUCL MED, V35, P217; Jacobs A, 1996, J NUCL MED, V37, P1605; JENNETT B, 1975, LANCET, V1, P480; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Marshall SB, 1991, J NEUROSURG S, V75, P14; Masdeu JC, 2008, SEMIN NEUROL, V28, P423, DOI 10.1055/s-0028-1083683; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Nayak P, 2011, J NEUROSCI RURAL PRA, V2, P12, DOI 10.4103/0976-3147.80079; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Son BC, 2000, ACT NEUR S, V76, P13; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427	35	14	14	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2014	21	5					745	750		10.1016/j.jocn.2013.07.038			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AH0JP	WOS:000335805500007	24417798				2021-06-18	
J	Niemela, M; Kinnunen, L; Paananen, R; Hakko, H; Merikukka, M; Karttunen, V; Gissler, M; Rasanen, S				Niemela, Mika; Kinnunen, Lotta; Paananen, Reija; Hakko, Helina; Merikukka, Marko; Karttunen, Vesa; Gissler, Mika; Rasanen, Sami			Parents' traumatic brain injury increases their children's risk for use of psychiatric care: the 1987 Finnish Birth Cohort study	GENERAL HOSPITAL PSYCHIATRY			English	Article						Psychiatric care; Children; Parental TBI	INDIVIDUALS; SUPPORT	Objective: Traumatic brain injury (TBI) of a parent causes significant changes in their family life and parent-children relationships. However, the number of children affected by parental TBI and the long-term consequences for these children remain unknown. We estimated the prevalence of children affected by parental TBI and investigated whether these children had greater use of psychiatric services than their peers. Methods: This a retrospective population-based register study. All 60,069 children born in Finland in 1987 were followed up through national health and social registers from 1987 to 2008. Results: During the 21-year follow-up, 1532 (2.6%) children had a parent with TBI. Overall, 22.5% of those having a parent with TBI were treated in specialized psychiatric care. Use of psychiatric care was significantly increased among those cohort members with a parent with mild [odds ratio (OR) 1.80, 95% confidence interval (CI) 1.37-2.38] or severe (OR 1.49, 95% CI 1.12-1.98) TBI compared to their peers. Conclusions: Parental TBI is associated with increased use of specialized psychiatric services by children. Adult health care services must have appropriate systems in place to address the psychosocial needs and support the welfare and development of children of patients with TBI. (C) 2014 Elsevier Inc. All rights reserved.	[Niemela, Mika] Natl Inst Hlth & Welf, Child & Adolescent Mental Hlth Unit, Helsinki, Finland; [Kinnunen, Lotta; Hakko, Helina] Oulu Univ Hosp, Dept Psychiat, Oulu, Finland; [Paananen, Reija; Merikukka, Marko] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Karttunen, Vesa] Oulu Univ Hosp, Dept Neurol, Oulu, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth NHV, Gothenburg, Sweden; [Rasanen, Sami] Oulu Deaconess Inst, Oulu, Finland	Niemela, M (corresponding author), Natl Inst Hlth & Welf, Child & Adolescent Mental Hlth Unit, Helsinki, Finland.	mika.niemela@thl.fi		Kinnunen, Lotta/0000-0001-5428-6938; Gissler, Mika/0000-0001-8254-7525	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K006525/1] Funding Source: Medline		Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Chuang E, 2013, J SUBST ABUSE TREAT, V45, P118, DOI 10.1016/j.jsat.2013.01.007; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Fryers T., 2007, CHILDREN RISK CHILDH; Gissler M, 1998, SOC SCI MED, V46, P1543, DOI 10.1016/S0277-9536(98)00013-6; Gissler M, 2004, NORSK EPIDEMIOLOGI, V14, P113; Gissler M, 1999, STAKES RES REPORTS; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kobak R., 2006, DEVELOPMENTAL PSYCHO, VI, P333; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617713000428; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Niemela M, 2012, STRUCTURED CHILD CTR; Niemela M, 2012, INT J CANCER, V131, P2117, DOI 10.1002/ijc.27466; Paananen R, 1987, INT J EPIDEMIOL, V2011, P1; Paananen R, 2013, EUR J PUBLIC HEALTH, V23, P372, DOI 10.1093/eurpub/cks147; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007	30	14	14	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	MAY-JUN	2014	36	3					337	341		10.1016/j.genhosppsych.2013.12.012			5	Psychiatry	Psychiatry	AF2AS	WOS:000334515600017	24556261				2021-06-18	
J	Pitkanen, A; Immonen, R; Ndode-Ekane, X; Grohn, O; Stohr, T; Nissinen, J				Pitkanen, A.; Immonen, R.; Ndode-Ekane, X.; Grohn, O.; Stoehr, T.; Nissinen, J.			Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats	EPILEPSY RESEARCH			English	Article						Antiepileptic drug; Lateral fluid-percussion; Magnetic resonance imaging; Neurodegeneration	GATED SODIUM-CHANNELS; POSTTRAUMATIC SEIZURES; STATUS EPILEPTICUS; SLOW INACTIVATION; BINDING; DRUG; PROPHYLAXIS; EPILEPSY; MODEL; EPILEPTOGENESIS	In a subgroup of patients, traumatic brain injury (TBI) results in the occurrence of acute epileptic seizures or even status epilepticus, which are treated with antiepileptic drugs (AEDs). Recent experimental data, however, suggest that administration of AEDs at the early post-injury phase can compromise the recovery process. The present study was designed to assess the profile of a novel anticonvulsant, lacosamide (Vimpat (R)) on post-TBI structural, motor and cognitive outcomes. Moderate TBI was induced by lateral fluid-percussion injury in adult rats. Treatment with 0.9% saline or lacosamide (30 mg/kg, i.p.) was started at 30 min post-injury and continued at 8 h intervals for 3 d (total daily dose 90 mg/kg/d). Rats were randomly assigned to 4 treatment groups: sham-operated controls treated with vehicle (Sham-Veh) or lacosamide (Sham-LCM) and injured animals treated with vehicle (TBI-Veh) or lacosamide (TBI-LCM). As functional outcomes we tested motor recovery with composite neuroscore and beam-walking at 2, 7, and 15 d post-injury. Cognitive recovery was tested with the Morris water-maze at 12-14 d post-TBI. To assess the structural outcome, animals underwent magnetic resonance imaging (MRI) at 2 d post-TBI. At 16 d post-TBI, rats were perfused for histology to analyze cortical and hippocampal neurodegeneration and axonal damage. Our data show that at 2 d post-TBI, both the TBI-Veh and TBI-LCM groups were equally impaired in neuroscore. Thereafter, motor recovery occurred similarly during the first week. At 2 wk post-TBI, recovery of the TBI-LCM group lagged behind that in the TBI-VEH group (p < 0.05). Performance in beam-walking did not differ between the TBI-Veh and TBI-LCM groups. Both TBI groups were similarly impaired in the Morris water-maze at 2 wk post-TBI. MRI and histology did not reveal any differences in the cortical or hippocampal damage between the TBI-Veh and TBI-LCM groups. Taken together, acute treatment with LCM had no protective effects on post-TBI structural or functional impairment. Composite neuroscore in the TBI-LCM group lagged behind that in the TBI-Veh group at 15 d post-injury, but no compromise was found in other indices of post-TBI recovery in the LCM treated animals. (C) 2014 Elsevier B.V. All rights reserved.	Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, FI-70211 Kuopio, Finland; [Pitkanen, A.] Kuopio Univ Hosp, Dept Neurol, FI-70211 Kuopio, Finland	Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi					Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Childers MK, 1997, BRAIN INJURY, V11, P537, DOI 10.1080/713802187; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cross SA, 2009, DRUGS, V69, P449, DOI 10.2165/00003495-200969040-00005; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; Errington AC, 2008, MOL PHARMACOL, V73, P157, DOI 10.1124/mol.107.039867; FREUND TF, 1992, BRAIN RES BULL, V28, P27, DOI 10.1016/0361-9230(92)90227-O; Geis C, 2011, NEUROPHARMACOLOGY, V61, P600, DOI 10.1016/j.neuropharm.2011.05.001; Halonen T, 1996, EUR J PHARMACOL, V299, P69, DOI 10.1016/0014-2999(95)00835-7; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Hernandez TD, 1997, TRENDS PHARMACOL SCI, V18, P59, DOI 10.1016/S0165-6147(96)01027-9; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Hup CK, 2010, MALAYS J MED SCI, V17, P36; Ivanhoe CB, 2004, J HEAD TRAUMA REHAB, V19, P29, DOI 10.1097/00001199-200401000-00004; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Keck CA, 2007, RESTOR NEUROL NEUROS, V25, P77; Koo TS, 2011, ARCH PHARM RES, V34, P2059, DOI 10.1007/s12272-011-1208-7; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Ma CY, 2010, CHIN J TRAUMATOL, V13, P293, DOI 10.3760/cma.j.issn.1008-1275.2010.05.008; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Montanez S, 2001, J NEUROTRAUM, V18, P1255, DOI 10.1089/089771501317095296; Narkilahti S, 2003, EUR J NEUROSCI, V18, P1486, DOI 10.1046/j.1460-9568.2003.02874.x; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Park KD, 2009, J MED CHEM, V52, P6897, DOI 10.1021/jm9012054; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Pitkanen A, 2004, EXPERT OPIN PHARMACO, V5, P777, DOI 10.1517/14656566.5.4.777; Pitkanen A, 2007, SEIZURE FREEDOM CLIN, P9; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Sheets PL, 2008, J PHARMACOL EXP THER, V326, P89, DOI 10.1124/jpet.107.133413; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; Steinbaugh LA, 2012, EPILEPSY BEHAV, V23, P280, DOI 10.1016/j.yebeh.2011.12.005; Stohr T, 2007, EPILEPSY RES, V74, P147, DOI 10.1016/j.eplepsyres.2007.03.004; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Uebachs M, 2012, EPILEPSIA, V53, P1959, DOI 10.1111/j.1528-1167.2012.03675.x; Wang B, 2013, NEUROCRIT CARE, V19, P125, DOI 10.1007/s12028-012-9808-8; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Wang YY, 2010, J BIOL CHEM, V285, P25296, DOI 10.1074/jbc.M110.128801; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wolff C, 2012, CNS NEUROSCI THER, V18, P493, DOI 10.1111/j.1755-5949.2012.00313.x; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132; Zaccara G, 2013, EPILEPSIA, V54, P66, DOI 10.1111/j.1528-1167.2012.03589.x	51	14	14	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	MAY	2014	108	4					653	665		10.1016/j.eplepsyres.2014.02.001			13	Clinical Neurology	Neurosciences & Neurology	AG7UA	WOS:000335623100006	24636248				2021-06-18	
J	Russo, A; D'Onofrio, F; Conte, F; Petretta, V; Tedeschi, G; Tessitore, A				Russo, A.; D'Onofrio, F.; Conte, F.; Petretta, V.; Tedeschi, G.; Tessitore, A.			Post-traumatic headaches: a clinical overview	NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	6th ANIRCEF National Congress on Headache and Social Context	MAY 29-31, 2014	Asti, ITALY	ANIRCEF		Post-traumatic headache; PTH; Clinical aspects; Whiplash injury; Trauma	TRAUMATIC BRAIN-INJURY; CONCUSSION; SOLDIERS	Headache attributed to head and/or neck trauma or injury, the so-called post-traumatic headache (PTH), is the most common secondary headache disorder and one of the most controversial clinical entities in the headache field, due to its unclear pathophysiological mechanisms and the unsolved role of associated psychological and medico-legal aspects. PTH, as a significant cause of morbidity after traumatic brain injury, may occur as an isolated symptom or as one of a constellation of symptoms known as post-concussive syndrome. However, in many cases, PTH might also represent an accentuation of non-disabling, remote or infrequent pre-existing primary headaches rather than a new onset headache strictly related to the trauma. Recently, the International Classification of Headache Disorders attempted to classify PTH; however, many unsolved issues are still to be clarified. In this brief review, we will focus on PTH clinical aspects and diagnostic criteria.	[Russo, A.; Conte, F.; Tedeschi, G.; Tessitore, A.] Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy; [Russo, A.; Tedeschi, G.] IDC Hermitage Capodimonte, SUN FISM Ctr, Naples, Italy; [D'Onofrio, F.; Petretta, V.] San G Moscati Hosp Avellino, Div Neurol, Avellino, Italy	Tessitore, A (corresponding author), Univ Naples 2, Dept Med Surg Neurol Metab & Aging Sci, Naples, Italy.	alessandro.tessitore@unina2.it	Tessitore, Alessandro/K-3124-2018	Tessitore, Alessandro/0000-0003-1740-8566			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Ribeiro MDD, 2013, CEPHALALGIA, V33, P897, DOI 10.1177/0333102413479833; Ekbom K, 1999, CEPHALALGIA, V19, P73; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lainez MJA, 2011, CURR PAIN HEADACHE R, V15, P467, DOI 10.1007/s11916-011-0220-4; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Molnar L, 2014, J ANESTH, V28, P102, DOI 10.1007/s00540-013-1671-z; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; Obermann M, 2009, EXPERT REV NEUROTHER, V9, P1361, DOI 10.1586/ERN.09.84; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Reddy CC, 2011, PM&R, V3, pS396, DOI 10.1016/j.pmrj.2011.07.012; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Waung MW, 2012, CURR PAIN HEADACHE R, V16, P533, DOI 10.1007/s11916-012-0294-7; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	36	14	14	0	9	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2014	35			1			S153	S156		10.1007/s10072-014-1758-9			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AI3EZ	WOS:000336744400029	24867854				2021-06-18	
J	Stergiannis, P; Katsoulas, T; Fildissis, G; Intas, G; Galanis, P; Kosta, N; Zidianakis, V; Baltopoulos, G				Stergiannis, Pantelis; Katsoulas, Theodoros; Fildissis, George; Intas, George; Galanis, Peter; Kosta, Natalia; Zidianakis, Vasilios; Baltopoulos, George			Health-Related Quality of Life and Rehabilitation Cost Following Intensive Care Unit Stay in Multiple Trauma Patients	JOURNAL OF TRAUMA NURSING			English	Article						Cost; Multiple trauma patients; Quality of life; Rehabilitation	WORK STATUS; INJURY; DETERMINANTS; SURVIVORS; MEMORIES; ICU	Objectives: The objective of this study was to assess changes in health-related quality of life (HRQOL) in multiple trauma patients due to motor vehicle crashes during a follow-up period of 2 years after discharge from an intensive care unit (ICU) and the effect of income and financial cost of rehabilitation in HRQOL. Methods: The study was a prospective observational study of multiple trauma patients from January 2009 to January 2011 who were hospitalized in a general, medical, and surgical ICU of a district hospital in Athens, Greece. Eighty-five patients with multiple traumas due to motor vehicle crashes and with an ICU stay of more than 24 hours were included in the study. HRQOL was assessed by a general questionnaire, the EuroQol 5D. Results: Increased monthly household income and absence of traumatic brain injuries were associated with an improved EQ-VAS score. The frequency of severe problems in mobility, self-care, usual activities, pain/discomfort, and anxiety/depression decreased over time. The financial cost of rehabilitation was initially high but decreased over time. Conclusions: Severely injured victims of motor vehicle crashes suffer from serious problems in terms of HRQOL which is gradually improved even 2 years after hospital discharge. In addition, HRQOL is significantly related to income. Resources used for rehabilitation decrease over time, but even at 24 months, the patients still use half of the amount as compared with the cost of the first 6 months after trauma.	[Stergiannis, Pantelis; Katsoulas, Theodoros; Fildissis, George; Kosta, Natalia; Zidianakis, Vasilios; Baltopoulos, George] Univ Athens, GONK Agioi Anargyroi Hosp, Intens Care Unit, Sch Nursing, Kalyftaki, N Kifisia, Greece; [Intas, George] Univ Athens, Sch Nursing, Athens 11528, Greece; [Galanis, Peter] Univ Athens, Sch Nursing, Ctr Hlth Serv Management & Evaluat, Athens 11528, Greece	Katsoulas, T (corresponding author), Agisilaou 70 Petroupoli, Athens 13231, Greece.	katsoula@otenet.gr	Katsoulas, Theodoros/AAD-8516-2019; Stergiannis, Pantelis I./G-2283-2016	Stergiannis, Pantelis I./0000-0001-8297-3460; Intas, George/0000-0001-7430-7724			Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Drummond MF, 2005, METHODS EC EVALUATIO; Fildissis G, 2007, CROAT MED J, V48, P814, DOI 10.3325/cmj.2007.6.814; Flaatten H, 2001, INTENS CARE MED, V27, P1005, DOI 10.1007/s001340100960; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Heyland DK, 1998, CRIT CARE MED, V26, P591, DOI 10.1097/00003246-199803000-00037; Hofhuis JGM, 2009, CURR OPIN CRIT CARE, V15, P425, DOI 10.1097/MCC.0b013e32833079e4; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Kaarlola A, 2003, INTENS CARE MED, V29, P1294, DOI 10.1007/s00134-003-1849-1; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KONOPAD E, 1995, CRIT CARE MED, V23, P1653, DOI 10.1097/00003246-199510000-00008; Kosty JA, 2013, NEUROL RES, V35, P277, DOI 10.1179/1743132813Y.0000000168; Kvale Reidar, 2003, Health Qual Life Outcomes, V1, P2, DOI 10.1186/1477-7525-1-2; Lizana FG, 2003, INTENS CARE MED, V29, P1286, DOI 10.1007/s00134-003-1875-z; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Ringdal M, 2010, CRIT CARE MED, V38, P38, DOI 10.1097/CCM.0b013e3181b42909; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Szende A, 2007, INVENTORY COMP REV U; Timmers TK, 2011, ARCH SURG-CHICAGO, V146, P412, DOI 10.1001/archsurg.2010.279; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Ulvik A, 2008, ACTA ANAESTH SCAND, V52, P195, DOI 10.1111/j.1399-6576.2007.01533.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2004, WORLD REPORT ROAD TR; Yfantopoulos J, 2001, ARCH HELL MED, V18, P180	29	14	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	MAY-JUN	2014	21	3					115	121		10.1097/JTN.0000000000000042			7	Critical Care Medicine; Nursing	General & Internal Medicine; Nursing	CB4ZS	WOS:000349637800007	24828773				2021-06-18	
J	Willmott, C; Ponsford, J; Downing, M; Carty, M				Willmott, Catherine; Ponsford, Jennie; Downing, Marina; Carty, Meagan			Frequency and Quality of Return to Study Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						traumatic brain injury; education; rehabilitation; study; outcomes	CLOSED-HEAD INJURY; STRATEGY APPLICATION; STUDENTS; SCHOOL; SCALE; WORK; TBI; IMPAIRMENTS; ATTENTION; EDUCATION	Objective: To examine the frequency and experience of return to secondary or tertiary study over a 10-year period following traumatic brain injury (TBI). Participants: A group of 295 students with moderate to severe TBI followed prospectively. Setting: Epworth HealthCare TBI outpatient rehabilitation program follow-up clinic 1 to 10 years postinjury. Main Outcome Measures: Frequency of return to study. Also, for a subset, changes in course enrollment, utilization of additional educational supports, and experience of return to study postinjury. Results: Of those studying preinjury, 295 attended the follow-up clinic appointments, with 167 (56%) having returned to study. Those who did not return to study had significantly longer posttraumatic amnesia duration. The cross-sectional follow-up revealed that 60.4% were studying at 1 year postinjury, 37.5% at 2 years postinjury, 50.0% at 3 years postinjury, 31.1% at 5 years postinjury, and 2.0% at 10 years postinjury. Many had migrated into employment. A subsample of 95 participants reported on their educational experience. Of those, 28.7% changed their course enrollment from full-time to part-time. While supports such as tuition and special consideration were greatly increased postinjury, students reported the proportion of subjects passed of 79.0%. However, they experienced cognitive difficulties and fatigue and felt less satisfied with their studies. Conclusions: Return to study was relatively successful; however, this was associated with the experience of fatigue and need for far greater effort, assistance and reduced study hours, and somewhat less overall satisfaction.	[Willmott, Catherine; Ponsford, Jennie; Downing, Marina] Monash Univ, Sch Psychol & Psychiat, Monash Psychol Ctr, Notting Hill, Vic 3168, Australia; [Willmott, Catherine; Ponsford, Jennie; Downing, Marina; Carty, Meagan] Monash Univ, Monash Epworth Rehabil Res Ctr, Notting Hill, Vic 3168, Australia; [Ponsford, Jennie] Monash Univ, Natl Trauma Res Inst, Notting Hill, Vic 3168, Australia	Willmott, C (corresponding author), Monash Univ, Sch Psychol & Psychiat, Monash Psychol Ctr, Bldg 1-270 Ferntree Gully Rd, Notting Hill, Vic 3168, Australia.	catherine.willmott@.monash.edu	Downing, Marina/AAX-2380-2020; Willmott, Catherine/AAA-5105-2019	Downing, Marina/0000-0002-3126-6632; Willmott, Catherine/0000-0001-8517-9035	Victorian Government Transport Accident Commission; Institute for Safety Compensation and Recovery Research	This project was supported by the Victorian Government Transport Accident Commission and the Institute for Safety Compensation and Recovery Research. The authors thank Professor John Olver, Dr Michael Ponsford, and Dr Rose Acher, who conducted the follow-up interviews with participants. The authors also thank all participants involved in this project, who gave so generously of their time.	*AUSTR I HLTH WELF, 2004, AUSTR HLTH 2004; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fortune N, 2000, DEFINITION INCIDENCE; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Jennett B, 1981, MANAGEMENT HEAD INJU; Kennedy MRT, 2011, J HEAD TRAUMA REHAB, V26, P212, DOI 10.1097/HTR.0b013e318218dd0e; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Kolakowsky-Hayner SA, 2012, NEUROREHABILITATION, V31, P63, DOI 10.3233/NRE-2012-0775; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; MacLennan DL, 2008, NEUROREHABILITATION, V23, P521; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; MCCULLAGH S, 2005, TXB TRAUMATIC BRAIN; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; ORance L., 2007, DISABILITY AUSTR ACQ; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Ponsford J, 2013, TRAUMATIC BRAIN INJU, P1; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sloan S., 2013, TRAUMATIC BRAIN INJU, P66; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Tate R, 2011, FINAL REPORT LIFETIM, P1; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wagner M., 2005, HIGH SCH 1 LOOK POST; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	47	14	14	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					248	256		10.1097/HTR.0000000000000014			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100013	24413073				2021-06-18	
J	Miyauchi, T; Wei, EP; Povlishock, JT				Miyauchi, Takashi; Wei, Enoch P.; Povlishock, John T.			Evidence for the Therapeutic Efficacy of Either Mild Hypothermia or Oxygen Radical Scavengers after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						superoxide dismutase; hypothermia; rats; Tempol; cerebrovascular reactivity; axonal damage	CLOSED-HEAD INJURY; TEMPORAL WINDOW; AXONAL INJURY; INTRACRANIAL-PRESSURE; ANIMAL-MODEL; VULNERABILITY; CONCUSSION; DAMAGE; FK506; TEMPERATURE	Repetitive brain injury, particularly that occurring with sporting-related injuries, has recently garnered increased attention in both the clinical and public settings. In the laboratory, we have demonstrated the adverse axonal and vascular consequences of repetitive brain injury and have demonstrated that moderate hypothermia and/or FK506 exerted protective effects after repetitive mild traumatic brain injury (mTBI) when administered within a specific time frame, suggesting a range of therapeutic modalities to prevent a dramatic exacerbation. In this communication, we revisit the utility of targeted therapeutic intervention to seek the minimal level of hypothermia needed to achieve protection while probing the role of oxygen radicals and their therapeutic targeting. Male Sprague-Dawley rats were subjected to repetitive mTBI by impact acceleration injury. Mild hypothermia (35 degrees C, group 2), superoxide dismutase (group 3), and Tempol (group 4) were employed as therapeutic interventions administered 1 h after the repetitive mTBI. To assess vascular function, cerebral vascular reactivity to acetylcholine was evaluated 3 and 4 h after the repetitive mTBI, whereas to detect the burden of axonal damage, amyloid precursor protein (APP) density in the medullospinal junction was measured. Whereas complete impairment of vascular reactivity was observed in group 1 (without intervention), significant preservation of vascular reactivity was found in the other groups. Similarly, whereas remarkable increase in the APP-positive axon was observed in group 1, there were no significant increases in the other groups. Collectively, these findings indicate that even mild hypothermia or the blunting free radical damage, even when performed in a delayed period, is protective in repetitive mTBI.	[Miyauchi, Takashi; Wei, Enoch P.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Miyauchi, Takashi] Yamaguchi Univ, Adv Med Emergency & Crit Care Ctr, Ube, Yamaguchi, Japan	Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077657, NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077675, P30NS047463, R01NS077657] Funding Source: NIH RePORTER	The authors thank Ms. Lynn Davis and Mrs. Susan Walker for their technical assistance. This study was supported by National Institutes of Health grants NS077657 and NS047463.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Byard RW, 2009, FORENSIC SCI MED PAT, V5, P36, DOI 10.1007/s12024-008-9063-7; Campbell K, 2013, BRAIN RES, V1502, P47, DOI 10.1016/j.brainres.2013.01.038; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035313; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Kawanishi Masahiko, 2008, J Stroke Cerebrovasc Dis, V17, P187, DOI 10.1016/j.jstrokecerebrovasdis.2008.01.003; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Khan JN, 2010, EUROPACE, V12, P266, DOI 10.1093/europace/eup376; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kuo JR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/145214; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Miyauchi T, 2013, J NEUROTRAUM, V30, P1664, DOI 10.1089/neu.2013.2995; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Mueller-Burke D, 2008, INT J DEV NEUROSCI, V26, P67, DOI 10.1016/j.ijdevneu.2007.08.015; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003	49	14	18	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					773	781		10.1089/neu.2013.3181			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200008	24341607	Green Published			2021-06-18	
J	Yang, Y; Zhang, YG; Lin, GA; Xie, HQ; Pan, HT; Huang, BQ; Liu, JD; Liu, H; Zhang, N; Li, L; Chen, JH				Yang, Yang; Zhang, Yong-Gang; Lin, Guo-An; Xie, He-Qiu; Pan, Hai-Tao; Huang, Ben-Qing; Liu, Ji-Dong; Liu, Hui; Zhang, Nan; Li, Li; Chen, Jian-Hua			The effects of different hyperbaric oxygen manipulations in rats after traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Hyperbaric oxygenation; Traumatic brain injury; Treatment	FLUID-PERCUSSION INJURY; ACCELERATES NEUROLOGIC RECOVERY; MITOCHONDRIAL-FUNCTION; CEREBRAL-ISCHEMIA; THERAPY; CLEARANCE; EXPOSURE	The protective effects of hyperbaric oxygenation following traumatic brain injury have been widely investigated; however, few studies have made systematic comparisons between the different hyperbaric oxygenation manipulations and their corresponding effects. In this study, male Sprague-Dawley rats were observed at 4 h, 15 d and 75 d after traumatic brain injury. The effects of the different hyperbaric oxygenation manipulations on the rats were compared based on morphological, molecular biological and behavioral tests. Our results showed that hyperbaric oxygenation inhibited cell apoptosis in the rat hippocampus and improved their physiological functions. The effects observed in the hyperbaric oxygen-early group were better than the hyperbaric oxygen-delayed group, and the hyperbaric oxygen-early-delayed group demonstrated the best effects among all the groups. Our results showed the hyperbaric oxygenation was recommended early and delayed post-traumatic brain injury and exposure to hyperbaric oxygenation should be prolonged. These findings provide new ideal therapeutic insight for the clinical treatment of traumatic brain injury. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yang, Yang; Liu, Ji-Dong; Liu, Hui; Li, Li; Chen, Jian-Hua] Zhumadian City Ctr Hosp, Dept Neurosurg, Zhumadian 463000, Peoples R China; [Zhang, Yong-Gang] Zhumadian City Ctr Hosp, Dept ICU, Zhumadian 463000, Peoples R China; [Lin, Guo-An] PLA, Hosp 159, Dept Burn, Zhumadian 463008, Peoples R China; [Xie, He-Qiu] Zhumadian City Ctr Hosp, Dept Pain, Zhumadian 463000, Peoples R China; [Pan, Hai-Tao] Xian Univ Finance & Econ, Sch Stat, Xian 710061, Peoples R China; [Huang, Ben-Qing] PLA, Hosp 159, Dept Oncol, Zhumadian 463008, Peoples R China; [Zhang, Nan] Xinxiang Med Univ, Dept Student Affairs, Xinxiang 453003, Peoples R China	Li, L (corresponding author), Zhumadian City Ctr Hosp, Dept Neurosurg, 747 Zhonghua Rd, Zhumadian 463000, Peoples R China.	zmdlil@163.com; yangyang19800627@163.com	Pan, Haitao/N-2529-2018	Pan, Haitao/0000-0003-4457-7349			Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; CONTRERAS FL, 1988, J NEUROSURG, V68, P137, DOI 10.3171/jns.1988.68.1.0137; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Demchenko IT, 1998, UNDERSEA HYPERBAR M, V25, P147; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; HUNT RC, 1978, EXP NEUROL, V62, P698, DOI 10.1016/0014-4886(78)90278-9; IWATSUKI N, 1994, CRIT CARE MED, V22, P858, DOI 10.1097/00003246-199405000-00024; IZAWA K, 1993, GASTROENTEROL JPN, V28, P284; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; KLEIN J, 1990, ANESTH ANALG, V70, P195; KOHSHI K, 1991, Neurologia Medico-Chirurgica, V31, P575, DOI 10.2176/nmc.31.575; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Manor T, 2003, ADV EXP MED BIOL, V510, P409; Mayumi P.L., 1996, DEV BRAIN RES, V95, P272; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pierson David J, 2002, Respir Care, V47, P249; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Speit G, 2002, MUTAT RES-REV MUTAT, V512, P111, DOI 10.1016/S1383-5742(02)00045-5; TAKAHASHI M, 1992, CRIT CARE MED, V20, P1588, DOI 10.1097/00003246-199211000-00018; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WEINSTEIN PR, 1987, NEUROSURGERY, V20, P518, DOI 10.1227/00006123-198704000-00002; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	27	14	16	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 20	2014	563						38	43		10.1016/j.neulet.2014.01.002			6	Neurosciences	Neurosciences & Neurology	AE5CR	WOS:000334005900008	24412131				2021-06-18	
J	Shaked, G; Douvdevani, A; Yair, S; Zlotnik, A; Czeiger, D				Shaked, Gad; Douvdevani, Amos; Yair, Silvia; Zlotnik, Alexander; Czeiger, David			The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Cell free DNA; Circulating DNA; Brain injury; Head trauma	GLASGOW COMA SCALE; FREE PLASMA DNA; BRAIN-INJURY; PREDICTIVE MARKER; NUCLEIC-ACIDS; CLASSIFICATION; DAMAGE; MORTALITY; FEATURES; SEPSIS	Background: Traumatic brain injury (TBI) is a major cause of death and disability. In this study a new method to measure cell free DNA (CFD) for the management of TBI is tested. Our hypothesis was that CFD concentrations correlate to the magnitude of brain damage, and may predict the outcome of injured patients. Methods: Twenty eight patients with isolated head injury were enrolled. Their demographic and clinical data were recorded. CFD levels were determined in patients' sera samples by a direct fluorescence method developed in our laboratory. Results: Mean admission CFD values were lower in patients with mild TBI compared to severe injury (760 +/- 340 ng/ml vs. 1600 +/- 2100 ng/ml, p = 0.03), and in patients with complete recovery upon discharge compared to patients with disabilities (680 +/- 260 ng/ml vs. 2000 +/- 2300 ng/ml, p = 0.003). Patients with high CFD values had a relative risk to require surgery of 1.5 (95% CI 0.83 to 2.9) a relative risk to have impaired outcome on discharge of 2.8 (95% CI 0.75 - 10), and a longer length of stay (12 +/- 13 days vs. 3.4 +/- 4.8 days, p = 0.02). CFD values did not correlate with CT scan based grading. Conclusions: CFD levels may be used as a marker to assess the severity of TBI and to predict the prognosis. Its use should be considered as an additional tool along with currently used methods or as a surrogate for them in limited resources environment.	[Shaked, Gad; Czeiger, David] Soroka Univ, Med Ctr, Dept Gen Surg, Trauma Unit, IL-84101 Beer Sheva, Israel; [Shaked, Gad; Yair, Silvia; Czeiger, David] Soroka Univ, Med Ctr, Dept Clin Biochem, IL-84101 Beer Sheva, Israel; [Douvdevani, Amos] Soroka Univ, Med Ctr, Dept Anesthesiol, IL-84101 Beer Sheva, Israel; [Zlotnik, Alexander] Soroka Univ, Med Ctr, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Beer Sheva, Israel	Shaked, G (corresponding author), Soroka Univ, Med Ctr, Dept Gen Surg, Trauma Unit, 68 Wingate St, IL-84101 Beer Sheva, Israel.	shakedg@bgu.ac.il	Douvdevani, Amos/E-3803-2010	Douvdevani, Amos/0000-0002-0197-6481	Dr. Montague Robin Fleisher Kidney Transplant Unit Fund	This work was supported by the "Dr. Montague Robin Fleisher Kidney Transplant Unit Fund". The fund was not involved in any way in the study. Amos Douvdevani submitted a US Patent Application No. 13/659,439 "Assay for Detecting Circulating Free Nucleic Acids". All other authors deny any other financial or personal relationships that might be considered as conflict of interest.	Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GERSTENBRAND F, 1970, Archiv fuer Psychiatrie und Nervenkrankheiten, V213, P264, DOI 10.1007/BF00342662; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; JENNETT B, 1975, LANCET, V1, P480; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Lam NYL, 2003, CLIN CHEM, V49, P1286, DOI 10.1373/49.8.1286; Lo YMD, 2000, CLIN CHEM, V46, P319; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Rainer TH, 2006, ANN NY ACAD SCI, V1075, P271, DOI 10.1196/annals.1368.035; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P63, DOI 10.1007/s12207-010-9066-z; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yurgel VC, 2007, J NEUROTRAUM, V24, P1172, DOI 10.1089/neu.2006.0160	34	14	15	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 19	2014	22								21	10.1186/1757-7241-22-21			6	Emergency Medicine	Emergency Medicine	AG5MU	WOS:000335463900001	24641833	DOAJ Gold, Green Published			2021-06-18	
J	Kawoos, U; Meng, X; Huang, SM; Rosen, A; McCarron, RM; Chavko, M				Kawoos, Usmah; Meng, Xu; Huang, Shi-Min; Rosen, Arye; McCarron, Richard M.; Chavko, Mikulas			Telemetric Intracranial Pressure Monitoring in Blast-Induced Traumatic Brain Injury	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Blast injury; intracranial pressure (ICP); telemetric monitoring; traumatic brain injury (TBI)	HEAD-INJURY; ICP; INCREASE; MODEL	The long-term monitoring of intracranial pressure (ICP) is important for the management of acute and chronic neuropathological conditions which include head injury, traumatic brain injury, hydrocephalus, etc. In this study, we developed an implantable device for measuring ICP over long periods of time in an animal model of blast-induced brain injury. The performance of the device was first evaluated in vitro and subsequently utilized to measure ICP in rats exposed to blast overpressures. The effects of blast-induced brain injury on ICP were measured for six days. A significant difference was observed between the injured group and the nonexposed control group. ICP in injured animals showed a biphasic transient increase; an immediate increase within the first 1-3 h and a more gradual elevation occurring two days after the blast. The ability to monitor changes of ICP continuously over long periods after brain injury and during the course of treatment may improve the prognosis after injury and can also serve as a tool in determining the therapeutic effectiveness of new drugs.	[Kawoos, Usmah; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept NeuroTrauma, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA; [Meng, Xu; Rosen, Arye] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Huang, Shi-Min] Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA	Kawoos, U (corresponding author), Naval Med Res Ctr, Dept NeuroTrauma, Operat & Undersea Med Directorate, Silver Spring, MD 20910 USA.	usmahk@gmail.com; xm26@drexel.edu; sh592@drexel.edu; ar86@drexel.edu; richard.mccarron@med.navy.mil; mikulas.chavko@med.navy.mil	Huang, Shimin/X-6369-2019		CDMRP Research Unit [2780.00000.22.A0810]	This work was supported in part by CDMRP Research Unit #2780.00000.22.A0810. Asterisk indicates corresponding author.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Poca MA, 2007, J NEUROSURG, V106, P548, DOI 10.3171/jns.2007.106.4.548; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Eide PK, 2008, MED ENG PHYS, V30, P34, DOI 10.1016/j.medengphy.2007.01.005; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; FRISEN L, 1982, J NEUROL NEUROSUR PS, V45, P13, DOI 10.1136/jnnp.45.1.13; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gregson BA, 2001, J NEUROL NEUROSUR PS, V70, P138; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; Jamali S, 1998, BRAIN INJURY, V12, P525, DOI 10.1080/026990598122485; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kiefer Michael, 2012, Acta Neurochir Suppl, V114, P111, DOI 10.1007/978-3-7091-0956-4_20; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Meng X, 2012, ELECTRON LETT, V48, P363, DOI 10.1049/el.2012.0281; Meng XL, 2011, PHIL MAG LETT, V91, P344, DOI 10.1080/09500839.2011.559912; MOSS SM, 1991, EUR J PEDIATR SURG, V1, P25, DOI 10.1055/s-2008-1042533; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; REID A, 1990, British Journal of Audiology, V24, P123, DOI 10.3109/03005369009077853; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Salvador L, 2010, J NEUROSURG ANESTH, V22, P240, DOI 10.1097/ANA.0b013e3181dbe1cc; Shapiro S, 1996, SURG NEUROL, V45, P278, DOI 10.1016/0090-3019(95)00359-2; Silasi G, 2009, CURR NEUROVASC RES, V6, P62, DOI 10.2174/156720209787466046; Weerakkody Ruwan Alwis, 2012, Acta Neurochir Suppl, V114, P181, DOI 10.1007/978-3-7091-0956-4_35; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	28	14	15	0	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	MAR	2014	61	3					841	847		10.1109/TBME.2013.2291239			7	Engineering, Biomedical	Engineering	AD5DX	WOS:000333273000023	24557686				2021-06-18	
J	Richmond, TS; Guo, WS; Ackerson, T; Hollander, J; Gracias, V; Robinson, K; Amsterdam, J				Richmond, Therese S.; Guo, Wensheng; Ackerson, Theimann; Hollander, Judd; Gracias, Vicente; Robinson, Keith; Amsterdam, Jay			The Effect of Postinjury Depression on Quality of Life following Minor Injury	JOURNAL OF NURSING SCHOLARSHIP			English	Article						injuries; depression; quality of life; trauma; Cohort study	POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL STATUS QUESTIONNAIRE; TRAUMATIC INJURY; HEALTH-STATUS; BRAIN-INJURY; CARE; RECOVERY; INDEX; RELIABILITY; SURVIVORS	Purpose To describe quality of life (QoL) in the year following minor injury and to test the hypothesis that individuals with depression in the postinjury year experience lower QoL than do individuals with no depression. Design Prospective, longitudinal, cohort design. A total of 275 adults were randomly selected from injured patients presenting to an urban emergency department. Methods All participants underwent structured psychiatric diagnostic interviews immediately after injury and at 3, 6, and 12 months. The primary outcome, QoL, was measured using the Quality of Life Index. Covariates included demographics, injury status, preinjury functional status, preinjury social support, and anticipation of problems postdischarge. The General Estimating Equation was used to compare changes in QoL between participants with and without depression over 3, 6, and 12 months, adjusting for covariates. Results An 18.1% proportion (95% confidence interval [CI] 13.3, 22.9%) of the sample met criteria for a mood disorder in the postinjury year. The depressed group reported a QoL that was 4.2 points (95% CI 2.8-5.6) lower in the year postinjury compared with that of the nondepressed group. Conclusions Depression after minor injury negatively affects QoL even a full year postinjury. Clinical Relevance The findings of this study show that patients who have injuries that are treated and discharged from an emergency department can have significantly lower QoL in the year after that injury that is attributed, in part, to postinjury depression. Nurses should provide anticipatory guidance to patients that they may experience feelings of sadness or being "blue," and that if they do, they should seek care.	[Richmond, Therese S.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Guo, Wensheng; Hollander, Judd; Robinson, Keith; Amsterdam, Jay] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ackerson, Theimann] Univ Windsor, Ctr Execut & Profess Educ, Windsor, ON N9B 3P4, Canada; [Gracias, Vicente] Robert Wood Johnson Univ Hosp, New Brunswick, NJ USA	Richmond, TS (corresponding author), Univ Penn, Sch Nursing, Fagin Hall 330,418 Curie Blvd, Philadelphia, PA 19104 USA.	terryr@nursing.upenn.edu		Hollander, Judd/0000-0002-1318-2785	National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH63818]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH063818] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Mental Health R01 MH63818 to Dr. Richmond.	Aitken L. M., 2012, J CLIN NURS, DOI [10.1111/jocn.12026, DOI 10.1111/JOCN12026]; Aitken LM, 2012, J TRAUMA ACUTE CARE, V72, P1702, DOI 10.1097/TA.0b013e318246bfe9; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Borg T, 2010, INJURY, V41, P400, DOI 10.1016/j.injury.2009.11.006; Brasel KJ, 2010, J TRAUMA, V68, P263, DOI 10.1097/TA.0b013e3181caa58f; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Disease Control and Prevention 1999, 1999, 1900 1999 MMWR MORB, V48, P241; Centers for Disease Control and Prevention (CDC), 2013, WEB BAS INJ STAT QUE; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cleary PD, 2000, QUAL LIFE RES, V9, P747, DOI 10.1023/A:1008977923785; Costanza R, 2007, ECOL ECON, V61, P267, DOI 10.1016/j.ecolecon.2006.02.023; Diggle PJ, 1994, ANAL LONGITUDINAL DA; FERRANS CE, 1992, RES NURS HEALTH, V15, P29, DOI 10.1002/nur.4770150106; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; First M., 1994, STRUCTURED CLIN INTE; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Gross T, 2011, SURGERY, V150, P985, DOI 10.1016/j.surg.2011.04.003; Gross T, 2010, J AM COLL SURGEONS, V211, P81, DOI 10.1016/j.jamcollsurg.2010.02.042; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; KELLER MB, 1987, ARCH GEN PSYCHIAT, V44, P540; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mason S, 2009, BRIT J CLIN PSYCHOL, V48, P31, DOI 10.1348/014466508X344799; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; O'Donnell ML, 2008, J CONSULT CLIN PSYCH, V76, P923, DOI 10.1037/a0012918; Orwelius L, 2012, J TRAUMA ACUTE CARE, V72, P504, DOI 10.1097/TA.0b013e31821a416a; Overgaard M, 2011, J TRAUMA, V71, P435, DOI 10.1097/TA.0b013e31820e7ec3; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Richmond TS, 2009, PSYCHOL MED, V39, P1709, DOI 10.1017/S0033291709005376; Richmond TS, 2011, J ADV NURS, V67, P2741, DOI 10.1111/j.1365-2648.2011.05749.x; Richmond TS, 2011, GEN HOSP PSYCHIAT, V33, P327, DOI 10.1016/j.genhosppsych.2011.05.003; Richmond TS, 2003, AM J CRIT CARE, V12, P197, DOI 10.4037/ajcc2003.12.3.197; Richmond TS, 2000, J ADV NURS, V32, P1341, DOI 10.1046/j.1365-2648.2000.01629.x; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Ringdal M, 2010, CRIT CARE MED, V38, P38, DOI 10.1097/CCM.0b013e3181b42909; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Sutherland AG, 2011, J ORTHOP TRAUMA, V25, P228, DOI 10.1097/BOT.0b013e3181ee40a9; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Trevino Colleen M, 2012, J Trauma Nurs, V19, P154, DOI 10.1097/JTN.0b013e318261d304; University of Illinois at Chicago, QUALITY LIFE; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Zarzaur BL, 2011, J TRAUMA, V70, P285, DOI 10.1097/TA.0b013e31820b5b80; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313	53	14	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6546	1547-5069		J NURS SCHOLARSHIP	J. Nurs. Scholarsh.	MAR	2014	46	2					116	124		10.1111/jnu.12064			9	Nursing	Nursing	AC2HT	WOS:000332321400007	24354500	Green Accepted			2021-06-18	
J	Robins, A; Pleiter, H; Latter, M; Phillips, CJC				Robins, A.; Pleiter, H.; Latter, M.; Phillips, C. J. C.			The efficacy of pulsed ultrahigh current for the stunning of cattle prior to slaughter	MEAT SCIENCE			English	Article						Halal; Welfare; Exsanguination; Reflex; Electro-encephalograph; Insensibility	HALAL SLAUGHTER; BLOOD-PRESSURE; ELECTROPORATION; DELIVERY; ARTERIES; QUALITY; CALVES; LAMBS; SHEEP	We present results from the development of a new system of reversible electrical stunning of cattle. A single-pulse ultra-high current (SPUC) was generated from a capacitance discharge current spike of at least 5000 Vat 70 A, for approximately 50 ms. Ninety-seven cattle were stunned in three experimental protocols. With improvements made to the design of the stun box and charge delivered, 38 cattle were either stunned and immediately jugulated or monitored for signs of reappearance of brain stem reflexes at which point a concussion stun was administered. This use of the SPUC charge, provided as a biphasic-pulse waveform, resulted in a high level of stunning efficacy, with unconsciousness lasting for up to 4 min. These results were supported by EEG data taken from a subsequent cohort of stunned cattle. The SPUC stun also apparently eliminated post-stun grand mal seizures that can occur following short-acting conventional electrical stun, with its associated negative consequences on operator safety and meat quality. (C) 2013 Elsevier Ltd. All rights reserved.	[Robins, A.; Latter, M.; Phillips, C. J. C.] Univ Queensland, Ctr Anim Welf & Eth, Sch Vet Sci, Gatton, Qld 4343, Australia; [Pleiter, H.] Meat & Livestock Australia, Brisbane, Qld, Australia	Robins, A (corresponding author), Univ Queensland, Ctr Anim Welf & Eth, Sch Vet Sci, Gatton, Qld 4343, Australia.		Robins, Andrew/T-9034-2019; Robins, Andrew/A-1398-2008	Robins, Andrew/0000-0001-7806-8409	MLA (Meat and Livestock, Australia); Came Technologies Ltd., N.Z.	This research was supported by the MLA (Meat and Livestock, Australia) and Came Technologies Ltd., N.Z.	Anil H., 2012, EFFECTS SLAUGHTER ME; Anil MH, 2006, ANIM WELFARE, V15, P325; Australian Meat Industry Council (AMIC), 2009, NAT AN WELF STAND LI, P37; AVMA, 2013, AVMA GUID EUTH AN; Berg C., 2007, Svensk Veterinartidning, V59, P21; COOK CJ, 1992, RES VET SCI, V52, P48, DOI 10.1016/0034-5288(92)90057-9; CSIRO, 2011, MEAT TECHN UPD EFF S; Daly C., 2005, INT S, p[77, 77]; Daly C. C., 1986, P EUR M MEAT RES WOR, V32, P103; De Vry J, 2010, PROG NEUROBIOL, V92, P227, DOI 10.1016/j.pneurobio.2010.10.001; Gilbert K. V., 1986, P 32 EUR M MEAT RES, V1, P117; GILBERT KV, 1982, MEAT SCI, V7, P197, DOI 10.1016/0309-1740(82)90086-9; Gregory NG, 2008, MEAT SCI, V79, P285, DOI 10.1016/j.meatsci.2007.09.012; Hanninen L, 2009, BEHAV RES METHODS, V41, P472, DOI 10.3758/BRM.41.2.472; Kirton A H, 1978, Meat Sci, V2, P199, DOI 10.1016/0309-1740(78)90005-0; NEWHOOK JC, 1982, MEAT SCI, V6, P295, DOI 10.1016/0309-1740(82)90040-7; Onenc A, 2004, MEAT SCI, V66, P809, DOI 10.1016/S0309-1740(03)00191-8; PETERSEN GV, 1986, MEAT SCI, V16, P1, DOI 10.1016/0309-1740(86)90008-2; Pleiter H, 2004, DEUT TIERARZTL WOCH, V111, P106; SHAW FD, 1990, NEW ZEAL VET J, V38, P14, DOI 10.1080/00480169.1990.35607; Singh BN, 1999, ANTI-CANCER DRUG, V10, P139, DOI 10.1097/00001813-199902000-00001; Wotton SB, 2000, VET REC, V147, P681	22	14	14	1	29	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0309-1740	1873-4138		MEAT SCI	Meat Sci.	MAR	2014	96	3					1201	1209		10.1016/j.meatsci.2013.10.030			9	Food Science & Technology	Food Science & Technology	AB1ZU	WOS:000331593600012	24334041				2021-06-18	
J	Wang, Y; Arun, P; Wei, YL; Oguntayo, S; Gharavi, R; Valiyaveettil, M; Nambiar, MP; Long, JB				Wang, Ying; Arun, Peethambaran; Wei, Yanling; Oguntayo, Samuel; Gharavi, Robert; Valiyaveettil, Manojkumar; Nambiar, Madhusoodana P.; Long, Joseph B.			Repeated Blast Exposures Cause Brain DNA Fragmentation in Mice	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; blast-induced neurotrauma; cell-free DNA; DNA damage; mitochondria	ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; NEUROPROTECTIVE EFFICACY; SELECTIVE VULNERABILITY; AMINOPROPYL CARBAZOLES; GLIAL PROLIFERATION; CELL-PROLIFERATION; COGNITIVE RECOVERY; MOUSE MODEL	The pathophysiology of blast-induced traumatic brain injury (TBI) and subsequent behavioral deficits are not well understood. Unraveling the mechanisms of injury is critical to derive effective countermeasures against this form of neurotrauma. Preservation of the integrity of cellular DNA is crucial for the function and survival of cells. We evaluated the effect of repeated blast exposures on the integrity of brain DNA and tested the utility of cell-free DNA (CFD) in plasma as a biomarker for the diagnosis and prognosis of blast-induced polytrauma. The results revealed time-dependent breakdown in cellular DNA in different brain regions, with the maximum damage at 24 h post-blast exposures. CFD levels in plasma showed a significant transient increase, which was largely independent of the timing and severity of brain DNA damage; maximum levels were recorded at 2?h after repeated blast exposure and returned to baseline at 24?h. A positive correlation was observed between the righting reflex time and CFD level in plasma at 2?h after blast exposure. Brain DNA damage subsequent to repeated blast was associated with decreased mitochondrial membrane potential, increased release of cytochrome C, and up-regulation of caspase-3, all of which are indicative of cellular apoptosis. Shock-wave-induced DNA damage and initiation of mitochondrial-driven cellular apoptosis in the brain after repeated blast exposures indicate that therapeutic strategies directed toward inhibition of DNA damage or instigation of DNA repair may be effective countermeasures.	[Wang, Ying; Arun, Peethambaran; Wei, Yanling; Oguntayo, Samuel; Gharavi, Robert; Valiyaveettil, Manojkumar; Nambiar, Madhusoodana P.; Long, Joseph B.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA	Long, JB (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	ying.wangv@us.army.mil; joseph.long@us.army.mil					Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Atkins C.M., 2010, EUR J NEUROSCI, V28, P35; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Langlois J, 2005, TRAUMATIC BRAIN INJU; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; van Praag H, 1999, NAT NEUROSCI, V2, P266; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	56	14	14	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2014	31	5					498	504		10.1089/NEU.2013.3074			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	AB4ZV	WOS:000331799600248	24074345				2021-06-18	
J	Wang, YH; Wang, CL; Yang, LK; Cai, S; Cai, XJ; Dong, JR; Zhang, JD; Zhu, J				Wang, Yuhai; Wang, Chunli; Yang, Likun; Cai, Sang; Cai, Xuejian; Dong, Jirong; Zhang, Jiandong; Zhu, Jun			Controlled Decompression for the Treatment of Severe Head Injury: A Preliminary Study	TURKISH NEUROSURGERY			English	Article						Brain swelling; Decompressive craniectomy; Severe; Head injury; Traumatic intracranial hematoma	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; CONTRALATERAL EXTRADURAL HEMATOMA; EPIDURAL HEMATOMA; CRANIECTOMY; EVACUATION; SURGERY	AIM: Fast direct decompression surgery for treatment of severe head injury often results in intraoperative and postoperative complications. Controlled decompression may help prevent these complications. This preliminary study aims to compare the effects of controlled and conventional decompression in patients with severe head injury. MATERIAL and METHODS: A total of 128 patients with severe head injury were included. Patients were allocated to receive either controlled decompression surgery (n = 64) or conventional decompressive craniectomy (n = 64). Controlled decompression comprised controlled ventricular drainage and controlled hematoma evacuation. The occurrence of delayed hematoma, acute brain swelling, and postoperative cerebral infarction were recorded. RESULTS: Significantly lower proportion of patients in the controlled decompression group had intraoperative acute brain swelling compared to patients in the decompressive craniectomy group (9.4% vs 26.6%, P = 0.011). Intraoperative acute encephalocele occurred in 3 of 13 patients (23.1%) who had delayed hematoma in the controlled decompression group compared with 11 of 18 patients (61.1%) in the decompressive craniectomy group. There was no significant between group difference in the incidence of delayed hematoma or postoperative cerebral infarction. CONCLUSION: Controlled decompression may reduce or delay intraoperative acute brain swelling by delaying hematoma formation in patients with severe head injury.	[Wang, Yuhai; Wang, Chunli; Yang, Likun; Cai, Sang; Cai, Xuejian; Dong, Jirong; Zhang, Jiandong; Zhu, Jun] Chinese Peoples Liberat Army, Hosp 101, Dept Neurosurg, Wu Xi, Jiangsu, Peoples R China	Wang, YH (corresponding author), Chinese Peoples Liberat Army, Hosp 101, Dept Neurosurg, XingYuan North Rd, Wu Xi, Jiangsu, Peoples R China.	dryuhaiwang@yeah.net			Nanjing Military Region	This work was supported by Nanjing Military Region.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Dong JR, 1999, CHIN J NEUROSURG, V15, P4; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; FUKAMACHI A, 1985, J TRAUMA, V25, P145, DOI 10.1097/00005373-198502000-00010; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Huang X, 2010, INT J MED SCI, V7, P385; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Munch E, 2000, NEUROSURGERY, V47, P315; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Saito T, 2003, ACTA NEUROCHIR SUPPL, V86, P351; Sawauchi S, 2008, ACTA NEUROCHIR, V150, P531, DOI 10.1007/s00701-007-1497-2; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9	17	14	18	0	13	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2014	24	2					214	220		10.5137/1019-5149.JTN.8135-13.1			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AF2RX	WOS:000334560800011	24831363	Bronze			2021-06-18	
J	Yaeger, K; Alhilali, L; Fakhran, S				Yaeger, Karl; Alhilali, Lea; Fakhran, Saeed			Evaluation of Tentorial Length and Angle in Sleep-Wake Disturbances After Mild Traumatic Brain Injury	AMERICAN JOURNAL OF ROENTGENOLOGY			English	Article						melatonin; mild traumatic brain injury; pineal gland; sleep-wake disturbances; tentorium	HEAD INJURY; MELATONIN; PHASE; DISORDERS	OBJECTIVE. The purpose of this study was to determine if there is an association between tentorial length and angle and sleep-wake disturbances in patients with mild traumatic brain injury (TBI). MATERIALS AND METHODS. MRI examinations of the brain of 34 consecutive patients with mild TBI with sleep-wake disturbance and 30 patients with mild TBI without sleep-wake disturbance were retrospectively reviewed. The length of the tentorium on a sagittal T1-weighted image (tentorial length) and the angle formed between the tentorium and a line through the foramen magnum (tentorial angle) were measured. Results were correlated with both neuropsychologic testing and any sleep-wake disturbance. RESULTS. No significant difference existed between patients with and without sleep-wake disturbances in terms of age (p = 0.44), sex (p = 0.13), Immediate Post-Concussion Assessment Cognitive Test total symptom score (p = 0.10), verbal memory score (p = 0.32), visual memory score (p = 0.31), processing speed (p = 0.15), or reaction time (p = 0.84). Tentorial length in patients with mild TBI with sleep-wake disturbances was significantly longer than patients with mild TBI without sleep-wake disturbances (p < 0.01), and tentorial angle was significantly smaller (p < 0.01). Tentorial angle was inversely correlated with length of time to recovery (p = 0.002), and tentorial length was directly correlated with length of time to recovery (p < 0.001). CONCLUSION. Among patients with mild TBI with similar cognitive function and symptom severity, those with sleep-wake disturbances have significantly longer tentorial length with a flatter angle than do patients with mild TBI without sleep symptoms, with length of time to recovery being directly correlated with tentorial length and indirectly correlated with tentorial angle. Direct impact between the tentorium and the pineal gland during mild TBI may lead to pineal gland injury, disruption of melatonin homeostasis, and sleep-wake disturbances.	[Yaeger, Karl; Alhilali, Lea; Fakhran, Saeed] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA	Yaeger, K (corresponding author), Univ Pittsburgh, Med Ctr, Dept Radiol, 3950 Presby South Towers,200 Lothrop St, Pittsburgh, PA 15213 USA.	yaegerk@upmc.edu					Al-Adawi S, 2009, BRAIN INJURY, V23, P559, DOI 10.1080/02699050902970745; Ates O, 2006, INT J DEV NEUROSCI, V24, P357, DOI 10.1016/j.ijdevneu.2006.08.003; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Hardeland R, 2012, SCI WORLD J, DOI 10.1100/2012/640389; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; McBride G.B., 2005, PROPOSAL STRENGTH OF; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Moskala Marek, 2004, Neurol Neurochir Pol, V38, P401; Nagtegaal JE, 1997, FUNCT NEUROL, V12, P345; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; van de Water ATM, 2011, J SLEEP RES, V20, P183, DOI 10.1111/j.1365-2869.2009.00814.x; van Wieringen S, 2001, CLIN DRUG INVEST, V21, P813, DOI 10.2165/00044011-200121120-00003; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wichmann MW, 1996, J SURG RES, V63, P256, DOI 10.1006/jsre.1996.0257	24	14	15	0	2	AMER ROENTGEN RAY SOC	RESTON	1891 PRESTON WHITE DR, SUBSCRIPTION FULFILLMENT, RESTON, VA 22091 USA	0361-803X	1546-3141		AM J ROENTGENOL	Am. J. Roentgenol.	MAR	2014	202	3					614	618		10.2214/AJR.13.11091			5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AC4SK	WOS:000332510900038	24555599				2021-06-18	
J	Hu, MH; Huang, GS; Wu, CT; Lin, JJ; Hsia, SH; Wang, HS; Lin, KL				Hu, Mei-Hua; Huang, Go-Shine; Wu, Chang-Teng; Lin, Jainn-Jim; Hsia, Shao-Hsuan; Wang, Huei-Shyong; Lin, Kuang-Lin		CHEESE Study Grp	Analysis of Plasma Multiplex Cytokines for Children With Febrile Seizures and Severe Acute Encephalitis	JOURNAL OF CHILD NEUROLOGY			English	Article						cytokine; febrile seizures; severe acute encephalitis; interleukin-6; inflammation	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; INTERLEUKIN-6; NEURONS; IL-6	We investigated the plasma cytokine profiles of children with febrile seizures or severe acute encephalitis using multiplex cytometry to evaluate the role of cytokines in these diseases. Interleukin-6, -10, -12p70, -17A, -2, -4, -5, -9, -13, -22, and -1, interferon-, and tumor necrosis factor- were measured in the plasma from children with febrile seizures (n = 9) or severe acute encephalitis (n = 21). In multivariate analysis, interleukin-6 was significantly increased in the plasma of the febrile seizure patients compared to those with severe acute encephalitis, suggesting that interleukin-6 is activated during the acute stage of a febrile seizure. A lower plasma interleukin-6 concentration was significantly associated with severe acute encephalitis. The cytokine network may be deregulated in severe acute encephalitis via the persistence of an uncontrolled inflammatory state in the brain.	[Hu, Mei-Hua] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Hu, Mei-Hua] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hu, Mei-Hua; Wu, Chang-Teng] Chang Gung Univ, Coll Med, Dept Gen Pediat, Chang Gung Childrens Hosp, Tao Yuan, Taiwan; [Hu, Mei-Hua; Wu, Chang-Teng; Lin, Jainn-Jim; Hsia, Shao-Hsuan; Wang, Huei-Shyong; Lin, Kuang-Lin] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Hu, Mei-Hua; Lin, Jainn-Jim] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Huang, Go-Shine] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Lin, Jainn-Jim; Hsia, Shao-Hsuan] Chang Gung Univ, Coll Med, Div Pediat Crit Care & Emergency Med, Chang Gung Childrens Hosp, Tao Yuan, Taiwan; [Lin, Jainn-Jim; Wang, Huei-Shyong; Lin, Kuang-Lin] Chang Gung Univ, Coll Med, Dept Pediat Neurol, Chang Gung Childrens Hosp, Tao Yuan, Taiwan; [Lin, Jainn-Jim; Wang, Huei-Shyong; Lin, Kuang-Lin; CHEESE Study Grp] Chang Gung Childrens Hosp, Study Grp Children Encephalitis Encephalopathy Re, Tao Yuan, Taiwan	Lin, KL (corresponding author), Chang Gung Childrens Hosp, Dept Pediat Neurol, 5 Fu Shin St,Kweishan 333, Tao Yuan, Taiwan.	lincgh@adm.cgmh.org.tw			Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPG 391261]	The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This study was supported by a grant from the Chang Gung Memorial Hospital (CMRPG 391261), Taiwan.	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Asano T, 2010, SCAND J IMMUNOL, V71, P447, DOI 10.1111/j.1365-3083.2010.02391.x; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Falchek SJ, 2012, PEDIATR REV, V33, P122, DOI 10.1542/pir.33-3-122; Fukuda M, 2007, BRAIN DEV-JPN, V29, P644, DOI 10.1016/j.braindev.2007.04.007; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Tran HYP, 2012, FREE RADICAL BIO MED, V52, P1159, DOI 10.1016/j.freeradbiomed.2011.12.008; Ishizaki Y, 2009, EPILEPSIA, V50, P761, DOI 10.1111/j.1528-1167.2008.01861.x; Kalita J, 2010, NEUROSCI LETT, V473, P48, DOI 10.1016/j.neulet.2010.02.017; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Lin JJ, 2012, J CHILD NEUROL; Morichi S, 2012, PEDIATR INT, V54, P536, DOI 10.1111/j.1442-200X.2011.03483.x; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; Pizzi M, 2004, MOL CELL NEUROSCI, V25, P301, DOI 10.1016/j.mcn.2003.10.022; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Straussberg R, 2001, PEDIATR NEUROL, V24, P49, DOI 10.1016/S0887-8994(00)00234-4; Thompson C, 2012, ARCH DIS CHILD, V97, P150, DOI 10.1136/archdischild-2011-300100; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; Yu N, 2012, NEUROSCI LETT, V514, P110, DOI 10.1016/j.neulet.2012.02.070	20	14	15	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	FEB	2014	29	2					182	186		10.1177/0883073813488829			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	289MT	WOS:000329687300005	23674232				2021-06-18	
J	Kit, KA; Mateer, CA; Tuokko, HA; Spencer-Rodgers, J				Kit, Karen A.; Mateer, Catherine A.; Tuokko, Holly A.; Spencer-Rodgers, Julie			Influence of Negative Stereotypes and Beliefs on Neuropsychological Test Performance in a Traumatic Brain Injury Population	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Self-efficacy; Head-injury; Stereotype threat; Performance anxiety; Testing environment; Neuropsychology	WOMENS MATH PERFORMANCE; MEMORY TEST-PERFORMANCE; VERBAL LEARNING TEST; MILD HEAD-INJURY; DIAGNOSIS THREAT; SUBSEQUENT PERFORMANCE; COGNITIVE PERFORMANCE; SELF-EFFICACY; PRIOR SUCCESS; EXPECTATION	The impact of stereotype threat and self-efficacy beliefs on neuropsychological test performance in a clinical traumatic brain injury (TBI) population was investigated. A total of 42 individuals with mild-to-moderate TBI and 42 (age-, gender-, educationally matched) healthy adults were recruited. The study consisted of a 2 (Type of injury: control, TBI) x 2 (Threat Condition: reduced threat, heightened threat) between-participants design. The purpose of the reduced threat condition was to reduce negative stereotyped beliefs regarding cognitive effects of TBI and to emphasize personal control over cognition. The heightened threat condition consisted of an opposing view. Main effects included greater anxiety, motivation, and dejection but reduced memory self-efficacy for head-injured-groups, compared to control groups. On neuropsychological testing, the TBI-heightened-threat-group displayed lower scores on Initial Encoding (initial recall) and trended toward displaying lower scores on Attention (working memory) compared to the TBI-reduced-threat-group. No effect was found for Delayed Recall measures. Memory self-efficacy mediated the relation between threat condition and neuropsychological performance, indicating a potential mechanism for the threat effect. The findings highlight the impact of stereotype threat and self-referent beliefs on neuropsychological test performance in a clinical TBI population. (JINS, 2013, 20, 1-11)	[Kit, Karen A.; Mateer, Catherine A.; Tuokko, Holly A.] Univ Victoria, Dept Psychol, Victoria, BC, Canada; [Spencer-Rodgers, Julie] Calif Polytech State Univ San Luis Obispo, Dept Psychol & Child Dev, San Luis Obispo, CA 93407 USA	Kit, KA (corresponding author), Victoria Gen Hosp, 1 Hosp Way, Victoria, BC V8Z 6R5, Canada.	kkaren32@gmail.com			Social Sciences and Humanities Research Council of CanadaSocial Sciences and Humanities Research Council of Canada (SSHRC)	This research was supported by a doctoral fellowship by the Social Sciences and Humanities Research Council of Canada. The authors have no conflict of interest affecting this manuscript.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; ARVEY RD, 1990, PERS PSYCHOL, V43, P695, DOI 10.1111/j.1744-6570.1990.tb00679.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Ben-Zeev T, 2005, J EXP SOC PSYCHOL, V41, P174, DOI 10.1016/j.jesp.2003.11.007; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; BREWIN CR, 1985, BRIT J SOC PSYCHOL, V24, P37, DOI 10.1111/j.2044-8309.1985.tb00658.x; Brown RP, 2003, J EXP SOC PSYCHOL, V39, P626, DOI 10.1016/S0022-1031(03)00039-8; Brown RP, 2006, J APPL PSYCHOL, V91, P979, DOI 10.1037/0021-9010.91.4.979; CAVANAUGH JC, 2000, COGNITIVE AGING PRIM, P115; CAVANAUGH JC, 1990, AGING COGNITION MENT, P189, DOI DOI 10.1016/S0166-4115(08)60788-8; Charles J. Brainerd, 1988, COGNITIVE DEV ADULTH, P65, DOI DOI 10.1007/978-1-4612-3852-2; Chasteen AL, 2005, EXP AGING RES, V31, P235, DOI 10.1080/03610730590948177; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cole JC, 2006, J PSYCHOPHARMACOL, V20, P518, DOI 10.1177/0269881105058572; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P585, DOI 10.1016/0191-8869(89)90043-3; Crowe S. F., 2008, STUDIES NEUROPSYCHOL, P282; Davis C, 2006, J BLACK PSYCHOL, V32, P399, DOI 10.1177/0095798406292464; Dellefield K. D., 1996, NURS RES, V43, P284; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Desrichard O, 2005, EUR J SOC PSYCHOL, V35, P537, DOI 10.1002/ejsp.249; DIXON RA, 1983, J GERONTOL, V38, P682, DOI 10.1093/geronj/38.6.682; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; DOUGLAS D, 1975, J EXP PSYCHOL HUMAN, V1, P411, DOI 10.1037/0096-1523.1.4.411; FEATHER NT, 1966, J PERS SOC PSYCHOL, V3, P287, DOI 10.1037/h0022965; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; Hamilton D.L., 1986, PREJUDICE DISCRIMINA, P127; Hertzog C., 1994, METACOGNITION KNOWIN, DOI 10.1016/s0166-4115(08)60158-2; Keller J, 2003, PERS SOC PSYCHOL B, V29, P371, DOI 10.1177/0146167202250218; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; LACHMAN ME, 1992, J GERONTOL, V47, pP293, DOI 10.1093/geronj/47.5.P293; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; Marx DM, 2006, J PERS SOC PSYCHOL, V91, P243, DOI 10.1037/0022-3514.91.2.243; MATHERLY TA, 1986, J SOC BEHAV PERS, V1, P267; Mayer DM, 2003, HUM PERFORM, V16, P207, DOI 10.1207/S15327043HUP1603_3; Mikulincer M., 2001, J SOC PSYCHOL, V130, P739; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; MOORE AD, 1991, NEUROPSYCHOL REHABIL, V1, P185, DOI DOI 10.1080/09602019108520164; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; PERRY RP, 1990, J EDUC PSYCHOL, V82, P262, DOI 10.1037/0022-0663.82.2.262; Ployhart RE, 2003, HUM PERFORM, V16, P231, DOI 10.1207/S15327043HUP1603_4; Reitan RM, 2000, ARCH CLIN NEUROPSYCH, V15, P433, DOI 10.1016/S0887-6177(99)00038-4; Rey A, 1964, EXAMEN CLIN PSYCHOL; Ross SR, 2003, ARCH CLIN NEUROPSYCH, V18, P905, DOI 10.1016/S0887-6177(02)00169-5; RYAN JJ, 1984, INT J CLIN NEUROPSYC, V6, P239; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Sobel M.E., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI [10.2307/270723., DOI 10.2307/270723, 10.2307/270723]; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stewart-Williams S, 2004, HEALTH PSYCHOL, V23, P198, DOI 10.1037/0278-6133.23.2.198; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUSS D. T., 1988, CLIN NEUROPSYCHOL, V2, P246, DOI DOI 10.1080/13854048808520107; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI DOI 10.1080/13854048708520046; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D, 1997, WAIS 3 ADM SCORING M; Weiner B., 1986, HDB MOTIVATION COGNI, P281; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WILSON TD, 1985, J PERS SOC PSYCHOL, V49, P287, DOI 10.1037/0022-3514.49.1.287	73	14	14	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	FEB	2014	20	2					157	167		10.1017/S1355617713001264			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	AC3VG	WOS:000332448700005	24352047				2021-06-18	
J	Phillips, LL; Chan, JL; Doperalski, AE; Reeves, TM				Phillips, Linda L.; Chan, Julie L.; Doperalski, Adele E.; Reeves, Thomas M.			Time dependent integration of matrix metalloproteinases and their targeted substrates directs axonal sprouting and synaptogenesis following central nervous system injury	NEURAL REGENERATION RESEARCH			English	Article						neuroregeneration; reactive synaptogenesis; matrix metalloproteinases; brain injury; adaptive and maladaptive neuroplasticity; metalloproteinase inhibition; osteopontin; lipocalin 2	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CHONDROITIN SULFATE PROTEOGLYCAN; LONG-TERM POTENTIATION; COMBINED FLUID PERCUSSION; EXTRACELLULAR-MATRIX; SYNAPTIC PLASTICITY; KAINIC ACID; TEMPORAL EXPRESSION; FUNCTIONAL RECOVERY	Over the past two decades, many investigators have reported how extracellular matrix molecules act to regulate neuroplasticity. The majority of these studies involve proteins which are targets of matrix metalloproteinases. Importantly,. these enzyme/substrate interactions can regulate degenerative and regenerative phases of synaptic plasticity, directing axonal and dendritic reorganization after brain insult. The present review first summarizes literature support for the prominent role of matrix metalloproteinases during neuroregeneration, followed by a discussion of data contrasting adaptive and maladaptive neuroplasticity that reveals time-dependent metalloproteinase/substrate regulation of postinjury synaptic recovery. The potential for these enzymes to serve as therapeutic targets for enhanced neuroplasticity after brain injury is illustrated with experiments demonstrating that metalloproteinase inhibitors can alter adaptive and maladaptive outcome. Finally, the complexity of metalloproteinase role in reactive synaptogenesis is revealed in new studies showing how these enzymes interact with immune molecules to mediate cellular response in the local regenerative environment, and are regulated by novel binding partners in the brain extracellular matrix. Together, these different examples show the complexity with which metalloproteinases are integrated into the process of neuroregeneration, and point to a promising new angle for future studies exploring how to facilitate brain plasticity.	[Phillips, Linda L.; Chan, Julie L.; Doperalski, Adele E.; Reeves, Thomas M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Phillips, LL (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23284 USA.	llphilli@vcu.edu		Chan, Julie/0000-0002-0782-6548	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS056247, R01 NS044372, R01 NS057758] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044372, R01NS057758, R01NS056247] Funding Source: NIH RePORTER		Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahina M, 2001, CLIN NEUROPATHOL, V20, P60; Bakos SR, 2010, CHEM SENSES, V35, P655, DOI 10.1093/chemse/bjq056; Belien ATJ, 1999, J CELL BIOL, V144, P373, DOI 10.1083/jcb.144.2.373; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chan JL, 2013, OSTEOPONTIN IN PRESS; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Clement AB, 2008, NEUROSCIENCE, V152, P459, DOI 10.1016/j.neuroscience.2007.10.060; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; Costanzo RM, 2008, NEUROREPORT, V19, P327, DOI 10.1097/WNR.0b013e3282f50c7b; Costanzo RM, 2006, NEUROREPORT, V17, P1787, DOI 10.1097/WNR.0b013e32800fef87; de Castro R, 2000, NEUROREPORT, V11, P3551, DOI 10.1097/00001756-200011090-00029; Deller T, 2001, RESTOR NEUROL NEUROS, V19, P159; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Fercakova A, 2001, Bratisl Lek Listy, V102, P552; Fredrich M, 2010, NEUROREPORT, V21, P324, DOI 10.1097/WNR.0b013e328335b518; Garwood J, 1999, J NEUROSCI, V19, P3888; Gonthier B, 2007, CEREB CORTEX, V17, P1712, DOI 10.1093/cercor/bhl082; Gonthier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005099; Gonzalez-Perez F, 2013, INT REV NEUROBIOL, V108, P257, DOI 10.1016/B978-0-12-410499-0.00010-1; Goussev S, 2003, J NEUROSURG, V99, P188, DOI 10.3171/spi.2003.99.2.0188; Grimpe B, 2002, PROG BRAIN RES, V137, P333; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Handsley MM, 2005, MATRIX METALLOPROTEINASES IN THE CENTRAL NERVOUS SYSTEM, P3, DOI 10.1142/9781860947179_0001; Harris JL, 2011, HIPPOCAMPUS, V21, P81, DOI 10.1002/hipo.20725; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Hayashita-Kinoh H, 2001, CELL GROWTH DIFFER, V12, P573; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Howell MD, 2012, NEUROSCIENCE, V217, P6, DOI 10.1016/j.neuroscience.2012.05.034; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9; Israelsson C, 2006, J NEUROSCI RES, V84, P47, DOI 10.1002/jnr.20856; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jones LL, 2003, J NEUROSCI, V23, P9276; Kaliszewska A, 2012, CEREB CORTEX, V22, P2160, DOI 10.1093/cercor/bhr303; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Le AP, 2012, J NEUROSCI, V32, P703, DOI 10.1523/JNEUROSCI.4128-11.2012; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lekic T, 2011, EXP NEUROL, V227, P96, DOI 10.1016/j.expneurol.2010.09.017; Li Ru-Bo, 2009, Leg Med (Tokyo), V11 Suppl 1, pS176, DOI 10.1016/j.legalmed.2009.02.029; Lin KT, 2008, J BIOL CHEM, V283, P28969, DOI 10.1074/jbc.M804401200; Liu HS, 2011, NEUROIMAGE, V56, P280, DOI 10.1016/j.neuroimage.2011.02.049; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Luo J, 2005, CEREBELLUM, V4, P239, DOI 10.1080/14734220500247646; Maier O, 2006, EXP CELL RES, V312, P500, DOI 10.1016/j.yexcr.2005.11.014; Mayer J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-52; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mizoguchi H, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/681385; Monea S, 2006, J NEUROSCI, V26, P2300, DOI 10.1523/JNEUROSCI.3521-05.2006; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Noble LJ, 2002, J NEUROSCI, V22, P7526; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Oh LYS, 1999, J NEUROSCI, V19, P8464; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Penedo LA, 2009, EXP NEUROL, V217, P108, DOI 10.1016/j.expneurol.2009.01.021; Peng H, 2012, PROTEIN CELL, V3, P875, DOI 10.1007/s13238-012-2092-8; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Piccolini VM, 2012, BRAIN RES, V1484, P15, DOI 10.1016/j.brainres.2012.09.025; Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012; Plantman S, 2012, NEUROREPORT, V23, P647, DOI 10.1097/WNR.0b013e328355380e; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Reeves TM, 2003, J NEUROSCI, V23, P10182; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Safciuc F, 2007, CURR NEUROVASC RES, V4, P228, DOI 10.2174/156720207782446351; Sagane K, 2010, J RECEPT SIG TRANSD, V30, P72, DOI 10.3109/10799891003614790; Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Shin T, 2005, BRAIN RES, V1041, P95, DOI 10.1016/j.brainres.2005.02.019; SNOW DM, 1991, DEVELOPMENT, V113, P1473; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Tian L, 2007, J CELL BIOL, V178, P687, DOI 10.1083/jcb.200612097; Treloar HB, 2009, J NEUROSCI, V29, P9405, DOI 10.1523/JNEUROSCI.2356-09.2009; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; Tsukatani T, 2003, NEUROREPORT, V14, P1135, DOI 10.1097/00001756-200306110-00007; Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Van Hove I, 2012, J NEUROCHEM, V123, P203, DOI 10.1111/j.1471-4159.2012.07900.x; Vansaun M, 2003, J NEUROCYTOL, V32, P1129, DOI 10.1023/B:NEUR.0000021907.68461.9c; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yang P, 2005, J COMP NEUROL, V490, P163, DOI 10.1002/cne.20659; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yong VW, 2007, J NEUROL SCI, V259, P79, DOI 10.1016/j.jns.2006.11.021; Zhang HQ, 2011, NEUROTHERAPEUTICS, V8, P206, DOI 10.1007/s13311-011-0038-0; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Ziemianska K, 2012, POSTEP HIG MED DOSW, V66, P959, DOI 10.5604/17322693.1021851	123	14	15	0	8	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2014	9	4			SI		362	376		10.4103/1673-5374.128237			15	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	AD3LD	WOS:000333139700004	25206824	DOAJ Gold, Green Published			2021-06-18	
J	Roquilly, A; Seguin, P; Mimoz, O; Feuillet, F; Rosenczweig, E; Chevalier, F; Loutrel, O; Malledant, Y; Sebille, V; Asehnoune, K				Roquilly, Antoine; Seguin, Philippe; Mimoz, Olivier; Feuillet, Fanny; Rosenczweig, Elise; Chevalier, Franck; Loutrel, Olivier; Malledant, Yannick; Sebille, Veronique; Asehnoune, Karim		ATLANREA Study Grp	Risk factors for prolonged duration of mechanical ventilation in acute traumatic tetraplegic patients-a retrospective cohort study	JOURNAL OF CRITICAL CARE			English	Article						Cervical spine injury/tetraplegia; Mechanical ventilation/complications; Pneumonia; Atelectasis; Neurological recovery	SPINAL-CORD-INJURY; RANDOMIZED CONTROLLED-TRIAL; RESPIRATORY COMPLICATIONS; TIDAL VOLUMES; ICU PATIENTS; PNEUMONIA; PREVENTION; MORTALITY; OUTCOMES; COSTS	Purpose: Respiratory complications constitute an important determinant of length of stay in tetraplegic patients. In a population of tetraplegic patients, we investigated the factors involved in the duration of mechanical ventilation (MV) and whether the duration of MV was associated with the long-term neurologic status. Material and Methods: In a retrospective study in 3 intensive care units (ICUs) (January 2001 to December 2009), consecutive patients (>= 18 years) hospitalized for acute (<= 24 hours) traumatic tetraplegia were included in the study. Patients with severe brain injury or who died in the first 48 hours were excluded. The primary outcome was the duration of MV. The secondary outcomes were the American Spinal Injury Association (ASIA) motor score on ICU discharge and at 1 year. Results: A total of 164 consecutive adult patients with tetraplegia were analyzed. Median (interquartile range) ASIA motor scores were 15 (6-26) on admission, 22 (9-40) on ICU discharge (n = 145 survivors), and 37 (10-80) at 1 year (n = 52 complete follow-up). The median duration of MV was 11 (2-26) days. In multivariate analysis, MV duration increased with pneumonia (P < .0001), atelectasis (P = .0042), and tracheotomy (P < .0001). In exploratory analysis, an increased duration of MV was the only factor associated in multivariate analysis with a low ASIA motor score on ICU discharge (P = .0201) and at 1 year (P = .0003). Conclusions: Prevention of pneumonia and atelectasis is critical for the reduction of MV in tetraplegic patients. Prolonged MV was independently associated with poor neurologic status. (C) 2014 Elsevier Inc. All rights reserved.	[Roquilly, Antoine; Loutrel, Olivier; Asehnoune, Karim] Univ Hosp Nantes, Hotel Dieu HME, Anesthesia & Crit Care Dept, Intens Care Unit, Nantes, France; [Roquilly, Antoine; Loutrel, Olivier; Asehnoune, Karim] UPRES EA 3826 Therapeut Clin & Expt Infect, Nantes, France; [Seguin, Philippe; Malledant, Yannick] Univ Hosp Rennes, Anesthesia & Crit Care Dept, Intens Care Unit, Rennes, France; [Seguin, Philippe; Malledant, Yannick] INSERM U991 Foie Metab & Canc, Rennes, France; [Mimoz, Olivier; Chevalier, Franck] Univ Hosp Poitiers, Anesthesia & Crit Care Dept, Intens Care Unit, Poitiers, France; [Mimoz, Olivier; Chevalier, Franck] INSERM U1070, Poitiers, France; [Feuillet, Fanny; Sebille, Veronique] Univ Nantes, CHU Nantes EA UFR Pharm 4275, Nantes, France; [Rosenczweig, Elise] Univ Hosp Nantes, Hotel Dieu HME, Med Intens Care Unit, Nantes, France	Asehnoune, K (corresponding author), CHU Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, F-44035 Nantes 01, France.	karim.asehnoune@chu-nantes.fr	Sebille, Veronique/I-3309-2015; Feuillet, Fanny/L-9041-2015; Roquilly, Antoine/P-9826-2017; Seguin, Philippe/P-9487-2019; Sebille, Veronique/L-8761-2015	Seguin, Philippe/0000-0002-7774-4257; mimoz, olivier/0000-0003-1737-7915; Malledant, yannick/0000-0001-6680-5184; Sebille, Veronique/0000-0002-0780-7742			[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; Cotton BA, 2005, J TRAUMA, V59, P1400, DOI 10.1097/01.ta.0000196005.49422.e6; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; ElMasry WS, 1996, SPINE, V21, P614, DOI 10.1097/00007632-199603010-00015; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Kallel H, 2005, J TRAUMA, V59, P705, DOI 10.1097/01.ta.0000177749.09844.c6; Keane RW, 2006, J NEUROTRAUM, V23, P335, DOI 10.1089/neu.2006.23.335; KONRAD F, 1994, CHEST, V105, P237, DOI 10.1378/chest.105.1.237; Manzano F, 2008, CRIT CARE MED, V36, P2225, DOI 10.1097/CCM.0b013e31817b8a92; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; MCMICHAN JC, 1980, JAMA-J AM MED ASSOC, V243, P528, DOI 10.1001/jama.243.6.528; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Peterson WP, 1999, SPINAL CORD, V37, P284, DOI 10.1038/sj.sc.3100818; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Ganuza JR, 2011, J SPINAL CORD MED, V34, P76, DOI 10.1179/107902610X12886261091875; Roquilly A, 2013, AM J RESP CRIT CARE, V188, P958, DOI 10.1164/rccm.201301-0116OC; Sacks GD, 2011, J TRAUMA, V71, P1668, DOI 10.1097/TA.0b013e31823246a5; Societe Francaise d'anesthesie reanimation, 2003, C EXP 2003; Staudinger T, 2010, CRIT CARE MED, V38, P486, DOI 10.1097/CCM.0b013e3181bc8218; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; van Middendorp JJ, 2011, LANCET, V377, P1004, DOI 10.1016/S0140-6736(10)62276-3; Winslow C, 2002, CHEST, V121, P1548, DOI 10.1378/chest.121.5.1548; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	30	14	17	2	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	FEB	2014	29	2							313.e7	10.1016/j.jcrc.2013.11.021			7	Critical Care Medicine	General & Internal Medicine	AC3IB	WOS:000332409400032	24412010				2021-06-18	
J	Sumowski, JF; Coyne, J; Cohen, A; DeLuca, J				Sumowski, James F.; Coyne, Julia; Cohen, Amanda; DeLuca, John			Retrieval Practice Improves Memory in Survivors of Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain trauma; Memory; Rehabilitation; Traumatic brain injuries	REHABILITATION	Objective: To investigate whether retrieval practice (RP) improves delayed recall after short and long delays in survivors of severe traumatic brain injury (TBI) relative to massed restudy (MR) and spaced restudy (SR). Design: 3(learning condition: MR, SR, RP)x 2(delayed recall: 30min, 1wk) within-subject experiment. Setting: Nonprofit medical rehabilitation research center. Participants: Memory-impaired (<5th percentile) survivors of severe TBI (N=10). Intervention: During RP, patients are quizzed on to-be-learned information shortly after it is presented, such that patients practice retrieval. MR consists of repeated restudy (ie, cramming) SR consists of restudy trials separated in time (ie, distributed learning). Main Outcome Measures: Forty-eight verbal paired associates (VPAs) were equally divided across 3 learning conditions (16 per condition). Delayed recall for one half of the VPAs was assessed after 30 minutes (8 per condition) and for the other half after 1 week (8 per condition). Results: There was a large effect of learning condition after the short delay (P<.001, eta(2)=.72), with much better recall of VPAs studied through RP (46.3%) relative to MR (12.5%) and SR (15.0%). This large effect of learning condition remained after the long delay (P=.001, eta(2)=.56), as patients recalled 11.3% of the VPAs studied through RP, but nothing through MR (0.0%) and only 1.3% through SR. That is, RP was essentially the only learning condition to result in successful recall after 1 week, with most patients recalling at least 1 VPA. Conclusions: The robust effect of RP among TBI survivors with severe memory impairment engenders confidence that this strategy would work outside the laboratory to improve memory in real-life settings. Future randomized controlled trials of RP training are needed. (C) 2014 by the American Congress of Rehabilitation Medicine	[Sumowski, James F.; Coyne, Julia; Cohen, Amanda; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Sumowski, James F.; DeLuca, John] Rutgers, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Coyne, Julia] Childrens Specialized Hosp, Mountainside, NJ USA	Sumowski, JF (corresponding author), Kessler Fdn Res Ctr, 300 Execut Dr,Ste 70, W Orange, NJ 07052 USA.	jsumowski@kesserfoundation.org			Kessler Foundation; Children's Specialized Hospital	Supported by the Kessler Foundation and Children's Specialized Hospital.	Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schuett S, 2009, NAT REV NEUROL, V5, P427, DOI 10.1038/nrneurol.2009.97; Sumowski JF, 2013, MULT SCLER J, V19, P1943, DOI 10.1177/1352458513485980; Sumowski JF, 2010, J INT NEUROPSYCH SOC, V16, P1147, DOI 10.1017/S1355617710001128; Sumowski JF, 2010, NEUROPSYCHOLOGY, V24, P267, DOI 10.1037/a0017533; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	10	14	14	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2014	95	2					397	400		10.1016/j.apmr.2013.10.021			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AA2LW	WOS:000330927100026	24231401				2021-06-18	
J	Chang, CM; Su, YF; Chang, CZ; Chung, CL; Tsai, YJ; Loh, JK; Lin, CL				Chang, Chia-Mao; Su, Yu-Feng; Chang, Chih-Zen; Chung, Chia-Li; Tsai, Yee-Jean; Loh, Joon-Khim; Lin, Chih-Lung			Progesterone Attenuates Experimental Subarachnoid Hemorrhage-Induced Vasospasm by Upregulation of Endothelial Nitric Oxide Synthase via Akt Signaling Pathway	BIOMED RESEARCH INTERNATIONAL			English	Article							ADENOSINE A(2A) RECEPTOR; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; PROTECTIVE ROLE; PROTEIN-KINASE; 17-BETA-ESTRADIOL; ACTIVATION; ESTROGEN; STRESS	Cerebral vasospasm is the leading cause of mortality and morbidity in patients after aneurysmal subarachnoid hemorrhage (SAH). However, the mechanism and adequate treatment of vasospasm are still elusive. In the present study, we evaluate the effect and possible mechanism of progesterone on SAH-induced vasospasm in a two-hemorrhage rodent model of SAH. Progesterone (8 mg/kg) was subcutaneously injected in ovariectomized female Sprague-Dawley rats one hour after SAH induction. The degree of vasospasm was determined by averaging the cross-sectional areas of basilar artery 7 days after first SAH. Expressions of endothelial nitric oxide synthase (eNOS) and phosphorylated Akt (phospho-Akt) in basilar arteries were evaluated. Prior to perfusion fixation, there were no significant differences among the control and treated groups in physiological parameters recorded. Progesterone treatment significantly (P < 0.01) attenuated SAH-induced vasospasm. The SAH-induced suppression of eNOS protein and phospho-Akt were relieved by progesterone treatment. This result further confirmed that progesterone is effective in preventing SAH-induced vasospasm. The beneficial effect of progesterone might be in part related to upregulation of expression of eNOS via Akt signaling pathway after SAH. Progesterone holds therapeutic promise in the treatment of cerebral vasospasm following SAH.	[Chang, Chia-Mao; Chung, Chia-Li] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 80708, Taiwan; [Chang, Chia-Mao; Su, Yu-Feng; Chang, Chih-Zen; Chung, Chia-Li; Tsai, Yee-Jean; Loh, Joon-Khim; Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 80708, Taiwan; [Chang, Chia-Mao; Chung, Chia-Li] Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Kaohsiung 81267, Taiwan; [Su, Yu-Feng; Chang, Chih-Zen; Lin, Chih-Lung] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Fac Med, Kaohsiung 80708, Taiwan; [Chang, Chih-Zen] Kaohsiung Municipal Tatung Hosp, Dept Surg, Kaohsiung 80145, Taiwan	Lin, CL (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurosurg, 100,Tzyou 1st Rd, Kaohsiung 80708, Taiwan.	chihlung1@yahoo.com		Su, Yu-feng/0000-0003-0355-3981	National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 100-2314-B-037-004]; Kaohsiung Medical University Hospital [KMUH 100-0R14]	This work was supported by the National Science Council, Taiwan, under Grant NSC 100-2314-B-037-004, and Kaohsiung Medical University Hospital (KMUH 100-0R14).	Busse R, 1998, J VASC RES, V35, P73, DOI 10.1159/000025568; Chou CH, 2010, NEUROSURGERY, V67, P345, DOI 10.1227/01.NEU.0000371980.08391.71; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; Florian M, 2004, STEROIDS, V69, P637, DOI 10.1016/j.steroids.2004.05.016; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Kao CH, 2013, J SURG RES, V183, pE23, DOI 10.1016/j.jss.2013.01.033; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Khorram O, 2009, FERTIL STERIL, V91, P2157, DOI 10.1016/j.fertnstert.2008.05.019; Khurana VG, 2002, STROKE, V33, P782, DOI 10.1161/hs0302.103735; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Lin CL, 2007, J NEUROSURG, V106, P436, DOI 10.3171/jns.2007.106.3.436; Lin CL, 2009, J SURG RES, V157, P208, DOI 10.1016/j.jss.2008.08.021; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; Moro MA, 2004, CELL CALCIUM, V36, P265, DOI 10.1016/j.ceca.2004.02.011; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Peng XQ, 2010, ACTA PHARMACOL SIN, V31, P175, DOI 10.1038/aps.2009.190; Roviezzo F, 2007, BRIT J PHARMACOL, V151, P377, DOI 10.1038/sj.bjp.0707233; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Selles J, 2001, LIFE SCI, V69, P815, DOI 10.1016/S0024-3205(01)01174-2; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Simoncini T, 2007, HUM REPROD, V22, P2325, DOI 10.1093/humrep/dem109; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Wang JP, 2010, BEHAV BRAIN RES, V209, P119, DOI 10.1016/j.bbr.2010.01.026; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079	35	14	14	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								207616	10.1155/2014/207616			6	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AH7FP	WOS:000336298700001	24949428	DOAJ Gold, Green Published			2021-06-18	
J	Dowdy, J; Pait, TG				Dowdy, Justin; Pait, T. Glenn			The influence of war on the development of neurosurgery	JOURNAL OF NEUROSURGERY			English	Article						history; medicine; neurosurgery; war trephination; head injury	PENETRATING HEAD-INJURIES; DECOMPRESSIVE CRANIECTOMY; NEUROLOGICAL SURGERY; TRAUMATIC ANEURYSMS; BONE FRAGMENTS; MISSILE WOUNDS; FOLLOW-UP; BRAIN; WARTIME; MANAGEMENT	The treatment of craniospinal war wounds proved to be a significant driving force in the early growth of neurosurgery as a specialty. This publication explores the historical relationship between the evolution of combat methodology from antiquity through modern conflicts as it dovetails with and drives corresponding advancements in the field of neurosurgery. Whether it's the basic management principles for intracranial projectile wounds derived from World War I experiences, the drastic improvement in the outcomes and management of spinal cord injuries observed in World War II, or the fact that both of these wars played a crucial role in the development of a training system that is the origin of modern residency programs, the influence of wartime experiences is pervasive.	[Dowdy, Justin; Pait, T. Glenn] Univ Arkansas Med Sci, Dept Neurosurg, Little Rock, AR 72205 USA	Dowdy, J (corresponding author), Univ Arkansas Med Sci, Dept Neurosurg, 4301 W Markham St,Slot 507, Little Rock, AR 72205 USA.	jtdowdy@uams.edu					AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; Agarwalla PK, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1038; Albutt TC, 1905, HIST RELATIONS MED S, P92; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Ascroft PB, 1944, ARCH NEUROL PSYCHIAT, V21, P295; BEDBROOK GM, 1987, PARAPLEGIA, V25, P172, DOI 10.1038/sc.1987.31; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1025; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Benini A, 1996, SPINE, V21, P1388, DOI 10.1097/00007632-199606010-00024; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Breasted J.H, 1930, E SMITH SURG PAPYRUS, V1; CAIRNS H, 1947, Br J Surg, V55, P9; Cairns H, 1944, Proc R Soc Med, V37, P371; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; Carey ME, 2011, J NEUROSURG, V114, P1495, DOI 10.3171/2011.1.JNS101259; Clower WT, 2001, NEUROSURGERY, V49, P1417, DOI 10.1097/00006123-200112000-00021; Coates JB, 1958, SURG WORLD WAR 2 NEU, V2, p[8, 25, 261]; Coates JB, 1965, NEUROLOGICAL SURG TR, p[17, 103]; Cushing H, 1908, SURG GYNECOL OBSTET, V6, P227; Cushing H, 1918, BRIT J SURG, V5, P558; Cushing H, 1918, Br Med J, V1, P221; Cushing H, 1905, B JOHNS HOPKINS HOSP, V16, P77; Cushing H, 1927, MED DEP UNITED STATE, VXI, P749; Cushing H, 1916, MIL SURG, V38, P601; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; Finger S, 2001, NEUROSURGERY, V48, P911, DOI 10.1097/00006123-200104000-00045; Goetz CG, 2003, ANN NEUROL, V53, pS2, DOI 10.1002/ana.8888; Gray HMW, 1916, BRIT MED J, V1916, P261, DOI 10.1136/bmj.1.2877.261; GUTTMANN L, 1979, PARAPLEGIA, V17, P6, DOI 10.1038/sc.1979.5; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; Hanigan WC, 2003, NEUROSURGERY, V53, P713, DOI 10.1227/01.NEU.0000079626.37622.6A; HANIGAN WC, 1988, NEUROSURGERY, V23, P283, DOI 10.1227/00006123-198809000-00001; Hanigan W, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS103; Hanigan William C, 2004, Neurosurg Focus, V16, pE4; KAUFMAN HH, 1993, J NEUROSURG, V78, P838, DOI 10.3171/jns.1993.78.5.0838; Lanska DJ, 2009, ANN NEUROL, V66, P444, DOI 10.1002/ana.21822; Lifshutz Jason, 2004, Neurosurg Focus, V16, pE5; Lister Joseph, 1867, LANCET, V90, P353, DOI DOI 10.1016/S0140-6736(02)51827-4; MacLeod GHB, 1862, NOTES SURG WAR CRIME, p[373, 760]; Marketos SG, 1999, SPINE, V24, P2358, DOI 10.1097/00007632-199911150-00012; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; MEIROWSKY AM, 1953, ANN SURG, V138, P178, DOI 10.1097/00000658-195308000-00003; MEIROWSKY AM, 1953, J NEUROSURG, V10, P373, DOI 10.3171/jns.1953.10.4.0373; Moodie RL, 1929, ANN MED HIST, V11, P698; Naderi Sait, 2004, Neurosurg Focus, V16, pE15; Otis GA, 1870, MED SURG HIST WAR RE, VII, p[35, 309]; Ragel BT, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1028; Rahimi Scott Y, 2007, Neurosurg Focus, V23, pE14; ROWE SN, 1945, J NEUROSURG, V2, P391, DOI 10.3171/jns.1945.2.5.0391; Rusk HA, 1972, WORLD CARE AUTOBIOGR, P97; Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033; Sargent P, 1915, BRIT MED J, V1915, P537, DOI 10.1136/bmj.1.2830.537; Sargent P, 1915, BRIT J SURG, V3, P475; Schurr PH, 2005, J ROY SOC MED, V98, P423, DOI 10.1258/jrsm.98.9.423; Silver JR, 2003, HIST TREATMENT SPINA, P85; SPURLING R G, 1960, Arch Surg, V80, P406; STONE JL, 1985, NEUROSURGERY, V17, P997, DOI 10.1227/00006123-198512000-00024; WILKINS RH, 1964, J NEUROSURG, V21, P240, DOI 10.3171/jns.1964.21.3.0240	62	14	14	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2014	120	1					237	243		10.3171/2013.8.JNS122369			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	281GL	WOS:000329087900034	24116730				2021-06-18	
J	Habbal, D; Gosseries, O; Noirhomme, Q; Renaux, J; Lesenfants, D; Bekinschtein, TA; Majerus, S; Laureys, S; Schnakers, C				Habbal, Dina; Gosseries, Olivia; Noirhomme, Quentin; Renaux, Jerome; Lesenfants, Damien; Bekinschtein, Tristan A.; Majerus, Steve; Laureys, Steven; Schnakers, Caroline			Volitional electromyographic responses in disorders of consciousness	BRAIN INJURY			English	Article						Brain injury; consciousness; electromyogram; minimally conscious state; unresponsive wakefulness syndrome; vegetative state	VEGETATIVE STATE; MOVEMENT; SPASTICITY; AWARENESS; ACCURACY; SERIES; COMA	Objective: The aim of the study was to validate the use of electromyography (EMG) for detecting responses to command in patients in vegetative state/unresponsive wakefulness syndrome (VS/UWS) or in minimally conscious state (MCS). Methods: Thirty-eight patients were included in the study (23 traumatic, 25 patients >1 year post-onset), 10 diagnosed as being in VS/UWS, eight in MCS- (no response to command) and 20 in MCS+ (response to command). Eighteen age-matched controls participated in the experiment. The paradigm consisted of three commands (i.e. 'Move your hands', 'Move your legs' and 'Clench your teeth') and one control sentence (i.e. 'It is a sunny day') presented in random order. Each auditory stimulus was repeated 4 times within one block with a stimulus-onset asynchrony of 30 seconds. Results: Post-hoc analyses with Bonferroni correction revealed that EMG activity was higher solely for the target command in one patient in permanent VS/UWS and in three patients in MCS+. Conclusion: The use of EMG could help clinicians to detect conscious patients who do not show any volitional response during standard behavioural assessments. However, further investigations should determine the sensitivity of EMG as compared to neuroimaging and electrophysiological assessments.	[Habbal, Dina; Gosseries, Olivia; Noirhomme, Quentin; Renaux, Jerome; Lesenfants, Damien; Laureys, Steven; Schnakers, Caroline] Univ & Univ Hosp Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Habbal, Dina; Gosseries, Olivia; Noirhomme, Quentin; Renaux, Jerome; Lesenfants, Damien; Laureys, Steven; Schnakers, Caroline] Univ & Univ Hosp Liege, Dept Neurol, Liege, Belgium; [Bekinschtein, Tristan A.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Majerus, Steve; Schnakers, Caroline] Univ Liege, Dept Psychol Cognit & Behaviour, Liege, Belgium; [Schnakers, Caroline] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Schnakers, Caroline] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA	Schnakers, C (corresponding author), Univ Calif Los Angeles, Dept Psychol & Neurosurg, Los Angeles, CA 90095 USA.	cschnakers@ucla.edu	Gosseries, Olivia/AAB-6469-2020; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807; Majerus, Steve/0000-0002-8206-8097; Noirhomme, Quentin/0000-0001-8247-4493; Gosseries, Olivia/0000-0001-9011-7496; Bekinschtein, Tristan/0000-0001-5501-8628	Belgian National Funds for Scientific Research (FNRS)Fonds de la Recherche Scientifique - FNRS; Fonds Leon Fredericq; James S. McDonnell Foundation; Mind Science Foundation; European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Concerted Research Action; Public Utility Foundation 'Universite Europeenne du Travail'; Fondazione Europea di Ricerca Biomedica; European Commission (FP7 DECODER)European Commission	This study was funded by the Belgian National Funds for Scientific Research (FNRS), Fonds Leon Fredericq, James S. McDonnell Foundation; Mind Science Foundation; European Commission; Concerted Research Action; Public Utility Foundation 'Universite Europeenne du Travail' and 'Fondazione Europea di Ricerca Biomedica'. This project has also been funded with the support of the European Commission (FP7 DECODER). This publication only reflects the view of the authors and the Commission cannot be held responsible for any use which may be made of the information contained therein. The authors report no conflicts of interest.	Bekinschtein TA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00005; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2011, J PERIPHER NERV SYST, V16, P315, DOI 10.1111/j.1529-8027.2011.00363.x; Bekinschtein TA, 2008, J NEUROL NEUROSUR PS, V79, P826, DOI 10.1136/jnnp.2007.132738; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bruno MA, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-35; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; De Luca CJ, 2010, J BIOMECH, V43, P1573, DOI 10.1016/j.jbiomech.2010.01.027; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hugger S, 2012, Int J Comput Dent, V15, P297; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Leeb R, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025011; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Natale M, 2012, CLIN NEUROL NEUROSUR, V114, P321, DOI 10.1016/j.clineuro.2011.10.046; Nojd N, 2008, METHOD INFORM MED, V47, P192, DOI 10.3414/ME9109; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Thibaut A, 2013, BRAIN INJURY, V27, P1093, DOI 10.3109/02699052.2013.804202; Vanhaudenhuyse A, 2012, COMA DISORDERS CONSC, P25; von Wild K, 2012, J Med Life, V5, P3	25	14	14	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	9			SI		1171	1179		10.3109/02699052.2014.920519			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AN2ZX	WOS:000340455700006	24911192				2021-06-18	
J	Kang, HJ; Dang, ABC; Joshi, SK; Halloran, B; Nissenson, R; Zhang, X; Li, JA; Kim, HT; Liu, XH				Kang, Heejae; Dang, Alexis B. C.; Joshi, Sunil K.; Halloran, Bernard; Nissenson, Robert; Zhang, Xia; Li, Jianan; Kim, Hubert T.; Liu, Xuhui			Novel mouse model of spinal cord injury-induced heterotopic ossification	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						bone morphogenetic protein-2; heterotopic ossification; injury; microcomputed tomography; mouse model; muscle; rehabilitation; spinal cord injury; trauma; Veterans	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; PREVALENCE; SYSTEM; BONE	Heterotopic ossification (HO) develops in about 20% to 30% of patients with spinal cord injury (SCI) and significantly impairs their rehabilitation. There is no effective prevention or treatment for this condition at this time. Our current understanding of its etiology and pathophysiology is limited partially due to the lack of clinically relevant animal models. In this study, we report a novel mouse model of SCI-induced HO by administering a subthreshold dose of bone morphogenetic protein (BMP)-2 to muscles in mice after SCI. Microcomputed tomography scanning showed that an intramuscular injection of 0.25 micrograms of BMP-2 causes significant HO in mice with SCI but not in control (sham surgery) mice. Our analysis of gene expression showed significantly increased BMP signaling in quadriceps following SCI, suggesting that BMP signaling may play a role in SCI-induced HO. Administering 0.25 micrograms of BMP-2 to the front arms of the mice with SCI also results in the development of significant HO but not in control mice. This suggests that SCI causes a systematic osteogenic effect, which is not limited to paralyzed limbs. This novel mouse model will serve as a powerful tool in exploring the molecular mechanisms of SCI-induced HO, which may lead to novel treatment for this disease.	[Kang, Heejae; Dang, Alexis B. C.; Joshi, Sunil K.; Halloran, Bernard; Nissenson, Robert; Kim, Hubert T.; Liu, Xuhui] San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Dang, Alexis B. C.; Joshi, Sunil K.; Kim, Hubert T.; Liu, Xuhui] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Halloran, Bernard; Nissenson, Robert] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Zhang, Xia; Li, Jianan] Nanjing Med Univ, Affiliate Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China	Liu, XH (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,Bldg 2,Room 639, San Francisco, CA 94121 USA.	Liux@orthosurg.ucsf.edu		Joshi, Sunil/0000-0003-2798-5762	Department of DefenseUnited States Department of Defense [W81XWH-11-2-0189]; Department of Veterans Affairs (VA) Rehabilitation Research and Development Merit ReviewUS Department of Veterans Affairs [RX000195]; Northern California Institute for Research and Education; Veterans AffairsUS Department of Veterans Affairs [I01BX001496, IP1BX001599] Funding Source: NIH RePORTER	This material was based on work supported by the Department of Defense (grant W81XWH-11-2-0189), Department of Veterans Affairs (VA) Rehabilitation Research and Development Merit Review (grant RX000195), and the Northern California Institute for Research and Education. We thank Drs. Olla Larm and Lars Adolfsson (ExThera AB; Stockholm, Sweden) for their kind gift of heparin-chitosan hydrogel.	Baldwin K, 2011, J HAND SURG-AM, V36A, P798, DOI 10.1016/j.jhsa.2011.01.015; Biering-Sorensen F, 2012, SPINAL CORD, V50, P797, DOI 10.1038/sc.2012.102; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Dang ABC, 2008, SPINE, V33, pE576, DOI 10.1097/BRS.0b013e31817ecc87; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Engstrand T, 2008, PLAST RECONSTR SURG, V121, P1920, DOI 10.1097/PRS.0b013e31817151b0; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; Liu XH, 2014, J ORTHOP RES, V32, P183, DOI 10.1002/jor.22500; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Schoenfeld AJ, 2013, SPINE, V38, P1770, DOI 10.1097/BRS.0b013e31829ef226; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152	20	14	15	0	2	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	7					1109	1117		10.1682/JRRD.2014.01.0019			9	Rehabilitation	Rehabilitation	AU8JB	WOS:000345841300010	25436890	Bronze			2021-06-18	
J	Li, PC; Yang, CH				Li, Pengcheng; Yang, Chaohua			Moderate hypothermia treatment in adult patients with severe traumatic brain injury: A meta-analysis	BRAIN INJURY			English	Article						Meta-analysis; Moderate hypothermia; severe traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; CEREBRAL HYPOTHERMIA; MANAGEMENT	Objectives: To evaluate the effect of moderate hypothermia treatment (MHT) in severe traumatic brain injury (sTBI) compared to normothermia management. Methods: PubMed, Medline, Springer, Elsevier Science Direct, Cochrane Library and Google scholar were searched up to December 2012. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) for the mortality and clinical neurological outcome of the adult patients with sTBI were collected and calculated in a fixed-effects model or a random-effects model. Summary effect estimates were stratified by study design and ethnicity. Egger's regression asymmetry tests were utilized for detecting the publication bias. Results: The overall estimates showed that MHT could reduce the mortality (hypothermia vs. normothermia, RR = 0.86, 95% CI = 0.73-1.01, p = 0.06) and unfavourable clinical neurological outcomes (RR = 1.21, 95% CI = 0.95-1.53, p = 0.12) for traumatic brain injured patients without statistical significance. Moreover, the further stratification sub-group analysis indicated that MHT presented a significant reduction (RR = 0.60, 95% CI = 0.44-0.83, p = 0.002) of mortality compared to the normothermia management in an Asian population. Surprisingly, American patients treated with moderate hypothermia showed an increasing mortality (RR = 1.07, 95% CI = 0.83-1.39, p = 0.61). Conclusions: MHT may be effective in reducing death and unfavourable clinical neurological outcomes, but this finding is not statistically significant, except for decreasing the mortality in Asian patients.	[Li, Pengcheng; Yang, Chaohua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Peoples R China	Yang, CH (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China.	yangchaohuua@hotmail.com					Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERING EA, 1961, AM J PHYSIOL, V200, P417; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Deeks JJ, 2001, SYSTEMATIC REV HLTH, DOI [10.1002/9780470693926.ch15, DOI 10.1002/9780470693926.CH15]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; FAY T, 1943, ASS RES NERV MENT DI, V24, P611; Franschman G, 2013, INJURY, V44, P1232, DOI 10.1016/j.injury.2013.06.002; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Le Roux P., 2013, CURRENT NEUROLOGY NE, V13, P1; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Mantel N, 2004, CHALLENGE EPIDEMIOLO, V1, P533; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moreno SG, 2012, STAT MED, V31, P1407, DOI 10.1002/sim.4488; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sahuquillo J, 2004, CURR PHARM DESIGN, V10, P2193, DOI 10.2174/1381612043384051; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zygun DA, 2003, CAN J NEUROL SCI, V30, P307, DOI 10.1017/S0317167100003000	37	14	14	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	8					1036	1041		10.3109/02699052.2014.910609			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AI6KP	WOS:000336983200003	24892219				2021-06-18	
J	Liston, DB; Stone, LS				Liston, Dorion B.; Stone, Leland S.			Oculometric assessment of dynamic visual processing	JOURNAL OF VISION			English	Article						oculometrics; pursuit; screening; assessment; clinical	PURSUIT EYE-MOVEMENTS; MOTION PERCEPTION DEFICITS; TRAUMATIC BRAIN-INJURY; HUMAN SMOOTH-PURSUIT; MIDLINE CEREBELLAR LESIONS; DIRECTION DISCRIMINATION; APPARENT MOTION; MACAQUE MONKEY; TIME-COURSE; TRACKING	Eye movements are the most frequent (similar to 3/s), shortest-latency (similar to 150-250 ms), and biomechanically simplest (one joint, no inertial complexities) voluntary motor behavior in primates, providing a model system to assess sensorimotor disturbances arising from trauma, fatigue, aging, or disease states. We have developed a 15-min behavioral tracking protocol consisting of randomized Rashbass (1961) step-ramp radial target motion to assess several aspects of the behavioral response to visual motion, including pursuit initiation, steady-state tracking, direction tuning, and speed tuning. We show how oculomotor data can be converted into direction- and speed-tuning oculometric functions, with large increases in efficiency over traditional button-press psychophysics. We also show how the latter two can be converted into standard visual psychometric thresholds. To assess our paradigm, we first tested for the psychometric criterion of repeatability, and report that our metrics are reliable across repeated sessions. Second, we tested for the psychometric criterion of validity, and report that our metrics show the anticipated changes as the motion stimulus degrades due to spatiotemporal undersampling. Third, we documented the distribution of these metrics across a population of 41 normal observers to provide a thorough quantitative picture of normal human ocular tracking performance, with practice and expectation effects minimized. Our method computes 10 metrics that quantify various aspects of the eye-movement response during a simple 15-min clinical test, which could be used as a screening or assessment tool for disorders affecting sensorimotor processing, including degenerative retinal disease; developmental, neurological or psychiatric disorders; strokes; and traumatic brain injury.	[Liston, Dorion B.; Stone, Leland S.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Liston, Dorion B.] San Jose State Univ, San Jose, CA 95192 USA	Liston, DB (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	dorion.b.liston@nasa.gov			NASA's Human Health and Performance Program [111-10-10]; NASA's Human Factors Engineering Program [131-20-30]; National Science Foundation's Program in Perception, Action, and Cognition Program [NSF 0924841]; National Space Biomedical Research Institute [SA 2002]; U.S. Air Force School of Aerospace Medicine; NASA Ames Research Center Director's Innovation Fund Award; Office of Naval ResearchOffice of Naval Research [SAA2-402925]	The development of this methodology has been supported over the past 10 years by NASA's Human Health and Performance Program (111-10-10), NASA's Human Factors Engineering Program (131-20-30), the National Science Foundation's Program in Perception, Action, and Cognition Program (NSF 0924841), the National Space Biomedical Research Institute (SA 2002), the U.S. Air Force School of Aerospace Medicine, a NASA Ames Research Center Director's Innovation Fund Award, and the Office of Naval Research (SAA2-402925).	Adler SA, 2002, J VISION, V2, P627, DOI 10.1167/2.9.5; Anderson TJ, 2013, NAT REV NEUROL, V9, P74, DOI 10.1038/nrneurol.2012.273; Antoniades C, 2013, VISION RES, V84, P1, DOI 10.1016/j.visres.2013.02.007; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Beutter BR, 2000, VISUAL NEUROSCI, V17, P139, DOI 10.1017/S0952523800171147; Beutter BR, 1998, VISION RES, V38, P1273, DOI 10.1016/S0042-6989(97)00276-9; Beutter BR, 2003, J OPT SOC AM A, V20, P1341, DOI 10.1364/JOSAA.20.001341; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; CARL JR, 1987, J NEUROPHYSIOL, V57, P1446; Carpenter R.H.S., 1981, EYE MOVEMENTS COGNIT, P237; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Churchland MM, 2000, J NEUROPHYSIOL, V84, P216; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; Diefendorf AR, 1908, BRAIN, V31, P451, DOI 10.1093/brain/31.3.451; Dodge R, 1901, PSYCHOL REV, V8, P145, DOI 10.1037/h0076100; Dodge R, 1903, AM J PHYSIOL, V8, P307; DURSTELER MR, 1987, J NEUROPHYSIOL, V57, P1262; Gegenfurtner KR, 2003, J VISION, V3, P865, DOI 10.1167/3.11.19; GREEN DM, 1964, PSYCHOL REV, V71, P392, DOI 10.1037/h0044520; Handel B, 2009, J NEUROSCI, V29, P15126, DOI 10.1523/JNEUROSCI.3972-09.2009; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Horton JC, 1999, AM J OPHTHALMOL, V128, P530, DOI 10.1016/S0002-9394(99)00177-4; Huang X, 2011, J VISION, V11, DOI 10.1167/11.4.7; KOWLER E, 1987, VISION RES, V27, P993, DOI 10.1016/0042-6989(87)90014-9; Krauzlis RJ, 2001, VISUAL NEUROSCI, V18, P365, DOI 10.1017/S0952523801183033; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822; Krukowski AE, 2003, J VISION, V3, P831, DOI 10.1167/3.11.16; Krukowski AE, 2005, NEURON, V45, P315, DOI 10.1016/j.neuron.2005.01.005; Kuroki Y., 2006, SID 06, V37, P14; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; LEVIN S, 1988, J PSYCHIAT RES, V22, P195, DOI 10.1016/0022-3956(88)90005-2; Levy DL, 2010, CURR TOP BEHAV NEURO, V4, P311, DOI 10.1007/7854_2010_60; Lisberger SG, 1998, J NEUROPHYSIOL, V79, P1918; LISBERGER SG, 1985, J NEUROSCI, V5, P1662; LISBERGER SG, 1981, J NEUROPHYSIOL, V46, P229; Liston D, 2005, J VISION, V5, P678, DOI 10.1167/5.9.3; Liston D, 2003, J NEUROSCI, V23, P11305; Liston DB, 2013, DISPLAYS, V34, P171, DOI 10.1016/j.displa.2012.10.002; Liston DB, 2008, J NEUROSCI, V28, P13866, DOI 10.1523/JNEUROSCI.3120-08.2008; Liu J, 2005, J NEUROSCI, V25, P711, DOI 10.1523/JNEUROSCI.4034-04.2005; Luce R.D., 1986, RESPONSE TIMES THEIR; Madelain L, 2003, J VISION, V3, P642, DOI 10.1167/3.11.1; Madelain L, 2003, J NEUROPHYSIOL, V90, P972, DOI 10.1152/jn.00869.2002; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; Nawrot M, 1998, VISION RES, V38, P2219, DOI 10.1016/S0042-6989(97)00297-6; NAWROT M, 1995, VISION RES, V35, P723, DOI 10.1016/0042-6989(94)00168-L; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604; NEWSOME WT, 1985, J NEUROSCI, V5, P825; NICKERSON RA, 1969, J EXP PSYCHOL, V79, P452, DOI 10.1037/h0026889; Nunnally J.C., 1967, PSYCHOMETRIC THEORY, V226; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osborne LC, 2007, J NEUROSCI, V27, P2987, DOI 10.1523/JNEUROSCI.5072-06.2007; Oswal A, 2007, J NEUROPHYSIOL, V97, P2722, DOI 10.1152/jn.01238.2006; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pelak VS, 2005, NEURO-OPHTHALMOLOGY, V29, P137, DOI 10.1080/01658100500218046; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P326, DOI 10.1113/jphysiol.1961.sp006811; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; Stone L. S., 2009, ENCY NEUROSCIENCE, V7, P503; Stone LS, 2000, PERCEPTION, V29, P771, DOI 10.1068/p2979; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sweet B. T., 2008, IMAGR SOC ST LOUIS M; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; THIER P, 1991, ANN NEUROL, V29, P443, DOI 10.1002/ana.410290419; THURSTON SE, 1988, ANN NEUROL, V23, P266, DOI 10.1002/ana.410230309; TURANO K, 1992, INVEST OPHTH VIS SCI, V33, P2411; TYCHSEN L, 1986, J NEUROPHYSIOL, V56, P953; van Zoest W, 2011, VISION RES, V51, P111, DOI 10.1016/j.visres.2010.10.013; Watamaniuk SNJ, 1999, VISION RES, V39, P59, DOI 10.1016/S0042-6989(98)00128-X; Watson A. B., 2013, SOC MOTION PICTURE T, V122, P18, DOI DOI 10.5594/J18266; Wessel K, 1998, ARCH NEUROL-CHICAGO, V55, P949, DOI 10.1001/archneur.55.7.949; Winn BJ, 2007, ARCH OPHTHALMOL-CHIC, V125, P1137, DOI 10.1001/archopht.125.8.1137; Zee DS, 2012, BIOCYBERN BIOMED ENG, V32, P65; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	79	14	15	0	10	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	1534-7362			J VISION	J. Vision		2014	14	14							12	10.1167/14.14.12			17	Ophthalmology	Ophthalmology	AX8TR	WOS:000347181800012	25527150	DOAJ Gold			2021-06-18	
J	Milne, G; Deck, C; Bourdet, N; Carreira, RP; Allinne, Q; Gallego, A; Willinger, R				Milne, G.; Deck, C.; Bourdet, N.; Carreira, R. P.; Allinne, Q.; Gallego, A.; Willinger, R.			Bicycle helmet modelling and validation under linear and tangential impacts	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						bicycle helmet; helmet modelling; validation; standard impacts; oblique impacts	HEAD; INJURY	In the context of head protection against traumatic brain injuries, this work attempts to understand the degree of protection offered by a commercial bicycle helmet under both linear and oblique impact conditions. In accordance with EN 1078 standard, an experimental program has been carried out on an existing helmet by performing 90 normative impacts. In parallel, a finite element model (FEM) of this helmet has been developed and implemented under the LS-DYNA (R) crash code to numerically reproduce the 90 experimental standard impact tests. Experimental oblique impacts on this commercial helmet have also been performed in order to validate it and to be able to assess its protection capability in case of tangential impact. Finally, the bicycle helmet FEM has been coupled to a Hybrid III dummy head FEM and oblique impacts have been reproduced numerically leading to a realistic behaviour of the helmet model in terms of rotational accelerations.	[Milne, G.; Deck, C.; Bourdet, N.; Willinger, R.] Univ Strasbourg, Fluid & Solid Mech Inst, Strasbourg, France; [Carreira, R. P.; Allinne, Q.; Gallego, A.] Oxylane Res, Villeneuve Dascq, France	Deck, C (corresponding author), Univ Strasbourg, Fluid & Solid Mech Inst, Strasbourg, France.	caroline.deck@unistra.fr		DECK, Caroline/0000-0003-2289-1222	French Department of Transport	The authors wish to thank the French Department of Transport for its support in the framework of the PREDIT-BICYTETE project.	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Aldman B., 1978, P IRCOBI C LYON; [Anonymous], 1995, 960 EN; [Anonymous], 2002, 6487 ISO; [Anonymous], 1999, INT J; [Anonymous], 1997, 1078 NF EN, pS72; Asiminei A.G., 2009, P IRCOBI C YORK; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; *BS, 1985, 6658 BS; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; COLLINS BA, 1993, NEW ZEAL MED J, V106, P514; Deck C, 2006, INT J CRASHWORTHINES, V11, P561, DOI 10.1533/ijcr.2006.0149; Deck C., 2007, P IRCOBI C MAASTR; EilertPetersson E, 1997, ACCIDENT ANAL PREV, V29, P363, DOI 10.1016/S0001-4575(97)00002-X; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Halldin P, 2001, INT J CRASHWORTHINES, V6, P53, DOI 10.1533/cras.2001.0162; Harrison T.I., 1996, P IRCOBI C DUBL; Larsen L.B., 1991, P IRCOBI C BERL; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh A, 1995, P 39 STAPP CAR CRASH; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; Mills NJ., 1996, INT J CRASHWORTHINES, V2, P7; *NIS, 2000, MOB 1998 1999; OSTROM M, 1993, INT J EPIDEMIOL, V22, P483, DOI 10.1093/ije/22.3.483; Otte D., 1999, CONTRIBUTION FINAL R; Otte D., 1985, P 33 STAPP CAR CRASH; Pang TY, 2011, INT J CRASHWORTHINES, V16, P297, DOI 10.1080/13588265.2011.559799; Takhounts E.G., 2011, 22 ESV C WASH DC; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Tinard V, 2012, INT J CRASHWORTHINES, V17, P209, DOI 10.1080/13588265.2011.648465; Untaroiu CD, 2013, INT J AUTO TECH-KOR, V14, P395, DOI 10.1007/s12239-013-0043-x; Willinger R., 1998, P IRCOBI C GOTH	35	14	15	1	25	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2014	19	4					323	333		10.1080/13588265.2013.859470			11	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AJ3JR	WOS:000337562900001					2021-06-18	
J	Palermo, S; Leotta, D; Bongioanni, MR; Amanzio, M				Palermo, S.; Leotta, D.; Bongioanni, M. R.; Amanzio, M.			Unawareness of deficits in ischemic injury: Role of the cingulate cortex	NEUROCASE			English	Article						Anterior cingulate cortex; Unawareness of deficits; Executive function assessment; Behavioral assessment of the dysexecutive syndrome; Case study	TRAUMATIC BRAIN-INJURY; UNDERSTANDING AWARENESS DEFICITS; MINI-MENTAL-STATE; SELF-AWARENESS; ALZHEIMERS-DISEASE; IMPAIRED AWARENESS; CORTICOBASAL DEGENERATION; DAMAGED PATIENTS; RATING-SCALE; ANOSOGNOSIA	Reduced awareness of illness is a well-known phenomenon that has been studied in patients with vascular disease, but the precise nature of their executive dysfunction is an intriguing question that still has to be resolved. It would be particularly interesting to study patients with reduced awareness of disease possibly related to vascular lesions of the prefrontal cortex. Due to the clinical importance of the case, here we present a patient with a selective right anterior cingulate ischemic injury and impaired awareness of deficits. We suggest that the cingulo-frontal area dysfunction may represent one of the corresponding neurobiological substrates of his persistent unawareness, which has not yet been evaluated in the literature on patients with acquired brain injury (ABI).	[Palermo, S.] Univ Turin, Dept Psychol, I-10123 Turin, Italy; [Palermo, S.; Leotta, D.; Bongioanni, M. R.] Martini Hosp, Neurol Unit, I-10100 Turin, Italy; [Amanzio, M.] Dept Psychol, I-10123 Turin, Italy; [Amanzio, M.] NIT, I-10123 Turin, Italy; [Amanzio, M.] Natl Inst Neurosci, Turin, Italy	Palermo, S (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	sara.palermo@unito.it	Amanzio, Martina/A-9085-2010; Palermo, Sara/M-7102-2013	Amanzio, Martina/0000-0002-2504-032X; Palermo, Sara/0000-0002-1451-3793			Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Amanzio M, 2008, BRAIN LANG, V107, P1, DOI 10.1016/j.bandl.2007.08.003; Amanzio M, 2013, J INT NEUROPSYCH SOC, V19, P63, DOI 10.1017/S1355617712000896; Amanzio M, 2011, BRAIN, V134, P1061, DOI 10.1093/brain/awr020; Amanzio M, 2010, BRAIN COGNITION, V72, P337, DOI 10.1016/j.bandc.2009.10.011; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; BECH P, 1978, NEUROPHARMACOLOGY, V17, P430, DOI 10.1016/0028-3908(78)90022-9; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Bisiach E., 1991, AWARENESS DEFICITS B; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BOGOUSSLAVSKY J, 1994, EUR NEUROL, V34, P306, DOI 10.1159/000117068; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Caffarra P., 2002, NUOVA RIV NEUROLOGIA, V12, P111; Colombo L., 2002, G ITAL PSICOL, V3, P613, DOI [10.1421/1256, DOI 10.1421/1256]; Conde-Sala JL, 2013, J GERIATR PSYCH NEUR, V26, P86, DOI 10.1177/0891988713481266; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [10.1097/00001199-198909000-00008, DOI 10.1097/00001199-198909000-00008]; Demertzi A, 2013, CURR OPIN NEUROBIOL, V23, P239, DOI 10.1016/j.conb.2012.12.003; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Devinsky Orrin, 2008, Rev Neurol Dis, V5, P97; Devue C, 2007, BRAIN RES, V1143, P169, DOI 10.1016/j.brainres.2007.01.055; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAINOTTI G, 1977, CORTEX, V13, P109, DOI 10.1016/S0010-9452(77)80002-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KUMRAL E, 1995, STROKE, V26, P964, DOI 10.1161/01.STR.26.6.964; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Liebson E, 2000, J NEUROL NEUROSUR PS, V68, P107, DOI 10.1136/jnnp.68.1.107; Litvan I, 1997, NEUROLOGY, V48, P119, DOI 10.1212/WNL.48.1.119; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; MIGLIORELLI R, 1995, J NEUROPSYCH CLIN N, V7, P338; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Morris R., 2004, COGNITIVE NEUROPSYCH, V2nd; Nelson HE, 1982, NATL ADULT READING T; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Perez DL, 2012, J NEUROPSYCH CLIN N, V24, P141, DOI 10.1176/appi.neuropsych.11050110; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Posner M.I., 1994, IMAGES MIND; Prigatano G. P., 1990, CLIN NEUROPSYCHOL, V4, P163, DOI [10.1080/13854049008401509, DOI 10.1080/13854049008401509]; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Ryan JJ, 2006, J CLIN PSYCHOL, V62, P1319, DOI 10.1002/jclp.20307; Saj A, 2009, JAMA-J AM MED ASSOC, V302, P2552, DOI 10.1001/jama.2009.1834; Sartori G., 1995, PROFESSIONE PSICOLOG, V4, P1; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sinanovic O, 2010, PSYCHIAT DANUB, V22, P278; Spinnler H., 1987, ITALIAN J NEUROLOGIC, V6, P25; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; Starkstein SE, 1996, STROKE, V27, P408, DOI 10.1161/01.STR.27.3.408; STARKSTEIN SE, 1992, STROKE, V23, P1446, DOI 10.1161/01.STR.23.10.1446; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Starkstein Sergio E, 2004, Cogn Behav Neurol, V17, P139, DOI 10.1097/01.wnn.0000119241.65522.90; Stuss D. T., 2001, PRINCIPLES FRONTAL L; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Vuilleumier P, 2004, CORTEX, V40, P9, DOI 10.1016/S0010-9452(08)70918-3; Wechsler D., 1945, WECHSLER MEMORY SCAL; Wilson BA, 1996, BEHAV ASSESSMENT DYS; ZAIDEL E, 1987, DUALITY UNITY BRAIN	94	14	14	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2014	20	5					540	555		10.1080/13554794.2013.826686			16	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	AJ8NU	WOS:000337963200007	23962086				2021-06-18	
J	Sigurdardottir, S; Andelic, N; Roe, C; Schanke, AK				Sigurdardottir, S.; Andelic, N.; Roe, C.; Schanke, A. K.			Identifying longitudinal trajectories of emotional distress symptoms 5 years after traumatic brain injury	BRAIN INJURY			English	Article						Coping; distress; post-traumatic stress disorder; resilience; trauma; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE ACCIDENTS; DEPRESSION SCALE; HOSPITAL ANXIETY; PSYCHOMETRIC PROPERTIES; LIFE SATISFACTION; BURN INJURY; HEAD-INJURY; DSM-IV; RESILIENCE	Primary objective: To evaluate longitudinal trajectories of emotional distress symptoms after traumatic brain injury (TBI). Research design: Longitudinal study. Methods and procedures: Patients with mild-to-severe TBI, 118 patients participated at 3 months, 109 attended at 1-year and 89 attended the 5-year follow-up. Emotional distress was measured with the Impact of Event Scale-Revised. Patients were also assessed for coping style, anxiety, depression, substance abuse and trauma severity. Main outcomes and results: Based on growth mixture modelling, four trajectories of emotional distress symptoms were identified: 73.5% of patients were characterized by a pattern of resilience, 6.8% by a pattern of delayed distress, 14.6% by recovery and 5.1% by chronic distress. Relative to the resilience trajectory, avoidant-coping style and psychiatric problems were related to recovery and chronic trajectories. The delayed trajectory was similar to the resilience trajectory, except for elevated depressive and anxiety symptoms at 1- and 5-years. Demographics and injury-related variables were not significantly associated with emotional distress trajectories. Conclusions: Resilience was the most common trajectory following TBI. Patients characterized by recovery and chronic trajectories required attention and long-term clinical monitoring of their symptoms. Future research would benefit from longitudinal studies to analyse emotional distress symptoms and the strength of resilience over time.	[Sigurdardottir, S.; Schanke, A. K.] Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway; [Sigurdardottir, S.; Andelic, N.] Univ Oslo, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Sigurdardottir, S.; Andelic, N.; Roe, C.] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Roe, C.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Schanke, A. K.] Univ Oslo, Dept Psychol, Fac Social Sci, Oslo, Norway	Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, Dept Res, N-1450 Nesoddtangen, Norway.	solrun.sigurdardottir@medisin.uio.no		Andelic, Nada/0000-0002-3719-4406	South-Eastern Norway Regional Health Authority [2005-217]	The authors are grateful to all the persons for their participation. Thanks to Morten Hestnes and Nils Oddvar Skaga from the Oslo University Hospital's Trauma Registry, for the extraction of trauma scores. S. Sigurdardottir received grant support from the South-Eastern Norway Regional Health Authority (Ref: 2005-217).	Amstadter AB, 2013, SOC PSYCH PSYCH EPID, V48, P215, DOI 10.1007/s00127-012-0537-2; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL REV 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonanno GA, 2002, J PERS SOC PSYCHOL, V83, P1150, DOI 10.1037//0022-3514.83.5.1150; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2012, SOC SCI MED, V74, P753, DOI 10.1016/j.socscimed.2011.11.022; Brewin CR, 2009, J TRAUMA STRESS, V22, P366, DOI 10.1002/jts.20443; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Eid J, 1999, SCAND J PSYCHOL, V40, P101, DOI 10.1111/1467-9450.00105; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Foa EB, 1997, J CLIN PSYCHIAT, V58, P25; Gill IJ, 2014, BRAIN INJURY, V28, P1, DOI 10.3109/02699052.2013.851416; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Hodgson J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hsieh MY, 2012, BRAIN INJURY, V26, P126, DOI 10.3109/02699052.2011.635365; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; JOSEPH S, 1992, PERS INDIV DIFFER, V13, P1249, DOI 10.1016/0191-8869(92)90262-N; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Quale AJ, 2009, INJURY, V40, P498, DOI 10.1016/j.injury.2008.11.006; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Ruff R, 2013, NEUROREHABILITATION, V32, P771, DOI 10.3233/NRE-130901; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sveen J, 2011, J TRAUMA, V71, P1808, DOI 10.1097/TA.0b013e31822a30b8; Sveen J, 2010, J ANXIETY DISORD, V24, P618, DOI 10.1016/j.janxdis.2010.03.021; Sveen J, 2010, J BURN CARE RES, V31, P310, DOI 10.1097/BCR.0b013e3181d0f523; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; TEASDALE G, 1974, LANCET, V2, P81; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Weiss Daniel S., 1997, P399; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	14	15	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1542	1550		10.3109/02699052.2014.934285			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700005	25029224				2021-06-18	
J	Edlow, BL; Giacino, JT; Hirschberg, RE; Gerrard, J; Wu, O; Hochberg, LR				Edlow, Brian L.; Giacino, Joseph T.; Hirschberg, Ronald E.; Gerrard, Jason; Wu, Ona; Hochberg, Leigh R.			Unexpected Recovery of Function After Severe Traumatic Brain Injury: The Limits of Early Neuroimaging-Based Outcome Prediction	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Coma; Magnetic resonance imaging; Traumatic axonal injury; Diffusion-weighted imaging; Apparent diffusion coefficient; Diffusion tensor imaging	DIFFUSE AXONAL INJURY; MINIMALLY CONSCIOUS STATE; DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; PERSISTENT VEGETATIVE STATE; WHITE-MATTER INJURY; PROGNOSTIC VALUE; WEIGHTED MR; CORPUS-CALLOSUM; CARDIAC-ARREST	Prognostication in the early stage of traumatic coma is a common challenge in the neuro-intensive care unit. We report the unexpected recovery of functional milestones (i.e., consciousness, communication, and community reintegration) in a 19-year-old man who sustained a severe traumatic brain injury. The early magnetic resonance imaging (MRI) findings, at the time, suggested a poor prognosis. During the first year of the patient's recovery, MRI with diffusion tensor imaging and T2*-weighted imaging was performed on day 8 (coma), day 44 (minimally conscious state), day 198 (post-traumatic confusional state), and day 366 (community reintegration). Mean apparent diffusion coefficient (ADC) and fractional anisotropy values in the corpus callosum, cerebral hemispheric white matter, and thalamus were compared with clinical assessments using the Disability Rating Scale (DRS). Extensive diffusion restriction in the corpus callosum and bihemispheric white matter was observed on day 8, with ADC values in a range typically associated with neurotoxic injury (230-400 x 10(-6) mm(2)/s). T2*-weighted MRI revealed widespread hemorrhagic axonal injury in the cerebral hemispheres, corpus callosum, and brainstem. Despite the presence of severe axonal injury on early MRI, the patient regained the ability to communicate and perform activities of daily living independently at 1 year post-injury (DRS = 8). MRI data should be interpreted with caution when prognosticating for patients in traumatic coma. Recovery of consciousness and community reintegration are possible even when extensive traumatic axonal injury is demonstrated by early MRI.	[Edlow, Brian L.; Hochberg, Leigh R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Edlow, Brian L.; Wu, Ona] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Giacino, Joseph T.; Hirschberg, Ronald E.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Giacino, Joseph T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Hirschberg, Ronald E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Gerrard, Jason] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Wu, Ona] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] Ctr Neurorestorat & Neurotechnol, Dept Vet Affairs Med Ctr, Providence, RI USA	Edlow, BL (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, 175 Cambridge St,Suite 300, Boston, MA 02114 USA.	bedlow@partners.org	Viani, Rafael/V-1196-2018; Hochberg, Leigh/R-6872-2019; Giacino, Joseph/AAF-1952-2021	Hochberg, Leigh/0000-0003-0261-2273; Giacino, Joseph/0000-0002-7916-9698; Wu, Ona/0000-0002-5509-9461; Gerrard, Jason/0000-0001-6971-1407	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25NS065743, P41EB015896]; National Institute on Disability and Rehabilitation Research [H133A120085]; Center for Integration of Medicine and Innovative Technology (Boston, MA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743] Funding Source: NIH RePORTER	This study was supported in part by grants from the National Institutes of Health (R25NS065743 and P41EB015896), the National Institute on Disability and Rehabilitation Research (H133A120085), and the Center for Integration of Medicine and Innovative Technology (Boston, MA). The views in this article represent those of the authors alone, and do not necessarily represent the views of the Department of Veterans Affairs or the U.S. Government.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grandin C, 2002, J NEURORADIOLOGY, V29, P68; GRAY FD, 1970, J AMER MED ASSOC, V211, P1815, DOI 10.1001/jama.211.11.1815; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Greer D, 2011, NEUROCRIT CARE, V14, P61, DOI 10.1007/s12028-010-9457-8; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; JENNETT B, 1972, LANCET, V1, P734; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Melhem ER, 2000, AM J NEURORADIOL, V21, P1813; Mlynash M, 2010, STROKE, V41, P1665, DOI 10.1161/STROKEAHA.110.582452; Muccio CF, 2009, BRAIN INJURY, V23, P466, DOI 10.1080/02699050902841912; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1034/j.1600-0455.2001.420404.x; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	76	14	14	0	15	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2013	19	3					364	375		10.1007/s12028-013-9870-x			12	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	257OB	WOS:000327393200015	23860665	Green Accepted			2021-06-18	
J	Liu, S; Shen, GY; Deng, SK; Wang, XB; Wu, QF; Guo, AS				Liu, Su; Shen, Guangyu; Deng, Shukun; Wang, Xiubin; Wu, Qinfeng; Guo, Aisong			Hyperbaric oxygen therapy improves cognitive functioning after brain injury	NEURAL REGENERATION RESEARCH			English	Article						neural regeneration; brain injury; hyperbaric oxygen; magnetic resonance spectroscopy; astrocytes; immunohistochemistry; choline; creatine; N-acetylaspartate; CA3 region; Morris water maze; hippocampus; neuroregeneration	MAGNETIC-RESONANCE SPECTROSCOPY; PROTON MR SPECTROSCOPY; RAT MODEL; HIPPOCAMPUS; IMPAIRMENT; ASTROCYTES; RESPONSES; H-1-MRS; DAMAGE; MOTOR	Hyperbaric oxygen therapy has been widely applied and recognized in the treatment of brain injury; however, the correlation between the protective effect of hyperbaric oxygen therapy and changes of metabolites in the brain remains unclear. To investigate the effect and potential mechanism of hyperbaric oxygen therapy on cognitive functioning in rats, we established traumatic brain injury models using Feeney's free falling method. We treated rat models with hyperbaric oxygen therapy at 0.2 MPa for 60 minutes per day. The Morris water maze test for spatial navigation showed that the average escape latency was significantly prolonged and cognitive function decreased in rats with brain injury. After treatment with hyperbaric oxygen therapy for 1 and 2 weeks, the rats' spatial learning and memory abilities were improved. Hydrogen proton magnetic resonance spectroscopy analysis showed that the N-acetylaspartate/creatine ratio in the hippocampal CA3 region was significantly increased at 1 week, and the N-acetylaspartate/choline ratio was significantly increased at 2 weeks after hyperbaric oxygen therapy. Nissl staining and immunohistochemical staining showed that the number of nerve cells and Nissl bodies in the hippocampal CA3 region was significantly increased, and glial fibrillary acidic protein positive cells were decreased after a 2-week hyperbaric oxygen therapy treatment. Our findings indicate that hyperbaric oxygen therapy significantly improves cognitive functioning in rats with traumatic brain injury, and the potential mechanism is mediated by metabolic changes and nerve cell restoration in the hippocampal CA3 region.	[Liu, Su; Shen, Guangyu; Deng, Shukun; Wu, Qinfeng; Guo, Aisong] Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong 226001, Jiangsu, Peoples R China; [Wang, Xiubin] Nantong Univ, Affiliated Hosp, Dept Imaging, Nantong 226001, Jiangsu, Peoples R China	Shen, GY (corresponding author), Nantong Univ, Affiliated Hosp, Dept Rehabil Med, Nantong 226001, Jiangsu, Peoples R China.	sgyrm@163.com					Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1399; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Du YL, 2011, NEUROL INDIA, V59, P31, DOI 10.4103/0028-3886.86540; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; [傅敏 FU Min], 2011, [中华航海医学与高气压医学杂志, Chinese Journal of Nautical Medicine and Hyperbaric Medicine], V18, P82; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Giorgio A, 2010, NEUROL SCI, V31, P245, DOI 10.1007/s10072-010-0370-x; Gossett WA, 2010, UNDERSEA HYPERBAR M, V37, P35; HAYAKAWA T, 1971, J NEUROL NEUROSUR PS, V34, P580, DOI 10.1136/jnnp.34.5.580; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kirov II, 2013, NEUROLOGY, V80, P39, DOI 10.1212/WNL.0b013e31827b1a8c; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Li DF, 2012, INT J NEUROSCI, V122, P200, DOI 10.3109/00207454.2011.639470; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu S, 2008, ZHONGHUA WULI YIXUE, V34, P415; Liu Zhan, 2006, Chin J Traumatol, V9, P168; Lucetti C, 2001, NEUROL SCI, V22, P69, DOI 10.1007/s100720170051; Marjanska M, 2013, PLOS ONE, V8; Metarugcheep Pichest, 2012, Journal of the Medical Association of Thailand, V95, P949; Nicola SD, 2001, J NEUROL, V248, P403; Nie K, 2013, PARKINSONISM RELAT D, V19, P329, DOI 10.1016/j.parkreldis.2012.11.012; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Pang HP, 2010, FANGSHEXUE SHIJIAN, V12, P12; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Semenova NA, 2011, B EXP BIOL MED+, V151, P532, DOI 10.1007/s10517-011-1374-0; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; [孙永安 Sun Yong-an], 2009, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V13, P5098; The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vartak-Sharma N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-195; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; Wang HZ, 2012, CLIN RADIOL, V67, P340, DOI 10.1016/j.crad.2011.09.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Ye B, 2010, ZHONGHUA SHENJING YI, V9, P158; Zhang Xiang-Gen, 2010, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V26, P373; [周红 ZHOU Hong], 2009, [中国医学影像技术, Chinese Journal of Medical Imaging Technology], V25, P1367	50	14	18	0	8	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2013	8	35					3334	3343		10.3969/j.issn.1673-5374.2013.35.008			10	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	284QX	WOS:000329336500008	25206655	DOAJ Gold			2021-06-18	
J	Sakai, K; Fukuda, T; Iwadate, K				Sakai, Kentaro; Fukuda, Takahiro; Iwadate, Kimiharu			Beading of the astrocytic processes (clasmatodendrosis) following head trauma is associated with protein degradation pathways	BRAIN INJURY			English	Article						Astrocyte; autophagy; clasmatodendrosis; traumatic brain injury; ubiquitin	SELECTIVE AUTOPHAGY; DISEASE PATIENTS; UBIQUITIN; P62/SQSTM1; ISCHEMIA; SYSTEM; BRAIN; DEATH; MICE; P62	Objectives: To present the incidence of clasmatodendrosis (injured astrocytic processes) and analyse the association between clasmatodendrosis and the ubiquitin proteasome system (UPS) and autophagy lysosome system (autophagy). Methods: The injured cerebral cortices of 36 autopsy cases were analysed by light microscopy by immunohistochemistry using an anti-glial fibrillary acidic protein (GFAP) antibody and UPS marker antibodies (ubiquitin and lysine 48-linked polyubiquitin chains (K-48) and autophagy marker (lysine 63-linked polyubiquitin chains (K-63), p62/sequestosome 1 and microtubule-associated protein 1 light chain 3 [LC3]). Double-immunofluorescence staining was used to detect the relationships between p62-K-48, p62-K-63 and GFAP-K-48. Results: Clasmatodendrosis that was immunoreactive to GFAP or K-48 was detected by 1 hour up to 14 days following head trauma. The survival time of cases with clasmatodendrosis was significantly shorter than that in cases without clasmatodendrosis (p<0.01). Involvement of contusion or oedema was significantly frequent in cases with clasmatodendrosis (p<0.01). There was no significant age difference between cases with clasmatodendrosis and cases without clasmatodendrosis (p=0.18). Double-immunofluorescence staining for p62-K-48 and GFAP-K-48 demonstrated clasmatodendrosis with overlapping fluorescence signals. Conclusion: Clasmatodendrosis is associated with UPS-mediated, autophagy and relatively acute pathological findings after traumatic intracranial injury.	[Sakai, Kentaro; Iwadate, Kimiharu] Jikei Univ, Sch Med, Dept Forens Med, Minato Ku, Tokyo 1058461, Japan; [Fukuda, Takahiro] Jikei Univ, Sch Med, Res Ctr Med Sci,Dept Neurosci,Div Neuropathol, Minato Ku, Tokyo 1058461, Japan	Sakai, K (corresponding author), Jikei Univ, Sch Med, Dept Forens Med, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	kentaro.sakai@jikei.ac.jp					Akiguchi I, 1997, STROKE, V28, P1423, DOI 10.1161/01.STR.28.7.1423; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CAVANAGH JB, 1993, NEUROPATH APPL NEURO, V19, P240, DOI 10.1111/j.1365-2990.1993.tb00434.x; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Duchen L. W., 1992, GREENFIELDS NEUROPAT, P1; FRIEDE RL, 1961, EXP NEUROL, V4, P197, DOI 10.1016/0014-4886(61)90041-3; Gelot A, 2009, DEV NEUROSCI-BASEL, V31, P459, DOI 10.1159/000232564; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; KRAIG RP, 1990, J CEREBR BLOOD F MET, V10, P104, DOI 10.1038/jcbfm.1990.13; Leesthma JE, 1988, FORENSIC NEUROPATHOL; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lim KL, 2011, NEUROBIOL DIS, V43, P9, DOI 10.1016/j.nbd.2010.08.001; LOBERG EM, 1989, MED SCI LAW, V29, P109, DOI 10.1177/002580248902900205; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qiao YL, 2003, J CEREBR BLOOD F MET, V23, P1113, DOI 10.1097/01.WCB.0000088765.02615.FE; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Rafalowska Janina, 1992, Neuropatologia Polska, V30, P73; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Tomimoto H, 1997, ACTA NEUROPATHOL, V94, P146, DOI 10.1007/s004010050686; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Vinters HV, 2008, GREENFIELDS NEUROPAT, V1, P1	30	14	14	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1692	1697		10.3109/02699052.2013.837198			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400027	24111565				2021-06-18	
J	Haran, FJ; Alphonso, AL; Creason, A; Campbell, JS; Johnson, D; Young, E; Tsao, JW				Haran, F. J.; Alphonso, Aimee L.; Creason, Alia; Campbell, Justin S.; Johnson, Dagny; Young, Emily; Tsao, Jack W.			Analysis of Post-Deployment Cognitive Performance and Symptom Recovery in US Marines	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; REACTION-TIME; CONCUSSION; SEQUELAE; FREEDOM; UTILITY; HEALTH; ANAM; IRAQ	Background: Computerized neurocognitive testing (NCAT) has been proposed to be useful as a screening tool for post-deployment cognitive deficits in the setting of mild traumatic brain injury (mTBI). We assessed the clinical utility of post-injury/post-deployment Automated Neurocognitive Assessment Metric (ANAM) testing, using a longitudinal design to compare baseline ANAM tests with two post-deployment ANAM tests in a group of Marines who experienced combat during deployment. Methods and Findings: Post-deployment cognitive performance and symptom recovery were compared in a subsample of 1324 U.S. Marines with high rates of combat exposure during deployment. Of the sample, 169 Marines had available baseline and twice repeated post-deployment ANAM results. A retrospective analysis of the ANAM data, which consisted of a self-report questionnaire about deployment-related blast exposure, recent history of mTBI, current clinical symptoms, and cognitive performance. Self-reported concussion sustained anytime during deployment was associated with a decrease in cognitive performance measured between 2-8 weeks post-deployment. At the second post-deployment test conducted on average eight months later, performance on the second simple reaction time test, in particular, remained impaired and was the most consistent and sensitive indicator of the cognitive decrements. Additionally, post-concussive symptoms were shown to persist in injured Marines with a self-reported history of concussion for an additional five months after most cognitive deficits resolved. Results of this study showed a measurable deployment effect on cognitive performance, although this effect appears to resolve without lasting clinical sequelae in those without history of deployment-related concussion. Conclusions: These results highlight the need for a detailed clinical examination for service members with history of concussion and persistent clinical symptoms. Reliance solely upon computerized neurocognitive testing as a method for identifying service members requiring clinical follow-up post-concussion is not recommended, as cognitive functioning only slowly returned to baseline levels in the setting of persistent clinical symptoms.	[Haran, F. J.] Navy Expt Div Unit, Biomed Res & Operat Dept, Panama City Beach, FL USA; [Alphonso, Aimee L.] Henry M Jackson Fdn Adv Mil Med, Arlington, VA USA; [Alphonso, Aimee L.] Walter Reed Natl Mil Med Ctr, Dept Orthoped & Rehabil, Bethesda, MD USA; [Creason, Alia] Univ Consulting Serv Inc, Arlington, VA USA; [Creason, Alia; Tsao, Jack W.] US Navy Bur Med & Surg BUMED, Traumat Brain Injury Programs, Wounded Ill & Injured Directorate, Arlington, VA USA; [Campbell, Justin S.] Naval Space & Warfare Syst Ctr Pacific, San Diego, CA USA; [Johnson, Dagny; Young, Emily] Eyak Corp, Arlington, VA USA	Haran, FJ (corresponding author), Navy Expt Div Unit, Biomed Res & Operat Dept, Panama City Beach, FL USA.	jay.haran@navy.mil		Campbell, Justin/0000-0002-3471-9430	Wounded, Ill & Injured Program, US Navy Bureau of Medicine and Surgery, Falls Church, VA	This study was funded by the Wounded, Ill & Injured Program, US Navy Bureau of Medicine and Surgery, Falls Church, VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barwick F, 2012, CLIN NEUROPHYSIOL, V123, P278, DOI 10.1016/j.clinph.2011.06.027; Bass E, 2012, VET HLTH ADM TREATME; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Casscells SW, 2007, TRAUMATIC BRAIN INJU; Center DaVBI, 2012, DOD TBI WORLDW 200 2; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Eonta SE, 2011, AVIAT SPACE ENVIR MD, V82, P34, DOI 10.3357/ASEM.2799.2011; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; Hayward P, 2008, LANCET NEUROL, V7, P200, DOI 10.1016/S1474-4422(08)70032-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johansson B, 2009, MENTAL FATIGUE IMPAI, P13; Kelly JC, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/371970; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Roebuck-Spencer T, 2007, ARCH CLIN NEUROPSYCH, V22, pS79, DOI 10.1016/j.acn.2006.10.011; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e79595	10.1371/journal.pone.0079595			7	Multidisciplinary Sciences	Science & Technology - Other Topics	261GG	WOS:000327652100012	24312183	DOAJ Gold, Green Published			2021-06-18	
J	Rados, A; Tiruta, C; Xiao, ZW; Kortbeek, JB; Tourigny, P; Ball, CG; Kirkpatrick, AW				Rados, Alma; Tiruta, Corina; Xiao, Zhengwen; Kortbeek, John B.; Tourigny, Paul; Ball, Chad G.; Kirkpatrick, Andrew W.			Does trauma team activation associate with the time to CT scan for those suspected of serious head injuries?	WORLD JOURNAL OF EMERGENCY SURGERY			English	Article						Trauma triage; Trauma activation; Trauma human factors; Traumatic brain injury; Diagnostic imaging	MULTISLICE COMPUTED-TOMOGRAPHY; MAJOR TRAUMA; MANAGEMENT; PROTOCOL; IMPACT; ROOM	Background: Traumatic brain injury (TBI) constitutes the leading cause of posttraumatic mortality. Practically, the major interventions required to treat TBI predicate expedited transfer to CT after excluding other immediately life-threatening conditions. At our center, trauma responses variably consist of either full trauma activation (FTA) including an attending trauma surgeon or a non-trauma team response (NTTR). We sought to explore whether FTAs expedited the time to CT head (TTCTH). Methods: Retrospective review of augmented demographics of 88 serious head injuries identified from a Regional Trauma Registry within one year at a level I trauma center. The inclusion criteria consisted of a diagnosis of head injury recorded as intubated or GCS < 13; and CT-head scanning after arriving the emergency department. Data was analyzed using STATA. Results: There were 58 FTAs and 30 NTTRs; 86% of FTAs and 17% of NTTRs were intubated prehospital out of 101 charts reviewed in detail; 13 were excluded due to missing data. Although FTAs were more seriously injured (median ISS 29, MAIS head 19, GCS score at scene 6.0), NTTRs were also severely injured (median ISS 25, MAIS head 21, GCS at scene 10) and older (median 54 vs. 26 years). Median TTCTH was double without dedicated FTA (median 50 vs. 26 minutes, p < 0.001), despite similar justifiable delays (53% NTTR, 52% FTA). Without FTA, most delays (69%) were for emergency intubation. TTCTH after securing the airway was longer for NTTR group (median 38 vs. 26 minutes, p =0.0013). Even with no requirements for ED interventions, TTCTH for FTA was less than half versus NTTR (25 vs. 61 minutes, p =0.0013). Multivariate regression analysis indicated age and FTA with an attending surgeon as significant predictors of TTCTH, although the majority of variability in TTCTH was not explained by these two variables (R-2 = 0.33). Conclusion: Full trauma activations involving attending trauma surgeons were quicker at transferring serious head injury patients to CT. Patients with FTA were younger and more seriously injured. Discerning the reasons for delays to CT should be used to refine protocols aimed at minimizing unnecessary delays and enhancing workforce efficiency and clinical outcome.	[Rados, Alma; Tiruta, Corina; Xiao, Zhengwen; Kortbeek, John B.; Ball, Chad G.; Kirkpatrick, Andrew W.] Univ Calgary, Foothills Med Ctr, Reg Trauma Serv, Calgary, AB 1403, Canada; [Kortbeek, John B.; Ball, Chad G.; Kirkpatrick, Andrew W.] Univ Calgary, Foothills Med Ctr, Dept Surg, Calgary, AB 1403, Canada; [Kortbeek, John B.; Tourigny, Paul; Kirkpatrick, Andrew W.] Univ Calgary, Foothills Med Ctr, Calgary, AB 1403, Canada	Kirkpatrick, AW (corresponding author), Univ Calgary, Foothills Med Ctr, Reg Trauma Serv, 29 St, Calgary, AB 1403, Canada.	Andrew.kirkpatrick@albertahealthservices.ca	Kortbeek, John B/AAO-5298-2020				Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Chen EH, 2006, ACAD EMERG MED, V13, P349, DOI 10.1197/j.aem.2005.10.011; Cherry RA, 2007, J TRAUMA, V63, P326, DOI 10.1097/TA.0b013e31811eaad1; *COMM TRAUM AM COL, 2006, RES OPT CAR INJ; Committee on Trauma American College of Surgeons, 2012, ADV TRAUM LIF SUPP C; Cook CH, 2001, ARCH SURG-CHICAGO, V136, P752, DOI 10.1001/archsurg.136.7.752; Davis T, 2010, INJURY, V41, P470, DOI 10.1016/j.injury.2010.01.003; Esposito TJ, 2006, J TRAUMA, V60, P8, DOI 10.1097/01.ta.0000197425.87092.d5; Grossman MD, 2009, J AM COLL SURGEONS, V208, P503, DOI 10.1016/j.jamcollsurg.2009.01.013; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Jin PHPFK, 2009, EUR J RADIOL, V72, P134, DOI 10.1016/j.ejrad.2008.06.022; Jin PHPFK, 2008, J TRAUMA, V64, P1320, DOI 10.1097/TA.0b013e318059b9ae; Jurkovich GJ, 2005, J TRAUMA, V58, P614, DOI 10.1097/01.TA0000159347.03278.E1; Kouzminova N, 2009, J TRAUMA, V67, P829, DOI 10.1097/TA.0b013e3181b57b6d; Lehmann RK, 2007, AM J SURG, V193, P630, DOI 10.1016/j.amjsurg.2007.01.017; Marion DW, 2006, NEUROSURGERY, V58, P655; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; *REG AHSC, 2010, TRAUM SERV ANN REP; Rieger M, 2009, J TRAUMA, V66, P648, DOI 10.1097/TA.0b013e31816275f3; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Salim A, 2006, ARCH SURG-CHICAGO, V141, P73, DOI DOI 10.1001/ARCHSURG.141.5.468; Self ML, 2003, AM J SURG, V186, P609, DOI 10.1016/j.amjsurg.2003.08.003; Shackford S, 2006, J TRAUMA, V60, P1, DOI 10.1097/01.ta.0000197144.19182.c4; Tillou A, 2009, J TRAUMA, V67, P779, DOI 10.1097/TA.0b013e3181b5f2eb; Tinkoff GH, 2002, J TRAUMA, V52, P1153, DOI 10.1097/00005373-200206000-00022; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Weninger P, 2007, J TRAUMA, V62, P584, DOI 10.1097/01.ta.0000221797.46249.ee; Willmann JK, 2002, AM J ROENTGENOL, V179, P437, DOI 10.2214/ajr.179.2.1790437; Wurmb TE, 2009, J TRAUMA, V66, P658, DOI 10.1097/TA.0b013e31817de3f4	30	14	14	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-7922			WORLD J EMERG SURG	World J. Emerg. Surg.	NOV 18	2013	8								48	10.1186/1749-7922-8-48			7	Emergency Medicine; Surgery	Emergency Medicine; Surgery	262GI	WOS:000327721900001	24245486	DOAJ Gold, Green Published			2021-06-18	
J	Jacobsson, L; Lexell, J				Jacobsson, Lars; Lexell, Jan			LIFE SATISFACTION 6-15 YEARS AFTER A TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						long-term outcome; outcome assessment; traumatic brain injury; quality of life; questionnaires	QUALITY-OF-LIFE; 18-TO 64-YEAR-OLD SWEDES; PSYCHOSOCIAL ADJUSTMENT; FOLLOW-UP; DISABILITY; SYMPTOMS; HEALTH; COMA	Objectives: To assess satisfaction with life as a whole and 10 domains of life satisfaction in Swedish individuals after a traumatic brain injury, to describe the relationship with demographic, social and injury related variables, and to compare the level of life satisfaction with a Swedish reference sample. Subjects: Fifty-one men and sixteen women, 6-15 years after a traumatic brain injury. Methods: Life Satisfaction Questionnaire (LiSat-11). Results: Many of the participants were, to some degree, satisfied with life as a whole and with all 10 domains of life satisfaction, but significantly less satisfied with life as whole and with 6 of the other 10 domains of life satisfaction in comparison with the Swedish reference sample. The participants' sex, injury severity or years post-injury was not related to any domains in LiSat-11, whereas age at time of injury, marital status and vocational situation were significantly related to a few of the domains. Conclusion: This study shows that life satisfaction can be affected several years after a traumatic brain injury. It appears that individuals who are married or cohabiting and productive had higher life satisfaction. This implies that regaining social participation is an important factor for life satisfaction many years after a traumatic brain injury.	[Jacobsson, Lars] Kalix Hosp, Dept Gen Med, Med Rehabil Sect, SE-95282 Kalix, Sweden; [Jacobsson, Lars; Lexell, Jan] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lexell, Jan] Dept Rehabil Med, Lund, Sweden; [Lexell, Jan] Skane Univ Hosp, Lund, Sweden	Jacobsson, L (corresponding author), Kalix Hosp, Dept Gen Med, SE-95282 Kalix, Sweden.	lars.jacobsson@nll.se		Jacobsson, Lars/0000-0002-1127-1178			Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1995, SOC INDIC RES, V34, P7, DOI 10.1007/BF01078966; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Fugl-Meyer A. R., 1991, CLIN REHABIL, V5, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105, 10.1177/026921559100500105.]; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Geyh S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-94; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Jacobsson LJ, 2011, NEUROPSYCHOL REHABIL, V21, P383, DOI 10.1080/09602011.2011.566711; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; Lund ML, 2011, DISABIL REHABIL-ASSI, V6, P402, DOI 10.3109/17483107.2011.574309; Lund ML, 2011, APPL RES QUAL LIFE, V6, P71, DOI 10.1007/s11482-010-9116-4; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Melin R, 2003, J REHABIL MED, V35, P84, DOI 10.1080/16501970306119; Merrick Daniel, 2010, BMC Res Notes, V3, P190, DOI 10.1186/1756-0500-3-190; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Roding J, 2010, J REHABIL MED, V42, P155, DOI 10.2340/16501977-0497; Sorbo AK, 2009, INT J REHABIL RES, V32, P139, DOI 10.1097/MRR.0b013e328325a5d1; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stalnacke BM, 2009, J REHABIL MED, V41, P353, DOI 10.2340/16501977-0349; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	37	14	14	0	6	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	NOV	2013	45	10					1010	1015		10.2340/16501977-1204			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	251TE	WOS:000326952800004	23995834	DOAJ Gold, Green Published			2021-06-18	
J	Fozouni, N; Chopp, M; Nejad-Davarani, SP; Zhang, ZG; Lehman, NL; Gu, S; Ueno, Y; Lu, M; Ding, GL; Li, L; Hu, JN; Bagher-Ebadian, H; Hearshen, D; Jiang, Q				Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Lehman, Norman L.; Gu, Steven; Ueno, Yuji; Lu, Mei; Ding, Guangliang; Li, Lian; Hu, Jiani; Bagher-Ebadian, Hassan; Hearshen, David; Jiang, Quan			Characterizing Brain Structures and Remodeling after TBI Based on Information Content, Diffusion Entropy	PLOS ONE			English	Article							WATER DIFFUSION; NERVOUS-SYSTEM; TENSOR; MRI; ANISOTROPY; COEFFICIENT; MODEL; RECOVERY; TISSUES; INDEXES	Background: To overcome the limitations of conventional diffusion tensor magnetic resonance imaging resulting from the assumption of a Gaussian diffusion model for characterizing voxels containing multiple axonal orientations, Shannon's entropy was employed to evaluate white matter structure in human brain and in brain remodeling after traumatic brain injury (TBI) in a rat. Methods: Thirteen healthy subjects were investigated using a Q-ball based DTI data sampling scheme. FA and entropy values were measured in white matter bundles, white matter fiber crossing areas, different gray matter (GM) regions and cerebrospinal fluid (CSF). Axonal densities' from the same regions of interest (ROIs) were evaluated in Bielschowsky and Luxol fast blue stained autopsy (n = 30) brain sections by light microscopy. As a case demonstration, a Wistar rat subjected to TBI and treated with bone marrow stromal cells (MSC) 1 week after TBI was employed to illustrate the superior ability of entropy over FA in detecting reorganized crossing axonal bundles as confirmed by histological analysis with Bielschowsky and Luxol fast blue staining. Results: Unlike FA, entropy was less affected by axonal orientation and more affected by axonal density. A significant agreement (r = 0.91) was detected between entropy values from in vivo human brain and histologically measured axonal density from post mortum from the same brain structures. The MSC treated TBI rat demonstrated that the entropy approach is superior to FA in detecting axonal remodeling after injury. Compared with FA, entropy detected new axonal remodeling regions with crossing axons, confirmed with immunohistological staining. Conclusions: Entropy measurement is more effective in distinguishing axonal remodeling after injury, when compared with FA. Entropy is also more sensitive to axonal density than axonal orientation, and thus may provide a more accurate reflection of axonal changes that occur in neurological injury and disease.	[Fozouni, Niloufar; Chopp, Michael; Nejad-Davarani, Siamak P.; Zhang, Zheng Gang; Gu, Steven; Ueno, Yuji; Ding, Guangliang; Li, Lian; Bagher-Ebadian, Hassan; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Lehman, Norman L.] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; [Hearshen, David] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Hu, Jiani] Harper Hospita, MR Ctr, Detroit, MI USA; [Fozouni, Niloufar; Chopp, Michael; Zhang, Zheng Gang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Lehman, Norman L/A-7351-2015; Ueno, Yuji/ABB-2492-2020; Nejad-Davarani, Siamak/AAH-8399-2021	Nejad-Davarani, Siamak/0000-0002-2415-6689; Lehman, Norman/0000-0001-8394-2607; Ding, Guangliang/0000-0003-1286-5901	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS64134, RO1 AG037506]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG037506] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants RO1 NS64134, RO1 AG037506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2005, NEUROIMAGE, V27, P357, DOI 10.1016/j.neuroimage.2005.04.008; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; Assaf Y, 2000, MAGNET RESON MED, V43, P191, DOI 10.1002/(SICI)1522-2594(200002)43:2<191::AID-MRM5>3.0.CO;2-B; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, BIOESSAYS, V30, P1235, DOI 10.1002/bies.20851; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bastin ME, 1999, NEUROREPORT, V10, P1385, DOI 10.1097/00001756-199905140-00001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Callaghan P. T., 1991, PRINCIPLES NUCL MAGN; Chen Y, 2005, LECT NOTES COMPUT SC, V3565, P246; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Correia MM, 2011, NEUROIMAGE, V57, P1103, DOI 10.1016/j.neuroimage.2011.03.004; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Horsfield MA, 1998, J NEUROL NEUROSUR PS, V64, pS80; Inglis BA, 1999, AM J NEURORADIOL, V20, P713; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Jones DK, 1999, STROKE, V30, P393, DOI 10.1161/01.STR.30.2.393; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Metwalli Nader S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2260; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGNET RESON MED, V50, P955, DOI 10.1002/mrm.10596; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Shannon CE, 1997, M D COMPUT, V14, P306; Tievsky AL, 1999, AM J NEURORADIOL, V20, P1491; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; von Bohlen und Halbach O, 1998, J NEUROSCI METH, V81, P169, DOI 10.1016/S0165-0270(98)00026-0; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wieshmann UC, 1999, NEUROIMAGE, V10, P225, DOI 10.1006/nimg.1999.0456; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zivadinov R, 2008, J NEUROL, V255, P61, DOI 10.1007/s00415-008-1009-1	54	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e76343	10.1371/journal.pone.0076343			9	Multidisciplinary Sciences	Science & Technology - Other Topics	237TP	WOS:000325894100021	24143186	DOAJ Gold, Green Published			2021-06-18	
J	Beynon, C; Scherer, M; Jakobs, M; Jung, C; Sakowitz, OW; Unterberg, AW				Beynon, Christopher; Scherer, Moritz; Jakobs, Martin; Jung, Carla; Sakowitz, Oliver W.; Unterberg, Andreas W.			Initial experiences with Multiplate (R) for rapid assessment of antiplatelet agent activity in neurosurgical emergencies	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Antiplatelet therapy; Aspirin; Clopidogrel; Intracerebral haemorrhage; Point-of-care	TRAUMATIC BRAIN-INJURY; WHOLE-BLOOD AGGREGOMETRY; ELECTRODE AGGREGOMETRY; PLATELET TRANSFUSION; CORONARY SYNDROMES; ASPIRIN; THERAPY; RISK	Objective: As the population ages, physicians encounter a growing number of patients who are treated with antiplatelet agents and present with severe conditions requiring urgent neurosurgical therapy. Standard laboratory investigations are insufficient to evaluate platelet activity and furthermore, it is difficult to evaluate effects of haemostatic measures on platelet function. In this article we report our initial experiences with the point-of-care device Multiplate (R) for assessment of platelet activity in neurosurgical emergencies on patients with a reported intake of antiplatelet medication. Methods: Multiplate (R) assessment of antiplatelet activity was carried out in 21 non-consecutive patients with a reported intake of antiplatelet medication (aspirin: n = 21, clopidogrel: n = 3, ticragrelor: n = 1) and urgent admission to our hospital because of conditions such as intracranial haemorrhage requiring urgent neurosurgical therapy. Analysis was repeated in order to evaluate the effectiveness of haemostatic drugs and platelet concentrate transfusion on platelet activity in six patients. Results: No technical difficulties occurred and in all cases, results were obtained within 15 min. On admission, patients' arachidonic acid induced platelet activity was reduced by 44.4 +/- 33.5% (range: -79.7% to +44.3%) compared to the lower reference limit. Two patients had a normal platelet activity despite a reported intake of aspirin. Haemostatic measures significantly increased arachidonic acid induced platelet activity by 100 +/- 66% (p < 0.005). Conclusion: The Multiplate device allowed rapid assessment of antiplatelet agent activity and evaluation of haemostatic measures on platelet activity. Further studies with larger patient numbers are needed, but this device may represent a valuable tool to improve treatment modalities in patients treated with antiplatelet medication and conditions requiring urgent neurosurgical therapy. (C) 2013 Elsevier B.V. All rights reserved.	[Beynon, Christopher; Scherer, Moritz; Jakobs, Martin; Jung, Carla; Sakowitz, Oliver W.; Unterberg, Andreas W.] Univ Heidelberg Hosp, Dept Neurosurg, D-69120 Heidelberg, Germany	Beynon, C (corresponding author), Univ Heidelberg Hosp, Dept Neurosurg, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	christopher.beynon@med.uni-heidelberg.de					Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11816; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Beynon C, 2013, J CLIN NEUR IN PRESS, DOI DOI 10.1016/JJ0CN.2013.02.022; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Gerlach R, 2009, ACTA NEUROCHIR, V151, P873, DOI 10.1007/s00701-009-0409-z; Hazarbasanov D, 2012, J THROMB THROMBOLYS, V34, P85, DOI 10.1007/s11239-012-0684-z; Hussein HM, 2013, AM J NEURORADIOL, V34, P700, DOI 10.3174/ajnr.A2963; Jambor C, 2011, ANESTH ANALG, V113, P31, DOI 10.1213/ANE.0b013e31821acddc; Lopes RD, 2011, J THROMB THROMBOLYS, V31, P306, DOI 10.1007/s11239-011-0558-9; Norfolk DR, 1998, BRIT J HAEMATOL, V101, P609; Ozal E, 2002, J THORAC CARDIOV SUR, V123, P539, DOI 10.1067/mtc.2002.117281; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Paniccia R, 2009, AM J CLIN PATHOL, V131, P834, DOI 10.1309/AJCPTE3K1SGAPOIZ; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Ranucci M, 2011, ANN THORAC SURG, V91, P123, DOI 10.1016/j.athoracsur.2010.09.022; Roden DM, 2011, CIRC RES, V109, P807, DOI 10.1161/CIRCRESAHA.110.230995; ROOS YB, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001245, 10.1002/14651858.CD001245]; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schulz C, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-13; Stead LG, 2010, CLIN NEUROL NEUROSUR, V112, P275, DOI 10.1016/j.clineuro.2009.12.002; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Ulehlova J, 2011, INT J LAB HEMATOL, V33, P305, DOI 10.1111/j.1751-553X.2010.01286.x; Weber CF, 2011, EUR J ANAESTH, V28, P57, DOI 10.1097/EJA.0b013e32834050ab	27	14	14	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2003	2008		10.1016/j.clineuro.2013.06.002			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200013	23830497				2021-06-18	
J	Eifert, B; Maurer-Karattup, P; Schorl, M				Eifert, Bernd; Maurer-Karattup, Petra; Schorl, Martin			Integration of Intensive Care Treatment and Neurorehabilitation in Patients With Disorders of Consciousness: A Program Description and Case Report	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Consciousness disorders; Persistent vegetative state; Rehabilitation	TRAUMATIC BRAIN-INJURY; MINIMALLY RESPONSIVE PATIENTS; EARLY REHABILITATION; VEGETATIVE STATE; HEAD-INJURY; RECOVERY; COMA; CONSORTIUM; GUIDELINES; MANAGEMENT	Severe brain injuries frequently result in disorders of consciousness, requiring intensive care unit treatment. We present a rehabilitative system that integrates neurorehabilitation into intensive care treatment. The system will be described using the case report of a young man who was in a vegetative state after a severe traumatic brain injury that resulted in major medical problems and complications. Despite these challenges, interdisciplinary therapies can be applied throughout the rehabilitative process. The patient in our case report showed significant improvements and functional gains during the course of treatment. Additional data from other patients support the feasibility of this system and show that integrating neurorehabilitation into intensive care treatment is possible and can lead to improved outcomes in this patient population. We will discuss the advantages, special features, and limitations of the system. Additional studies are needed to further demonstrate the efficacy of this approach compared with standard treatment. (c) 2013 by the American Congress of Rehabilitation Medicine	[Eifert, Bernd; Maurer-Karattup, Petra; Schorl, Martin] SRH Fachkrankenhaus Neresheim, Clin Neurorehabil Severe Head Injuries, Neresheim, Germany	Maurer-Karattup, P (corresponding author), SRH Fachkrankenhaus Neresheim GmbH, Kosinger St 11, D-73450 Neresheim, Germany.	petra.maurer@fkne.srh.de					ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; BAR [German workforce for rehabilitation], 1995, REC NEUR REH PAT SEV; Bertram M, 2007, NERVENARZT, V78, P1160, DOI 10.1007/s00115-007-2269-1; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Dolce G, 2002, POST-TRAUMATIC VEGETATIVE STATE, P11; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Gianutsos R, 1990, Neuropsychol Rev, V1, P21, DOI 10.1007/BF01108857; GOBIET W, 1989, Neurosurgical Review, V12, P143, DOI 10.1007/BF01790637; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hildebrandt H., 2002, Z NEUROSPYCHOL, V13, P91; Hopkins RO, 2009, AACN ADV CRIT CARE, V20, P277, DOI 10.1097/NCI.0b013e3181acaef0; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Lippert-Gruner M, 2002, ACT NEUR S, V79, P21; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Maurer-Karattup P., 2010, THESIS U TUBINGEN TU; McFetridge Brian, 2011, Intensive Crit Care Nurs, V27, P57, DOI 10.1016/j.iccn.2011.02.003; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Piguet O, 1999, BRAIN INJURY, V13, P829, DOI 10.1080/026990599121223; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; Schorl M, 2009, CENT EUR NEUROSURG, V70, P68, DOI 10.1055/s-0028-1093355; Schorl M, 2012, NEUROL REHABIL, V18, P99; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sherburne E, 1986, J Neurosci Nurs, V18, P140; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Spranger M, 2005, NEUROL REHABIL, V11, P317; Stier-Jarmer M, 2002, PHYS MED REHAB KUROR, V12, P260, DOI 10.1055/s-2002-35154; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; Whyte John, 1986, J HEAD TRAUMA REHAB, V1, P1; WOOD RL, 1993, NEUROPSYCHOL REHABIL, V3, P177; Zieger A, 1992, Zentralbl Neurochir, V53, P92; Zieger A., 2005, NEUR REH CTR ZIHLSCH	43	14	14	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1924	1933		10.1016/j.apmr.2013.03.030			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	231TU	WOS:000325442100010	23810352				2021-06-18	
J	Irimia, A; Goh, SYM; Torgerson, CM; Stein, NR; Chambers, MC; Vespa, PM; Van Horn, JD				Irimia, Andrei; Goh, S. -Y. Matthew; Torgerson, Carinna M.; Stein, Nathan R.; Chambers, Micah C.; Vespa, Paul M.; Van Horn, John D.			Electroencephalographic inverse localization of brain activity in acute traumatic brain injury as a guide to surgery, monitoring and treatment	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Electroencephalography; Traumatic brain injury; Localization; Monitoring; Outcome; Epilepsy	INTENSIVE-CARE-UNIT; SPREADING DEPOLARIZATIONS; ELECTROGRAPHIC SEIZURES; EEG; MEG; MODEL; MAGNETOENCEPHALOGRAPHY; SEGMENTATION; SIMULATION; ANISOTROPY	Objective: To inverse-localize epileptiform cortical electrical activity recorded from severe traumatic brain injury (TBI) patients using electroencephalography (EEG). Methods: Three acute TBI cases Were imaged using computed tomography (CT) and multimodal magnetic resonance imaging (MRI). Semi-automatic segmentation was performed to partition the complete TBI head into 25 distinct tissue types, including 6 tissue types accounting for pathology. Segmentations were employed to generate a finite element method model of the head, and EEG activity generators were modeled as dipolar currents distributed over the cortical surface. Results: We demonstrate anatomically faithful localization of EEG generators responsible for epileptiform discharges in severe TBI. By accounting for injury-related tissue conductivity changes, our work offers the most realistic implementation currently available for the inverse estimation of cortical activity in TBI. Conclusion: Whereas standard localization techniques are available for electrical activity mapping in uninjured brains, they are rarely applied to acute TBI. Modern models of TBI-induced pathology can inform the localization of epileptogenic foci, improve surgical efficacy, contribute to the improvement of critical care monitoring and provide guidance for patient-tailored treatment. With approaches such as this, neurosurgeons and neurologists can study brain activity in acute TBI and obtain insights regarding injury effects upon brain metabolism and clinical outcome. Published by Elsevier B.V.	[Irimia, Andrei; Goh, S. -Y. Matthew; Torgerson, Carinna M.; Van Horn, John D.] Univ So Calif, Inst Neuroimaging & Informat, Keck Sch Med, Los Angeles, CA 90089 USA; [Stein, Nathan R.; Vespa, Paul M.] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA USA; [Chambers, Micah C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	Van Horn, JD (corresponding author), Univ So Calif, Inst Neuroimaging & Informat, Keck Sch Med, 2001 North Soto St,Room 102,MC 9232, Los Angeles, CA 90089 USA.	jvanhorn@usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	National Alliance for Medical Image Computing (NA-MIC) under NIH Roadmap Initiative [2U54EB005149]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922, U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER	This work was supported by the National Alliance for Medical Image Computing (NA-MIC; www.na-mic.org), under NIH Roadmap Initiative grant 2U54EB005149, sub-award to J. D. V. H. and by the NINDS, grant P01NS058489 to P. M. V.	Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Acar Z., 2004, PHYS MED BIOL, V49, P5011; Acar ZA, 2010, J NEUROSCI METH, V190, P258, DOI 10.1016/j.jneumeth.2010.04.031; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Babiloni F, 2003, NEUROIMAGE, V19, P1, DOI 10.1016/S1053-8119(03)00052-1; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; EBERSOLE J S, 1990, Brain Topography, V3, P21, DOI 10.1007/BF01128858; Ebersole JS, 1999, EEG CL N SU, V50, P167; EBERSOLE JS, 1991, NEUROLOGY, V41, P1425, DOI 10.1212/WNL.41.9.1425; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gramfort A, 2013, NEUROIMAGE, V70, P410, DOI 10.1016/j.neuroimage.2012.12.051; Halgren E, 2011, HUM BRAIN MAPP, V32, P1260, DOI 10.1002/hbm.21106; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Irimia A, 2013, CLIN NEUROPHYSIOLOGY; Irimia A, 2012, NEUROIMAGE, V59, P2464, DOI 10.1016/j.neuroimage.2011.08.104; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; Kikinis R, 2011, IEEE ENG MED BIO, P6982, DOI 10.1109/IEMBS.2011.6091765; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; McDonald CR, 2009, EPILEPSIA, V50, P2256, DOI 10.1111/j.1528-1167.2009.02172.x; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Ramon C, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-55; Rosenthal ES, 2012, NEUROTHERAPEUTICS, V9, P24, DOI 10.1007/s13311-011-0101-x; Shiraishi H, 2005, EPILEPSIA, V46, P1264, DOI 10.1111/j.1528-1167.2005.65504.x; Steinbaugh LA, 2012, EPILEPSY BEHAV, V23, P280, DOI 10.1016/j.yebeh.2011.12.005; Tanaka N, 2009, EPILEPSY RES, V85, P279, DOI 10.1016/j.eplepsyres.2009.03.023; Vatta F, 2002, J CLIN NEUROPHYSIOL, V19, P1, DOI 10.1097/00004691-200201000-00001; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2009, STROKE, V40, P1547, DOI 10.1161/STROKEAHA.108.542803; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Zumer JM, 2007, NEUROIMAGE, V37, P102, DOI 10.1016/j.neuroimage.2007.04.054	52	14	15	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2159	2165		10.1016/j.clineuro.2013.08.003			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200041	24011495	Green Accepted			2021-06-18	
J	Stamataki, E; Stathopoulos, A; Garini, E; Kokkoris, S; Glynos, C; Psachoulia, C; Pantziou, H; Nanas, S; Routsi, C				Stamataki, Elisavet; Stathopoulos, Anastasios; Garini, Eleanna; Kokkoris, Stelios; Glynos, Constantinos; Psachoulia, Christina; Pantziou, Harikleia; Nanas, Serafeim; Routsi, Christina			SERUM S100B PROTEIN IS INCREASED AND CORRELATES WITH INTERLEUKIN 6, HYPOPERFUSION INDICES, AND OUTCOME IN PATIENTS ADMITTED FOR SURGICAL CONTROL OF HEMORRHAGE	SHOCK			English	Article						Hemorrhagic shock; inflammation; S100B protein; interleukin 6; lactate; brain damage; control of bleeding	NEURON-SPECIFIC ENOLASE; CARDIAC-SURGERY; TRAUMA PATIENTS; BRAIN-INJURY; CYTOKINE; SHOCK; BLOOD; RESUSCITATION; ISCHEMIA; PATTERNS	S100B protein, an acknowledged biomarker of brain injury, has been reported to be increased in hemorrhagic shock. Also, acute hemorrhage is associated with inflammatory response. The aim of this study was to investigate the concentrations of serum S100B and the potential relationships with interleukin 6 (IL-6), severity of tissue hypoperfusion, and prognosis in patients admitted for surgical control of severe hemorrhage. Patients undergoing elective abdominal aortic aneurysm surgery participated as control subjects. Serum samples were drawn before, at the end of surgery, and after 6 and 24 h. Sixty-four patients with severe hemorrhage (23 trauma and 41 nontrauma) and 17 control subjects were included. Increased preoperative concentrations of S100B protein (1.70 +/- 2.13 and 0.81 +/- 1.23 mu g/L) and IL-6 (241 +/- 291 and 226 +/- 238 pg/mL) were found in patients with traumatic and nontraumatic reason, respectively, and remained elevated throughout 24 h. Compared with nontrauma, trauma patients exhibited higher preoperative S100B levels (P < 0.05). Overall mortality was 47%. In control subjects, preoperative S100B and IL-6 levels were within normal limits and increased at the end of surgery (P < 0.001 and P < 0.01, respectively). Preoperative S100B correlated with IL-6 (r = 0.78, P < 0.01), arterial lactate (r = 0.50, P < 0.01), pH (r = -0.45, P < 0.01), and bicarbonate (r = -0.40, P < 0.01). Multiple analysis revealed that preoperative S100B in trauma and lactate in nontrauma patients were independently associated with outcome. In predicting death, preoperative S100B yielded receiver operator characteristics curve areas of 0.75 for all patients and 0.86 for those with trauma. These results indicate that severe hemorrhage in patients without brain injury is associated with increased serum levels of S100B, which correlates with IL-6 and tissue hypoperfusion. Moreover, the predictive ability of S100B for mortality, suggests that it could be a marker of potential clinical value in identifying, among patients with severe hemorrhage, those at greater risk for adverse outcome.	[Stamataki, Elisavet; Stathopoulos, Anastasios; Garini, Eleanna] Univ Athens, Sch Med, Dept Anesthesiol, Athens 10676, Greece; [Stathopoulos, Anastasios; Kokkoris, Stelios; Glynos, Constantinos; Nanas, Serafeim; Routsi, Christina] Univ Athens, Sch Med, Dept Crit Care 1, Athens 10676, Greece; [Psachoulia, Christina; Pantziou, Harikleia] Evangelismos Med Ctr, Biochem Lab, Athens, Greece	Routsi, C (corresponding author), Univ Athens, Sch Med, Evangelismos Hosp, Crit Care Dept, 45-47 Ipsilantou Str, Athens 10676, Greece.	chroutsi@hotmail.com		Nanas, Serafim/0000-0003-4666-4550			Anderson RE, 2003, J CARDIOTHOR VASC AN, V17, P598, DOI 10.1016/S1053-0770(03)00203-9; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Ashraf S, 1999, EUR J CARDIO-THORAC, V16, P32, DOI 10.1016/S1010-7940(99)00136-0; Beer C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-71; Brin T, 2011, SHOCK, V36, P356, DOI 10.1097/SHK.0b013e31822bd07d; Cai BL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/642462; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; CHEN RYZ, 1984, STROKE, V15, P343, DOI 10.1161/01.STR.15.2.343; CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Guerra MC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-128; Herrmann M, 2001, NEUROSURGERY, V49, P1272, DOI 10.1097/00006123-200111000-00058; Hu YY, 2010, SHOCK, V33, P134, DOI 10.1097/SHK.0b013e3181ad5c88; Johnsson P, 2003, ANN THORAC SURG, V75, P162, DOI 10.1016/S0003-4975(02)04318-7; Lee CC, 2007, ANN EMERG MED, V49, P37, DOI 10.1016/j.annemergmed.2006.05.031; Li YK, 2000, J NEUROCHEM, V74, P143; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; McDonagh DL, 2010, ANESTHESIOLOGY, V112, P852, DOI 10.1097/ALN.0b013e3181d31fd7; Meybohm P, 2008, RESUSCITATION, V76, P449, DOI 10.1016/j.resuscitation.2007.09.002; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Molina PE, 2001, NEUROIMMUNOMODULAT, V9, P125, DOI 10.1159/000049016; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Pelinka LE, 2003, SHOCK, V19, P422, DOI 10.1097/01.shk.0000055345.58165.52; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Rasmussen LS, 2000, BRIT J ANAESTH, V84, P242; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Welborn MB, 2000, CRIT CARE MED, V28, P3191, DOI 10.1097/00003246-200009000-00013; Zhao PC, 2012, CLIN LAB, V58, P1051, DOI 10.7754/Clin.Lab.2011.111004	35	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	OCT	2013	40	4					274	280		10.1097/SHK.0b013e3182a35de5			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	297HK	WOS:000330246300004	23856918				2021-06-18	
J	Bendinelli, C; Bivard, A; Nebauer, S; Parsons, MW; Balogh, ZJ				Bendinelli, Cino; Bivard, Andrew; Nebauer, Shane; Parsons, Mark W.; Balogh, Zsolt J.			Brain CT perfusion provides additional useful information in severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain CT perfusion (CTP); Severe traumatic brain injury (STBI); Post-traumatic stroke	SEVERE HEAD TRAUMA; BLOOD-FLOW	Background: The role of brain CT perfusion (CTP) imaging in severe traumatic brain injury (STBI) is unclear. We hypothesised that in STBI early CTP may provide additional information beyond the non contrast CT (NCCT). Methods: Subset analysis of an ongoing prospective observational study on trauma patients with STBI who did not require craniectomy and deteriorated or failed to improve neurologically during the first 48 h from trauma. Subsequently to follow-up NCCT, a CTP was obtained. Additional findings were defined as an area of altered perfusion on CTP larger than the abnormal area detected by the simultaneous NCCT. Patients who had additional finding (A-CTP) were compared with patients who did not have additional findings (NA-CTP). Results: Study population was 30 patients [male: 90%, mean age: 38.6 (SD 16.9), blunt trauma: 100%; prehospital intubation: 6 (20%); lowest GCS before intubation: 5.1 (SD 2.0); mean ISS: 30.5 (SD 8.3); mean head and neck AIS: 4.4 (SD 0.8). Days in ICU: 10.2 (SD 6.3). Intracranial pressure (ICP) monitored in 12 (40%). Mean highest ICP in mmHg: 30.1 (SD14.1). There were five (17%) deaths. Findings of NCCT: primarily diffuse axonal injury (DAI) pattern in seven (23%), primarily haematoma in ten (33%), and primarily intracerebral contusion in nine (30%). CTP was performed 24.9 (SD 13) hours from trauma. There were 18 (60%) patients in the A-CTP group and 12 (40.0%) in NA-CTP. The A-CTP group was older (41.7 (SD16.9) vs 27.7 (SD 12.8): P < 0.02) and showed on admission NCCT presence of cerebral contusion and absence of DAI. The degree of hypoperfusion was found to be severe enough to be in the ischaemic range in eight patients (27%). CTP altered clinical management in three patients (10%), who were diagnosed with massive and unsurvivable strokes despite minimal changes on NCCT. Conclusion: When compared to NCCT, CTP provided additional diagnostic information in 60% of patients with STBI. CTP altered clinical management in 10% of patients. (C) 2013 Elsevier Ltd. All rights reserved.	[Bendinelli, Cino; Balogh, Zsolt J.] Dept Traumatol, Newcastle, NSW, Australia; [Bivard, Andrew; Parsons, Mark W.] Dept Neurol, Newcastle, NSW, Australia; [Bendinelli, Cino; Bivard, Andrew; Parsons, Mark W.; Balogh, Zsolt J.] John Hunter Hosp, Newcastle, NSW 2300, Australia; [Nebauer, Shane; Parsons, Mark W.; Balogh, Zsolt J.] Univ Newcastle, Newcastle, NSW 2300, Australia	Balogh, ZJ (corresponding author), John Hunter Hosp, Dept Traumatol, Newcastle, NSW 2300, Australia.	Cino.bendinelli@hnehealth.nsw.gov.au; Andrew.bivard@unimelb.edu.au; Shane.nebauer@uon.edu.au; Mark.parson@hnehealth.nsw.gov.au; zsolt.balogh@hnehealth.nsw.gov.au	Balogh, Zsolt J/A-2002-2010; Parsons, Mark W./G-3750-2014	Balogh, Zsolt J/0000-0002-0277-4822; 			[Anonymous], 2012, GRAPHPAD ONL SOFTW; Bivard A, 2011, BRAIN, V134, P3408, DOI 10.1093/brain/awr257; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Horn P, 2001, AM J NEURORADIOL, V22, P1543; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Parsons MW, 2007, NEUROLOGY, V68, P730, DOI 10.1212/01.wnl.0000256366.86353.ff; Parsons MW, 2008, INT J STROKE, V3, P41, DOI 10.1111/j.1747-4949.2008.00175.x; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; von Oettingen G, 2000, NEURORADIOLOGY, V42, P168, DOI 10.1007/s002340050039; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824	18	14	16	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1208	1212		10.1016/j.injury.2013.03.039			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600013	23642628				2021-06-18	
J	Borich, MR; Cheung, KL; Jones, P; Khramova, V; Gavrailoff, L; Boyd, LA; Virji-Babul, N				Borich, Michael R.; Cheung, Katharine L.; Jones, Paul; Khramova, Vera; Gavrailoff, Lauren; Boyd, Lara A.; Virji-Babul, Naznin			Concussion: Current Concepts in Diagnosis and Management	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						clinical outcomes; exercise; mild traumatic brain injury; neuroimaging; rehabilitation	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HEAD-INJURY; HIGH-SCHOOL; STANDARDIZED ASSESSMENT; UP-REGULATION; RISK-FACTORS; EPIDEMIOLOGY; EXERCISE; RECOVERY	Current understanding of the term "concussion" is fraught with misconceptions regarding the extent and nature of brain injury. Despite increasing attention in popular media and within the context of sports, considerable gaps exist in our knowledge of the diagnosis, underlying brain pathology, recovery of function, and optimal interventions for concussion. In this special interest article, we discuss the definition and risk factors associated with concussion, summarize and highlight some of the most widely used assessment tools, and critique the evidence for current principles of concussion management. Our evaluation has identified opportunities for novel neuroimaging techniques to improve the understanding of the pathophysiology of concussion and to evaluate the changes in the recovering brain in response to rehabilitation. In summary, a clear definition of the underlying brain pathology, the potential long-term consequences, and the risk factors of injury and recovery will help guide future research aiming to minimize the impact of injury and develop innovative and successful therapeutic approaches aimed at ameliorating the functional impairments associated with concussion. Video Abstract available (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A51) for more insights from the authors.	[Borich, Michael R.; Boyd, Lara A.; Virji-Babul, Naznin] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V6T 1Z3, Canada; [Cheung, Katharine L.; Jones, Paul; Gavrailoff, Lauren; Boyd, Lara A.] Univ British Columbia, Grad Program Neurosci, Vancouver, BC V6T 1Z3, Canada; [Khramova, Vera; Virji-Babul, Naznin] Child & Family Res Inst, Vancouver, BC, Canada	Virji-Babul, N (corresponding author), Univ British Columbia, Dept Phys Therapy, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	naznin.virji-babul@ubc.ca	Meijer, Anna/K-5118-2016; Borich, Michael Robert/E-1683-2011	Borich, Michael Robert/0000-0002-0469-6282; Virji-Babul, Naznin/0000-0002-8984-5848			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Almasi Stephen J, 2012, WMJ, V111, P21; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, BRIT J SPORT MED, V41, P370, DOI 10.1136/bjsm.2006.032334; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; GEVINS A, 1995, TRENDS NEUROSCI, V18, P429, DOI 10.1016/0166-2236(95)94489-R; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Koscs M, 2009, ATHL TRAIN SPORTS HL, V1, P24; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lovell MR, 2000, IMPACT IMMEDIATE P S; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2000, STANDARDIZED ASSES S; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, P1; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; McLeod TCV, 2011, J SPORT REHABIL, V20, P46, DOI 10.1123/jsr.20.1.46; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NAATANEN R, 1994, TRENDS NEUROSCI, V17, P389, DOI 10.1016/0166-2236(94)90048-5; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Silverberg ND, 2012, J HEAD TRAUMA REHA S, P1; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005	75	14	14	0	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	SEP	2013	37	3					133	139		10.1097/NPT.0b013e31829f7460			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	299FF	WOS:000330380500007	23872682				2021-06-18	
J	Khaksari, M; Keshavarzi, Z; Gholamhoseinian, A; Bibak, B				Khaksari, Mohammad; Keshavarzi, Zakieh; Gholamhoseinian, Ahmad; Bibak, Bahram			The effect of female sexual hormones on the intestinal and serum cytokine response after traumatic brain injury: different roles for estrogen receptor subtypes	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						proinflammatory cytokines; gut; brain injury; estrogen receptors	NF-KAPPA-B; GASTRIC-ACID; INFLAMMATORY CYTOKINES; STEROID-HORMONES; BARRIER FUNCTION; DOWN-REGULATION; UP-REGULATION; NITRIC-OXIDE; TNF-ALPHA; PROGESTERONE	The purpose of this study was to evaluate the effect of female sexual hormones on intestinal and serum cytokines following traumatic brain injury (TBI). Adult female rats were ovariectomized and distributed among the following 9 groups: (i) sham trauma, (ii) TBI (Marmarou's method), (iii) vehicle (dimethylsulfoxide) treated, (iv) estrogen (E2) treated, (v) progesterone (P) treated, (vi) treated with E2+P, (vii) propylpyrazole triol (PPT) treated, (viii) diarylpropionitrile (DPN) treated, and (ix) control. PPT and DPN are estrogen receptor alpha and beta agonists, respectively. Serum and intestinal levels of interleukin (IL)-1 beta were increased by TBI (P < 0.001). The level of intestinal IL-1 beta was increased in the group treated with E2 (P < 0.001). There was a reduction in serum IL-1 beta (P < 0.01) and an increase in intestinal IL-1 beta level (P < 0.001) in the PPT-treated group compared with the vehicle-treated group. TBI reduced serum IL-6 (P < 0.01) and increased intestinal IL-6 (P < 0.001). Serum IL-6 was increased in the group treated with E2 (P < 0.001), P (P < 0.001), E2+P (P < 0.01), and DPN (P < 0.001) after TBI; however, intestinal IL-6 was higher in the E2-treated group compared with the vehicle-treated group (P < 0.01). Intestinal tumor necrosis factor alpha (TNF-alpha) was increased by TBI (P < 0.001). Progesterone decreased serum TNF-alpha (P < 0.01). Intestinal TNF-alpha in the E2 (P < 0.01), E2+P (P < 0.001), and PPT (P < 0.001) treatment groups was less than in the vehicle-treated group. In conclusion, estrogen influences the intestinal levels of proinflammatory cytokines, in particular TNF-alpha, mediated through estrogen receptor alpha	[Khaksari, Mohammad] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman 76175113, Iran; [Keshavarzi, Zakieh] Kerman Univ Med Sci, Physiol Res Ctr, Kerman 76175113, Iran; [Gholamhoseinian, Ahmad] Kerman Univ Med Sci, Fac Med, Kerman 76175113, Iran; [Bibak, Bahram] Bojnurd Univ Med Sci, Bojnurd, Iran	Keshavarzi, Z (corresponding author), Kerman Univ Med Sci, Physiol Res Ctr, Kerman 76175113, Iran.	zakieh_keshavarzi@yahoo.com	Haddad, Mohammad Khaksari/AAB-9025-2019; Najar, Ahmad Gholamhoseinian/AAD-1367-2021; Keshavarzi, Zakieh/ABG-4268-2020	Haddad, Mohammad Khaksari/0000-0003-0770-4281; Najar, Ahmad Gholamhoseinian/0000-0003-3550-6290; 			ARJANDI BH, 1993, BONE MINER, V21, P63; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI 10.1089/neu.2008-0858; BARTON BE, 1993, INFECT IMMUN, V61, P1496, DOI 10.1128/IAI.61.4.1496-1499.1993; Brzozowski T, 2000, EUR J PHARMACOL, V398, P147, DOI 10.1016/S0014-2999(00)00287-9; Castillo L, 1999, REV MED CHILE, V127, P639; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Chen JG, 2008, AM J PHYSIOL-GASTR L, V295, pG1131, DOI 10.1152/ajpgi.90443.2008; Colucci M, 2008, PHARMACOL RES, V57, P419, DOI 10.1016/j.phrs.2008.04.004; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Deitch EA, 2008, SHOCK, V29, P78, DOI 10.1097/shk.0b013e318063e98a; Doucet D., 2010, PLOS ONE, V5, pe9422, DOI [10.1371/journal.pone.0009421, DOI 10.1371/J0URNAL.P0NE.0009421.PMID:20195535]; FRANKS AK, 1991, INFECT IMMUN, V59, P2609, DOI 10.1128/IAI.59.8.2609-2614.1991; FURNER SE, 1989, CANCER RES, V49, P4936; GIROUD M, 1991, INT J EPIDEMIOL, V20, P892, DOI 10.1093/ije/20.4.892; Gunel O, 2003, INFLAMMATION, V27, P351; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Harnish DC, 2006, CURR OPIN INVESTIG D, V7, P997; Hildebrand F, 2005, UNFALLCHIRURG, V108, P793, DOI 10.1007/s00113-005-1005-1; HOGABOAM CM, 1993, J IMMUNOL, V151, P3767; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Kawano N, 2004, HISTOCHEM CELL BIOL, V121, P399, DOI 10.1007/s00418-004-0644-6; Keck C, 1998, EXP CLIN ENDOCR DIAB, V106, P334, DOI 10.1055/s-0029-1211994; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI 10.1139/y10-103; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; Lan L, 1999, MOL CELL ENDOCRINOL, V155, P123, DOI 10.1016/S0303-7207(99)00066-0; Laurer HL, 2000, EUR J TRAUMA, V26, P95, DOI DOI 10.1007/S000680050007; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Malisorn N, 2010, AFR J PHARM PHARMACO, V4, P806; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin GR, 2006, EXP BIOL MED, V231, P130; Mazzon E, 2006, SHOCK, V25, P515, DOI 10.1097/01.shk.0000209556.31457.e7; Mizushima Y, 2000, ANN SURG, V232, P673, DOI 10.1097/00000658-200011000-00009; OLSON ME, 1986, CAN VET J, V27, P523; PALMER RMJ, 1993, BIOCHEM BIOPH RES CO, V193, P398, DOI 10.1006/bbrc.1993.1637; Partrick DA, 1997, J TRAUMA, V43, P297, DOI 10.1097/00005373-199708000-00015; Picotto G, 1999, BIOCHEM J, V339, P71, DOI 10.1042/0264-6021:3390071; Pioli PA, 2007, J IMMUNOL, V179, P6284, DOI 10.4049/jimmunol.179.9.6284; Playford RJ, 2005, J PATHOL, V205, P417, DOI 10.1002/path.1722; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; SAPERAS ES, 1990, GASTROENTEROLOGY, V99, P1599, DOI 10.1016/0016-5085(90)90463-B; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; SEKUT L, 1995, CLIN EXP IMMUNOL, V99, P461; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SHIBASAKI T, 1991, LIFE SCI, V48, P2267, DOI 10.1016/0024-3205(91)90342-9; Smith A, 2008, ENDOCRINOLOGY, V149, P4554, DOI 10.1210/en.2007-1597; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; Stice JP, 2008, MOL MED, V14, P517, DOI 10.2119/2008-00026.Stice; Telleria CM, 1998, ENDOCRINOLOGY, V139, P3597, DOI 10.1210/en.139.8.3597; THOMAS ML, 1993, ENDOCRINOLOGY, V132, P426, DOI 10.1210/en.132.1.426; UEHARA A, 1989, BIOCHEM BIOPH RES CO, V162, P1578, DOI 10.1016/0006-291X(89)90855-3; Vural P, 2006, PHARMACOL RES, V54, P298, DOI 10.1016/j.phrs.2006.06.006; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559; WALLACE JL, 1992, GASTROENTEROLOGY, V102, P1176; WALLACE JL, 1990, EUR J PHARMACOL, V186, P279, DOI 10.1016/0014-2999(90)90444-B; Won CK, 2006, J VET MED SCI, V68, P277, DOI 10.1292/jvms.68.277; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; WU KK, 1991, P NATL ACAD SCI USA, V88, P2384, DOI 10.1073/pnas.88.6.2384; Yang Xia, 2006, Shengli Xuebao, V58, P275; Yu HP, 2007, J LEUKOCYTE BIOL, V82, P774, DOI 10.1189/jlb.0307182; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596	68	14	14	0	11	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4212	1205-7541		CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	SEP	2013	91	9					700	707		10.1139/cjpp-2012-0359			8	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	208VS	WOS:000323710300007	23984641				2021-06-18	
J	Kiehna, EN; Huffmyer, JL; Thiele, RH; Scalzo, DC; Nemergut, EC				Kiehna, Erin N.; Huffmyer, Julie L.; Thiele, Robert H.; Scalzo, David C.; Nemergut, Edward C.			Use of the intrathoracic pressure regulator to lower intracranial pressure in patients with altered intracranial elastance: a pilot study Clinical article	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; intracranial hypertension; intrathoracic pressure regulator	ORGAN PERFUSION PRESSURES; PORCINE MODEL	Object. The intrathoracic pressure regulator (ITPR) is a novel noninvasive device designed to increase circulation and blood pressure. By applying negative pressure during the expiratory phase of ventilation it decreases intrathoracic pressure and enhances venous return, which increases cardiac output. It is possible that the ITPR may both decrease intracranial pressure (ICP) and increase cerebral perfusion pressure (CPP) in brain-injured patients by decreasing cerebral venous blood volume and increasing cardiac output. The authors conducted an open-label, "first-in-humans" study of the ITPR in patients with an ICP monitor or external ventricular drain and altered intracranial elastance. Methods. This prospective randomized trial commenced July 2009. Baseline hemodynamic variables and ICP were recorded prior to inserting one of the two ITPRs into the ventilator circuit based on a randomization scheme. Depending on the device selected, activation provided either -5 or -9 mm Hg endotracheal tube pressure. Hemodynamic and ICP data were recorded sequentially every 2 minutes for 10 minutes. The first device was turned off for 10 minutes, then it was removed and the second device was applied, and then the procedure was repeated for the second device. Results. Ten patients with elevated ICP secondary to intracranial hemorrhage (n = 4), trauma (n = 2), obstructive hydrocephalus (n = 2), or diffuse cerebral processes (n = 2) were enrolled. Baseline ICP ranged from 12 to 38 mm Hg. With device application, a decrease in ICP was observed in 16 of 20 applications. During treatment with the 5 mm Hg device, there was a mean maximal decrease of 3.3 mm Hg in ICP (21.7 vs 18.4 mm Hg, p = 0.003), which was associated with an increase in CPP of 6.5 mm Hg (58.2 vs 64.7 mm Hg, p = 0.019). During treatment with the 9 mm Hg device, there was a mean maximal decrease of 2.4 mm Hg in ICP (21.1 vs 18.7 mm Hg, p = 0.044), which was associated with an increase in CPP of 6.5 mm Hg (59.2 vs 65.7 mm Hg, p = 0.001). Conclusions. This pilot study demonstrates that use of the ITPR in patients with altered intracranial elastance is feasible. Although this study was not powered to demonstrate efficacy, these data strongly suggest that the ITPR may be used to rapidly lower ICP and increase CPP without apparent adverse effects. Additional studies will be needed to assess longitudinal changes in ICP when the device is in use and to delineate treatment parameters.	[Kiehna, Erin N.] Hosp Sick Children, Dept Neurosurg, Toronto, ON M5G 1X8, Canada; [Huffmyer, Julie L.; Thiele, Robert H.; Scalzo, David C.; Nemergut, Edward C.] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA 22908 USA	Nemergut, EC (corresponding author), Univ Virginia Hlth Syst, Dept Anesthesiol, POB 800710, Charlottesville, VA 22908 USA.	en3x@virginia.edu		Kiehna, Erin/0000-0002-2289-3917; Thiele, Robert/0000-0001-7262-0653			Brain Trauma F, 2008, J NEUROTRAUM, V25, P276; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Huffmyer JL, 2011, SHOCK, V35, P114, DOI 10.1097/SHK.0b013e3181f7d92b; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Yannopoulos D, 2005, CIRCULATION, V112, P803, DOI 10.1161/CIRCULATIONAHA.105.541508; Yannopoulos D, 2006, CRIT CARE MED, V34, pS495, DOI 10.1097/01.CCM.0000246082.10422.7E; Yannopoulos D, 2006, RESUSCITATION, V70, P445, DOI 10.1016/j.resuscitation.2006.02.005; Yannopoulos D, 2007, ANESTH ANALG, V104, P157, DOI 10.1213/01.ane.0000249047.80184.5a	9	14	15	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2013	119	3					756	759		10.3171/2013.4.JNS122489			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	204IJ	WOS:000323358700027	23706051				2021-06-18	
J	Takayanagi, Y; Gerner, G; Takayanagi, M; Rao, V; Vannorsdall, TD; Sawa, A; Schretlen, DJ; Cascella, NG				Takayanagi, Yoichiro; Gerner, Gwendoly; Takayanagi, Mizuho; Rao, Vani; Vannorsdall, Tracy D.; Sawa, Akira; Schretlen, David J.; Cascella, Nicola G.			Hippocampal Volume Reduction Correlates With Apathy in Traumatic Brain Injury, But Not Schizophrenia	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							NEGATIVE-SYMPTOMS; TEMPORAL-LOBE; WHITE-MATTER; HEAD-INJURY; DEFICIT SCHIZOPHRENIA; ATROPHY; ABNORMALITIES; DISEASE; REGIONS; STROKE	Apathy commonly accompanies both traumatic brain injury (TBI) and deficit syndrome schizophrenia (DSZ), despite unclear neurological bases. The authors examined differences in cortical thickness and subcortical/cerebellar regional volumes between adult TBI survivors, patients with DSZ, and healthy-control subjects by use of 3-D magnetic resonance imaging (MRI), and correlated imaging findings with clinical ratings of apathy and selected cognitive test scores. Imaging findings revealed specific areas of volume reduction in TBI survivors and areas of cortical thinning among patients with DSZ. The severity of apathy symptoms was similar across patient groups; however, severity of apathy was only correlated with imaging findings in TBI survivors.	[Cascella, Nicola G.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Cascella, NG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA.	dschret@jhmi.edu; ncascel1@gmail.com			NARSADNARSAD; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH060504, R01 MH077852, P50 MH094268, R01 MH078175, R33 MH079017]; Stanley Foundation; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH094268, R01MH078175, R33MH079017, R01MH077852, R01MH060504] Funding Source: NIH RePORTER	This study was supported by a NARSAD Young Investigator Award (to Dr. Cascella) and NIH grants R01 MH060504 and R01 MH077852 (to Dr. Schretlen); P50 MH094268 (to Dr. Sawa); R01 MH078175 and R33 MH079017 (to Dr. Cascella); and a grant from the Stanley Foundation (to Dr. Cascella).	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Arango C, 2004, EUR PSYCHIAT, V19, P21, DOI 10.1016/j.eurpsy.2003.10.004; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578; Cascella NG, 2008, J PSYCHIATR RES, V42, P930, DOI 10.1016/j.jpsychires.2007.10.002; Cascella NG, 2010, SCHIZOPHR RES, V120, P63, DOI 10.1016/j.schres.2010.03.039; Clarke DE, 2011, J PSYCHOSOM RES, V70, P73, DOI 10.1016/j.jpsychores.2010.01.012; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Hampshire A, 2012, NEUROIMAGE, V59, P4102, DOI 10.1016/j.neuroimage.2011.10.072; Jorge RE, 2010, CAN J PSYCHIAT, V55, P350, DOI 10.1177/070674371005500603; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Leeson VC, 2009, BIOL PSYCHIAT, V66, P586, DOI 10.1016/j.biopsych.2009.05.016; LIDDLE PF, 1991, BRIT J PSYCHIAT, V158, P340, DOI 10.1192/bjp.158.3.340; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; MATSUSHITA M, 1981, ACTA NEUROPATHOL, V54, P89, DOI 10.1007/BF00689400; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Rao V, 2007, PSYCHOSOMATICS, V48, P217, DOI 10.1176/appi.psy.48.3.217; Roth RM, 2004, AM J PSYCHIAT, V161, P157, DOI 10.1176/appi.ajp.161.1.157; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Schrag A, 2004, J NEUROL, V251, P795, DOI 10.1007/s00415-004-0483-3; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sigmundsson T, 2001, AM J PSYCHIAT, V158, P234, DOI 10.1176/appi.ajp.158.2.234; STOLAR N, 1994, BIOL PSYCHIAT, V35, P164, DOI 10.1016/0006-3223(94)91148-7; Stuss DT, 2000, NEUROPSYCHOLOGY EMOT; Szabo K, 2009, STROKE, V40, P2042, DOI 10.1161/STROKEAHA.108.536144; Takayanagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021047; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; TURETSKY B, 1995, ARCH GEN PSYCHIAT, V52, P1061; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; WING JK, 1996, SCHEDULES CLIN ASSES	44	14	14	0	6	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2013	25	4					292	301		10.1176/appi.neuropsych.12040093			10	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	286TN	WOS:000329491700037	24247856				2021-06-18	
J	Funderud, I; Lovstad, M; Lindgren, M; Endestad, T; Due-Tonnessen, P; Meling, TR; Knight, RT; Solbakk, AK				Funderud, Ingrid; Lovstad, Marianne; Lindgren, Magnus; Endestad, Tor; Due-Tonnessen, Paulina; Meling, Torstein R.; Knight, Robert T.; Solbakk, Anne-Kristin			Preparatory attention after lesions to the lateral or orbital prefrontal cortex - An event-related potentials study	BRAIN RESEARCH			English	Article						Event-related potentials; Contingent negative variation (CNV); Lateral prefrontal cortex; Orbitofrontal cortex	CONTINGENT NEGATIVE-VARIATION; CLOSED HEAD-INJURY; HUMAN BRAIN; FRONTAL-CORTEX; CNV; PERFORMANCE; COMPONENT; NETWORKS; HUMANS; AREAS	The prefrontal cortex (PFC) plays a central role in preparatory and anticipatory attentional processes. To investigate whether subregions of the PFC play differential roles in these processes we investigated the effect of focal lesions to either lateral prefrontal (lateral PFC; n=11) or orbitofrontal cortex (OFC; n=13) on the contingent negative variation (CNV), an electrophysiological index of preparatory brain processes. The CNV was studied using a Go/NoGo delayed response task where an auditory 51 signaled whether or not an upcoming visual S2 was a Go or a NoGo stimulus. Neither early (500-1000 ms) nor late (3200-3700 ms) phase Go trial CNV amplitude was reduced for any of the patient groups in comparison to controls. However, the lateral PFC group showed enhanced Go trial early CNV and reduced late CNV Go/NoGo differentiation. These data suggests that normal orienting and evaluation as reflected by the CNV is intact after OFC lesions. The enhanced early CNV after lateral PFC damage may be due to failure in inhibition and the reduced late CNV difference wave confirms a deficit in preparatory attention after damage to this frontal subregion. (C) 2013 Elsevier B.V. All rights reserved.	[Funderud, Ingrid; Lindgren, Magnus; Endestad, Tor; Solbakk, Anne-Kristin] Natl Hosp Norway, Oslo Univ Hosp, Dept Psychosomat Med, Div Surg & Clin Neurosci, N-0424 Oslo, Norway; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesodden, Norway; [Lindgren, Magnus] Lund Univ, Dept Psychol, S-22100 Lund, Sweden; [Endestad, Tor] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Due-Tonnessen, Paulina] Natl Hosp Norway, Oslo Univ Hosp, Dept Radiol, N-0424 Oslo, Norway; [Meling, Torstein R.] Natl Hosp Norway, Oslo Univ Hosp, Dept Neurosurg, N-0424 Oslo, Norway; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Funderud, I (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Dept Psychosomat Med, Div Surg & Clin Neurosci, Pb 4950 Nydalen, N-0424 Oslo, Norway.	ifunderu@ous-hf.no	Meling, Torstein/Q-2568-2019	Meling, Torstein/0000-0001-6595-0873; Due-Tonnessen, Paulina/0000-0002-3615-1914; Funderud, Ingrid/0000-0002-4481-7237; Endestad, Tor/0000-0002-4403-6887	Southeastern Norway Regional Health Authority [SUN-001-SS, 2008047]; Research Council of NorwayResearch Council of Norway [186504/V50]; National Institute of Neurological Disorders and Stroke, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21135, PO 40813]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS021135, R37NS021135, P01NS040813, R01NS021135] Funding Source: NIH RePORTER	This research is supported by the Southeastern Norway Regional Health Authority (Grants SUN-001-SS and 2008047), the Research Council of Norway (Grant 186504/V50), and the National Institute of Neurological Disorders and Stroke, USA (NS21135 and PO 40813). The authors would like to thank Bradley Voytek for assistance on ERP analysis and establishment of scripts for analyzing EEG data in Mat lab, and Haakon Engen and Clay Campbell Clayworth for support in establishing routines for lesion reconstructions. This work forms part of a doctoral thesis to be submitted to the Department of Psychology at the University of Oslo.	Barcelo F, 2007, CEREB CORTEX, V17, pI51, DOI 10.1093/cercor/bhm111; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DIPELLEGRINO G, 1991, BRAIN, V114, P951; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Fassbender C, 2006, HUM BRAIN MAPP, V27, P819, DOI 10.1002/hbm.20223; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Flores AB, 2009, BRAIN COGNITION, V71, P129, DOI 10.1016/j.bandc.2009.04.011; Funderud I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048504; GEMBA H, 1990, NEUROSCI LETT, V113, P275, DOI 10.1016/0304-3940(90)90597-3; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hultin L, 1996, ELECTROEN CLIN NEURO, V98, P435, DOI 10.1016/0013-4694(96)95507-8; Ikeda A, 1996, ELECTROEN CLIN NEURO, V98, P206, DOI 10.1016/0013-4694(95)00239-1; IOANNIDES AA, 1994, ELECTROEN CLIN NEURO, V91, P399, DOI 10.1016/0013-4694(94)90125-2; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; KOK A, 1978, BIOL PSYCHOL, V6, P219, DOI 10.1016/0301-0511(78)90024-8; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; LOVELESS NE, 1974, J GERONTOL, V29, P52, DOI 10.1093/geronj/29.1.52; Low M., 1979, PROG CLIN NEUROPHYS, V6, P258; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCCARTHY G, 1978, NEUROPSYCHOLOGIA, V16, P571, DOI 10.1016/0028-3932(78)90085-4; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; PFURTSCHELLER G, 1982, J NEUROL NEUROSUR PS, V45, P1106, DOI 10.1136/jnnp.45.12.1106; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; ROHRBAUGH JW, 1976, SCIENCE, V191, P1055, DOI 10.1126/science.1251217; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; Rosler F, 1997, BIOL PSYCHOL, V45, P109, DOI 10.1016/S0301-0511(96)05225-8; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Voytek B, 2010, J COGNITIVE NEUROSCI, V22, P2491, DOI 10.1162/jocn.2009.21384; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wascher E, 1996, PSYCHOPHYSIOLOGY, V33, P262, DOI 10.1111/j.1469-8986.1996.tb00423.x; Wechsler D., 2011, WECHLSER ABBREVIATED; Weerts T C, 1973, Biol Psychol, V1, P1, DOI 10.1016/0301-0511(73)90010-0; Zappoli R, 2000, INT J PSYCHOPHYSIOL, V38, P109; Zappoli R, 2002, INT J PSYCHOPHYSIOL, V44, P117, DOI 10.1016/S0167-8760(01)00197-0	57	14	15	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 21	2013	1527						174	188		10.1016/j.brainres.2013.06.017			15	Neurosciences	Neurosciences & Neurology	215QM	WOS:000324225400017	23831520	Green Accepted			2021-06-18	
J	Lee, SC; Kang, SW; Kim, MT; Kim, YK; Chang, WH; Im, SH				Lee, Sang Chul; Kang, Seong-Woong; Kim, Min Tae; Kim, Yong Kyun; Chang, Won Hyuk; Im, Sang Hee			Correlation Between Voluntary Cough and Laryngeal Cough Reflex Flows in Patients With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Aspiration; Brain injuries; Cough; Rehabilitation	ASPIRATION FOLLOWING STROKE; DEVELOPING PNEUMONIA; RISK	Objective: To correlate voluntary cough and laryngeal cough reflex (LCR) flows in patients with traumatic brain injury (TBI). Design: Cross-sectional study. Setting: University rehabilitation hospital. Participants: Patients with TBI (n=25) and healthy controls (n=48). Interventions: Not applicable. Main Outcome Measures: Peak cough flows (PCFs) and LCR flows were measured using a peak flow meter at the oral-nasal interface. The largest value of 3 attempts was recorded for PCF and LCR, respectively. LCR was elicited by 20% solution of pharmaceutic-grade citric acid dissolved in sterile .15M NaCl solution that was inhaled from a nebulizer. Results: PCF was 447.4 +/- 99.0L/min in the control group and 211.7 +/- 58.2L/min in the patient group. LCR was 209.2 +/- 63.8L/min in the control group and 170.0 +/- 59.7L/min in the patient group. Both PCF (P=.000) and LCR (P=.013) were significantly reduced in patients with TBI compared to that of the control group. LCR was strongly related to the PCF in both control (R=.645; P=.000) and patient (R=.711; P=.000) groups. Conclusions: As LCR can be measured as a numerical value and significantly correlates with PCF, LCR can be used to estimate cough ability of patients with TBI who cannot cooperate with PCF measurement. (c) 2013 by the American Congress of Rehabilitation Medicine	[Lee, Sang Chul; Kim, Min Tae; Kim, Yong Kyun; Im, Sang Hee] Kwandong Univ, Coll Med, Dept Phys Med & Rehabil, Gyunggi, South Korea; [Kang, Seong-Woong] Yonsei Univ, Coll Med, Rehabil Inst Muscular Dis, Dept Rehabil Med, Seoul, South Korea; [Chang, Won Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Phys & Rehabil Med, Suwon, South Korea	Im, SH (corresponding author), Kwandong Univ, Coll Med, Dept Phys Med & Rehabil, 697-24 Hwajungdong, Goyang, Gyunggi, South Korea.	dongin32@yahoo.com		Im, Sang Hee/0000-0001-5128-5526; Kang, Seong-Woong/0000-0002-7279-3893			Addington W Robert, 2005, Cough, V1, P4, DOI 10.1186/1745-9974-1-4; Addington WR, 1999, ARCH PHYS MED REHAB, V80, P150, DOI 10.1016/S0003-9993(99)90112-0; Addington WR, 1999, STROKE, V30, P1203, DOI 10.1161/01.STR.30.6.1203; Addington WR, 1998, AM J PHYS MED REHAB, V77, P523, DOI 10.1097/00002060-199811000-00014; Bach JR, 1996, CHEST, V110, P1566, DOI 10.1378/chest.110.6.1566; Croghan John E., 1994, Dysphagia, V9, P141, DOI 10.1007/BF00341256; Daniels SK, 1999, J NEUROIMAGING, V9, P91, DOI 10.1111/jon19999291; Hammond CAS, 2001, NEUROLOGY, V56, P502, DOI 10.1212/WNL.56.4.502; HORNER J, 1988, NEUROLOGY, V38, P317, DOI 10.1212/WNL.38.2.317; JOHNSON ER, 1993, ARCH PHYS MED REHAB, V74, P973; Nakajoh K, 2000, J INTERN MED, V247, P39, DOI 10.1046/j.1365-2796.2000.00565.x; Smithard DG, 1997, CLIN REHABIL, V11, P73, DOI 10.1177/026921559701100111; Wagner A, 2011, PHYS MED REHABILITAT, P1133; Ward K, 2010, EUR RESPIR J, V36, P1383, DOI 10.1183/09031936.00010510; Wiercisiewski DR, 1998, J HEAD TRAUMA REHAB, V13, P28, DOI 10.1097/00001199-199802000-00006	15	14	14	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2013	94	8					1580	1583		10.1016/j.apmr.2012.11.006			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	196TZ	WOS:000322801600021	23154134				2021-06-18	
J	Majidi, S; Siddiq, F; Qureshi, AI				Majidi, Shahram; Siddiq, Farhan; Qureshi, Adnan I.			Prehospital neurologic deterioration is independent predictor of outcome in traumatic brain injury: analysis from National Trauma Data Bank	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							SEVERE HEAD-INJURY; GLASGOW COMA SCALE; INTRACRANIAL-PRESSURE; CONTROLLED-TRIAL; EMERGENCY CARE; PROGNOSIS; IMPACT; CENTERS; DEXTRAN; SCORES	Background: The prevalence and impact of prehospital neurologic deterioration (PhND) in patients with traumatic brain injury (TBI) have not been investigated. We aimed to determine the prevalence of PhND during emergency medical service (EMS) transportation among patients with TBI and its impact on patient's outcome. Methods: We used the National Trauma Data Bank, using data files from 2009 to 2010 to identify patients with TBI through International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. The initial Glasgow Coma Scale (GCS) score ascertained at the scene by EMS was compared with the subsequent GCS score evaluation in the emergency department (ED) to identify neurologic deterioration (defined as a decrease in GCS of >= 2 points). Patients' demographics, initial injury severity score (ISS), admission GCS score, and hospital outcome were compared between patients with PhND and patients without neurologic deterioration. Results: A total of 257 127 patients with TBI were identified. Among patients with TBI, 22 254 patients had PhND, which comprised 9% of all patients with TBI. The mean of GCS score decrease during EMS transport was 5 points (+/- 3). Patients without PhND tended to have higher GCS recorded by EMS (median, 15 vs 12; P < .0001). Patients with TBI who had PhND had significantly higher hospital length of stay and intensive care unit days after adjusting for baseline characteristics and EMS GCS score, EMS transport time, type of injury, presence of intracranial hemorrhages, and ED ISS (P < .0001). These patients had higher rate of in-hospital mortality after adjusting for the same variables (odds ratio, 2.30; 95% confidence interval, 2.18-2.41). Conclusion: Prehospital neurologic deterioration occurs in 9% of patients with TBI. It is more prevalent in men and associated with lower EMS GCS level and higher ED ISS. Prehospital neurologic deterioration is an independent predictor of worse hospital outcome and higher resource use in patients with TBI. (C) 2013 Elsevier Inc. All rights reserved.	[Majidi, Shahram; Siddiq, Farhan; Qureshi, Adnan I.] Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA; [Siddiq, Farhan; Qureshi, Adnan I.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA	Majidi, S (corresponding author), Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA.	drsmajidi@gmail.com		Qureshi, Adnan/0000-0003-4962-540X	National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS062091-01A2]; American Heart AssociationAmerican Heart Association [0840053N]	Dr Adnan I. Qureshi is supported by the National Institute of Neurological Diseases and Stroke (principal investigator: Antihypertensive Treatment in Acute Cerebral Hemorrhage II), 1R01NS062091-01A2 (medication provided by Cornerstone Therapeutics Inc.), and American Heart Association Established Investigator Award 0840053N, Innovative Strategies for Treating Cerebral Hemorrhage.	Alkhoury F, 2011, AM SURGEON, V77, P277; Arbabi S, 2004, J TRAUMA, V56, P1029, DOI 10.1097/01.TA.0000123036.20919.4B; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Bazarian JJ, 2003, BRAIN INJURY, V17, P553, DOI 10.1080/0269905031000070260; Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Defazio MV, 2013, WORLD NEUROSURGERY; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; Inhospital Severe TBI Guidelines, 2007, INHOSPITAL SEVERE TB; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Lane PL, 2000, CAN J SURG, V43, P442; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Moon JS, 2008, CRIT CARE MED, V36, P172, DOI 10.1097/01.CCM.0000297876.62464.6B; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Salazar AM, 2002, J NEUROL NEUROSUR PS, V73, P239, DOI 10.1136/jnnp.73.3.239; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Souayah N, 2012, J NEUROTRAUMA; Traumatic Brain Injury In The United States, 2010, TRAUMATIC BRAIN INJU; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; WINKLER J V, 1984, Journal of Emergency Medicine, V2, P1, DOI 10.1016/0736-4679(84)90038-6	37	14	16	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	AUG	2013	31	8					1215	1219		10.1016/j.ajem.2013.05.026			5	Emergency Medicine	Emergency Medicine	201SN	WOS:000323163400011	23809095				2021-06-18	
J	Rienstra, A; Twennaar, MK; Schmand, B				Rienstra, Anne; Twennaar, Michelle Klein; Schmand, Ben			Neuropsychological Characterization of Patients with the WMT Dementia Profile	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity; Effort testing; Word Memory Test; Cognitive impairment; Classification accuracy	SYMPTOM VALIDITY TEST; TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; TEST-PERFORMANCE; HIGH SPECIFICITY; TESTS; VETERANS	The "dementia profile" is used to reduce false positives on the Word Memory Test (WMT). Provided that this profile reflects genuine memory impairment, corresponding cognitive deficits should be found in neuropsychological testing. We examined whether a WMT dementia profile is a significant indicator of cognitive impairment and/or decline. In addition, we evaluated the classification accuracy for the clinical diagnosis of dementia. Elderly patients (n = 167) with cognitive complaints were given an extensive neuropsychological test battery, including the WMT. This was repeated 2 years later. The results demonstrate that patients with the dementia profile have a higher chance of showing real cognitive impairment at baseline, and even more so 2 years later. They showed a faster cognitive decline than patients who passed the WMT effort subtasks. Sensitivity of the profile was a moderate 60%. However, the positive predictive value was high, viz. 81% at baseline and 93% at follow-up.	[Rienstra, Anne; Twennaar, Michelle Klein; Schmand, Ben] Univ Amsterdam, Dept Brain & Cognit, NL-1018 XA Amsterdam, Netherlands; [Rienstra, Anne; Twennaar, Michelle Klein; Schmand, Ben] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	Rienstra, A (corresponding author), Univ Amsterdam, Dept Brain & Cognit, Weesperpl 4, NL-1018 XA Amsterdam, Netherlands.	a.rienstra@uva.nl			Psychology Research Institute of the University of Amsterdam; Department of Neurology of the Academic Medical Center of the University of Amsterdam; Department of Radiology of the Academic Medical Center of the University of Amsterdam; Graduate School of Neurosciences Amsterdam-Rotterdam	This study was financed by the Psychology Research Institute of the University of Amsterdam, the Departments of Neurology and Radiology of the Academic Medical Center of the University of Amsterdam, and the Graduate School of Neurosciences Amsterdam-Rotterdam.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Benton AL, 1983, MULTILINGUAL APHASIA; Bickart W. T., 1991, AM J FORENSIC PSYCH, V9, P3; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P., 2003, GREENS WORD MEMORY T; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97, DOI DOI 10.1300/J151V02N03_05; Green P., 2004, MANUAL MED SYMPTOM V; Green P., 1996, WORD MEMORY TEST USE; Green P., 2009, ADV INTERPRETATION P; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Hartman DE, 2002, ARCH CLIN NEUROPSYCH, V17, P709, DOI 10.1016/S0887-6177(01)00172-X; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Iverson G. L., 1999, J COGNITIVE REHABILI, V17, P4; Jolles J, 1995, MAASTRICHT AGING STU; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Lim WS, 2007, CLIN MED RES, V5, P61, DOI 10.3121/cmr.2007.693; Lindeboom J, 2003, VISUAL ASS TEST; Luteijn F., 2004, GRONINGEN INTELLIGEN; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Miller L, 2001, NEUROREHABILITATION, V16, P109; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Reitan R. M., 1992, TRAIL MAKING TEST MA; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Schmand B, 2012, NORMEN PSYCHOL TESTS; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tilvis RS, 2004, J GERONTOL A-BIOL, V59, P268; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO	45	14	15	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2013	28	5					463	475		10.1093/arclin/act026			13	Psychology, Clinical; Psychology	Psychology	186CN	WOS:000322019600008	23644672	Bronze			2021-06-18	
J	Fraisier, C; Camoin, L; Lim, S; Bakli, M; Belghazi, M; Fourquet, P; Granjeaud, S; Osterhaus, ADME; Koraka, P; Martina, B; Almeras, L				Fraisier, Christophe; Camoin, Luc; Lim, Stephanie; Bakli, Mahfoud; Belghazi, Maya; Fourquet, Patrick; Granjeaud, Samuel; Osterhaus, Ab D. M. E.; Koraka, Penelope; Martina, Byron; Almeras, Lionel			Altered Protein Networks and Cellular Pathways in Severe West Nile Disease in Mice	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; TRAUMATIC BRAIN-INJURY; JAPANESE ENCEPHALITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; RNA PROFILING REVEALS; PLASMODIUM-FALCIPARUM; CEREBROSPINAL-FLUID; ARP2/3 COMPLEX; DENGUE-VIRUS; IN-VIVO	Background: The recent West Nile virus (WNV) outbreaks in developed countries, including Europe and the United States, have been associated with significantly higher neuropathology incidence and mortality rate than previously documented. The changing epidemiology, the constant risk of (re-)emergence of more virulent WNV strains, and the lack of effective human antiviral therapy or vaccines makes understanding the pathogenesis of severe disease a priority. Thus, to gain insight into the pathophysiological processes in severe WNV infection, a kinetic analysis of protein expression profiles in the brain of WNV-infected mice was conducted using samples prior to and after the onset of clinical symptoms. Methodology/Principal Findings: To this end, 2D-DIGE and gel-free iTRAQ labeling approaches were combined, followed by protein identification by mass spectrometry. Using these quantitative proteomic approaches, a set of 148 proteins with modified abundance was identified. The bioinformatics analysis (Ingenuity Pathway Analysis) of each protein dataset originating from the different time-point comparisons revealed that four major functions were altered during the course of WNV-infection in mouse brain tissue: i) modification of cytoskeleton maintenance associated with virus circulation; ii) deregulation of the protein ubiquitination pathway; iii) modulation of the inflammatory response; and iv) alteration of neurological development and neuronal cell death. The differential regulation of selected host protein candidates as being representative of these biological processes were validated by western blotting using an original fluorescence-based method. Conclusion/Significance: This study provides novel insights into the in vivo kinetic host reactions against WNV infection and the pathophysiologic processes involved, according to clinical symptoms. This work offers useful clues for anti-viral research and further evaluation of early biomarkers for the diagnosis and prevention of severe neurological disease caused by WNV.	[Fraisier, Christophe; Bakli, Mahfoud; Almeras, Lionel] IRBA, Armed Forces Biomed Res Inst, Inst Rech Biomed Armees, Unite Parasitol,URMITE UM 63, Marseille, France; [Camoin, Luc; Fourquet, Patrick; Granjeaud, Samuel] Aix Marseille Univ, Inserm,CNRS,CRCM, U1068,UMR7258, UM 105, Marseille, France; [Camoin, Luc; Fourquet, Patrick; Granjeaud, Samuel] Inst J Paoli I Calmettes, Marseille Prote, F-13009 Marseille, France; [Lim, Stephanie; Osterhaus, Ab D. M. E.; Koraka, Penelope; Martina, Byron] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Belghazi, Maya] Aix Marseille Univ, CNRS, UMR 7286, Marseille, France; [Almeras, Lionel] Aix Marseille Univ, Fac Med, WHO Collaborat Ctr Rickettsioses & Other Arthropo, URMITE,UM 63,CNRS 7278,IRD 198,Inserm 1095, Marseille, France	Almeras, L (corresponding author), IRBA, Armed Forces Biomed Res Inst, Inst Rech Biomed Armees, Unite Parasitol,URMITE UM 63, Marseille, France.	almeras.lionel@gmail.com	Camoin, Luc/AAB-3856-2019	Camoin, Luc/0000-0002-1230-4787; Granjeaud, Samuel/0000-0001-9245-1535; bakli, mahfoud/0000-0002-1427-2985; ALMERAS, Lionel/0000-0003-0490-5774; Martina, Byron/0000-0003-4980-4619	European CommunityEuropean Commission [261466]; Delegation Generale pour l'Armement (DGA) [ArthroSer 10Ca 401]	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under the project "VECTORIE", EC grant agreement number 261466. This study was also supported by Delegation Generale pour l'Armement (DGA, ArthroSer 10Ca 401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhoot MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034060; Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Almeras L, 2004, PROTEOMICS, V4, P2184, DOI 10.1002/pmic.200300732; Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Auer J, 2010, J PROTEOMICS, V73, P1004, DOI 10.1016/j.jprot.2009.12.014; Beasley DWC, 2001, ANN NY ACAD SCI, V951, P332; Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293; Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Bin H, 2001, ANN NY ACAD SCI, V951, P127; Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430; Boja ES, 2012, PROTEOMICS, V12, P1093, DOI 10.1002/pmic.201100387; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Bourgeois MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024371; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Cepeda V, 2011, CELL MICROBIOL, V13, P846, DOI 10.1111/j.1462-5822.2011.01583.x; Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008; Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004; Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Del Giudice P, 2004, EMERG INFECT DIS, V10, P1885, DOI 10.3201/eid1010.031021; Dhingra V, 2005, J BIOMED BIOTECHNOL, P271, DOI 10.1155/JBB.2005.271; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Feart C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029480; Fontaine A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-276; Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004; Gao G, 2006, CAN J PHYSIOL PHARM, V84, P5, DOI 10.1139/y05-144; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Gnanapavan S, 2010, J NEUROIMMUNOL, V225, P118, DOI 10.1016/j.jneuroim.2010.04.020; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Grummer B, 2004, J VET MED B, V51, P427, DOI 10.1111/j.1439-0450.2004.00798.x; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; He XL, 2010, INT J CLIN EXP PATHO, V3, P156; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hoe HS, 2012, CNS NEUROSCI THER, V18, P47, DOI 10.1111/j.1755-5949.2010.00221.x; Hollidge BS, 2012, J VIROL, V86, P7988, DOI 10.1128/JVI.00140-12; Huang HC, 2012, J VIROL, V86, P9443, DOI 10.1128/JVI.00873-12; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f; Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kleinschmidt MC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-49; Kobayashi S, 2012, NEUROPATHOLOGY, V32, P398, DOI 10.1111/j.1440-1789.2011.01275.x; Koh WL, 2005, EMERG INFECT DIS, V11, P629, DOI 10.3201/eid1104.041076; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kong KF, 2008, VIRAL IMMUNOL, V21, P78, DOI 10.1089/vim.2007.0072; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; LANFORD RE, 1994, VIROLOGY, V202, P606, DOI 10.1006/viro.1994.1381; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Li S, 2010, BBA-PROTEINS PROTEOM, V1804, P1882, DOI 10.1016/j.bbapap.2010.05.011; Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811; Lin RJ, 2004, J VIROL, V78, P9285, DOI 10.1128/JVI.78.17.9285-9294.2004; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Lundstrom JO, 1999, J VECTOR ECOL, V24, P1; Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06; McCarthy Derrick P, 2012, Methods Mol Biol, V900, P381, DOI 10.1007/978-1-60761-720-4_19; McGinnis KM, 1998, J BIOL CHEM, V273, P19993, DOI 10.1074/jbc.273.32.19993; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Murgue B, 2001, ANN NY ACAD SCI, V951, P117; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Najjar I, 2010, BIOCHIMIE, V92, P425, DOI 10.1016/j.biochi.2010.02.009; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0; Okuma Y, 2012, ANN NEUROL; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Papa A, 2010, EURO SURVEILL, V15; Parquet MD, 2001, FEBS LETT, V500, P17; Passali D, 2012, ACTA OTORHINOLARYNGO, V32, P46; Pastorino B, 2009, MOL CELL PROTEOMICS, V8, P1623, DOI 10.1074/mcp.M800565-MCP200; Petzold A, 2010, MUSCLE NERVE, V41, P42, DOI 10.1002/mus.21448; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11; Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006; Rossman JS, 2012, J VIROL, V86, P10950, DOI 10.1128/JVI.05992-11; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Skruzny M, 2012, P NATL ACAD SCI USA, V109, pE2533, DOI 10.1073/pnas.1207011109; Smithburn K., 1940, AM J TROP MED HYG, V20, P471, DOI [10.4269/ajtmh.1940.s1-20.471, DOI 10.4269/AJTMH.1940.S1-20.471]; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Stohlman SA, 2001, BRAIN PATHOL, V11, P92; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tian Zuo-jun, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P250; Togashi H, 2009, CELL ADHES MIGR, V3, P29, DOI 10.4161/cam.3.1.6773; Torrentino-Madamet M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-4; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Tseng YF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-20; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; Van den Broeke C, 2011, VIRUSES-BASEL, V3, P278, DOI 10.3390/v3040278; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Venter M, 2005, VIROLOGY, V342, P119, DOI 10.1016/j.virol.2005.07.013; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang W, 2012, NEUROCHEM RES, V37, P819, DOI 10.1007/s11064-011-0677-x; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Whitaker JN, 1998, MULT SCLER J, V4, P16, DOI 10.1191/135245898678909123; Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224; Zakharov VV, 2001, NEUROSCI RES, V39, P447, DOI 10.1016/S0168-0102(01)00201-2; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zheng J, 2011, ANAL CHIM ACTA, V702, P149, DOI 10.1016/j.aca.2011.06.045	130	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e68318	10.1371/journal.pone.0068318			23	Multidisciplinary Sciences	Science & Technology - Other Topics	182SU	WOS:000321765300041	23874584	DOAJ Gold, Green Published			2021-06-18	
J	Yang, JF; Han, YF; Ye, WW; Liu, F; Zhuang, K; Wu, GY				Yang, Jinfu; Han, Yongfeng; Ye, Weiwei; Liu, Feng; Zhuang, Kai; Wu, Guangyong			Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Alpha tocopherol; Traumatic brain injury; Nogo; Regeneration	OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; VITAMIN-E; INHIBITION; RECOVERY; NEURONS; LIGAND; REPAIR; DAMAGE; CELLS	Background: Neurite outgrowth inhibitor-A (Nogo-A), myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein are three myelin-associated proteins that act as inhibitors to central nervous system regeneration. Neurite outgrowth inhibitor-A imposes the strongest effect on inhibiting axonal regeneration after traumatic brain injury. Alphatocopherol, a member of the vitamin E family, is recognized as an active antioxidative substance. Its use has not been well studied in brain injury research, especially in axonal regeneration research. Methods: We obtained 99 intact adult male Sprague-Dawley rats (200-250 g) from the Experimental Animal Center of Central South University. We used the modified method of Freeney to generate moderate brain injury in the rats. We injected 600 mg/kg alpha-tocopherol intraperitoneally daily as traumatic brain injury (TBI) treatment. Then, we performed behavioral tests in the corresponding time point, examined brain tissues after hematoxylin-eosin staining to identify changes in cell morphology, and performed immunohistochemical staining and quantitative real-time polymerase chain reaction to detect the expression of NoGo and Nogo receptor (NgR) in brain tissue. Results: For the Neurological Severity Scores of rats, there were obvious differences among the three groups at the corresponding time points. Standard hematoxylin-eosin staining showed that the brain structure of a sham-operated group of rats was clear, uniform, and compact. A TBI group exhibited hemorrhage, edema, inflammatory cell infiltration, condensed nuclei, and necrosis. We also saw glial cells and fibrous tissue proliferation. The alpha-tocopherol-treated TBI group had similar but less severe changes than the TBI group. Expression of Nogo-A and NgR increased after TBI compared with the sham-operated group. However, Nogo-A and NgR expression was significantly lower in the alpha-tocopherol-treated TBI group compared with the TBI group. Similarly, results showed that functional neurological deficits among rats in the alpha-tocopherol-treated TBI group were less pronounced than in the TBI group (model group). Conclusions: Our data demonstrate that alpha-tocopherol-treated rats had reduced microscopic evidence of brain damage. Alpha-tocopherol reduced Nogo-A and NgR expression in brain tissue after traumatic brain injury and promoted nerve regeneration. Alpha-tocopherol treatment of TBI rats had a neuroprotective role in their recovery. (C) 2013 Elsevier Inc. All rights reserved.	[Yang, Jinfu; Han, Yongfeng; Ye, Weiwei; Liu, Feng; Zhuang, Kai; Wu, Guangyong] Cent South Univ, Xiangya Hosp 3, Dept Neurosurg, Changsha, Hunan, Peoples R China	Han, YF (corresponding author), First Hosp Shijiazhuang City, Dept Neurosurg, Shijiazhuang 050001, Hebei, Peoples R China.	maoping627@126.com					Bandtlow CE, 1997, EUR J NEUROSCI, V9, P2743, DOI 10.1111/j.1460-9568.1997.tb01703.x; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cherdyntseva N, 2005, J RADIAT RES, V46, P37, DOI 10.1269/jrr.46.37; Desrumaux C, 1999, FASEB J, V13, P883; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferreira MCD, 2005, FREE RADICAL BIO MED, V39, P1009, DOI 10.1016/j.freeradbiomed.2005.05.021; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Guo Q, 2007, NEUROSCI LETT, V422, P103, DOI 10.1016/j.neulet.2007.05.034; HARA H, 1990, BRAIN RES, V510, P335, DOI 10.1016/0006-8993(90)91386-U; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jin XL, 2012, CARDIOVASC TOXICOL, V12, P10, DOI 10.1007/s12012-011-9134-y; Kapelusiak-Pielok M, 2005, FOLIA NEUROPATHOL, V43, P103; Kemaloglu S, 2003, YONSEI MED J, V44, P955, DOI 10.3349/ymj.2003.44.6.955; Kramer JKG, 1997, LIPIDS, V32, P323, DOI 10.1007/s11745-997-0040-1; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mi YJ, 2012, CELL DEATH DIFFER, V19, P1175, DOI 10.1038/cdd.2011.206; Silva DNE, 2012, ACTA CIR BRAS, V27, P325, DOI 10.1590/S0102-86502012000400008; Ovalle F, 2012, ANN PLAS SURG, V68, P518, DOI 10.1097/SAP.0b013e3182380974; Papadopoulos CM, 2006, CEREB CORTEX, V16, P529, DOI 10.1093/cercor/bhi132; Raicevic R, 2000, Vojnosanit Pregl, V57, P647; Ren ZW, 2012, REV NEUROSCIENCE, V23, P135, DOI 10.1515/revneuro-2011-0069; Schallert T, 1997, ADV NEUROL, V73, P229; Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Smolarek AK, 2011, NUTRIENTS, V3, P962, DOI 10.3390/nu3110962; Sperling O, 2003, NEUROSCI LETT, V351, P137, DOI 10.1016/S0304-3940(03)00858-9; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Whitlon DS, 2010, NEUROSCIENCE, V171, P23, DOI 10.1016/j.neuroscience.2010.08.069; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462	35	14	15	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 15	2013	182	2					E69	E77		10.1016/j.jss.2012.11.010			9	Surgery	Surgery	143ZI	WOS:000318907900004	23207171				2021-06-18	
J	Deye, KP; Berger, RP; Lindberg, DM				Deye, Katherine P.; Berger, Rachel P.; Lindberg, Daniel M.		ExSTRA Investigators	Occult abusive injuries in infants with apparently isolated skull fractures	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Skull fracture; child abuse; skeletal survey	SUSPECTED PHYSICAL ABUSE; TRAUMATIC BRAIN-INJURY; CHILD-ABUSE; SKELETAL SURVEYS; HEAD TRAUMA; PREVALENCE; EVALUATE; YIELD	BACKGROUND: There is currently no consensus about which screening studies should be undertaken to identify abusive injuries in infants with apparently isolated skull fractures. Our objective was to determine rates of screening, rates of injury identification, and rates of reporting to child protective services among infants who underwent subspecialty evaluation for abuse after presenting with an apparently isolated skull fracture. METHODS: This was a retrospectively planned, secondary analysis of index children enrolled in a large network of children with concerns for physical abuse. For this analysis, we included infants (<12 months) who presented with signs and symptoms attributable to a skull fracture. We determined rates of skeletal survey, dedicated ophthalmologic examination and abdominal injury screening, rates of injury identification by testing and reports to child protective services. RESULTS: A total of 215 infants underwent abuse consultation for apparently isolated skull fractures. Skeletal surveys were performed in 201 subjects (93.4%) and identified additional fractures in 12 (5.6%; 95% confidence interval, 2.9-9.6%). Patient age, trauma history, and fracture type (simple/complex) were not sensitive predictors of finding additional fractures on skeletal survey. Only one additional fracture was associated with clinical signs or symptoms. Dedicated ophthalmologic examination was undertaken in 100 subjects (46.5%); one child had retinal hemorrhages. Hepatic transaminases were obtained in 135 subjects (62.7%), and 5 subjects (2.3%) had abdominal computed tomography. No abdominal injuries were identified. A total of 146 subjects (67.9%) were reported to child protective services. CONCLUSION: Infants with apparently isolated skull fractures are an important fraction of consultations for physical abuse. Additional fractures are identified in a small subset of the skeletal surveys completed in these children. (Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Deye, Katherine P.] George Washington Univ, Sch Med & Hlth Sci, Childrens Natl Med Ctr, Freddie Mac Fdn,Child & Adolescent Protect Ctr, Washington, DC 20052 USA; [Berger, Rachel P.] Univ Pittsburgh, Dept Pediat, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Lindberg, Daniel M.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Lindberg, Daniel M.] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA	Lindberg, DM (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St,Neville House, Boston, MA 02115 USA.	dlindberg@partners.org			Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program [H34MC19346-01-02]; Eleanor and Miles Shore Fellowship for Scholars in Medicine from Harvard Medical School	This project was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau, Emergency Medical Services for Children Program (H34MC19346-01-02). D.M.L.'s effort is funded in part by an Eleanor and Miles Shore Fellowship for Scholars in Medicine from Harvard Medical School. D. M. L. has provided paid expert testimony for prosecution and defense in cases of alleged child physical abuse. K. P. D. and R. P. B. declare that they have no conflicts of interest.	ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; Bennett BL, 2011, PEDIATR EMERG CARE, V27, P941, DOI 10.1097/PEC.0b013e3182307afe; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Drubach LA, 2010, RADIOLOGY, V255, P173, DOI 10.1148/radiol.09091368; Duffy SO, 2011, PEDIATRICS, V127, pE47, DOI 10.1542/peds.2010-0298; Dupuis O, 2005, AM J OBSTET GYNECOL, V192, P165, DOI 10.1016/j.ajog.2004.06.035; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C, 2007, PEDIATRICS, V119, P1232, DOI 10.1542/peds.2007-0883; Karmazyn B, 2011, AM J ROENTGENOL, V197, pW159, DOI 10.2214/AJR.10.5733; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Lane WG, 2009, PEDIATRICS, V124, P1595, DOI 10.1542/peds.2009-0904; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; Laskey AL, 2013, J PEDIATR-US, V162, P86, DOI 10.1016/j.jpeds.2012.06.038; Leventhal JM, 2012, PEDIATRICS, V130, P847, DOI 10.1542/peds.2012-0922; Levi BH, 2005, PEDIATRICS, V116, pE5, DOI 10.1542/peds.2004-2649; Levin AV, 2010, PEDIATRICS, V126, P376, DOI 10.1542/peds.2010-1397; Lindberg D, 2009, PEDIATRICS, V124, P509, DOI 10.1542/peds.2008-2348; Lindberg DM, 2012, PEDIATRICS, V130, P193, DOI 10.1542/peds.2012-0085; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Oral R, 2011, PEDIATR EMERG CARE, V27, P490, DOI 10.1097/PEC.0b013e31821d860f; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Ravichandiran N, 2010, PEDIATRICS, V125, P60, DOI 10.1542/peds.2008-3794; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Sege RD, 2008, ARCH DIS CHILD, V93, P822, DOI 10.1136/adc.2006.100545; Thackeray JD, 2010, PEDIATRICS, V125, pE1066, DOI 10.1542/peds.2009-2184; Thackeray JD, 2007, PEDIATR EMERG CARE, V23, P735, DOI 10.1097/PEC.0b013e3181568039; United States Department of Health & Human Services, 2012, CHILD MALTR 2011; Wood JN, 2012, PEDIATRICS, V130, pE358, DOI 10.1542/peds.2011-3755; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467; WORLOCK P, 1986, BRIT MED J, V293, P100, DOI 10.1136/bmj.293.6539.100	34	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2013	74	6					1553	1558		10.1097/TA.0b013e31828b7fc4			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	AB4DO	WOS:000331739800026	23694887				2021-06-18	
J	Durazzo, TC; Abadjian, L; Kincaid, A; Bilovsky-Muniz, T; Boreta, L; Gauger, GE				Durazzo, Timothy C.; Abadjian, Linda; Kincaid, Adam; Bilovsky-Muniz, Tobias; Boreta, Lauren; Gauger, Grant E.			The Influence of Chronic Cigarette Smoking on Neurocognitive Recovery after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cigarette smoking; cognition; mild traumatic brain injury; recovery	ALCOHOL-DEPENDENT INDIVIDUALS; OXIDATIVE STRESS; NICOTINE ADDICTION; ANTIOXIDANT STATUS; TOBACCO-SMOKE; TEENAGE GIRLS; VITAMIN-C; IN-VITRO; HISTORY; DAMAGE	The majority of the approximately 1.7 million civilians in the United States who seek emergency care for traumatic brain injury (TBI) are classified as mild (MTBI). Premorbid and comorbid conditions that commonly accompany MTBI may influence neurocognitive and functional recovery. This study assessed the influence of chronic smoking and hazardous alcohol consumption on neurocognitive recovery after MTBI. A comprehensive neurocognitive battery was administered to 25 non-smoking MTBI participants (nsMTBI), 19 smoking MTBI (sMTBI) 38 +/- 22 days (assessment point 1: AP1) and 230 +/- 36 (assessment point 2: AP2) days after injury. Twenty non-smoking light drinkers served as controls (CON). At AP1, nsMTBI and sMTBI were inferior to CON on measures of auditory-verbal learning and memory; nsMTBI performed more poorly than CON on processing speed and global neurocognition, and sMTBI performed worse than CON on working memory measures; nsMTBI were inferior to sMTBI on visuospatial memory. Over the AP1-AP2 interval, nsMTBI showed significantly greater improvement than sMTBI on measures of processing speed, visuospatial learning and memory, visuospatial skills, and global neurocognition, whereas sMTBI only showed significant improvement on executive skills. At AP2, sMTBI remained inferior to CON on auditory-verbal learning and auditory-verbal memory; there were no significant differences between nsMTBI and CON or among nsMTBI and sMTBI on any domain at AP2. Hazardous alcohol consumption was not significantly associated with change in any neurocognitive domain. For sMTBI, over the AP1-AP2 interval, greater lifetime duration of smoking and pack-years were related to significantly less improvement on multiple domains. Results suggest consideration of the effects of chronic cigarette smoking is necessary to understand the potential factors influencing neurocognitive recovery after MTBI.	[Durazzo, Timothy C.; Abadjian, Linda; Bilovsky-Muniz, Tobias; Boreta, Lauren; Gauger, Grant E.] San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94121 USA; [Durazzo, Timothy C.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Kincaid, Adam; Gauger, Grant E.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Durazzo, TC (corresponding author), San Francisco VA Med Ctr, Ctr Imaging Neurodegenerat Dis 114M, 4150 Clement St, San Francisco, CA 94121 USA.	timothy.durazzo@ucsf.edu			Department of DefenseUnited States Department of Defense [W81XWII-05-2-0094]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [DA24136]; National Institute on Alcohol and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA10788]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA010788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K01DA024136] Funding Source: NIH RePORTER	This material is the result of work supported by the Department of Defense (W81XWII-05-2-0094 to TCD and GEG), National Institute on Drug Abuse (DA24136 to TCD), National Institute on Alcohol and Alcoholism (AA10788 to Dieter J. Meyerhoff), and with resources and the use of facilities at the San Francisco Veterans Affairs Medical Center, San Francisco, CA. We thank Dr. Geoffrey Manley and Michelle Meeker for invaluable assistance in recruitment, Hana Lee for assistance with neurocognitive assessment, and Dr. Dieter J. Meyerhoff for providing a portion of the neurocognitive data for control participants. We also wish to extend our gratitude to the study participants, who made this research possible.	Alonso JR, 2004, EUR RESPIR J, V23, P214, DOI 10.1183/09031936.03.00038203; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anbarasi K, 2006, LIFE SCI, V78, P1378, DOI 10.1016/j.lfs.2005.07.030; Azizian Allen, 2009, Handb Exp Pharmacol, P113, DOI 10.1007/978-3-540-69248-5_5; Babor T., 2001, ALCOHOL USE DISORDER, V2nd ed.; Bartal M, 2001, Monaldi Arch Chest Dis, V56, P545; Bates C, 1999, TOBACCO ADDITIVES CI; Beck AT., 1978, DEPRESSION INVENTORY; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bloomer RJ, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-39; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Delis DC, 2000, CALIFORNIA VERBAL LE; Deveci SE, 2004, RESP MED, V98, P551, DOI 10.1016/j.rmed.2003.11.018; Dikmen S. S., 1993, NEUROPSYCHOLOGIA, V7, P296, DOI DOI 10.1037/0894-4105.7.3.296; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dube S. R., 2010, VITAL SINGS CURRENT; Durazzo TC, 2004, ALCOHOL CLIN EXP RES, V28, P1849, DOI 10.1097/01.ALC.0000148112.92525.AC; Durazzo TC, 2008, ALCOHOL, V42, P439, DOI 10.1016/j.alcohol.2008.06.001; Durazzo TC, 2007, ALCOHOL CLIN EXP RES, V31, P1114, DOI 10.1111/j.1530-0277.2007.00398.x; Durazzo TC, 2007, FRONT BIOSCI-LANDMRK, V12, P4079, DOI 10.2741/2373; Durazzo TC, 2012, ALZHEIMERS DEMENT, V8, P513, DOI 10.1016/j.jalz.2011.10.006; Durazzo TC, 2012, DRUG ALCOHOL DEPEN, V122, P105, DOI 10.1016/j.drugalcdep.2011.09.019; Durazzo TC, 2010, INT J ENV RES PUB HE, V7, P3760, DOI 10.3390/ijerph7103760; Durazzo TC, 2010, ALCOHOL ALCOHOLISM, V45, P507, DOI 10.1093/alcalc/agq057; Fagerstrom K., 1991, ENT-EAR NOSE THROAT, V69, P763; First M.B., 1998, STRUCTURED CLIN INTE; Fowles J., 2000, CHEM CONSTITUENTS CI; Golden C., 1978, STROOP COLOR WORD TE; GOLDEN CJ, 1978, J CONSULT CLIN PSYCH, V46, P1258, DOI 10.1037/0022-006X.46.6.1258; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Haustein KO, 1999, INT J CLIN PHARM TH, V37, P76; Heaton R.K., 1991, COMPREHENSIVE NORMS; John U, 2003, ALCOHOL ALCOHOLISM, V38, P606, DOI 10.1093/alcalc/agg122; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kim SH, 2004, NUTRITION, V20, P437, DOI 10.1016/j.nut.2004.01.008; Kim SH, 2003, NUTRITION, V19, P240, DOI 10.1016/S0899-9007(02)01002-X; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Mansvelder HD, 2006, PSYCHOPHARMACOLOGY, V184, P292, DOI 10.1007/s00213-005-0070-z; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKee SA, 2007, ARCH INTERN MED, V167, P716, DOI 10.1001/archinte.167.7.716; Mendez-Alvarez E, 1998, J APPL TOXICOL, V18, P443, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<443::AID-JAT530>3.0.CO;2-P; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Meyerhoff DJ, 2013, CURR TOP BEHAV NEURO, V13, P511, DOI 10.1007/7854_2011_131; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Northrop-Clewes CA, 2007, CLIN CHIM ACTA, V377, P14, DOI 10.1016/j.cca.2006.08.028; Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Reitan RM., 1985, HALSTEAD REITAN NEUR; Robertson Jr E., 1994, ASSESSMENT MILD BRAI; Rourke S.B., 2009, NEUROPSYCHOLOGICAL A, P398; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; SPIELBERGER CD, 1977, SELF EVALUATION QUES; Swan GE, 2007, NEUROPSYCHOL REV, V17, P259, DOI 10.1007/s11065-007-9035-9; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Volkow N D, 1999, Nicotine Tob Res, V1 Suppl 2, pS127; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wetzel L., 1987, SHORT CATEGORY TEST; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yang YM, 2003, BIOMED ENVIRON SCI, V16, P256	74	14	14	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2013	30	11					1013	1022		10.1089/neu.2012.2676			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	166WD	WOS:000320589300012	23421788	Green Published			2021-06-18	
J	Ozturk, G; Cengiz, N; Erdogan, E; Him, A; Oguz, EK; Yenidunya, E; Aysit, N				Ozturk, G.; Cengiz, N.; Erdogan, E.; Him, A.; Oguz, E. K.; Yenidunya, E.; Aysit, N.			Two distinct types of dying back axonal degeneration in vitro	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						axotomy; caspase; degeneration; dying back; laser; neurone death	TRAUMATIC BRAIN-INJURY; SPINAL-CORD; NEURITE TRANSECTION; SCHWANN-CELLS; II-SPECTRIN; CROSS-TALK; ADULT-RAT; CALPAIN; NEURONS; CALCIUM	G. ozturk, N. Cengiz, E. Erdoan, A. Him, E. K. Ouz, E. Yenidunya and N. Ayit (2013) Neuropathology and Applied Neurobiology39, 362376 Two distinct types of dying back axonal degeneration in vitro Aims: In many neurodegenerative diseases and following traumas, dying back degeneration is a common phenomenon that aggravates the pathology and may eventually lead to death of the affected neurone. We aimed to investigate the mechanism of dying back degeneration with an in vitro axonal injury model. Methods: We cultured adult mouse dorsal root ganglion neurones and with a precise laser beam, cut the axons they extended. Preparations were imaged continuously and images were analysed to describe and quantify ensuing events. Potential contributions of calpains and caspases to the degeneration were explored using specific inhibitors and immunohistochemistry. In vivo implications of the results were sought in nerve sections after sciatic nerve cut. Results: The proximal part of the transected axons went under basically two types of dying back degeneration, fragmentation and retraction. In fragmentation the cytoplasm became condensed and with concomitant axial collapse the axon disintegrated into small pieces. In retraction, the severed axon was pulled back to the soma in an organized manner. We demonstrated that fragmentation was associated with a high risk of cell death, while survival rate with retraction was as high as those of uninjured neurones. Regeneration of transected axon was more likely after retraction than following fragmentation. Activities of caspase-3 and calpains but not of caspase-6 were found linked with retraction and regeneration but not with the fragmentation. Conclusions: This study describes two quite distinct types of dying back degeneration that lead an injured neurone to quite different fates.	[Ozturk, G.; Aysit, N.] Istanbul Medipol Univ, Sch Med, Dept Physiol, TR-34083 Istanbul, Turkey; [Cengiz, N.] Yuzuncu Yil Univ, Sch Med, Dept Histol & Embryol, Van, Turkey; [Erdogan, E.] Selcuk Univ, Sch Med, Dept Histol & Embryol, Konya, Turkey; [Him, A.] Ondokuz Mayis Univ, Sch Med, Dept Biophys, Samsun, Turkey; [Oguz, E. K.] Yuzuncu Yil Univ, Fac Educ, Dept Sci Educ, Van, Turkey; [Yenidunya, E.] Yuzuncu Yil Univ, Fac Sci, Dept Biol, Van, Turkey	Ozturk, G (corresponding author), Istanbul Medipol Univ, Ataturk Bulv 27, TR-34083 Istanbul, Turkey.	gozturk@medipol.edu.tr	Ozturk, Gurkan/AAE-1401-2019; Cengiz, Nureddin/A-4949-2018; Him, Aydin/B-4728-2018; Ozturk, Gurkan/C-7035-2018	Cengiz, Nureddin/0000-0002-2486-5901; Ozturk, Gurkan/0000-0003-0352-1947; KAVAL OGUZ, Elif/0000-0003-0196-2693	Yuzuncu Yil University Directorate of Scientific Research ProjectsYuzuncu Yil University [TF073]	This study was supported by Yuzuncu Yil University Directorate of Scientific Research Projects with the grant TF073.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; Andre S, 2003, NEUROREPORT, V14, P147, DOI 10.1097/01.wnr.0000051545.96524.bb; Barron K. D., 1989, NEURAL REGENERATION, P79; BARRON KD, 1988, J NEUROPATH EXP NEUR, V47, P62, DOI 10.1097/00005072-198801000-00008; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; BOULDIN TW, 1979, AM J PATHOL, V94, P241; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cajal R., 1928, DEGENERATION REGENER; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; CAVANAGH JB, 1979, ARCH PATHOL LAB MED, V103, P659; Cengiz N, 2012, J NEUROTRAUM, V29, P2465, DOI 10.1089/neu.2009.0947; Chen QX, 1997, J NEUROSCI, V17, P4032; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Court FA, 2011, GLIA, V59, P1529, DOI 10.1002/glia.21196; DALE SM, 1995, EXP NEUROL, V135, P67, DOI 10.1006/exnr.1995.1066; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fishman PS, 1998, BRAIN RES, V779, P231, DOI 10.1016/S0006-8993(97)01125-6; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; GOSHGARIAN HG, 1983, J COMP NEUROL, V214, P251, DOI 10.1002/cne.902140303; GROSS GW, 1983, J NEUROSCI, V3, P1979; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Houle JD, 2001, EXP NEUROL, V169, P208, DOI 10.1006/exnr.2001.7645; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kim KA, 2007, INT J PARASITOL, V37, P1209, DOI 10.1016/j.ijpara.2007.03.011; Lamoureux P, 2010, DEV NEUROBIOL, V70, P135, DOI 10.1002/dneu.20764; LASEK RJ, 1974, P NATL ACAD SCI USA, V71, P1188, DOI 10.1073/pnas.71.4.1188; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; LUCAS JH, 1987, BRAIN RES, V425, P384, DOI 10.1016/0006-8993(87)90526-9; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NICOTERA P, 1992, ANN NY ACAD SCI, V648, P17, DOI 10.1111/j.1749-6632.1992.tb24520.x; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; OLNEY JW, 1994, J NEURAL TRANSM-SUPP, P47; Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x; Ozturk G, 2004, MICROSC RES TECHNIQ, V64, P228, DOI 10.1002/jemt.20075; Pan YA, 2003, J NEUROSCI, V23, P11479; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Samsam M, 2003, J NEUROSCI, V23, P2833; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; SCHLAEPFER WW, 1973, J CELL BIOL, V59, P456, DOI 10.1083/jcb.59.2.456; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192, DOI 10.1097/00005072-199105000-00002; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sun M, 2008, CELL MOL NEUROBIOL, V28, P71, DOI 10.1007/s10571-007-9250-1; Tang YP, 1997, J NEUROTRAUM, V14, P863, DOI 10.1089/neu.1997.14.863; Vaisid T, 2005, BBA-MOL CELL RES, V1743, P223, DOI 10.1016/j.bbamcr.2005.01.001; Vaisid T, 2009, INT J BIOCHEM CELL B, V41, P2450, DOI 10.1016/j.biocel.2009.07.010; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Vickers JC, 1996, EXP NEUROL, V141, P1, DOI 10.1006/exnr.1996.0133; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; von Meyenburg J, 1998, EXP NEUROL, V154, P583, DOI 10.1006/exnr.1998.6912; Waller A, 1850, PHIL T R SOC LOND BI, V140, P432; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; Wood DE, 1999, J BIOL CHEM, V274, P8309, DOI 10.1074/jbc.274.12.8309; XIE XY, 1991, J NEUROSCI, V11, P3257; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878	72	14	14	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	JUN	2013	39	4					362	376		10.1111/j.1365-2990.2012.01295.x			15	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	137HI	WOS:000318425900004	22845867				2021-06-18	
J	Zhou, TE; Jiang, J; Zhang, M; Fu, Y; Yang, ZF; Jiang, LY				Zhou, Tianen; Jiang, Jun; Zhang, Meng; Fu, Yue; Yang, Zhengfei; Jiang, Longyuan			Protective effect of mild hypothermia on oxygen-glucose deprivation injury in rat hippocampal neurons after hypoxia	MOLECULAR MEDICINE REPORTS			English	Article						neuron; oxygen-glucose deprivation; mild hypothermia; lactic acid dehydrogenase; release rate; MTT; caspase-3	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; THERAPEUTIC HYPOTHERMIA; CORTICAL CULTURES; FLUID-PERCUSSION; ISCHEMIA; MODEL; NEUROPROTECTION; EXCITOTOXICITY; REOXYGENATION	The present study aimed to establish an oxygen-glucose deprivation (OGD) model of ischemic and hypoxic cerebral neurons to investigate the protective effect of mild hypothermia on neuronal OGD and its mechanisms. OGD injury was significantly mitigated in cells with 24 h of mild hypothermia compared with cells without mild hypothermia; cell morphology improved, the lactic acid dehydrogenase (LDH) release rate was decreased, cytoactivity was increased and the neuronal apoptotic rate was decreased. By contrast, no significant improvement in injury was observed after 6 h of mild hypothermia. This suggests that mild hypothermia treatment following OGD is effective only when implemented for 24 h. Additionally, the caspase-3 activity of neurons increased following OGD, which was positively associated with the neuronal apoptotic rate. However, the caspase-3 activity after 24 h of mild hypothermia was reduced. Simultaneously, the neuronal apoptotic rate was decreased, suggesting that mild hypothermia may inhibit neuronal apoptosis by reducing caspase-3 activity. Therefore, reducing caspase-3 activity potentially constitutes one of the protective mechanisms of mild hypothermia in neuronal OGD.	[Zhou, Tianen; Zhang, Meng; Yang, Zhengfei; Jiang, Longyuan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Emergency, Guangzhou 510120, Guangdong, Peoples R China; [Jiang, Jun; Fu, Yue] Sun Yat Sen Univ, Affiliated Foshan Hosp, Dept Emergency, Foshan 528000, Guangdong, Peoples R China	Jiang, LY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Emergency, 107 Yanjiangxi Rd,Yuexiu, Guangzhou 510120, Guangdong, Peoples R China.	longyuanjiang@yeah.net					Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Bai Y, 2009, NEUROSCIENCE, V160, P371, DOI 10.1016/j.neuroscience.2009.01.076; Baltan S, 2011, J NEUROSCI, V31, P3990, DOI 10.1523/JNEUROSCI.5379-10.2011; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Cheah SO, 2010, ANN ACAD MED SINGAP, V39, P542; Dalen ML, 2009, BRAIN RES, V1259, P80, DOI 10.1016/j.brainres.2008.12.055; Diestel A, 2011, CRYOBIOLOGY, V62, P53, DOI 10.1016/j.cryobiol.2010.12.003; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Fritz HG, 2004, J NEUROSURG ANESTH, V16, P43, DOI 10.1097/00008506-200401000-00009; Gwak MS, 2011, ENVIRON TOXICOL PHAR, V31, P262, DOI 10.1016/j.etap.2010.10.009; Inamasu J, 2003, J NEUROL SCI, V209, P55, DOI 10.1016/S0022-510X(02)00463-X; Iwamoto S, 2010, J TRAUMA, V68, P669, DOI 10.1097/TA.0b013e3181a0fbb3; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kunimatsu T, 2011, J CLIN NEUROSCI, V18, P545, DOI 10.1016/j.jocn.2010.07.140; Kunimatsu Teruhito, 2009, J Oral Sci, V51, P615; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Labrande C, 2006, NEUROSCIENCE, V137, P231, DOI 10.1016/j.neuroscience.2005.08.080; Lei ZG, 2006, NEUROSCI LETT, V407, P224, DOI 10.1016/j.neulet.2006.06.019; Li H, 2011, BRAIN RES, V1368, P59, DOI 10.1016/j.brainres.2010.10.073; Lin CH, 2010, AM J MED SCI, V339, P258, DOI 10.1097/MAJ.0b013e3181ce507f; Liu Cui-Qing, 2010, Zhongguo Dang Dai Er Ke Za Zhi, V12, P690; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Montero M, 2007, EXP NEUROL, V204, P106, DOI 10.1016/j.expneurol.2006.09.026; National Research Council of the National Academies, 2011, GUIDE CARE USE LAB A, V8, P199; Noguchi K, 2011, RESUSCITATION, V82, P481, DOI 10.1016/j.resuscitation.2010.09.477; Okauchi M, 2002, J NEUROTRAUM, V19, P741, DOI 10.1089/08977150260139110; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; Savoia Claudia, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P57; Scorziello A, 2001, J NEUROSCI RES, V63, P20, DOI 10.1002/1097-4547(20010101)63:1<20::AID-JNR3>3.0.CO;2-N; Shibuta S, 2010, BRIT J ANAESTH, V104, P52, DOI 10.1093/bja/aep320; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Wang ZF, 2007, FEBS LETT, V581, P596, DOI 10.1016/j.febslet.2007.01.016; Wang ZC, 2010, PLATELETS, V21, P229, DOI 10.3109/09537100903443949; Yokoyama H, 2011, CIRC J, V75, P1063, DOI 10.1253/circj.CJ-11-0137; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	41	14	14	0	8	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUN	2013	7	6					1859	1864		10.3892/mmr.2013.1410			6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	179AH	WOS:000321488300024	23563479	Bronze			2021-06-18	
J	Huston, JM; Field, AS				Huston, Jason M.; Field, Aaron S.			Clinical Applications of Diffusion Tensor Imaging	MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA			English	Article						Diffusion tensor imaging; Tractography; Tissue characterization; Lesion localization; Tract mapping; Preoperative planning; Image guided therapy	TRAUMATIC BRAIN-INJURY; MILD COGNITIVE IMPAIRMENT; APPEARING WHITE-MATTER; SPINAL-CORD-INJURY; WATER DIFFUSION; FRACTIONAL ANISOTROPY; ALZHEIMERS-DISEASE; FIBER TRACTOGRAPHY; CORPUS-CALLOSUM; MULTIPLE-SCLEROSIS	The potential utility of diffusion tensor (DT) imaging in clinical practice is broad, and new applications continue to evolve as technology advances:Clinical applications of DT imaging and tractography include tissue characterization, lesion localization, and mapping of white matter tracts. DT imaging metrics are sensitive to microstructural changes associated with central nervous system disease; however, further research is needed to enhance specificity so as to facilitate more widespread clinical application. Preoperative tract mapping, with either directionally encoded color maps or tractography, provides useful information to the neurosurgeon and has been shown to improve clinical outcomes.	[Huston, Jason M.; Field, Aaron S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Madison, WI 53792 USA	Field, AS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, 600 Highland Ave,M-C 3252, Madison, WI 53792 USA.	AField@uwhealth.org					Akpinar E, 2007, J COMPUT ASSIST TOMO, V31, P657, DOI 10.1097/RCT.0b013e318033df1a; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, MAGN RESON IMAGING, V20, P511, DOI 10.1016/S0730-725X(02)00509-X; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Assaf BA, 2003, AM J NEURORADIOL, V24, P1857; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Barkovich A., 2011, PEDIAT NEUROIMAGING, V5, P20; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Bastin ME, 2000, NEUROREPORT, V11, P2867, DOI 10.1097/00001756-200009110-00008; Bastin ME, 2002, NEUROREPORT, V13, P1335, DOI 10.1097/00001756-200207190-00024; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Bozzali M, 2007, MAGN RESON IMAGING, V25, P969, DOI 10.1016/j.mri.2007.03.017; Bozzali M, 2012, HUM BRAIN MAPP, V33, P1295, DOI 10.1002/hbm.21287; Briganti C, 2012, EPILEPSY RES, V98, P251, DOI 10.1016/j.eplepsyres.2011.09.001; Brown R., 1828, EDINBURGH N PHIL J, V4, P358; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Castillo M, 2001, AM J NEURORADIOL, V22, P60; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chen ZQ, 2008, NEUROL RES, V30, P720, DOI 10.1179/174313208X297968; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Davis DP, 2006, J EMERG MED, V31, P269, DOI 10.1016/j.jemermed.2005.10.003; Dombovy Mary L, 2011, Continuum (Minneap Minn), V17, P584, DOI 10.1212/01.CON.0000399074.07686.76; Ducreux D, 2006, AM J NEURORADIOL, V27, P214; Einstein A., 1956, INVESTIGATIONS THEOR, P17; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Field AS, 2004, J MAGN RESON IMAGING, V20, P555, DOI 10.1002/jmri.20169; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Fischer FU, 2012, J MAGN RESON IMAGING, V36, P84, DOI 10.1002/jmri.23621; Fonseca Viviane de Carvalho, 2012, Front Neurol, V3, P121, DOI 10.3389/fneur.2012.00121; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Ge YL, 2005, ANN NY ACAD SCI, V1064, P202, DOI 10.1196/annals.1340.039; Groen WB, 2011, J PSYCHIATR NEUROSCI, V36, P32, DOI 10.1503/jpn.090100; Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x; Hagmann P, 2004, INT S MAGN RES MED I, V12, P623; Hesseltine SM, 2006, AM J NEURORADIOL, V27, P1189; Holodny AI, 2005, RADIOLOGY, V234, P649, DOI 10.1148/radiol.2343032087; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Hughes JR, 2009, EPILEPSY BEHAV, V16, P569, DOI 10.1016/j.yebeh.2009.09.023; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Huppi PS, 2002, CLIN PERINATOL, V29, P827, DOI 10.1016/S0095-5108(02)00049-0; Cruz LCH, 2009, ARQ NEURO-PSIQUIAT, V67, P391, DOI 10.1590/S0004-282X2009000300004; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jiang Q, 2010, STROKE, V41, P410, DOI 10.1161/STROKEAHA.109.568048; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Knopman DS, 2003, MAYO CLIN PROC, V78, P1290, DOI 10.4065/78.10.1290; Konishi J, 2005, NEUROLOGY, V64, P108, DOI 10.1212/01.WNL.0000148477.65273.0C; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Langen M, 2012, CORTEX, V48, P183, DOI 10.1016/j.cortex.2011.05.018; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JE, 2010, J NEUROL NEUROSUR PS, V81, P320, DOI 10.1136/jnnp.2009.184747; Lee SK, 2010, YONSEI MED J, V51, P590, DOI 10.3349/ymj.2010.51.4.590; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Lee SK, 2004, NEUROIMAGE, V22, P1826, DOI 10.1016/j.neuroimage.2004.04.028; Liao Y, 2013, J PSYCHIATR NEUROSCI, V38, P49, DOI 10.1503/jpn.110180; Lin X, 2005, J NEUROL SCI, V237, P13, DOI 10.1016/j.jns.2005.04.019; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Love S, 2006, J CLIN PATHOL, V59, P1151, DOI 10.1136/jcp.2005.031195; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Lu S, 2003, AM J NEURORADIOL, V24, P937; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Maier SE, 2005, ANN NY ACAD SCI, V1064, P50, DOI 10.1196/annals.1340.011; Maldjian JA, 2001, AM J NEURORADIOL, V22, P112; Maniega SM, 2004, J NEUROL NEUROSUR PS, V75, P1714, DOI 10.1136/jnnp.2003.033852; McKeith Ian, 2004, Dialogues Clin Neurosci, V6, P333; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Murphy ML, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-3; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Nimsky C, 2005, RADIOLOGY, V234, P218, DOI 10.1148/radiol.2341031984; Nimsky C, 2005, NEUROSURGERY, V56, P130, DOI 10.1227/01.NEU.0000144842.18771.30; Ohgiya Y, 2007, EUR RADIOL, V17, P2499, DOI 10.1007/s00330-007-0672-4; Ota M, 2009, NMR BIOMED, V22, P280, DOI 10.1002/nbm.1321; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Pipe JG, 2002, MAGNET RESON MED, V47, P42, DOI 10.1002/mrm.10014; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Poupon C, 2001, MED IMAGE ANAL, V5, P1, DOI 10.1016/S1361-8415(00)00030-X; Provenzale JM, 2004, RADIOLOGY, V232, P451, DOI 10.1148/radiol.2322030959; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Radlinska B, 2010, NEUROLOGY, V75, P1048, DOI 10.1212/WNL.0b013e3181f39aa0; Ratcliffe MR, 2011, NEUROGRAPHICS, V1, P17; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Roberts TPL, 2005, AM J NEURORADIOL, V26, P2183; Rollins N, 2005, AM J NEURORADIOL, V26, P2148; Romano A, 2009, EUR RADIOL, V19, P2798, DOI 10.1007/s00330-009-1483-6; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shanmuganathan K, 2008, AM J NEURORADIOL, V29, P655, DOI 10.3174/ajnr.A0916; Sinha S, 2002, AM J NEURORADIOL, V23, P520; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Stadnik TW, 2001, AM J NEURORADIOL, V22, P969; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Taoka T, 2008, AM J NEURORADIOL, V29, P1329, DOI 10.3174/ajnr.A1101; Tartaglia MC, 2012, CAN J NEUROL SCI, V39, P304, DOI 10.1017/S0317167100013421; Tham MW, 2011, J AFFECT DISORDERS, V132, P26, DOI 10.1016/j.jad.2010.09.013; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Ture U, 1997, NEUROSURGERY, V40, P1226; Ulmer JL, 2004, TECHNOL CANCER RES T, V3, P567, DOI 10.1177/153303460400300606; Vargas MI, 2008, NEURORADIOLOGY, V50, P25, DOI 10.1007/s00234-007-0309-y; Wahl M, 2009, AM J NEURORADIOL, V30, P282, DOI 10.3174/ajnr.A1361; Wahl M, 2010, PEDIATR RADIOL, V40, P59, DOI 10.1007/s00247-009-1448-6; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wei CW, 2008, ARCH PHYS MED REHAB, V89, pS85, DOI 10.1016/j.apmr.2008.07.005; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894; Welker KM, 2012, SEMIN NEUROL, V32, P15, DOI 10.1055/s-0032-1306382; Werring DJ, 2000, BRAIN, V123, P1667, DOI 10.1093/brain/123.8.1667; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Whitford TJ, 2011, SCHIZOPHR RES TREAT, V2011, DOI 10.1155/2011/709523; Widjaja E, 2011, AM J NEURORADIOL, V32, P1789, DOI 10.3174/ajnr.A2801; Widjaja E, 2009, RADIOLOGY, V251, P206, DOI 10.1148/radiol.2511081092; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu JS, 2007, NEUROSURGERY, V61, P935, DOI 10.1227/01.neu.0000303189.80049.ab; Wu YC, 2004, MAGN RESON MED, V52, P1146, DOI 10.1002/mrm.20254; Xu Q, 2010, DEMENT GERIATR COGN, V30, P317, DOI 10.1159/000320491; Yamada K, 2004, J MAGN RESON IMAGING, V20, P923, DOI 10.1002/jmri.20215; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Yu CS, 2005, EUR J RADIOL, V56, P197, DOI 10.1016/j.ejrad.2005.04.010; Zuo NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037561	167	14	17	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1064-9689	1557-9786		MAGN RESON IMAGING C	Magn. Reson. Imaging Clin. N. Am.	MAY	2013	21	2					279	+		10.1016/j.mric.2012.12.003			21	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	161PC	WOS:000320204800006	23642554				2021-06-18	
J	Kolakowsky-Hayner, SA; Wright, J; Englander, J; Duong, T; Ladley-O'Brien, S				Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Englander, Jeffrey; Duong, Thao; Ladley-O'Brien, Susan			Impact of late post-traumatic seizures on physical health and functioning for individuals with brain injury within the community	BRAIN INJURY			English	Article						Post-traumatic seizures; epilepsy; traumatic brain injury; health; function; community integration	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; RISK-FACTORS; RATING-SCALE; EPILEPSY; MODERATE; PEOPLE; ADULTS; REHABILITATION; PARTICIPATION	Primary objective: To better characterize, describe and highlight issues that individuals with TBI and active LPTS may face in their daily lives. Design: Prospective multi-centre mixed method qualitative and quantitative interview. Participants: Twenty-five individuals, 5-13 years post-injury, who had reported having LPTS and TBI. Measures: Disability Rating Scale (DRS); Supervision Rating Scale (SRS); Glasgow Outcome Scale-Extended (GOS-E); Perceived Stress Scale (PSS); Craig Handicap Assessment Reporting Technique-Short Form (CHART-SF) sub-scales: Physical Independence, Cognitive Independence, Mobility, Occupation, Social Integration; and Craig Hospital Inventory of Environmental Factors (CHIEF); and qualitative interview questions pertaining to management of the seizure disorder and its effect on the individual's health, function, community integration and participation. Results: Data are presented regarding seizure activity and management; return to driving post-seizure; coping and participation; and standardized outcome measures. Conclusions: Individuals with TBI and LPTS are at a double-barrelled disadvantage regarding ongoing physical, cognitive, psychosocial and reintegration issues following brain injury and epilepsy. Clearer clinical guidelines and treatment strategies need to be developed to help ameliorate these ongoing issues. Additional research is needed to identify what the rehabilitation community can do to continue to facilitate people living safely and independently.	[Kolakowsky-Hayner, Stephanie A.; Wright, Jerry] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Englander, Jeffrey; Duong, Thao] Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA; [Ladley-O'Brien, Susan] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Denver Hlth Med Ctr, Denver, CO USA	Kolakowsky-Hayner, SA (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	stephanie.hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909	Santa Clara Valley Medical Center; Denver Health Medical Center; NIDRR; NIDRR [H133A070038]	The authors wish to thank all of the data collectors and project staff at Santa Clara Valley Medical Center and Denver Health Medical Center and NIDRR for the continued support and funding.; The authors report no conflicts of interest. This study was partially supported by NIDRR Grant # H133A070038.	Achterberg TJ, 2009, J OCCUP REHABIL, V19, P129, DOI 10.1007/s10926-009-9169-0; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arida RM, 2008, SPORTS MED, V38, P607, DOI 10.2165/00007256-200838070-00006; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Buck D, 1997, EPILEPSIA, V38, P439, DOI 10.1111/j.1528-1157.1997.tb01733.x; Bushnik T, 2004, J HEAD TRAUMA REHAB, V19, P296, DOI 10.1097/00001199-200407000-00004; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Drazkowski JF, 2011, NEUROLOGY, V76, pS44, DOI 10.1212/WNL.0b013e31820c360c; Dunne JW, 2011, NEUROL ASIA, V16, P45; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Formisano R, 2007, BRAIN INJURY, V21, P499, DOI 10.1080/02699050701310994; Gilliam F, 1997, EPILEPSIA, V38, P233, DOI 10.1111/j.1528-1157.1997.tb01102.x; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hartshorn J C, 1994, J Neurosci Nurs, V26, P288; Holland P, 2009, EPILEPSIA, V50, P1030, DOI 10.1111/j.1528-1167.2008.01819.x; Hoofien D, 2011, BRAIN INJURY M, V15, P189; Hup CK, 2010, MALAYS J MED SCI, V17, P36; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jehi L, 2011, EPILEPSY BEHAV, V22, P723, DOI 10.1016/j.yebeh.2011.08.039; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Khan N, 2011, GOMAL J MED SCI, V9, P42; Leidy NK, 1999, EPILEPSIA, V40, P97, DOI 10.1111/j.1528-1157.1999.tb01995.x; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Misra UK, 2011, ANN INDIAN ACAD NEUR, V14, P2, DOI 10.4103/0972-2327.78041; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALINSKY MC, 1992, EPILEPSIA, V33, P469, DOI 10.1111/j.1528-1157.1992.tb01693.x; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; The Traumatic Brain Injury Model Systems National Data and Statistical Center (TBINDSC), 2011, TBI MOD SYST PRES; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Wilson JT, 2001, J NEUROL NEUROSUR PS, V70, P267; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	58	14	14	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2013	27	5					578	586		10.3109/02699052.2013.765595			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	124UK	WOS:000317493000008	23472705				2021-06-18	
J	Wolffbrandt, MM; Poulsen, I; Engberg, AW; Hornnes, N				Wolffbrandt, Mia M.; Poulsen, Ingrid; Engberg, Aase W.; Hornnes, Nete			Occurrence and Severity of Agitated Behavior After Severe Traumatic Brain Injury	REHABILITATION NURSING			English	Article						Agitated behavior; sub-acute rehabilitation; traumatic brain injury	OVERT AGGRESSION SCALE; HEAD-INJURY; RELIABILITY; OUTCOMES; REHABILITATION; PATIENT; UNIT; CARE	Purpose To investigate the occurrence and severity of agitation in patients after severe traumatic brain injury (TBI), to identify predictors of agitation and to study interrater reliability for a translated version of the Agitated Behavior Scale (ABS). Design Prospective observational study. From November 1, 2006, through October 2007, 46 consecutive patients with TBI were included in the early rehabilitation phase following neurosurgical intervention. Agitated behavior was assessed by the ABS, which was implemented in clinical practice. Logistic regression analysis identified predictors of agitated behavior and Intra Class Correlation was used to analyze reliability. Findings Agitated behavior occurred in 41% of patients, of whom one third exhibited severely agitated behavior. The interrater reliability between three nurses was good to excellent. Conclusions Using ABS as a tool in care of patients with agitated behavior may be effective through working as a common language. Clinical Relevance We recommend the use of ABS as a routine assessment in early rehabilitation of patients with TBI.	[Wolffbrandt, Mia M.; Poulsen, Ingrid; Engberg, Aase W.] Copenhagen Univ Hosp, Dept Neurorehabil TBI Unit, Glostrup, Denmark; [Hornnes, Nete] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark	Poulsen, I (corresponding author), Copenhagen Univ Hosp, Glostrup, Denmark.	Ingrid.Poulsen@regionh.dk	Poulsen, ingrid/AAH-2052-2019		Copenhagen University Hospital Hvidovre	We thank the staff of the Department of Neurorehabilitation, TBI Unit, especially the key persons, the nursing staff, occupational therapists and physiotherapists for their contribution to the data collection. We also thank the management of the department for their support, the neurologist Annette Liebach and Ph.D. Carla Caetano for translation and backtranslation of ABS. and DMSc Lars Peter Kammersgaard for performing the data analysis. We thank John Corrigan and Jennifer Bogner for their interest and helpful comments. Finally we thank Copenhagen University Hospital Hvidovre for funding MMW, during the data collection and - analyzing.	Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Amato S, 2012, REHABIL NURS, V37, P19, DOI 10.1002/RNJ.00001; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; Becker C, 2012, REHABIL NURS, V37, P171, DOI 10.1002/rnj.50; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Fleminger S, 2006, COCHRANE DATABASE SY, V18; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Heck S., 2000, NEUROLOGISCHEN REHAB, V6, P125; Jennett B., 1983, REHABILITATION HEAD, P3; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SECHREST L, 1972, J CROSS CULT PSYCHOL, V3, P41, DOI 10.1177/002202217200300103; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	28	14	15	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807			REHABIL NURS	Rehabil. Nurs.	MAY-JUN	2013	38	3					133	141		10.1002/rnj.82			9	Nursing; Rehabilitation	Nursing; Rehabilitation	141ZI	WOS:000318764800004	23658127				2021-06-18	
J	Carlson, BE; Stromwall, LK; Lietz, CA				Carlson, Bonnie E.; Stromwall, Layne K.; Lietz, Cynthia A.			Mental Health Issues in Recently Returning Women Veterans: Implications for Practice	SOCIAL WORK			English	Article						military; OEF/OIF; veterans; women	POSTTRAUMATIC-STRESS-DISORDER; MILITARY SEXUAL TRAUMA; FEMALE VETERANS; PSYCHIATRIC DIAGNOSES; GENDER-DIFFERENCES; SERVICE MEMBERS; WAR VETERANS; BRAIN-INJURY; PRIMARY-CARE; ALCOHOL-USE	Increasing numbers of women are found in the military, and they are now performing roles very similar to those of male service members. More returning servicewomen and veterans have been exposed to stressful and traumatic experiences, such as combat and difficult living circumstances, and military sexual trauma is common. These experiences have been found to be associated with adverse mental health outcomes, posttraumatic stress disorder, depression, and substance abuse in particular. Comorbidity rates are also high. In addition, more veterans are returning with injuries, including traumatic brain injuries. Although more women veterans of Operation Enduring Freedom and Operation Iraqi Freedom are seeking health services at Veterans Administration facilities, many are not. Thus, community-based social workers need to be familiar with the needs of this growing population to serve them effectively. Use of empirically supported assessment instruments and screening for military sexual trauma are recommended. Recommended interventions include the use of evidence-supported practices, such as cognitive behavioral treatment, and offering assistance to enhance social support among women veterans.	[Stromwall, Layne K.; Lietz, Cynthia A.] Arizona State Univ, Sch Social Work, Phoenix, AZ 85004 USA	Stromwall, LK (corresponding author), Arizona State Univ, Sch Social Work, Mail Code 3920,411 N Cent Ave,Suite 800, Phoenix, AZ 85004 USA.	stromwall@asu.edu					Barber JA, 2008, COMMUNITY MENT HLT J, V44, P433, DOI 10.1007/s10597-008-9146-7; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell E A, 1998, J Psychosoc Nurs Ment Health Serv, V36, P19; Bell ME, 2011, SOC WORK HEALTH CARE, V50, P34, DOI 10.1080/00981389.2010.513917; Berg I. K., 2008, INTERVIEWING FOR SOL; Bowling UB, 2008, PROF PSYCHOL-RES PR, V39, P451, DOI 10.1037/0735-7028.39.4.451; Bradley KA, 2001, PSYCHOL ADDICT BEHAV, V15, P297, DOI 10.1037/0893-164X.15.4.297; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Coyle BS, 1996, MIL MED, V161, P588; Department of Defense, 2007, DEMOGRAPHICS 2007 PR; Dobie DJ, 2004, ARCH INTERN MED, V164, P394, DOI 10.1001/archinte.164.4.394; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Escalona R, 2004, PSYCHOSOMATICS, V45, P291, DOI 10.1176/appi.psy.45.4.291; Fontana A, 1998, PSYCHIATR SERV, V49, P658, DOI 10.1176/ps.49.5.658; Frayne SM, 2006, J GEN INTERN MED, V21, pS40, DOI 10.1111/j.1525-1497.2006.00373.x; Gradus JL, 2008, J STUD ALCOHOL DRUGS, V69, P348, DOI 10.15288/jsad.2008.69.348; Grant M., 1989, ALCOHOL HEALTH RES W, V13, P371; Graybeal C, 2001, FAM SOC-J CONTEMP H, V82, P233, DOI 10.1606/1044-3894.236; Hamilton AB, 2011, WOMEN HEALTH ISS, V21, pS203, DOI 10.1016/j.whi.2011.04.005; Hankin CS, 1999, J TRAUMA STRESS, V12, P601, DOI 10.1023/A:1024760900213; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Himmelfarb N, 2006, J TRAUMA STRESS, V19, P837, DOI 10.1002/jts.20163; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2010, RETURNING HOME FROM; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Johnson S. J., 2007, THE PSYCHOLOGICAL NE; Katz LS, 2007, PSYCHOL SERV, V4, P239, DOI DOI 10.1037/1541-1559.4.4.239; Kelly MM, 2008, J GEN INTERN MED, V23, P741, DOI 10.1007/s11606-008-0589-x; Kimerling R, 2007, AM J PUBLIC HEALTH, V97, P2160, DOI 10.2105/AJPH.2006.092999; King DW, 1999, J ABNORM PSYCHOL, V108, P164, DOI 10.1037/0021-843X.108.1.164; Lietz C. A., FAMILIES IN SOCIETY; Maguen S, 2012, WOMEN HEALTH ISS, V22, pE61, DOI 10.1016/j.whi.2011.07.010; Malebranche K., 2011, OEF OIF WOMENS INITI; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Murdoch M, 2004, MIL MED, V169, P392, DOI 10.7205/MILMED.169.5.392; Murdoch M, 2005, MED CARE, V43, P112, DOI 10.1097/00005650-200502000-00004; Murdoch M, 1995, Arch Fam Med, V4, P411, DOI 10.1001/archfami.4.5.411; National Center for PTSD, 2011, PTSD SCREENING INSTR; National Center for PTSD, 2011, MOBILE APP PTSD COAC; National Center for Telehealth and Technology, 2011, WELLNESS RESOURCES F; Norwood AE, 1997, MIL MED, V162, P643; Ouimette P, 2008, J ANXIETY DISORD, V22, P337, DOI 10.1016/j.janxdis.2007.02.010; Ouimette PC, 1996, J SUBST ABUSE, V8, P335, DOI 10.1016/S0899-3289(96)90188-1; Pfeiffer PN, 2011, GEN HOSP PSYCHIAT, V33, P29, DOI 10.1016/j.genhosppsych.2010.10.002; Pierce PF, 1997, AVIAT SPACE ENVIR MD, V68, P317; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosen LN, 1996, MIL MED, V161, P342; Rowe EL, 2009, MIL PSYCHOL, V21, P387, DOI 10.1080/08995600902914768; Russell Marcia, 1994, Alcohol Health Res World, V18, P55; Sadler AG, 2000, OBSTET GYNECOL, V96, P473, DOI 10.1016/S0029-7844(00)00919-4; Saleebey D, 2009, STRENGTHS PERSPECTIV; Sammons MT, 2008, J CLIN PSYCHOL, V64, P921, DOI 10.1002/jclp.20519; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Schultz J. R., 2006, CHILD SEXUAL ABUSE A; Skinner KM, 2000, J INTERPERS VIOLENCE, V15, P291, DOI 10.1177/088626000015003005; Stein MB, 2004, GEN HOSP PSYCHIAT, V26, P178, DOI 10.1016/j.genhosppsych.2003.11.003; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Suffoletta-Maierle Samantha, 2003, J Psychiatr Pract, V9, P367, DOI 10.1097/00131746-200309000-00005; Suris A, 2004, PSYCHOSOM MED, V66, P749, DOI 10.1097/01.psy.0000138117.58559.7b; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Turchik JA, 2010, AGGRESS VIOLENT BEH, V15, P267, DOI 10.1016/j.avb.2010.01.005; U.S. Department of Veterans Affairs, 2011, WOMEN VETERANS POPUL; U.S. Department of Veterans Affairs, 2011, THE CHANGING FACE OF; U.S. Department of Veterans Affairs, 2007, WOMEN VETERANS PAST; U.S. Department of Veterans Affairs, 2011, WOMENS TRAUMA RECOVE; U.S. Department of Veterans Affairs, 2011, POST TRAUMATIC STRES; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vogt DS, 2005, J TRAUMA STRESS, V18, P271; Weathers F. W., 1993, PAPER PRESENTED AT T; Wojcik BE, 2009, MIL MED, V174, P1010, DOI 10.7205/MILMED-D-01-6108; Wolfe J, 1998, J INTERPERS VIOLENCE, V13, P40, DOI 10.1177/088626098013001003	77	14	14	0	27	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0037-8046	1545-6846		SOC WORK	Soc. Work	APR	2013	58	2					105	114		10.1093/sw/swt001			10	Social Work	Social Work	137UG	WOS:000318463100002	23724574				2021-06-18	
J	Lopez, MR; Cheng, JY; Kanner, AM; Carvalho, DZ; Diamond, JA; Wallace, DM				Lopez, M. R.; Cheng, J. Y.; Kanner, A. M.; Carvalho, D. Z.; Diamond, J. A.; Wallace, D. M.			Insomnia symptoms in South Florida military veterans with epilepsy	EPILEPSY & BEHAVIOR			English	Article						Veterans; Epilepsy; Insomnia; Sleep disturbances; Post-traumatic epilepsy; Lamotrigine; Levetiracetam	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCE; DISORDERS; PREVALENCE; LAMOTRIGINE; COMORBIDITY; MANAGEMENT; RISK; CBTI	Background: Despite the high prevalence of insomnia in veterans with epilepsy, it remains understudied. Our aim was to identify the associations of insomnia with epilepsy, comorbidities, and treatment-related variables in South Florida veterans. Methods: We performed a cross-sectional analysis of veterans attending an epilepsy clinic over 18 months. Participants completed standardized assessments of seizure and sleep. Insomnia was defined as 1) difficulty with sleep onset, maintenance, or premature awakenings with daytime consequences or 2) sedative-hypnotic use on most nights of the previous month. Results: One hundred sixty-five veterans (87% male, age 56 +/- 15 years) were included: 66 reporting insomnia (40%). In logistic regression analysis, insomnia was significantly associated with post-traumatic seizure etiology, lamotrigine prescription, and mood and psychotic disorders. Female gender and levetiracetam treatment were associated with lower odds for insomnia. Conclusion: Insomnia was associated with post-traumatic epilepsy, mood/psychotic comorbidities, and antiepileptic regimen. Insomnia represents an under-recognized opportunity to improve comprehensive epilepsy care. Published by Elsevier Inc.	[Lopez, M. R.; Cheng, J. Y.; Kanner, A. M.; Diamond, J. A.; Wallace, D. M.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Lopez, M. R.; Cheng, J. Y.; Kanner, A. M.; Diamond, J. A.; Wallace, D. M.] Vet Affairs Med Ctr, Bruce W Carter Dept, Dept Neurol, Miami, FL 33125 USA; [Carvalho, D. Z.] Univ Fed Rio Grande do Sul, Sch Med, Hosp Clin Porto Alegre, Sleep Lab, Porto Alegre, RS, Brazil	Wallace, DM (corresponding author), Vet Affairs Med Ctr, Bruce W Carter Dept, 1201 NW 16th St, Miami, FL 33125 USA.	dwallace@med.miami.edu	Wallace, Douglas/AAL-3719-2020	Wallace, Douglas/0000-0002-8982-1088; Cheng, Jocelyn/0000-0001-5318-5668; Carvalho, Diego/0000-0002-8822-1638	VA Epilepsy Center of Excellence	This study was funded by a grant from the VA Epilepsy Center of Excellence.	Alanis-Guevara I, 2005, EPILEPSY BEHAV, V7, P481, DOI 10.1016/j.yebeh.2005.06.010; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, P1; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bell C, 2002, J SLEEP RES, V11, P255, DOI 10.1046/j.1365-2869.2002.00301.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bootzin RR, 2012, J CLIN SLEEP MED, V8, P219, DOI 10.5664/jcsm.1788; Budhiraja R, 2011, SLEEP, V34, P859, DOI 10.5665/SLEEP.1114; Cho YW, 2011, SEIZURE-EUR J EPILEP, V20, P336, DOI 10.1016/j.seizure.2011.01.006; Daley M, 2009, SLEEP, V32, P55; de Weerd A, 2004, EPILEPSIA, V45, P1397, DOI 10.1111/j.0013-9580.2004.46703.x; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Foldvary N, 2001, EPILEPSIA, V42, P1569, DOI 10.1046/j.1528-1157.2001.46100.x; Foldvary-Schaefer N, 2009, SEMIN NEUROL, V29, P419, DOI 10.1055/s-0029-1237115; Freeman D, 2009, SCHIZOPHR RES, V108, P280, DOI 10.1016/j.schres.2008.12.001; Harden C, 2001, EPILEPSIA, V42, P36, DOI 10.1046/j.1528-1157.2001.00008.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ishak Waguih W, 2012, Innov Clin Neurosci, V9, P13; Kessler RC, 2012, SLEEP, V35, P825, DOI 10.5665/sleep.1884; Khatarni R, 2006, SEIZURE-EUR J EPILEP, V15, P299, DOI 10.1016/j.seizure.2006.02.018; Krishnan P, 2012, EPILEPSY BEHAV, V23, P305, DOI 10.1016/j.yebeh.2011.12.018; Krystal AD, 2008, ANN CLIN PSYCHIATRY, V20, P39, DOI 10.1080/10401230701844661; Kwan P, 2009, EPILEPSIA, V50, P1059, DOI 10.1111/j.1528-1167.2008.01938.x; Lee YJ, 2012, SLEEP, V35, P455, DOI 10.5665/sleep.1722; Legros B, 2003, SLEEP MED, V4, P51, DOI 10.1016/S1389-9457(02)00217-4; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Manni R, 2000, ACTA NEUROL SCAND, V101, P301, DOI 10.1034/j.1600-0404.2000.90369a.x; Manni R, 2010, EPILEPSY RES, V90, P171, DOI 10.1016/j.eplepsyres.2010.05.006; Mayer G, 2011, SLEEP MED REV, V15, P369, DOI 10.1016/j.smrv.2011.01.005; Sanchez-Ortuno MM, 2012, CURR PSYCHIAT REP, V14, P519, DOI 10.1007/s11920-012-0312-9; Nierenberg AA, 2010, PSYCHOL MED, V40, P41, DOI 10.1017/S0033291709006011; Ohayon MM, 2005, J PSYCHIAT RES, V39, P151, DOI 10.1016/j.jpsychires.2004.07.001; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2005, ARCH INTERN MED, V165, P35, DOI 10.1001/archinte.165.1.35; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Pigeon WR, 2012, BEHAV RES THER, V50, P685, DOI 10.1016/j.brat.2012.07.005; Piperidou C, 2008, SEIZURE-EUR J EPILEP, V17, P588, DOI 10.1016/j.seizure.2008.02.005; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Sadler M, 1999, EPILEPSIA, V40, P322, DOI 10.1111/j.1528-1157.1999.tb00712.x; Siebern AT, 2010, MED CLIN N AM, V94, P581, DOI 10.1016/j.mcna.2010.02.005; Vendrame MYB, J CLIN SLEE IN PRESS, V9; Vgontzas AN, 2010, SLEEP, V33, P1159, DOI 10.1093/sleep/33.9.1159; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Wallace DM, 2012, INT J STROKE, V7, P231, DOI 10.1111/j.1747-4949.2011.00760.x	44	14	14	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	APR	2013	27	1					159	164		10.1016/j.yebeh.2013.01.008			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	118MG	WOS:000317029000030	23434722				2021-06-18	
J	O'Kelly, J; Magee, WL				O'Kelly, Julian; Magee, Wendy L.			The complementary role of music therapy in the detection of awareness in disorders of consciousness: An audit of concurrent SMART and MATADOC assessments	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Music therapy; Assessment; Disorders of consciousness; MATADOC; SMART; Diagnosis	SENSORY MODALITY ASSESSMENT; TRAUMATIC BRAIN-INJURY; REHABILITATION TECHNIQUE; VEGETATIVE STATE; EPIDEMIOLOGY; TOOL	In the behavioural assessment of disorders of consciousness (DOC), best practice is for several different assessment tools to be used to encourage a variety of different responses indicative of awareness. Anecdotal evidence suggests a range of musical stimuli may be particularly effective in eliciting responses to guide the assessment process, although comparative data regarding behavioural domains is lacking. This study examined 42 concurrent records of patients assessed using the Sensory Modality Assessment and Rehabilitation Technique (SMART), and the Music Therapy Assessment Tool for Awareness in Disorders of Consciousness (MATADOC) to explore the relationship between diagnosis and behavioural characteristics of the cohort. Whilst the two tools produced a high level of agreement in diagnostic outcome (Spearman Rho .80), divergent diagnosis and weaker correlations between behavioural response items highlight contrasting sensitivities of the tools. Whilst MATADOC has higher sensitivity within auditory and visual domains relative to SMART, SMART has higher sensitivity in the motor domain. The significant contribution of musical response items in MATADOC, and the tactile response item in SMART, indicates both tools provide unique behavioural data predictive of awareness. Multidisciplinary assessment using SMART and MATADOC provides complementary data contributing to a fuller understanding of a patient's level of awareness.	[O'Kelly, Julian] Royal Hosp Neurodisabil, London SW15 3SW, England; [O'Kelly, Julian] Aalborg Univ, Aalborg, Denmark; [Magee, Wendy L.] Temple Univ, Boyer Coll Mus & Dance, Philadelphia, PA 19122 USA	O'Kelly, J (corresponding author), Royal Hosp Neurodisabil, West Hill, London SW15 3SW, England.	jokelly@rhn.org.uk	Magee, Wendy L./AAP-6839-2020	Magee, Wendy L./0000-0003-4350-1289	Aalborg University; Neuro-disability Research Trust; Music Therapy Charity	The authors would like to acknowledge the support of Dr Sophie Duport, Head of Research at the Royal Hospital for Neuro-disability (RHN); the RHN Music Therapy and Occupational Therapy staff; and funding from Aalborg University, the Neuro-disability Research Trust and the Music Therapy Charity.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Daveson BA, 2007, INT J THER REHABIL, V14, P545, DOI 10.12968/ijtr.2007.14.12.27760; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Gill-Thwaites H, 2004, BRAIN INJURY, V18, P1255, DOI 10.1080/02699050410001719952; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; Magee W.L., 2012, BRAIN INJURY, V26, P309; Magee W.L., 2012, MUSIC THERAPY UNPUB; Magee WL, 2007, NEUROREHABILITATION, V22, P319; Magee WL, 2005, NEUROPSYCHOL REHABIL, V15, P522, DOI 10.1080/09602010443000461; O'Kelly J., 2012, NORDIC J MU IN PRESS; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2000, WHIM WESSEX HEAD INJ; The Royal College of Physicians, 2003, VEG STAT GUID DIAGN; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	20	14	14	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 1	2013	23	2					287	298		10.1080/09602011.2012.753395			12	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	105KU	WOS:000316068800008	23302033				2021-06-18	
J	Porter, CK; Thura, N; Riddle, MS				Porter, Chad K.; Thura, Nadia; Riddle, Mark S.			Quantifying the Incidence and Burden of Postinfectious Enteric Sequelae	MILITARY MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; FUNCTIONAL GASTROINTESTINAL DISORDERS; SALMONELLA REACTIVE ARTHRITIS; SYNDROME FOLLOWING INFECTION; BACTERIAL GASTROENTERITIS; CAMPYLOBACTER-JEJUNI; FOLLOW-UP	Background: Evidence continues to reveal that travelers' diarrhea (TD) may be associated with several chronic conditions. We quantified the burden of these TD sequelae (TDS) and compared it to post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI), both well-appreciated long-term health outcomes (LTHO) of deployment. Methods: A systematic review of outcome-specific incidence and disability was conducted to estimate years lived with disability (YLDs) allowing for comparisons of disease burden across outcomes. Results: Estimates varied within outcomes across publication year, study design, and data source. YLD estimates showed that although PTSD results in the highest overall disability (1,225 per 100,000), the impact of TDS is similarly elevated with the greatest burden associated with irritable bowel syndrome (627 per 100,000) followed by reactive arthritis (139). Conclusion: Given the significant impact of the acute effects of TD on troop readiness and the growing appreciation for its LTHO, the need for improved primary prevention strategies are evident. Additional study of the pathogen-specific risk of these sequelae and duration and level of disability are needed to further refine our understanding of morbidity and inform evidence-based decisions on policy toward disease mitigation among those put in harm's way.	[Porter, Chad K.; Thura, Nadia; Riddle, Mark S.] Naval Med Res Ctr, Infect Dis Res Directorate, Enter Dis Dept, Silver Spring, MD 20910 USA	Porter, CK (corresponding author), Naval Med Res Ctr, Infect Dis Res Directorate, Enter Dis Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.		Riddle, Mark/R-8788-2019	Riddle, Mark/0000-0002-0607-7880	Military Infectious Disease Research Program	This study was conducted under support of the Military Infectious Disease Research Program.	Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Andersen J, 2010, PSYCHOSOM MED, V72, P498, DOI 10.1097/PSY.0b013e3181d969a1; [Anonymous], 2006, Clin Privil White Pap, P1; [Anonymous], 2008, 9780833044549 RAND C; Bernsen RAJAM, 2002, J NEUROL SCI, V201, P13, DOI 10.1016/S0022-510X(02)00158-2; Bevan Gwyn, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P469, DOI 10.1586/14737167.3.4.469; Borgaonkar MR, 2006, DIGEST DIS SCI, V51, P1026, DOI 10.1007/s10620-006-9348-1; BREMELL T, 1991, ANN RHEUM DIS, V50, P934, DOI 10.1136/ard.50.12.934; Cumberland P, 2003, EPIDEMIOL INFECT, V130, P453, DOI 10.1017/S0950268803008410; Curry JA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-266; DeFraites RF, 2011, MIL MED, V176, P17, DOI 10.7205/MILMED-D-11-00115; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Dworkin MS, 2001, CLIN INFECT DIS, V33, P1010, DOI 10.1086/322644; EASTMOND CJ, 1983, J RHEUMATOL, V10, P107; Garg AX, 2008, RHEUMATOLOGY, V47, P200, DOI 10.1093/rheumatology/kem339; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Gaylord KM, 2008, J TRAUMA, V64, pS5; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Gray GC, 1996, NEW ENGL J MED, V335, P1505, DOI 10.1056/NEJM199611143352007; Gwee KA, 1996, LANCET, V347, P150, DOI 10.1016/S0140-6736(96)90341-4; Haagsma JA, 2008, INJURY PREV, V14, P5, DOI 10.1136/ip.2007.017178; Haagsma JA, 2006, 3303310012009 RIVM I; Haagsma JA, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-10; Haagsma Juanita A, 2008, Popul Health Metr, V6, P7, DOI 10.1186/1478-7954-6-7; HAKANSSON U, 1976, SCAND J INFECT DIS, V8, P245, DOI 10.3109/inf.1976.8.issue-4.05; Halvorson HA, 2006, AM J GASTROENTEROL, V101, P1894, DOI 10.1111/j.1572-0241.2006.00654.x; Hanevik K, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-27; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Hannu T, 2005, ANN RHEUM DIS, V64, P594, DOI 10.1136/ard.2004.027524; Hannu T, 2002, ANN RHEUM DIS, V61, P264, DOI 10.1136/ard.61.3.264; Hannu T, 2011, BEST PRACT RES CL RH, V25, P347, DOI 10.1016/j.berh.2011.01.018; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hermann BA, 2012, MIL MED, V177, P1; Hoang Hanh T M, 2008, Cost Eff Resour Alloc, V6, P17, DOI 10.1186/1478-7547-6-17; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ilnyckyj A, 2003, AM J GASTROENTEROL, V98, P596, DOI [10.1016/S0002-9270(02)06019-7, 10.1111/j.1572-0241.2003.07297.x]; INMAN RD, 1988, ARTHRITIS RHEUM, V31, P1377, DOI 10.1002/art.1780311106; Institute of Medicine, 2008, GULF WAR HLTH, V7; Institute of Medicine (IOM), 2008, TREATM POSTTR STRESS, P21; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Ji S, 2005, J GASTROEN HEPATOL, V20, P381, DOI 10.1111/j.1440-1746.2005.03574.x; Kim Hee Sun, 2006, Korean J Gastroenterol, V47, P300; KOSUNEN TU, 1980, LANCET, V1, P1312; LAUHIO A, 1988, ARTHRITIS RHEUM, V31, P1190, DOI 10.1002/art.1780310917; Locht H, 2002, J RHEUMATOL, V29, P767; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Marshall JK, 2010, GUT, V59, P605, DOI 10.1136/gut.2009.202234; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Mathers C, 1999, BURDEN DIS INJURY AU; Mattila L, 1998, J INFECTION, V36, P289, DOI 10.1016/S0163-4453(98)94243-8; McCarthy N, 1999, EPIDEMIOL INFECT, V122, P15, DOI 10.1017/S0950268898001861; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; McColl GJ, 2000, AUST NZ J MED, V30, P28, DOI 10.1111/j.1445-5994.2000.tb01050.x; MCKENDRICK MW, 1994, J INFECTION, V29, P1, DOI 10.1016/S0163-4453(94)94871-2; Mearin F, 2005, GASTROENTEROLOGY, V129, P98, DOI 10.1053/j.gastro.2005.04.012; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Neal KR, 1997, BRIT MED J, V314, P779, DOI 10.1136/bmj.314.7083.779; Nelson Laura, 2009, BMC Res Notes, V2, P171, DOI 10.1186/1756-0500-2-171; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Parry SD, 2003, AM J GASTROENTEROL, V98, P1970, DOI 10.1016/S0002-9270(03)00627-0; Piche T, 2007, CAN J GASTROENTEROL, V21, P727, DOI 10.1155/2007/262478; Pitzurra R, 2011, J TRAVEL MED, V18, P250, DOI 10.1111/j.1708-8305.2011.00529.x; Pope JE, 2007, SEMIN ARTHRITIS RHEU, V37, P48, DOI 10.1016/j.semarthrit.2006.12.006; Porter CK, 2008, GASTROENTEROLOGY, V135, P781, DOI 10.1053/j.gastro.2008.05.081; Porter CK, 2011, DIGEST DIS SCI, V56, P3262, DOI 10.1007/s10620-011-1762-3; Porter CK, 2011, AM J GASTROENTEROL, V106, P130, DOI 10.1038/ajg.2010.371; Rees JR, 2004, CLIN INFECT DIS, V38, pS311, DOI 10.1086/381601; Riddle MS, 2006, AM J TROP MED HYG, V74, P891, DOI 10.4269/ajtmh.2006.74.891; Rodriguez LAG, 1999, BRIT MED J, V318, P565, DOI 10.1136/bmj.318.7183.565; Rohekar S, 2008, J RHEUMATOL, V35, P1599; Ruigomez A, 2007, CLIN GASTROENTEROL H, V5, P465, DOI 10.1016/j.cgh.2007.02.008; Sanderson K, 2001, AUST NZ J PSYCHIAT, V35, P668, DOI 10.1080/0004867010060517; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schiellerup P, 2008, J RHEUMATOL, V35, P480; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sostek MB, 1996, AM J GASTROENTEROL, V91, P2494; Soyturk M, 2007, AM J GASTROENTEROL, V102, P1064, DOI 10.1111/j.1572-0241.2007.01084.x; Stermer E, 2006, CLIN INFECT DIS, V43, P898, DOI 10.1086/507540; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Ternhag A, 2008, EMERG INFECT DIS, V14, P143, DOI 10.3201/eid1401.070524; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thabane M, 2007, ALIMENT PHARM THER, V26, P535, DOI 10.1111/j.1365-2036.2007.03399.x; THOMSON GTD, 1995, AM J MED, V98, P13, DOI 10.1016/S0002-9343(99)80076-X; THOMSON GTD, 1992, CLIN IMMUNOL IMMUNOP, V64, P227, DOI 10.1016/0090-1229(92)90204-2; Townes JM, 2010, CLIN INFECT DIS, V50, P247, DOI 10.1086/649540; Uotila T, 2011, SCAND J RHEUMATOL, V40, P358, DOI 10.3109/03009742.2011.562533; Wang LH, 2004, GUT, V53, P1096, DOI [10.1136/gut.2003.021154, 10.1136/gut.2003.021154corr1]; World Health Organization, NAT BURD DIS SUPPL F	92	14	14	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	APR	2013	178	4					452	469		10.7205/MILMED-D-12-00510			18	Medicine, General & Internal	General & Internal Medicine	AN7TY	WOS:000340805100019	23707833	Bronze			2021-06-18	
J	Dapul, HR; Park, J; Zhang, J; Lee, C; DanEshmand, A; Lok, J; Ayata, C; Gray, T; Scalzo, A; Qiu, JH; Lo, EH; Whalen, MJ				Dapul, Heda R.; Park, Juyeon; Zhang, Jimmy; Lee, Christopher; DanEshmand, Ali; Lok, Josephine; Ayata, Cenk; Gray, Tory; Scalzo, Allison; Qiu, Jianhua; Lo, Eng H.; Whalen, Michael J.			Concussive Injury before or after Controlled Cortical Impact Exacerbates Histopathology and Functional Outcome in a Mixed Traumatic Brain Injury Model in Mice	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cognition; concussion; controlled cortical impact; mice; models	DIFFUSE AXONAL INJURY; MICROGLIAL ACTIVATION; SEIZURE SUSCEPTIBILITY; CEREBRAL CONCUSSION; COGNITIVE DEFICITS; CELL-DEATH; RATS; NEURODEGENERATION; PATHOPHYSIOLOGY; INCREASES	Traumatic brain injury (TBI) may involve diverse injury mechanisms (e. g., focal impact vs. diffuse impact loading). Putative therapies developed in TBI models featuring a single injury mechanism may fail in clinical trials if the model does not fully replicate multiple injury subtypes, which may occur concomitantly in a given patient. We report development and characterization of a mixed contusion/concussion TBI model in mice using controlled cortical impact (CCI; 0.6mm depth, 6 m/sec) and a closed head injury (CHI) model at one of two levels of injury (53 vs. 83 g weight drop from 66 in). Compared with CCI or CHI alone, sequential CCI-CHI produced additive effects on loss of consciousness (p < 0.001), acute cell death (p < 0.05), and 12-day lesion size (p < 0.05) but not brain edema or 48-h contusion volume. Additive effects of CHI and CCI on post-injury motor (p < 0.05) and cognitive (p < 0.005) impairment were observed with sequential CCI-CHI (83 g). The data suggest that concussive forces, which in isolation do not induce histopathological damage, exacerbate histopathology and functional outcome after cerebral contusion. Sequential CHI-CCI may model complex injury mechanisms that occur in some patients with TBI and may prove useful for testing putative therapies.	[Dapul, Heda R.; Park, Juyeon; Zhang, Jimmy; Lee, Christopher; DanEshmand, Ali; Lok, Josephine; Ayata, Cenk; Qiu, Jianhua; Lo, Eng H.; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA USA; [Dapul, Heda R.; Park, Juyeon; Zhang, Jimmy; Lee, Christopher; Lok, Josephine; Gray, Tory; Qiu, Jianhua; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Charlestown, MA USA; [DanEshmand, Ali; Ayata, Cenk; Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA; [Ayata, Cenk; Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Scalzo, Allison] Penn State Univ, University Pk, PA 16802 USA	Whalen, MJ (corresponding author), Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Charlestown, MA 02129 USA.	mwhalen@partners.org			 [1R21NS075226];  [RO1NS047447];  [RO1NS064545]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047447, R21NS075226, K08NS057339, R01NS064545] Funding Source: NIH RePORTER	This work was supported by 1R21NS075226, RO1NS047447 and RO1NS064545 (MJW).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Golarai G, 2001, J NEUROSCI, V21, P8523; JENKINS A, 1986, LANCET, V2, P445; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Mirzayan MJ, 2012, EXP TOXICOL PATHOL, V64, P133, DOI 10.1016/j.etp.2010.07.007; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wang HC, 2010, J NEUROTRAUM, V27, P707, DOI 10.1089/neu.2009.1071; Wang XJ, 2011, FREE RADICAL BIO MED, V50, P1094, DOI 10.1016/j.freeradbiomed.2011.01.032; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhou Y, 2005, MOL CELL PROTEOMICS, V4, P1471, DOI 10.1074/mcp.M500114-MCP200	43	14	16	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2013	30	5					382	391		10.1089/neu.2012.2536			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	103CI	WOS:000315891600008	23153355	Green Published			2021-06-18	
J	Knutson, KM; Rakowsky, ST; Solomon, J; Krueger, F; Raymont, V; Tierney, MC; Wassermann, EM; Grafman, J				Knutson, Kristine M.; Rakowsky, Shana T.; Solomon, Jeffrey; Krueger, Frank; Raymont, Vanessa; Tierney, Michael C.; Wassermann, Eric M.; Grafman, Jordan			Injured brain regions associated with anxiety in Vietnam veterans	NEUROPSYCHOLOGIA			English	Article						Anxiety; Traumatic brain injury; Voxel-based lesion symptom mapping	POSTTRAUMATIC-STRESS-DISORDER; PENETRATING HEAD-INJURY; AVERSIVE VISUAL-STIMULI; BED NUCLEUS; ORBITOFRONTAL CORTEX; HIPPOCAMPAL-LESIONS; PREFRONTAL CORTEX; FUNCTIONAL NEUROANATOMY; HEMISPHERIC-ASYMMETRY; BASOLATERAL AMYGDALA	Anxiety negatively affects quality of life and psychosocial functioning. Previous research has shown that anxiety symptoms in healthy individuals are associated with variations in the volume of brain regions, such as the amygdala, hippocampus, and the bed nucleus of the stria terminalis. Brain lesion data also suggests the hemisphere damaged may affect levels of anxiety. We studied a sample of 182 male Vietnam War veterans with penetrating brain injuries, using a semi-automated voxel-based lesion-symptom mapping (VLSM) approach. VLSM reveals significant associations between a symptom such as anxiety and the location of brain lesions, and does not require a broad, subjective assignment of patients into categories based on lesion location. We found that lesioned brain regions in cortical and limbic areas of the left hemisphere, including middle, inferior and superior temporal lobe, hippocampus, and fusiform regions, along with smaller areas in the inferior occipital lobe, parahippocampus, amygdala, and insula, were associated with increased anxiety symptoms as measured by the Neurobehavioral Rating Scale (NRS). These results were corroborated by similar findings using Neuropsychiatric Inventory (NPI) anxiety scores, which supports these regions' role in regulating anxiety. In summary, using a semi-automated analysis tool, we detected an effect of focal brain damage on the presentation of anxiety. We also separated the effects of brain injury and war experience by including a control group of combat veterans without brain injury. We compared this control group against veterans with brain lesions in areas associated with anxiety, and against veterans with lesions only in other brain areas. Published by Elsevier Ltd.	[Knutson, Kristine M.; Tierney, Michael C.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, NIH, Bethesda, MD 20892 USA; [Rakowsky, Shana T.] Georgetown Univ, Georgetown Coll, Washington, DC USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Raymont, Vanessa] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Raymont, Vanessa] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Chicago, IL 60611 USA	Knutson, KM (corresponding author), NINDS, Behav Neurol Unit, NIH, 10 Ctr Dr, Bethesda, MD 20892 USA.	knutsonk@ninds.nih.gov; jgrafman@ric.org	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Knutson, Kristine/0000-0003-4626-4514; Grafman, Jordan H./0000-0001-8645-4457	United States National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program; United States Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD17-01-1-0675]	We especially thank the Vietnam War veterans who participated in this study. We thank the National Naval Medical Center for their support and provision of their facilities and S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for their invaluable help with the testing of participants and organization of this study. The work was supported by the United States National Institutes of Health, National Institute of Neurological Disorders and Stroke, intramural research program, and a project grant from the United States Army Medical Research and Material Command administrated by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study, Grant DAMD17-01-1-0675). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, nor the United States Government.	Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; AMARAL D G, 1992, P1; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anderson AK, 2000, NEUROPSYCHOLOGY, V14, P526, DOI 10.1037/0894-4105.14.4.526; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; BLANCHARD RJ, 1993, BEHAV BRAIN RES, V58, P155, DOI 10.1016/0166-4328(93)90100-5; Blanco E, 2009, BEHAV BRAIN RES, V201, P338, DOI 10.1016/j.bbr.2009.03.001; BUYDENSBRANCHEY L, 1990, J NERV MENT DIS, V178, P582, DOI 10.1097/00005053-199009000-00005; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; CORRIGAN J D, 1990, Brain Injury, V4, P215, DOI 10.3109/02699059009026170; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; DAVIS M, 1994, INT REV NEUROBIOL, V36, P225, DOI 10.1016/S0074-7742(08)60305-0; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; De Bellis MD, 2002, BIOL PSYCHIAT, V51, P553, DOI 10.1016/S0006-3223(01)01375-0; de Geus EJC, 2007, BIOL PSYCHIAT, V61, P1062, DOI 10.1016/j.biopsych.2006.07.026; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Dellacherie D, 2011, NEUROPSYCHOLOGIA, V49, P618, DOI 10.1016/j.neuropsychologia.2010.11.008; Duvarci S, 2009, J NEUROSCI, V29, P10357, DOI 10.1523/JNEUROSCI.2119-09.2009; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein R. S., 1994, NEUROPSYCHIATRY TRAU; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; File SE, 1998, NEUROPSYCHOPHARMACOL, V19, P397, DOI 10.1016/S0893-133X(98)00035-9; First MB., STRUCTURED CLIN INTE, V1996; Fox AS, 2010, J NEUROSCI, V30, P7023, DOI 10.1523/JNEUROSCI.5952-09.2010; Gainotti G, 1972, Cortex, V8, P41; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Glascher J, 2003, J NEUROSCI, V23, P10274; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Gray J., 1982, NEUROPSYCHOLOGY ANXI; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heller W, 1998, COGNITION EMOTION, V12, P421; Heller W., 1990, PSYCHOL BIOL APPROAC, P167; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kalin NH, 2003, ANN NY ACAD SCI, V1008, P189, DOI 10.1196/annals.1301.021; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kier EL, 2004, AM J NEURORADIOL, V25, P677; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEE GP, 1988, NEUROLOGY, V38, P1233, DOI 10.1212/WNL.38.8.1233; Letizia B, 2008, J PSYCHIATR RES, V42, P752, DOI 10.1016/j.jpsychires.2007.08.004; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Liberzon I, 2000, NEUROPSYCHOPHARMACOL, V23, P508, DOI 10.1016/S0893-133X(00)00157-3; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Machado CJ, 2009, EMOTION, V9, P147, DOI 10.1037/a0014539; Mainio A, 2003, J NEUROL NEUROSUR PS, V74, P1278, DOI 10.1136/jnnp.74.9.1278; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mason WA, 2006, EMOTION, V6, P73, DOI 10.1037/1528-3542.6.1.73; Mathiak K. A., 2006, MAGNETIC RESONANCE M, V25, P177; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Montag C, 2012, NEUROSCIENCE, V217, P77, DOI 10.1016/j.neuroscience.2012.05.017; Mori S., 2005, MRI ATLAS HUMAN WHIT; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Oler JA, 2010, NATURE, V466, P864, DOI 10.1038/nature09282; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; REIMAN EM, 1984, NATURE, V310, P683, DOI 10.1038/310683a0; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; SANDERS SK, 1995, BIOL PSYCHIAT, V37, P473, DOI 10.1016/0006-3223(94)00183-4; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; Schiltz C, 2006, CEREB CORTEX, V16, P574, DOI 10.1093/cercor/bhj005; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spampinato MV, 2009, J NEUROPSYCH CLIN N, V21, P199, DOI 10.1176/appi.neuropsych.21.2.199; Spielberger CD, 1983, STATE TRAIT ANXIETY; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Syal S, 2012, METAB BRAIN DIS, V27, P299, DOI 10.1007/s11011-012-9299-5; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; Thomas KM, 2001, ARCH GEN PSYCHIAT, V58, P1057, DOI 10.1001/archpsyc.58.11.1057; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Truitt WA, 2007, PSYCHOPHARMACOLOGY, V191, P107, DOI 10.1007/s00213-006-0674-y; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uchidi R. R., 2000, PSYCHIAT RES-NEUROIM, V163, P21; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vythilingam M, 2000, PSYCHIAT RES-NEUROIM, V99, P75, DOI 10.1016/S0925-4927(00)00055-X; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; WELLER KL, 1982, BRAIN RES, V232, P255, DOI 10.1016/0006-8993(82)90272-4; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wright CI, 2003, BIOL PSYCHIAT, V54, P1067, DOI 10.1016/S0006-3223(03)00548-1	120	14	15	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAR	2013	51	4					686	694		10.1016/j.neuropsychologia.2013.01.003			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	121PV	WOS:000317257600012	23328629	Green Accepted			2021-06-18	
J	Kowalczyk, M; Nestorowicz, A; Fijalkowska, A; Kwiatosz-Muc, M				Kowalczyk, Michal; Nestorowicz, Andrzej; Fijalkowska, Anna; Kwiatosz-Muc, Magdalena			Emotional sequelae among survivors of critical illness: a long-term retrospective study	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article							QUALITY-OF-LIFE; RESPIRATORY-DISTRESS-SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; CARE-UNIT SURVIVORS; INTENSIVE-CARE; PSYCHOLOGICAL DISTRESS; DEPRESSION SCALE; HOSPITAL ANXIETY; MENTAL-HEALTH; ICU SURVIVORS	Context Treatment in an ICU can be stressful and traumatic for patients, and can lead to various physical, psychological and cognitive sequelae. Objectives The aim of the study was to assess the influence of the social, economic and working status of individuals in regard to long-term anxiety and depression among ICU convalescents. Design Retrospective, cross-sectional, 5-year survey between 2005 and 2009. Setting The general ICUs of two hospitals in Lublin (Poland): the Teaching Hospital, Medical University of Lublin and the District Hospital. Patients All adults surviving an ICU stay of more than 24 h were eligible. In December 2010, 533 questionnaires were sent to discharged ICU survivors, and 195 (36.6%) were returned. One hundred and eighty-six patients were enrolled in the study. Patients with brain injuries were excluded. Main outcome measures The questionnaire consisted of the Hospital Anxiety and Depression Scale (HADS); questions defining social, economic and working status before and after intensive care stay, health status before intensive care stay, as well as questions about memories and readmissions to intensive care were included. Results According to HADS, 34.4% patients had an anxiety disorder and 27.4% were depressed. There was a strong positive correlation between anxiety and depression (r = +0.726, P < 0.001). Better material and housing conditions correlated with lower anxiety and depression rates. Acute Physiology and Chronic Health Evaluation II scores on admission positively correlated with both anxiety (r = +0.187; P = 0.011) and depression (r = +0.239; P = 0.001). A negative correlation between health status before intensive care admission and HADS scores was observed (anxiety r(s) = -0.193; P = 0.008; depression r(s) = -0.227; P = 0.002); better health resulted in less anxiety and depression disorders. Conclusion Adverse social and economic status is associated with higher rates of anxiety and depression following ICU stay. Eur J Anaesthesiol 2013; 30:111-118	[Kowalczyk, Michal; Nestorowicz, Andrzej; Fijalkowska, Anna; Kwiatosz-Muc, Magdalena] Med Univ Lublin, Dept Anaesthesiol & Intens Care 1, Lublin, Poland	Kowalczyk, M (corresponding author), Ul Szwajcarska 10-16, PL-20861 Lublin, Poland.	michalkowalczyk@vp.pl	Kowalczyk, Michal/AAN-1914-2021	Kowalczyk, Michal/0000-0002-1991-190X; Kwiatosz-Muc, Magdalena/0000-0002-0064-1604			Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Brooks R, 1997, INTENS CARE MED, V23, P581, DOI 10.1007/s001340050376; Cuthbertson BH, 2005, ANAESTHESIA, V60, P332, DOI 10.1111/j.1365-2044.2004.04109.x; Davydow DS, 2009, INTENS CARE MED, V35, P796, DOI 10.1007/s00134-009-1396-5; Eddleston JM, 2000, CRIT CARE MED, V28, P2293, DOI 10.1097/00003246-200007000-00018; Griffiths RD, 1999, BRIT MED J, V319, P427, DOI 10.1136/bmj.319.7207.427; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Jackson JC, 2009, CRIT CARE CLIN, V25, P615, DOI 10.1016/j.ccc.2009.04.005; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; KATZ IR, 1982, PSYCHOSOMATICS, V23, P846; Katz IR, 1996, AM J GERIAT PSYCHIAT, V4, P1, DOI 10.1097/00019442-199624410-00001; Kiekkas P, 2010, INT NURS REV, V57, P288, DOI 10.1111/j.1466-7657.2010.00809.x; Kowalczyk Michal, 2008, Anestezjol Intens Ter, V40, P162; Nelson BJ, 2000, CRIT CARE MED, V28, P3626, DOI 10.1097/00003246-200011000-00013; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Orwelius L, 2005, CRIT CARE MED, V33, P1557, DOI 10.1097/01.CCM.0000168208.32006.1C; PEARLSON GD, 1989, PSYCHOL MED, V19, P573, DOI 10.1017/S003329170002417X; Rattray JE, 2005, ANAESTHESIA, V60, P1085, DOI 10.1111/j.1365-2044.2005.04336.x; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Schelling G, 1998, CRIT CARE MED, V26, P651, DOI 10.1097/00003246-199804000-00011; Scragg P, 2001, ANAESTHESIA, V56, P9, DOI 10.1046/j.1365-2044.2001.01714.x; Snaith RP, 1994, HOSP ANXIETY DEPRESS, P1; Sukantarat KT, 2007, ANAESTHESIA, V62, P239, DOI 10.1111/j.1365-2044.2006.04948.x; Sukantarat K, 2007, BRIT J HEALTH PSYCH, V12, P65, DOI 10.1348/135910706X94096; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Toien K, 2010, J TRAUMA, V69, P1552, DOI 10.1097/TA.0b013e3181e125f3; Truman Brenda, 2003, Crit Care Nurse, V23, P25; Wojcik M., 2003, THESIS MED U LUBLIN, P286; Zifko UA, 2000, MUSCLE NERVE, pS49; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	14	17	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	MAR	2013	30	3					111	118		10.1097/EJA.0b013e32835dcc45			8	Anesthesiology	Anesthesiology	085QT	WOS:000314630000005	23358098				2021-06-18	
J	Radomski, MV; Weightman, MM; Davidson, LF; Finkelstein, M; Goldman, S; McCulloch, K; Roy, TC; Scherer, M; Stern, EB				Radomski, Mary Vining; Weightman, Margaret M.; Davidson, Leslie Freeman; Finkelstein, Marsha; Goldman, Sarah; McCulloch, Karen; Roy, Tanja C.; Scherer, Matthew; Stern, Erica B.			Development of a Measure to Inform Return-to-Duty Decision Making After Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							ECOLOGICAL VALIDITY; COGNITIVE TASKS; CONCUSSION; PERFORMANCE; ATTENTION; RECOVERY; DEFICITS; GAIT; INTERFERENCE; STABILITY	Mild traumatic brain injury (mTBI), a principal injury of the wars in Iraq and Afghanistan, can result in significant morbidity. To make accurate return-to-duty decisions for soldiers with mTBI, military medical personnel require sensitive, objective, and duty-relevant data to characterize subtle cognitive and sensorimotor injury sequelae. A military-civilian research team reviewed existing literature and obtained input from stakeholders, end users, and experts to specify the concept and develop a preliminary assessment protocol to address this need. Results of the literature review suggested the potential utility of a test based on dual-task and multitask assessment methods. Thirty-three individuals representing a variety of military and civilian stakeholders/experts participated in interviews. Interview data suggested that reliability/validity, clinical feasibility, usability across treatment facilities, military face validity, and capacity to challenge mission-critical mTBI vulnerabilities were important to ultimate adoption. The research team developed the Assessment of Military Multitasking Performance, a tool composed of eight dual and multitasking test-tasks. A concept test session with 10 subjects indicated preliminary face validity and informed modifications to scoring and design. Further validation is needed. The Assessment of Military Multitasking Performance may fill a gap identified by stakeholders for complex cognitive/motor testing to assist return-to-duty decisions for service members with mTBI.	[Radomski, Mary Vining; Weightman, Margaret M.; Finkelstein, Marsha] Sister Kenny Res Ctr, Minneapolis, MN 55407 USA; [Davidson, Leslie Freeman] Shenandoah Univ, Div Occupat Therapy, Winchester, VA 22601 USA; [Goldman, Sarah; Roy, Tanja C.; Scherer, Matthew] US Army Res Inst Environm Med, Natick, MA 01760 USA; [McCulloch, Karen] Univ N Carolina, Sch Med, Div Phys Therapy, Chapel Hill, NC 27599 USA; [Stern, Erica B.] Univ Minnesota, Ctr Allied Hlth Programs, Program Occupat Therapy, Minneapolis, MN 55455 USA	Radomski, MV (corresponding author), Sister Kenny Res Ctr, 800 East 28th St & Chicago Ave, Minneapolis, MN 55407 USA.				U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-2-0149]	The research team acknowledges the contribution of those interviewed and the following partners and experts who have helped to shape the AMMP protocol: Amanda Antczalc, MS; Kristin Heaton, PhD; Val Kelly PT, PhD; Lynne M. Lowe, PT, DPT, OCS; Tracy Morrison, OTD, OTR/L; Lars Oddsson, PhD; John Whyte, MD, PhD; and Tim Wolf, OTD, MSCI, OTR/L. This project was funded by the U.S. Army Medical Research and Materiel Command (award number W81XWH-09-2-0149).	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Armed Forces Health Surveillance Center, TBI NUMB SEV ALL ARM; Arnadottir A, 1990, BRAIN BEHAV ASSESSIN; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P465; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cockburn J, 2003, CLIN REHABIL, V17, P167, DOI 10.1191/0269215503cr597oa; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Department of the Army, 2006, SOLD MAN COMM TASKS; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kenworthy L, 2008, NEUROPSYCHOL REV, V18, P320, DOI 10.1007/s11065-008-9077-7; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; LAWTON MP, 1971, J AM GERIATR SOC, V19, P465, DOI 10.1111/j.1532-5415.1971.tb01206.x; Loewenstein D, 2010, NEUROPSYCHOLOGY EVER, P93; Lynn WJI, 2010, 09033 DTM DEP DEF; Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46, P1; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; Maylor EA, 2001, BRIT J PSYCHOL, V92, P319, DOI 10.1348/000712601162211; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Meher I, 2004, J AM GERIATR SOC, V52, P1255, DOI 10.1111/j.1532-5415.2004.52353.x; Moore DJ, 2007, J PSYCHIATR RES, V41, P97, DOI 10.1016/j.jpsychires.2005.10.008; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Siu KC, 2009, BRAIN RES, V1248, P59, DOI 10.1016/j.brainres.2008.10.078; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vaskinn A, 2009, J NERV MENT DIS, V197, P700, DOI 10.1097/NMD.0b013e3181b3ae62; Wolf TJ, 2008, WORK, V31, P221	48	14	14	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2013	178	3					246	253		10.7205/MILMED-D-12-00144			8	Medicine, General & Internal	General & Internal Medicine	AN7TX	WOS:000340805000003	23707109	Bronze			2021-06-18	
J	Valiyaveettil, M; Alamneh, Y; Wang, Y; Arun, P; Oguntayo, S; Wei, YL; Long, JB; Nambiar, MP				Valiyaveettil, Manojkumar; Alamneh, Yonas; Wang, Ying; Arun, Peethambaran; Oguntayo, Samuel; Wei, Yanling; Long, Joseph B.; Nambiar, Madhusoodana P.			Contribution of systemic factors in the pathophysiology of repeated blast-induced neurotrauma	NEUROSCIENCE LETTERS			English	Article						Repeated blast exposure; Platelets; Leukocytes; Systemic factors; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; LYSOPHOSPHATIDIC ACID; SUICIDAL-BEHAVIOR; INTRACRANIAL-PRESSURE; NERVOUS-SYSTEM; SEROTONIN; MYELOPEROXIDASE; PLATELETS; MODEL; OVERPRESSURE	Blast-induced traumatic brain injury is complex and involves multiple factors including systemic pathphysiological factors in addition to direct brain injuries. We hypothesize that systemic activation of platelets/leukocytes plays a major role in the development and exacerbation of brain injury after blast exposure. A mouse model of repeated blast exposure that results in significant neuropathology, neurobehavioral changes and regional specific alterations in various biomolecules in the brain was used for the proposed study. Activation of platelets was evaluated by flow cytometry and serotonin content was analyzed by ELISA. Expression of myeloperoxidase was analyzed by Western blotting. Histopathology of the brain was used to assess blast-induced cerebral vasoconstriction. The data showed an increase in the activation of platelets at 4 h after repeated blast exposures, indicating changes in platelet phenotype in blast neurotrauma. Platelet serotonin concentration showed a significant decrease at 4 h after blast with a concurrent increase in the plasma serotonin levels, confirming the early onset of platelet activation after repeated blast exposures. Blood, plasma and brain myeloperoxidase enzyme activity and expression was increased in repeated blast exposed mice at multiple time points. Histopathological analysis of the brains of blast exposed mice showed constriction of blood vessels compared to the respective controls, a phenomenon similar to the reported cerebral vasoconstriction in blast affected victims. These results suggest that repeated blast exposure leads to acute activation of platelets/leukocytes which can augment the pathological effects of brain injury. Platelet/leukocyte targeted therapies can be evaluated as potential acute treatment strategies to mitigate blast-induced neurotrauma. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Valiyaveettil, Manojkumar; Alamneh, Yonas; Wang, Ying; Arun, Peethambaran; Oguntayo, Samuel; Wei, Yanling; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA	Valiyaveettil, M (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, Silver Spring, MD 20910 USA.	m.valiyaveettil@us.army.mil; madhunambiar1@gmail.com					Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Frisca F, 2012, INT REV CEL MOL BIO, V296, P273, DOI 10.1016/B978-0-12-394307-1.00005-9; Frugier T, 2011, CELL MOL NEUROBIOL, V31, P569, DOI 10.1007/s10571-011-9650-0; GARCIA JH, 1994, AM J PATHOL, V144, P188; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Goldshmit Y, 2010, CELL TISSUE RES, V341, P23, DOI 10.1007/s00441-010-0977-5; Gorbunov NV, 2005, INT J IMMUNOPATH PH, V18, P547, DOI 10.1177/039463200501800315; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovacic Z, 2008, PROG NEURO-PSYCHOPH, V32, P544, DOI 10.1016/j.pnpbp.2007.10.014; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Noguchi N, 2000, J BIOCHEM-TOKYO, V127, P971, DOI 10.1093/oxfordjournals.jbchem.a022713; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ryding E, 2008, PROG BRAIN RES, V172, P307, DOI 10.1016/S0079-6123(08)00915-1; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; VITOLO E, 1962, BRIT HEART J, V24, P422; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; WHITE JG, 1969, BLOOD-J HEMATOL, V33, P598, DOI 10.1182/blood.V33.4.598.598; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	31	14	15	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 28	2013	539						1	6		10.1016/j.neulet.2013.01.028			6	Neurosciences	Neurosciences & Neurology	120FJ	WOS:000317155900001	23370286				2021-06-18	
J	Aungst, S; England, PM; Thompson, SM				Aungst, Stephanie; England, Pamela M.; Thompson, Scott M.			Critical role of trkB receptors in reactive axonal sprouting and hyperexcitability after axonal injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						traumatic brain injury; hippocampus; lesion; plasticity; posttraumatic epilepsy	TRAUMATIC BRAIN-INJURY; MOSSY FIBER PATHWAY; SYNAPTIC-TRANSMISSION; POSTTRAUMATIC EPILEPSY; HIPPOCAMPAL-NEURONS; KAINIC ACID; RAT HIPPOCAMPUS; CEREBRAL-CORTEX; MESSENGER-RNA; DENTATE GYRUS	Aungst S, England PM, Thompson SM. Critical role of trkB receptors in reactive axonal sprouting and hyperexcitability after axonal injury. J Neurophysiol 109: 813-824, 2013. First published November 14, 2012; doi:10.1152/jn.00869.2012.-Traumatic brain injury (TBI) causes many long-term neurological complications. Some of these conditions, such as posttraumatic epilepsy, are characterized by increased excitability that typically arises after a latent period lasting from months to years, suggesting that slow injury-induced processes are critical. We tested the hypothesis that trkB activation promotes delayed injury-induced hyperexcitability in part by promoting reactive axonal sprouting. We modeled penetrative TBI with transection of the Schaffer collateral pathway in knock-in mice having an introduced mutation in the trkB receptor (trkB(F616A)) that renders it susceptible to inhibition by the novel small molecule 1NMPP1. We observed that trkB activation was increased in area CA3 1 day after injury and that expression of a marker of axonal growth, GAP43, was increased 7 days after lesion. Extracellular field potentials in stratum pyramidale of area CA3 in acute slices from sham-operated and lesioned mice were normal in control saline. Abnormal bursts of population spikes were observed under conditions that were mildly proconvulsive but only in slices taken from mice lesioned 7-21 days earlier and not in slices from control mice. trkB activation, GAP43 upregulation, and hyperexcitability were diminished by systemic administration of 1NMPP1 for 7 days after the lesion. Synaptic transmission from area CA3 to area CA1 recovered 7 days after lesion in untreated mice but not in mice treated with 1NMPP1. We conclude that trkB receptor activation and reactive axonal sprouting are critical factors in injury-induced hyperexcitability and may contribute to the neurological complications of TBI.	[Aungst, Stephanie; Thompson, Scott M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Aungst, Stephanie; Thompson, Scott M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [England, Pamela M.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Thompson, SM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.	sthom003@umaryland.edu	Thompson, Scott M/K-8921-2015		National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-40338, F31 NS-071981-01A1]; Epilepsy Foundation of America; Sandler Foundation; Whitehall Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040338, F31NS071981] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (R01 NS-40338 to S. M. Thompson, F31 NS-071981-01A1 to S. Aungst), the Epilepsy Foundation of America Predoctoral Fellowship to S. Aungst, and the Sandler Foundation and Whitehall Foundation to P. M. England.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bausch SB, 2004, J NEUROPHYSIOL, V92, P3582, DOI 10.1152/jn.01028.2003; Bendotti C, 1997, EUR J NEUROSCI, V9, P93, DOI 10.1111/j.1460-9568.1997.tb01357.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENOWITZ LI, 1990, MOL BRAIN RES, V8, P17, DOI 10.1016/0169-328X(90)90004-W; Binder DK, 1999, J NEUROSCI, V19, P4616; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Cavazos JE, 2004, NEUROSCIENCE, V126, P677, DOI 10.1016/j.neuroscience.2004.04.014; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; da Silva A M, 1992, Acta Neurochir Suppl (Wien), V55, P56; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Emery DL, 2000, J COMP NEUROL, V424, P521; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Golarai G, 2001, J NEUROSCI, V21, P8523; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; HAAS HL, 1980, J PHYSIOL-LONDON, V308, P315, DOI 10.1113/jphysiol.1980.sp013473; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; NADLER JV, 1980, BRAIN RES, V182, P1; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; SCHWARTZKROIN PA, 1980, BRAIN RES, V183, P61, DOI 10.1016/0006-8993(80)90119-5; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; TASKER RR, 1991, SYMP PAIN R, P31; Tian GF, 2002, J NEUROPHYSIOL, V88, P236, DOI 10.1152/jn.00572.2001; Traub RD, 1991, NEURONAL NETWORKS HI; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	54	14	15	0	9	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	FEB	2013	109	3					813	824		10.1152/jn.00869.2012			12	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	085TI	WOS:000314636800020	23155176	Green Published			2021-06-18	
J	Kim, H; Colantonio, A; Dawson, DR; Bayley, MT				Kim, Hwan; Colantonio, Angela; Dawson, Deirdre R.; Bayley, Mark T.			Community integration outcomes after traumatic brain injury due to physical assault	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Brain injuries; Community integration; Outcomes assessment	FUNCTIONAL INDEPENDENCE MEASURE; QUALITY-OF-LIFE; INPATIENT REHABILITATION; MARITAL STABILITY; RISK-FACTORS; REINTEGRATION; DISCHARGE; ADULTS; PERSPECTIVES; PREDICTORS	Background. Community integration is considered an ultimate goal for rehabilitation after traumatic brain injury (TBI). Purpose. To determine (a) whether differences exist in rehabilitation outcomes between intentional and unintentional TBI populations and (b) whether TBI from assault is a predictor of community integration following inpatient rehabilitation. Method. Retrospective cohort study using population-based data from Canadian hospital administration records, 2001 to 2006. Outcome measure was the Reintegration to Normal Living Index (RNLI). Findings. From a sample of 243 persons, 24 (9.9%) had sustained TBI from physical assault. Persons with TBI from physical assault reported significantly lower scores on two items on the RNLI's Daily Functioning sub-scale: "recreation'' and "family role.'' Implications. These findings suggest that targeted intervention in these specific areas could be beneficial, which are often primarily addressed by occupational therapists in both inpatient rehabilitation and community settings.	[Kim, Hwan] Daegu Univ, Coll Rehabil Sci, Dept Occupat Therapy, Gyongsan 712714, Gyeongbuk, South Korea; [Kim, Hwan] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Kim, Hwan; Colantonio, Angela] UHN, Toronto Rehabil Inst, Toronto, ON, Canada; [Colantonio, Angela; Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Dawson, Deirdre R.] Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Bayley, Mark T.] UHN, Toronto Rehabil Inst, Neuro Rehabil Program, Toronto, ON M5G 2A2, Canada; [Bayley, Mark T.] Univ Toronto, Fac Med, Div Physiatry, Toronto, ON M5G 1V7, Canada	Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121; Bayley, Mark/0000-0001-7860-9463; Colantonio, Angela/0000-0003-2094-4765	Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute; Toronto Rehabilitation Institute Foundation; Canadian Institutes of Health Research Strategic Team Grant [TIR-103946]	This study was supported by the Ontario Ministry of Health and Long Term Care, which provided funding under the Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute, and the Toronto Rehabilitation Institute Foundation. The Canadian Traumatic Brain Injury and Violence Research Team provided additional support through the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (No. TIR-103946) and the Ontario Neurotrauma Foundation.	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bourdeau I, 2008, INT J REHABIL RES, V31, P267, DOI 10.1097/MRR.0b013e3282fc0ff2; Bowman M, 2008, AUST J RURAL HEALTH, V16, P237, DOI 10.1111/j.1440-1584.2008.00970.x; Canadian Institute for Health Information, 2004, INP REH CAN 2002 200; Canadian Institute for Health Information, 2009, NAT REH REP SYST DAT; Carbonneau H, 2011, BRAIN IMPAIR, V12, P140, DOI 10.1375/brim.12.2.140; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; Centers for Disease Control and Prevention, 2007, INT CLASS DIS 9 REV; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Colantonio A, 2010, J REHABIL MED, V42, P773, DOI 10.2340/16501977-0582; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Cott C. A., 2006, HOSP REPORT REV NATL; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Donnelly C, 2005, SPINAL CORD, V43, P278, DOI 10.1038/sj.sc.3101702; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C., 2001, CRAIG HOSP INVENTORY; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Holford T. R., 2002, MULTIVARIATE METHODS, DOI [10.1093/acprof:oso/9780195124408.001.0001, DOI 10.1093/ACPROF:OSO/9780195124408.001.0001]; Hunt A., FACILITATING G UNPUB; Johansson Ulla, 2007, Scand J Occup Ther, V14, P116, DOI 10.1080/11038120601095093; Kim H, 2011, J TRAUMA, V71, P1219, DOI 10.1097/TA.0b013e3182190fa6; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; Kleinbaum D., 1998, APPL REGRESSION ANAL; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Law M., 2005, CANADIAN OCCUPATIONA, V4th ed; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mammi P, 2006, Eura Medicophys, V42, P17; Mayo NE, 2000, STROKE, V31, P1016, DOI 10.1161/01.STR.31.5.1016; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McColl MA, 2007, BRAIN IMPAIR, V8, P238, DOI DOI 10.1375/BRIM.8.3.238; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Murtezani Ardiana, 2009, Med Arh, V63, P216; Passalent LA, 2011, DISABIL REHABIL, V33, P579, DOI 10.3109/09638288.2010.500346; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wells JL, 2009, CAN J OCCUP THER, V76, P294, DOI 10.1177/000841740907600408; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; WOODDAUPHINEE S, 1987, J CHRON DIS, V40, P491, DOI 10.1016/0021-9681(87)90005-1; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583	57	14	14	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	FEB	2013	80	1					49	58		10.1177/0008417412473262			10	Rehabilitation	Rehabilitation	302HS	WOS:000330595300008	23550497				2021-06-18	
J	Krawczyk, DC; de la Plata, CM; Schauer, GF; Vas, AK; Keebler, M; Tuthill, S; Gardner, C; Jantz, T; Yu, WK; Chapman, SB				Krawczyk, Daniel C.; de la Plata, Carlos Marquez; Schauer, Guido F.; Vas, Asha K.; Keebler, Molly; Tuthill, Stephanie; Gardner, Claire; Jantz, Tiffani; Yu, Weikei; Chapman, Sandra B.			Evaluating the effectiveness of reasoning training in military and civilian chronic traumatic brain injury patients: study protocol	TRIALS			English	Article						Cognitive rehabilitation; Traumatic brain injury; Neuroimaging; Neuropsychology; Reasoning; Memory; Attention	WORKING-MEMORY; CORTEX; MILD; AREA	Background: Individuals who sustain traumatic brain injuries (TBIs) often continue to experience significant impairment of cognitive functions mediated by the prefrontal cortex well into chronic stages of recovery. Traditional brain training programs that focus on improving specific skills fall short of addressing integrative functions that draw upon multiple higher-order processes critical for social and vocational integration. In the current study, we compare the effects of two short-term, intensive, group-based cognitive rehabilitation programs for individuals with chronic TBI. One program emphasizes learning about brain functions and influences on cognition, while the other program adopts a top-down approach to improve abstract reasoning abilities that are largely reliant on the prefrontal cortex. These treatment programs are evaluated in civilian and military veteran TBI populations. Methods/design: One hundred individuals are being enrolled in this double-blinded clinical trial (all measures and data analyses will be conducted by blinded raters and analysts). Each individual is randomly assigned to one of two treatment conditions, with each condition run in groups of five to seven individuals. The primary anticipated outcomes are improvement in abstract reasoning and everyday life functioning, measured through behavioral tasks and questionnaires, and attention modulation, as measured by functional neuroimaging. Secondary expected outcomes include improvements in the cognitive processes of working memory, attention, and inhibitory control. Discussion: Results of this trial will determine whether cognitive rehabilitation aimed at teaching TBI-relevant information about the brain and cognition versus training in TBI-affected thinking abilities (e.g., memory, attention, and executive functioning) can improve outcomes in chronic military and civilian TBI patient populations. It should shed light on the nature of improvements and the characteristics of patients most likely to benefit. This trial will also provide information about the sustainability of treatment-related improvements 3 months post-training.	[Krawczyk, Daniel C.; de la Plata, Carlos Marquez; Schauer, Guido F.; Vas, Asha K.; Keebler, Molly; Tuthill, Stephanie; Gardner, Claire; Jantz, Tiffani; Yu, Weikei; Chapman, Sandra B.] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75235 USA; [Krawczyk, Daniel C.; de la Plata, Carlos Marquez] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	Krawczyk, DC (corresponding author), Univ Texas Dallas, Ctr BrainHlth, 2200 Mockingbird Lane, Dallas, TX 75235 USA.	daniel.krawczyk@utdallas.edu			US Department of Defense (DOD) through the program in Psychological Health/Traumatic Brain Injury (PH/TBI) of the Congressionally Directed Medical Research Programs (CDMRP) Cognitive Rehabilitation for TBI Clinical Trial Award [W81XWH-11-2-0194, W81XWH-11-2-01945]	This study is funded by the US Department of Defense (DOD) through the program in Psychological Health/Traumatic Brain Injury (PH/TBI) of the Congressionally Directed Medical Research Programs (CDMRP) Cognitive Rehabilitation for TBI Clinical Trial Award (Award W81XWH-11-2-0194 to DCK) and (Award W81XWH-11-2-01945 to SBC). The funding agency has not had a direct role in the design, data collection, analysis, or interpretation of the data for this study, nor have they had a direct role in the preparation of this manuscript or the decision to submit it. We would like to acknowledge Dr. John Hart for helpful input on various aspects of the design and implementation of the study and to thank Bruce Jones and Sarah Sprinkle for contributions to the administration of the study.	Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Alderman N, 2003, J INT NEUROPSYCH SOC, V12, P194; Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Binder DTG, 2008, BRAIN HEALTHW ROTM R; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delis DC, 2001, D KEFS EXECUTIVE FUN; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gamino JF, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00188; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Humeniuk VD, 2008, TECHNICAL REPORT PHA; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Krawczyk DC, 2008, NEUROPSYCHOLOGIA, V46, P2020, DOI 10.1016/j.neuropsychologia.2008.02.001; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Shallice, 1997, HAYLING BRIXTON TEST; Sherer M., 2004, AWARENESS QUESTIONAI; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Weathers FLB, 1993, SAN ANT ANN M INT SO; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wechsler D., 2008, WECHSLER MEMORY SCAL, V3; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1997, BRAIN INJURY, V11, P403	40	14	14	0	28	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JAN 30	2013	14								29	10.1186/1745-6215-14-29			11	Medicine, Research & Experimental	Research & Experimental Medicine	083WS	WOS:000314496700001	23363480	DOAJ Gold, Green Published			2021-06-18	
J	Shehadah, A; Chen, JL; Kramer, B; Zacharek, A; Cui, YS; Roberts, C; Lu, M; Chopp, M				Shehadah, Amjad; Chen, Jieli; Kramer, Brian; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Lu, Mei; Chopp, Michael			Efficacy of Single and Multiple Injections of Human Umbilical Tissue-Derived Cells following Experimental Stroke in Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBRAL-ISCHEMIA; STEM-CELLS; SYNAPTIC PLASTICITY; GENE-EXPRESSION; RECOVERY; SYNAPTOGENESIS; SYNAPTOPHYSIN	Introduction: Human umbilical tissue-derived cells (hUTC) are a promising source of cells for regenerative treatment of stroke. In this study, we tested the efficacy of hUTC in experimental stroke and whether multiple injections of hUTC provide additional therapeutic benefits as compared to a single injection. Methods: Adult male Wistar rats were subjected to 2 hours of middle cerebral artery occlusion (MCAo), and randomly selected animals were injected (i.v) with 3 x 10(6) hUTC or with vehicle control (at day: 1, 1&3 or 1&7 after MCAo, n = 8-9/group). A battery of functional outcome tests was performed at days 1, 7, 14, 21, 28, 35, 42, 49, 56 and 63 after MCAo. Rats were sacrificed at 63 days after MCAo and lesion volumes were measured. To investigate the underlying mechanism of hUTC treatment of stroke, Von Willebrand Factor (vWF), and Synaptophysin immunostaining were performed. Results: All hUTC treated groups, single or multiple injections, had better functional recovery compared to control (p<0.01). There was no statistically significant difference between a single and multiple injections of hUTC (p = 0.23) or between different multiple injections groups (p>0.07) in functional outcome. All hUTC treatment groups showed significant increases in Synaptophysin, vascular density and perimeter compared to the control group (p<0.05). There was no statistically significant difference between a single and multiple injections of hUTC or between the two groups of multiple injections in all immunohistochemical measurements (p>0.1). Conclusion: hUTC treatment significantly improves long term functional outcome after stroke and promotes vascular density and synaptic plasticity. At the proscribed doses, multiple injections of hUTC were not superior to single injection therapy in both functional outcome and histological assessments.	[Shehadah, Amjad; Chen, Jieli; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Kramer, Brian] Adv Technol & Regenerat Med LLC, Somerville, NJ USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Shehadah, Amjad/0000-0001-8679-3774	Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ, USA; Advanced Technologies and Regenerative Medicine	This work was funded by Advanced Technologies and Regenerative Medicine, LLC, Somerville, NJ 08876, USA. The funders had no role in study design, data collection, analysis or preparation of the manuscript. Study design and decision to publish were approved by the funders.; The authors declare that one of our co-authors, Brian Kramer PhD, is an employee of Advanced Technologies and Regenerative Medicine, the commercial funder of the study. This affiliation does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors do not have any other declarations related to patents, products in development or marketed products.	Alder J, 2012, DEV NEUROBIOL, V72, P755, DOI 10.1002/dneu.20980; BARTH TM, 1990, STROKE, V21, P153; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Bohotin Catalina Roxana, 2004, Rom J Physiol, V41, P99; CABALKA LM, 1990, J COMP NEUROL, V295, P83, DOI 10.1002/cne.902950108; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2002, J NEUROL SCI, V199, P17, DOI 10.1016/S0022-510X(02)00075-8; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cui X, 2010, STROKE, V41, P2044, DOI 10.1161/STROKEAHA.110.589333; GARCIA JH, 1971, ACTA NEUROPATHOL, V18, P273, DOI 10.1007/BF00688441; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; MASLIAH E, 1990, J HISTOCHEM CYTOCHEM, V38, P837, DOI 10.1177/38.6.2110586; Mochizuki N, 2008, EXP NEUROL, V211, P194, DOI 10.1016/j.expneurol.2008.01.027; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rempe DA, 2002, NEUROLOGY, V59, P486, DOI 10.1212/WNL.59.4.486; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; Sun JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024529; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zacharek A, 2009, STROKE, V40, P254, DOI 10.1161/STROKEAHA.108.524116; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang Y, 2011, CARDIOVASC PATHOL, V20, P204, DOI [10.1016/j.carpath.2010.06.007, 10.1088/1674-1056/20/11/110204]; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	47	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e54083	10.1371/journal.pone.0054083			6	Multidisciplinary Sciences	Science & Technology - Other Topics	087KE	WOS:000314759400119	23342081	DOAJ Gold, Green Published			2021-06-18	
J	Albers, CE; von Allmen, M; Evangelopoulos, DS; Zisakis, AK; Zimmermann, H; Exadaktylos, AK				Albers, C. E.; von Allmen, M.; Evangelopoulos, D. S.; Zisakis, A. K.; Zimmermann, H.; Exadaktylos, A. K.			What Is the Incidence of Intracranial Bleeding in Patients with Mild Traumatic Brain Injury? A Retrospective Study in 3088 Canadian CT Head Rule Patients	BIOMED RESEARCH INTERNATIONAL			English	Article							COMPUTED-TOMOGRAPHY	Objective. Only limited data exists in terms of the incidence of intracranial bleeding (ICB) in patients with mild traumatic brain injury (MTBI). Methods. We retrospectively identified 3088 patients (mean age 41 range (7-99) years) presenting with isolated MTBI and GCS 14-15 at our Emergency Department who had undergone cranial CT (CCT) between 2002 and 2011. Indication for CCT was according to the "Canadian CT head rules." Patients with ICB were either submitted for neurosurgical treatment or kept under surveillance for at least 24 hours. Pearson's correlation coefficient was used to correlate the incidence of ICB with age, gender, or intake of coumarins, platelet aggregation inhibitors, or heparins. Results. 149 patients (4.8%) had ICB on CCT. No patient with ICB died or deteriorated neurologically. The incidence of ICB increased with age and intake of anticoagulants without clinically relevant correlation (R = 0.11; P < 0.001; R = -0.06; P < 0.001). Conclusion. Our data show an incidence of 4.8% for ICB after MTBI. However, neurological deterioration after MTBI seems to be rare, and the need for neurosurgical intervention is only required in selected cases. Thegeneral need for CCT in patients after MTBI is therefore questionable, and clinical surveillance may be sufficient when CCT is not available.	[Albers, C. E.; von Allmen, M.; Evangelopoulos, D. S.; Zimmermann, H.; Exadaktylos, A. K.] Univ Bern, Inselspital, Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland; [Zisakis, A. K.] Red Cross Hosp, Dept Neurosurg, Athens 11526, Greece	Exadaktylos, AK (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Emergency Med, CH-3010 Bern, Switzerland.	aristomenis.exadaktylos@insel.ch	Albers, Christoph E./Y-9703-2019				Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dalbayrak S, 2011, TURK NEUROSURG, V21, P591, DOI [10.5137/1019-5149.JTN.3570-10.2, 10.5137/1019-5149.JTN .3570-10.2]; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pearson K, 1909, Science, V30, P23, DOI 10.1126/science.30.757.23; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Stein SC, 2000, NEW ENGL J MED, V343, P1570; Steyerberg EW., 2009, CLIN PREDICTION MODE; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	21	14	14	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								453978	10.1155/2013/453978			4	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	192JZ	WOS:000322481800001	23936802	DOAJ Gold, Green Published			2021-06-18	
J	Chan, V; Zagorski, B; Parsons, D; Colantonio, A				Chan, Vincy; Zagorski, Brandon; Parsons, Daria; Colantonio, Angela			Older Adults with Acquired Brain Injury: Outcomes After Inpatient Rehabilitation	CANADIAN JOURNAL ON AGING-REVUE CANADIENNE DU VIEILLISSEMENT			English	Article						aging; acquired brain injury; functional outcomes; rehabilitation	FUNCTIONAL OUTCOMES; LENGTH	This study examined a population-based profile of older adults with acquired brain injury, and their functional outcomes, in in-patient rehabilitation. Older adults aged 65 and older admitted to in-patient rehabilitation from acute care with traumatic brain injury (TBI) (n = 1214) or non-traumatic brain injury (nTBI) (n = 1,530) from 2003/04 to 2009/10 in Ontario were identified. Demographic and clinical characteristics and the total function score from the FIM((TM)()) Instrument were examined. The Discharge Abstract Database and National Rehabilitation Reporting System were used. Results indicated that older adults with TBI had significantly higher total function scores than those with nTBI at admission and at discharge (p<.001). However, both groups made significant (p<.001) and similar gains (p>.05) in total function scores. We conclude that older adults with TBI and nTBI make similar in-patient rehabilitation gains. Lower initial functional ability of nTBI patients on admission and patients' different clinical profiles have implications for clinical care and resources.	[Chan, Vincy; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Chan, Vincy; Colantonio, Angela] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Zagorski, Brandon] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5G 1V7, Canada	Colantonio, A (corresponding author), Univ Toronto, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	Chan, Vincy/AAA-7813-2020	Chan, Vincy/0000-0002-6884-044X; Colantonio, Angela/0000-0003-2094-4765	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Canadian Institute for Health Information, 2009, ALT LEV CAR CAN; Canadian Institute for Health Information, 2012, NAT REH REP SYST NRS; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Colantonio A., 2011, ACQUIRED BRAIN INJUR; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cullen NK, 2011, BRAIN INJURY, V25, P35, DOI 10.3109/02699052.2010.531691; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; ERABI, 2011, FUNCT IND MEAS; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Juurlink D., 2006, Canadian Institute for Health Information Discharge Abstract Database: a validation study; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Statistics Canada, 2012, POP SEX AG GROUPS PR; Statistics Canada, 2012, POP YEAR PROV TERR; Statistics Canada, 2012, PROJ POP AG GROUP AC; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; World Health Organization, 2006, NEUR DIS PUBL HLTH C	27	14	14	0	11	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0714-9808	1710-1107		CAN J AGING	Can. J. Aging-Rev. Can. Vieil.		2013	32	3					278	286		10.1017/S0714980813000317			9	Gerontology	Geriatrics & Gerontology	216FS	WOS:000324268000007	23915910				2021-06-18	
S	Gray, ST; Wu, AW		Bleier, BS		Gray, Stacey T.; Wu, Arthur W.			Pathophysiology of latrogenic and Traumatic Skull Base Injury	COMPREHENSIVE TECHNIQUES IN CSF LEAK REPAIR AND SKULL BASE RECONSTRUCTION	Advances in Oto-Rhino-Laryngology		English	Article; Book Chapter							CEREBROSPINAL-FLUID LEAKS; ENDOSCOPIC SINUS SURGERY; COMPLICATIONS; MANAGEMENT; EXPERIENCE; REPAIR; RHINORRHEA; FISTULAS; RECONSTRUCTION; METAANALYSIS	Traumatic skull base injuries can be divided into iatrogenic injuries from surgery and accidental traumatic injuries. The most common cause of iatrogenic skull base injury is endoscopic sinus surgery. The reported rate of cerebrospinal fluid (CSF) leak as a complication of endoscopic sinus surgery is less than 1%. Intraoperative injury most commonly occurs at the ethmoid roof and the lateral lamella of the cribiform plate. Case complexity, such as revision surgery, as well as surgical experience has been shown to be a contributing factor to iatrogenic CSF leaks during endoscopic sinus surgery. Other causes of iatrogenic CSF leaks include endoscopic skull base and open neurosurgical procedures. CSF leak occurs in 2.6% of all closed head traumas and is more likely in the case of a definitive skull base fracture. The majority of accidental trauma CSF leaks can be managed conservatively, but those that persist beyond a week are typically managed surgically to avoid the risk of meningitis. Copyright (C) 2013 S. Karger AG, Basel	[Gray, Stacey T.; Wu, Arthur W.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA	Gray, ST (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Otol & Laryngol, 243 Charles St, Boston, MA 02114 USA.	stacey_gray@meei.harvard.edu		Wu, Arthur/0000-0001-8993-6355			Anderson P, 2009, LARYNGOSCOPE, V119, P1828, DOI 10.1002/lary.20565; Banks CA, 2009, OTOLARYNG HEAD NECK, V140, P826, DOI 10.1016/j.otohns.2008.12.060; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bernal-Sprekelsen M, 2000, AM J RHINOL, V14, P257, DOI 10.2500/105065800779954473; Bolger WE, 1999, OTOLARYNG HEAD NECK, V120, P308, DOI 10.1016/S0194-5998(99)70267-6; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Bumm K, 2009, AURIS NASUS LARYNX, V36, P671, DOI 10.1016/j.anl.2009.03.004; Chi JH, 2006, NEUROSURGERY, V59, P101, DOI 10.1227/01.NEU.0000219962.15984.34; Church CA, 2003, OTOLARYNG HEAD NECK, V129, P204, DOI 10.1016/S0194-5998(03)00521-7; Deschler DG, 1996, SKULL BASE SURG, V6, P113, DOI 10.1055/s-2008-1058652; Germani RM, 2007, AM J RHINOL, V21, P615, DOI 10.2500/ajr.2007.21.3080; Gil Z, 2009, OTOLARYNG HEAD NECK, V140, P218, DOI 10.1016/j.otohns.2008.10.042; Kacker A, 2005, OTOLARYNG CLIN N AM, V38, P473, DOI 10.1016/j.otc.2004.10.021; Kassam AB, 2011, J NEUROSURG, V114, P1544, DOI 10.3171/2010.10.JNS09406; Keerl R, 1999, LARYNGOSCOPE, V109, P546, DOI 10.1097/00005537-199904000-00005; KEROS P, 1962, Z Laryngol Rhinol Otol, V41, P809; Lee DH, 2011, J CRANIOFAC SURG, V22, P1266, DOI 10.1097/SCS.0b013e31821c6ad3; Leng LZ, 2008, NEUROSURGERY, V62, P342, DOI [10.1227/01.neu.0000326017.84315.1f, 10.1227/01.NEU.0000312720.93685.17]; Lindstrom DR, 2004, LARYNGOSCOPE, V114, P969, DOI 10.1097/00005537-200406000-00003; Manolidis S, 2007, PLAST RECONSTR SURG, V120, p32S, DOI 10.1097/01.prs.0000260732.58496.1b; MAY M, 1994, LARYNGOSCOPE, V104, P1080; Mosher HP, 1929, T AM ACAD OPHTHALMOL, V34, P376; Ommaya AK, 1996, NEUROSURGERY, V2, P2773; Platt MP, 2007, AM J RHINOL, V21, P611, DOI 10.2500/ajr.2007.21.3073; Reh DD, 2008, ARCH OTOLARYNGOL, V134, P1187, DOI 10.1001/archotol.134.11.1187; Samaha M, 2003, ARCH OTOLARYNGOL, V129, P854, DOI 10.1001/archotol.129.8.854; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Smith TL, 2007, AM J RHINOL, V21, P80, DOI 10.2500/ajr.2007.21.2962; STANKIEWICZ JA, 1987, LARYNGOSCOPE, V97, P1270, DOI 10.1288/00005537-198711000-00004; Stankiewicz JA, 2011, LARYNGOSCOPE, V121, P2684, DOI 10.1002/lary.21446; Tabaee A, 2005, OTOLARYNG HEAD NECK, V133, P936, DOI 10.1016/j.otohns.2005.07.028; Tabaee A, 2007, LARYNGOSCOPE, V117, P1133, DOI 10.1097/MLG.0b013e31805c08c5; White DR, 2003, AM J OTOLARYNG, V24, P213, DOI 10.1016/S0196-0709(03)00031-0; Zuckerman JD, 2008, AM J RHINOL, V22, P151, DOI 10.2500/ajr.2008.22.3150; Zweig JL, 2000, OTOLARYNG HEAD NECK, V123, P195, DOI 10.1067/mhn.2000.107452	35	14	14	0	0	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0065-3071	1662-2847	978-3-8055-9953-5; 978-3-8055-9952-8	ADV OTO-RHINO-LARYNG	Adv.Otorhinolaryngol.		2013	74						12	23		10.1159/000342264			12	Otorhinolaryngology; Surgery	Otorhinolaryngology; Surgery	BDY61	WOS:000315658300003	23257548				2021-06-18	
J	Kalpinski, RJ; Williamson, MLC; Elliott, TR; Berry, JW; Underhill, AT; Fine, PR				Kalpinski, Ryan J.; Williamson, Meredith L. C.; Elliott, Timothy R.; Berry, Jack W.; Underhill, Andrea T.; Fine, Philip R.			Modeling the Prospective Relationships of Impairment, Injury Severity, and Participation to Quality of Life Following Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							INTERNATIONAL CLASSIFICATION; HEALTH; REHABILITATION; SATISFACTION; DISABILITY; PERFORMANCE; VALIDATION; PREDICTION; HAPPINESS; OUTCOMES	Identifying reliable predictors of positive adjustment following traumatic brain injury (TBI) remains an important area of inquiry. Unfortunately, much of available research examines direct relationships between predictor variables and outcomes without attending to the contextual relationships that can exist between predictor variables. Relying on theoretical models of well-being, we examined a theoretical model of adjustment in which the capacity to engage in intentional activities would be prospectively associated with greater participation, which in turn would predict subsequent life satisfaction and perceived health assessed at a later time. Structural equation modeling of data collected from 312 individuals (226 men, 86 women) with TBI revealed that two elements of participation-mobility and occupational activities-mediated the prospective influence of functional independence and injury severity to optimal adjustment 60 months following medical discharge for TBI. The model accounted for 21% of the variance in life satisfaction and 23% of the variance in self-rated health. Results indicate that the effects of functional independence and injury severity to optimal adjustment over time may be best understood in the context of participation in meaningful, productive activities. Implications for theoretical models of well-being and for clinical interventions that promote adjustment after TBI are discussed.	[Kalpinski, Ryan J.; Williamson, Meredith L. C.; Elliott, Timothy R.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77845 USA; [Berry, Jack W.] Samford Univ, Birmingham, AL 35229 USA; [Underhill, Andrea T.; Fine, Philip R.] Univ Alabama Birmingham, Injury Control Res Ctr, Birmingham, AL 35294 USA	Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, 4225 TAMU, College Stn, TX 77845 USA.	telliott@tamu.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			Bond T.G., 2001, APPL RASCH MODEL FUN; BRASURE M, 2012, AHRQ PUBLICATION, V12; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Doninger NA, 2003, REHABIL PSYCHOL, V48, P67, DOI 10.1037/0090-5550.48.2.67; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Dunn D. S., 2013, OXFORD HDB POSITIVE, P427; Elliott T. R., 2002, HDB POSITIVE PSYCHOL, P687; Elliott T. R., 2009, OXFORD HDB POSITIVE, V2, P651, DOI DOI 10.1093/OXFORDHB/9780195187243.013.0062; EROSA NA, BRIT J HLTH PSYCHOL; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hoyt WT, 2008, REHABIL PSYCHOL, V53, P321, DOI 10.1037/a0013021; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kline R. B., 2011, PRINCIPLES PRACTICES; KOK B, 2008, POSITIVE PSYCHOL EXP, P1; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Linacre JM, 2003, USERS GUIDE WINSTEPS; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; MACHAMER J, J NEUROTRAU IN PRESS; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Mausbach BT, 2011, CLIN PSYCHOL REV, V31, P900, DOI 10.1016/j.cpr.2011.04.004; Mc Dowell I., 2006, MEASURING HLTH GUIDE, V3rd; Muthen L. K., 2010, MPLUS USERS GUIDE; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Reed GM, 2005, REHABIL PSYCHOL, V50, P122, DOI 10.1037/0090-5550.50.2.122; Seligman M., 2002, AUTHENTIC HAPPINESS; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; SPEAKE DL, 1989, RES NURS HEALTH, V12, P93, DOI 10.1002/nur.4770120206; Stiers W, 2012, J REHABIL RES DEV, V49, P139, DOI 10.1682/JRRD.2010.07.0131; Thompson, 2006, FDN BEHAV STAT INSIG; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; van Leeuwen CM, 2012, ARCH PHYS MED REHAB, V93, P82, DOI 10.1016/j.apmr.2011.07.203; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2001, INT CLASS FUNCT DIS; Yu C.Y., 2002, EVALUATION MODEL FIT	50	14	14	0	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								102570	10.1155/2013/102570			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	233PA	WOS:000325580000001	24199186	DOAJ Gold, Green Published			2021-06-18	
J	Lagbas, C; Bazargan-Hejazi, S; Shaheen, M; Kermah, D; Pan, DY				Lagbas, Clint; Bazargan-Hejazi, Shahrzad; Shaheen, Magda; Kermah, Dulcie; Pan, Deyu			Traumatic Brain Injury Related Hospitalization and Mortality in California	BIOMED RESEARCH INTERNATIONAL			English	Article							UNITED-STATES; OLDER-ADULTS; TRENDS; POPULATION; MODERATE; OUTCOMES; CHILDREN; FALL	Objective. The aim of this study is to describe the traumatic brain injury (TBI) population and causes and identify factors associated with TBI hospitalizations and mortality in California. Methods. This is a cross-sectional study of 61,188 patients with TBI from the California Hospital Discharge Data 2001 to 2009. We used descriptive, bivariate, and multivariate analyses in SAS version 9.3. Results. TBI-related hospitalizations decreased by 14% and mortality increased by 19% from 2001 to 2009. The highest percentages of TBI hospitalizations were due to other causes (38.4%), falls (31.2%), being of age > 75 years old (37.2%), being a males (58.9%), and being of Medicare patients (44%). TBIs due to falls were found in those age <= 4 years old (53.5%), >= 75 years old (44.0%), and females (37.2%). TBIs due to assaults were more frequent in Blacks (29.0%). TBIs due to motor vehicle accidents were more frequent in 15-19 and 20-24 age groups (48.7% and 48.6%, resp.) and among Hispanics (27.8%). Higher odds of mortality were found among motor vehicle accident category (adjusted odds ratio (AOR): 1.27, 95% CI: 1.14-1.41); males (AOR: 1.36, 95% CI: 1.27-1.46); and the >= 75-year-old group (AOR: 6.4, 95% CI: 4.9-8.4). Conclusions. Our findings suggest a decrease in TBI-related hospitalizations but an increase in TBI-related mortality during the study period. The majority of TBI-related hospitalizations was due to other causes and falls and was more frequent in the older, male, and Medicare populations. The higher likelihood of TBI-related mortalities was found among elderly male >= 75 years old who had motor vehicle accidents. Our data can inform practitioners, prevention planners, educators, service sectors, and policy makers who aim to reduce the burden of TBI in the community. Implications for interventions are discussed.	[Lagbas, Clint] Univ Calif Los Angeles, Charles R Drew Univ Med & Sci, David Geffen Sch Med, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, Shahrzad] Charles R Drew Univ Med, Coll Med, Dept Psychiat, Los Angeles, CA 90059 USA; [Bazargan-Hejazi, Shahrzad] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Shaheen, Magda] Charles R Drew Univ Med & Sci, Coll Med, Los Angeles, CA 90059 USA; [Kermah, Dulcie; Pan, Deyu] Charles R Drew Univ Med & Sci, Dept Res, Los Angeles, CA 90059 USA	Bazargan-Hejazi, S (corresponding author), Charles R Drew Univ Med, Coll Med, Dept Psychiat, 1731 East 120th St, Los Angeles, CA 90059 USA.	shahrzadbazargan@cdrewu.edu			Accelerating Excellence in Translational Science AXIS Grant [U54MD007598]; NIH/NCRRN/NCATS UCLA CTSI Grant [UL1TR000124];  [S21MD000103]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [U54MD007598, S21MD000103] Funding Source: NIH RePORTER	This study was supported in part by the Endowment Grant S21MD000103 and by the Accelerating Excellence in Translational Science AXIS Grant (U54MD007598) and NIH/NCRRN/NCATS UCLA CTSI Grant UL1TR000124.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Beiki O., 2013, J INJURY VIOLENCE RE; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P276; Clark ED, ICDPIC VERSION 3 0 I; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Ellis AA, 2001, J GERONTOL A-BIOL, V56, pM686, DOI 10.1093/gerona/56.11.M686; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Givens JL, 2002, ACAD MED, V77, P918, DOI 10.1097/00001888-200209000-00024; Gujral IB, 2006, BRAIN INJURY, V20, P283, DOI 10.1080/02699050500488058; Kalaiselvan Ganapathy, 2011, J Inj Violence Res, V3, P62, DOI 10.5249/jivr.v3i2.74; Langlois J. A., 2004, US DEP HLTH HUMAN SE; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Li Shaohua, 2013, J Inj Violence Res, V5, P89, DOI 10.5249/jivr.v5i2.304; Lyman S, 2002, INJ PREV, V8, P116, DOI 10.1136/ip.8.2.116; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Robertson B. D., 2013, J INJURY VIOLENCE RE, V5; Rosen Tony, 2013, J Inj Violence Res, V5, P61, DOI 10.5249/jivr.v5i1.177; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	33	14	14	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								143092	10.1155/2013/143092			9	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	256VI	WOS:000327341700001	24324953	DOAJ Gold, Green Published			2021-06-18	
J	Stenclik, JH; Miele, AS; Silk-Eglit, G; Lynch, JK; McCaffrey, RJ				Stenclik, Jessica H.; Miele, Andrea S.; Silk-Eglit, Graham; Lynch, Julie K.; McCaffrey, Robert J.			Can the Sensitivity and Specificity of the TOMM Be Increased with Differential Cutoff Scores?	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						cutoff scores; medico-legal; performance validity; symptom validity tests; Test of Memory Malingering	MEMORY MALINGERING TOMM; SCREENING MEASURE; TRIAL-1; INJURY; RATES	Accurate determination of performance validity is paramount in any neuropsychological assessment. Numerous freestanding symptom validity tests, like the Test of Memory Malingering (TOMM), have been developed to assist in this process; however, research and clinical experiences have suggested that each may not function with the same classification accuracy. In an effort to increase the TOMM's ability to accurately classify performance validity, recent research has investigated the use of nonstandard cutoff scores. The purpose of this study was to potentially validate the use of two, nonstandard cutoff scores (<49 on Trial 2 or the Retention Trial or <= 39 on Trial 1) applied to the TOMM in a medicolegal sample of mild traumatic brain injury litigants. Both descriptive and inferential statistics found that the cutoff of <49 on Trial 2 or the Retention Trial was the most sensitive to performance validity as compared with both the standard TOMM criteria and the cutoff of <= 39. These findings support the use of nonstandard cutoffs to increase the TOMM's classification accuracy.	[Stenclik, Jessica H.; Miele, Andrea S.; Silk-Eglit, Graham; McCaffrey, Robert J.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Lynch, Julie K.; McCaffrey, Robert J.] Albany Neuropsychol Associates, Albany, NY USA	Stenclik, JH (corresponding author), SUNY Albany, Dept Psychol, 1400 Washington Ave, Albany, NY 12222 USA.	JG826918@Albany.edu		Eglit, Graham/0000-0001-7592-9859			Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Gavett BE, 2005, APPL NEUROPSYCHOL, V12, P1, DOI 10.1207/s15324826an1201_1; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Hom J, 2002, DETECTION RESPONSE B; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Rey A, 1964, EXAMEN CLIN PSYCHOL; Rogers R., 1997, RES DISSIMULATION; Schroeder R, 2011, RNA BIOL, V8, P1; SCHROEDER RW, 2011, CLIN NEUROPSYCHOL, V25, P564; Slick D., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 1996, TEST MEMORY MALINGER; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th	28	14	14	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2013	20	4					243	248		10.1080/09084282.2012.704603			6	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	298ST	WOS:000330345400002	23530574				2021-06-18	
J	Tomaszewski, W; Manko, G; Ziolkowski, A; Pachalska, M				Tomaszewski, Wieslaw; Manko, Grzegorz; Ziolkowski, Artur; Pachalska, Maria			An evaluation of health-related quality of life of patients aroused from prolonged coma when treated by physiotherapists with or without training in the 'Academy of Life' programme	ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE			English	Article						social isolation; aphasia; dysarthria; memory; paresis; akinetic mutism	TRAUMATIC BRAIN-INJURY; REHABILITATION; EPIDEMIOLOGY	Objective: To evaluate the health-related quality of life (HRQOL) in patients aroused from prolonged coma after a severe traumatic brain injury (TBI) treated by physiotherapists trained in the 'Academy of Life' programme. It was assumed that physiotherapists who acquired this knowledge and experience would create a better therapeutic milieu, and would be more effective than physiotherapists who had not received this training. Material and methods: 40 patients who had suffered a severe TBI in a motor vehicle accident and had been aroused from prolonged coma were examined. All the patients underwent long-term rehabilitation according to a standard, phased programme. They were divided into two numerically even groups: an experimental group, treated by therapists trained in the 'Academy of Life' programme, and a control group, treated by physiotherapists who were not trained in this programme. The research instruments included an analysis of documentation, a structured clinical interview, and the Quality of Life Scale. Results: As hypothesized, the experimental group showed significant improvement in HRQOL, whereas in the control group improvement was statistically non-significant. Conclusions: The patients from the experimental group, treated by physiotherapists trained in the 'Academy of Life', obtained a significantly greater improvement in physical and social functioning, and thus in HRQOL, than patients from the control group.	[Tomaszewski, Wieslaw] Coll Physiotherapy, Wroclaw, Poland; [Manko, Grzegorz] Jagiellonian Univ, Dept Ergon & Exert Physiol, Inst Physiotherapy, Fac Allied Hlth Sci,Coll Med, Krakow, Poland; [Ziolkowski, Artur] Acad Phys Educ & Sport Gdansk, Gdansk, Poland; [Pachalska, Maria] Andrzej Frycz Modrzewski Univ, Chair Neuropsychol, Krakow, Poland	Tomaszewski, W (corresponding author), Jagiellonska 3-20, PL-03721 Warsaw, Poland.						Atrice M, 1995, NEUROLOGICAL REHABIL, P484; Baranowski P, 2000, Ortop Traumatol Rehabil, V2, P31; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Di Mauro S, 1998, STROKE REHABILITATIO, P508; Marvasti Jamshid A, 2011, Conn Med, V75, P133; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Meinzer M, 2011, APHASIOLOGY, V25, P271, DOI 10.1080/02687038.2010.530672; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Pachalska M, 1998, SKALA OCENY JAKOSCI; Pachalska M, 2008, REHABILITACJA NEUROP; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M, 2012, MED SCI MONITOR, V18, pCR432; Pachalska M, 2010, MED SCI MONITOR, V16, pCS157; Pachalski Adam, 2004, Ortop Traumatol Rehabil, V6, P643; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Talar J, 2002, URAZY PNIA MOZGU KOM, P207; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Tomaszewski W, 2011, MED SCI MONITOR, V17, P35; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Worthington AD, 2003, HDB CLIN NEUROPSYCHO, P322	25	14	14	0	6	INST AGRICULTURAL MEDICINE	LUBLIN	JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND	1232-1966	1898-2263		ANN AGR ENV MED	Ann. Agr. Env. Med.		2013	20	2					361	365					5	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	172SN	WOS:000321025300029	23772592	DOAJ Gold			2021-06-18	
J	Tsushima, WT; Shirakawa, N; Geling, O				Tsushima, William T.; Shirakawa, Nicole; Geling, Olga			Neurocognitive Functioning and Symptom Reporting of High School Athletes Following a Single Concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						concussion; high school athletes; ImPACT; neurocognitive functioning; symptom reporting	SPORTS-RELATED CONCUSSION; COLLEGIATE; RECOVERY; MANAGEMENT; IMPACT	The aim of this research was to evaluate the neurocognitive functioning and symptom reporting of high school athletes with the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery after sustaining a single sports-related concussion. The ImPACT battery was administered to 26 athletes at an average of 6.8 days after their head injury. ImPACT composite scores, including neurocognitive measures of Verbal Memory, Visual Memory, Processing Speed, and Reaction Time, as well as a Total Symptom Score, were also obtained from an equivalent group of 25 nonconcussed football players. The composite scores of the concussed athletes were lower but not statistically different than the nonconcussed athletes. The findings were consistent with previous ImPACT research that reported no differences between concussed and nonconcussed athletes 7 days after a concussion. The symptom scores of the concussed athletes, on the other hand, were significantly higher than those who had no concussion. The similarities and differences in ImPACT test performances of the present sample of concussed high school athletes as compared with previous studies of concussed high school athletes are discussed. This study raises awareness that with high school athletes, symptom complaints may persist, even after cognitive functioning has returned to preinjury levels.	[Tsushima, William T.] Straub Clin & Hosp, Honolulu, HI 96813 USA; [Shirakawa, Nicole] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Geling, Olga] Univ Hawaii, Honolulu, HI 96822 USA	Tsushima, WT (corresponding author), Straub Clin & Hosp, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			Hawaii Pacific Health Conference Service's Summer Student Research Program	This research was supported in part by the Hawaii Pacific Health Conference Service's Summer Student Research Program. The study was approved by the institutional review board of the Hawaii Pacific Health Research Institute.	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell M.R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304	20	14	14	1	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2013	2	1					13	16		10.1080/09084282.2011.643967			4	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	AD0SV	WOS:000332945300003	23427772				2021-06-18	
J	Zaben, M; El Ghoul, W; Belli, A				Zaben, Malik; El Ghoul, Wessam; Belli, Antonio			Post-traumatic head injury pituitary dysfunction	DISABILITY AND REHABILITATION			English	Article						Concussion; head injury; hormone; metabolism; neuro-rehabilitation; pituitary	TRAUMATIC BRAIN-INJURY; CLINICAL-RESEARCH CENTER; GROWTH-HORMONE GH; REPLACEMENT THERAPY; DIABETES-INSIPIDUS; NATURAL-HISTORY; HYPOGONADAL MEN; HYPOPITUITARISM; PREVALENCE; REHABILITATION	Partial or complete pituitary dysfunction affects 33-50% of all traumatic brain injury (TBI) survivors and is a significant contributor to the overall disability burden. The hypophyseal vessels are anatomically vulnerable to shearing injuries, raised intracranial pressure and anterior base of skull fractures, and pituitary ischaemia or haemorrhage is a common finding at autopsy. Post-traumatic hypopituitarism (PTHP) can affect all grades of severity of injury and is often difficult to diagnose, as its features largely overlap with common post-concussive symptoms. PTHP has a wide range of manifestations, including fatigue, myopathy, cognitive difficulties, depression, behavioural changes or life-threatening complications such as sodium dysregulation and adrenal crisis. In some instances, mild PTHP can recover, at least partially, but cases of late onset are also known. At present, there is no consensus on whether all TBI patients should be screened (including mild TBI) and at what time points, given that neuroendocrine tests in the acute phase are simply likely to reflect a non-specific trauma response rather than true pituitary damage and that the time course of PTHP is unclear. A full investigation of the hypothalamic-pituitary axis requires specialized neuroendocrine assessment, including stimulation tests, as random hormone levels can be misleading in this context. Given the high incidence of TBI, this may have significant resource implications for Endocrinology services but, on the other hand, patients with PTHP may receive suboptimal rehabilitation unless the underlying hormone deficiency is identified and treated.	[Zaben, Malik] Univ Wales Hosp, Dept Neurosurg, Cardiff CF4 4XW, S Glam, Wales; [El Ghoul, Wessam] Southampton Univ Hosp, Wessex Neurol Ctr, Southampton, Hants, England; [Belli, Antonio] Queen Elizabeth Hosp, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England; [Belli, Antonio] Univ Birmingham, Birmingham B15 2TT, W Midlands, England	Belli, A (corresponding author), Univ Birmingham, Inst Biomed Res W, NIHR Surg Reconstruct & Microbiol Res Ctr, Neurotrauma & Neurodegenerat Sect,Sch Clin & Expt, Birmingham B15 2TT, W Midlands, England.	a.belli@bham.ac.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Zaben, Malik/0000-0002-7446-4532			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Alaca R, 2002, AM J PHYS MED REHAB, V81, P788, DOI 10.1097/00002060-200210000-00013; Banks E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1364; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Blair JC, 2010, BRIT J NEUROSURG, V24, P10, DOI 10.3109/02688690903536637; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Boughey JC, 2004, AM SURGEON, V70, P500; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Casanueva FF, 2005, J ENDOCRINOL INVEST, V28, P299; CLARK JDA, 1988, CLIN ENDOCRINOL, V29, P153, DOI 10.1111/j.1365-2265.1988.tb00257.x; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Leal-Cerro Alfonso, 2009, Endocrinol Nutr, V56, P293, DOI 10.1016/S1575-0922(09)71944-8; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; Park KD, 2010, BRAIN INJURY, V24, P1330, DOI 10.3109/02699052.2010.506863; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3654, DOI 10.1210/jc.81.10.3654; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3578, DOI 10.1210/jc.81.10.3578; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	35	14	15	1	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	6					522	525		10.3109/09638288.2012.697252			4	Rehabilitation	Rehabilitation	089XZ	WOS:000314944600012	22779906				2021-06-18	
J	Amorim, RL; Bor-Seng-Shu, E; Gattas, GS; Paiva, W; de Andrade, AF; Teixeira, MJ				Amorim, Robson Luis; Bor-Seng-Shu, Edson; Gattas, Gabriel S.; Paiva, Wellingson; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen			Decompressive craniectomy and cerebral blood flow regulation in head injured patients: A case studied by perfusion CT	JOURNAL OF NEURORADIOLOGY			English	Article						Traumatic brain injury; Decompressive craniectomy; Perfusion computed tomography; Cerebral hemodynamics	TRAUMATIC BRAIN-INJURY; HEMODYNAMIC-CHANGES; AUTOREGULATION	Previous studies have reported increased cerebral blood flow (CBF) velocity after decompressive craniectomy in traumatic brain injury (TBI) patients. A 27-year-old man presented with clinical and tomographic signs of cerebral herniation secondary to TBI. Prior to decompressive craniectomy, hemodynamic study by perfusion computed tomography (CT) indicated diffuse cerebral hyperperfusion. Following surgical decompression, the patient recovered neurologically and perfusion CT disclosed a decrease in the intensity of cerebral perfusion. The patient's blood pressure levels were similar at both pre- and postoperative perfusion CT examinations. This finding provides indirect evidence that decompressive craniectomy may improve mechanisms of CBF regulation in TBI, providing pathophysiological insights in the cerebral hemodynamics of TBI patients. This is the first report analyzing the hemodynamic changes through perfusion CT (PCT) in a patient with decompressive craniotomy due to TBI. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Amorim, Robson Luis; Bor-Seng-Shu, Edson; Paiva, Wellingson; de Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Sch Med, Dept Neurosurg, Sao Paulo, Brazil; [Gattas, Gabriel S.] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil	Amorim, RL (corresponding author), 718 Alves Guimaraes St,Appartment 112, BR-05410001 Sao Paulo, Brazil.	amorim.robson@uol.com.br	Amorim, Robson/AAK-1368-2021; Paiva, Wellingson S/G-5517-2013; BOR-SENG-SHU, EDSON/H-7784-2013; BOR-SENG-SHU, EDSON/AAC-9762-2019	Amorim, Robson/0000-0003-2391-7519; Paiva, Wellingson S/0000-0002-5165-7040; BOR-SENG-SHU, EDSON/0000-0002-6713-8974; BOR-SENG-SHU, EDSON/0000-0002-6713-8974			Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Engelhorn T, 2003, NEUROSCI LETT, V344, P127, DOI 10.1016/S0304-3940(03)00441-5; Heppner P, 2006, J NEUROSURG, V104, P738, DOI 10.3171/jns.2006.104.5.738; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Miller JD, 1992, J NEUROTRAUMA S1, P317; Urasaki E, 2001, NEUROL MED-CHIR, V41, P306, DOI 10.2176/nmc.41.306; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Wintermark M, 2006, J NEURORADIOLOGY, V33, P27, DOI 10.1016/S0150-9861(06)77225-X	10	14	15	0	4	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861			J NEURORADIOLOGY	J. Neuroradiol.	DEC	2012	39	5					346	349		10.1016/j.neurad.2012.02.006			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	067MO	WOS:000313298800010	22633048				2021-06-18	
J	Athiviraham, A; Bartsch, A; Mageswaran, P; Benzel, EC; Perse, B; Jones, MH; Schickendantz, M				Athiviraham, Aravind; Bartsch, Adam; Mageswaran, Prasath; Benzel, Edward C.; Perse, Brian; Jones, Morgan H.; Schickendantz, Mark			Analysis of Baseball-to-Helmet Impacts in Major League Baseball	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; beanball; helmet impact; baseball pitch; head injury	HIGH-SCHOOL; FOOTBALL PLAYERS; CONCUSSION; IDENTIFICATION; MANAGEMENT; STATEMENT; INJURIES; CATCHERS; SPORT	Background: In Major League Baseball (MLB), helmet hit-by-pitch (H-HBP) incidents are a leading cause of concussion. However, not all H-HBPs result in diagnosed concussion. Purpose: This study was designed to (1) quantify batter concussion risk as a function of H-HBP pitch velocity, time duration batter spent on the ground post-H-HBP, first responder assessment time duration, and number of days missed post-H-HBP and (2) estimate H-HBP impact locations on the helmet with respect to current National Operating Committee on Standards for Athletic Equipment (NOCSAE) helmet test standards and correlate impact locations with concussion diagnosis. Study Design: Case-control study; Level of evidence, 3. Methods: A retrospective case-control study of 18 MLB players with H-HBP incidents in the 2009 and 2010 seasons was undertaken. A database was compiled via quantitative and qualitative analysis using video coverage obtained from MLB. Quantitative factors included batter concussion diagnosis, pitch velocity, number of days missed post-H-HBP, time duration batter spent on the ground post-H-HBP, and first responder assessment time duration. The H-HBP impact location was among several qualitative factors developed via video analysis of each H-HBP from 4 raters. Results: In our study, 9 players (50%) were diagnosed with concussion. Concussion diagnoses were more frequent for posterior versus anterior impacts. The majority of H-HBP impact locations were different from those in the current NOCSAE standard tests. First responders took an average of approximately 65 seconds (time to reach batter plus assessment time) to decide on batter removal/return to play. The 25% logistic regression concussion risk threshold for pitch velocity and days missed was 86.2 mph and 1.3 days, respectively. The number of days missed after H-HBP showed a significant correlation (P = .02) among concussed and nonconcussed batters. Conclusion: In professional baseball H-HBP incidents, first responders should (1) be aware of pitch velocity in excess of 86 mph and (2) be provided ample time when assessing batters' removal/return to play.	[Athiviraham, Aravind; Bartsch, Adam; Mageswaran, Prasath; Benzel, Edward C.; Perse, Brian; Jones, Morgan H.; Schickendantz, Mark] Cleveland Clin, Cleveland, OH 44106 USA	Athiviraham, A (corresponding author), Baylor Coll Med, Dept Orthoped Surg, 6620 Main 11A-35, Houston, TX 77030 USA.	aravindathi@yahoo.com	Athiviraham, Aravind/AAQ-9512-2020	Athiviraham, Aravind/0000-0003-1121-2634; Jones, Morgan/0000-0002-5466-0624			[Anonymous], 1920, NY TIMES; Batting season finder, 2012, BATTING SEASON FINDE; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Campanelli J, 2010, PLAIN DEALER    0406, V6; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Cummings D, 2009, FINDINGDULCINEA 0815; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; GOLDSMITH W, 1982, AM J SPORT MED, V10, P31, DOI 10.1177/036354658201000108; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; James Bill Handbook., 2011, B JAMES HDB; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; NOCSAE, STAND PERF SPEC NEWL; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P303; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Sowell M., 1991, PITCH KILLED	21	14	14	0	27	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	DEC	2012	40	12					2808	2814		10.1177/0363546512461754			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	045KC	WOS:000311693700017	23104607				2021-06-18	
J	Bandt, SK; Greenberg, JK; Yarbrough, CK; Schechtman, KB; Limbrick, DD; Leonard, JR				Bandt, S. Kathleen; Greenberg, Jacob K.; Yarbrough, Chester K.; Schechtman, Kenneth B.; Limbrick, David D.; Leonard, Jeffrey R.			Management of pediatric intracranial gunshot wounds: predictors of favorable clinical outcome and a new proposed treatment paradigm Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						gunshot wound; head injury; clinical outcome; patient management; traumatic brain injury; trauma	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; PROGNOSTIC-FACTORS; CHILDREN; MORTALITY; SCALE; AGE	Object. There has been an increase in civilian gun violence since the late 1980s, with a disproportionately high increase occurring within the pediatric population. To date, no definite treatment paradigm exists for the management of these patients, nor is there a full understanding of the predictors of favorable clinical outcome in this population. Methods. The authors completed a retrospective review of all victims of intracranial gunshot injury from birth to age 18 years at a major metropolitan Level 1 trauma center (n = 48) from 2002 to 2011. The predictive values of widely accepted adult clinical and radiographic factors for poor prognosis were investigated. Results. Eight statistically significant factors (p < 0.05) for favorable outcome were identified. These factors include single hemispheric involvement, absence of a transventricular trajectory, < 3 lobes involved, >= 1 reactive pupil on arrival, systolic blood pressure > 100 mm Hg on arrival, absence of deep nuclei and/or third ventricular involvement, initial ICP < 30 mm Hg when monitored, and absence of midline shift. Of these 8 factors, 5 were strong predictors of favorable clinical outcome as defined by Glasgow Outcome Scale score of 4 or 5. These predictive factors included absence of a transventricular trajectory, < 3 lobes involved, >= 1 reactive pupil on arrival, absence of deep nuclei and/or third ventricular involvement, and initial ICP < 30 mm Hg. These findings form the basis of the St. Louis Scale for Pediatric Gunshot Wounds to the Head, a novel metric to inform treatment decisions for pediatric patients who sustain these devastating injuries. Conclusions. The pediatric population tends to demonstrate more favorable outcomes following intracranial gunshot injury when compared with the adult population; therefore some patients may benefit from more aggressive treatment than is considered for adults. The St. Louis Scale for Pediatric Gunshot Wounds to the Head may provide critical data toward evidence-based guidelines for clinical decision making. (http://thejns.org/doi/abs/10.3171/2012.8.PEDS123)	[Bandt, S. Kathleen; Yarbrough, Chester K.; Limbrick, David D.; Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Schechtman, Kenneth B.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Limbrick, David D.; Leonard, Jeffrey R.] St Louis Childrens Hosp, Dept Pediat Neurosurg, St Louis, MO 63178 USA	Bandt, SK (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, Campus Box 8057,660 S Euclid Ave, St Louis, MO 63110 USA.	bandtk@wudosis.wustl.edu		yarbrough, chester/0000-0003-0546-6435			BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; JENNETT B, 1975, LANCET, V1, P480; Karch Debra L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; LEVY ML, 1993, NEUROSURGERY, V33, P1018; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; Missouri Department of Health and Senior Services, 2011, MISS INF COMM ASS; Murano T, 2005, AM SURGEON, V71, P1009; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; Petridis AK, 2011, CENT EUR NEUROSURG, V72, P5, DOI 10.1055/s-0029-1241850; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Pruitt BA, 2001, J TRAUMA, V51, pS1, DOI 10.1097/00005373-200108001-00001; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; STONE JL, 1995, J TRAUMA, V38, P851, DOI 10.1097/00005373-199506000-00002	27	14	14	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	DEC	2012	10	6					511	517		10.3171/2012.8.PEDS123			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	042IE	WOS:000311464100011	23020154				2021-06-18	
J	Friedman, LS				Friedman, Lee S.			Dose-response relationship between in-hospital mortality and alcohol following acute injury	ALCOHOL			English	Article						Alcohol; Ethanol; Injury; Mortality; Dose-response; Trauma	ACUTE ETHANOLISM; BRAIN; INTOXICATION; LEVEL; ABUSE; ASSOCIATION; MORBIDITY; SEVERITY; MODERATE; IMPACT	Although the relationship between alcohol and injury incidence is well researched, there continues to be dispute about the relationship between alcohol and mortality following an injury. Findings from past studies have varied primarily because of methodological issues and have failed to characterize the dose response relationship. The main objective of this study was to evaluate the dose response relationship of in-hospital mortality and blood alcohol concentration (BAC). This study was a retrospective analysis of traumatic injuries occurring between 1995 and 2009 as reported by all level 1 and 2 trauma units in the State of Illinois. The study includes all patients with blood alcohol toxicological examination levels ranging from zero to 500 mg/dl (N = 190,612). The Illinois trauma registry includes all patients sustaining traumatic injuries and admitted to a trauma center for >= 12 h. A total of 6733 patients meeting the inclusion criteria died following admission. Patients that were dead on arrival and those that died during the initial assessment within the emergency room were excluded. In the adjusted multivariable model, a decrease in in-hospital mortality was strongly associated with an increase in blood alcohol concentration (adjusted OR = 0.83 per 100 mg/dl units change in BAC; CI 95%: 0.80, 0.85; p < 0.001). The direction of the dose response relationship was consistent across the stratified models, with the exception of patients suffering burns. The largest reduction of in-hospital case fatality rates by blood alcohol concentration was observed among patients suffering penetrating or severe injuries (Injury Severity Score >= 16). In the clinical setting, it is important to understand not only how to recognize intoxicated patients, but also how alcohol may affect the course of treatment. The consistency of the findings across the multivariable models indicates that blood alcohol concentration is strongly associated with lower in-hospital mortality among those that survive long enough to receive treatment in specialized trauma units. (C) 2012 Elsevier Inc. All rights reserved.	[Friedman, Lee S.] Univ Illinois, Sch Publ Hlth, Div Environm & Occupat Hlth Sci, Chicago, IL 60612 USA; [Friedman, Lee S.] Social Policy Res Inst, Skokie, IL 60076 USA	Friedman, LS (corresponding author), Social Policy Res Inst, 4001 Emerson, Skokie, IL 60612 USA.	lfriedman@tspri.org	Friedman, Lee/G-9799-2011	Friedman, Lee/0000-0001-9312-6099			Allison P.D., 2002, MISSING DATA; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHERPITEL CJ, 1995, ACCIDENT ANAL PREV, V27, P651, DOI 10.1016/0001-4575(95)00011-N; Cherpitel CJ, 2003, ADDICTION, V98, P1277, DOI 10.1046/j.1360-0443.2003.00459.x; Choudhry MA, 2006, FRONT BIOSCI-LANDMRK, V11, P998, DOI 10.2741/1857; Fabbri A, 2001, J TRAUMA, V50, P521, DOI 10.1097/00005373-200103000-00018; Friedman LS, 2007, J OCCUP ENVIRON MED, V49, P401, DOI 10.1097/JOM.0b013e31803b9527; Griffin R, 2009, J BURN CARE RES, V30, P395, DOI 10.1097/BCR.0b013e3181a28966; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KELLEY D, 1992, Journal of Burn Care and Rehabilitation, V13, P218, DOI 10.1097/00004630-199203000-00008; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; LOWENFELS AB, 1984, ANN EMERG MED, V13, P1056, DOI 10.1016/S0196-0644(84)80070-0; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Madan AK, 1999, J TRAUMA, V47, P568, DOI 10.1097/00005373-199909000-00026; McKim W. A., 1991, DRUGS BEHAV; Mitchell M C, 1985, J Stud Alcohol Suppl, V10, P109; Molina PE, 2004, ALCOHOL, V33, P217, DOI 10.1016/j.alcohol.2004.07.002; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Ogden E J D, 2004, Traffic Inj Prev, V5, P185; Peck RC, 2008, J SAFETY RES, V39, P311, DOI 10.1016/j.jsr.2008.02.030; Phelan H, 2002, J TRAUMA, V52, P675, DOI 10.1097/00005373-200204000-00010; Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; Subramanian R., 2003, MULTIPLE IMPUTATION; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; von Heymann C, 2002, J TRAUMA, V52, P95, DOI 10.1097/00005373-200201000-00017; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; World Health Organisation (WHO), 2008, WHO COLL STUD ALC IN; Yaghoubian A, 2009, AM SURGEON, V75, P950; Zeckey C, 2011, ALCOHOL, V45, P245, DOI 10.1016/j.alcohol.2010.08.004	45	14	14	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0741-8329	1873-6823		ALCOHOL	Alcohol	DEC	2012	46	8					769	775		10.1016/j.alcohol.2012.08.006			7	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Substance Abuse; Pharmacology & Pharmacy; Toxicology	047VX	WOS:000311870700007	23085114				2021-06-18	
J	Homnick, A; Sifri, Z; Yonclas, P; Mohr, A; Livingston, D				Homnick, Adena; Sifri, Ziad; Yonclas, Peter; Mohr, Alicia; Livingston, David			The temporal course of intracranial haemorrhage progression: How long is observation necessary?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury (TBI); Mild traumatic brain injury (MTBI); Intracranial haemorrhage (ICH); Temporal course of TBI; Timing of ICH progression; Non-operative management of TBI; Minimal head injury (MHI)	TRAUMATIC BRAIN-INJURY; MINIMAL HEAD-INJURY; COMPUTED-TOMOGRAPHY; FOLLOW-UP; CT; UTILITY	Introduction: Patients with mild traumatic brain injury (MTBI) and intracranial haemorrhage (ICH) are hospitalized and monitored for progression of injury. The timeframe for ICH progression is unknown, and so the optimal duration and location of observation are generally discretionary. The goal of this study was to examine the temporal course of injury progression and establish a timeframe for when haemorrhage ceases. Methods: We performed a retrospective review of all adult patients (age >= 18) with MTBI (GCS >= 13) and ICH admitted to a level 1 trauma centre over a consecutive 36 month period, who underwent a minimum of 2 cranial CT scans (HCT) within 48 h from ED presentation prior to any neurosurgical intervention (NSI). Patients with a history of NSI or nontraumatic cerebral lesions were excluded. Data collected include demographics and the number, timing and findings of serial HCT scans. Results: A total of 341 patients met inclusion criteria. The timing for cessation of bleeding could not be confirmed in 37 patients (11 had NSI after 2nd HCT, 1 died of coagulopathy prior to NSI and 25 had no repeat HCT that could confirm the cessation of bleeding). Of the remaining 304 ICH, 96% stopped progressing by 24 h and 99% by 48 h. The remaining 1% stopped by 72 h. Of all 341 ICH, 236 (69%) showed no progression after initial HCT, indicating that haemorrhage had stopped by that time (1.2 h (SD +/- 1.1 h) from admission). None required a NSI. Conclusion: Almost all ICH in MTBI stop progressing within the first 24 h post injury, supporting a 24-h observational period. In fact, over 3/4 s of ICH has stopped by the time of the initial HCT (< 2 h from arrival). This suggests that early repeat HCT may identify those ICH no longer progressing, and possibly avoid unnecessary admission and prolonged observation in those patients not requiring admission for post-TBI symptom management. Prospective data are needed to evaluate this proposed paradigm change in the management of MTBI. (c) 2012 Elsevier Ltd. All rights reserved.	[Homnick, Adena] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma, Newark, NJ 07103 USA	Homnick, A (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Div Trauma, 150 Bergen St, Newark, NJ 07103 USA.	homnicat@umdnj.edu	Mohr, Alicia M/E-3016-2015	Mohr, Alicia/0000-0003-1732-1313			Beaumont A, 2006, ACTA NEUROCHIR SUPPL, V96, P30; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	19	14	15	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2122	2125		10.1016/j.injury.2012.04.013			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600027	22658418				2021-06-18	
J	Nolin, P; Stipanicic, A; Henry, M; Joyal, CC; Allain, P				Nolin, Pierre; Stipanicic, Annie; Henry, Mylene; Joyal, Christian C.; Allain, Philippe			Virtual reality as a screening tool for sports concussion in adolescents	BRAIN INJURY			English	Article						Virtual reality; virtual classroom; ClinicaVR: Classroom; sports concussion; mTBI; mild traumatic brain injury; adolescents	TRAUMATIC BRAIN-INJURY; CONTINUOUS PERFORMANCE-TEST; UNITED-STATES; ENRICHED ENVIRONMENTS; EXERCISE PROGRAMS; MILD; REHABILITATION; CHILDREN; CLASSROOM; SYMPTOMS	Primary objective: There is controversy surrounding the cognitive effects of sports concussion. This study aimed to verify whether the technique of virtual reality could aid in the identification of attention and inhibition deficits in adolescents. Study design: A prospective design was used to assess 25 sports-concussed and 25 non-sports-concussed adolescents enrolled in a sport and education programme. Methods and procedures: Participants were evaluated in immersive virtual reality via ClinicaVR: Classroom-CPT and in real life via the traditional VIGIL-CPT. Main outcomes and results: The neuropsychological assessment using virtual reality showed greater sensitivity to the subtle effects of sports concussion compared to the traditional test, which showed no difference between groups. The results also demonstrated that the sports concussion group reported more symptoms of cybersickness and more intense cybersickness than the control group. Conclusions: Sports concussion was associated with subtle deficits in attention and inhibition. However, further studies are needed to support these results.	[Nolin, Pierre; Stipanicic, Annie; Henry, Mylene; Joyal, Christian C.; Allain, Philippe] Univ Quebec Trois Rivieres, Dept Psychol, Lab Rech Interdisciplinaire Realite Virtuelle LAR, Trois Rivieres, PQ G9A 5H7, Canada; [Allain, Philippe] Univ Angers, Lab Psychol Proc Pensee & Intervent, Angers, France	Nolin, P (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Lab Rech Interdisciplinaire Realite Virtuelle, CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	pierre.nolin@uqtr.ca		ALLAIN, Philiooe/0000-0003-0668-0986			Adams R, 2009, CHILD NEUROPSYCHOL, V15, P120, DOI 10.1080/09297040802169077; Alexander GE, 1992, DISS ABSTR INT B 1, V52, P6651; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cegalis J., 1991, VIGIL SOFTWARE ASSES; De Beaumont L., 2010, LONG TERM EFFECTS SP; De Brito SA, 2009, CRIM JUSTICE BEHAV, V36, P1173, DOI 10.1177/0093854809342883; de Kenedy, 2002, TRADUCTION POSTEXPOS; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Egeland J, 2010, J ATTEN DISORD, V13, P339, DOI 10.1177/1087054708323019; Fauzy WM., 2004, J INTERACT LEARN RES, V15, P147; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Kelly JP, 1997, NEUROLOGY, V48, P581; Kenedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203; Larson EB, 2011, BRAIN INJURY, V25, P274, DOI 10.3109/02699052.2010.551648; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; Levin HS, 1987, MINOR HEAD INJURY PO; Levin MF, 2011, EXPERT REV NEUROTHER, V11, P153, DOI 10.1586/ERN.10.201; Martin C, 2009, A N A E APPROCHE NEU, V21, P28; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McAllister WR, 2006, LEARN BEHAV, V34, P44, DOI 10.3758/BF03192870; McCrory P, 2004, CLIN J SPORT MED, V14, P139, DOI 10.1097/00042752-200405000-00006; McCrory Paul, 2005, Clin J Sport Med, V15, P48; MIDDLETON J, 1989, J CHILD PSYCHOL PSYC, V30, P663, DOI 10.1111/j.1469-7610.1989.tb00780.x; Moreau G, 2006, ANN REV CYBERTHERAPY, V4, P59; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Mumford N, 2009, BRAIN INJURY, V23, P179, DOI 10.1080/02699050802695566; Nolin P, 2001, REV NEUROPSYCHOL, V11, P23; Nolin P, 2009, STUD HEALTH TECHNOL, V144, P240, DOI 10.3233/978-1-60750-017-9-240; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Penn PR, 2009, DEV NEUROREHABIL, V12, P32, DOI 10.1080/17518420902739365; Pollak Y, 2010, CNS SPECTRUMS, V15, P125, DOI 10.1017/S109285290002736X; Pollak Y, 2009, J DEV BEHAV PEDIATR, V30, P2, DOI 10.1097/DBP.0b013e3181969b22; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; PRATT DR, 1995, COMPUTER, V28, P17; Ptito A, 2007, NEUROREHABILITATION, V22, P217; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rizzo AA, 2006, CNS SPECTRUMS, V11, P35, DOI 10.1017/S1092852900024196; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schatz P., 2011, HDB SPORT NEUROPSYCH, P173; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trepagnier CG, 1999, NEUROREHABILITATION, V12, P63; UQO Cyberpsychology Laboratory, 2004, TRAD PRES QUEST WITM; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Yen HL, 2007, ANN ACAD MED SINGAP, V36, P62; Yip BCB, 2009, BRAIN INJURY, V23, P1017, DOI 10.3109/02699050903379412; Zhang J, 2003, INT J E LEARNING, V2, P17	84	14	14	0	27	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1564	1573		10.3109/02699052.2012.698359			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700003	22775556				2021-06-18	
J	Yuan, Q; Liu, H; Wu, X; Sun, YR; Yao, HJ; Zhou, LF; Hu, J				Yuan, Qiang; Liu, Hua; Wu, Xing; Sun, Yirui; Yao, Haijun; Zhou, Liangfu; Hu, Jin			Characteristics of acute treatment costs of traumatic brain injury in Eastern China-a multi-centre prospective observational study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Brain injury; Costs; Length of stay; Traumatic brain injury	HOSPITAL LENGTH; UNITED-STATES; HEAD-INJURY; CHARGES; OUTCOMES; STAY; CARE	Introduction: This study investigated acute treatment costs and related factors for traumatic brain injuries (TBI) in eastern China based on a prospective multicentre study. Materials and methods: Data were prospectively collected from 80 hospitals in eastern China by standardized structured questionnaires during 2004. Included patients were admitted to hospitals via an emergency service with a diagnosis of TBI. The total acute hospitalization treatment costs derived from unsubsidized total hospital billings were used as the main outcome measure. Univariate and multivariable regression models were used to examine factors associated with each outcome. Results: In total, 13,007 TBI cases were identified from 80 hospitals in eastern China. The median cost per hospitalization was $879 US (range, $72-45,894). The median cost per day was $79 (interquartile range, $49-126). The hospitalization costs varied based on the cause of TBI, with a median of $1017 for traffic accidents, $816 for falls, $490 for blows to the head, and $712 for falls. The hospitalization costs also varied by injury type with a mean of $918 for TBI associated with other injuries and $831 for isolated TBI. Using multiple regression analyses, lower admission Glasgow Coma score, longer hospital stay (LOS), male sex, transient patient status, traffic accident, injury occurring on a construction site, treatment at a tertiary hospital, neurosurgical intensive care unit (NICU) or ICU stay, associated polytrauma, and those who needed a neurosurgical operation had significantly higher total acute hospitalization costs than those of other groups. Good recovery and self-paying patients had lower total costs. A double LOS was associated with a 1.61 (95% confidence interval, 1.59-1.62) times higher hospital cost. Conclusion: Our results have potential implications for health-care resource planning during TBI treatment. Measures to prevent traffic accidents and reduce the LOS may help to reduce acute hospitalization costs. Crown Copyright (C) 2012 Published by Elsevier Ltd. All rights reserved.	[Wu, Xing; Sun, Yirui; Zhou, Liangfu; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Yuan, Qiang; Yao, Haijun] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China; [Liu, Hua] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China	Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	297260090@qq.com; wacilii@163.com; bttnirvina@gmail.com; yirui.sun@live.cn; yaohaijun0913@126.com; sunyinfengabc@163.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30371454]; Shanghai Nature Science Foundation [0841195200]	This study was funded by National Natural Science Foundation of China (NSFC Grants 30371454), Shanghai Nature Science Foundation (0841195200).	American Association of Neurological Surgeons, 1996, J NEUROTRAUM, V13, P639; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Brell M, 2001, NEUROCIRUGIA, V12, P105; Brooks CA, 1995, J HEAD TRAUMA REHAB, V104, P1; Davis KL, 2007, J TRAUMA, V62, P622, DOI 10.1097/TA.0b013e318031afe3; Firsching R, 2001, WORLD J SURG, V25, P1221; Gardner R, 2007, ARCH PEDIAT ADOL MED, V161, P889, DOI 10.1001/archpedi.161.9.889; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Max W, 2001, J HEAD TRAUMA REHAB, V6, P26; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	16	14	18	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	DEC	2012	43	12					2094	2099		10.1016/j.injury.2012.03.028			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	028XM	WOS:000310458600022	22595490				2021-06-18	
J	Li, J; Gu, L; Feng, DF; Ding, F; Zhu, GY; Rong, JD				Li, Jia; Gu, Lei; Feng, Dong-Fu; Ding, Fang; Zhu, Guangyao; Rong, Jiandong			Exploring Temporospatial Changes in Glucose Metabolic Disorder, Learning, and Memory Dysfunction in a Rat Model of Diffuse Axonal Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; hippocampus; hypometabolism; learning and memory dysfunction; rat	TRAUMATIC BRAIN-INJURY; POSITRON-EMISSION-TOMOGRAPHY; FLUID-PERCUSSION INJURY; REGIONAL CEREBRAL METABOLISM; STATISTICAL IMAGE-ANALYSIS; CORTICAL IMPACT INJURY; WATER MAZE PERFORMANCE; HEAD-INJURY; CELL-DEATH; FDG-PET	Diffuse axonal injury (DAI) is the predominant effect of severe traumatic brain injury and contributes significantly to cognitive deficits. The mechanisms underlying these cognitive deficits are often associated with complex metabolic alterations. However, the relationships between temporospatial alterations in cerebral glucose metabolism and the pathophysiology of DAI-related learning and memory dysfunction are not yet completely understood. We used a small animal positron emission tomography (PET) scanner with 2-[F-18]-fluoro-2-deoxy-D-glucose (F-18-FDG) as a molecular probe to evaluate temporospatial glucose metabolism in vulnerable areas of rats with DAI. The Morris water maze (MWM) was used to evaluate the development and progression of learning and memory dysfunction. Compared to the sham-treated group, PET-MRI fusion images showed that glucose metabolism was reduced in animals with DAI. In addition, the standardized uptake value (SUV) of F-18-FDG was significantly decreased in the sensorimotor cortex, hippocampus, corpus callosum, caudate putamen, brain stem, and cerebellum at days 1, 3, and 7 after injury. SUV returned to baseline levels by 30 days after injury. The escape latency of the injured group was significantly increased, and the percentages of distance travelled and time spent in the target quadrant were significantly decreased 1 month after injury. These effects persisted for 3 months. SUVs in the hippocampus at the acute stage were significantly correlated with MWM performance during the recovery stage of DAI. These results demonstrate that microstructural injury-induced hypometabolism in the hippocampus at the acute stage are all significantly correlated with learning and memory dysfunctions during the recovery stage of DAI.	[Li, Jia; Gu, Lei; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Neurosurg, Shanghai 200030, Peoples R China; [Li, Jia; Ding, Fang; Zhu, Guangyao; Rong, Jiandong] Ningbo Univ, Sch Med, Lihuili Hosp, Ningbo Med Ctr,Dept Neurosurg, Ningbo, Peoples R China; [Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai 200030, Peoples R China	Feng, DF (corresponding author), 280 Mo He Rd, Shanghai 201900, Peoples R China.	feng_df@yahoo.com			Shanghai Committee of Science and TechnologyShanghai Science & Technology Committee [114119a8300]; Baosan Science and Technology Development Fund [11-E-1]; Medicine-Engineering Combination Project of Shanghai Jiao Tong Universtiy [YG08PETMS19]	This study was supported by grants from the Shanghai Committee of Science and Technology (No. 114119a8300), Baosan Science and Technology Development Fund (No. 11-E-1) and the Medicine-Engineering Combination Project of Shanghai Jiao Tong Universtiy (No. YG08PETMS19).	Alavi A, 1997, J NUCL MED, V38, P1717; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Baron J C, 1981, Trans Am Neurol Assoc, V105, P459; Beresford MJ, 2006, J MAGN RESON IMAGING, V24, P1316, DOI 10.1002/jmri.20768; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Brauck K, 2008, RADIOLOGY, V246, P910, DOI 10.1148/radiol.2463062017; Clausen F, 2005, NEUROSURGERY, V57, P154, DOI 10.1227/01.NEU.0000163412.07546.57; Coello C, 2011, J NEUROSCI METH, V199, P166, DOI 10.1016/j.jneumeth.2011.04.026; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; COLLE LM, 1986, BRAIN RES, V397, P27, DOI 10.1016/0006-8993(86)91366-1; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Doot RK, 2007, J NUCL MED, V48, P920, DOI 10.2967/jnumed.106.037382; Dunnwald LK, 2011, CLIN CANCER RES, V17, P2400, DOI 10.1158/1078-0432.CCR-10-2649; Frumberg DB, 2007, BRAIN RES, V1144, P209, DOI 10.1016/j.brainres.2007.01.134; Gao F, 2009, NEUROBIOL DIS, V34, P477, DOI 10.1016/j.nbd.2009.03.001; Garcia AN, 2011, PM&R, V3, pS18, DOI 10.1016/j.pmrj.2011.03.017; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gerlai RT, 2002, BRAIN RES BULL, V57, P3, DOI 10.1016/S0361-9230(01)00630-X; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Goffin K, 2009, EXP NEUROL, V217, P205, DOI 10.1016/j.expneurol.2009.02.008; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Guo Y, 2009, NEUROSCIENCE, V162, P972, DOI 10.1016/j.neuroscience.2009.05.041; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hattori N, 2004, J NUCL MED, V45, P775; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Huang SC, 2000, NUCL MED BIOL, V27, P643; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; KEYES JW, 1995, J NUCL MED, V36, P1836; KOCHS E, 1993, ANESTH ANALG, V76, P1222, DOI 10.1213/00000539-199376060-00007; KUSHNER M, 1984, ANN NEUROL, V15, P425, DOI 10.1002/ana.410150505; Lagali PS, 2010, CLIN GENET, V78, P321, DOI 10.1111/j.1399-0004.2010.01503.x; Lebesgue D, 2006, J NEUROTRAUM, V23, P1814, DOI 10.1089/neu.2006.23.1814; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lipton P, 1999, PHYSIOL REV, V79, P1431; Loeffelbein DJ, 2012, J ORAL MAXIL SURG, V70, P473, DOI 10.1016/j.joms.2011.02.120; Lou M, 2007, NEUROSCIENCE, V146, P555, DOI 10.1016/j.neuroscience.2007.01.046; Mankoff David A, 2003, Mol Imaging Biol, V5, P281, DOI 10.1016/j.mibio.2003.09.002; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Muller MJ, 2006, AM J NEURORADIOL, V27, P440; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; PAXINOS G, 1996, RAT BRAIN STEREOTAXI; Pichler Bernd J., 2008, V185, P109, DOI 10.1007/978-3-540-72718-7_6; Prieto E, 2011, EUR J NUCL MED MOL I, V38, P2228, DOI 10.1007/s00259-011-1905-y; Prins ML, 2012, EPILEPSY RES, V100, P218, DOI 10.1016/j.eplepsyres.2011.09.027; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Raylman RR, 2006, PHYS MED BIOL, V51, P6371, DOI 10.1088/0031-9155/51/24/006; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Shih YYI, 2008, NEUROSCIENCE, V155, P1221, DOI 10.1016/j.neuroscience.2008.07.013; Shimoji K, 2004, J NUCL MED, V45, P665; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Szutowicz A, 2006, METAB BRAIN DIS, V21, P149, DOI 10.1007/s11011-006-9007-4; TODD MM, 1984, ANESTHESIOLOGY, V60, P276, DOI 10.1097/00000542-198404000-00002; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Witgen BM, 2006, J NEUROTRAUM, V23, P1320, DOI 10.1089/neu.2006.23.1320; WORLEY G, 1995, DEV MED CHILD NEUROL, V37, P213; WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8; Yamaki T, 1996, J NUCL MED, V37, P1166; Yamamoto S, 2010, ANN NUCL MED, V24, P89, DOI 10.1007/s12149-009-0333-6; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	76	14	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2012	29	17					2635	2646		10.1089/neu.2012.2411			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	047QU	WOS:000311856400005	22880625	Green Published			2021-06-18	
J	Minns, RA; Jones, PA; Tandon, A; Fleck, BW; Mulvihill, AO; Elton, RA				Minns, Robert A.; Jones, Patricia A.; Tandon, Anamika; Fleck, Brian W.; Mulvihill, Alan O.; Elton, Robert A.			Prediction of Inflicted Brain Injury in Infants and Children Using Retinal Imaging	PEDIATRICS			English	Article						inflicted brain injury; infants and children; retinal hemorrhages; predictive probability	YOUNG-CHILDREN; OPHTHALMOLOGIC FINDINGS; HEAD TRAUMA; HEMORRHAGES; ABUSE; CLASSIFICATION	BACKGROUND: Retinal hemorrhages (RHs) occur in inflicted traumatic brain injury (ITBI), accidental traumatic brain injury (ATBI), and some medical conditions, although the reported number, distribution, type, and frequency vary greatly between these different etiologies. We hypothesize that these RH characteristics reliably help to distinguish ITBI from ATBI and nontraumatic etiologies. METHODS: A 6-year prospective observational study using wide-field retinal imaging (RetCam) was conducted within 24 hours of admission to PICU, on serially recruited children with traumatic and nontraumatic encephalopathies. "Definite" and "probable" ITBI cases were confirmed by multiagency child protection case conferences. Image analysis used digital color and grayscale images for retinal "zoning" and "layering" of hemorrhages. RESULTS: Significant differences were found between the mean numbers of hemorrhages in ATBI/ITBI, and ITBI/nontraumatic etiologies for the 3 retinal zones (range, P = .003-.009) and for the dot-blot hemorrhages (range P = .001-.002). The mean numbers of RHs per ITBI patient in the peripapillary, macula, and peripheral zones were 14, 28, and 31 respectively. RHs in ATBI were near the optic disc and more superficial than in ITBI, where hemorrhages involved deeper layers (range, P = .003-.039) and were more peripheral (P = .03). The positive predictive value for ITBI in children <3 years with >25 dot-blot (intraretinal) hemorrhages was 93%. CONCLUSIONS: This prospective study, which included all potential causes of RHs, with objective retinal methodology, has confirmed that a young age and a high dot-blot count are strong predictors of ITBI. This high predictive value may support medicolegal deliberations. Pediatrics 2012;130:e1227-e1234	[Elton, Robert A.] Univ Edinburgh, Dept Med Stat, Edinburgh EH9 1UW, Midlothian, Scotland; [Minns, Robert A.; Jones, Patricia A.] Royal Hosp Sick Children Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Tandon, Anamika; Fleck, Brian W.; Mulvihill, Alan O.] Royal Hosp Sick Children Edinburgh, Dept Pediat Ophthalmol, Edinburgh, Midlothian, Scotland	Minns, RA (corresponding author), Univ Edinburgh, Coll Med & Vet Med, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland.	robert.minns@ed.ac.uk			R.S. Macdonald Charitable Trust Edinburgh; Royal College of Surgeons Edinburgh; Friends of The Sick Kids Foundation, Edinburgh, Scotland	Funding was obtained from the R.S. Macdonald Charitable Trust Edinburgh, from the Royal College of Surgeons Edinburgh (Ophthalmology Grant), and from the Friends of The Sick Kids Foundation, Edinburgh, Scotland. The funders had no role in study design; in the collection, analysis, and interpretation of data; or in the writing of the report or the decision to submit the article for publication.	Arlotti SA, 2007, J AAPOS, V11, P175, DOI 10.1016/j.jaapos.2006.09.023; Barry GP, 2010, J AAPOS, V14, pe11; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Betz P, 1996, FORENSIC SCI INT, V78, P71, DOI 10.1016/0379-0738(95)01866-2; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; BUDENZ DL, 1994, OPHTHALMOLOGY, V101, P559; Dinakaran S, 2002, J AAPOS, V6, P221, DOI 10.1067/mpa.2002.124648; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Fleck BW, 2010, BRIT J OPHTHALMOL, V94, P886, DOI 10.1136/bjo.2009.162271; Gilles EE, 2003, J PEDIATR-US, V143, P494, DOI 10.1067/S0022-3476(03)00416-5; Gilliland MGF, 2003, P AM AC FOR SCI M CH, P232; Healey K, 2006, AM J EMERG MED, V24, P616, DOI 10.1016/j.ajem.2005.11.016; Keenan H., 2002, INFLICTED CHILDHOOD, P3; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire S, 2008, BURNS, V34, P1072, DOI 10.1016/j.burns.2008.02.011; Mok JYQ, 1998, CHILD ABUSE REV, V7, P194; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Mulvihill AO, 2011, BRIT J OPHTHALMOL, V95, P99, DOI 10.1136/bjo.2009.168153; MUNGER CE, 1993, AM J FOREN MED PATH, V14, P193, DOI 10.1097/00000433-199309000-00004; Pierre-Kahn V, 2003, OPHTHALMOLOGY, V110, P1718, DOI 10.1016/S0161-6420(03)00581-5; RIFFENBURGH RS, 1991, OPHTHALMOLOGY, V98, P1519; Shaw AD, 2010, JAAPOS, V14, pe27; Sturm V, 2009, EYE, V23, P1535, DOI 10.1038/eye.2008.317; Tandon A, 2011, BRIT J OPHTHALMOL, V95, P1719, DOI 10.1136/bjophthalmol-2011-300248; THOMAS SA, 1991, PEDIATRICS, V88, P471; Togioka BM, 2009, J EMERG MED, V37, P98, DOI 10.1016/j.jemermed.2008.06.022; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037	34	14	14	0	8	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2012	130	5					E1227	E1234		10.1542/peds.2011-3274			8	Pediatrics	Pediatrics	029OT	WOS:000310505900022	23045566				2021-06-18	
J	Schnell, E; Bensen, AL; Washburn, EK; Westbrook, GL				Schnell, Eric; Bensen, AeSoon L.; Washburn, Eric K.; Westbrook, Gary L.			Neuroligin-1 Overexpression in Newborn Granule Cells In Vivo	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; TRAUMATIC BRAIN-INJURY; INHIBITORY SYNAPSE FORMATION; DENTATE GYRUS; PARKINSONS-DISEASE; EXCITATORY SYNAPSES; ADULT HIPPOCAMPUS; ADHESION MOLECULE; NEUROGENESIS; PLASTICITY	Adult-born dentate granule cells integrate into the hippocampal network, extend neurites and form synapses in otherwise mature tissue. Excitatory and inhibitory inputs innervate these new granule cells in a stereotyped, temporally segregated manner, which presents a unique opportunity to study synapse development in the adult brain. To examine the role of neuroligins as synapse-inducing molecules in vivo, we infected dividing neural precursors in adult mice with a retroviral construct that increased neuroligin-1 levels during granule cell differentiation. By 21 days post-mitosis, exogenous neuroligin-1 was expressed at the tips of dendritic spines and increased the number of dendritic spines. Neuroligin-1-overexpressing cells showed a selective increase in functional excitatory synapses and connection multiplicity by single afferent fibers, as well as an increase in the synaptic AMPA/NMDA receptor ratio. In contrast to its synapse-inducing ability in vitro, neuroligin-1 overexpression did not induce precocious synapse formation in adult-born neurons. However, the dendrites of neuroligin-1-overexpressing cells did have more thin protrusions during an early period of dendritic outgrowth, suggesting enhanced filopodium formation or stabilization. Our results indicate that neuroligin-1 expression selectively increases the degree, but not the onset, of excitatory synapse formation in adult-born neurons.	[Schnell, Eric] Portland VA Med Ctr, Portland, OR USA; [Schnell, Eric] OHSU Dept Anesthesiol & Perioperat Med, Portland, OR USA; [Bensen, AeSoon L.; Washburn, Eric K.; Westbrook, Gary L.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Schnell, E (corresponding author), Portland VA Med Ctr, Portland, OR USA.	schneler@ohsu.edu		Schnell, Eric/0000-0002-5623-5015	Oregon Medical Research Foundation; Department of Veteran's Affairs Career Development Award; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH46613]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS06180]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS061800] Funding Source: NIH RePORTER	This work was supported by the Oregon Medical Research Foundation (ES), a Department of Veteran's Affairs Career Development Award (ES), the National Institute of Mental Health (R01MH46613; GLW), and the Jungers Center Light Microscopy Image Core that is supported in part by NIH P30 NS06180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstikaitis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016998; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; El-Hussein AE, 2000, SCIENCE, V290, P1364; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gorecki DC, 1999, MOL CELL NEUROSCI, V13, P218, DOI 10.1006/mcne.1999.0740; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hagell P, 2005, BRAIN RES BULL, V68, P4, DOI 10.1016/j.brainresbull.2004.10.013; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Kernie SG, 2009, NEUROBIOL DIS; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Liu JL, 1998, J NEUROSCI, V18, P7768; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Petralia RS, 1999, NAT NEUROSCI, V2, P31; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Sahay A, 2007, PROG BRAIN RES, V163, P697, DOI 10.1016/S0079-6123(07)63038-6; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	79	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e48045	10.1371/journal.pone.0048045			11	Multidisciplinary Sciences	Science & Technology - Other Topics	025MM	WOS:000310193400031	23110172	DOAJ Gold, Green Published			2021-06-18	
J	Jeon, SJ; Han, SH; Yang, SI; Choi, JW; Kwon, KJ; Park, SH; Kim, HY; Cheong, JH; Ryu, JH; Ko, KH; Wells, DG; Shin, CY				Jeon, Se Jin; Han, Seol-Heui; Yang, Sung-Il; Choi, Ji Woong; Kwon, Kyoung Ja; Park, Seung Hwa; Kim, Hahn Young; Cheong, Jae Hoon; Ryu, Jong Hoon; Ko, Kwang Ho; Wells, David G.; Shin, Chan Young			Positive feedback regulation of Akt-FMRP pathway protects neurons from cell death	JOURNAL OF NEUROCHEMISTRY			English	Article						Akt; Bcl-xL; FMRP; glutamate; ischemia; neuronal survival	MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; LONG-TERM DEPRESSION; RNA-BINDING-PROTEIN; NEURAL STEM-CELLS; MESSENGER-RNA; SIGNALING PATHWAY; TARGET; SURVIVAL; GENE	J. Neurochem. (2012) 123, 226238. Abstract Fragile X syndrome (FXS), the most common single genetic cause of mental retardation and autistic spectrum disease, occurs when FMR1 gene is mutated. FMR1 encodes fragile X mental retardation protein (FMRP) which regulates translation of mRNAs playing important roles in the development of neurons as well as formation and maintenance of synapses. To examine whether FMRP regulates cell viability, we induced apoptosis in rat primary cortical neurons with glutamate in vitro and with middle cerebral artery occlusion (MCAO) in striatal neurons in vivo. Both conditions elicited a rapid, but transient FMRP expression in neurons. This up-regulated FMRP expression was abolished by pre-treatment with PI3K and Protein Kinase B (Akt) inhibitors: LY294002, Akt inhibitor IV, and VIII. Reduced FMRP expression in vitro or in vivo using small hairpin Fmr1 virus exacerbated cell death by glutamate or MCAO, presumably via hypophosphorylation of Akt and reduced expression of B-cell lymphoma-extra large (Bcl-xL). However, over-expression of FMRP using enhanced green fluorescent protein (eGFP)-FMRP constructs alleviated cell death, increased Akt activity, and enhanced Bcl-xL production. The pro-survival role of Akt-dependent up-regulation of FMRP in glutamate-stimulated cultured neuron as well as in ischemic brain may have a clinical importance in FXS as well as in neurodegenerative disorders and traumatic brain injury.	[Yang, Sung-Il; Shin, Chan Young] Konkuk Univ, Sch Med, Dept Pharmacol, Seoul 143701, South Korea; [Jeon, Se Jin; Ko, Kwang Ho] Seoul Natl Univ, Dept Pharmacol, Coll Pharm, Seoul, South Korea; [Jeon, Se Jin; Han, Seol-Heui; Kwon, Kyoung Ja; Park, Seung Hwa; Kim, Hahn Young; Shin, Chan Young] Konkuk Univ, Inst SMART IABS, Neurosci Res Ctr, Seoul 143701, South Korea; [Cheong, Jae Hoon] Sahmyook Univ, Dept Pharm, Seoul, South Korea; [Ryu, Jong Hoon] Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul, South Korea; [Wells, David G.] Yale Univ, New Haven, CT USA; [Choi, Ji Woong] Gachon Univ, Coll Pharm, Dept Pharmacol, Inchon 406799, South Korea	Shin, CY (corresponding author), Konkuk Univ, Sch Med, Dept Pharmacol, 1 Hwayang Dong, Seoul 143701, South Korea.	chanyshin@kku.ac.kr	Jeon, Sangchoon/E-3800-2013	Jeon, Sangchoon/0000-0003-2855-2053	National Research Foundation of KoreaNational Research Foundation of Korea [2011-0014258]	This work was supported by a grant (2011-0014258) from National Research Foundation of Korea.	Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; Bardoni B, 2003, EXP CELL RES, V289, P95, DOI 10.1016/S0014-4827(03)00222-2; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Berry-Kravis E, 1998, J NEUROSCI RES, V51, P41, DOI 10.1002/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Callan MA, 2011, GENESIS, V49, P424, DOI 10.1002/dvg.20745; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Castren M, 2005, P NATL ACAD SCI USA, V102, P17834, DOI 10.1073/pnas.0508995102; Castren M, 2006, CELL CYCLE, V5, P1528, DOI 10.4161/cc.5.14.3096; Chakrabarti L, 1997, CURR OPIN NEUROL, V10, P142, DOI 10.1097/00019052-199704000-00012; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dong X. X., 2009, ACTA PHARMACOL SIN, V30, P9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feng Y, 1997, J NEUROSCI, V17, P1539; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Guo WX, 2011, NAT MED, V17, P559, DOI 10.1038/nm.2336; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jeon SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-17; Jeon SJ, 2011, NEUROSCI RES, V69, P214, DOI 10.1016/j.neures.2010.11.008; Kan MC, 2010, MOL CELL BIOL, V30, P5658, DOI 10.1128/MCB.00716-10; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Kim JW, 2011, NEUROCHEM INT, V58, P423, DOI 10.1016/j.neuint.2010.12.020; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu C, 2010, J NEUROCHEM, V112, P1500, DOI 10.1111/j.1471-4159.2009.06561.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Narayanan U, 2008, J BIOL CHEM, V283, P18478, DOI 10.1074/jbc.C800055200; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; Schultz-Pedersen S, 2001, AM J MED GENET, V103, P226, DOI 10.1002/ajmg.1533; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; de la Torre AV, 2012, PHARMACOL RES, V65, P66, DOI 10.1016/j.phrs.2011.08.006; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Wagner-Golbs A, 2012, J NEUROCHEM, V120, P495, DOI 10.1111/j.1471-4159.2011.07591.x; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Ye Z, 2012, NEUROCHEM RES, V37, P321, DOI 10.1007/s11064-011-0615-y; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang Hao, 2010, Yaoxue Xuebao, V45, P945; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104; Zhao WF, 2011, J NEUROSCI, V31, P725, DOI 10.1523/JNEUROSCI.2915-10.2011; Zhong N, 1999, AM J MED GENET, V84, P268, DOI 10.1002/(SICI)1096-8628(19990528)84:3<268::AID-AJMG20>3.0.CO;2-#	67	14	14	0	12	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042			J NEUROCHEM	J. Neurochem.	OCT	2012	123	2					226	238		10.1111/j.1471-4159.2012.07886.x			13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	015NX	WOS:000309454300003	22817682				2021-06-18	
J	Kolakowsky-Hayner, SA; Hammond, FM; Wright, J; Novack, TA; Englander, J; Diaz-Arrastia, R; Dennison, A; Sueno, P				Kolakowsky-Hayner, Stephanie A.; Hammond, Flora M.; Wright, Jerry; Novack, Thomas A.; Englander, Jeffrey; Diaz-Arrastia, Ramon; Dennison, Andrew; Sueno, Paul			Ageing and traumatic brain injury: Age, decline in function and level of assistance over the first 10 years post-injury	BRAIN INJURY			English	Article						Aging; decline; functional change; level of assistance; traumatic brain injury; TBI model systems	DISABILITY RATING-SCALE; LONG-TERM RECOVERY; INPATIENT REHABILITATION; OLDER-ADULTS; OUTCOMES; PREDICTORS	Objectives: To understand the course of changes in function and need for assistance in the chronic stages of TBI; and to identify factors associated with these changes. Design: Longitudinal review of participants in the TBI Model Systems Database, who have been prospectively followed for at least 10 years. Participants: Four hundred and seventy-eight individuals with TBI that occurred between 25 October 1988 and 31 December 1998, enrolled in the TBI Model Systems National Database, eligible for 10-year follow-up when data was extracted, with completed data collection at either year 1 or 2 and year 10. Results: Significant between age group differences were found for FIM toileting, bladder, bowel, toilet transfers, locomotion, problem-solving and memory; SRS; DRS level of functioning, employability and total; and GOS. With regard to functional independence, there were significant differences by age category for all FIM components except memory. Significant differences were noted for age category and level of dependence as measured by the DRS (LOF 1.5-5) and GOS (GOS 2-4). Supervision needs significantly increased as a function of age. Significant differences were found for diminished function over time. Significant differences were noted for residence at 10 years post-injury. Conclusions: For those individuals that survive to 10 years post-TBI, age is a major factor in requiring assistance of another person for supervision as well as assistance in basic self-care, continence and mobility.	[Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Englander, Jeffrey; Sueno, Paul] Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; [Hammond, Flora M.; Dennison, Andrew] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ, Indianapolis, IN 46204 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Spain Rehabil Ctr, Birmingham, AL USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA	Kolakowsky-Hayner, SA (corresponding author), Rehabil Res Ctr, Dept PM&R, 751S Bascom Ave, San Jose, CA 95128 USA.	stephanie.hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Diaz-Arrastia, Ramon/0000-0001-6051-3594	TBI Model System Center; National Data and Statistical Center; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A070038, H13 3A070042, H133A070039, H133A070027]	The authors wish to thank all of the data collectors, project staff and project directors at each participating TBI Model System Center, the National Data and Statistical Center and the National Institute on Disability and Rehabilitation Research (NIDRR) for the continued support and funding.; This study was partially supported by NIDRR Grants # H133A070038, H13 3A070042, H133A070039 and H133A070027. The authors report no conflicts of interest.	Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 1986, TOP GERIATR REHABIL, V1, P59, DOI 10.1097/00013614-198604000-00007; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Horsburgh K, 2000, NEUROPATH APPL NEURO, V26, P124, DOI 10.1046/j.1365-2990.2000.026002124.x; IOM, 2009, GULF WAR HLTH, V7; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; The Traumatic Brain Injury Model Systems National Data and Statistical Center (TBINDSC), 2010, 2010 TBI MOD SYST PR; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	29	14	14	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2012	26	11					1328	1337		10.3109/02699052.2012.706353			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	005AQ	WOS:000308723100006	22897421				2021-06-18	
J	Kim, JY; Choi, SY; Moon, Y; Kim, HJ; Chin, JH; Kim, H; Sun, W				Kim, J. Y.; Choi, S. Y.; Moon, Y.; Kim, H. J.; Chin, J. H.; Kim, H.; Sun, W.			DIFFERENT EXPRESSION PATTERNS OF PHACTR FAMILY MEMBERS IN NORMAL AND INJURED MOUSE BRAIN	NEUROSCIENCE			English	Article						Phactrs; neural stem/progenitor cell; traumatic brain injury; in situ hybridization	PROTEIN PHOSPHATASE 1; PROGRAMMED CELL-DEATH; NITRIC-OXIDE SYNTHASE; NEURAL STEM-CELLS; REACTIVE ASTROCYTES; HIPPOCAMPAL CONTINUATION; INDUSIUM GRISEUM; ADULT BRAIN; GLIOSIS; RAT	Phosphatase and actin regulators (Phactrs) are a novel family of proteins expressed in the brain, and they exhibit both strong modulatory activity of protein phosphatase 1 and actin-binding activity. Phactrs are comprised of four family members (Phactr1-4), but their detailed expression patterns during embryonic and postnatal development are not well understood. We found that these family members exhibit different spatiotemporal mRNA expression patterns. Phactr4 mRNA was found in neural stem cells in the developing and adult brains, whereas Phactr1 and 3 appeared to be expressed in post-mitotic neurons. Following traumatic brain injury which promotes neurogenesis in the neurogenic region and gliogenesis in the injury penumbra, the mRNA expression of phactr2 and 4 was progressively increased in the injury penumbra, and phactr4 mRNA and protein induction was observed in reactive astrocytes. These differential expression patterns of phactrs imply specific functions for each protein during development, and the importance of Phactr4 in the reactive gliosis following brain injury. (c) 2012 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kim, J. Y.; Choi, S. Y.; Kim, H. J.; Chin, J. H.; Kim, H.; Sun, W.] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Moon, Y.] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Brain & Neuroendocrine Lab, Seoul 151742, South Korea	Sun, W (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea.	woongsun@korea.ac.kr	Choi, So Yoen/AAV-1947-2020	Moon, Younghye/0000-0002-3737-0043	Korean Ministry of Education, Science, and Technology by Brain Research Center of the twenty-first century Frontier Program in Neuroscience [2011K000262, 2011K000288]; National Research Foundation of KoreaNational Research Foundation of Korea [20110019409]	This work is supported by Grants from the Korean Ministry of Education, Science, and Technology by Brain Research Center of the twenty-first century Frontier Program in Neuroscience (2011K000262; 2011K000288) and the National Research Foundation of Korea (20110019409).	Allain B, 2012, CELL SIGNAL, V24, P214, DOI 10.1016/j.cellsig.2011.09.003; Allen PB, 2004, P NATL ACAD SCI USA, V101, P7187, DOI 10.1073/pnas.0401673101; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Brown AM, 2008, J BIOL CHEM, V283, P14286, DOI 10.1074/jbc.M801377200; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Farghaian H, 2011, J BIOL CHEM, V286, P19724, DOI 10.1074/jbc.M110.205781; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; Horiguchi T, 2002, NEUROSCI LETT, V325, P115, DOI 10.1016/S0304-3940(02)00244-6; Jiang Y, 2009, ONCOGENE, V28, P2999, DOI 10.1038/onc.2009.157; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kim WR, 2012, NEUROSCI LETT, V513, P155, DOI 10.1016/j.neulet.2012.02.023; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Kunzle H, 2004, ANAT EMBRYOL, V208, P183, DOI 10.1007/s00429-004-0384-3; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Pahan K, 1998, J BIOL CHEM, V273, P12219, DOI 10.1074/jbc.273.20.12219; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Runden E, 1998, J NEUROSCI, V18, P7296; Sagara J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004247; Saha RN, 2006, NEUROCHEM INT, V49, P154, DOI 10.1016/j.neuint.2006.04.007; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Wider C, 2009, NEUROSCI LETT, V453, P9, DOI 10.1016/j.neulet.2009.02.009; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; WYSS JM, 1983, J COMP NEUROL, V219, P251, DOI 10.1002/cne.902190302; Yi KD, 2005, J NEUROSCI, V25, P7191, DOI 10.1523/JNEUROSCI.1328-05.2005; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4	40	14	14	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	SEP 27	2012	221						37	46		10.1016/j.neuroscience.2012.06.059			10	Neurosciences	Neurosciences & Neurology	003RD	WOS:000308628100005	22766235				2021-06-18	
J	Booth-Kewley, S; Highfill-McRoy, RM; Larson, GE; Garland, CF; Gaskin, TA				Booth-Kewley, Stephanie; Highfill-McRoy, Robyn M.; Larson, Gerald E.; Garland, Cedric F.; Gaskin, Thomas A.			Anxiety and Depression in Marines Sent to War in Iraq and Afghanistan	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Anxiety; depression; psychiatric disorders; military populations; Marines; Iraq/Afghanistan wars; veterans; combat; deployment stressors	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; TRAUMATIC BRAIN-INJURY; GULF-WAR; PSYCHIATRIC DIAGNOSES; DEPLOYMENT STRESSORS; COMBAT DEPLOYMENT; ZONE STRESSORS; SOCIAL SUPPORT; RISK-FACTORS	Although the effects of combat deployment on posttraumatic stress disorder have been extensively studied, little is known about the effects of combat deployment on depression and anxiety. This study examined the factors associated with anxiety and depression in a sample of 1560 US Marines who were deployed to Iraq and Afghanistan. Eleven demographic and psychosocial factors were studied in relation to depression and anxiety. Five factors emerged as significant in relation to depression: deployment-related stressors, combat exposure, attitudes toward leadership, mild traumatic brain injury symptoms, and marital status. The same factors, with the exception of marital status, emerged as significant in relation to anxiety. Deployment-related stressors had a stronger association with both depression and anxiety than any other variable, including combat exposure. This finding is important because deployment-related stressors are potentially modifiable by the military.	[Booth-Kewley, Stephanie] Naval Hlth Res Ctr, Behav Sci & Epidemiol Dept, San Diego, CA 92106 USA; [Garland, Cedric F.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Garland, Cedric F.] Univ Calif San Diego, Moores UCSD Canc Ctr, San Diego, CA 92103 USA; [Gaskin, Thomas A.] US Marine Corps, Combat Operat Stress Control, Quantico, VA USA	Booth-Kewley, S (corresponding author), Naval Hlth Res Ctr, Behav Sci & Epidemiol Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	stephanie.kewley@med.navy.mil			Headquarters, Marine Corps (Combat Operational Stress Control), Work Unit [60518]	This research was supported by Headquarters, Marine Corps (Combat Operational Stress Control), Work Unit 60518. The authors declare no conflict of interest.	Adler AB, 1996, MIL PSYCHOL, V8, P1, DOI 10.1207/s15327876mp0801_1; ANDRESEN EM, 1994, AM J PREV MED, V10, P77; Bartone PT, 1998, MIL MED, V163, P587; Booth-Kewley S, 2010, J TRAUMA STRESS, V23, P69, DOI 10.1002/jts.20485; BRAY RM, 2006, RTI7841106FR; Britt TW, 2004, MIL MED, V169, P541, DOI 10.7205/MILMED.169.7.541; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Brown WJ, 2005, AM J PREV MED, V29, P265, DOI 10.1016/j.amepre.2005.06.009; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Castro CA, 2007, TRAUMATOLOGY, V13, P6, DOI [DOI 10.1177/1534765607309950, 10.1177/1534765607309950]; DELONGIS A, 1988, J PERS SOC PSYCHOL, V54, P486, DOI 10.1037/0022-3514.54.3.486; Dohrenwend BP, 2007, J TRAUMA STRESS, V20, P449, DOI 10.1002/jts.20296; DUBOIS DL, 1992, CHILD DEV, V63, P542, DOI 10.1111/j.1467-8624.1992.tb01645.x; Engelhard IM, 2007, CAN J PSYCHIAT, V52, P505, DOI 10.1177/070674370705200808; Fiedler N, 2006, BRIT J PSYCHIAT, V188, P453, DOI 10.1192/bjp.188.5.453; Fikretoglu D, 2006, CAN J PSYCHIAT, V51, P755, DOI 10.1177/070674370605101205; FISHER CD, 1985, J MANAGE, V11, P39, DOI 10.1177/014920638501100304; Fontana A, 1999, J TRAUMA STRESS, V12, P111, DOI 10.1023/A:1024750417154; GRIFFITH J, 1988, BASIC APPL SOC PSYCH, V9, P149, DOI 10.1207/s15324834basp0902_6; Griffith J, 2010, MIL PSYCHOL, V22, P176, DOI 10.1080/08995601003638967; Hoffman DL, 2008, DEPRESS ANXIETY, V25, P72, DOI 10.1002/da.20257; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iversen A, 2005, BRIT J PSYCHIAT, V186, P480, DOI 10.1192/bjp.186.6.480; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; KARASEK RA, 1982, J OCCUP BEHAV, V3, P181, DOI 10.1002/job.4030030205; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KING DW, 1995, J ABNORM PSYCHOL, V104, P184, DOI 10.1037/0021-843X.104.1.184; Koenen KC, 2003, J CONSULT CLIN PSYCH, V71, P980, DOI 10.1037/0022-006X.71.6.980; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Litz BT, 1997, J CONSULT CLIN PSYCH, V65, P1001, DOI 10.1037/0022-006X.65.6.1001; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; Mental Health Advisory Team, 2008, MENT HLTH ADV TEAM M; Mental Health Advisory Team VI, 2009, MENT HLTH ADV TEAM M; Miller MW, 2008, J TRAUMA STRESS, V21, P58, DOI 10.1002/jts.20303; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renshaw KD, 2009, ANXIETY STRESS COPIN, V22, P101, DOI 10.1080/10615800802354000; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simon RW, 2002, AM J SOCIOL, V107, P1065, DOI 10.1086/339225; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; SOUTHWICK SM, 1995, AM J PSYCHIAT, V152, P1150; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Vogt DS, 2008, J TRAUMA STRESS, V21, P66, DOI 10.1002/jts.20306; Vogt DS, 2005, J TRAUMA STRESS, V18, P115, DOI 10.1002/jts.20018; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Wolfe J, 1999, J CONSULT CLIN PSYCH, V67, P520, DOI 10.1037/0022-006X.67.4.520; WOLFE J, 1993, J SOC ISSUES, V49, P15, DOI 10.1111/j.1540-4560.1993.tb01179.x; Yi MS, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00643.x; Zauszniewski JA, 2009, WESTERN J NURS RES, V31, P219, DOI 10.1177/0193945908326065	55	14	14	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	SEP	2012	200	9					749	757		10.1097/NMD.0b013e318266b7e7			9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	003KX	WOS:000308611500004	22922233				2021-06-18	
J	Frisch, S; Forstl, S; Legler, A; Schope, S; Goebel, H				Frisch, Stefan; Foerstl, Sabine; Legler, Angela; Schoepe, Sabine; Goebel, Hans			The interleaving of actions in everyday life multitasking demands	JOURNAL OF NEUROPSYCHOLOGY			English	Article							ANTERIOR PREFRONTAL CORTEX; EXECUTIVE DEFICITS; FRONTAL-LOBE; VALIDITY; STROKE; RELIABILITY; DISORDER; AREA-10; TASK	It has been argued that executive tests should capture central aspects of executive functions in everyday life such as initiating and monitoring parallel actions in low-structured environments (so-called multitasking; see Burgess, 2000). We present a cooking task in order to assess executive function impairments in brain-damaged patients, which focuses on a central feature of multitasking, the interleaving of tasks (Burgess, 2000). Behavioural performance of 21 brain-damaged patients (stroke, traumatic brain injury) and of a group of matched controls was analysed on the basis of a standardized protocol. In comparison to controls, the patients explored less, were less successful in monitoring their actions and corrected errors less efficiently. Interleaving of actions was observed less frequently in patients, with respect to both cooking itself as well as to subordinate goals (e.g., cleaning up). Interleaving proved efficient, as it was associated with less time to complete the task. Patients scores in the cooking task correlated with performance in both the Behavioural Assessment of the Dysexecutive Syndrome (BADS) Zoo Map Test and the BADS Six Elements Test, but not with tests of attention, verbal memory, or figural fluency, thus demonstrating convergent and discriminant validity. In summary, our task demonstrates that cooking can provide a valid testing ground for assessing a central aspect of everyday multitasking demands, namely, the interleaving of actions.	[Frisch, Stefan] Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany; [Frisch, Stefan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Frisch, Stefan; Foerstl, Sabine; Legler, Angela; Goebel, Hans] Univ Clin, Day Care Clin Cognit Neurol, Leipzig, Germany; [Foerstl, Sabine; Legler, Angela; Goebel, Hans] Univ Clin, Dept Phys Therapy, Leipzig, Germany; [Schoepe, Sabine] Sozialwerk St Michael, Leipzig, Germany	Frisch, S (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Schleusenweg 2-16,Haus 95, D-60528 Frankfurt, Germany.	frisch@cbs.mpg.de		Frisch, Stefan/0000-0002-7294-4786			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Alderman N, 2009, REHABILITATION EXECU, P97; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Brasil P., 2009, R PACKAGE DIAGNOSISM; Burgess P. W., 1997, COGNITIVE MODELS MEM, P247; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Camchong J, 2006, BIOL PSYCHIAT, V60, P235, DOI 10.1016/j.biopsych.2005.11.014; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Haid T., 2002, Z NEUROPSYCHOLOGIE, V13, P233; Harting C., 2000, WECHSLER GEDACHTNIST; Hartman-Maeir A, 2009, AM J OCCUP THER, V63, P592, DOI 10.5014/ajot.63.5.592; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Horn W., 1983, L P S LEISTUNGSPRUFS; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Koechlin E, 1999, NATURE, V399, P148; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lazar RM, 2007, COGN BEHAV NEUROL, V20, P157, DOI 10.1097/WNN.0b013e31804c703f; Luria A. R, 1973, WORKING BRAIN; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Metzler P., 2000, STANDARDISIERTE LINK; Nieuwenhuis R, 2008, HUMAN CENTRAL NERVOU; Penfield W, 1935, BRAIN, V58, P115, DOI 10.1093/brain/58.1.115; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; R Development Core Team, 2011, R LANG ENV STAT COMP; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Schroeter ML, 2012, BRAIN, V135, P201, DOI 10.1093/brain/awr311; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simons J.S., 2005, EFFECTIVENESS REHABI, V211, DOI [10.1093/acprof:oso/9780198526544.003.0018, DOI 10.1093/ACPROF:OSO/9780198526544.001.0001]; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Wilson BA, 1996, BEHAV ASSESSMENT DYS; ZIMMERMANN P, 1993, TEST ATTENTIONAL PER	38	14	14	0	16	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1748-6645			J NEUROPSYCHOL	J. Neuropsychol.	SEP	2012	6		2				257	269		10.1111/j.1748-6653.2012.02026.x			13	Psychology; Psychology, Experimental	Psychology	000ZN	WOS:000308429700007	22329754				2021-06-18	
J	Wall, L; O'Donnell, JC; Schoenecker, PL; Keeler, KA; Dobbs, MB; Luhmann, SJ; Gordon, JE				Wall, Lindley; O'Donnell, June C.; Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric			Titanium elastic nailing radius and ulna fractures in adolescents	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						adolescent; forearm; fracture; internal fixation; intramedullary; nail; pediatric; radius; titanium elastic nail; trauma; ulna; upper extremity	UNSTABLE FOREARM FRACTURES; COMPRESSION-PLATE FIXATION; INTRAMEDULLARY FIXATION; OPEN REDUCTION; INTERNAL-FIXATION; OPERATIVE MANAGEMENT; DIAPHYSEAL FRACTURES; PEDIATRIC FRACTURES; SHAFT FRACTURES; CHILDREN	Over the last 40 years, anatomic reduction with plate stabilization has become the standard in adult patients with diaphyseal fractures of the radius and ulna. When operative fixation has been indicated in skeletally immature patients with these fractures, a variety of techniques have been reported, with intramedullary fixation becoming increasingly accepted. There is currently significant variability in the treatment of adolescents with forearm fractures. The purpose of this study was to investigate the clinical and radiographic outcomes in the adolescent population after intramedullary fixation of both bone forearm fractures. A retrospective review identified 32 patients 12-18 years of age who had undergone intramedullary fixation of both forearm bones in the past 20 years at our institution. Galeazzi, Monteggia, radial head, and distal metaphyseal fractures were excluded. Radiographic evaluation was performed to determine union and postoperative radial bow. Clinical follow-up was carried out for postoperative complications and range of motion of the wrist, forearm, and elbow. The mean age of the patients was 14.1 years. A total of 19 fractures were closed injuries, nine were grade 1, three were grade 2, and one fracture was a grade 3b. Of the patients, 15.6% had limited postoperative range of motion. All patients in the older age group, 15-18 years of age, had a normal range of motion. A decrease in radial bow was not associated with limitation in motion. There was a 98% union rate, and all unions occurred by 7.5 months. Only three major complications occurred, two refractures and one ulnar hardware migration, and subsequent radius nonunion occurred in the one grade 3b injury. Flexible intramedullary nailing of both bone forearm fractures provides reliable bony union and excellent postoperative clinical results in adolescents. Level of evidence, IV. J Pediatr Orthop B 21:482-488 (c) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric] St Louis Childrens Hosp, St Louis, MO 63110 USA; [Wall, Lindley; O'Donnell, June C.; Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA; [Schoenecker, Perry L.; Keeler, Kathryn A.; Dobbs, Matthew B.; Luhmann, Scott J.; Gordon, J. Eric] St Louis Shriners Hosp, St Louis, MO USA	Gordon, JE (corresponding author), St Louis Childrens Hosp, 4S-60,1 Childrens Pl, St Louis, MO 63110 USA.	Gordone@wustl.edu		Wall, Lindley/0000-0003-0818-8995			ANDERSON LD, 1975, J BONE JOINT SURG AM, VA 57, P287, DOI 10.2106/00004623-197557030-00001; Ballal MS, 2009, J PEDIATR ORTHOP B, V18, P261, DOI 10.1097/BPB.0b013e32832f0648; CHAPMAN MW, 1989, J BONE JOINT SURG AM, V71A, P159, DOI 10.2106/00004623-198971020-00001; Chitgopkar SD, 2008, J PEDIATR ORTHOP B, V17, P251, DOI 10.1097/BPB.0b013e328306898d; Cullen MC, 1998, J PEDIATR ORTHOPED, V18, P14, DOI 10.1097/00004694-199801000-00004; Dell'Oca AAF, 2001, CLIN ORTHOP RELAT R, P196; Dennison DG, 2007, J HAND SURG-AM, V32A, P801, DOI 10.1016/j.jhsa.2007.03.010; Fernandez FF, 2005, INJURY, V36, P1210, DOI 10.1016/j.injury.2005.03.004; Firl M, 2004, J BONE JOINT SURG BR, V86B, P1047, DOI 10.1302/0301-620X.86B7.14294; Flynn JM, 2010, J PEDIATR ORTHOPED, V30, P313, DOI 10.1097/BPO.0b013e3181d98f2c; Flynn John M, 2002, Instr Course Lect, V51, P355; Hong G, 2006, CLIN ORTHOP RELAT R, P186, DOI 10.1097/01.blo.0000214444.87645.75; Garg NK, 2008, J TRAUMA, V65, P109, DOI 10.1097/TA.0b013e3181623309; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Gustilo RB., 1982, MANAGEMENT OPEN FRAC; Hanel DP, 2006, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000205885.58458.f9; Huber RI, 1996, J PEDIATR ORTHOPED, V16, P602, DOI 10.1097/01241398-199609000-00011; Kang SN, 2011, J BONE JOINT SURG BR, V93B, P262, DOI 10.1302/0301-620X.93B2.24882; Kose O, 2008, J Orthop Surg (Hong Kong), V16, P165; Krzykawski Ryszard, 2008, Ortop Traumatol Rehabil, V10, P35; LASCOMBES P, 1990, J PEDIATR ORTHOPED, V10, P167; Lascombes P, 2006, J PEDIATR ORTHOPED, V26, P827, DOI 10.1097/01.bpo.0000235397.64783.d6; Lee S, 2002, CLIN ORTHOP RELAT R, P245; LIGIER JN, 1985, Z KINDERCHIR, V40, P209; Luhmann SJ, 1998, J PEDIATR ORTHOPED, V18, P451, DOI 10.1097/00004694-199807000-00009; Majed A, 2007, J PEDIATR ORTHOP B, V16, P129, DOI 10.1097/01.bpb.0000210597.66146.2a; MANN DC, 1990, J PEDIATR ORTHOPED, V10, P713, DOI 10.1097/01241398-199011000-00002; MOED BR, 1986, J BONE JOINT SURG AM, V68A, P1008, DOI 10.2106/00004623-198668070-00007; Noonan K J, 1998, J Am Acad Orthop Surg, V6, P146; ONO M, 1989, CLIN ORTHOP RELAT R, P236; Ortega R, 1996, J PEDIATR ORTHOPED, V16, P651, DOI 10.1097/01241398-199609000-00019; Reinhardt KR, 2008, J PEDIATR ORTHOPED, V28, P403, DOI 10.1097/BPO.0b013e31816d71f2; Richter D, 1998, J PEDIATR ORTHOPED, V18, P457, DOI 10.1097/00004694-199807000-00010; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000156480.76450.04; ROY DR, 1990, ORTHOP CLIN N AM, V21, P245; SAGE FP, 1959, J BONE JOINT SURG AM, V41, P1489, DOI 10.2106/00004623-195941080-00010; Schmittenbecher PP, 2005, INJURY, V36, pA25, DOI 10.1016/j.injury.2004.12.010; Shah AS, 2010, J ORTHOP TRAUMA, V24, P440, DOI 10.1097/BOT.0b013e3181ca343b; Smith VA, 2005, J PEDIATR ORTHOPED, V25, P309, DOI 10.1097/01.bpo.0000153943.45396.22; STREET DM, 1986, CLIN ORTHOP RELAT R, P219; Van der Reis WL, 1998, J PEDIATR ORTHOPED, V18, P9, DOI 10.1097/00004694-199801000-00003; Visna P, 2008, ACTA CHIR BELG, V108, P333, DOI 10.1080/00015458.2008.11680232; Wal A, 1997, AUST NZ J SURG, V67, P622, DOI 10.1111/j.1445-2197.1997.tb04610.x; Wyrsch B, 1996, J PEDIATR ORTHOPED, V16, P644, DOI 10.1097/01241398-199609000-00018; Yuan PS, 2004, J PEDIATR ORTHOPED, V24, P370, DOI 10.1097/01241398-200407000-00005	45	14	16	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SEP	2012	21	5					482	488		10.1097/BPB.0b013e3283528db5			7	Orthopedics; Pediatrics	Orthopedics; Pediatrics	983NE	WOS:000307125200021	22415404				2021-06-18	
J	Roehl, AB; Zoremba, N; Kipp, M; Schiefer, J; Goetzenich, A; Bleilevens, C; Kuehn-Velten, N; Tolba, R; Rossaint, R; Hein, M				Roehl, Anna B.; Zoremba, Norbert; Kipp, Markus; Schiefer, Johannes; Goetzenich, Andreas; Bleilevens, Christian; Kuehn-Velten, Nikolaus; Tolba, Rene; Rossaint, Rolf; Hein, Marc			The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia	BMC NEUROLOGY			English	Article						Levosimendan; Cerebral ischaemia; Hypoxia; Microdialysis	SENSITIVE POTASSIUM CHANNELS; FOCAL CEREBRAL-ISCHEMIA; INFARCT SIZE; DIFFUSION PARAMETERS; REPERFUSION INJURY; GLUTAMATE RELEASE; NITRIC-OXIDE; SPINAL-CORD; IN-VITRO; MODEL	Backround: Neuroprotective strategies after cardiopulmonary resuscitation are currently the focus of experimental and clinical research. Levosimendan has been proposed as a promising drug candidate because of its cardioprotective properties, improved haemodynamic effects in vivo and reduced traumatic brain injury in vitro. The effects of levosimendan on brain metabolism during and after ischaemia/hypoxia are unknown. Methods: Transient cerebral ischaemia/hypoxia was induced in 30 male Wistar rats by bilateral common carotid artery clamping for 15 min and concomitant ventilation with 6% O-2 during general anaesthesia with urethane. After 10 min of global ischaemia/hypoxia, the rats were treated with an i.v. bolus of 24 mu g kg(-1) levosimendan followed by a continuous infusion of 0.2 mu g kg(-1) min(-1). The changes in the energy-related metabolites lactate, the lactate/pyruvate ratio, glucose and glutamate were monitored by microdialysis. In addition, the effects on global haemodynamics, cerebral perfusion and autoregulation, oedema and expression of proinflammatory genes in the neocortex were assessed. Results: Levosimendan reduced blood pressure during initial reperfusion (72 +/- 14 vs. 109 +/- 2 mmHg, p = 0.03) and delayed flow maximum by 5 minutes (p = 0.002). Whereas no effects on time course of lactate, glucose, pyruvate and glutamate concentrations in the dialysate could be observed, the lactate/pyruvate ratio during initial reperfusion (144 +/- 31 vs. 77 +/- 8, p = 0.017) and the glutamate release during 90 minutes of reperfusion (75 +/- 19 vs. 24 +/- 28 mu mol.L-1) were higher in the levosimendan group. The increased expression of IL-6, IL-1 beta TNFa and ICAM-1, extend of cerebral edema and cerebral autoregulation was not influenced by levosimendan. Conclusion: Although levosimendan has neuroprotective actions in vitro and on the spinal cord in vivo and has been shown to cross the blood-brain barrier, the present results showed that levosimendan did not reduce the initial neuronal injury after transient ischaemia/hypoxia.	[Roehl, Anna B.; Zoremba, Norbert; Goetzenich, Andreas; Bleilevens, Christian; Rossaint, Rolf; Hein, Marc] RWTH Aachen Univ Hosp, Dept Anesthesiol, D-52074 Aachen, Germany; [Kipp, Markus] Rhein Westfal TH Aachen, Dept Neuroanat, D-52072 Aachen, Germany; [Schiefer, Johannes] RWTH Aachen Univ Hosp, Dept Neurol, D-52074 Aachen, Germany; [Kuehn-Velten, Nikolaus] Med Lab Bremen, MLHB, D-28357 Bremen, Germany; [Tolba, Rene] RWTH Aachen Univ Hosp, Dept Expt Anim Sci, D-52074 Aachen, Germany	Roehl, AB (corresponding author), RWTH Aachen Univ Hosp, Dept Anesthesiol, Pauwelstr 30, D-52074 Aachen, Germany.	aroehl@ukaachen.de	Bleilevens, Christian/AAG-8034-2020; Kipp, Markus/K-2694-2015	Bleilevens, Christian/0000-0002-2104-1843; 	Medical Faculty RWTH Aachen (START) [10/2010]	This work was supported by the Medical Faculty RWTH Aachen (START grant number 10/2010). We would like to specifically thank Renate Nadenau and Christian Beckers (Department of Anaesthesiology) for their help in our laboratory and Dr. Hartmut Kirchherr (MLHB) for the HPLC-MS/MS analyses.	Abo-Ramadan U, 2009, EXP NEUROL, V219, P328, DOI 10.1016/j.expneurol.2009.06.002; Antila S, 1999, EUR J PHARM SCI, V9, P85, DOI 10.1016/S0928-0987(99)00048-2; Bantel C, 2009, ANESTHESIOLOGY, V110, P986, DOI 10.1097/ALN.0b013e31819dadc7; Bernard S, 2009, CRIT CARE MED, V37, pS227, DOI 10.1097/CCM.0b013e3181aa5d0c; Blaustein MP, 1999, PHYSIOL REV, V79, P763; Cengiz SL, 2010, BRAIN INJURY, V24, P877, DOI 10.3109/02699051003789260; Choi SK, 2011, J KOREAN NEUROSURG S, V49, P1, DOI 10.3340/jkns.2011.49.1.1; Das B, 2007, VASC PHARMACOL, V47, P248, DOI 10.1016/j.vph.2007.06.008; Bravo MD, 2011, NEONATOLOGY, V99, P217, DOI 10.1159/000314955; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Dethloff TJ, 2008, J CEREBR BLOOD F MET, V28, P916, DOI 10.1038/sj.jcbfm.9600589; Domoki F, 1999, STROKE, V30, P2713; Fukuda S, 2007, BRIT J ANAESTH, V99, P10, DOI 10.1093/bja/aem140; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; GROVER GJ, 1991, J PHARMACOL EXP THER, V257, P156; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Hein M, 2009, ACTA ANAESTH SCAND, V53, P941, DOI 10.1111/j.1399-6576.2009.01994.x; Honisch A, 2010, BASIC RES CARDIOL, V105, P155, DOI 10.1007/s00395-009-0064-9; Iqbal S, 2002, BRAIN RES, V946, P162, DOI 10.1016/S0006-8993(02)02871-8; Kang SW, 2011, BRAIN RES, V1371, P121, DOI 10.1016/j.brainres.2010.11.057; Katircioglu SF, 2008, J CARDIAC SURG, V23, P44, DOI 10.1111/j.1540-8191.2007.00486.x; Kersten JR, 2000, ANESTH ANALG, V90, P5, DOI 10.1097/00000539-200001000-00003; Koizumi H, 2011, NEUROL MED-CHIR, V51, P337, DOI 10.2176/nmc.51.337; Kopustinskiene DM, 2001, EUR J PHARMACOL, V428, P311, DOI 10.1016/S0014-2999(01)01350-4; Kulik A, 2000, J NEUROPHYSIOL, V83, P2905; Kunimatsu T, 1999, BRAIN RES, V831, P273, DOI 10.1016/S0006-8993(99)01481-X; Lafci B, 2008, EUR SURG RES, V41, P1, DOI 10.1159/000121394; Lasarzik I, 2011, NEUROCRIT CARE, V15, P577, DOI 10.1007/s12028-011-9562-3; Lenzser G, 2005, BRAIN RES, V1051, P72, DOI 10.1016/j.brainres.2005.05.064; Mayanagi K, 2007, BRAIN RES, V1168, P106, DOI 10.1016/j.brainres.2007.06.071; Munakata H, 2010, PERFUSION-UK, V25, P159, DOI 10.1177/0267659110370068; Nakayama R, 2002, ANESTHESIOLOGY, V96, P705, DOI 10.1097/00000542-200203000-00029; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Valtysson J, 1998, ACTA NEUROCHIR, V140, P387, DOI 10.1007/s007010050113; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Zhao ZQ, 2006, CARDIOVASC RES, V70, P200, DOI 10.1016/j.cardiores.2006.01.024; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zhu HL, 2008, NEUROSCIENCE, V157, P884, DOI 10.1016/j.neuroscience.2008.09.033; Zoremba N, 2008, J CEREBR BLOOD F MET, V28, P1665, DOI 10.1038/jcbfm.2008.58; Zoremba N, 2007, EXP NEUROL, V203, P34, DOI 10.1016/j.expneurol.2006.07.017	45	14	18	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	AUG 24	2012	12								81	10.1186/1471-2377-12-81			10	Clinical Neurology	Neurosciences & Neurology	035AN	WOS:000310914100001	22920500	DOAJ Gold, Green Published			2021-06-18	
J	Fujieda, Y; Ueno, S; Ogino, R; Kuroda, M; Jonsson, TJ; Guo, LN; Bamba, T; Fukusaki, E				Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko; Joensson, Thomas J.; Guo, Lining; Bamba, Takeshi; Fukusaki, Eiichiro			Metabolite Profiles Correlate Closely with Neurobehavioral Function in Experimental Spinal Cord Injury in Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYL-ASPARTATE; ORNITHINE-DECARBOXYLASE; MULTIPLE-SCLEROSIS; BRAIN ISCHEMIA; RECOVERY; DISEASE; ACETYLASPARTATE; METABOLOMICS; MAINTENANCE	Traumatic spinal cord injury (SCI) results in direct physical damage and the generation of local factors contributing to secondary pathogenesis. Untargeted metabolomic profiling was used to uncover metabolic changes and to identify relationships between metabolites and neurobehavioral functions in the spinal cord after injury in rats. In the early metabolic phase, neuronal signaling, stress, and inflammation-associated metabolites were strongly altered. A dynamic inflammatory response consisting of elevated levels of prostaglandin E2 and palmitoyl ethanolamide as well as pro- and anti-inflammatory polyunsaturated fatty acids was observed. N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-aspartate (NAA) were significantly decreased possibly reflecting neuronal cell death. A second metabolic phase was also seen, consistent with membrane remodeling and antioxidant defense response. These metabolomic changes were consistent with the pathology and progression of SCI. Several metabolites, including NAA, NAAG, and the omega-3 fatty acids docosapentaenoate and docosahexaenoate correlated greatly with the established Basso, Beattie and Bresnahan locomotive score (BBB score). Our findings suggest the possibility of a biochemical basis for BBB score and illustrate that metabolites may correlate with neurobehavior. In particular the NAA level in the spinal cord might provide a meaningful biomarker that could help to determine the degree of injury severity and prognosticate neurologic recovery.	[Fujieda, Yusuke; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Fujieda, Yusuke; Ueno, Shinya; Ogino, Ryoko; Kuroda, Mariko] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Joensson, Thomas J.; Guo, Lining] Metabolon Inc, Durham, NC USA	Fujieda, Y (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	fujieda.yusuke.aw@asubio.co.jp; fukusaki@bio.eng.osaka-u.ac.jp					Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bazan NG, 2006, CELL MOL NEUROBIOL, V26, P901, DOI 10.1007/s10571-006-9064-6; Blamire AM, 2007, MAGN RESON MED, V58, P880, DOI 10.1002/mrm.21382; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Dabney A, 2010, Q VALUE Q VALUE ESTI; Demougeot C, 2004, J NEUROCHEM, V90, P776, DOI 10.1111/j.1471-4159.2004.02583.x; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; Erschbamer M, 2011, EUR J NEUROSCI, V33, P678, DOI 10.1111/j.1460-9568.2010.07562.x; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Falconer JC, 1996, J NEUROCHEM, V66, P717; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Giroud M, 1996, NEUROL RES, V18, P241; Griffith HR, 2008, ALZ DIS ASSOC DIS, V22, P54, DOI 10.1097/WAD.0b013e3181611011; Hayashi S, 2009, BIOCHEM BIOPH RES CO, V386, P268, DOI 10.1016/j.bbrc.2009.06.041; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kendi ATK, 2004, NEURORADIOLOGY, V46, P764, DOI 10.1007/s00234-004-1231-1; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Marliani AF, 2007, MAGN RESON MED, V57, P160, DOI 10.1002/mrm.21113; Mautes AEM, 1999, NEUROSCI LETT, V264, P153, DOI 10.1016/S0304-3940(99)00197-4; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Pouw MH, 2009, SPINAL CORD, V47, P519, DOI 10.1038/sc.2008.176; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Resnick DK, 2004, NEUROREPORT, V15, P837, DOI 10.1097/00001756-200404090-00020; SAGER TN, 1995, J CEREBR BLOOD F MET, V15, P639, DOI 10.1038/jcbfm.1995.79; Schott JM, 2010, BRAIN, V133, P3315, DOI 10.1093/brain/awq208; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Tator C H, 1996, J Spinal Cord Med, V19, P206; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Vera-Portocarrero LP, 2002, BRAIN RES, V927, P104, DOI 10.1016/S0006-8993(01)03329-7; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007	42	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43152	10.1371/journal.pone.0043152			8	Multidisciplinary Sciences	Science & Technology - Other Topics	988OJ	WOS:000307500100068	22912814	DOAJ Gold, Green Published			2021-06-18	
J	Marks, JA; Li, SH; Gong, WF; Sanati, P; Eisenstadt, R; Sims, C; Smith, DH; Reilly, PM; Pascual, JL				Marks, Joshua A.; Li, Shenghui; Gong, Wanfeng; Sanati, Paymon; Eisenstadt, Rachel; Sims, Carrie; Smith, Douglas H.; Reilly, Patrick M.; Pascual, Jose L.			Similar effects of hypertonic saline and mannitol on the inflammation of the blood-brain barrier microcirculation after brain injury in a mouse model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Intravital microscopy; pial cranial window; neutrophil; endothelium; traumatic brain injury	HEMORRHAGIC-SHOCK; INTRACRANIAL HYPERTENSION; CEREBRAL MICROCIRCULATION; NEUTROPHIL; RESUSCITATION; INTERLEUKIN-1-BETA; ENDOTHELIUM; INCREASES; PERMEABILITY	BACKGROUND: There has been substantial debate regarding the efficacy of hypertonic saline (HTS) versus mannitol (MTL) in treating moderate and severe traumatic brain injury (TBI). HTS blunts polymorphonuclear neutrophil (PMN) and endothelial cell (EC) activation and reduces tissue edema after resuscitated shock in systemic microvascular beds. MTL also modulates PMN activation markers. It remains unknown if either of these osmotherapies exert similar anti-inflammatory effects along the blood-brain barrier (BBB). We hypothesized that HTS, as compared with MTL, would more greatly reduce PMN-EC interactions, thereby reducing BBB permeability and tissue edema after simulated TBI. METHODS: CD1 male mice (25-30 g) underwent craniotomy and window placement for observation of in vivo PMN-EC interactions in pial venules using intravital video microscopy. TBI was simulated through local suffusion of the brain surface with interleukin 1 beta (100 ng/0.1 mL). Animals were randomized to receive a single, equiosmolar, intravenous dose of 20% MTL or 5% HTS after injury. Live microcirculatory footage was obtained every 15 minutes for 2 hours, after which fluorescent-labeled albumin was administered to assess microvascular permeability. PMN rolling and adhesion and macromolecular leakage were analyzed offline by a blinded observer and postmortem brain and lung edema assessed by wet-to-dry ratios. Student's t test and Mann-Whitney U test determined significance (p <= 0.05). RESULTS: Neither osmotherapy resulted in significant differences in PMN rolling or adhesion; however, both trended higher in HTS. Similarly, vessel permeability did not differ between groups but also trended higher with HTS. In contrast, brain and lung edema was greater in MTL than HTS as compared with controls (p = 0.05). CONCLUSION: MTL and HTS have indistinguishable effects on PMN-EC interactions in the brain after simulated TBI. Additional studies are needed to determine if either osmotherapy has more subtle effects on BBB PMN-EC interactions after injury exerting a potential clinical advantage. (J Trauma Acute Care Surg. 2012; 73: 351-357. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Pascual, Jose L.] Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Trauma Ctr Penn, Perelman Sch Med,Dept Surg, Philadelphia, PA 19104 USA; [Marks, Joshua A.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA	Pascual, JL (corresponding author), Univ Penn, Div Traumatol Surg Crit Care & Emergency Surg, Trauma Ctr Penn, Perelman Sch Med,Dept Surg, 3400 Spruce St,Maloney Bldg,5th Floor, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912; Sanati-Mehrizy, Paymon/0000-0002-1134-6125			Ahmed N, 1996, SHOCK, V6, pS39, DOI 10.1097/00024382-199610001-00008; Angle N, 2000, SHOCK, V14, P503, DOI 10.1097/00024382-200014050-00002; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Barone M, 1997, ACT NEUR S, V70, P267; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Carrithers MD, 2000, BRAIN, V123, P1092, DOI 10.1093/brain/123.6.1092; Chen LW, 2004, CRIT CARE MED, V32, P2476, DOI 10.1097/01.CCM.0000147831.07329.32; Chen LW, 2004, SHOCK, V22, P472, DOI 10.1097/01.shk.0000140304.71215.f7; Coiombra R, 2003, J TRAUMA, V54, P130; Gaber MW, 2004, BRAIN RES PROTOC, V13, P1, DOI 10.1016/j.brainresprot.2003.11.005; Gando S, 2002, THROMB HAEMOSTASIS, V88, P943; Gao XP, 1997, AM J PHYSIOL-REG I, V272, pR294; Gong WF, 2011, J TRAUMA, V71, P275, DOI 10.1097/TA.0b013e318226eb51; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; LINTHORST ACE, 1994, ENDOCRINOLOGY, V135, P520, DOI 10.1210/en.135.2.520; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; NOLTE D, 1992, AM J PHYSIOL, V263, pH1411; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Papia G, 2008, SURGERY, V144, P814, DOI 10.1016/j.surg.2008.07.008; Pascual JL, 2003, J TRAUMA, V54, pS133, DOI 10.1097/01.TA.0000064526.33647.63; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rizoli SB, 1998, J IMMUNOL, V161, P6288; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH815; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Shapiro ML, 2011, J TRAUMA, V71, P281; Shields CJ, 2003, ANN SURG, V238, P249, DOI 10.1097/01.sla.0000080827.77985.fc; Staudenmayer KL, 2005, SHOCK, V23, P459, DOI 10.1097/01.shk.0000160523.37106.33; Turina M, 2008, INFLAMMATION, V31, P74, DOI 10.1007/s10753-007-9051-1; Vachharajani V, 2007, MICROCIRCULATION, V14, P223, DOI 10.1080/10739680601139153; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wakai A, 2005, COCHRANE DB SYST REV, V3; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Woiciechowsky C, 1999, NEUROBIOL DIS, V6, P200, DOI 10.1006/nbdi.1999.0242; Yada-Langui MM, 2004, EXP BIOL MED, V229, P684; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017	40	14	20	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73	2					351	357		10.1097/TA.0b013e3182592f76			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	992VG	WOS:000307807400013	22846939				2021-06-18	
J	Pickham, DM; Callcut, RA; Maggio, PM; Mell, MW; Spain, DA; Bech, F; Staudenmayer, K				Pickham, Danielle M.; Callcut, Rachael A.; Maggio, Paul M.; Mell, Matthew W.; Spain, David A.; Bech, Fritz; Staudenmayer, Kristan			Payer status is associated with the use of prophylactic inferior vena cava filter in high-risk trauma patients	SURGERY			English	Article							VENOUS THROMBOEMBOLISM; INSURANCE STATUS; PREVENTION	Background. It is controversial whether patients at high risk for pulmonary embolism (PE) should receive prophylactic inferior vena cava filters (IVC) filters. This lack of clarity creates the potential for variability and disparities in care. We hypothesized there would be differential use of prophylactic IVC filters for patients at high risk for PE on the basis of insurance status. Methods. We performed a retrospective analysis using the National Trauma Databank (2002-2007). We included adult patients at high risk for PE (traumatic brain injury or spinal cord injury) and excluded patients with a diagnosis of deep venous thrombosis (DVT) or PE. Logistic regression was performed to control for confounders and a hierarchical mixed effects model was used to control for center. Results. A prophylactic filter was placed in 3,331 (4.3%) patients in the study cohort. Patients without insurance had an IVC filter placed less often compared with those with any form of insurance (2.7% vs 4.9%, respectively). After adjusting for confounders, we found that patients without insurance were less likely to receive a prophylactic IVC filter even when we controlled for center (OR 5.3, P < .001). Conclusion. When guidelines lack clarity, unconscious bias has the potential to create a system with different levels of care based on socioeconomic disparities. (Surgery 2012;152:232-7.)	[Pickham, Danielle M.; Callcut, Rachael A.; Maggio, Paul M.; Mell, Matthew W.; Spain, David A.; Bech, Fritz; Staudenmayer, Kristan] Stanford Univ Hosp, Dept Surg, Stanford, CA 94305 USA	Staudenmayer, K (corresponding author), Stanford Univ, Dept Surg, 300 Pasteur Dr,Grant Bldg S-067, Stanford, CA 94305 USA.	kristans@stanford.edu					Bhalotra Sarita, 2007, J Natl Black Nurses Assoc, V18, P36; CHANG HJ, 1990, ARCH INTERN MED, V150, P83, DOI 10.1001/archinte.150.1.83; Dossett LA, 2011, J TRAUMA, V70, P1066, DOI 10.1097/TA.0b013e31821282d5; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Goodman DC, 2009, PEDIATR CLIN N AM, V56, P745, DOI 10.1016/j.pcl.2009.05.007; Gundle KR, 2010, J BONE JOINT SURG AM, V92A, P2452, DOI 10.2106/JBJS.I.01369; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Nasr DM, 2011, J STROKE CEREBROVASC; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 1998, ARCH SURG-CHICAGO, V133, P406, DOI 10.1001/archsurg.133.4.406; Shackford SR, 2007, J TRAUMA, V63, P764, DOI 10.1097/01.ta.0000240444.14664.5f; Stiefel Matt, 2008, Perm J, V12, P4; Trinh QD, 2012, CANCER-AM CANCER SOC, V118, P1894, DOI 10.1002/cncr.26527; Velmahos GC, 2000, J TRAUMA, V49, P140, DOI 10.1097/00005373-200007000-00021	14	14	14	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2012	152	2					232	237		10.1016/j.surg.2012.05.041			6	Surgery	Surgery	983ZP	WOS:000307157500013	22828145				2021-06-18	
J	Wilde, AM; Nailor, MD; Nicolau, DP; Kuti, JL				Wilde, Ashley M.; Nailor, Michael D.; Nicolau, David P.; Kuti, Joseph L.			Inappropriate Antibiotic Use Due to Decreased Compliance with a Ventilator-Associated Pneumonia Computerized Clinical Pathway: Implications for Continuing Education and Prospective Feedback	PHARMACOTHERAPY			English	Article						antimicrobial stewardship; ventilator-associated pneumonia; appropriate antibiotic therapy	INTENSIVE-CARE-UNIT; THERAPY; GUIDELINES; MANAGEMENT; IMPACT; METAANALYSIS; STEWARDSHIP; INFECTION; BACTERIA; OUTCOMES	Study Objective To assess the impact of noncompliance with a ventilator-associated pneumonia (VAP) computerized clinical pathway (CCP) on antibiotic use after removal of prospective antibiotic stewardship resources. Design Retrospective, observational, quasi-experimental study. Setting Three intensive care units (medical, surgical, and neurotrauma) in a large, tertiary care hospital. Patients A total of 136 patients with culture-positive VAP; 72 were treated from September 2006August 2007 (period 1), during which use of the CCP was mandatory along with aggressive stewardship support, and 64 were treated from September 2009April 2010 (period 2), during which use of the CCP was voluntary. Measurements and Main Results Compliance with use of the CCP was 100% during period 1 and 44% (28/64 patients) during period 2. For the 36 patients (56%) whose antibiotic selection did not comply with the CCP, empiric antibiotics were selected by provider discretion. Most patients had late-onset VAP and were similar with respect to age, sex, and comorbidities between the two periods. Staphylococcus aureus (1117% methicillin-resistant S. aureus) and Pseudomonas aeruginosa were the most common pathogens during both periods. The proportion of patients with appropriate antibiotics within 24 hours of VAP identification was not significantly different between period 1 (70.8%) and period 2 (56.3%, p=0.112). During period 2, patients who were treated according to the CCP were more likely to receive appropriate antibiotic therapy compared with patients treated according to provider discretion (82.1% vs 36.1%, p=0.001). Time to appropriate therapy was also shorter for patients treated according to the CCP (mean +/- SD 0.43 +/- 1.14 vs 1.29 +/- 1.36 days, p=0.003). Treatment with the CCP was the only variable significantly associated with appropriate antibiotic therapy (odds ratio 4.8, 95% confidence interval 2.110.9). Mortality was not significantly different between period 1 and period 2, and only Acute Physiology and Chronic Health Evaluation II score and admission with a head injury were predictive of death. Finally, a greater proportion of patients treated with the CCP were de-escalated from anti- Pseudomonas beta-lactams (85.0% vs 33.3%, p=0.006) when they were not necessary. Conclusion These data highlight the importance of continued stewardship resources after CCP implementation to ensure compliance and to maximize antibiotic stewardship outcomes.	[Nicolau, David P.; Kuti, Joseph L.] Hartford Hosp, Ctr Antiinfect Res & Dev, Hartford, CT 06102 USA; [Wilde, Ashley M.; Nailor, Michael D.] Univ Connecticut, Sch Pharm, Storrs, CT USA	Kuti, JL (corresponding author), Hartford Hosp, Ctr Antiinfect Res & Dev, 80 Seymour St, Hartford, CT 06102 USA.	jkuti@harthosp.org			Center for Anti-Infective Research and Development	Supported internally by the Center for Anti-Infective Research and Development.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arnold HM, 2011, SEMIN RESP CRIT CARE, V32, P215, DOI 10.1055/s-0031-1275534; Beardsley JR, 2006, CHEST, V130, P787, DOI 10.1378/chest.130.3.787; Carter BL, 2010, PHARMACOTHERAPY, V30, P228, DOI 10.1592/phco.30.3.228; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Dellit TH, 2008, INFECT CONT HOSP EP, V29, P525, DOI 10.1086/588160; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Eachempati SR, 2009, J TRAUMA, V66, P1343, DOI 10.1097/TA.0b013e31819dca4e; Garcin F, 2010, INTENS CARE MED, V36, P75, DOI 10.1007/s00134-009-1660-8; Green David L, 2005, J Intensive Care Med, V20, P296, DOI 10.1177/0885066605278650; Gums JG, 2010, PHARMACOTHERAPY, V30, P221, DOI 10.1592/phco.30.3.221; Ibrahim EH, 2001, CRIT CARE MED, V29, P1109, DOI 10.1097/00003246-200106000-00003; Kuti EL, 2008, J CRIT CARE, V23, P91, DOI 10.1016/j.jcrc.2007.08.007; Kuti JL, 2009, SEMIN RESP CRIT CARE, V30, P102, DOI 10.1055/s-0028-1119814; Bassi GL, 2010, CURR OPIN INFECT DIS, V23, P171, DOI 10.1097/QCO.0b013e328337241a; Nicasio AM, 2010, PHARMACOTHERAPY, V30, P453, DOI 10.1592/phco.30.5.453; Nicasio AM, 2010, J CRIT CARE, V25, P69, DOI 10.1016/j.jcrc.2009.02.014; Niederman MS, 2010, CLIN INFECT DIS, V51, pS93, DOI 10.1086/653055; Rello J, 2011, EUR RESPIR J, V37, P1332, DOI 10.1183/09031936.00093010; Shorr AF, 2005, CRIT CARE MED, V33, P46, DOI 10.1097/01.CCM.0000149852.32599.31; Thiel SW, 2009, CRIT CARE MED, V37, P819, DOI 10.1097/CCM.0b013e318196206b; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yong MK, 2010, J ANTIMICROB CHEMOTH, V65, P1062, DOI 10.1093/jac/dkq058	23	14	15	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008			PHARMACOTHERAPY	Pharmacotherapy	AUG	2012	32	8			SI		755	763		10.1002/j.1875-9114.2012.01161.x			9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	982CM	WOS:000307019300010	23307523				2021-06-18	
J	Bay, EH; Blow, AJ; Yan, X				Bay, Esther H.; Blow, Adrian J.; Yan, Xie (Emily)			Interpersonal Relatedness and Psychological Functioning following Traumatic Brain Injury: Implications for Marital and Family Therapists	JOURNAL OF MARITAL AND FAMILY THERAPY			English	Article							COMPETENCE RATING-SCALE; IMPAIRED SELF-AWARENESS; PSYCHOMETRIC PROPERTIES; DEPRESSIVE SYMPTOMS; CHRONIC STRESS; HEAD-INJURY; MILD HEAD; CONFLICT; SENSE; PREDICTORS	Recovery from a mild-to-moderate traumatic brain injury (TBI) is a challenging process for injured persons and their families. Guided by attachment theory, we investigated whether relationship conflict, social support, or sense of belonging were associated with psychological functioning. Community-dwelling persons with TBI (N = 75) and their relatives/significant others (N = 74) were surveyed on relationship variables, functional status, and TBI symptom severity. Results from this cross-sectional study revealed that only sense of belonging was a significant predictor of postinjury psychological functioning, although interpersonal conflict approached significance. No relevant preinjury or injury-related variables impacted these relationships, except marital status. Our findings suggest that interventions targeting strengthening the injured persons sense of belonging and lowering interpersonal conflict may benefit those living with TBI.	[Bay, Esther H.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Blow, Adrian J.] Michigan State Univ, Couple & Family Therapy Program, Dept Human Dev & Family Studies, E Lansing, MI 48824 USA; [Yan, Xie (Emily)] Michigan State Univ, CSTAT, Dept Stat, E Lansing, MI 48824 USA	Bay, EH (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy,Suite 300, Ann Arbor, MI 48108 USA.	pdq@med.umich.edu	Blow, Adrian/U-1647-2019		NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD007422] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422] Funding Source: NIH RePORTER		AINSWORTH MDS, 1989, AM PSYCHOL, V44, P709, DOI 10.1037/0003-066X.44.4.709; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E., 2005, J NEUROSCIENCE NURSI, V36, P55; Bay E., 2007, J NEUROSCIENCE NURSI, V39, P33; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2007, ARCH PSYCHIAT NURS, V21, P2, DOI 10.1016/j.apnu.2006.07.005; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/088971804780957108; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Center for Outcome Measurement in Brain Injury, 2008, OUTCOME MEASUREMENT; Centers for Disease Control and Prevention, 2011, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2010, WHAT ARE POTENTIAL L; Clark PC, 2004, NURS RES, V53, P406, DOI 10.1097/00006199-200411000-00009; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COHEN NJ, 1993, J CHILD PSYCHOL PSYC, V34, P545, DOI 10.1111/j.1469-7610.1993.tb01035.x; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Florian V, 1991, Int Disabil Stud, V13, P150; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; Frohlich KL, 1997, PSYCHOL REP, V80, P883, DOI 10.2466/pr0.1997.80.3.883; Hagerty B M, 1993, Image J Nurs Sch, V25, P291; Hagerty B M, 1992, Arch Psychiatr Nurs, V6, P172, DOI 10.1016/0883-9417(92)90028-H; Hagerty BM, 1999, NURS RES, V48, P215, DOI 10.1097/00006199-199907000-00004; Hagerty BM, 1996, ARCH PSYCHIAT NURS, V10, P235, DOI 10.1016/S0883-9417(96)80029-X; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Johnson SM, 2002, GUIL FAM TH, P3; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kupfer D. J., 1974, K D S MODERN MENTAL, V1; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; McEwen BS, 2008, METABOLISM, V57, pS11, DOI 10.1016/j.metabol.2008.07.006; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; SAS Software, 2002, SAS SOFTWARE SAS SYS; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Tilden V P, 1994, J Nurs Meas, V2, P63; TILDEN VP, 1990, NURS RES, V39, P337; Turner HA, 2003, J YOUTH ADOLESCENCE, V32, P89, DOI 10.1023/A:1021853600645; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Whiffen VE, 2005, TRAUMA VIOLENCE ABUS, V6, P24, DOI 10.1177/1524838004272543; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Young E A, 1997, Depress Anxiety, V5, P66, DOI 10.1002/(SICI)1520-6394(1997)5:2<66::AID-DA2>3.0.CO;2-3	61	14	14	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0194-472X	1752-0606		J MARITAL FAM THER	J. Marital Fam. Ther.	JUL	2012	38	3					556	567		10.1111/j.1752-0606.2011.00231.x			12	Psychology, Clinical; Family Studies	Psychology; Family Studies	973ZO	WOS:000306399600010	22804472	Green Accepted			2021-06-18	
J	Carney, N; Lujan, S; Dikmen, S; Temkin, N; Petroni, G; Pridgeon, J; Barber, J; Machamer, J; Cherner, M; Chaddock, K; Hendrix, T; Rondina, C; Videtta, W; Celix, JM; Chesnut, R				Carney, Nancy; Lujan, Silvia; Dikmen, Sureyya; Temkin, Nancy; Petroni, Gustavo; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Cherner, Mariana; Chaddock, Kelley; Hendrix, Terence; Rondina, Carlos; Videtta, Walter; Celix, Juanita M.; Chesnut, Randall			Intracranial Pressure Monitoring in Severe Traumatic Brain Injury in Latin America: Process and Methods for a Multi-Center Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						international; intracranial pressure monitoring; randomized controlled trial; traumatic brain injury	FLUENCY; MEMORY; SCALE; NORMS	In patients with severe traumatic brain injury (TBI), the influence on important outcomes of the use of information from intracranial pressure (ICP) monitoring to direct treatment has never been tested in a randomized controlled trial (RCT). We are conducting an RCT in six trauma centers in Latin America to test this question. We hypothesize that patients randomized to ICP monitoring will have lower mortality and better outcomes at 6-months post-trauma than patients treated without ICP monitoring. We selected three centers in Bolivia to participate in the trial, based on (1) the absence of ICP monitoring, (2) adequate patient accession and data collection during the pilot phase, (3) preliminary institutional review board approval, and (4) the presence of equipoise about the value of ICP monitoring. We conducted extensive training of site personnel, and initiated the trial on September 1, 2008. Subsequently, we included three additional centers. A total of 176 patients were entered into the trial as of August 31, 2010. Current enrollment is 81% of that expected. The trial is expected to reach its enrollment goal of 324 patients by September of 2011. We are conducting a high-quality RCT to answer a question that is important globally. In addition, we are establishing the capacity to conduct strong research in Latin America, where TBI is a serious epidemic. Finally, we are demonstrating the feasibility and utility of international collaborations that share resources and unique patient populations to conduct strong research about global public health concerns.	[Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [Lujan, Silvia; Petroni, Gustavo; Rondina, Carlos] Hosp Emergencias, Rosario, Santa Fe, Argentina; [Dikmen, Sureyya; Temkin, Nancy; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Chaddock, Kelley; Celix, Juanita M.; Chesnut, Randall] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Cherner, Mariana; Hendrix, Terence] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina	Carney, N (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	carneyn@ohsu.edu	cherner, mariana/N-4810-2015	cherner, mariana/0000-0002-5479-7401; Chesnut, Randall/0000-0001-6377-3666	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NINDS through the Brain Disorders in the Developing World: Research Across the Lifespan program [R01 NS058302]; Integra Life-Sciences; InnerSpace; Integra LifeSciences-Duraplasty histology study; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS058302] Funding Source: NIH RePORTER	This project was funded by the NIH and NINDS through the Brain Disorders in the Developing World: Research Across the Lifespan program, grant no. R01 NS058302 for Traumatic Brain Injury in Latin America: Lifespan Analysis.; Randy Chesnut has these consultant fees: Integra Life-Sciences $5000, InnerSpace $2000; grant from the Integra LifeSciences-Duraplasty histology study, amount in discussion. No competing financial interests exist for the remaining authors.	Artiola-i-Fortuny L, 1999, MANUAL NORMAS PROCED; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Chesnut R M, 1995, New Horiz, V3, P581; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Heaton RK, 2004, REVISED COMPREHENSIV; Klove H., 1963, GROOVED PEGBOARD; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson D., 1993, HALSTEAD REITAN NEUR; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460	24	14	16	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	11					2022	2029		10.1089/neu.2011.2019			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	983CX	WOS:000307095800003	22435793	Green Published			2021-06-18	
J	Link, TW; Woodworth, GF; Chaichana, KL; Grossman, SA; Mayer, RS; Brem, H; Weingart, JD; Quinones-Hinojosa, A				Link, Thomas W.; Woodworth, Graeme F.; Chaichana, Kaisorn L.; Grossman, Stuart A.; Mayer, Robert S.; Brem, Henry; Weingart, Jon D.; Quinones-Hinojosa, Alfredo			Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Function; Glioblastoma; Hyperglycemia; Rehabilitation	QUALITY-OF-LIFE; INSULIN THERAPY; BLOOD-GLUCOSE; SURVIVAL; STROKE; MORTALITY; COMPLICATIONS; EPIDEMIOLOGY; PREDICTORS; INCREASES	The poor prognosis for patients with glioblastoma (GB) heightens the importance of maintaining function throughout treatment. Hyperglycemia has been linked to poor neurological outcomes following stroke, traumatic brain and spinal cord injury. We hypothesized this may also be true following the resection of GB. We assessed associations with post-operative function with the goal of identifying modifiable factors in the pen-operative period with a particular focus on blood glucose levels. Independent associations with worse post-operative function included: patient age, pre-operative motor deficit, deep tumor location, post-operative motor deficit, and elevated mean pen-operative glucose. Interestingly, controlling for associated factors including dexamethasone dosing, patients with elevated pen-operative glucose levels were nearly twice as likely to have new post-operative neurological deficits. These results suggest, together with the broad literature supporting a role for hyperglycemia in neurological injury, that this may represent a modifiable factor in the pen-operative care of these patients. (C) 2012 Elsevier Ltd. All rights reserved.	[Link, Thomas W.; Woodworth, Graeme F.; Chaichana, Kaisorn L.; Grossman, Stuart A.; Brem, Henry; Weingart, Jon D.; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Grossman, Stuart A.; Brem, Henry; Weingart, Jon D.; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Sch Med, Dept Oncol, Dept Neurooncol, Baltimore, MD 21205 USA; [Mayer, Robert S.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Brem, Henry] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Quinones-Hinojosa, A (corresponding author), 4940 Eastern Ave,301 Mason Lord Dr,Suite 2100, Baltimore, MD 21224 USA.	aquinon2@jhmi.edu			NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA006973] Funding Source: NIH RePORTER		Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Barber M, 2004, GERONTOLOGY, V50, P102, DOI 10.1159/000075561; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bhalla A, 2002, CEREBROVASC DIS, V13, P95, DOI 10.1159/000047757; Brown PD, 2006, J NEURO-ONCOL, V76, P283, DOI 10.1007/s11060-005-7020-9; Brown PD, 2005, NEUROSURGERY, V57, P495, DOI 10.1227/01.NEU.0000170562.25335.C7; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Bussiere M, 2005, CAN J NEUROL SCI, V32, P50, DOI 10.1017/S0317167100016875; Casartelli G, 2009, CANCER BIOL THER, V8, P1719, DOI 10.4161/cbt.8.18.9209; Chaichana KL, 2011, J NEUROSURG, V114, P604, DOI 10.3171/2010.4.JNS091340; Christensen H, 2002, EUR J NEUROL, V9, P297, DOI 10.1046/j.1468-1331.2002.00409.x; CLEMENTS RS, 1985, AM J MED, V79, P2, DOI 10.1016/0002-9343(85)90503-0; HARIK SI, 1988, J NEUROCHEM, V51, P1924, DOI 10.1111/j.1471-4159.1988.tb01179.x; Henry RMA, 2004, STROKE, V35, P671, DOI 10.1161/01.STR.0000115752.58601.0B; Kawai N, 1998, ACT NEUR S, V71, P219; Kernan Walter N, 2004, Curr Treat Options Neurol, V6, P443, DOI 10.1007/s11940-004-0002-y; Khoury W, 2004, J TRAUMA, V57, P1132, DOI 10.1097/01.TA.0000141889.31903.9C; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Krolewski AS, 1996, ENDOCRIN METAB CLIN, V25, P217, DOI 10.1016/S0889-8529(05)70322-4; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Li SW, 2009, CHINESE MED J-PEKING, V122, P1245, DOI 10.3760/cma.j.issn.0366-6999.2009.11.002; MATCHAR DB, 1992, ANN INTERN MED, V117, P449, DOI 10.7326/0003-4819-117-6-449; McGirt MJ, 2007, J NEUROSURG, V107, P1080, DOI 10.3171/JNS-07/12/1080; McGirt MJ, 2006, NEUROSURGERY, V58, P1066, DOI 10.1227/01.NEU.0000215887.59922.36; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Mcgirt MJ, 2009, J NEUROSURG-SPINE, V10, P9, DOI 10.3171/2008.10.SPI08333; McGirt MJ, 2005, J NEUROSURG, V102, P897, DOI 10.3171/jns.2005.102.5.0897; Pittas AG, 2004, ARCH INTERN MED, V164, P2005, DOI 10.1001/archinte.164.18.2005; Recht L, 2003, J NEURO-ONCOL, V61, P127, DOI 10.1023/A:1022187502917; Resl M, 2010, WIEN MED WOCHENSCHR, V160, P3, DOI 10.1007/s10354-010-0744-y; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sala F, 1999, ANN NY ACAD SCI, V890, P133, DOI 10.1111/j.1749-6632.1999.tb07989.x; Stark AM, 2010, EUR J CANCER CARE, V19, P39, DOI 10.1111/j.1365-2354.2008.00956.x; Taphoorn MJB, 2005, LANCET ONCOL, V6, P937, DOI 10.1016/S1470-2045(05)70432-0; TRACEY F, 1993, Q J MED, V86, P439; TRACEY F, 1994, STROKE, V25, P524, DOI 10.1161/01.STR.25.2.524; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; Williams LS, 2002, NEUROLOGY, V59, P67, DOI 10.1212/WNL.59.1.67; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	42	14	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2012	19	7					996	1000		10.1016/j.jocn.2011.09.031			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	040LJ	WOS:000311323800014	22595358	Green Accepted			2021-06-18	
J	Chiu, CC; Li, YN; Lin, LJ; Hsiao, CT; Hsiao, KY; Chen, IC				Chiu, Chun-Cheng; Li, Yi-Nong; Lin, Leng-Jye; Hsiao, Cheng-Ting; Hsiao, Kuang-Yu; Chen, I-Chuan			Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						D-dimer; ICH; Mortality; Spontaneous intracerebral hemorrhage	ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ACTIVATION; COAGULOPATHY; HEMOSTASIS; PLASMA; SCALE; SCORE; COMA	It has been found that the hemostatic system is activated following a brain injury. To explore the role of D-dimer in spontaneous intracerebral hemorrhage (ICH), this prospective study aimed to evaluate the association between serum D-dimer concentration, clinical outcome and radiographic findings of ICH patients in the emergency department (ED). Patients with acute (<24 hours) spontaneous ICH were enrolled in this study. The D-dimer concentration was related to: baseline ICH volume (r = 0.198. p = 0.01); Glasgow Coma Scale (GCS) score 3-8 (p = 0.01); GCS score 13-15 (p = 0.002); midline shift >15 mm (p = 0.016); and to subarachnoid extension of the blood (p < 0.0001). Diabetes mellitus (odds ratio [OR]: 2.93; 95% confidence interval [CI]: 1.1-7.76, p = 0.031), ICH volume (OR: 1.16; 95% CI: 1.07-1.27, p < 0.0001) and D-dimer concentration (OR: 2.72; 95% CI: 1.08-6.9, p = 0.002) were associated with 30-day mortality. This study shows that in patients with spontaneous ICH, a higher initial D-dimer concentration is associated with higher 30-day mortality. (C) 2011 Elsevier Ltd. All rights reserved.	[Chen, I-Chuan] Chang Gung Mem Hosp, Dept Emergency Med, Puzih City 613, Chiayi County, Taiwan; Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chen, IC (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, 6 W Sec,Jiapu Rd, Puzih City 613, Chiayi County, Taiwan.	giomacky@gmail.com			Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPG660283]	This study was supported by the Chang Gung Memorial Hospital research program CMRPG660283.	Barber M, 2004, STROKE, V35, P1421, DOI 10.1161/01.STR.0000126890.63512.41; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FUJII Y, 1995, NEUROSURGERY, V37, P226, DOI 10.1227/00006123-199508000-00006; Fujii Y, 2001, STROKE, V32, P883, DOI 10.1161/01.STR.32.4.883; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Ikeda K, 1997, NEUROSURGERY, V41, P344, DOI 10.1097/00006123-199708000-00002; Ilveskero S, 2005, NEUROSURGERY, V57, P16, DOI 10.1227/01.NEU.0000163085.48999.D6; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; JUVELA S, 1990, STROKE, V21, P566, DOI 10.1161/01.STR.21.4.566; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Parra A, 2006, NAT CLIN PRACT NEURO, V2, P592, DOI 10.1038/ncpneuro0341; Pathak A, 2005, Neurol India, V53, P178; Peltonen S, 1997, J NEUROSURG, V87, P207, DOI 10.3171/jns.1997.87.2.0207; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Takahashi H, 1998, AM J HEMATOL, V59, P110; Ungerstedt JS, 2003, J NEUROSURG ANESTH, V15, P13, DOI 10.1097/00008506-200301000-00003	28	14	17	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUN	2012	19	6					810	813		10.1016/j.jocn.2011.08.032			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	955SH	WOS:000305040700007	22377638				2021-06-18	
J	Gurkoff, GG; Shahlaie, K; Lyeth, BG				Gurkoff, Gene G.; Shahlaie, Kiarash; Lyeth, Bruce G.			In vitro mechanical strain trauma alters neuronal calcium responses: Implications for posttraumatic epilepsy	EPILEPSIA			English	Article						Traumatic brain injury; Calcium; Cell culture; Glutamate; Excitability	FLUID PERCUSSION INJURY; LONG-TERM POTENTIATION; BRAIN-INJURY; CORTICAL-NEURONS; HEAD TRAUMA; SEIZURES; ASTROCYTES; MODEL; RAT; SUSCEPTIBILITY	Traumatic brain injury (TBI) is known to initiate a series of chemical cascades resulting in neuronal dysfunction and death. Epidemiology studies have found that a prior incidence of TBI is the most important cause of remote symptomatic epilepsy in young adults and children. TBI-induced changes in neuronal sensitivity to stimulation may contribute to acute seizures and the eventual generation of epilepsy. This study examined TBI-induced changes in neuronal sensitivity to stimulation by measuring intracellular calcium ([Ca++]i) responses in neurons during glutamate application in vitro. Initial experiments examined neuronal and glial cell death and determined that a 31% mechanical strain trauma to mixed neuronal-astrocyte rat cortical cultures produced a trend, but no significant cell death at 48 h after injury. Subsequent experiments utilized this magnitude of trauma to examine the sensitivity of cortical neurons to changes in [Ca++]i in response to 100-mu m glutamate at five time points postinjury (1, 6, 24, 48, and 72 h). Traumatically strain-injured neurons responded with a dynamic change in the accumulation of [Ca++]i, with a significant increase at 48 h and a significant decrease at 72 h as compared to uninjured cultures. These data highlight that TBI leads to abnormal responsiveness to stimulation, an indicator of neuronal dysfunction in surviving cells. Such changes in sensitivity to stimulation may also be associated with changes in excitability in the first hours to days after TBI, and may play a role in early posttraumatic seizures observed in patients with TBI. In addition, this study provides an in vitro paradigm for testing the function of surviving cells following treatment interventions targeted at reducing cell death and dysfunction.	[Gurkoff, Gene G.; Shahlaie, Kiarash; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Shahlaie, Kiarash] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA	Gurkoff, GG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS29995]; Center for Biophotonics Science and Technology, NSF Science and Technology Center [PHY 0120999]; Bronte Epilepsy Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH NINDS) NS29995, the Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center, managed by the University of California, Davis, under Cooperative Agreement number PHY 0120999, and the Bronte Epilepsy Research Program. Expert technical assistance was provided by Paul Mello and Vanessa Atkinson. We want to thank H. Jurgen Wenzel for the many years of friendship, collegial interactions, and insightful discussions of neuroanatomy and neuropathology. Jurgen has been an inspiration that has enriched our science and a trustworthy friend that has enriched our lives.	Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Beller JA, 2011, RESTOR NEUROL NEUROS, V29, P331, DOI 10.3233/RNN-2011-603; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DAWSON RE, 1951, J NEUROSURG, V8, P613, DOI 10.3171/jns.1951.8.6.0613; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faul M., 2010, TRAUMATIC BRAIN INJU, P1; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Golarai G, 2001, J NEUROSCI, V21, P8523; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.3.CO;2-2; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Segatore M, 1993, Axone, V15, P34; Shahlaie K, 2010, J NEUROTRAUM, V27, P175, DOI 10.1089/neu.2009.1003; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	37	14	15	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580			EPILEPSIA	Epilepsia	JUN	2012	53			1	SI		53	60		10.1111/j.1528-1167.2012.03475.x			8	Clinical Neurology	Neurosciences & Neurology	945FH	WOS:000304257700008	22612809				2021-06-18	
J	Kong, WM; Tang, D; Luo, XY; Yu, ITS; Liang, YX; He, YH				Kong, Wenming; Tang, Dan; Luo, Xiaoyuan; Yu, Ignatius Tak Sun; Liang, Youxin; He, Yonghua			Prediction of Return to Work Outcomes Under an Injured Worker Case Management Program	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						Case management; Return to work; Intervention; Occupational injury	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; LOW-BACK-PAIN; VOCATIONAL-REHABILITATION; MENTAL-HEALTH; SICK LEAVE; INTERVENTIONS; WORKPLACE; DISABILITY	Introduction Many factors affect worker return to work (RTW) after occupational injury, among which effective case management strategies play a particularly vital role in prompting workers for a successful RTW. Objectives This study aimed at predicting the RTW outcome and optimizing the intervention scheme of a case management program initiated in China. Methods A retrospective cohort was formed with 523 injured workers treated at a rehabilitation center for work injuries in southern China. The social demographic information, medical data and intervention process were extracted from the medical records of the rehabilitation center. A Cox Regression Model was used to examine the predictors of RTW case management. Results 261 patients (77.9%) out of the 335 valid subjects successfully returned to work after median absence duration of 36.0 days. A computer skills training program was a positive factor for RTW outcomes (hazard ratio 1.5, P < 0.001). Psychological counseling was possibly an important measure to improve RTW with a hazard ratio of 3.4 (95% CI 0.94-16, P > 0.05). Disability adjustment accommodations did not specifically benefit RTW. Education level, family's attitude to RTW, personal perceptions about social support for RTW, and injury severity were significantly associated with outcomes of RTW. Conclusions It was implied that RTW intervention should be focused on a specific skill reconstruction and training which was presumably related with labor market needs. However, tailored psychological counseling and disability adjustment activity should not be ignored in RTW.	[Yu, Ignatius Tak Sun; He, Yonghua] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Kong, Wenming] Zhengjiang Prov Inst Dermatoses Prevent & Cure, Deqing Cty 313200, Zhejiang, Peoples R China; [Tang, Dan; Luo, Xiaoyuan] Guangdong Prov Work Injury Rehabil Ctr, Guangzhou 510970, Guangdong, Peoples R China; [Liang, Youxin; He, Yonghua] Fudan Univ, Sch Publ Health, Fudan Liberty Mutual SafeWork Ctr, Shanghai 200032, Peoples R China	He, YH (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Room 416,4-F,Sch Public Hlth Bldg, Shatin, Hong Kong, Peoples R China.	yhhe@cuhk.edu.hk	Yu, Ignatius Tak Sun/A-9936-2008				Adams H, 2007, J OCCUP REHABIL, V17, P305, DOI 10.1007/s10926-007-9082-3; ALTMAIER EM, 1992, PAIN, V49, P329, DOI 10.1016/0304-3959(92)90240-C; Ammendolia C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-65; Athanasou James A, 2005, Med Leg J, V73, P29; Baril R, 2003, SOC SCI MED, V57, P2101, DOI 10.1016/S0277-9536(03)00131-X; Bloch FS, 1997, INT SOCIAL SECURITY, V50, P3; Braathen TN, 2007, J REHABIL MED, V39, P493, DOI 10.2340/16501977-0081; Briand C, 2007, INT J LAW PSYCHIAT, V30, P444, DOI 10.1016/j.ijlp.2007.06.014; Brouwers EPM, 2006, GEN HOSP PSYCHIAT, V28, P223, DOI 10.1016/j.genhosppsych.2006.02.005; Cheng ASK, 2011, J OCCUP REHABIL, V21, pS44, DOI 10.1007/s10926-010-9272-2; CRISP R, 1992, J REHABIL, V58, P27; Dan T, 2011, J OCCUP REHABIL, V21, P55; Drews B, 2007, SCAND J PUBLIC HEALT, V35, P86, DOI 10.1080/14034940600868598; Durand MJ, 2002, J OCCUP REHABIL, V12, P191, DOI 10.1023/A:1016846712499; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Feuerstein M, 2003, J OCCUP ENVIRON MED, V45, P803, DOI 10.1097/01.jom.0000079091.95532.92; Feuerstein M, 2011, J OCCUP REHABIL, V21, pS5, DOI 10.1007/s10926-011-9295-3; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Franche RL, 2005, J OCCUP REHABIL, V15, P525, DOI 10.1007/s10926-005-8032-1; Franche RL, 2002, J OCCUP REHABIL, V12, P233, DOI 10.1023/A:1020270407044; Hagen EM, 2000, SPINE, V25, P1973, DOI 10.1097/00007632-200008010-00017; He YH, 2010, J OCCUP REHABIL, V20, P378, DOI 10.1007/s10926-010-9232-x; Hess DW, 2000, ARCH PHYS MED REHAB, V81, P359, DOI 10.1016/S0003-9993(00)90084-4; Jang Y, 2005, ARCH PHYS MED REHAB, V86, P681, DOI 10.1016/j.apmr.2004.10.025; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Lai HS, 2007, J OCCUP REHABIL, V17, P712, DOI 10.1007/s10926-007-9110-3; Li-Tsang CWP, 2008, J OCCUP REHABIL, V18, P299, DOI 10.1007/s10926-008-9138-z; Li-Tsang WPC, 2006, J OCCUP REHABIL, V17, P270; Loisel P, 1997, SPINE, V22, P2911, DOI 10.1097/00007632-199712150-00014; Rebergen DS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-183; Salazar M K, 1999, AAOHN J, V47, P348; Scheel IB, 2002, SPINE, V27, P2734, DOI 10.1097/00007632-200212010-00014; Shaw W, 2008, J OCCUP REHABIL, V18, P2, DOI 10.1007/s10926-007-9115-y; Sullivan MJL, 2005, J OCCUP REHABIL, V15, P475, DOI 10.1007/s10926-005-8029-9; Tompa E, 2008, J OCCUP REHABIL, V18, P16, DOI 10.1007/s10926-007-9116-x; van der Klink JJL, 2003, OCCUP ENVIRON MED, V60, P429, DOI 10.1136/oem.60.6.429; Verbeek JH, 2002, SPINE, V27, P1844, DOI 10.1097/00007632-200209010-00006; World Health Organisation (WHO), 2005, MENT HLTH POL PROGR; Xiaohong G, 2010, SAFETY, V31, P1; Xu YW, 2007, J OCCUP REHABIL, V17, P727, DOI 10.1007/s10926-007-9105-0; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0	41	14	15	1	27	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	JUN	2012	22	2					230	240		10.1007/s10926-011-9343-z			11	Rehabilitation; Social Issues	Rehabilitation; Social Issues	926DS	WOS:000302812100008	22120023				2021-06-18	
J	McGinn, MJ; Colello, RJ; Sun, D				McGinn, Melissa J.; Colello, Raymond J.; Sun, Dong			Age-related proteomic changes in the subventricular zone and their association with neural stem/progenitor cell proliferation	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						subventricular zone; aging; neurogenesis; proteome	TRAUMATIC BRAIN-INJURY; STEM-CELLS; DENTATE GYRUS; 2-DIMENSIONAL ELECTROPHORESIS; ALZHEIMERS-DISEASE; PROGENITOR CELLS; ADULT; NEUROGENESIS; NEURONS; RAT	In the mammalian central nervous system, generation of new neurons persists in the subventricular zone (SVZ) throughout life. However, the capacity for neurogenesis in this region declines with aging. Recent studies have examined the degree of these age-related neurogenic declines and the changes of cytoarchitecture of the SVZ with aging. However, little is known about the molecular changes in the SVZ with aging. In this study, we dissected the SVZs from rats aged postnatal day 28, 3 months, and 24 months. The SVZ tissues were processed for 2-D gel electrophoresis to identify protein changes following aging. Protein spots were subsequently subjected to mass spectrometry analysis to compare age-related alterations in the SVZ proteome. We also examined the level of cell proliferation in the SVZ in animals of these three age groups by using bromodeoxyuridine labeling. We found significant age-related changes in the expression of several proteins that play critical roles in the proliferation and survival of neural stem/progenitor cells in the SVZ. Among these proteins, glial fibrillary acidic protein, ubiquitin carboxy terminal hydrolase 1, glutathione S-transferase omega, and preproalbumin were increased with aging, whereas collapsin response-mediated protein 4 (CRMP-4), CRMP-5, and microsomal protease ER60 exhibited declines with aging. We have also observed a significant decline of neural stem/progenitor cell proliferation in the SVZ with aging. These alterations in protein expression in the SVZ with aging likely underlie the diminishing proliferative capacity of stem/progenitor cells in the aging brain. (c) 2012 Wiley Peridicals, Inc.	[Sun, Dong] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; [McGinn, Melissa J.; Colello, Raymond J.] Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat & Neurobiol, Richmond, VA 23298 USA	Sun, D (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, POB 980631, Richmond, VA 23298 USA.	dsun@vcu.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055086, NS048377]; NIH-NINDS centerUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R01NS055086, R21NS048377] Funding Source: NIH RePORTER	Contract grant sponsor: NIH/NINDS; Contract grant number: NS055086 (to D.S.); Contract grant number: NS048377 (to R.J.C.).; Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS center core grant 5P30NS047463.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Alonso G, 2001, GLIA, V34, P253, DOI 10.1002/glia.1059; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Babu GJ, 2004, ANAL BIOCHEM, V325, P121, DOI 10.1016/j.ab.2003.10.024; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; Celli CM, 2003, CANCER RES, V63, P6016; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Colello RJ, 2002, ELECTROPHORESIS, V23, P144, DOI 10.1002/1522-2683(200201)23:1<144::AID-ELPS144>3.0.CO;2-P; Della-Maggiore V, 2002, REV NEUROSCIENCE, V13, P167; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; GOLDFIEN RD, 1991, J IMMUNOL, V146, P3703; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GOSS JR, 1991, NEUROBIOL AGING, V12, P165, DOI 10.1016/0197-4580(91)90056-P; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Harada T, 2004, AM J PATHOL, V164, P59, DOI 10.1016/S0002-9440(10)63096-9; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hopkins A., 1993, CLIN NEUROLOGY MODER; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Lee CK, 2000, NAT GENET, V25, P294; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Limke TL, 2002, J CELL MOL MED, V6, P475, DOI 10.1111/j.1582-4934.2002.tb00451.x; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Lubec G, 2003, PROG NEUROBIOL, V69, P193, DOI 10.1016/S0301-0082(03)00036-4; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Madhavan L, 2005, ANN NY ACAD SCI, V1049, P185, DOI 10.1196/annals.1334.017; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nacher J, 2000, J COMP NEUROL, V424, P628, DOI 10.1002/1096-9861(20000904)424:4<628::AID-CNE5>3.0.CO;2-4; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rodriguez JJ, 2009, NEUROREPORT, V20, P907, DOI 10.1097/WNR.0b013e32832be77d; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; SELKOE DJ, 1992, SCI AM, V267, P135, DOI 10.1038/scientificamerican0992-134; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Taylor CM, 2003, PROTEOMICS, V3, P1303, DOI 10.1002/pmic.200300451; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Walter J, 2011, NEUROBIOL AGING, V32, P1906, DOI 10.1016/j.neurobiolaging.2009.11.011; Wilkinson KD, 1997, FASEB J, V11, P1245; Wu Y, 2005, NEUROCHEM INT, V46, P565, DOI 10.1016/j.neuint.2005.01.002	65	14	15	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2012	90	6					1159	1168		10.1002/jnr.23012			10	Neurosciences	Neurosciences & Neurology	922GV	WOS:000302536300006	22344963	Green Accepted			2021-06-18	
J	Tomasevic, G; Laurer, HL; Mattiasson, G; van Steeg, H; Wieloch, T; McIntosh, TK				Tomasevic, Gregor; Laurer, Helmut L.; Mattiasson, Gustav; van Steeg, Harry; Wieloch, Tadeusz; McIntosh, Tracy K.			Delayed neuromotor recovery and increased memory acquisition dysfunction following experimental brain trauma in mice lacking the DNA repair gene XPA	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; xeroderma pigmentosum; neuronal cell death; Morris water maze; neuroscoring; transgenic mouse	NUCLEOTIDE EXCISION-REPAIR; CONTROLLED CORTICAL IMPACT; XERODERMA-PIGMENTOSUM; MAMMALIAN-CELLS; OXIDATIVE DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; POSTTRAUMATIC HYPOTHERMIA; NEUROLOGICAL DISEASE; BEHAVIORAL DEFICITS; MITOCHONDRIAL-DNA	Object. This study investigates the outcome after traumatic brain injury (TBI) in mice lacking the essential DNA repair gene xeroderma pigmentosum group A (XPA). As damage to DNA has been implicated in neuronal cell death in various models, the authors sought to elucidate whether the absence of an essential DNA repair factor would affect the outcome of TBI in an experimental setting. Methods. Thirty-seven adult mice of either wild-type (n = 18) or XPA-deficient ("knock-out" [n = 19]) genotype were subjected to controlled cortical impact experimental brain trauma, which produced a focal brain injury. Sham-injured mice of both genotypes were used as controls (9 in each group). The mice were subjected to neurobehavoral tests evaluating learning/acquisition (Morris water maze) and motor dysfunction (Rotarod and composite neuroscore test), pre- and postinjury up to 4 weeks. The mice were killed after 1 or 4 weeks, and cortical lesion volume, as well as hippocampal and thalamic cell loss, was evaluated. Hippocampal staining with doublecortin antibody was used to evaluate neurogenesis after the insult. Results. Brain-injured XPA(-/-) mice exhibited delayed recovery from impairment in neurological motor function, as well as pronounced cognitive dysfunction in a spatial learning task (Morris water maze), compared with injured XPA(+/+) mice (p < 0.05). No differences in cortical lesion volume, hippocampal damage, or thalamic cell loss were detected between XPA(+/+) and XPA(-/-) mice after brain injury. Also, no difference in the number of cells stained with doublecortin in the hippocampus was detected. Conclusions. The authors' results suggest that lack of the DNA repair factor XPA may delay neurobehavioral recovery after TBI, although they do not support the notion that this DNA repair deficiency results in increased cell or tissue death in the posttraumatic brain. (http://thejns.org/doi/abs/10.3171/2012.2.JNS11888)	[Tomasevic, Gregor; Mattiasson, Gustav; Wieloch, Tadeusz] Wallenberg Neurosci Ctr, Expt Brain Res Lab, SE-22184 Lund, Sweden; [Laurer, Helmut L.; McIntosh, Tracy K.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [van Steeg, Harry] Natl Inst Publ Hlth & Environm, Dept Carcinogenesis Mutagenesis & Genet, NL-3720 BA Bilthoven, Netherlands	Tomasevic, G (corresponding author), Wallenberg Neurosci Ctr, Expt Brain Res Lab, BMC A13, SE-22184 Lund, Sweden.	gregor.tomasevic@med.lu.se		Wieloch, Tadeusz/0000-0002-7669-2520	NIH from the National Institute of Neurological Disorders and Stroke [P50-NS08803]; NIH from the National Institute of General Medical Sciences [R01-GM34690]; Veterans AdministrationUS Department of Veterans Affairs [74R]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2008-3134]; EU through the European Stroke Network [201024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803] Funding Source: NIH RePORTER	This study was supported in part by NIH Grant No. P50-NS08803 from the National Institute of Neurological Disorders and Stroke, Grant No. R01-GM34690 from the National Institute of General Medical Sciences, a Veterans Administration Merit Review grant (74R), the Swedish Research Council (No. 2008-3134), and the EU 7th work program through the European Stroke Network (Grant No. 201024).	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Brooks PJ, 1998, MUTAT RES-DNA REPAIR, V408, P37, DOI 10.1016/S0921-8777(98)00018-4; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chen KH, 1998, NUCLEIC ACIDS RES, V26, P2001, DOI 10.1093/nar/26.8.2001; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; deVries A, 1996, SEMIN CANCER BIOL, V7, P229, DOI 10.1006/scbi.1996.0031; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Druzhyna N, 1998, MUTAT RES-DNA REPAIR, V409, P81, DOI 10.1016/S0921-8777(98)00042-1; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Franklin K.P.G., 1996, MOUSE BRAIN STEREOTA; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goosen N, 2010, DNA REPAIR, V9, P593, DOI 10.1016/j.dnarep.2010.02.015; GREWAL RP, 1991, MED HYPOTHESES, V34, P171, DOI 10.1016/0306-9877(91)90188-5; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Kisby GE, 1997, NEUROREPORT, V8, P1337, DOI 10.1097/00001756-199704140-00004; Kohji T, 1998, NEUROSCI LETT, V243, P133, DOI 10.1016/S0304-3940(98)00109-8; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; Lovell MA, 1999, J NEUROCHEM, V72, P771, DOI 10.1046/j.1471-4159.1999.0720771.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIMAKI T, 1989, ACTA NEUROL SCAND, V80, P136, DOI 10.1111/j.1600-0404.1989.tb03855.x; MIMAKI T, 1986, ANN NEUROL, V20, P70, DOI 10.1002/ana.410200112; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; Nakamura J, 1999, CANCER RES, V59, P2522; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; ROBBINS JH, 1991, BRAIN, V114, P1335, DOI 10.1093/brain/114.3.1335; ROBBINS JH, 1993, EUR NEUROL, V33, P188, DOI 10.1159/000116932; ROYTTA M, 1986, ACTA NEUROL SCAND, V73, P191; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SANCAR A, 1995, J BIOL CHEM, V270, P15915, DOI 10.1074/jbc.270.27.15915; Sancar A, 1995, ANNU REV GENET, V29, P69, DOI 10.1146/annurev.ge.29.120195.000441; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; WOOD RD, 1995, PHILOS T ROY SOC B, V347, P69, DOI 10.1098/rstb.1995.0011	61	14	14	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2012	116	6					1368	1378		10.3171/2012.2.JNS11888			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	945RP	WOS:000304294000033	22462511				2021-06-18	
J	Yang, Y; Li, L; Wang, YG; Fei, Z; Zhong, J; Wei, LZ; Long, QF; Liu, WP				Yang, Yang; Li, Ling; Wang, Yan-Gang; Fei, Zhou; Zhong, Jun; Wei, Li-Zhou; Long, Qian-Fa; Liu, Wei-Ping			Acute neuroprotective effects of extremely low-frequency electromagnetic fields after traumatic brain injury in rats	NEUROSCIENCE LETTERS			English	Article						TBI; ELFEF; Secondary insults	NEURONAL DAMAGE; VULNERABILITY; ISCHEMIA; PROTECTS; EXPOSURE; SEIZURE	Traumatic brain injury commonly has a result of a short window of opportunity between the period of initial brain injury and secondary brain injury, which provides protective strategies and can reduce damages of brain due to secondary brain injury. Previous studies have reported neuroprotective effects of extremely low-frequency electromagnetic fields. However, the effects of extremely low-frequency electromagnetic fields on neural damage after traumatic brain injury have not been reported yet. The present study aims to investigate effects of extremely low-frequency electromagnetic fields on neuroprotection after traumatic brain injury. Male Sprague-Dawley rats were used for the model of lateral fluid percussion injury, which were placed in non-electromagnetic fields and 15 Hz (Hertz) electromagnetic fields with intensities of 1 G (Gauss), 3 G and 5 G. At various time points (ranging from 0.5 to 30 h) after lateral fluid percussion injury, rats were treated with kainic acid (administered by intraperitoneal injection) to induce apoptosis in hippocampal cells. The results were as follows: (1) the expression of hypoxia-inducible factor-1 alpha was dramatically decreased during the neuroprotective time window. (2) The kainic acid-induced apoptosis in the hippocampus was significantly decreased in rats exposed to electromagnetic fields. (3) Electromagnetic fields exposure shortened the escape time in water maze test. (4) Electromagnetic fields exposure accelerated the recovery of the blood-brain barrier after brain injury. These findings revealed that extremely low-frequency electromagnetic fields significantly prolong the window of opportunity for brain protection and enhance the intensity of neuroprotection after traumatic brain injury. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Yang, Yang; Wang, Yan-Gang; Fei, Zhou; Zhong, Jun; Wei, Li-Zhou; Long, Qian-Fa; Liu, Wei-Ping] Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China; [Li, Ling] Fourth Mil Med Univ, Dept Neurol, Xijing Hosp, Xian 710032, Peoples R China	Liu, WP (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 17 W Changle Rd, Xian 710032, Peoples R China.	yangyang19800627@163.com; liuwp008@163.com	Long, Qianfa/F-6461-2017	Long, Qianfa/0000-0001-8848-9688			Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bernabo N, 2010, THERIOGENOLOGY, V73, P1293, DOI 10.1016/j.theriogenology.2009.12.010; Burda J, 2009, CELL MOL NEUROBIOL, V29, P821, DOI 10.1007/s10571-009-9363-9; Chang AY, 2005, EXP NEUROL, V195, P40, DOI 10.1016/j.expneurol.2004.09.014; Chen W, 2009, EXP NEUROL, V216, P7, DOI 10.1016/j.expneurol.2008.10.016; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Feeney D M, 1987, Brain Inj, V1, P27, DOI 10.3109/02699058709034441; Franzellitti S, 2010, MUTAT RES-FUND MOL M, V683, P35, DOI 10.1016/j.mrfmmm.2009.10.004; Grafstrom G, 2008, BRAIN RES BULL, V77, P257, DOI 10.1016/j.brainresbull.2008.08.004; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Gustavsson M, 2005, PEDIATR RES, V57, P305, DOI 10.1203/01.PDR.0000151122.58665.70; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Juutilainen J, 2005, BIOELECTROMAGNETICS, pS107, DOI 10.1002/bem.20125; KATO H, 1992, BRAIN RES BULL, V29, P395, DOI 10.1016/0361-9230(92)90074-8; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Li F., 2007, J MED COLL PLA, V22, P106; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo E, 2007, BIOELECTROMAGNETICS, V28, P608, DOI 10.1002/bem.20342; Najm IM, 1998, BRAIN RES, V810, P72, DOI 10.1016/S0006-8993(98)00886-5; Nakasono S, 2008, MUTAT RES-GEN TOX EN, V649, P187, DOI 10.1016/j.mrgentox.2007.09.003; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Strasak L, 2002, BIOELECTROCHEMISTRY, V55, P161, DOI 10.1016/S1567-5394(01)00152-9; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P837, DOI 10.1037/0735-7044.103.4.837; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	28	14	18	0	22	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 10	2012	516	1					15	20		10.1016/j.neulet.2012.03.022			6	Neurosciences	Neurosciences & Neurology	941LG	WOS:000303964100004	22484017				2021-06-18	
J	Conidi, FX				Conidi, Francis X.			Sports-Related Concussion: The Role of the Headache Specialist	HEADACHE			English	Article						headache; sports; concussion	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY; MILD; MECHANISM; FOOTBALL; RETURN; BLAST; PLAY; PREVENTION; MANAGEMENT	Over the past few years, sports-related concussion has received significant media attention making it one of the most, if not highest profile neurological disorder. Thirty-one states now have passed sports concussion laws, with 14 states pending legislation. Most concussions are managed by primary care physicians, ie, family practice trained sports medicine physicians and pediatricians. Symptoms are usually short lived and do not require treatment. The one exception is headache, which is usually present from onset and is often the last symptom to resolve. Headache is the most common reason for referral to a specialist, and therefore it is imperative that the headache specialist have at least a basic understanding of all aspects of sports concussion as they are likely going to be called upon to evaluate these athletes, especially the more refractory cases.	Florida Ctr Headache & Sports Neurol Neurol, Port St Lucie, FL 34952 USA	Conidi, FX (corresponding author), Florida Ctr Headache & Sports Neurol Neurol, 10377 S US Highway 1 Suite 104, Port St Lucie, FL 34952 USA.	fxneuro@bellsouth.net					Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Charles A, 2007, J HEADACHE PAIN, V8, P248, DOI 10.1007/s10194-007-0406-7; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Keightley M, 2011, J VIS EXP, V306, P79; Kelly JP, 1997, NEUROLOGY, V48, P581; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LESCOHIER I, 1993, PEDIATRICS, V91, P721; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mayers L, 2008, ARCH NEUROL-CHICAGO, V65, P1158, DOI 10.1001/archneur.65.9.1158; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zafonte R, 2011, JAMA-J AM MED ASSOC, V306, P79, DOI 10.1001/jama.2011.819	34	14	14	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAY	2012	52			1	SI		15	21		10.1111/j.1526-4610.2012.02138.x			7	Clinical Neurology	Neurosciences & Neurology	932WH	WOS:000303320700006	22540200				2021-06-18	
J	Eriksson, EA; Barletta, JF; Figueroa, BE; Bonnell, BW; Sloffer, CA; Vanderkolk, WE; McAllen, KJ; Ott, M				Eriksson, Evert A.; Barletta, Jeffrey F.; Figueroa, Bryan E.; Bonnell, Bruce W.; Sloffer, Chris A.; Vanderkolk, Wayne E.; McAllen, Karen J.; Ott, Mickey			The first 72 hours of brain tissue oxygenation predicts patient survival with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; pBtO(2); traumatic brain injury; brain tissue oxygenation; intracranial pressure	PO-2	BACKGROUND: Utilization of brain tissue oxygenation (pBtO(2)) is an important but controversial variable in the treatment of traumatic brain injury. We hypothesize that pBtO(2) values over the first 72 hours of monitoring are predictive of mortality. METHODS: Consecutive, adult patients with severe traumatic brain injury and pBtO(2) monitors were retrospectively identified. Time-indexed measurements of pBtO(2), cerebral perfusion pressure (CPP), and intracranial pressure (ICP) were collected, and average values over 4-hour blocks were determined. Patients were stratified according to survival, and repeated measures analysis of variance was used to compare pBtO(2), CPP, and ICP. The pBtO(2) threshold most predictive for survival was determined. RESULTS: There were 8,759 time-indexed data points in 32 patients. The mean age was 39 years +/- 16.5 years, injury severity score was 27.7 +/- 10.7, and Glasgow Coma Scale score was 6.6 +/- 3.4. Survival was 68%. Survivors consistently demonstrated higher pBtO(2) values compared with nonsurvivors including age as a covariate (F +/- 12.898, p < 0.001). Individual pBtO(2) was higher at the time points 8 hours, 12 hours, 20 hours to 44 hours, 52 hours to 60 hours, and 72 hours of monitoring (p < 0.05). There was no difference in ICP (F = 1.690, p = 0.204) and CPP (F = 0.764, p = 0.389) values between survivors and nonsurvivors including age as a covariate. Classification and regression tree analysis identified 29 mm Hg as the threshold at which pBtO(2) was most predictive for mortality. CONCLUSION: The first 72 hours of pBtO(2) neurologic monitoring predicts mortality. When the pBtO(2) monitor remains below 29 mm Hg in the first 72 hours of monitoring, mortality is increased. This study challenges the brain oxygenation threshold of 20 mm Hg that has been used conventionally and delineates a time for monitoring pBtO(2) that is predictive of outcome. (J Trauma. 2012;72: 1345-1349. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Eriksson, Evert A.] Med Univ S Carolina, Dept Gen Surg, Div Gen Trauma Surg, Charleston, SC 29425 USA; [Barletta, Jeffrey F.] Midwestern Univ, Coll Pharm, Dept Pharm Practice, Glendale, AZ USA; [Figueroa, Bryan E.] Spectrum Hlth, Dept Neurosurg, Grand Rapids, MI USA; [Bonnell, Bruce W.] Spectrum Hlth, Dept Surg Crit Care, GRMEC MSU Surg Crit Care, Grand Rapids, MI USA; [Sloffer, Chris A.] Bronson Neurosci Ctr, Dept Neurosurg, Kalamazoo, MI USA; [Vanderkolk, Wayne E.] St Marys Hlth Care, Dept Trauma, Grand Rapids, MI USA; [McAllen, Karen J.] Spectrum Hlth, Dept Pharm, Acute Crit Care, Grand Rapids, MI USA; [Ott, Mickey] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN USA	Eriksson, EA (corresponding author), Med Univ S Carolina, Dept Gen Surg, Div Gen Trauma Surg, 96 Jonathan Lucas St,Suite 420, Charleston, SC 29425 USA.	evsurgery@gmail.com	Barletta, Jeffrey F./B-2644-2013	Eriksson, Evert/0000-0002-4099-325X			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Dings J, 1998, NEUROL RES, V20, pS71; Eriksson EA, 2011, CLIN NEUROPHYSI 1118; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	19	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1345	1349		10.1097/TA.0b013e318249a0f4			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	944JD	WOS:000304195100043	22673264				2021-06-18	
J	Gioia, GA				Gioia, Gerard A.			Pediatric Assessment and Management of Concussions	PEDIATRIC ANNALS			English	Article							SPORT		[Gioia, Gerard A.] Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Safe Concuss Outcome Recovery & Educ SCORE Progra, Washington, DC USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Dept Pediat, Washington, DC 20052 USA; [Gioia, Gerard A.] George Washington Univ, Sch Med, Div Pediat Neuropsychol, Dept Psychiat & Behav Sci, Washington, DC 20052 USA	Gioia, GA (corresponding author), Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA.	ggioia@childrensnational.org					Centers for Disease Control and Prevention, 2007, NAT CTR INJ PREV CON; Gioia GA, 2006, HEADS BRAIN INJURY Y; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008	7	14	14	0	8	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481			PEDIATR ANN	Pediatr. Annu.	MAY	2012	41	5					198	203		10.3928/00904481-20120426-10			6	Pediatrics	Pediatrics	965FH	WOS:000305752000014	22587503				2021-06-18	
J	Mei-Dan, O; Carmont, MR; Monasterio, E				Mei-Dan, Omer; Carmont, Michael R.; Monasterio, Erik			The Epidemiology of Severe and Catastrophic Injuries in BASE Jumping	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						epidemiology; injury; BASE jumping; parachuting	PROFESSIONAL RUGBY UNION; EVENTS	Objective: To report the demographic characteristics, injury rate, severity, and morbidity in BASE jumping. Design: Cross-sectional survey. Setting: BASE jumping group meetings from 2006 to 2010. Participants: Heterogenic group of 102 International BASE jumpers. Assessment of Risk Factors: Injuries reported as function of jumps made, jumping days, age, experience, and sex. Main Outcome Measures: Incidence, severity, and type of injuries. Results: Responses from 68 subjects were available for analysis. The median number of jumps was estimated at 286 per respondent. The median time respondents had participated in BASE jumping was 5.8 years. There were 39 reported severe injuries sustained by 29 different jumpers. Nineteen thousand four hundred ninety-seven jumps were reported, resulting in 2 severe injuries per 1000 jumps (0.2% severe injury rate) or 2.6 severe injuries per 1000 jumping days. Forty-nine respondents (72%) had witnessed the death or serious injury of other participants in the sport. Twenty-four accidents (61%) involved the lower limbs, 8 (20%) the back/spine, 7 (18%) the chest wall, and 5 (13%) were a head injury. The mean Abbreviated Injury Score was 3.2 (range, 2-5). Fifteen (52%) of the 29 injured jumpers required 20 acute surgical interventions, which were mostly orthopedic related. There was a significant correlation between number of jumps made and injuries sustained (P < 0.05). Conclusions: BASE jumpers have an average of I severe injury for every 500 jumps. Most active BASE jumpers have witnessed death or severe injury of a participant and have experienced a "close call" incident.	[Mei-Dan, Omer] Univ Colorado, Sch Med, Dept Orthopaed, Div Sports Med, Aurora, CO 80045 USA; [Carmont, Michael R.] Princess Royal Hosp, Telford TF6 6TF, Shrops, England; [Monasterio, Erik] Hillmorton Hosp, Forens Psychiat Serv, Christchurch, New Zealand	Mei-Dan, O (corresponding author), Univ Colorado, Sch Med, Dept Orthopaed, Div Sports Med, Aurora, CO 80045 USA.	omer@extremegate.com					Agel J, 2010, CAN J SURG, V53, P319; Barrows TH, 2005, J EMERG MED, V28, P63, DOI 10.1016/j.jemermed.2004.07.008; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Di Giovanni N, WORLD BASE FATALITY; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Emery CA, 2010, JAMA-J AM MED ASSOC, V9, P2265; Fiore DC, 2001, BRIT J SPORT MED, V35, P235, DOI 10.1136/bjsm.35.4.235; International Parachuting Commission FAI Technical and Safety Committee, 2006 SAF REP; International Parachuting Commission FAI Technical and Safety Committee, 2009 SAF REP; Joint Committee on Injury Scaling, 1980, ABBR INJ SCAL AIS 19; Kim PTW, 2006, J TRAUMA, V60, P312, DOI 10.1097/01.ta.0000202714.31780.5f; Maland S, 2004, NORSK ANTROPOLOGISK, V1, P80; Monasterio E, 2008, NZ MED J, V4, P70; Monasterio M Erik, 2005, N Z Med J, V118, pU1249; Nathanson A, 2007, AM J SPORT MED, V35, P113, DOI 10.1177/0363546506293702; Nickel C, 2004, AM J SPORT MED, V32, P921, DOI 10.1177/0363546503262162; Paul S, 2009, USPA PARACHUTIST MAG, V50, P30; Soreide K, 2007, J TRAUMA, V62, P1113, DOI 10.1097/01.ta.0000239815.73858.88; Torjussen J, 2006, BRIT J SPORT MED, V40, P230, DOI 10.1136/bjsm.2005.021329; Westman A, 2008, BRIT J SPORT MED, V42, P431, DOI 10.1136/bjsm.2008.046565; Westman A, 2005, ACCIDENT ANAL PREV, V37, P1040, DOI 10.1016/j.aap.2005.06.002; Westman A, 2007, BRIT J SPORT MED, V41, P356, DOI 10.1136/bjsm.2006.031682	23	14	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2012	22	3					262	267		10.1097/JSM.0b013e31824bd53a			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	945OC	WOS:000304284900010	22450590				2021-06-18	
J	Newsome, MR; Scheibel, RS; Chu, ZL; Hunter, JV; Li, XQ; Wilde, EA; Lu, HZ; Wang, ZYJ; Lin, XD; Steinberg, JL; Vasquez, AC; Cook, L; Levin, HS				Newsome, Mary R.; Scheibel, Randall S.; Chu, Zili; Hunter, Jill V.; Li, Xiaoqi; Wilde, Elisabeth A.; Lu, Hanzhang; Wang, Zhiyue J.; Lin, Xiaodi; Steinberg, Joel L.; Vasquez, Ana C.; Cook, Lori; Levin, Harvey S.			The relationship of resting cerebral blood flow and brain activation during a social cognition task in adolescents with chronic moderate to severe traumatic brain injury: a preliminary investigation	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Cerebral blood flow; fMRI; Social cognition; Adolescents	PROBLEM-SOLVING SKILLS; CLOSED-HEAD-INJURY; EMOTION RECOGNITION; FMRI SIGNAL; 3.0 TESLA; CHILDREN; CHILDHOOD; PERFUSION; SELF; TERM	`Alterations in cerebrovascular function are evident acutely in moderate to severe traumatic brain injury (TBI), although less is known about their chronic effects. Adolescent and adult patients with moderate to severe TBI have been reported to demonstrate diffuse activation throughout the brain during functional magnetic resonance imaging (fMRI). Because fMRI is a measure related to blood flow, it is possible that any deficits in blood flow may alter activation. An arterial spin labeling (ASL) perfusion sequence was performed on seven adolescents with chronic moderate to severe TBI and seven typically developing (TD) adolescents during the same session in which they had performed a social cognition task during fMRI. In the TD group, prefrontal CBF was positively related to prefrontal activation and negatively related to non-prefrontal, posterior, brain activation. This relationship was not seen in the TBI group, who demonstrated a greater positive relationship between prefrontal CBF and non-prefrontal activation than the TD group. An analysis of CBF data independent of fMRI showed reduced CBF in the right non-prefrontal region (p < .055) in the TBI group. To understand any role reduced CBF may play in diffuse extra-activation, we then related the right non-prefrontal CBF to activation. CBF in the right non-prefrontal region in the TD group was positively associated with prefrontal activation, suggesting an interactive role of non-prefrontal and prefrontal blood flow throughout the right hemisphere in healthy brains. However, the TBI group demonstrated a positive association with activation constrained to the right non-prefrontal region. These data suggest a relationship between impaired non-prefrontal CBF and the presence of non-prefrontal extra-activation, where the region with more limited blood flow is associated with activation limited to that region. In a secondary analysis, pathology associated with hyperintensities on T2-weighted FLAIR imaging over the whole brain was related to whole brain activation, revealing a negative relationship between lesion volume and frontal activation, and a positive relationship between lesion volume and posterior activation. These preliminary data, albeit collected with small sample sizes, suggest that reduced non-prefrontal CBF, and possibly pathological tissue associated with T2-hyperintensities, may provide contributions to the diffuse, primarily posterior extra-activation observed in adolescents following moderate to severe TBI. Published by Elsevier Ltd on behalf of ISDN.	[Newsome, Mary R.] Univ Texas Houston Med Sch, Baylor Coll Med, Cognit Neurosci Lab, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [Newsome, Mary R.; Scheibel, Randall S.; Li, Xiaoqi; Wilde, Elisabeth A.; Lin, Xiaodi; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Traumat Brain Injury Ctr Excellence, Houston, TX USA; [Chu, Zili; Hunter, Jill V.; Wilde, Elisabeth A.; Wang, Zhiyue J.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Chu, Zili; Hunter, Jill V.; Wang, Zhiyue J.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lu, Hanzhang] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX USA; [Steinberg, Joel L.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat, Houston, TX USA; [Cook, Lori] Univ Texas Dallas, Ctr Brain Hlth, Richardson, TX 75083 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	Newsome, MR (corresponding author), Univ Texas Houston Med Sch, Baylor Coll Med, Cognit Neurosci Lab, Phys Med & Rehabil Alliance, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mnewsome@bcm.edu	Wang, Zhiyue J/L-3851-2014	Wang, Zhiyue J/0000-0002-5649-2900	National Institute Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS21889]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH084021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889, R01NS067015] Funding Source: NIH RePORTER	This work was supported by the National Institute Neurological Disorders and Stroke grant R01-NS21889 ("Neurobehavioral outcome of head injury in children," Harvey S. Levin, PI, R01 MH084021Normalized functional MRI in human brain disorders and R01 NS067015Modulation of brain activity by control of the inspired air, Hanzhang Lu, PI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We are grateful to the adolescents and their families for taking part in the research, to two anonymous reviewers for valuable comments to Jason Crowther, Ragini Yallampalli Sanyal, Zahra Kadivar, Joshua Cooper, and Vanessa Abadia for assistance in the preparation of the manuscript, and to the Michael E. DeBakey VA Medical Center and the South Central Mental Illness Research, Education, and Clinical Center (MIRECC) for providing facilities that allowed the analyses of the fMRI data.	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Agnati LF, 2010, BRAIN RES REV, V64, P137, DOI 10.1016/j.brainresrev.2010.03.003; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; Beer JS, 2006, BRAIN RES, V1079, P98, DOI 10.1016/j.brainres.2006.01.002; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brett M., 2002, NEUROIMAGE, V16; BRETT M, 2002, MNI BRAIN TALAIRACH; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Golay X, 1999, JMRI-J MAGN RESON IM, V9, P454, DOI 10.1002/(SICI)1522-2586(199903)9:3<454::AID-JMRI14>3.3.CO;2-2; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Graham D I, 2002, GREENFIELDS NEUROPAT, P823; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hendrikse J, 2003, MAGNET RESON MED, V50, P429, DOI 10.1002/mrm.10525; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lindauer U., 2010, FRONT NEUROENERGETIC, V2; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lu HZ, 2005, J MAGN RESON IMAGING, V22, P13, DOI 10.1002/jmri.20356; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; Magri C., 2011, MAGN RESON IMAGING; Markowitsch HJ, 2011, NEUROPSYCHOLOGIA, V49, P718, DOI 10.1016/j.neuropsychologia.2010.10.007; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; Mayer A.R., 2011, HUM BRAIN MAPP; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmer HS, 2010, J NEUROTRAUM, V27, P853, DOI 10.1089/neu.2009.1225; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2008, NEUROCRIT CARE, V9, P45, DOI 10.1007/s12028-007-9036-9; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D., 2011, WECHLSER ABBREVIATED; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Wong SBC, 2006, PROG BRAIN RES, V157, P173, DOI 10.1016/S0079-6123(06)57011-6; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	75	14	14	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	MAY	2012	30	3			SI		255	266		10.1016/j.ijdevneu.2011.10.008			12	Developmental Biology; Neurosciences	Developmental Biology; Neurosciences & Neurology	936XH	WOS:000303622800012	22120754	Green Accepted			2021-06-18	
J	Liu, CF; Bryson, CL; Burgess, JF; Sharp, N; Perkins, M; Maciejewski, ML				Liu, Chuan-Fen; Bryson, Chris L.; Burgess, James F., Jr.; Sharp, Nancy; Perkins, Mark; Maciejewski, Matthew L.			Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients	BMC HEALTH SERVICES RESEARCH			English	Article						Outpatient; Utilization; Primary care; Veterans; Medicare	TRAUMATIC BRAIN-INJURY; RISK ADJUSTMENT; HEALTH-CARE; SERVICES; AFFAIRS; BENEFICIARIES; IRAQ; WAR; PERFORMANCE; POPULATION	Background: More than half of veterans who use Veterans Health Administration (VA) care are also eligible for Medicare via disability or age, but no prior studies have examined variation in use of outpatient services by Medicare-eligible veterans across health system, type of care or time. Objectives: To examine differences in use of VA and Medicare outpatient services by disability-eligible or age-eligible veterans among veterans who used VA primary care services and were also eligible for Medicare. Methods: A retrospective cohort study of 4,704 disability-and 10,816 age-eligible veterans who used VA primary care services in fiscal year (FY) 2000. We tracked their outpatient utilization from FY2001 to FY2004 using VA administrative and Medicare claims data. We examined utilization differences for primary care, specialty care, and mental health outpatient visits using generalized estimating equations. Results: Among Medicare-eligible veterans who used VA primary care, disability-eligible veterans had more VA primary care visits (p < 0.001) and more VA specialty care visits (p < 0.001) than age-eligible veterans. They were more likely to have mental health visits in VA (p < 0.01) and Medicare-reimbursed visits (p < 0.01). Disability-eligible veterans also had more total (VA+Medicare) visits for primary care (p < 0.01) and specialty care (p < 0.01), controlling for patient characteristics. Conclusions: Greater use of primary care and specialty care visits by disability-eligible veterans is most likely related to greater health needs not captured by the patient characteristics we employed and eligibility for VA care at no cost. Outpatient care patterns of disability-eligible veterans may foreshadow care patterns of veterans returning from Afghanistan and Iraq wars, who are entering the system in growing numbers. This study provides an important baseline for future research assessing utilizations among returning veterans who use both VA and Medicare systems. Establishing effective care coordination protocols between VA and Medicare providers can help ensure efficient use of taxpayer resources and high quality care for disabled veterans.	[Liu, Chuan-Fen; Bryson, Chris L.; Sharp, Nancy; Perkins, Mark] VA Puget Sound Hlth Care Syst, NW Ctr Outcomes Res Older Adults, Seattle, WA 98101 USA; [Liu, Chuan-Fen; Sharp, Nancy] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Bryson, Chris L.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA; [Burgess, James F., Jr.] VA Boston Healthcare Syst, Ctr Org Leadership & Management Res, Boston, MA USA; [Burgess, James F., Jr.] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Maciejewski, Matthew L.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; [Maciejewski, Matthew L.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA	Liu, CF (corresponding author), VA Puget Sound Hlth Care Syst, NW Ctr Outcomes Res Older Adults, 1100 Olive Way,Suite 1400, Seattle, WA 98101 USA.	Chuan-Fen.Liu@va.gov		Burgess, James/0000-0002-6646-7071	Office of Research and Development, Health Services Research and Development Service, Department of Veterans AffairsUS Department of Veterans Affairs [IIR 04- 292]	This work was supported by the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs, project number IIR 04- 292. Drs. Liu, Bryson, Sharp, and Perkins are at the Northwest Center for Outcomes Research in Older Adults at the VA Puget Sound Health Care System, Seattle Division. Dr. Burgess is at the Center for Organization, Leadership and Management Research at the VA Boston Healthcare System. Dr. Maciejewski is at Center for Health Services Research in Primary Care at the Durham VA Medical Center and a VA Research Career Scientist. The views expressed herein are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs, the University of Washington, Boston University, or Duke University.	Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Atherly A, 2005, HEALTH CARE FINANC R, V26, P93; Bean-Mayberry Bevanne, 2004, J Am Med Womens Assoc (1972), V59, P192; BRIESACHER B, 2002, MEDICARES DISABLED B; Burgess JF, 2011, HEALTH ECON, V20, P239, DOI 10.1002/hec.1588; Chan L, 1999, ARCH PHYS MED REHAB, V80, P642, DOI 10.1016/S0003-9993(99)90166-1; Cubanski J, 2005, MEDICARE CHARTBOOK; Cubanski J, 2010, HEALTH AFFAIR, V29, P1725, DOI 10.1377/hlthaff.2009.0962; Davis MH, 1996, HEALTH CARE FINANC R, V17, P179; Fan VS, 2006, HEALTH SERV OUTCOME, V6, P21, DOI 10.1007/s10742-006-0004-1; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gleberg L, 2000, HEALTH SERV RES, V34, P30; Grabowski DC, 2009, HEALTH AFFAIR, V28, P136, DOI 10.1377/hlthaff.28.1.136; Hanson KW, 2003, HLTH AFF MILLWOOD S; Hoff RA, 2000, J BEHAV HEALTH SER R, V27, P98, DOI 10.1007/BF02287807; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hwang K., 2009, J DISABIL POLICY STU, V20, DOI [10.1177/1044207308315564, DOI 10.1177/1044207308315564]; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Iezzoni LI, 2003, ARCH INTERN MED, V163, P2085, DOI 10.1001/archinte.163.17.2085; Iezzoni LI, 2008, J HEALTH SERV RES PO, V13, P129, DOI 10.1258/jhsrp.2008.008034; Jha A, 2002, ARCH PHYS MED REHAB, V83, P1335, DOI 10.1053/apmr.2002.33986; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kazis LE, 1999, AM J MED QUAL, V14, P28, DOI 10.1177/106286069901400105; Kennedy Jae, 2007, J Health Hum Serv Adm, V30, P268; Kizer KW, 2000, MED CARE, V38, pS7; Liu CF, 2003, HEALTH SERV RES, V38, P1319, DOI 10.1111/1475-6773.00179; Liu Chuan-Fen, 2005, Health Res Policy Syst, V3, P5, DOI 10.1186/1478-4505-3-5; Liu CF, 2010, HEALTH SERV RES, V45, P1268, DOI 10.1111/j.1475-6773.2010.01123.x; Maciejewski ML, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-56; Maciejewski ML, 2005, HEALTH SERV RES, V40, P887, DOI 10.1111/j.1475-6773.2005.00390.x; Moon S, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-88; Morgan RO, 2009, AM J MANAG CARE, V15, pE1; O'Leary JE, 2007, HEALTH CARE FINANC R, V28, P57; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Perry M., 2003, ROLE HLTH COVERAGE P; Petersen LA, 1999, J GEN INTERN MED, V14, P318, DOI 10.1046/j.1525-1497.1999.00343.x; PETERSEN LA, 2010, HEALTH SERV RES, V45, P29; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Pope GC, 2000, HEALTH CARE FINANC R, V21, P93; Richardson T, 2003, REDISTRIBUTION EFFEC, P243; Riley GF, 2003, INQUIRY-J HEALTH CAR, V40, P71, DOI 10.5034/inquiryjrnl_40.1.71; Rosenbach M L, 1995, Health Care Financ Rev, V17, P29; Sales AE, 2003, MED CARE, V41, P753, DOI 10.1097/00005650-200306000-00008; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; StataCorp, 2009, STATA REF MAN REL 11, Patent No. College Station, TX; Veterans' Disability Benefits Commission, 2007, HON CALL DUT VAT DIS; Weeks WB, 2005, J RURAL HEALTH, V21, P167, DOI 10.1111/j.1748-0361.2005.tb00077.x; Weeks WB, 2005, J HEALTHC MANAG, V50, P95; Weeks WB, 2009, J RURAL HEALTH, V25, P62, DOI 10.1111/j.1748-0361.2009.00200.x; Wright SM, 1997, HEALTH SERV RES, V31, P739; Wright SM, 1999, MED CARE, V37, P529, DOI 10.1097/00005650-199906000-00002	55	14	14	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6963		BMC HEALTH SERV RES	BMC Health Serv. Res.	MAR 5	2012	12								51	10.1186/1472-6963-12-51			13	Health Care Sciences & Services	Health Care Sciences & Services	947DV	WOS:000304407900001	22390389	DOAJ Gold, Green Published			2021-06-18	
J	Auriat, AM; Klahr, AC; Silasi, G; MacLellan, CL; Penner, M; Clark, DL; Colbourne, F				Auriat, Angela M.; Klahr, Ana C.; Silasi, Gergely; MacLellan, Crystal L.; Penner, Mark; Clark, Darren L.; Colbourne, Frederick			Prolonged Hypothermia in Rat: A Safety Study Using Brain-Selective and Systemic Treatments	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article								Hypothermia is an effective neuroprotectant for cardiac arrest and perinatal ischemic injury. Hypothermia also improves outcome after traumatic brain injury and stroke. Although the ideal treatment parameters (duration, delay, and depth) are not fully delineated, prolonged cooling is usually more effective than shorter periods. There is the concern that extended cooling may be hazardous to brain plasticity and cause damage. In order to evaluate this possibility, we assessed the effects of 3 days of systemic hypothermia (32 degrees C) in rats subjected to a sham stroke surgery. There were no detrimental behavioral effects or signs of brain damage. As even longer cooling may be needed in some patients, we cooled (similar to 32 degrees C) the right hemisphere of rats for 3 or 21 days. Physiological variables, functional outcome, and measures of cell injury were examined. Focal brain cooling for 21 days modestly decreased heart rate, blood pressure, and core temperature. However, focal hypothermia did not affect subsequent behavior (e.g., spontaneous limb usage), cell morphology (e.g., dendritic arborization, ultrastructure), or cause cell death. In conclusion, prolonged mild hypothermia did not harm the brain of normal animals. Further research is now needed to evaluate whether such treatments affect plasticity after brain injury.	[Colbourne, Frederick] Univ Alberta, Dept Psychol, Frederick, AB T6G 2E9, Canada; Univ Alberta, Ctr Neurosci, Frederick, AB T6G 2E9, Canada	Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, P217 Biol Sci Bldg, Frederick, AB T6G 2E9, Canada.	fcolbour@ualberta.ca	Colbourne, Frederick/ABB-7774-2020	Colbourne, Frederick/0000-0002-9567-2082; Clark, Darren/0000-0002-9152-6539; Silasi, Gergely/0000-0003-1036-1304	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	Research supported primarily by a grant to F. Colbourne from the Canadian Institutes of Health Research (CIHR).	Auriat AM, 2010, BEHAV BRAIN RES, V214, P42, DOI 10.1016/j.bbr.2010.04.025; Boris-Moller F, 1998, MOL BRAIN RES, V63, P163, DOI 10.1016/S0169-328X(98)00286-1; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Clark DL, 2009, EXP NEUROL, V220, P391, DOI 10.1016/j.expneurol.2009.10.002; Clark DL, 2007, J CEREBR BLOOD F MET, V27, P115, DOI 10.1038/sj.jcbfm.9600327; Colbourne F, 1999, J NEUROSCI, V19, P4200; Corbett D, 1997, STROKE, V28, P2238, DOI 10.1161/01.STR.28.11.2238; Covaciu L, 2008, RESUSCITATION, V76, P83, DOI 10.1016/j.resuscitation.2007.07.002; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; DeBow S, 2003, METHODS, V30, P167, DOI 10.1016/S1046-2023(03)00080-X; Dong H, 2001, STROKE, V32, P788, DOI 10.1161/01.STR.32.3.788; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Kollmar R, 2010, STROKE, V41, P1684, DOI 10.1161/STROKEAHA.110.587758; Kuo JR, 2010, J TRAUMA, V69, P1467, DOI 10.1097/TA.0b013e3181f31b06; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; MacLellan CL, 2004, J CEREBR BLOOD F MET, V24, P432, DOI 10.1097/00004647-200404000-00008; MacLellan CL, 2009, J NEUROTRAUM, V26, P313, DOI 10.1089/neu.2008.0580; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Nakamura T, 1999, J NEUROSURG, V91, P114, DOI 10.3171/jns.1999.91.1.0114; Nguyen AP, 2008, CURR NEUROVASC RES, V5, P171, DOI 10.2174/156720208785425710; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Silasi G, 2012, J CEREBR BLOOD F MET, V32, P1525, DOI 10.1038/jcbfm.2012.38; Silasi G, 2011, J CEREBR BLOOD F MET, V31, P1725, DOI 10.1038/jcbfm.2011.25; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083	33	14	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	MAR 1	2012	2	1					37	43		10.1089/ther.2012.0005			7	Critical Care Medicine	General & Internal Medicine	V38PJ	WOS:000209355000009	24717136				2021-06-18	
J	Nout, YS; Beattie, MS; Bresnahan, JC				Nout, Yvette S.; Beattie, Michael S.; Bresnahan, Jacqueline C.			Severity of Locomotor and Cardiovascular Derangements after Experimental High-Thoracic Spinal Cord Injury Is Anesthesia Dependent in Rats	JOURNAL OF NEUROTRAUMA			English	Article						animal model; arterial blood pressure; chronic telemetry; critical care; hemodynamics; HR; hypotension; isofluorane; MAP; neurology; pentobarbital; recovery of function	ARTERIAL-BLOOD-PRESSURE; POST-TRAUMATIC ISCHEMIA; PENTOBARBITAL-ANESTHESIA; CONSCIOUS RATS; CRITICAL-CARE; BRAIN-INJURY; FLOW; TRANSECTION; RECOVERY; HEART	Anesthetics affect outcomes from central nervous system (CNS) injuries differently. This is the first study to show how two commonly used anesthetics affect continuously recorded hemodynamic parameters and locomotor recovery during a 2-week period after two levels of contusion spinal cord injury (SCI) in rats. We hypothesized that the level of cardiovascular depression and recovery of locomotor function would be dependent upon the anesthetic used during SCI. Thirty-two adult female rats were subjected to a sham, 25-mm or 50-mm SCI at T3-4 under pentobarbital or isoflurane anesthesia. Mean arterial pressure (MAP) and heart rate (HR) were telemetrically recorded before, during, and after SCI. Locomotor function recovered best in the 25-mm-injured isoflurane-anesthetized animals. There was no significant difference in locomotor recovery between the 25-mm-injured pentobarbital-anesthetized animals and the 50-mm-injured isoflurane-anesthetized animals. White matter sparing and extent of intermediolateral cell column loss appeared larger in animals anesthetized with pentobarbital, but this was not significant. There were no differential effects of anesthetics on HR and MAP before SCI, but recovery from anesthesia was significantly slower in pentobarbital-anesthetized animals. At the time of SCI, MAP was acutely elevated in the pentobarbital-anesthetized animals, whereas MAP decreased in the isoflurane-anesthetized animals. Hypotension occurred in the pentobarbital-anesthetized groups and in the 50-mm-injured isoflurane-anesthetized group. In pentobarbital-anesthetized animals, SCI resulted in acute elevation of HR, although HR remained low. Return of HR to baseline was much slower in the pentobarbital-anesthetized animals. Severe SCI at T3 produced significant chronic tachycardia that was injury severity dependent. Although some laboratories monitor blood pressure, HR, and other physiological variables during surgery for SCI, inherently few have monitored cardiovascular function during recovery. This study shows that anesthetics affect hemodynamic parameters differently, which in turn can affect functional outcome measures. This supports the need for a careful evaluation of cardiovascular and other physiological measures in experimental models of SCI. Choice of anesthetic should be an important consideration in experimental designs and data analyses.	[Nout, Yvette S.; Beattie, Michael S.; Bresnahan, Jacqueline C.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA	Nout, YS (corresponding author), Calif State Polytech Univ Pomona, Coll Agr, 3801 W Temple Ave, Pomona, CA 91768 USA.	yvette.nout@ucsf.edu			Craig H. Neilsen Foundation [124585]; Roman Reed Spinal Cord Injury Research Fund of California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038079] Funding Source: NIH RePORTER	This study was supported by the Craig H. Neilsen Foundation (124585) and Roman Reed Spinal Cord Injury Research Fund of California.	Baldridge BR, 2002, AM J PHYSIOL-REG I, V283, pR748, DOI 10.1152/ajpregu.00003.2002; Ball PA, 2001, SPINE, V26, pS27, DOI 10.1097/00007632-200112151-00006; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BONICA JJ, 1968, ANESTHESIOLOGY, V29, P793, DOI 10.1097/00000542-196807000-00023; Bravo G, 2002, NEUROSCI LETT, V319, P95, DOI 10.1016/S0304-3940(01)02557-5; Bravo G, 2001, LIFE SCI, V68, P1527, DOI 10.1016/S0024-3205(01)00952-3; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; COCHRANE KL, 1988, J AUTONOM NERV SYST, V22, P181, DOI 10.1016/0165-1838(88)90105-1; Fee JPH, 1997, DRUG SAFETY, V16, P157, DOI 10.2165/00002018-199716030-00002; Filho MBL, 2005, NEUROSCI LETT, V373, P165, DOI 10.1016/j.neulet.2004.10.019; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; GRISSOM TE, 1994, ANESTH ANALG, V79, P66; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GUHA A, 1989, STROKE, V20, P372, DOI 10.1161/01.STR.20.3.372; Guizar-Sahagun G, 2004, J NEUROTRAUM, V21, P1614, DOI 10.1089/0897715042441765; Ho SM, 2002, EXP NEUROL, V177, P494, DOI 10.1006/exnr.2002.8013; Iltis I, 2005, J MAGN RESON IMAGING, V22, P242, DOI 10.1002/jmri.20352; Kiyatkin EA, 2005, PHYSIOL BEHAV, V84, P563, DOI 10.1016/j.physbeh.2005.02.002; KOBRINE AI, 1976, J NEUROSURG, V44, P12, DOI 10.3171/jns.1976.44.1.0012; Kube S, 2003, J AM ANIM HOSP ASSOC, V39, P513, DOI 10.5326/0390513; Laird AS, 2006, J PHYSIOL-LONDON, V577, P539, DOI 10.1113/jphysiol.2006.116301; Leal P. R., 2007, Autonomic & Autacoid Pharmacology, V27, P167, DOI 10.1111/j.1474-8673.2007.00408.x; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; LEVINE S, 1960, AM J PATHOL, V36, P1; Maiorov DN, 1998, J NEUROTRAUM, V15, P365, DOI 10.1089/neu.1998.15.365; Mathias C.J., 1992, SPINAL CORD TRAUMA H, P435; Mayorov DN, 2001, J NEUROTRAUM, V18, P727, DOI 10.1089/089771501750357663; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; National Spinal Cord Injury Statistical Center, 2010, FACTS FIG GLANC; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; OSBORN JW, 1989, AM J PHYSIOL, V256, pR666; OSSENBERG FW, 1975, J PHARMACOL EXP THER, V194, P111; Rodenbaugh DW, 2003, BRAIN RES, V980, P242, DOI 10.1016/S0006-8993(03)02982-2; SALZMAN SK, 1990, BRAIN RES, V521, P33, DOI 10.1016/0006-8993(90)91521-H; Savci V, 1998, NEUROCHEM RES, V23, P733, DOI 10.1023/A:1022407409727; SEGEL LD, 1986, J CARDIOVASC PHARM, V8, P392, DOI 10.1097/00005344-198603000-00024; SENTER HJ, 1979, J NEUROSURG, V50, P198, DOI 10.3171/jns.1979.50.2.0198; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; STAUFFER JL, 1988, AM J VET RES, V49, P1143; Szczesny G, 2004, LAB ANIM-UK, V38, P64, DOI 10.1258/00236770460734416; TATOR CH, 1991, NEUROCHIRURGIE, V37, P291; Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007; Tei R, 2005, NEUROL RES, V27, P403, DOI 10.1179/016164105X25180; Torbati D, 1999, CRIT CARE MED, V27, P1878, DOI 10.1097/00003246-199909000-00028; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; VALEN G, 1993, J MOL CELL CARDIOL, V25, P31, DOI 10.1006/jmcc.1993.1005; Waibl H., 1973, TOPOGRAPHIE MEDULLA; WALKER LA, 1986, J PHARMACOL EXP THER, V236, P721; Wallis D, 1996, MICROSC RES TECHNIQ, V35, P69; WEBBER CL, 1979, RESP PHYSIOL, V38, P37, DOI 10.1016/0034-5687(79)90005-7; Weightman W., 2004, ANZCA SCI M PERTH AU; YAMADA KA, 1983, J PHARMACOL EXP THER, V226, P349; Yanagawa Y, 2001, J NEUROTRAUM, V18, P635, DOI 10.1089/089771501750291873; YOUNG W, 1982, J NEUROSURG, V56, P706, DOI 10.3171/jns.1982.56.5.0706; YOUNG W, 1993, RES P ARNMD, V71, P191	55	14	16	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					990	999		10.1089/neu.2011.1845			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900025	21545262	Green Published			2021-06-18	
J	Zhang, LL; Liu, J; Cheng, C; Yuan, Y; Yu, BY; Shen, AG; Yan, MJ				Zhang, Lili; Liu, Jie; Cheng, Chun; Yuan, Ying; Yu, Biyun; Shen, Aiguo; Yan, Meijuan			The Neuroprotective Effect of Pyrroloquinoline Quinone on Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						galactosidase beta-1; beta-1,4-galactosyltransferase I; 4-galactosyltransferase V; 4-galactosyltransferase N-acylsphingosine group; Morris water maze; pyrroloquinoline quinone; training; traumatic brain injury	CELL-ADHESION MOLECULE; REDOX MODULATORY SITE; OXIDATIVE STRESS; MOUSE-BRAIN; ALPHA-SYNUCLEIN; N-GLYCANS; PQQ; RAT; EXPRESSION; COENZYME	Pyrroloquinoline quinone (PQQ) is a water-soluble, anionic, quinonoid substance that has been established as an essential nutrient in animals. Owing to the inherent properties of PQQ as an antioxidant and redox modulator in various systems, PQQ is expected to be used in pharmacological applications in the near future. Although many recent studies have investigated its neuroprotective effects, the effect of PQQ on traumatic brain injury (TBI) has not been examined. In this study we employed Morris water maze (MWM) training, the results of which showed that PQQ led to improved behavioral performance in post-TBI animals. Considering that many experiments have suggested that beta-1,4-galactosyltransferase I (beta-1,4-GalT-I) and -V play significant roles in inflammation and the nervous system, in the present study we used Western blot analysis to study the effect of PQQ on the expression of beta-1,4-GalT-I and -V. We found apparent expression upregulation of beta-1,4-GalT-I and -V after PQQ was systemically administered. Lectin-fluorescent staining with RCA-I also revealed that PQQ contributed to expression upregulation of the galactosidase beta-1 (Gal beta-1), 4-galactosyltransferase N-acylsphingosine (4-GlcNAc) group in microglia and neurons of the cortex and hippocampal CA2 region. In summary, our experiment established that PQQ may play an important role in recovery post-TBI.	[Zhang, Lili; Liu, Jie; Cheng, Chun; Yuan, Ying; Yu, Biyun; Shen, Aiguo; Yan, Meijuan] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China	Yan, MJ (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	ymz_888@yahoo.com.cn			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070275, 31070723, 30970996]; College and University Natural Scientific Research Program of Jiangsu Province [08KJB320011]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Nantong University [10ZY013]	This work was supported by the National Nature Science Foundation of China (grant nos. 81070275, 31070723, and 30970996), the College and University Natural Scientific Research Program of Jiangsu Province (08KJB320011), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Natural Science Foundation of Nantong University (10ZY013).	AIZENMAN E, 1992, J NEUROSCI, V12, P2362; Alexandrova ML, 2005, FREE RADICAL BIO MED, V39, P297, DOI 10.1016/j.freeradbiomed.2005.04.017; Allendoerfer KL, 1999, DEV BIOL, V211, P208, DOI 10.1006/dbio.1999.9308; Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; GALLOP PM, 1989, TRENDS BIOCHEM SCI, V14, P343, DOI 10.1016/0968-0004(89)90169-2; GALLOP PM, 1993, CONNECT TISSUE RES, V29, P153, DOI 10.3109/03008209309014242; GALLOP PM, 1989, BIOCHEM BIOPH RES CO, V163, P755, DOI 10.1016/0006-291X(89)92287-0; HAMAGISHI Y, 1990, J PHARMACOL EXP THER, V255, P980; He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Kim J, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-20; Kobayashi M, 2006, BIOCHEM BIOPH RES CO, V349, P1139, DOI 10.1016/j.bbrc.2006.08.144; KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D; KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Mori R, 2004, AM J PATHOL, V164, P1303, DOI 10.1016/S0002-9440(10)63217-8; Nakamura N, 2001, J NEUROCHEM, V76, P29, DOI 10.1046/j.1471-4159.2001.00004.x; Niu SQ, 2008, J CHEM NEUROANAT, V35, P245, DOI 10.1016/j.jchemneu.2008.01.002; Nunome K, 2008, BIOL PHARM BULL, V31, P1321, DOI 10.1248/bpb.31.1321; Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005; PAZ MA, 1989, CONNECT TISSUE RES, V20, P251, DOI 10.3109/03008208909023895; Ronn LCB, 2000, INT J DEV NEUROSCI, V18, P193, DOI 10.1016/S0736-5748(99)00088-X; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; Sanchez RM, 2000, J NEUROSCI, V20, P2409; Scanlon JM, 1997, EUR J PHARMACOL, V326, P67, DOI 10.1016/S0014-2999(97)00137-4; Shen AG, 2002, NEUROSCI LETT, V327, P45, DOI 10.1016/S0304-3940(02)00381-6; TSUCHIDA T, 1993, J GASTROEN HEPATOL, V8, P342, DOI 10.1111/j.1440-1746.1993.tb01525.x; Venkatesh YP, 1997, GLYCOBIOLOGY, V7, P329, DOI 10.1093/glycob/7.3.329; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yan MJ, 2008, J MOL HISTOL, V39, P317, DOI 10.1007/s10735-008-9168-z; Zhang JJ, 2009, NEUROSCI LETT, V464, P165, DOI 10.1016/j.neulet.2009.08.037; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111; Zhou DP, 1998, BBA-GEN SUBJECTS, V1425, P204, DOI 10.1016/S0304-4165(98)00070-1; Zhu BQ, 2004, CARDIOVASC DRUG THER, V18, P421, DOI 10.1007/s10557-004-6219-x	37	14	17	1	16	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	5					851	864		10.1089/neu.2011.1882			14	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	907TZ	WOS:000301442900013	22040225	Green Published			2021-06-18	
J	Cicerone, KD				Cicerone, Keith D.			Facts, Theories, Values: Shaping the Course of Neurorehabilitation. The 60th John Stanley Coulter Memorial Lecture	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Evidence-based practice; Plasticity; Rehabilitation; Research	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; COGNITIVE REHABILITATION; NEUROSCIENCE; OUTPATIENTS; DEFICITS; NETWORK	Cicerone KD. Facts, theories, values: shaping the course of neurorehabilitation. The 60th John Stanley Coulter memorial lecture. Arch Phys Med Rehabil 2012;93: 188-91. We have seen an increase in efforts to establish evidence-based parameters for the practice of rehabilitation. This effort has been placed in a broader context involving the role of theory in advancing rehabilitation science, particularly in relation to specifying the active ingredients and mechanisms of action of interventions. One approach to cognitive rehabilitation is through direct training of cognitive functions such as working memory, which purportedly relies on mechanisms of neuroplasticity. However, this approach is also shown to be dependent on qualities of active attention and learning, feedback, effort, and motivation. Changes in functional and structural connectivity after cognitive rehabilitation suggest that the dynamic adjustment of task-related and resting activity in areas connected to the site of injury is the most likely mechanism underlying recovery of function. Behavioral interventions that address this process have emphasized the role of metacognitive and emotional regulation, as well as an appreciation of the role of subjective experience and beliefs, as central to the rehabilitation process. Our understanding of these processes occurs in the context of scientific values that influence judgments about how much evidence is sufficient to support the evaluation and acceptance of scientific results, including judgments about the effectiveness of rehabilitation. Evidence and theory are necessary to understanding rehabilitation, but we also need to acknowledge the values that directly and indirectly guide our research and practice.	JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ 08820 USA	Cicerone, KD (corresponding author), JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, 2048 Oak Tree Rd, Edison, NJ 08820 USA.	kcicerone@jfkhealth.org					Bach-y-Rita P, 2003, ARCH PHYS MED REHAB, V84, P1100, DOI 10.1016/S0003-9993(03)00312-5; Ben-Yishay Y., 2011, HDB HOLISTIC NEUROPS; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Corbetta M, 2008, COGNITIVE NEUROREHAB, P162; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Diller L, 2005, ARCH PHYS MED REHAB, V86, P1075, DOI 10.1016/j.apmr.2004.11.009; Douglas H., 2009, SCI POLICY VALUE FRE; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Evans JJ, 2009, J INT NEUROPSYCH SOC, V15, P112, DOI 10.1017/S1355617708090152; Fine C, 2006, MIND ITS OWN YOUR BR; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Halstead LS, 2001, ARCH PHYS MED REHAB, V82, P149, DOI 10.1053/apmr.2001.22207; Institute of Medicine, 2011, COGN REH THER TRAUM; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Lasagna L., HIPPOCRATIC OATH MOD; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Luria A. R., 1963, RESTORATION FUNCTION; Mahoney MJ., 1977, COGNITIVE THER RES, V1, P161, DOI [10.1007/BF01173636, DOI 10.1007/BF01173636]; Mangels JA, 2006, SOC COGN AFFECT NEUR, V1, P75, DOI 10.1093/scan/nsl013; Mercier H, 2011, BEHAV BRAIN SCI, V34, P57, DOI 10.1017/S0140525X10000968; Miller GA., 1960, PLANS STRUCTURE BEHA; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; SHALLICE T, 1981, BRIT MED BULL, V37, P187, DOI 10.1093/oxfordjournals.bmb.a071699; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Teuber H. L., 1964, FRONTAL GRANULAR COR, P410; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P203, DOI 10.1016/j.apmr.2007.11.026	42	14	14	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2012	93	2					188	191		10.1016/j.apmr.2011.12.003			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	893ER	WOS:000300338900002	22289226				2021-06-18	
J	Arenth, PM; Russell, KC; Scanlon, JM; Kessler, LJ; Ricker, JH				Arenth, Patricia M.; Russell, Kathryn C.; Scanlon, Joelle M.; Kessler, Lauren J.; Ricker, Joseph H.			Encoding and recognition after traumatic brain injury: Neuropsychological and functional magnetic resonance imaging findings	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Magnetic resonance imaging; Episodic memory; Encoding; Recognition	POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; MEMORY; PATTERNS; STRATEGY; MODERATE; ATLAS; FMRI	Although impairment of episodic memory is common after traumatic brain injury (TBI), the complex nature of human memory suggests the need to study more than recall alone. For this reason, we are presenting an extension with additional analyses of persons reported in a previous publication (Russell, Arenth, Scanlon, Kessler, & Ricker, 2011). We examined both the encoding and recognition components of an episodic memory paradigm containing both word and letter string blocks using functional magnetic resonance imaging (fMRI) and neuropsychological testing. This paradigm was completed by 12 persons with complicated mild, moderate, or severe TBI and 12 matched uninjured controls. Comparisons were made between groups and stimulus types. While task behavioral performance was not significantly different between groups, imaging results showed greater activation for the TBI group during the encoding portion of the task, while the control group exhibited more activation on the recognition portion. Observed areas of activation suggest that the TBI group may have used a less effective, but more automatic verbal strategy for encoding the nonpronounceable letter strings, while controls may have opted for more of a recognition-focused strategy. Group differences in California Verbal Learning Test-Second Edition (CVLT-II) performance supported these ideas, and further neuropsychological testing also suggested limitations in executive functioning in the TBI group that may have influenced performance. Implications for intervention are discussed.	[Ricker, Joseph H.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Arenth, Patricia M.; Russell, Kathryn C.; Ricker, Joseph H.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Ricker, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Kaufmann Med Bldg,Suite 201,3471 5th Ave, Pittsburgh, PA 15213 USA.	ricker@pitt.edu		Ricker, Joseph/0000-0003-3415-991X	National Institutes of Health-National Institute of Neurological Disorders and Stroke, NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048178-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048178] Funding Source: NIH RePORTER	This study was supported in part by a grant (National Institutes of Health-National Institute of Neurological Disorders and Stroke, NIH-NINDS R01NS048178-01) awarded to J. H. Ricker. The first two authors contributed equally to this manuscript. First authorship was determined randomly. The authors have no conflicts of interest to report. No competing financial interests exist.	Army Individual Test Battery, 1944, MAN DIR SCOR; Benton A., 1976, MULTILINGUAL APHASIA; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Delis DC, 2000, CALIFORNIA VERBAL LE; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Derogatis L. R., 1993, BSI BRIEF SYMPTOM IN; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Golden CJ, 2002, STROOP COLOR WORD TE; GRANT AD, 1948, J EXP PSYCHOL, V38, P404, DOI DOI 10.1037/H0059831; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Miller MB, 2009, NEUROIMAGE, V48, P625, DOI 10.1016/j.neuroimage.2009.06.033; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Nolde SF, 1998, NEUROREPORT, V9, P3509, DOI 10.1097/00001756-199810260-00032; Raskin S. A., 2000, NEUROPSYCHOLOGICAL M, P93; Raye CL, 2000, PSYCHOBIOLOGY, V28, P197; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Spreen O, 1969, NEUROSENSORY CTR COM; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Talairach J., 1988, COPLANAR STEREOTAXIC; Teasdale G, 1974, LANCET, V2, P480; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler, 1997, WAIS 3 WMS 3 TECHNIC; Wechsler D., 2001, WECHSLER TEST ADULT; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010	42	14	14	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	4					333	344		10.1080/13803395.2011.633896			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	935ZY	WOS:000303561900001	22360275	Green Accepted			2021-06-18	
J	Ayer, RE; Jafarian, N; Chen, WQ; Applegate, RL; Colohan, ART; Zhang, JH				Ayer, Robert E.; Jafarian, Nazanin; Chen, Wanqiu; Applegate, Richard L., II; Colohan, Austin R. T.; Zhang, John H.			Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						surgical brain injury; mucosal tolerance; neuroprotection; traumatic brain injury; mouse	MYELIN BASIC-PROTEIN; GROWTH-FACTOR-BETA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FOCAL CEREBRAL-ISCHEMIA; PPAR-GAMMA AGONIST; ORAL TOLERANCE; IN-VIVO; IMMUNOLOGICAL-TOLERANCE; MULTIPLE-SCLEROSIS; T-CELLS	Object. Intracranial surgery causes cortical injury from incisions, hemorrhage, retraction, and electrocautery. The term "surgical brain injury" (SBI) has been developed to categorize this injury inherent to the procedure. Neuroinflammation plays a significant role in SBI. Traditional antiinflammatory therapies are often limited by their immunosuppressive side effects and poor CNS penetration. This study uses mucosal tolerance to develop an immune system that is tolerant to brain myelin basic protein (MBP) so that inflammation can be suppressed in a timely and site-specific manner following surgical disruption of the blood-brain barrier. Methods. A standard SBI model using CD57 mice was used. Nasopharyngeal mucosa was exposed to vehicle, ovalbumin, or MBP to develop mucosal tolerance to these antigens. Immunological tolerance to MBP was confirmed in vivo through hypersensitivity testing. Neurological scores, cerebral edema, and interleukin (IL)-1 beta and transforming growth factor (TGF)-beta 1 cytokine levels were measured 48 hours postoperatively. Results. Hypersensitivity testing confirmed the development of immune tolerance to MBP. Myelin basic protein-tolerant mice demonstrated reduced neurological injury, less cerebral edema, decreased levels of IL-1 beta, and increased levels of TGF beta 1 following SBI. Conclusions. Developing preoperative immunological tolerance to brain antigens through mucosal tolerance provides neuroprotection, reduces brain edema, and modulates neuroinflammation following SBI. (DOI: 10.3171/2011.8.JNS11883)	[Ayer, Robert E.; Colohan, Austin R. T.; Zhang, John H.] Loma Linda Univ, Med Ctr, Dept Neurosurg, Loma Linda, CA 92354 USA; [Jafarian, Nazanin; Applegate, Richard L., II; Zhang, John H.] Loma Linda Univ, Med Ctr, Dept Anesthesiol, Loma Linda, CA 92354 USA; [Chen, Wanqiu; Zhang, John H.] Loma Linda Univ, Med Ctr, Dept Physiol & Pharmacol, Loma Linda, CA 92354 USA	Zhang, JH (corresponding author), Loma Linda Univ, Med Ctr, Dept Neurosurg, 11234 Anderson St,Room 2562B, Loma Linda, CA 92354 USA.	johnzhang3910@yahoo.com	Applegate, Richard/Y-1249-2019	Applegate, Richard/0000-0002-1454-4549	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS053407]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053407] Funding Source: NIH RePORTER	This study was supported by a grant (No. NS053407) awarded by NIH to Dr. Zhang.	Allahtavakoli M, 2009, BRAIN RES, V1271, P121, DOI 10.1016/j.brainres.2009.03.040; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Becker KJ, 2005, J CEREBR BLOOD F MET, V25, P1634, DOI 10.1038/sj.jcbfm.9600160; Becker KJ, 1997, P NATL ACAD SCI USA, V94, P10873, DOI 10.1073/pnas.94.20.10873; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Chen YH, 1996, P NATL ACAD SCI USA, V93, P388, DOI 10.1073/pnas.93.1.388; Clark SR, 2008, J CEREBR BLOOD F MET, V28, P387, DOI 10.1038/sj.jcbfm.9600537; Esiri MM, 2007, J NEUROIMMUNOL, V184, P4, DOI 10.1016/j.jneuroim.2006.11.013; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Gee JM, 2008, STROKE, V39, P1575, DOI 10.1161/STROKEAHA.107.501486; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Jadhav V, 2008, FRONT BIOSCI, V13, P3793, DOI 10.2741/2968; Jadhav V, 2007, J NEUROSURG, V106, P680, DOI 10.3171/jns.2007.106.4.680; Jadhav V, 2007, SURG NEUROL, V67, P15, DOI 10.1016/j.surneu.2006.07.014; KHOURY SJ, 1990, CELL IMMUNOL, V131, P302, DOI 10.1016/0008-8749(90)90256-Q; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Li Khan W, 2005, Neurosurg Focus, V19, pE1; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maciunas Robert J, 2006, Clin Neurosurg, V53, P267; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021; Peron JPS, 2010, J NEUROIMMUNOL, V227, P10, DOI 10.1016/j.jneuroim.2010.06.002; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Rozet I, 2007, ANESTHESIOLOGY, V107, P697, DOI 10.1097/01.anes.0000286980.92759.94; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Solaroglu I, 2009, NEUROL RES, V31, P167, DOI 10.1179/174313209X393582; Tharin S, 2007, NEUROSURGERY, V60, P185, DOI 10.1227/01.0000255386.95464.52; TRENTHAM DE, 1993, SCIENCE, V261, P1727, DOI 10.1126/science.8378772; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yong VW, 2010, NEUROLOGY, V74, pS9, DOI 10.1212/WNL.0b013e3181c97d04; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	49	14	17	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JAN	2012	116	1					246	253		10.3171/2011.8.JNS11883			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	869XJ	WOS:000298632500039	22017304	Green Accepted			2021-06-18	
J	Bulson, R; Jun, W; Hayes, J				Bulson, Ryan; Jun, Weon; Hayes, John			Visual symptomatology and referral patterns for Operation Iraqi Freedom and Operation Enduring Freedom veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Neurobehavioral Symptom Inventory; Operation Enduring Freedom; Operation Iraqi Freedom; postconcussive syndrome; postdeployment; posttraumatic stress disorder; symptom; traumatic brain injury; veteran; vision	POLYTRAUMA; IMPAIRMENT; HEALTH	Advances in protective armor technology and changes in the "patterns of war" have created a population of Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) veterans with traumatic brain injury (TBI) that provide a unique challenge to Department of Veterans Affairs (VA) healthcare practitioners. The purpose of the study was to determine the frequency of symptomatic ocular and visual sequelae of TBI in OIF/OEF veterans at the Portland VA Medical Center, a Polytrauma Support Clinic Team site. A retrospective analysis of 100 OIF/OEF veterans with TBI was conducted to determine the prevalence of ocular and visual complaints. Referral patterns were also investigated. Visual symptoms were reported in approximately 50% of veterans with TBI. Loss of consciousness, but not number of deployments or number of blast exposures, was found to have a statistically significant association with severity of reported visual symptoms. The most commonly reported symptoms included blurred vision (67%), photosensitivity (50%), and accommodative problems (40%). Visual symptoms of OIF/OEF veterans at the Portland VA Medical Center are reported at slightly lower rates than similar studies conducted at the Palo Alto and Edward Hines Jr VA facilities.	[Bulson, Ryan; Jun, Weon] Portland Dept Vet Affairs Med Ctr, Portland, OR USA; [Bulson, Ryan; Jun, Weon; Hayes, John] Univ Pacific, Coll Optometry, Forest Grove, OR USA	Bulson, R (corresponding author), 2043 Coll Way,Jefferson Hall, Forest Grove, OR 97116 USA.	ryan.bulson@pacificu.edu					Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Han ME, 2007, ACQUIRED BRAIN INJUR, P146; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kapoor N, 2009, MED MANAGEMENT ADULT, P407; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; *VET HLTH ADM, 2008, PERF TRAUM BRAIN INJ	20	14	14	0	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1075	1082		10.1682/JRRD.2011.02.0017			8	Rehabilitation	Rehabilitation	149EZ	WOS:000319303100010	23341280	Bronze			2021-06-18	
J	Capo-Aponte, JE; Tarbett, AK; Urosevich, TG; Temme, LA; Sanghera, NK; Kalich, ME				Capo-Aponte, Jose E.; Tarbett, Aaron K.; Urosevich, Thomas G.; Temme, Leonard A.; Sanghera, Navjit K.; Kalich, Melvyn E.			Effectiveness of computerized oculomotor vision screening in a military population: Pilot study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						accommodation; binocular vision; computerized oculomotor vision screening; mTBI; oculomotor function; TBI; traumatic brain injury; vergence; version; vision	TRAUMATIC BRAIN-INJURY; RANDOMIZED CLINICAL-TRIAL; POLYTRAUMA NETWORK SITE; DUAL SENSORY IMPAIRMENT; CONVERGENCE INSUFFICIENCY; VISUAL FUNCTION; REHABILITATION; RECOVERY; DYSFUNCTION; REDUCTION	The prevalence of oculomotor dysfunctions associated with blast-induced mild traumatic brain injury (mTBI) in warfighters has increased as a consequence of recent conflicts. This study evaluated the effectiveness of computerized oculomotor vision screening (COVS) in a military population. Oculomotor functions were assessed with COVS and by conventional methods in 20 U.S. military personnel with and 20 without mTBI. The validity of COVS was determined by Pearson correlation and Bland-Altman method or the kappa coefficient. The repeatability of the COVS was assessed with the coefficient of repeatability or the kappa coefficient. The results showed that COVS had high sensitivity and specificity for screening near oculomotor functions. Overall, the COVS showed excellent validity and repeatability for assessing near lateral and vertical phorias, Worth 4 Dot, and fixation, as well as pursuit and saccadic eye movements. Despite the strong Pearson correlation, the Bland-Altman analysis identified minor to moderate discrepancies for both positive and negative fusional vergence and their associated recovery as well as for the monocular accommodative facility measurements. This study demonstrated that non-eye-care professionals may be able to use the COVS as a tool to efficiently screen oculomotor functions in a military population with or without mTBI.	[Capo-Aponte, Jose E.; Urosevich, Thomas G.; Temme, Leonard A.; Kalich, Melvyn E.] USA, Visual Sci Branch, Aeromed Res Lab, Ft Rucker, AL 36362 USA; [Tarbett, Aaron K.] Walter Reed Natl Mil Med Ctr, Optometry Serv, Bethesda, MD USA; [Sanghera, Navjit K.] Illinois Coll Optometry, Clin Serv, Chicago, IL USA	Capo-Aponte, JE (corresponding author), USA, Visual Sci Branch, Aeromed Res Lab, Ft Rucker, AL 36362 USA.	jose.capoaponte@us.army.mil			USAARL	This material is based on work supported with resources and funding from the USAARL.	Armitage P., 1971, STAT METHODS MED RES; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOMAN DK, 1985, AM J OPTOM PHYS OPT, V62, P222; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Carlson NB, 2004, CLIN PROCEDURES OCUL; Chan Y H, 2003, Singapore Med J, V44, P614; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Ciuffreda KJ, 2007, JBO, V18, P72; Ciuffreda KJ, 2001, VISUAL VESTIBULAR CO, P77; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; COOPER J, 1983, AM J OPTOM PHYS OPT, V60, P982; COOPER J, 1988, AM J OPTOM PHYS OPT, V65, P455; COOPER J, 1978, AM J OPTOM PHYS OPT, V55, P599; COOPER J, 1987, AM J OPTOM PHYS OPT, V64, P430; COOPER J, 1980, American Journal of Optometry and Physiological Optics, V57, P205; Cooper J., 1998, PRACT OPTOM, P6; Cooper J, 2009, OPTOMETRY, V80, P481, DOI 10.1016/j.optm.2009.05.007; DAUM KM, 1984, AM J OPTOM PHYS OPT, V61, P184; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; FELDMAN J, 1980, J AM OPTOM ASSOC, V51, P767; FELDMAN JM, 1989, OPTOMETRY VISION SCI, V66, P375, DOI 10.1097/00006324-198906000-00007; Feldman JM, 1993, BIN VIS EYE MUS SURG, V8, P23; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goss DA, 1991, CLIN PROCEDURES OPTO, P716; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Maples W C, 1988, J Am Optom Assoc, V59, P549; McAllister T., 2005, TXB TRAUMATIC BRAIN, P279; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Scheiman M, 2002, OPTOMETRY VISION SCI, V79, P151, DOI 10.1097/00006324-200203000-00009; Serna A, 2011, J AAPOS, V15, P140, DOI 10.1016/j.jaapos.2010.11.023; Sheedy JE., 1983, VERGENCE EYE MOVEMEN; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff IB, 2000, PHYS MED REHABILITAT; Vandiver VL, 2003, J HEAD TRAUMA REHAB, V18, P457, DOI 10.1097/00001199-200309000-00007; Zasler ND, 2000, REHABILITATION INJUR, P207	50	14	14	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	9					1377	1398		10.1682/JRRD.2011.07.0128			22	Rehabilitation	Rehabilitation	149FB	WOS:000319303300009	23408219	Bronze			2021-06-18	
J	Chen, BJ; Zuberi, M; Borgens, RB; Cho, Y				Chen, Bojun; Zuberi, Mahvash; Borgens, Richard Ben; Cho, Youngnam			Affinity for, and localization of, PEG-functionalized silica nanoparticles to sites of damage in an ex vivo spinal cord injury model	JOURNAL OF BIOLOGICAL ENGINEERING			English	Article							POLYETHYLENE-GLYCOL; MOLECULAR REPAIR; MEMBRANE-FUSION; NERVE MEMBRANES; POLOXAMER 188; RECOVERY; CELLS; NEUROPROTECTION; BRAIN; TOXICITY	Background: Traumatic spinal cord injury (SCI) leads to serious neurological and functional deficits through a chain of pathophysiological events. At the molecular level, progressive damage is initially revealed by collapse of plasma membrane organization and integrity produced by breaches. Consequently, the loss of its role as a semi-permeable barrier that generally mediates the regulation and transport of ions and molecules eventually results in cell death. In previous studies, we have demonstrated the functional recovery of compromised plasma membranes can be induced by the application of the hydrophilic polymer polyethylene glycol (PEG) after both spinal and brain trauma in adult rats and guinea pigs. Additionally, efforts have been directed towards a nanoparticle-based PEG application. The in vivo and ex vivo applications of PEG-decorated silica nanoparticles following CNS injury were able to effectively and efficiently enhance resealing of damaged cell membranes. Results: The possibility for selectivity of tetramethyl rhodamine-dextran (TMR) dye-doped, PEG-functionalized silica nanoparticles (TMR-PSiNPs) to damaged spinal cord was evaluated using an ex vivo model of guinea pig SCI. Crushed and nearby undamaged spinal cord tissues exhibited an obvious difference in both the imbibement and accumulation of the TMR-PSiNPs, revealing selective labeling of compression-injured tissues. Conclusions: These data show that appropriately functionalized nanoparticles can be an efficient means to both 1.) carry drugs, and 2.) apply membrane repair agents where they are needed in focally damaged nervous tissue.	[Chen, Bojun; Zuberi, Mahvash; Borgens, Richard Ben; Cho, Youngnam] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA; [Borgens, Richard Ben] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Cho, Youngnam] Natl Canc Ctr, Mol Imaging & Therapy Branch, Goyang Si 410769, Gyeonggi Do, South Korea	Borgens, RB (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA.	cpr@purdue.edu			General Funds from the CPR (State of Indiana) [HB 1440]	We would gratefully like to thank Debra Bohnert for her expert surgery and handling of these whole animal experiments. We appreciate the excellent illustrations and graphics by Michel Schweinsberg, and the administrative assistance of Jennifer Danaher for manuscript preparation. This research was supported by General Funds from the CPR (State of Indiana HB 1440), and an endowment from Mrs. Mari Hulman George.	Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; BITTNER GD, 1986, BRAIN RES, V367, P351, DOI 10.1016/0006-8993(86)91617-3; Borgens RB, 2000, FASEB J, V14, P27; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Borgens RB, 2002, J EXP BIOL, V205, P1; Borgens RB, 2001, NEUROSURGERY, V49, P370, DOI 10.1097/00006123-200108000-00021; Borgens RB, 2001, J NEUROSCI RES, V66, P1179; Borgens RB, 1989, ELECTRIC FIELDS VERT, P117; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Brent J, 2001, DRUGS, V61, P979, DOI 10.2165/00003495-200161070-00006; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Caravati EM, 2005, CLIN TOXICOL, V43, P327, DOI 10.1080/07313820500184971; Cho Y, 2008, SMALL, V4, P1676, DOI 10.1002/smll.200800838; Cho Y, 2008, NANOMEDICINE-UK, V3, P507, DOI 10.2217/17435889.3.4.507; Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028; Cho Youngnam, 2010, J Biol Eng, V4, P2, DOI 10.1186/1754-1611-4-2; Cho Y, 2010, J NEUROSCI RES, V88, P1433, DOI 10.1002/jnr.22309; Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162; Cole A, 2005, TOXICOL IN VITRO, V19, P215, DOI 10.1016/j.tiv.2004.10.007; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Detlof MR, 2006, J NEUROL PHYS THER, V30, P201; Detloff MR, 2005, J NEUROTRAUM, V22, P1219; Ditor DS, 2007, J NEUROSCI RES, V85, P1458, DOI 10.1002/jnr.21283; Donaldson J, 2002, NEUROSURGERY, V50, P147, DOI 10.1097/00006123-200201000-00023; Fang N, 2001, BIOMACROMOLECULES, V2, P1161, DOI 10.1021/bm015548s; Fang N, CHITOSAN INDUCED RES; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Koob Andrew O, 2008, J Biol Eng, V2, P9, DOI 10.1186/1754-1611-2-9; Koob AO, 2006, J NEUROSCI RES, V83, P1558, DOI 10.1002/jnr.20837; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Laverty PH, 2004, J NEUROTRAUM, V21, P1767, DOI 10.1089/neu.2004.21.1767; Lee RC, 2002, ANN NY ACAD SCI, V961, P271, DOI 10.1111/j.1749-6632.2002.tb03100.x; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lentz BR, 2007, EUR BIOPHYS J BIOPHY, V36, P315, DOI 10.1007/s00249-006-0097-z; Liu-Snyder P, 2007, J EXP BIOL, V210, P1455, DOI 10.1242/jeb.02756; Luo J, 2004, J NEUROTRAUM, V21, P994, DOI 10.1089/0897715041651097; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; MACDONALD RI, 1985, BIOCHEMISTRY-US, V24, P4058, DOI 10.1021/bi00336a039; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; Merchant FA, 1998, J SURG RES, V74, P131, DOI 10.1006/jsre.1997.5252; Mohanraj V. J., 2006, Tropical Journal of Pharmaceutical Research, V5, P561; Palmer JS, 1998, J UROLOGY, V159, P2136, DOI 10.1016/S0022-5347(01)63295-6; Quinlan JG, 2006, NEUROMUSCULAR DISORD, V16, P855, DOI 10.1016/j.nmd.2006.09.016; SCHNEIDERMAN S, 1979, SOMAT CELL GENET, V5, P263, DOI 10.1007/BF01539165; Schwab Jan M., 2001, Trends in Neurosciences, V24, P437, DOI 10.1016/S0166-2236(00)01893-2; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi YZ, 2010, NAT NANOTECHNOL, V5, P80, DOI [10.1038/NNANO.2009.303, 10.1038/nnano.2009.303]; SZABO G, 1982, CYTOMETRY, V3, P59, DOI 10.1002/cyto.990030113; Webster R, 2009, MILESTONES DRUG THER, P127, DOI 10.1007/978-3-7643-8679-5_8; Weinreb G, 2007, BIOPHYS J, V92, P4012, DOI 10.1529/biophysj.106.090043; Zuberi Mahvash, 2008, J Biol Eng, V2, P17, DOI 10.1186/1754-1611-2-17	54	14	16	1	13	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1754-1611			J BIOL ENG	J. Biol. Eng.		2012	6	1							18	10.1186/1754-1611-6-18			10	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	V31TG	WOS:000208905300018	22979980	DOAJ Gold, Green Published			2021-06-18	
J	Deng, ZH; Yan, GT; Wang, LH; Zhang, JY; Xue, H; Zhang, K				Deng, Zi-Hui, Jr.; Yan, Guang-Tao; Wang, Lu-Huan; Zhang, Jin-Ying; Xue, Hui; Zhang, Kai			Leptin relieves intestinal ischemia/reperfusion injury by promoting ERK1/2 phosphorylation and the NO signaling pathway	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Leptin; nitric oxide; intestinal I/R injury; mucosal repair; oxygen radicals	CYTOSOLIC PHOSPHOLIPASE A(2); ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; ETHANOL CYTOTOXICITY; PROTECTION; PROSTAGLANDIN; ACTIVATION; EXPRESSION; CYTOKINE; PROTEIN	BACKGROUND: Recently, research has indicated that leptin plays a protective role in traumatic brain and liver injury. We studied the protective effect of leptin on intestinal I/R injury and examined its mechanism by using mice intestinal I/R model and murine peritoneal macrophage hypoxia/reoxygenation (H/R) injury model. METHODS: Leptin was intraperitoneally administrated at 45 minutes after ischemia, then reperfusion for two hours. Cells were treated with different concentrations of leptin at three hours after hypoxia, then reoxygenation for six hours. Mice intestines were harvested for histopathologic properties. The malondialdehyde, nitric oxide (NO), interleukin-6, and total antioxidative capacity were detected according to respective assay kit. Phosphorylated extracellular regulated kinase1/2 (p-ERK1/2) and phosphorylated cytosolic phospholipase A(2) (p-cPLA(2)) were determined by Western blot assay. RESULTS: Here, we show that leptin reduced intestinal histologic alterations, malondialdehyde and interleukin-6 levels but increased the endogenous leptin expression and NO production in the intestines. Leptin also increased the NO and total antioxidative capacity levels in cells. We further demonstrated that leptin markedly activated ERK1/2 in the intestines and activated ERK1/2 and cPLA(2) in the cells. Moreover, the protective effect of leptin against intestinal I/R injury and elevated NO production was attenuated by blocking the ERK1/2 pathway. CONCLUSIONS: These data demonstrate that leptin ameliorated intestinal I/R and peritoneal macrophage H/R injury by enhancing ERK1/2 phosphorylation and promoting the NO production signaling pathway. (J Trauma. 2012;72: 143-149. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Deng, Zi-Hui, Jr.; Yan, Guang-Tao; Wang, Lu-Huan; Zhang, Jin-Ying; Xue, Hui; Zhang, Kai] Gen Hosp PLA, Biochem Res Lab, Basic Med Inst, Beijing, Peoples R China	Yan, GT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Biochem Res Lab, Basic Med Inst, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yan301@263.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670821]	Supported by the National Natural Science Foundation of China (No. 30670821).	BARATTA M, 2002, MED SCI MONITOR, V8, P282; Breithaupt-Faloppa AC, 2009, SHOCK, V32, P55, DOI 10.1097/SHK.0b013e31818bb7a1; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Fernandez-Riejos P, 2008, CLIN EXP IMMUNOL, V151, P505, DOI 10.1111/j.1365-2249.2007.03563.x; Hacioglu A, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-37; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Lanas A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2465; Lin J, 2004, PEPTIDES, V25, P2187, DOI 10.1016/j.peptides.2004.08.006; Lin Ji, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P1254; Mahapatra SK, 2009, TOXICOL MECH METHOD, V19, P100, DOI 10.1080/15376510802255184; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Sainz N, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/784343; Slomiany BL, 2008, J PHYSIOL PHARMACOL, V59, P301; Slomiany B. L., 2009, Inflammopharmacology, V17, P6, DOI 10.1007/s10787-008-8037-4; Slomiany BL, 2005, J PHYSIOL PHARMACOL, V56, P531; Sukhotnik I, 2009, PEDIATR RES, V66, P648, DOI 10.1203/PDR.0b013e3181be9f84; Yan GT, 2009, EUR J PHARMACOL, V616, P244, DOI 10.1016/j.ejphar.2009.06.039; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	21	14	15	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					143	149		10.1097/TA.0b013e3182222f67			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	898IF	WOS:000300734800030	21857261				2021-06-18	
J	Dethier, M; Blairy, S; Rosenberg, H; McDonald, S				Dethier, Marie; Blairy, Sylvie; Rosenberg, Hannah; McDonald, Skye			Spontaneous and posed emotional facial expressions following severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Posed facial expression; Spontaneous facial expression; Traumatic brain injury; Nonverbal communication; Interpersonal functioning	PERSONALITY-ASSESSMENT INVENTORY; FOCAL CEREBRAL-LESIONS; CLOSED-HEAD-INJURY; NEUROPSYCHIATRIC DISORDERS; DIFFERENT MEDIA; RECOGNITION; IMPAIRMENT; DEFICITS; PERCEPTION; SEQUELAE	The current study aimed to test the intensity of spontaneous emotional expressions and the accuracy of posed emotional expressions in patients with severe traumatic brain injury (TBI). Method: Twenty-three participants with TBI and 27 matched control participants were asked to relate personal angry, happy, and sad events (spontaneous expressivity) and to pose angry, happy, and sad expressions in response to a photo or word cue (posed expressivity). Their emotional facial expressions were coded via judges' ratings. Results: Participants with TBI had less intense sad expressions when relating a sad event than did control participants. No group difference emerged in the happy and angry events, the latter possibly due to differentially low interrater reliability for anger ratings. Participants with TBI were impaired in their ability to pose sad emotions. Conclusions: These preliminary findings suggest that patients with TBI are impaired at expressing sad expressions either spontaneously or deliberately. This may reflect difficulties in the initiation or suppression of facial expression as well as an impaired semantic knowledge of the facial configuration of sad expression.	[Dethier, Marie] Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, B-4000 Liege, Belgium; [Rosenberg, Hannah; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Dethier, M (corresponding author), Univ Liege, Dept Psychol Cognit & Behav, Unit Cognit & Behav Clin Psychol, Blvd Rectorat 3,B33, B-4000 Liege, Belgium.	marie.dethier@ulg.ac	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094	University of LiegeUniversity of Liege	This study was supported by a research grant from the University of Liege. This study is the result of collaboration between the University of New South Wales and the University of Liege and was conducted while the first author was visiting the University of New South Wales. The authors wish to thank all the people with traumatic brain injuries and community controls who willingly donated their time to participate in this research. We also would like to acknowledge the contribution of Rebekah Randall who assisted with data collection and entry.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; Angrilli A, 1999, NEUROREPORT, V10, P1741, DOI 10.1097/00001756-199906030-00021; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Blanchard J. J., 1998, HDB SOCIAL FUNCTIONI; BOROD JC, 1990, J COMMUN DISORD, V23, P247, DOI 10.1016/0021-9924(90)90003-H; Brozgold A Z, 1998, Appl Neuropsychol, V5, P15, DOI 10.1207/s15324826an0501_2; Calvo MG, 2010, VIS COGN, V18, P1274, DOI 10.1080/13506285.2010.481867; Camras L. A., 1994, NATURE EMOTION, P347; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Dethier M., 2011, EMOTIONAL REGU UNPUB; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; Elfenbein HA, 2010, J PERS SOC PSYCHOL, V98, P301, DOI 10.1037/a0017766; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; Fridlund A. J., 1994, HUMAN FACIAL EXPRESS; FRIDLUND AJ, 1991, J PERS SOC PSYCHOL, V60, P229, DOI 10.1037/0022-3514.60.2.229; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kornreich C, 2002, ALCOHOL ALCOHOLISM, V37, P394, DOI 10.1093/alcalc/37.4.394; Lovibond SH, 1995, MANUAL DEPRESSION AN; Matsumoto D., 1988, JAPANESE CAUCASIAN F; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Park S, 2008, SCHIZOPHRENIA BULL, V34, P698, DOI 10.1093/schbul/sbn048; Parkinson B, 2005, PERS SOC PSYCHOL REV, V9, P278, DOI 10.1207/s15327957pspr0904_1; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schneider W., 2002, E PRIME USERS GUIDE; Shamay-Tsoory SG, 2007, EMPATHY IN MENTAL ILLNESS, P89, DOI 10.1017/CBO9780511543753.007; Smith M C, 1996, J Int Neuropsychol Soc, V2, P383; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; StatSoft I, 2011, STATISTICA VERS 10 D; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Wechsler D, 1997, WAIS 3 ADM SCORING M; WEDDELL RA, 1988, NEUROPSYCHOLOGIA, V26, P373, DOI 10.1016/0028-3932(88)90092-9; WEDDELL RA, 1994, BRAIN COGNITION, V25, P161, DOI 10.1006/brcg.1994.1029; WEDDELL RA, 1990, NEUROPSYCHOLOGIA, V28, P49, DOI 10.1016/0028-3932(90)90085-3; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183	65	14	16	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	9					936	947		10.1080/13803395.2012.702734			12	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	030YB	WOS:000310604900005	22827155				2021-06-18	
J	Luo, YH; Li, ZX; Chen, HX				Luo, Yunhua; Li, Zhaoxia; Chen, Hongxi			Finite-element study of cerebrospinal fluid in mitigating closed head injuries	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						Cerebrospinal fluid; intracranial pressure; closed head injury; mild impact; finite-element modeling	DYNAMIC-RESPONSE; LARGE-DEFORMATION; BRAIN-INJURY; IMPACT; SIMULATION; MODEL; BIOMECHANICS; HELMETS; FUTURE; STATE	The mechanism of cerebrospinal fluid in mitigating closed head injuries caused by mild impacts was investigated by finite-element modeling. Three biomechanical models were constructed. In these models, cerebrospinal fluid was considered as a soft solid material, an inviscid fluid without intracranial pressure, and an inviscid fluid with normal intracranial pressure, respectively, while other conditions such as the finite-element mesh, the impact, and the boundary conditions were kept the same. The recently developed nearest nodes finite-element method was adopted to deal with large deformations in brain tissue. Results obtained from the numerical studies showed that cerebrospinal fluid was able to remarkably reduce the maximum peak strains, especially the shear strains induced by impacts and transmitted to the brain. Cerebrospinal fluid with intracranial pressure was able to further buffer relative oscillations between the skull and the brain.	[Luo, Yunhua; Li, Zhaoxia; Chen, Hongxi] Univ Manitoba, Fac Engn, Dept Mech & Mfg Engn, Winnipeg, MB R3T 5V6, Canada	Luo, YH (corresponding author), Univ Manitoba, Fac Engn, Dept Mech & Mfg Engn, Winnipeg, MB R3T 5V6, Canada.	Yunhua.Luo@ad.umanitoba.ca		Luo, Yunhua/0000-0003-0271-1319	Manitoba Health Research Council (MHRC)	The reported research has been supported by an Establishment Grant awarded to the first author by the Manitoba Health Research Council (MHRC), which is gratefully acknowledged.	Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Al-Bsharat A, 1999, INTRACRANIAL PRESSUR, V42, P113; BISHOP PJ, 1993, ASTM STP, V1212, P175; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; CHAN HS, 1974, P 18 STAPP CAR CRASH, P557; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; Dassios G, 1998, COMPUT MECH, V21, P382, DOI 10.1007/s004660050315; Davis J, 1988, WAVE PROPAGATION SOL; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Faul M., 2010, TECHNICAL REPORT; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; Gong SW, 2008, IEEE T BIO-MED ENG, V55, P1226, DOI 10.1109/TBME.2007.912431; Halabieh O, 2008, LECT NOTES COMPUT SC, V5104, P107, DOI 10.1007/978-3-540-70521-5_12; HARDY CH, 1973, J APPL MECH-T ASME, V40, P838, DOI 10.1115/1.3423172; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Haw-Ming Huang, 1995, Chinese Journal of Medical and Biological Engineering, V15, P127; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Jirousek O., 2006, Proceedings of the Fourth IASTED International Conference on Biomechanics; Jirousek O, 2005, VDI BER, V1899, P463; KHALIL TB, 1982, P 26 STAPP CAR CRASH, P87; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; KLEIVEN S, 2002, THESIS ROYAL I TECHN; KORMI K, 1992, J BIOMED ENG, V14, P203, DOI 10.1016/0141-5425(92)90053-N; Kuijpers A. H. W. M., 1996, Computer Methods in Biomechanics and Biomedical Engineering, P207; Leestma J, 1987, FORENSIC NEUROPATHOL; Lovas A., 1995, Acta Technica Academiae Scientiarum Hungaricae, V107, P83; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Luo Y, 2008, ADV THEORETICAL APPL, V1, P225; Luo Y, 2008, ADV THEOR APPL MECH, V1, P31; Luo YH, 2008, FINITE ELEM ANAL DES, V44, P797, DOI 10.1016/j.finel.2008.06.004; Luo YH, 2008, INT J SOLIDS STRUCT, V45, P5074, DOI 10.1016/j.ijsolstr.2008.05.006; Luo YH, 2010, INT J NUMER METH BIO, V26, P1125, DOI 10.1002/cnm.1184; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MCELHANEY JH, 1973, HUMAN IMPACT RESPONS, P85; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; McGuine T, 1997, AM SOC TEST MATER, V1305, P83, DOI 10.1520/STP11775S; Mehta B. V., 1996, Computer Methods in Biomechanics and Biomedical Engineering, P217; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mota A, 2003, COMPUT MECH, V31, P115, DOI 10.1007/s00466-002-0398-8; Nahum A. M., 1977, P 21 STAPP CAR CRASH; NICKELL RE, 1974, J ENG IND-T ASME, V96, P490, DOI 10.1115/1.3438355; Ogden R.W., 1984, NONLINEAR ELASTIC DE; PFEFFERBAUM A, 1986, J COMPUT ASSIST TOMO, V10, P571, DOI 10.1097/00004728-198607000-00004; Prange M, 2001, BIOENG C, V50, P833; Rousseau P, 2009, J ASTM INT, V6, P11; Ruan J, 1995, P 1995 BIOENG C JUN, P319; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Ruan S-J, 2004, CHIN J BIOMED ENG, V23, P52; Shealy JE, 2009, AM SOC TEST MATER, V1510, P39, DOI 10.1520/STP47464S; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Sussman T, COMPUT STRUCT, V26, P357; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Ueno JW, 1991, 2 DIMENSIONAL FINITE, V126, P121; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yang KH, 2003, INT J VEHICLE DES, V32, P116, DOI 10.1504/IJVD.2003.003240; Zhang JY, 2007, PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007, P605; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1; Zou H, 2008, INT J CRASHWORTHINES, V13, P337, DOI 10.1080/13588260801943047	70	14	15	1	14	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.		2012	226	H7					499	509		10.1177/0954411912445729			11	Engineering, Biomedical	Engineering	012AL	WOS:000309207600001	22913097				2021-06-18	
J	Malakouti, A; Sookplung, P; Siriussawakul, A; Philip, S; Bailey, N; Brown, M; Farver, K; Zimmerman, JJ; Bell, MJ; Vavilala, MS				Malakouti, Amin; Sookplung, Pimwan; Siriussawakul, Arunotai; Philip, Shaji; Bailey, Natalia; Brown, Marcia; Farver, Katie; Zimmerman, Jerry J.; Bell, Michael J.; Vavilala, Monica S.			Nutrition support and deficiencies in children with severe traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						nutrition; head injury; children; outcome; delivery; risk factor	MEASURED ENERGY-EXPENDITURE; ENTERAL NUTRITION; GUIDELINES	Objective: Adequate nutrition support is considered important to recovery after pediatric traumatic brain injury. The 2003 Pediatric Guidelines recommend initiation of nutrition within 72 hrs after traumatic brain injury. We examined our local experience with nutritional support in severe pediatric traumatic brain injury patients (cases) and non-traumatic brain injury patients (controls). Design: A retrospective review of pediatric patients with severe traumatic brain injury over an 11-yr period (1997-2009) and without traumatic brain injury over a 3-yr period (2007-2009). Setting: Level I pediatric trauma center pediatric intensive care unit. Patients: Patients with severe pediatric traumatic brain injury (age <15 yrs, Glasgow Coma Scale score of <9) and admitted to the pediatric intensive care unit for >7 days and patients without traumatic brain injury (age <15 yrs, head Abbreviated Injury Scale score of 0) and admitted to pediatric intensive care unit. Interventions: None. Measurements and Main Results: Data from 101 severe traumatic brain injury and 92 non-traumatic brain injury patients were analyzed. Traumatic brain injury patients: All received enteral nutrition while 13 (12%) also received parenteral nutrition. Nutrition was started 53 +/- 20 hrs (range 12-162) after pediatric intensive care unit admission. Fifty patients (52%) received nutrition within the first 48 hrs, and 83 (82%) received nutrition support within the first 72 hrs. Caloric and protein intakes were 47% and 40% of the goals on pediatric intensive care unit day 7 and 76% and 70% of the goals on pediatric intensive care unit day 14. Caloric and protein goals were met in 26% +/- 16% and 18% +/- 19% of pediatric intensive care unit stay, respectively. Patients whose intake met nutritional goals on pediatric intensive care unit day 7 had earlier initiation of nutrition support at admission than patients who never met the goals (calorie goal met vs. unmet by day 7, 44 +/- 23 hrs vs. 67 +/- 31 hrs; p < .001; protein goal met vs. unmet by day 7, 43 +/- 17 hrs vs. 65 +/- 29 hrs; p = .001). Patients gained 0.6% +/- 11% weight by pediatric intensive care unit day 7 and lost 7% +/- 11% weight by pediatric intensive care unit day 14. Non-traumatic brain injury patients: The time to start of nutrition for the non-traumatic brain injury group was earlier only for patients with isolated orthopedic injuries (24 +/- 6 hrs; p = .02). The average caloric and protein intakes were less for the traumatic brain injury (n = 20) group (caloric 52% +/- 16% of goal and protein 42% +/- 18% of goal) than for the non-traumatic brain injury (n = 23) group (65% +/- 11% of goal and protein 51% +/- 20% of goal; both p < .01) for pediatric intensive care unit days 0-7. For pediatric intensive care unit days 8-14, there was no difference in average caloric (82% +/- 22% vs. 79% +/- 18% of goal) or protein (77% +/- 6% vs. 79% +/- 7% of goal) between the traumatic brain injury (n = 12) and non-traumatic brain injury (n = 10) groups. Addition of a nutritionist was associated with earlier time to nutrition start (p = .02). Conclusions: Nutritional support was initiated in most patients within 72 hrs of pediatric intensive care unit admission. Although daily caloric and protein goals were not achieved in the first 2 wks of pediatric intensive care unit stay and nutritional deficiencies were common, earlier start of nutritional support was associated with involvement of a nutritionist and with meeting both caloric and protein goals by pediatric intensive care unit day 7. (Pediatr Crit Care Med 2012; 13:e18-e24)	[Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Malakouti, Amin; Sookplung, Pimwan; Siriussawakul, Arunotai; Brown, Marcia] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Zimmerman, Jerry J.; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Bailey, Natalia; Farver, Katie] Univ Washington, Dept Nutr Sci, Seattle, WA 98195 USA; [Philip, Shaji] Columbia Univ, Dept Internal Med, New York, NY USA; [Zimmerman, Jerry J.] Seattle Childrens Hosp, Div Pediat Crit Care Med, Seattle, WA USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA	Vavilala, MS (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	vavilala@u.washington.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS68; [Anonymous], 1989, REC DIET ALL; ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN J Parenter Enteral Nutr, V26, p1SA; Braga JM, 2006, J AM DIET ASSOC, V106, P281, DOI 10.1016/j.jada.2005.10.039; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; Darbar A, 2001, NUTRITION, V17, P71, DOI 10.1016/S0899-9007(00)00476-7; de Lucas C, 2000, J PEDIATR GASTR NUTR, V30, P175, DOI 10.1097/00005176-200002000-00015; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Havalad Suresh, 2006, Nutr Clin Pract, V21, P175, DOI 10.1177/0115426506021002175; KLEINMAN RE, 1998, PEDIAT NUTR HDB; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Langlois JA, 2001, TRAUMATIC BRAIN INJU; Loan T, 1999, NUTRITION, V15, P809; MATTHEWS DSF, 1995, ARCH DIS CHILD, V72, P507, DOI 10.1136/adc.72.6.507; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Meert KL, 2004, CHEST, V126, P872, DOI 10.1378/chest.126.3.872; Mehta NM, 2009, JPEN-PARENTER ENTER, V33, P260, DOI 10.1177/0148607109333114; MOORE R, 1989, J TRAUMA, V29, P1633, DOI 10.1097/00005373-198912000-00007; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; PHILLIPS R, 1987, J NEUROSURG, V67, P846, DOI 10.3171/jns.1987.67.6.0846; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Rogers EJ, 2003, NUTRITION, V19, P865, DOI 10.1016/S0899-9007(03)00170-9	24	14	17	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1					E18	E24		10.1097/PCC.0b013e31820aba1f			7	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	875YT	WOS:000299073000004	21317678				2021-06-18	
J	Morali, G; Montes, P; Gonzalez-Burgos, I; Velazquez-Zamora, DA; Cervantes, M				Morali, Gabriela; Montes, Pedro; Gonzalez-Burgos, Ignacio; Velazquez-Zamora, Dulce A.; Cervantes, Miguel			Cytoarchitectural characteristics of hippocampal CA1 pyramidal neurons of rats, four months after global cerebral ischemia and progesterone treatment	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Progesterone neuroprotection; global cerebral ischemia; hippocampal pyramidal neurons cytoarchitecture; dendritic spines; rat	NEUROTROPHIC FACTOR EXPRESSION; DENDRITIC SPINE DENSITY; TRAUMATIC BRAIN-INJURY; MORRIS WATER MAZE; LONG-TERM; ARTERY OCCLUSION; MOLECULAR-MECHANISMS; FUNCTIONAL DEFICITS; MEMORY DEFICITS; CARDIAC-ARREST	Purpose: To analyze the cytoarchitectural characteristics of the remaining pyramidal neurons in the hippocampal CA1 subfield of rats, four months after global cerebral ischemia (GCI) and progesterone treatment. Methods: Dendritic arborization, and density and shape of the dendritic spines of CA1 pyramidal neurons in brains of intact rats, or rats submitted 120 days earlier to GCI and treatment with progesterone (8 mg/kg) or its vehicle, at 15 min, and 2, 6, 24, 48, and 72 h after the onset of reperfusion, were analyzed in samples processed by a modified Golgi method. Results: Few impregnated CA1 pyramidal neurons were identified in the ischemic vehicle-treated rats, with a short apical dendrite devoid of bifurcations and dendritic spines. In contrast, the remaining CA1 pyramidal neurons sampled from ischemic progesterone-treated rats showed sinuously branched dendrites with similar number of bifurcations and whole density of spines, and higher proportional density of mushroom spines than those in the intact group. Conclusions: These cytoarchitectural characteristics may underlie the long-term preservation of place learning and memory functions seen after ischemia and progesterone neuroprotective treatment, possibly compensating for the severe reduction in neuronal population.	[Morali, Gabriela; Montes, Pedro] UMAE Hosp Especialidades, Ctr Med Nacl Siglo XXI, Unidad Invest Med Farmacol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Gonzalez-Burgos, Ignacio; Velazquez-Zamora, Dulce A.] Univ Guadalajara, Ctr Invest Biomed Occidente, Div Neurociencias, Lab Psicobiol,IMSS, Guadalajara 44430, Jalisco, Mexico; [Gonzalez-Burgos, Ignacio; Velazquez-Zamora, Dulce A.] Univ Guadalajara, CUCBA, Guadalajara 44430, Jalisco, Mexico; [Cervantes, Miguel] Univ Michoacana SNH, Fac Ciencias Med & Biol Dr Ignacio Chavez, Morelia, Michoacan, Mexico	Morali, G (corresponding author), UMAE Hosp Especialidades, Ctr Med Nacl Siglo XXI, Unidad Invest Med Farmacol, Inst Mexicano Seguro Social, Mexico City, DF, Mexico.	gmorali@hotmail.com	Morali, Gabriela/AAH-8014-2020	Montes, Pedro/0000-0003-1630-5047	Instituto Mexicano del Seguro Social, MEXICO [2006/1A/I/029, FIS/IMSS/PROT/196]	Partially supported by Instituto Mexicano del Seguro Social, MEXICO (2006/1A/I/029; FIS/IMSS/PROT/196).	Arvidsson A, 2001, NEUROSCIENCE, V106, P27, DOI 10.1016/S0306-4522(01)00268-8; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Cai WY, 2008, NEUROPHARMACOLOGY, V55, P127, DOI 10.1016/j.neuropharm.2008.04.023; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Crepel V, 2003, J CELL MOL MED, V7, P401, DOI 10.1111/j.1582-4934.2003.tb00242.x; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Gonzalez SL, 2009, CELL MOL NEUROBIOL, V29, P27, DOI 10.1007/s10571-008-9291-0; Gonzalez-Burgos I, 2007, NEUROSCI LETT, V423, P162, DOI 10.1016/j.neulet.2007.06.050; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; GONZALEZBURGOS I, 1992, BIOTECH HISTOCHEM, V67, P288, DOI 10.3109/10520299209110037; GOULD E, 1990, J NEUROSCI, V10, P1286; HARRIS KM, 1989, HIPPOCAMPUS NEW VIST, P17; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Jourdain P, 2002, J NEUROSCI, V22, P3108, DOI 10.1523/JNEUROSCI.22-08-03108.2002; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; KOGURE K, 1988, NEUROCHEM PATHOL, V9, P145; Kovalenko T, 2006, HIPPOCAMPUS, V16, P814, DOI 10.1002/hipo.20211; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Letechipia-Vallejo G, 2007, J PINEAL RES, V42, P139, DOI 10.1111/j.1600-079X.2006.00395.x; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Morali G, 2011, RESTOR NEUROL NEUROS, V29, P1, DOI 10.3233/RNN-2011-0571; MUDRICK LA, 1989, BRAIN RES, V493, P179, DOI 10.1016/0006-8993(89)91014-7; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; OLSEN GM, 1994, BEHAV NEUROSCI, V108, P681, DOI 10.1037/0735-7044.108.4.681; Olvera-Cortes E, 2002, BRAIN RES BULL, V58, P261, DOI 10.1016/S0361-9230(02)00769-4; ONODERA H, 1990, NEUROSCIENCE, V38, P125, DOI 10.1016/0306-4522(90)90379-I; Plamondon H, 2008, PHYSIOL BEHAV, V95, P492, DOI 10.1016/j.physbeh.2008.07.020; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Roberge MC, 2008, BEHAV BRAIN RES, V187, P123, DOI 10.1016/j.bbr.2007.09.002; Ruan YW, 2006, NEUROSCIENCE, V140, P191, DOI 10.1016/j.neuroscience.2006.01.039; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schmidt-Kastner R, 2001, MOL BRAIN RES, V92, P157, DOI 10.1016/S0169-328X(01)00157-7; Silva AJ, 1998, NEUROBIOL LEARN MEM, V70, P44, DOI 10.1006/nlme.1998.3837; Skibo GG, 2010, VITAM HORM, V82, P107, DOI 10.1016/S0083-6729(10)82006-0; Spruston N, 2007, HIPPOCAMPUS BOOK, P133; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Velazquez-Zamora D.A., 2011, BRAIN RES IN PRESS; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	63	14	14	1	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	1					1	8		10.3233/RNN-2011-0605			8	Neurosciences	Neurosciences & Neurology	901HN	WOS:000300955300001	22377905				2021-06-18	
J	Patel, TP; Ventre, SC; Meaney, DF				Patel, Tapan P.; Ventre, Scott C.; Meaney, David F.			Dynamic Changes in Neural Circuit Topology Following Mild Mechanical Injury In Vitro	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Concussions; Calcium indicator dyes; Stochastic integrate-and-fire model; Neural network; Synchrony; Cluster; Excitatory tone; Calpain	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; CORTICAL-NEURONS; CULTURED NEURONS; CELL-CULTURES; SHEAR STRAIN; MODEL; CALCIUM; NETWORKS; STRETCH	Despite its enormous incidence, mild traumatic brain injury is not well understood. One aspect that needs more definition is how the mechanical energy during injury affects neural circuit function. Recent developments in cellular imaging probes provide an opportunity to assess the dynamic state of neural networks with single-cell resolution. In this article, we developed imaging methods to assess the state of dissociated cortical networks exposed to mild injury. We estimated the imaging conditions needed to achieve accurate measures of network properties, and applied these methodologies to evaluate if mild mechanical injury to cortical neurons produces graded changes to either spontaneous network activity or altered network topology. We found that modest injury produced a transient increase in calcium activity that dissipated within 1 h after injury. Alternatively, moderate mechanical injury produced immediate disruption in network synchrony, loss in excitatory tone, and increased modular topology. A calcium-activated neutral protease (calpain) was a key intermediary in these changes; blocking calpain activation restored the network nearly completely to its pre-injury state. Together, these findings show a more complex change in neural circuit behavior than previously reported for mild mechanical injury, and highlight at least one important early mechanism responsible for these changes.	[Patel, Tapan P.; Ventre, Scott C.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, 220 S 33rd St, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Patel, Tapan/0000-0001-8959-6645; Meaney, David/0000-0002-0954-4122	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department of DefenseUnited States Department of Defense [W911NF-10-1-0526]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176] Funding Source: NIH RePORTER	We thank Dr. Pallab Singh (University of Pennsylvania) for providing NMDAR and AMPAR activation profiles and for helpful discussions that led to the development of our stochastic integrate-and-fire model. Funding for this work was provided from the National Institutes of Health and the Department of Defense (W911NF-10-1-0526).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bialonski S, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051909; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; Breskin I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188102; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Dev KK, 1996, J NEUROCHEM, V67, P2609; DiFiori JP, 2010, CURR SPORT MED REP, V9, P35, DOI 10.1249/JSR.0b013e3181caba67; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fetcho JR, 1998, HISTOCHEM J, V30, P153, DOI 10.1023/A:1003243302777; French DA, 2006, J COMPUT NEUROSCI, V21, P227, DOI 10.1007/s10827-006-7815-5; Garofalo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006482; Geddes-Klein DM, 2006, J NEUROCHEM, V97, P462, DOI 10.1111/j.1471-4159.2006.03761.x; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kamioka H, 1996, NEUROSCI LETT, V206, P109, DOI 10.1016/S0304-3940(96)12448-4; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li XL, 2007, J NEUROPHYSIOL, V98, P3341, DOI 10.1152/jn.00977.2007; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mittmann W, 2011, NAT NEUROSCI, V14, P1089, DOI 10.1038/nn.2879; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; Nenadic Z, 2005, IEEE T BIO-MED ENG, V52, P74, DOI 10.1109/TBME.2004.839800; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Pardo E, 2006, ULTRASONICS, V44, pE1063, DOI 10.1016/j.ultras.2006.05.101; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rummel C, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066703; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Sieg F, 1999, J NEUROTRAUM, V16, P1197, DOI 10.1089/neu.1999.16.1197; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takahashi N, 2007, NEUROSCI RES, V58, P219, DOI 10.1016/j.neures.2007.03.001; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; vanVreeswijk C, 1996, SCIENCE, V274, P1724; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	64	14	14	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964			ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		23	36		10.1007/s10439-011-0390-6			14	Engineering, Biomedical	Engineering	895HJ	WOS:000300486700003	21994056	Green Accepted			2021-06-18	
J	Seipel, R; Langner, S; Platz, T; Lippa, M; Kuehn, JP; Hosten, N				Seipel, R.; Langner, S.; Platz, T.; Lippa, M.; Kuehn, J. P.; Hosten, N.			Neurogenic heterotopic ossification: epidemiology and morphology on conventional radiographs in an early neurological rehabilitation population	SKELETAL RADIOLOGY			English	Article						Heterotopic ossification; Neurological rehabilitation; Radiography	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MYOSITIS-OSSIFICANS; RISK-FACTORS; APPEARANCE; MANAGEMENT	To retrospectively evaluate neurogenic heterotopic ossification in an early neurological rehabilitation population (phases B and C) with respect to epidemiology and morphology on conventional radiographs. Over a 4-year period, 1,463 patients treated at a clinic for early neurological rehabilitation were evaluated for clinical symptoms of neurogenic heterotopic ossification. In case of clinical suspicion, plain radiographs of the expected sites were obtained. If heterotopic ossification was detected, the initial and subsequent radiographs were retrospectively analyzed for sites, size, and morphology. Immature lesions were categorized as small (< 10 mm) or large (10-100 mm). The prevalence rate of neurogenic heterotopic ossification was 2.05%. The condition was most common in young male adults. The hip was the most common site accounting for more than half of the cases. Two or more ossifications were seen in 56.7% of the affected patients with approximately two-thirds showing bilateral symmetric involvement of corresponding joint regions. The size of ossifications strongly varied interindividually. Small immature lesions demonstrated less progression in size than large lesions during maturation (P < 0.05). Standard radiographs, as a fast and inexpensive technique, allow the expected size progression of heterotopic ossifications during maturation to be estimated, which is relevant in terms of therapeutic decisions, patient mobilization, and neurological rehabilitation.	[Seipel, R.; Langner, S.; Lippa, M.; Kuehn, J. P.; Hosten, N.] Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, D-17487 Greifswald, Germany; [Platz, T.] Inst Ernst Moritz Arndt Univ, BDH Klin Greifswald GmbH, Neurol Rehabil Zentrum, D-17491 Greifswald, Germany; [Platz, T.] Inst Ernst Moritz Arndt Univ, Querschnittgelahmtenzentrum, D-17491 Greifswald, Germany	Langner, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, Ferdinand Sauerbruch Str, D-17487 Greifswald, Germany.	Soenke.langner@uni-greifswald.de		Platz, Thomas/0000-0003-2629-9744			AHRENGART L, 1991, CLIN ORTHOP RELAT R, P49; Banovac K, 1997, SPINAL CORD, V35, P158, DOI 10.1038/sj.sc.3100380; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286; DESMET AA, 1992, SKELETAL RADIOL, V21, P503, DOI 10.1007/BF00195231; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GOLDBERG MA, 1977, ARCH INTERN MED, V137, P619, DOI 10.1001/archinte.137.5.619; Guo JJ, 2009, CHINESE MED J-PEKING, V122, P219, DOI 10.3760/cma.j.issn.0366-6999.2009.02.020; KRAMER FL, 1979, SKELETAL RADIOL, V4, P19, DOI 10.1007/BF00350588; KRANSDORF MJ, 1991, AM J ROENTGENOL, V157, P1243, DOI 10.2214/ajr.157.6.1950874; MCATEER EJ, 1990, BRIT J RADIOL, V63, P809, DOI 10.1259/0007-1285-63-754-809; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; ORZEL JA, 1985, J NUCL MED, V26, P125; Popken F, 2003, UNFALLCHIRURG, V106, P28, DOI 10.1007/s00113-002-0461-0; RAGONE DJ, 1986, ARCH PHYS MED REHAB, V67, P339; Richards PJ, 2008, DISABIL REHABIL, V30, P1651, DOI 10.1080/09638280701785866; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SHIRKHODA A, 1995, JMRI-J MAGN RESON IM, V5, P287, DOI 10.1002/jmri.1880050312; Taly AB, 2001, NEUROL INDIA, V49, P37; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215	23	14	18	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2348	1432-2161		SKELETAL RADIOL	Skeletal Radiol.	JAN	2012	41	1					61	66		10.1007/s00256-011-1115-5			6	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	855DK	WOS:000297543700007	21331512				2021-06-18	
J	Stevens, LF; Arango-Lasprilla, JC; Deng, XY; Schaaf, KW; Aragon, CJD; Quijano, MC; Kreutzer, J				Stevens, Lillian Flores; Carlos Arango-Lasprilla, Juan; Deng, Xiaoyan; Schaaf, Kathryn Wilder; De los Reyes Aragon, Carlos Jose; Cristina Quijano, Maria; Kreutzer, Jeffrey			Factors associated with depression and burden in Spanish speaking caregivers of individuals with traumatic brain injury	NEUROREHABILITATION			English	Article						Caregivers; depression; burden	TREATING FAMILIES; HEALTH; PREDICTORS; DISTRESS; CARERS; NEEDS; TBI; REHABILITATION; PERSPECTIVE; VALIDATION	Objective: To determine which factors are highly associated with burden and depression in a group of caregivers of persons with Traumatic Brain Injury (TBI) in Colombia, South America. Design: Prospective. Participants: Fifty-one pairs of individuals with TBI and their caregivers from two major cities in Colombia completed a comprehensive psychosocial evaluation that included information related to patient and caregiver sociodemographic factors, patient factors, and caregiver estimation of patient neurobehavioral functioning. Outcome measures: Caregiver burden (Zarit Burden Interview) and caregiver depression (PHQ-9). Results: Generalized linear models revealed that patient language problems and caregiver perception of patient functioning on six neurobehavioral domains were related to caregiver burden. Caregiver socioeconomic status and caregiver perception of patient functioning on six neurobehavioral domains were related to caregiver depression. These variables were then selected as candidates for the multiple regression models, which were fit separately for caregiver depression and burden, and revealed that caregivers' perception of patient depression was the only factor associated with both caregiver burden and depression. Conclusion: Caregivers' perception of patient depression was the single best predictor of both caregiver burden and depression. Implications for treatment based on these preliminary findings are discussed.	[Stevens, Lillian Flores] Hunter Holmes McGuire VAMC, Richmond, VA 23249 USA; [Schaaf, Kathryn Wilder; Kreutzer, Jeffrey] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, IKERBASQUE, Basque Fdn Sci, Bilbao, Spain; [Deng, Xiaoyan] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [De los Reyes Aragon, Carlos Jose] Univ Norte, Dept Psychol, Barranquilla, Colombia; [Cristina Quijano, Maria] Pontificia Univ Javeriana Cali, Dept Social Sci, Cali, Colombia	Stevens, LF (corresponding author), Hunter Holmes McGuire VAMC, 1201 Broad Rock Blvd,116-B, Richmond, VA 23249 USA.	Lillian.Stevens@va.gov	De los Reyes Aragon, Carlos Jose/P-3516-2019; De los Reyes Aragon, Carlos Jose CDA/E-2585-2015	De los Reyes Aragon, Carlos Jose/0000-0003-4472-0635; De los Reyes Aragon, Carlos Jose CDA/0000-0003-4472-0635; Quijano Martinez, Maria Cristina/0000-0003-3548-1628			Alonso J, 2008, ACTA PSYCHIAT SCAND, V118, P305, DOI 10.1111/j.1600-0447.2008.01241.x; Anez Luis M, 2005, J Psychiatr Pract, V11, P221; Beck A., 1979, COGNITIVE THERAPY EM; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Centers for Disease Control and Prevention (CDC), MAN PEOPL HAV TBI; Cuellar I, 1995, J COMMUNITY PSYCHOL, V23, P339, DOI 10.1002/1520-6629(199510)23:4<339::AID-JCOP2290230406>3.0.CO;2-7; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; De Silva MJ, 2008, INT J EPIDEMIOL, V38, P1; DEPOMPEI R, 1994, TOP LANG DISORD, V15, P68, DOI 10.1097/00011363-199411000-00007; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hayes S. C., 2004, PRACTICAL GUIDE ACCE; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karlikaya G., 2005, INTERNET J NEUROLOGY, V4; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Livingston MG., 1990, REHABILITATION ADULT, P225; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Martin-Carrasco M., 1996, REV GERONTOLOGIA, V6, P338; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; MILLER B, 1991, J HEALTH SOC BEHAV, V32, P165, DOI 10.2307/2137150; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Ostrosky-Solis F, 1999, J INT NEUROPSYCH SOC, V5, P413, DOI 10.1017/S1355617799555045; Pereira F., 2007, AVANCES PSIQUIATRIA, V8, P153; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Sander AM, 2007, NEUROREHABILITATION, V22, P9; SIEGEL K, 1991, CANCER, V68, P1131, DOI 10.1002/1097-0142(19910901)68:5<1131::AID-CNCR2820680541>3.0.CO;2-N; TEASDALE G, 1974, LANCET, V2, P81; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; WULSIN L, 2002, PRIM CARE COMPANION, V4, P191, DOI DOI 10.4088/PCC.V04N0504; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	55	14	15	0	17	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2012	31	4					443	452		10.3233/NRE-2012-00815			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	052GV	WOS:000312186600014	23232169				2021-06-18	
J	Sundstrom, T; Helland, CA; Aarhus, M; Wester, K				Sundstrom, Terje; Helland, Christian Andre; Aarhus, Mads; Wester, Knut			What is the Pressure in Chronic Subdural Hematomas? A Prospective, Population-Based Study	JOURNAL OF NEUROTRAUMA			English	Article						clinical management of CNS injury; CT scanning; geriatric brain injury; head trauma; ICP	CLOSED-SYSTEM DRAINAGE; INTRACRANIAL-PRESSURE; ARACHNOID CYSTS; IRRIGATION; RECOVERY; ADULTS; VOLUME	Surgery for chronic subdural hematoma (CSDH) is performed to relieve brain displacement and high intracranial pressure (ICP). However, the intraoperative impression is often that the pressure inside the CSDH is low, despite marked clinical symptoms. We wanted to quantify the CSDH pressure and relate this to radiological and clinical characteristics. This prospective, population-based study of unilateral CSDHs was conducted over a 3-year period. CSDHs that were secondary to other conditions, re-operations, or CSDHs requiring other procedures than burr hole craniostomy under local anesthesia were excluded. Subdural pressure registration was performed via a simple manometric technique, and full compliance with a standardized protocol was mandatory. Sixty patients were included (mean age 76.2 years; for men, 77.4, and for women, 72.9). The mean pressure in the CSDHs was 15.2 cm H(2)O (range, 0-40) with no gender difference. Men had significantly larger volumes (mean 158.1 vs. 103.2 cm(3)) and midline shifts (mean 1.04 vs. 0.68 cm) than did women. Large hematomas with large midline shifts had higher pressures and more often required repeat surgery. With a patient's increasing age, the volumes and midline shifts seemed to become larger, whereas the pressures became lower. We did not find an association between repeat surgery and pressure or age. Our results are generally in line with those of previous studies reporting quantitative pressure registrations. However, there are important disparities regarding methodology, not least when comparing with various subjective scales that are widely used in clinical practice. A mean subdural pressure of 15.2 cm H(2)O is probably within the range of a normal ICP.	[Sundstrom, Terje] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; Univ Bergen Bergen, Dept Surg Sci, Bergen, Norway	Sundstrom, T (corresponding author), Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway.	terje.sundstrom@gmail.com		Sundstrom, Terje/0000-0002-6503-7141; Helland, Christian/0000-0001-7754-5955			ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Bratton B. L., 2007, J NEUROTRAUM, V24, pS45; DEVOLDER AG, 1994, J NEUROL NEUROSUR PS, V57, P296, DOI 10.1136/jnnp.57.3.296; FRIDEN HG, 1983, NEUROSURGERY, V13, P351, DOI 10.1227/00006123-198310000-00002; Gaab M., 1979, NEUROSURGERY, V4, pS476; GJERRIS F, 1980, ACTA NEUROCHIR, V54, P53, DOI 10.1007/BF01401943; Helland CA, 2007, J NEUROL NEUROSUR PS, V78, P1129, DOI 10.1136/jnnp.2006.107995; Horiguchi T, 2000, World J Biol Psychiatry, V1, P159, DOI 10.3109/15622970009150585; ISHIKAWA T, 1992, J NEUROL NEUROSUR PS, V55, P401, DOI 10.1136/jnnp.55.5.401; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; Matsumoto M, 1999, ACTA NEUROCHIR, V141, P177, DOI 10.1007/s007010050283; Merlicco G, 1995, NEUROSURG REV, V18, P247, DOI 10.1007/BF00383875; MINNS RA, 1984, ARCH DIS CHILD, V59, P486, DOI 10.1136/adc.59.5.486; Nakaguchi H, 2000, J NEUROSURG, V93, P791, DOI 10.3171/jns.2000.93.5.0791; Ogasawara K, 2000, SURG NEUROL, V54, P155, DOI 10.1016/S0090-3019(00)00281-0; Santarius T, 2004, BRIT J NEUROSURG, V18, P328, DOI 10.1080/02688690400004845; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Sgouros S, 2001, PEDIATR NEUROSURG, V35, P188, DOI 10.1159/000050420; Sucu HK, 2005, STROKE, V36, P998, DOI 10.1161/01.STR.0000162714.46038.0f; Tabaddor K, 1979, NEUROSURGERY, V4, pS476; Takeda N, 2006, ACTA NEUROCHIR, V148, P541, DOI 10.1007/s00701-005-0689-x; Tanaka A, 1997, SURG NEUROL, V47, P346, DOI 10.1016/S0090-3019(96)00369-2; Tsurushima H, 2000, NEUROL MED-CHIR, V40, P339, DOI 10.2176/nmc.40.339; Zaatreh MM, 2002, PEDIATR NEUROL, V26, P134, DOI 10.1016/S0887-8994(01)00379-4	25	14	16	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2012	29	1					137	142		10.1089/neu.2011.1776			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	879GI	WOS:000299317300016	21635185				2021-06-18	
J	Walker, CT; Stone, JJ; Jacobson, M; Phillips, V; Silberstein, HJ				Walker, Corey T.; Stone, Jonathan J.; Jacobson, Max; Phillips, Valerie; Silberstein, Howard J.			Indications for Pediatric External Ventricular Drain Placement and Risk Factors for Conversion to a Ventriculoperitoneal Shunt	PEDIATRIC NEUROSURGERY			English	Article						Cerebrospinal fluid diversion; External ventricular drain; Hydrocephalus; Intracranial pressure; Trauma; Ventriculoperitoneal shunt; Ventriculostomy	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CLINICAL ARTICLE; UNITED-STATES; BRAIN-TUMORS; HYDROCEPHALUS; CHILDREN	Background/Aims: The external ventricular drain (EVD) is commonly used for the treatment of hydrocephalus and intracranial pressure (ICP) monitoring. In this study, we retrospectively reviewed indications for EVD placement over the last 20 years in pediatric patients at our institution. Additionally, we evaluated the rate that an EVD needed to be converted to a ventriculoperitoneal shunt (VPS) and ascertained how hydrocephalus etiology impacted long-term drainage requirements. Methods: Patients that received an EVD between 1990 and 2010 at our institution were identified using billing codes. Demographics, etiology of hydrocephalus, length of stay (LOS) and EVD duration were recorded. Only patients receiving their first EVD were included; those with any prior ventricular catheter (including prior shunts) were excluded from this study. Results: A total of 180 patients underwent first-time placement of an EVD over the 20-year period. Of these, 78.9% were placed on the right side and 81.7% were performed through a frontal burr hole site. The average age of all patients at their initial procedure was 9.3 years (median 9.8; range 0-18), hospital LOS was 22.5 days (median 16; range 1-174) and EVD duration was 7.8 days (median 7; range 1-37). Trauma (43.3%) and neoplasms (32.2%) were the most common indications. Approximately, one quarter of the patients were unable to become EVD independent and, therefore, required a VPS. Only patients receiving an EVD for traumatic brain injury were significantly less likely to be converted to a shunt than other causes of hydrocephalus (relative risk, RR = 0.18, 95% confidence interval, CI = 0.07-0.46). Conversely, patients with neoplasms (RR = 3.56, 95% CI = 1.74-7.31), obstructive hydrocephalus (RR = 5.48, 95% CI = 1.37-22.0) and intraventricular hemorrhage (RR = 9.86, 95% CI = 1.05-92.3) were more likely to need a shunt. Conclusion: Traumatic brain injuries and neoplasms represent the most common indications for EVD placement in the pediatric population. While patients with neoplasm were much more likely to need conversion to a VPS for long-term cerebrospinal fluid diversion, the majority of EVDs in patients with head injuries were successfully weaned. Copyright (C) 2013 S. Karger AG, Basel	[Walker, Corey T.; Stone, Jonathan J.; Jacobson, Max; Phillips, Valerie; Silberstein, Howard J.] Univ Rochester, Med Ctr, Dept Neurol Surg, Rochester, NY 14642 USA	Stone, JJ (corresponding author), Univ Rochester, Sch Med & Dent, 601 Elmwood Ave,Box 670, Rochester, NY 14642 USA.	jonathan_stone@urmc.rochester.edu			Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship	C.T.W. received support for this study from the Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship.	Brandner S, 2012, Acta Neurochir Suppl, V114, P217, DOI 10.1007/978-3-7091-0956-4_42; Chan M, 2009, J NEUROSURG, V110, P44, DOI 10.3171/2008.5.17560; FRIEDMAN WA, 1980, J NEUROSURG, V53, P662, DOI 10.3171/jns.1980.53.5.0662; Kang DH, 2010, NEUROSURGERY, V66, P904, DOI 10.1227/01.NEU.0000368385.74625.96; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Klopfenstein JD, 2004, J NEUROSURG, V100, P225, DOI 10.3171/jns.2004.100.2.0225; KUSSKE JA, 1973, J NEUROSURG, V38, P591, DOI 10.3171/jns.1973.38.5.0591; Mayer SA, 2005, LANCET NEUROL, V4, P662, DOI 10.1016/S1474-4422(05)70195-2; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Notarianni C, 2009, J NEUROSURG-PEDIATR, V4, P547, DOI 10.3171/2009.7.PEDS08371; Rammos S, 2008, J NEUROSURG, V109, P1001, DOI 10.3171/JNS.2008.109.12.1001; Reddy GK, 2012, NEUROSURGERY, V70, P380, DOI 10.1227/NEU.0b013e318231d551; Sekula RF, 2008, BRIT J NEUROSURG, V22, P213, DOI 10.1080/02688690701832084; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Stone JJ, 2013, J NEUROSURG-PEDIATR, V11, P15, DOI 10.3171/2012.9.PEDS1298; Tuli S, 2000, J NEUROSURG, V92, P31, DOI 10.3171/jns.2000.92.1.0031; Wong TT, 2011, CHILD NERV SYST, V27, P1723, DOI 10.1007/s00381-011-1523-9	17	14	14	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.		2012	48	6					342	347		10.1159/000353608			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	220PR	WOS:000324597900002	23941907				2021-06-18	
J	Yao, CH; Chang, RL; Chang, SL; Tsai, CC; Tsai, FJ; Chen, YS				Yao, Chun-Hsu; Chang, Ruey-Lin; Chang, Shih-Liang; Tsai, Chin-Chuan; Tsai, Fuu-Jen; Chen, Yueh-Sheng			Electrical stimulation improves peripheral nerve regeneration in streptozotocin-induced diabetic rats	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Electrical stimulation; peripheral nerve regeneration; diabetes; rehabilitation; peripheral neurotrauma	GENE-RELATED PEPTIDE; SCIATIC-NERVE; WALLERIAN DEGENERATION; ENHANCED REMYELINATION; MELLITUS; INJURY; MACROPHAGES; NEUROPATHY; REGULATORS; RECOVERY	We discuss if percutaneous electrical stimulation (ES) at 1 mA and 2 Hz after peripheral nerve transection could enhance axonal regeneration and functional recovery in diabetic animals. METHODS: Four groups of adult rats (group A: normal rats; group B: normal rats with ES; group C: streptozotocin-induced diabetic rats; and group D: streptozotocin-induced diabetic rats with ES) were subjected to sciatic nerve section followed by repair using silicone rubber conduits across a 10-mm gap. Rats in groups B and D received ES for 15 minutes every other day for three weeks. The groups A and C received no ES. RESULTS: At four weeks after surgery in groups B and D, immunohistochemical staining showed that lamina I and II regions in the dorsal horn ipsilateral to the injury were significantly calcitonin gene-related peptide-immunolabeled, and a significantly higher number of macrophages were recruited in the distal sciatic nerve compared with group C. In groups A, B, and D, electrophysiological results showed higher levels of reinnervation with significantly shorter latencies and faster nerve conductive velocities, and the histologic evaluations showed relatively larger mean values of myelinated axon densities and endoneurial areas compared with group C. CONCLUSIONS: Thus, the ES may improve the recovery of a severe peripheral nerve injury in diabetic animals, which could be considered as a supplementary treatment in diabetic neurotrauma. (J Trauma. 2012;72: 199-205. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Yao, Chun-Hsu; Chang, Ruey-Lin; Tsai, Fuu-Jen; Chen, Yueh-Sheng] China Med Univ, Lab Biomat, Sch Chinese Med, Taichung, Taiwan; [Yao, Chun-Hsu] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Chang, Shih-Liang] Da Yeh Univ, Dept Med Bot & Hlth Applicat, Changhua, Taiwan; [Tsai, Chin-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Tsai, Chin-Chuan] E DA Hosp, Chinese Med Dept, Kaohsiung, Taiwan	Chen, YS (corresponding author), China Med Univ, Lab Biomat, Sch Chinese Med, Taichung, Taiwan.	yuehsc@mail.cmu.edu.tw	Tsai, Fuu-Jen/J-4140-2015; Chang, Shih-Liang/E-5328-2012	Chang, Shih-Liang/0000-0001-5884-3850	National Science Council of the Republic of China, TaiwanMinistry of Science and Technology, Taiwan [NSC99-2221-E-039-006-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]	Supported by National Science Council of the Republic of China, Taiwan [Contract No. NSC99-2221-E-039-006-MY3] and Taiwan Department of Health Clinical Trial and Research Center of Excellence [Contract No. DOH100-TD-B-111-004].	Adeghate E, 2006, ANN NY ACAD SCI, V1084, P296, DOI 10.1196/annals.1372.030; Alrashdan MS, 2010, ACTA NEUROL BELG, V110, P168; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Chen YS, 2010, J NEUROPATH EXP NEUR, V69, P294, DOI 10.1097/NEN.0b013e3181d26487; Dahlin LB, 2008, NEUROREPORT, V19, P987, DOI 10.1097/WNR.0b013e328302f4ec; Dellon A Lee, 2007, Clin Podiatr Med Surg, V24, P425, DOI 10.1016/j.cpm.2007.03.003; Gao J, 2010, BRAIN RES, V1313, P53, DOI 10.1016/j.brainres.2009.11.072; Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412; Huang JH, 2010, NEUROREHAB NEURAL RE, V24, P736, DOI 10.1177/1545968310368686; Kennedy JM, 2000, BRAIN, V123, P2118, DOI 10.1093/brain/123.10.2118; Kennedy JM, 2005, J PERIPHER NERV SYST, V10, P144, DOI 10.1111/j.1085-9489.2005.0010205.x; Kennedy JM, 2002, DIABETES, V51, P2233, DOI 10.2337/diabetes.51.7.2233; Lago N, 2007, J NEUROSCI RES, V85, P2800, DOI 10.1002/jnr.21286; Lee TH, 2010, IEEE ENG MED BIO, P1511, DOI 10.1109/IEMBS.2010.5626837; Loesch A, 2010, ANGIOLOGY, V61, P651, DOI 10.1177/0003319709360030; LONGO FM, 1986, MUSCLE NERVE, V9, P385, DOI 10.1002/mus.880090502; Lu MC, 2008, NEUROREHAB NEURAL RE, V22, P367, DOI 10.1177/1545968307313507; Lu MC, 2009, J TRAUMA, V67, P1066, DOI 10.1097/TA.0b013e318182351a; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Serafin A, 2010, MUSCLE NERVE, V41, P630, DOI 10.1002/mus.21564; Shen LF, 2009, J NEUROCHEM, V108, P1187, DOI 10.1111/j.1471-4159.2008.05865.x; Suzuki C, 2000, NEUROLOGY, V54, P1932, DOI 10.1212/WNL.54.10.1932; Terada M, 1998, J NEUROL SCI, V155, P23, DOI 10.1016/S0022-510X(97)00269-4; Toth CC, 2009, J NEUROPATH EXP NEUR, V68, P326, DOI 10.1097/NEN.0b013e31819ac71b; Wan LD, 2010, NEUROSCIENCE, V169, P1029, DOI 10.1016/j.neuroscience.2010.05.051; Wan LD, 2010, J NEUROSCI RES, V88, P2578, DOI 10.1002/jnr.22426; WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Yeh CC, 2010, NEUROREHAB NEURAL RE, V24, P730, DOI 10.1177/1545968310376758; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zochodne DW, 2007, DIABETES-METAB RES, V23, P490, DOI 10.1002/dmrr.716	32	14	15	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					199	205		10.1097/TA.0b013e31822d233c			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	898IF	WOS:000300734800037	22310128				2021-06-18	
J	Zeilig, G; Weingarden, H; Shemesh, Y; Herman, A; Heim, M; Zeweker, M; Dudkiewicz, I				Zeilig, Gabi; Weingarden, Harold; Shemesh, Yeheskel; Herman, Amir; Heim, Michael; Zeweker, Manual; Dudkiewicz, Israel			Functional and environmental factors affecting work status in individuals with longstanding poliomyelitis	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Employment status; Disability; Poliomyelitis; Post-polio syndrome; Activities of daily living; Mobility; Orthotics	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; POSTPOLIO SYNDROME; POLIO SURVIVORS; RETURN; DISABILITY; HEALTH; WALKING	Introduction: Remunerative employment is a major concern of individuals with chronic disabilities, among them, those with longstanding poliomyelitis (LSP). Although LSP is not rare there are almost no data related to work participation. Purpose: The aims of the current study were to determine the effects of a number of social and functional variables as barriers or facilitators to work participation in persons with LSP. Patients and methods: Charts of 123 LSP patients of working age that were seen in the post-polio outpatient clinic, between the years 2000 and 2005 were reviewed for the study. Data on age, gender, family status, level of function in activities of daily living, basic, and extended (B-ADL and E-ADL), and mobility were then analyzed for correlation to the vocational status. Results: Seventy-two people (58.5%) were employed at the time of the survey. Gender and marital status were not found to significantly differ as regard to employment. Using assistive devices for mobility or being dependent for basic ADL were associated with lower levels of employment. Driving was positively associated with the employment status of the LSP individuals. Conclusion: Persons with LSP encounter important barriers to work participation, particularly on the International Classification of Functioning, Disability, and Health (ICF) components of activity and environment.	[Dudkiewicz, Israel] Tel Aviv Sourasky Med Ctr, Dept Rehabil, IL-64239 Tel Aviv, Israel; [Zeilig, Gabi; Weingarden, Harold; Shemesh, Yeheskel; Zeweker, Manual] Chaim Sheba Med Ctr, Dept Neurol Rehabil, IL-52621 Tel Hashomer, Israel; [Zeilig, Gabi; Weingarden, Harold; Shemesh, Yeheskel; Heim, Michael; Zeweker, Manual; Dudkiewicz, Israel] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Herman, Amir] Chaim Sheba Med Ctr, Dept Orthoped Surg, IL-52621 Tel Hashomer, Israel; [Herman, Amir] Univ Haifa, Dept Stat, IL-31999 Haifa, Israel; [Heim, Michael] Chaim Sheba Med Ctr, Dept Orthoped Rehabil, IL-52621 Tel Hashomer, Israel	Dudkiewicz, I (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Rehabil, IL-64239 Tel Aviv, Israel.	Israel.dudkiewicz@gmail.com					Anderson CJ, 2003, SPINAL CORD, V41, P684, DOI 10.1038/sj.sc.3101533; Brehm MA, 2007, J REHABIL MED, V39, P651, DOI 10.2340/16501977-0110; Burger H, 2007, DISABIL REHABIL, V29, P1323, DOI 10.1080/09638280701320797; Elrod Lisa M, 2005, Work, V25, P155; Farbu E, 1997, ACTA NEUROL SCAND, V96, P353; Farbu E, 2001, J NEUROL, V248, P500, DOI 10.1007/s004150170160; Farbu E, 2010, THER CLIN RISK MANAG, V6, P307; Genet F., 2010, Annals of Physical and Rehabilitation Medicine, V53, P51, DOI 10.1016/j.rehab.2009.11.005; Gonzalez H, 2010, LANCET NEUROL, V9, P634, DOI 10.1016/S1474-4422(10)70095-8; GRIMBY G, 1994, PHYS THER, V74, P415, DOI 10.1093/ptj/74.5.415; Hachisuka K, 2007, J REHABIL MED, V39, P646, DOI 10.2340/16501977-0105; Halbritter T, 2001, J Am Acad Nurse Pract, V13, P555; Halstead LS, 2011, ARCH PHYS MED REHAB, V92, P1344, DOI 10.1016/j.apmr.2011.03.002; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Jacob T, 2010, J REHABIL MED, V42, P377, DOI 10.2340/16501977-0515; Jang Y, 2005, ARCH PHYS MED REHAB, V86, P681, DOI 10.1016/j.apmr.2004.10.025; Johnson KL, 2010, PHYS MED REH CLIN N, V21, P267, DOI 10.1016/j.pmr.2009.12.004; Karmarkar A, 2008, ARCH PHYS MED REHAB, V89, P1191, DOI 10.1016/j.apmr.2007.10.029; Kelley C, 2007, J PROSTHET ORTHOT, V19, P109; Krause JS, 2006, ARCH PHYS MED REHAB, V87, P1318, DOI 10.1016/j.apmr.2006.07.254; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LaBan MM, 2010, ARCH PHYS MED REHAB, V91, P966, DOI 10.1016/j.apmr.2010.03.019; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Marini I, 2008, J VOCAT REHABIL, V28, P1; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P995, DOI 10.1016/S0003-9993(96)90058-1; R Development Core Team, 2008, R LANGUAGE ENV STAT; Rekand T, 2003, J EPIDEMIOL COMMUN H, V57, P368, DOI 10.1136/jech.57.5.368; ROBERTSON T, 1981, ANN STAT, V9, P1248, DOI 10.1214/aos/1176345641; Stanghelle JK, 1997, SPINAL CORD, V35, P503, DOI 10.1038/sj.sc.3100425; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Sweetland J, 2007, MULT SCLER J, V13, P1183, DOI 10.1177/1352458507078414; Tomassen PCD, 2000, SPINAL CORD, V38, P51, DOI 10.1038/sj.sc.3100948; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wekre LL, 1998, SPINAL CORD, V36, P280, DOI 10.1038/sj.sc.3100557; Yasuda S, 2002, NEUROREHABILITATION, V17, P177	36	14	14	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JAN	2012	35	1					22	27		10.1179/2045772311Y.0000000048			6	Clinical Neurology	Neurosciences & Neurology	879PX	WOS:000299345200004	22330187	Green Published			2021-06-18	
J	Huong, NQ; Nakamura, Y; Kuramoto, N; Yoneyama, M; Nagashima, R; Shiba, T; Yamaguchi, T; Hasebe, S; Ogita, K				Nguyen Quynh Huong; Nakamura, Yukary; Kuramoto, Nobuyuki; Yoneyama, Masanori; Nagashima, Reiko; Shiba, Tatsuo; Yamaguchi, Taro; Hasebe, Shigeru; Ogita, Kiyokazu			Indomethacin Ameliorates Trimethyltin-Induced Neuronal Damage in Vivo by Attenuating Oxidative Stress in the Dentate Gyrus of Mice	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cyclooxygenase; neuronal degeneration; indomethacin; oxidative stress; trimethyltin	TRAUMATIC BRAIN-INJURY; CA1 PYRAMIDAL NEURONS; NITRIC-OXIDE SYNTHASE; FACTOR-ALPHA RELEASE; MICROGLIAL ACTIVATION; FOREBRAIN ISCHEMIA; INDUCED APOPTOSIS; CELL-DEATH; CYCLOOXYGENASE-2; EXPRESSION	The organotin trimethyltin (TMT) is well known to cause neuronal degeneration in the hippocampal dentate gyrus of mice. The first purpose of the present study was to examine whether the cyclooxygenase (COX) inhibitor indomethacin could ameliorate neuronal degeneration in the dentate gyrus of mice following TMT treatment in vivo. The systemic injection into mice of TMT at 2.8 mg/kg produced activation of endogenous caspase-3 and calpain, enhanced the gene expression of COX-1 and COX-2, activated microglial cells, and caused the formation of the lipid peroxidation product 4-hydroxynonenal in the hippocampus. Given at 12-h post-TMT treatment, the systemic injection of indomethacin (5 or 10 mg/kg, subcutaneously) significantly decreased the TMT-induced damage to neurons having active caspase-3 and single-stranded DNA in the dentate granule cell layer of the hippocampus. The results of the alpha-Fodrin degradation test revealed that the post-treatment with indomethacin was effective in attenuating TMT-induced activation of endogenous caspases and calpain in the hippocampus. In TMT-treated animals, interestingly, the post-treatment with indomethacin produced not only activation of microglial cells in the dentate gyrus but also the formation of 4-hydroxynonenal in the dentate granule cell layer. Taken together, our data suggest that COX inhibition by indomethacin ameliorated TMT-induced neuronal degeneration in the dentate gyrus by attenuating intensive oxidative stress.	[Nguyen Quynh Huong; Nakamura, Yukary; Kuramoto, Nobuyuki; Yoneyama, Masanori; Nagashima, Reiko; Shiba, Tatsuo; Yamaguchi, Taro; Hasebe, Shigeru; Ogita, Kiyokazu] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacol, Hirakata, Osaka 5730101, Japan	Ogita, K (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacol, Hirakata, Osaka 5730101, Japan.	ogita@pharm.setsunan.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This work was supported in part by Grants-in-Aid for Scientific Research to M.Y. and K.O. from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arai K, 2003, BRAIN RES, V985, P176, DOI 10.1016/S0006-8993(03)03156-1; Asanuma M, 2001, J NEUROCHEM, V76, P1895, DOI 10.1046/j.1471-4159.2001.00205.x; Boldyrev AA, 1999, BIOCHEM BIOPH RES CO, V256, P320, DOI 10.1006/bbrc.1999.0325; BOULDIN TW, 1981, AM J PATHOL, V104, P237; Caggiano AO, 1996, J COMP NEUROL, V376, P447, DOI 10.1002/(SICI)1096-9861(19961216)376:3<447::AID-CNE7>3.0.CO;2-2; CHANG LW, 1985, J TOXICOL ENV HEALTH, V16, P641, DOI 10.1080/15287398509530770; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Collaco-Moreaes Y., 1996, BLOOD, V16, P1366; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Eskes C, 2003, J NEUROSCI RES, V71, P583, DOI 10.1002/jnr.10508; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Geloso MC, 2002, EXP NEUROL, V175, P152, DOI 10.1006/exnr.2002.7866; Godin JD, 2010, EMBO J, V29, P2433, DOI 10.1038/emboj.2010.117; Gunasekar PG, 1998, J PHARMACOL EXP THER, V285, P236; Harry GJ, 2001, NEUROTOX RES, V3, P307, DOI 10.1007/BF03033270; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Kawada K, 2008, J NEUROSCI RES, V86, P1635, DOI 10.1002/jnr.21612; Kim EJ, 2001, BRAIN RES, V908, P1, DOI 10.1016/S0006-8993(01)02432-5; Kinouchi H, 1999, J NEUROSURG, V91, P1005, DOI 10.3171/jns.1999.91.6.1005; Kondo F, 1998, BRAIN RES, V791, P352, DOI 10.1016/S0006-8993(98)00211-X; Kondo F, 2000, BRAIN RES, V853, P93, DOI 10.1016/S0006-8993(99)02256-8; Kuramoto N, 2011, J NEUROSCI RES, V89, P552, DOI 10.1002/jnr.22588; Kurkowska-Jastrzebska I, 2002, INT IMMUNOPHARMACOL, V2, P1213, DOI 10.1016/S1567-5769(02)00078-4; Kurkowska-Jastrzebska I, 2010, J NEUROSCI RES, V88, P24, DOI 10.1002/jnr.22187; Nagashima R, 2010, J PHARMACOL SCI, V113, P267, DOI 10.1254/jphs.09158SC; Ogita K, 2005, J NEUROSCI RES, V82, P609, DOI 10.1002/jnr.20678; Ogita K, 2004, NEUROPHARMACOLOGY, V47, P619, DOI 10.1016/j.neuropharm.2004.06.012; Ogita K, 2003, J NEUROCHEM, V85, P1336, DOI 10.1046/j.1471-4159.2003.01778.x; Pantovic R, 2005, SPINAL CORD, V43, P519, DOI 10.1038/sj.sc.3101763; Pasinetti GM, 1998, NEUROSCIENCE, V87, P319, DOI 10.1016/S0306-4522(98)00218-8; Rohl C, 2009, TOXICOL IN VITRO, V23, P1541, DOI 10.1016/j.tiv.2009.04.013; Shin EJ, 2005, NEUROSCIENCE, V133, P715, DOI 10.1016/j.neuroscience.2005.02.030; Shuto M, 2009, J PHARMACOL SCI, V110, P424, DOI 10.1254/jphs.09107FP; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Strohmeyer R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-18; Viviani B, 2001, TOXICOL APPL PHARM, V172, P93, DOI 10.1006/taap.2001.9136; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yoneyama M, 2008, NEUROCHEM INT, V52, P761, DOI 10.1016/j.neuint.2007.09.003; Yoneyama M, 2009, NEUROCHEM INT, V55, P257, DOI 10.1016/j.neuint.2009.03.008; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4; Zhang L, 2006, TOXICOL APPL PHARM, V216, P34, DOI 10.1016/j.taap.2006.05.004	43	14	16	0	4	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	DEC	2011	34	12					1856	1863		10.1248/bpb.34.1856			8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	853AS	WOS:000297399200015	22130242	Bronze			2021-06-18	
J	Willis, PF; Farrer, TJ; Bigler, ED				Willis, Pamelia F.; Farrer, Thomas J.; Bigler, Erin D.			Are Effort Measures Sensitive to Cognitive Impairment?	MILITARY MEDICINE			English	Article							WORD MEMORY TEST; TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; CARD SORTING TEST; NEUROPSYCHOLOGICAL ASSESSMENT; AMERICAN-ACADEMY; TEST-PERFORMANCE; RETENTION TRIAL; SCORES; DAMAGE	The basic premise of symptom validity tests (SVTs) is that appropriate effort can be assessed because the designs of SVT measures are thought to be insensitive to all but the most extreme forms of impairment of memory. In patients with mild traumatic brain injury in particular, it is thought that failure on effort measures consistently reflects poor effort or even conscious exaggeration of symptoms. This study examines the issue of SVT failure as a reflection of cognitive impairment and/or neuropsychiatric impairment by presenting cases of three patients who were given full neuropsychological batteries but in each case failed the Word Memory Test (WMT), a verbal recognition SVT measure. One patient who failed the WMT was probably in the early stages of dementia. The WMT fit the "Genuine Memory Impaired Profile". Two mild traumatic brain injury patients failed the WMT but their patterns of performance suggested that cognitive deficits influenced WMT performance. In determining the validity of neuropsychological test data in the individual case, it is recommended that the examiner consider whether cognitive impairment could affect performance on effort measures and the recommended cut score. Also, it is recommended that examiners use multiple indicators of effort.	[Willis, Pamelia F.] Brooke Army Med Ctr, Dept Behav Med, ATTN MCHE BM, Ft Sam Houston, TX 78234 USA; [Farrer, Thomas J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA	Willis, PF (corresponding author), Brooke Army Med Ctr, Dept Behav Med, ATTN MCHE BM, 3851 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.			Farrer, Thomas J./0000-0001-8092-6214			Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Booksh RL, 2007, ARCH CLIN NEUROPSYCH, V22, P87, DOI 10.1016/j.acn.2006.11.002; Conners C, 2004, CONNERS CONTINUOUS P; DEFILIPUS N, 2005, CATEGORY TEST COMPUT; Delis DC, 2000, CALIFORNIA VERBAL LE; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; Dwyer CA, 1996, PSYCHOL ASSESSMENT, V8, P360, DOI 10.1037/1040-3590.8.4.360; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2005, GREENS WORD MEMORY T; GREEN P, 2003, MANUAL WORLD MEMORY; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P117, DOI 10.1016/j.acn.2005.06.009; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; HEATON RK, 2005, WISCONSIN CARD SORTI; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Wechsler D., 1997, WAIS 3 ADM SCORING M; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020; Wolfson D., 1993, HALSTEAD REITAN NEUR	31	14	14	0	11	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	DEC	2011	176	12					1426	1431		10.7205/MILMED-D-11-00168			6	Medicine, General & Internal	General & Internal Medicine	861OK	WOS:000298028900014	22338360	Bronze			2021-06-18	
J	Carlstrom, LP; Hines, JH; Henle, SJ; Henley, JR				Carlstrom, Lucas P.; Hines, Jacob H.; Henle, Steven J.; Henley, John R.			Bidirectional remodeling of beta 1-integrin adhesions during chemotropic regulation of nerve growth	BMC BIOLOGY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CHONDROITIN SULFATE PROTEOGLYCANS; XENOPUS SPINAL NEURONS; NEURITE OUTGROWTH; FOCAL ADHESION; AXONAL REGENERATION; INTEGRIN ACTIVATION; CELL-ADHESION; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION	Background: Chemotropic factors in the extracellular microenvironment guide nerve growth by acting on the growth cone located at the tip of extending axons. Growth cone extension requires the coordination of cytoskeleton-dependent membrane protrusion and dynamic adhesion to the extracellular matrix, yet how chemotropic factors regulate these events remains an outstanding question. We demonstrated previously that the inhibitory factor myelin-associated glycoprotein (MAG) triggers endocytic removal of the adhesion receptor beta 1-integrin from the growth cone surface membrane to negatively remodel substrate adhesions during chemorepulsion. Here, we tested how a neurotrophin might affect integrin adhesions. Results: We report that brain-derived neurotropic factor (BDNF) positively regulates the formation of substrate adhesions in axonal growth cones during stimulated outgrowth and prevents removal of beta 1-integrin adhesions by MAG. Treatment of Xenopus spinal neurons with BDNF rapidly triggered beta 1-integrin clustering and induced the dynamic formation of nascent vinculin-containing adhesion complexes in the growth cone periphery. Both the formation of nascent beta 1-integrin adhesions and the stimulation of axon extension by BDNF required cytoplasmic calcium ion signaling and integrin activation at the cell surface. Exposure to MAG decreased the number of beta 1-integrin adhesions in the growth cone during inhibition of axon extension. In contrast, the BDNF-induced adhesions were resistant to negative remodeling by MAG, correlating with the ability of BDNF pretreatment to counteract MAG-inhibition of axon extension. Pre-exposure to MAG prevented the BDNF-induced formation of beta 1-integrin adhesions and blocked the stimulation of axon extension by BDNF. Conclusions: Altogether, these findings demonstrate the neurotrophin-dependent formation of integrin-based adhesions in the growth cone and reveal how a positive regulator of substrate adhesions can block the negative remodeling and growth inhibitory effects of MAG. Such bidirectional remodeling may allow the growth cone to rapidly adjust adhesiveness to the extracellular matrix as a general mechanism for governing axon extension. Techniques for manipulating integrin internalization and activation state may be important for overcoming local inhibitory factors after traumatic injury or neurodegenerative disease to enhance regenerative nerve growth.	[Hines, Jacob H.; Henle, Steven J.; Henley, John R.] Mayo Clin, Dept Neurol Surg, Coll Med, Rochester, MN 55905 USA; [Carlstrom, Lucas P.] Mayo Clin, Med Scientist Training Program, Mayo Grad Sch, Coll Med, Rochester, MN 55905 USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med, Rochester, MN 55905 USA; [Hines, Jacob H.] Univ Colorado, Dept Pediat, Aurora, CO 80045 USA	Henley, JR (corresponding author), Mayo Clin, Dept Neurol Surg, Coll Med, Rochester, MN 55905 USA.	Henley.John@mayo.edu		Hines, Jacob/0000-0003-1557-3795; Henley, John/0000-0003-1846-5941; Henle, Steven/0000-0002-8007-1030	Mayo Clinic; Craig Neilsen Foundation; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Robert D. and Patricia E. Kern Predoctoral Fellowship; Langan MD/PhD Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067311] Funding Source: NIH RePORTER	We thank David Marks and the late Dick Pagano (Mayo Clinic) for insightful discussions and for the lipid probes; Jim Tarara, Zheyan Chen and Jarred Nesbitt for technical assistance; and members of the Henley lab for critical comments. We would also like to thank Ken Yamada (US National Institutes of Health) and Doug DeSimone (University of Virginia) for their generous gifts of antibodies to beta 1-integrin and alpha 5-integrin, respectively. This work was supported by a John M. Nasseff, Sr. Career Development Award in Neurologic Surgery Research from the Mayo Clinic (JRH), career development funds from the Craig Neilsen Foundation (JRH), and the US National Institutes of Health (JRH). A Robert D. and Patricia E. Kern Predoctoral Fellowship award supported JHH. A Langan MD/PhD Predoctoral Fellowship award supported LPC.	Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bechara A, 2008, EMBO J, V27, P1549, DOI 10.1038/emboj.2008.86; Blackmore M, 2006, J NEUROBIOL, V66, P1564, DOI 10.1002/neu.20311; BURDENGULLEY SM, 1995, J NEUROSCI, V15, P4370; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DUBAND JL, 1991, J CELL SCI, V98, P517; Eastwood SL, 2003, MOL PSYCHIATR, V8, P148, DOI 10.1038/sj.mp.4001233; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Frame M, 2008, NAT CELL BIOL, V10, P1017, DOI 10.1038/ncb0908-1017; Gatlin JC, 2006, MOL BIOL CELL, V17, P5115, DOI 10.1091/mbc.E05-12-1183; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gomez TM, 2003, METHOD CELL BIOL, V71, P129, DOI 10.1016/S0091-679X(03)01008-2; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Grabham PW, 1997, J NEUROSCI, V17, P5455; Grabham PW, 2000, J CELL SCI, V113, P3003; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; HINKLE PM, 1987, J BIOL CHEM, V262, P16333; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Isenberg G, 1998, INT REV CYTOL, V178, P73; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Kim D, 2001, NEUROREHAB NEURAL RE, V15, P141, DOI 10.1177/154596830101500207; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Leventhal PS, 1997, J BIOL CHEM, V272, P5214, DOI 10.1074/jbc.272.8.5214; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LINDSAY RM, 1985, J CELL SCI, P115; Liu Y, 1999, J NEUROSCI, V19, P4370; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Ming GL, 1997, J NEUROSCI, V17, P7860; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Myers JP, 2011, J NEUROSCI, V31, P13585, DOI 10.1523/JNEUROSCI.2381-11.2011; Niederost B, 2002, J NEUROSCI, V22, P10368; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Pande G, 2000, CURR OPIN CELL BIOL, V12, P569, DOI 10.1016/S0955-0674(00)00133-2; Pfenninger KH, 2003, J CELL SCI, V116, P1209, DOI 10.1242/jcs.00285; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Ramon y Cajal S, 1928, DEGENERATION REGENER; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Santiago-Medina M., 2011, DEV NEUROBIOL; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Schwab ME, 1996, PHYSIOL REV, V76, P319; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Sydor AM, 1996, J CELL BIOL, V134, P1197, DOI 10.1083/jcb.134.5.1197; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Urbaniak GC, Research Randomizer; VANBERKUM MFA, 1995, NEURON, V14, P43, DOI 10.1016/0896-6273(95)90239-2; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Woo S, 2009, J NEUROSCI, V29, P13981, DOI 10.1523/JNEUROSCI.4028-09.2009; ZHENG MZ, 1993, J BIOL CHEM, V268, P2217; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	84	14	14	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1741-7007			BMC BIOL	BMC Biol.	NOV 30	2011	9								82	10.1186/1741-7007-9-82			15	Biology	Life Sciences & Biomedicine - Other Topics	895QY	WOS:000300512600001	22126462	DOAJ Gold, Green Published			2021-06-18	
J	Shamim, MS; Qadeer, M; Murtaza, G; Enam, SA; Farooqi, NB				Shamim, Muhammad Shahzad; Qadeer, Mohsin; Murtaza, Ghulam; Enam, S. Ather; Farooqi, Najiha B.			Emergency department predictors of tracheostomy in patients with isolated traumatic brain injury requiring emergency cranial decompression	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; tracheostomy; mechanical ventilation	PROLONGED ENDOTRACHEAL INTUBATION; VENTILATOR-ASSOCIATED PNEUMONIA; LUND CONCEPT; OUTCOMES; EPIDEMIOLOGY; TRACHEOTOMY	Object. Patients with severe traumatic brain injury (TBI) frequently require a tracheostomy for prolonged mechanical ventilation and/or pulmonary toilet. It is now proven that the earlier the procedure is done, the more beneficial it is to the patient. The present study was carried out to determine if the requirement of a tracheostomy can be predicted on arrival of a patient to the emergency department. The prediction can potentially aid in combining the procedure with cranial decompression. In this study, the authors' aim was to determine the emergency department predictors of tracheostomy in patients with isolated TBI requiring emergency cranial decompression. Methods. The authors performed a retrospective chart review of all patients who underwent surgery for isolated TBI and required more than 4 days of mechanical ventilation. Multivariate logistic regression analysis was used for predictive indicators. Results. In patients with isolated severe TBI, a patient age of 31-50 years, the presence of preexisting medical comorbid conditions, a delay in emergency department arrival exceeding 1.5 hours, an abnormal pupil response on arrival, and a preoperative neurological worsening during hospital stay were independent predictors of the requirement for tracheostomy. These findings were validated in a small cohort of patients and were found to be significant. Conclusions. Requirement of a tracheostomy can be predicted in patients with severe TBI on arrival to the emergency department. These results were validated in a small cohort of patients, and it was found that the positive predictive value of requirement of tracheostomy was directly proportional to the number of predictors present. Larger prospective studies with appropriate control groups are further recommended to validate the authors' findings. (DOI: 10.3171/2011.7.JNS101829)	[Shamim, Muhammad Shahzad; Qadeer, Mohsin; Murtaza, Ghulam; Enam, S. Ather; Farooqi, Najiha B.] Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, Karachi 74800, Pakistan	Shamim, MS (corresponding author), Aga Khan Univ Hosp, Dept Surg, Neurosurg Sect, POB 3500,Stadium Rd, Karachi 74800, Pakistan.	shahzad.shamim@aku.edu					Agrawal Amit, 2009, J Emerg Trauma Shock, V2, P56, DOI 10.4103/0974-2700.44687; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Branco BC, 2011, J TRAUMA, V70, P111, DOI 10.1097/TA.0b013e3181d9a559; Chintamani, 2005, BMC EMERG MED, V5, DOI 10.1186/1471-227X-5-8; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Gurkin MA, 2002, AM SURGEON, V68, P324; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Holmgren EF, 2007, J ORAL MAXIL SURG, V65, P2005, DOI 10.1016/j.joms.2007.05.019; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Kane T D, 1997, Respir Care Clin N Am, V3, P1; Kollef MH, 1999, CRIT CARE MED, V27, P1714, DOI 10.1097/00003246-199909000-00003; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Nordstrom CH, 2007, INTENS CARE MED, V33, P558, DOI 10.1007/s00134-006-0521-y; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Richard I, 2005, ANN FR ANESTH, V24, P659, DOI 10.1016/j.annfar.2005.03.010; Ross BJ, 1996, AM SURGEON, V62, P19; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Vincent JL, 2001, J CHEMOTHERAPY, V13, P211, DOI 10.1179/joc.2001.13.Supplement-2.211	23	14	14	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2011	115	5					1007	1012		10.3171/2011.7.JNS101829			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	839OR	WOS:000296377800025	21819192				2021-06-18	
J	Zhu, M; Li, MW; Yang, F; Ou, XM; Ren, QX; Gao, H; Zhu, CQ; Guo, JC				Zhu, Min; Li, Mingwei; Yang, Fan; Ou, Xiaomin; Ren, Qingxiao; Gao, Hui; Zhu, Cuiqing; Guo, Jingchun			Mitochondrial ERK plays a key role in delta-opioid receptor neuroprotection against acute mitochondrial dysfunction	NEUROCHEMISTRY INTERNATIONAL			English	Article						Delta-opioid receptor; Primary rat cortical neuron cultures; Sodium azide; Mitogen-activated protein kinases; Neuroprotection; Acute mitochondrial dysfunction	PROTECTS CORTICAL-NEURONS; TRAUMATIC BRAIN-INJURY; INDUCED APOPTOSIS; CYTOCHROME-C; CELL-DEATH; ACTIVATION; INHIBITION; HEART; MECHANISMS; GLUTAMATE	It is well established that stimulating delta-opioid receptor (DOR) with its specific agonists elicits neuroprotection against hypoxia/ischemia. Mitochondrial dysfunction plays a key role in hypoxic neuronal injury, but the effects of DOR activation on mitochondrial dysfunction in neurons are poorly elucidated. In this investigation, we studied the effects of [D-Ala2, D-Leu5] enkephalin (DADLE), a potent DOR agonist, on acute mitochondrial dysfunction and ensuing cell damage induced by sodium azide in primary rat cortical neuronal cultures, and explored possible mechanisms underlying. Here, we show that DADLE reverses NaN3-induced acute mitochondrial dysfunction by selectively activating DOR, mainly including mitochondrial membrane depolarization, mitochondrial Ca2+ overload and reactive oxygen species generation. DOR stimulation also inhibits cytochrome c release and caspase-3 activation, and attenuates neuronal death caused by acute NaN3 insults. Furthermore. DOR activation with DADLE protects neurons from acute NaN3 insults mainly through PKC-ERK pathway, and mitochondrial ERK activation is especially required for DOR neuroprotection against acute mitochondrial dysfunction. (C) 2011 Elsevier B.V. All rights reserved.	[Zhu, Min; Li, Mingwei; Yang, Fan; Ou, Xiaomin; Ren, Qingxiao; Gao, Hui; Zhu, Cuiqing; Guo, Jingchun] Fudan Univ, Shanghai Med Coll, Dept Neurobiol, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Guo, JC (corresponding author), Room 809,Zhidao Bldg,138 YiXueYuan Rd, Shanghai 200032, Peoples R China.	jingchunguo@shmu.edu.cn		Ou, Xiaomin/0000-0002-4626-4429	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30873318]; Science and Technology Commission of ShanghaiScience & Technology Commission of Shanghai Municipality (STCSM) [06DZ19734]	This work was supported by National Natural Science Foundation of China (No. 30873318), and the Science and Technology Commission Program of Shanghai (No. 06DZ19734).	Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bell SP, 2000, J AM COLL CARDIOL, V36, P2296, DOI 10.1016/S0735-1097(00)01011-1; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Chao DM, 2008, CEREB CORTEX, V18, P2217, DOI 10.1093/cercor/bhm247; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Engedal N, 2003, J BIOL CHEM, V278, P10934, DOI 10.1074/jbc.M211556200; Gao Y, 2003, J NEUROSCI, V23, P11770; Gaspar T, 2008, J CEREBR BLOOD F MET, V28, P1090, DOI 10.1038/sj.jcbfm.9600611; Grammatopoulos T, 2002, MOL BRAIN RES, V99, P114, DOI 10.1016/S0169-328X(02)00101-8; Halestrap AP, 1999, BIOCHEM SOC SYMP, V66, P181, DOI 10.1042/bss0660181; He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Iwata M, 2007, BRIT J ANAESTH, V99, P538, DOI 10.1093/bja/aem220; Kaneko T, 2005, BRIT J ANAESTH, V95, P662, DOI 10.1093/bja/aei228; Kang XZ, 2009, CELL MOL LIFE SCI, V66, P3505, DOI 10.1007/s00018-009-0136-x; Kis B, 2003, J NEUROCHEM, V87, P969, DOI 10.1046/j.1471-4159.2003.02072.x; Kowalczyk Joanna Ewa, 2008, Postepy Biochem, V54, P209; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Laing JM, 2010, J NEUROCHEM, V112, P662, DOI 10.1111/j.1471-4159.2009.06475.x; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Li YC, 2010, J NEUROCHEM, V114, P62, DOI 10.1111/j.1471-4159.2010.06720.x; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; Malek SA, 2003, J NEUROSCI, V23, P3826; Marino S, 2007, NEUROTOXICOLOGY, V28, P622, DOI 10.1016/j.neuro.2007.01.005; Martinou JC, 2000, NAT CELL BIOL, V2, pE41, DOI 10.1038/35004069; Maslov L N, 2009, Ross Fiziol Zh Im I M Sechenova, V95, P1175; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Monick MM, 2008, J IMMUNOL, V180, P7485, DOI 10.4049/jimmunol.180.11.7485; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Penna C, 2008, J CELL MOL MED, V12, P435, DOI 10.1111/j.1582-4934.2007.00210.x; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Risso F, 2004, NEUROPHARMACOLOGY, V47, P65, DOI 10.1016/j.neuropharm.2004.02.018; Ryazantseva N. V., 2009, Uspekhi Fiziologicheskikh Nauk, V40, P3; Satoh M, 1995, PHARMACOL THERAPEUT, V68, P343, DOI 10.1016/0163-7258(95)02011-X; Selvatici R, 2009, NEUROCHEM RES, V34, P909, DOI 10.1007/s11064-008-9852-0; Seymour EM, 2003, J SURG RES, V114, P187, DOI 10.1016/S0022-4804(03)00248-8; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Sun K, 2009, BRAIN RES, V1292, P100, DOI 10.1016/j.brainres.2009.06.104; Uppington KM, 2008, J NEUROCHEM, V105, P842, DOI 10.1111/j.1471-4159.2007.05192.x; Wang ZJ, 2006, ACTA PHARMACOL SIN, V27, P145, DOI 10.1111/j.1745-7254.2006.00259.x; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yang YL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-55; Zhang JH, 2006, STROKE, V37, P1094, DOI 10.1161/01.STR.0000206444.29930.18; Zhang JH, 2002, AM J PHYSIOL-CELL PH, V282, pC1225, DOI 10.1152/ajpcell.00226.2001; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zhang Z, 1999, J NEUROCHEM, V73, P1502, DOI 10.1046/j.1471-4159.1999.0731502.x; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zhu M, 2009, BRAIN RES, V1252, P183, DOI 10.1016/j.brainres.2008.11.030	55	14	14	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2011	59	6					739	748		10.1016/j.neuint.2011.08.005			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	853BH	WOS:000297400700001	21864608				2021-06-18	
J	Xu, DW; Cui, SY; Sun, YY; Bao, GF; Li, WD; Liu, W; Zhu, XH; Fan, JB; Wang, YH; Cui, ZM				Xu, Dawei; Cui, Shengyu; Sun, Yuyu; Bao, Guofeng; Li, Weidong; Liu, Wei; Zhu, Xinhui; Fan, Jianbo; Wang, Youhua; Cui, Zhiming			Overexpression of glucose-regulated protein 94 after spinal cord injury in rats	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Glucose-regulated protein 94; Spinal cord injury; Apoptosis; Rat	ENDOPLASMIC-RETICULUM STRESS; NEURONAL CELL-DEATH; C-JUN; SIGNALING PATHWAY; EPITHELIAL-CELLS; TRAUMATIC BRAIN; APOPTOSIS; GRP94; ACTIVATION; INDUCTION	Glucose-regulated protein (GRP) 94 is a member of the stress protein family, which is localized in the endoplasmic reticulum (ER). Spinal cord injury (SCI) induced ER stress that results in apoptosis. However, the role of GRP94 in injury of the central nervous system remains unknown. In this study, we performed SCI in adult rats and investigated acutely the protein expression and cellular localization of GRP94 in the spinal cord. Western blot analysis revealed that GRP94 was low in normal spinal cord. It rose at 6 h after SCI, peaked at 1 day, remained for another 3 days, then declined to basal levels at 5 days after injury. lmmunohistochemistry further confirmed that GRP94 immunoactivity was expressed at low levels in gray matter and white matter in normal condition and increased after SCI. Double immunofluorescence staining showed that GRP94 was co-expressed with NeuN (neuronal marker), and GFAP (astroglial marker). In addition, caspase-12, caspase-3 and phospho-c-Jun NH2-kinase (p-JNK) levels increased at 6 h, peaked at 1 day, and then gradually reduced to normal levels for 2 weeks after SCI by western blot analysis. Co-localization of GRP94/caspase-12 and GRP94/p-JNK was detected in neurons and glial cells. Taken together, these data suggest GRP94 involvement in the injury response of the adult spinal cord of the rats. (C) 2011 Published by Elsevier B.V.	[Xu, Dawei; Cui, Shengyu; Sun, Yuyu; Bao, Guofeng; Li, Weidong; Liu, Wei; Zhu, Xinhui; Fan, Jianbo; Wang, Youhua; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China	Xu, DW (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China.	xdw_nt@163.com; david290@sohu.com			Health Department of Jiangsu Province [kf200953]; Social Development Project of Nantong [S2008042, S2009014, S2010005]	This work was supported by the Open Project of Health Department of Jiangsu Province (no. kf200953) and Social Development Project of Nantong (no. S2008042, S2009014, S2010005).	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Bando Y, 2004, APOPTOSIS, V9, P501, DOI 10.1023/B:APPT.0000031446.95532.ad; Bando Y, 2003, EUR J NEUROSCI, V18, P829, DOI 10.1046/j.1460-9568.2003.02818.x; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; DUCKER TB, 1971, J NEUROSURG, V35, P700, DOI 10.3171/jns.1971.35.6.0700; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAIRHOLM D, 1970, Surgical Forum (Chicago), V21, P453; Gao YQ, 2005, J CEREBR BLOOD F MET, V25, P694, DOI 10.1038/sj.jcbfm.9600062; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; HALL ED, 1993, RES P ARNMD, V71, P81; Herdegen T, 1998, J NEUROSCI, V18, P5124; HIRANO N, 1995, EUR J BIOCHEM, V234, P336, DOI 10.1111/j.1432-1033.1995.336_c.x; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Ishiguro S, 2002, EMBO J, V21, P898, DOI 10.1093/emboj/21.5.898; JACOBS TP, 1987, STROKE, V18, P741, DOI 10.1161/01.STR.18.4.741; Katoh K, 1996, NEUROSCI LETT, V216, P9; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Li QM, 2007, J NEUROSCI, V27, P8395, DOI 10.1523/JNEUROSCI.2478-07.2007; Li W, 2007, PEPTIDES, V28, P1252, DOI 10.1016/j.peptides.2007.03.021; LIN HY, 1993, MOL BIOL CELL, V4, P1109; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Lu Qing, 2005, Keio Journal of Medicine, V54, P184, DOI 10.2302/kjm.54.184; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Nicchitta CV, 2000, ESSAYS BIOCHEM, V36, P15, DOI 10.1042/bse0360015; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; Nishisho T, 1996, NEUROSURGERY, V39, P950, DOI 10.1097/00006123-199611000-00014; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; SENTER HJ, 1978, J NEUROSURG, V49, P569, DOI 10.3171/jns.1978.49.4.0569; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Widmann C, 1999, PHYSIOL REV, V79, P143; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yin KJ, 2005, NEUROBIOL DIS, V20, P881, DOI 10.1016/j.nbd.2005.05.026; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	46	14	16	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	OCT 15	2011	309	1-2					141	147		10.1016/j.jns.2011.06.024			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	825SV	WOS:000295303300029	21807380				2021-06-18	
J	Chen, Y; Montcalm-Smith, E; Schlaerth, C; Auker, C; McCarron, RM				Chen, Ye; Montcalm-Smith, Elizabeth; Schlaerth, Christine; Auker, Charles; McCarron, Richard M.			Acclimation to decompression: stress and cytokine gene expression in rat lungs	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						decompression sickness; inflammation; dive	TRAUMATIC BRAIN-INJURY; BUBBLE FORMATION; SICKNESS; PATHOPHYSIOLOGY; ACTIVATION; ALPHA; HEART; MODEL; EGR-1	Chen Y, Montcalm-Smith E, Schlaerth C, Auker C, McCarron RM. Acclimation to decompression: stress and cytokine gene expression in rat lungs. J Appl Physiol 111: 1007-1013, 2011. First published July 14, 2011; doi:10.1152/japplphysiol.01402.2010.-Previous studies demonstrated that animals exposed to repeated compression-decompression stress acclimated (i.e., developed reduced susceptibility) to rapid decompression. This study endeavored to characterize inflammatory and stress-related gene expression and signal transduction associated with acclimation to rapid decompression. Rats were divided into four groups: 1) control-sham: pressure naive rats; 2) acclimation-sham: nine acclimation dives [70 feet seawater (fsw), 30 min]; 3) control-dive: test dive only (175 fsw, 60 min); and 4) acclimation-dive: nine acclimation dives and a test dive. After the test dive, rats were observed for decompression sickness (DCS). Expression of 13 inflammatory and stress-related genes and Akt (or PKB, a serine/threonine protein kinase) and MAPK phosphorylation of lung tissue were examined. The expression of immediate early gene/transcription factor early growth response gene 1 (Egr-1) was observed in both control and acclimation animals with DCS but not in animals without DCS. Increased Egr-1 in control-dive animals with DCS was significantly greater than in acclimation-dive animals with DCS. TNF-alpha, IL-1 beta, IL-6, and IL-10 were significantly elevated in control-DCS animals. Acclimation-DCS animals had increased TNF-alpha, but there was no change in IL-1 beta, IL-6, and IL-10. High levels of Akt phosphorylation were observed in lungs of acclimation-sham, acclimation-dive, and control-dive animals; phosphorylated ERK1/2 was only observed in animals with DCS. This study suggests that activation of ERK1/2 and upregulation of Egr-1 and its target cytokine genes by rapid decompression may play a role in the initiation and progression of DCS. It may be that the downregulated expression of these genes in animals with DCS is associated with previous exposure to repeated compression-decompression cycles. This study represents an initial step toward understanding the molecular mechanisms associated with acclimation to decompression.	[Chen, Ye; Auker, Charles; McCarron, Richard M.] USN, Dept NeuroTrauma, Med Res Ctr, Silver Spring, MD 20910 USA; [Montcalm-Smith, Elizabeth; Schlaerth, Christine] USN, Dept Undersea Med, Med Res Ctr, Silver Spring, MD 20910 USA; [Auker, Charles] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA	Chen, Y (corresponding author), USN, Dept NeuroTrauma, Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Ye.Chen@med.navy.mil			Office of Naval Research Work UnitOffice of Naval Research [602236N.4122.A0301]	This work was funded by the Office of Naval Research Work Unit Number 602236N.4122.A0301.	Bakovic D, 2008, AVIAT SPACE ENVIR MD, V79, P626, DOI 10.3357/ASEM.2244.2008; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bigley NJ, 2008, J INTERF CYTOK RES, V28, P55, DOI 10.1089/jir.2007.0084; BUTLER BD, 1991, AVIAT SPACE ENVIR MD, V62, P997; CAGNOL S, FEBS J, V277, P2; Doolette DJ, 2003, UNDERSEA HYPERBAR M, V30, P127; ECKENHOFF RG, 1990, J APPL PHYSIOL, V69, P914; Ersson A, 1998, UNDERSEA HYPERBAR M, V25, P217; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Huang KL, 2003, J APPL PHYSIOL, V94, P1485, DOI 10.1152/japplphysiol.00952.2002; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Jun T., 1999, SCI STKE, V1999, pPE1; Kaufmann K, 2001, J NEUROL SCI, V189, P83, DOI 10.1016/S0022-510X(01)00562-7; Kaur K, 2009, HEART FAIL REV, V14, P113, DOI 10.1007/s10741-008-9104-z; Kim HS, 2005, FASEB J, V19, P1042, DOI 10.1096/fj.04-2841fje; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Levett DZH, 2008, POSTGRAD MED J, V84, P571, DOI 10.1136/pgmj.2008.068320; LILLO RS, 1985, J APPL PHYSIOL, V59, P1503; Montcalm-Smith E, 2007, AVIAT SPACE ENVIR MD, V78, P87; MONTCALMSMITH EA, J APPL PHYSL, V108, P596; Muth CM, 2000, ANAESTHESIST, V49, P302, DOI 10.1007/s001010050832; Pontier JM, 2009, AVIAT SPACE ENVIR MD, V80, P15, DOI 10.3357/ASEM.2347.2009; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Su CL, 2004, AM J PHYSIOL-REG I, V287, pR1214, DOI 10.1152/ajpregu.00260.2004; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Vann RD, 2008, AVIAT SPACE ENVIR MD, V79, P797, DOI 10.3357/ASEM.2316.2008; WALDER D. N., 1966, ANN ROY COLL SURG ENGL, V38, P288; WARD CA, 1987, J APPL PHYSIOL, V62, P1160; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	31	14	19	0	4	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	OCT	2011	111	4					1007	1013		10.1152/japplphysiol.01402.2010			7	Physiology; Sport Sciences	Physiology; Sport Sciences	834OR	WOS:000295972000009	21757575				2021-06-18	
J	Imaizumi, T; Miyata, K; Inamura, S; Kohama, I; Nyon, KS; Nomura, T				Imaizumi, Toshio; Miyata, Kei; Inamura, Shigeru; Kohama, Ikuhide; Nyon, Kim Sang; Nomura, Tatsufumi			The Difference in Location between Traumatic Cerebral Microbleeds and Microangiopathic Microbleeds Associated with Stroke	JOURNAL OF NEUROIMAGING			English	Article						Microbleed; diffuse axonal injury; concussion; head trauma	DIFFUSE AXONAL INJURY; AMYLOID ANGIOPATHY; INTRACEREBRAL HEMORRHAGE; HEMOSIDERIN SPOTS; BRAIN-INJURY; CORPUS-CALLOSUM; HEAD-INJURY; CT FINDINGS; MR; ECHO	BACKGROUND AND PURPOSE Microbleeds (MBs) are low-intensity spots on gradient echo T2*-weighted MRI frequently associated with cerebral microangiopathies resulting in stroke. MBs can also be caused by cerebral axonal injuries. We compared the location of MBs associated with cerebral microangiopathies with those associated with trauma. METHODS T2*-weighted MRI identified traumatic MBs (t-MBs) in 23 (6 females; 38.7 +/- 25.8 years old) of the 312 patients with head trauma consecutively admitted to our hospital between March 2003 and March 2009. We prospectively examined for the presence of microangiopathic MBs (m-MBs) in the 131 patients (59 females; 65.2 +/- 9.2 years old) admitted consecutively for stroke (May -December 2004) as controls. RESULTS We identified a total of 145 t-MBs and 504 m-MBs. t-MBs were frequently located in the mid portion of the subcortical area of the cerebrum, above the corpus callosum in axial slices, and were absent from the basal ganglia. In contrast, m-MBs were frequently located within the basal ganglia or thalamus. CONCLUSION There are substantial differences in locations of MB development in trauma patients in comparison to stroke patients.	[Imaizumi, Toshio; Miyata, Kei; Inamura, Shigeru; Kohama, Ikuhide; Nyon, Kim Sang; Nomura, Tatsufumi] Kushiro City Gen Hosp, Dept Neurosurg, Kushiro, Hokkaido 0850822, Japan	Imaizumi, T (corresponding author), Kushiro City Gen Hosp, Dept Neurosurg, 1-12 Shunkodai, Kushiro, Hokkaido 0850822, Japan.	timaizum@d9.dion.ne.jp					Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Gadda D, 2004, NEURORADIOLOGY, V46, P812, DOI 10.1007/s00234-004-1250-y; Gennarelli TA, 1993, HEAD INJURY, P137; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; GODERSKY JC, 1990, ACT NEUR S, V51, P311; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Good CD, 1998, NEURORADIOLOGY, V40, P308, DOI 10.1007/s002340050590; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, P281; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Greenberg SM, 1999, NEUROLOGY, V53, P1135, DOI 10.1212/WNL.53.5.1135; Hahnel S, 2008, AM J NEURORADIOL, V29, P388, DOI 10.3174/ajnr.A0799; Horita Y, 2003, NEUROL SURG TOKYO, V31, P263; Imaizumi T, 2005, J NEUROIMAGING, V15, P157, DOI 10.1177/1051228404274307; Imaizumi T, 2004, J NEUROSURG, V101, P915, DOI 10.3171/jns.2004.101.6.0915; Imaizumi T, 2003, J NEUROIMAGING, V13, P155, DOI 10.1177/1051228403251250; Imaizumi Toshio, 2008, J Stroke Cerebrovasc Dis, V17, P30, DOI 10.1016/j.jstrokecerebrovasdis.2007.11.001; Kidwell CS, 2002, STROKE, V33, P95, DOI 10.1161/hs0102.101792; Kinoshita T, 2000, STROKE, V31, P1646, DOI 10.1161/01.STR.31.7.1646; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; McCarron MO, 1999, STROKE, V30, P1643, DOI 10.1161/01.STR.30.8.1643; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nighoghossian N, 2002, STROKE, V33, P735, DOI 10.1161/hs0302.104615; Roob G, 2000, STROKE, V31, P2665, DOI 10.1161/01.STR.31.11.2665; Rosand J, 2000, NEUROLOGY, V55, P947, DOI 10.1212/WNL.55.7.947; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Tanaka A, 1999, STROKE, V30, P1637, DOI 10.1161/01.STR.30.8.1637; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006	35	14	14	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1051-2284			J NEUROIMAGING	J. Neuroimaging	OCT	2011	21	4					359	364		10.1111/j.1552-6569.2011.00593.x			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	834OF	WOS:000295970700011	21447027				2021-06-18	
J	Li, XG; von Holst, H; Kleiven, S				Li, Xiaogai; von Holst, Hans; Kleiven, Svein			Influence of gravity for optimal head positions in the treatment of head injury patients	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Brain edema; Finite element method; Gravitational force; Neurosurgery	PRESSURE; HYDROCEPHALUS; PATHOPHYSIOLOGY; EDEMA	Brain edema is a major neurological complication of traumatic brain injury (TBI), commonly including a pathologically increased intracranial pressure (ICP) associated with poor outcome. In this study, gravitational force is suggested to have a significant impact on the pressure of the edema zone in the brain tissue and the objective of the study was to investigate the significance of head position on edema at the posterior part of the brain using a finite element (FE) model. A detailed FE model including the meninges, brain tissue and a fully connected cerebrospinal fluid (CSF) system was used in this study. Brain tissue was modelled as a poroelastic material consisting of an elastic solid skeleton composed of neurons and neuroglia, permeated by interstitial fluid. The effect of head positions (supine and prone position) due to gravity was investigated for a localized brain edema at the posterior part of the brain. The water content increment at the edema zone remained nearly identical for both positions. However, the interstitial fluid pressure (IFP) inside the edema zone decreased around 15% by having the head in a prone position compared with a supine position. The decrease of IFP inside the edema zone by changing patient position from supine to prone has the potential to alleviate the damage to central nervous system nerves. These observations indicate that considering the patient's head position during intensive care and at rehabilitation might be of importance to the treatment of edematous regions in TBI patients.	[Li, Xiaogai; von Holst, Hans; Kleiven, Svein] KTH Royal Inst Technol, Div Neuron Engn, S-14152 Huddinge, Sweden; [von Holst, Hans] Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Stockholm, Sweden	Li, XG (corresponding author), KTH Royal Inst Technol, Div Neuron Engn, Alfred Nobels Alle 10, S-14152 Huddinge, Sweden.	xiaogai@kth.se		Li, Xiaogai/0000-0001-8522-4705	Swedish Research CouncilSwedish Research CouncilEuropean Commission [621-2008-3400]; Chinese Council Scholarship (CSC)	We are grateful for the technical support from Comsol support on the implementation of poroelastisity in the software. We would like to acknowledge financial support provided by the Swedish Research Council D.nr. 621-2008-3400, and the Chinese Council Scholarship (CSC) for the first author.	AGACHE PG, 1980, ARCH DERMATOL RES, V269, P221, DOI 10.1007/BF00406415; ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Coffey AM, 2010, PROC SPIE, V7625, DOI 10.1117/12.844477; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Dutta-Roy T, 2008, J BIOMECH, V41, P2263, DOI 10.1016/j.jbiomech.2008.04.014; Edsbagge M, 2004, AM J PHYSIOL-REG I, V287, pR1450, DOI 10.1152/ajpregu.00215.2004; Feigin V. L., 2007, HDB CLIN NEUROEPIDEM, P197; Hertelendy AJ, 2009, CRITICAL CARE TRANSP, P364; Hinghofer-Szalkay H, 2011, EUR J APPL PHYSIOL, V111, P163, DOI 10.1007/s00421-010-1646-9; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Ju WK, 2009, MOL VIS, V15, P120; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Kim JH, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3169248; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Levine DN, 1999, B MATH BIOL, V61, P875, DOI 10.1006/bulm.1999.0116; LI XG, 2009, P WORLD C MED PHYS B, P1478; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2003, ACT NEUR S, V86, P7; Miga MI, 2001, NEUROSURGERY, V49, P75, DOI 10.1097/00006123-200107000-00012; Mindermann T, 1999, J CLIN NEUROSCI, V6, P464, DOI 10.1016/S0967-5868(99)90001-2; NAGASHIMA T, 1990, Neurologia Medico-Chirurgica, V30, P1, DOI 10.2176/nmc.30.1; NAGASHIMA T, 1987, NEUROSURGERY, V21, P898, DOI 10.1227/00006123-198712000-00019; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; REULEN HJ, 1973, ACTA NEUROCHIR, V29, P29, DOI 10.1007/BF01414614; Smillie A, 2005, J FLUID MECH, V539, P417, DOI 10.1017/S0022112005005707; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	31	14	14	0	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2011	153	10					2057	2064		10.1007/s00701-011-1078-2			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	818WU	WOS:000294787400021	21739174				2021-06-18	
J	Zlotnik, A; Gruenbaum, BF; Klin, Y; Gruenbaum, SE; Ohayon, S; Sheiner, E; Kuts, R; Boyko, M; Bichovsky, Y; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Gruenbaum, Benjamin Fredrick; Klin, Yael; Gruenbaum, Shaun Evan; Ohayon, Sharon; Sheiner, Eyal; Kuts, Ruslan; Boyko, Matthew; Bichovsky, Yoav; Shapira, Yoram; Teichberg, Vivian I.			The Effects of Insulin, Glucagon, Glutamate, and Glucose Infusion on Blood Glutamate and Plasma Glucose Levels in Naive Rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						endocrine; glucagon; glucose; glutamate; insulin; neuroprotection	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; AMINO-ACIDS; CEREBROSPINAL-FLUID; INDUCED HYPOGLYCEMIA; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; ISCHEMIC-STROKE; AMPA SUBTYPE; ISLET CELLS	Background: Elevated levels of glutamate in brain fluids, in the context of several neurodegenerative conditions, are associated with a worsened neurological outcome. Because there is a clear relationship between brain glutamate levels and glutamate levels in the blood, and an association of the latter with stress, the purpose of this study was to investigate the effects of glucose, insulin, and glucagon on rat blood glutamate levels. Methods: Rats received either 1 mL/100 g of rat body weight (BW) intravenous isotonic saline (control), 150 mg/1 mL/100 g BW intravenous glucose, 75 mg/1 mL/100 g BW intravenous glutamate, 50 mu g/100 g BW intraparitoneal glucagon, or 0.2 UI/100 g BW intraparitoneal insulin. Blood samples were subsequently drawn at 0, 30, 60, 90, and 120 minutes for determination of blood glutamate and glucose levels. Results: We observed a significant decrease in blood glutamate levels at 30 minutes after injection of glucose (P < 0.05), at 30 and 60 minutes after injection of insulin (P < 0.05), and at 90 and 120 minutes after injection of glucagon. Plasma glucose levels were elevated after infusion of glutamate and glucose but were decreased after injection of insulin. Conclusions: The results of this study demonstrate that glucose, insulin, and glucagon significantly reduce blood glutamate levels. The effect of insulin is immediate and transient, whereas the effect of glucagon is delayed but longer lasting, suggesting that the sensitivity of pancreatic glucagon and insulin-secreting cells to glutamate is dependent on glucose concentration. The results of this study provide insight into blood glutamate homeostasis and may assist in the implementation of new therapies for brain neuroprotection from excess glutamate.	[Zlotnik, Alexander; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Kuts, Ruslan; Boyko, Matthew; Bichovsky, Yoav; Shapira, Yoram] Ben Gurion Univ Negev, Div Anesthesiol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Sheiner, Eyal] Ben Gurion Univ Negev, Dept Obstet & Gynecol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; [Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Gruenbaum, Shaun Evan] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA	Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Div Anesthesiol, Soroka Med Ctr, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	SHEINER, EYAL/F-1488-2012	Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases; Braintact Ltd; Irwin Green Fund for Studying the Development of the Brain; Carl and Micaela Einhorn-Dominic Institute for Brain Research	Supported in part by grants to VIT from the Nella and Leon Benoziyo Center for Neurological Diseases, Braintact Ltd, the Irwin Green Fund for Studying the Development of the Brain, and the Carl and Micaela Einhorn-Dominic Institute for Brain Research. VIT is the incumbent of the Louis and Florence Katz-Cohen Chair of Neuropharmacology.	ASSAN R, 1977, DIABETES, V26, P300, DOI 10.2337/diabetes.26.4.300; BAUM D, 1979, AM J PHYSIOL, V237, pE404; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; BERTRAND G, 1995, AM J PHYSIOL-ENDOC M, V269, pE551; BUTCHER SP, 1987, J NEUROCHEM, V48, P722, DOI 10.1111/j.1471-4159.1987.tb05576.x; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; DEFEO P, 1989, AM J PHYSIOL, V257, pE35; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; FELIG P, 1976, DIABETES, V25, P1091, DOI 10.2337/diabetes.25.12.1091; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; GRINO M, 1992, ENDOCRINOLOGY, V131, P2763, DOI 10.1210/en.131.6.2763; Harbrecht BG, 2004, SHOCK, V22, P157, DOI 10.1097/01.shk.0000131579.22409.33; HAVEL PJ, 1989, ENDOCR REV, V10, P332, DOI 10.1210/edrv-10-3-332; Huypens P, 2000, DIABETOLOGIA, V43, P1012, DOI 10.1007/s001250051484; INAGAKI N, 1995, FASEB J, V9, P686; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; KAWAI K, 1995, DIABETOLOGIA, V38, P274, DOI 10.1007/BF00400630; Kerner A, 2007, NEUROL RES, V29, P647, DOI 10.1179/016164107X248983; Koura SS, 1998, ACT NEUR S, V71, P244; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; MORITA Y, 1962, ENDOCRINOL JAPON, V9, P103; MORITA Y, 1962, ENDOCRINOL JAPON, V9, P57; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Rotllant J, 1997, J FISH BIOL, V51, P21, DOI 10.1111/j.1095-8649.1997.tb02510.x; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; THOMASSEN A, 1991, METABOLISM, V40, P378, DOI 10.1016/0026-0495(91)90148-P; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2007, NEUROCHEM RES; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	48	14	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2011	23	4					323	328		10.1097/ANA.0b013e3182299b15			6	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	818ML	WOS:000294755700006	21836527				2021-06-18	
J	Fahlenkamp, AV; Coburn, M; Haase, H; Kipp, M; Ryang, YM; Rossaint, R; Beyer, C				Fahlenkamp, Astrid V.; Coburn, Mark; Haase, Hajo; Kipp, Markus; Ryang, Yu-Mi; Rossaint, Rolf; Beyer, Cordian			Xenon Enhances LPS-Induced IL-1 beta Expression in Microglia via the Extracellular Signal-Regulated Kinase 1/2 Pathway	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Anaesthetics; Inhalation; Xenon Mitogen-activated protein kinases; Phosphoprotein phosphatases	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; INFLAMMATORY RESPONSE; TNF-ALPHA; CARDIOPULMONARY BYPASS; STIMULATED MACROPHAGES; SODIUM ORTHOVANADATE; GENE-EXPRESSION; ACTIVATION; CELLS	The extracellular signal-regulated kinase (ERK) is involved in the cytokine production of immune cells. In this study, we show the influence of xenon on phosphatase activity, ERK 1/2 signalling and cytokine expression in microglia. The murine microglia cell line BV-2 was treated with 50 ng/ml lipopolysaccharide (LPS) and 74% xenon in 21% O-2 and 5% CO2. Cytokine levels were examined by gene expression analysis, Western blot and enzyme-linked immunosorbent assay. Phosphatase inhibition was assessed with p-nitrophenylphosphate and phosphorylation of ERK 1/2 via Western blot. Xenon significantly enhanced LPS-mediated IL-1 beta expression. ERK 1/2 phosphorylation was observed after xenon or LPS treatment which was inhibited by the use of the MEK inhibitor U0126. Xenon and LPS in combination superimposed individual effects on ERK 1/2 activation. Xenon decreased cellular phosphatase activity in microglia by 20% and inhibited dephosphorylation of ERK 1/2 up to 1 h. The blocking of ERK 1/2 reduced IL-1 beta expression in xenon and LPS-treated cells to a level obtained by LPS alone. In conclusion, xenon enhanced LPS-induced IL-1 beta expression in microglia by activation of ERK 1/2 signalling. Xenon's interference with phosphatases may be a key feature to affect multiple intracellular signalling pathways.	[Fahlenkamp, Astrid V.; Coburn, Mark; Rossaint, Rolf] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anaesthesiol, Fac Med, D-52074 Aachen, Germany; [Fahlenkamp, Astrid V.; Kipp, Markus; Beyer, Cordian] Rhein Westfal TH Aachen, Inst Neuroanat, Fac Med, D-52074 Aachen, Germany; [Haase, Hajo] Rhein Westfal TH Aachen, Inst Immunol, Univ Hosp Aachen, Fac Med, D-52074 Aachen, Germany; [Ryang, Yu-Mi] Tech Univ Munich, Dept Neurosurg, Klinikum Rechts Isar, D-81675 Munich, Germany	Coburn, M (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anaesthesiol, Fac Med, Pauwelsstr 30, D-52074 Aachen, Germany.	mcoburn@ukaachen.de	Kipp, Markus/K-2694-2015; Haase, Hajo/B-9280-2009; Ryang, Yu-Mi/Q-8373-2016	Haase, Hajo/0000-0002-1622-8718; Ryang, Yu-Mi/0000-0002-9045-5038; Coburn, Mark/0000-0002-7930-0270	Air Liquide Sante International; RWTH Aachen University	Dr. Coburn and Prof. Dr. Rossaint received lecture and consultant fees from Air Liquide Sante International, a company interested in developing clinical applications for medical gases including xenon. None of the remaining authors received any corporate support, honoraria etc.; The study was supported by two grants allocated to A. Fahlenkamp (Forschungsrotation, START, both RWTH Aachen University).	Amantea D, 2009, FEBS J, V276, P13, DOI 10.1111/j.1742-4658.2008.06766.x; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Clark JA, 2005, J CARDIOTHOR VASC AN, V19, P488, DOI 10.1053/j.jvca.2005.05.007; Coburn M, 2005, BRIT J ANAESTH, V94, P198, DOI 10.1093/bja/aei023; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Cooper ZA, 2010, AM J PHYSIOL-CELL PH, V298, pC171, DOI 10.1152/ajpcell.00346.2009; de Rossi LW, 2004, ANESTH ANALG, V98, P1007, DOI 10.1213/01.ANE.0000106860.27791.44; Feng YZ, 2008, BRAIN RES BULL, V76, P102, DOI 10.1016/j.brainresbull.2008.01.012; Gabbita SP, 2000, ARCH BIOCHEM BIOPHYS, V376, P1, DOI 10.1006/abbi.1999.1685; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gerling N, 2004, NEUROCHEM INT, V44, P505, DOI 10.1016/j.neuint.2003.08.013; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hasegawa Y, 2003, J CEREBR BLOOD F MET, V23, P1040, DOI 10.1097/01.WCB.0000085160.71791.3F; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kriz Jasna, 2006, Critical Reviews in Neurobiology, V18, P145; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee K, 2002, FREE RADICAL BIO MED, V33, P1121, DOI 10.1016/S0891-5849(02)01000-6; Liu JL, 2010, BRAIN RES, V1316, P101, DOI 10.1016/j.brainres.2009.12.055; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Mio Y, 2009, ANESTH ANALG, V108, P858, DOI 10.1213/ane.0b013e318192a520; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Saravanan P, 2009, BRIT J ANAESTH, V103, P805, DOI 10.1093/bja/aep297; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Torres M, 2002, ANN NY ACAD SCI, V973, P345, DOI 10.1111/j.1749-6632.2002.tb04663.x; Weber NC, 2006, BRIT J ANAESTH, V97, P298, DOI 10.1093/bja/ael153; Weber NC, 2005, BRIT J PHARMACOL, V144, P123, DOI 10.1038/sj.bjp.0706063; Weber NC, 2006, EUR J PHARMACOL, V539, P1, DOI 10.1016/j.ejphar.2006.03.054; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Wu J, 2008, ACTA NEUROCHIR SUPPL, V105, P59	45	14	14	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2011	45	1					48	59		10.1007/s12031-010-9432-z			12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	798GT	WOS:000293191300007	20680516				2021-06-18	
J	Meirelles, CMJ; de Aguilar-Nascimento, JE				Justo Meirelles, C. Ma; de Aguilar-Nascimento, J. E.			Enteral or parenteral nutrition in traumatic brain injury: a prospective randomised trial	NUTRICION HOSPITALARIA			English	Article						Enteral nutrition; Parenteral nutrition; Brain injury; Trauma; Nutritional therapy	SEVERE HEAD-INJURY; CRITICALLY-ILL; INFLAMMATORY RESPONSE; METABOLIC-RESPONSE; GLUCOSE CONTROL; SUPPORT; PATIENT; PNEUMONIA; MORTALITY; ONSET	Introduction: Few studies have evaluated the route of nutritional therapy in patients with head trauma. Objective: We aimed at investigating whether early enteral (EN) or parenteral nutrition (TPN) may differ in protein/ calorie supply, serum glucose modifications, and acute phase response in patients with traumatic brain injury (TBI). Methods: Twenty two patients with moderate TBI (Glasgow score between 9-12) were randomized to receive isocaloric and isonitrogeneous either EN (n = 12) or TPN (n = 10). The daily amount of calories and nitrogen (N) supplied, the nitrogen balance, and the daily serum level of glucose, C-reactive protein, and albumin were collected for 5 consecutive days. Clinical endpoints as length of stay and mortality were also compared. Results: Mortality was 9.1% (two cases) with one case in each group. A progressive caloric deficit occurred in both groups (p = 0.001) without difference between them. The mean serum glucose level in TNP patients (134.4, 95% CI = 122.6 to 146.2 mg/dl) was significantly higher than in the EN group (102,4; 95% CI 91.6 to 113.2 mg/dL) (p < 0.001). There was a trend (p = 0.06) of 24 h urinary N loss to be greater in TPN group which received higher amounts of N than the NE group (p < 0.05). However, nitrogen balance was similar in the two groups. There was no difference in either the clinical outcome variables or the acute phase response. Conclusion: Both routes were able to supply increasing provision of calories to brain injured patients. TPN provided significantly greater amount of nitrogen but losses were also greater. Nitrogen balance was similar with both types of therapy. Parenteral compared to enteral nutrition lead to greater hyperglycemia. There was no influence of the route in both the early inflammatory response and clinical outcome.	[de Aguilar-Nascimento, J. E.] Univ Fed Mato Grosso, Sch Med Sci, Dept Surg, Cuiaba, Brazil; [Justo Meirelles, C. Ma] Univ Fed Mato Grosso, Sch Med Sci, Hlth Sci Postgrad Course, Cuiaba, Brazil	de Aguilar-Nascimento, JE (corresponding author), Hosp Univ Julio Muller, Rua Estevao de Mendonca 81,Apto 801, BR-78043300 Cuiaba, Mato Grosso, Brazil.	aguilar@terra.com.br					BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS77, DOI DOI 10.1089/NEU.2006.9984; Bratton SL, 2007, J NEUROTRAUM, V24, P77; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; Collier B, 2008, NUTR CLIN PRACT, V23, P3, DOI 10.1177/011542650802300103; Borges Dock-Nascimento D., 2005, Nutr. Hosp., V20, P343; ESCRIBANO JAA, 2001, NUTR HOSP, V16, P262; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; Davila JG, 2010, NUTR HOSP, V25, P443, DOI 10.3305/nh.2010.25.3.4414; Goiburu ME, 2006, NUTR HOSP, V21, P604; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; HADFIELD RJ, 1995, AM J RESP CRIT CARE, V152, P1545, DOI 10.1164/ajrccm.152.5.7582291; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Nataloni S, 1999, CLIN NUTR, V18, P247, DOI 10.1016/S0261-5614(99)80077-6; Niinikoski H, 2004, J NUTR, V134, P1467; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; RAURICH JM, 1994, JPEN-PARENTER ENTER, V18, P521, DOI 10.1177/0148607194018006521; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Vizzini A, 2010, NUTRITION       0623; Wernerman J, 2008, CURR OPIN CLIN NUTR, V11, P160, DOI 10.1097/MCO.0b013e3282f53370; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076	28	14	15	0	6	AULA MEDICA EDICIONES	MADRID	C/ISABEL COLBRAND, 10-12 NAVE 78 S PLANTA CIUDAD INDUSTRIAL VENECIA-EDIFICIO ALFA, MADRID, 28050, SPAIN	0212-1611	1699-5198		NUTR HOSP	Nutr. Hosp.	SEP-OCT	2011	26	5					1120	1124		10.3305/nh.2011.26.5.5133			5	Nutrition & Dietetics	Nutrition & Dietetics	817SC	WOS:000294694100030	22072362	DOAJ Gold			2021-06-18	
J	Petkovic, S; Maletin, M; Durendic-Brenesel, M				Petkovic, Stojan; Maletin, Miljen; Durendic-Brenesel, Maja			Complex Suicide: An Unusual Case with Six Methods Applied	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; complex suicide; screwdriver; traumatic brain injury; insecticide; hypothermia		Complex suicides (CSs) are committed by using more than one method. They account for 1.5-5% of all suicides. We present a case of CSs of a 44-year-old man, found dead in the vicinity of his car, in a deserted frozen field. Police investigation excluded homicide, and no medical data confirmed mental illnesses. Autopsy revealed wrist cuts, neck cuts, acid burns in the GI tract, multiple stab wounds to the head by a screwdriver, and several uncertain signs of hypothermia. Toxicology analysis (gas chromatography-mass spectrometry) confirmed ingestion of insecticide. We concluded that stab wounds to the head were the cause of death, while external hemorrhage and hypothermia were contributing factors. This is the first case of CSs reviewed in the literature where six suicide methods were applied. This particular case is interesting because the victim used a screwdriver as a tool for inflicting stab wounds to the head, which is a rare suicidal method.	[Petkovic, Stojan; Maletin, Miljen; Durendic-Brenesel, Maja] Clin Ctr Vojvodina, Inst Forens Med, Novi Sad 21000, Serbia	Petkovic, S (corresponding author), Clin Ctr Vojvodina, Inst Forens Med, Hajduk Veljkova 5-7, Novi Sad 21000, Serbia.	pstojan@eunet.rs			Ministry of Science and Technological Development, Republic of Serbia [III41012]	The Ministry of Science and Technological Development, Republic of Serbia (grant number III41012) supported this work.	Altun G, 2006, FORENSIC SCI INT, V157, P83, DOI 10.1016/j.forsciint.2005.04.039; Arevalo-Silva C, 2006, LARYNGOSCOPE, V116, P1422, DOI 10.1097/01.mlg.0000225376.83670.4d; Bohnert M, 2003, FORENSIC SCI INT, V131, P197, DOI 10.1016/S0379-0738(02)00449-8; Bohnert M, 2004, FOREN PATHOL REV, V2, P127; Bohnert Michael, 2004, Archiv fuer Kriminologie, V213, P138; Bozzeto-Ambrosi P, 2008, ARQ NEURO-PSIQUIAT, V66, P93, DOI 10.1590/S0004-282X2008000100024; Cingolani M, 2000, AM J FOREN MED PATH, V21, P255, DOI 10.1097/00000433-200009000-00015; Demirci S, 2009, AM J FOREN MED PATH, V30, P152, DOI 10.1097/PAF.0b013e318187deb7; Harrington T, 2000, HEAD INJURY, P349; MADEA B, 1989, Z RECHTSMED, V102, P59; MARCINKOWSKI T, 1974, FORENSIC SCI, V3, P95, DOI 10.1016/0300-9432(74)90013-2; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; Racette S, 2007, J FORENSIC SCI, V52, P449, DOI 10.1111/j.1556-4029.2007.00387.x; Smrkolj V, 1995, FORENSIC SCI INT, V76, P211, DOI 10.1016/0379-0738(95)01824-7; Toero K, 2009, FORENSIC SCI INT, V184, P6, DOI 10.1016/j.forsciint.2008.10.020; Turk EE, 2004, FORENSIC SCI INT, V139, P35, DOI 10.1016/j.forsciint.2003.09.013; Viel G, 2009, FORENSIC SCI INT, V187, pE7, DOI 10.1016/j.forsciint.2009.01.022; VILLIERS JCD, 1975, BRIT J OPHTHALMOL, V59, P52	18	14	14	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2011	56	5					1368	1372		10.1111/j.1556-4029.2011.01821.x			5	Medicine, Legal	Legal Medicine	816OT	WOS:000294612600048	21644993				2021-06-18	
J	Sabin, MJ; Van Boxtel, BA; Nohren, MW; Broglio, SP				Sabin, Matthew J.; Van Boxtel, Bridget A.; Nohren, Matthew W.; Broglio, Steven P.			Presence of Headache Does Not Influence Sideline Neurostatus or Balance in High School Football Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; postural control	SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; POSTURAL STABILITY; NCAA CONCUSSION; PLAYERS; EPIDEMIOLOGY; COLLEGIATE; MANAGEMENT; SYMPTOMS; PERFORMANCE	Objective: Headache is the primary self-reported symptom used to indicate concussion. Thus, we examined the relationship between reports of nonconcussion-induced headache after contact sport participation and scores on common concussion assessment measures. Design: Two-group repeated measures. Setting: Secondary school. Participants: One hundred five athletes from 3 area football teams completed a baseline evaluation. Sixteen athletes reported headaches after a practice/game and were compared with 16 gender-matched, age-matched, height-matched, weight-matched, and position-matched controls. Independent Variable: Self-report headache. Main Outcome Measures: Symptom severity and endorsement reported on the Graded Symptoms Checklist (GSC), neurostatus measured using the Standard Assessment of Concussion (SAC), and postural control evaluated with the Balance Error Scoring System (BESS). Results: Total symptom severity significantly increased (P < 0.01; 8.06 +/- 2.22 to 16.06 +/- 3.82) in the headache group and significantly decreased in the nonheadache group (P = 0.01; 6.81 +/- 1.85 to 3.00 +/- 1.08). Symptom endorsement increased in the headache group (P = 0.06; 3.25 +/- 0.80 to 5.25 +/- 1.08) and significantly decreased in the nonheadache group (P = 0.01; 3.19 +/- 0.78 to 1.69 +/- 0.58). Both groups showed nonsignificant (P > 0.05) changes in SAC scores (headache, 24.75 +/- 0.73 to 24.81 +/- 0.75; nonheadache, 24.50 +/- 0.73 to 24.87 +/- 1.20). Errors of the BESS significantly increased in both the groups at postgame/postpractice evaluation (headache, P = 0.01; 14.94 +/- 1.86 to 20.31 +/- 2.23; nonheadache, P < 0.01; 13.31 +/- 1.68 to 18.13 +/- 1.69). The presence of headache was significantly correlated with symptom reports (P > 0.05) but not SAC or BESS performance. Conclusions: These findings indicate that the use of headache, exclusively or in combination with other concussion-related symptoms, does not indicate performance on common concussion tools. This supports previous works, suggesting that clinicians must adopt a multifaceted approach to concussion assessment.	[Sabin, Matthew J.] Eastern Kentucky Univ, Dept Exercise & Sport Sci, Richmond, KY 40475 USA; [Van Boxtel, Bridget A.] Steadman Clin, Vail, CO USA; [Nohren, Matthew W.] ATI Phys Therapy, Chicago, IL USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Neurotrauma Res Lab, Ann Arbor, MI 48109 USA	Sabin, MJ (corresponding author), Eastern Kentucky Univ, Dept Exercise & Sport Sci, Moberly Bldg,Room 231,521 Lancaster Ave, Richmond, KY 40475 USA.	mnmsabin@yahoo.com					Blau JN, 2004, HEADACHE, V44, P79, DOI 10.1111/j.1526-4610.2004.04014.x; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Crystal SC, 2010, CURR PAIN HEADACHE R, V14, P449, DOI 10.1007/s11916-010-0146-2; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Klenck Chris A, 2007, Curr Sports Med Rep, V6, P25, DOI 10.1007/s11932-007-0008-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M., 1997, STANDARDIZED ASSESSM; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Patel AV, 2007, J ATHL TRAINING, V42, P66; Ramadan Nabih M, 2004, Curr Pain Headache Rep, V8, P301, DOI 10.1007/s11916-004-0012-1; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Susco TM, 2004, J ATHL TRAINING, V39, P241; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	33	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2011	21	5					411	415		10.1097/JSM.0b013e318223f3a4			5	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	814VJ	WOS:000294485000005	21860349				2021-06-18	
J	Wang, ZP; Chen, HS; Wang, FX				Wang, Zhi-ping; Chen, Hong-sheng; Wang, Feng-xiang			Influence of Plasma and Cerebrospinal Fluid Levels of Endothelin-1 and No in Reducing Cerebral Vasospasm after Subarachnoid Hemorrhage During Treatment with Mild Hypothermia, in a Dog Model	CELL BIOCHEMISTRY AND BIOPHYSICS			English	Article						Mild hypothermia; Subarachnoid hemorrhage; Cerebral vasospasm; Endothelin-1	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; RESUSCITATIVE HYPOTHERMIA; PROLONGED VASOSPASM; NITRIC-OXIDE; FEASIBILITY; KINASE; INTERVENTION; INHIBITORS; MECHANISM	Using vascular heat-exchange controller implemented mild hypothermia treatment, the authors established the cerebral vasospasm model in which blood was injected twice into dog's foramen magnum; and it was discussed the influence of the concentration of endothelin-1 and NO in blood plasma and cerebrospinal fluid through continuing treatment of mild hypothermia at different times in secondary brain vasospasm model after subarachnoid hemorrhage. Thirty healthy mongrel dogs were randomly divided into five groups; artificial cerebrospinal fluid group (group A), normal temperature control group (group C), mild hypothermia 8 h group (group H1), mild hypothermia 16 h group (group H2), and mild hypothermia 32 h group (group H3). The authors injected the artificial CSF into dog's foramen magnum in group A while the other four groups were injected with autologous arterial blood. The normal group's temperature maintained 38.5A degrees C. The authors set the temperature at 33.5A degrees C in mild hypothermia groups and this was maintained for 8, 16, and 32 h, respectively. ET-1 and NO levels in the cerebrospinal fluid and plasma were assayed in each group on days 0, 7, 14, and 21. Then the changes of the diameter of blood vessels of cerebral basilar artery and overall performance categories score in each group through application of CT angiography were recorded. In the cerebral vasospasm model which was constructed by injecting the blood to dog twice, mild hypothermia treatment, through the application of vascular heat-exchange controller, could reduce cerebral vasospasm. It was observed that the duration of the mild hypothermia is directly proportional to the longer duration of the relieving of cerebral vasospasm. The reciprocal changes observed in the levels of ET-1 and NO in cerebrospinal fluid and plasma revealed that it might be possible to reduce the cerebral vasospasm by regulating the rising amplitude of ET-1 and the decrease in NO in CSF and plasma.	[Wang, Zhi-ping] Nanjing Med Univ, Dept Anesthesiol, Wuxi Peoples Hosp, Affiliated Hosp, Wuxi 241023, Jiangsu, Peoples R China; [Chen, Hong-sheng; Wang, Feng-xiang] Hosp Xuzhou Med Coll, Jiangsu Prov Inst Anesthesiol, Dept Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China	Wang, ZP (corresponding author), Nanjing Med Univ, Dept Anesthesiol, Wuxi Peoples Hosp, Affiliated Hosp, Wuxi 241023, Jiangsu, Peoples R China.	zhpsqxt@163.com					Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Alabadi JA, 1997, NEUROSURGERY, V41, P245, DOI 10.1097/00006123-199707000-00039; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Doufas AG, 2002, ANESTH ANALG, V95, P1752, DOI 10.1097/00000539-200212000-00052; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Jung CS, 2007, J NEUROSURG, V107, P945, DOI 10.3171/JNS-07/11/0945; Juvela S, 2000, J NEUROSURG, V92, P390, DOI 10.3171/jns.2000.92.3.0390; Kandzari DE, 2004, AM J CARDIOL, V93, P636, DOI 10.1016/j.amjcard.2003.11.038; Kastner S, 2005, ACTA NEUROCHIR, V147, P1271, DOI 10.1007/s00701-005-0633-0; Koide M, 2002, NEUROSURGERY, V51, P1468, DOI 10.1227/01.NEU.0000036389.57399.DS; Leung JWC, 2009, BRAIN RES, V1266, P121, DOI 10.1016/j.brainres.2009.01.070; Levati A, 1998, J Neurosurg Sci, V42, P27; Liu Zhen, 2007, Shengli Xuebao, V59, P285; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mascia L, 2001, STROKE, V32, P1185, DOI 10.1161/01.STR.32.5.1185; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; Mizuno Y, 2008, VASC PHARMACOL, V48, P21, DOI 10.1016/j.vph.2007.11.002; Neuschmelting V, 2009, ACTA NEUROCHIR, V151, P795, DOI 10.1007/s00701-009-0350-1; Nishizawa S, 2000, ACTA NEUROCHIR, V142, P1409, DOI 10.1007/s007010070013; Nishizawa S, 2003, J VASC RES, V40, P169, DOI 10.1159/000070714; OHLSTEIN EH, 1992, J NEUROSURG, V77, P274, DOI 10.3171/jns.1992.77.2.0274; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; POOL JL, 1958, J NEUROSURG, V15, P52, DOI 10.3171/jns.1958.15.1.0052; Popovic R, 2000, ANESTHESIOLOGY, V92, P1343, DOI 10.1097/00000542-200005000-00024; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; WEBB WR, 1962, SURGERY, V52, P643; Yanagawa Y, 1998, RESUSCITATION, V39, P61, DOI 10.1016/S0300-9572(98)00118-X; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86	32	14	15	3	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1085-9195	1559-0283		CELL BIOCHEM BIOPHYS	Cell Biochem. Biophys.	SEP	2011	61	1					137	143		10.1007/s12013-011-9170-z			7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	805UA	WOS:000293753300015	21347657				2021-06-18	
J	McGregor, SJ; Armstrong, WJ; Yaggie, JA; Bollt, EM; Parshad, R; Bailey, JJ; Johnson, SM; Goin, AM; Kelly, SR				McGregor, Stephen J.; Armstrong, W. Jeffrey; Yaggie, James A.; Bollt, Erik M.; Parshad, Rana; Bailey, Jerry J.; Johnson, Sean M.; Goin, Aleta M.; Kelly, Samuel R.			Lower extremity fatigue increases complexity of postural control during a single-legged stance	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article							APPROXIMATE ENTROPY; TRUNK ACCELEROMETRY; CEREBRAL CONCUSSION; BALANCE	Background: Non-linear approaches to assessment of postural control can provide insight that compliment linear approaches. Control entropy (CE) is a recently developed statistical tool from non-linear dynamical systems used to assess the complexity of non-stationary signals. We have previously used CE of high resolution accelerometry in running to show decreased complexity with exhaustive exercise. The purpose of this study was to determine if complexity of postural control decreases following fatiguing exercise using CE. Methods: Ten subjects (5 M/5 F; 25 +/- 3 yr; 169.4 +/- 11.7 cm; 79.0 +/- 16.9 kg) consented to participation approved by Western Oregon University IRB and completed two trials separated by 2-7 days. Trials consisted of two single-legged balance tests separated by two Wingate anaerobic tests (WAnT; PreFat/PostFat), or rest period (PreRest/PostRest). Balance tests consisted of a series of five single-legged stances, separated by 30 s rest, performed while standing on the dominant leg for 15-s with the participant crossing the arms over the chest and flexing the non-dominant knee to 90 degrees. High resolution accelerometers (HRA) were fixed superficial to L3/L4 at the approximate center of mass (COM). Triaxial signals from the HRA were streamed in real time at 625 Hz. COM accelerations were recorded in g's for vertical (VT), medial/lateral (ML), and anterior/posterior (AP) axes. A newly developed statistic (R-test) was applied to group response shapes generated by Karhunen Loeve (KL) transform modes resulting from Control Entropy (CE) analysis. Results: R-tests showed a significant mean vector difference (p < .05) within conditions, between axes in all cases, except PostFat, indicating the shape of the complexity response was different in these cases. R-test between conditions, within axis, differences were only present in PostFat for AP vs. PreFat (p < .05). T-tests showed a significantly higher overall CE PostFat in VT and ML compared to PreFat and PostRest (p < .0001). PostFat CE was also higher than PostRest in AP (p < .0001). Conclusions: These data indicate that fatiguing exercise eliminates the differential complexity response between axes, but increases complexity in all axes compared to the non-fatigued condition. This has implications with regard to the effects of fatigue on strategies of the control system to maintain postural control.	[McGregor, Stephen J.] Eastern Michigan Univ, Sch HPHP, Ypsilanti, MI 48197 USA; [Armstrong, W. Jeffrey; Bailey, Jerry J.; Johnson, Sean M.; Goin, Aleta M.; Kelly, Samuel R.] Western Oregon Univ, Div HPF, Monmouth, OR USA; [Yaggie, James A.] Univ Findlay, Coll Hlth Profess, Findlay, OH USA; [Bollt, Erik M.; Parshad, Rana] Clarkson Univ, Dept Math & Comp Sci, Potsdam, NY USA	McGregor, SJ (corresponding author), Eastern Michigan Univ, Sch HPHP, Ypsilanti, MI 48197 USA.	smcgregor@emich.edu					Adlerton Anna-Karin, 2003, Physiother Res Int, V8, P187, DOI 10.1002/pri.289; ARMSTRONG WJ, J ELECTROMYOGR KINES, V20, P726; Bollt EM, 2009, MATH BIOSCI ENG, V6, P1, DOI 10.3934/mbe.2009.6.1; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cover T., 2006, ELEMENTS INFORM THEO; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Kantz H, 2004, NONLINEAR TIME SERIE; Mardia K.V., 1979; McGregor SJ, 2009, CHAOS, V19, DOI 10.1063/1.3147423; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; PARSHAD R, 2011, MATH BIOSCIENCES ENG; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; TDE MV, 2009, J ELECTROMYOGR KINES, V19, pE513; Yaggie J, 2004, J SPORT REHABIL, V13, P312, DOI 10.1123/jsr.13.4.312; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	20	14	14	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	AUG 4	2011	8								43	10.1186/1743-0003-8-43			10	Engineering, Biomedical; Neurosciences; Rehabilitation	Engineering; Neurosciences & Neurology; Rehabilitation	819JO	WOS:000294821400001	21816084	DOAJ Gold, Green Published			2021-06-18	
J	Lee, HJ; Goudarzi, K; Baldwin, B; Rosenfield, D; Telch, MJ				Lee, Han-Joo; Goudarzi, Katy; Baldwin, Brian; Rosenfield, David; Telch, Michael J.			The Combat Experience Log: A web-based system for the in theater assessment of war zone stress	JOURNAL OF ANXIETY DISORDERS			English	Article						Assessment; PTSD; Combat experiences; Iraq; Army soldiers; War zone stress; Military	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; POSTTRAUMATIC-STRESS; RESILIENCE INVENTORY; DEPLOYMENT RISK; PTSD CHECKLIST; VIETNAM VETERANS; NATIONAL SAMPLE; DISORDER; IRAQ	This article presents preliminary data on the Combat Experience Log (CEL) - a web-based prospective data collection system for the in theater assessment of war zone stressors and stress reactions. 177 U.S. Army soldiers deployed to Iraq took part in the study. The overall response rate was 90.1% and the majority of CEL responders perceived the CEL system to be quite easy and convenient to use, and relevant to their war-zone experiences. Preliminary data on stress reactions, CEL utilization and soldier satisfaction are encouraging and suggest that the CEL assessment system offers a potentially useful assessment tool for enhancing our understanding of war-zone stress experiences and their contribution to PTSD and other combat stress disorders. (C) 2011 Elsevier Ltd. All rights reserved.	[Goudarzi, Katy; Telch, Michael J.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Lee, Han-Joo] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Baldwin, Brian] Univ Texas Austin, Inst Adv Technol, Austin, TX 78712 USA; [Rosenfield, David] So Methodist Univ, Dallas, TX 75275 USA	Telch, MJ (corresponding author), Univ Texas Austin, Dept Psychol, 1 Univ Stn,A8000, Austin, TX 78712 USA.	telch@austin.utexas.edu	Telch, Michael J/E-7027-2010	Telch, Michael/0000-0003-3444-8500			ANDRESEN EM, 1994, AM J PREV MED, V10, P77; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; BEEVERS CG, AM J PSYCHI IN PRESS; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; BURKE A, 1992, MEM COGNITION, V20, P277, DOI 10.3758/BF03199665; Carlson EB, 1997, TRAUMA ASSESSMENT CL; Connor KM, 2001, INT CLIN PSYCHOPHARM, V16, P279, DOI 10.1097/00004850-200109000-00005; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Fikretoglu D, 2006, CAN J PSYCHIAT, V51, P755, DOI 10.1177/070674370605101205; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Grieger TA, 2007, MIL MED, V172, P451, DOI 10.7205/MILMED.172.5.451; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; King DW, 1999, J ABNORM PSYCHOL, V108, P164, DOI 10.1037/0021-843X.108.1.164; KING DW, 1995, J ABNORM PSYCHOL, V104, P184, DOI 10.1037/0021-843X.104.1.184; King DW, 1996, J CONSULT CLIN PSYCH, V64, P520, DOI 10.1037/0022-006X.64.3.520; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; LOFTUS EF, 1982, MEM COGNITION, V10, P318, DOI 10.3758/BF03202423; McNally RJ, 2007, J ANXIETY DISORD, V21, P192, DOI 10.1016/j.janxdis.2006.09.005; Metts S., 1991, STUDYING INTERPERSON, P162; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shen YC, 2009, MIL MED, V174, P217, DOI 10.7205/MILMED-D-03-4307; Smith TC, 2008, EPIDEMIOLOGY, V19, P505, DOI 10.1097/EDE.0b013e31816a9dff; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Tanielian T, 2008, INVISIBLE WOUNDS WAR; TELCH MJ, 2011, SOLDIERS EMOTI UNPUB; Vaishnavi S, 2006, DEPRESS ANXIETY, V23, P437, DOI 10.1002/da.20202; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Watkins PC, 1996, J ABNORM PSYCHOL, V105, P34, DOI 10.1037/0021-843X.105.1.34; Weathers F. W., 1993, ANN M INT SOC TRAUM	40	14	15	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6185	1873-7897		J ANXIETY DISORD	J. Anxiety Disord.	AUG	2011	25	6					794	800		10.1016/j.janxdis.2011.03.018			7	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	779HF	WOS:000291768000006	21550204				2021-06-18	
J	Cook, A; Osler, T; Gaudet, M; Berne, J; Norwood, S				Cook, Alan; Osler, Turner; Gaudet, Matthew; Berne, John; Norwood, Scott			Blunt Cerebrovascular Injury Is Poorly Predicted by Modeling With Other Injuries: Analysis of NTDB Data	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Blunt cerebrovascular injury; Carotid artery injury; Vertebral artery injury; Prediction	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; VASCULAR NECK INJURIES; CAROTID-ARTERY; EARLY-DIAGNOSIS; TRAUMA; SEVERITY; IMPROVES; OUTCOMES	Background: Traumatic blunt cerebrovascular injury (BCVI) may portend catastrophic complications if untreated. Who should be screened for BCVI is controversial. The purpose of this study was to develop and validate a prediction score (pBCVI) to identify those at sufficient risk to warrant dedicated screening. Methods: We conducted a cohort study using data for years 2002-2007 from the National Trauma Data Bank. Blunt trauma patients aged 16 years and older were randomly divided into two groups for score creation and validation. Final prediction model included age, sex, Trauma Mortality Prediction Model p(death), traumatic intracranial hemorrhage, cerebellar/brain stem injury, malar/maxillary fracture, mandible fracture, cervical spine fracture, cervical spinal cord injury, thoracic spinal cord injury, and chest Abbreviated Injury Scale >= 3. pBCVI was evaluated using receiver operating characteristic curve area and the Hosmer-Lemeshow statistic. The Youden Index estimated an optimal cut-point (J) of the pBCVI. Results: The cohort numbered 1,398,310 patients, including 2,125 with BCVI. The overall incidence of BCVI was 0.15%. Cervical spine fracture had the strongest association with BCVI (odds ratio 4.82, p < 0.001). The receiver operating characteristic curve for pBCVI was 0.93 and the Hosmer-Lemeshow statistic was 206.3, p < 0.01. The optimal cut-point (J) of pBCVI was 0.0013 (sensitivity 0.91, specificity 0.82) and would miss 186 (8.8%) injuries in our cohort. To identify all BCVI using this model, an unrealistic 96% of the cohort would require screening. Conclusions: A model based on a pattern of other injuries cannot be used as a stand-alone instrument to determine screening for BCVI. "Optimal" model cut-points are not ideal for all injuries. Clinical suspicion that integrates energy of mechanism and associated injuries remains essential to effectively screen for BCVI and minimize patient risk for a catastrophic missed injury.	[Cook, Alan] Baylor Univ, Med Ctr, Div Trauma, Dallas, TX 75246 USA; [Osler, Turner] Univ Vermont, Coll Med, Dept Surg, Burlington, VT USA; [Gaudet, Matthew] Ochsner Clin Fdn, Dept Surg, New Orleans, LA USA; [Norwood, Scott] Reg Med Ctr Bayonet Point, Trauma Serv, Hudson, FL USA; [Berne, John] E Texas Med Ctr, Div Trauma Crit Care, Tyler, TX USA	Cook, A (corresponding author), Baylor Univ, Med Ctr, Div Trauma, 3409 Worth St,Suite 640, Dallas, TX 75246 USA.	adcookmd@gmail.com					Berne JD, 2001, J AM COLL SURGEONS, V192, P314, DOI 10.1016/S1072-7515(01)00772-4; Berne JD, 2006, J TRAUMA, V60, P1204, DOI 10.1097/01.ta.0000220435.55791.ce; Berne JD, 2010, J VASC SURG, V51, P57, DOI 10.1016/j.jvs.2009.08.071; Berne JD, 2009, J TRAUMA, V67, P1333, DOI 10.1097/TA.0b013e31818888c7; Biffl WL, 2009, J TRAUMA, V67, P1150, DOI 10.1097/TA.0b013e3181c1c1d6; Biffl WL, 2006, J TRAUMA, V60, P745, DOI 10.1097/01.ta.0000204034.94034.c4; Biffl WL, 2002, J TRAUMA, V53, P850, DOI 10.1097/00005373-200211000-00008; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 2000, ANN SURG, V231, P672, DOI 10.1097/00000658-200005000-00007; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Brown LH, 2009, PREHOSP EMERG CARE, V13, P516, DOI 10.1080/10903120903144809; Carrillo EH, 1999, J TRAUMA, V46, P1120, DOI 10.1097/00005373-199906000-00030; COGBILL TH, 1994, J TRAUMA, V37, P473, DOI 10.1097/00005373-199409000-00024; Cothren CC, 2005, AM J SURG, V190, P845, DOI 10.1016/j.amsurg.2005.08.007; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; DiCocco JM, 2011, ANN SURG, V253, P444, DOI 10.1097/SLA.0b013e31820d946b; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; Giacobetti FB, 1997, SPINE, V22, P188, DOI 10.1097/00007632-199701150-00011; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Goodwin RB, 2009, J TRAUMA, V67, P1046, DOI 10.1097/TA.0b013e3181b83b63; Malhotra AK, 2007, ANN SURG, V246, P632, DOI 10.1097/SLA.0b013e3181568cab; MARTIN RF, 1991, J VASC SURG, V14, P789, DOI 10.1067/mva.1991.32076; McKevitt EC, 2002, J TRAUMA, V53, P472, DOI 10.1097/00005373-200209000-00013; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Mulholland SA, 2005, INJURY, V36, P1298, DOI 10.1016/j.injury.2005.07.010; Mulholland SA, 2008, J TRAUMA, V64, P754, DOI 10.1097/01.ta.0000244384.85267.c5; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Parikh AA, 1997, J AM COLL SURGEONS, V185, P80, DOI 10.1016/S1072-7515(01)00886-9; Richter M, 2001, J TRAUMA, V51, P10, DOI 10.1097/00005373-200107000-00002; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Schneidereit NP, 2006, J TRAUMA, V60, P209, DOI 10.1097/01.ta.0000195651.60080.2c; Sliker CW, 2007, EUR J RADIOL, V64, P3, DOI 10.1016/j.ejrad.2007.02.015; Spain DA, 2006, J TRAUMA, V60, P929; Spain DA, 2006, J TRAUMA, V60, P751; Vaca FE, 2009, WEST J EMERG MED, V10, P62; VERNEUIL M, 1872, B ACAD NAT MED PARIS, V1, P46; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	38	14	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					114	119		10.1097/TA.0b013e31821c350f			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	790RR	WOS:000292607400030	21818020				2021-06-18	
J	Mogensen, J				Mogensen, Jesper			Almost Unlimited Potentials of a Limited Neural Plasticity Levels of Plasticity in Development and Reorganization of the Injured Brain	JOURNAL OF CONSCIOUSNESS STUDIES			English	Article							FORNIX AND/OR ABLATION; LONG-TERM POTENTIATION; SPATIAL DELAYED ALTERNATION; GENE-EXPRESSION; CORTICAL REPRESENTATION; FUNCTIONAL RECOVERY; STRIATE CORTEX; VISUAL-FIELD; COGNITIVE REHABILITATION; SOMATOSENSORY CORTEX	Neuroplasticity is a core feature of the brain throughout the entire life of the individual. And when injury to the adult brain destroys part of the circuitry mediating behaviour and/or conscious experience, neuroplasticity is required to bring about the highest possible degree of post-traumatic functional recovery. But is the brain able to recreate the lost circuitry? Scrutiny of the impressive plasticity seen during development and in the adult brain reveals many similarities but also some crucial differences. And studies of the mechanisms of functional recovery demonstrate that even an apparently full recovery' of the surface phenomena of behaviour and/or conscious representations is accomplished without a recreation of the lost circuitry. Instead, the post-traumatic process utilizes mechanisms, which have evolved to mediate problem solving in the intact brain. The newly developed REF (Reorganization of Elementary Functions) model suggests how such dynamic reorganizations occur in the intact and injured brain.	Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, DK-1353 Copenhagen K, Denmark	Mogensen, J (corresponding author), Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, Oester Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	jesper.mogensen@psy.ku.dk		Mogensen, Jesper/0000-0003-1959-581X			Albrecht T, 2010, CONSCIOUS COGN, V19, P656, DOI 10.1016/j.concog.2009.12.002; Antonini A, 1999, J NEUROSCI, V19, P4388; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Bach-y-Rita P, 1998, J REHABIL RES DEV, V35, P427; Bao JX, 1998, J NEUROSCI, V18, P458; Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; Bechtel W, 1999, PHILOS SCI, V66, P175, DOI 10.1086/392683; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Berry M, 1982, Bibl Anat, P1; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLOCK NJ, 1972, PHILOS REV, V81, P159, DOI 10.2307/2183991; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRIDGEMAN B, 1982, VISION RES, V22, P1199, DOI 10.1016/0042-6989(82)90085-2; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Choi JY, 2007, J NUCL MED, V48, P194; Chokron S, 2008, RESTOR NEUROL NEUROS, V26, P305; CRAGG BG, 1975, J COMP NEUROL, V160, P147, DOI 10.1002/cne.901600202; Del Rio JA, 2007, CURR PHARM DESIGN, V13, P2485; DELFS JM, 1995, J NEUROSCI, V15, P6562; DERRICK BE, 1994, P NATL ACAD SCI USA, V91, P10290, DOI 10.1073/pnas.91.22.10290; DINEEN J, 1981, EXP BRAIN RES, V41, P338; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fodor J. A., 1983, MODULARITY MIND; Fodor Jerry, 2000, MIND DOESNT WORK WAY; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friston KJ, 2003, TRENDS COGN SCI, V7, P151, DOI 10.1016/S1364-6613(03)00054-8; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hagemann G, 1998, ANN NEUROL, V44, P255, DOI 10.1002/ana.410440217; Hamburger V, 1934, J EXP ZOOL, V68, P449, DOI 10.1002/jez.1400680305; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Henriksson L, 2007, J NEUROL NEUROSUR PS, V78, P74, DOI 10.1136/jnnp.2006.099374; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041; HUMPHREY NK, 1974, PERCEPTION, V3, P241, DOI 10.1068/p030241; Irvine DRF, 2007, HEARING RES, V229, P158, DOI 10.1016/j.heares.2007.01.006; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; KELSO SR, 1986, SCIENCE, V232, P85; Keynes R J, 1992, Curr Opin Neurobiol, V2, P55, DOI 10.1016/0959-4388(92)90162-E; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Krechevsky I, 1933, J COMP PSYCHOL, V16, P99, DOI 10.1037/h0072223; Krechevsky I, 1932, PSYCHOL REV, V39, P516, DOI 10.1037/h0073500; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; Leon Carrion J., 2001, REV ESPANOLA NEUROPS, V3, P58; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Levi-Montallini R, 1942, Archives de Biologie Liege, V53, P537; LEVIMONTALCINI R, 1982, ANNU REV NEUROSCI, V5, P341, DOI 10.1146/annurev.ne.05.030182.002013; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Magavi SS, 2000, NATURE, V405, P951; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Maguire EA, 1997, J NEUROSCI, V17, P7103; Mala H, 2007, J NEUROTRAUM, V24, P1647, DOI 10.1089/neu.2007.0292; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; McLeod P., 1998, INTRO CONNECTIONIST; Merzenich M M, 1993, J Hand Ther, V6, P89; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MOGENSEN J, 1982, BEHAV BRAIN RES, V5, P375, DOI 10.1016/0166-4328(82)90041-9; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; MOGENSEN J, 1987, PHARMACOL BIOCHEM BE, V26, P89, DOI 10.1016/0091-3057(87)90539-9; Mogensen J, 2003, PHARMACOL BIOCHEM BE, V75, P381, DOI 10.1016/S0091-3057(03)00107-2; MOGENSEN J, 1994, PHARMACOL BIOCHEM BE, V47, P647, DOI 10.1016/0091-3057(94)90170-8; Mogensen J, 2002, NEUROBIOL LEARN MEM, V78, P139, DOI 10.1006/nlme.2001.4055; MOGENSEN J, 1991, BEHAV BRAIN RES, V42, P135, DOI 10.1016/S0166-4328(05)80004-X; Mogensen J., NEUROREHABI IN PRESS; Mogensen J., 2011, HDB LAB ANIMAL SCI, VII, P47; Mogensen J., 2003, HDB LAB ANIMAL SCI, VII, P95; Mogensen J, 2008, BEHAV BRAIN RES, V186, P215, DOI 10.1016/j.bbr.2007.08.009; Mogensen J, 2007, BRAIN RES BULL, V73, P86, DOI 10.1016/j.brainresbull.2007.02.006; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; Mogensen J, 2009, SCAND J PSYCHOL, V50, P561, DOI 10.1111/j.1467-9450.2009.00781.x; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; NORMAN DA, 1986, CONSCIOUSNESS SELF R, V4, P4; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Overgaard M., 2011, FRONT PSYCHOL, V2, P1; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Peter ME, 1997, CELL DEATH DIFFER, V4, P523, DOI 10.1038/sj.cdd.4400285; PINES J, 1992, Current Opinion in Cell Biology, V4, P144, DOI 10.1016/0955-0674(92)90024-7; Pinker S., 1999, MIND WORKS; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polleux F, 2000, NATURE, V404, P567; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; RAKIC P, 1985, MOL BASES NEURAL DEV, P139; Rampon C, 2000, NAT NEUROSCI, V3, P238; Raninen A, 2007, J NEUROL NEUROSUR PS, V78, P66, DOI 10.1136/jnnp.2006.099366; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; RECANZONE GH, 1993, J NEUROSCI, V13, P87; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.ne.14.030191.002531; Renner M.J., 1987, ENRICHED IMPOVERISHE; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROSENZWEIG MR, 1984, AM PSYCHOL, V39, P365, DOI 10.1037/0003-066X.39.4.365; ROSENZWEIG MR, 1971, BIOPSYCHOLOGY DEV, P303; ROSENZWEIG MR, 1961, CURRENT TRENDS PSYCH, P87; Rumelhart D. E., 1986, PARALLEL DISTRIBUTED; Sahraie A, 2006, P NATL ACAD SCI USA, V103, P14971, DOI 10.1073/pnas.0607073103; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Schafer R, 2008, NEUROSCI LETT, V439, P61, DOI 10.1016/j.neulet.2008.04.098; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Scheich H, 1991, Curr Opin Neurobiol, V1, P236, DOI 10.1016/0959-4388(91)90084-K; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; Schwiedrzik CM, 2009, J VISION, V9, DOI 10.1167/9.10.18; Shapiro L., 2004, THE MIND INCARNATE; Shapiro LA, 2008, PHILOS SCI, V75, P514, DOI 10.1086/594503; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Sterr A, 1998, J NEUROSCI, V18, P4417; Sterr A, 1998, NATURE, V391, P134, DOI 10.1038/34322; Stoerig P, 2006, PROG BRAIN RES, V155, P217, DOI 10.1016/S0079-6123(06)55012-5; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tang YP, 1999, NATURE, V401, P63; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Thai-Van H, 2007, HEARING RES, V233, P14, DOI 10.1016/j.heares.2007.06.003; Weiss T, 2000, EXP BRAIN RES, V134, P199, DOI 10.1007/s002210000456; Werbos P.J., 1994, ROOTS BACKPROPAGATIO, VVolume 1; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060; Witte OW, 1998, CURR OPIN NEUROL, V11, P655, DOI 10.1097/00019052-199812000-00008; Xerri C, 1996, J PHYSIOLOGY-PARIS, V90, P277, DOI 10.1016/S0928-4257(97)81438-6; YANG TT, 1994, NEUROREPORT, V5, P701, DOI 10.1097/00001756-199402000-00010; ZIHL J, 1980, NEUROPSYCHOLOGIA, V18, P71, DOI 10.1016/0028-3932(80)90085-8; ZIHL J, 1984, NEUROPSYCHOLOGIA, V22, P13, DOI 10.1016/0028-3932(84)90003-4	159	14	14	0	6	IMPRINT ACADEMIC	EXETER	PO BOX 200, EXETER EX5 5YX, DEVON, ENGLAND	1355-8250			J CONSCIOUSNESS STUD	J. Conscious. Stud.	JUL-AUG	2011	18	7-8			SI		13	45					33	Philosophy; Social Sciences, Interdisciplinary	Philosophy; Social Sciences - Other Topics	802DO	WOS:000293489700002					2021-06-18	
J	Agostini, V; Chiaramello, E; Bredariol, C; Cavallini, C; Knaflitz, M				Agostini, Valentina; Chiaramello, Emma; Bredariol, Carla; Cavallini, Chanda; Knaflitz, Marco			Postural control after traumatic brain injury in patients with neuro-ophthalmic deficits	GAIT & POSTURE			English	Article						Traumatic brain injury; Balance; Neuro-ophthalmic deficits; Static posturography; Quiet standing	HEAD TRAUMA; BODY SWAY; STABILITY; BALANCE; ADULTS; MANIFESTATIONS; POSTUROGRAPHY; INSTABILITY; MODERATE; YOUNG	Postural instability is a common and devastating consequence of traumatic brain injury (TBI). The majority of TBI patients also suffer from neuro-ophthalmic deficits that can be an important contributing element to their sensation of vertigo and dizziness. Static posturography aims at the objective evaluation of patient balance impairment, but is usually affected by large inter- and intra-subject variability. Here we propose a protocol based on 10 randomized trials stimulating in different ways the visual and vestibular systems. Due to its completeness, our protocol highlights the specific residual difficulties of each patient in the various conditions. In this way, it was possible to evidence significant balance abnormalities in TBI patients with respect to controls. Moreover, by means of a multivariate analysis we were able to discriminate different levels of residual neuro-ophthalmic impairment. (C) 2011 Elsevier B.V. All rights reserved.	[Agostini, Valentina; Chiaramello, Emma; Knaflitz, Marco] Politecn Torino, Dipartimento Elettron, I-10129 Turin, Italy; [Bredariol, Carla; Cavallini, Chanda] Osped Oftalm Torino, Clin C Sperino, Turin, Italy	Agostini, V (corresponding author), Politecn Torino, Dipartimento Elettron, Corso Duca degli Abruzzi 24, I-10129 Turin, Italy.	valentina.agostini@polito.it; emma.chiaramello@polito.it; neuroftalmologia.to@gmail.com; marco.knaflitz@polito.it	Agostini, Valentina/A-9570-2009; Chiaramello, Emma/AAY-8463-2020	Agostini, Valentina/0000-0001-5887-1499; Chiaramello, Emma/0000-0003-2503-4779			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dehail P, 2007, J REHABIL MED, V39, P531, DOI 10.2340/16501977-0096; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Johnson R.A., 2002, APPL MULTIVARIATE ST; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Krzanowski WJ., 1988, PRINCIPLES MULTIVARI; Kulkarni AR, 2005, EYE, V19, P1257, DOI 10.1038/sj.eye.6701753; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mardia K.V., 1979; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rocchi L, 2004, MED BIOL ENG COMPUT, V42, P71, DOI 10.1007/BF02351013; SAMSON M, 1996, GAIT POSTURE, V4, P252; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tarantola J, 1997, NEUROSCI LETT, V228, P75, DOI 10.1016/S0304-3940(97)00370-4; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Winter D., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	29	14	14	1	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362			GAIT POSTURE	Gait Posture	JUN	2011	34	2					248	253		10.1016/j.gaitpost.2011.05.008			6	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	801HS	WOS:000293429800020	21646021				2021-06-18	
J	Chan, YM; Williams, S; Davidson, LE; Drummond, BK				Chan, Yin Man; Williams, Sheila; Davidson, Lesley E.; Drummond, Bernadette K.			Orofacial and dental trauma of young children in Dunedin, New Zealand	DENTAL TRAUMATOLOGY			English	Article							OF-THE-LITERATURE; FACIAL FRACTURES; INJURIES; DENTISTRY; SCHOOLCHILDREN; EPIDEMIOLOGY; SCHOOL; TEETH	Aim: The aims were to identify the predominant causes and types of orofacial injury in young children attending clinics at a University Dental School in Dunedin, New Zealand. Material and methods: A retrospective analysis of data from the records of all children aged 0-10 years who had been seen for orofacial trauma in 1999 and 2000 was undertaken. Results and conclusions: Three hundred traumatic incidents in 288 children were analysed; 86.6% had causes noted. In very young children, most injuries were because of falls, while collisions, falling and sports were responsible for more injuries in school-aged children. Playground equipment and ride-on vehicles played a role particularly in the older children. There were no incidents of trauma as a result of road traffic accidents. Ten injuries were caused by animals, mainly dogs. Location was recorded for two-thirds of accidents: the predominant place was at home, followed by school. No seasonal variation was apparent. There were 228 non-dental injuries, of which the majority were to the lips. The predominant dental injuries in both dentitions were concussions and subluxations with a significantly higher occurrence of both in the primary dentition (P < 0.001). Upper central incisors were most often involved. The age distribution for boys and girls was similar. In conclusion, the causes and types of orofacial trauma in this group of young New Zealand school children attending a university dental school were similar to other studies, except for the high proportion of concussions recorded in both dentitions. While the injuries were well described, not all records noted the cause or location. This has resulted in changes to the standard recording form to provide consistency in data capture. Information from this study will also be used to support child injury prevention strategies in New Zealand.	[Drummond, Bernadette K.] Univ Otago, Sch Dent, Dept Oral Sci, Fac Dent, Dunedin, New Zealand	Drummond, BK (corresponding author), Univ Otago, Sch Dent, Dept Oral Sci, Fac Dent, POB 647, Dunedin, New Zealand.	bernadette.drummond@dent.otago.ac.nz	Williams, Sheila/L-4028-2019		New Zealand Child Injury Prevention Foundation	This study was supported by The New Zealand Child Injury Prevention Foundation.	Al-Jundi SH, 2002, DENT TRAUMATOL, V18, P181, DOI 10.1034/j.1600-9657.2002.02081.x; Andreasen J O, 1972, Int J Oral Surg, V1, P235, DOI 10.1016/S0300-9785(72)80042-5; Andreasen JO, 1970, SCAND J DENT RES, V78, P339; ATLAY N, 2001, DENT TRAUMATOL, V17, P201; BAGHDADY VS, 1981, COMMUNITY DENT ORAL, V9, P91, DOI 10.1111/j.1600-0528.1981.tb01036.x; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Borum M K, 2001, Int J Paediatr Dent, V11, P249; Caldas AD, 2001, DENT TRAUMATOL, V17, P250; CALVALCANTI AL, 2009, DENT TRAUMATOL, V25, P198; Chadwick BL, 2006, BRIT DENT J, V200, P379, DOI 10.1038/sj.bdj.4813424; Cunha RF, 2001, DENT TRAUMATOL, V17, P210; Fried Irwin, 1996, Pediatric Dentistry, V18, P145; Gabris K, 2001, DENT TRAUMATOL, V17, P103, DOI 10.1034/j.1600-9657.2001.017003103.x; GARCIA-GODOY F, 1987, Endodontics and Dental Traumatology, V3, P126; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; HAMMOND K L, 1991, New Zealand Dental Journal, V87, P5; Kieser J, 2002, INT J ORAL MAX SURG, V31, P206, DOI 10.1054/ijom.2002.0208; KOOREY AJ, 1992, INT J ORAL MAX SURG, V21, P77, DOI 10.1016/S0901-5027(05)80535-1; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-4469.2003.00203.x; Love Robert M., 1998, New Zealand Dental Journal, V94, P146; Love RM, 2008, DENT TRAUMATOL, V24, P170, DOI 10.1111/j.1600-9657.2007.00520.x; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; RAVN JJ, 1974, COMMUNITY DENT ORAL, V2, P231, DOI 10.1111/j.1600-0528.1974.tb01658.x; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; Skaare AB, 2003, DENT TRAUMATOL, V19, P67, DOI 10.1034/j.1600-9657.2003.00133.x; Ferreira JMS, 2009, DENT TRAUMATOL, V25, P219, DOI 10.1111/j.1600-9657.2008.00754.x; *STAT NZ TE TAR NO, 1998, NZ NOW CHILDR; StataCorp, 2007, STAT STAT SOFTW REL; Wright G, 2007, DENT TRAUMATOL, V23, P226, DOI 10.1111/j.1600-9657.2006.00430.x; York A H, 1978, N Z Dent J, V74, P218; Zaragoza AA, 1998, J DENT CHILD, V65, P492	31	14	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	JUN	2011	27	3					199	202		10.1111/j.1600-9657.2011.00989.x			4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	763FS	WOS:000290541400008	21457187				2021-06-18	
J	Liu, ZQ; Wang, DL; Shao, B; Wu, XH; Xu, J; Lu, QH; Wang, YD; Li, CM; Shen, AG; Wu, QY				Liu, Zhiqiang; Wang, Donglin; Shao, Bai; Wu, Xiaohong; Xu, Jian; Lu, Qiuhui; Wang, Yidan; Li, Chunmiao; Shen, Aiguo; Wu, Qiyun			Increased expression of transcription initiation factor IIB after rat traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						General transcription initiation factor; Traumatic brain injury; Western blot; Rat	RNA-POLYMERASE-II; FACTOR-TFIIB; FUNCTIONAL DOMAINS; TBP; DROSOPHILA; PROTEIN; NEURODEGENERATION; PROLIFERATION; SPECIFICITY; MECHANISMS	The protein TFIIB is a general transcription initiation factor that plays a pivotal role in the preinitiation complex (PIC) and selects the transcription initiation site. However, its distribution and function in the central nervous system (CNS) remains unclear. In the present study, we mainly investigated the expression and cellular localization of TFIIB during traumatic brain injury (TBI). Western blot analysis revealed that TFIIB was present in normal rat brain cortex. It gradually increased, reached a peak at the 5th day after TBI, and then decreased. Importantly, more TFIIB was colocalized with astrocytes and microglia, which are largely proliferated. In addition, Western blot detection showed that the 5th day post injury was also the proliferation peak indicated by the elevated expression of PCNA. Importantly, injury-induced expression of TFIIB was colabelled by proliferating cell nuclear antigen (proliferating cells marker). These data suggested that TFIIB may be implicated in the proliferation of astrocytes and microglia and the recovery of neurological outcomes. But the inherent mechanisms remained unknown. Further studies are needed to confirm the exact role of TFIIB after brain injury.	[Liu, Zhiqiang; Wang, Donglin; Shen, Aiguo; Wu, Qiyun] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Liu, Zhiqiang; Wang, Donglin; Shao, Bai; Wu, Xiaohong; Xu, Jian; Lu, Qiuhui; Wang, Yidan; Li, Chunmiao] Nantong Univ, Dept Pathol, Coll Med, Nantong 226001, Peoples R China	Shen, AG (corresponding author), Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China.	shen_aiguo@yahoo.com; qiyunwu@163.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320, 31070723, 81070275]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009157, BK2009161, BK2010169]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22890134] Funding Source: KAKEN	This work was supported by the National Natural Science Foundation of China (No. 30770488, No. 30870320, No. 31070723 and No. 81070275); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009157, No. BK2009161 and No. BK2010169); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Clark RSB, 1999, FASEB J, V13, P813; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Felzien LK, 1999, MOL CELL BIOL, V19, P4241; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HISATAKE K, 1991, NUCLEIC ACIDS RES, V19, P6639, DOI 10.1093/nar/19.23.6639; Hochheimer A, 2002, NATURE, V420, P439, DOI 10.1038/nature01167; Jia JX, 2010, MOL CELL BIOCHEM, V335, P127, DOI 10.1007/s11010-009-0249-4; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LOGAN A, 1992, J NEUROSCI, V12, P3828; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; Moore PA, 1999, MOL CELL BIOL, V19, P7610; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Shi W, 2011, NEUROCHEM RES, V36, P375, DOI 10.1007/s11064-010-0332-y; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Tehranian R, 2008, J NEUROTRAUM, V25, P755, DOI 10.1089/neu.2007.0441; TSUBOI A, 1992, NUCLEIC ACIDS RES, V20, P3250, DOI 10.1093/nar/20.12.3250; WAMPLER SL, 1992, GENE DEV, V6, P1542, DOI 10.1101/gad.6.8.1542; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; YAMASHITA S, 1992, P NATL ACAD SCI USA, V89, P2839, DOI 10.1073/pnas.89.7.2839	37	14	14	0	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2011	42	3					265	271		10.1007/s10735-011-9330-x			7	Cell Biology	Cell Biology	793QP	WOS:000292838500007	21544596				2021-06-18	
J	Vetreno, RP; Klintsova, A; Savage, LM				Vetreno, Ryan P.; Klintsova, Anna; Savage, Lisa M.			Stage-dependent alterations of progenitor cell proliferation and neurogenesis in an animal model of Wernicke-Korsakoff syndrome	BRAIN RESEARCH			English	Article						Neurogenesis; Cell proliferation; BrdU; Pyrithiamine; Wernicke-Korsakoff syndrome	INDUCED THIAMINE-DEFICIENCY; TRAUMATIC BRAIN-INJURY; IMPAIRED HIPPOCAMPAL NEUROGENESIS; SEIZURE-INDUCED NEUROGENESIS; NEWLY GENERATED CELLS; ADULT NEUROGENESIS; DENTATE GYRUS; NEUROTROPHIC FACTOR; DIENCEPHALIC AMNESIA; VOLUNTARY EXERCISE	Alcohol-induced Wernicke-Korsakoff syndrome (WKS) culminates in bilateral diencephalic lesion and severe amnesia. Using the pyrithiamine-induced thiamine deficiency (PTD) animal paradigm of WKS, our laboratory has demonstrated hippocampal dysfunction in the absence of gross anatomical pathology. Extensive literature has revealed reduced hippocampal neurogenesis following a neuropathological insult, which might contribute to hippocampus-based learning and memory impairments. Thus, the current investigation was conducted to determine whether PTD treatment altered hippocampal neurogenesis in a stage-dependent fashion. Male Sprague-Dawley rats were assigned to one of 4 stages of thiamine deficiency based on behavioral symptoms: pre-symptomatic stage, ataxic stage, early post-opisthotonus stage, or the late post-opisthotonus stage. The S-phase mitotic marker 5'-bromo-2'-deoxyuridine (BrdU) was administered at the conclusion of each stage following thiamine restoration and subjects were perfused 24 hours or 28 days after BrdU to assess cellular proliferation or neurogenesis and survival, respectively. Dorsal hippocampal sections were immunostained for BrdU (proliferating cell marker), NeuN (neurons), GFAP (astrocytes), Iba-1 (microglia), and O4 (oligodendrocytes). The PTD treatment increased progenitor cell proliferation and survival during the early post-opisthotonus stage. However, levels of neurogenesis were reduced during this stage as well as the late post-opisthotonus stage where there was also an increase in astrocytogenesis. The diminished numbers of newly generated neurons (BrdU/NeuN co-localization) was paralleled by increased BrdU cells that did not co-localize with any of the phenotypic markers during these later stages. These data demonstrate that long-term alterations in neurogenesis and gliogenesis might contribute to the observed hippocampal dysfunction in the PTD model and human WKS. Published by Elsevier B.V.	[Vetreno, Ryan P.; Klintsova, Anna; Savage, Lisa M.] SUNY Binghamton, Dept Psychol, Vestal, NY 13902 USA	Vetreno, RP (corresponding author), SUNY Binghamton, Dept Psychol, Vestal, NY 13902 USA.	rvetren1@binghamton.edu		Klintsova, Anna/0000-0003-0626-8385	 [NINDS 054272]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054272] Funding Source: NIH RePORTER	This work was supported by a research grant NINDS 054272 to LMS.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Anzalone S, 2010, EUR J NEUROSCI, V32, P847, DOI 10.1111/j.1460-9568.2010.07358.x; ARENDT T, 1983, ACTA NEUROPATHOL, V61, P101, DOI 10.1007/BF00697388; Bauer S, 2005, J CELL BIOL, V171, P641, DOI 10.1083/jcb.200505072; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Berchtold NC, 2002, J NEUROSCI RES, V68, P511, DOI 10.1002/jnr.10256; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Butters N, 1981, Curr Alcohol, V8, P205; BUTTERWORTH RF, 1989, J NEUROCHEM, V52, P1079, DOI 10.1111/j.1471-4159.1989.tb01850.x; Calingasan NY, 2008, NEUROSCIENCE, V153, P986, DOI 10.1016/j.neuroscience.2008.02.071; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Campbell NR, 2010, J NEUROSCI, V30, P8734, DOI 10.1523/JNEUROSCI.0931-10.2010; Caulo M, 2005, BRAIN, V128, P1584, DOI 10.1093/brain/awh496; Chevallier NL, 2005, AM J PATHOL, V167, P151, DOI 10.1016/S0002-9440(10)62962-8; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Conner JM, 2009, J NEUROSCI, V29, P10883, DOI 10.1523/JNEUROSCI.2594-09.2009; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Crews FT, 2004, ALCOHOL, V33, P63, DOI 10.1016/j.alcohol.2004.04.005; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Fama R, 2004, J INT NEUROPSYCH SOC, V10, P427, DOI 10.1017/S135561770410310X; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; GIBSON GE, 1984, NEUROCHEM RES, V9, P803, DOI 10.1007/BF00965667; GILBEA FJ, 2010, HIPPOCAMPUS, DOI DOI 10.1002/HIPO.0812; Gold JJ, 2006, LEARN MEMORY, V13, P699, DOI 10.1101/lm.357406; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guo YJ, 2009, PROG NEURO-PSYCHOPH, V33, P688, DOI 10.1016/j.pnpbp.2009.03.022; HARPER CG, 1990, ALCOHOL ALCOHOLISM, V25, P207, DOI 10.1093/oxfordjournals.alcalc.a044994; Hattiangady B, 2010, HIPPOCAMPUS, V20, P97, DOI 10.1002/hipo.20594; Hazell AS, 2009, ALCOHOL ALCOHOLISM, V44, P141, DOI 10.1093/alcalc/agn120; He J, 2009, ALCOHOL CLIN EXP RES, V33, P129, DOI 10.1111/j.1530-0277.2008.00823.x; Helfer JL, 2009, BRAIN RES, V1294, P1, DOI 10.1016/j.brainres.2009.07.090; Helfer JL, 2009, J COMP NEUROL, V514, P259, DOI 10.1002/cne.22018; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Jessberger S, 2007, J NEUROSCI, V27, P5967, DOI 10.1523/JNEUROSCI.0110-07.2007; Karuppagounder Saravanan, 2009, P235, DOI 10.1007/978-0-387-79112-8_12; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; KOPELMAN MD, 1995, BRIT J PSYCHIAT, V166, P154, DOI 10.1192/bjp.166.2.154; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Kotani S, 2008, CHEM-BIOL INTERACT, V175, P227, DOI 10.1016/j.cbi.2008.04.004; Kril JJ, 1996, METAB BRAIN DIS, V11, P9, DOI 10.1007/BF02080928; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuhn HG, 2001, EUR ARCH PSY CLIN N, V251, P152, DOI 10.1007/s004060170035; Langlais PJ, 1996, METAB BRAIN DIS, V11, P19, DOI 10.1007/BF02080929; Langlais PJ, 1997, ALCOHOL CLIN EXP RES, V21, P434; LANGLAIS PJ, 1992, BEHAV BRAIN RES, V48, P177, DOI 10.1016/S0166-4328(05)80155-X; LANGLAIS PJ, 1995, BEHAV BRAIN RES, V68, P75, DOI 10.1016/0166-4328(94)00162-9; LANGLAIS PJ, 1990, J NEUROSCI, V10, P1664; LAPCHAK PA, 1993, NEUROSCIENCE, V52, P575, DOI 10.1016/0306-4522(93)90407-7; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Leong DK, 1996, METAB BRAIN DIS, V11, P71, DOI 10.1007/BF02080932; Linnarsson S, 2000, MOL BRAIN RES, V75, P61, DOI 10.1016/S0169-328X(99)00295-8; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mair R G, 1994, Rev Neurosci, V5, P105; MARKOWITSCH HJ, 1988, BRAIN RES REV, V13, P351, DOI 10.1016/0165-0173(88)90012-4; Massey KA, 2006, MOL CELL NEUROSCI, V33, P381, DOI 10.1016/j.mcn.2006.08.011; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morris SA, 2010, HIPPOCAMPUS, V20, P596, DOI 10.1002/hipo.20665; Zhao N, 2008, NEUROBIOL DIS, V29, P176, DOI 10.1016/j.nbd.2007.08.014; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ngwenya LB, 2008, HIPPOCAMPUS, V18, P210, DOI 10.1002/hipo.20384; Nixon K, 2008, NEUROBIOL DIS, V31, P218, DOI 10.1016/j.nbd.2008.04.009; Nonner D, 1996, J NEUROSCI, V16, P6665; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Pfefferbaum A, 2007, NEUROPSYCHOPHARMACOL, V32, P1159, DOI 10.1038/sj.npp.1301107; Pires RGW, 2005, BEHAV BRAIN RES, V162, P11, DOI 10.1016/j.bbr.2005.02.032; Pires RGW, 2001, PHARMACOL BIOCHEM BE, V70, P227, DOI 10.1016/S0091-3057(01)00593-7; Pitkin SR, 2004, BEHAV BRAIN RES, V148, P93, DOI 10.1016/S0166-4328(03)00208-0; Pitkin SR, 2001, BEHAV BRAIN RES, V119, P167, DOI 10.1016/S0166-4328(00)00350-8; Redila VA, 2006, HIPPOCAMPUS, V16, P305, DOI 10.1002/hipo.20164; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; ROBINSON JK, 1992, BEHAV NEUROSCI, V106, P623; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Roland JJ, 2009, NEUROSCIENCE, V160, P32, DOI 10.1016/j.neuroscience.2009.02.044; Roland JJ, 2007, NEUROBIOL LEARN MEM, V87, P123, DOI 10.1016/j.nlm.2006.07.007; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Savage LM, 2003, LEARN MEMORY, V10, P242, DOI 10.1101/lm.60003; Shetty AK, 2011, HIPPOCAMPUS, V21, P631, DOI 10.1002/hipo.20776; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Sullivan EV, 2009, ALCOHOL ALCOHOLISM, V44, P155, DOI 10.1093/alcalc/agn103; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; TRONCOSO JC, 1981, ARCH NEUROL-CHICAGO, V38, P350, DOI 10.1001/archneur.1981.00510060052007; Van der Borght K, 2005, BRAIN RES BULL, V67, P117, DOI 10.1016/j.brainresbull.2005.06.018; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266; VETRENO RP, NEUROBIOL L IN PRESS; Vetreno RP, 2008, NEUROBIOL LEARN MEM, V90, P237, DOI 10.1016/j.nlm.2008.04.001; Victor M., 1971, WERNICKE KORSAKOFF S; VICTOR M, 1989, WEMICKE KORSAKOFF SY; Voloboueva LA, 2010, J NEUROSCI, V30, P12242, DOI 10.1523/JNEUROSCI.1752-10.2010; VORHEES CV, 1977, J NUTR, V107, P1902; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; WITT ED, 1985, ALCOHOL ALCOHOLISM, V20, P201; Wojtowicz JM, 2008, EUR J NEUROSCI, V27, P1494, DOI 10.1111/j.1460-9568.2008.06128.x; Wrenn CC, 1998, INT J DEV NEUROSCI, V16, P595, DOI 10.1016/S0736-5748(98)00071-9; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582; ZHANG SX, 1995, J NEUROPATH EXP NEUR, V54, P255, DOI 10.1097/00005072-199503000-00012; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao YL, 2009, J NEUROCHEM, V111, P537, DOI 10.1111/j.1471-4159.2009.06341.x	127	14	14	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 19	2011	1391						132	146		10.1016/j.brainres.2011.03.048			15	Neurosciences	Neurosciences & Neurology	773EU	WOS:000291290600014	21440532	Green Accepted			2021-06-18	
J	Cherian, L; Goodman, JC; Robertson, C				Cherian, Leela; Goodman, J. Clay; Robertson, Claudia			Improved Cerebrovascular Function and Reduced Histological Damage with Darbepoietin Alfa Administration after Cortical Impact Injury in Rats	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							TRAUMATIC BRAIN-INJURY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; NITRIC-OXIDE SYNTHASE; DARBEPOETIN-ALPHA; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; TISSUE PROTECTION; GENE-EXPRESSION; IN-VIVO; MODEL	Darbepoetin alfa (darbEpo) is an erythropoietic glycoprotein that activates the erythropoietin receptor. The aim of our study was to determine whether darbEpo is neuroprotective in a cortical impact injury (CII) model and to determine the characteristics of dose response and time window. To better understand the vascular mechanism of darbEpo neuroprotection, the reactivity of cerebral blood flow (CBF) to L-arginine administration was also studied. Rats were given saline or darbEpo from 2.5 to 50 mu g/kg at 5 min after CII or a dose of 25 mu g/kg darbEpo at times ranging from 5 min to 24 h after CII. Histological assessment was determined 2 weeks after a severe CII. Other rats were given either darbEpo (25 mu g/kg) or saline daily for 3 days before injury. Five minutes after severe CII, they were given either L-arginine or D-arginine. Hemodynamic variables were monitored for 2 h after injury. In the dose-response study, darbEpo in doses of 25 and 50 mu g/kg significantly reduced contusion volume from 39.1 +/- 6.7 to 8.1 +/- 3.1 and 11.2 +/- 6.0 mm(3), respectively. In the time window study, darbEpo reduced contusion volume when given in a dose of 25 mu g/kg at 5 min to 6 h after the impact injury. In animals pretreated with darbEpo, the CBF response to L-arginine was significantly greater than in the animals pretreated with saline. These data demonstrate that darbEpo has neuroprotective effects in traumatic brain injury in a dose-and time-dependent manner and that vascular effects of darbEpo may have a role in neuroprotection.	[Cherian, Leela; Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Goodman, J. Clay] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Cherian, L (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	lcherian@bcm.tmc.edu			National Institutes of Health National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]; Amgen, Inc.Amgen; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke [Grant P01-NS38660] and a grant from Amgen, Inc.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Aydin A, 2003, BRAIN DEV-JPN, V25, P494, DOI 10.1016/S0387-7604(03)00039-1; Baker JE, 2007, J CARDIOVASC PHARM, V49, P337, DOI 10.1097/FJC.0b013e318040cf81; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Brendt P, 2009, SHOCK, V31, P50, DOI 10.1097/SHK.0b013e31817c0188; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Emir M, 2004, TRANSPLANT P, V36, P2935, DOI 10.1016/j.transproceed.2004.11.101; Fishbane S, 2004, KIDNEY INT, V65, P452, DOI 10.1111/j.1523-1755.2004.00400.x; Gao E, 2007, AM J PHYSIOL-HEART C, V293, pH60, DOI 10.1152/ajpheart.00227.2007; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Kanellakis P, 2010, BRIT J PHARMACOL, V160, P2085, DOI 10.1111/j.1476-5381.2010.00876.x; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Mann C, 2008, EXP NEUROL, V211, P34, DOI 10.1016/j.expneurol.2007.12.013; Noguchi CT, 2007, CRIT REV ONCOL HEMAT, V64, P159, DOI 10.1016/j.critrevonc.2007.03.001; Shafi NI, 2008, J NEUROTRAUM, V25, P257, DOI 10.1089/neu.2007.0347; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Wang XQ, 1999, HYPERTENSION, V33, P894, DOI 10.1161/01.HYP.33.3.894; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yidirim E, 2005, J TRAUMA, V58, P1252, DOI 10.1097/01.TA.0000169803.09482.F8; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015; Zhu L, 2009, J TRAUMA, V66, P730, DOI 10.1097/TA.0b013e318184b4db	40	14	15	0	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	MAY	2011	337	2					451	456		10.1124/jpet.110.176602			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	752EG	WOS:000289671600013	21270134	Green Published			2021-06-18	
J	Mao, YT; Hua, TM; Pallas, SL				Mao, Yu-Ting; Hua, Tian-Miao; Pallas, Sarah L.			Competition and convergence between auditory and cross-modal visual inputs to primary auditory cortical areas	JOURNAL OF NEUROPHYSIOLOGY			English	Article						cross-modal plasticity; sensory substitution; cortical development; traumatic brain injury; stroke	INFERIOR COLLICULUS LESION; FERRET MUSTELA-PUTORIUS; RETINAL PROJECTIONS; OCULAR DOMINANCE; WORD DEAFNESS; MULTISENSORY INTEGRATION; COCHLEAR IMPLANTS; EVOKED POTENTIALS; RECEPTIVE-FIELDS; THALAMIC LESION	Mao YT, Hua TM, Pallas SL. Competition and convergence between auditory and cross-modal visual inputs to primary auditory cortical areas. J Neurophysiol 105: 1558-1573, 2011. First published January 27, 2011; doi: 10.1152/jn.00407.2010.-Sensory neocortex is capable of considerable plasticity after sensory deprivation or damage to input pathways, especially early in development. Although plasticity can often be restorative, sometimes novel, ectopic inputs invade the affected cortical area. Invading inputs from other sensory modalities may compromise the original function or even take over, imposing a new function and preventing recovery. Using ferrets whose retinal axons were rerouted into auditory thalamus at birth, we were able to examine the effect of varying the degree of ectopic, cross-modal input on reorganization of developing auditory cortex. In particular, we assayed whether the invading visual inputs and the existing auditory inputs competed for or shared postsynaptic targets and whether the convergence of input modalities would induce multisensory processing. We demonstrate that although the cross-modal inputs create new visual neurons in auditory cortex, some auditory processing remains. The degree of damage to auditory input to the medial geniculate nucleus was directly related to the proportion of visual neurons in auditory cortex, suggesting that the visual and residual auditory inputs compete for cortical territory. Visual neurons were not segregated from auditory neurons but shared target space even on individual target cells, substantially increasing the proportion of multisensory neurons. Thus spatial convergence of visual and auditory input modalities may be sufficient to expand multisensory representations. Together these findings argue that early, patterned visual activity does not drive segregation of visual and auditory afferents and suggest that auditory function might be compromised by converging visual inputs. These results indicate possible ways in which multisensory cortical areas may form during development and evolution. They also suggest that rehabilitative strategies designed to promote recovery of function after sensory deprivation or damage need to take into account that sensory cortex may become substantially more multisensory after alteration of its input during development.	[Pallas, Sarah L.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30302 USA; [Mao, Yu-Ting; Hua, Tian-Miao; Pallas, Sarah L.] Georgia State Univ, Dept Biol, Atlanta, GA USA	Pallas, SL (corresponding author), Georgia State Univ, Inst Neurosci, POB 5030, Atlanta, GA 30302 USA.	spallas@gsu.edu	Pallas, Sarah/W-1860-2019; Mao, Yu-Ting/M-8586-2017	Mao, Yu-Ting/0000-0001-8438-079X	National Science Foundation (NSF)National Science Foundation (NSF) [IBN-0451018]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY/MH12696]; Georgia State University (GSU) Research Foundation; GSU; NSF Science and Technology Centers [IBN-9876754]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012696] Funding Source: NIH RePORTER	This work was funded by National Science Foundation (NSF) Grant IBN-0451018, National Institutes of Health Grant EY/MH12696, and a Georgia State University (GSU) Research Foundation grant to S. L. Pallas, by a GSU Brains and Behavior scholarship to Y.-T. Mao, and by the NSF Science and Technology Centers Program Grant IBN-9876754.	Allman BL, 2009, P NATL ACAD SCI USA, V106, P5925, DOI 10.1073/pnas.0809483106; Angelucci A, 1998, J COMP NEUROL, V400, P417, DOI 10.1002/(SICI)1096-9861(19981026)400:3<417::AID-CNE10>3.0.CO;2-O; Angelucci A, 1997, J NEUROSCI, V17, P2040; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Beauchamp MS, 2008, J NEUROSCI, V28, P13696, DOI 10.1523/JNEUROSCI.3872-08.2008; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; BOGNAR L, 1994, ACTA NEUROCHIR, V127, P161, DOI 10.1007/BF01808760; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; de la Mothe LA, 2006, J COMP NEUROL, V496, P72, DOI 10.1002/cne.20924; Fallon JB, 2009, HEARING RES, V257, P93, DOI 10.1016/j.heares.2009.08.006; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; FOX JG, 1998, BIOL DIS FERRET; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hoistad DL, 2003, AUDIOL NEURO-OTOL, V8, P111, DOI 10.1159/000068999; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; Hunt DL, 2006, NEUROSCIENCE, V139, P1507, DOI 10.1016/j.neuroscience.2006.01.023; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Karlen SJ, 2006, NEUROSCIENCE, V142, P843, DOI 10.1016/j.neuroscience.2006.06.055; KELLY JB, 1986, HEARING RES, V24, P111, DOI 10.1016/0378-5955(86)90054-7; Kimiskidis VK, 2004, OTOL NEUROTOL, V25, P178, DOI 10.1097/00129492-200403000-00017; Kingsbury MA, 2000, J COMP NEUROL, V424, P165, DOI 10.1002/1096-9861(20000814)424:1<165::AID-CNE12>3.0.CO;2-U; Kingsbury MA, 2002, DEV BRAIN RES, V138, P35, DOI 10.1016/S0165-3806(02)00456-X; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Lee SS, 2009, J COMPUT ASSIST TOMO, V33, P305, DOI 10.1097/RCT.0b013e31817e6f58; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; MAO Y, FRONT NEUR C 2010 S, DOI DOI 10.3389/CONF.FNINS.2010.04.00013; MAO YT, 2007, SOC NEUR ABSTR, V36, P2; Masuda S, 2000, ANN OTO RHINOL LARYN, V109, P1107, DOI 10.1177/000348940010901204; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640; Meyer B, 1996, J NEUROL NEUROSUR PS, V61, P423, DOI 10.1136/jnnp.61.4.423; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Musiek FE, 2004, J AM ACAD AUDIOL, V15, P172; Musiek Frank E, 2004, J Am Acad Audiol, V15, P133, DOI 10.3766/jaaa.15.2.4; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; NEVILLE HJ, 1983, BRAIN RES, V266, P127, DOI 10.1016/0006-8993(83)91314-8; Nishimura H, 2000, NEUROREPORT, V11, P811, DOI 10.1097/00001756-200003200-00031; PALLAS SL, 1990, J COMP NEUROL, V298, P50, DOI 10.1002/cne.902980105; Pallas SL, 1999, P NATL ACAD SCI USA, V96, P8751, DOI 10.1073/pnas.96.15.8751; PALLAS SL, 1993, J COMP NEUROL, V337, P317, DOI 10.1002/cne.903370212; PHILLIPS DP, 1988, BRAIN RES, V443, P281, DOI 10.1016/0006-8993(88)91622-8; REH TA, 1985, J NEUROSCI, V5, P1132; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Ro T, 2007, ANN NEUROL, V62, P433, DOI 10.1002/ana.21219; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1993, J COMP NEUROL, V334, P263, DOI 10.1002/cne.903340208; ROE AW, 1992, J NEUROSCI, V12, P3651; Sathian K, 2010, RESTOR NEUROL NEUROS, V28, P271, DOI 10.3233/RNN-2010-0534; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; SHESKIN D, 2004, HDB PARAMETRIC NONPA, pR33; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; STEIN BE, 1993, PROG BRAIN RES, V95, P79, DOI 10.1016/S0079-6123(08)60359-3; Sterr A, 2003, BIOL PSYCHOL, V63, P117, DOI 10.1016/S0301-0511(03)00051-6; Stryker M P, 1982, Neurosci Res Program Bull, V20, P540; STRYKER MP, 1986, J NEUROSCI, V6, P2117; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Yaka R, 2000, EXP BRAIN RES, V131, P144, DOI 10.1007/s002219900295	73	14	16	0	15	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	APR	2011	105	4					1558	1573		10.1152/jn.00407.2010			16	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	751LW	WOS:000289620500012	21273321	Green Published			2021-06-18	
J	Menzler, K; Thiel, P; Hermsen, A; Chen, X; Benes, L; Miller, D; Sure, U; Knake, S; Rosenow, F				Menzler, Katja; Thiel, Patricia; Hermsen, Anke; Chen, Xu; Benes, Ludwig; Miller, Dorothea; Sure, Ulrich; Knake, Susanne; Rosenow, Felix			The role of underlying structural cause for epilepsy classification: Clinical features and prognosis in mesial temporal lobe epilepsy caused by hippocampal sclerosis versus cavernoma	EPILEPSIA			English	Article						Cavernoma; Hippocampal sclerosis; Mesiotemporal lobe epilepsy; Vascular lesions; Epileptogenicity	SURGERY; PREDICTORS; LOBECTOMY	Purpose: The recent "Report of the ILAE Commission on Classification and Terminology" recommends an epilepsy classification that gives more emphasis to the underlying structural or metabolic cause rather than to the localization of the epileptogenic zone. The aim of the present study was to investigate differences in clinical features, treatment response, and prognosis in patients with mesial temporal lobe epilepsy (MTLE) caused by hippocampal sclerosis (MTLE-HS) or singular mesiotemporal cavernomas (MTLE-C) in order to evaluate the impact of underlying pathology on the course of the disease while controlling for localization. Methods: Age at onset, age at surgery, seizure frequency and semiology, pharmacoresistance, psychiatric comorbidities, memory deficits, or initial precipitating insults (e. g., febrile seizures, traumatic brain injury, infection of the central nervous system, birth complications) as well as postoperative outcome were compared in eleven patients with MTLE-C and 33 patients with MTLE-HS using nonparametric statistical methods. Key Findings: The postoperative outcome was significantly better in patients with MTLE-C, even after controlling for preoperative epilepsy duration. Patients with MTLE-HS more frequently were drug resistant (88% vs. 36%) and more often presented with an initial precipitating insult (70% vs. 27%) and with automotor seizures (79% vs. 46%). Significance: The results suggest that patients with MTLE-C show a more favorable postoperative outcome, supporting the commission's suggestion to put more emphasis on the underlying cause in future epilepsy classifications.	[Menzler, Katja; Thiel, Patricia; Hermsen, Anke; Knake, Susanne; Rosenow, Felix] Univ Hosp Giessen & Marburg, Dept Neurol, Interdisciplinary Epilepsy Ctr, Marburg, Germany; [Chen, Xu] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Peoples R China; [Benes, Ludwig; Miller, Dorothea; Sure, Ulrich] Univ Hosp Giessen & Marburg, Interdisciplinary Epilepsy Ctr, Dept Neurosurg, Marburg, Germany; [Miller, Dorothea; Sure, Ulrich] Univ Hosp Essen, Dept Neurosurg, Essen, Germany	Rosenow, F (corresponding author), Univ Marburg, Dept Neurol, Interdisciplinary Epilepsy Ctr, Rudolf Bultmann Str 8, D-35033 Marburg, Germany.	rosenow@med.uni-marburg.de	Knake, Susanne/AAJ-4487-2021; Miller, Dorothea/ABB-2588-2020	Knake, Susanne/0000-0002-6298-0513; Miller, Dorothea/0000-0001-7851-1917			[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baumann CR, 2007, EPILEPSIA, V48, P559, DOI 10.1111/j.1528-1167.2006.00941.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Diehl B, 2003, SEIZURE-EUR J EPILEP, V12, P307, DOI 10.1016/S1059-1311(02)00272-8; Elsharkawy AE, 2009, J NEUROSURG, V110, P1135, DOI 10.3171/2008.6.JNS17613; Janszky J, 2005, EPILEPSY RES, V64, P35, DOI 10.1016/j.eplepsyres.2005.02.004; Jeong SW, 1999, EPILEPSIA, V40, P1735, DOI 10.1111/j.1528-1157.1999.tb01591.x; Jutila L, 2002, J NEUROL NEUROSUR PS, V73, P486, DOI 10.1136/jnnp.73.5.486; Kanner AM, 2009, NEUROLOGY, V72, P793, DOI 10.1212/01.wnl.0000343850.85763.9c; KUZNIECKY R, 1993, ARCH NEUROL-CHICAGO, V50, P65, DOI 10.1001/archneur.1993.00540010059018; Lortie A, 2002, EPILEPSY RES, V51, P133, DOI 10.1016/S0920-1211(02)00102-X; Menzler K, 2010, NEUROSURGERY, V67, P918, DOI 10.1227/NEU.0b013e3181eb5032; Radhakrishnan K, 1998, NEUROLOGY, V51, P465, DOI 10.1212/WNL.51.2.465; Rasmussen T.B., 1993, SURG TREATMENT EPILE, P609; Semah F, 2005, EPILEPTIC DISORD, V7, pS10; Semah F, 2002, ARCH NEUROL-CHICAGO, V59, P1042, DOI 10.1001/archneur.59.6.1042-a; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Stephen LJ, 2001, EPILEPSIA, V42, P357, DOI 10.1046/j.1528-1157.2001.29000.x	20	14	15	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	APR	2011	52	4					707	711		10.1111/j.1528-1167.2011.02984.x			5	Clinical Neurology	Neurosciences & Neurology	745HO	WOS:000289156700009	21426322				2021-06-18	
J	Potter, MR; Snyder, AJ; Smith, GA				Potter, Matthew R.; Snyder, Ashley J.; Smith, Gary A.			Boxing Injuries Presenting to US Emergency Departments, 1990-2008	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; PROFESSIONAL BOXERS; AMATEUR; RISK; DIFFUSION; CHILDREN	Background: Boxing injuries can have serious consequences. Purpose: To examine the epidemiology of boxing injuries in the U.S. with attention to head injuries and children. Methods: National estimates of boxing injuries were calculated using data from the National Electronic Injury Surveillance System. Injury rates per 1000 participants for the year 2003 were calculated using boxing participation data. Data analysis was conducted in 2009-2010. Results: An estimated 165,602 individuals (95% CI=134891, 196313) sustained boxing injuries that resulted in a visit to a U.S. hospital emergency department from 1990 through 2008. An average of 8716 (95% CI=7078, 10354) injuries occurred annually, and there was a statistically significant increase in the annual number of injuries during the 19-year study period (slope=610, p<0.001). The rate of injury was 12.7 per 1000 participants. Those injured were predominately male (90.9%). The most common diagnosis was fracture (27.5%), and the most common body regions injured were the hand (33.0%) and head and neck (22.5%). Punching bag-related injuries accounted for 36.8% of boxing injuries. The percentage of injuries that were concussions/closed head injuries in the group aged 12-17 years (8.9%) was similar to that in the group aged 18-24 years (8.1%) and the group aged 25-34 years (8.5%). Conclusions: These findings, based on a nationally representative sample, indicate that injuries related to boxing are increasing in number. Increased efforts are needed to prevent boxing injuries. (Am J Prev Med 2011;40(4):462-467) (C) 2011 American Journal of Preventive Medicine	[Potter, Matthew R.; Snyder, Ashley J.; Smith, Gary A.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [Potter, Matthew R.; Smith, Gary A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	Smith, GA (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Gary.Smith@nationwidechildrens.org			Ohio State University College of MedicineOhio State University	The authors gratefully acknowledge the student stipend support provided to author MRP during this study from the Dorothy M. Bennett and Clark L. Bennett Medical Research Scholarship Fund at the Ohio State University College of Medicine.	American Medical Association, H 470 963 BOX INJ; *AUSTR MED ASS, 2007, BOX AUSTR MED ASS PO; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; *BRIT MED ASS, BOX UPD BOARD SCI; *CAN MED ASS, 2001, CMA POL BOX; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Jako P, 2002, BRIT J SPORT MED, V36, P394, DOI 10.1136/bjsm.36.6.394; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; McCrory P, 2002, BRIT J SPORT MED, V36, P2, DOI 10.1136/bjsm.36.1.2; McCrory P, 2007, BMJ-BRIT MED J, V335, P781, DOI 10.1136/bmj.39352.454792.80; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NEISS, 2000, NAT EL INJ SURV SYST; Pearn J, 1998, J PAEDIATR CHILD H, V34, P311, DOI 10.1046/j.1440-1754.1998.00231.x; Playfor SD, 1999, J PAEDIATR CHILD H, V35, P223; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Risser WL, 1997, PEDIATRICS, V99, P134; Shields BJ, 2006, PEDIATRICS, V117, P122, DOI 10.1542/peds.2005-1139; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; 2004, SUPERSTUDY SPORTS PA, V2	26	14	14	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	APR	2011	40	4					462	467		10.1016/j.amepre.2010.12.018			6	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	734FN	WOS:000288319700010	21406281				2021-06-18	
J	Mao, L; Wang, HD; Pan, H; Qiao, LA				Mao, Lei; Wang, Han-Dong; Pan, Hao; Qiao, Liang			Sulphoraphane enhances aquaporin-4 expression and decreases spinal cord oedema following spinal cord injury	BRAIN INJURY			English	Article						Spinal cord injury; sulphoraphane; Nrf2; Aquaporin-4; vasogenic oedema	TRAUMATIC BRAIN-INJURY; COMPRESSION INJURY; ISCHEMIC-INJURY; NULL MICE; SULFORAPHANE; RATS; CHEMOPREVENTION; RECOVERY; MOUSE; MODEL	Background: Aquaporin-4 (AQP4) is a water channel protein and it is an important determinant of outcome after brain injury. Sulphoraphane (SFN) increases AQP4 levels with reduction of brain oedema at 3 days post-traumatic brain injury. However, little is known about the effect of SFN on AQP4 expression and oedema after spinal cord injury (SCI). Methods and procedures: The present study used a murine SCI model induced by compression injury. AQP4 protein level and mRNA level were detected by Western blot and by RT-PCR at 48 hours after SCI, respectively. In addition, immunohistochemical study was used to show AQP4 expression in the spinal cord segments and water content of the spinal cord segments were measured by wet : dry weight ratio. Main outcomes and results: This study shows that AQP4 level was decreased in the injured spinal cord segments at 48 hours following SCI. Post-injury administration of SFN increased AQP4 levels, which was accompanied by a significant reduction in spinal cord segment oedema at 48 hours post-injury. Conclusion: These findings suggest that the reduction of spinal cord oedema in response to SFN administration could be due, in part, to water clearance by AQP4 from the injured spinal cord segments.	[Mao, Lei; Wang, Han-Dong; Pan, Hao; Qiao, Liang] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, Nanjing 210002, Jiangsu Prov, Peoples R China	Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	hdwang_nj@yahoo.com.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81070974]; Jiangsu Provincial Key Subject [X4200722]; Jinling Hospital of Nanjing, China [2009Q016]	This work was supported by grants from National Natural Science Foundation of China (No. 81070974), the Jiangsu Provincial Key Subject (X4200722), and Jinling Hospital of Nanjing, China (2009Q016). The authors alone are responsible for the content and writing of the paper.	Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boldin C, 2006, SPINE, V31, P554, DOI 10.1097/01.brs.0000201274.59427.a4; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Joshi M, 2002, J NEUROTRAUM, V19, P175, DOI 10.1089/08977150252806947; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Li S, 1999, SPINAL CORD, V37, P820, DOI 10.1038/sj.sc.3100941; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marques SA, 2009, J NEUROSCI METH, V177, P183, DOI 10.1016/j.jneumeth.2008.10.015; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nesic O, 2002, J NEUROSCI RES, V68, P406, DOI 10.1002/jnr.10171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9612(03)00497-6; Taniguchi M, 2000, MOL BRAIN RES, V78, P131, DOI 10.1016/S0169-328X(00)00084-X; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; vonEuler M, 1997, EXP NEUROL, V145, P502, DOI 10.1006/exnr.1997.6481; Wang YF, 2009, NEUROREPORT, V20, P145, DOI 10.1097/WNR.0b013e32831c6c44; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Xu WB, 2008, BRAIN RES, V1246, P11, DOI 10.1016/j.brainres.2008.09.087; Yan W, 2008, BRAIN INJURY, V22, P802, DOI 10.1080/02699050802372174; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	30	14	16	1	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2011	25	3					300	306		10.3109/02699052.2010.542432			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	734UP	WOS:000288365400006	21280976				2021-06-18	
J	Lorenz, LS; Chilingerian, JA				Lorenz, Laura S.; Chilingerian, Jon A.			Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Medicine; Issue 48; person-centered care; participatory visual methods; photovoice; photo-elicitation; narrative medicine; acquired brain injury; disability; rehabilitation; palliative care	BRAIN-INJURY; KNOWLEDGE; EXPERIENCE; CHILDREN; ILLNESS; CANCER	The Institute of Medicine has targeted patient-centeredness as an important area of quality improvement. A major dimension of patient-centeredness is respect for patient's values, preferences, and expressed needs. Yet specific approaches to gaining this understanding and translating it to quality care in the clinical setting are lacking. From a patient perspective quality is not a simple concept but is best understood in terms of five dimensions: technical outcomes; decision-making efficiency; amenities and convenience; information and emotional support; and overall patient satisfaction. Failure to consider quality from this five-pronged perspective results in a focus on medical outcomes, without considering the processes central to quality from the patient's perspective and vital to achieving good outcomes. In this paper, we argue for applying the concept of fair process in clinical settings. Fair process involves using a collaborative approach to exploring diagnostic issues and treatments with patients, explaining the rationale for decisions, setting expectations about roles and responsibilities, and implementing a core plan and ongoing evaluation. Fair process opens the door to bringing patient expertise into the clinical setting and the work of developing health care goals and strategies. This paper provides a step by step illustration of an innovative visual approach, called photovoice or photo-elicitation, to achieve fair process in clinical work with acquired brain injury survivors and others living with chronic health conditions. Applying this visual tool and methodology in the clinical setting will enhance patient-provider communication; engage patients as partners in identifying challenges, strengths, goals, and strategies; and support evaluation of progress over time. Asking patients to bring visuals of their lives into the clinical interaction can help to illuminate gaps in clinical knowledge, forge better therapeutic relationships with patients living with chronic conditions such as brain injury, and identify patient-centered goals and possibilities for healing. The process illustrated here can be used by clinicians, ( primary care physicians, rehabilitation therapists, neurologists, neuropsychologists, psychologists, and others) working with people living with chronic conditions such as acquired brain injury, mental illness, physical disabilities, HIV/AIDS, substance abuse, or post-traumatic stress, and by leaders of support groups for the types of patients described above and their family members or caregivers.	[Lorenz, Laura S.] Brandeis Univ, Inst Behav Hlth, Waltham, MA 02254 USA; [Lorenz, Laura S.; Chilingerian, Jon A.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA	Lorenz, LS (corresponding author), Brandeis Univ, Inst Behav Hlth, Waltham, MA 02254 USA.	llorenz@brandeis.edu		Lorenz, Laura/0000-0003-0898-4537	Brain Injury Association of Massachusetts; Statewide Health Injury Program of the Massachusetts Rehabilitation Commission; Agency for Healthcare Research in QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality; Schneider Institutes for Health Policy at the Heller School for Social Policy and Management, Brandeis University	We thank the 14 brain injury patients who are members of the "Amazing" Brain Injury Survivor Support Group in Framingham, MA or accessing outpatient services through Spaulding Rehabilitation Hospital for participating in the study that led to this paper. Funding and other support for the study were provided by the Brain Injury Association of Massachusetts, the Statewide Health Injury Program of the Massachusetts Rehabilitation Commission, and the Agency for Healthcare Research in Quality and the Schneider Institutes for Health Policy at the Heller School for Social Policy and Management, Brandeis University, through a doctoral training fellowship in health services research and policy analysis.	Berland G, 2007, NEW ENGL J MED, V357, P2533, DOI 10.1056/NEJMp0706823; Boyle P. J, 2001, PARK RIDGE CTR B REL, V19, P479; Chalfen R., 2004, VIS ANTHR REV, V20, P17, DOI DOI 10.1525/VAR.2004.20.ISSUE-1; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Chilingerian J. A, 2004, CONSUMER DRIVEN HLTH, P443, DOI Jossey-Bass; Chilingerian JA, 2006, MANAGING LEADING ALL, P191; Entwistle V, 2002, EUR J CANCER CARE, V11, P232, DOI 10.1046/j.1365-2354.2002.00344.x; Guillemin M, 2004, QUAL HEALTH RES, V14, P272, DOI 10.1177/1049732303260445; Hagen C, 1997, DALLAS TEXAS RANCHOS; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kim WC, 1997, HARVARD BUS REV, V75, P65; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin T, 2007, TOP STROKE REHABIL, V14, P72, DOI 10.1310/tsr1401-72; Lorenz L. S., 2007, 13 ANN NRSA TRAIN RE; Lorenz L. S., 2009, DOING YOUR OWN PHOTO; Lorenz L. S., 2010, DISABILITY SOC; Lorenz LS, 2010, VISUAL STUD, V25, P210, DOI 10.1080/1472586X.2010.523273; Lorenz LS, 2010, SOCIOL HEALTH ILL, V32, P862, DOI 10.1111/j.1467-9566.2010.01244.x; Lorenz LS, 2009, HEALTH EXPECT, V12, P262, DOI 10.1111/j.1369-7625.2009.00560.x; OAKLEY A, 1995, BRIT MED J, V310, P1029, DOI 10.1136/bmj.310.6986.1029; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Prior L, 2003, SOCIOL HEALTH ILL, V25, P41, DOI 10.1111/1467-9566.00339; Radley A, 2003, QUAL HEALTH RES, V13, P77, DOI 10.1177/1049732302239412; Rich M, 2000, J ADOLESCENT HEALTH, V27, P155, DOI 10.1016/S1054-139X(00)00114-2; Sherry M., 2006, I ONLY HAD BRAIN DEC; Van der Heyden L, 2005, FAM BUS REV, V18, P1, DOI 10.1111/j.1741-6248.2005.00027.x; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Yin R. K., 2008, CASE STUDY RES DESIG, V4th	30	14	14	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	FEB	2011		48							e2342	10.3791/2342			11	Multidisciplinary Sciences	Science & Technology - Other Topics	V36LG	WOS:000209212900007	21372785	Bronze, Green Published			2021-06-18	
J	Mihara, Y; Dohi, K; Yofu, S; Nakamachi, T; Ohtaki, H; Shioda, S; Aruga, T				Mihara, Yuko; Dohi, Kenji; Yofu, Sachiko; Nakamachi, Tomoya; Ohtaki, Hirokazu; Shioda, Seiji; Aruga, Tohru			Expression and Localization of the Orexin-1 Receptor (OX1R) After Traumatic Brain Injury in Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Orexin-1 receptor (OX1R); Orexin; Traumatic brain injury; Neuron; Microglia; Immunohistochemistry	NARCOLEPSY; MICROGLIA; APOPTOSIS; DEFICIENCY; PEPTIDES; NEURONS	Orexins are neuropeptides that have a wide range of physiological effects, and recent studies have suggested that the orexin system may be involved in traumatic brain injury. However, the expression and localization of orexin receptors have not been examined yet under brain injury conditions. In the present study, we used immunohistochemical techniques to investigate the expression of orexin-1 receptor (OX1R) and its time-dependent changes in the mouse brain after controlled cortical impact (CCI) injury. OX1R-like immunoreactivity was first detected 6 h after injury in the surrounding penumbra of the injury. The intensity of this immunoreactivity was increased at 12 h, peaked at day 1, and then decreased from day 2 to day 7. To identify the cellular localization of OX1R, we also performed double-immunohistochemical staining with OX1R and several cell marker antibodies. OX1R-like immunopositive cells were clearly co-localized with immunoreactivity for the neuronal marker NeuN at day 7. It was also expressed on the periphery of cells immunopositive for CD11b, a microglial cell marker, at days 1 and 7. These results suggest that orexin and its receptor may play roles in traumatic brain injury, and that OX1R is induced in neurons and microglial cells after traumatic brain injury.	[Dohi, Kenji; Yofu, Sachiko; Nakamachi, Tomoya; Ohtaki, Hirokazu; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Mihara, Yuko; Dohi, Kenji; Aruga, Tohru] Showa Univ, Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan	Shioda, S (corresponding author), Showa Univ, Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shioda@med.showa-u.ac.jp		dohi, kenji/0000-0002-4451-0382	Ministry of Education, Science, Sports and CultureMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Showa University; Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21659059, 21659356, 22791695] Funding Source: KAKEN	This study was supported in part by grants from the Ministry of Education, Science, Sports and Culture, from a Showa University Grant-in Aid for Innovative Collaborative Research Projects, and from a Special Research Grant-in Aid for Development of Characteristic Education from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Adeghate E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008587; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Conti AC, 1998, J NEUROSCI, V18, P5663; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dohi K, 2005, PEPTIDES, V26, P2339, DOI 10.1016/j.peptides.2005.04.004; Dohi K, 2006, NEUROPEPTIDES, V40, P245, DOI 10.1016/j.npep.2006.06.003; Drouot X, 2003, NEUROLOGY, V61, P540, DOI 10.1212/01.WNL.0000078194.53210.48; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hervieu GJ, 2001, NEUROSCIENCE, V103, P777, DOI 10.1016/S0306-4522(01)00033-1; Ida T, 2000, BIOCHEM BIOPH RES CO, V270, P318, DOI 10.1006/bbrc.2000.2412; Irving EA, 2002, NEUROSCI LETT, V324, P53, DOI 10.1016/S0304-3940(02)00176-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Nakamachi T, 2005, REGUL PEPTIDES, V126, P49, DOI 10.1016/j.regpep.2004.08.037; Nishino S, 2005, SLEEP MED REV, V9, P269, DOI 10.1016/j.smrv.2005.03.004; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Savitz SI, 1998, NEUROSURGERY, V42, P555, DOI 10.1097/00006123-199803000-00026; Stricker-Krongrad A, 2002, BIOCHEM BIOPH RES CO, V296, P129, DOI 10.1016/S0006-291X(02)00848-3; Suzuki R, 2002, NEUROSCI LETT, V324, P5, DOI 10.1016/S0304-3940(02)00140-4; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201	31	14	15	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2011	43	2					162	168		10.1007/s12031-010-9438-6			7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	711QK	WOS:000286606300006	20803175				2021-06-18	
J	Su, YL; Chen, W; Zhang, Q; Li, BJ; Li, ZY; Guo, MK; Pan, JS; Zhang, YZ				Su, Yanling; Chen, Wei; Zhang, Qi; Li, Baojun; Li, Zhiyong; Guo, Mingke; Pan, Jinshe; Zhang, Yingze			An irreducible variant of femoral neck fracture: A minimally traumatic reduction technique	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Irreducible femoral neck fracture; Displaced-impacted fracture; Dislocated fracture; Surgical technique	COMPRESSION SCREW FIXATION; INTRACAPSULAR FRACTURES; AVASCULAR NECROSIS; INTERNAL-FIXATION; HIP-FRACTURES; YOUNG-ADULTS; HEAD; FEMUR	We present 25 cases of irreducible variant femoral neck fractures that require surgical management after routine manipulative manoeuvre attempts have failed. In our study, an irreducible variant of femoral neck fractures is defined as a reduction that cannot be achieved after multiple attempts at closed reduction. This was evident radiographically, as seen in displaced-impacted femoral neck fractures when the proximal femur compacts and rotates along with the distal part, and anatomical reduction cannot be achieved with manipulative manoeuvres. Another rare situation also included is when the proximal fragment disconnects from the femur and dislocates as a 'floating' component, consequently resulting in failure of alignment of the distal fragment to the proximal femur. Here, we describe a technique, applied as a minimally traumatic procedure to achieve anatomic reduction in such cases. With the patient placed in supine position on the fracture table under general anaesthesia, the injury site is exposed and the procedure performed under intra-operative radiographic control. Location of the femoral artery is done first by palpation. The insertion site of the K-wires or Steinman pins on the proximal thigh is 1.5-3 cm lateral to the femoral artery. The K-wires or Steinman pins are inserted vertically into the middle 1/2-2/3 of the femoral head and more than 1 cm inferior to the sub-chondral bone of the femoral head to a depth of approximately, 1/2 diameter of the femoral head. The pins are then used as a joystick to control the movement of the proximal femur. With the help of the K-wires, surgeons can manually control the movement of the proximal femur and ensure anatomic reduction with the distal fragment using routine-closed reduction. Three cannulated screws are used to stabilise the fracture after anatomic reduction is achieved and maintained in a stable position. All cases were treated with this minimally invasive procedure and internal fixation, 25 fractures united, uneventfully, whilst two of them developed femoral head necrosis at 10 months and 4.5 years postoperatively, respectively. Crown Copyright (C) 2010 Published by Elsevier Ltd. All rights reserved.	[Su, Yanling; Chen, Wei; Zhang, Qi; Li, Baojun; Li, Zhiyong; Pan, Jinshe; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed, Shijiazhuang 050051, Hebei, Peoples R China; [Guo, Mingke] Chinese Peoples Liberat Army, Dept Orthopaed, Shijiazhuang 050041, Hebei, Peoples R China	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed, 139 Ziqiang Rd, Shijiazhuang 050051, Hebei, Peoples R China.	drchenwei1981@gmail.com; drzhangqi@yahoo.com.cn; jinshe.pan@gmail.com; dryzzhang@yahoo.com.cn					ARNOLD WD, 1974, J BONE JOINT SURG AM, VA 56, P254, DOI 10.2106/00004623-197456020-00003; Bachiller FGC, 2002, CLIN ORTHOP RELAT R, P87; BANKS HH, 1974, ORTHOP CLIN N AM, V5, P865; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2; BONFIGLIO M, 1968, J BONE JOINT SURG AM, VA 50, P48, DOI 10.2106/00004623-196850010-00003; Bosch U, 2001, CHIRURG, V72, P1292, DOI 10.1007/s001040170034; CHAPMAN MW, 1975, J BONE JOINT SURG BR, V57, P735; CHRISTIE J, 1988, J BONE JOINT SURG BR, V70, P199; DICKSON JA, 1953, J BONE JOINT SURG AM, V35-A, P805, DOI 10.2106/00004623-195335040-00001; FIELDING JW, 1974, J BONE JOINT SURG AM, VA 56, P1464, DOI 10.2106/00004623-197456070-00015; FRANDSEN PA, 1983, ACTA ORTHOP SCAND, V54, P681, DOI 10.3109/17453678308996611; GERBER C, 1993, CLIN ORTHOP RELAT R, P77; Hirata T, 2001, CLIN ORTHOP RELAT R, P294; HOAGLUND FT, 1980, CLIN ORTHOP RELAT R, P10; Johansson T, 2006, INT ORTHOP, V30, P1, DOI 10.1007/s00264-005-0037-z; KOFOED H, 1982, INJURY, V14, P146, DOI 10.1016/0020-1383(82)90049-3; Koval, 1994, J Am Acad Orthop Surg, V2, P141; LINDEQUIST S, 1995, J ORTHOP TRAUMA, V9, P215, DOI 10.1097/00005131-199506000-00006; LUCIE RS, 1981, CLIN ORTHOP RELAT R, P207; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; Molnar RB, 2007, J ORTHOP TRAUMA, V21, P490, DOI 10.1097/BOT.0b013e31804a7f7f; PARKER MJ, 1994, INJURY S2, V25, P3; PFORRINGER W, 1980, ACTA ORTHOP SCAND, V51, P91, DOI 10.3109/17453678008990774; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; REHNBERG L, 1989, J BONE JOINT SURG BR, V71, P173; Roden M, 2003, ACTA ORTHOP SCAND, V74, P42, DOI 10.1080/00016470310013635; Schmidt AH, 2002, ORTHOP CLIN N AM, V33, P97, DOI 10.1016/S0030-5898(03)00074-9; SKINNER PW, 1986, J BONE JOINT SURG BR, V68, P78; SWIONTKOWSKI MF, 1994, J BONE JOINT SURG AM, V76A, P129, DOI 10.2106/00004623-199401000-00019; SWIONTKOWSKI MF, 1987, J ORTHOPAED RES, V5, P433, DOI 10.1002/jor.1100050316; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003; SWIONTKOWSKI MF, 1986, CLIN ORTHOP RELAT R, P248; Wazir N N, 2006, J Orthop Surg (Hong Kong), V14, P43; Zhang Q, 2009, SKELETAL RADIOL, V38, P1175, DOI 10.1007/s00256-009-0662-5	34	14	35	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	FEB	2011	42	2					140	145		10.1016/j.injury.2010.05.008			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	705LY	WOS:000286135100006	20570257				2021-06-18	
J	Bauer, DF; McGwin, G; Melton, SM; George, RL; Markert, JM				Bauer, David F.; McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.; Markert, James M.			Risk Factors for Conversion to Permanent Ventricular Shunt in Patients Receiving Therapeutic Ventriculostomy for Traumatic Brain Injury	NEUROSURGERY			English	Article						Hemorrhage; Shunt; Trauma; Ventriculostomy	POSTTRAUMATIC HYDROCEPHALUS	BACKGROUND: Intracranial pressure is routinely monitored in patients with severe traumatic brain injury (TBI). Patients with TBI sometimes develop hydrocephalus, requiring permanent cerebrospinal fluid (CSF) diversion. OBJECTIVE: To quantify the need for permanent CSF diversion in patients with TBI. METHODS: Patients who received a ventriculostomy after TBI between June 2007 and July 2008 were identified, and their medical records were abstracted to a database. RESULTS: Sixteen of 71 patients (22.5%) receiving a ventriculostomy required a ventriculoperitoneal or ventriculoatrial shunt before discharge from the hospital. The average number of days between ventriculostomy and shunt was 18.3. Characteristics that predispose these patients to require permanent CSF diversion include the need for craniotomy within 48 hours of admission (odds ratio, 5.20; 95% confidence interval, 1.48-18.35) and history of culture-positive CSF (odds ratio, 5.52; 95% confidence interval, 1.19-25.52). Length of stay was increased in patients receiving permanent CSF diversion (average length of stay, 61 vs 31 days; P = .04). Patient discharge disposition was similar between shunted and nonshunted patients. CONCLUSION: In this retrospective study, 22% of TBI patients who required a ventriculostomy eventually needed permanent CSF diversion. Patients with TBI should be assessed for the need for permanent CSF diversion before discharge from the hospital. Care must be taken to prevent ventriculitis. Future studies are needed to evaluate more thoroughly the risk factors for the need for permanent CSF diversion in this patient population.	[Bauer, David F.; Markert, James M.] Univ Alabama Birmingham, Div Neurosurg, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.] Univ Alabama Birmingham, Sect Trauma Burns & Surg Crit Care, Dept Surg, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA	Markert, JM (corresponding author), Univ Alabama Birmingham, Div Neurosurg, FOT 1060,1530 3rd Ave S, Birmingham, AL 35294 USA.	markert@uab.edu		Bauer, David/0000-0003-3548-0887			*AM ASS NEUR SURG, 2006, NAT NEUR PROC STAT; BRAIN TRAUM FD, 2000, J NEUROTRAUM, V17, P457; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Chan M, 2009, J NEUROSURG, V110, P44, DOI 10.3171/2008.5.17560; Dorai Z, 2003, NEUROSURGERY, V52, P763, DOI 10.1227/01.NEU.0000053222.74852.2D; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; KELLY DF, 1995, OPERATIVE NEUROSURGI, P47; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; Licata C, 2001, J Neurosurg Sci, V45, P141; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; OKOR MO, 2008, GEN SURG PRINCIPLES; Phuenpathom Nakornchai, 1999, Journal of the Medical Association of Thailand, V82, P46; Rammos S, 2008, J NEUROSURG, V109, P1001, DOI 10.3171/JNS.2008.109.12.1001; Roitberg BZ, 2001, BRIT J NEUROSURG, V15, P324; Tribl G, 2000, BRAIN INJURY, V14, P345; VESPA PM, 2000, OPERATIVE NEUROSURGE, P1205	19	14	15	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2011	68	1					85	88		10.1227/NEU.0b013e3181fd85f4			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	694IE	WOS:000285288200034	21099716				2021-06-18	
B	Cozza, SJ; Guimond, JM		Wadsworth, SM; Riggs, D		Cozza, Stephen J.; Guimond, Jennifer M.			Working with Combat-Injured Families Through the Recovery Trajectory	RISK AND RESILIENCE IN U S MILITARY FAMILIES			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; OPERATION IRAQI FREEDOM; MULTIPLE-SCLEROSIS; SOCIAL SUPPORT; HEALTH-STATUS; CHILDREN; PARENTS; ADJUSTMENT; REHABILITATION	Combat injury can profoundly affect the children and families of service members. The range of experiences for these families varies depending the specific injury type, severity, and recovery trajectory; composition of the family; developmental age of the children; preexisting parent, child, or family characteristics; as well as the longer-term functional impact on the injured parent. Following the injury children and adolescents may display distress, emotional or behavioral problems, risk-taking behaviors, increased helpfulness within the family, or motivation to participate in community service. The impact on children is influenced by the capacity of both the injured and noninjured parents to cope effectively, maintain effective parenting, and help the child adjust to changes in family relationships and circumstances. Interventions with combat-injured families should focus on reducing distress, supporting healthy child and parent functioning, and encouraging constructive communication within families and with service providers about the injury.	[Cozza, Stephen J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA	Cozza, SJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA.	scozza@usuhs.mil		Guimond, Jennifer/0000-0002-8887-5885			ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; [Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; ANTHONY EJ, 1970, CHILD HIS FAMILY, P131; ARMISTEAD L, 1995, CLIN PSYCHOL REV, V15, P409, DOI 10.1016/0272-7358(95)00023-I; BEARDSLEE WR, 1984, PEDIATR ANN, V13, P32; BEARDSLEE WR, 1994, HDB DEPRESSION CHILD; BRETON JJ, 1993, J AM ACAD CHILD PSY, V32, P438, DOI 10.1097/00004583-199303000-00028; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Charles N, 2007, NEUROREHABILITATION, V22, P61; CHESNUT RM, 1999, REHABILITATION TRAUM; Cohen J. P., 2006, INTERVENTIONS FOLLOW, P227; COYNE JC, 1991, ANNU REV PSYCHOL, V42, P401, DOI 10.1146/annurev.ps.42.020191.002153; Cozza S. J., 2009, P WORKGR INT COMB IN; Cozza SJ, 2005, PSYCHIAT QUART, V76, P371, DOI 10.1007/s11126-005-4973-y; COZZA SJ, 2009, DISCUSSIONS CO UNPUB; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; De Judicibus MA, 2004, ADOLESCENCE, V39, P551; Diareme S, 2006, EUR CHILD ADOLES PSY, V15, P309, DOI 10.1007/s00787-006-0534-7; DOHRENWEND BS, 1981, STRESSFUL LIFE EVENT; Ducharme JM, 2002, AM J ORTHOPSYCHIAT, V72, P585, DOI 10.1037/0002-9432.72.4.585; FINNEY JW, 1998, DEV ISSUES CLIN TREA, V1, P433; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Halcomb Elizabeth, 2005, Contemp Nurse, V19, P232; Kelley SDM, 1997, REHABIL COUNS BULL, V41, P105; KINZIE JD, 1986, J AM ACAD CHILD PSY, V25, P370, DOI 10.1016/S0002-7138(09)60259-4; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Korneluk Y G, 1998, Clin Child Fam Psychol Rev, V1, P179, DOI 10.1023/A:1022654831666; Kotchick BA, 1997, BEHAV MODIF, V21, P409, DOI 10.1177/01454455970214002; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Laor N, 1996, ARCH GEN PSYCHIAT, V53, P416, DOI 10.1001/archpsyc.1996.01830050052008; LECLERE FB, 1994, J MARRIAGE FAM, V56, P457, DOI 10.2307/353112; Lester P, 2003, J DEV BEHAV PEDIATR, V24, P242, DOI 10.1097/00004703-200308000-00004; MacGregor AJ, 2009, INJURY, V40, P1004, DOI 10.1016/j.injury.2009.04.006; Martire LM, 2004, HEALTH PSYCHOL, V23, P599, DOI 10.1037/0278-6133.23.6.599; MCFARLANE AC, 1987, J AM ACAD CHILD PSY, V26, P764, DOI 10.1097/00004583-198709000-00025; McLaughlin AM, 1992, J COGNITIVE REHABILI, V10, P12; Meiser-Stedman R, 2007, J ABNORM CHILD PSYCH, V35, P191, DOI 10.1007/s10802-006-9068-1; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pakenham KI, 2006, CLIN REHABIL, V20, P709, DOI 10.1191/0269215506cre976oa; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; PETERS LC, 1985, J CHRON DIS, V38, P301, DOI 10.1016/0021-9681(85)90076-1; Pfefferbaum B, 1997, J AM ACAD CHILD PSY, V36, P1503, DOI 10.1016/S0890-8567(09)66558-8; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; POWER PW, 1979, FAM COORD, V28, P616, DOI 10.2307/583526; PYNOOS RS, 1989, J AM ACAD CHILD PSY, V28, P236, DOI 10.1097/00004583-198903000-00015; RUTTER M, 1984, PSYCHOL MED, V14, P853, DOI 10.1017/S0033291700019838; Rutter M, 1966, CHILDREN SICK PARENT; SACK WH, 1995, J AM ACAD CHILD PSY, V34, P1160, DOI 10.1097/00004583-199509000-00013; Saltzman William R., 2009, FOCUS MILITARY FAMIL; Urbach J R, 1989, Psychiatr Med, V7, P17; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; *US DEP DEF, 2010, MIL CAS INF; US Department of Defense, 2007, DEM 2007 PROF MIL CO; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Visser-Meily A, 2005, STROKE, V36, P2436, DOI 10.1161/01.STR.0000185681.33790.0a; Visser-Meily A, 2005, J REHABIL MED, V37, P236, DOI 10.1080/16501970510025990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zatzick DF, 2001, GEN HOSP PSYCHIAT, V23, P114, DOI 10.1016/S0163-8343(01)00140-2; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	61	14	14	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-7063-3				2011							259	277		10.1007/978-1-4419-7064-0_13	10.1007/978-1-4419-7064-0		19	Psychology, Clinical; Psychology, Developmental	Psychology	BSJ70	WOS:000284727200013					2021-06-18	
J	Hauke, J; Fimm, B; Sturm, W				Hauke, Johanna; Fimm, Bruno; Sturm, Walter			Efficacy of alertness training in a case of brainstem encephalitis: Clinical and theoretical implications	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Arousal deficit; Alertness training; Improvement of attention functions; Long-term effects	COGNITIVE REHABILITATION; SUSTAINED ATTENTION; INTRINSIC ALERTNESS; RIGHT-HEMISPHERE; LOCUS-COERULEUS; NEGLECT; TASK; INFORMATION; MODULATION; NETWORKS	Although attention functions are often impaired after stroke, traumatic brain injury or inflammatory diseases, little is known about the time course and the long-term efficacy of training-induced improvement. The present single case study evaluates the time course and longitudinal stability of attention improvement after alertness training by repeatedly testing the subject between individual training sessions as well as one and seven months after the end of the training. The outpatient (M.P.) trained developed severe alertness deficits following brainstem encephalitis in 2003 without signs of cortical damage, and since then had not achieved full recovery. In 2008, M.P. participated in 15 treatment sessions on 15 separate working days over a period of three weeks. In each session a 45-minute alertness training task was administered, using the CogniPlus ALERT computer training program. Attention performance was assessed by neuropsychological tests four years, one year, and immediately before the therapy after every third training session and three times after the termination of therapy. Furthermore, a self-report questionnaire measured subjective experience of attention in everyday life situations. In order to compare the performance between training sessions, a procedure specialised for psychometric single-case diagnosis was used to analyse the data. Surprisingly, even after three consecutive training sessions, M.P. showed immense improvement in alertness. Furthermore, after two weeks she felt more energetic and more able to concentrate. Six months after the end of the training the improvement remained stable. The unexpectedly fast time course of recovery induced by the training, as well as the stable long-term effects, probably depend on intact cortical structures. In M.P. it appeared that top-down control of the alertness network on impaired brainstem arousal structures had been re-activated by the training procedure and had remained stable across a long time period.	[Sturm, Walter] Rhein Westfal TH Aachen, Univ Hosp, Neurol Clin, Sect Clin Neuropsychol, D-52074 Aachen, Germany	Sturm, W (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Neurol Clin, Sect Clin Neuropsychol, Pauwelsstr 30, D-52074 Aachen, Germany.	sturm@neuropsych.rwth-aachen.de					Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Dreisbach G, 2008, PSYCHOL RES-PSYCH FO, V72, P355, DOI 10.1007/s00426-007-0131-5; Engelberts NHJ, 2002, EPILEPSIA, V43, P587, DOI 10.1046/j.1528-1157.2002.29401.x; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Goschke T, 2008, PSYCHOL SCI, V19, P25, DOI 10.1111/j.1467-9280.2008.02042.x; Horn W, 1983, LEISTUNGSPRUFSYSTEM; Huber H. P., 1973, PSYCHOMETRISCHE EINZ; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mottaghy FM, 2006, NEUROIMAGE, V29, P225, DOI 10.1016/j.neuroimage.2005.07.034; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; PARDO JV, 1990, NATURE, V349, P61; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Plohmann AM, 1998, J NEUROL NEUROSUR PS, V64, P455, DOI 10.1136/jnnp.64.4.455; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1997, IMAGES MINDS, P153; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Sturm W, 2006, RESTOR NEUROL NEUROS, V24, P371; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P434, DOI 10.1016/j.neuropsychologia.2003.09.001; Sturm W., 2005, AUFMERKSAMKEITSSTORU; STURM W, 2007, MANUAL WIENER TESTSY; Sturm W, 2003, Z NEUROPSYCHOL, V14, P283, DOI [DOI 10.1024/1016-264X.14.4.283, 10.1024/1016-264X.14.4.283]; Sturm W, 2008, HDB NEURO BIOPSYCHOL, P329; Thimm M, 2006, NEUROPSYCHOLOGIA, V44, P1230, DOI 10.1016/j.neuropsychologia.2005.09.008; Thimm M, 2009, CORTEX, V45, P850, DOI 10.1016/j.cortex.2008.10.007; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Walker AD, 2009, PSYCHOPHYSIOLOGY, V46, P217, DOI 10.1111/j.1469-8986.2008.00718.x; WILLMES K, 1990, APHASIOLOGY, V4, P415, DOI 10.1080/02687039008249092; Witte EA, 1997, PSYCHOPHARMACOLOGY, V132, P315, DOI 10.1007/s002130050351; Zimmermann P, 2007, TEST ATTENTIONAL PER; Zimmermann P., 1997, FRAGEBOGEN ERLEBTER	37	14	14	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	2					164	182	PII 931808942	10.1080/09602011.2010.541792			19	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	733NZ	WOS:000288270700002	21391120				2021-06-18	
J	Jacob, AT; Heuer, GG; Grant, R; Georgoff, P; Danish, SF; Storm, PB; Stein, SC				Jacob, Arun T.; Heuer, Gregory G.; Grant, Ryan; Georgoff, Patrick; Danish, Shabbar F.; Storm, Phillip B.; Stein, Sherman C.			Decompressive Hemicraniectomy for Pediatric Traumatic Brain Injury: Long-Term Outcome Based on Quality of Life	PEDIATRIC NEUROSURGERY			English	Article						Pediatric traumatic brain injury; Hemicraniectomy, outcome; Quality of life	SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CEREBRAL EDEMA; CRANIECTOMY; CHILDREN; CRANIOTOMY; MANAGEMENT; PRESSURE; EXPERIENCE; SCALE	Aims: The impact of decompressive hemicraniectomy (DCH) on the overall outcome of pediatric brain injury patients has not been fully determined. In this paper, the authors performed a systematic review of patient outcome based on quality of life following DCH in a pediatric population. Methods: We describe our experience with decompressive craniectomy in pediatric patients and perform a literature review and pooled outcomes analysis to supplement these findings. A total of 13 children underwent DCH for intractable intracranial pressure in our institution from 2000 to 2008. Follow-up was available in 11 patients with 1 death (9%) and 7 survivors (70%) obtaining a favorable outcome (Glasgow Outcome Scale, GOS, scores = 4-5). Results: A literature review to determine the usefulness of DCH identified 17 articles that, when combined with our series, resulted in 186 pediatric DCH cases. Pooled outcomes found 42 deaths and 112 patients who had favorable outcomes at 6 months. The average 6-month mortality was 21.1%, and the pooled mean quality of life among survivors 0.75 (0.68-0.82), midway between moderate disability and good outcome. Conclusions: Based on our findings, DCH results in a majority of pediatric patients having a good outcome based on the GOS score. Copyright (C) 2011 S. Karger AG, Basel	[Jacob, Arun T.; Heuer, Gregory G.; Grant, Ryan; Georgoff, Patrick; Storm, Phillip B.; Stein, Sherman C.] Univ Penn Hlth Syst, Dept Neurosurg, Philadelphia, PA 19104 USA; [Heuer, Gregory G.; Storm, Phillip B.] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA; [Danish, Shabbar F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Neurosurg, New Brunswick, NJ USA	Jacob, AT (corresponding author), Univ Penn Hlth Syst, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.	arun.jacob@uphs.upenn.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Brain Trauma Foundation, 2003, MAN PROGN SEV TRAUM; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Cushing H, 1908, ANN SURG, V47, P641, DOI 10.1097/00000658-190805000-00001; Doppenberg EMR, 1997, ANN NY ACAD SCI, V825, P305, DOI 10.1111/j.1749-6632.1997.tb48441.x; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Gold M., 1996, Cost-Effectiveness in Health and Medicine.; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; Maas AIR, 2004, ACT NEUR S, V89, P113; Messing-Junger AM, 2003, ZBL NEUROCHIR, V64, P171; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Mukherjee KK, 2006, SURG NEUROL, V66, P305, DOI 10.1016/j.surneu.2005.12.035; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Simma B, 2002, INTENS CARE MED, V28, P1000, DOI 10.1007/s00134-002-1333-3; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410	34	14	14	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2011	47	2					81	86		10.1159/000329624			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	842BP	WOS:000296561900001	21934271				2021-06-18	
J	Kreitschmann-Andermahr, I; Hartmann, Y; Poll, E; Schneider, HJ; Buchfelder, M; Stalla, GK				Kreitschmann-Andermahr, I.; Hartmann, Y.; Poll, E.; Schneider, H. J.; Buchfelder, M.; Stalla, G. K.		Investigator Board	The German Database on Hypopituitarism after Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage - Description, Objectives and Design	EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES			English	Article						traumatic brain injury; subarachnoid hemorrhage; hypopituitarism; growth hormone deficiency; database		Within the last years, a number of clinical studies have addressed the topic of hypothalamo-pituitary dysfunction following traumatic brain injury (TBI) and aneurysmal subarachnoid hemorrhage (SAH). Clinical studies oftentimes reflect the investigation of highly selective patient groups, very standardized test procedures and may be influenced by a publication bias. Epidemiological data on the prevalence and incidence of hypopituitarism after TBI and SAH in the general population still do not exist. Moreover, very little is known about risk factors and clinical characteristics of pituitary impairment after brain damage. Epidemiologic surveys which aggregate information of many different treatment centers become an increasingly important means of bridging the gap between standardized study situations and clinical practice. Therefore, a multi-center, structured data assessment to create a national registry of TB! and SAH patients has been established in 2005. The Structured Data Assessment of Hypopituitarism after TBI and SAH is coordinated by the Department of Endocrinology, Max-Planck-Institute in Munich with participation of at present 13 neurosurgical, rehabilitation and endocrinological centers in Germany and one Austrian center. Within this database, a large scope of very detailed, clinical, endocrine and outcome information is collected. It also offers the possibility of long-term follow up of the recorded patients. This is the first report of the registry describing goals, organization, methodology, funding and the descriptive data of the first 1 242 patients entered until November 20(th), 2008.	[Kreitschmann-Andermahr, I.; Hartmann, Y.; Poll, E.] Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany; [Buchfelder, M.] Univ Erlangen Nurnberg, Dept Neurosurg, D-8520 Erlangen, Germany; [Stalla, G. K.] Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, D-80804 Munich, Germany; [Schneider, H. J.] Univ Munich, Med Klin Innenstadt, D-80804 Munich, Germany	Kreitschmann-Andermahr, I (corresponding author), Univ Technol RWTH Aachen, Dept Neurosurg, Pauwelsstr 30, D-52074 Aachen, Germany.	ikreitschmann-andermahr@ukaachen.de			PfizerPfizer; Novo NordiskNovo Nordisk; NovartisNovartis; LillyEli Lilly	IKA received research grants from Pfizer and Novo Nordisk and travel grants from Pfizer, Novo Nordisk and Novartis. HJS received research grants from Pfizer, speaker fees and travel grants from Pfizer and Novo Nordisk, and travel grants from Lilly and Novartis. MB received research grants, speaker fees, and travel grants from Pfizer, Novo Nordisk and Novartis. GKS received research grants, speaker fees, and travel grants from Pfizer, Novo Nordisk and Novartis.	FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Hutter BO, 1999, ACT NEUR S, V72, P157; JENNETT B, 1975, LANCET, V1, P480; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tamargo R J, 1997, New Horiz, V5, P364; TEASDALE G, 1974, LANCET, V2, P81; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6	11	14	17	0	1	JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH	STUTTGART	RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY	0947-7349	1439-3646		EXP CLIN ENDOCR DIAB	Exp. Clin. Endocrinol. Diabet.	JAN	2011	119	1					15	20		10.1055/s-0030-1253414			6	Endocrinology & Metabolism	Endocrinology & Metabolism	734TN	WOS:000288361900003	20533178				2021-06-18	
J	Liu, M; Wei, WL; Fergenbaum, J; Comper, P; Colantonio, A				Liu, Margaret; Wei, Wenli; Fergenbaum, Jennifer; Comper, Paul; Colantonio, Angela			Work-related mild-moderate traumatic brain injury and the construction industry	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Person-Environment-Occupation model; occupation; prevention; workplace safety	ACCIDENTS; DEATHS	Background: Consequences of traumatic brain injury underscore the need to study high-risk groups. Few studies have investigated work-related traumatic brain injuries (WrTBIs) in the construction industry. Objective: To examine WrTBIs in Ontario for the construction industry compared to other industries. Methods: A retrospective study of individuals who sustained a WrTBI and had a clinical assessment as an outpatient at a hospital-based referral centre. Data were collected for a number of factors including demographic, injury and occupation and were analyzed according to the Person-Environment-Occupation (PEO) model. Participants: 435 individuals who sustained a WrTBI. Results: There were 19.1% in the construction industry, 80.9% in other industries. Compared to other industries, individuals in the construction industry were more likely to be male, to not have attained post-secondary education, and experience multiple traumas. WrTBIs in the construction industry were commonly due to elevated work. The construction occupations involved included skilled workers and general labourers, and compared to other industries, WrTBIs occurred most often for those employed for a short duration in the construction industry. Conclusions: Construction industry workers experience serious WrTBIs that are amenable to prevention. Use of the PEO model increased our understanding of WrTBIs in the construction industry.	[Colantonio, Angela] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Fergenbaum, Jennifer; Comper, Paul; Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada	Colantonio, A (corresponding author), Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Rehabil Sci Bldg,500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765; Salerno, Jennifer/0000-0001-7282-5579			Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; COLEMAN VP, 1986, J OCCUP ACCID, V8, P161, DOI 10.1016/0376-6349(86)90002-7; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; Haslam RA, 2005, APPL ERGON, V36, P401, DOI 10.1016/j.apergo.2004.12.002; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Hsiao H, 2001, ERGONOMICS, V44, P537, DOI 10.1080/00140130110034480; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kim H, 2006, NEUROREHABILITATION, V21, P269; KISNER SM, 1994, J OCCUP ENVIRON MED, V36, P137, DOI 10.1097/00043764-199402000-00008; Law M., 1996, CANADIAN J OCCUPATIO, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Lipscomb HJ, 2006, APPL ERGON, V37, P267, DOI 10.1016/j.apergo.2005.07.008; McCann M, 2003, J SAFETY RES, V34, P507, DOI 10.1016/j.jsr.2003.07.001; Neitzel R L, 2001, Appl Occup Environ Hyg, V16, P1106; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schaller Bernhard J, 2008, J Trauma, V64, pE29, DOI 10.1097/01.ta.0000197145.19876.38; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Workplace Safety and Insurance Board, 2008, STAT SUPPL 2007 ANN	17	14	14	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2011	39	3					283	290		10.3233/WOR-2011-1176			8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	806TL	WOS:000293835300009	21709364				2021-06-18	
J	McMahon, CG; Kenny, R; Bennett, K; Little, R; Kirkman, E				McMahon, C. Geraldine; Kenny, RoseAnne; Bennett, Kathleen; Little, Roderick; Kirkman, Emrys			EFFECT OF ACUTE TRAUMATIC BRAIN INJURY ON BAROREFLEX FUNCTION	SHOCK			English	Article						Brain injuries; trauma; phenylephrine; homeostasis	CHOLINERGIC ANTIINFLAMMATORY PATHWAY; KAPPA-B ACTIVATION; SEVERE HEAD-INJURY; BLOOD-PRESSURE; CARDIOVASCULAR CONTROL; HEMORRHAGIC-SHOCK; RATS; REFLEX; HYPERTENSION; SENSITIVITY	The integrity of the arterial baroreflex is central to cardiovascular homeostasis. There is evidence of altered cardiovascular regulation after acute traumatic brain injury (TBI). We hypothesized that arterial baroreflex is modified by acute TBI. An experimental study using 18 terminally anesthetized male Wistar rats weighing 240 to 260 g was undertaken at a university laboratory setting. Brain injury was induced using the lateral fluid percussion brain injury model. The fluid percussion device delivered an applied cortical pressure of 1.2 atm and 1.8 atm, producing mild and moderate TBI, respectively. Control animals underwent identical surgical procedures but no applied cortical pressure. Arterial baroreflex was assessed by determining the relationship between heart period (R - R interval) and systolic blood pressure using the modified phenylephrine pressor test adapted for the rat. The arterial baroreflex was tested before (Tcon), post-TBI, at 10 min (T10), and 30 min (T30). Analysis of baroreflex function after moderate TBI using repeated-measures analysis of variance revealed significant differences in baroreflex sensitivity (BRS) at T10 and T30 (F(2,15) = 10.18; P = 0.005) compared with pre-TBI (weighted mean +/- SD; Tcon, 0.39 +/- 0.00 ms mmHg(-1); T10, 0.85 +/- 0.01 ms mmHg(-1); T30, 0.81 +/- 0.01 ms mmHg(-1)). The changes in BRS were not significant after mild TBI (P = 0.152). Repeated-measures analysis of variance comparing trends between the three groups indicated significant differences between the control and moderate TBI groups only (F(2,15) = 6.26; P = 0.01). Acute TBI of moderate severity is associated with an early significant modification in arterial BRS. This is a key component of cardiovascular homeostasis. The clinical implications of this observation require further investigation.	[McMahon, C. Geraldine] St James Hosp, Trinity Coll Dubin, Dublin 8, Ireland; Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland; Trinity Coll Dublin, Dept Pharmacol & Therapeut, Dublin 2, Ireland; Univ Manchester, N Western Injury Res Ctr, Manchester, Lancs, England	McMahon, CG (corresponding author), St James Hosp, Trinity Coll Dubin, Dublin 8, Ireland.	geraldinemcmahon@upcmail.ie	McMahon, C Geraldine/M-8684-2019	McMahon, C Geraldine/0000-0002-9870-3104	Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	This study was supported by the Medical Research Council, UK, as part of the North West Injury Research Program Grant. The authors have no other financial interests to disclose.	Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; Barcroft H, 1944, LANCET, V1, P489; Casadei B, 2000, J HYPERTENS, V18, P3, DOI 10.1097/00004872-200018010-00002; CERUTTI C, 1994, AM J PHYSIOL, V266, pH1993; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287; Grassi G, 1998, HYPERTENSION, V31, P68, DOI 10.1161/01.HYP.31.1.68; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hammer PE, 2005, AM J PHYSIOL-REG I, V288, pR1637, DOI 10.1152/ajpregu.00050.2004; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JOHNSTON WE, 1994, ANESTH ANALG, V79, P14; JONES RO, 1990, EXP PHYSIOL, V75, P483, DOI 10.1113/expphysiol.1990.sp003425; Jordan J, 2000, CIRCULATION, V102, P2611; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Keyl C, 2001, J APPL PHYSIOL, V91, P283; Kongo M, 1999, EXP PHYSIOL, V84, P47, DOI 10.1111/j.1469-445X.1999.tb00071.x; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Mascarucci P, 1998, NEUROSCIENCE, V86, P1285, DOI 10.1016/S0306-4522(98)00105-5; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Oikawa S, 2005, AUTON NEUROSCI-BASIC, V117, P105, DOI 10.1016/j.autneu.2004.11.009; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699; REDFERN WS, 1984, Q J EXP PHYSIOL CMS, V69, P763, DOI 10.1113/expphysiol.1984.sp002867; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; SEAR JW, 1979, BRIT J ANAESTH, V51, P867, DOI 10.1093/bja/51.9.867; Simms AE, 2007, J PHYSIOL-LONDON, V579, P473, DOI 10.1113/jphysiol.2006.124396; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; Song XM, 2008, SHOCK, V30, P468, DOI 10.1097/SHK.0b013e31816d5e49; SPYER KM, 1984, RECENT ADV PHYSL, V10, P163; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TIMMS RJ, 1976, J PHYSIOL-LONDON, V256, pP71; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	39	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	JAN	2011	35	1					53	58		10.1097/SHK.0b013e3181e687c6			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	695OK	WOS:000285381500009	20458265				2021-06-18	
J	Rochat, L; Beni, C; Billieux, J; Annoni, JM; Van der Linden, M				Rochat, Lucien; Beni, Catia; Billieux, Joel; Annoni, Jean-Marie; Van der Linden, Martial			How Impulsivity Relates to Compulsive Buying and the Burden Perceived by Caregivers after Moderate-to-Severe Traumatic Brain Injury	PSYCHOPATHOLOGY			English	Article						Impulsivity; Executive functions; Compulsive buying; Burden; Traumatic brain injury; Urgency	VALIDATION; DISTRESS; BEHAVIOR; MODEL	Background: Impulsivity is a core feature in patients with traumatic brain injury (TBI). The aim of the study is to investigate how a specific dimension of impulsivity, namely urgency (the tendency to act rashly when distressed), might shed new light on the aetiology of compulsive buying proneness in patients with TBI and to explore how urgency and compulsive buying relate to the burden perceived by the caregivers. Sampling and Methods: Caregivers of 74 patients with TBI were given 3 questionnaires in order to assess their subjective burden as well as patients' impulsivity and compulsive buying proneness. Results: Both urgency and compulsive buying tendencies significantly increased after TBI. Furthermore, path analyses revealed that current urgency was both directly and indirectly related to the subjective burden perceived by the caregivers, and this indirect pathway was mediated by compulsive buying. Conclusion: Urgency plays a central role in understanding specific problematic behaviours after TBI and their impact on caregivers. These findings are discussed in light of the cognitive processes underlying the urgency component of impulsivity in relation to the occurrence of compulsive buying behaviours after TBI. Copyright (C) 2011 S. Karger AG, Basel	[Rochat, Lucien; Beni, Catia; Billieux, Joel; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, CH-1205 Geneva, Switzerland; [Rochat, Lucien; Billieux, Joel; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, CH-1205 Geneva, Switzerland; [Annoni, Jean-Marie] Univ Hosp Geneva, Neuropsychol Unit, Geneva, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, Liege, Belgium	Rochat, L (corresponding author), Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, 40 Blvd Pont Arve, CH-1205 Geneva, Switzerland.	Lucien.Rochat@unige.ch		Billieux, Joel/0000-0002-7388-6194; Rochat, Lucien/0000-0002-9992-2720			Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Billieux J, 2007, ADDICT BEHAV, V32, P1189, DOI 10.1016/j.addbeh.2006.08.007; Billieux J, 2008, PERS INDIV DIFFER, V44, P1432, DOI 10.1016/j.paid.2007.12.011; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Billieux J, 2008, APPL COGNITIVE PSYCH, V22, P1195, DOI 10.1002/acp.1429; BLAUG M, 1972, HIGH EDUC, V1, P53, DOI 10.1007/BF01956881; BURSTEIN A, 1993, PSYCHOSOMATICS, V34, P194, DOI 10.1016/S0033-3182(93)71920-9; Byrne B. M, 2001, STRUCTURAL EQUATION; Byrne B.M., 1994, STRUCTURAL EQUATION; CHRISTENSON GA, 1994, J CLIN PSYCHIAT, V55, P5; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, pXXI; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fischer S, 2004, PSYCHOL ADDICT BEHAV, V18, P269, DOI 10.1037/0893-164X.18.3.269; Fischer S, 2003, INT J EAT DISORDER, V33, P406, DOI 10.1002/eat.10165; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; FLORIAN V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Kellett S, 2009, CLIN PSYCHOL PSYCHOT, V16, P83, DOI 10.1002/cpp.585; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lejoyeux M, 1997, J CLIN PSYCHIAT, V58, P169, DOI 10.4088/JCP.v58n0406; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Miltenberger RG, 2003, J BEHAV THER EXP PSY, V34, P1, DOI 10.1016/S0005-7916(03)00002-8; Muthen L., 2006, MPLUS USERS GUIDE; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; van den Heuvel OA, 2010, J NEUROL SCI, V289, P55, DOI 10.1016/j.jns.2009.08.043; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Whiteside SP, 2005, EUR J PERSONALITY, V19, P559, DOI 10.1002/per.556; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; Wood RL, 2001, BRAIN DAM B, P3; Zarit S., 1985, HIDDEN VICTIMS ALZHE	38	14	15	0	7	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0254-4962	1423-033X		PSYCHOPATHOLOGY	Psychopathology		2011	44	3					158	164		10.1159/000322454			7	Psychiatry	Psychiatry	747SB	WOS:000289338600004	21372628				2021-06-18	
B	Zupanc, GKH		Seki, T; Sawamoto, K; Parent, JM; AlvarezBuylla, A		Zupanc, Guenther K. H.			Adult Neurogenesis in Teleost Fish	NEUROGENESIS IN THE ADULT BRAIN I: NEUROBIOLOGY			English	Article; Book Chapter							CENTRAL-NERVOUS-SYSTEM; LONG-TERM PERSISTENCE; NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; TRAUMATIC BRAIN-INJURY; POST-EMBRYONIC GROWTH; MULLER GLIAL CELLS; OPTIC TECTUM; PROLIFERATION ZONES; ENTORHINAL CORTEX	Adult neurogenesis in the brain of teleost fish has been studied since the 1960s. These investigations have demonstrated mitotic activity in dozens of brain areas and relative rates of cell proliferation 10-100 times higher than in the adult mammalian brain. The source of the new cells are stem cells in distinct proliferation zones, which give rise to both neurons and glial cells. Depending on the brain region, the young cells either reside in close vicinity to the proliferation zone from which they originate, or they migrate long distance to specific target areas. During migration, they are guided by radial glial fibers. Approximately half the young cells undergo apoptotic cell death within the first few weeks of their life; the other half persist long term. This continuous addition of new cells to the population of older cells leads to a permanent growth of the brain. A major function of adult neurogenesis in teleosts appears to be to ensure numerical matching of neurons in the central nervous system and sensory receptors cells or muscle fibers in the periphery. Neurogenesis also plays a central role in brain repair by replacing cells lost to injury by newly generated ones. Large-scale identification of regeneration-associated proteins by proteome analysis has revealed cytoskeletal proteins essential for the formation of new cells, proteins involved in cell proliferation, cellular motility, neuroprotection, and energy metabolism, as well as a zinc finger protein that may act as a transcriptional regulator.	Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Zupanc, GKH (corresponding author), Northeastern Univ, Dept Biol, 134 Mugar Life Sci Bldg,360 Huntington Ave, Boston, MA 02115 USA.	g.zupanc@neu.edu					ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ANDERSON MJ, 1987, MOL BRAIN RES, V2, P131, DOI 10.1016/0169-328X(87)90006-4; ANDERSON MJ, 1983, ANAT REC, V205, P73, DOI 10.1002/ar.1092050110; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; BRADFORD MR, 1995, BRAIN BEHAV EVOLUT, V46, P259; Butler AB, 2000, NEUROSCI LETT, V293, P95, DOI 10.1016/S0304-3940(00)01497-X; Cameron DA, 2000, VISUAL NEUROSCI, V17, P789, DOI 10.1017/S0952523800175121; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Candal E, 2005, DEV BRAIN RES, V154, P101, DOI 10.1016/j.devbrainres.2004.10.008; CARLSEN J, 1982, J COMP NEUROL, V208, P196, DOI 10.1002/cne.902080208; Clint SC, 2002, NEUROREPORT, V13, P317, DOI 10.1097/00001756-200203040-00014; Clint SC, 2001, DEV BRAIN RES, V130, P15, DOI 10.1016/S0165-3806(01)00193-6; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; CORWIN JT, 1981, J COMP NEUROL, V201, P541, DOI 10.1002/cne.902010406; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FINE ML, 1989, BRAIN BEHAV EVOLUT, V34, P13, DOI 10.1159/000116487; Fontana X, 2006, CEREB CORTEX, V16, P301, DOI 10.1093/cercor/bhi120; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GREGORY WA, 1988, J NEUROSCI, V8, P1728; GROSCHE J, 1995, NEUROSCI LETT, V185, P119, DOI 10.1016/0304-3940(94)11239-F; HAGEDORN M, 1992, J COMP NEUROL, V321, P193, DOI 10.1002/cne.903210203; Han ZG, 1999, J BIOL CHEM, V274, P35741, DOI 10.1074/jbc.274.50.35741; HARTIG W, 1995, J NEUROCYTOL, V24, P507, DOI 10.1007/BF01179976; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; HERRUP K, 1987, J NEUROSCI, V7, P829; Herrup K, 1996, DEV BRAIN RES, V96, P28, DOI 10.1016/S0165-3806(96)00069-7; Higgs DM, 2002, JARO-J ASSOC RES OTO, V3, P174, DOI 10.1007/s101620020035; Hinsch K, 2007, NEUROSCIENCE, V146, P679, DOI 10.1016/j.neuroscience.2007.01.071; Hinsch K, 2006, J NEUROSCI METH, V158, P75, DOI 10.1016/j.jneumeth.2006.05.020; HITCHCOCK PF, 1992, J NEUROBIOL, V23, P187, DOI 10.1002/neu.480230209; Insausti R, 2002, BRAIN RES BULL, V57, P557, DOI 10.1016/S0361-9230(01)00684-0; JANSSEN J, 1987, BRAIN BEHAV EVOLUT, V30, P210, DOI 10.1159/000118647; JOHNS PR, 1977, J COMP NEUROL, V176, P331, DOI 10.1002/cne.901760303; JOHNS PR, 1982, J NEUROSCI, V2, P178; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KERR JFR, 1995, METHOD CELL BIOL, V46, P1; Kirsche W., 1967, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V77, P313; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; KOUMANS JTM, 1995, COMP BIOCHEM PHYS A, V110, P3, DOI 10.1016/0300-9629(94)00150-R; Kranz D, 1970, Z. mikrosk.-anat. Forsch., V82, P42; KRANZ D, 1970, Zeitschrift fuer Mikroskopisch-Anatomische Forschung (Leipzig), V82, P264; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee TH, 2002, J BIOL CHEM, V277, P44826, DOI 10.1074/jbc.M205667200; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; LEWIS GP, 1989, EXP EYE RES, V49, P93, DOI 10.1016/0014-4835(89)90079-1; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lund LM, 1996, J NEUROBIOL, V31, P476; Lund LM, 2002, EXP NEUROL, V178, P306, DOI 10.1006/exnr.2002.8034; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MAGRASSI L, 1995, ANAT EMBRYOL, V192, P77; MANSOURROBAEY S, 1990, J HIRNFORSCH, V31, P495; Marcus RC, 1999, VISUAL NEUROSCI, V16, P417, DOI 10.1017/S095252389916303X; MEYER RL, 1978, EXP NEUROL, V59, P99, DOI 10.1016/0014-4886(78)90204-2; Moore S, 1996, PROG NEUROBIOL, V48, P441, DOI 10.1016/0301-0082(95)00051-8; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nguyen V, 1999, J COMP NEUROL, V413, P385, DOI 10.1002/(SICI)1096-9861(19991025)413:3<385::AID-CNE3>3.0.CO;2-P; Nieuwenhuys R., 1990, Cerebral Cortex, V8A, P31; Northcutt R. G., 1980, COMP NEUROLOGY TELEN, P41; NORTHCUTT RG, 1995, BRAIN BEHAV EVOLUT, V46, P275, DOI 10.1159/000113279; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Osada T, 2002, CYTOGENET GENOME RES, V97, P7, DOI 10.1159/000064037; Ott R, 1997, NEUROSCI LETT, V221, P185, DOI 10.1016/S0304-3940(96)13322-X; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; PAULIN MG, 1993, BRAIN BEHAV EVOLUT, V41, P39, DOI 10.1159/000113822; PEACEA V, 2001, EXP NEUROL, V172, P1; Portavella M, 2004, J NEUROSCI, V24, P2335, DOI 10.1523/JNEUROSCI.4930-03.2004; POUWELS E, 1978, ANAT EMBRYOL, V152, P291, DOI 10.1007/BF00350526; POUWELS E, 1978, ANAT EMBRYOL, V153, P37, DOI 10.1007/BF00569848; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Rahmann H., 1968, Journal fuer Hirnforschung, V10, P279; Rajendran RS, 2008, DEV NEUROBIOL, V68, P1257, DOI 10.1002/dneu.20656; Rajendran RS, 2007, DEV NEUROBIOL, V67, P1334, DOI 10.1002/dneu.20365; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAYMOND PA, 1983, J NEUROSCI, V3, P1077; RAYMOND PA, 1983, J NEUROSCI, V3, P1092; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Reier PJ, 1983, SPINAL CORD RECONSTR, P163; Richter W, 1970, Z. mikrosk.-anat. Forsch., V82, P76; RICHTER W, 1970, Zeitschrift fuer Mikroskopisch-Anatomische Forschung (Leipzig), V81, P530; Rodriguez F, 2002, J NEUROSCI, V22, P2894, DOI 10.1523/JNEUROSCI.22-07-02894.2002; ROWE RWD, 1969, J ANAT, V104, P519; Rowlerson A., 2001, Fish Physiology, V18, P103; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; SIRBULESCU RF, BRAIN RES R IN PRESS; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Soutschek J, 1996, DEV BRAIN RES, V97, P279, DOI 10.1016/S0165-3806(96)00145-9; Soutschek J, 1995, NEUROSCI LETT, V202, P133, DOI 10.1016/0304-3940(95)12231-1; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Takeda A, 2008, NEUROSCIENCE, V151, P1132, DOI 10.1016/j.neuroscience.2007.10.059; TETZLAFF W, 1991, J NEUROSCI, V11, P2528; Vajda FJE, 2002, J CLIN NEUROSCI, V9, P4, DOI 10.1054/jocn.2001.1027; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Groen T, 2002, BRAIN RES BULL, V57, P553, DOI 10.1016/S0361-9230(01)00683-9; Vargas JP, 2000, BRAIN RES, V865, P77, DOI 10.1016/S0006-8993(00)02220-4; Waxman S.G., 1986, P183; WEATHERLEY AH, 1985, EXPERIENTIA, V41, P353, DOI 10.1007/BF02004500; WETTS R, 1983, DEV BRAIN RES, V10, P41, DOI 10.1016/0165-3806(83)90119-0; Williams RW, 2000, RES PRO CEL, V30, P21; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Wullimann M. F., 1996, NEUROANATOMY ZEBRAFI; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; ZAKON HH, 1984, J COMP NEUROL, V228, P557, DOI 10.1002/cne.902280408; Zhang ZY, 1997, EXP NEUROL, V143, P141, DOI 10.1006/exnr.1996.6355; Zikopoulos B, 2000, BRAIN BEHAV EVOLUT, V56, P310, DOI 10.1159/000047215; Zimmerman AM, 1999, J EXP ZOOL, V284, P299, DOI 10.1002/(SICI)1097-010X(19990801)284:3&lt;299::AID-JEZ7&gt;3.0.CO;2-6; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y; Zupanc GKH, 2009, NEUROSCIENCE, V159, P1338, DOI 10.1016/j.neuroscience.2009.02.014; Zupanc GKH, 1996, J COMP NEUROL, V370, P443; ZUPANC GKH, 1995, J COMP NEUROL, V353, P213, DOI 10.1002/cne.903530205; Zupanc GKH, 1998, EXP NEUROL, V152, P221, DOI 10.1006/exnr.1998.6853; Zupanc GKH, 1999, J EXP BIOL, V202, P1435; Zupanc GKH, 2005, J COMP NEUROL, V488, P290, DOI 10.1002/cne.20571; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 2003, BRAIN BEHAV EVOLUT, V62, P31, DOI 10.1159/000071958; Zupanc GKH, 2003, GLIA, V43, P77, DOI 10.1002/glia.10236; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182; ZUPANC GKH, 1992, P NATL ACAD SCI USA, V89, P9539, DOI 10.1073/pnas.89.20.9539; ZUPANC GKH, 2006, EVOLUTION NERVOUS SY, P485; Zupanc GKH, 2007, PROTEOM CLIN APPL, V1, P1362, DOI 10.1002/prca.200700420; Zupanc GKH, 2006, REGEN MED, V1, P207, DOI 10.2217/17460751.1.2.207; Zupanc GKH, 2011, ADV NEUROBIOL, V2, P511, DOI 10.1007/978-1-4419-7197-5_20; Zupanc GKH, 2009, SEMIN CELL DEV BIOL, V20, P683, DOI 10.1016/j.semcdb.2008.12.001; Zupanc GKH, 2008, J PHYSIOL-PARIS, V102, P357, DOI 10.1016/j.jphysparis.2008.10.007; Zupanc Guenther K. H., 2008, V52, P571; Zupanc MM, 2006, BRAIN RES, V1095, P26, DOI 10.1016/j.brainres.2006.04.005; Zupanc MM, 2006, PROTEOMICS, V6, P677, DOI 10.1002/pmic.200500167	144	14	14	0	4	SPRINGER-VERLAG TOKYO	TOKYO	37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN			978-4-431-53932-2				2011							137	167		10.1007/978-4-431-53933-9_5			31	Neurosciences	Neurosciences & Neurology	BWB24	WOS:000293357800005					2021-06-18	
J	Bartnik-Olson, BL; Oyoyo, U; Hovda, DA; Sutton, RL				Bartnik-Olson, Brenda L.; Oyoyo, Udochukwu; Hovda, David A.; Sutton, Richard L.			Astrocyte Oxidative Metabolism and Metabolite Trafficking after Fluid Percussion Brain Injury in Adult Rats	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; compartmentation; fluid percussion injury; glutamate; glutamine; neuron	PYRUVATE-CARBOXYLASE; GLUCOSE-METABOLISM; GLUTAMATE METABOLISM; CEREBRAL CONCUSSION; EX-VIVO; MITOCHONDRIAL; COMPARTMENTATION; NEURONS; SPECTROSCOPY; SUBSTRATE	Despite various lines of evidence pointing to the compartmentation of metabolism within the brain, few studies have reported the effect of a traumatic brain injury (TBI) on neuronal and astrocyte compartments and/or metabolic trafficking between these cells. In this study we used ex vivo C-13 NMR spectroscopy following an infusion of [1-C-13] glucose and [1,2-C-13(2)] acetate to study oxidative metabolism in neurons and astrocytes of sham-operated and fluid percussion brain injured (FPI) rats at 1, 5, and 14 days post-surgery. FPI resulted in a decrease in the 13 C glucose enrichment of glutamate in neurons in the injured hemisphere at day 1. In contrast, enrichment of glutamine in astrocytes from acetate was not significantly decreased at day 1. At day 5 the C-13 enrichment of glutamate and glutamine from glucose in the injured hemisphere of FPI rats did not differ from sham levels, but glutamine derived from acetate metabolism in astrocytes was significantly increased. The C-13 glucose enrichment of the C3 position of glutamate (C3) in neurons was significantly decreased ipsilateral to FPI at day 14, whereas the enrichment of glutamine in astrocytes had returned to sham levels at this time point. These findings indicate that the oxidative metabolism of glucose is reduced to a greater extent in neurons compared to astrocytes following a FPI. The increased utilization of acetate to synthesize glutamine, and the acetate enrichment of glutamate via the glutamate-glutamine cycle, suggests an integral protective role for astrocytes in maintaining metabolic function following TBI-induced impairments in glucose metabolism.	[Bartnik-Olson, Brenda L.] Loma Linda Univ, Dept Radiol, Sch Publ Hlth, Loma Linda, CA 92354 USA; [Bartnik-Olson, Brenda L.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Bartnik-Olson, Brenda L.; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Bartnik-Olson, BL (corresponding author), Loma Linda Univ, Dept Radiol, Sch Publ Hlth, 11234 Anderson St,Room B623, Loma Linda, CA 92354 USA.	bbartnik@llu.edu		Bartnik-Olson, Brenda/0000-0002-1137-9437	UCLA Brain Injury Research Center; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS27544, P01NS058489]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544, P01NS058489] Funding Source: NIH RePORTER	We thank Dr. N.G. Harris for his review and comments on the manuscript. This work was supported by the UCLA Brain Injury Research Center and Award Numbers R01NS27544 and P01NS058489 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is the sole responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health.	Arun P, 2010, J NEUROTRAUM, V27, P293, DOI 10.1089/neu.2009.0994; BADARGOFFER RS, 1990, BIOCHEM J, V266, P133, DOI 10.1042/bj2660133; Bambrick L, 2004, NEUROCHEM RES, V29, P601, DOI 10.1023/B:NERE.0000014830.06376.e6; Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Cruz F, 1999, NMR BIOMED, V12, P451, DOI 10.1002/(SICI)1099-1492(199911)12:7<451::AID-NBM571>3.3.CO;2-5; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Fukushima M, 2009, J NEUROTRAUM, V26, P1095, DOI 10.1089/neu.2008.0771; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Hertz L, 2003, NEUROCHEM RES, V28, P243, DOI 10.1023/A:1022377100379; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Melo TM, 2006, NEUROCHEM INT, V48, P498, DOI 10.1016/j.neuint.2005.12.037; Merle M, 2002, J NEUROCHEM, V82, P47, DOI 10.1046/j.1471-4159.2002.00924.x; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Peng L, 2007, J NEUROSCI RES, V85, P3480, DOI 10.1002/jnr.21262; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Qu H, 2000, DEV NEUROSCI-BASEL, V22, P429, DOI 10.1159/000017472; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schousboe A, 1997, GLIA, V21, P99; Serres S, 2008, J CEREBR BLOOD F MET, V28, P712, DOI 10.1038/sj.jcbfm.9600568; Serres S, 2007, J NEUROCHEM, V101, P1428, DOI 10.1111/j.1471-4159.2006.04442.x; SHANK RP, 1985, BRAIN RES, V329, P364, DOI 10.1016/0006-8993(85)90552-9; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Shokati T, 2005, NEUROCHEM RES, V30, P1269, DOI 10.1007/s11064-005-8798-8; Sonnewald U, 2003, NMR BIOMED, V16, P424, DOI 10.1002/nbm.837; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; SUTTON RL, 2005, 4717 SOC NEUR; Taylor A, 1996, DEV NEUROSCI-BASEL, V18, P434, DOI 10.1159/000111438; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; VANDENBE.CJ, 1971, BIOCHEM J, V123, P211, DOI 10.1042/bj1230211; VANDENBERG CJ, 1969, BIOCHEM J, V113, P281, DOI 10.1042/bj1130281; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Waagepetersen HS, 2005, NEUROCHEM INT, V47, P92, DOI 10.1016/j.neuint.2005.04.012; Waniewski RA, 1998, J NEUROSCI, V18, P5225; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; YU ACH, 1983, J NEUROCHEM, V41, P1484, DOI 10.1111/j.1471-4159.1983.tb00849.x; YU ACH, 1984, J NEUROCHEM, V42, P951, DOI 10.1111/j.1471-4159.1984.tb12696.x	58	14	17	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2010	27	12					2191	2202		10.1089/neu.2010.1508			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	691PN	WOS:000285093400009	20939699	Green Published			2021-06-18	
J	Courtney, MW; Courtney, AC				Courtney, Michael W.; Courtney, Amy C.			Note: A table-top blast driven shock tube	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								The prevalence of blast-induced traumatic brain injury in conflicts in Iraq and Afghanistan has motivated laboratory scale experiments on biomedical effects of blast waves and studies of blast wave transmission properties of various materials in hopes of improving armor design to mitigate these injuries. This paper describes the design and performance of a table-top shock tube that is more convenient and widely accessible than traditional compression driven and blast driven shock tubes. The design is simple: it is an explosive driven shock tube employing a rifle primer that explodes when impacted by the firing pin. The firearm barrel acts as the shock tube, and the shock wave emerges from the muzzle. The small size of this shock tube can facilitate localized application of a blast wave to a subject, tissue, or material under test. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3518970]	[Courtney, Michael W.] USAF Acad, Colorado Springs, CO 80840 USA; [Courtney, Amy C.] Force Protect Ind Inc, Ladson, SC 29456 USA	Courtney, MW (corresponding author), USAF Acad, 2354 Fairchild Dr, Colorado Springs, CO 80840 USA.	Michael.Courtney@usafa.edu		Courtney, Amy/0000-0002-1925-8736			Alley M., 2009, THESIS PURDUE U W LA; ALLEY MD, NEUROIMAGE IN PRESS; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; COURTNEY MW, NEUROIMAGE IN PRESS; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Richmond D. R., 1966, 1854 DASA; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109	9	14	16	0	10	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0034-6748	1089-7623		REV SCI INSTRUM	Rev. Sci. Instrum.	DEC	2010	81	12							126103	10.1063/1.3518970			3	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	700UW	WOS:000285770800052	21198058				2021-06-18	
J	Neil, S; Padgham, C; Martin, CJ				Neil, S.; Padgham, C.; Martin, C. J.			A study of the relationship between peak skin dose and cumulative air kerma in interventional neuroradiology and cardiology	JOURNAL OF RADIOLOGICAL PROTECTION			English	Article							FLUOROSCOPICALLY GUIDED PROCEDURES; KODAK EDR2 FILM; AREA PRODUCT; INJURIES; RADIOLOGY	A study of peak skin doses (PSDs) during neuroradiology and cardiology interventional procedures has been carried out using Gafchromic XR-RV2 film. Use of mosaics made from squares held in cling film has allowed doses to the head to be mapped successfully. The displayed cumulative air kerma (CAK) has been calibrated in terms of cumulative entrance surface dose (CESD) and results indicate that this can provide a reliable indicator of the PSD in neuroradiology. Results linking PSD to CESD for interventional cardiology were variable, but CAK is still considered to provide the best option for use as an indicator of potential radiation-induced effects. A CESD exceeding 3 Gy is considered a suitable action level for triggering follow-up of patients in neuroradiology and cardiology for possible skin effects. Application of dose action levels defined in this way would affect 8% of neurological embolisation procedures and 5% of cardiology ablation and multiple stent procedures at the hospitals where the investigations were carried out. A close relationship was observed between CESD and dose-area product (DAP) for particular types of procedure, and DAPs of 200-300 Gy cm(2) could be used as trigger levels where CAK readings were not available. The DAP value would depend on the mean field size and would need to be determined for each application.	[Neil, S.; Padgham, C.; Martin, C. J.] Gartnavel Royal Hosp, Glasgow G12 0XH, Lanark, Scotland	Neil, S (corresponding author), Ninewells Hosp, Dept Med Phys, Dundee DD1 9SY, Scotland.						Baiter S, 2008, MED PHYS, V35, P673, DOI 10.1118/1.2829868; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Bogaert E, 2009, BRIT J RADIOL, V82, P303, DOI 10.1259/bjr/29449648; Butson MJ, 2006, MED PHYS, V33, P2923, DOI 10.1118/1.2219330; Chida K, 2006, AM J ROENTGENOL, V186, P774, DOI 10.2214/AJR.04.1653; Chida K, 2007, AM J ROENTGENOL, V189, pW224, DOI 10.2214/AJR.07.2422; Chu RYL, 2006, HEALTH PHYS, V91, P41, DOI 10.1097/01.HP.0000198784.94210.1f; D'Ercole L, 2007, AM J NEURORADIOL, V28, P503; Domienik J, 2008, RADIAT PROT DOSIM, V132, P18, DOI 10.1093/rpd/ncn247; Faulkner K, 2005, RADIAT PROT DOSIM, V117, P166, DOI 10.1093/rpd/nci737; Ferreira BC, 2009, PHYS MED BIOL, V54, P1073, DOI 10.1088/0031-9155/54/4/017; Giles ER, 2002, HEALTH PHYS, V82, P875, DOI 10.1097/00004032-200206000-00017; Imanishi Y, 2005, EUR RADIOL, V15, P41, DOI 10.1007/s00330-004-2459-1; International Commission on Radiological Protection (ICRP), 2000, ICRP PUBL, V85; International Electrotechnical Commission (IEC), 2000, 60601243 IEC; Karambatsakidou A, 2005, BRIT J RADIOL, V78, P803, DOI 10.1259/bjr/14000648; Koenig TR, 2001, AM J ROENTGENOL, V177, P3, DOI 10.2214/ajr.177.1.1770003; Koenig TR, 2001, AM J ROENTGENOL, V177, P13, DOI 10.2214/ajr.177.1.1770013; Mooney RB, 2000, BRIT J RADIOL, V73, P745, DOI 10.1259/bjr.73.871.11089467; Morrell RE, 2006, BRIT J RADIOL, V79, P756, DOI 10.1259/bjr/57359387; Morrell RE, 2006, BRIT J RADIOL, V79, P603, DOI 10.1259/bjr/78359708; Morrell RE, 2004, PHYS MED BIOL, V49, P5559, DOI 10.1088/0031-9155/49/24/011; Padovani R, 2005, RADIAT PROT DOSIM, V117, P247, DOI 10.1093/rpd/nci757; Rampado O, 2006, PHYS MED BIOL, V51, pN403, DOI 10.1088/0031-9155/51/23/N01; Rampado O, 2005, RADIAT PROT DOSIM, V117, P256, DOI 10.1093/rpd/nci759; Shope TB, 1996, RADIOGRAPHICS, V16, P1195, DOI 10.1148/radiographics.16.5.8888398; Struelens L, 2005, RADIAT PROT DOSIM, V114, P143, DOI 10.1093/rpd/nch537; Taylor JB, 2009, HEALTH PHYS, V96, P138, DOI 10.1097/01.HP.0000327665.46577.af; van de Putte S, 2000, BRIT J RADIOL, V73, P504, DOI 10.1259/bjr.73.869.10884747; Vano E, 2005, RADIAT PROT DOSIM, V117, P190, DOI 10.1093/rpd/nci714; Vano E, 2001, BRIT J RADIOL, V74, P48, DOI 10.1259/bjr.74.877.740048; Zontar D, 2010, RADIAT PROT DOSIM, V139, P262, DOI 10.1093/rpd/ncq013	32	14	14	0	9	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0952-4746	1361-6498		J RADIOL PROT	J. Radiol. Prot.	DEC	2010	30	4					659	672		10.1088/0952-4746/30/4/002			14	Environmental Sciences; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Environmental Sciences & Ecology; Public, Environmental & Occupational Health; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	691PK	WOS:000285093100003	21149930				2021-06-18	
J	Weiss, H; Agimi, Y; Steiner, C				Weiss, Harold; Agimi, Yll; Steiner, Claudia			Youth Motorcycle-Related Hospitalizations and Traumatic Brain Injuries in the United States in 2006	PEDIATRICS			English	Article						hospitalizations; motorcycle; scooters; traffic accidents; nontraffic accidents; adolescents; injury; traumatic brain injury; costs; injury severity		OBJECTIVES: The objectives were to provide national injury and health care cost estimates for youth motorcycle injuries in traffic and non-traffic settings and to focus on the burden of serious motorcycle-related traumatic brain injuries (TBIs) in children and young adults. METHODS: The 2006 Kids' Inpatient Database is a sample of inpatient discharges for US patients <21 years of age from 38 states. This cross-sectional analysis of the 2006 Kids' Inpatient Database included comparisons of TBI versus non-TBI and traffic versus nontraffic motorcycle-related crashes for ages 12 to 20, with national estimates of hospital charges and costs, length of stay, severity, and long-term disability rates. RESULTS: Motorcycle-related crashes accounted for 5662 discharges (95% confidence interval: 5201-6122 discharges), which amounts to 3% of injury hospitalizations among youths and 5% of TBI diagnoses; two-thirds of cases were traffic-related, and one-third of patients sustained a TBI (1793 patients [95% confidence interval: 1631-1955 patients]). Among patients with TBIs, the overall probability of long-term disability was 24%. Patients with TBIs were 3.6 times more likely to be discharged to a rehabilitation facility and >10 times more likely to die in the hospital than were patients without TBIs. CONCLUSIONS: Motorcycle injuries are a substantial cause of youth injury hospitalizations. The large proportion, costs, and morbidity of TBI diagnoses in youth motorcycle crashes emphasize the need for effective crash prevention and head protection. Pediatrics 2010;126:1141-1148	[Weiss, Harold] Univ Pittsburgh, Ctr Injury Res & Control, Pittsburgh, PA USA; [Agimi, Yll] Assoc Sch Publ Hlth, Washington, DC USA; [Steiner, Claudia] Ctr Delivery Org & Markets Agcy Healthcare Res &, Rockville, MD USA	Weiss, H (corresponding author), POB 56, Dunedin 9054, New Zealand.	hw@injurycontrol.com	AGIMI, YLL/AAL-9337-2021		National Highway Traffic Safety Administration [DTNH22-04-H-05087]	This work was performed under a cooperative agreement with the National Highway Traffic Safety Administration (grant DTNH22-04-H-05087).	Agency for Healthcare Research and Quality, 2008, INTR HCUP KIDS INP D; Agency for Healthcare Research and Quality, CLIN CLASS SOFTW CCS; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Butler J, 2001, CENTRAL NERVOUS SYST; Centers for Disease Control and Prevention, BRIDG RAC POP EST; Centers for Disease Control and Prevention, WISQARS INJ MORT REP; Clark DE, 2008, 8 WORLD C INJ PREV S; Coben JH, 2007, ACCIDENT ANAL PREV, V39, P190, DOI 10.1016/j.aap.2006.06.018; *NAT CTR HLTH STAT, BAR INJ DIAGN MATR F; National Center for Injury Prevention and Control, 2010, WISQARS NONF INJ REP; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568	13	14	14	0	2	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	DEC	2010	126	6					1141	1148		10.1542/peds.2010-0271			8	Pediatrics	Pediatrics	688EF	WOS:000284831900040	21078737	Bronze			2021-06-18	
J	Baird, LC; Newman, CB; Volk, H; Svinth, JR; Conklin, J; Levy, ML				Baird, Lissa C.; Newman, C. Benjamin; Volk, Hunter; Svinth, Joseph R.; Conklin, Jordan; Levy, Michael L.			Mortality Resulting From Head Injury in Professional Boxing	NEUROSURGERY			English	Article						Boxing; Head trauma; mortality	MEDICAL ASPECTS; BRAIN-INJURY; BIOMECHANICS; CONCUSSION; FATALITIES; FOOTBALL; PUNCH	BACKGROUND: The majority of boxing-related fatalities result from traumatic brain injury. Biomechanical forces in boxing result in rotational acceleration with resultant subdural hematoma and diffuse axonal injury. OBJECTIVE: Given the inherent risk and the ongoing criticism boxing has received, we evaluated mortalities associated with professional boxing. METHODS: We used the Velaquez Fatality Collection of boxing injuries and supplementary sources to analyze mortality from 1950 to 2007. Variables evaluated included age at time of death, association with knockout or other outcome of match, rounds fought, weight class, location of fight, and location of pretermial event. RESULTS: There were 339 mortalities between 1950 and 2007 (mean age, 24 +/- 3.8 years); 64% were associated with knockout and 15% with technical knockout. A higher percentage occured in the lower weight classes. The preterminal event occured in the ring (61%), in the locker room (17%), and outside the arena (22%), We evaluated for significant changes after 1983 when championship bouts were reduced from 15 to 12 rounds. CONCLUSION: There was a significant decline in mortality after 1983. We found no significant variables to support that this decline is related to a reduction in rounds. Rather, we hypothesize the decline to be the result of a reduction in exposure to repetitive head trauma (shorter careers and fewer fights), along with increased medical oversight and stricter safety regulations. Increased efforts should be made to improve medical supervisions of boxers. Mandatory central nervous system imaging after a knockout could lead to a significant reduction in associated mortality	[Baird, Lissa C.; Newman, C. Benjamin; Volk, Hunter; Levy, Michael L.] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA; [Svinth, Joseph R.; Conklin, Jordan] Rady Childrens Hosp San Diego, San Diego, CA USA	Levy, ML (corresponding author), 8010 Frost St,Ste 502, San Diego, CA USA.	mlevy@chsd.org	Levy, Michael/AAL-4647-2020				ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BORGES R, 25 YEARS IS LONG TIM; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; COHEN L, 1984, CAN MED ASSOC J, V130, P767; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Ghiselli G, 2003, CLIN SPORT MED, V22, P445, DOI 10.1016/S0278-5919(02)00109-6; GONZALES TA, 1951, JAMA-J AM MED ASSOC, V146, P1506, DOI 10.1001/jama.1951.03670160048012; Hodgson V. R., 1972, P 16 STAPP CAR CRASH; Joch W, 1981, BIOMECHANICS A, P343; JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KING AI, 1995, BIOMEDICAL ENG HDB, P357; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037; MCCOWN IA, 1959, AM J SURG, V98, P509, DOI 10.1016/0002-9610(59)90545-8; Miele VJ, 2007, NEUROSURGERY, V60, P307, DOI 10.1227/01.NEU.0000249247.48299.5B; Miele Vincent J, 2006, Neurosurg Focus, V21, pE8; Moore M, 1980, Phys Sportsmed, V8, P101, DOI 10.1080/00913847.1980.11710972; MORRISON RG, 1986, JAMA-J AM MED ASSOC, V255, P2475, DOI 10.1001/jama.255.18.2475; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PINCEMAILLE Y, 1989, P 33 STAPP CAR CRASH; POLIN AW, 1996, NEUROLOGY TRAUMA, P166; REFSHAUGE JG, 1963, MED J AUSTRALIA, V1, P611, DOI 10.5694/j.1326-5377.1963.tb25567.x; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; SERCL M., 1962, WORLD NEUROL, V3, P351; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; SUGAR BR, 1981, RING RECORD BOOK BOX; Svinth J., 2007, J COMBATIVE SPORT; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Unterharnscheidt F J, 1972, Scand J Rehabil Med, V4, P77; VIANO D, 1988, P 32 STAPP CAR CRASH; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; WHITING WC, 1988, AM J SPORT MED, V16, P130, DOI 10.1177/036354658801600207	40	14	15	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2010	67	5					1444	1450		10.1227/NEU.0b013e3181e5e2cd			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	671DF	WOS:000283479500062	20948404				2021-06-18	
J	Bechir, M; Meierhans, R; Brandi, G; Sommerfeld, J; Fasshauer, M; Cottini, SR; Stocker, R; Stover, JF				Bechir, M.; Meierhans, R.; Brandi, G.; Sommerfeld, J.; Fasshauer, M.; Cottini, S. R.; Stocker, R.; Stover, J. F.			Insulin differentially influences brain glucose and lactate in traumatic brain injured patients	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries; Glucose; Lactates; Critical care; Pharmacology	CEREBRAL ENERGY-METABOLISM; NERVOUS-SYSTEM; INTENSIVE-CARE; GLUT4; HYPERGLYCEMIA; MICRODIALYSIS; TRANSPORTERS; THERAPY; HYPOGLYCEMIA; EXPRESSION	Background. Hypo- and hyperglycemia must be avoided to prevent additional brain damage following traumatic brain injury (TBI). However, the optimal blood glucose range requiring insulin remains unknown. Cerebral microdialysis is helpful in unmasking signs of metabolic impairment, thereby identifying deleterious blood glucose levels. Methods. A retrospective analysis of prospectively collected cerebral microdialysis samples obtained from 20 non-diabetic patients with severe TBI treated at the trauma surgical intensive care unit at the University Hospital Zurich, Switzerland. Results. The impact of different arterial blood glucose values and concomitant insulin administration on cerebral interstitial glucose and lactate levels was investigated. In addition, energetic impairment was determined by calculating lactate-to-glucose ratios. Insulin administration was associated with significantly reduced cerebral glucose concentrations and significantly increased lactate-to-glucose ratios with arterial blood glucose levels <5 mM. At arterial blood glucose levels >7 mM, insulin administration was associated with significantly increased interstitial glucose values, significantly decreased lactate concentrations, and markedly diminished lactate-to-glucose ratios. Conclusion. Insulin exerts differential effects that depend strongly on the underlying arterial blood glucose concentrations. To avoid energetic impairment, insulin should not be administered at arterial blood glucose levels <5 mM. However, at arterial blood glucose levels >7-8 mM, insulin administration appears to be encouraged to increase extra-cellular glucose concentrations and decrease energetic impairment reflected by reduced interstitial brain lactate and decreased lactate-to-glucose ratios. Nevertheless, frequent analysis is required to minimize the risk of inducing impaired brain metabolism. (Minerva Anestesiol 2010;76:896-904)	[Bechir, M.; Meierhans, R.; Brandi, G.; Sommerfeld, J.; Fasshauer, M.; Cottini, S. R.; Stocker, R.; Stover, J. F.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Brandi, G.] Osped Maggiore, Neurosurg Intens Care Unit, Dept Anesthesia & Crit Care Med, Policlin IRCCS Fdn, Milan, Italy	Stover, JF (corresponding author), Univ Zurich Hosp, CH-8091 Zurich, Switzerland.	john.stover@access.unizh.ch			Swiss National Science Foundation (SNF)Swiss National Science Foundation (SNSF); SUVA Fonds	The help of:the nursing staff in collecting and analyzing cerebral microdialysis samples is gratefully acknowledged. The study was supported by grants from the Swiss National Science Foundation (SNF) and the SUVA Fonds to JFS and RS.	Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Holbein M, 2009, CRIT CARE, V13, DOI 10.1186/cc7711; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Leloup C, 1996, MOL BRAIN RES, V38, P45, DOI 10.1016/0169-328X(95)00306-D; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nehlig A, 1997, DIABETES METAB, V23, P18; Ngarmukos C, 2001, BRAIN RES, V900, P1, DOI 10.1016/S0006-8993(01)02184-9; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sankar R, 2002, MOL BRAIN RES, V107, P157, DOI 10.1016/S0169-328X(02)00487-4; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sonnewald U, 1996, DEV NEUROSCI-BASEL, V18, P443, DOI 10.1159/000111439; Sperry JL, 2007, J TRAUMA, V63, P487, DOI 10.1097/TA.0b013e31812e51fc; Stocchetti N, 2008, MINERVA ANESTESIOL, V74, P199; Strong AJ, 2007, CURR OPIN CRIT CARE, V13, P126, DOI 10.1097/MCC.0b013e32807faffb; Uehara Y, 1997, AM J PHYSIOL-ENDOC M, V272, pE716; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vannucci SJ, 1998, BRAIN RES, V797, P1, DOI 10.1016/S0006-8993(98)00103-6; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Zovein A, 2004, AM J PHYSIOL-REG I, V286, pR273, DOI 10.1152/ajpregu.00160.2003; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	33	14	16	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	NOV	2010	76	11					896	904					9	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	691XN	WOS:000285114200005	20634790				2021-06-18	
J	Huebinger, RM; Rivera-Chavez, F; Chang, LY; Liu, MM; Minei, JP; Purdue, GF; Hunt, JL; Arnoldo, BD; Barber, RC				Huebinger, Ryan M.; Rivera-Chavez, Fernando; Chang, Ling-Yu; Liu, Ming-Mei; Minei, Joseph P.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Barber, Robert C.			IL-10 Polymorphism Associated with Decreased Risk for Mortality After Burn Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						interleukin-10; genetic association; burn injury; mortality	SEVERE SEPSIS; INTERLEUKIN-10; EXPRESSION; GENE	Objective. Evaluation of single nucleotide polymorphisms (SNPs) in the interleukin-10 promoter (-592 and -819) on risk for death after burn injury. Methods. Association between the IL-10 SNPs and outcome after burn injury was evaluated in a cohort of 265 patients from Parkland Hospital, Dallas, TX with >= 15% TBSA burns without non-burn trauma (ISS <= 16), traumatic or anoxic brain injury or spinal cord injury, who survived > 48 h under an IRB-approved protocol. Clinical data were collected prospectively and genotyping was conducted by TaqMan assay. Whole blood from 31 healthy volunteers was stimulated with LPS (100 ng/mL) to determine the level of IL-10 expression for each allele by enzyme-linked immunosorbent assay (ELISA). Results. After adjustment for percent total body surface area (TBSA) burned, inhalation injury, age, gender, and race/ethnicity, carriage of -592A and/or -819T was significantly associated (P = 0.014) with a decreased risk for death (adjusted odds ratio: 0.404; 95% CI: 0.197-0.829). As the candidate SNPs were in complete linkage disequilibrium, it was not possible to distinguish which allele was associated with decreased mortality risk. Age, inhalation injury, and full-thickness burn size were significantly associated with increased risk for death. In the LPS stimulated blood of healthy controls, carriage of the -592A and/or -819T allele demonstrated a trend for decreased levels of IL-10 (P = 0.079). Conclusion. Carriage of the -592A and/or -819T allele in the IL-10 promoter appears to reduce the risk for death after burn injury. (C) 2010 Elsevier Inc. All rights reserved.	[Barber, Robert C.] Univ N Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Huebinger, Ryan M.; Rivera-Chavez, Fernando; Chang, Ling-Yu; Liu, Ming-Mei; Minei, Joseph P.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	Barber, RC (corresponding author), Univ N Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, 3500 Camp Bowie Rd, Ft Worth, TX 76107 USA.	robert.barber@UNTHSC.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P50 GM21681-42, 5T32 GM008593-13]; NIH/NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32 GM008593-13, 5P50 GM21681-43, 5K08GM071646-5]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM071646, T32GM008593, P50GM021681] Funding Source: NIH RePORTER	This study was supported by NIH grants 5P50 GM21681-42 and 5T32 GM008593-13.; SS SSupported by NIH/NIGMS 5P50 GM21681-43, 5T32 GM008593-13, 5K08GM071646-5.	Amre DK, 2009, ALIMENT PHARM THER, V29, P1025, DOI 10.1111/j.1365-2036.2009.03953.x; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bagnoli S, 2007, NEUROSCI LETT, V418, P262, DOI 10.1016/j.neulet.2007.03.030; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Csontos C, 2010, BURNS, V36, P483, DOI 10.1016/j.burns.2009.10.009; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Hee Chee Seng, 2007, Mod Rheumatol, V17, P429, DOI 10.1007/s10165-007-0612-9; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Lowe PR, 2003, CRIT CARE MED, V31, P34, DOI 10.1097/00003246-200301000-00005; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; MERRELL SW, 1989, J TRAUMA, V29, P1362, DOI 10.1097/00005373-198910000-00012; Miller SF, 2006, J BURN CARE RES, V27, P411, DOI 10.1097/01.BCR.0000226260.17523.22; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Yao JG, 2008, CLIN CHIM ACTA, V388, P84, DOI 10.1016/j.cca.2007.10.012	17	14	15	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2010	164	1					E141	E145		10.1016/j.jss.2010.07.021			5	Surgery	Surgery	700MR	WOS:000285747600020	20863526	Green Accepted			2021-06-18	
J	Degeneffe, CE; Lee, GK				Degeneffe, Charles Edmund; Lee, Gloria K.			Quality of Life After Traumatic Brain Injury: Perspectives of Adult Siblings	JOURNAL OF REHABILITATION			English	Article							REHABILITATION; DEPRESSION; SERVICES; SF-36	This study examined sibling perceptions on the quality of life of their brothers and sisters with traumatic brain injury (TBI). The authors examined how a national sample of 279 adult siblings of persons with TBI felt about the quality of life of their injured brothers and sisters. Using a constant comparative approach to text analysis, the authors analyzed responses to the question, "What is your feeling regarding your sibling's quality of life?" Participants expressed views that the life quality for their injured siblings was overall more negative than positive. Participants believed that the quality of life for their injured siblings was negative when they found difficulties in meeting expected life roles, when they were unable to psychologically adjust to their injuries, and when they received poor professional care. Alternatively, quality of life was rated positively when their injured siblings psychologically adjusted to their post-injury lives, when they experienced recovery from their post-injury functional impairments, and when they received positive support from family and professionals.	[Degeneffe, Charles Edmund] San Diego State Univ, Interwork Inst, Rehabil Counseling Program, San Diego, CA USA; [Lee, Gloria K.] SUNY Buffalo, Buffalo, NY 14260 USA	Degeneffe, CE (corresponding author), San Diego State Univ, Interwork Inst, Rehabil Counseling Program, 3590 Camino Rio N, San Diego, CA USA.	cdegenef@mail.sdsu.edu					Baker K. A., 2002, J SOCIAL WORK DISABI, V1, P25, DOI [10.1300/j198v01n04_03, DOI 10.1300/J198V01N04_03]; Basu M., 2006, ATLANTA J CONSTITUTI; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; BILLINGTON R, 1999, WHOQOL ANNOTATED BIB; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Bogdan R. C., 1998, QUALITATIVE RES ED I; *BRAIN INJ ASS AM, 2004, TBI INC COMP TRAUM B; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Chandra Ashish, 2005, Hosp Top, V83, P33, DOI 10.3200/HTPS.83.1.33-37; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CROW N, 2005, PERCEPTIONS REALITY; Cunningham J.M., 1999, CASE MANAGEMENT REHA, P91; Degeneffe C. E., 2008, REHABILITATION ED, V22, P101; Degeneffe C. E., 2008, J APPL REHABILITATIO, V39, P42; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; DEPUIS PR, 1994, HYPERRESEARCH VERSIO; Dillman D.A., 1978, MAIL TELEPHONE SURVE; Elliott TE, 2003, PAIN MED, V4, P331, DOI 10.1111/j.1526-4637.2003.03040.x; FRANKSTROMBERG M, 1988, INSTRUMENTS CLIN NUR; Gephart R, 1997, J ORGAN BEHAV, V18, P583, DOI 10.1002/(SICI)1099-1379(199711)18:1+<583::AID-JOB908>3.0.CO;2-T; Gilbride D, 2003, REHABIL COUNS BULL, V46, P130, DOI 10.1177/00343552030460030101; HAGNER DC, 1994, REHABIL COUNS BULL, V37, P290; KINCAID CA, 1998, DISS ABSTR INT, V59, P93; Livneh H., 1997, PSYCHOSOCIAL ADAPTAT; *NIH, 1999, REP NIH CONS DEV C R; OCAMPO S, 1997, OCCUPATIONAL THERAPY, V4, P163; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; REDMOND G, 1988, DISSERT ABSTR, V49, P3608; Rontondi A. J., 2005, J HEAD TRAUMA REHAB, V20, P173; Spearman RC, 2001, J HEAD TRAUMA REHAB, V16, P47, DOI 10.1097/00001199-200102000-00007; SPRIGGS VT, 1998, PROMOTING CULTURAL C, P149; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Strauss A., 1998, BASICS QUALITATIVE R; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Tian Y, 2006, CORP COMMUN, V11, P13, DOI 10.1108/13563280610643516; Vaughn SL, 2001, J HEAD TRAUMA REHAB, V16, P20, DOI 10.1097/00001199-200102000-00005; Vickrey Barbara G., 1993, P623; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	40	14	14	0	1	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	OCT-DEC	2010	76	4					27	36					10	Rehabilitation	Rehabilitation	674NY	WOS:000283755100004					2021-06-18	
J	Risselada, R; Lingsma, HF; Molyneux, AJ; Kerr, RSC; Yarnold, J; Sneade, M; Steyerberg, EW; Sturkenboom, MCJM				Risselada, Roelof; Lingsma, Hester F.; Molyneux, Andrew J.; Kerr, Richard S. C.; Yarnold, Julia; Sneade, Mary; Steyerberg, Ewout W.; Sturkenboom, Miriam C. J. M.			Prediction of two month modified Rankin Scale with an ordinal prediction model in patients with aneurysmal subarachnoid haemorrhage	BMC MEDICAL RESEARCH METHODOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL ANEURYSMS; REGRESSION-MODELS; ADJUSTMENT; TRIALS	Background: Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating event with a frequently disabling outcome. Our aim was to develop a prognostic model to predict an ordinal clinical outcome at two months in patients with aSAH. Methods: We studied patients enrolled in the International Subarachnoid Aneurysm Trial (ISAT), a randomized multicentre trial to compare coiling and clipping in aSAH patients. Several models were explored to estimate a patient's outcome according to the modified Rankin Scale (mRS) at two months after aSAH. Our final model was validated internally with bootstrapping techniques. Results: The study population comprised of 2,128 patients of whom 159 patients died within 2 months (8%). Multivariable proportional odds analysis identified World Federation of Neurosurgical Societies (WFNS) grade as the most important predictor, followed by age, sex, lumen size of the aneurysm, Fisher grade, vasospasm on angiography, and treatment modality. The model discriminated moderately between those with poor and good mRS scores (c statistic = 0.65), with minor optimism according to bootstrap re-sampling (optimism corrected c statistic = 0.64). Conclusion: We presented a calibrated and internally validated ordinal prognostic model to predict two month mRS in aSAH patients who survived the early stage up till a treatment decision. Although generalizability of the model is limited due to the selected population in which it was developed, this model could eventually be used to support clinical decision making after external validation.	[Risselada, Roelof; Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Molyneux, Andrew J.; Yarnold, Julia; Sneade, Mary] Univ Oxford, Oxford Neurovasc & Neuroradiol Res Unit, Oxford, England; [Sturkenboom, Miriam C. J. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Kerr, Richard S. C.] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England	Risselada, R (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	r.risselada@erasmusmc.nl	Steyerberg, Ewout/C-1509-2018	Steyerberg, Ewout/0000-0002-7787-0122	European CommissionEuropean CommissionEuropean Commission Joint Research Centre; Medical Research Council, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC); French Ministry of Health [AOM 98150]; Assistance Publique, HOpitaux de Paris (AP-HP); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Stroke Association of the UK for the Neuropsychological assessments; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0700479] Funding Source: researchfish	This study was performed within the scope of the @neurIST-project ('@neurIST, Integrated biomedical informatics for the management of cerebral aneurysms', http://www.aneurist.org), funded by the European Commission 6th Framework Programme. The International Subarachnoid Aneurysm Trial was supported by grants from: the Medical Research Council, UK; and Programme Hospitalier de Recherche Clinique 1998 of the French Ministry of Health (AOM 98150). It was sponsored by Assistance Publique, HOpitaux de Paris (AP-HP); the Canadian Institutes of Health Research; and the Stroke Association of the UK for the Neuropsychological assessments.	Ambler G, 2002, STAT MED, V21, P3803, DOI 10.1002/sim.1422; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Box G.E.P., 1979, ROBUSTNESS STRATEGY; Eriksson M, 2008, CEREBROVASC DIS, V25, P423, DOI 10.1159/000121343; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.0.CO;2-O; Hayakawa M, 2005, AM J NEURORADIOL, V26, P1366; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Langham J, 2009, STROKE, V40, P111, DOI 10.1161/STROKEAHA.108.517805; Machado SS, 1999, BIOCATAL BIOTRANSFOR, V17, P179, DOI 10.3109/10242429909040114; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Risselada R, 2010, EUR J EPIDEMIOL, V25, P261, DOI 10.1007/s10654-010-9432-x; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Starke RM, 2009, J CLIN NEUROSCI, V16, P26, DOI 10.1016/j.jocn.2008.02.010; Steyerberg E., 2009, PRACTICAL APPROACH D; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; YEE TW, 2010, J STAT SOFTW, P32; ZHANG C, 2009, IEEE T MED IMAGING	27	14	15	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	SEP 29	2010	10								86	10.1186/1471-2288-10-86			8	Health Care Sciences & Services	Health Care Sciences & Services	667UA	WOS:000283218700001	20920243	DOAJ Gold, Green Published			2021-06-18	
J	Crockett, A; Stawicki, SP; Thomas, YM; Jarvis, AM; Wang, CF; Beery, PR; Whitmill, ML; Lindsey, DE; Steinberg, SM; Cook, CH				Crockett, Andrew; Stawicki, Stanislaw P.; Thomas, Yalaunda M.; Jarvis, Amy M.; Wang, Cecily F.; Beery, Paul R.; Whitmill, Melissa L.; Lindsey, David E.; Steinberg, Steven M.; Cook, Charles H.			Tree Stands, Not Guns, are the Midwestern Hunter's Most Dangerous Weapon	AMERICAN SURGEON			English	Article							INJURIES; FALLS	Although the prevailing stereotype is that most hunting injuries are gunshot wounds inflicted by intoxicated hunting buddies, our experience led us to hypothesize that falls comprise a significant proportion of hunting related injuries. Trauma databases of two Level I trauma centers in central Ohio were queried for all hunting related injuries during a 10-year period. One hundred and thirty patients were identified (90% male, mean age 41.0 years, range 17-76). Fifty per cent of injuries resulted from falls, whereas gunshot wounds accounted for 29 per cent. Most hunters were hunting deer and 92 per cent of falls were from tree stands. Alcohol was involved in only 2.3 per cent, and drugs of abuse in 4.6 per cent. Of gunshots, 58 per cent were self-inflicted, and 42 per cent were shot by another hunter. Tree stand falls were highly morbid, with 59 per cent of fall victims suffering spinal fractures, 47 per cent lower extremity fractures, 18 per cent upper extremity fractures, and 18 per cent closed head injuries. Surgery was required for 81 per cent of fall-related injuries, and 8.2 per cent of fall victims had permanent neurological deficits. In contrast to prevailing beliefs, in our geographic area tree-stand falls are the most common mechanism of hunting related injury requiring admission to a Level 1 trauma center.	[Crockett, Andrew; Stawicki, Stanislaw P.; Thomas, Yalaunda M.; Jarvis, Amy M.; Wang, Cecily F.; Beery, Paul R.; Whitmill, Melissa L.; Lindsey, David E.; Steinberg, Steven M.; Cook, Charles H.] Ohio State Univ, Med Ctr, Dept Surg, Div Crit Care Trauma & Burn, Columbus, OH 43210 USA	Cook, CH (corresponding author), 410 W 10th Ave,N749 Doan Hall, Columbus, OH 43210 USA.	charles.cook@osumc.edu	Cook, Charles/D-5574-2009; Cook, Charles/AAE-3222-2020; Lindsey, David E/E-3517-2011; Steinberg, Steven/E-4142-2011	Cook, Charles/0000-0003-4446-3616; Stawicki, Stanislaw/0000-0002-8893-6668			*CDCP, 1996, MMWR-MORBID MORTAL W, V45, P884; Christensen TL, 2008, SOUTH MED J, V101, P383, DOI 10.1097/SMJ.0b013e318167a851; Fayssoux RS, 2008, SPINE J, V8, P522, DOI 10.1016/j.spinee.2006.11.005; Gates RL, 2002, J TRAUMA, V53, P705, DOI 10.1097/00005373-200210000-00014; Halanski Matthew A, 2008, WMJ, V107, P20; Huiras C M, 1990, Wis Med J, V89, P573; Metz M, 2004, SOUTH MED J, V97, P715, DOI 10.1097/00007611-200408000-00003; *ODNR, 2009, HUNT ED MAN; Reishus AD, 2007, WILD ENVIRON MED, V18, P20, DOI 10.1580/06-WEME-OR-014R1.1; ROSE WD, 1994, J WILDERNESS MED, V5, P382, DOI 10.1580/0953-9859-5.4.382; Smith JL, 2005, J TRAUMA, V58, P582, DOI 10.1097/01.TA.0000151348.91729.B6	11	14	14	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2010	76	9					1006	1010					5	Surgery	Surgery	643LD	WOS:000281297000018	20836352				2021-06-18	
J	Hurley, M; Dineen, R; Padfield, CJH; Wilson, S; Stephenson, T; Vyas, H; Mcconachie, N; Jaspan, T				Hurley, M.; Dineen, R.; Padfield, C. J. H.; Wilson, S.; Stephenson, T.; Vyas, H.; Mcconachie, N.; Jaspan, T.			Is there a causal relationship between the hypoxia-ischaemia associated with cardiorespiratory arrest and subdural haematomas? An observational study	BRITISH JOURNAL OF RADIOLOGY			English	Article							INTRACRANIAL HEMORRHAGE; MR; ENCEPHALOPATHY; PREVALENCE; INJURY; BRAIN	The aim of this study was to determine the frequency of subdural haematomas (SDHs) occurring in infants presenting following atraumatic cardiorespiratory collapse. This study was a review of retrospective case notes, brain imaging and post-mortem examinations carried out in the paediatric intensive care unit (PICU) and emergency department (ED) in a tertiary paediatric centre in the UK. The study included infants and children less than 4 years old dying in the ED or admitted to the PICU after atraumatic cardiorespiratory arrest. We identified macroscopic SDHs on brain imaging or post-mortem examination. Of those children who experienced a cardiorespiratory arrest from a non-traumatic cause and met inclusion criteria, 33 presented and died in the ED and 17 were admitted to the PICU. These children had a post-mortem examination, brain imaging or both. None of these infants had a significant SDH. One child had a small clot adherent to the dura found on post-mortem and two had microscopic intradural haemorrhage, but it is unclear in each case whether this was artefact, as each had otherwise normal brains. Subdural haematoma arising in infants or young children in the context of catastrophic cardiorespiratory compromise from a non-traumatic cause was not observed.	[Hurley, M.; Stephenson, T.; Vyas, H.; Mcconachie, N.; Jaspan, T.] Univ Nottingham, Nottingham NG7 2RD, England; [Hurley, M.; Dineen, R.; Padfield, C. J. H.; Wilson, S.; Vyas, H.] Queens Med Ctr, Nottingham NG7 2UH, England	Jaspan, T (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.	tim.jaspan@nuh.nhs.uk	Dineen, Robert/S-7192-2019	Stephenson, Terence/0000-0001-8871-7847; Dineen, Robert/0000-0002-9523-2546; Hurley, Matthew/0000-0002-2439-8522			Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P427; BARKOVICH AJ, PEDIAT NEUROIMAGING, P226; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Christophe C, 2002, AM J NEURORADIOL, V23, P716; Cohen MC, 2009, PEDIATR DEVEL PATHOL, V12, P169, DOI 10.2350/08-08-0509.1; Geddes J F, 2004, Pediatr Rehabil, V7, P261, DOI 10.1080/13638490412331280435; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Levene M., 2009, FETAL NEONATAL NEURO, P395; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Rao P, 1999, CLIN RADIOL, V54, P495, DOI 10.1016/S0009-9260(99)90845-0; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Rutty GN, 2005, NEUROPATH APPL NEURO, V31, P247, DOI 10.1111/j.1365-2990.2004.00633.x; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; VOLPE JJ, 2008, HYPOXICISCHEMIC ENCE, P408; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9	18	14	14	0	4	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285			BRIT J RADIOL	Br. J. Radiol.	SEP	2010	83	993					736	743		10.1259/bjr/36871113			8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	642WX	WOS:000281252800008	20647510	Green Published			2021-06-18	
J	Antonucci, F; Cerri, C; Maya-Vetencourt, JF; Caleo, M				Antonucci, F.; Cerri, C.; Maya-Vetencourt, J. F.; Caleo, M.			ACUTE NEUROPROTECTION BY THE SYNAPTIC BLOCKER BOTULINUM NEUROTOXIN E IN A RAT MODEL OF FOCAL CEREBRAL ISCHAEMIA	NEUROSCIENCE			English	Article						stroke; synaptic transmission; glutamate release; hippocampus; SNAP-25	ENDOTHELIN-1 INDUCED LESIONS; INDUCED NEURONAL INJURY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; STROKE; GLUTAMATE; EPILEPSY; RELEASE; CORTEX; MICRODIALYSIS	Evidence indicates that accumulation of excitotoxic mediators, such as glutamate, contributes to neuronal damage after an ischaemic insult. It is not clear, however, whether this accumulation is due to excess synaptic release or to impaired uptake. To test a role for synaptic release, here we investigated the neuroprotective potential of the synaptic blocker botulinum neurotoxin E (BoNT/E), that prevents vesicle fusion via the cleavage of the SNARE (soluble NSF-attachment receptor) protein SNAP-25 (synaptosomal-associated protein of 25 kDa). Focal ischaemia was induced in vivo by infusing the potent vasoconstricting peptide endothelin-1 (ET-1) into the CA1 area of the hippocampus in adult rats; BoNT/E or vehicle were administered into the same site 20 min later. Injection of ET-1 was found to produce a transient and massive increase in glutamate release that was potently antagonized by BoNT/E. To assess whether blocking transmitter release translates into neuroprotection, the extent of the ischaemic damage was determined 24 h and 6 weeks after the insult. We found that BoNT/E administration consistently reduced the loss of CA1 pyramidal neurons at 24 h. The neuroprotective effect of BoNT/E, however, was no longer significant at 6 weeks. These data provide evidence that blockade of synaptic transmitter release delays neuronal cell death following focal brain ischaemia, and underline the importance of assessing long-term neuroprotection in experimental stroke studies. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Antonucci, F.; Caleo, M.] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Cerri, C.; Maya-Vetencourt, J. F.] Scuola Normale Super Pisa, I-56100 Pisa, Italy	Caleo, M (corresponding author), CNR, Ist Neurosci, Via G Moruzzi 1, I-56100 Pisa, Italy.	caleo@in.cnr.it	Maya-Vetencourt, Jose Fernando/Q-6539-2019; Maya-Vetencourt, JF/AAT-5130-2020	Maya-Vetencourt, Jose Fernando/0000-0003-3808-8944; Antonucci, Flavia/0000-0002-0198-4529; CALEO, MATTEO/0000-0002-4333-6378	International Institute for Research in Paraplegia (Zurich, Switzerland) [P94]; Regione ToscanaRegione Toscana; Italian Ministry of Education, University and ResearchMinistry of Education, Universities and Research (MIUR) [2008338WNL]	This work was supported by a grant (P94) from the International Institute for Research in Paraplegia (Zurich, Switzerland), by Regione Toscana and by the Italian Ministry of Education, University and Research (PRIN grant 2008338WNL and FIRB project "CHEM-Profarma-NET"). We thank V.H. Perry (Univ. Southampton) for help in setting up the ET-1 ischaemia model. We are indebted to Adriano Tacchi for histological work and to Dr. A. Viegi for help with the HPLC system. Nicola Carucci participated in some experiments. We thank to C. Montecucco and O. Rossetto (University of Padua. Italy) for providing antibodies against cleaved SNAP-25.	Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; ASHTON AC, 1988, J NEUROCHEM, V50, P1808, DOI 10.1111/j.1471-4159.1988.tb02482.x; Bartus RT, 1998, BRAIN RES, V790, P1, DOI 10.1016/S0006-8993(97)01414-5; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Berger C, 2002, STROKE, V33, P519, DOI 10.1161/hs0102.100878; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bogaert L, 2000, BRAIN RES, V887, P266, DOI 10.1016/S0006-8993(00)02959-0; Bozzi Y, 2006, NEUROTOX RES, V9, P197, DOI 10.1007/BF03033939; Calabresi P, 2003, ANN NEUROL, V53, P693, DOI 10.1002/ana.10603; Caleo M, 2007, J NEUROSCI, V27, P4530, DOI 10.1523/JNEUROSCI.0772-07.2007; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Costantin L, 2005, J NEUROSCI, V25, P1943, DOI 10.1523/JNEUROSCI.4402-04.2005; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Fuxe K, 1997, NEUROREPORT, V8, P2623, DOI 10.1097/00001756-199707280-00040; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Gilmour G, 2004, BEHAV BRAIN RES, V150, P171, DOI 10.1016/j.bbr.2003.07.006; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hughes PM, 2003, J NEUROPATH EXP NEUR, V62, P1276, DOI 10.1093/jnen/62.12.1276; Larsson E, 2001, BRAIN RES, V913, P117, DOI 10.1016/S0006-8993(01)02762-7; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; LUSTIG HS, 1992, NEUROSCI LETT, V139, P15, DOI 10.1016/0304-3940(92)90847-Z; Mateffyova A, 2006, EUR J NEUROSCI, V24, P351, DOI 10.1111/j.1460-9568.2006.04910.x; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; MONYER H, 1992, NEURON, V8, P967, DOI 10.1016/0896-6273(92)90211-U; NIKOLOV R, 1993, EUR J PHARM-ENVIRON, V248, P205, DOI 10.1016/0926-6917(93)90044-Q; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; SCHIAVO G, 1995, METHOD ENZYMOL, V248, P643; Schiavo G, 2000, PHYSIOL REV, V80, P717; SHARKEY J, 1995, J NEUROSCI METH, V60, P125, DOI 10.1016/0165-0270(95)00003-D; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Shuaib A, 2008, EUR NEUROL, V59, P4, DOI 10.1159/000109254; UEKI A, 1993, EXP BRAIN RES, V96, P89, DOI 10.1007/BF00230442; VALTYSSON J, 1994, ACTA NEUROCHIR, V129, P58, DOI 10.1007/BF01400874; Van Hemelrijck A, 2003, J NEUROCHEM, V87, P66, DOI 10.1046/j.1471-4159.2003.01977.x; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Verderio C, 2007, TRAFFIC, V8, P142, DOI 10.1111/j.1600-0854.2006.00520.x; Vidwans AS, 2004, EXP NEUROL, V190, P91, DOI 10.1016/j.expneurol.2004.06.018; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009	44	14	14	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	AUG 11	2010	169	1					395	401		10.1016/j.neuroscience.2010.04.059			7	Neurosciences	Neurosciences & Neurology	621LB	WOS:000279579200039	20447449				2021-06-18	
J	Bourdeaux, C; Brown, J				Bourdeaux, Chris; Brown, Jules			Sodium Bicarbonate Lowers Intracranial Pressure After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Intracranial pressure; Osmotherapy; Sodium bicarbonate; Hypertonic solutions	LACTATED RINGERS SOLUTION; HYPERTONIC SALINE; BLOOD-FLOW; CHLORIDE; MANAGEMENT; ACIDOSIS; INFUSION; SURGERY	Hypertonic saline is routinely used to treat rises in intracranial pressure (ICP) post-traumatic head injury. Repeated doses often cause a hyperchloremic metabolic acidosis. We investigated the efficacy of 8.4% sodium bicarbonate as an alternative method of lowering ICP without generating a metabolic acidosis. We prospectively studied 10 episodes of unprovoked ICP rise in 7 patients treated with 85 ml of 8.4% sodium bicarbonate in place of our usual 100 ml 5% saline. We measured ICP and mean arterial pressure continuously for 6 h after infusion. Serum pH, pCO(2), [Na+], and [Cl-] were measured at baseline, 30 min, 60 min and then hourly for 6 h. At the completion of the infusion (t = 30 min), the mean ICP fell from 28.5 mmHg (+/- 2.62) to 10.33 mmHg (+/- 1.89), P < 0.01. Mean ICP remained below 20 mmHg at all time points for 6 h. Mean arterial pressure was unchanged leading to an increased cerebral perfusion pressure at all time points for 6 h post-infusion. pH was elevated from 7.45 +/- A 0.05 at baseline to 7.50 +/- A 0.05, P < 0.01 at t = 30 min, and remained elevated. Serum [Na+] increased from 145.4 +/- A 6.02 to 147.1 +/- A 6.3 mmol/l, P < 0.01 at t = 30 min. pCO(2) did not change. A single dose of 8.4% sodium bicarbonate is effective at treating rises in ICP for at least 6 h. Serum sodium was raised but without generation of a hyperchloremic metabolic acidosis.	[Bourdeaux, Chris; Brown, Jules] Frenchay Hosp, Dept Anaesthesia, Bristol BS16 1LE, Avon, England	Bourdeaux, C (corresponding author), Frenchay Hosp, Dept Anaesthesia, Frenchay Pk Rd, Bristol BS16 1LE, Avon, England.	chrisbourdeaux@gmail.com; Jules.brown@nbt.nhs.uk			Frenchay Hospital Intensive Care Unit	The authors would like to thank Dr Will English for his help preparing the protocol and all the nursing staff at Frenchay Hospital Intensive Care Unit for their help and support of this study.	Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Hansen PB, 1998, HYPERTENSION, V32, P1066, DOI 10.1161/01.HYP.32.6.1066; Nakashima K, 1996, ACTA NEUROL SCAND, V93, P96, DOI 10.1111/j.1600-0404.1996.tb00561.x; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Scheingraber S, 1999, ANESTHESIOLOGY, V90, P1265, DOI 10.1097/00000542-199905000-00007; SCHIEVE JF, 1953, J CLIN INVEST, V32, P33, DOI 10.1172/JCI102707; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Waters JH, 1999, CRIT CARE MED, V27, P2142, DOI 10.1097/00003246-199910000-00011; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Weed LH, 1919, AM J PHYSIOL, V48, P512; Weed LH, 1919, AM J PHYSIOL, V48, P531; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006; YOUNG RSK, 1984, ACTA NEUROPATHOL, V65, P124, DOI 10.1007/BF00690465	18	14	16	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2010	13	1					24	28		10.1007/s12028-010-9368-8			5	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	620NF	WOS:000279505900005	20422466				2021-06-18	
J	Dong, XQ; Huang, M; Hu, YY; Yu, WH; Zhang, ZY				Dong, Xiao-Qiao; Huang, Man; Hu, Yue-Yu; Yu, Wen-Hua; Zhang, Zu-Yong			Time Course of Plasma Leptin Concentrations After Acute Spontaneous Basal Ganglia Hemorrhage	WORLD NEUROSURGERY			English	Article						Biomarker; Inflammatory reaction; Intracerebral hemorrhage; Leptin; Outcome; Stroke	TRAUMATIC BRAIN-INJURY; ADIPOKINE GENE-EXPRESSION; INTRACEREBRAL HEMORRHAGE; AUTOIMMUNE ENCEPHALOMYELITIS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; PITUITARY-GLAND; POTENTIAL ROLE; FOOD-INTAKE; INFLAMMATION	BACKGROUND: Brain cortex leptin messenger riboneucleic acid (mRNA) expression and serum leptin level are up-regulated in ischemic mouse brain, as well as in rat brain with traumatic brain injury. Elevated leptin plasma levels predict cerebral hemorrhagic stroke independently of traditional risk factors. The goal of this study was to investigate change in plasma leptin level after intracerebral hemorrhage (ICH) and to evaluate its relation with disease outcome. METHODS: Eighty-six patients admitted within 6 hrs after ICH and 30 healthy controls were included. Plasma samples were obtained on admission and at days 1, 2, 3, 5, and 7 after ICH. Its concentration was measured by enzyme-linked immunosorbent assay (ELISA). RESULTS: After ICH, plasma leptin level in patients increased during the 6-hour period immediately, peaked in 24 hours, decreased gradually thereafter, and was substantially higher than that in healthy controls during the 7-day period. Plasma leptin levels were highly associated with initial Glasgow coma scores, ICH volumes, presences of intraventricular hemorrhage, and survival rates (all P < 0.05). A multivariate analysis selected plasma leptin level related to plasma C-reactive protein level (standardized coefficient, 0.293; P = 0.003). A multivariate analysis showed baseline plasma leptin level as a good predictor for 1-week mortality (odds ratio, 1.228; 95% confidence interval, 1.070-1.409; P = 0.003). A receiver operating characteristic curve identified that a baseline plasma leptin level greater than 34.1 ng/mL predicted 1-week mortality of patients with 75.0% sensitivity and 85.2% specificity (P < 0.001). Area under curve of GCS score was statistically significantly larger than that of plasma leptin level (P = 0.035), but ICH volume's area under curve not (P = 0.078). CONCLUSIONS: Increased plasma leptin level is found after ICH and may contribute to inflammatory process of ICH, in association with a poor clinical outcome.	[Dong, Xiao-Qiao; Yu, Wen-Hua; Zhang, Zu-Yong] Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Huang, Man; Hu, Yue-Yu] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Intens Care Unit, Hangzhou 310003, Zhejiang, Peoples R China	Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	dxqhyy@163.com					Ahima RS, 2006, PROG BRAIN RES, V153, P155, DOI 10.1016/S0079-6123(06)53009-2; Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Arnalich F, 1999, J INFECT DIS, V180, P908, DOI 10.1086/314963; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Brown R, 2005, MOL BRAIN RES, V139, P357, DOI 10.1016/j.molbrainres.2005.05.009; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Butcher K, 2003, J CLIN NEUROSCI, V10, P158, DOI 10.1016/S0967-5868(02)00324-7; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; De Rosa S, 2009, J VASC RES, V46, P609, DOI 10.1159/000226229; DeClercq Vanessa, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P228, DOI 10.2174/187152908785849080; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Loffreda S, 1998, FASEB J, V12, P57; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Malendowicz LK, 2007, INT REV CYTOL, V263, P63, DOI 10.1016/S0074-7696(07)63002-2; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Morash B, 1999, ENDOCRINOLOGY, V140, P5995, DOI 10.1210/en.140.12.5995; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Patel SB, 2008, CURR HYPERTENS REP, V10, P131, DOI 10.1007/s11906-008-0025-y; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Russo VC, 2004, ENDOCRINOLOGY, V145, P4103, DOI 10.1210/en.2003-1767; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Sarraf P, 1997, J EXP MED, V185, P171, DOI 10.1084/jem.185.1.171; Sierra-Johnson J, 2007, AM J CARDIOL, V100, P234, DOI 10.1016/j.amjcard.2007.02.088; Soderberg S, 1999, STROKE, V30, P328, DOI 10.1161/01.STR.30.2.328; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Wilkinson M, 2007, NEUROENDOCRINOLOGY, V86, P191, DOI 10.1159/000108635; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; Zhang XJ, 2006, NEUROL INDIA, V54, P402	42	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG-SEP	2010	74	2-3					286	293		10.1016/j.wneu.2010.02.019			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	792WM	WOS:000292781100031	21492562				2021-06-18	
J	Schutte, C; Hanks, R				Schutte, Christian; Hanks, Robin			Impact of the Presence of Alcohol at the Time of Injury on Acute and One-Year Cognitive and Functional Recovery After Traumatic Brain Injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						alcohol; cognitive recovery; functional recovery; traumatic brain injury	HEAD-INJURY; GALVESTON ORIENTATION; SUBSTANCE-ABUSE; PRACTICAL SCALE; AMNESIA TEST; OUTCOMES; LEVEL; PREVALENCE; COMA	The presence of alcohol is clearly a risk factor for sustaining a traumatic brain injury (TBI); however, the impact of alcohol on injury severity, and functional or cognitive outcome is unclear, as there is mixed evidence in the literature. This study examined 482 participants in a large urban medical center with documented mild-complicated to severe TBI and blood alcohol testing for functional and cognitive outcome. Functional outcomes were measured by the Functional Independence Measure (FIM) and cognitive outcomes were measured using neuropsychological tests known to be sensitive to the sequelae of TBI. Consistent with the hypotheses, there was a statistically significant negative impact of alcohol intoxication at the time of injury on Glasgow Coma Scale (GCS); however intoxication only lowered GCS by an average of 1.9 points. There was a statistically significant relationship between blood alcohol levels (BAL) and FIM at the time of admission to inpatient rehabilitation, but BAL accounted for only 3% of the variance in FIM total score. There was no relationship between BAL and FIM at discharge from rehabilitation or at 1-year follow-up. There was no statistically significant relationship between BAL at the time of injury and cognitive functioning at 1-year follow-up; however, contrary to the hypotheses GCS failed to show a strong relationship with cognitive outcome.	[Schutte, Christian] John D Dingell VAMC, Mental Hlth Serv, Detroit, MI 48201 USA; [Hanks, Robin] Rehabil Inst Michgian, Dept Neuropsychol, Detroit, MI USA	Schutte, C (corresponding author), John D Dingell VAMC, Mental Hlth Serv, 4646 John R,11MH, Detroit, MI 48201 USA.	christian.schutte@va.gov			National Institute on Disability and Rehabilitation Research [H133A020515]	This research was supported by the National Institute on Disability and Rehabilitation Research (Grant #H133A020515).	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Christensen M A, 2001, J Neurosci Nurs, V33, P184; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cunningham RM, 2002, ALCOHOL ALCOHOLISM, V37, P236, DOI 10.1093/alcalc/37.3.236; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kongs SK, 2000, WISCONSIN CARD SORTI; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Reitan R.M., 1993, HALSTEADREITAN NEURO; Russell E., 1993, H RUSSELL NEUROPSYCH; Schmidt M., 1996, REY AUDITORY VERBAL; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Tate PS, 1999, BRAIN INJURY, V13, P767; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; TEASDALE G, 1974, LANCET, V2, P81; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604	23	14	14	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	AUG	2010	120	8					551	556		10.3109/00207454.2010.494789			6	Neurosciences	Neurosciences & Neurology	639XT	WOS:000281011100005	20615059				2021-06-18	
J	Zlotnik, A; Klin, Y; Kotz, R; Dubilet, M; Boyko, M; Ohayon, S; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Klin, Yael; Kotz, Ruslan; Dubilet, Michael; Boyko, Mathew; Ohayon, Sharon; Shapira, Yoram; Teichberg, Vivian I.			Regulation of blood L-glutamate levels by stress as a possible brain defense mechanism	EXPERIMENTAL NEUROLOGY			English	Article						Adrenaline; Isoproterenol; beta-Adrenoreceptor; Blood; Brain; CRF; L-Glutamate; Stress	CLOSED-HEAD-INJURY; CORTICOTROPIN-RELEASING-FACTOR; EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; ISCHEMIC-STROKE; INFARCT SIZE; RAT; NEUROPROTECTION	Isoflurane-anesthetized rats submitted to a closed head injury (CHI) display a significant decrease of their blood glutamate levels. Having demonstrated that a decrease of blood L-glutamate (glutamate) causes an increase of the driving force for a spontaneous brain-to-blood glutamate efflux, and consequently affords brain neuroprotection, we investigated here the possible mechanisms which can affect blood glutamate levels. Reasoning that the spontaneous decrease of blood glutamate levels post CHI could be part of a stress response, we observed that the stress involved in tail artery catheterization under isoflurane anesthesia does not affect blood glutamate levels. Investigating in naive rats the stress effectors, we found that corticotropin-releasing factor (CRF) significantly decreased blood glutamate levels. Pretreatment with antalarmine (a selective type-1 CRF receptor antagonist) occludes the CRF-mediated decrease in blood glutamate levels. In contrast, the adrenocorticotrophic hormone (ACTH) did not affect blood glutamate levels. Investigating the effectors of the sympathetic/adrenomedullary system, we observed that in naive rats, adrenaline but not noradrenaline decreased blood glutamate levels. Confirming the role of adrenaline, propranolol pretreatment (a non-selective beta-antagonist) prevented the spontaneous decrease of blood glutamate observed post CHI. On the strength of these results, we further observed that isoproterenol (a beta(1/2)-selective adrenoreceptor agonist) produced a marked sustained decrease in blood glutamate levels. These results suggest that stress induces a decrease of blood glutamate levels partly via the activation of peripheral CRF receptors and the activation of the beta-adrenoreceptors. We propose that this newly identified component of the stress response could be a peripherally mediated defense mechanism of the injured brain against the deleterious effects of excess glutamate. (C) 2010 Elsevier Inc. All rights reserved.	[Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Zlotnik, Alexander; Kotz, Ruslan; Dubilet, Michael; Boyko, Mathew; Ohayon, Sharon; Shapira, Yoram] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Zlotnik, Alexander; Kotz, Ruslan; Dubilet, Michael; Boyko, Mathew; Ohayon, Sharon; Shapira, Yoram] Soraka Med Ctr, Div Anesthesiol, Beer Sheva, Israel	Teichberg, VI (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	Vivian.teichberg@weizmann.ac.il		Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases, Braintact Ltd.; Irwin Green Alzheimer's Research Fund; Carl and Micaela Einhorn-Dominic Institute for Brain Research	The authors thank Dorit Reymond for superb technical assistance. This work was supported in part by grants to V.I.T. from the Nella and Leon Benoziyo Center for Neurological Diseases, Braintact Ltd., the Irwin Green Alzheimer's Research Fund, and the Carl and Micaela Einhorn-Dominic Institute for Brain Research. The data obtained were part of A.Z.'s PhD thesis. V.I.T. is the incumbent of the Louis and Florence Katz-Cohen Chair of Neuropharmacology.	Adelson DW, 2007, J NEUROPHYSIOL, V97, P3004, DOI 10.1152/jn.01143.2006; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Berger C, 2008, EXP NEUROL, V210, P543, DOI 10.1016/j.expneurol.2007.12.002; BROWN MR, 1982, ENDOCRINOLOGY, V111, P928, DOI 10.1210/endo-111-3-928; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Han JL, 2008, NEUROSCI LETT, V432, P167, DOI 10.1016/j.neulet.2007.07.056; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Reyes BAS, 2005, EUR J NEUROSCI, V22, P93, DOI 10.1111/j.1460-9568.2005.04197.x; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Schneider AM, 2000, BEHAV NEUROSCI, V114, P1256; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shohami E, 1995, J NEUROTRAUM, V12, P1069, DOI 10.1089/neu.1995.12.1069; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; SUTTON RE, 1982, NATURE, V297, P331, DOI 10.1038/297331a0; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Tran TY, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E8; Valentino RJ, 2008, EUR J PHARMACOL, V583, P194, DOI 10.1016/j.ejphar.2007.11.062; WILSON KM, 1985, J APPL PHYSIOL, V58, P534; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; YASUDA N, 1977, EXPERIENTIA, V33, P683, DOI 10.1007/BF01946575; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang YH, 2008, EXP NEUROL, V210, P514, DOI 10.1016/j.expneurol.2007.11.027; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b; Zorrilla EP, 2002, BRAIN RES, V952, P188, DOI 10.1016/S0006-8993(02)03189-X	39	14	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	AUG	2010	224	2					465	471		10.1016/j.expneurol.2010.05.009			7	Neurosciences	Neurosciences & Neurology	631II	WOS:000280339600017	20493841				2021-06-18	
J	Cadosch, D; Thyer, M; Gautschi, OP; Lochnit, G; Frey, SP; Zellweger, R; Filgueira, L; Skirving, AP				Cadosch, Dieter; Thyer, Matthew; Gautschi, Oliver P.; Lochnit, Guenter; Frey, Soenke P.; Zellweger, Rene; Filgueira, Luis; Skirving, Allan P.			Functional and proteomic analysis of serum and cerebrospinal fluid derived from patients with traumatic brain injury: a pilot study	ANZ JOURNAL OF SURGERY			English	Article						cerebrospinal fluid; osteogenic effect; proteomic analysis; serum; traumatic brain injury	CALLUS FORMATION; HEAD; ELECTROPHORESIS; PROTEINS; S100B	Background: An enhanced fracture healing response has been reported in patients with traumatic brain injury (TBI). This has been attributed to circulating humoral factors that are thought to be proteins produced and released by the injured brain. However, these factors remain unknown. The aim of this study was to identify osteogenic factors in serum and cerebrospinal fluid (CSF) from TBI patients. This was carried out using in vitro proliferation assays with the human foetal osteoblastic 1.19 cell line (hFOB) combined with a novel proteomic approach. Methods: Serum was collected from brain-injured (n = 12) and non-brain-injured (n = 9) patients with a comorbid femur shaft fracture. Similarly, CSF was obtained from TBI (n = 7) and non-TBI (n = 9) patients. The osteoinductive potential of these samples was determined by measuring the in vitro proliferation rate of hFOB cells. Highly osteogenic serum and CSF samples of TBI patients were chosen for protein analysis and were compared to those of non-brain-injured patients. A new hFOB cell-based method was used to enrich the proteins in these samples, which had a functional affinity for these osteoprogenitor cells. These enriched protein fractions were mapped using two-dimensional gel electrophoresis and protein imaging methods displaying serum and CSF proteins of brain-injured and control subjects that had an affinity for human osteoprogenitor cells. Results: Serum and CSF derived from brain-injured patients demonstrated a greater osteoinductive potential (P < 0.05) than their non-brain-injured counterparts. Clear-cut differences in the pattern of proteins in two-dimensional gels were detected between TBI and control patients. Fourteen proteins were exclusively present in the serum of TBI patients, while other proteins were either up- or downregulated in samples collected from TBI patients (P < 0.05). Conclusion: Osteoinductive factors are present in the serum and CSF of brain-injured patients. These may include one or more of those proteins identified as having an affinity for osteoprogenitor cells that are either exclusively present or up- or downregulated in the serum and CSF of brain-injured patients.	[Cadosch, Dieter; Thyer, Matthew; Gautschi, Oliver P.; Frey, Soenke P.; Filgueira, Luis] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA 6009, Australia; [Cadosch, Dieter; Gautschi, Oliver P.; Frey, Soenke P.; Zellweger, Rene; Skirving, Allan P.] Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA, Australia; [Lochnit, Guenter] Inst Biochem, Giessen, Germany	Cadosch, D (corresponding author), Univ Western Australia, Sch Anat & Human Biol, 35 Stirling Highway, Crawley, WA 6009, Australia.	dcadosch@gmx.net	Filgueira, Luis/B-6492-2008	Filgueira, Luis/0000-0002-2266-6650			Banner LR, 1997, EXP NEUROL, V147, P1, DOI 10.1006/exnr.1997.6536; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brenner C., 2004, ONCOGENOMICS MOL APP; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CELIS JE, 1994, ELECTROPHORESIS, V15, P309, DOI 10.1002/elps.1150150153; Conti A, 2004, J NEUROTRAUM, V21, P854, DOI 10.1089/0897715041526212; Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.0.CO;2-C; Denslow N, 2003, J NEUROTRAUM, V20, P401, DOI 10.1089/089771503765355487; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; LEMKE R, 1999, GLIA, V75, P1; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; RABILLOUD T, 1994, ELECTROPHORESIS, V15, P278, DOI 10.1002/elps.1150150147; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shehab D, 2002, J NUCL MED, V43, P346; THYER M, 2007, ANN SCI M AUSTR ORTH; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Whiteaker JR, 2007, J PROTEOME RES, V6, P828, DOI 10.1021/pr0604920	30	14	17	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JUL-AUG	2010	80	7-8					542	547		10.1111/j.1445-2197.2010.05268.x			6	Surgery	Surgery	635PN	WOS:000280668500017	20795970				2021-06-18	
J	Vincent, AL; Kelly, P				Vincent, Andrea L.; Kelly, Patrick			Retinal haemorrhages in inflicted traumatic brain injury: the ophthalmologist in court	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						child abuse; medicolegal; retinal haemorrhage; shaken baby syndrome; traumatic brain injury	SHAKEN BABY SYNDROME; HEAD-INJURIES; COHERENCE TOMOGRAPHY; YOUNG-CHILDREN; INFANTS; FOLDS; RETINOPATHY; PREVALENCE; MECHANISMS; OUTCOMES	P>Child abuse is a significant social and public health problem in many societies. One particular form of physical abuse is inflicted traumatic brain injury (ITBI) - the so-called 'Shaken Baby Syndrome'. One of the key features associated with ITBI is characteristic ocular findings - only observed on fundal examination. It is crucial not to miss the diagnosis of ITBI as there may be implications for the safety of the child. The ophthalmologist is one key contributor to the process required to make the diagnosis of ITBI accurately and on the basis of all the relevant evidence. This article discusses some medicolegal implications of examining a child with retinal haemorrhages in the context of suspected ITBI, with practical advice for the ophthalmologist to be as objective and prepared as possible. The scientific validity of some alternative explanations advanced in court is discussed, with a strong emphasis on the literature.	[Vincent, Andrea L.] Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Natl Eye Ctr, Auckland 1142, New Zealand; [Vincent, Andrea L.] Univ Auckland, Eye Dept, Greenlane Clin Ctr, Auckland 1142, New Zealand; [Kelly, Patrick] Univ Auckland, Dept Paediat, Fac Med & Hlth Sci, Auckland 1142, New Zealand; [Kelly, Patrick] Auckland Dist Hlth Board, Starship Childrens Hosp, Te Puaruruhau Child Abuse Assessment Unit, Auckland, New Zealand	Vincent, AL (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Ophthalmol, Natl Eye Ctr, Private Bag 92019, Auckland 1142, New Zealand.	a.vincent@auckland.ac.nz	Vincent, Andrea L/A-5389-2013	Vincent, Andrea L/0000-0002-4185-3267; Kelly, Patrick/0000-0002-8813-8877			Arlotti SA, 2007, J AAPOS, V11, P175, DOI 10.1016/j.jaapos.2006.09.023; Aryan HE, 2005, J CLIN NEUROSCI, V12, P624, DOI 10.1016/j.jocn.2005.05.005; Baker ML, 2008, J CLIN NEUROSCI, V15, P313, DOI 10.1016/j.jocn.2006.09.011; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; BUYS YM, 1992, OPHTHALMOLOGY, V99, P1718; Carraro MC, 2001, EUR J HAEMATOL, V67, P238, DOI 10.1034/j.1600-0609.2001.00539.x; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; COATES J, 2004, N Z MED J, V117, P792; Curcoy AI, 2009, ARCH DIS CHILD, V94, P873, DOI 10.1136/adc.2007.132522; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Duhaime AC, 2008, J NEUROSURG-PEDIATR, V2, P320, DOI 10.3171/PED.2008.2.11.320; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Gago LC, 2003, RETINA-J RET VIT DIS, V23, P724, DOI 10.1097/00006982-200310000-00027; Gardner HB, 2007, PEDIATR NEUROSURG, V43, P433, DOI 10.1159/000106399; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; GILLILAND MGF, 1993, AM J FOREN MED PATH, V14, P187, DOI 10.1097/00000433-199309000-00003; Glick JC, 2007, PEDIATR NEUROSURG, V43, P436, DOI 10.1159/000106400; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; Hans SA, 2009, GRAEF ARCH CLIN EXP, V247, P561, DOI 10.1007/s00417-008-0994-1; Herr S, 2004, PEDIATRICS, V113, P1658, DOI 10.1542/peds.113.6.1658; Hughes LA, 2006, J AAPOS, V10, P102, DOI 10.1016/j.jaapos.2005.12.005; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KAUR B, 1992, SURV OPHTHALMOL, V37, P1, DOI 10.1016/0039-6257(92)90002-B; KELLY P, 2004, N Z MED J, V117, P1; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kivlin JD, 2001, CURR OPIN OPHTHALMOL, V12, P158, DOI 10.1097/00055735-200106000-00002; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Leestma J. E., 2006, J AM PHYS SURG, V11, P14; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Levin AV, 2000, RECENT ADV PAEDIAT, P151; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; MASSICOTTE SJ, 1991, OPHTHALMOLOGY, V98, P1124; Meier P, 2005, GRAEF ARCH CLIN EXP, V243, P824, DOI 10.1007/s00417-005-1213-y; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Parr J., 1989, INTRO OPHTHALMOLOGY; Pierce MC, 2008, ANNU REV BIOMED ENG, V10, P85, DOI 10.1146/annurev.bioeng.9.060906.151907; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Rangarajan N, 2009, J AAPOS, V13, P364, DOI 10.1016/j.jaapos.2008.11.006; *RANZCR, 2005, GUID EXP WITN; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reece RM, 2008, AM J PREV MED, V34, pS116, DOI 10.1016/j.amepre.2007.11.005; Sandramouli S, 1997, ARCH DIS CHILD, V76, P449, DOI 10.1136/adc.76.5.449; Schloff S, 2002, OPHTHALMOLOGY, V109, P1472, DOI 10.1016/S0161-6420(02)01086-2; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; Spivack B, 2001, AM J FOREN MED PATH, V22, P332, DOI 10.1097/00000433-200109000-00028; Spraul CW, 1997, SURV OPHTHALMOL, V42, P3, DOI 10.1016/S0039-6257(97)84041-6; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Sturm V, 2008, AM J OPHTHALMOL, V146, P363, DOI 10.1016/j.ajo.2008.04.023; Sturm V, 2009, AM J OPHTHALMOL, V147, P561, DOI 10.1016/j.ajo.2008.11.013; Superstein R, 2000, CAN J OPHTHALMOL, V35, P385, DOI 10.1016/S0008-4182(00)80126-X; Tyagi AK, 1998, BRIT J OPHTHALMOL, V82, P659, DOI 10.1136/bjo.82.6.659; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Vinchon M, 2009, CHILD NERV SYST, V25, P639, DOI 10.1007/s00381-008-0775-5; Watts P, 2008, EYE, V22, P1514, DOI 10.1038/eye.2008.224; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037	75	14	14	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1442-6404	1442-9071		CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	JUL	2010	38	5					521	532		10.1111/j.1442-9071.2010.02324.x			12	Ophthalmology	Ophthalmology	622HA	WOS:000279650800016	20491801	Bronze			2021-06-18	
J	Kim, YW; Shin, JC; An, YS				Kim, Yong Wook; Shin, Ji-Cheol; An, Young-sil			Changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy: a preliminary study	ANNALS OF NUCLEAR MEDICINE			English	Article						Cerebral metabolism; Posttraumatic cognitive impairment; Memantine	TRAUMATIC BRAIN-INJURY; NMDA RECEPTOR; GLUTAMATE; PHARMACOLOGY; ANTAGONIST; DEMENTIA; DISEASE; TRIAL; PET	Objective To investigate the changes in cerebral glucose metabolism in patients with posttraumatic cognitive impairment after memantine therapy. Methods We performed serial F-18 fluorodeoxyglucose positron emission tomography studies before and after memantine therapy (20 mg per day) on 17 patients with posttraumatic cognitive impairment using statistical parametric mapping analysis. In addition, covariance analysis was performed to identify regions, where changes in regional cerebral glucose metabolism correlated significantly with increased Mini-Mental Status Examination scores. Results Statistical parametric mapping analysis demonstrated that, compared with baseline, significantly increased cerebral glucose metabolism occurred in both inferior, middle and superior frontal gyri, both angular gyri, both precuneus, the right middle cingulum, the left inferior parietal lobule, the left fusiform gyrus, the left precentral gyrus, the left paracentral lobule, and the left lingual gyrus after memantine therapy (P-uncorrected < 0.005). In contrast, cerebral glucose metabolism was significantly decreased in both cerebellum, the left thalamus, the left olfactory, the right middle temporal gyrus, the right amygdala, and the right insula (P-uncorrected < 0.005). In the correlation analysis, improvements in Mini-Mental Status Examination scores after memantine therapy were significantly associated with increased cerebral glucose metabolism in the inferior and middle frontal gyri and the inferior parietal lobule of the left hemisphere (P-corrected < 0.0001). Conclusions Our findings indicate that the prefrontal and the parietal association cortices may be the relevant structures for the pharmacological response to memantine therapy in patients with posttraumatic cognitive impairment.	[Kim, Yong Wook; Shin, Ji-Cheol] Yonsei Univ, Coll Med, Dept Rehabil Med, Seoul 120752, South Korea; [Kim, Yong Wook; Shin, Ji-Cheol] Yonsei Univ, Coll Med, Res Inst Rehabil Med, Seoul 120752, South Korea; [An, Young-sil] Ajou Univ, Sch Med, Dept Nucl Med, Suwon 441749, South Korea	Kim, YW (corresponding author), Yonsei Univ, Coll Med, Dept Rehabil Med, 250 Seongsanno, Seoul 120752, South Korea.	ywkim1@yuhs.ac		An, Young-Sil/0000-0003-0777-6226; KIM, YONGWOOK/0000-0002-5234-2454; Shin, Ji Cheol/0000-0002-1133-1361			Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; AREOSA SA, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003154.pub4; Ben Smail D, 2006, BRAIN INJURY, V20, P111, DOI 10.1080/02699050500309700; Berthier ML, 2009, ANN NEUROL, V65, P577, DOI 10.1002/ana.21597; Cerullo MA, 2007, SCHIZOPHR RES, V97, P294, DOI 10.1016/j.schres.2007.07.034; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Liu CH, 2009, BRAIN RES, V1282, P173, DOI 10.1016/j.brainres.2009.05.071; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Mukhin A, 1996, J NEUROSCI, V16, P6012; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Phillips JP, 2003, J HEAD TRAUMA REHAB, V18, P342, DOI 10.1097/00001199-200307000-00005; Pomara N, 2007, ALZ DIS ASSOC DIS, V21, P60, DOI 10.1097/WAD.0b013e318032cf29; Preuss UW, 2001, EUR NEUROL, V45, P57, DOI 10.1159/000052094; Rao VLR, 2001, BRAIN RES, V911, P96; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Riepe MW, 2007, DEMENT GERIATR COGN, V23, P301, DOI 10.1159/000100875; Rogers M, 2009, AM J HOSP PALLIAT ME, V26, P57, DOI 10.1177/1049909108330025; Sencer A, 2008, NEUROL RES, V30, P497, DOI 10.1179/016164107X251664; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	29	14	14	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187	1864-6433		ANN NUCL MED	Ann. Nucl. Med.	JUN	2010	24	5					363	369		10.1007/s12149-010-0360-3			7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	621HE	WOS:000279565800004	20237871				2021-06-18	
J	Weddell, RA				Weddell, Rodger A.			Relatives' Criticism Influences Adjustment and Outcome After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anger; Brain injuries; Depression; Expressed emotion; Family; Rehabilitation	EMOTIONAL OVER-INVOLVEMENT; EXPRESSED EMOTION; HEAD-INJURY; SCHIZOPHRENIC-PATIENTS; 1ST-EPISODE PSYCHOSIS; FAMILY INTERVENTION; SELF-AWARENESS; DEPRESSION; PREDICTORS; DISTRESS	Objectives: To apply some of the methods developed to study the effects of relatives' expressed emotion (EE) on psychiatric relapse rates and to test the prediction that relatives' criticism and psychiatric distress would be associated with outcome and emotional distress after traumatic brain injury (TBI). Design: Retrospective cohort design with correlational analyses of quantitative and qualitative measures of TBI outcomes. Setting: The author interviewed participants in the hospital. The research assistant interviewed close relatives at home. Participants: Participants and relatives (N=78) were interviewed 34.3 +/- 15.2 months (mean +/- SD) after a severe TBI. Interventions: None. Main Outcome Measures: Dependent variables in a series of hierarchical linear regression models were participants' scores on the Zung Depression Scale, Spielberger Trait Anxiety Inventory, State-Trait Anger Expression Inventory, an Anger Towards Relative questionnaire constructed for this study, and Extended Glasgow Outcome Scores. Participant-independent variables were social class, posttraumatic amnesia, Wechsler Memory Scale Delayed Recall score, WAIS-R intelligence quotient, and a short version of the Smell Identification Test. Relative independent variables were the number of critical comments directed toward participants in the interview and psychiatric distress as measured by the General Health Questionnaire. Results: The contributions of variance associated with relative independent variables (predominantly criticism) were significant in stage 2 of most hierarchical regression analyses after the adjustments for variance associated with participant independent variables made in stage I. Conclusions: Future application of EE research methods is warranted. If the present results are replicated, then evidence-based family interventions developed by EE researchers to reduce criticism might also improve TBI outcomes.	[Weddell, Rodger A.] ABM Univ Hlth Board, Neuropsychol Dept, Morriston Hosp, Swansea, W Glam, Wales; [Weddell, Rodger A.] Univ Coll Swansea, Dept Psychol, Swansea, W Glam, Wales	Weddell, RA (corresponding author), ABM Univ Hlth Board, Neuropsychol Dept, Morriston Hosp, Swansea, W Glam, Wales.	r.wedd@yahoo.co.uk			Headway (Swansea)	Supported in part by Headway (Swansea).	Alvarez-Jimenez M, 2010, PSYCHOL MED, V40, P63, DOI 10.1017/S0033291708004765; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Bentsen H, 1996, BRIT J PSYCHIAT, V169, P622, DOI 10.1192/bjp.169.5.622; Boye B, 2001, ACTA PSYCHIAT SCAND, V104, P42, DOI 10.1034/j.1600-0447.2001.00190.x; Breitborde NJK, 2009, SOC PSYCH PSYCH EPID, V44, P716, DOI 10.1007/s00127-008-0492-0; BRESSI C, 1996, NEW TREND EXPER CLIN, V12, P135; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; EVANS RL, 1987, ARCH PHYS MED REHAB, V68, P508; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grice SJ, 2009, BEHAV RES THER, V47, P783, DOI 10.1016/j.brat.2009.06.004; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; IVISON DJ, 1977, AUST PSYCHOL, V12, P303, DOI 10.1080/00050067708254291; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; LEFF J, 1994, BRIT J PSYCHIAT, V164, P71, DOI 10.1192/S0007125000292775; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Martin JH., 2003, NEUROANATOMY TEXT AT; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MELAMED S, 1985, SCAND J REHABIL MED, P21; Mittelman MS, 2004, J GERONTOL B-PSYCHOL, V59, pP27, DOI 10.1093/geronb/59.1.P27; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Muntaner C, 2004, EPIDEMIOL REV, V26, P53, DOI 10.1093/epirev/mxh001; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; *OPCS, 1980, OPCS CLASS OCC 1980; Peterson EC, 2004, PSYCHIATRY, V67, P197, DOI 10.1521/psyc.67.2.197.35959; Pilling S, 2002, PSYCHOL MED, V32, P763, DOI 10.1017/S0033291702005895; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Raune D, 2004, BRIT J PSYCHIAT, V184, P321, DOI 10.1192/bjp.184.4.321; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Scazufca M, 1998, PSYCHOL MED, V28, P453, DOI 10.1017/S0033291797005977; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shimodera S, 2000, COMPR PSYCHIAT, V41, P392, DOI 10.1053/comp.2000.9019; Smejkal V, 2003, Bratisl Lek Listy, V104, P184; Spielberger CD., 1988, STATE TRAIT ANGER EX; Spielberger CD, 1983, STATE TRAIT ANXIETY; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; VAUGHN C, 1976, BRIT J SOC CLIN PSYC, V15, P157, DOI 10.1111/j.2044-8260.1976.tb00021.x; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; WEDDELL RA, 1987, SCAND J REHABIL MED, V19, P93; Weddell RA, 2006, BRAIN INJURY, V20, P1221, DOI 10.1080/02699050601049783; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZATORRE RJ, 1991, BRAIN, V114, P71; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	69	14	14	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2010	91	6					897	904		10.1016/j.apmr.2010.01.020			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	610SM	WOS:000278755800011	20510981				2021-06-18	
J	Davis, AR; Shear, DA; Chen, ZY; Lu, XCM; Tortella, FC				Davis, Angela R.; Shear, Deborah A.; Chen, Zhiyong; Lu, Xi-Chun M.; Tortella, Frank C.			A comparison of two cognitive test paradigms in a penetrating brain injury model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Penetrating brain injury; Morris water maze; Novel object recognition	ONE-TRIAL TEST; MEMORY; RATS; RECOGNITION; MOTOR	A rat model of penetrating ballistic-like brain injury (PBBI) was recently established to study military-relevant severe traumatic brain injury (TBI). The purpose of this study was to conduct a side-by-side evaluation of two well-established cognitive testing paradigms: the novel object recognition (NOR) task and the Morris water maze (MWM) task. Accordingly, male Sprague-Dawley rats were subjected to PBBI and their cognitive abilities were assessed at 7 and 21 days post-PBBI. Although PBBI animals had more difficulty completing both tasks compared to sham animals, their performance on the NOR task was confounded by a high degree of within-group variability that was likely due to attention deficits produced by the injury. In contrast, PBBI produced consistent, significant spatial learning deficits in the MWM task. Overall, these results suggest that the MWM task provides a more appropriate cognitive test for the PBBI model that would be useful for testing promising neuroprotective therapeutics. Published by Elsevier B.V.	[Davis, Angela R.; Shear, Deborah A.; Chen, Zhiyong; Lu, Xi-Chun M.; Tortella, Frank C.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Davis, Angela R.] Geneva Fdn, Lakewood, WA 98499 USA	Shear, DA (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Angela.R.Davis@amedd.army.mil; Deborah.Shear@amedd.army.mil; Zhiyong.Chen@us.army.mil; May.Lu@us.army.mil; Frank.C.Tortella@us.army.mil	Shear, Deborah/B-3607-2011		Department of the Army [W81XWH-08-2-0127]	This work was supported by the Department of the Army, award W81XWH-08-2-0127, with The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, as the awarding and administering acquisition office. The information has been reviewed by the Walter Reed Army Institute of Research with no objection to its presentation and/or publication. The content of the information are the private views of the authors and does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred.	Abe H, 2004, NEUROSCI LETT, V356, P191, DOI 10.1016/j.neulet.2003.11.049; BELLAMY R, 1998, TXB MILITARY MED 1; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; ENNACEUR A, 1989, BEHAV BRAIN RES, V33, P197, DOI 10.1016/S0166-4328(89)80051-8; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Shear DA, 2009, PHARMACOL BIOCHEM BE, V94, P56, DOI 10.1016/j.pbb.2009.07.006; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313	15	14	15	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAY 30	2010	189	1					84	87		10.1016/j.jneumeth.2010.03.012			4	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	604PL	WOS:000278290900013	20346980				2021-06-18	
J	McNett, M; Doheny, M; Sedlak, CA; Ludwick, R				McNett, Molly; Doheny, Margaret; Sedlak, Carol A.; Ludwick, Ruth			JUDGMENTS OF CRITICAL CARE NURSES ABOUT RISK FOR SECONDARY BRAIN INJURY	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; INTRA-CRANICAL PRESSURE; INTRACRANIAL-PRESSURE; INTENSIVE-CARE; DECISION-MAKING; OUTCOME PREDICTION; ADULTS; HYPERTENSION; AGE	Background Interdisciplinary care for patients with traumatic brain injury focuses on treating the primary brain injury and limiting further brain damage from secondary injury. Intensive care unit nurses have an integral role in preventing secondary brain injury; however, little is known about factors that influence nurses' judgments about risk for secondary brain injury. Objective To investigate which physiological and situational variables influence judgments of intensive care unit nurses about patients' risk for secondary brain injury, management solely with nursing interventions, and management by consulting another member of the health care team. Methods A multiple segment factorial survey design was used. Vignettes reflecting the complexity of real-life scenarios were randomly generated by using different values of each independent variable. Surveys containing the vignettes were sent to nurses at 2 level I trauma centers. Multiple regression was used to determine which variables influenced judgments about secondary brain injury. Results Judgments about risk for secondary brain injury were influenced by a patient's oxygen saturation, intracranial pressure, cerebral perfusion pressure, mechanism of injury, and primary diagnosis, as well as by nursing shift. Judgments about interventions were influenced by a patient's oxygen saturation, intracranial pressure, and cerebral perfusion pressure and by nursing shift. The initial judgments made by nurses were the most significant variable predictive of follow-up judgments. Conclusions Nurses need standardized, evidence-based content for management of secondary brain injury in critically ill patients with traumatic brain injury. (American Journal of Critical Care. 2010;19:250-260)	[McNett, Molly] Metrohlth Med Ctr, Nursing Business Off, Dept Nursing Res, Cleveland, OH 44109 USA; [Doheny, Margaret] Kent State Univ, Coll Nursing, Grad Nursing Adult Program, Kent, OH 44242 USA; [Sedlak, Carol A.; Ludwick, Ruth] Kent State Univ, Coll Nursing, Off Int Initiat, Kent, OH 44242 USA	McNett, M (corresponding author), Metrohlth Med Ctr, Nursing Business Off, Dept Nursing Res, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	mmcnett@metrohealth.org	Ludwick, Ruth/K-8066-2019	Ludwick, Ruth/0000-0002-2384-2599			*AM ASS NEUR SURG, JOINT SECT NEUR CRIT; *AM HEART ASS, HDB EM CARD CAR 2005; American Association of Critical-Care Nurses, STAND CAR AC CRIT CA; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bakalis N, 2003, INT J NURS STUD, V40, P749, DOI 10.1016/S0020-7489(03)00014-2; Bardt TF, 1998, ACT NEUR S, V71, P153; Bekar A, 1998, NEUROSURG REV, V21, P98, DOI 10.1007/BF02389312; Benner P., 1999, CLIN WISDOM INTERVEN; BROWN RL, 1992, MED CARE, V30, P1083, DOI 10.1097/00005650-199212000-00002; Brown RL, 1997, J GEN INTERN MED, V12, P44; Brucia J, 1996, HEART LUNG, V25, P295, DOI 10.1016/S0147-9563(96)80065-3; Bucknall TK, 2000, J CLIN NURS, V9, P25, DOI 10.1046/j.1365-2702.2000.00333.x; *CDCP DIV INJ DIS, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention Division of Injury and Disability Outcomes and Progress, 2004, TRAUM BRAIN INJ US E; Chamberlain D J, 1998, Aust Crit Care, V11, P123, DOI 10.1016/S1036-7314(98)70499-0; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cooksey R.W., 1996, THINK REASONING, V2, P141, DOI [10.1080/135467896394483, DOI 10.1080/135467896394483]; Corcoran-Perry S A, 1999, Nurs Health Sci, V1, P49, DOI 10.1046/j.1442-2018.1999.00008.x; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Crosby L J, 1992, J Neurosci Nurs, V24, P40; Currey J, 2006, J CLIN NURS, V15, P1081, DOI 10.1111/j.1365-2702.2006.01392.x; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; FONTEYN ME, 1994, NURSING INFORMATICS: AN INTERNATIONAL OVERVIEW FOR NURSING IN A TECHNOLOGICAL ERA, P481; Ganong LH, 2006, J MARRIAGE FAM, V68, P455, DOI 10.1111/j.1741-3737.2006.00264.x; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GRAHAM DI, 1987, NEUROPATH APPL NEURO, V13, P209, DOI 10.1111/j.1365-2990.1987.tb00184.x; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hickey J, 2003, CLIN PRACTICE NEUROL; HOLMES MM, 1989, MED CARE, V27, P59, DOI 10.1097/00005650-198901000-00006; Hugo M, 1987, Intensive Care Nurs, V3, P78, DOI 10.1016/0266-612X(87)90029-0; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KENNER G, 2000, THESIS U WASHINGTON; Kerr ME, 1997, NURS RES, V46, P195, DOI 10.1097/00006199-199707000-00003; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; LAI FC, 2007, THESIS KENT STATE U; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lauri S, 1998, HEART LUNG, V27, P133, DOI 10.1016/S0147-9563(98)90021-8; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; Ludwick R, 2004, ADV NURS SCI, V27, P224, DOI 10.1097/00012272-200407000-00007; Ludwick R, 2001, NURS RES, V50, P129, DOI 10.1097/00006199-200103000-00009; Ludwick R., 1999, J CLIN GEROPSYCHOLOG, V5, P177, DOI [10.1023/A:1022947615257, DOI 10.1023/A:1022947615257]; March K, 1990, J Neurosci Nurs, V22, P375; March K, 2004, AANN CORE CURRICULUM, P277; McNair ND, 1999, NURS CLIN N AM, V34, P637; McNett Molly, 2007, J Neurosci Nurs, V39, P68; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Minick P, 1995, Sch Inq Nurs Pract, V9, P303; MITCHELL PH, 1981, NURS RES, V30, P212; MITCHELL PH, 1978, NURS RES, V27, P4; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; PARSONS LC, 1984, HEART LUNG, V13, P372; Pasquale MD, 2005, CRIT CARE MED, V33, pA40, DOI 10.1097/00003246-200512002-00148; Peden-McAlpine Cynthia, 2002, Dimens Crit Care Nurs, V21, P144, DOI 10.1097/00003465-200207000-00006; Rising C J, 1993, J Neurosci Nurs, V25, P302; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; RUDY EB, 1991, HEART LUNG, V20, P667; Scheetz LJ, 2005, RES NURS HEALTH, V28, P198, DOI 10.1002/nur.20075; SNYDER M, 1983, J ADV NURS, V8, P273; Tanner CA, 2006, J NURS EDUC, V45, P204, DOI 10.3928/01484834-20060601-04; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P151; Thompson Hilaire J, 2007, Intensive Crit Care Nurs, V23, P91, DOI 10.1016/j.iccn.2006.11.005; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Villanueva N E, 1999, J Neurosci Nurs, V31, P216	75	14	15	1	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264	1937-710X		AM J CRIT CARE	Am. J. Crit. Care	MAY 1	2010	19	3					250	260		10.4037/ajcc2009293			11	Critical Care Medicine; Nursing	General & Internal Medicine; Nursing	590DX	WOS:000277205300005	19542058				2021-06-18	
J	Portugal-Cohen, M; Numa, R; Yaka, R; Kohen, R				Portugal-Cohen, Meital; Numa, Ran; Yaka, Rami; Kohen, Ron			Cocaine induces oxidative damage to skin via xanthine oxidase and nitric oxide synthase	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Cocaine; Skin; Oxidative stress; Xanthine oxidase; Inducible nitric oxide synthase	TOTAL ANTIOXIDANT CAPACITY; MOLECULAR-WEIGHT ANTIOXIDANTS; RADICAL ABSORBENCY CAPACITY; CLOSED-HEAD INJURY; IN-VIVO; POSSIBLE MECHANISM; N-DEMETHYLATION; ASCORBIC-ACID; EXPRESSION; STRESS	Background: Heavy cocaine abusers are known to develop adverse skin manifestations, however, a possible mechanism for such damages has not yet been proposed. Objective: The present study was designed to investigate whether a systemic cocaine administration affects skin characteristics by elucidating modifications of reactive oxygen species (ROS) production, antioxidant defense and iNOS and XO activity. Methods: Two models were used: an in vivo rat model (male Sabra), in which skin specimens were taken 20 days after i.p. cocaine injection (15 mg/kg) and an in vitro model based on HaCaT cells representing human keratinocytes. Results: Our findings clearly showed that cocaine promoted skin oxidation via the involvement of the enzymes inducible nitric oxide synthase (iNOS) and xanthine oxidase (XO). Cocaine administration significantly increased iNOS expression in rats' skin. It also decreased total scavenging capacity (TSC), as well as reduced glutathione (GSH) and ascorbic acid (AA). HaCaT cells treatment with a cocaine concentration of 2 mM for 2411 (as was chosen by dose-response experiments) markedly enhanced superoxide radicals and peroxides formation. It also decreased TSC and GSH levels. Addition of iNOS and XO inhibitors completely abolished these findings. This study indicates for the first time that systemic cocaine administration affects skin condition, even after a long period of withdrawal. Conclusion: Our study therefore, suggests additional metabolic outcomes of cocaine due to its ability to enhance oxidative stress in skin. (c) 2010 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Portugal-Cohen, Meital; Numa, Ran; Yaka, Rami; Kohen, Ron] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel	Kohen, R (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, POB 12065, IL-91120 Jerusalem, Israel.	meitalp@ekmd.huji.ac.il; ronk@ekmd.huji.ac.il			Ydidut Foundation (Mexico); Israel Science FoundationIsrael Science Foundation [292/05]	This study is supported by the Ydidut Foundation (Mexico) and by the Israel Science Foundation (Grant No.: 292/05 R.Y.). R.K. and R.Y. are affiliated with the David R. Bloom Center of Pharmacy. R.K. is the incumbent of the Richard and Jean Zarbin Chair in Medical Studies at the Hebrew University of Jerusalem.; We would like to thank Prof. Yoram Milner and Dr. Yoram Soroka (Department of Biological Chemistry, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem) for their valuable assistance.	Abd-El-Aleem SA, 2000, J PATHOL, V191, P434, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH654>3.0.CO;2-S; ABIDIN MR, 1990, ANN PLAS SURG, V24, P268, DOI 10.1097/00000637-199003000-00012; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Aoki K, 1997, EUR J PHARMACOL, V336, P43, DOI 10.1016/S0014-2999(97)01230-2; Ashton T, 1999, J APPL PHYSIOL, V87, P2032; Bagetta G, 2004, NEUROSCI LETT, V356, P183, DOI 10.1016/j.neulet.2003.11.065; Bashkatova V, 2005, NEUROREPORT, V16, P1217, DOI 10.1097/00001756-200508010-00017; Bashkatova V, 2006, ANN NY ACAD SCI, V1074, P632, DOI 10.1196/annals.1369.061; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bhargava HN, 1997, PHARMACOLOGY, V55, P292, DOI 10.1159/000139541; BOELSTERLI UA, 1991, ARCH TOXICOL, V65, P351, DOI 10.1007/BF02284256; Brewer JD, 2008, J AM ACAD DERMATOL, V59, P483, DOI 10.1016/j.jaad.2008.03.040; CAO G, 1995, CLIN CHEM, V41, P1738; CHEVALIER X, 1995, CLIN NEPHROL, V43, P348; CONLEE RK, 1991, J APPL PHYSIOL, V70, P1323; Devi BG, 1996, J PHARMACOL EXP THER, V279, P359; Diez-Fernandez C, 1999, BIOCHEM PHARMACOL, V58, P797, DOI 10.1016/S0006-2952(99)00168-9; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Elliott JC, 2003, INT IMMUNOPHARMACOL, V3, P1011, DOI 10.1016/S1567-5769(03)00099-7; ENGERSON TD, 1987, J CLIN INVEST, V79, P1564, DOI 10.1172/JCI112990; Fan L, 2009, J PHARMACOL EXP THER, V328, P99, DOI 10.1124/jpet.108.145201; Ferdinandy P, 2006, BRIT J PHARMACOL, V148, P1, DOI 10.1038/sj.bjp.0706693; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P505, DOI 10.1016/0891-5849(95)00034-U; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hofbauer GFL, 1999, BRIT J DERMATOL, V141, P600; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Imam SZ, 2005, ANN NY ACAD SCI, V1053, P482, DOI 10.1196/annals.1344.042; Isabelle M, 2007, J MOL CELL CARDIOL, V42, P326, DOI 10.1016/j.yjmcc.2006.11.011; Itzhak Y, 1997, J PHARMACOL EXP THER, V282, P521; Janmohamed A, 2001, BIOCHEM PHARMACOL, V62, P777, DOI 10.1016/S0006-2952(01)00718-3; KLOSS MW, 1984, BIOCHEM PHARMACOL, V33, P169, DOI 10.1016/0006-2952(84)90471-4; KLOSS MW, 1983, MOL PHARMACOL, V23, P482; Kohen R, 2000, TOXICOLOGY, V148, P149, DOI 10.1016/S0300-483X(00)00206-7; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; Koren E, 2008, BIOMED PHARMACOTHER, V62, P179, DOI 10.1016/j.biopha.2007.12.012; LEDUC BW, 1993, PHARMACOLOGY, V46, P294, DOI 10.1159/000139058; MACGOWAN SW, 1995, ANN THORAC SURG, V60, P1289, DOI 10.1016/0003-4975(95)00616-S; MARLETTA MA, 1993, ADV EXP MED BIOL, V338, P281; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MEISTER A, 1994, CANCER RES, V54, pS1969; MENDELSON JH, 1992, J PHARMACOL EXP THER, V263, P505; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Moritz F, 2003, J CARDIOVASC PHARM, V42, P642, DOI 10.1097/00005344-200311000-00010; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; NATHAN C, 1994, J BIOL CHEM, V269, P13725; Numa R, 2008, NEUROSCIENCE, V155, P649, DOI 10.1016/j.neuroscience.2008.05.058; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Oliveira MT, 2002, ANN NY ACAD SCI, V965, P487; Ornoy A, 1999, TERATOLOGY, V60, P376, DOI 10.1002/(SICI)1096-9926(199912)60:6<376::AID-TERA10>3.0.CO;2-Q; Pacifici R, 2003, INT IMMUNOPHARMACOL, V3, P581, DOI 10.1016/S1567-5769(03)00050-X; Park KK, 2001, PHYSIOL BEHAV, V74, P441, DOI 10.1016/S0031-9384(01)00588-1; PELLINEN P, 1994, EUR J PHARM-ENVIRON, V270, P35, DOI 10.1016/0926-6917(94)90078-7; Portugal Meital, 2008, P19, DOI 10.1007/978-1-4020-8399-0_2; PORTUGALCOHEN M, 2009, J DERMATOL SCI; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Richeson CE, 1998, J AM CHEM SOC, V120, P7211, DOI 10.1021/ja980871x; ROBERTS SM, 1991, DRUG METAB DISPOS, V19, P1046; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shilo S, 2003, BIOCHEM J, V370, P283, DOI 10.1042/BJ20021022; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SHUSTER L, 1983, BIOCHEM PHARMACOL, V32, P3045, DOI 10.1016/0006-2952(83)90247-2; Sies H, 2007, J NUTR, V137, P1493; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Szabo C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6; Toda N, 2008, J ANESTH, V22, P155, DOI 10.1007/s00540-007-0590-2; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; ZAMORAQUEZADA JC, 1988, ANN INTERN MED, V108, P564, DOI 10.7326/0003-4819-108-4-564; Zaragoza A, 2000, BBA-MOL CELL RES, V1496, P183, DOI 10.1016/S0167-4889(00)00036-7	76	14	17	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	MAY	2010	58	2					105	112		10.1016/j.jdermsci.2010.03.010			8	Dermatology	Dermatology	594MZ	WOS:000277543100004	20399619				2021-06-18	
J	Zweifel, C; Czosnyka, M; Lavinio, A; Castellani, G; Kim, DJ; Carrera, E; Pickard, JD; Kirkpatrick, PJ; Smielewski, P				Zweifel, Christian; Czosnyka, Marek; Lavinio, Andrea; Castellani, Gianluca; Kim, Dong-Joo; Carrera, Emmanuel; Pickard, John D.; Kirkpatrick, Peter J.; Smielewski, Peter			A comparison study of cerebral autoregulation assessed with transcranial Doppler and cortical laser Doppler flowmetry	NEUROLOGICAL RESEARCH			English	Article						Autoregulation; laser Doppler flowmetry; transcranial Doppler	HEAD-INJURED PATIENTS; BLOOD-FLOW; INTRACRANIAL-PRESSURE; CEREBROVASCULAR AUTOREGULATION; SPONTANEOUS FLUCTUATIONS; DYNAMIC AUTOREGULATION; MICROCIRCULATION; VALIDATION; RESPONSES; PERFUSION	Objectives: We compared autoregulation monitored with cortical laser Doppler flowmetry (LDF) and autoregulation monitored with transcranial Doppler (TCD) in the middle cerebral artery (MCA) to verify the hypothesis that, following brain trauma, cortical vessel autoregulation to intracranial hypertension is different than assessed in the MCA. Methods: Data collected from 29 head injured patients were analysed retrospectively. Arterial blood pressure (ABP), intracranial pressure (ICP), flow velocity (FV) of the MCA and cortical flux (LDF) were monitored. Indices of cortical autoregulation (Lx) and autoregulation of cerebral blood flow in the MCA (Mx) were calculated as a moving correlation coefficient between slow waves of LDF and cerebral perfusion pressure (CPP) (Lx) or FV and CPP (Mx), respectively. Intact autoregulation was indicated by negative values for Lx and Mx; disturbed autoregulation was reflected by positive values. Results: FV and LDF showed a high coherence in the slow wave spectrum of 1-4 cycles/min (mean: 0.79 +/- 0.12), indicating that similar information regarding autoregulation is carried by both signals. Mx and Lx correlated in all patients (R=0.43, p=0.02). On average, Lx was significantly higher than Mx; the mean difference was 0.13 +/- 0.38 (p=0.032), potentially due to severe intracranial hypertension above 40 mmHg, driving CPP values below 60 mmHg. Conclusion: After traumatic brain injury, cortical autoregulation appears to be worse than autoregulation assessed in the MCA during rising ICP and falling CPP. When CPP is above 60 mmHg, cortical assessed autoregulation is similar to autoregulation assessed in the MCA.	[Zweifel, Christian; Czosnyka, Marek; Lavinio, Andrea; Castellani, Gianluca; Kim, Dong-Joo; Carrera, Emmanuel; Pickard, John D.; Kirkpatrick, Peter J.; Smielewski, Peter] Univ Cambridge, Sch Clin, Acad Neurosurg Unit, Cambridge, England	Zweifel, C (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Acad Neurosurg Unit, Level 4,A Block, Cambridge CB2 2QQ, England.	zweifelch@gmx.ch	Lavinio, Andrea/M-1778-2016	Carrera, Emmanuel/0000-0003-0045-5382; Smielewski, Peter/0000-0001-5096-3938	Swiss National Science Foundation, Bern, SwitzerlandSwiss National Science Foundation (SNSF) [PBBSP3-125550, PBLAB-119620, PASSMP3-124262]; SICPA Foundation, Lausanne, Switzerland; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This work was supported by the Swiss National Science Foundation (PBBSP3-125550 to C. Zweifel; PBLAB-119620 and PASSMP3-124262 to E. Carrera), Bern, Switzerland and the SICPA Foundation, Lausanne, Switzerland, to E. Carrera. M. Czosnyka is on leave from Warsaw University of Technology, Poland. The software for brain monitoring ICM+ (http://www.neurosurg.cam.ac.uk/icmplus) is licensed by the University of Cambridge (Cambridge Enterprise). P. Smielewski and M. Czosnyka have a financial interest in a part of the licensing fee.	AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Huber P, 1967, Invest Radiol, V2, P17, DOI 10.1097/00004424-196701000-00016; KIRKPATRICK PJ, 1994, J NEUROL NEUROSUR PS, V57, P1382, DOI 10.1136/jnnp.57.11.1382; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lewis PM, 2007, ACTA NEUROCHIR, V149, P549, DOI 10.1007/s00701-007-1160-y; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Smielewski P, 2005, ACT NEUR S, V95, P43; Soehle M, 2004, ANESTH ANALG, V98, P1133, DOI 10.1213/01.ANE.0000111101.41190.99; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; STERN MD, 1975, NATURE, V254, P56, DOI 10.1038/254056a0; ZABOLOTNY W, 1994, INTRACRANIAL PRESSUR, V9, P439	25	14	16	0	4	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAY	2010	32	4					425	428		10.1179/174313209X459165			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	593IJ	WOS:000277446600016	19703359				2021-06-18	
J	Waybright, T; Avellino, AM; Ellenbogen, RG; Hollinger, BJ; Veenstra, TD; Morrison, RS				Waybright, Timothy; Avellino, Anthony M.; Ellenbogen, Richard G.; Hollinger, Bradley J.; Veenstra, Timothy D.; Morrison, Richard S.			Characterization of the human ventricular cerebrospinal fluid proteome obtained from hydrocephalic patients	JOURNAL OF PROTEOMICS			English	Article; Proceedings Paper	3rd EuPA Congress	JUN 14-17, 2009	Stockholm, SWEDEN			Cerebrospinal fluid; Mass spectrometry; Proteomics; Fractionation; Ventricular CSF; Lumbar CSF	TANDEM MASS-SPECTROMETRY; MULTIDIMENSIONAL CHROMATOGRAPHY; BIOMARKERS; PROTEINS; CHILDREN; DISEASE; BRAIN	The continuing expansion of proteomic technology has been fueled by the potential for discovering novel biomarkers that may be used for the early detection of disease. It has been proposed that human cerebrospinal fluid (CSF), which surrounds and protects the brain and spinal cord from traumatic injury, may be a valuable target for the diagnosis of a variety of conditions such as Alzheimer's disease, traumatic brain injury, amyotrophic lateral sclerosis and Parkinson's disease. The immense complexity of biofluids, however, still requires that considerable development be made in the analytical techniques used so that comprehensive coverage of the proteins present in such samples is achieved. Using a simple separation strategy the protein complement of human ventricular cerebrospinal fluid obtained from patients with hydrocephalus was evaluated. The study resulted in the identification of over 1500 unique proteins that were found within all nine CSF samples that were analyzed. Comparison with the HUPO serum proteome database demonstrated that human ventricular CSF contains a large array of proteins that may be unique to CSF. This analysis greatly increases our knowledge of the protein content of this clinically important biofluid. (C) 2010 Elsevier B.V. All rights reserved.	[Waybright, Timothy; Hollinger, Bradley J.; Veenstra, Timothy D.] NCI, SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, Frederick, MD 21702 USA; [Avellino, Anthony M.; Ellenbogen, Richard G.] Seattle Childrens Hosp, Dept Neurol Surg, Seattle, WA 98105 USA; [Avellino, Anthony M.; Ellenbogen, Richard G.; Morrison, Richard S.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA	Veenstra, TD (corresponding author), NCI, SAIC Frederick Inc, Lab Prote & Analyt Technol, Adv Technol Program, POB B,Bldg 469,Rm 160, Frederick, MD 21702 USA.	veenstra@ncifcrf.gov; yael@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035533] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [N01-CO-12400] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35533] Funding Source: Medline		Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Chi JH, 2005, J NEUROSURG, V103, P113, DOI 10.3171/ped.2005.103.2.0113; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fishman R., 1992, CEREBROSPINAL FLUID, P183; Hintsch G, 2002, MOL CELL NEUROSCI, V21, P393, DOI 10.1006/mcne.2002.1181; Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r; Johnson MD, 2005, AM J PHARMACOGENOMIC, V5, P259, DOI 10.2165/00129785-200505040-00006; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Lacy M, 2008, PEDIATR NEUROSURG, V44, P376, DOI 10.1159/000149904; Lee BPL, 2008, NAT IMMUNOL, V9, P117, DOI 10.1038/ni0208-117; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petrik V, 2006, BRIT J NEUROSURG, V20, P275, DOI 10.1080/02688690600999620; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Provencio JJ, 2005, J NEUROIMMUNOL, V163, P179, DOI 10.1016/j.jneuroim.2005.03.003; Rekate HL, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-2; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k	21	14	14	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-3919	1876-7737		J PROTEOMICS	J. Proteomics	APR 18	2010	73	6			SI		1156	1162		10.1016/j.jprot.2010.02.004			7	Biochemical Research Methods	Biochemistry & Molecular Biology	597ND	WOS:000277763800013	20176152				2021-06-18	
J	Carlile, M; Nicewander, D; Yablon, SA; Brown, A; Brunner, R; Burke, D; Chae, H; Englander, J; Flanagan, S; Hammond, F; Khademi, A; Lombard, LA; Meythaler, JM; Mysiw, WJ; Zafonte, R; Diaz-Arrastia, R				Carlile, Mary; Nicewander, David; Yablon, Stuart A.; Brown, Allen; Brunner, Robert; Burke, David; Chae, Heechin; Englander, Jeffrey; Flanagan, Steve; Hammond, Flora; Khademi, Allen; Lombard, Lisa A.; Meythaler, Jay M.; Mysiw, W. Jerry; Zafonte, Ross; Diaz-Arrastia, Ramon			Prophylaxis for Venous Thromboembolism During Rehabilitation for Traumatic Brain Injury: A Multicenter Observational Study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Venous thromboembolism; Prophylactic anticoagulation; Traumatic brain injury	MOLECULAR-WEIGHT HEPARIN; PROPENSITY SCORE METHODS; DEEP-VEIN THROMBOSIS; ENOXAPARIN; PREVENTION; RISK; MANAGEMENT; SAFETY; POWER; HEAD	Background: Deep venous thrombosis (DVT) is a major cause of mortality and morbidity after traumatic brain injury (TBI). There is no consensus regarding appropriate screening, prophylaxis, or treatment during acute rehabilitation. Methods: This prospective observational study evaluated prophylactic anticoagulation during rehabilitation in patients with TBI aged 16 years or older admitted to 12 TBI Model Systems rehabilitation centers (July 2004 December 2007). After propensity score stratification within center, the odds ratio associated with incidence of symptomatic DVT or pulmonary embolism (PE) for patients who did and did not receive prophylactic anticoagulation was estimated using conditional logistic regression in patients who were not screened for DVT on rehabilitation admission or who screened negative; the analysis was repeated in these two subgroups. Results: Patients with identified DVTs at rehabilitation admission (n = 266) were excluded, leaving 1,897 patients: 1,002 screened negative, 895 un-screened; 932 received prophylactic anticoagulation, and 965 did not. Symptomatic DVT/PE was detected in 32 patients (15 of 932 [1.6%] with prophylaxis, 17 of 965 [1.8%] without). After propensity score adjustment, the odds ratio (95% confidence interval) for symptomatic DVT/PE with prophylaxis versus no prophylaxis was 0.80 (0.33-1.94) in the full analytic population and 0.46 (0.12-1.84) in the screened-negative subgroup. The only probable venous thromboembolism-related death occurred in the prophylactic anticoagulation group. Fewer new/expanded intracranial hemorrhages occurred among patients who received prophylactic anticoagulation. Conclusions: Prophylactic anticoagulation during rehabilitation seemed safe for TBI patients whose physicians deemed it appropriate, but did not conclusively reduce venous thromboembolism. Given the number of DVTs present before rehabilitation, screening and prophylaxis during acute care may be more important.	[Carlile, Mary] Baylor Inst Rehabil, N Texas Traumat Brain Injury Model Syst, Dallas, TX 75246 USA; [Nicewander, David] Inst Hlth Care Res & Improvement, Baylor Hlth Care Syst, Dallas, TX USA; [Yablon, Stuart A.] Methodist Rehabil Ctr, Traumat Brain Injury Model Syst Mississippi, Jackson, MS USA; [Brown, Allen] Mayo Clin, Coll Med, Mayo Clin Traumat Brain Injury Model Syst, Rochester, MN USA; [Brunner, Robert; Meythaler, Jay M.] Birmingham TBI Injury Care Ctr, Univ Alabama, Univ Alabama Birmingham Traumat Brain Injury Mode, Birmingham, AL USA; [Meythaler, Jay M.] Rehabil Inst Michigan, So Michigan Traumat Brain Injury Model Syst, Detroit, MI USA; [Burke, David; Chae, Heechin] Harvard Univ, Sch Med, Spaulding Rehabil Hosp Network, Spaulding Partners Traumat Brain Injury Model Sys, Boston, MA USA; [Englander, Jeffrey] Santa Clara Med Ctr, Rehabil Res Ctr, No Calif Traumat Brain Injury Model Syst, Santa Clara, CA USA; [Flanagan, Steve] Mt Sinai Sch Med, New York Traumat Brain Injury Model Syst, New York, NY USA; [Hammond, Flora] Carolinas Hlth Care Syst, Carolinas Rehabil Traumat Brain Injury Model Syst, Charlotte, NC USA; [Khademi, Allen] JFK Johnson Rehabil Inst, JFK Johnson Rehabil Inst TBI Model Syst, Edison, NJ USA; [Lombard, Lisa A.; Zafonte, Ross] Univ Pittsburgh, Med Ctr, Univ Pittsburgh Med Ctr TBI Model Syst, Pittsburgh, PA USA; [Mysiw, W. Jerry] Ohio Valley Ctr Brain Injury Prevent & Rehabil, Ohio Reg TBI Model Syst, Columbus, OH USA; [Diaz-Arrastia, Ramon] Univ Texas SW Med Ctr Dallas, N Texas Traumat Brain Injury Model Syst, Dallas, TX 75390 USA	Carlile, M (corresponding author), Baylor Inst Rehabil, N Texas Traumat Brain Injury Model Syst, 909 N,Washington Ave, Dallas, TX 75246 USA.	marycar@baylorhealth.edu	Mysiw, Walter/E-3724-2011	Brown, Allen W./0000-0001-7228-3351; Diaz-Arrastia, Ramon/0000-0001-6051-3594	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A020526]	Supported by National Institute on Disability and Rehabilitation Research, US Department of Education Grant H133A020526.	Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Allen Donner, 2000, DESIGN ANAL CLUSTER; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Brandt MM, 2007, AM J SURG, V193, P383; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS32, DOI DOI 10.1089/NEU.2007.9991; Carlile MC, 2006, J HEAD TRAUMA REHAB, V21, P483, DOI 10.1097/00001199-200611000-00003; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Cipolle MD, 2002, J TRAUMA, V52, P453, DOI 10.1097/00005373-200203000-00007; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Elliott B, 2006, DISABIL REHABIL, V28, P333, DOI 10.1080/09638280500190722; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Haviland A, 2007, PSYCHOL METHODS, V12, P247, DOI 10.1037/1082-989X.12.3.247; Kim J, 2002, J TRAUMA, V53, P38, DOI 10.1097/00005373-200207000-00008; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Lai JM, 1997, BRAIN INJURY, V11, P331, DOI 10.1080/026990597123485; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Raabe A, 2001, ACTA NEUROCHIR, V143, P1, DOI 10.1007/s007010170131; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SHOJANIA KG, 2001, 43 AG HEALTHC RES QU; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; Yablon SA, 2004, NEUROLOGY, V63, P485, DOI 10.1212/01.WNL.0000133009.24727.9F	35	14	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2010	68	4					916	923		10.1097/TA.0b013e3181b16d2d			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	583GY	WOS:000276663100032	19996796				2021-06-18	
J	Jagersberg, M; Schaller, C; Bostrom, J; Schatlo, B; Kotowski, M; Thees, C				Jaegersberg, M.; Schaller, C.; Bostroem, J.; Schatlo, B.; Kotowski, M.; Thees, C.			Simultaneous Bedside Assessment of Global Cerebral Blood Flow and Effective Cerebral Perfusion Pressure in Patients with Intracranial Hypertension	NEUROCRITICAL CARE			English	Article						Transcerebral double-indicator dilution technique; Global cerebral blood flow; Effective cerebral perfusion pressure; Critical closing pressure; Intracranial hypertension; Mannitol; Hypertonic saline	HEAD-INJURED PATIENTS; CRITICAL CLOSING PRESSURE; HYPERTONIC SALINE; BRAIN EDEMA; HYPERVENTILATION; MANNITOL; PATHOPHYSIOLOGY; HEMODYNAMICS; MODERATE; TONE	We examined a bedside technique transcerebral double-indicator dilution (TCID) for global cerebral blood flow (CBF) as well as the concept of effective cerebral perfusion pressure (CPPeff) during different treatment options for intracranial hypertension, and compared global CBF and CPPeff with simultaneously obtained conventional parameters. Twenty-six patients developing intracranial hypertension in the course of traumatic brain injury or subarachnoid hemorrhage were prospectively analyzed using a combined assessment during elevated ventilation (n = 15) or osmotherapy (hypertonic saline or mannitol). For calculation of global CBF, injections of ice-cold indocyanine green boluses were performed and temperature and dye concentration changes were monitored in the thoracic aorta and the jugular bulb. CBF was then calculated according to the mean transit time principle. Estimation of CCP, the arterial pressure at which cerebral blood flow becomes zero, was performed by synchronized registration of corresponding values of blood flow velocity in the middle cerebral artery and arterial pressure and extrapolation to zero-flow velocity. CPPeff was calculated as mean arterial pressure minus critical closing pressure (CPPeff = MAP(c) - CCP). Elevated ventilation causes a decrease in both ICP (P < 0.001) and CBF (P < 0.001). While CPPconv increased (P < 0.001), CPPeff decreased during this observation (P = 0.002). Administration of osmotherapeutic agents resulted in a decrease of ICP (P < 0.001) and a temporary increase of CBF (P = 0.052). CPPconv and CPPeff showed no striking difference under osmotherapy. TCID allows repeated measurements of global CBF at the bedside. Elevated ventilation lowered and osmotherapy temporarily raised global CBF. In situations of increased vasotonus, CPPeff is a better indicator of blood flow changes than conventional CPP.	[Jaegersberg, M.; Schaller, C.; Schatlo, B.; Kotowski, M.] Univ Geneva, Med Ctr, Dept Neurosurg, CH-1211 Geneva, Switzerland; [Jaegersberg, M.; Schaller, C.; Bostroem, J.; Schatlo, B.; Kotowski, M.] Univ Bonn, Med Ctr, Dept Neurosurg, D-5300 Bonn, Germany; [Thees, C.] Univ Bonn, Med Ctr, Dept Anaesthesiol, D-5300 Bonn, Germany	Jagersberg, M (corresponding author), Univ Geneva, Med Ctr, Dept Neurosurg, CH-1211 Geneva, Switzerland.	max.jaegersberg@bluewin.ch	SCHATLO, Bawarjan/F-4285-2010				Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Baethmann A, 1997, ZBL NEUROCHIR, V58, P20; Baethmann A, 1997, ZBL NEUROCHIR, V58, P29; BARZO P, 1993, NEUROSURGERY, V32, P611; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; BURTON AC, 1951, AM J PHYSIOL, V164, P319; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Coplin WM, 1997, NEUROSURGERY, V41, P101, DOI 10.1097/00006123-199707000-00022; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; DRAKE CG, 1988, J NEUROSURG, V68, P985; EARLY CB, 1974, J NEUROSURG, V41, P590, DOI 10.3171/jns.1974.41.5.0590; Ertel W, 1998, UNFALLCHIRURG, V101, P520, DOI 10.1007/s001130050304; FEGLER G, 1954, Q J EXP PHYSIOL CMS, V39, P153, DOI 10.1113/expphysiol.1954.sp001067; FOX IJ, 1957, P STAFF M MAYO CLIN, V32, P478; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Keller E, 2000, CRIT CARE MED, V28, P511, DOI 10.1097/00003246-200002000-00037; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; KISCH H, 1995, CRIT CARE MED, V23, P885, DOI 10.1097/00003246-199505000-00017; LASSEN NA, 1979, TRACER KINETIC METHO; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marmarou A, 1997, ACT NEUR S, V70, P68; Marshall SB, 1991, J NEUROSURG S, V75, P14; MEIER P, 1954, J APPL PHYSIOL, V6, P731; Mielck F, 2004, EUR J ANAESTH, V21, P289, DOI 10.1017/S0265021504004077; Mielck F, 2001, EUR J ANAESTH, V18, P653, DOI 10.1046/j.1365-2346.2001.00994.x; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PERMUTT S, 1963, J APPL PHYSIOL, V18, P924; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Servadei F, 2000, NEUROSURGERY, V46, P70; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; Wietasch GJK, 2000, ANESTHESIOLOGY, V92, P367, DOI 10.1097/00000542-200002000-00017; ZIERLER KL, 1962, CIRC RES, V10, P393, DOI 10.1161/01.RES.10.3.393; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	39	14	14	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2010	12	2					225	233		10.1007/s12028-009-9300-2			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	573IL	WOS:000275905800013	20182922				2021-06-18	
J	Maguen, S; Cohen, G; Cohen, BE; Lawhon, GD; Marmar, CR; Seal, KH				Maguen, Shira; Cohen, Greg; Cohen, Beth E.; Lawhon, G. Dawn; Marmar, Charles R.; Seal, Karen H.			The Role of Psychologists in the Care of Iraq and Afghanistan Veterans in Primary Care Settings	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article						integrated care; veterans; mental health; post-traumatic stress disorder; health care	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; MENTAL-HEALTH-SERVICES; STEPPED COLLABORATIVE CARE; TRAUMATIC BRAIN-INJURY; AFFAIRS PRIMARY-CARE; UNITED-STATES; DEPRESSION; OUTCOMES; MANAGEMENT	Although military personnel serving in Iraq and Afghanistan are at high risk of developing mental health problems, many report significant barriers to care and few seek help. Integrated primary care is a comprehensive model of health care that aims to improve access to care and provides a framework to assess and meet the complex psychiatric needs of newly returning veterans by embedding mental health specialists within primary care. We describe the role of psychologists in a Department of Veterans Affairs (VA) integrated primary care clinic that serves veterans of Iraq and Afghanistan. Psychologists based in primary care can assist veterans with reintegration to civilian life by providing rapid mental health assessment, normalizing readjustment concerns, planning for veterans safety, implementing brief interventions within primary care. facilitating transition to additional mental health care, and informing veterans of other available psychosocial services. A case example demonstrating the psychologist's role highlights the benefits of an integrated care model. Implications of employing this model include reduction of symptoms and impairment by reducing stigma and barriers to seeking mental health care, increased motivation to engage ill treatment, and implementation of early interventions. This model may also be beneficial in the civilian health care sector with groups that are at high risk for mental health problems, yet experience barriers to care. particularly stigma.	[Maguen, Shira; Cohen, Greg; Cohen, Beth E.; Lawhon, G. Dawn; Marmar, Charles R.; Seal, Karen H.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Marmar, Charles R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	Maguen, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement St 116-P, San Francisco, CA 94121 USA.	shira.maguen@va.gov	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607			Babor TF., 2001, AUDIT ALCOHOL USE DI, V2nd; Bartels SJ, 2004, AM J PSYCHIAT, V161, P1455, DOI 10.1176/appi.ajp.161.8.1455; Blount A., 2003, FAMILIES SYSTEMS HLT, V21, P121, DOI DOI 10.1037/1091-7527.21.2.121; Blount A, 2007, PROF PSYCHOL-RES PR, V38, P290, DOI 10.1037/0735-7028.38.3.290; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Dobscha SK, 2006, ANN INTERN MED, V145, P477, DOI 10.7326/0003-4819-145-7-200610030-00005; Engel CC, 2008, MIL MED, V173, P935, DOI 10.7205/MILMED.173.10.935; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Felker Bradford L, 2006, Prim Care Companion J Clin Psychiatry, V8, P12; Galovski TE, 2009, J TRAUMA STRESS, V22, P197, DOI 10.1002/jts.20418; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Hedrick SC, 2003, J GEN INTERN MED, V18, P9, DOI 10.1046/j.1525-1497.2003.11109.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KATON W, 1994, PSYCHOSOMATICS, V35, P268, DOI 10.1016/S0033-3182(94)71775-8; Katon W, 2001, GEN HOSP PSYCHIAT, V23, P138, DOI 10.1016/S0163-8343(01)00136-0; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; Katon WJ, 2008, J OCCUP ENVIRON MED, V50, P459, DOI 10.1097/JOM.0b013e318168efb7; Kilbourne AM, 2006, ADM POLICY MENT HLTH, V33, P208, DOI 10.1007/s10488-006-0034-6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Magruder KM, 2005, GEN HOSP PSYCHIAT, V27, P169, DOI 10.1016/j.genhosppsych.2004.11.001; MAGUEN S, J TRAUMATIC IN PRESS; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Robinson P., 2007, BEHAV CONSULTATION P; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr P P, 1999, Semin Clin Neuropsychiatry, V4, P295; Schwartz I, 2007, ARCH PHYS MED REHAB, V88, P440, DOI 10.1016/j.apmr.2007.01.001; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SEAL KH, VA MENTAL H IN PRESS; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wells K, 2004, ARCH GEN PSYCHIAT, V61, P378, DOI 10.1001/archpsyc.61.4.378; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zeiss AM, 2008, J CLIN PSYCHOL MED S, V15, P73, DOI 10.1007/s10880-008-9100-4	37	14	14	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028	1939-1323		PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	APR	2010	41	2					135	142		10.1037/a0018835			8	Psychology, Multidisciplinary	Psychology	586EY	WOS:000276886800007					2021-06-18	
J	Rasmusson, CG; Koch, G				Rasmusson, Carl Gosta; Koch, Goran			Assessment of traumatic injuries to primary teeth in general practise and specialized paediatric dentistry	DENTAL TRAUMATOLOGY			English	Article							PRIMARY INCISORS; PRIMARY DENTITION; CHILDREN	Aim: The aim of this prospective study was to compare diagnosis, severity of trauma and treatment of traumatic injuries to the primary dentition in two groups of children, the first recommended for treatment by general practitioners and the second referred for treatment by a specialist paediatric dentist. Materials and methods: A total of 323 children with traumatic injuries, 184 boys and 139 girls aged 7-83 months, participated in the study. All the children had first presented at a Public Dental Service clinic where they were examined by general dentists who decided, based on the severity of the trauma, to assign each child to one of the following two groups: Group A - recommended for treatment at the general practise (166 children with 257 traumatized incisor teeth). Group B - recommended for referral to a specialist in paediatric dentistry (157 children with 261 traumatized incisor teeth). Even in Group A, the specialist controlled the treatment decisions. The clinical diagnose and follow-up followed the recommendations presented by Andreasen & Andreasen. Results: The distribution of trauma by age was similar in both groups, with about 60% occurring between 1 and 3 years. More injured teeth were extracted in children in Group B (n = 111) than in Group A (n = 33). A higher percentage of intruded primary incisors were recorded in Group B (24%) compared with Group A (16%). Similarly, the percentage of concussions/subluxations, lateral luxations and complicated crown fractures was higher in Group B than in Group A. Conclusions: The group referred for specialist treatment had more severe injuries and needed more complicated treatment than the group recommended for care by general dentists. However, the rate of sequelae in permanent successors was the same in both.	[Rasmusson, Carl Gosta] Publ Dent Hlth, Specialist Unit, Dept Pedodont, Uddevalla, Sweden; [Koch, Goran] Inst Postgrad Dent Educ, Dept Paediat Dent, Jonkoping, Sweden	Rasmusson, CG (corresponding author), Fornstigen 3, SE-45533 Munkedal, Sweden.	ansacege@swipnet.se					Andreasen J, 1994, TXB COLOR ATLAS TRAU, P151; Andreasen J O, 1972, Int J Oral Surg, V1, P235, DOI 10.1016/S0300-9785(72)80042-5; Borum MK, 1998, ENDOD DENT TRAUMATOL, V14, P31; BORUM MK, 1994, THESIS COPENHAGEN U; CROLL TP, 1987, J DENT CHILD, V54, P401; Diab M, 2000, QUINTESSENCE INT, V31, P327; Flores MT, 2002, DENT TRAUMATOL, V18, P287, DOI 10.1034/j.1600-9657.2002.00153.x; Holan G, 2004, DENT TRAUMATOL, V20, P276, DOI 10.1111/j.1600-9657.2004.00285.x; Horie N, 2005, DENT TRAUMATOL, V21, P201, DOI 10.1111/j.1600-9657.2005.00313.x; JACOBSEN I, 1978, ACTA ODONTOL SCAND, V36, P199, DOI 10.3109/00016357809004668; JOHO JP, 1980, J DENT CHILD, V47, P167; ODERSJO ML, 2001, EUR J PAEDIATR DENT, V4, P165; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; Robertson A, 1997, EUR J ORAL SCI, V105, P196, DOI 10.1111/j.1600-0722.1997.tb00201.x; Schroder U, 1977, Swed Dent J, V1, P95; SONIS A L, 1987, Journal of Pedodontics, V11, P247	16	14	15	0	8	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	APR	2010	26	2					129	132		10.1111/j.1600-9657.2009.00862.x			4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	568OD	WOS:000275531100003	20141524				2021-06-18	
J	van den Elsen, MJLJ; Leenen, LPH; Kesecioglu, J				van den Elsen, Maarten J. L. J.; Leenen, Luke P. H.; Kesecioglu, Jozef			Hemodynamic support of the trauma patient	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						colloids; crystalloids; endpoints of resuscitation; fluids; hemorrhagic shock; hypertonic saline; inotropes; trauma; traumatic brain injury; vasopressors	ABDOMINAL COMPARTMENT SYNDROME; UNCONTROLLED HEMORRHAGIC-SHOCK; HYPERTONIC SALINE RESUSCITATION; INCREASED INTRACRANIAL-PRESSURE; RANDOMIZED CONTROLLED-TRIAL; LACTATED RINGERS SOLUTION; INTENSIVE-CARE-UNIT; OF-THE-LITERATURE; FLUID RESUSCITATION; BRAIN-INJURY	Purpose of review The aim of this review is to address and summarize some key issues and recent insights into the hemodynamic support of the trauma patient related to fluid administration. Recent findings Colloids are not superior to crystalloids in treating hypovolemia in the trauma patient and show no survival benefit. Furthermore, several adverse effects (renal failure, bleeding complications and anaphylaxis) have been reported with the use of artificial colloids. Hypertonic saline is effective and well tolerated in the treatment of hypovolemic shock and traumatic brain injury. Potential benefits are reduced fluid requirements and immune modulation. Resuscitation strategies should depend on the type of injury (penetrating vs. blunt; concomitant brain injury). Excessive fluid resuscitation, which can cause acute respiratory distress syndrome, abdominal compartment syndrome and brain edema, should be avoided. Dynamic parameters to guide volume therapy are probably more reliable than static parameters and minimally invasive techniques to monitor the microcirculation are becoming more important to determine the endpoints of resuscitation. Summary Hemodynamic support is an early goal in the treatment of the trauma patient. The use of crystalloids is currently recommended in trauma resuscitation. The amount of fluid we give should be tailored to the individual trauma patient in which clear endpoints of resuscitation are of vital importance to maximize the chances of survival.	[van den Elsen, Maarten J. L. J.; Kesecioglu, Jozef] Univ Med Ctr Utrecht, Dept Intens Care Med, NL-3584 CX Utrecht, Netherlands; [Leenen, Luke P. H.] Univ Med Ctr Utrecht, Dept Surg, NL-3584 CX Utrecht, Netherlands	van den Elsen, MJLJ (corresponding author), Univ Med Ctr Utrecht, Dept Intens Care, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	melsen1@planet.nl		Leenen, Luke/0000-0001-8385-1801			Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Balogh ZJ, 2009, WORLD J SURG, V33, P1134, DOI 10.1007/s00268-009-0002-x; Baron BJ, 2007, J TRAUMA, V62, P120, DOI 10.1097/TA.0b013e31802d96ec; Barron ME, 2004, ARCH SURG-CHICAGO, V139, P552, DOI 10.1001/archsurg.139.5.552; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bauer M, 2009, BEST PRACT RES-CLIN, V23, P173, DOI 10.1016/j.bpa.2008.12.002; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Boldt J, 2009, INTENS CARE MED, V35, P1331, DOI 10.1007/s00134-009-1520-6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; BUNN F, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002045.PUB.2; Cammarata GAAM, 2009, SHOCK, V31, P207, DOI 10.1097/SHK.0b013e31817c0eb7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Choi PTL, 1999, CRIT CARE MED, V27, P200, DOI 10.1097/00003246-199901000-00053; Chytra I, 2007, CRIT CARE, V11, DOI 10.1186/cc5703; Cohn SM, 2007, J TRAUMA, V62, P44, DOI 10.1097/TA.0b013e31802eb817; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2006, SHOCK, V26, P115, DOI 10.1097/01.shk.0000209564.84822.f2; Crookes BA, 2005, J TRAUMA, V58, P806, DOI 10.1097/01.TA.0000158269.68409.1C; Carvalho Werther Brunow de, 2003, J. Pediatr. (Rio J.), V79, pS187, DOI 10.1590/S0021-75572003000800008; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Drobin D, 2002, ANESTHESIOLOGY, V96, P1371, DOI 10.1097/00000542-200206000-00016; Durairaj L, 2008, CHEST, V133, P252, DOI 10.1378/chest.07-1496; Ernest D, 1999, CRIT CARE MED, V27, P46, DOI 10.1097/00003246-199901000-00025; Ertmer C, 2009, BEST PRACT RES-CLIN, V23, P193, DOI 10.1016/j.bpa.2008.11.001; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Geeraedts LMG, 2009, INJURY, V40, P11, DOI 10.1016/j.injury.2008.10.007; Gunst M, 2008, J TRAUMA, V65, P509, DOI 10.1097/TA.0b013e3181825bc5; HANNEMANN L, 1994, ADV EXP MED BIOL, V345, P101; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hartog C, 2009, INTENS CARE MED, V35, P1337, DOI 10.1007/s00134-009-1521-5; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Husain FA, 2003, AM J SURG, V185, P485, DOI 10.1016/S0002-9610(03)00044-8; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Ikossi DG, 2006, J TRAUMA, V61, P780, DOI 10.1097/01.ta.0000239500.71419.58; Jarrar D, 1999, INT J MOL MED, V4, P575; Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Kiraly LN, 2006, J TRAUMA, V61, P57, DOI 10.1097/01.ta.0000220373.29743.69; Kirkpatrick AW, 2006, J AM COLL SURGEONS, V202, P668, DOI 10.1016/j.jamcollsurg.2005.11.020; Knudson MM, 2003, J TRAUMA, V54, P242, DOI 10.1097/01.TA.0000037776.28201.75; Kolsen-Petersen JA, 2008, BRIT J ANAESTH, V100, P478, DOI 10.1093/bja/aen015; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Lienhart HG, 2008, CURR OPIN CRIT CARE, V14, P247, DOI 10.1097/MCC.0b013e3282fce62a; Madigan MC, 2008, J TRAUMA, V64, P280, DOI 10.1097/TA.0b013e3181622bb6; Magder Sheldon, 2007, J Intensive Care Med, V22, P44, DOI 10.1177/0885066606295303; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; McKinley BA, 2000, J TRAUMA, V48, P637, DOI 10.1097/00005373-200004000-00009; McNelis J, 2001, AM J SURG, V182, P481, DOI 10.1016/S0002-9610(01)00755-3; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nydam TL, 2009, SHOCK, V31, P466, DOI 10.1097/SHK.0b013e31818ec47d; Oda J, 2006, J TRAUMA, V60, P64, DOI 10.1097/01.ta.0000199431.66938.99; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Ogino R, 1998, J TRAUMA, V44, P59, DOI 10.1097/00005373-199801000-00005; Perel P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub3; Phillips CR, 2009, CRIT CARE, V13, DOI 10.1186/cc7736; Raedler C, 2004, ANESTH ANALG, V98, P1759, DOI 10.1213/01.ANE.0000117150.29361.5A; Renner J, 2009, BEST PRACT RES-CLIN, V23, P159, DOI 10.1016/j.bpa.2008.12.001; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; Rossaint R, 2006, SHOCK, V26, P322, DOI 10.1097/01.shk.0000225403.15722.e9; Rotstein OD, 2000, J TRAUMA, V49, P580, DOI 10.1097/00005373-200010000-00002; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Schierhout G, 1998, BMJ-BRIT MED J, V316, P961, DOI 10.1136/bmj.316.7136.961; Schroth M, 2006, PEDIATRICS, V118, pE76, DOI 10.1542/peds.2005-2795; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Sperry JL, 2008, J TRAUMA, V64, P9, DOI 10.1097/TA.0b013e31815dd029; Stadlbauer KH, 2007, CRIT CARE, V11, DOI 10.1186/cc5977; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; STURM JA, 1986, J TRAUMA, V26, P409, DOI 10.1097/00005373-198605000-00001; Thompson R, 2006, J R Army Med Corps, V152, P6; Tisherman SA, 2004, J TRAUMA, V57, P898, DOI 10.1097/01.TA.0000133577.25793.E5; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; Verheij J, 2006, BRIT J ANAESTH, V96, P21, DOI 10.1093/bja/aei286; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Vincent JL, 2009, BEST PRACT RES-CLIN, V23, P183, DOI 10.1016/j.bpa.2008.11.004; Vincenzi R, 2009, AM J SURG, V198, P407, DOI 10.1016/j.amjsurg.2009.01.017; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Waxman AB, 2005, CRIT CARE, V9, DOI 10.1186/cc2940; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; WISNER DH, 1986, INJURY, V17, P295, DOI 10.1016/0020-1383(86)90149-X; Yanagawa Y, 2007, J TRAUMA, V63, P1245, DOI 10.1097/TA.0b013e318068d72b; Zhao L, 2009, RESUSCITATION, V80, P253, DOI 10.1016/j.resuscitation.2008.10.014; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	94	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2010	23	2					269	275		10.1097/ACO.0b013e328336b8d0			7	Anesthesiology	Anesthesiology	572GZ	WOS:000275817300023	20061942				2021-06-18	
J	Duquette, J; McKinley, P; Mazer, B; Gelinas, I; Vanier, M; Benoit, D; Gresset, J				Duquette, Josee; McKinley, Patricia; Mazer, Barbara; Gelinas, Isabelle; Vanier, Marie; Benoit, Dana; Gresset, Jacques			Impact of Partial Administration of the Cognitive Behavioral Driver's Inventory on Concurrent Validity for People With Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						automobile driving; brain injuries; cognition; reproducibility of results; stroke; task performance and analysis	STROKE; SKILLS; DAMAGE	OBJECTIVES. We sought to determine whether the partial administration of the Cognitive Behavioral Driver's Inventory (CBDI) has a significant effect on its concurrent validity. METHOD. Data were extracted from charts of clients with cerebrovascular accident or traumatic brain injury from three centers. The CBDI was administered either completely or partially (right and left perimetry or Wechsler Adult Intelligence Scale Revised (WAIS-R; Wechsler, 1982; Picture Completion and Digit Symbol tests were not completed). Concurrent validity indicators were calculated for the CBDI and three different scenarios of partial administration of the CBDI. RESULTS. Only 52% of the road test failures were predicted correctly by the completely administered CBDI. Nonadministration of the WAIS-R rarely modified the CBDI results. Omission of perimetry scores tended to increase the sensitivity and decrease the specificity (not significantly). CONCLUSION. The CBDI should be used as a complement, not a substitution, for a road test. Partially administrating the CBDI, specifically excluding perimetry measures, can affect its concurrent validity.	[Duquette, Josee; Gresset, Jacques] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [McKinley, Patricia; Mazer, Barbara; Gelinas, Isabelle; Vanier, Marie; Benoit, Dana] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Quebec City, PQ, Canada; [Duquette, Josee; Benoit, Dana] Constance Lethbridge Rehabil Ctr, Montreal, PQ, Canada; [Gresset, Jacques] Univ Montreal, Ecole Optometrie, Quebec City, PQ, Canada; [Vanier, Marie] Univ Montreal, Ecole Readaptat, Quebec City, PQ, Canada; [Vanier, Marie] Inst Readaptat Montreal, Quebec City, PQ, Canada; [Mazer, Barbara; Gelinas, Isabelle] Jewish Rehabil Hosp, Laval, PQ, Canada; [McKinley, Patricia; Mazer, Barbara; Gelinas, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3G 1Y5, Canada	Duquette, J (corresponding author), Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada.	isabelle.gelinas@mcgill.ca		Duquette, Josee/0000-0002-0258-1166			Antrim J. M., 1989, COGNITIVE REHABILITA, V7, P16; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; BRACY OL, 1985, COGNITIVE REHABILITA, V4, P10; DUBINSKY RM, 1991, NEUROLOGY, V41, P517, DOI 10.1212/WNL.41.4.517; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; ENGUM ES, 1989, COGNITIVE REHABILITA, V7, P22; ENGUM ES, 1990, COGNIT REHABIL, V2, P20; ENGUM ES, 1988, COGNITIVE REHABILITA, V6, P12; Engum ES, 1990, COGNITIVE REHABILITA, V8, P20; FEINSTEIN A, 1977, CLIN BIOSTATISTICS; GOLPER LAC, 1980, ARCH PHYS MED REHAB, V61, P34; Klavora P, 2000, ARCH PHYS MED REHAB, V81, P701, DOI 10.1053/apmr.2000.6285; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; KORNERBITENSKY N, 1990, CAN FAM PHYSICIAN, V36, P323; LAMBERT EW, 1990, COGNITIVE REHABILITA, V8, P34; LeBlang Theodore R, 1979, Loyola Univ Chic Law J, V10, P203; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; Michon J.A., 1985, HUMAN BEHAV TRAFFIC, P485; Noreau L, 1999, SPINAL CORD, V37, P730, DOI 10.1038/sj.sc.3100918; QUIGLEY FL, 1983, AM J OCCUP THER, V37, P474, DOI 10.5014/ajot.37.7.474; Reitan R, 1986, TRAIL MAKING TEST MA; SHORE D, 1980, ARCH PHYS MED REHAB, V61, P481; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SPRIGLE S, 1995, OCCUP THER J RES, V15, P147, DOI 10.1177/153944929501500301; Unsworth C.A., 2005, AUST OCCUP THER J, V52, P57, DOI [10.1111/j.1440, DOI 10.1111/J.1440-1630.2005.00456.X]; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; WEAVER J, 1989, DRIVER PERFORMANCE T; WECHSLER D, 1982, WECHSLER ADULT INTEL	28	14	14	1	1	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAR-APR	2010	64	2			SI		279	287		10.5014/ajot.64.2.279			9	Rehabilitation	Rehabilitation	583YR	WOS:000276717100009	20437915				2021-06-18	
J	Ghorbanian, MT; Tiraihi, T; Mesbah-Namin, SA; Fathollahi, Y				Ghorbanian, Mohammad Taghi; Tiraihi, Taki; Mesbah-Namin, Seyed A.; Fathollahi, Yaghoub			Selegiline is an efficient and potent inducer for bone marrow stromal cell differentiation into neuronal phenotype	NEUROLOGICAL RESEARCH			English	Article						Selegiline; marrow stromal cells; differentiation; neuronal phenotype	IN-VITRO DIFFERENTIATION; BUTYLATED HYDROXYANISOLE BHA; SISTER-CHROMATID EXCHANGES; MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NEURAL-TUBE DEFECTS; RETINOIC ACID; VALPROIC ACID; ANTIEPILEPTIC DRUGS; GENE-EXPRESSION	Objective: Bone marrow stromal cells (BMSCs) were documented as a feasible candidate for cell therapy. Several protocols with one or more steps, using different chemicals, were used for inducing BMSCs differentiation into neuronal phenotype. Many of these chemicals were reported to be of mutagenic, teratogenic or carcinogenic properties. The purpose of this work was to evaluate the neuronal inductivity of selegiline to BMSCs. Methods: Selegiline was used to induce BMSCs following pre-induction with beta-mercaptoethanol and retinoic acid. The neuronal phenotype was evaluated using antineurofilament 200, neurofilament 68, anti-Map-2 and synapsin I antibodies. In addition, reverse transcription polymerase chain reaction was used for the expression of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin 3 (NT-3), neuroligin 1 and post-synaptic density protein 95 (PSD-95). Results: The result of the work showed that the induced BMSCs were immunoreactive for neurofilaments 200 and 68. Moreover, anti-Map-2 and synapsin I antibodies showed a structure morphologically consistent with synapses. Reverse transcription polymerase chain reaction showed that the induced BMSCs could express BDNF, NGF, NT-3, neuroligin 1 and PSD-95. The time course used was 1, 3, 6, 12, 24, 36 and 48 hours, and the percentages of neurofilament 200 immunoreactive cells were analysed using the logistic growth curve. Discussion: The results showed that selegiline was efficient and a potent inducer for BMSCs into neuronal phenotype, which can be used in the cell therapy in neurodegeneration and traumatic nervous tissue injuries.	[Ghorbanian, Mohammad Taghi; Tiraihi, Taki] Tarbiat Modares Univ, Dept Anat Sci, Tehran, Iran; [Mesbah-Namin, Seyed A.] Tarbiat Modares Univ, Dept Clin Biochem, Tehran, Iran; [Fathollahi, Yaghoub] Tarbiat Modares Univ, Sch Med Sci, Dept Physiol, Tehran, Iran	Tiraihi, T (corresponding author), Tarbiat Modares Univ, Dept Anat Sci, Jalal Al Ahmed Express Way,POB 14155-4838, Tehran, Iran.	takialtr@modares.ac.ir	fathollahi, yaghoub/C-1670-2010	fathollahi, yghoub/0000-0002-3695-4805			Ali BH, 2001, VET HUM TOXICOL, V43, P228; BANTLE JA, 1990, DRUG CHEM TOXICOL, V13, P267, DOI 10.3109/01480549009032286; Barnes GL, 1996, TERATOLOGY, V54, P93, DOI 10.1002/(SICI)1096-9926(199606)54:2<93::AID-TERA5>3.0.CO;2-5; Bertani N, 2005, J CELL SCI, V118, P3925, DOI 10.1242/jcs.02511; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BRENNAN SM, 1991, TERATOLOGY, V43, P341, DOI 10.1002/tera.1420430409; CHIUEH CC, 1994, ANN NY ACAD SCI, V738, P25; Delgado A, 2005, J MICROBIOL METH, V62, P121, DOI 10.1016/j.mimet.2005.01.006; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Ebadi M, 2002, J NEUROSCI RES, V67, P285, DOI 10.1002/jnr.10148; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Esmaeili F, 2006, REJUV RES, V9, P475, DOI 10.1089/rej.2006.9.475; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; GRESSENS P, 1992, J NEUROPATH EXP NEUR, V51, P206, DOI 10.1097/00005072-199203000-00010; GU XF, 1993, EUR J PHARMACOL, V235, P51, DOI 10.1016/0014-2999(93)90819-4; Hagell P, 1998, MOVEMENT DISORD, V13, P34, DOI 10.1002/mds.870130110; Hansen DK, 2001, REPROD TOXICOL, V15, P31; Hellmann MA, 2006, NEUROSCI LETT, V395, P124, DOI 10.1016/j.neulet.2005.10.097; Henchcliffe Claire, 2005, Expert Rev Neurother, V5, P811, DOI 10.1586/14737175.5.6.811; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann Andreas, 2006, Expert Opin Biol Ther, V6, P653, DOI 10.1517/14712598.6.7.653; Hobbenaghi R, 2003, CLIN NEUROPHARMACOL, V26, P263, DOI 10.1097/00002826-200309000-00011; HSIAO WLW, 1985, MOL CELL BIOL, V5, P1800, DOI 10.1128/MCB.5.7.1800; HU LJ, 1990, MUTAT RES, V243, P63, DOI 10.1016/0165-7992(90)90124-3; Huang FJ, 2005, FERTIL STERIL, V83, P238, DOI 10.1016/j.fertnstert.2004.07.955; Huang FJ, 2003, HUM REPROD, V18, P130, DOI 10.1093/humrep/deg018; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; IVERSON F, 1995, CANCER LETT, V93, P49, DOI 10.1016/0304-3835(95)03787-W; Jin KL, 2003, EXP NEUROL, V184, P78, DOI 10.1016/S0014-4886(03)00133-X; Kabos P, 2002, EXP NEUROL, V178, P288, DOI 10.1006/exnr.2002.8039; Kim BJ, 2002, NEUROREPORT, V13, P1185, DOI 10.1097/00001756-200207020-00023; Kini U, 2006, ARCH DIS CHILD-FETAL, V91, pF90, DOI 10.1136/adc.2004.067421; KITCHIN KT, 1984, TOXICOLOGY, V30, P45, DOI 10.1016/0300-483X(84)90061-1; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; KOCHHAR DM, 1993, PROG CLIN BIOL RES, V383, P815; Kohyama J, 2001, DIFFERENTIATION, V68, P235, DOI 10.1046/j.1432-0436.2001.680411.x; Kramer BC, 2006, BIOCHEM BIOPH RES CO, V343, P1045, DOI 10.1016/j.bbrc.2006.02.191; KURISHITA A, 1989, TERATOLOGY, V39, P163, DOI 10.1002/tera.1420390208; Labouyrie E, 1999, AM J PATHOL, V154, P405, DOI 10.1016/S0002-9440(10)65287-X; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li TY, 2004, CELL BIOL INT, V28, P801, DOI 10.1016/j.cellbi.2004.07.010; LINDHOUT D, 1992, EPILEPSIA, V33, pS41; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Magaki T, 2005, NEUROSCI LETT, V384, P282, DOI 10.1016/j.neulet.2005.05.025; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Miescher K, 1938, BIOCHEM J, V32, P725, DOI 10.1042/bj0320725; Mis K, 2005, CHEM-BIOL INTERACT, V157, P29, DOI 10.1016/j.cbi.2005.10.003; MIYAKAWA Y, 1991, CARCINOGENESIS, V12, P1169, DOI 10.1093/carcin/12.7.1169; MONTERO D, 1990, LIFE SCI, V46, P1619; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nakaso K, 2006, BIOCHEM BIOPH RES CO, V339, P915, DOI 10.1016/j.bbrc.2005.11.095; NAU H, 1991, PHARMACOL TOXICOL, V69, P310, DOI 10.1111/j.1600-0773.1991.tb01303.x; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; OBEREMM A, 1992, TERATOGEN CARCIN MUT, V12, P251, DOI 10.1002/tcm.1770120603; Ornoy A, 2006, REPROD TOXICOL, V22, P214, DOI 10.1016/j.reprotox.2006.03.014; Panahi M, 2002, CLIN NEUROPHARMACOL, V25, P75, DOI 10.1097/00002826-200203000-00003; Paterson IA, 1997, NEUROSCI BIOBEHAV R, V21, P181, DOI 10.1016/S0149-7634(96)00008-5; Pennati R, 2001, TERATOGEN CARCIN MUT, V21, P121, DOI 10.1002/1520-6866(2001)21:2<121::AID-TCM2>3.0.CO;2-N; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; PHILLIPS BJ, 1989, MUTAT RES, V214, P105, DOI 10.1016/0027-5107(89)90203-0; Raedt R, 2007, EXP NEUROL, V203, P542, DOI 10.1016/j.expneurol.2006.09.016; Rismanchi N, 2003, BRAIN RES, V991, P46, DOI 10.1016/j.brainres.2003.07.004; Rutledge JC, 1997, MUTAT RES-FUND MOL M, V396, P113, DOI 10.1016/S0027-5107(97)00178-4; Saito M, 2003, ANTICANCER RES, V23, P4693; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SATO H, 1987, CARCINOGENESIS, V8, P1231, DOI 10.1093/carcin/8.9.1231; SCHAUMANN BA, 1989, EPILEPSY RES, V3, P182, DOI 10.1016/0920-1211(89)90048-X; Scintu F, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-14; SPEIT G, 1980, MUTAT RES, V78, P267, DOI 10.1016/0165-1218(80)90108-1; SULIK KK, 1995, TERATOLOGY, V51, P398, DOI 10.1002/tera.1420510605; Suon S, 2006, BRAIN RES, V1106, P46, DOI 10.1016/j.brainres.2006.05.109; Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013; Tzeng SF, 2004, NEUROSCI LETT, V367, P23, DOI 10.1016/j.neulet.2004.05.117; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; Wang N, 2004, ACTA PHARMACOL SIN, V25, P442; Wang N, 2006, BIOORG MED CHEM LETT, V16, P4780, DOI 10.1016/j.bmcl.2006.06.080; WEST RW, 1993, CARCINOGENESIS, V14, P285, DOI 10.1093/carcin/14.2.285; WHITAKERAZMITIA PM, 1994, NEUROPSYCHOPHARMACOL, V11, P125, DOI 10.1038/npp.1994.42; Whitsel AI, 2002, TERATOLOGY, V66, P153, DOI 10.1002/tera.10093; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Williams SS, 2004, PHYSIOL GENOMICS, V19, P184, DOI 10.1152/physiolgenomics.00136.2004; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Yu JK, 2003, PEDIATR SURG INT, V19, P355, DOI 10.1007/s00383-003-1010-9; Zhao LX, 2004, EXP NEUROL, V190, P396, DOI 10.1016/j.expneurol.2004.06.025	88	14	15	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2010	32	2					185	193		10.1179/174313209X409016			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	558XJ	WOS:000274781900013	19422735				2021-06-18	
J	Rao, V; Rosenberg, P; Miles, QS; Patadia, D; Treiber, K; Bertrand, M; Norton, M; Steinberg, M; Tschanz, J; Lyketsos, C				Rao, Vani; Rosenberg, Paul; Miles, Quincy Samus; Patadia, Deepa; Treiber, Kate; Bertrand, Melaine; Norton, Maria; Steinberg, Martin; Tschanz, JoAnn; Lyketsos, Constantine			Neuropsychiatric Symptoms in Dementia Patients With and Without a History of Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							QUALITY-OF-LIFE; LONG-TERM-CARE; ALZHEIMERS-DISEASE; CACHE COUNTY; BEHAVIORAL DISTURBANCES; ASSOCIATION; PREVALENCE; VALIDATION; INVENTORY; RESIDENTS	The authors aim to determine if a history of traumatic brain injury (TBI) assessed before dementia onset is associated with a higher risk of neuropsychiatric symptoms after dementia onset. A population-based incident series of people with dementia were assessed for TBI prior to onset of dementia and for neuropsychiatric symptoms after the onset, using the Neuropsychiatric Inventory. Participants with predementia TBI were more likely to exhibit disinhibition (12.7% versus 5.4%, OR = 2.8, p = 0.02), but not other neuropsychiatric symptoms. Traumatic brain injury may increase the risk of disinhibition in patients with dementia. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22: 166-172)	[Rao, Vani] Johns Hopkins Univ, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Johns Hopkins Sch Med, Baltimore, MD 21224 USA; [Patadia, Deepa] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Rootstown, OH 44272 USA; [Treiber, Kate; Norton, Maria; Tschanz, JoAnn] Utah State Univ, Logan, UT 84322 USA	Rao, V (corresponding author), Johns Hopkins Univ, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Johns Hopkins Sch Med, 5300 Alpha Commons Dr,4th Floor,444, Baltimore, MD 21224 USA.	vrao@jhmi.edu	Tschanz, JoAnn T./E-5986-2010	Steinberg, Martin/0000-0001-8800-8020	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG11380, AG18712, AG21136]; Cache County Study; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021136, R01AG011380, R01AG018712] Funding Source: NIH RePORTER	This work was supported by NIH grants AG11380, AG18712, and AG21136. We thank the neurogenetics laboratory of the Bryan Alzheimer's Disease Research Center at Duke University for the APOE genotyping. We are grateful to Drs. Kathleen A. Welsh-Bohmer and John C. S. Breitner, current and former principal investigators of the Cache County Study, for sharing the data and for their support and encouragement of this manuscript.; These results were presented as a poster by DP at Northeastern Ohio Universities College of Medicine's Summer Research Fellowship Program on 9/3/08 in Rootstown, Ohio, and as an oral presentation at Summa Health System on 1/8/09 in Akron, Ohio. DP is a Medical Student Training in Aging Research (MSTAR) scholar and presented these results at the 2009 American Geriatric Society Annual Scientific Meeting.	Alkhalil Chadi, 2004, Am J Ther, V11, P231, DOI 10.1097/00045391-200405000-00013; Bassiony MM, 2003, PSYCHOSOMATICS, V44, P388, DOI 10.1176/appi.psy.44.5.388; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Cohen-Mansfield J, 2005, ALZ DIS ASSOC DIS, V19, P37, DOI 10.1097/01.wad.0000155066.39184.61; Creese J, 2008, INT PSYCHOGERIATR, V20, P149, DOI 10.1017/S1041610207005339; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davis JD, 2007, J NEUROPSYCH CLIN N, V19, P43, DOI 10.1176/appi.neuropsych.19.1.43; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; Fernandez HH, 2000, MOVEMENT DISORD, V15, P490, DOI 10.1002/1531-8257(200005)15:3<490::AID-MDS1011>3.0.CO;2-E; Freymann N, 2005, PHARMACOPSYCHIATRY, V38, P144, DOI 10.1055/s-2005-864127; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Greve KW, 2001, BRAIN INJURY, V15, P255; Ikeda M, 2004, J NEUROL NEUROSUR PS, V75, P146; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Lyketsos CG, 2006, J NEUROPSYCH CLIN N, V18, P445, DOI 10.1176/appi.neuropsych.18.4.445; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Politis AM, 2004, INT J GERIATR PSYCH, V19, P1087, DOI 10.1002/gps.1215; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Samus QM, 2005, GERONTOLOGIST, V45, P19, DOI 10.1093/geront/45.suppl_1.19; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tschanz JT, 2002, NEUROPSY NEUROPSY BE, V15, P28; Tun SM, 2007, AM J GERIAT PSYCHIAT, V15, P314, DOI 10.1097/01.JGP.0000239263.52621.97	32	14	15	0	2	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2010	22	2					166	172		10.1176/jnp.2010.22.2.166			7	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	595ZY	WOS:000277654200004	20463110	Green Accepted			2021-06-18	
J	Lechner, R; Achatz, G; Hauer, T; Palm, HG; Lieber, A; Willy, C				Lechner, R.; Achatz, G.; Hauer, T.; Palm, H. -G.; Lieber, A.; Willy, C.			Patterns and causes of injuries in a contemporary combat environment	UNFALLCHIRURG			German	Article						Combat injuries; Military surgery; Wounds; Injuries; Injury pattern	PENETRATING MISSILE INJURIES; OPERATION IRAQI FREEDOM; CASUALTIES; AFGHANISTAN; WAR; EXPERIENCE; MANAGEMENT; TRAUMA; SINGLE; CARE	Epidemiological analyses of injury patterns and mechanisms help to identify the expertise military surgeons need in a combat setting and accordingly help to adjust infrastructure and training requirements. Therefore, a MEDLINE search (1949-2009), World Wide Web search (keywords "combat, casualties, war, military, wounded and neurosurgery") and an analysis of deaths among allied war casualties in Afghanistan and Iraq were performed. Up to 10th December 2009 there had been 4,688 allied military deaths in Iraq and 1,538 in Afghanistan. Of these 22% died in non-hostile action, 33% in direct combat situations and the majority of 45% in indirect combat actions. The leading causes of injury were explosive devices (70%) and gunshot wounds. Chest or abdominal injuries (40%) and traumatic brain injuries (35%) were the main causes of death for soldiers killed in action. The case fatality rate in Iraq is approximately half that of the Vietnam War, whereas the killed-in-action rate in Afghanistan (18.7%) is similar to the Vietnam War (20%); however, the amputation rate is twice as high in modern conflicts. Approximately 8-15% of the fatal injuries seem to be potentially survivable. Military surgeons must have an excellent expertise in a wide variety of surgical specialties. Life saving emergency care, especially in the fields of thoracic, visceral and vascular surgery as well as practical skills in the fields of neurosurgery and oral and maxillofacial surgery are required. Additionally, it is of vital importance to ensure the availability of sufficient tactical and strategic medical evacuation capabilities for the wounded.	[Lechner, R.; Achatz, G.; Hauer, T.] Bundeswehrkrankenhaus Ulm, Chirurg Zentrum, Klin Unfallchirurg & Orthopadie, D-89081 Ulm, Germany; [Lieber, A.] Bundeswehrkrankenhaus Berlin, Abt Allgemein Viszeral Gefass & Thoraxchirurg, Berlin, Germany	Lechner, R (corresponding author), Bundeswehrkrankenhaus Ulm, Chirurg Zentrum, Klin Unfallchirurg & Orthopadie, Oberer Eselsberg 40, D-89081 Ulm, Germany.	RaimundEdgarLechner@Bundeswehr.org	Willy, Christian/AAJ-3174-2021				Appenzeller GN, 2004, MIL MED, V169, P187, DOI 10.7205/MILMED.169.3.187; BAER D, 2005, MILITARY NEEDS COMBA; Brusov PG, 2005, WORLD J SURG, V29, pS25, DOI 10.1007/s00268-004-2081-z; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Clouse WD, 2006, ANN VASC SURG, V20, P429, DOI 10.1007/s10016-006-9090-3; Cohen SP, 2005, ANESTH ANALG, V101, P1098, DOI 10.1213/01.ane.0000169332.45209.cf; COVEY C, 2006, ANN M MARCH 2006 AM; Davidovic L, 1997, Cardiovasc Surg, V5, P37, DOI 10.1016/S0967-2109(96)00067-1; Davidovic LB, 2005, VASCULAR, V13, P141; Dyer O, 2005, BRIT MED J, V330, P557, DOI 10.1136/bmj.330.7491.557; Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gomez R, 2009, J AM COLL SURGEONS, V208, P348, DOI 10.1016/j.jamcollsurg.2008.11.012; Hinsley DE, 2005, BRIT J SURG, V92, P637, DOI 10.1002/bjs.4911; Hodgetts TJ, 2006, LANCET, V367, P1393, DOI 10.1016/S0140-6736(06)68604-2; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; HYER R, 2006, MEDSCAPE MED NEWS 20; Kashuk JL, 2009, J AM COLL SURGEONS, V209, P134, DOI 10.1016/j.jamcollsurg.2009.01.049; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Lakstein D, 2005, MIL MED, V170, P427, DOI 10.7205/MILMED.170.5.427; LEE C, 2005, SURVEY BLAST TRAUMA; McPherson JJ, 2006, J TRAUMA, V60, P573, DOI 10.1097/01.ta.0000209179.79946.92; Mody RM, 2009, J TRAUMA, V67, P758, DOI 10.1097/TA.0b013e3181af6aa6; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P12, DOI 10.1016/j.jamcollsurg.2005.04.009; Murray CK, 2009, MIL MED, V174, P598, DOI 10.7205/MILMED-D-03-8008; Peoples GE, 2005, MIL MED, V170, P462, DOI 10.7205/MILMED.170.6.462; PHILPOTT T, 2005, RISE SURVIVAL RATE; Ramalingam T, 2005, ANN ROY COLL SURG, V87, P113, DOI 10.1308/1478708051685; Ramasamy A, 2009, ANN ROY COLL SURG, V91, P551, DOI 10.1308/003588409X464720; Ramasamy A, 2009, INJURY, V40, P493, DOI 10.1016/j.injury.2008.03.028; Rich NM, 2005, J AM COLL SURGEONS, V200, P321, DOI 10.1016/j.jamcollsurg.2004.10.028; SCHLESINGER R, 2003, COMBAT WOUNDS PROVIN; Seal A, 2006, LANCET, V367, P1393, DOI 10.1016/S0140-6736(06)68605-4; Sise MJ, 2006, J TRAUMA, V60, P1162; VICK K, 2004, WASHINGTON POST FORE; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Zarocostas J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1347	38	14	14	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	FEB	2010	113	2					106	113		10.1007/s00113-009-1732-9			8	Emergency Medicine; Surgery	Emergency Medicine; Surgery	553RR	WOS:000274385000004	20101383				2021-06-18	
J	De Monte, VE; Geffen, GM; May, CR; McFarland, K				De Monte, Veronica Eileen; Geffen, Gina Malke; May, Christopher Randall; McFarland, Ken			Improved sensitivity of the rapid screen of mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Acute effects; Neuropsychology; Sensitivity; Severity	NEUROPSYCHOLOGICAL TESTING USEFUL; SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; MINOR HEAD-INJURY; FOOTBALL PLAYERS; STANDARDIZED ASSESSMENT; ATTENTION DEFICITS; WORD REPETITION; CT-SCAN; RECOVERY	This study aimed to investigate the acute effects of mild traumatic brain injury (mTBI) in an emergency department sample. A total of 246 (186 male, 60 female) cases of mTBI and 102 (65 male and 37 female) cases of orthopedic injuries were tested within 24 hours of injury. Mild TBI patients performed more poorly on all subtests of the Rapid Screen of Concussion (RSC) and completed fewer symbols on Digit Symbol than did orthopedic controls. RSC scores predicted group membership better than chance, and Digit Symbol scores contributed significantly to predicting group membership over and above the contribution of the RSC, resulting in 70.4% sensitivity and 74% specificity for the extended protocol. The results of this study indicate that learning and memory, orientation, and speed of information processing are impaired immediately following mTBI. Furthermore, a brief battery of tests that include word recall, orientation, and the Digit Symbol Substitution Test could assess the severity of dysfunction following mTBI, and assist in clinical decision making regarding discharge, return to routine activities, and management of the effects of injury.	[Geffen, Gina Malke] Univ Queensland, Sch Psychol, Cognit Psychophysiol Lab, Brisbane, Qld 4072, Australia; [May, Christopher Randall] Royal Brisbane Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia	Geffen, GM (corresponding author), Univ Queensland, Sch Psychol, Cognit Psychophysiol Lab, Brisbane, Qld 4072, Australia.	geffen@psy.uq.edu.au					Baddeley A.D., 1992, SPEED CAPACITY LANGU; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barrow IM, 2006, J TRAUMA, V61, P1142, DOI 10.1097/01.ta.0000241238.70269.c1; Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; Barth JT., 1989, MILD HEAD INJURY, P257; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P624, DOI 10.1080/13803390490918589; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; De Monte VE., 2005, BRAIN IMPAIR, V6, P109, DOI [10.1375/brim.2005.6.2.109, DOI 10.1375/BRIM.2005.6.2.109]; Falconer EK, 2006, BRAIN INJURY, V20, P1251, DOI 10.1080/02699050601049601; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; *HEADM INC, 1999, CONC RES IND COMP PR; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Kwapil KJ., 2003, BRAIN IMPAIR, V4, P155; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LOVELL MR, 1998, IMPACT IMMEDIATE POS; Macciocchi SN, 2005, J ATHL TRAINING, V40, P152; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McHugh T, 2006, BRAIN COGNITION, V60, P209; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Randolph C, 2005, J ATHL TRAINING, V40, P139; Sadowski-Cron C, 2006, BRAIN INJURY, V20, P1131, DOI 10.1080/02699050600832569; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; YOUNGJOHN JR, 1992, CLIN NEUROPSYCHOL, V0006, P00276, DOI DOI 10.1080/13854049208404129	55	14	14	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	1					28	37		10.1080/13803390902806519			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	550YJ	WOS:000274170400003	19418329				2021-06-18	
J	DeJong, J; Donders, J				DeJong, Joy; Donders, Jacobus			Cluster subtypes on the California Verbal Learning Test-Second Edition (CVLT-II) in a traumatic brain injury sample	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Learning; Memory; Cluster analysis; Traumatic brain injury	CONFIRMATORY FACTOR-ANALYSIS; STANDARDIZATION SAMPLE; WAIS-III; RECALL DISCRIMINABILITY; CRITERION VALIDITY; CHILDRENS VERSION; 2ND EDITION; WISC-III; PERFORMANCE; MEMORY	Subtypes of learning and memory on the California Verbal Learning Test-Second Edition (CVLT-II; Delis, Kramer, Kaplan, Ober, 2000) were examined in a clinical sample of 223 persons with traumatic brain injury (TBI), screened to remove individuals with complicating premorbid (e.g., psychiatric) or comorbid (e.g., financial compensation-seeking) histories. The z scores from 4 key CVLT-II variables were entered into a two-stage cluster analysis. These variables were selected to represent 4 latent constructs, identified in a recent confirmatory factor analysis: List A1 (Attention Span), List A5 (Learning Efficiency), Long Delay Free Recall (Delayed Memory), and False Positives (Inaccurate Memory). Six reliable subtypes were found (similar to those in the standardization sample) that were differentiated by both level and pattern of performance, with differences in level of performance meaningfully related to length of coma. In conclusion, the impact of TBI on CVLT-II performance can be manifested in various patterns that are not specifically unique, but are affected by injury severity.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA	Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com			Campbell Foundation	This research was supported by a grant from the Campbell Foundation.	Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; BLASHFIELD RK, 1976, PSYCHOL BULL, V83, P377, DOI 10.1037/0033-2909.83.3.377; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CARTER RL, 1989, PSYCHOMETRIKA, V54, P9, DOI 10.1007/BF02294446; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; DeJong J, 2009, ASSESSMENT, V16, P328, DOI 10.1177/1073191109336989; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CVLT 2 COMPREHENSIVE; Delis DC, 2000, CALIFORNIA VERBAL LE; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1999, DEV NEUROPSYCHOL, V15, P395, DOI 10.1080/87565649909540757; Donders J, 2008, J CLIN EXP NEUROPSYC, V30, P741, DOI 10.1080/13803390701689595; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Donders J, 2006, PSYCHOL ASSESSMENT, V18, P458, DOI 10.1037/1040-3590.18.4.458; Fuerst DR, 1995, CHILD NEUROPSYCHOL, V1, P38, DOI 10.1080/09297049508401341; Hair JF., 2002, READING UNDERSTANDIN, P147; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MILLIGAN GW, 2003, HDB PSYCHOL RES METH, V2, P165; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Mottram L, 2006, DEV NEUROPSYCHOL, V30, P865, DOI 10.1207/s15326942dn3003_6; *SAS I, 1990, SAS STAT US GUID VER, V1; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; Strong CAH, 2005, J CLIN EXP NEUROPSYC, V27, P746, DOI 10.1081/13803390490919155; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; WECHSLER W, 2008, WECHSLER ADULT INTEL; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Zasler N. D., 2007, BRAIN INJURY MED PRI, P779	33	14	14	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	9					953	960	PII 921416138	10.1080/13803391003645640			8	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	676CU	WOS:000283888500005	20408004				2021-06-18	
S	Difede, J; Barchas, JD		Barchas, JD; Difede, J		Difede, JoAnn; Barchas, Jack D.			Psychiatric and neurologic aspects of war: an overview and perspective	PSYCHIATRIC AND NEUROLOGIC ASPECTS OF WAR	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	89th Annual Conference of the Association for Research in Nervous and Mental Disease	DEC 16, 2009	Rockefeller Univ, New York, NY		Rockefeller Univ	posttraumatic stress disorder; traumatic brain injury; veterans; technology; methodology; virtual reality; valor; terrorist behavior; genocide prevention; mass violence	MENTAL-HEALTH DIAGNOSES; AFGHANISTAN VETERANS; EXPOSURE THERAPY; IRAQ; DISORDERS; SERVICES	The growing number of soldiers returning home with psychiatric and neurologic disorders, notably posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI), underscores the need for an interdisciplinary framework for understanding the emergent consequences of combat. Among the challenges facing the scientific community is the development of effective treatment strategies for TBI from blast and other injuries, given the confounding effects of comorbid psychological symptoms on accurate diagnoses. At the individual level, emerging technologies including virtual reality, the use of genetic biomarkers to inform treatment response, and new brain imaging methodology are playing an important role in the development of differential therapeutics to best address a soldier's particular clinical needs. At the macro level, new approaches toward understanding the political, cultural, and ideological contexts of mass conflict, the decision to join in violence, and ways of preventing genocide are discussed.	[Difede, JoAnn; Barchas, Jack D.] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA	Difede, J (corresponding author), Weill Cornell Med Coll, Dept Psychiat, 525 E 68th St,Box 200, New York, NY 10065 USA.	jdifede@med.cornell.edu					Andreasen NC, 2006, INTRO TXB PSYCHIAT; [Anonymous], 2009, DEPRESS ANXIETY, V26, P493, DOI 10.1002/da.20581; Arendt H., 1994, EICHMANN JERUSALEM R; Barry JM., 2004, GREAT INFLUENZA EPIC; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; Bogdanos M., 2006, THIEVES BAGHDAD; Bremner JD, 1998, PROG PSYCH, pXIII; Cahill SP, 2006, J TRAUMA STRESS, V19, P597, DOI 10.1002/jts.20173; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Foa EB, 2002, BIOL PSYCHIAT, V52, P987, DOI 10.1016/S0006-3223(02)01552-4; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gombrich EH, 2008, LITTLE HIST WORLD; Hamburg D. A., 2004, LEARNING LIVE TOGETH; Hamburg David A., 2008, PREVENTING GENOCIDE; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Institute of Medicine (IOM), 2008, TREATM POSTTR STRESS; IOM (Institute of Medicine), 2006, POSTTR STRESS DIS DI; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; NESTLER EJ, 2008, MOL NEUROPHARMACOLOG; Post JM, 2008, MIND TERRORIST PSYCH; Rees CS, 2005, PROF PSYCHOL-RES PR, V36, P649, DOI 10.1037/0735-7028.36.6.649; Rowland LPP, 2009, MERRITTS NEUROLOGY; Sadock BJ, 2009, KAPLAN SADOCKS COMPR, VII; Schatzberg AF, 2009, AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF PSYCHOPHARMACOLOGY, 4TH EDITION, P1; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shay Jonathan, 2002, ODYSSEUS AM COMBAT T; Tanielian T, 2008, INVISIBLE WOUNDS WAR; TASMAN A, 2008, PSYCHIATRY, V2; Tasman A., 2008, PSYCHIATRY, V1; Thase ME, 2008, ANNU REV CLIN PSYCHO, V4, P53, DOI 10.1146/annurev.clinpsy.2.022305.095301; *US CENS BUR, 2003, VET 2000 CENS BRIEF; *US CENS BUR, 1990, 1990 VET POP 1990 CE; WRAY BT, 2003, AUSTR ASS COGN BEH T	35	14	14	0	16	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-804-4	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2010	1208						1	9		10.1111/j.1749-6632.2010.05795.x			9	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	BSK28	WOS:000284742000001	20955319				2021-06-18	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			Recreational physical activities among children with a history of severe traumatic brain injury	BRAIN INJURY			English	Article						LTPA, leisure time physical activity; TBI, traumatic brain injury; TD, typically developed; G&S, Godin and Shephard; TUG, timed up and go test; FRT, functional reach test; EEI, energy expenditure index	DISABILITIES; RELIABILITY; PARTICIPATION; EXERCISE; CAPACITY; PEOPLE; SWAY	Objective: To describe leisure time physical activity (LTPA) and physical capabilities such as balance, muscle strength and walking performance and to evaluate the associations between physical capabilities and LTPA among children post-traumatic brain injury (TBI) as compared to a peer group of typically-developed (TD) controls. Participants: Convenience sample of 15 children, 1.5-7 years post-severe TBI and 15 age- and sex-matched controls. Main outcome measures: LTPA by the Godin and Shephard (G&S) questionnaire. Balance tests-the Timed Up and Go test (TUG) and functional reach test (FRT). Maximal isometric strength was assessed by using a hand-held dynamometer; walking dynamics were recorded by an electronic mat and the 6 minute walk test and energy expenditure index (EEI). Perceived exertion was rated by the OMNI scale. Results: Children post-severe TBI participate significantly less in LTPA as compared to TD controls (p < 0.01). Walking performance was comparable between groups except for step length which was significantly shorter among children post-TBI. Hip extensor strength and balance performance were significantly lower among children post-TBI. Balance performance was positively associated with LTPA. Conclusions: This study suggests that attention should be directed towards improving balance performance as part of the training repertoire of children and adolescents with post-severe TBI. The efficacy of such a training programme, in particular its contribution to LTPA participation, should then be further assessed.	[Katz-Leurer, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Meyer, Shirley] Alyn Childrens Orthoped Hosp, Jerusalem, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Meyer, Shirley] Rehabil Ctr, Jerusalem, Israel; [Keren, Ofer] Sheba Med Ctr, Head Trauma Rehabil Dept, Tel Aviv, Israel	Katz-Leurer, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Phys Therapy Dept, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; DAMIANO DL, 1995, DEV MED CHILD NEUROL, V37, P731, DOI 10.1111/j.1469-8749.1995.tb15019.x; DAULT MC, 1999, P 11 INT S AD PHYS E, P59; Donahoe B, 1994, PEDIAT PHYSICAL THER, V6, P189, DOI DOI 10.1097/00001577-199400640-00004; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, pV, DOI 10.1097/00001199-199808000-00001; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P254, DOI 10.1097/PEP.0b013e3181820dd8; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P259, DOI 10.1097/PEP.0b013e3181824782; Kinne S, 2004, AM J PUBLIC HEALTH, V94, P443, DOI 10.2105/AJPH.94.3.443; Kosak M, 2005, J REHABIL RES DEV, V42, P103, DOI 10.1682/JRRD.2003.11.0171; Livingstone MBE, 2000, MED SCI SPORT EXER, V32, P1513, DOI 10.1097/00005768-200008000-00022; Lowes LP, 1996, PEDIAT PHYS THERAPY, V8, P176; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; RIDDLE DL, 1989, PHYS THER, V69, P182, DOI 10.1093/ptj/69.3.182; Rimmer JH, 2006, DISABIL REHABIL, V28, P1087, DOI 10.1080/09638280500493860; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Robertson RJ, 2006, MED SCI SPORT EXER, V38, P158, DOI 10.1249/01.mss.0000190595.03402.66; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SALLIS JF, 1993, MED SCI SPORT EXER, V25, P99, DOI 10.1249/00005768-199301000-00014; Shaughnessy M, 2006, REHABIL NURS, V31, P15, DOI 10.1002/j.2048-7940.2006.tb00005.x; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151; World Health Organization, 2001, INT CLASS FUNCT DIS	29	14	15	0	17	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	13-14					1561	1567		10.3109/02699052.2010.523046			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	691QV	WOS:000285096800005	20973625				2021-06-18	
J	Larsen, JD; Allen, MD; Bigler, ED; Goodrich-Hunsaker, NJ; Hopkins, RO				Larsen, James D.; Allen, Mark D.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.			Different patterns of cerebral activation in genuine and malingered cognitive effort during performance on the Word Memory Test	BRAIN INJURY			English	Article						fMRI; Word Memory Test; neuropsychological assessment; symptom validity testing; effort testing; malingering	TRAUMATIC BRAIN-INJURY; FMRI; EXAGGERATION; RECOGNITION; IMPAIRMENT; RETRIEVAL; DECEPTION; ATTENTION; RESPONSES; SEVERITY	Primary objective: The Word Memory Test (WMT) is a popular symptom validity test in which individuals are required to remember and recall semantically-related word pairs. Research shows successful WMT completion employs a wide neural network which is involved in tasks requiring high cognitive effort. The primary purpose of this study was to replicate earlier fMRI findings using a larger sample and extend previous findings by including male and female subjects. The second purpose was to investigate the neural networks involved during intentional malingering on the WMT. Research design: For all trials, a time-series ANCOVA design was implemented using SPM5 software. Methods and procedures: Ten subjects (five male and five female) underwent fMRI imaging while completing the WMT in full-effort and simulated poor effort conditions. Main outcome and results: Full-effort trials found activation peaks in dorsolateral prefrontal cortex, superior parietal lobe, anterior cingulate, bilateral lingual cortices and anterior insula/frontal operculum, supporting earlier findings. Simulated poor effort trials had similar foci of activation, with additional peak strength in surrounding cortical regions identified previously as relevant to simulated malingering. No sex differences were observed in either condition. Conclusions: These findings demonstrate the neural underpinnings of WMT performance in normal and simulated performance.	[Larsen, James D.; Allen, Mark D.; Bigler, Erin D.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larsen, James D.] Univ Hawaii, Dept Psychol, Honolulu, HI 96822 USA; [Allen, Mark D.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.; Hopkins, Ramona O.] Univ Utah, Utah Brain Inst, Salt Lake City, UT USA; [Goodrich-Hunsaker, Naomi J.] Calif State Univ Sacramento, NeuroTherapeut Res Inst, Davis Med Ctr, Sacramento, CA 95819 USA; [Goodrich-Hunsaker, Naomi J.] Calif State Univ Sacramento, Dept Psychiat & Behav Sci, Davis Med Ctr, Sacramento, CA 95819 USA; [Hopkins, Ramona O.] Intermountain Med Ctr, Dept Med, Div Pulm & Crit Care, Murray, UT USA	Allen, MD (corresponding author), Brigham Young Univ, Dept Psychol, 1022 SWKT, Provo, UT 84602 USA.	m_allen@byu.edu			College of Family, Home and Social Science, Brigham Young University	Dr Erin Bigler does forensic consultation where similar to 70% of the referrals are from the plaintiff side and 30% defense. There are no other financial interests or relationships that could be interpreted as conflicts of interest associated with any authors of this manuscript. Portions of this project were funded by grants from the College of Family, Home and Social Science, Brigham Young University.	Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Batt K, 2008, J INT NEUROPSYCH SOC, V14, P1074, DOI 10.1017/S135561770808137X; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bengtsson SL, 2009, CEREB CORTEX, V19, P797, DOI 10.1093/cercor/bhn127; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bles M, 2008, NEUROCASE, V14, P82, DOI 10.1080/13554790801992784; BOONE KB, 2007, ASSESSMENT FEIGNED N; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Cabeza R, 2003, NEUROPSYCHOLOGIA, V41, P241, DOI 10.1016/S0028-3932(02)00156-2; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Carpenter PA, 1999, J COGNITIVE NEUROSCI, V11, P9, DOI 10.1162/089892999563210; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Csernansky JG, 2008, AM J PSYCHIAT, V165, P937, DOI 10.1176/appi.ajp.2008.08050700; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; DICHTER GS, SCHIZOPHREN IN PRESS; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Garn CL, 2009, CORTEX, V45, P610, DOI 10.1016/j.cortex.2008.02.004; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2007, ASSESSMENT FEIGNED C, P50; Green P., 2003, MANUAL WORD MEMORY T; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kingery L. R., 2007, ASSESSMENT FEIGNED C, P13; Kuo WJ, 2003, NEUROIMAGE, V18, P720, DOI 10.1016/S1053-8119(03)00015-6; Lee TMC, 2009, BRAIN COGNITION, V69, P406, DOI 10.1016/j.bandc.2008.09.002; Lee TMC, 2005, NEUROIMAGE, V28, P305, DOI 10.1016/j.neuroimage.2005.06.051; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Radulescu AR, 2008, NEUROPSYCHOBIOLOGY, V57, P206, DOI 10.1159/000151731; Ranganath C, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0005.2000; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Steinbrink C, 2009, HUM BRAIN MAPP, V30, P2401, DOI 10.1002/hbm.20674; Toga AW, 2007, NEUROIMAGE, V37, P1045, DOI 10.1016/j.neuroimage.2007.02.018; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vijayaraghavan L, 2008, NEUROPSYCHOLOGY, V22, P412, DOI 10.1037/0894-4105.22.3.412; White T, 2008, SCHIZOPHRENIA BULL, V34, P18, DOI 10.1093/schbul/sbm110; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zasler N. D., 2007, BRAIN INJURY MED PRI, P779	54	14	14	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	2					89	99		10.3109/02699050903508218			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	597BF	WOS:000277729500004	20085446				2021-06-18	
J	McAuliffe, MJ; Carpenter, S; Moran, C				McAuliffe, Megan J.; Carpenter, Sonja; Moran, Catherine			Speech intelligibility and perceptions of communication effectiveness by speakers with dysarthria following traumatic brain injury and their communication partners	BRAIN INJURY			English	Article						Dysarthria; communicative effectiveness; traumatic brain injury; intelligibility; speech	FUNCTIONAL COMMUNICATION; SOCIAL COMMUNICATION; EFFECTIVENESS INDEX; IMPAIRMENT; APHASIA; INDIVIDUALS; PERFORMANCE; VALIDITY; ABILITY; SKILLS	Primary objective: This study examined differences in perceived communicative effectiveness between a group of eight participants with chronic dysarthria following TBI and their nominated communication partners (TBIP). The relationship between communicative effectiveness and listener ratings of speech intelligibility was also examined. Research design: Group comparison design. Methods and procedures: The Communicative Effectiveness Survey was completed by the participants with TBI and their communication partner. Speech intelligibility of the eight adults with dysarthria was rated by nine naive listeners using direct magnitude estimation. Main outcomes and results: The participants with TBI tended to rate their communicative effectiveness higher than their TBIP; however, this trend was not significant. No significant differences were noted between the TBI and TBIP groups in ratings of communicative effectiveness in various communication settings. No significant relationship was found between conversation level intelligibility and perceptions of communicative effectiveness, as rated by individuals with TBI and TBIP. Conclusions: The findings of this study highlight the need for collaborative participation in the therapeutic process by all stakeholders. The lack of correlation between speech intelligibility and perceived communicative effectiveness highlights the need for careful examination of activity and participation during assessment and goal-setting.	[McAuliffe, Megan J.; Carpenter, Sonja; Moran, Catherine] Univ Canterbury, Dept Commun Disorders, Christchurch 1, New Zealand	McAuliffe, MJ (corresponding author), Univ Canterbury, Dept Commun Disorders, Christchurch 1, New Zealand.	megan.mcauliffe@canterbury.ac.nz		McAuliffe, Megan/0000-0003-3827-2215	New Zealand Neurological Foundation [0533-SPG]	The authors wish to thank the participants and their communication partners for taking part in this study. The financial support of the New Zealand Neurological Foundation Small Project Grant 0533-SPG is gratefully acknowledged.	ANGLEM J, 2007, COMMUNICATION; Bakheit AMO, 2005, DISABIL REHABIL, V27, P287, DOI 10.1080/09638280400009006; Ball LJ, 2004, J COMMUN DISORD, V37, P197, DOI 10.1016/j.jcomdis.2003.09.002; BLUMBERGER J, 1995, BRAIN INJURY, V9, P797, DOI 10.3109/02699059509008235; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Donovan NJ, 2008, AM J SPEECH-LANG PAT, V17, P335, DOI 10.1044/1058-0360(2008/07-0010); Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Duffy JR, 2019, MOTOR SPEECH DISORDE; HUSTAD KC, 1999, MANAGEMENT MOTOR SPE; Irwin WH, 2002, APHASIOLOGY, V16, P823, DOI 10.1080/02687030244000086; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Jones HN, 2006, J MED SPEECH-LANG PA, V14, P207; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Schiavetti N, 1992, INTELLIGIBILITY SPEE, P11; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sullivan M, 2002, HEAD NECK-J SCI SPEC, V24, P530, DOI 10.1002/hed.10095; Sullivan M. D., 1993, J MED SPEECH-LANG PA, V1, P73; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, P27; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; Tjaden K, 2004, J SPEECH LANG HEAR R, V47, P766, DOI 10.1044/1092-4388(2004/058); Wang YT, 2004, CLIN LINGUIST PHONET, V18, P57, DOI 10.1080/02699200310001596160; Weismer G, 2002, J SPEECH LANG HEAR R, V45, P421, DOI 10.1044/1092-4388(2002/033); World Health Organization [WHO], 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Yorkston K. M., 1996, AM J SPEECH-LANG PAT, V5, P55, DOI [DOI 10.1044/1058-0360.0501.55, 10.1044/ 1058-0360.0501.55]; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173	32	14	14	0	13	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	12					1408	1415		10.3109/02699052.2010.511590			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	667NR	WOS:000283200800004	20858025				2021-06-18	
S	Merikangas, KR; Swanson, SA		Stein, MB; Steckler, T		Merikangas, Kathleen Ries; Swanson, Sonja Alsemgeest			Comorbidity in Anxiety Disorders	BEHAVIORAL NEUROBIOLOGY OF ANXIETY AND ITS TREATMENT	Current Topics in Behavioral Neurosciences		English	Article; Book Chapter						Comorbidity; Anxiety disorders; NCS-R; Epidemiology; Family studies; Medical conditions	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; NATIONAL EPIDEMIOLOGIC SURVEY; MAJOR DEPRESSIVE DISORDER; CORONARY-HEART-DISEASE; SUBSTANCE USE DISORDERS; MENTAL-DISORDERS; PANIC-ATTACKS; CO-MORBIDITY; SOCIAL PHOBIA	Ever since Feinstein coined the term "comorbidity", referring to the presence of any additional coexisting ailment in a patient with a particular index disease (J Chronic Dis 23:455-468, 1970), aspects of the phenomenon have been extensively studied. The aims of this chapter are: (1) to summarize the evidence of psychiatric comorbidity in anxiety disorders from adult population-based studies; (2) to present findings from the National Comorbidity Survey Replication (NCS-R); (3) to summarize evidence of psychiatric comorbidity in anxiety disorders from child and adolescent population-based samples; (4) to provide a summary of evidence on comorbidity from family and genetic studies; and (5) to examine patterns of comorbidity between anxiety disorders and medical conditions. Throughout each of these aims, implications of the comorbidity are explored, including whether these patterns reflect a need for redefining the disorders or rather an etiologic or even causal path.	[Merikangas, Kathleen Ries; Swanson, Sonja Alsemgeest] NIMH, Genet Epidemiol Res Branch, Mood & Anxiety Disorders Program, US Dept HHS,NIH, Bethesda, MD 20892 USA; [Merikangas, Kathleen Ries] NIMH, Intramural Res Program, Bethesda, MD 20892 USA	Merikangas, KR (corresponding author), NIMH, Genet Epidemiol Res Branch, Mood & Anxiety Disorders Program, US Dept HHS,NIH, 35 Convent Dr,MSC 3720, Bethesda, MD 20892 USA.	Kathleen.Merikangas@nih.gov		Merikangas, Kathkeen/0000-0002-4667-2414	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIAMH002804] Funding Source: NIH RePORTER		Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P28; ANDERSON JC, 1987, ARCH GEN PSYCHIAT, V44, P69; ANGOLD A, 1993, AM J PSYCHIAT, V150, P1779; ANGST J, 1993, INT CLIN PSYCHOPHARM, V8, P21, DOI 10.1097/00004850-199309001-00003; Aschenbrand SG, 2003, J AM ACAD CHILD PSY, V42, P1478, DOI 10.1097/00004583-200312000-00015; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P24; Barger SD, 2005, J AFFECT DISORDERS, V88, P87, DOI 10.1016/j.jad.2005.05.012; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; BIRD HR, 1988, ARCH GEN PSYCHIAT, V45, P1120; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Bovasso G, 1999, COMPR PSYCHIAT, V40, P469, DOI 10.1016/S0010-440X(99)90092-5; BOYD JH, 1984, ARCH GEN PSYCHIAT, V41, P983; BRADY EU, 1992, PSYCHOL BULL, V111, P244, DOI 10.1037/0033-2909.111.2.244; BRESLAU N, 1991, PSYCHIAT RES, V37, P11, DOI 10.1016/0165-1781(91)90102-U; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; CANINO GJ, 1987, ARCH GEN PSYCHIAT, V44, P727; CHEN YW, 1995, AM J PSYCHIAT, V152, P280; Coelho HF, 2007, J AFFECT DISORDERS, V100, P103, DOI 10.1016/j.jad.2006.10.001; CORYELL W, 1986, AM J PSYCHIAT, V143, P508; Craske MG, 2001, J AM ACAD CHILD PSY, V40, P556, DOI 10.1097/00004583-200105000-00015; DAVIDSON JRT, 1993, PSYCHOL MED, V23, P709, DOI 10.1017/S0033291700025484; Depla MFIA, 2008, SOC PSYCH PSYCH EPID, V43, P200, DOI 10.1007/s00127-007-0291-z; EATON WW, 1990, ARCH GEN PSYCHIAT, V47, P819; FEINSTEIN AR, 1970, J CHRON DIS, V23, P455, DOI 10.1016/0021-9681(70)90054-8; GELLER B, 1995, J AFFECT DISORDERS, V34, P259, DOI 10.1016/0165-0327(95)00023-G; Giaconia RM, 2000, AM J ORTHOPSYCHIAT, V70, P253, DOI 10.1037/h0087634; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Goodwin RD, 2003, PSYCHOL MED, V33, P879, DOI 10.1017/S0033291703007633; Goodwin RD, 2003, J ASTHMA, V40, P139, DOI 10.1081/JAS-120017984; Goodwin RD, 2003, PSYCHIAT RES, V117, P159, DOI 10.1016/S0165-1781(02)00320-7; Goodwin RD, 2002, PSYCHOSOM MED, V64, P862, DOI 10.1097/01.PSY.0000038935.67401.F3; Goodwin RD, 2002, CHEST, V122, P645, DOI 10.1378/chest.122.2.645; Goodwin RD, 2008, J PSYCHIATR RES, V43, P239, DOI 10.1016/j.jpsychires.2008.05.006; Gotlib IH., 1992, PSYCHOL ASPECTS DEPR; Grant BF, 2005, PSYCHOL MED, V35, P1747, DOI 10.1017/S0033291705006069; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Grant BF, 2005, J PSYCHIATR RES, V39, P1, DOI 10.1016/j.jpsychires.2004.05.004; Green H., 2005, MENTAL HLTH CHILDREN; Hamalainen J, 2008, DEPRESS ANXIETY, V25, P27, DOI 10.1002/da.20256; Haines H, 2001, HEART, V85, P385, DOI 10.1136/heart.85.4.385; Hansen S, 2003, PSYCHIAT CLIN N AM, V26, P693, DOI 10.1016/S0193-953X(03)00037-6; Harter MC, 2003, EUR ARCH PSY CLIN N, V253, P313, DOI 10.1007/s00406-003-0449-y; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hasler G, 2005, AM J RESP CRIT CARE, V171, P1224, DOI 10.1164/rccm.200412-1669OC; Hayward C, 2000, J AM ACAD CHILD PSY, V39, P207, DOI 10.1097/00004583-200002000-00021; HELZER JE, 1991, PSYCHIAT DISORDERS A; Johnson JG, 2000, JAMA-J AM MED ASSOC, V284, P2348, DOI 10.1001/jama.284.18.2348; Jones C, 2005, J TRAUMA STRESS, V18, P181, DOI 10.1002/jts.20031; Kagan J., 1997, GALENS PROPHECY TEMP; Kalaydjian A, 2008, PSYCHOSOM MED, V70, P773, DOI 10.1097/PSY.0b013e31817f9e80; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; KASHANI JH, 1990, AM J PSYCHIAT, V147, P313; KATON W, 1989, J CLIN PSYCHIAT, V50, P299; Kessler RC, 1999, PSYCHOL MED, V29, P555, DOI 10.1017/S0033291799008375; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; KEYL PM, 1990, AM J EPIDEMIOL, V131, P301, DOI 10.1093/oxfordjournals.aje.a115499; Klein DN, 2003, PSYCHOL MED, V33, P703, DOI 10.1017/S0033291703007487; Kovalenko PA, 2001, AUST NZ J PSYCHIAT, V35, P815, DOI 10.1046/j.1440-1614.2001.00961.x; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Kubzansky LD, 2006, ANN BEHAV MED, V31, P21, DOI 10.1207/s15324796abm3101_5; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Lewinsohn PM, 1997, J ANXIETY DISORD, V11, P377, DOI 10.1016/S0887-6185(97)00017-0; LEWINSOHN PM, 1993, J ABNORM PSYCHOL, V102, P133, DOI 10.1037/0021-843X.102.4.517; Low NCP, 2008, J PSYCHIATR RES, V42, P596, DOI 10.1016/j.jpsychires.2007.07.002; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Lydiayd RB, 2001, J CLIN PSYCHIAT, V62, P38; MAIER W, 1995, J PSYCHIAT RES, V29, P375, DOI 10.1016/0022-3956(95)00024-Y; MAIER W, 1994, J PSYCHIAT RES, V28, P303, DOI 10.1016/0022-3956(94)90013-2; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Merikangas KR, 1998, ADDICT BEHAV, V23, P893, DOI 10.1016/S0306-4603(98)00076-8; MERIKANGAS KR, 1990, ARCH GEN PSYCHIAT, V47, P849; MERIKANGAS KR, 1995, EUR ARCH PSY CLIN N, V244, P297, DOI 10.1007/BF02190407; Merikangas KR, 2003, ARCH GEN PSYCHIAT, V60, P993, DOI 10.1001/archpsyc.60.9.993; MERIKANGAS KR, 1990, COMORBIDITY MOOD ANX; Middeldorp CM, 2005, PSYCHOL MED, V35, P611, DOI 10.1017/S003329170400412X; MOLDIN SO, 1993, PSYCHOL MED, V23, P755, DOI 10.1017/S0033291700025526; Nestadt G, 2003, BIOL PSYCHIAT, V53, P914, DOI 10.1016/S0006-3223(02)01677-3; Ortega AN, 2004, PSYCHOSOMATICS, V45, P93, DOI 10.1176/appi.psy.45.2.93; Ortega AN, 2002, J NERV MENT DIS, V190, P275, DOI 10.1097/00005053-200205000-00001; ORVASCHEL H, 1995, J AM ACAD CHILD PSY, V34, P1525, DOI 10.1097/00004583-199511000-00020; Patton GC, 1998, AM J PUBLIC HEALTH, V88, P1518, DOI 10.2105/AJPH.88.10.1518; Peterlin BL, 2008, HEADACHE, V48, P517, DOI 10.1111/j.1526-4610.2008.00917.x; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Ratcliffe GE, 2009, GEN HOSP PSYCHIAT, V31, P14, DOI 10.1016/j.genhosppsych.2008.09.006; REINHERZ HZ, 1989, J AM ACAD CHILD PSY, V28, P942, DOI 10.1097/00004583-198911000-00021; ROGERS MP, 1994, INT J PSYCHIAT MED, V24, P83, DOI 10.2190/TXM9-EVX8-Q4WT-G03J; Rohde P, 1996, J AM ACAD CHILD PSY, V35, P101, DOI 10.1097/00004583-199601000-00018; ROHDE P, 1991, J ABNORM PSYCHOL, V100, P214, DOI 10.1037/0021-843X.100.2.214; Sareen J, 2005, DEPRESS ANXIETY, V21, P193, DOI 10.1002/da.20072; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Sareen J, 2006, PSYCHIAT RES, V142, P11, DOI 10.1016/j.psychres.2006.01.009; Saunders K, 2008, NEUROLOGY, V70, P538, DOI 10.1212/01.wnl.0000297192.84581.21; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; SCHNEIER FR, 1992, ARCH GEN PSYCHIAT, V49, P282; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Slattery MJ, 2002, J AM ACAD CHILD PSY, V41, P947, DOI 10.1097/00004583-200208000-00013; Smoller JW, 2007, ARCH GEN PSYCHIAT, V64, P1153, DOI 10.1001/archpsyc.64.10.1153; Spencer TJ, 2006, J CLIN PSYCHIAT, V67, P27; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; STEWART WF, 1989, PSYCHOSOM MED, V51, P559, DOI 10.1097/00006842-198909000-00007; Stinson FS, 2007, PSYCHOL MED, V37, P1047, DOI 10.1017/S0033291707000086; STRAUSS CC, 1988, J ABNORM CHILD PSYCH, V16, P57, DOI 10.1007/BF00910500; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Swartz KL, 2000, ARCH GEN PSYCHIAT, V57, P945, DOI 10.1001/archpsyc.57.10.945; SWENDSEN J, 2009, MENTAL DISORDERS RIS; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; WACKER HR, 1992, INT J METH PSYCH RES, V2, P91; Waldie KE, 2002, J NEUROL NEUROSUR PS, V72, P86, DOI 10.1136/jnnp.72.1.86; WISE MG, 1990, J CLIN PSYCHIAT, V51, P27; WITTCHEN H U, 1989, Psychiatrie and Psychobiologie, V4, P315; WITTCHEN HU, 1994, ARCH GEN PSYCHIAT, V51, P355; WITTCHEN HU, 1999, CHILDHOOD ONSET ADUL, P259; Zimmermann P, 2003, PSYCHOL MED, V33, P1211, DOI 10.1017/S0033291703008158	119	14	14	0	8	SPRINGER-VERLAG BERLIN	BERLIN	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY	1866-3370		978-3-642-02911-0	CURR TOP BEHAV NEURO	Cur. Top. Behav. Neurosci.		2010	2						37	59		10.1007/7854_2009_32	10.1007/978-3-642-02912-7		23	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	BPM17	WOS:000279232700003	21309105				2021-06-18	
J	Noggle, CA; Pierson, EE				Noggle, Chad A.; Pierson, Eric E.			Psychosocial and Behavioral Functioning Following Pediatric TBI: Presentation, Assessment, and Intervention	APPLIED NEUROPSYCHOLOGY			English	Article						behavioral functioning; pediatric TBI; psychosocial functioning; TBI residuals	TRAUMATIC BRAIN-INJURY; OBSESSIVE-COMPULSIVE DISORDER; HEAD-INJURY; NEUROBEHAVIORAL SYMPTOMS; SOCIAL COMPETENCE; ANXIETY DISORDERS; YOUNG-CHILDREN; ADOLESCENTS; CHILDHOOD; MILD	This article reviews the current literature surrounding the emotional and behavioral consequences as a result of traumatic brain injury (TBI) for children and adolescents. The use of a treatment planning model incorporating developmental theory, recovery, and family needs is advocated. The article reviews the current literature for treatment of primary emotional and psychiatric problems associated with TBI. Additional research into the treatment and intervention of psychiatric, emotional, and behavioral problems in children with TBI remains necessary.	[Noggle, Chad A.] So Illinois Univ, Sch Med, Dept Psychiat, Springfield, IL 62794 USA; [Pierson, Eric E.] Ball State Univ, Dept Educ Psychol, Muncie, IN 47306 USA	Noggle, CA (corresponding author), So Illinois Univ, Sch Med, Dept Psychiat, 901 W Jefferson,POB 19642, Springfield, IL 62794 USA.	cnoggle@siumed.edu					Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V.A, 2001, DEV NEUROPSYCHOLOGY; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barry CT, 1996, CHILD NEUROPSYCHOL, V2, P213, DOI 10.1080/09297049608402254; Bayliss DM, 2000, DEV NEUROPSYCHOL, V17, P161, DOI 10.1207/S15326942DN1702_02; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Bond M. R., 1990, REHABILITATION ADULT, P179; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, AM J PSYCHIAT, V156, P374; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hellawell DJ, 2001, DISABIL REHABIL, V23, P300, DOI 10.1080/769979114; Jaffe K. M., 1990, REHABILITATION ADULT, P539; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; JANUSZ JA, 2000, J INT NEUROPSYCH SOC, V6, P226; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Konrad KN, 2000, BRAIN INJURY, V14, P859; Levinson M M, 1987, J Card Surg, V2, P3, DOI 10.1111/j.1540-8191.1987.tb00168.x; Livingston RB, 1996, CHILD NEUROPSYCHOL, V2, P48, DOI 10.1080/09297049608401350; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; Mesulam M.-M., 2002, PRINCIPLES FRONTAL L, P8, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0002; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; Nybo T, 1999, BRAIN INJURY, V13, P759; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Roberts MA, 1996, BRAIN INJURY, V10, P739, DOI 10.1080/026990596124007; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; SEMRUDCLIKEMAN M, 2001, TRAUMATIC BRAIN INJU; Slifer KJ, 1997, BRAIN INJURY, V11, P877; Stebbins P, 2001, REHABIL PSYCHOL, V46, P178, DOI 10.1037/0090-5550.46.2.178; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	54	14	14	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					110	115	PII 922182262	10.1080/09084281003708977			6	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800006	20467951				2021-06-18	
J	Rasool, A; Wani, AH; Darzi, MA; Zaroo, MI; Iqbal, S; Bashir, SA; Rashid, S; Lone, RA				Rasool, Altaf; Wani, Adil Hafeez; Darzi, Mohammad Ashraf; Zaroo, M. Inam; Iqbal, Shabir; Bashir, Shiekh Adil; Rashid, Shafaq; Lone, Reyaz Ahmad			Incidence and pattern of bear maul injuries in Kashmir	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Incidence; Pattern; Bear maul; Encounters; Termination; Injury; Face; Fractures; Soft tissue; Viscera	BITE	Background: Injuries due to mauling by bears are rarely reported in the literature. The high incidence of such injuries in Kashmir, India, which is a valley surrounded by dense forests and is a habitat of Asiatic Black bears, urged us to undertake such a study in our department. Materials and methods: The study was conducted both retrospectively (January 1990-July 2005) and prospectively (August 2005-December 2007). Results: A total of 417 cases were recorded and all the injuries were caused by black bears alone. Majority of the patients were young to middle-aged (96.8% of cases) and predominantly males (80.33%). The incidence was highest during July to November (76.82%), and most of the attacks (97%) occurred during daytime. Soft-tissue injury occurred in all 417 cases, bones were involved in 131 (31.41%) while the visceral organs were injured in four (12.94%) patients. The face (80.57%) was most common part of the body injured, followed by the head (54.67%), and all the patients had soft-tissue injury (100%). In spite of devastating injuries caused by bear maulings, the mortality rate was only 2.39%. Conclusion: Injuries due to mauling by black bear occur mainly between July and November. The young and middle-aged men have a higher tendency to be wounded. The face and head were the most commonly affected sites, while visceral injuries were rare. Mortality was low, and reconstruction of many of the injuries was challenging, often necessitating a staged procedure. Those living in villages close to black bear habitats may benefit from education related to the risk and severity of the attacks in the hope of reducing the number of injuries seen. (C) 2009 Elsevier Ltd. All rights reserved.	[Rasool, Altaf; Wani, Adil Hafeez; Darzi, Mohammad Ashraf; Zaroo, M. Inam; Iqbal, Shabir; Bashir, Shiekh Adil; Rashid, Shafaq] Sherikashmir Inst Med Sci, Dept Plast & Reconstruct Surg, Srinagar 190015, Kashmir, India; [Lone, Reyaz Ahmad] Sherikashmir Inst Med Sci, Dept Cardiovasc & Thorac Surg, Srinagar 190015, Jammu & Kashmir, India	Rasool, A (corresponding author), Sherikashmir Inst Med Sci, Dept Plast & Reconstruct Surg, Srinagar 190015, Kashmir, India.	altafrsl@rediffmail.com					Dvivedi S, 2003, TROP DOCT, V33, P115, DOI 10.1177/004947550303300223; Floyd T, 1999, WILD ENVIRON MED, V10, P75, DOI 10.1580/1080-6032(1999)010[0075:BIHIAF]2.3.CO;2; GOVILA A, 1989, BRIT J PLAST SURG, V42, P101, DOI 10.1016/S0007-1226(89)90124-0; Hayashi Y, 2003, J TRAUMA, V55, P1178, DOI 10.1097/01.TA.0000025324.27227.D4; HERRERO S, 1970, SCIENCE, V170, P593, DOI 10.1126/science.170.3958.593; Jethani Jitendra, 2006, Indian J Ophthalmol, V54, P287; Kunimoto D, 2004, J CLIN MICROBIOL, V42, P3374, DOI 10.1128/JCM.42.7.3374-3376.2004; Middaugh J P, 1987, Alaska Med, V29, P121; Rose S C, 1982, Alaska Med, V24, P29; TOUGH SC, 1993, AM J FOREN MED PATH, V14, P22, DOI 10.1097/00000433-199303000-00005; VENKATASWAMY G, 1962, J All India Ophthalmol Soc, V10, P22; Vougiouklakis T, 2006, AM J FOREN MED PATH, V27, P266, DOI 10.1097/01.paf.0000220930.00053.43	12	14	14	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2010	41	1					116	119		10.1016/j.injury.2009.07.077			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	547ND	WOS:000273895400022	19733351				2021-06-18	
J	Sonnenberg, LK; Dupuis, A; Rumney, PG				Sonnenberg, Lyn K.; Dupuis, Annie; Rumney, Peter G.			Pre-school traumatic brain injury and its impact on social development at 8 years of age	BRAIN INJURY			English	Article						Paediatric; acquired brain injury; social development; cognition; Mayo Portland Adaptive Inventory; outcomes	LONG-TERM OUTCOMES; CHILDREN; CHILDHOOD; PLASTICITY	Objective: To confirm the clinical impression that younger pre-school children (<4 years at time of injury) who are referred to a tertiary care centre for management with moderate-to-severe traumatic brain injury (TBI) have poorer social, cognitive, physical and emotional outcomes compared to older pre-schoolers (4-6 years at time of injury) and to describe the prevalence and severity of their social impairment at 8 years of age. Methods: This is a retrospective review of pre-schoolers with moderate-to-severe TBI from 1995-2009. Their social, cognitive, physical and emotional outcomes were assessed at 8 years of age using the Mayo-Portland Adaptability Inventory-Paediatric. Results: Of 130 pre-schoolers enrolled in the database who sustained a TBI < 6 years, 93 were seen at 8 years of age (57 males, 36 females). Younger pre-schoolers (n = 61, mean 2.6 years) had inferior social outcomes (p = 0.04) and cognitive abilities (p = 0.006), trended toward poorer physical outcomes (p = 0.1), with no difference for emotional outcomes (p = 0.2), compared to older pre-schoolers (n = 32, mean 5.0 years). Overall, 19/93 had normal social function, 38/93 had mild impairment, 21/93 had moderate impairment and 15/93 had severe impairment to social function. Conclusions: Children <4 years at the time of moderate-to-severe TBI have poorer social, cognitive and physical outcomes compared to older pre-schoolers.	[Rumney, Peter G.] Univ Toronto, Bloorview Kids Rehab, Div Dev Pediat, Sect Head Brain Injury & Rehabil Team, Toronto, ON M4G 1R8, Canada; [Sonnenberg, Lyn K.] Univ Alberta, Div NeuroDev NeuroMotor Paediat, Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Dupuis, Annie] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada	Rumney, PG (corresponding author), Univ Toronto, Bloorview Kids Rehab, Div Dev Pediat, Sect Head Brain Injury & Rehabil Team, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	prumney@bloorview.ca		Dupuis, Annie/0000-0002-8704-078X; Sonnenberg, Lyn/0000-0002-9982-4282			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; DIXON SD, 2006, ENCOUNTERS CHILDREN, P831; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Pan SY, 2006, INJURY PREV, V12, P155, DOI 10.1136/ip.2005.010561; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	16	14	14	0	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	7-8					1003	1007		10.3109/02699052.2010.489033			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000010	20545454				2021-06-18	
J	Oliveira, HM; Sallam, HS; Espana-Tenorio, J; Chinkes, D; Chung, DH; Chen, JDDZ; Herndon, DN				Oliveira, Hermes M.; Sallam, Hanaa S.; Espana-Tenorio, Jonathan; Chinkes, David; Chung, Dai H.; Chen, Jiande D. Z.; Herndon, David N.			Gastric and small bowel ileus after severe burn in rats: The effect of cyclooxygenase-2 inhibitors	BURNS			English	Article						Burn; COX-2 inhibitors; Gastric emptying; Small bowel ileus	TRAUMATIC BRAIN-INJURY; POSTOPERATIVE ILEUS; THERMAL-INJURY; COX-2; EXPRESSION; INFLAMMATION; KETOROLAC; MOTILITY; DISEASE; SURGERY	Gastrointestinal (GI) ileus is a common complication after severe burns. Selective cyclooxygenase-2 inhibitors (COX-2i) improved post-operative ileus, but its effect on burn-induced GI dysmotility is unknown. Our aim was to test whether a COX-2i improves gastric emptying (GE) and small bowel transit (SBT) after burn. Experiment on GE: rats were anesthetized and randomized into sham/scald burn, treated/untreated with COX-2i. Six hours after burn, rats received a phenol red meal and were sacrificed 30 min later. Gastric emptying was determined based on the percentage of phenol red recovered in harvested stomachs. Experiment on SBT: rats received a duodenostomy and were scald/sham burned 5 days later. Six hours after burn, rats received a phenol red meal through the duodenostomy catheter and were sacrificed 100 min later. Geometric center (GC) was calculated for SBT. GE was decreased significantly in burned vs. sham animals (p < 0.001). SBT was significantly impaired in burned vs. sham animals (p < 0.001). The COX-2i improved GE in the burn rats but not GE in the control rats or SBT in the burn rats. COX-2i improves bum-induced delayed GE, suggesting the mediation of the latter via the prostaglandin pathway. (C) 2009 Published by Elsevier Ltd and ISBI.	[Herndon, David N.] Shriners Hosp Children, Med Staff, Galveston, TX 77550 USA; [Espana-Tenorio, Jonathan; Chinkes, David; Chung, Dai H.; Herndon, David N.] Univ Texas Med Branch, Dept Surg, Galveston, TX USA; [Oliveira, Hermes M.; Sallam, Hanaa S.; Chen, Jiande D. Z.] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol, Galveston, TX USA; [Sallam, Hanaa S.] Suez Canal Univ, Dept Physiol, Fac Med, Ismailia, Egypt; [Oliveira, Hermes M.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil	Herndon, DN (corresponding author), Shriners Hosp Children, Med Staff, 815 Market St,7th Floor, Galveston, TX 77550 USA.	dherndon@utmb.edu	Sallam, Hanaa/ABD-7361-2020; Herndon, David/AAC-3354-2020	Sallam, Hanaa/0000-0003-3848-3055; 	Shriners Hospitals for Children [8556]	This study was supported by Shriners Hospitals for Children Grant # 8556 (Herndon).	ALICAN J, 1995, BURNS, V21, P171; Burns Smith J., 1998, EMERGEN MED, P1107; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; CHEN CF, 1982, BURNS, V9, P142, DOI 10.1016/0305-4179(82)90063-8; Cheng AZ, 1996, AM J SURG, V171, P85, DOI 10.1016/S0002-9610(99)80079-8; CZAJA AJ, 1974, NEW ENGL J MED, V291, P925, DOI 10.1056/NEJM197410312911801; Dubois RN, 1998, FASEB J, V12, P1063; FRANTZIDES CT, 1992, AM J PHYSIOL, V262, pG488; Gan HT, 2007, AM J SURG, V193, P530, DOI 10.1016/j.amjsurg.2006.05.019; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; JONES WG, 1991, AM J PHYSIOL, V261, pH1190; Josephs MD, 1999, J SURG RES, V86, P50, DOI 10.1006/jsre.1999.5692; Kawata K, 2003, HEPATO-GASTROENTEROL, V50, P1970; KELLEY MC, 1993, AM J SURG, V165, P107, DOI 10.1016/S0002-9610(05)80412-X; Kim JT, 2005, J CLIN ANESTH, V17, P439, DOI 10.1016/j.jclinane.2004.09.008; Komenaka IK, 2000, DIGEST SURG, V17, P578, DOI 10.1159/000051965; Korolkiewicz RP, 2003, J SURG RES, V109, P161, DOI 10.1016/S0022-4804(02)00095-1; Kreiss C, 2003, GUT, V52, P527, DOI 10.1136/gut.52.4.527; Kyle C, 2008, INT J CLIN PRACT, V62, P1684, DOI 10.1111/j.1742-1241.2008.01906.x; Macfarlane RJ, 2008, EXPERT OPIN PHARMACO, V9, P767, DOI 10.1517/14656566.9.5.767; Nadarajah A., 2006, SMJ Singapore Medical Journal, V47, P534; Oktar BK, 2002, BURNS, V28, P209, DOI 10.1016/S0305-4179(02)00004-9; PILBEAM CC, 1993, J BIOL CHEM, V268, P25643; Porcher C, 2004, NEUROGASTROENT MOTIL, V16, P785, DOI 10.1111/j.1365-2982.2004.00568.x; Porcher C, 2002, GASTROENTEROLOGY, V122, P1442, DOI 10.1053/gast.2002.33065; Sallam HS, 2007, AM J PHYSIOL-REG I, V292, pR253, DOI 10.1152/ajpregu.00100.2006; SCARPIGNATO C, 1980, ARCH INT PHARMACOD T, V246, P286; Schmidt J, 2008, NEUROGASTROENT MOTIL, V20, P689, DOI 10.1111/j.1365-2982.2007.01078.x; Schwarz NT, 2001, GASTROENTEROLOGY, V121, P1354, DOI 10.1053/gast.2001.29605; Strong VEM, 2001, SURGERY, V130, P249, DOI 10.1067/msy.2001.115901; Strong VEM, 2001, J SURG RES, V98, P40, DOI 10.1006/jsre.2001.6154; Unluer EE, 2000, BURNS, V26, P335, DOI 10.1016/S0305-4179(99)00135-7; Wolf SE, 1999, J AM COLL SURGEONS, V188, P10, DOI 10.1016/S1072-7515(98)00260-9	33	14	14	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	DEC	2009	35	8					1180	1184		10.1016/j.burns.2009.02.022			5	Critical Care Medicine; Dermatology; Surgery	General & Internal Medicine; Dermatology; Surgery	526UY	WOS:000272321400018	19464805				2021-06-18	
J	Schrupp, LE; Ciuffreda, KJ; Kapoor, N				Schrupp, Laura E.; Ciuffreda, Kenneth J.; Kapoor, Neera			Foveal versus eccentric retinal critical flicker frequency in mild traumatic brain injury	OPTOMETRY-JOURNAL OF THE AMERICAN OPTOMETRIC ASSOCIATION			English	Article						Traumatic brain injury; Acquired brain injury; Critical flicker fusion frequency; Motion sensitivity; Light sensitivity; Temporal processing		BACKGROUND: The purpose of this study was to assess the critical flicker fusion frequency (CFF) at the fovea and at 10 degrees of horizontal retinal eccentricity and to determine if there was a correlation between CFF and the degree of light and motion sensitivity in individuals with mild traumatic brain injury (TBI). METHODS: Mean CFF thresholds at the fovea, and 10 degrees to the left and right of the fovea, were obtained in 14 mild TBI and 29 visually normal subjects. A questionnaire was used to quantify the degree of light and motion sensitivity and related factors. RESULTS: There was no effect of age on CFF under any test condition in either group, nor was there a relation in the TBI group between reported light or motion sensitivity and CFF. Peripheral CFF values were lower in both populations. Among the TBI subjects, there was a trend for lower peripheral CFF values in the periphery and greater mean variability under all 3 test conditions. CONCLUSIONS: Decreased sensitivity and increased variability in CFF measurements in the TBI population can be attributed to damage to the higher visual pathways. Optometry 2009;80:642-650	[Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Vis Sci, New York, NY 10036 USA	Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Dept Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T35EY020481] Funding Source: NIH RePORTER		AUSTIN MW, 1994, CURR EYE RES, V13, P717, DOI 10.3109/02713689409047005; BATTERSBY WS, 1951, J EXP PSYCHOL, V42, P135, DOI 10.1037/h0057037; BATTERSBY WS, 1951, J EXP PSYCHOL, V42, P59, DOI 10.1037/h0063538; Callaway EM, 2005, J PHYSIOL-LONDON, V566, P13, DOI 10.1113/jphysiol.2005.088047; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Carmel D, 2006, CURR BIOL, V16, P907, DOI 10.1016/j.cub.2006.03.055; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; Chen PC, 2000, J FORMOS MED ASSOC, V99, P45; del Romo GB, 2005, INVEST OPHTH VIS SCI, V46, P1107, DOI 10.1167/iovs.04-1138; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; EVANS RW, 1992, NEUROL CLIN, V10, P815; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; GRANIT R, 1930, AM J PHYSIOL, V95, P313; Hammond BR, 2005, OPHTHAL PHYSL OPT, V25, P315, DOI 10.1111/j.1475-1313.2005.00271.x; JACKOWSKI MM, 2001, VISUAL VESTIBULAR CO, P145; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KOOI KA, 1958, NEUROLOGY, V8, P764, DOI 10.1212/WNL.8.10.764; Kurylo DD, 2006, BRAIN INJURY, V20, P237, DOI 10.1080/02699050500487415; KUYK TK, 1991, OPTOMETRY VISION SCI, V68, P786, DOI 10.1097/00006324-199110000-00005; LACHENMAYR BJ, 1994, INVEST OPHTH VIS SCI, V35, P2741; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; McKendrick A.M., 2003, ADLERS PHYSL EYE, P511; MERIGAN WH, 1990, VISUAL NEUROSCI, V5, P347, DOI 10.1017/S0952523800000432; POINTER JS, 1989, VISION RES, V29, P1133, DOI 10.1016/0042-6989(89)90061-8; Porter TC, 1902, P R SOC LONDON, V70, P313, DOI 10.1098/rspl.1902.0032; RANINEN A, 1987, J OPT SOC AM A, V4, P1620, DOI 10.1364/JOSAA.4.001620; SCHWARTZ SH, 2004, VISUAL PERCEPTION CL, P197; Seiple W, 1996, J OPT SOC AM A, V13, P658, DOI 10.1364/JOSAA.13.000658; SNELGAR RS, 1985, DOC OPHTHALMOL, V60, P79, DOI 10.1007/BF00164571; Talcott JB, 1998, NEURO-OPHTHALMOLOGY, V20, P187, DOI 10.1076/noph.20.4.187.3931; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; ZIHL J, 1990, CLIN VISION SCI, V5, P185	34	14	14	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-1839			OPTOMETRY	Optometry	NOV	2009	80	11					642	650		10.1016/j.optm.2009.04.097			9	Ophthalmology	Ophthalmology	V18QL	WOS:000208019200009	19861221				2021-06-18	
J	Hutchings, L; Atijosan, O; Burgess, C; Willett, K				Hutchings, Lynn; Atijosan, Oluwarantimi; Burgess, Chris; Willett, Keith			Developing a Spinal Clearance Protocol for Unconscious Pediatric Trauma Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Pediatric; Spinal injury; Obtunded; Unconscious; Trauma; Clearance	CERVICAL-SPINE; INJURIES; CHILDREN	Background: Spinal injury in pediatric trauma is associated with significant morbidity and mortality, but no current consensus exists on the safest and most effective method of clearance in the high-risk pediatric trauma patient. Methods: A retrospective analysis was performed on the records of 115 pediatric patients who had suffered major trauma and required admission to the pediatric intensive care unit of a United Kingdom level 1 trauma centre during a 7-year period from January 2000 to December 2006. The spinal imaging performed, and methods of clearance for each spinal region were obtained from analysis of written and electronic medical documentation. Results: In the cohort of 115 patients, there was a male predominance (63%) with motor vehicle accidents as the major mechanism of injury (63.5%). Ten patients (8.7%) were identified with spinal injuries, all of whom had sustained closed head injuries. Two of these patients had spinal cord injuries; one subsequently died. Spinal injury resulted in longer intubation times and intensive care stays, but no difference in new injury severity score or outcome. Clearance methods ranged from clinical examination to imaging with radiographs, computed tomography (CT), and dynamic screening. Magnetic resonance imaging was used as a secondary modality in two cases only, and in neither case was it used for clearance. CT demonstrated 100% specificity and sensitivity with positive and negative predictive values of I for all spinal regions. There were no cases of Spinal Cord Injury WithOut Radiologic Abnormality and no evidence of missed injuries. Conclusions: There is a need for an evidence-based protocol for the clearance of the spine in the obtunded and high-risk pediatric trauma patient. High-resolution CT with sagittal and coronal reconstructions should be the basis for cervical spinal clearance, in combination with the interpretation of films by an expert radiologist. All spinal regions should be imaged, and clearance should be formally documented. The role of magnetic resonance imaging in routine clearance remains controversial. Multicenter prospective studies are needed to develop consensus for an evidenced-based protocol for clearance in this high-risk group.	[Hutchings, Lynn; Atijosan, Oluwarantimi; Burgess, Chris] John Radcliffe Hosp, Kadoorie Ctr Crit Care Res, Oxford OX3 9DU, England; [Willett, Keith] John Radcliffe Hosp, Dept Trauma, Oxford OX3 9DU, England	Hutchings, L (corresponding author), John Radcliffe Hosp, Kadoorie Ctr Crit Care Res, Oxford OX3 9DU, England.	lynnhutchings@doctors.org.uk					Brooks RA, 2001, J TRAUMA, V50, P862; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; Flynn JM, 2002, J PEDIATR ORTHOPED, V22, P573, DOI 10.1097/00004694-200209000-00002; Frank JB, 2002, SPINE, V27, P1176, DOI 10.1097/00007632-200206010-00008; Givens TG, 1996, J TRAUMA, V41, P310, DOI 10.1097/00005373-199608000-00019; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Khanna G, 2007, SKELETAL RADIOL, V36, P477, DOI 10.1007/s00256-006-0223-0; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Martin BW, 2004, ARCH DIS CHILD, V89, P860, DOI 10.1136/adc.2003.029223; Mower WR, 2002, J TRAUMA, V53, P1198, DOI 10.1097/00005373-200212000-00039; *NAT HLTH SERV NAT, HEAD INJ GUID CG56; ORENSTEIN JB, 1994, PEDIATR EMERG CARE, V10, P132, DOI 10.1097/00006565-199406000-00003; PANG D, 1982, J NEUROSURG, V57, P114, DOI 10.3171/jns.1982.57.1.0114; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Powers Jan, 2006, J Trauma Nurs, V13, P198; Proctor MR, 2002, CRIT CARE MED, V30, pS489, DOI 10.1097/00003246-200211001-00014; Roche C, 2001, PEDIATR RADIOL, V31, P677, DOI 10.1007/s002470100532; Shaw M, 1999, CLIN RADIOL, V54, P377, DOI 10.1053/crad.1999.0192; Slack SE, 2004, EMERG MED J, V21, P189, DOI 10.1136/emj.2003.012310; Spiteri V, 2006, J TRAUMA, V61, P1171, DOI 10.1097/01.ta.0000236000.95954.9a; Tomycz ND, 2008, J TRAUMA, V64, P1258, DOI 10.1097/TA.0b013e318166d2bd; Viccellio P, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e20	26	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2009	67	4					681	686		10.1097/TA.0b013e3181a5f0ed			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	506BE	WOS:000270747000001	19820570				2021-06-18	
J	Piebes, SK; Gourley, M; McLeod, TCV				Piebes, Sarah K.; Gourley, Meganne; McLeod, Tamara C. Valovich			Caring for Student-Athletes Following a Concussion	JOURNAL OF SCHOOL NURSING			English	Article						athlete health; injuries; safety; injury prevention; school nurse	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; POSTTRAUMATIC HEADACHE; TEST-PERFORMANCE; UNITED-STATES; MANAGEMENT; COLLEGIATE; CHILDREN; RECOVERY; INJURY	The school nurse plays a dynamic role in the care and treatment of a concussed athlete. Concussions in the adolescent populations are of special concern due to their potential impact on mental development and cognitive function, as well as an increased risk of serious complications including second impact syndrome. The complexity of a concussion requires collaboration between of a variety of health care and school personnel to create an optimal situation for the student-athlete and their family. As the primary health care provider for students during the school day, school nurses can help ensure all necessary steps are taken to aid the recovery of an injured student-athlete. It is important that school nurses are up-to-date on current concussion information to allow for optimal care following injury and during the recovery process.	[Piebes, Sarah K.] Univ Vermont, Dept Athlet Med, Burlington, VT 05405 USA; [Gourley, Meganne] Desert Ridge High Sch, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Program, Mesa, AZ USA	Piebes, SK (corresponding author), Univ Vermont, Dept Athlet Med, Burlington, VT 05405 USA.		McLeod, Tamara/AAU-9435-2020				Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Callaghan M, 2001, DEV MED CHILD NEUROL, V43, P819, DOI 10.1017/S0012162201001487; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CICCONE C, 2002, NONSTEROIDAL ANTIINF, P206; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; DEBETTENCOURT LU, 2002, TEACHING EXCEPTIONAL, V34, P16; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grazzi L, 2004, NEUROL SCI, V25, pS111, DOI 10.1007/s10072-004-0265-9; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; HOSSLER P, 2006, GETTING HEAD CONCUSS; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lake AE, 1999, J HEAD TRAUMA REHAB, V14, P70, DOI 10.1097/00001199-199902000-00008; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; MCCRORY P, 2004, PRAGUE BRIT J SPORTS, V39, P196; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; National Athletic Trainers' Association, 2009, ATHL TRAIN FILL NEC; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; U.S. Department of Education, 2000, GUID IND ED PROGR; *US DEP ED, 2007, FREE APPR PUBL ED ST; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	41	14	14	0	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1059-8405	1546-8364		J SCH NURS	J. Sch. Nurs.	AUG	2009	25	4					270	281		10.1177/1059840509339782			12	Nursing	Nursing	483TH	WOS:000268990600005	19535497				2021-06-18	
J	Pothos, EM; Wood, RL				Pothos, Emmanuel M.; Wood, Rodger L.			Separate influences in learning: Evidence from artificial grammar learning with traumatic brain injury patients	BRAIN RESEARCH			English	Article						Learning; Categorization; COVIS; AGL; Traumatic brain injury	PREFRONTAL CORTEX; SIMILARITY; IMPLICIT; INTERFERENCE; SYSTEMS; ACQUISITION; FMRI	Artificial grammar learning (AGL) is one of the most extensively employed paradigms for the study of learning, Grammaticality is one of the most common ways to index performance in AGL. However, there is still extensive debate on whether there is a distinct psychological process which can lead to grammaticality knowledge. An application of the COVIS model of categorization in AGL suggests that grammaticality might arise from a hypothesis-testing system (when grammaticality is appropriately balanced with other knowledge influences), so that prefrontal cortex damage should be associated with impaired grammaticality and intact chunk strength performance. This prediction was confirmed in a study of traumatic brain injury (TBI) patients and matched controls. The TBI patient cohort had diffuse prefrontal cortex damage as evidenced by the history of their injury, CT scans, and severe executive functioning problems. Our results allow a novel interpretation of grammaticality and AGL in general. (C) 2009 Elsevier B.V. All rights reserved.	[Pothos, Emmanuel M.; Wood, Rodger L.] Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales	Pothos, EM (corresponding author), Swansea Univ, Dept Psychol, Swansea SA2 8PP, W Glam, Wales.	e.m.pothos@swansea.ac.uk; R.L.Wood@Swansea.ac.uk			ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [R000222655]; ECEuropean CommissionEuropean Commission Joint Research Centre [516542]	This research was partly supported by ESRC grant R000222655 and EC Framework 6 grant contract 516542 (NEST) to EMP. We would like to thank Louise Cleobury for collecting the data and Clare Williams for her helpful advice regarding the patient assessment.	Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A., 2002, PRINCIPLES FRONTAL L; Bailey TM, 2008, BEHAV RES METHODS, V40, P164, DOI 10.3758/BRM.40.1.164; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; BANICH MT, CURRENT DIR IN PRESS; Berry D. C., 1993, IMPLICIT LEARNING TH; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Chang GY, 2004, J EXP PSYCHOL LEARN, V30, P714, DOI 10.1037/0278-7393.30.3.714; Conway CM, 2006, PSYCHOL SCI, V17, P905, DOI 10.1111/j.1467-9280.2006.01801.x; Dienes Z, 1999, BEHAV BRAIN SCI, V22, P735, DOI 10.1017/S0140525X99002186; DULANY DE, 1984, J EXP PSYCHOL GEN, V113, P541, DOI 10.1037/0096-3445.113.4.541; Fletcher P, 1999, CEREB CORTEX, V9, P168, DOI 10.1093/cercor/9.2.168; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Johnstone T, 1999, J EXP PSYCHOL LEARN, V25, P524, DOI 10.1037/0278-7393.25.2.524; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; Knowlton BJ, 1996, J EXP PSYCHOL LEARN, V22, P169, DOI 10.1037/0278-7393.22.1.169; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; MATHEWS RC, 1989, J EXP PSYCHOL LEARN, V15, P1083, DOI 10.1037/0278-7393.15.6.1083; Minda JP, 2008, J EXP PSYCHOL LEARN, V34, P1518, DOI 10.1037/a0013355; Nosofsky RM, 2002, PSYCHON B REV, V9, P169, DOI 10.3758/BF03196274; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Opitz B, 2004, J NEUROSCI, V24, P8436, DOI 10.1523/JNEUROSCI.2220-04.2004; Pothos EM, 2005, BEHAV BRAIN SCI, V28, P1, DOI 10.1017/S0140525X05000014; Pothos EM, 2000, J EXP PSYCHOL LEARN, V26, P847, DOI 10.1037//0278-7393.26.4.847; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; Pothos EM, 2006, AM J PSYCHOL, V119, P275, DOI 10.2307/20445339; Reber A, 1993, IMPLICIT LEARNING TA; REBER AS, 1978, COGNITION, V6, P189, DOI 10.1016/0010-0277(78)90013-6; Redington M, 1996, J EXP PSYCHOL GEN, V125, P123, DOI 10.1037/0096-3445.125.2.123; Skosnik PD, 2002, NEUROIMAGE, V17, P1306, DOI 10.1006/nimg.2002.1291; Sloman SA, 1998, COGNITION, V65, P87, DOI 10.1016/S0010-0277(97)00048-6; Smith JG, 2006, BRAIN RES, V1067, P216, DOI 10.1016/j.brainres.2005.10.025; Smith JG, 2006, NEUROPSYCHOLOGIA, V44, P275, DOI 10.1016/j.neuropsychologia.2005.05.001; Stanton RD, 2007, MEM COGNITION, V35, P1747, DOI 10.3758/BF03193507; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tunney RJ, 2003, MEM COGNITION, V31, P1060, DOI 10.3758/BF03196127; Tunney RJ, 2001, J EXP PSYCHOL LEARN, V27, P614, DOI 10.1037//0278-7393.27.3.614; Wechsler D, 1998, WECHSLER ADULT INTEL; Wechsler D., 2001, WECHSLER TEST ADULT; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wood RL, 2001, NEUROBEHAVIOURAL DIS; Zeithamova D, 2006, MEM COGNITION, V34, P387, DOI 10.3758/BF03193416	46	14	14	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 12	2009	1275						67	72		10.1016/j.brainres.2009.04.019			6	Neurosciences	Neurosciences & Neurology	462RY	WOS:000267374900007	19389386	Green Accepted			2021-06-18	
J	Kim, HW; Cho, KJ; Park, SC; Kim, HJ; Kim, GW				Kim, Hyun-Woo; Cho, Kyoung-Joo; Park, Soo-Chul; Kim, Hyun-Jeong; Kim, Gyung W.			The adenoviral vector-mediated increase in apurinic/apyrimidinic endonuclease inhibits the induction of neuronal cell death after transient ischemic stroke in mice	BRAIN RESEARCH			English	Article						DNA repair; DNA fragmentation; Cerebral ischemia; Adenoviral vector	FOCAL CEREBRAL-ISCHEMIA; SUPEROXIDE-DISMUTASE DEFICIENCY; SUBSEQUENT DNA FRAGMENTATION; EXCISION-REPAIR PATHWAY; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; EARLY DECREASE; STRAND BREAKS; MOUSE-BRAIN; RAT-BRAIN	Despite the correlation between changes in the levels of apurinic/apyrimidinic endonuclease and ischemic neuronal damage, no studies have addressed the question of whether increased APE/Ref-1 can prevent ischemic neuronal cell death in vivo. Using an adenoviral vector, we investigated whether increased APE/Ref-1 can inhibit the loss of APE/Ref-1 and thereby prevent oxidative DNA damage after transient focal cerebral ischemia. Mice were subjected to intraluminal suture occlusion of the middle cerebral artery for 1 h, followed by reperfusion. Pre-ischemic treatment of the adenoviral vector was introduced intra cerebrally. An adenoviral vector harboring the entire APE/Ref-1 gene sequence or a control virus without the APE/Ref-1 sequence was introduced 3 days before ischemia/reperfusion (I/R). The reduction of APE/Ref-1 occurred before DNA fragmentation, which was shown by temporal and spatial analysis, Increased APE/Ref-1 significantly decreased DNA damage and infarct volume after I/R. In conclusion, increased APE/Ref-1 enhanced DNA repair and inhibited the induction of ischemic oxidative DNA damage and cerebral infarction after I/R. (C) 2009 Elsevier B.V. All rights reserved.	[Kim, Gyung W.] Yonsei Univ, Dept Neurol, Coll Med, Seoul 120752, South Korea; Yonsei Univ, Brain Korea Project Med Sci 21, Coll Med, Seoul 120752, South Korea	Kim, GW (corresponding author), Yonsei Univ, Dept Neurol, Coll Med, 134 Sinchon Dong, Seoul 120752, South Korea.	gyungkim@yuhs.ac		Kim, Gyung Whan/0000-0001-7053-4372	Korea Science and Engineering FoundationKorea Science and Engineering Foundation [KOSEF-2-0709-0008]	This work was supported by a grant from the Korea Science and Engineering Foundation (KOSEF-2-0709-0008).	Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chang YY, 1999, NEUROSCI LETT, V277, P61, DOI 10.1016/S0304-3940(99)00799-5; Chen J, 1997, J NEUROCHEM, V69, P232; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Evans AR, 2000, MUTAT RES-DNA REPAIR, V461, P83, DOI 10.1016/S0921-8777(00)00046-X; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; Fujimura M, 1999, J CEREBR BLOOD F MET, V19, P495, DOI 10.1097/00004647-199905000-00003; Fujimura M, 1999, J NEUROSCI, V19, P3414; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gillardon F, 1997, MOL BRAIN RES, V52, P194, DOI 10.1016/S0169-328X(97)00237-4; Grosch S, 1999, BIOCHEM BIOPH RES CO, V261, P859, DOI 10.1006/bbrc.1999.1125; Grosch S, 1998, CANCER RES, V58, P4410; Hanna M, 2004, DNA REPAIR, V3, P51, DOI 10.1016/j.dnarep.2003.09.005; Huang DY, 2000, FASEB J, V14, P407; Kawase M, 1999, STROKE, V30, P441, DOI 10.1161/01.STR.30.2.441; Kim CS, 2006, CARDIOVASC RES, V69, P520, DOI 10.1016/j.cardiores.2005.10.014; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P1690, DOI 10.1097/00004647-200012000-00008; Kim GW, 2003, J NEUROSCI, V23, P8733; Kim GW, 2001, STROKE, V32, P1401, DOI 10.1161/01.STR.32.6.1401; Kumura E, 1996, AM J PHYSIOL-CELL PH, V270, pC748; Lan J, 2003, J CEREBR BLOOD F MET, V23, P1324, DOI 10.1097/01.WCB.0000091540.60196.F2; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Li WJ, 2006, J CEREBR BLOOD F MET, V26, P181, DOI 10.1038/sj.jcbfm.9600180; Lin LH, 2000, J NEUROCHEM, V74, P1098; Liu PK, 1996, J NEUROSCI, V16, P6795; Morita-Fujimura Y, 1999, NEUROSCIENCE, V93, P1465, DOI 10.1016/S0306-4522(99)00231-6; Murakami K, 1998, J NEUROSCI, V18, P205; Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Song YJ, 2008, BIOCHEM BIOPH RES CO, V368, P68, DOI 10.1016/j.bbrc.2008.01.037; Sugawara T, 2001, STROKE, V32, P2388, DOI 10.1161/hs1001.097109; Sweder K., 2002, Journal of Biomedicine & Biotechnology, V2, P94, DOI 10.1155/S1110724302205033; Tenenbaum L, 2004, J GENE MED, V6, pS212, DOI 10.1002/jgm.506; Tsuchiya D, 2003, BRAIN RES, V970, P131, DOI 10.1016/S0006-8993(03)02300-X; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006; Walton M, 1997, MOL BRAIN RES, V44, P167, DOI 10.1016/S0169-328X(96)00291-4; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yan MD, 2000, ACTA BIOCH BIOPH SIN, V32, P63; Yenari MA, 2001, NEUROL RES, V23, P543, DOI 10.1179/016164101101198802; ZHAO B, 1992, NUCLEIC ACIDS RES, V20, P4097, DOI 10.1093/nar/20.15.4097; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	46	14	16	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 5	2009	1274						1	10		10.1016/j.brainres.2009.04.006			10	Neurosciences	Neurosciences & Neurology	457BB	WOS:000266898700001	19374886				2021-06-18	
J	Colak, A; Kaya, M; Karaoglan, A; Sagmanligil, A; Akdemir, O; Sahan, E; Celik, O				Colak, A.; Kaya, M.; Karaoglan, A.; Sagmanligil, A.; Akdemir, O.; Sahan, E.; Celik, Oe			Calpain inhibitor AK 295 inhibits calpain-induced apoptosis and improves neurologic function after traumatic spinal cord injury in rats	NEUROCIRUGIA			English	Article						AK 295; Apoptosis; Calpain inhibitor; Secondary damage; Spinal cord trauma	ACTIVATED NEUTRAL PROTEINASE; CRYSTAL-STRUCTURE; DOWN-REGULATION; CALCIUM; BRAIN; CALPASTATIN; EXPRESSION; NEUROPROTECTION; DEGRADATION; MECHANISM	Background. An increase in the level of intracellular calcium activates the calcium-dependent neutral protease calpain, which in turn leads to cellular dysfunction and cell death after an insult to the central nervous system. fit this study, we evaluated the effect of a calpain inhibitor, AK 295, on spinal cord structure, neurologic function, and apoptosis after spinal cord injury (SCI) in a murine model. Methods. Thirty albino Wistar rats were divided into 3 groups of 10 each: the sham-operated control group (group 1), the spinal cord trauma group (group 2), and the spinal cord trauma plus AK 295 treatment group (group 3). After having received a combination of ketamine 60 mg/kg and xylazine 9 mg/kg to induce anesthesia, the rats in groups 2 and 3 were subjected to thoracic trauma by the weight drop technique (40 g-cm). One hour after having been subjected to that trauma, the rats in groups 2 and 3 were treated with an intraperitoneal injection of either dimethyl sulfoxide 2 mg/kg or AK 295 2 mg/kg. The effects of the injury and the efficacy of AK 295 were determined by an assessment of the TUNEL technique and the results of examination with a light microscope. The neurologic performance of 5 rats from group 2 and 5 from group 3 was assessed by means of the inclined plane technique and the modified Tarlov's motor grading scale 1, 3, and 5 days after spinal cord trauma. Findings. Light-microscopic examination of spinal cord specimens from group 2 revealed hemorrhage, edema, necrosis, and vascular thrombi 24 : hours after trauma. Similar (but less prominent) features were seen in specimens obtained from group 3 rats. Twenty-four hours after injury, the mean apoptotie cell numbers in groups I and 2 were zero and 4.57 +/- 0.37 cells, respectively. In group 3, the mean apoptotic cell number was 2.30 +/- 0.34 cells, a value significantly lower than that in group 2 (P < .05). Five days after trauma, the injured rats in group 2 demonstrated significant motor dysfunction (P < .05). In comparison, the motor scores exhibited by group 3 rats were markedly better (P < .05). Conclusions. AK 295 inhibited apoptosis via calpain-dependent pathway's and provided neuroprotection and improved neurologic function in a rat model of SCI. To our knowledge, this is the first study to evaluate the use of AK 295, a calpain inhibitor, after SCI. Our data suggest that AK 295 might be a novel therapeutic compound for the neuroprotection of tissue and the recovery of function in patients with a SCI.	[Colak, A.; Karaoglan, A.] Maltepe Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Kaya, M.; Sagmanligil, A.; Akdemir, O.] Taksim Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Sahan, E.] Taksim Educ & Res Hosp, Dept Pathol, Istanbul, Turkey; [Celik, Oe] Istanbul Kultur Univ, Fac Sci & Letters, Dept Mol Biol & Genet, Istanbul, Turkey	Colak, A (corresponding author), Terakki Caddesi 47-7, Istanbul, Turkey.		Celik, Ozge/AAG-4778-2019				Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Banik NL, 1997, BRAIN RES, V748, P205, DOI 10.1016/S0006-8993(96)01302-9; Banik NL, 1998, ANN NY ACAD SCI, V844, P131, DOI 10.1111/j.1749-6632.1998.tb08228.x; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; BANIK NL, 1986, J NEUROL SCI, V73, P245, DOI 10.1016/0022-510X(86)90149-8; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; Bresnahan J. C., 1996, Society for Neuroscience Abstracts, V22, P1185; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Colak A, 2005, J NEUROSURG-SPINE, V2, P327, DOI 10.3171/spi.2005.2.3.0327; Crowe MJ, 1997, NAT MED, V3, P240; Du S, 1999, EXP NEUROL, V157, P96, DOI 10.1006/exnr.1999.7041; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; GUROFF G, 1964, J BIOL CHEM, V239, P149; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Katoh K, 1996, NEUROSCI LETT, V216, P9; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Li ZH, 1996, NEUROCHEM RES, V21, P441, DOI 10.1007/BF02527708; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; MOHAN PS, 1995, J NEUROCHEM, V64, P859; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ray GE, 1999, SOC DEV, V8, P380, DOI 10.1111/1467-9507.00102; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Ray SK, 2001, BRAIN RES, V916, P115, DOI 10.1016/S0006-8993(01)02874-8; Ray SK, 1999, ANN NY ACAD SCI, V890, P261, DOI 10.1111/j.1749-6632.1999.tb08001.x; RAY SK, 2002, WILEY ENCY MOL MED, V5, P435; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saido TC, 1997, NEUROSCI LETT, V227, P75, DOI 10.1016/S0304-3940(97)00309-1; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shields DC, 2000, J NEUROSCI RES, V61, P146; Sorimachi Y, 1997, J BIOCHEM-TOKYO, V122, P743; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; SUZUKI K, 1987, FEBS LETT, V220, P271, DOI 10.1016/0014-5793(87)80828-1; TARLOV IM, 1957, SPINAL CORD COMPRESS, P147; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsuji T, 1998, NEUROSCI LETT, V248, P109, DOI 10.1016/S0304-3940(98)00348-6; Villa PG, 1998, J CELL SCI, V111, P713; Wootz H, 2006, EXP CELL RES, V312, P1890, DOI 10.1016/j.yexcr.2006.02.021; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1	51	14	19	0	4	SOC ESPANOLA NEUROCIRUGIA	MURCIA	C/O  DR POZA, GRAN VIA SALZILLO 42, 30005 MURCIA, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	JUN	2009	20	3					245	254					10	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	479TY	WOS:000268685000002	19575128				2021-06-18	
J	Willmott, C; Ponsford, J; Olver, J; Ponsford, M				Willmott, Catherine; Ponsford, Jennie; Olver, John; Ponsford, Michael			SAFETY OF METHYLPHENIDATE FOLLOWING TRAUMATIC BRAIN INJURY: IMPACT ON VITAL SIGNS AND SIDE-EFFECTS DURING INPATIENT REHABILITATION	JOURNAL OF REHABILITATION MEDICINE			English	Article						methylphenidate; traumatic brain injury; rehabilitation; vital signs; side-effects	HEART-RATE; PLACEBO	Objective: The aim of the present study was to evaluate the safety of methylphenidate administered during inpatient rehabilitation following traumatic brain injury. Methods: Forty inpatients with moderate-severe traumatic brain injury (mean 68.4 days post-injury) participated in a randomized, cross-over, double-blind, placebo-controlled trial of methylphenidate administered at a dose of 0.3 mg/kg body weight twice daily. Results: Methylphenidate administration resulted in a statistically significant increase in pulse of 12.3 beats/min (95% confidence interval ( 9.25-15.36), diastolic blood pressure of 4.1 mmHg (95%. CI 2.11-6.10), and mean arterial pressure of 3.75 mmHg (95% CI 1.79-5.72). These changes did not, however, appear to be symptomatic, as no participants were withdrawn due to adverse events, and there was no significant self-report of increased heart rate with methylphenidate. Blinding was successful. Significantly greater reporting of irritability of 0.14 points (95%, CI 0.02-0.26), difficulty sleeping of 0.17 points (95% CI 0.02-0.31) and total side-effects of 0.68 points (95% CI 0.06-1.30) was associated with methylphenidate compared with placebo. Conclusion: Methylphenidate given at 0.3 mg/kg body weight appears to be safe in the inpatient rehabilitation phase. This trial is registered with the Australian New Zealand Clinical Trials Registry (12607000503426).	[Willmott, Catherine] Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia; [Olver, John; Ponsford, Michael] Epworth HealthCare, Epworth Rehabil, Richmond, Australia; [Willmott, Catherine; Ponsford, Jennie; Olver, John; Ponsford, Michael] Monash Epworth Rehabil Res Ctr, Richmond, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Prahran, Vic, Australia	Willmott, C (corresponding author), Monash Univ, Dept Psychol, Sch Psychol Psychiat & Psychol Med, Bldg 17, Clayton, Vic 3800, Australia.	catherine.willmott@med.monash.edu.au	Willmott, Catherine/AAA-5105-2019	Willmott, Catherine/0000-0001-8517-9035; Olver, John/0000-0001-7069-1191			Al-Adawi S., 2005, Journal of Applied Research, V5, P61; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Burke DT, 2003, AM J PHYS MED REHAB, V82, P493, DOI 10.1097/00002060-200307000-00001; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kimko HC, 1999, CLIN PHARMACOKINET, V37, P457, DOI 10.2165/00003088-199937060-00002; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86	13	14	14	0	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	JUN	2009	41	7					585	587		10.2340/16501977-0369			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	463HD	WOS:000267421100014	19543672	DOAJ Gold			2021-06-18	
J	Kinsella, GJ; Ong, B; Tucker, J				Kinsella, Glynda J.; Ong, Ben; Tucker, Jodie			Traumatic Brain Injury and Prospective Memory in a Virtual Shopping Trip Task: Does It Matter Who Generates the Prospective Memory Target?	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; prospective memory; naturalistic task; generation effect	WORKING-MEMORY; PERFORMANCE; EVENT; ADULTS; TIME	The current study aimed to investigate prospective memory in traumatic brain injury by using a laboratory-based but naturalistic style assessment task. The objective was to determine if performance differed when the prospective memory targets were self-generated or experimenter-generated (a generation effect). Sixteen people who had sustained a traumatic brain injury and had received rehabilitation were compared to 16 healthy age-matched control participants on a naturalistic virtual measure of shopping and prospective memory. Results demonstrated that the traumatic brain group was less accurate in overall prospective remembering performance than the control group but there was a lack of difference between the self-and experimenter-generated prospective memory targets for both participant groups. Both retrospective memory and executive attention of working memory were associated with prospective memory performance in the naturalistic task. The findings of the study suggest that the generation effect commonly observed in retrospective memory performance may not impact performance in prospective memory.	[Kinsella, Glynda J.; Ong, Ben; Tucker, Jodie] La Trobe Univ, Melbourne, Vic 3086, Australia	Kinsella, GJ (corresponding author), La Trobe Univ, Melbourne, Vic 3086, Australia.	g.kinsella@latrobe.edu.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934			Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bertsch S, 2007, MEM COGNITION, V35, P201, DOI 10.3758/BF03193441; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; EINSTEIN GO, 2004, MEMORY FITNESS GUIDE; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Logie R, 2004, EUR J COGN PSYCHOL, V16, P441, DOI 10.1080/09541440340000114; Marsh RL, 2000, APPL COGNITIVE PSYCH, V14, pS29, DOI 10.1002/acp.769; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mulligan NW, 2004, J EXP PSYCHOL LEARN, V30, P838, DOI 10.1037/0278-7393.30.4.838; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Rendell PG, 2007, J INT NEUROPSYCH SOC, V13, P410, DOI 10.1017/S1355617707070579; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D., 2002, BRAIN IMPAIR, V3, DOI [https://doi.org/10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Titov N, 2000, BRAIN INJURY, V14, P877; Titov N, 2001, APPL COGNITIVE PSYCH, V15, P61, DOI 10.1002/1099-0720(200101/02)15:1<61::AID-ACP689>3.0.CO;2-Y; Uttl B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001568; Wechsler D, 1997, WAIS 3 ADM SCORING M	32	14	14	1	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2009	10	1			SI		45	51		10.1375/brim.10.1.45			7	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	443CQ	WOS:000265888200007					2021-06-18	
J	Sahuquillo, J; Perez-Barcena, J; Biestro, A; Zavala, E; Merino, MA; Vilalta, A; Poca, MA; Garnacho, A; Adalia, R; Homar, J; LLompart-Pou, JA				Sahuquillo, Juan; Perez-Barcena, Jon; Biestro, Alberto; Zavala, Elizabeth; Merino, Mari-Angels; Vilalta, Anna; Antonia Poca, Maria; Garnacho, Angel; Adalia, Ramon; Homar, Javier; Antonio LLompart-Pou, Juan			Intravascular cooling for rapid induction of moderate hypothermia in severely head-injured patients: results of a multicenter study (IntraCool)	INTENSIVE CARE MEDICINE			English	Article						Intravascular temperature management; Moderate hypothermia; Pilot study; Refractory high ICP; Severe head injury; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; INTRACRANIAL HYPERTENSION; THERAPEUTIC HYPOTHERMIA; VASOCONSTRICTION; PRESSURE; CORE	To evaluate the feasibility, safety and effectiveness of a new method of intravascular temperature management for inducing moderate hypothermia (MHT). Prospective, international-multicenter clinical trial conducted in four university hospitals. In a 2-year period 24 patients with severe head injury and refractory high ICP were treated with MHT (32.5A degrees C) by intravascular methods. Seventeen were males and seven females, with a median age of 25 years (range 15-60). The median Glasgow Coma Scale upon admission was 7 (range 3-13) and the median Injury Severity Score was 22 (range 13-43). A total of 75% of patients presented a diffuse lesion in the pre-enrollment computed tomography. Median time from injury until reaching refractory high ICP was 71.5 h after injury (minimum 14 h, maximum 251 h). Twelve patients (50%) reached this situation within the first 72 h after injury. MHT was attained in a median time of 3 h. Pre-enrollment median ICP was 23.8 mmHg and was reduced to 16.8 mmHg upon reaching target temperature. At 6 months after injury, nine patients had died (37.5%), six were severely disabled (25%), two moderately disabled (8.3%) and seven had a good recovery (29.2%). Of the nine patients who died, in four the cause was rebound ICP during rewarming, one death was attributed to accidental potassium overload, two to septic shock, one to cardiac arrest of unknown origin and the ninth to a pulmonary embolism. Intravascular methods to induce MHT combined with precooling with cold saline at 4A degrees C appear to be feasible and effective in reducing ICP in patients with high ICP refractory to first-line therapeutic measures.	[Sahuquillo, Juan; Antonia Poca, Maria] Univ Autonoma Barcelona, Dept Neurosurg, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Perez-Barcena, Jon; Homar, Javier; Antonio LLompart-Pou, Juan] Son Dureta Univ Hosp, Intens Care Unit, Palma de Mallorca, Spain; [Biestro, Alberto] Hosp Clin Montevideo, Intens Care Unit, Montevideo, Uruguay; [Zavala, Elizabeth; Adalia, Ramon] Clin Univ Hosp, Surg ICU, Dept Anesthesiol, Barcelona, Spain; [Merino, Mari-Angels; Vilalta, Anna] Univ Autonoma Barcelona, Neurotraumatol Res Unit, Vall Hebron Univ Hosp, Barcelona 08035, Spain; [Garnacho, Angel] Univ Autonoma Barcelona, Neurotraumatol ICU, Vall Hebron Univ Hosp, Barcelona 08035, Spain	Sahuquillo, J (corresponding author), Univ Autonoma Barcelona, Dept Neurosurg, Vall Hebron Univ Hosp, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	sahuquillo@neurotrauma.net; jperez@hsd.es; mapibies@adinet.com.uy; ezavala@clinic.ub.es; mamerino@neurotrauma.net; annavilalta@neurotrauma.net; pocama@neurotrauma.net; garnacho@neurotrauma.net; 30717rab@comb.es; jhomar@hsd.es; jallompart@hsd.es	Garnacho, Angel/A-9309-2013; Poca, Maria A./B-8475-2008; Sahuquillo, Juan/B-3577-2008	Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Vilalta, Anna/0000-0002-2183-072X			*AM ASS NEUR SURG, 2007, J NEUROTRAUMA S1, V24, pS21; *AM ASS NEUR SURG, 2007, J NEUROTRAUMA S1, V24, pS71; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1995, J NEUROSURG ANESTH, V7, P152, DOI 10.1097/00008506-199504000-00023; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; FAY T, 1945, RES PUBL ASS NERV ME, V24, P611; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Grosse-Wortmann L, 2006, PEDIATR CARDIOL, V27, P286, DOI 10.1007/s00246-005-1248-1; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; KURZ A, 1995, ANESTHESIOLOGY, V82, P870, DOI 10.1097/00000542-199504000-00008; LASKOWSKI EJ, 1960, NEUROLOGY, V10, P499, DOI 10.1212/WNL.10.5.499; LEOD AA, 1982, BRIT HEART J, V47, P221; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall SB, 1991, J NEUROSURG S, V75, P14; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P1169, DOI 10.1097/00000542-199505000-00012; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Perez-Barcena J, 2005, NEUROCIRUGIA, V16, P5; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pichon N, 2007, CRIT CARE, V11, DOI 10.1186/cc5956; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; POLDERMAN KH, 2003, INTENS CARE MED, V29, P1637; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; QUI W, 2006, J CLIN NEUROSCI, V13, P995; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; ROBERTS I, 2005, BARBITURATES ACUTE T; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; SHAPIRO HM, 1974, J NEUROSURG, V40, P90, DOI 10.3171/jns.1974.40.1.0090; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wittebole X, 2005, J ELECTROCARDIOL, V38, P77, DOI 10.1016/j.jelectrocard.2004.09.004; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	39	14	16	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAY	2009	35	5					890	898		10.1007/s00134-008-1357-4			9	Critical Care Medicine	General & Internal Medicine	440NL	WOS:000265706900016	19034424				2021-06-18	
J	Claro, R; Sousa, R; Massada, M; Ramos, J; Lourenco, JM				Claro, Rui; Sousa, Ricardo; Massada, Marta; Ramos, Joaquim; Lourenco, Jose M.			Bilateral posterior fracture-dislocation of the shoulder: Report of two cases	INTERNATIONAL JOURNAL OF SHOULDER SURGERY			English	Article						Convulsive seizure; electrocution; posterior fracture-dislocation shoulder	PROXIMAL HUMERAL FRACTURES; MCLAUGHLIN PROCEDURE; CLOSED REDUCTION; HEAD	Bilateral posterior fracture-dislocation of the shoulder is a very rare injury. Almost 50 of bilateral posterior dislocations are due to a convulsive seizure, rising to 90 if the dislocations are associated with fractures. Electric shock accounts for less than 5 of bilateral posterior dislocations of the shoulder. A systematization of the clinical and radiological approach, followed by an early diagnosis and proper surgical treatment is essential. Authors report 2 cases of bilateral posterior fracture-dislocation of the shoulder, one caused by a convulsive seizure and the other by an electric shock. A review of literature and a treatment protocol are also presented.	[Claro, Rui; Sousa, Ricardo; Massada, Marta; Ramos, Joaquim; Lourenco, Jose M.] Hosp Santo Antonio, Ctr Hosp Porto, Dept Orthopaed, P-4099001 Oporto, Portugal	Claro, R (corresponding author), Hosp Santo Antonio, Ctr Hosp Porto, Dept Orthopaed, P-4099001 Oporto, Portugal.	ruiclaromed@yahoo.com	Claro, Rui/AAC-9689-2021	Claro, Rui/0000-0003-4836-2994; Sousa, Ricardo/0000-0003-4293-7347			Alta TDW, 2008, EUR J ORTHOP SURG TR, V18, P381, DOI 10.1007/s00590-008-0316-7; BELL HM, 1965, J BONE JOINT SURG AM, VA 47, P1521, DOI 10.2106/00004623-196547080-00006; Brackstone M, 2001, NEUROLOGY, V56, P1403, DOI 10.1212/WNL.56.10.1403; Checchia SL, 1998, J SHOULDER ELB SURG, V7, P53, DOI 10.1016/S1058-2746(98)90183-5; Cheng SL, 1997, J SHOULDER ELB SURG, V6, P11, DOI 10.1016/S1058-2746(97)90065-3; Clough T M, 2001, Eur J Emerg Med, V8, P161; Connor PM, 1997, J SHOULDER ELB SURG, V6, P480, DOI 10.1016/S1058-2746(97)80002-X; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Cooke SJ, 2005, INJURY, V36, P90; Dervin GF, 2002, J BONE JOINT SURG AM, V84A, P804, DOI 10.2106/00004623-200205000-00018; DeWall M, 2005, J ORTHOP TRAUMA, V19, P48, DOI 10.1097/00005131-200501000-00009; Duparc F, 2001, SURG RADIOL ANAT, V23, P185, DOI 10.1007/s00276-001-0185-9; GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486, DOI 10.2106/00004623-199072100-00009; Gerber C, 1996, J BONE JOINT SURG AM, V78A, P376, DOI 10.2106/00004623-199603000-00008; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; KARPINSKI MRK, 1984, INJURY, V15, P274, DOI 10.1016/0020-1383(84)90013-5; Martens C, 1995, Acta Orthop Belg, V61, P249; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; Neyton L, 2008, NICE SHOULDER COURSE, P227; NICOLA FG, 1981, J BONE JOINT SURG AM, V63, P1175, DOI 10.2106/00004623-198163070-00018; SHAW JL, 1971, J BONE JOINT SURG AM, VA 53, P1437, DOI 10.2106/00004623-197153070-00023; Sperling JW, 2004, J SHOULDER ELB SURG, V13, P522, DOI 10.1016/j.jse.2004.02.012; WADLINGTON VR, 1992, J TRAUMA, V32, P113, DOI 10.1097/00005373-199201000-00024; WALCH G, 1990, REV CHIR ORTHOP, V76, P546	27	14	18	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0973-6042			INT J SHOULDER SURG	Int. J. Shoulder Surg.	APR-JUN	2009	3	2					41	45		10.4103/0973-6042.57935			5	Orthopedics; Surgery	Orthopedics; Surgery	V28IA	WOS:000208673300005	20661400	Green Published			2021-06-18	
J	Siegmund, GP; Blouin, JS				Siegmund, Gunter P.; Blouin, Jean-Sebastien			Head and neck control varies with perturbation acceleration but not jerk: implications for whiplash injuries	JOURNAL OF PHYSIOLOGY-LONDON			English	Article							REAR-END IMPACTS; FACET JOINT KINEMATICS; POSTURAL RESPONSES; MUSCLE-ACTIVITY; SEATED SUBJECTS; STARTLE; HUMANS; TRANSLATION; VARIABILITY; MOVEMENTS	Recent studies have proposed that a high rate of acceleration onset, i.e. high jerk, during a low-speed vehicle collision increases the risk of whiplash injury by triggering inappropriate muscle responses and/or increasing peak head acceleration. Our goal was to test these proposed mechanisms at realistic jerk levels and then to determine how collision jerk affects the potential for whiplash injuries. Twenty-three seated volunteers (8 F, 15 M) were exposed to multiple experiments involving perturbations simulating the onset of a vehicle collision in eyes open and eyes closed conditions. In the first experiment, subjects experienced five forward and five rearward perturbations to look for the inappropriate muscle responses and 'floppy' head kinematics previously attributed to high jerk perturbations. In the second experiment, we independently varied the jerk (similar to 125 to 3 000 ms(-3)) and acceleration (similar to 0.65 to 2.6 g) of the perturbation to assess their effect on the electromyographic (EMG) responses of the sternocleidomastoid (SCM), scalene (SCAL) and cervical paraspinal (PARA) muscles and the kinematic responses of the head and neck. In the first experiment, we found neither inappropriate muscle responses nor floppy head kinematics when subjects had their eyes open, but observed two subjects with floppy head kinematics with eyes closed. In the second experiment, we found that about 70% of the variations in the SCM and SCAL responses and about 95% of the variations in head/neck kinematics were explained by changes in perturbation acceleration in both the eyes open and eyes closed conditions. Less than 2% of the variation in the muscle and kinematic responses was explained by changes in perturbation jerk and, where significant, response amplitudes diminished with increasing jerk. Based on these findings, collision jerk appears to have little or no role in the genesis of whiplash injuries in low-speed vehicle crashes.	[Siegmund, Gunter P.] MEA Forens Engn & Scientists, Richmond, BC V7A 4S5, Canada; [Siegmund, Gunter P.; Blouin, Jean-Sebastien] Univ British Columbia, Sch Human Kinet, Vancouver, BC V5Z 1M9, Canada	Siegmund, GP (corresponding author), MEA Forens Engn & Scientists, 11-11151 Horseshoe Way, Richmond, BC V7A 4S5, Canada.	gunter.siegmund@meaforensic.com	Siegmund, Gunter P/B-7003-2013	Siegmund, Gunter/0000-0003-2387-941X	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; BC Neurotrauma Grant; MEA Forensic Engineers Scientists; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Chiropractic Research Foundation; Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research	This work was funded by the Natural Sciences and Engineering Research Council of Canada, BC Neurotrauma Grant and MEA Forensic Engineers & Scientists. JSB received salary support from the Canadian Institutes of Health Research - Canadian Chiropractic Research Foundation and Michael Smith Foundation for Health Research.	Allum JHJ, 1997, J VESTIBUL RES-EQUIL, V7, P189; Blouin JS, 2007, J APPL PHYSIOL, V102, P1574, DOI 10.1152/japplphysiol.00703.2006; Blouin JS, 2006, J PHYSIOL-LONDON, V573, P857, DOI 10.1113/jphysiol.2006.108274; Blouin JS, 2006, SPINE, V31, P146, DOI 10.1097/01.brs.0000195157.75056.df; Blouin JS, 2003, NEUROSCI LETT, V347, P1, DOI 10.1016/S0304-3940(03)00632-3; Blouin JS, 2003, EXP BRAIN RES, V150, P458, DOI 10.1007/s00221-003-1466-9; Brault JR, 2000, CLIN BIOMECH, V15, P426, DOI 10.1016/S0268-0033(99)00097-2; Buchanan JJ, 1999, J NEUROPHYSIOL, V81, P2325; Castro W H, 1997, Eur Spine J, V6, P366, DOI 10.1007/BF01834062; Corna S, 1999, EXP BRAIN RES, V124, P331, DOI 10.1007/s002210050630; EVANS RW, 1992, NEUROL CLIN, V10, P975; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; GRESTY M, 1989, MOVEMENT DISORD, V4, P233, DOI 10.1002/mds.870040305; GUITTON D, 1986, EXP BRAIN RES, V64, P59; Hernandez IA, 2006, EUR SPINE J, V15, P876, DOI 10.1007/s00586-005-0956-9; Hynes LM, 2008, ACCIDENT ANAL PREV, V40, P1063, DOI 10.1016/j.aap.2007.11.012; Ivancic PC, 2004, EUR SPINE J, V13, P61, DOI 10.1007/s00586-003-0590-3; Jones TA, 1998, J VESTIBUL RES-EQUIL, V8, P253; Kanaya T, 1995, J PHYSIOL-LONDON, V489, P895, DOI 10.1113/jphysiol.1995.sp021102; KRAFFT M, 2005, P 19 ESV C; Krafft M., 2002, TRAFFIC INJ PREV, V3, P141, DOI [10.1080/15389580212001, DOI 10.1080/15389580212001]; Kumar S, 2002, SPINE, V27, P1044, DOI 10.1097/00007632-200205150-00009; Kumar S, 2000, ACCIDENT ANAL PREV, V32, P233, DOI 10.1016/S0001-4575(99)00114-1; Magnusson ML, 1999, EUR SPINE J, V8, P118, DOI 10.1007/s005860050140; Ono K, 1996, ACCIDENT ANAL PREV, V28, P493, DOI 10.1016/0001-4575(96)00019-X; ONO K, 1997, P 41 STAPP CAR CRASH, V41, P39; PADGAOKAR AJ, 1975, T AM SOC MECH ENG, V75, P522; Pearson AM, 2004, SPINE, V29, P390, DOI 10.1097/01.BRS.0000090836.50508.F7; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Siegmund GP, 2003, SPINE, V28, P671, DOI 10.1097/00007632-200304010-00010; Siegmund GP, 2002, EXP BRAIN RES, V144, P314, DOI 10.1007/s00221-002-1048-2; SIEGMUND GP, 1997, P 41 STAPP CAR CRASH, V41, P357; Siegmund GP, 2008, EXERC SPORT SCI REV, V36, P76, DOI 10.1097/JES.0b013e318168f1ce; Siegmund Gunter P, 2004, Stapp Car Crash J, V48, P419; Siegmund GP, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-80; Stemper BD, 2004, SPINE, V29, P1764, DOI 10.1097/01.BRS.0000134563.10718.A7; Sterner Y, 2004, J REHABIL MED, V36, P193, DOI 10.1080/16501970410030742; SZABO TJ, 1996, P 40 STAPP CAR CRASH, V40, P295; Vibert N, 2006, GAIT POSTURE, V23, P355, DOI 10.1016/j.gaitpost.2005.04.006; Vibert N, 2001, J PHYSIOL-LONDON, V532, P851, DOI 10.1111/j.1469-7793.2001.0851e.x	40	14	14	0	9	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3751			J PHYSIOL-LONDON	J. Physiol.-London	APR	2009	587	8					1829	1842		10.1113/jphysiol.2009.169151			14	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	439GY	WOS:000265616800017	19237420	Green Published			2021-06-18	
J	Gomez, R; O'Keeffe, T; Chang, LY; Huebinger, RM; Minei, JP; Barber, RC				Gomez, Ruben; O'Keeffe, Terence; Chang, Ling-Yu; Huebinger, Ryan M.; Minei, Joseph P.; Barber, Robert C.			Association of Mitochondrial Allele 4216C With Increased Risk for Complicated Sepsis and Death After Traumatic Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	67th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma/Meeting of the Association-for-Acute-Medicine	SEP 24-27, 2008	Maui, HI	Amer Assoc Surg Trauma, Assoc Acute Med		Mitochondrial electron-transport-chain; Mitochondrial polymorphism; Posttraumatic sepsis; Posttraumatic death; Genetic association; Complex I; ND1	PARKINSONS-DISEASE; DYSFUNCTION; POLYMORPHISMS; EPIDEMIOLOGY; MORTALITY; NETWORKS; LINKAGE; VARIANT	Objectives: Numerous studies have linked impaired mitochondrial activity with increased risk for clinical complications after injury. Furthermore, a number of nonsynonymous polymorphisms have been identified within the mitochondrial genome that are believed to impair cellular respiration. These DNA variants include a nonsynonymous polymorphism (T4216C) in the NADH dehydrogenase 1 gene (ND1), which encodes a key member of Complex I of the electron transport chain. We hypothesized that trauma patients who carry the ND1 4216C allele may be less able to generate the cellular energy necessary to mount an effective immune response and are at increased risk for death as well as sepsis complicated by organ dysfunction or shock. Methods: We enrolled a cohort of 136 patients admitted to the Parkland Hospital Surgical intensive care unit (ICU) with significant trauma (Injury Severity Score ? 16), >= 16 years of age, and with a minimum intensive care unit stay of ?24 hours under a protocol approved by the UTSW and Parkland IRBs. Patients with brain death, spinal cord injury, active malignancy, HIV/AIDS or who survived <48 hours after admission were excluded. Clinical data were collected prospectively and T4216C was genotyped by polymerase chain reaction-restriction fragment length polymorphism. Results: After multivariate adjustment for mechanism, severity of injury, units of packed red blood cells given in the first 24 hours, age, gender,, and race/ethnicity, carriage of the 4216 C-allele was significantly associated with increased risk for sepsis complicated by organ dysfunction or septic shock (adjusted odds ratio [aOR] = 3.68; 95% CI: 1.17-11.52; p = 0.02) as well as death (aOR = 4.56; 95% CI: 1.05-19.79; p = 0.04), relative to carriers of the T-allele. Conclusion: Carriage of the mitochondrial 4216C-allele increases the risk for infectious complications and death after severe trauma.	[Gomez, Ruben; O'Keeffe, Terence; Chang, Ling-Yu; Huebinger, Ryan M.; Minei, Joseph P.; Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA	Barber, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.barber@utsouthwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM021681] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P50 GM21681-42, 5T32 GM00859313] Funding Source: Medline		Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107001-00035; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Barber RC, 2008, SHOCK, V29, P38; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barber RC, 2007, J BURN CARE RES, V28, P205, DOI 10.1097/BCR.0B013E318031A1BF; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Canter JA, 2007, ANN SURG, V246, P406, DOI 10.1097/SLA.0b013e3181469955; Choudhry MA, 2005, SHOCK, V24, P101, DOI 10.1097/01.shk.0000191341.31530.5e; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Hofmann S, 1997, AM J HUM GENET, V60, P1539; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016; Imahara Scott D, 2004, Curr Opin Crit Care, V10, P318, DOI 10.1097/01.ccx.0000140942.42247.7e; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; Kudsk K A, 1994, Nutr Clin Pract, V9, P165, DOI 10.1177/0115426594009005165; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; Militsa B, 2001, Neurol India, V49 Suppl 1, pS75; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; O'Keefe GE, 1999, J TRAUMA, V46, P473, DOI 10.1097/00005373-199903000-00023; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Sigalet DL, 2004, CAN J SURG, V47, P109; Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Velez DR, 2008, MITOCHONDRION, V8, P130, DOI 10.1016/j.mito.2007.10.007; Vyrostek S.B., 2001, MMWR SURVEILL SUMM, V53, P1	33	14	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2009	66	3					850	857		10.1097/TA.0b013e3181991ac8			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	419ZU	WOS:000264259000042	19276764				2021-06-18	
J	Hayashi, N				Hayashi, Nariyuki			Management of Pitfalls for the Successful Clinical Use of Hypothermia Treatment	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	2nd International Brain Hypothermia Symposium	OCT, 2007	Miami Beach, FL			clinical management of CNS injury; hypothermia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ACUTE HYPERKETONEMIA; DOPAMINE; ISCHEMIA; GLUTAMATE; RELEASE	Therapeutic hypothermia is a promising method for controlling intracranial pressure (ICP) in severely brain-injured patients. However, clinical data regarding the effect of brain hypothermia on overall outcome of these patients is limited. This may be because there are specific pitfalls associated with the clinical management of induced hypothermia in patients with severe traumatic brain injury (TBI). These pitfalls may be avoided by preventing specific risk factors when cooling is induced and with rewarming. However, these risk factors have not been well systematically discussed in the literature. In this paper, three categories of clinical issues regarding the management of brain hypothermia are discussed: (1) stress-induced secondary brain injury mechanisms; (2) technical aspects of intensive care unit (ICU) cooling management; and (3) rewarming rates and methods. For patients with a Glasgow Coma Scale (GCS) score of less than 8, management of stress-induced insulin-resistant hyperglycemia, and unstable systemic circulation due to impaired cardiac contractility are especially important. For example, in our experience, posttraumatic hyperglycemia, exacerbated by cooling, may be ameliorated by the administration of a ketone body with mannitol. Prevention of selective free radical damage to neurons is also an important target for successful brain hypothermia treatment. Taken together, it is clear that several orchestrated steps should be initiated to enhance the protective effects of hypothermia therapy and prevent these possible pitfalls.	[Hayashi, Nariyuki] Nihon Univ, Dept Life Sci, Adv Res Inst Sci & Humanity, Tokyo, Japan	Hayashi, N (corresponding author), 6F Ichigaya Tokyu Bldg 2-1 Kudan,Kita 4 Chome Chi, Tokyo 1020073, Japan.	hayashi-nariyuki@arish.nihon-u.ac.jp					*AM HEART ASS, 2002, CIRCULATION, V11, P1; BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; BOELS PJ, 1985, EXPERIENTIA, V41, P1374, DOI 10.1007/BF01949995; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Dietrich W, 1991, J CEREB BLOOD FLO S2, V11, pS846; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dudariev V P, 1999, Fiziol Zh, V45, P97; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746; Hayashi N, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P328, DOI 10.1007/4-431-28576-8_49; Hayashi N, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P124, DOI 10.1007/4-431-28576-8_20; Hayashi N, 1999, CELL MOL NEUROBIOL, V19, P3, DOI 10.1023/A:1006918722029; HAYASHI N, 2004, BRAIN HYPOTHERMIA TR, P37; HAYASHI N, 2008, SHIKOU NO KAITAI SHI, P67; Insel TR, 1998, ADV EXP MED BIOL, V449, P215; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P247; Kerendi F, 2005, J THORAC CARDIOV SUR, V130, P1079, DOI 10.1016/j.jtevs.2005.05.045; KUBULUS D, 2001, BRIT J SURG, V92, P1432; MORIN PJR, 2005, BIOCHIM BIOPHYS ACTA, V25, P32; MORRIS J, 2004, HUMAN BRAIN FUNCTION, P36; Pan JW, 2001, J NEUROCHEM, V79, P539, DOI 10.1046/j.1471-4159.2001.00575.x; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Phelps EA, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1005; Portas C, 2004, HUMAN BRAIN FUNCTION, P269; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SILVKA A, 1985, J BIOL CHEM, V260, P15466; TRANEL D, 1995, NEUROSCIENCE MED, P555; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602	31	14	15	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	2009	26	3					445	453		10.1089/neu.2008.0648			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	420ZO	WOS:000264327900020	19292696				2021-06-18	
S	Hayes, RL; Robinson, G; Muller, U; Wang, KKW		Ottens, AK; Wang, KKW		Hayes, Ronald L.; Robinson, Gillian; Muller, Uwe; Wang, Kevin K. W.			Translation of Neurological Biomarkers to Clinically Relevant Platforms	NEUROPROTEOMICS: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Biomarkers; Brain injury; Translational research; Assay development; Clinical trials	TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; TANDEM MASS-SPECTROMETRY; BASIC-PROTEIN ISOFORMS; METHAMPHETAMINE EXPOSURE; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; CALPAIN; NEUROPROTEOMICS; PROTEOLYSIS	Like proteomics more generally, neuroproteomics has recently been linked to the discovery of biochemical markets of central nervous system (CNS) injury and disease. Although neuroproteomics has enjoyed considerable success in discovery of candidate biomarkers, there arc a number of challenges facing investigators interested in developing clinically useful platforms to assess biomarkers for damage to the CNS. These challenges include intrinsic physiological complications such as the blood-brain barrier. Effective translation of biomarkers to clinical practice also requires development of entirely novel pathways and product development strategies. Drawing from lessons learned from applications of biomarkers to traumatic brain injury, this study outlines major elements of such a pathway. As with other indications, biomarkers can have three major areas of application: (1) drug development; (2) diagnosis and prognosis; (3) patient management. Translation of CNS biomarkers to practical clinical platforms raises a number of integrated elements. Biomarker discovery and initial selection needs to be integrated at the earliest stages with components that will allow systematic prioritization and triage of biomarker candidates. A number of important criteria need to be considered in selecting clinical biomarker candidates. Development of proof of concept assays and their optimization and validation represent an often overlooked feature of biomarker translational research. Initial assay optimization should confirm that assays can detect biomarkers in relevant clinical samples. Since access to human clinical samples is critical to identification of biomarkers relevant to injury and disease as well as for assay development, design of human clinical validation studies is an important component of translational biomarker research platforms. Although these clinical studies share much in common with clinical trials for assessment of drug therapeutic efficacy, there are a number of considerations unique to these efforts. Finally, platform selection and potential assay commercialization need to be considered. Decisions regarding whether or not to seek FDA approval also significantly influence translational research structures.	[Hayes, Ronald L.] Banyan Biomarkers Inc, Clin Dept, Ctr Innovat Res, Alachua, FL USA; [Wang, Kevin K. W.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA	Hayes, RL (corresponding author), Banyan Biomarkers Inc, Clin Dept, Ctr Innovat Res, Alachua, FL USA.						Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Ottens AK, 2005, ANAL CHEM, V77, P4836, DOI 10.1021/ac050478r; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Papa L., EXP OPIN MED DIAG, V2, P937; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schonberger SJ, 2001, PROTEOMICS, V1, P1519, DOI 10.1002/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Warren MW, 2007, INT J NEUROPSYCHOPH, V10, P479, DOI 10.1017/S1461145706007061; Warren MW, 2006, J ADDICT DIS, V25, P115, DOI 10.1300/J069v25n04_11; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; YEALY D M, 1991, Emergency Medicine Clinics of North America, V9, P707	22	14	14	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-934115-84-8	METHODS MOL BIOL	Methods Mol. Biol.		2009	566						303	313		10.1007/978-1-59745-562-6_20	10.1007/978-1-59745-562-6		11	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	BLU16	WOS:000271018600020					2021-06-18	
J	Himanen, L; Portin, R; Tenovuo, O; Taiminen, T; Koponen, S; Hiekkanen, H; Helenius, H				Himanen, Leena; Portin, Raija; Tenovuo, Olli; Taiminen, Tero; Koponen, Salla; Hiekkanen, Heli; Helenius, Hans			Attention and depressive symptoms in chronic phase after traumatic brain injury	BRAIN INJURY			English	Article						TBI; attention; depression; reaction time	HEAD-INJURY; MAJOR DEPRESSION; MILD; COGNITION; DISORDER; RECOVERY; DEFICITS	Objective: To study whether attention deficits differ between TBI (traumatic brain injury) patients with and without depressive symptoms. Method: The study group (n = 61, mean age = 59 years) consisted of symptomatic TBI patients injured on average 30 years earlier. They were studied with a broad range of attention tasks including computerized methods. The patients were divided into those with depressive symptoms (n = 32) and those without (n = 29), according to the short form of the Beck depression scale with a cut-off score of 5. In addition, a diagnosis of major depression was applied according to the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (n = 6). The groups with depression or depressive symptoms were compared with the non-depressed TBI patients and with an age- and education-matched healthy control group (n = 31). Results: Cognitive methods that require flexibility (Trail making B, Card sorting, Word fluency) and working memory (Subtraction test) were sensitive to discriminate TBI patients without depressive symptoms from the control subjects (p 0.001). Only a few methods were able to discriminate the TBI patients with depressive symptoms from those without (p 0.001 for Simple reaction time, p 0.003 for Vigilance test). The depressed TBI patients (assessed by SCAN) did not differ from the non-depressed TBI patients in attention functions. Conclusions: The results suggest that problems in complex attention processing are more specific to TBI, while slowness in simple psychomotor speed and impaired sustained attention may be mostly related to depressive symptoms in patients with chronic TBI sequelae.	[Himanen, Leena; Portin, Raija; Tenovuo, Olli; Hiekkanen, Heli] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland; [Taiminen, Tero; Koponen, Salla] Turku Univ Hosp, Dept Psychiat, FIN-20520 Turku, Finland; [Helenius, Hans] Univ Turku, Dept Biostat, SF-20500 Turku, Finland	Himanen, L (corresponding author), Turku Univ Hosp, Dept Neurol 720, PL 52, FIN-20521 Turku, Finland.	ls.himanen@pp1.inet.fi		Himanen, Leena/0000-0001-7261-8027			Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; BLEIBERG J, 1997, CLIN NEUROPSYCHOL, V14, P287; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; COFFEY CE, 1990, AM J PSYCHIAT, V147, P187; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franulic A, 2000, BRAIN INJURY, V14, P431; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Hickie I, 1999, PSYCHIAT RES-NEUROIM, V92, P75, DOI 10.1016/S0925-4927(99)00038-4; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KUJALA P, 1994, BRAIN, V117, P1115, DOI 10.1093/brain/117.5.1115; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; REVONSUO A, 1995, COGNISPEED COMPUTER; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Ruttan LA, 2003, J CLIN EXP NEUROPSYC, V25, P407, DOI 10.1076/jcen.25.3.407.13812; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Tavares JVT, 2003, PSYCHOL MED, V33, P959, DOI 10.1017/S0033291703008432; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	35	14	14	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	3					220	227	PII 908613377	10.1080/02699050902748323			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	406AJ	WOS:000263267100005	19205958				2021-06-18	
J	Jang, SH; Kim, DS; Son, SM; Cho, YW; Kim, SH; Kim, OL; Ahn, SH				Jang, Sung Ho; Kim, Dae-Shik; Son, Su Min; Cho, Yun Woo; Kim, Seong Ho; Kim, Oh Lyong; Ahn, Sang Ho			Clinical application of diffusion tensor tractography for elucidation of the causes of motor weakness in patients with traumatic brain injury	NEUROREHABILITATION			English	Article						Brain injury; diffusion tensor tractography; corticospinal tract; motor function	TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL TRACT; AXONAL INJURY; FUNCTIONAL MRI; RECOVERY; LOCALIZATION; INTEGRITY; TRACKING; FEATURES; ROUTINE	Diffusion tensor tractography (DTT) is useful for elucidating the status of the corticospinal tract (CST). The purpose of this study was to investigate the usefulness of DTT for determining the causes of motor weakness in patients with traumatic brain injury (TBI). Five patients with TBI were recruited for this study. DTT was performed using 1.5-T with a Synergy-L Sensitivity Encoding (SENSE) head coil. DTT was obtained with termination criteria of FA < 0.2 and an angle change > 45 degrees. On the DTT of patient 1, who had diffuse axonal injury, the focal lesion was detected in the left pons, and was not detected on routine brain images. In patients with deep cerebral hemorrhage, the integrity of the CST of patient 3 was preserved, although the lesion was more extensive than that of patient 2, who showed severe degeneration with the disruption of the CST at the lesion site. In patient 4, the integrity of the left CST was disrupted by a left transtentorial herniation. Although the CST of the affected hemisphere was connected at the cortex level in patient 5, who had a cortical contusional hemorrhage, the motor function of the lower extremity was worse than that of the upper extremity according to the involvement of the somatotopic area of the primary motor cortex. DTT would be useful in elucidating the causes of motor weakness in patients with TBI at the subcortical level, including conditions such as diffuse axonal injury, deep intracerebral hemorrhage, and transtentorial herniation.	[Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Sch Med, Taegu 705717, South Korea; [Kim, Dae-Shik] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kim, Seong Ho; Kim, Oh Lyong] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Sch Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net	Kim, Dae-Shik/C-2071-2011				Ahn YH, 2006, NEUROREHABILITATION, V21, P239; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Binkofski F, 1996, ANN NEUROL, V39, P460, DOI 10.1002/ana.410390408; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Gossl C, 2002, NEUROIMAGE, V16, P378, DOI 10.1006/nimg.2002.1055; Han BS, 2007, NEUROREHABILITATION, V22, P151; Itoh D, 2006, J COMPUT ASSIST TOMO, V30, P618, DOI 10.1097/00004728-200607000-00011; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2007, J COMPUT ASSIST TOMO, V31, P901, DOI 10.1097/rct.0b013e31804089a6; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; Kim DG, 2007, NEUROREHABILITATION, V22, P273; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Macdonell RAL, 1999, NEUROLOGY, V53, P1462, DOI 10.1212/WNL.53.7.1462; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nguyen T, 2005, NEURORADIOLOGY, V47, P334, DOI 10.1007/s00234-005-1338-z; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073; YORK DH, 1987, NEUROSURGERY, V20, P70; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	27	14	15	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	24	3					273	278		10.3233/NRE-2009-0478			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	452ZR	WOS:000266580200010	19458435				2021-06-18	
J	Ogino, T; Watanabe, K; Nakano, K; Kado, Y; Morooka, T; Takeuchi, A; Oka, M; Sanada, S; Ohtuska, Y				Ogino, Tatsuya; Watanabe, Kiyoko; Nakano, Kousuke; Kado, Yoko; Morooka, Teruko; Takeuchi, Akihito; Oka, Makio; Sanada, Satoshi; Ohtuska, Yoko			Predicting executive function task scores with the Rey-Osterrieth Complex Figure	BRAIN & DEVELOPMENT			English	Article						The Rey-Osterrieth Complex Figure Test; Boston Qualitative Scoring System; Executive function; Children; Pervasive developmental disorders; Attention-deficit/hyperactivity disorder	QUALITATIVE SCORING SYSTEM; TRAUMATIC BRAIN INJURY; CARD SORTING TEST; PERFORMANCE	The Boston Qualitative Scoring System (BQSS) is one of the scoring methods of the Rey-Osterrieth Complex Figure Test (ROCF). With BQSS, 17 qualitative ratings are generated, and subsequently 6 summary scores are calculated by combining several qualitative scores. Previously we showed that 5 of 6 BQSS summary scores were correlated with the scores of the several executive function tests in children. The objective of this study was to develop a new summary score which correlates with the executive function test scores more strongly than the existing summary scores. For this purpose, we conducted multiple regression analysis to predict PEN, CA, DSM of the Wisconsin Card Sorting Test Keio Version, and the Mazes scores from WISC-III, by the BQSS qualitative scores derived from ROCF drawings in copy condition. The subjects were 78 children with various neuropsychological disorders (5 years 5 months-14 years 11 months; mean: 9 years 2 months; F 22, M 56). Significant predictive models were generated for PEN, CA, and Mazes scores. Among them the models for the Mazes scores were the most accurate. The second model for the Mazes scores was most suitable for a new summary score. Its degree-of-freedom-adjusted coefficient of multiple determination and multiple correlation coefficient reached 0.467 and 0.695, respectively. A new summary score should be applied in future studies to evaluate its clinical usefulness. (C) 2008 Elsevier B.V. All rights reserved.	[Ogino, Tatsuya] Chugokugakuen Univ, Fac Children Studies, Dept Children Studies, Okayama 7010197, Japan; [Watanabe, Kiyoko; Morooka, Teruko; Takeuchi, Akihito; Oka, Makio; Ohtuska, Yoko] Okayama Univ, Dept Child Neurol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Nakano, Kousuke] Matsuyama Red Cross Hosp, Dept Pediat, Matsuyama, Ehime, Japan; [Kado, Yoko] Kansai Univ, Fac Letters, Dept Psychol, Osaka, Japan; [Sanada, Satoshi] Okayama Univ, Div Special Educat, Okayama, Japan	Ogino, T (corresponding author), Chugokugakuen Univ, Fac Children Studies, Dept Children Studies, Niwase 83, Okayama 7010197, Japan.	tatsu@cjc.ac.jp	Takeuchi, Akihito/I-8872-2019	Takeuchi, Akihito/0000-0003-4332-4075	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19730564] Funding Source: KAKEN		Beebe DW, 2004, APPL NEUROPSYCHOL, V11, P91, DOI 10.1207/s15324826an1102_4; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Heaton R., 1993, WISCONSIN CARD SORTI; KASHIMA H, 1993, SHINKEI KENKYU NO SH, V37, P93; Kirsch P, 2006, NEUROPSYCHOBIOLOGY, V54, P51, DOI 10.1159/000095742; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Levin HS, 2001, NEUROPSYCHOLOGY, V15, P557, DOI 10.1037//0894-4105.15.4.557; Nagahama Y, 2003, DEMENT GERIATR COGN, V16, P103, DOI 10.1159/000070683; Nakano K, 2006, BRAIN DEV-JPN, V28, P641, DOI 10.1016/j.braindev.2006.04.011; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Somerville J, 2000, J CLIN EXP NEUROPSYC, V22, P613, DOI 10.1076/1380-3395(200010)22:5;1-9;FT613; STERN RA, 1994, CLIN NEUROPSYCHOL, V8, P309, DOI 10.1080/13854049408404137; STERN RA, 1999, BOSTON QUALITATIVE S; Taylor E.M., 1959, PSYCHOL APPRAISAL CH; Watanabe K, 2005, BRAIN DEV-JPN, V27, P564, DOI 10.1016/j.braindev.2005.02.007	16	14	14	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604			BRAIN DEV-JPN	Brain Dev.	JAN	2009	31	1					52	57		10.1016/j.braindev.2008.07.003			6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	395QV	WOS:000262539500009	18723303				2021-06-18	
J	Pyun, SB; Yang, H; Lee, S; Yook, J; Kwon, J; Byun, EM				Pyun, Sung-Bom; Yang, Heeseung; Lee, Sangil; Yook, Jinsook; Kwon, Jaesung; Byun, Eun-Mi			A home programme for patients with cognitive dysfunction: A pilot study	BRAIN INJURY			English	Article						Stroke; cognitive therapy; cognition disorders; activites of daily living	TRAUMATIC BRAIN-INJURY; REHABILITATION; STROKE; IMPAIRMENT; DEMENTIA; OUTCOMES; FREQUENCY; APHASIA	Objective: To evaluate the effectiveness of a 12-week individualized home programme of rehabilitation for patients with cognitive impairment. Methods: Six patients with cognitive dysfunction, after haemorrhagic stroke, participated in this study. A programme was carried out in the home environment that consisted of four mixed training programmes: cognitive remediation therapy, story retelling, cognitive enhancing games and aerobic exercise. The patients performed the home programme for 2 hours a day, 7 days a week, for 12 weeks. The main outcomes were measured using the MMSE, Neurobehavioural Cognitive Status Examination (NCSE), domain-specific computerized neuropsychological test for attention, memory and executive function, the Lowenstein Occupational Therapist Cognitive Assessment (LOTCA), the Modified Barthel Index (MBI) and the Seoul-Instrumental Activity of Daily Living (S-IADL). Results: After completion of a 12-week home programme, the patients' S-IADL scores improved significantly (p 0.05). The patients' MMSE and NCSE scores improved marginally, with mean score changes of 4.2 (p = 0.058), 4.7 (p = 0.078) and 6.8 (p = 0.068) points, respectively. However, the patients' domain-specific cognitive test and LOTCA scores did not significantly change. Conclusion: The results of this study showed that an individualized home programme improved IADL performance in patients with cognitive dysfunction and may have a beneficial effect on cognition, as assessed by general cognitive measures.	[Pyun, Sung-Bom] Korea Univ, Med Ctr, Dept Phys Med & Rehabil, Coll Med, Seoul 136705, South Korea; [Yang, Heeseung] Seoul Vet Hosp, Dept Phys Med & Rehabil, Seoul, South Korea; [Lee, Sangil; Yook, Jinsook; Kwon, Jaesung; Byun, Eun-Mi] Asan Med Ctr, Dept Phys Med & Rehabil, Seoul, South Korea	Pyun, SB (corresponding author), Korea Univ, Med Ctr, Dept Phys Med & Rehabil, Coll Med, 5 Ga 126-1 Anam Dong, Seoul 136705, South Korea.	rmpyun@korea.ac.kr			Korea government (MOST)Ministry of Science and Technology (MOST) KoreaKorean Government [R01-2006-000-10733-0]	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST) (R01-2006-000-10733-0). This study was presented at the 10 November 2006 AAPM&R Annual Assembly in Hawaii.	Aftonomos LB, 1999, STROKE, V30, P1370, DOI 10.1161/01.STR.30.7.1370; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Cappa SF, 2005, EUR J NEUROL, V12, P665; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cordoliani-Mackowiak MA, 2003, ARCH NEUROL-CHICAGO, V60, P585, DOI 10.1001/archneur.60.4.585; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Ivan CS, 2004, STROKE, V35, P1264, DOI 10.1161/01.STR.0000127810.92616.78; Jordan BD, 2000, JAMA-J AM MED ASSOC, V283, P3123, DOI 10.1001/jama.283.23.3123; Jung HY, 2007, ANN REHABIL MED-ARM, V31, P283; Kase CS, 1998, STROKE, V29, P805, DOI 10.1161/01.STR.29.4.805; KATZ N, 1989, AM J OCCUP THER, V43, P184, DOI 10.5014/ajot.43.3.184; 구형모, 2004, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V43, P189; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Macko R F, 2005, Top Stroke Rehabil, V12, P45; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; Marsh EB, 2006, PROG BRAIN RES, V157, P143, DOI 10.1016/S0079-6123(06)57009-8; Pace GM, 1999, BRAIN INJURY, V13, P535; Rasquin SMC, 2004, DEMENT GERIATR COGN, V18, P138, DOI 10.1159/000079193; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Serrano S, 2007, STROKE, V38, P105, DOI 10.1161/01.STR.0000251804.13102.c0; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	27	14	15	1	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	7-8					686	692	PII 912684686	10.1080/02699050902997862			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	462QL	WOS:000267370600013	19557572				2021-06-18	
J	Ryu, WHA; Feinstein, A; Colantonio, A; Streiner, DL; Dawson, D				Ryu, Won Hyung A.; Feinstein, Anthony; Colantonio, Angela; Streiner, David L.; Dawson, Deirdre			Regional Variability in the Use of CT for Patients with Suspected Mild Traumatic Brain Injury	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							COMPUTED-TOMOGRAPHY; GUIDELINE	Objective: To investigate the use of computed tomography (CT) scans in patients with Suspected acute mild traumatic brain injury (mTBI) presenting to emergency departments. Method: 850 potential mTBI cases were identified through reviews of three months of health records from nine selected emergency departments across the province of Ontario. Records for review were selected using the International Classification of Disease, 9th revision. Clinical Modification codes and Injury codes. Results: Patients who received head CT were significantly older (p<0.01), had documented loss-of-consciousness (LOC) &/or Post-Traumatic Amnesia (PTA) (p<0.001), documented nausea (P<0.01), documented vomiting, (p<0.001), abnormal neurological exam results (p<0.01), had visited an urban center (p<0.001). and/or arrived by ambulance (p<0.001). The significant predictors of CT scan prescription (in a forward stepwise logistic repression) were urban location of hospital (OR=5.14; p <= 0.001) LOC &/or PTA (OR=4.83; p <= 0.001), vomiting (OR=2.56; p <= 0.01). arrival by ambulance (OR=2.15; p <= 0.001). nausea (OR=1.92; p=<= 0.02) and older age (OR=1.02; p <= 0.01). Conclusion: These data extend our knowledge regarding the use of CT during acute diagnosis and management of suspected mTBI patients. In addition to confirming previously reported risk factors of intracranial complication. geographical location of hospital and arrival Mode Were found to be significant predictors of CT use. The results suggest that the management patterns for acute mTBI are inconsistent. The implications Of this are discussed.	[Ryu, Won Hyung A.; Streiner, David L.; Dawson, Deirdre] Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; [Colantonio, Angela; Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Ryu, Won Hyung A.; Colantonio, Angela; Dawson, Deirdre] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Feinstein, Anthony; Streiner, David L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Feinstein, Anthony] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Ryu, Won Hyung A.; Colantonio, Angela; Dawson, Deirdre] Toronto Rehabil Inst, Toronto, ON, Canada	Dawson, D (corresponding author), Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.		Streiner, David/E-6563-2011; Ryu, Won H/AAU-6774-2020; Dawson, Deirdre R/I-8882-2014	Streiner, David/0000-0003-0610-6271; Dawson, Deirdre R/0000-0001-7517-6121; Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ontario Ministry of Training, Colleges and Universities (OGS)Ontario Graduate Scholarship; BaycrestUniversity of Toronto; Toronto Rehabilitation InstituteUniversity of Toronto; University of TorontoUniversity of Toronto; participating hospitals	This research was made possible by a grant from the Ontario Neurotrauma Foundation to Dr. D. Dawson and Dr. A. Feinstein. Won Hyung A. Ryu was supported by fellowships from Canadian Institutes of Health Research (CIHR), Ontario Ministry of Training, Colleges and Universities (OGS), Baycrest, Toronto Rehabilitation Institute, and University of Toronto. The authors also gratefully acknowledge the support of the participating hospitals, and our research assistants: A. Hatvani, K. Kit. T. Koscik, K. Krpan, S. Mack, K. Menezes, M. Peer, and M. Rvan, and thank Dr. P. Verhoeff and Dr. J. Ween for reviewing earlier versions of this manuscript.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Goel V, 1996, PATT HLTH CAR ONT; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hebb MO, 2007, CAN J SURG, V50, P187; ISCOE NA, 1994, CAN MED ASSOC J, V150, P345; Kelly JP, 1997, NEUROLOGY, V48, P581; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; Norman G.R., 2000, BIOSTATISTICS BARE E, V2nd; *ONT HOSP ASS, ONT HOSP ASS REG; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wennberg J E, 1984, Health Manage Q, P6, DOI 10.1377/hlthaff.3.2.6; 1992, CMAJ, V146, P467; 2006 CENSUS	20	14	14	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2009	36	1					42	46		10.1017/S0317167100006296			5	Clinical Neurology	Neurosciences & Neurology	396TJ	WOS:000262613800010	19294887	Bronze			2021-06-18	
J	Scarponi, F; Sattin, D; Leonardi, M; Raggi, A; Zampolini, M				Scarponi, Federico; Sattin, Davide; Leonardi, Matilde; Raggi, Alberto; Zampolini, Mauro			The description of severe traumatic brain injury in light of the ICF classification	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; ICF; disability	QUALITY-OF-LIFE; INTERNATIONAL-CLASSIFICATION; HEALTH ICF; ABI REHABILITATION; CORE SETS; DISABILITY; DISORDERS; OUTPATIENT; RETURN; MODEL	Purpose. To review on the application of the ICF Classification to assess the person with traumatic brain injury (TBI) and his/her interaction with the environment. Method. Studies and reviews about the use of ICF in TBI have been included, by searching in Pubmed and in the proceedings of international meetings. Results. Eleven studies have been identified and classified into three types: (a) application of the classification; (b) single case study; (c) the use of other scales. Some studies are related to the application of ICF checklist. Finally, we analyse the most used ICF codes. Conclusions. The ICF is a useful tool describes conditions and needs of patients with TBI. A diffuse utilisation could become the key resource for both health professionals and administrators that are in charge of allocating resources to pursue quality of life improvement. The ICF could be applied as a shared language to define health programmes' goals and as system for carrying out epidemiological studies. For this reason, it is desirable to define and validate the ICF Core Sets for TBI to provide a mean to be easily used, comprehensive and universal.	[Scarponi, Federico; Zampolini, Mauro] San Giovanni Battista Hosp, Dept Rehabil, Foligno, Italy; [Sattin, Davide; Leonardi, Matilde; Raggi, Alberto] Neurol Inst C Besta IRCCS, Neurol Publ Hlth & Disabil Unit, Milan, Italy	Zampolini, M (corresponding author), San Giovanni Battista Hosp, Dept Rehabil, Local Hlth Serv 3, Foligno, Italy.	mauro.zampolini@tin.it	Sattin, Davide/K-5963-2016; leonardi, matilde/J-9997-2018; Raggi, Alberto/K-5787-2016; Zampolini, Mauro/B-7749-2009; Sattin, Davide/AAX-4083-2020; Scarponi, Federico/K-5714-2018	Sattin, Davide/0000-0001-7736-4337; leonardi, matilde/0000-0003-0552-8923; Raggi, Alberto/0000-0002-7433-7779; Sattin, Davide/0000-0001-7736-4337; Scarponi, Federico/0000-0001-9683-8104			Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Chiambretto P, 2006, G Ital Med Lav Ergon, V28, P15; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Francescutti C, 2009, DISABIL REHABIL, V31, pS46, DOI 10.3109/09638280903317757; Fries W, 2008, REHABILITATION, V47, P265, DOI 10.1055/s-2008-1081473; Jaracz K, 2008, NEUROL NEUROCHIR POL, V42, P525; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kuipers P, 2003, DISABIL REHABIL, V25, P154, DOI 10.1080/0963828021000024898; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Larkins Brigette, 2007, Seminars in Speech and Language, V28, P334, DOI 10.1055/s-2007-986530; LAXE S, 2009, 5 WORLD C INT SOC PH, P117; Leonardi M, 2009, DISABIL REHABIL, V31, pS128, DOI 10.3109/09638280903317765; Maini M, 2008, DISABIL REHABIL, V30, P1146, DOI 10.1080/09638280701478397; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODONOVAN MA, 2009, DISABIL REHABIL, V21, P1; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; PISTARINI C, 2009, 5 WORLD C INT SOC PH, P118; Post MWM, 2008, J REHABIL MED, V40, P620, DOI 10.2340/16501977-0223; Rauch A, 2008, EUR J PHYS REHAB MED, V44, P329; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stucki A, 2008, SLEEP MED, V9, P191, DOI 10.1016/j.sleep.2007.01.019; Stucki G, 2008, EUR J PHYS REHAB MED, V44, P343; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, DISABIL REHABIL, V24, P281, DOI 10.1080/09638280110105222; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thonnard J L, 2007, Eura Medicophys, V43, P525; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; WHO, 2006, INT CLASS FUNCT DIS; ZAMPOLINI M, 2006, INDIVIDUAZIONE INDIC, P405	40	14	14	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2009	31			1			S134	S143		10.3109/09638280903317906			10	Rehabilitation	Rehabilitation	553BB	WOS:000274338300021	19968526				2021-06-18	
J	Youse, KM; Coelho, CA				Youse, Kathleen M.; Coelho, Carl A.			Treating underlying attention deficits as a means for improving conversational discourse in individuals with closed head injury: A preliminary study	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; TRAINING-PROGRAM; EFFECT SIZES; ADULTS; REHABILITATION; LISTENER; SKILLS; TASK	Background: It is documented that individuals with closed head injury (CHI) demonstrate difficulty with narrative and conversational discourse. Effective conversational discourse requires a complex interaction of linguistic, cognitive, and social abilities [6]. Reduced attention and concentration are among the most common cognitive sequela following CHI [39]. Aims: The present study investigated whether treatment of attention would facilitate conversational discourse for individuals with CHI. Two treatment protocols were investigated, the first social skills-based, and the second attention-based. It was hypothesized that attention training would improve not only attentional skills but also conversation, however social skills training, would only facilitate conversational skills. Methods and Procedures: A single subject multiple treatments comparison design was employed with two individuals who were post-onset of CHI. Treatment effects on conversational performance were calculated using the f statistic [18] for measures of response appropriateness during conversations. Outcomes and Results: Effect sizes suggested that both treatments were active; however, the participants' performances were variable reducing the magnitude of change observed. Results indicated minimal change from baselines, only partially supporting the research hypotheses. Conclusions: Although the two treatment regimens had some effect on the participants' conversational performances it was not to the extent anticipated. The issues of candidacy for such treatments as well as the importance of incorporating natural contingencies into interventions for conversation training are discussed.	[Youse, Kathleen M.] Univ Kentucky, Coll Hlth Sci, Div Commun Disorders, Lexington, KY 40536 USA; [Coelho, Carl A.] Univ Connecticut, Storrs, CT USA	Youse, KM (corresponding author), Univ Kentucky, Coll Hlth Sci, Div Commun Disorders, 900 S Limestone St,120J, Lexington, KY 40536 USA.	kathleen.youse@uky.edu					Adamovich B.L.B., 2005, APHASIA RELATED NEUR; Body R., 1999, COMMUNICATION DISORD; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coelho C. A., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COELHO CA, 1993, CLIN APHASIOLOGY, V21, P183; Coelho CA, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; COELHO CA, 1999, COMMUNICATION DISORD; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GOLPER LC, 2001, EVIDENCE BASED PRACT; HAGEN C, 1998, REHABILITATION HEAD; HELFFENSTEIN DA, 1982, CLIN NEUROPSYCHOLOGY, V4, P139; Kertesz A., 1982, W APHASIA BATTERY; Kromrey JD, 1996, J EXP EDUC, V65, P73, DOI 10.1080/00220973.1996.9943464; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARSH NV, 1999, COMMUNICATION DISORD; Mattis S, 1976, GERIATRIC PSYCHIAT; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 1999, COMMUNICATION DISORD; McReynolds L.V., 1983, SINGLE SUBJECT EXPT; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Palmese CA, 2000, BRAIN INJURY, V14, P535; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robey RR, 1999, APHASIOLOGY, V13, P445, DOI 10.1080/026870399402028; ROBEY RR, 2001, SPECIAL INTEREST DIV, V11; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; SNOW P, 1999, COMMUNICATION DISORD; Sohlberg M. M., 2001, COGNITIVE REHABILITA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SOHLBERG MM, 1994, ATTENTION PROCESS TR, V2; STRUCHEN MA, 2005, REHABILITATION TRAUM; Togher L, 1999, APHASIOLOGY, V13, P709, DOI 10.1080/026870399401821; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; TOGHER L, 1999, COMMUNICATION DISORD; Turkstra L, 2003, LANG SPEECH HEAR SER, V34, P117, DOI 10.1044/0161-1461(2003/010); Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Ylvisaker M, 2002, J MED SPEECH-LANG PA, V10, pXXV	46	14	14	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2009	24	4					355	364		10.3233/NRE-2009-0490			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	481VH	WOS:000268839800009	19597274				2021-06-18	
J	Dolinak, D; Wise, SH; Jones, CT				Dolinak, David; Wise, Steven H.; Jones, Curtiss			Microscopic and Spectroscopic Features of Gunpowder and its Documentation in Gunshot Wounds in Charred Bodies	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						gunpowder; charred body; Fourier Transform Infrared (FT-IR) microscopy; soot; autopsy; gunshot wound		Determining the direction and range of fire of gunshot wounds in charred bodies can be difficult because soot resulting from thermal injury can grossly be identical to soot arising from a contact or close-range firearm discharge. Two charred bodies had gunshot wounds of the head and neck region that were distorted by thermal effect, precluding determination of the direction and range of fire by gross findings alone. By microscopy, deep wound tissue from each charred body had foreign material suggestive of gunpowder. Samples of the foreign material were examined by Fourier transform infrared (FT-IR) microscopy and determined to be cellulose nitrate (nitrocellulose), a main component of gunpowder. In addition, 12 cases of suicide in well-preserved bodies with contact gunshot Wounds were examined with FT-IR microscopy, confirming the presence of cellulose nitrate in 6 (50%) of the cases. Identification of cellulose nitrate in the tracks of gunshot wounds can assist in the determination of direction and range of fire when the surface features are charred.	[Dolinak, David; Wise, Steven H.; Jones, Curtiss] Cuyahoga Cty Coroners Off, Trace Evidence Dept, Cleveland, OH USA	Dolinak, D (corresponding author), Travis Cty Med Examiner Dept, 1213 Sabine St, Austin, TX 78701 USA.	ddolinak@hotmail.com					ADELSON L, 1961, AM J CLIN PATHOL, V35, P393, DOI 10.1093/ajcp/35.5.393; DAVIS JH, 1998, J INT WOUND BALL ASS, P5	2	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	2008	29	4					312	319		10.1097/PAF.0b013e31818582cc			8	Medicine, Legal; Pathology	Legal Medicine; Pathology	379UK	WOS:000261421500008	19259016				2021-06-18	
J	Kaiser, C; Schnabel, A; Berkefeld, J; Bratzke, H				Kaiser, Ch; Schnabel, A.; Berkefeld, J.; Bratzke, H.			Traumatic rupture of the intracranial vertebral artery due to rotational acceleration	FORENSIC SCIENCE INTERNATIONAL			English	Article						Trauma; Subarachnoidal haemorrhage; Rupture; Rotational acceleration; Vertebral artery		The reason for blunt forces against the head to rupture the basal brain arteries has been discussed in forensic and trauma research. However, well-documented case reports demonstrating the mechanism of injury, the clinical course and the forensic work up are rare. We present the case of a 40-year-old man, who was assaulted with blunt force to the head resulting in death 34 h later from a longitudinal rupture of the distal left vertebral artery. Computer tomography of the brain and the face demonstrated a basal subarachnoidal haemorrhage, signs of increased intracranial pressure and a fracture of the right orbital bone. Angiography showed a long fusiform dilatation of both intracranial vertebral arteries with an active pseudoaneurysm on the left side. At autopsy signs of a blunt trauma to the head, extensive basal subarachnoidal haemorrhage and a minor subdural haemorrhage were found. Histological examination revealed a transmural longitudinal rupture of the left vertebral artery with vital reaction and no signs of preexisting vascular disease. We discuss the current literature regarding traumatic basal brain artery rupture, important clinical decision making processes as well as pitfalls in the forensic work up. In addition, this singular well-documented case gives new insights in the underlying pathophysiological mechanisms of traumatic basal artery rupture. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Kaiser, Ch; Schnabel, A.; Bratzke, H.] Univ Frankfurt Main, Ctr Legal Med, Inst Forens Med, D-60596 Frankfurt, Germany; [Berkefeld, J.] Univ Frankfurt Main, Ctr Radiol, D-60596 Frankfurt, Germany	Kaiser, C (corresponding author), Univ Frankfurt Main, Ctr Legal Med, Inst Forens Med, Kennedyallee 104, D-60596 Frankfurt, Germany.	kaiser@med.uni-frankfurt.de					BOLTZ W, 1965, BEITR GERICHTL MED, V23, P49; Bratzke H, 1989, Beitr Gerichtl Med, V47, P437; Hiraiwa K, 2005, NEUROL MED-CHIR, V45, P549, DOI 10.2176/nmc.45.549; KLAGES U, 1970, Z RECHTSMED, V67, P67; KRAULAND W, 1981, Z RECHTSMED, V87, P19; KRAULAND W, 1981, Z RECHTSMED, V87, P1; KRAULAND W, 1961, BEITR GERICHTL MED, V21, P171; KRAULAND W, 1949, BEITR GERICHTL MED, V18, P24; KRAULAND W, 1955, HDB SPEZ PATH ANAT H, V13; LAMPERT K, 1926, FRANKFURT Z PATHOL, V33, P471; MACHEBOEUF M, 1948, CR SOC BIOL, V142, P61; MAXEINER H, 1980, THESIS BERLIN; METZ U, 1979, VIRCHOWS ARCH, V317, P385; PETERS G, 1969, NEUROTRAUMATOLOGIE; SAATHOFF E, 1905, DTSCH ARCH KLEIN MED, V84, P384; SELLIER K, 1963, Hefte Unfallheilkd, V76, P1; WEILER G, 1980, Z RECHTSMED, V85, P225, DOI 10.1007/BF02116324; WOLFF K, 1928, DTSCH Z GES GERICHTL, V11, P464	18	14	16	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV 20	2008	182	1-3					E15	E17		10.1016/j.forsciint.2008.10.001			3	Medicine, Legal	Legal Medicine	V15RK	WOS:000207818900004	19008059				2021-06-18	
J	Kaiser, C; Schnabel, A; Berkefeld, J; Bratzke, H				Kaiser, Ch.; Schnabel, A.; Berkefeld, J.; Bratzke, H.			Traumatic rupture of the intracranial vertebral artery due to rotational acceleration	FORENSIC SCIENCE INTERNATIONAL			English	Article						Trauma; Subarachnoidal haemorrhage; Rupture; Rotational acceleration; Vertebral artery	HEMORRHAGE	The reason for blunt forces against the head to rupture the basal brain arteries has been discussed in forensic and trauma research. However, well-documented case reports demonstrating the mechanism of injury, the clinical course and the forensic work up are rare. We present the case of a 40-year-old man, who was assaulted with blunt force to the head resulting in death 34 h later from a longitudinal rupture of the distal left vertebral artery. Computer tomography of the brain and the face demonstrated a basal subarachnoidal haemorrhage, signs of increased intracranial pressure and a fracture of the right orbital bone. Angiography showed a long fusiform dilatation of both intracranial vertebral arteries with an active pseudoaneurysm on the left side. At autopsy signs of a blunt trauma to the head, extensive basal subarachnoidal haemorrhage and a minor subdural haemorrhage were found. Histological examination revealed a transmural longitudinal rupture of the left vertebral artery with vital reaction and no signs of preexisting vascular disease. We discuss the current literature regarding traumatic basal brain artery rupture, important clinical decision making processes as well as pitfalls in the forensic work up. In addition, this singular well-documented case gives new insights in the underlying pathophysiological mechanisms of traumatic basal artery rupture. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Kaiser, Ch.] Goethe Univ Frankfurt, Ctr Legal Med, Inst Forens Med, D-60596 Frankfurt, Germany; [Berkefeld, J.] Goethe Univ Frankfurt, Ctr Radiol, D-60596 Frankfurt, Germany	Kaiser, C (corresponding author), Goethe Univ Frankfurt, Ctr Legal Med, Inst Forens Med, Kennedyallee 104, D-60596 Frankfurt, Germany.	kaiser@med.uni-frankfurt.de					BOLTZ W, 1965, BEITR GERICHTL MED, V23, P49; Bratzke H, 1989, Beitr Gerichtl Med, V47, P437; Hiraiwa K, 2005, NEUROL MED-CHIR, V45, P549, DOI 10.2176/nmc.45.549; KLAGES U, 1970, Z RECHTSMED, V67, P67; KRAULAND W, 1981, Z RECHTSMED, V87, P1; KRAULAND W, 1981, BERECHNUNGEN MODELLV, V87, P19; KRAULAND W, 1961, BEITR GERICHTL MED, V21, P171; KRAULAND W, 1955, ANAL HISTOL, V13, P3; KRAULAND W, 1949, BEITR GERICHTL MED, V18, P24; LAMPERT H, 1926, FRANKFURT Z PATHOL, V33, P471; MACHEBOEUF M, 1948, CR SOC BIOL, V142, P61; MAXEINER H, 1980, THESIS MED BERLIN; METZ U, 1949, VIRCHOWS ARCH, V317, P385; PETERS G, 1969, NEUROTRAUMATOLOGIE; SAATHOFF E, 1905, DTSCH ARCH KLEIN MED, V84, P384; SELLIER K, 1963, MSCHR UNFALLHEILK, V76, P1; WEILER G, 1980, Z RECHTSMED, V85, P225, DOI 10.1007/BF02116324; WOLFF K, 1928, DTSCH Z GES GERICHTL, V11, P464	18	14	16	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	NOV 20	2008	182	1-3					E15	E17		10.1016/j.forsciint.2008.10.001			3	Medicine, Legal	Legal Medicine	389BP	WOS:000262065300014	19008059				2021-06-18	
J	Sunico, CR; Portillo, F; Gonzalez-Forero, D; Kasparov, S; Moreno-Lopez, B				Sunico, C. R.; Portillo, F.; Gonzalez-Forero, D.; Kasparov, S.; Moreno-Lopez, B.			EVIDENCE FOR A DETRIMENTAL ROLE OF NITRIC OXIDE SYNTHESIZED BY ENDOTHELIAL NITRIC OXIDE SYNTHASE AFTER PERIPHERAL NERVE INJURY	NEUROSCIENCE			English	Article						eNOS; hypoglossal nerve; adenoviral vectors; peripheral neuropathy	NUCLEUS-TRACTUS-SOLITARII; ELECTRICAL-STIMULATION PROMOTES; GROWTH CONE COLLAPSE; SCHWANN-CELLS; NO SYNTHASE; REGENERATION; INHIBITION; EXPRESSION; BRAIN; DEATH	Physical injury to a nerve is the most common cause of acquired peripheral neuropathy. Identification of molecules involved in degenerative and regenerative processes is a key step toward development of therapeutic tools in order to accelerate motor, sensory and/or autonomic function recovery. We have studied the role of nitric oxide (NO) using as a model the severe crushing of a motor nerve in adult rats. This type of injury up-regulates the three isoforms of nitric oxide synthase (NOS) in the affected nerve. Chronic systemic inhibition of NOS accelerated the onset of functional muscle reinnervation evaluated by the recording of compound muscle action potential evoked by electrical stimulation of the injured nerve. Besides, it increased the number of back-labeled motoneurons by application, 2 days after injury, of a retrograde marker 10 mm distal to the crushing site. These effects were mimicked by chronic specific inhibition of the endothelial isoform of nitric oxide synthase (eNOS), but not by specific inhibitors of the neuronal or inducible isoform. Next, we intraneurally injected a replication-deficient adenoviral vector directing the expression of a dominant negative mutant of eNOS (Ad-TeNOS). A single injection of Ad-TeNOS on the day of crushing significantly accelerated functional recovery of neuromuscular junction and increased axonal regeneration. Moreover, Ad-TeNOS did not compromise motoneuron viability or stability of reestablished neuromuscular junctions. Taken together, these results suggest that NO of endothelial origin slows down muscle reinnervation by means of detrimental actions on axonal regeneration after peripheral nerve injury. These experiments identify eNOS as a potential therapeutic target for treatment of traumatic nerve injuries and highlight the potential of gene therapy in treating injuries of this type using viral vectors to suppress the activity of eNOS. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.	[Sunico, C. R.; Portillo, F.; Gonzalez-Forero, D.; Moreno-Lopez, B.] Univ Cadiz, Fac Med, Area Fisiol, Cadiz 11003, Spain; [Kasparov, S.] Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England	Moreno-Lopez, B (corresponding author), Univ Cadiz, Fac Med, Area Fisiol, Plaza Falla 9, Cadiz 11003, Spain.	bernardo.moreno@uca.es	Moreno-Lopez, Bernardo/S-5148-2019; Gonzalez-Forero, David/AAU-2935-2020; Kasparov, Sergey/AAH-5286-2019; Kasparov, Sergey/C-4932-2014; Portillo Pacheco, Federico Luis/I-1048-2015	Moreno-Lopez, Bernardo/0000-0003-2897-6227; Kasparov, Sergey/0000-0002-1824-1764; Kasparov, Sergey/0000-0002-1824-1764; Gonzalez Forero, David/0000-0001-5748-9546; Portillo Pacheco, Federico Luis/0000-0003-0095-1378	Ministerio de Educaciao y Ciencia, SpainSpanish Government [BFI2001-3816, SAF2005-00585]; Consejeria de Innovacion, Ciencia y Empresa from the Junta de Andalucia, SpainJunta de Andalucia [PA12005-CTS-844]	This study was supported by grants from the Ministerio de Educaciao y Ciencia, Spain (BFI2001-3816, SAF2005-00585) and the Consejeria de Innovacion, Ciencia y Empresa from the Junta de Andalucia, Spain (PA12005-CTS-844),	Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Bajrovic FF, 2002, J PERIPHER NERV SYST, V7, P141, DOI 10.1046/j.1529-8027.2002.02020.x; BERTELLI JA, 1995, J NEUROSCI METH, V58, P151, DOI 10.1016/0165-0270(94)00169-H; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; Brushart TM, 2002, J NEUROSCI, V22, P6631; Chang HM, 2000, BRAIN RES, V873, P243, DOI 10.1016/S0006-8993(00)02489-6; Chen ML, 2008, J MOL NEUROSCI, V34, P89, DOI 10.1007/s12031-007-9005-y; DEMEDINACELI L, 1988, EXP NEUROL, V100, P166, DOI 10.1016/0014-4886(88)90209-9; DEVOR M, 1979, EXP NEUROL, V64, P260, DOI 10.1016/0014-4886(79)90267-X; Elder GA, 2001, J NEUROSCI RES, V65, P493, DOI 10.1002/jnr.1179; Gonzalez-Forero D, 2004, J PHYSIOL-LONDON, V557, P991, DOI 10.1113/jphysiol.2003.059972; Gonzalez-Forero D, 2007, J NEUROSCI, V27, P6302, DOI 10.1523/JNEUROSCI.1019-07.2007; Gonzalez-Hernandez T, 1999, J NEUROSCI RES, V55, P198, DOI 10.1002/(SICI)1097-4547(19990115)55:2<198::AID-JNR7>3.0.CO;2-M; Greenebaum B, 1996, BIOELECTROMAGNETICS, V17, P293, DOI 10.1002/(SICI)1521-186X(1996)17:4<293::AID-BEM5>3.0.CO;2-Z; Haapaniemi T, 2002, J PERIPHER NERV SYST, V7, P149, DOI 10.1046/j.1529-8027.2002.02021.x; HESS DT, 1993, NATURE, V366, P562, DOI 10.1038/366562a0; HWANG JC, 1983, J APPL PHYSIOL, V55, P793; Ide C, 1996, NEUROSCI RES, V25, P101; Jiang W, 2004, NEUROSCI LETT, V367, P344, DOI 10.1016/j.neulet.2004.06.031; Kantor DB, 1996, SCIENCE, V274, P1744, DOI 10.1126/science.274.5293.1744; Kasparov S, 2004, PROG BIOPHYS MOL BIO, V84, P251, DOI 10.1016/j.pbiomolbio.2003.11.011; Kasparov S, 2005, CONTEMP CARDIOL, P247, DOI 10.1385/1-59259-883-8:247; Kasparov S, 2007, NAT METHODS, V4, P379, DOI 10.1038/nmeth0507-379a; Keilhoff G, 2002, NEUROREPORT, V13, P1463, DOI 10.1097/00001756-200208070-00023; Keilhoff G, 2002, J CHEM NEUROANAT, V24, P181, DOI 10.1016/S0891-0618(02)00055-8; Keilhoff G, 2002, J NEUROSCI RES, V68, P432, DOI 10.1002/jnr.10229; LEE CM, 1995, J BIOL CHEM, V270, P27403, DOI 10.1074/jbc.270.46.27403; Levy D, 1998, EUR J NEUROSCI, V10, P1846, DOI 10.1046/j.1460-9568.1998.00186.x; Levy D, 2001, J NEUROPATH EXP NEUR, V60, P411, DOI 10.1093/jnen/60.5.411; Longo FM, 1999, J NEUROSCI RES, V55, P230, DOI 10.1002/(SICI)1097-4547(19990115)55:2<230::AID-JNR10>3.0.CO;2-3; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Mert T, 2007, EUR J PHARMACOL, V568, P25, DOI 10.1016/j.ejphar.2007.05.004; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Moreno-Lopez B, 2006, REV NEUROSCIENCE, V17, P309; Nagano S, 2001, J NEUROCHEM, V77, P1486, DOI 10.1046/j.1471-4159.2001.00358.x; Paton JFR, 2002, TRENDS NEUROSCI, V25, P626, DOI 10.1016/S0166-2236(02)02261-0; Paton JFR, 2001, J PHYSIOL-LONDON, V531, P445, DOI 10.1111/j.1469-7793.2001.0445i.x; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; RENDE M, 1995, J COMP NEUROL, V363, P249, DOI 10.1002/cne.903630207; Schwarte RC, 2004, DEV BIOL, V273, P276, DOI 10.1016/j.ydbio.2004.06.003; SISKEN BF, 1989, BRAIN RES, V485, P309, DOI 10.1016/0006-8993(89)90575-1; Sohn YK, 1999, J NEUROL SCI, V162, P133, DOI 10.1016/S0022-510X(98)00297-4; Stokes CEL, 2003, EXP PHYSIOL, V88, P459, DOI 10.1113/eph8802551; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; SWETT JE, 1991, J COMP NEUROL, V304, P234, DOI 10.1002/cne.903040207; Tanaka H, 1998, J Oral Sci, V40, P147; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; Waki H, 2003, J PHYSIOL-LONDON, V546, P233, DOI 10.1113/jphysiol.2002.030270; Waki H, 2006, HYPERTENSION, V48, P644, DOI 10.1161/01.HYP.0000238200.46085.c6; Yamada RX, 2006, NEUROREPORT, V17, P661, DOI 10.1097/00001756-200604240-00021; Yu WHA, 1997, DEV NEUROSCI-BASEL, V19, P247; YU WHA, 1994, J HISTOCHEM CYTOCHEM, V42, P451, DOI 10.1177/42.4.7510317; Zhou LH, 2006, EXP NEUROL, V197, P84, DOI 10.1016/j.expneurol.2005.08.019; Zochodne DW, 1997, NEUROSCI LETT, V228, P71, DOI 10.1016/S0304-3940(97)00359-5; Zochodne DW, 2005, CELL MOL BIOL, V51, P255, DOI 10.1170/T626; Zochodne DW, 1999, NEUROSCIENCE, V91, P1515, DOI 10.1016/S0306-4522(98)00729-5	59	14	15	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	NOV 11	2008	157	1					40	51		10.1016/j.neuroscience.2008.09.001			12	Neurosciences	Neurosciences & Neurology	369UE	WOS:000260718600005	18824216				2021-06-18	
J	Wang, YJ; Zhu, L; Rosengart, AJ				Wang, Yunjian; Zhu, Liang; Rosengart, Axel J.			Targeted brain hypothermia induced by an interstitial cooling device in the rat neck: Experimental study and model validation	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Brain hypothermia; Ischemic brain injury; Interstitial cooling; Rat; Surgery	THEORETICAL ANALYSES; INJURY; TEMPERATURE; ISCHEMIA	Targeted brain hypothermia has the potential to prevent cerebral ischemia injury during open heart and neck surgeries or after traumatic head injury. In this study, in vivo experiments were performed to test the performance of a newly developed cooling device in an inexpensive animal model. Rat brain hypothermia was induced by inserting an interstitial cooling device in the rat neck muscle and placing the device on the common carotid artery to cool the arterial blood supplied to the brain. Coolant was circulating inside the cooling device to achieve either mild or moderate temperature reductions at the surface of the device. Temperatures were measured inside the rat brain tissue, as well as on the head skin surface. For the mild cooling (cooling device surface temperature was 18.7 +/- 4.5 degrees C), the temperature reductions were 2.2 +/- 0.6 degrees C, 2.1 +/- 0.6 degrees C, 1.9 +/- 0.6 degrees C and 1.6 +/- 0.9 degrees C at sites of brain-5 mm, brain-2 mm, skull, and scalp, respectively. After the surface temperature was further decreased to 12.8 +/- 2.8 degrees C (moderate cooling), the temperature reduction in the head increased more than 85% to 3.7 +/- 3.2 degrees C, 3.7 +/- 3.0 degrees C, 3.3 +/- 2.5 degrees C and 2.5 +/- 1.0 degrees C, respectively. The experimental data were also used to validate a previously developed theoretical model for humans. Experimentally measured geometrical and physiological parameters of the rat neck and brain were substituted into the scaled-down theoretical model to simulate the temperature distribution in the rat neck and brain. The theoretically predicted brain temperatures showed a good agreement with the experiment data. We believe that this study is the first step in developing a reliable cooling device to achieve fast cooling and to control rewarming in future clinical studies and to benefit a large patient population. (C) 2008 Elsevier Ltd. All rights reserved.	[Wang, Yunjian; Zhu, Liang] Univ Maryland Baltimore Cty, Dept Mech Engn, Baltimore, MD 21250 USA; [Rosengart, Axel J.] New York Presbyterian Hosp, New York, NY USA	Zhu, L (corresponding author), Univ Maryland Baltimore Cty, Dept Mech Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	zliang@umbc.edu			NSFNational Science Foundation (NSF); Brain Research Foundation; University of Chicago Medical CenterUniversity of Chicago; Cancer Research Foundation, Chicago	The authors are grateful to Drs. Olav Thulesius and Huan Wang for their helpful comments. Dr. Zhu thankfully acknowledges financial assistance by an NSF-supported UMBC ADVANCE program. Dr. Rosengart was supported in part by the Brain Research Foundation, The University of Chicago Medical Center, and the Cancer Research Foundation, Chicago, Illinois. The research was performed in partial fulfillment of the requirements for the Ph.D. degree from the University of Maryland Baltimore County by Yunjian Wang.	Allers M, 2006, CARDIOVASC INTER RAD, V29, P260, DOI 10.1007/s00270-004-0271-6; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Bommadevara M, 2002, BIOMECH MODEL MECHAN, V1, P137, DOI 10.1007/s10237-002-0011-2; DIAO C, 2004, THESIS U MARYLAND BA; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Diao CG, 2006, MED PHYS, V33, P2565, DOI 10.1118/1.2208918; ILLIEVICH UM, 1994, ANESTH ANALG, V78; LEVINE S, 1966, EXP NEUROL, V16, P255, DOI 10.1016/0014-4886(66)90062-8; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MILLER JH, 1993, J VASC SURG, V17, P546; MINAMISAWA H, 1990, J CEREBR BLOOD F MET, V10, P365, DOI 10.1038/jcbfm.1990.66; NURSE S, 1994, J NEUROSCI, V14, P7726; Nussmeier Nancy A, 2002, J Extra Corpor Technol, V34, P4; OLSEN RW, 1985, ASME, V107, P354; PENNES HH, 1948, J APPL PHYSIOL, V1, P93; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; WEINBAUM S, 1984, J BIOMECH ENG-T ASME, V106, P321, DOI 10.1115/1.3138501; Xu XJ, 1999, J APPL PHYSIOL, V86, P265; Zhu L, 2000, ANN BIOMED ENG, V28, P269, DOI 10.1114/1.266; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442; Zhu L, 2008, HEAT TRANSFER ENG, V29, P284, DOI 10.1080/01457630701758062	24	14	15	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310			INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	NOV	2008	51	23-24					5662	5670		10.1016/j.ijheatmasstransfer.2008.04.042			9	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	370IK	WOS:000260755700021					2021-06-18	
J	Citron, BA; Arnold, PM; Haynes, NG; Ameenuddin, S; Farooque, M; SantaCruz, K; Festoff, BW				Citron, Bruce A.; Arnold, Paul M.; Haynes, Neal G.; Ameenuddin, Syed; Farooque, Mohammed; SantaCruz, Karen; Festoff, Barry W.			Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury	SPINE			English	Article						apoptosis; executioner enzyme; trophic; behavior; neuropathology; RNA; RT-PCR; gene microarrays	INTERLEUKIN-1-BETA CONVERTING-ENZYME; RANDOMIZED CONTROLLED-TRIAL; ISCHEMIC BRAIN-INJURY; NEURONAL CELL-DEATH; CEREBRAL-ISCHEMIA; RAT MODEL; IN-VIVO; NEUROLOGICAL DYSFUNCTION; INFLAMMATORY CYTOKINE; TIRILAZAD MESYLATE	Study Design. We used gene microarrays and found that caspase-related death genes were upregulated. We tested caspase inhibition and evaluated its effect on the spinal cord after traumatic injury. Objective. The logical extension of previous studies was to determine whether downstream CASP genes might also be involved and whether inhibition might prevent injury-induced cell death. Summary of Background Data. Apoptotic cell death occurs in all endogenous cellular compartments of the spinal cord, peaking at 3 days after injury in neurons, astrocytes, and microglia. The downstream effector caspase-3 cleaves several important cellular sites after being activated by upstream initiator caspases. Along with others, we have previously identified caspase signature cleavage of PARP, a-fodrin, and DFF45/ICAD in the injured rat spinal cord. We also showed rapid upregulation of caspase-3 gene expression along with localization of active caspase-3 in neurons and activated microglia after SCI. Others have reported that a more general active-site mimetic peptide ketone, benzylocarbonyl-Val-Ala-Asp-fluromethylketone (zVAD-fmk) was neuroprotective after rat spinal cord injury (SCI). Methods. In this study, we administered the caspase-3 subfamily tetrapeptide cell permeable inhibitor Z-Asp(O-Me)-Glu(O-Me)-Val-Asp(O-Me) fluoromethyl ketone (DEVDfmk) intraperitoneally 1 hour after laminectomy and moderate (25 g cm force) SCI in rats. Results. We used the open field locomotor rating (LRS) over a 14-day course and found statistically significant improvement in DEVD-fmk-treated rats, LRS, 9.8 +/- 0.93 SEM, compared with vehicle, 6.6 +/- 0.4 (P < 0.05). Histologic analysis of percent spinal cord tissue volume spared was 50% greater for DEVD-fmk versus control (P < 0.5). Conclusion. These results indicate neuroprotection at both the cellular level and with substantial functional recovery, suggesting caspase-3 inhibition may be a viable therapy in the early hours after experimental SCI.	[Citron, Bruce A.; Arnold, Paul M.; Haynes, Neal G.; Ameenuddin, Syed; Farooque, Mohammed; Festoff, Barry W.] Vet Affairs Med Ctr, Neurobiol Res Lab, Kansas City, MO USA; [Citron, Bruce A.; Farooque, Mohammed; Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Arnold, Paul M.; Haynes, Neal G.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66103 USA; [SantaCruz, Karen] Univ Kansas, Med Ctr, Dept Pathol, Kansas City, KS 66103 USA; [Festoff, Barry W.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	Festoff, BW (corresponding author), VA Med Ctr, Neurobiol Res Lab 151, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	bfestoff@kumc.edu					ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Arnold PM, 2000, J NEUROCHEM, V74, pS73; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bossenmeyer-Pourie C, 1999, MOL BRAIN RES, V71, P225, DOI 10.1016/S0169-328X(99)00190-4; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Chan YM, 2001, NEUROREPORT, V12, P541, DOI 10.1097/00001756-200103050-00022; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Colak A, 2005, J NEUROSURG-SPINE, V2, P327, DOI 10.3171/spi.2005.2.3.0327; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Conti AC, 1998, J NEUROSCI, V18, P5663; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DUCKER TB, 1994, SPINE, V19, P2281, DOI 10.1097/00007632-199410150-00006; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Festoff BW, 2004, J NEUROTRAUM, V21, P907, DOI 10.1089/0897715041526168; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; GEHRMANN J, 1995, J NEUROPATH EXP NEUR, V54, P680, DOI 10.1097/00005072-199509000-00010; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HALL ED, 1996, NEUROTRAUMA, P1405; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HAMERS FPT, 1999, J NEUROTRAUM, V16, P1010; HAMERS FPT, 1998, J NEUROTRAUM, V15, P873; Hara H, 1999, Nihon Yakurigaku Zasshi, V113, P97; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Knoblach SM, 2005, J NEUROSCI RES, V80, P369, DOI 10.1002/jnr.20465; Krupinski J, 2000, NEUROBIOL DIS, V7, P332, DOI 10.1006/nbdi.2000.0310; Lankhorst AJ, 1999, J NEUROTRAUM, V16, P323, DOI 10.1089/neu.1999.16.323; Lee YL, 2000, NEUROCHEM INT, V36, P417, DOI 10.1016/S0197-0186(99)00133-3; Lemke M, 1990, J NEUROTRAUM, V7, P41, DOI 10.1089/neu.1990.7.41; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li H, 2000, STROKE, V31, P176, DOI 10.1161/01.STR.31.1.176; Liu XZ, 1997, J NEUROSCI, V17, P5395; Namura S, 1998, J NEUROSCI, V18, P3659; Nath R, 2001, CELL MOL BIOL LETT, V6, P173; Nemecek S, 1978, Adv Neurol, V20, P395; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; O'Neill R R, 1989, Appl Theor Electrophor, V1, P163; Ozawa H, 2002, EXP NEUROL, V177, P306, DOI 10.1006/exnr.2002.7998; Pointillart V, 2000, SPINAL CORD, V38, P71, DOI 10.1038/sj.sc.3100962; Pong K, 2001, EXP NEUROL, V171, P84, DOI 10.1006/exnr.2001.7747; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Puka-Sundvall M, 2000, DEV BRAIN RES, V125, P43, DOI 10.1016/S0165-3806(00)00111-5; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Riss TL, 2001, UROLOGY, V57, P141, DOI 10.1016/S0090-4295(00)00960-2; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Saez-Valero J, 2000, NEUROSCI LETT, V293, P207, DOI 10.1016/S0304-3940(00)01532-9; Short DJ, 2000, SPINAL CORD, V38, P273, DOI 10.1038/sj.sc.3100986; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; Simakajornboon N, 2001, BRAIN RES, V895, P111, DOI 10.1016/S0006-8993(01)02054-6; Siman R, 1999, NEUROSCIENCE, V92, P1425, DOI 10.1016/S0306-4522(99)00034-2; Smirnova IV, 1998, J NEUROBIOL, V36, P64, DOI 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.0.CO;2-8; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Verdaguer E, 2002, BRIT J PHARMACOL, V135, P1297, DOI 10.1038/sj.bjp.0704581; Viviani B, 2000, GLIA, V32, P84, DOI 10.1002/1098-1136(200010)32:1<84::AID-GLIA80>3.0.CO;2-Q; Wiessner C, 2000, CELL MOL BIOL, V46, P53; Wu KLH, 2003, NEUROBIOL DIS, V14, P19, DOI 10.1016/S0969-9961(03)00078-0; Wu M, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P79; Yaginuma H, 2001, MOL CELL NEUROSCI, V18, P168, DOI 10.1006/mcne.2001.1009; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5	83	14	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	OCT 1	2008	33	21					2269	2277		10.1097/BRS.0b013e3181831f7e			9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	354KF	WOS:000259637800003	18827691				2021-06-18	
J	Pasvogel, AE; Miketova, P; Moore, IM				Pasvogel, Alice E.; Miketova, Petra; Moore, Ida M. (Ki)			Cerebrospinal fluid phospholipid changes following traumatic brain injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						phospholipids; traumatic brain injury; membrane damage	FREE FATTY-ACIDS; ISCHEMIA; REPERFUSION; INHIBITORS; DISORDERS; DAMAGE; RATS; A(2)	Traumatic brain injury (TBI)) is a leading cause of morbidity and mortality, with approximately 1.4 million people suffering a TBI each year. With TBI, a cascade of events is initiated including the activation of phospholipases, which leads to the disruption of the lipid bilayer of the membrane of neurons and neuroglia. The purpose of this study is to describe phospholipid changes following TBI. A total of 39 cerebrospinal fluid samples were obtained from the ventricular catheter system of 10 participants who received a TBI as a result of a motor vehicle crash, being struck by a vehicle as a pedestrian, or a fall. Phospholipids were extracted from samples and measured by normal-phase high-performance liquid chromatography with ultraviolet detector at a wavelength of 206 nm. The highest mean concentration of lysophosphatidylcholine occurred on Day I after injury. The concentration of phosphatidylserine was variable, with the highest mean concentration occurring on Day 2 after injury. The highest mean concentrations of phosphatidylethanolamine, phosphatidylcholine, and sphingomyelin occurred on Day 4 after injury. Findings provide preliminary evidence for disruption of central nervous system membrane phospholipids following TBI.	[Pasvogel, Alice E.; Miketova, Petra; Moore, Ida M. (Ki)] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA	Pasvogel, AE (corresponding author), Univ Arizona, Coll Nursing, 1305 N Martin, Tucson, AZ 85721 USA.	pasvogel@nursing.arizona.edu			Sigma Theta Tau International	This study was supported by a grant from Beta Mu Chapter, Sigma Theta Tau International.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; CHEN SF, 1985, J CHROMATOGR, V344, P297, DOI 10.1016/S0378-4347(00)82030-7; Drgova A, 2004, GEN PHYSIOL BIOPHYS, V23, P337; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Graham DI GT, 2000, HEAD INJURY, P133; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; ILLINGWORTH DR, 1971, J NEUROCHEM, V18, P769, DOI 10.1111/j.1471-4159.1971.tb12006.x; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Koch S, 2001, J LIPID RES, V42, P1143; Kolko M, 2003, NEUROSCI LETT, V338, P164, DOI 10.1016/S0304-3940(02)01385-X; KUNZ F, 1972, Z NEUROL, V203, P259, DOI 10.1007/BF00316117; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; PARSONS L, 1997, J NEUROTRAUM, V14, P784; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Pilitsis JG, 2002, BRAIN RES, V951, P96, DOI 10.1016/S0006-8993(02)03142-6; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	21	14	14	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	OCT	2008	10	2					113	120		10.1177/1099800408323218			8	Nursing	Nursing	353VI	WOS:000259596200005	18829594				2021-06-18	
J	Sengul, G; Takci, E; Malcok, UA; Akar, A; Erdogan, F; Kadioglu, HH; Aydin, IH				Sengul, Goksin; Takci, Ethan; Malcok, Umit Ali; Akar, All; Erdogan, Fazli; Kadioglu, Hakan Hadi; Aydin, Ismail Hakki			A preliminary histopathological study of the effect of agmatine on diffuse brain injury in rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						agmatine; brain injury; rat	SPINAL-CORD-INJURY; NITRIC-OXIDE PRODUCTION; HIPPOCAMPAL-NEURONS; AXONAL INJURY; DAMAGE; GLUTAMATE; MODEL; ISCHEMIA; RECEPTOR; NEUROPROTECTION	The present study evaluates the effects of agmatine oil histopathological damage following traumatic injury using a clinically relevant model of diffuse brain injury. A total of 27 male Sprague-Dawley rats weighing 200-225 g were anaesthetised and subjected to head trauma using Marmarou's impact-acceleration model. The rats were then separated into two main groups: one was treated with agmatine and the other with saline for LIP to 4 days immediately after head trauma. Rats from both groups were killed 1, 3 or 8 days post-injury. The brains were examined histopathologically and scored according to the axonal, neuronal and Vascular changes associated with diffuse brain injury. There were no significant differences between the groups at I clay or 3 days after trauma, but evaluation after 8 days revealed,I significant improvement in the group treated with agmatine. Our data indicate that agmatine has a beneficial effect in diffuse brain injury and Should be trialled for therapeutic use in the management of this condition. (c) 2008 Elsevier Ltd. All rights reserved.	[Sengul, Goksin; Takci, Ethan; Malcok, Umit Ali; Akar, All; Kadioglu, Hakan Hadi; Aydin, Ismail Hakki] Ataturk Univ, Sch Med, Aziziye Res Hosp, Dept Neurosurg, TR-25070 Erzurum, Turkey; [Erdogan, Fazli] Ataturk Univ, Sch Med, Dept Pathol, Erzurum, Turkey	Sengul, G (corresponding author), Ataturk Univ, Sch Med, Aziziye Res Hosp, Dept Neurosurg, TR-25070 Erzurum, Turkey.	goksinsengul@gmail.com		Kadioglu, Hakan Hadi/0000-0002-7744-6241			Abe K, 2000, BRAIN RES, V872, P141, DOI 10.1016/S0006-8993(00)02517-8; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ASHWAL S, 1995, PEDIATR RES, V38, P652, DOI 10.1203/00006450-199511000-00004; Budd SL, 1998, PHARMACOL THERAPEUT, V80, P203, DOI 10.1016/S0163-7258(98)00029-1; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Demady DR, 2001, MOL PHARMACOL, V59, P24; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fairbanks CA, 2000, P NATL ACAD SCI USA, V97, P10584, DOI 10.1073/pnas.97.19.10584; Feng YZ, 2002, PEDIATR RES, V52, P606, DOI 10.1203/01.PDR.0000028057.79132.1F; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gilad GM, 2000, NEUROSCI LETT, V296, P97, DOI 10.1016/S0304-3940(00)01625-6; Gilad GM, 1996, NEUROSCI LETT, V216, P33; GILAD GM, 1996, LIFE SCI, V58, P41; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; Kotil K, 2006, J NEUROSURG-SPINE, V4, P392, DOI 10.3171/spi.2006.4.5.392; Malcok UA, 2005, J INT MED RES, V33, P90, DOI 10.1177/147323000503300109; Olmos G, 1999, BRIT J PHARMACOL, V127, P1317, DOI 10.1038/sj.bjp.0702679; Povlishock John T., 1995, P504; Sahuquillo J, 2002, ADV TECH STAND NEUR, V27, P23; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang WP, 2006, BRAIN RES, V1084, P210, DOI 10.1016/j.brainres.2006.02.024; Yang XC, 1999, J PHARMACOL EXP THER, V288, P544; Yu CG, 2000, NEUROREPORT, V11, P3203, DOI 10.1097/00001756-200009280-00031; Zhu M, 2006, NEUROSCIENCE, V141, P2019, DOI 10.1016/j.neuroscience.2006.05.011	28	14	16	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2008	15	10					1125	1129		10.1016/j.jocn.2007.11.005			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	350AM	WOS:000259324800011	18640839				2021-06-18	
J	Wang, Y; Zhao, J; Kalsotra, A; Turman, CM; Grill, RJ; Dash, PK; Strobel, HW				Wang, Ying; Zhao, Jing; Kalsotra, Auinash; Turman, Cheri M.; Grill, Raymond J.; Dash, Pramod K.; Strobel, Henry W.			CYP4Fs Expression in Rat Brain Correlates with Changes in LTB4 Levels after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	International Symposium on Traumatic Brain Injury Research Priorities	OCT 13-16, 2005	Johnstown, PA	John P Murtha Neursci & Pain Inst, Natl Brain Injury Res, Treatments & Training Fdn, Brain Injury Assoc Amer		cytochrome P450 4Fs (CYP4Fs); inflammation; leukotriene B-4 (LTB4); omega-hydroxylation; traumatic brain injury (TBI)	PROTEIN EXPRESSION; ARACHIDONIC-ACID; CEREBRAL-CORTEX; CDNA CLONING; CYTOCHROME-P450; INFLAMMATION; SPECIFICITY; METABOLISM; RECEPTORS; CYTOKINES	Cytochrome P450 (CYP) 4Fs constitute a subgroup of the cytochrome P450 superfamily and are involved in cellular protection and metabolism of numerous molecules, including drugs, toxins, and eicosanoids. CYP4Fs are widely distributed in rat brain with each isoform having a unique distribution pattern throughout different brain regions. The present study shows that traumatic brain injury (TBI) triggers inflammation and elicits changes in mRNA expression of CYP4Fs in the frontal and occipital lobes and the hippocampus. At 24 h post-injury, almost all CYP4F mRNA expression is suppressed compared with sham control throughout these three regions, while at 2 weeks post-injury, all CYP4F mRNAs increase, reaching levels higher than those at 24 h post-injury or uninjured controls. These changes in CYP4F levels inversely correlate with levels of leukotriene B4 (LTB4) levels in the brain following injury at the same time points. TBI also causes changes in CYP4F protein expression and localization around the injury site. CYP4F1 and CYP4F6 immunoreactivity increases in surrounding astrocytes, while CYP4F4 immunoreactivity shifts from endothelia of cerebral vessels to astrocytes.	[Wang, Ying; Kalsotra, Auinash; Turman, Cheri M.; Strobel, Henry W.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA; [Zhao, Jing; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Grill, Raymond J.; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA	Strobel, HW (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77225 USA.	henry.w.strobel@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002; Kalsotra, Auinash/0000-0002-1011-0006	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044174, R01NS049409, R01NS035457] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049409, NS35457, NS44174] Funding Source: Medline		Amaral SL, 2003, AM J PHYSIOL-HEART C, V284, pH1528, DOI 10.1152/ajpheart.00406.2002; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Boehme CL, 2001, NEUROTOX RES, V3, P329, DOI 10.1007/BF03033194; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Bylund J, 2003, ARCH BIOCHEM BIOPHYS, V412, P34, DOI 10.1016/S0003-9861(03)00030-4; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cui X, 2003, BBA-GEN SUBJECTS, V1619, P325, DOI 10.1016/S0304-4165(02)00491-9; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Frontczak-Baniewicz M, 2002, NEUROENDOCRINOL LETT, V23, P396; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Hoagland KM, 2001, NEPHROL DIAL TRANSPL, V16, P2283, DOI 10.1093/ndt/16.12.2283; Jiang M, 2004, CIRC RES, V94, P167, DOI 10.1161/01.RES.0000111523.12842.FC; Jin RY, 1998, ARCH BIOCHEM BIOPHYS, V359, P89, DOI 10.1006/abbi.1998.0880; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Kalsotra A, 2002, DRUG METAB DISPOS, V30, P1022, DOI 10.1124/dmd.30.9.1022; Kawashima H, 1995, BIOCHEM BIOPH RES CO, V217, P1137, DOI 10.1006/bbrc.1995.2887; Kawashima H, 1997, ARCH BIOCHEM BIOPHYS, V347, P148, DOI 10.1006/abbi.1997.0342; Kawashima H, 1996, J BIOL CHEM, V271, P28176, DOI 10.1074/jbc.271.45.28176; KIKUTA Y, 1993, J BIOL CHEM, V268, P9376; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nicholson TE, 1999, BRAIN RES, V827, P12, DOI 10.1016/S0006-8993(99)01261-5; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Poloyac SM, 2006, J CEREBR BLOOD F MET, V26, P1551, DOI 10.1038/sj.jcbfm.9600309; SAITO T, 1981, J BIOL CHEM, V256, P984; Schuhmann MU, 2003, NEUROL RES, V25, P481, DOI 10.1179/016164103101201896; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Williams J F, 1991, J Fla Med Assoc, V78, P517; Xu FY, 2004, J PHARMACOL EXP THER, V308, P887, DOI 10.1124/jpet.103.059626; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x	37	14	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2008	25	10					1187	U23		10.1089/neu.2008.0542			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	370XK	WOS:000260796200007	18847377	Green Published			2021-06-18	
J	Gao, X; Chen, JH				Gao, Xiang; Chen, Jinhui			Direct isolation of neural stem cells in the adult hippocampus after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						fluorescence-activated cell sorting; neural stem cell; transgenic mice; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; FLUORO-JADE-B; INTERMEDIATE-FILAMENT PROTEIN; DENTATE GYRUS; NESTIN EXPRESSION; NEURONAL DEGENERATION; ENHANCED NEUROGENESIS; PROGENITOR CELLS; PROLIFERATIVE ENDOTHELIUM	Recently, we have manipulated endogenous neural stem/progenitor cells (NSCs) in situ in the adult mouse to undergo neurogenesis and anatomic circuit re-formation de novo in the neocortex, where it does not normally occur, by using a highly targeted brain injury model. However, how the NSCs respond to injury in the adult mouse brain is poorly understood. While studying the molecular mechanisms that regulate NSC fates after brain injury, it is important to develop a strategy to identify NSCs in niches and isolate them directly from fresh tissue after brain injury. Here we report that we directly isolated NSCs from adult brains after traumatic brain injury by genetically labeling NSCs with EGFP combined with fluorescence-activated cell sorting (FACS) technique without an intervening cell culture and with high concentrations of growth factors. The isolated EGFP-positive cells can self-renew and have the potential to differentiate into both neurons and glia in vitro, confirming that the FACS-sorted EGFP-positive cells are NSCs. This unique approach provides a useful tool to isolate large amounts of endogenous NSCs in situ for identifying the critical molecules that regulate fate decision and neurogenesis in the adult brain after injury.	[Gao, Xiang; Chen, Jinhui] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Chen, Jinhui] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	Chen, JH (corresponding author), 741 S Limestone St, Lexington, KY 40536 USA.	jchen@uky.edu	Chen, Jinhui/A-7138-2009	Chen, Jinhui/0000-0002-6864-7121	Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [4-2]	We appreciate Dr. Grigori Enikolopov at Cold Spring Harbor Laboratory for kindly providing the nestin-EGFP mice, and we thank Dr. Gary Van Zant and Barry Grimes for their kind assistance in cell sorting. This work was supported by a grant from the Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT grant 4-2) to J. Chen.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Ballok DA, 2003, BRAIN RES, V964, P200, DOI 10.1016/S0006-8993(02)03980-X; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; GAO X, 2008, J NEUROSCI IN PRESS; Ha Y, 2002, NEUROSCI RES, V44, P207, DOI 10.1016/S0168-0102(02)00126-8; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Holley JE, 2003, NEUROPATH APPL NEURO, V29, P434, DOI 10.1046/j.1365-2990.2003.00491.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johansson CB, 2002, J NEUROSCI RES, V69, P784, DOI 10.1002/jnr.10376; Kee NJ, 2001, EXP BRAIN RES, V136, P313, DOI 10.1007/s002210000591; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Lardon J, 2002, HISTOCHEM CELL BIOL, V117, P535, DOI 10.1007/s00418-002-0412-4; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Magavi SS, 2000, NATURE, V405, P951; Markakis EA, 1999, J COMP NEUROL, V406, P449; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Mehrholz J, 2005, CLIN REHABIL, V19, P63, DOI 10.1191/0269215505cr824oa; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mokry J, 1999, Gen Physiol Biophys, V18 Suppl 1, P25; Murayama A, 2002, J NEUROSCI RES, V69, P837, DOI 10.1002/jnr.10339; Parent JM, 2002, PROG BRAIN RES, V135, P121; Parent JM, 1997, J NEUROSCI, V17, P3727; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Reh TA, 2002, NAT NEUROSCI, V5, P392, DOI 10.1038/nn0502-392; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt-Kastner R, 2002, INT J DEV NEUROSCI, V20, P29, DOI 10.1016/S0736-5748(02)00003-5; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Sergent-Tanguy S, 2006, J NEUROSCI RES, V83, P1515, DOI 10.1002/jnr.20846; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shimizu T, 2006, NEUROL MED-CHIR, V46, P111, DOI 10.2176/nmc.46.111; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Taupin P, 2005, MED SCI MONITOR, V11, pRA247; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TOHYAMA T, 1992, LAB INVEST, V66, P303; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	74	14	18	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	2008	25	8					985	995		10.1089/neu.2008.0460			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	343ZT	WOS:000258895700004	18665804				2021-06-18	
J	Richmond, TS; Lemaire, J				Richmond, Therese S.; Lemaire, Jean			Years of life lost because of gunshot injury to the brain and spinal cord	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						life expectancy; brain injuries; spinal cord injuries; wounds; gunshot	MORTALITY; SUICIDE; BURDEN; DEATH; FIREARMS; HEALTH; TRENDS; STATES	Objective: A recent study (Lemaire) estimated the life expectancy loss attributable to gun deaths at 103.6 days for the overall U.S. population: 150.7 days for white males and 361.5 days for black males. This study estimates the life expectancy loss attributable to the premature death of individuals who initially survived gun-related traumatic brain injury (TBI) and spinal cord injury (SCI) in the United States. Design: Interpersonal TBI data were drawn from a surveillance system, and self-inflicted TBI data were obtained from the Web-based Injury Statistics and Reporting System. SCI data were obtained from a national database. Multiple decrement analysis was used to calculate the days of life lost to gunshot wounds to the brain and spinal cord, by race and gender, in the United States. Results: On average, across age, gender, and race, life expectancy in the United States is reduced by 3.1 days because of the shorter lifespan for individuals who survive an initial gunshot wound to the brain or spinal cord. Black males bear a disproportionate burden, losing 9.5 days, whereas white males lose 4.6 days. Black and white females lose 1.5 and 1.0 days, respectively. Conclusions: We add these findings to the Lemaire study, resulting in a total of 106.7 days of life expectancy loss from gunshot wounds for the U.S. population, with 37 1.0 days of life lost for black males.	[Richmond, Therese S.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Richmond, Therese S.] Univ Penn, Firearm & Injury Ctr Penn, Philadelphia, PA 19104 USA; [Lemaire, Jean] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	Richmond, TS (corresponding author), Univ Penn, Sch Nursing, Fagin Hall,418 Curie Blvd, Philadelphia, PA 19104 USA.						Bowers NewtonL., 1997, ACTUARIAL MATH, V2nd ed.; *CDC, 2002, HLTH EXP PERC GROSS; *CENTR INT AG, 2006, FACTB; *CTR INJ PREV CONT, WISQARS; Cukier W. T. Sarkar, 2000, CANADIAN CRIMINAL LA, V6, P99; DeVivo MJ, 1999, ARCH PHYS MED REHAB, V80, P1411, DOI 10.1016/S0003-9993(99)90252-6; Fingerhut L A, 1998, Adv Data, P1; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hyder AA, 2006, HEALTH POLICY, V77, P129, DOI 10.1016/j.healthpol.2005.07.008; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062; Lai DJ, 1999, INT J EPIDEMIOL, V28, P894, DOI 10.1093/ije/28.5.894; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lemaire J, 2005, J RISK INSUR, V72, P359, DOI 10.1111/j.1539-6975.2005.00128.x; Miller M, 2004, J TRAUMA, V57, P626, DOI 10.1097/01.TA.0000093367.07960.E4; *NAT SPIN CORD INJ, 2004, 2004 ANN STAT REP MO; National Spinal Cord Injury Statistical Center, SPIN CORD INJ FACTS; Perrott GSJ, 2005, MILBANK Q, V83, P569, DOI 10.1111/j.1468-0009.2005.00393.x; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; SHAVELLE RM, 2007, BRAIN INJURY MED PRI; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; *SPIN CORD INF NET, 2004, FACTS FIG GLANC; Stolzenberg L, 2000, SOC FORCES, V78, P1461, DOI 10.2307/3006181; Sutton L, 2005, SOC PSYCH PSYCH EPID, V40, P324, DOI 10.1007/s00127-005-0889-y; Wadman MC, 2003, ANN EMERG MED, V42, P468, DOI 10.1067/S0196-0644(03)00489-X; Yeo JD, 1998, SPINAL CORD, V36, P329, DOI 10.1038/sj.sc.3100628	29	14	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2008	87	8					609	615		10.1097/PHM.0b013e31817fb496			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	333AK	WOS:000258124200001	18645321				2021-06-18	
J	Roscigno, CI; Van Liew, K				Roscigno, Cecelia I.; Van Liew, Kevin			Pushed to the Margins and Pushing Back: A Case Study of One Adult's Reflections on Social Interactions After a Traumatic Brain Injury Sustained as an Adolescent	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SELF; MIND; NARRATIVES; PEOPLE; LIFE	Traumatic brain injury (TBI) is a worldwide chronic health problem. Current empirical approaches to defining factors that contribute to a meaningful life after TBI have been limited to the biomedical perspective. Such a limited paradigm fails to address how people with TBI find meaning and act on and are acted on by the world in which they live. Between 2005 and 2007 an in-depth qualitative case study was conducted. The primary data source was a man's retrospective journal writings about his life after sustaining a severe TBI. The qualitative perspective of symbolic interactionism framed this case study analysis. Meaning is strongly influenced by the ways in which the social world interacts with the injured person. Despite an accumulation of negative social experiences, a traumatically brain-injured person can also assign positive meanings to the quality of his or her life. This has been ignored or explained away as a defense mechanism in previous investigations. More studies that include unbiased methods able to capture subjective experiences and what they mean to individuals with TBI are needed. This information will lead to more relevant interventions and better outcome instruments for use with this population.	[Roscigno, Cecelia I.] Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA		graymtr@u.washington.edu			National Institutes of Nursing [1 F31 NR009599-02]; University of WashingtonUniversity of Washington [6 T73 MC 00041-11-02]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR009599] Funding Source: NIH RePORTER	The first author would like to acknowledge funding and training support from a National Institutes of Nursing Research Individual Ruth L. Kirschstein Predoctoral Research Fellowship (1 F31 NR009599-02), the University of Washington Leadership Education in Neurodevelopmental and Related Disabilities traineeship (TG # 6 T73 MC 00041-11-02), and the University of Washington Gatzert Child Welfare Fellowship during this case study. The first author also would like to acknowledge Kevin for his selfless sharing of his personal life so that others could learn. This publication is in honor of him.	Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blumer Herbert, 1969, SYMB INTERACT; Donnelly JP, 2005, BRAIN INJURY, V19, P1077, DOI 10.1080/02699050500110728; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21; Frankl VE., 1984, MANS SEARCH MEANING; Glaser B. G., 1967, DISCOVERY GROUNDED T; Goffman E., 1963, STIGMA NOTES MANAGEM; Hall E.T., 1973, SILENT LANGUAGE; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; HAUERWAS S, 2006, SEPT 2006 C; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hoofien D, 2001, BRAIN INJURY, V15, P189; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; KEAGAN R, 1982, EVOLVING SELF PROBLE; KEEN J, 1995, BRIT MED J, V311, P444, DOI 10.1136/bmj.311.7002.444; KNAPP ML, 1996, INTERPERSONAL COMMUN, P97; Luck L, 2006, NURS INQ, V13, P103, DOI 10.1111/j.1440-1800.2006.00309.x; Marris P., 1974, LOSS CHANGE; Martsolf DS, 1998, J ADV NURS, V27, P294, DOI 10.1046/j.1365-2648.1998.00519.x; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Mead G. H., 1934, MIND SELF SOC STANDP; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Morris Paul Graham, 2005, BMC Fam Pract, V6, P30, DOI 10.1186/1471-2296-6-30; NIETZSCHE F, 1964, COMPLETE WORKS F NIE, V16; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Swanson K M, 1993, Image J Nurs Sch, V25, P352; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Wendell S., 1996, REJECTED BODY FEMINI; WHO. Geneva: World Health Organisation, 2004, WORLD REP ROAD TRAFF; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	39	14	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	AUG	2008	40	4					212	221		10.1097/01376517-200808000-00005			10	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	516XR	WOS:000271577200005	18727337	Green Accepted			2021-06-18	
J	Hallen, M; Carlhed, R; Karlsson, M; Hallgren, T; Bergenheim, M				Hallen, Magnus; Carlhed, Rickard; Karlsson, Mathias; Hallgren, Thomas; Bergenheim, Mikael			A comparison of two different assays for determining S-100B in serum and urine	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						head trauma; methods; protein S-100B; serum analysis; urine analysis	MINOR HEAD-INJURY; TRAUMATIC BRAIN-DAMAGE; PROTEIN MEASUREMENTS; S100B PROTEIN; ELIMINATION; EXPRESSION; S100-BETA; FAMILY	Background: Brain injury after head trauma can be detected by S-100B measurements in serum. Recent preliminary studies indicate that urinary levels of S-100B are also increased after head injury, a finding that is of possible clinical value. The aims of the present study are two-fold: to compare serum measurements of two assays, the Liaison Sangtec (R) 100 system and the Elecsys (R) S100 test, and to investigate to what extent they can detect and measure S-100B in urine. Methods: A total of 191 serum and 174 urine samples from 107 patients (children aged between 1 and 18 years following head trauma) were measured with both assays. The results were compared using correlation analysis and Bland-Altman difference plots. Results: Serum values of the Sangtec (R) system ranged from 0.02 to 2.28 mu g/L, and from 0.005 to 2.13 mu g/L for the Elecsys (R) test. Comparisons showed a clear correlation (correlation coefficient 0.80) but not an agreement between the methods. The Sangtec (R) system could only detect S-100B in 20 out of 174 urine samples (range 0.02-0.06 mu g/L), whereas the Elecsys (R) test could detect S-100B in 171 samples (range 0.005-0.14 mu g/L). No clear relation was observed between the two methods in urine analysis (correlation coefficient 0.60). Conclusion: The Sangtec (R) and Elecsys (R) assays are not interchangeable methods when analyzing S-100B in serum or urine samples after head injury.	[Hallen, Magnus; Karlsson, Mathias; Hallgren, Thomas; Bergenheim, Mikael] Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden; [Carlhed, Rickard] Cent Hosp Karlstad, Dept Lab Med, S-65185 Karlstad, Sweden	Bergenheim, M (corresponding author), Cent Hosp Karlstad, Dept Surg, S-65185 Karlstad, Sweden.	mikael.bergenheim@liv.se					Banfalvi T, 2003, ONCOLOGY-BASEL, V64, P374, DOI 10.1159/000070296; BAUDIER J, 1984, BIOCHIM BIOPHYS ACTA, V790, P164, DOI 10.1016/0167-4838(84)90220-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2001, CLIN CHEM, V47, P1836; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Smit LHM, 2005, INT J BIOL MARKER, V20, P34; VANELDIK LJ, 1994, BBA-MOL CELL RES, V1223, P398, DOI 10.1016/0167-4889(94)90101-5; Ytrebo LM, 2001, SCAND J CLIN LAB INV, V61, P217; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	23	14	15	0	3	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	JUL	2008	46	7					1025	1029		10.1515/CCLM.2008.190			5	Medical Laboratory Technology	Medical Laboratory Technology	334JS	WOS:000258218700021	18624623				2021-06-18	
J	Hobbs, CE; Oorschot, DE				Hobbs, Catherine E.; Oorschot, Dorothy E.			Neonatal rat hypoxia-ischemia: Long-term rescue of striatal neurons and motor skills by combined antioxidant-hypothermia treatment	BRAIN PATHOLOGY			English	Article						hypoxia-ischemia; motor skills; stereology; striatum	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; RETINAL GANGLION-CELLS; MEDIUM SPINY NEURONS; BUTYL-NITRONE PBN; NEUROTROPHIC FACTOR; RADICAL SCAVENGERS; SELECTIVE HEAD; BASAL GANGLIA; ANIMAL-MODELS	Perinatal hypoxia-ischemia can cause long-term neurological and behavioral disability. Recent multicenter clinical trials suggest that moderate hypothermia, within 6 h of birth, offers significant yet incomplete protection. We investigated the effect of combined treatment with the antioxidant N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN) and moderate hypothermia on long-term neuronal injury and behavioral disability. S-PBN or its diluent was administered 12-hourly to rats from postnatal day (PN) 7 to 10. On PN8, hypoxia-ischemia was induced. Immediately post-hypoxia, additional S-PBN and 6 h of moderate hypothermia or additional diluent and 6 h of normothermia were administered. At 1 week, and at 11 weeks, after hypoxia-ischemia, the absolute number of surviving medium-spiny neurons was measured in the coded right striatum. In a separate experiment, skilled forepaw ability was investigated in coded 9- to 11-week-old rats. Normal, uninjured animals were also tested for motor skills at 9- to 11-weeks-of-age. The combination of S-PBN and moderate hypothermia provided statistically significant short- and long-term protection of the striatal medium-spiny neurons to normal control levels. This combinatorial treatment also preserved fine motor skills to normal control levels. The impressive histological and functional preservation suggests that S-PBN and moderate hypothermia is a safe and attractive combination therapy for perinatal hypoxia-ischemia.	[Hobbs, Catherine E.; Oorschot, Dorothy E.] Univ Otago, Dept Anat & Struct Biol, Otago Sch Med Sci, Dunedin 9054, New Zealand	Oorschot, DE (corresponding author), Univ Otago, Dept Anat & Struct Biol, Otago Sch Med Sci, POB 913, Dunedin 9054, New Zealand.	dorothy.oorschot@stonebow.otago.ac.nz	Oorschot, Dorothy/AAJ-9543-2020	Oorschot, Dorothy/0000-0003-0212-4456			ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Benders MJNL, 2006, ARCH DIS CHILD-FETAL, V91, pF163, DOI 10.1136/adc.2005.086652; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHEN GM, 1990, FREE RADICAL RES COM, V9, P317, DOI 10.3109/10715769009145690; Covey MV, 2007, PEDIATR RES, V62, P646, DOI 10.1203/PDR.0b013e318157d1fe; Covey MV, 2006, EXP NEUROL, V199, P513, DOI 10.1016/j.expneurol.2005.12.026; Dawson DA, 2001, BRAIN RES, V892, P344, DOI 10.1016/S0006-8993(00)03269-8; Dehouck MP, 2002, BRAIN RES, V955, P229, DOI 10.1016/S0006-8993(02)03469-8; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Fricker RA, 1996, BRAIN RES BULL, V41, P409, DOI 10.1016/S0361-9230(96)00083-4; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fukuda H, 2001, BRAIN RES, V910, P187, DOI 10.1016/S0006-8993(01)02659-2; Galvin KA, 1998, PEDIATR RES, V44, P740, DOI 10.1203/00006450-199811000-00017; Galvin KA, 2003, NEUROSCIENCE, V118, P1023, DOI 10.1016/S0306-4522(03)00066-6; GERFEN CR, 1982, J COMP NEUROL, V207, P283, DOI 10.1002/cne.902070308; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GRABOWSKI M, 1993, STROKE, V24, P889, DOI 10.1161/01.STR.24.6.889; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; Hallenbeck JM, 1996, ADV NEUROL, V71, P281; Hamrick SEG, 2003, CURR OPIN NEUROL, V16, P147, DOI 10.1097/00019052-200304000-00005; Hayashi T, 2005, BRAIN RES, V1038, P41, DOI 10.1016/j.brainres.2004.12.048; Hensley K, 1997, INT REV NEUROBIOL, V40, P299; HICKS SP, 1975, AM J ANAT, V143, P1, DOI 10.1002/aja.1001430102; HOBBS CE, 2008, PEDIAT INT IN PRESS; Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x; Jeyasingham RA, 2001, BRAIN RES BULL, V55, P541, DOI 10.1016/S0361-9230(01)00557-3; Klocker N, 1998, J NEUROSCI, V18, P1038; Ko ML, 2000, INVEST OPHTH VIS SCI, V41, P2967; Kohzuki M, 2006, AM J OBSTET GYNECOL, V195, P240, DOI 10.1016/j.ajog.2005.12.036; Kumral A, 2006, BRAIN RES, V1115, P169, DOI 10.1016/j.brainres.2006.07.114; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; Larsen M, 2004, ANAT EMBRYOL, V208, P239, DOI 10.1007/s00429-004-0395-0; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; MacLellan CL, 2006, STROKE, V37, P1266, DOI 10.1161/01.STR.0000217268.81963.78; MacLellan CL, 2006, BEHAV BRAIN RES, V175, P82, DOI 10.1016/j.bbr.2006.08.001; Maples KR, 2004, CNS DRUGS, V18, P1071, DOI 10.2165/00023210-200418150-00003; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; MONTOYA CP, 1990, PROG BRAIN RES, V82, P459; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Nedelcu J, 2000, BRAIN PATHOL, V10, P61; OORSCHOT DE, 1994, PROG NEUROBIOL, V44, P233, DOI 10.1016/0301-0082(94)90040-X; Oorschot DE, 2002, ADV BEHAV BIOL, V52, P421; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; Peterson SL, 2005, NEUROTOXICOLOGY, V26, P969, DOI 10.1016/j.neuro.2005.04.002; PRICE AW, 1981, BRAIN RES, V205, P81, DOI 10.1016/0006-8993(81)90721-6; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Rogalska J, 2004, BEHAV BRAIN RES, V154, P321, DOI 10.1016/j.bbr.2004.02.020; Roohey T, 1997, EARLY HUM DEV, V47, P115, DOI 10.1016/S0378-3782(96)01773-2; Rumiris D, 2006, HYPERTENS PREGNANCY, V25, P241, DOI 10.1080/10641950600913016; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; SCHULZ JB, 1995, J CEREBR BLOOD F MET, V15, P948, DOI 10.1038/jcbfm.1995.120; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Smith JM, 2007, BRAIN, V130, P915, DOI 10.1093/brain/awl393; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Toien O, 2001, AM J PHYSIOL-REG I, V281, pR572; Tomimatsu T, 2002, BRAIN RES, V926, P108, DOI 10.1016/S0006-8993(01)03311-X; Tuor UI, 2001, EXP NEUROL, V167, P272, DOI 10.1006/exnr.2000.7565; Volpe J., 2001, NEUROLOGY NEWBORN, V4th ed.; Wagner CL, 1999, PEDIATR NEUROL, V21, P429, DOI 10.1016/S0887-8994(99)00020-X; Wemer J, 2006, CURR MED RES OPIN, V22, P1813, DOI 10.1185/030079906X121075; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Wickens J., 1993, THEORY STRIATUM; Yang Y, 2000, EXP NEUROL, V163, P39, DOI 10.1006/exnr.2000.7364	74	14	14	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2008	18	3					443	454		10.1111/j.1750-3639.2008.00146.x			12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	308MU	WOS:000256395500015	18371175				2021-06-18	
J	Reicker, LI				Reicker, Lindsay I.			The ability of reaction time tests to detect simulation: An investigation of contextual effects and criterion scores	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	34th Annual Meeting of the International-Neuropsychological-Society	FEB 01-04, 2006	Boston, MA	Int Neuropsychol Soc		simulation; malingering; reaction time tests; Computerized Tests of Information Processing; CTIP	SYMPTOM VALIDITY TESTS; NEUROPSYCHOLOGICAL TESTS; RESPONSE LATENCY; MEMORY DEFICITS; INFORMATION; ATTENTION; INJURY; FAKING; SPEED	Two experiments examined whether experience gained with a series of reaction time tests [Computerized Tests of Information Processing (CTIP); Tombaugh, T. N. & Rees, L. (in press). Computerized Tests of Information Processing (CTIP). Toronto, Canada: Multi-Health Systems Inc.] influenced the performance of individuals instructed to simulate the cognitive effects of a traumatic brain injury. Experience with the tests was manipulated by varying the order and number of tests administered for simulator and control groups. Simulators responded significantly slower and exhibited increased variability compared to controls. Performance was not affected by order or number of tests. The results of a third experiment showed that criterion scores could be established that correctly classified members of control, simulator, mild TBI, and severe TBI groups. Overall, the results suggest that the performance of the simulators was based on a context-free, absolute judgment and that reaction time measures show considerable promise for detecting low effort. (C) 2008 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada	Reicker, LI (corresponding author), Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada.	lreicker@connect.carleton.ca					AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Bender SD, 2004, ARCH CLIN NEUROPSYCH, V19, P49, DOI 10.1016/S0887-6177(02)00165-8; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; BRANDT J, 1988, CLIN ASSESSMENT MALI, P65; CERCY SP, 1985, CLIN ASSESSMENT MALI, P1997; Chiu VWY, 2002, REHABIL PSYCHOL, V47, P194, DOI 10.1037//0090-5550.47.2.194; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; Resnick P. J., 1988, CLIN ASSESSMENT MALI, P84; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; SCHAGEN S, 1997, J CLIN EXPT NEUROPSY, V19, P443; Slick D. J., 1997, VICTORIA SYMPTON VAL; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Tombaugh TN, 1996, TEST MEMORY MALINGER; TOMBAUGH TN, COMPUTERIZE IN PRESS; TOMBAUGH TN, COMPUTERIZED T UNPUB; TOMBAUGH TN, 2007, NORMATIVE DATA UNPUB; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wogar MA, 1998, BRIT J CLIN PSYCHOL, V37, P327, DOI 10.1111/j.2044-8260.1998.tb01389.x	31	14	14	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	2008	23	4					419	431		10.1016/j.acn.2008.02.003			13	Psychology, Clinical; Psychology	Psychology	320CJ	WOS:000257211000006	18420373				2021-06-18	
J	Puppo, C; Lopez, L; Caragna, E; Biestro, A				Puppo, Corina; Lopez, Lucia; Caragna, Elia; Biestro, Alberto			One-minute dynamic cerebral autoregulation in severe head injury patients and its comparison with static autoregulation. A transcranial doppler study	NEUROCRITICAL CARE			English	Article						severe head injury; cerebral autoregulation; outcome; cerebral perfusion pressure; intracranial pressure	VALSALVA MANEUVER; PRESSURE; FLOW; HUMANS; ARTERIES; RESPONSES; VELOCITY	Objective To compare dynamic and static responses of cerebral blood flow to sudden or slow changes in arterial pressure in severe traumatic brain injury (TBI) patients. Design Prospective study. Patients and Methods We studied 12 severe TBI patients, age 16-63 years, and median GCS 6. We determined the dynamic cerebral autoregulation: response of cerebral blood flow velocity to a step blood pressure drop, and the static cerebral autoregulation: change in cerebral blood flow velocity after a slow hypertensive challenge. Results During the dynamic response, the median drop in arterial pressure was 21 mm Hg. Dynamic response was graded between 9 (best) and 0 (worst). The median value was 5; four patients showed high values, (8-9), five patients showed intermediate values (4-6). In three patients (value = 0), the CBFV drop was greater than the cerebral perfusion pressure drop, and maintained through 60 s. The static cerebral autoregulation was preserved in 6/11 patients. The comparison between the two showed four different combinations. The five patients with impaired static cerebral autoregulation showed unfavorable outcome. Conclusions A sharp dynamic vasodilator response could not be sustained, and a slow or absent reaction to a sudden hypotensive challenge could show an acceptable cerebral autoregulation in the steady state. We found that patients with impaired static cerebral autoregulation had a poor outcome, whereas those with preserved static cerebral autoregulation experience favorable outcomes.	[Puppo, Corina; Lopez, Lucia; Biestro, Alberto] Univ Republica, Hosp Clin, Intens Care Unit, Montevideo, Uruguay; [Puppo, Corina; Caragna, Elia] IMPASA, Unidad Neurocrit, Montevideo, Uruguay	Puppo, C (corresponding author), Univ Republica, Hosp Clin, Intens Care Unit, Ave Italia S-N,CP 11200, Montevideo, Uruguay.	cpuppo@chasque.apc.org					AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BEVAN JA, 1987, FASEB J, V1, P193; BEVAN JA, 1993, NEWS PHYSIOL SCI, V8, P149; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Dawson SL, 1999, J APPL PHYSIOL, V86, P675; DUCKWORTH JW, 1989, CIRC RES, V65, P316, DOI 10.1161/01.RES.65.2.316; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; GREENFIELD JC, 1984, STROKE, V15, P76, DOI 10.1161/01.STR.15.1.76; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; NEWELL DW, 1992, CEREBROVAS BRAIN MET, V4, P122; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Puppo C, 2002, ACTA NEUROCHIR SUPPL, V81, P129; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Ter Minassian A, 2002, CRIT CARE MED, V30, P1616, DOI 10.1097/00003246-200207000-00036; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3	22	14	15	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	JUN	2008	8	3					344	352		10.1007/s12028-008-9069-8			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	301DT	WOS:000255877300006	18363042				2021-06-18	
J	Armstrong, CM; Allen, DN; Donohue, B; Mayfield, J				Armstrong, Christina M.; Allen, Daniel N.; Donohue, Bradley; Mayfield, Joan			Sensitivity of the comprehensive trail making test to traumatic brain injury in adolescents	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Comprehensive Trail Making Test; traumatic brain injury; adolescents; sensitivity; ROC analysis	OLDER CHILDREN; UNITED-STATES	The current study examined the sensitivity of the Comprehensive Trail Making Test (CTMT Reynolds) to neurocognitive deficits in adolescents with traumatic brain injury (TBI). Participants included 60 adolescents, 30 who had sustained TBI and 30 healthy controls (HC) that were individually matched to the TBI sample on age, gender, ethnicity, and geographical region. For both the TBI and HC groups the mean age was 15.0 years (S.D. = 2.3 years, range = 11-19). The TBI group had a mean IQ of 81.7 (S.D. = 14.9), had sustained moderate to severe brain injury, and was assessed an average of 21.1 months (S.D. = 20.7) following injury. The TBI group performed approximately 2 standard deviations below the control sample mean on each of the five CTMT trails as well as on the composite index and these differences were significant (p < .001). Significant correlations were present between the CTMT trails and clinical variables associated with brain injury severity. Finally, receiver operating characteristic analyses indicated good classification of the TBI and control cases for the CTMT, although some variability in classification accuracy was present among the various trails. Results suggest that the CTMT is sensitive to TBI in adolescents but continued research is needed with larger samples of individuals with TBI and other types of neurological disorders to further establish the present findings. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Armstrong, Christina M.; Allen, Daniel N.; Donohue, Bradley] Univ Nevada, Neuropsychol Res Program, Dept Psychol, Las Vegas, NV 89154 USA	Allen, DN (corresponding author), Univ Nevada, Neuropsychol Res Program, Dept Psychol, 4505 Maryland Pkwy, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu	Armstrong, Christina M./AAU-4242-2020	Armstrong, Christina M./0000-0002-2942-6553; Allen, Daniel/0000-0003-4868-2242			Allen DN, 1998, SCHIZOPHR RES, V34, P87, DOI 10.1016/S0920-9964(98)00090-5; [Anonymous], 1944, MANUAL DIRECTIONS SC; BOLL TJ, 1974, CLIN NEUROPSYCHOLOGY, P91; Burton D. B., 1994, PSYCHOL ASSESSMENT, V6, P380; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; GOLDSTEIN G, 1966, PERCEPT MOTOR SKILL, V22, P347, DOI 10.2466/pms.1966.22.2.347; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hosmer D. W., 2000, APPL LOGISTIC REGRES; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, pS87; KRAEMER BR, 1997, STUDENTS ACQUIRED BR, P3; LANGLOIS JA, 2004, TRAUMATIC BRAIN US E; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MITTELMEIER C, 1989, INT J CLIN NEUROPSYC, V11, P163; Partington J., 1949, PSYCHOL SERVICE CTR, V1, P9; Partington J, 1949, PSYCHOL SERVICE CTR, V1, P46; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REED HBC, 1965, J CONSULT PSYCHOL, V29, P247, DOI 10.1037/h0022145; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Reitan RM., 1992, HALSTEAD REITAN NEUR, V2; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	27	14	14	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2008	23	3					351	358		10.1016/j.acn.2007.11.004			8	Psychology, Clinical; Psychology	Psychology	310VT	WOS:000256559500010	18280107	Bronze			2021-06-18	
J	Yurdakoc, A; Gunday, I; Memis, D				Yurdakoc, A.; Gunday, I.; Memis, D.			Effects of halothane, isoflurane, and sevoflurane on lipid peroxidation following experimental closed head trauma in rats	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						traumatic brain injury; halothane; isoflurane; sevoflurane; malondialdehyde; rats	INCOMPLETE CEREBRAL-ISCHEMIA; D-ASPARTATE RECEPTOR; BRAIN-INJURY; VOLATILE ANESTHETICS; BLOOD-FLOW; IN-VITRO; GLUTAMATE; FENTANYL; CHANNELS; NEUROPROTECTION	Background: In a rat closed head trauma model we examined both the time course of lipid peroxidation and the effects of halothane, isoflurane, and sevoflurane on it by analysis of malondialdehyde (MDA) formation. Methods: Animals were divided randomly into five groups: sham-operated (SO), n=18; control-closed head trauma to left frontal pole, n=18; closed head trauma model+halothane, n=18; closed head trauma model+isoflurane, n=18; and closed head trauma model+sevoflurane, n=18. Halothane, isoflurane, or sevoflurane were applied 15 min after trauma for 30 min. Rats were euthanized 1,3, and 5 h after the inhalation agents. Brain tissue samples were taken 5 mm from the left and right frontal poles. MDA was considered to reflect the degree of lipid peroxidation. Results: MDA concentrations were greater in the control, halothane, sevoflurane, and isoflurane groups than in SO animals (P < 0.001). No statistical difference between the hemispheres was found between the halothane, isoflurane, or sevoflurane groups, but MDA levels were lower with isoflurane than in the halothane, sevoflurane, and control groups at 1, 3, and 5 h (P < 0.001). MDA levels were higher as compared with the halothane and sevoflurane groups at 1 h but not at 3 or 5 h (P < 0.001). Conclusion: MDA levels with the isoflurane group were lower than in the other trauma groups, which suggest that isoflurane, given after closed head trauma, might be protective against lipid peroxidation of cerebral injury.	[Gunday, I.; Memis, D.] Trakya Univ, Fac Med, Dept Anaesthesiol, TR-22030 Edirne, Turkey; [Yurdakoc, A.] Trakya Univ, Fac Med, Dept Anaesthesiol, Trakya Univ Hosp, TR-22030 Edirne, Turkey	Memis, D (corresponding author), Trakya Univ, Fac Med, Dept Anaesthesiol & Reanimat, TR-22030 Edirne, Turkey.	dilmemis@mynet.com					BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BICKLER PE, 1994, ANESTHESIOLOGY, V81, P1461, DOI 10.1097/00000542-199412000-00022; Bickler PE, 2003, ANESTH ANALG, V97, P564, DOI 10.1213/01.ANE.0000068880.82739.7B; BROWN BR, 1972, ANESTHESIOLOGY, V458; Cope DK, 1997, ANESTHESIOLOGY, V86, P699, DOI 10.1097/00000542-199703000-00023; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Di X, 1997, STROKE, V28, P2244, DOI 10.1161/01.STR.28.11.2244; Elsersy H, 2004, ANESTHESIOLOGY, V100, P1160, DOI 10.1097/00000542-200405000-00018; Engelhard K, 2004, EUR J ANAESTH, V21, P530, DOI 10.1017/S0265021504007057; Gross GJ, 2000, CIRC RES, V87, P431; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; HOFFMAN WE, 1993, ANESTH ANALG, V76, P279; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kaplanski J, 2003, RESUSCITATION, V56, P207, DOI 10.1016/S0300-9572(02)00371-4; Karamanlioglu B, 2002, NUCL MED COMMUN, V23, P53, DOI 10.1097/00006231-200201000-00009; Kawaguchi M, 2004, ANESTH ANALG, V98, P798; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; Kehl F, 2004, BRAIN RES, V1021, P76, DOI 10.1016/j.brainres.2004.06.038; Kingery WS, 2002, ANESTHESIOLOGY, V96, P367, DOI 10.1097/00000542-200202000-00023; KOENIG HM, 1994, J NEUROSURG ANESTH, V6, P229; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mitsuyo T, 2006, ANESTH ANALG, V103, P753, DOI 10.1213/01.ane.0000230605.22930.52; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OZS H, 2005, NEUROSURG REV, V28, P143; Patel PM, 1998, ANESTH ANALG, V86, P773, DOI 10.1097/00000539-199804000-00018; PATEL PM, 1993, J CEREB BLOOD FLOW M, pS685; Rehberg B, 1996, ANESTHESIOLOGY, V84, P1223, DOI 10.1097/00000542-199605000-00025; SCATTON B, 1991, CEREBROVASC DIS, V1, P121, DOI 10.1159/000108829; SCHMIDLEY JW, 1990, STROKE, V21, P1086, DOI 10.1161/01.STR.21.7.1086; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2003, BRAIN RES, V994, P37, DOI 10.1016/j.brainres.2003.09.042; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Toner CC, 2001, BRIT J ANAESTH, V86, P550, DOI 10.1093/bja/86.4.550; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Werner C, 2005, ANESTH ANALG, V101, P509, DOI 10.1213/01.ANE.0000160586.71403.A4; WERNER C, 1995, BRIT J ANAESTH, V75, P756, DOI 10.1093/bja/75.6.756; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047	46	14	15	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	MAY	2008	52	5					658	663		10.1111/j.1399-6576.2008.01635.x			6	Anesthesiology	Anesthesiology	289FL	WOS:000255040300014	18419720				2021-06-18	
J	Herrmann, B				Herrmann, B.			Non-accidental head injury and shaking baby syndrome. Clinical and pathophysiological aspects	RECHTSMEDIZIN			German	Article						non-accidental head injury; shaken baby syndrome; inflicted traumatic brain injury; subdural hemorrhages; retinal hemorrhages; child abuse	TRAUMATIC BRAIN-INJURY; SHAKEN INFANT SYNDROME; CHILDREN; ABUSE; NEUROPATHOLOGY; HEMORRHAGES; SYMPTOMS; INTERVAL; DAMAGE	Traumatic brain injury, in particular the shaken baby syndrome, leads to significant neurological disability in more than two-thirds of surviving victims and is fatal in 12-27% of cases. It is characterized by a constellation of subdural hematoma and mostly marked retinal hemorrhaging with severe diffuse brain injury, usually without external signs of injuries. Shaken baby syndrome resulting in significant brain damage requires extensive, violent shaking of a child leading to uncontrolled rotation of the head. The resulting subdural and retinal hemorrhages are, however, not important for the prognosis. The combination of diffuse axonal injury and initial traumatic apnea leading to hypoxia, ischemia and intracranial hypertension is assumed to be responsible for the marked brain damage. Clinical symptoms are irritability, feeding problems, somnolence, apathy, cerebral convulsions, vomiting, apnea, coma and death. Shaking injury is a syndromic diagnosis dependant on the total picture of clinical, ophthalmological, radiological and brain imaging features.	Klinikum Kassel, Kinderklin, D-34125 Kassel, Germany	Herrmann, B (corresponding author), Klinikum Kassel, Kinderklin, Monchebergstr 43, D-34125 Kassel, Germany.	herrmann@klinikum-kassel.de					Adams G, 2004, EYE, V18, P795, DOI 10.1038/sj.eye.6701643; Alexander RC, 2001, CHILD ABUSE MED DIAG, P47; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bays J., 2001, CHILD ABUSE MED DIAG, P177; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; CAFFEY J, 1974, PEDIATRICS, V54, P396; Davies W. H., 2001, J AGGRESS MALTREAT T, V5, P41; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gilliland MGF, 1998, J FORENSIC SCI, V43, P723; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Hartley LM, 2001, PEDIATRICS, V107, P174, DOI 10.1542/peds.107.1.174; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Herrmann B, 2002, MONATSSCHR KINDERH, V150, P1324, DOI 10.1007/s00112-002-0610-0; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Jenny C., 2003, INFLICTED CHILDHOOD, P49; Kairys SW, 2001, PEDIATRICS, V108, P206; Keenan H, 2003, INFLICTED CHILDHOOD, P3; KOCHANEK PM, 2003, INFLICTED CHILDHOOD, P191; Kuker W, 2006, MONATSSCHR KINDERH, V154, P659, DOI 10.1007/s00112-004-1043-8; LEVIN AV, 2001, CHILD ABUSE MED DIAG, P97; Lloyd B, 1998, BRIT MED J, V317, P1538, DOI 10.1136/bmj.317.7172.1538; Matschke J, 2008, RECHTSMEDIZIN, V18, P36, DOI 10.1007/s00194-007-0488-1; Minns RA, 2005, CLIN DEV MED, P1; NASHELSKY MB, 1995, AM J FOREN MED PATH, V16, P154, DOI 10.1097/00000433-199506000-00016; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; Sane SM, 2000, PEDIATRICS, V105, P1345; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STENGER RD, 2005, PADIATR PRAX, V67, P294; Thomsen H, 1998, MONATSSCHR KINDERH, V146, P875, DOI 10.1007/s001120050339; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130	36	14	14	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819	1434-5196		RECHTSMEDIZIN	Rechtsmedizin	FEB	2008	18	1					9	16		10.1007/s00194-007-0482-7			8	Medicine, Legal	Legal Medicine	316KH	WOS:000256947800003					2021-06-18	
J	Bushnik, T; Englander, J; Wright, J				Bushnik, Tamara; Englander, Jeffrey; Wright, Jerry			Patterns of fatigue and its correlates over the first 2 years after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; fatigue; longitudinal studies; pain; sleep; traumatic brain injury	TRANSCRANIAL MAGNETIC STIMULATION; REHABILITATION OUTCOMES; HEAD-INJURY; RECOVERY; MODERATE; ASSOCIATION; INSTRUMENT; DISABILITY; DEPRESSION; INVENTORY	This study used a prospective longitudinal design to quantify fatigue and associated factors during the first 2 years after traumatic brain injury (TBI). Fifty-one individuals were assessed at 3 time points: within the first 6, 12, and 18-24 months after TBI. Self-reported fatigue improved during the first year, as did pain, sleep quality, cognitive independence, and involvement in productive activity. Further changes up to 2 years after TBI were not observed. The subset of individuals who reported significant increases in fatigue over the first 2 years demonstrated poorer outcomes in cognition, motor symptoms, and general functioning than those with decreased or stable fatigue.	[Bushnik, Tamara; Englander, Jeffrey; Wright, Jerry] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA	Bushnik, T (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	tamara@tbi-sci.org		Bushnik, Tamara/0000-0003-3328-257X			Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; BAROSSO J, 2002, J ASSOC NURSE AIDS C, V13, P66; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BELZA BL, 1995, J RHEUMATOL, V22, P639; BERRIOS GE, 1990, COMPR PSYCHIAT, V31, P140, DOI 10.1016/0010-440X(90)90018-N; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bormann J, 2001, J Assoc Nurses AIDS Care, V12, P75, DOI 10.1016/S1055-3290(06)60146-5; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; BUSHNIK T, 2006, 2 FED INT C TBI MARC; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Bushnik T, 2007, BRAIN INJURY, V21, P559, DOI 10.1080/02699050701426915; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Cope Helen, 1992, International Review of Psychiatry, V4, P273, DOI 10.3109/09540269209066328; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; FISK JD, 1994, CLIN INFECT DIS   S1, V18, P79; FRYER LJ, 1987, J HEAD TRAUMA REHAB, V2, P51, DOI DOI 10.1097/00001199-198709000-00007; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hillier SL, 1997, BRAIN INJURY, V11, P661; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LIEBERMAN SA, 1996, J PEDIAT, V128, P58; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Meek PM, 2000, NURS RES, V49, P181, DOI 10.1097/00006199-200007000-00001; Meek PM, 1997, ONCOL NURS FORUM, V24, P334; Michael Kathleen, 2002, Rehabil Nurs, V27, P89; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N; STOKES MJ, 1988, BRIT MED J, V297, P1014, DOI 10.1136/bmj.297.6655.1014; Substance Abuse and Mental Health Services Administration, NAT HOUS SURV DRUG A; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Taylor RR, 2002, PSYCHOSOM MED, V64, P319, DOI 10.1097/00006842-200203000-00016; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wambach K A, 1998, J Hum Lact, V14, P219, DOI 10.1177/089033449801400311; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	54	14	15	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2008	23	1					25	32		10.1097/01.HTR.0000308718.88214.bb			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	256HS	WOS:000252719800006	18219232				2021-06-18	
J	Granacher, RP				Granacher, Robert P., Jr.			Commentary: Applications of functional neuroimaging to civil litigation of mild traumatic brain injury	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							METAANALYSIS	The current definition of mild traumatic brain injury (MTBI) is in flux. Presently, there are at least three working definitions of this disorder in the United States, with no clear consensus. Functional neuroimaging, such as single photon emission computed tomography (SPECT) and positron emission tomography (PET), initially showed promise in their ability to improve the diagnostic credibility of MTBI. Over the past decade, that promise has not been fulfilled and there is a paucity of quality studies or standards for the application of functional neuroimaging to traumatic brain injury, particularly in litigation. The legal profession is ahead of the science in this matter. The emergence of neurolaw is driving a growing use of functional neuroimaging, as a sole imaging modality, used by lawyers in an attempt to prove MTBI at trial. The medical literature on functional neuroimaging and its applications to MTBI is weak scientifically, sparse in quality publications, lacking in well-designed controlled studies, and currently does not meet the complete standards of Doubert v. Merrell Dow Pharmaceuticals, Inc., for introduction of scientific evidence at trial. At the present time, there is a clear lack of clinical correlation between functional neuroimaging of MTBI and behavioral, neuropsychological, or structural neuroimaging deficits. The use of SPECT or PET, without concurrent clinical correlation with structural neuroimaging (CT or MRI), is not recommended to be offered as evidence of MTBI in litigation.	[Granacher, Robert P., Jr.] Lexington Forens Neuropsychiat, Lexington, KY 40504 USA; [Granacher, Robert P., Jr.] Univ Kentucky, Coll Med, Lexington, KY USA	Granacher, RP (corresponding author), Lexington Forens Neuropsychiat, 1401 Harrodsburg Rd, Lexington, KY 40504 USA.	rgranacher@aol.com					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ANDERSON KE, 2005, TXB TRAUMATIC BRAIN, P107; ATLAS SW, 2002, MAGNETIC RESONANCE I, V1; BARKOVICH JA, 1971, PEDIAT NEUROIMAGING; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Dougherty D., 2004, ESSENTIALS NEUROIMAG; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Granacher R. P., 2008, TRAUMATIC BRAIN INJU, VSecond; Herscovitch Peter, 1996, P89; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Iverson GL, 2007, BRAIN INJURY MED PRI, P333; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; OSBORN A, 1971, DIAGNOSTIC IMAGING B; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; RICKER JH, 2004, REHABILITATION MED, P229; Rozen J., 2007, NY TIMES MAGAZI 0311, P48; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; *SOC NUCL MED, 2002, SOC NUCL MED PROC GU, P113; Valk P. E., 2003, POSITRON EMISSION TO; Wortzel HS, 2008, J AM ACAD PSYCHIATRY, V36, P310	28	14	14	0	5	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2008	36	3					323	328					6	Law; Psychiatry	Government & Law; Psychiatry	356EZ	WOS:000259762800008	18802179				2021-06-18	
J	Guo, YE; Togher, L				Guo, Yiting Emily; Togher, Leanne			The impact of dysarthria on everyday communication after traumatic brain injury: A pilot study	BRAIN INJURY			English	Article						brain injury; dysarthia; communication; discourse analysis	CALL CENTERS; HEAD-INJURY; DISCOURSE; INTELLIGIBILITY; ACCEPTABILITY; PERCEPTIONS; PEOPLE; INTEGRATION; POPULATION; COMPETENCE	Primary objective: To compare the everyday communication of individuals with mild and moderate dysarthria and concomitant cognitive-communication impairments following traumatic brain injury (TBI). Methods and procedures: Five participants with mild dysarthria and five with moderate dysarthria following TBI were recorded during telephone service enquiries with bus timetable call centre operators. Transcripts were analysed using exchange structure analysis derived from systemic functional linguistics. Listener comfort ratings were collected using a novel equal appearing interval scale to measure how comfortable people would feel interacting with the participants. Main outcomes and results: Participants with moderate dysarthria were not necessarily penalized for having poorer intelligibility during bus timetable service encounters. While participants with moderate dysarthria were given poorer listener comfort ratings, this did not affect the way information was exchanged with bus timetable call centre operators. These findings were attributed to the powerful interactional role of TBI participants as customers, the amount of disability awareness training and experience held by call centre operators and the highly structured nature of bus timetable service enquiries. Listener comfort ratings could be predicted with moderate accuracy from intelligibility scores. Conclusions: Service encounters where individuals with TBI are placed in a powerful interactional role of customer may be functional generalization tasks for people with moderate dysartrhia. Training and education of service providers may also impact on the communicative effectiveness of individuals with TBI.	[Guo, Yiting Emily; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Lidcombe, NSW 1825, Australia	Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, S Block,POB 170,East St, Lidcombe, NSW 1825, Australia.	l.togher@usyd.edu.au	Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Berry M., 1981, STUDIES DISCOURSE AN, P120; COELHO C, 1996, J SPEECH HEAR RES, V39, P5; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Comrie P, 2001, CLIN LINGUIST PHONET, V15, P383, DOI 10.1080/02699200110036380; Dagenais PA, 2006, CLIN LINGUIST PHONET, V20, P141, DOI 10.1080/02699200400026843; Dagenais PA, 1999, J MED SPEECH-LANG PA, V7, P91; DAGENAIS PA, 2002, INVESTIGATIONS CLIN; Darley F., 1975, MOTOR SPEECH DISORDE; Deery S, 2002, J MANAGE STUD, V39, P471, DOI 10.1111/1467-6486.00300; Drager K. D. R., 2004, AUGMENTATIVE ALTERNA, V20, P103, DOI [DOI 10.1080/07434610410001699681, 10.1080/07434610410001699681]; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Duffy JR, 2019, MOTOR SPEECH DISORDE; Enderby P. M., 2000, NEUROGENIC COMMUNICA, P247; ENDERBY PM, 1983, FRENCH DYSARTHRIA AS; Fleiss J., 1986, DESIGN ANAL CLIN EXP; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GERRATT BR, 1993, J SPEECH HEAR RES, V36, P14, DOI 10.1044/jshr.3601.14; Halliday M., 1994, INTRO FUNCTIONAL GRA, V3rd; Holman D, 2002, MOTIV EMOTION, V26, P57, DOI 10.1023/A:1015194108376; Hustad Katherine C., 1998, Seminars in Speech and Language, V19, P291, DOI 10.1055/s-2008-1064051; KAZDIN AE, 1977, SOCIAL INSTRUCTIONAL; Larkins B., 2000, NEUROGENIC COMMUNICA, P206; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; LASS NJ, 1988, J COMMUN DISORD, V21, P385, DOI 10.1016/0021-9924(88)90023-8; Lass Norman J., 1993, Journal of Communication Disorders, V26, P3, DOI 10.1016/0021-9924(93)90012-Y; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; Linden MA, 2005, BRAIN INJURY, V19, P1011, DOI 10.1080/02699050500110314; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; *MIN TRASP, 2005, ACC TRANSP ACT PLAN; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; MURDOCH BE, 1999, COMMUNICATION DISORD; O'Brian S, 2003, J SPEECH LANG HEAR R, V46, P503, DOI 10.1044/1092-4388(2003/041); Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Redpath SJ, 2004, BRAIN INJURY, V18, P861, DOI 10.1080/02699050410001671838; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sewell-Staples W. J., 2003, MANAGERIAL AUDITING, V18, P68; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Southwood M., 1993, J MED SPEECH-LANG PA, V1, P151; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Susca M, 2002, J FLUENCY DISORD, V27, P135, DOI 10.1016/S0094-730X(02)00126-2; Susca M, 2001, J SPEECH LANG HEAR R, V44, P61, DOI 10.1044/1092-4388(2001/006); Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Taylor P, 2002, WORK EMPLOY SOC, V16, P133, DOI 10.1177/09500170222119281; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; TOGHER L, 1998, INTERPERSONAL COMMUN; Ventola E, 2005, FOLIA LINGUIST, V39, P19, DOI 10.1515/flin.2005.39.1-2.19; Ventola E., 1987, STRUCTURE SOCIAL INT; Whitehill TL, 2004, J MED SPEECH-LANG PA, V12, P229; World Health Organization, 2001, INT CLASS IMP ACT PA; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Zapf D., 2003, EUR, V12, P311, DOI [10.1080/13594320344000183, DOI 10.1080/13594320344000183]	62	14	16	0	10	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	1					83	97		10.1080/02699050701824150			15	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400010	18183512				2021-06-18	
J	Johansson, SH; Jamora, CW; Ruff, RM; Pack, NM				Johansson, Sven H.; Jamora, Christina Weyer; Ruff, Ronald M.; Pack, Nathaniel M.			A biopsychosocial perspective of aggression in the context of traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; anger; aggression; ruff neurobehavioral inventory; biopsychosocial; treatment	HOSTILITY; AGITATION; AWARENESS; BEHAVIOR; SUPPORT; HEALTH	Primary objective: The aim of this study was to explore the factors associated with aggression in the traumatic brain injury population. The focus of the study was to evaluate the (a) frequency and severity of aggressive behaviours in outpatients with traumatic brain injury (TBI), (b) ecological validity of the Ruff Neurobehavioral Inventory (RNBI) Anger scale, and (c) comorbid and pre-morbid factors associated with aggression in patients with TBIs. Research design: A multi-group comparative research design was employed. Methods and procedure: An outpatient sample of 67 patients with TBIs using the RNBI and clinical interviews. Main outcomes and results: Based on clinical ratings, 25% endorsed no aggression, 38% reported mild aggression and 37% reported moderate-to-severe aggression, which was validated with the RNBI Anger post-morbid scale. A MANOVA found that none of the pre-morbid RNBI scales were significantly elevated across the anger groups; however, pre-post-morbid differences between the groups were found. A principle component analysis showed three main domains: 'physical, cognitive and emotional' that related to elevated post-morbid anger. Conclusions: A biopsychosocial model of post-morbid aggression is proposed to advance both the diagnosis and treatment of patients with TBIs who experience elevated anger.	[Johansson, Sven H.] Univ Gothenburg, Gothenburg, Sweden; [Johansson, Sven H.; Jamora, Christina Weyer; Ruff, Ronald M.; Pack, Nathaniel M.] San Francisco Clin Neurosci, San Francisco, CA USA; [Jamora, Christina Weyer; Ruff, Ronald M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Jamora, CW (corresponding author), 909 Hyde St,Suite 620, San Francisco, CA 94109 USA.	cyweyer@aol.com					Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Benotsch EG, 1997, J BEHAV MED, V20, P163, DOI 10.1023/A:1025530711432; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; *CDCP, 1996, TRAUM BRAIN INJ US E; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; Crick NR, 2006, J ABNORM CHILD PSYCH, V34, P131, DOI 10.1007/s10802-005-9009-4; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Houtveen JH, 2007, J PSYCHOSOM RES, V62, P277, DOI 10.1016/j.jpsychores.2006.11.006; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1996, NEUROTRAUMA, P13; Lee R, 2007, CAMB HANDB PSYCHOL, P170; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Mueller J., 2007, NEUROPSYCHIATRIC PRO; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; ROBERTS JV, 1984, CAN J CRIMINOL, V26, P283, DOI 10.3138/cjcrim.26.3.283; RUFF R, 2004, YOUMANS NEUROLOGICAL, P5181; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SMITH T, 1994, CONCEPTS METHODS STU, P23; SMITH TW, 1992, HEALTH PSYCHOL, V11, P139, DOI 10.1037/0278-6133.11.3.139; Storch Eric A, 2004, Violence Vict, V19, P689, DOI 10.1891/088667004780927738; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vandervoort DJ, 2006, CURR PSYCHOL, V25, P50, DOI 10.1007/s12144-006-1016-2; VANWOERKOM TCAM, 1977, LANCET, V1, P812	34	14	14	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	13-14					999	1006	PII 907304266	10.1080/02699050802530573			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	389ZM	WOS:000262134100003	19117178				2021-06-18	
J	Lombardi, F				Lombardi, F.			Pharmacological treatment of neurobehavioural sequelae of traumatic brain injury	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article; Proceedings Paper	Brain Annual Meeting	MAY 09-12, 2007	Brescia, ITALY			brain injury; psychosis; trauma; depression; long-term effects; cognition; disorders	TERM BENZODIAZEPINE USERS; PSYCHIATRIC-DISORDERS; CORTEX INJURY; HALOPERIDOL; RECOVERY; OLANZAPINE; METAANALYSIS; AMPHETAMINE; MEMORY; DRUGS	Neurobehavioural sequelae of traumatic brain injuries require an appropriate/effective pharmacological response in that they represent an important cause of disability. In this field, there is no evidence that reaches the level of a standard: there are guidelines on the use of methylphenidate, donepezil and bromocriptine for the treatment of cognitive disturbances, for the non-use of phenytoin and for the use of beta-blockers for controlling aggressiveness. Resolving a single symptom is not relevant in a rehabilitation project if it is not in the context of a more complex picture of neurobehavioural recovery, in which the positive and negative effects of every therapeutic choice are considered. For example, phenytoin could be used for the positive control of epileptic crises but is not advised since it impedes the recovery of cognitive functions in general. Analogous effects not yet identified may concern benzodiazepine, neuroleptics and other sedatives usually prescribed in cases of cranial trauma. Psychotropic drugs are considered to be able to influence the neuronal plasticity processes. Studies on animals have shown that the administration of D-amphetamine combined with sensorial-motor exercise produces the steady acceleration of motor recovery, which acts as a catalyst to the neurological recovery process. On the other hand, alpha(1)-NA receptor antagonist drugs produce negative effects; these include clonidine (antihypertension) and haloperidol (neuroleptic). Studies need to be carried out to evaluate the effectiveness of particular drugs. These studies need to focus not only on the disappearance of symptoms but also on the positive and negative effects on overall rehabilitation and on the neurobiological recovery of the patient.	[Lombardi, F.] Riabil Intens Neurol Osped S Sebastiano, I-42015 Correggio, Italy	Lombardi, F (corresponding author), Riabil Intens Neurol Osped S Sebastiano, Via Mandriolo Super 11, I-42015 Correggio, Italy.	lombardif@ausl.re.it		LOMBARDI, Francesco/0000-0002-7184-6391			Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; ARCINIEGAS DB, 2000, CURRENT TREATMENT OP, V2, P169; Barker MJ, 2004, CNS DRUGS, V18, P37, DOI 10.2165/00023210-200418010-00004; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GENTILINI M, 1989, MILD HEAD INJURY, P163; Goldstein LB, 1999, REV NEUROL-FRANCE, V155, P731; GOLOMBOK S, 1988, PSYCHOL MED, V18, P365, DOI 10.1017/S0033291700007911; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; Keefe RSE, 2004, AM J PSYCHIAT, V161, P985, DOI 10.1176/appi.ajp.161.6.985; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kudoh A, 2004, ANESTH ANALG, V99, P1674, DOI 10.1213/01.ANE.0000136845.24802.19; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Matsumoto E, 1999, MATER SCI RES INT, V5, P1; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233, DOI 10.1093/oxfordjournals.schbul.a033376; Mintzer MZ, 2005, EXP CLIN PSYCHOPHARM, V13, P336, DOI 10.1037/1064-1297.13.4.336; Morrens M, 2007, J CLIN PSYCHOPHARM, V27, P15, DOI 10.1097/jcp.0b013e31802dfff0; Paterniti S, 2002, J CLIN PSYCHOPHARM, V22, P285, DOI 10.1097/00004714-200206000-00009; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RASKIN SA, 2000, NEUROPSYCHOLOGICAL M; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Woodward ND, 2007, SCHIZOPHR RES, V89, P211, DOI 10.1016/j.schres.2006.08.021	29	14	16	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0265-0215			EUR J ANAESTH	Eur. J. Anaesth.		2008	25			42			131	136		10.1017/S0265021507003316			6	Anesthesiology	Anesthesiology	283AY	WOS:000254610100022	18289430				2021-06-18	
J	Lule, D; Ludolph, AC; Ludolph, AG				Lule, D.; Ludolph, A. C.; Ludolph, A. G.			Neurodevelopmental and neurodegenerative diseases - Is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples	MEDICAL HYPOTHESES			English	Article							DEFICIT HYPERACTIVITY DISORDER; EMISSION COMPUTED-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; MOTOR-NEURON DISEASE; DOPAMINE TRANSPORTER; RECEPTOR SUBUNIT; SPORADIC ALS; ADULT ADHD; RISK; ASSOCIATION	Attention-deficit/hyperactivity disorder (ADHD), the most common neurobehavioural disorder and amyotrophic lateral sclerosis (ALS), the most common adult motoneuron disease, may be two distinct entities on first sight. This paper aims to highlight parallels concerning clinical features and neurobiology. The presence of increased physical and psychological activity and largely non-progressive frontal dysfunction associated with impaired executive control and decreased attention are characteristic clinical features of both, ADHD and ALS. At the neurobiological level, there is evidence for hyperactivity in the glutamatergic system and a - potentially related - dopaminergic hypoactivity in ADHD and ALS. The clinical features of ALS resembling ADHD are particularly characteristic for the premorbid stage of the patient. Therefore, we hypothesize that clinical features of ADHD may be a risk factor for the development of ALS. This hypothesis is currently of unknown pathogenetic, but of potential future therapeutic relevance. Our hypothesis of a link between ADHD and ALS could also be considered as an example how research on neurodevelopmental diseases might influence the understanding and possibly the prevention and treatment of neurodegenerative diseases. (C) 2007 Elsevier Ltd. All rights reserved.	[Lule, D.; Ludolph, A. C.] Univ Ulm, Dept Neurol Neurophysiol, D-89081 Ulm, Germany; [Ludolph, A. G.] Univ Ulm, Dept Child & Adolescent Psychiat, D-89081 Ulm, Germany	Lule, D (corresponding author), Univ Ulm, Dept Neurol Neurophysiol, Oberer Eselsberg 47, D-89081 Ulm, Germany.	dorothee.lule@uni-ulm.de	Ludolph, Andrea G/G-2567-2014				Abel EL, 2007, PERCEPT MOTOR SKILL, V104, P1251, DOI 10.2466/PMS.104.4.1251-1254; Ascherio A, 2005, ANN NEUROL, V57, P104, DOI 10.1002/ana.20316; Barkley RA, 2003, BRAIN DEV-JPN, V25, P77, DOI 10.1016/S0387-7604(02)00152-3; Boonstra AM, 2007, SLEEP, V30, P433, DOI 10.1093/sleep/30.4.433; Borasio GD, 1998, J NEUROL NEUROSUR PS, V65, P263, DOI 10.1136/jnnp.65.2.263; Carrey NJ, 2007, J CHILD ADOL PSYCHOP, V17, P11, DOI 10.1089/cap.2006.0008; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Dorval KM, 2007, GENES BRAIN BEHAV, V6, P444, DOI 10.1111/j.1601-183X.2006.00273.x; Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1; Findling RL, 2007, J CHILD ADOL PSYCHOP, V17, P19, DOI 10.1089/cap.2006.0044; GOKSOYR PK, 2007, ADDICT BEHAV; Ionov ID, 2007, AMYOTROPH LATERAL SC, V8, P260, DOI 10.1080/17482960701523124; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; KATO S, 1993, NEUROPATH APPL NEURO, V19, P300, DOI 10.1111/j.1365-2990.1993.tb00444.x; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kihira T, 2007, AMYOTROPH LATERAL SC, V8, P150, DOI 10.1080/17482960601179407; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Kuner R, 2005, ANN NY ACAD SCI, V1053, P269, DOI 10.1196/annals.1344.024; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; LUDOLPH AC, 1992, ACTA NEUROL SCAND, V85, P81, DOI 10.1111/j.1600-0404.1992.tb04003.x; LUDOLPH AC, 1989, EUR NEUROL, V29, P255, DOI 10.1159/000116422; Lule D, 2005, J NEUROL, V252, P1517, DOI 10.1007/s00415-005-0907-8; LULE D, 2006, THESIS U TUBINGEN; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; Miller SR, 2006, J CHILD NEUROL, V21, P139, DOI 10.1177/08830738060210021901; Moore CM, 2006, AM J PSYCHIAT, V163, P316, DOI 10.1176/appi.ajp.163.2.316; Murphy J, 2007, ARCH NEUROL-CHICAGO, V64, P330, DOI 10.1001/archneur.64.3.330; Pineda DA, 2007, PEDIATR NEUROL, V36, P373, DOI 10.1016/j.pediatrneurol.2007.02.002; PINKHARDT E, 2002, ELECTROPHYSIOLOGIC C; Pinkhardt EH, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-48; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Roman Tatiana, 2004, Am J Pharmacogenomics, V4, P83, DOI 10.2165/00129785-200404020-00003; Rudnicki SA, 2007, AMYOTROPH LATERAL SC, V8, P126, DOI 10.1080/17482960701223808; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schreiber H, 2005, J NEUROL, V252, P772, DOI 10.1007/s00415-005-0739-6; SINN N, 2007, J DEV BEHAV PEDEATR, V28, P139; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; St Louis EK, 1999, SEMIN NEUROL, V19, P25; Stabeno M, 2004, ADHD AFFECTED ATHLET; TAIOLI E, EUR J PUBLIC HLTH; TAKAHASHI H, 1993, LANCET, V342, P1016, DOI 10.1016/0140-6736(93)92878-W; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; Veldink JH, 2007, J NEUROL NEUROSUR PS, V78, P367, DOI 10.1136/jnnp.2005.083378; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C; Vieregge P, 1999, COGNITIVE BRAIN RES, V8, P27, DOI 10.1016/S0926-6410(99)00004-X; Vogels OJM, 1999, NEUROLOGY, V52, P1275, DOI 10.1212/WNL.52.6.1275; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Weisskopf MG, 2005, AM J EPIDEMIOL, V162, P1146, DOI 10.1093/aje/kwi343; Wicks P, 2007, AMYOTROPH LATERAL SC, V8, P177, DOI 10.1080/17482960701195220; Yang BR, 2007, AM J MED GENET B, V144B, P541, DOI 10.1002/ajmg.b.30453; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Young JM, 1998, HEALTH SOC WORK, V23, P35, DOI 10.1093/hsw/23.1.35; Zanette G, 2002, CLIN NEUROPHYSIOL, V113, P1688, DOI 10.1016/S1388-2457(02)00288-2; Ziemann U, 1997, NEUROLOGY, V49, P1292, DOI 10.1212/WNL.49.5.1292	58	14	14	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses		2008	70	6					1133	1138		10.1016/j.mehy.2007.11.002			6	Medicine, Research & Experimental	Research & Experimental Medicine	311BX	WOS:000256576200010	18158219				2021-06-18	
J	Piscopo, P; Bernardo, A; Calamandrei, G; Venerosi, A; Valanzano, A; Bianchi, D; Confaloni, A; Minghetti, L				Piscopo, Paola; Bernardo, Antonletta; Calamandrei, Gemma; Venerosi, Aldina; Valanzano, Angela; Bianchi, Daniela; Confaloni, Annarnaria; Minghetti, Luisa			Altered expression of cyclooxygenase-2, presenilins and oxygen radical scavenging enzymes in a rat model of global perinatal asphyxia	EXPERIMENTAL NEUROLOGY			English	Article						hypoxia-ischemia; brain; Isoprostanes; cyclooxygenase; presenilin; superoxide dismutase; oxidative stress	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; IN-VIVO; PERIVENTRICULAR LEUKOMALACIA; LIPID-PEROXIDATION; CEREBRAL-ISCHEMIA; PROSTAGLANDIN E-2; OXIDATIVE INJURY; FOCAL ISCHEMIA; MESSENGER-RNA	Cyclooxygenase-2 (COX-2) and presenilin (PSEN) I and 2 genes are regulated during development as well as in pathological conditions associated to hypoxia. In this study, we investigated their patterns of expression during the first 2 weeks of postnatal life in a rat model of moderate global perinatal asphyxia that we have previously reported to be characterized by early oxidative stress and delayed behavioral alterations. In the hippocampus, global perinatal asphyxia induced an early up-regulation COX-2 mRNA (postnatal day, pnd, 1), which preceded those of PSEN 1 and 2 genes, observed at pnd 4. At pod 11, the expression of all three genes was decreased compared to control animals. In addition, we analyzed the expression of the scavenging enzymes catalase, copper/zinc- and manganese-superoxide dismutase. As for COX-2, the three enzymes were upregulated in the hippocampus at prid I and returned at or below baseline by prid 4. In the cortex, only PSEN I and 2 showed a moderate up-regulation at prid I followed by a down-regulation at pnd 11. These findings suggest that moderate perinatal hypoxic episodes are associated with a dysregulation of the several genes involved in brain development and anti-oxidant defenses, which follows a rapid and transient oxidative stress. Such alterations are particularly evident in the hippocampus and could represent an adaptive response to the hypoxic condition. The delayed down-regulation of the scavenging enzymes could set the ground for brain damage and delayed behavioral alterations and further support the potential benefit of early anti-oxidant treatments in a short therapeutic window soon after birth. (c) 2007 Elsevier Inc. All rights reserved.	[Piscopo, Paola; Bernardo, Antonletta; Calamandrei, Gemma; Venerosi, Aldina; Valanzano, Angela; Bianchi, Daniela; Confaloni, Annarnaria; Minghetti, Luisa] Ist Super Sanita, Dept Neurosci & Cell Biol, I-00161 Rome, Italy	Minghetti, L (corresponding author), Ist Super Sanita, Dept Neurosci & Cell Biol, Viale Regina Elena 299, I-00161 Rome, Italy.	luisa.minghetti@iss.it	Venerosi, Aldina/AAI-2808-2020; Piscopo, Paola/J-6504-2016; Antonietta, Bernardo/H-4415-2016; Minghetti, Luisa/I-9540-2014; Calamandrei, Gemma/M-3815-2014	Venerosi, Aldina/0000-0002-6599-0581; Piscopo, Paola/0000-0002-0693-4969; Antonietta, Bernardo/0000-0002-6590-7530; Minghetti, Luisa/0000-0002-7065-4689; Calamandrei, Gemma/0000-0003-3762-3132; Confaloni, Annamaria/0000-0002-5390-8536			Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bernardo A, 2006, NEUROBIOL DIS, V22, P25, DOI 10.1016/j.nbd.2005.09.012; BJELKE B, 1991, BRAIN RES, V543, P1, DOI 10.1016/0006-8993(91)91041-X; Calamandrei G, 2004, PEDIATR RES, V55, P85, DOI 10.1203/01.PDR.0000099774.17723.D4; Crestini A, 2006, J MOL NEUROSCI, V30, P311, DOI 10.1385/JMN:30:3:311; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; Fuso A, 2007, J ALZHEIMERS DIS, V11, P275; Greco A, 2004, CURR NEUROVASC RES, V1, P341, DOI 10.2174/1567202043362036; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hoeger H, 2006, AMINO ACIDS, V31, P385, DOI 10.1007/s00726-006-0393-z; Iadecola C, 1999, ACTA NEUROPATHOL, V98, P9, DOI 10.1007/s004010051045; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Inder T, 2002, PEDIATR RES, V52, DOI 10.1203/01.PDR.0000020088.11295.13; Inder T, 2002, J PEDIATR-US, V140, P617, DOI 10.1067/mpd.2002.123627; Ishii Hideshi, 2003, J Exp Ther Oncol, V3, P291, DOI 10.1111/j.1533-869X.2003.01101.x; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, BRAIN DEV-JPN, V19, P25, DOI 10.1016/S0387-7604(96)00047-2; Khan JY, 2003, PEDIATR RES, V54, P77, DOI 10.1203/01.PDR.0000065736.69214.20; Koistinaho J, 1999, STROKE, V30, P1900, DOI 10.1161/01.STR.30.9.1900; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Lu S, 2002, BBA-GENE STRUCT EXPR, V1574, P152, DOI 10.1016/S0167-4781(01)00359-1; Mattson MP, 2000, J NEUROSCI, V20, P1358; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Minghetti L, 2000, J NEUROPATH EXP NEUR, V59, P866, DOI 10.1093/jnen/59.10.866; Pepicelli O, 2002, J NEUROCHEM, V81, P1028, DOI 10.1046/j.1471-4159.2002.00897.x; Planas AM, 1995, NEUROSCI LETT, V200, P187, DOI 10.1016/0304-3940(95)12108-G; Qin Y, 2000, BRIT J OBSTET GYNAEC, V107, P973, DOI 10.1111/j.1471-0528.2000.tb10399.x; Ricceri L, 2004, EXP NEUROL, V189, P162, DOI 10.1016/j.expneurol.2004.05.025; Sairanen T, 1998, ANN NEUROL, V43, P738, DOI 10.1002/ana.410430608; Scheepens A, 2003, DEV BRAIN RES, V142, P67, DOI 10.1016/S0165-3806(03)00032-4; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Toti P., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P245; Van de Berg WDJ, 2002, EXP NEUROL, V174, P29, DOI 10.1006/exnr.2001.7855; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Venerosi A, 2004, BEHAV BRAIN RES, V154, P155, DOI 10.1016/j.bbr.2004.02.008; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922	43	14	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	JAN	2008	209	1					192	198		10.1016/j.expneurol.2007.09.014			7	Neurosciences	Neurosciences & Neurology	253EG	WOS:000252500900025	17963755				2021-06-18	
J	Schefft, BK; Dulay, MF; Fargo, JD				Schefft, Bruce K.; Dulay, Mario F.; Fargo, Jamison D.			The use of a self-generation memory encoding strategy to improve verbal memory and learning in patients with traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						generation effect; learning; memory; traumatic brain injury; verbal paired associates	CLOSED-HEAD INJURY; ALZHEIMER-TYPE; COGNITIVE REHABILITATION; 3-FACTOR THEORY; FREE-RECALL; DEMENTIA; WORDS; DEFICITS; MOOD; CUES	The generation effect refers to the theory that optimal acquisition and retention of information is achieved by active participation rather than by passive observation. The efficacy of a self-generation memory encoding strategy was tested using a verbal paired-associate task for free recall, cued recall, and recognition memory in 40 traumatically brain-injured outpatients in two studies. In study #1, self-generation encoding procedures improved recognition memory, but not free recall, compared with the didactic presentation of information. In study #2, self-generation procedures improved cued recall test performance, but the results demonstrated that the type of cue that is provided moderates the efficacy of self-generation procedures. Results provide preliminary empirical support for the use of self-generation encoding procedures in improving upon verbal memory and learning abilities in individuals with TBI.	[Schefft, Bruce K.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Schefft, Bruce K.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Dulay, Mario F.] Inst Rehabil & Res Hosp, Houston, TX USA; [Dulay, Mario F.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Fargo, Jamison D.] Utah State Univ, Dept Psychol, Res & Evaluat Methodol Program, Logan, UT 84322 USA	Schefft, BK (corresponding author), Univ Cincinnati, Dept Psychol, POB 210376, Cincinnati, OH 45221 USA.	scheffbk@email.uc.edu	Fargo, Jamison/E-8361-2010				Barrett AM, 2000, NEUROLOGY, V54, P1258, DOI 10.1212/WNL.54.6.1258; BASSO MR, 1994, J PERS SOC PSYCHOL, V66, P363, DOI 10.1037/0022-3514.66.2.363; BEGG I, 1989, J EXP PSYCHOL LEARN, V15, P977, DOI 10.1037/0278-7393.15.5.977; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J., 1977, STAT POWER ANAL BEHA, P1; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CRUTCHER RJ, 1989, J EXP PSYCHOL LEARN, V15, P669, DOI 10.1037/0278-7393.15.4.669; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DICK MB, 1989, BRAIN COGNITION, V9, P88, DOI 10.1016/0278-2626(89)90046-8; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; GARDINER JM, 1984, MEM COGNITION, V12, P433; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; Hamsher K. D., 1984, HDB PSYCHOL ASSESSME, P235; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; JOHNSON MMS, 1989, J GERONTOL, V44, P91; Kanfer F.H., 1988, GUIDING PROCESS THER; KLONOFF PS, 1996, THEORETICAL FDN CLIN; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LIPINSKA B, 1994, J CLIN EXP NEUROPSYC, V16, P809, DOI 10.1080/01688639408402695; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MARSHALL RC, 1992, APHASIOLOGY, V6, P567, DOI 10.1080/02687039208249492; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MCDANIEL MA, 1990, J EXP PSYCHOL LEARN, V16, P789, DOI 10.1037/0278-7393.16.5.789; MCDANIEL MA, 1988, J MEM LANG, V27, P521, DOI 10.1016/0749-596X(88)90023-X; MCGLYNN SM, 1990, PSYCHOL BULL, V108, P420, DOI 10.1037/0033-2909.108.3.420; McNamara D. S., 1995, LEARNING MEMORY KNOW, P132; Multhaup KS, 1997, NEUROPSYCHOLOGY, V11, P382, DOI 10.1037/0894-4105.11.3.382; OLOFSSON U, 1992, PSYCHOL RES-PSYCH FO, V54, P103, DOI 10.1007/BF00937138; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Salkind n, 2003, USING SPSS WINDOWS M; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Schacter D. L., 1990, NEUROPSYCHOLOGY EVER, P231; SCHEFFT BK, 1985, INT J CLIN NEUROPSYC, V7, P207; SCHEFFT BK, 1990, J SOC CLIN PSYCHOL, V9, P354, DOI 10.1521/jscp.1990.9.3.354; SCHEFFT BK, 1992, ANN M ASS ADV BEH TH; Schefft BK, 1997, CLIN NEUROPSYCHOLOGY, P237; Sharifian F., 2001, ISSUES ED RES, V11, P15; Smith ML, 1996, NEUROPSYCHOLOGIA, V34, P553, DOI 10.1016/0028-3932(95)00139-5; Souliez L, 1996, CORTEX, V32, P347, DOI 10.1016/S0010-9452(96)80056-6; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; Steffens MC, 1998, Q J EXP PSYCHOL-A, V51, P705, DOI 10.1080/027249898391350; Taconnat L, 2003, ANN PSYCHOL, V103, P199; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; VANDAM G, 1988, J GEN PSYCHOL, V115, P151, DOI 10.1080/00221309.1988.9711098; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530; WALSH KR, 1995, P 1 AM C INF SYST AS, P621	56	14	15	0	7	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2008	15	1					61	68		10.1080/09084280801917806			8	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	287KZ	WOS:000254917300008	18443942				2021-06-18	
J	Ziaja, M; Pyka, J; Machowska, A; Maslanka, A; Plonka, PM				Ziaja, Marek; Pyka, Janusz; Machowska, Anna; Maslanka, Anna; Plonka, Przemyslaw M.			Nitric oxide spin-trapping and NADPH-diaphorase activity in mature rat brain after injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; EPR; NADPH-diaphorase; nitric oxide; spin trapping	CEREBRAL-BLOOD-FLOW; ELECTRON-PARAMAGNETIC-RESONANCE; CORTICAL IMPACT INJURY; L-ARGININE; IN-VIVO; SYNTHASE; EPR; EXPRESSION; ISCHEMIA; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) induces inflammatory reactions, and one of the essential mediators of this reaction is nitric oxide (NO). The action of this compound is still under study because no clear consensus has been reached about its exact action in the central nervous system. Further, it is unknown if, in the damaged brain, its neuroprotective activity outweighs its putative neurodegenerative properties. Using ferrous-diethyldithiocarbamate chelate, a lipophilic spin trap for NO detection by electron paramagnetic resonance (EPR) spectroscopy, we followed NO production in injured brain of mature Wistar rats. To relate changes in the amount of NO in the lesioned brain to the activity of NO synthase (NOS), this study also used NADPH-diaphorase staining. Our data show a rapid drop of NO concentration in the damaged brain below control values. This phenomenon persisted over several hours postinjury and varied with brain region. This decrease in NO concentration was accompanied by a simultaneous increase in the number of NADPH-diaphorase-positive cells, perhaps indicative of increased NOS activity. It is therefore assumed that, in the lesioned brain, a very rapid removal of NO occurs via its transformation to other reactive species such as peroxynitrite, which further adversely influence the damaged tissue.	[Ziaja, Marek; Machowska, Anna] Jagiellonian Univ, Inst Zool, Dept Neuroanat, PL-30060 Krakow, Poland; [Pyka, Janusz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Biophys, Lab Radiospectroscope Studies, Krakow, Poland; [Maslanka, Anna] Jagiellonian Univ, Coll Med, Dept Inorgan & Analyt Chem, Krakow, Poland; [Plonka, Przemyslaw M.] Jagiellonian Univ, Fac Biophys & Biotechnol, Dept Biophys, Lab Radiospectroscopy Canc & Radiobiol, Krakow, Poland	Ziaja, M (corresponding author), Jagiellonian Univ, Inst Zool, Dept Neuroanat, Ingardena 6, PL-30060 Krakow, Poland.	ziajam@poczta.fm		Ziaja, Marek/0000-0002-8576-0206; Pyka, Janusz/0000-0002-7723-5321; Plonka, Przemyslaw/0000-0002-0261-3439			Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Andriambeloson E, 1997, BRIT J PHARMACOL, V120, P1053, DOI 10.1038/sj.bjp.0701011; ARCHER S, 1993, FASEB J, V7, P349; AUGUET M, 1995, JPN J PHARMACOL, V69, P285, DOI 10.1254/jjp.69.285; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Berliner LJ, 2004, ANTIOXID REDOX SIGN, V6, P649, DOI 10.1089/152308604773934413; BUNE AJ, 1995, FEBS LETT, V366, P127, DOI 10.1016/0014-5793(95)00495-U; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cheung RTF, 2003, J PINEAL RES, V34, P153, DOI 10.1034/j.1600-079X.2003.00034.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Del Moral ML, 2004, MICROSC RES TECHNIQ, V64, P304, DOI 10.1002/jemt.20081; Ergenekon E, 1999, BIOL NEONATE, V76, P200, DOI 10.1159/000014159; Gahm C, 2000, NEUROSURGERY, V46, P169; Gallez B, 2004, NMR BIOMED, V17, P223, DOI 10.1002/nbm.913; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Huang PL, 1999, BRAZ J MED BIOL RES, V32, P1353, DOI 10.1590/S0100-879X1999001100005; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Janeczko K, 1997, BRAIN RES, V770, P237, DOI 10.1016/S0006-8993(97)00873-1; Kozlov AV, 2003, FREE RADICAL BIO MED, V34, P1555, DOI 10.1016/S0891-5849(03)00179-5; KUBRINA LN, 1992, BIOCHIM BIOPHYS ACTA, V1099, P233, DOI 10.1016/0005-2728(92)90032-W; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Plonka PM, 2003, ACTA BIOCHIM POL, V50, P807; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; SCHMIDT HHHW, 1992, J HISTOCHEM CYTOCHEM, V40, P1439, DOI 10.1177/40.10.1382087; Shutenko Z, 1999, BIOCHEM PHARMACOL, V57, P199, DOI 10.1016/S0006-2952(98)00296-2; Sjakste N, 1999, BIOCHEM PHARMACOL, V58, P1955, DOI 10.1016/S0006-2952(99)00281-6; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Suzuki H, 2001, CIRCULATION, V103, pE81; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; TOMINAGA T, 1994, J CEREBR BLOOD F MET, V14, P715, DOI 10.1038/jcbfm.1994.92; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wolf G, 1994, J Neural Transm Suppl, V43, P105; WU GY, 1993, AM J PHYSIOL, V265, pH1965; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Zhang YN, 1996, J NEUROSCI METH, V68, P165; Zhou P, 2005, J CEREBR BLOOD F MET, V25, P348, DOI 10.1038/sj.jcbfm.9600036; Ziaja M, 1999, J NEUROSCI RES, V58, P379, DOI 10.1002/(SICI)1097-4547(19991101)58:3<379::AID-JNR3>3.0.CO;2-J; Ziaja M, 2005, CURR TOP BIOPHYS, V29, P73	47	14	14	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2007	24	12					1845	1854		10.1089/neu.2007.0303			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	245BR	WOS:000251910000007	18159996				2021-06-18	
J	Teruel, GC; Rico, AP; Lasaosa, FJC; Temprano, AC; Julian, AN; Clara, JMC				Claret Teruel, Gemma; Palomeque Rico, Antonio; Jos Cambra Lasaosa, Francisco; Catala Temprano, Albert; Noguera Julian, Antoni; Maria Costa Clara, Josep			Severe head injury among children: computed tomography evaluation as a prognostic factor	JOURNAL OF PEDIATRIC SURGERY			English	Article						severe head injury; computed tomography; intracranial pressure; intracranial hypertension; child; prognosis	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; CLASSIFICATION	Background: The value of neuroimaging in predicting unfavorable events in the outcome of pediatric patients has not been established. Our objectives were to determine clinical characteristics and outcome of severely head-injured children admitted to the pediatric intensive care unit (PICU) of a pediatric third-level university hospital and to evaluate the use of neuroimaging as a prognostic factor of morbimortality in these patients. Methods: We performed a 9-year retrospective review. We included all patients with severe head injury admitted to the pediatric intensive care unit of our hospital from January 1995 to December 2003 requiring invasive intracranial pressure monitoring. Clinical summaries and imaging studies were reviewed. Results: Data for 156 pediatric patients, aged 1 to 18 years, were collected. We reclassified neuroimaging patterns into 2 groups: those with few imaging findings and those with important lesions. These 2 groups were significantly correlated with initial Glasgow Coma Scale (P <.05). We classified patients into favorable evolution, moderate disability, and unfavorable evolution. Poorer evolution correlated with poorer initial neuroimaging patterns, and these differences were statistically significant (P <.05). Conclusions: In our group of patients, initial Glasgow Coma Scale was related with the initial neuroimaging pattern, and this relation was statistically significant. Findings in the first and second neuroimaging were useful as prognostic factors in our series. (c) 2007 Elsevier Inc. All rights reserved.	[Claret Teruel, Gemma; Palomeque Rico, Antonio; Jos Cambra Lasaosa, Francisco; Catala Temprano, Albert; Noguera Julian, Antoni] Univ Barcelona, Hosp Univ St Joan de Deu, Integrated Unit St Joan de Deu Clin, Paediat Dept,Pediat Intens Care Unit, Barcelona 08950, Spain; [Maria Costa Clara, Josep] Univ Barcelona, Hosp Univ St Joan de Deu, Integrated Unit St Joan de Deu Clin, Dept Neurosurg, Barcelona 08950, Spain	Teruel, GC (corresponding author), Passeig St Joan de Deu 2, Barcelona 08950, Spain.	gclaret@hsjdbcn.org	lasosa, Francisco Jose Cambra/ABH-4656-2020	Noguera-Julian, Antoni/0000-0001-7485-0583; CATALA, ALBERT/0000-0003-0133-1752			Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; *BRAIN TRAUM FDN, 2003, PEDIAT  CRIT CARE ME, V4, pS1; *BRAIN TRAUMA FDN, 1996, GUIDL MAN SEV HEAD I; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FERNANDEZ A, 2001, MED INTENSIVA, V25, P8; Givner A, 2002, J PEDIATR SURG, V37, P381, DOI 10.1053/jpsu.2002.30825; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maidaun MVC, 2002, ARQ NEURO-PSIQUIAT, V60, P967, DOI 10.1590/S0004-282X2002000600015; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002	17	14	14	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	NOV	2007	42	11					1903	1906		10.1016/j.jpedsurg.2007.07.020			4	Pediatrics; Surgery	Pediatrics; Surgery	239XN	WOS:000251551700019	18022444				2021-06-18	
J	Obonsawin, MC; Jefferis, S; Lowe, R; Crawford, JR; Fernandes, J; Holland, L; Woldt, K; Worthington, E; Bowie, G				Obonsawin, M. C.; Jefferis, S.; Lowe, R.; Crawford, J. R.; Fernandes, J.; Holland, L.; Woldt, K.; Worthington, E.; Bowie, G.			A model of personality change after traumatic brain injury and the development of the Brain Injury Personality Scales	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							HEAD-INJURY; RATINGS; RELATIVES; AWARENESS; VALIDITY; TRAITS	Objective: The aims of this study were to develop models of personality change after traumatic brain injury (TBI) based on information provided by the TBI survivor and a significant other (SO), and to compare the models generated from the two different sources of information. Methods: Individuals with and without TBI and an SO were interviewed separately about their current personality. The SOs were also interviewed about the personality of the TBI survivor before the injury. A subset of TBI survivors and their SOs were interviewed twice to assess test-retest reliability. Items which were not associated with personality change after TBI, which could not be measured reliably or which did not contribute to the model, were excluded. Results: Of the 123 original items, 29 items from the interview with the survivor and 31 items from the interview with the SO were retained to form the Brain Injury Personality Scales. Separate factor analyses of ratings from each interview (survivor and SO) resulted in seven first order factors. The second order factor analyses for each interview resulted in four factors. Concordance between the information obtained from the two interviews was low. Conclusions: The information obtained from the interviews with the TBI survivors and the SOs produced two models with a similar structure: three superordinate factors of personality items (affective regulation, behavioural regulation and engagement) and one superordinate factor of items relevant to mental state (restlessness and range of thought). Despite the similarity in structure, the content of the information obtained from the two interviews was different.	Univ Strathclyde, Dept Psychol, Glasgow G1 1XQ, Lanark, Scotland; Univ Aberdeen, Aberdeen, Scotland	Obonsawin, MC (corresponding author), Univ Strathclyde, Dept Psychol, 16 Richmond St, Glasgow G1 1XQ, Lanark, Scotland.	m.c.obonsawin@strath.ac.uk	Crawford, John R/A-4165-2008	Crawford, John R/0000-0003-3403-3428; Obonsawin, Marc/0000-0002-8314-2527			ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen N.C., 1983, SCALE ASSESSMENT NEG; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Cronbach L. J., 1972, DEPENDABILITY BEHAV; Eames P, 1985, Int Rehabil Med, V7, P130; Eysenck H.J., 1985, PERSONALITY INDIVIDU; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Hair J.F, 1998, MULTIVARIATE DATA AN; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; MCCRAE RR, 1982, J PERS SOC PSYCHOL, V43, P293, DOI 10.1037/0022-3514.43.2.293; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; NELSON LD, 1989, J CONSULT CLIN PSYCH, V1, P266; PRIDMORE S, 2000, PSYCHIAT INTERVIEW G; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Sachdev P, 1996, AUST NZ J PSYCHIAT, V30, P38, DOI 10.3109/00048679609076071; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WATSON D, 1991, J PERS SOC PSYCHOL, V60, P927, DOI 10.1037/0022-3514.60.6.927; WATSON D, 2000, MOOD TEMPERAMENT, P31	29	14	14	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2007	78	11					1239	1247		10.1136/jnnp.2004.052654			9	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	225LE	WOS:000250518600018	17259352	Green Published			2021-06-18	
J	Strom, TQ; Kosciulek, J				Strom, Thad Q.; Kosciulek, John			Stress, appraisal and coping following mild traumatic brain injury	BRAIN INJURY			English	Article						mild TBI; adjustment; stress; coping	BECK DEPRESSION INVENTORY; COMMUNITY INTEGRATION; REHABILITATION; ADJUSTMENT; SEQUELAE	Purpose: The present study tested a portion of the stress, appraisal and coping ( SAC) model proposed by Godfrey, Knight and Partridge. Methods: Using data gathered from 94 individuals who had sustained a traumatic brain injury, path analysis results indicated that a model based on Godfrey et al.' s SAC model did not fit the sample data. Based on relevant statistical output, previous research and theory, are- specified model was tested. Results: The final model was shown to meet common statistical measures for establishing model fit. The final model indicated that higher levels of perceived stress were predictive of higher levels of self- reported depression, higher levels of depression were predictive of lower levels of dispositional hope and dispositional hope was predictive of increased life satisfaction and work productivity. Conclusions: The present findings hold implications for both research and for clinical practice. The findings do suggest the need for additional research to further clarify factors that contribute to emotional adjustment following traumatic brain injury.	Nat Ctr PTSD, Pacific Isl Div, Honolulu, HI 96819 USA; Michigan State Univ, E Lansing, MI 48824 USA	Strom, TQ (corresponding author), Nat Ctr PTSD, Pacific Isl Div, 3375 Koapaka St,Suite I-560, Honolulu, HI 96819 USA.	thad.strom2@va.gov		Strom, Thad/0000-0001-6743-9999			BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT, 1967, DEPRESSION; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Byrne B. M, 2001, STRUCTURAL EQUATION; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; ELLIS A, 1977, HDB RATIONAL EMOTIVE, V1; GARSON GD, 2006, INTERNET RELEIGH NC; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Groth-Marnat G., 1990, HDB PSYCHOL ASSESSME, V2nd ed.; Hair J.F, 1998, MULTIVARIATE DATA AN; Heppner PP, 2004, COUNS PSYCHOL, V32, P344, DOI 10.1177/0011000003262793; HEPPNER PP, 1982, J COUNS PSYCHOL, V29, P66, DOI 10.1037/0022-0167.29.1.66; Heppner PP, 1997, MEAS EVAL COUNS DEV, V29, P229, DOI 10.1080/07481756.1997.12068907; HEPPNER PP, 1988, LVING INVENTORY MANU; Klem L., 1995, READING UNDERSTANDIN, P65; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LAZARUS RS, 1994, STRESS APPRAISAL COP; LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Lezak M. D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI [10.1097/00001199-198703000-00009, DOI 10.1097/00001199-198703000-00009]; LIVNEH H, 1997, PSYCHOL ADAPTATION C; Lopez, 2002, HDB POSITIVE PSYCHOL, P257, DOI DOI 10.1521/SCPQ.18.2.122.21854; Lopez S. J., 2000, HDB HOPE THEORY MEAS, P57, DOI DOI 10.1016/B978-012654050-5/50006-3; MCNENY R, 1990, REHABILITATION ADULT, P193; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; *NIH, 1998, CONS DEV PAN REH PER; NOBLE JH, 1990, J DISABIL POLICY STU, V1, P19; NOVACK TA, 1983, CLIN NEUROPSYCHOLOGY, V6, P139; Nunnelly J. C., 1978, PSYCHOMETRIC THEORY; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1986, BRAIN INJURY, V31, P89; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Rath JF, 2003, REHABIL PSYCHOL, V48, P137, DOI 10.1037/0090-5550.48.3.137; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Snyder C. R., 1994, PSYCHOL HOPE YOU CAN; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Sokol K, 1999, 127 ANN M AM PUBL HL; Thurman DJ, 2001, HEAD TRAUMA, P327; VONCRAMON DY, 1992, NEUROPSYCHOL REHABIL, V2, P207; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	53	14	16	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1137	1145		10.1080/02699050701687334			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900005	17952714				2021-06-18	
J	Beretta, L; Aldrovandi, V; Grandi, E; Citerio, G; Stocchetti, N				Beretta, L.; Aldrovandi, V.; Grandi, E.; Citerio, G.; Stocchetti, N.			Improving the quality of data entry in a low-budget head injury database	ACTA NEUROCHIRURGICA			English	Article						audit; database; head injury; quality; review	CARDIAC-NATIONAL-DATABASE; INTENSIVE-CARE; REGISTRY DATA; VALIDATION; CONSORTIUM; PROGRAM; SOCIETY	Background. To assess the efficacy of a centralised review of a voluntary low-budget head injury database with a retrospective analysis of data before and after a centralised review. Method. A computerised data collection (Neurolink) on traumatic brain injury cases admitted to three neuro-intensive care units in Milan (Italy): analysis of a three-year period (1999-2001). Data from 499 patients (epidemiology, type of lesion, clinical course, monitoring, treatment, complications and outcome). The audit involved a review of forms relating to patients enrolled in the three-year period, with the aim of improving the quality of data entry. Missing data in all empty fields were identified; evident errors and contradictory data were identified and corrected; missing and final data were analysed to test the efficacy of the review. Findings. The total post-review missing data rate was significantly lower than the paired pre-review missing data rate (p = 0.001). The same was confirmed for each of the 3 years (p = 0.001 for each year). The missing data rate significantly improved over the three-year period (p = 0.001). Data for the pre-hospitalisation period had the highest missing rates; data regarding the ICU stay showed the greatest improvement after the review. A total of 407 items (0.44%) were identified as errors. Conclusions. Data quality is fundamental to avoid information bias in database analysis. This study indicates that it is possible to generate a serious data collection without significant resources. Audit seems to be an important tool before the final data is used for scientific projects.	IRCCS, Ospedale S Raffaele, Neurointens Care Unit, Monza, Italy; Osped San Gerardo, Neurointens Care Unit, Monza, Italy; Univ Milan, IRCCS, Neurointens Care Unit, Osped Maggiore Mangiagalli & Reg Elena, Milan, Italy	Beretta, L (corresponding author), Hosp San Raffaele, Inst Sci, Via Olgettina 60, I-20132 Milan, Italy.		Citerio, Giuseppe/B-1839-2015; Stocchetti, Nino/O-7444-2017	Citerio, Giuseppe/0000-0002-5374-3161; Stocchetti, Nino/0000-0003-3250-6834			Arts D, 2002, INTENS CARE MED, V28, P656, DOI 10.1007/s00134-002-1272-z; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Beretta L., 2003, MINERVA ANESTESIOL, V69, P223; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Fine LG, 2003, BRIT MED J, V326, P25, DOI 10.1136/bmj.326.7379.25; Grover FL, 1996, ANN THORAC SURG, V62, P1229, DOI 10.1016/0003-4975(96)00589-9; Hlaing T, 2006, J TRAUMA, V61, P1400, DOI 10.1097/01.ta.0000195732.64475.87; JENNET B, 1997, J NEUROL NEUROSUR PS, V40, P291; KUNTORO LRE, 1994, J CLIN EPIDEMIOL, V47, P779; Malin JL, 2002, J NATL CANCER I, V94, P835, DOI 10.1093/jnci/94.11.835; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; RICKETTS D, 1993, ANN ROY COLL SURG, V75, P393; Shroyer ALW, 1998, ANN THORAC SURG, V65, P1494, DOI 10.1016/S0003-4975(98)00261-6; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Warsi AA, 2002, EUR J SURG ONCOL, V28, P850, DOI 10.1053/ejso.2002.1283	17	14	14	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	SEP	2007	149	9					903	909		10.1007/s00701-007-1257-3			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	204AT	WOS:000249015900016	17665088				2021-06-18	
J	Feng, D; Xu, W; Chen, G; Hang, C; Gao, H; Yin, H				Feng, D.; Xu, W.; Chen, G.; Hang, C.; Gao, H.; Yin, H.			Influence of glutamine on intestinal inflammatory response, mucosa structure alterations and apoptosis following traumatic brain injury in rats	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						glutamine; rat model; traumatic brain injury; intestinal mucosa; inflammation apoptosis	CYTOKINE-INDUCED APOPTOSIS; COLONIC EPITHELIAL-CELLS; GUT IN-VITRO; BACTERIAL TRANSLOCATION; MONONUCLEAR-CELLS; AMINO-ACIDS; PERMEABILITY; NUTRITION; BARRIER; SUPPLEMENTATION	Traumatic brain injury (TBI) can induce a persistent inflammatory response, histopathological changes and apoptosis in the intestine. Glutamine has been shown to reduce bacterial translocation and maintain intestine mucosal integrity, but its effects on the inflammatory response, structural alterations and apoptosis in intestinal mucosa following TBI have not been previously investigated. Using the weight-drop method, a right parietal cortical contusion was induced in rats and, for the next 5 days, they were fed either chow alone or chow mixed with glutamine. Intestinal tissue samples were then removed for analysis. Following TBI, glutamine supplementation was found to: decrease intestinal concentrations of interleukin (IL) -1 beta, tumour necrosis factor-alpha (TNF-alpha) and IL-6; downregulate intercellular adhesion molecule-1 (ICAM-1) expression; attenuate TBI-induced damage to the intestine structure; and reduce apoptosis. These results suggest that post-TBI glutamine administration could suppress intestinal inflammation, protect intestinal mucosal structure and reduce mucosal apoptosis.	Southeast Univ, Jiangyin Hosp, Sch Med, Dept Neurosurg, Jiangyin 214400, Jiangsu, Peoples R China; Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Feng, D (corresponding author), Southeast Univ, Jiangyin Hosp, Sch Med, Dept Neurosurg, 163 Shoushan Rd, Jiangyin 214400, Jiangsu, Peoples R China.	jeanne88@163.com					AHLMAN B, 1993, CLIN NUTR, V12, P266, DOI 10.1016/0261-5614(93)90044-5; Aosasa S, 2003, JPEN-PARENTER ENTER, V27, P333, DOI 10.1177/0148607103027005333; Arndt H, 1999, JPEN-PARENTER ENTER, V23, P12, DOI 10.1177/014860719902300112; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; Coeffier M, 2003, CLIN NUTR, V22, P407, DOI 10.1016/S0261-5614(03)00040-2; Coeffier M, 2002, CYTOKINE, V18, P92, DOI 10.1006/cyto.2002.1027; Coeffier M, 2001, CYTOKINE, V13, P148, DOI 10.1006/cyto.2000.0813; deBlaauw I, 1997, GASTROENTEROLOGY, V112, P118, DOI 10.1016/S0016-5085(97)70226-9; EPSTEIN MD, 1992, PLAST RECONSTR SURG, V90, P524, DOI 10.1097/00006534-199209000-00032; Erbil Y, 1999, HEPATO-GASTROENTEROL, V46, P2791; Evans ME, 2005, AM J PHYSIOL-GASTR L, V289, pG388, DOI 10.1152/ajpgi.00072.2005; Evans ME, 2003, J NUTR, V133, P3065; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Foitzik T, 1999, INT J COLORECTAL DIS, V14, P143, DOI 10.1007/s003840050200; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hall JC, 1996, BRIT J SURG, V83, P305, DOI 10.1002/bjs.1800830306; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Houdijk APJ, 1998, LANCET, V352, P772, DOI 10.1016/S0140-6736(98)02007-8; Ikeda S, 2002, JPEN-PARENTER ENTER, V26, P169, DOI 10.1177/0148607102026003169; Li N, 2004, AM J PHYSIOL-GASTR L, V286, pG914, DOI 10.1152/ajpgi.00493.2003; Margaritis VG, 2005, WORLD J SURG, V29, P1329, DOI 10.1007/s00268-005-7721-4; Mates JM, 2006, FRONT BIOSCI-LANDMRK, V11, P3164, DOI 10.2741/2040; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Papaconstantinou HT, 2000, J GASTROINTEST SURG, V4, P416, DOI 10.1016/S1091-255X(00)80022-0; Paquette JC, 2005, J CELL PHYSIOL, V202, P912, DOI 10.1002/jcp.20194; Quan ZF, 2004, WORLD J GASTROENTERO, V10, P1992; SCHRODER J, 1995, JPEN-PARENTER ENTER, V19, P502, DOI 10.1177/0148607195019006502; Souba WW, 1997, NEW ENGL J MED, V336, P41, DOI 10.1056/NEJM199701023360107; SOUBA WW, 1993, ANN SURG, V218, P715, DOI 10.1097/00000658-199312000-00004; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; VENTE JP, 1989, ANN SURG, V209, P57, DOI 10.1097/00000658-198901000-00009; Wischmeyer PE, 2003, NUTRITION, V19, P1, DOI 10.1016/S0899-9007(02)00839-0; Wischmeyer PE, 2001, SHOCK, V16, P398, DOI 10.1097/00024382-200116050-00014	37	14	16	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	SEP-OCT	2007	35	5					644	656		10.1177/147323000703500509			13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	215ER	WOS:000249791600009	17900404	Bronze			2021-06-18	
J	Louin, G; Neveux, N; Cynober, L; Plotkine, M; Marchand-Leroux, C; Jafarian-Tehrani, M				Louin, G.; Neveux, N.; Cynober, L.; Plotkine, M.; Marchand-Leroux, C.; Jafarian-Tehrani, M.			Plasma concentrations of arginine and related amino acids following traumatic brain injury: Proline as a promising biomarker of brain damage severity	NITRIC OXIDE-BIOLOGY AND CHEMISTRY			English	Article						nitric oxide; arginine; proline; fluid percussion brain injury; neurological deficit	OXIDE SYNTHASE EXPRESSION; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; NITRIC-OXIDE; NEUROLOGICAL DEFICIT; CEREBROSPINAL-FLUID; METABOLISM; GLUTAMINE; NITRATE; BIOSYNTHESIS	The aim of this study was to find a plasma biomarker, in relation with nitric oxide (NO), as a sign of brain damage severity following traumatic brain injury (TBI). We first investigated the post-traumatic evolution of the plasma concentrations of NO via the level of NO end-products metabolites (nitrite plus nitrate, NOx), that of L-arginine (Arg) and amino acids involved in its metabolism as well as the time course of neurological score in a rat model of lateral fluid percussion brain injury. First, the level of NOx, was increased in plasma at 24 and 48 h post-TBI with a marked increase at 72 h. In contrast, this elevation was neither accompanied by a modification of plasma concentrations of Arg, nor of amino acids involved in NO and Arg metabolism, L-ornithine (Orn), L-glutamate (Glu), and L-glutamine (Gln). Second, TBI induced a fall of plasma L-proline (Pro) concentrations. The time course of post-TBI neurological deficit showed also a decrease of neurological score at 24, 48, and 72 h. Furthermore, there is a weak negative correlation between the neurological score and the plasma level of NOx (r = -0.305; P < 0.05), while a marked positive correlation has been found between the neurological score and the plasma level of Pro (r = 0.563; P < 0.001). In conclusion, the plasma concentrations of Pro could be a promising marker of post-traumatic neurological deficit. (c) 2007 Elsevier Inc. All rights reserved.	Univ Paris 05, UPRES EA 2510, Pharmacol Lab, F-75270 Paris 6, France; Univ Paris 05, UPRES EA 2498, Lab Biol Nutr, F-75270 Paris, France	Jafarian-Tehrani, M (corresponding author), Univ Paris 05, UPRES EA 2510, Pharmacol Lab, 4,Ave Observ, F-75270 Paris 6, France.	mehrnazjafarian@univ-paris5.fr	Cynober, Luc/ABB-2368-2020; MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Jafarian-Tehrani, Mehrnaz/0000-0001-6895-5856			Adibhatla RM, 2002, BRAIN RES, V938, P81, DOI 10.1016/S0006-8993(02)02447-2; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Armengou A, 2003, J CEREBR BLOOD F MET, V23, P978, DOI 10.1097/01.WCB.0000080651.64357.C6; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; BERHOLD HK, 1995, METABOLISM, V44, P466; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; CERRA FB, 1979, ANN SURG, V190, P577, DOI 10.1097/00000658-197911000-00004; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; COUDRAYLUCAS C, 1985, CLIN NUTR, V4, P179, DOI 10.1016/0261-5614(85)90026-3; CYNOBER L, 2004, ENCY BIOL CHEM, P90; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; DEUTSCHMAN CS, 1987, WORLD J SURG, V11, P182, DOI 10.1007/BF01656401; Doumit J, 1999, AMINO ACIDS, V16, P107, DOI 10.1007/BF01321530; FLAKOLL PJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE636; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hlatky R, 2002, ACT NEUR S, V81, P331; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; JAKSIC T, 1990, AM J CLIN NUTR, V52, P307; JAKSIC T, 1991, AM J CLIN NUTR, V54, P408; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Luiking YC, 2007, J NUTR, V137, p1662S, DOI 10.1093/jn/137.6.1662S; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Murphy C, 1998, CLIN SCI, V95, P397, DOI 10.1042/CS19980194; Neveux N., 2004, METABOLIC THERAPEUTI, P17; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; PETERSEN SR, 1993, J TRAUMA, V34, P653, DOI 10.1097/00005373-199305000-00007; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Salimuddin, 1999, AM J PHYSIOL-ENDOC M, V277, pE110, DOI 10.1152/ajpendo.1999.277.1.E110; Schmidlin A, 1998, GLIA, V24, P428, DOI 10.1002/(SICI)1098-1136(199812)24:4<428::AID-GLIA8>3.0.CO;2-1; Sharma AC, 1998, NEUROL RES, V20, P632; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wakabayashi Y, 2003, METABOLIC THERAPEUTI, P135; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; WU GY, 1992, BIOCHEM J, V281, P45, DOI 10.1042/bj2810045; YAMANAKA K, 1995, NEUROSCI LETT, V194, P124, DOI 10.1016/0304-3940(95)11715-9; ZHANG P, 2000, PLANT CELL, V12, P1	52	14	14	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1089-8603	1089-8611		NITRIC OXIDE-BIOL CH	Nitric Oxide-Biol. Chem.	SEP	2007	17	2					91	97		10.1016/j.niox.2007.05.006			7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	206BB	WOS:000249157800006	17613263				2021-06-18	
J	Hooper, L; Williams, WH; Wall, SE; Chua, KC				Hooper, Lucy; Williams, W. Huw; Wall, Sarah E.; Chua, Kia-Chong			Caregiver distress, coping and parenting styles in cases of childhood encephalitis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; BEHAVIOR PROBLEMS; HEAD-INJURY; FAMILY ADJUSTMENT; CHILDREN; DISABILITY; MODEL; LONG; PREVALENCE; PREDICTORS	This study presents an exploration of the impact of childhood encephalitis on parental mood, coping and disciplinary strategies. Thirty six parents of children aged between 10 and 17 years were recruited. They were split into groups of recent and remote cases (within or beyond 7 years). Group comparison revealed that neurobehavioural consequences of childhood encephalitis appear to persist over time. Higher levels of behavioural symptoms consistent with dysexecutive disorder were associated with greater parental distress. Parents remain distressed despite reporting proactive profiles of coping. There was an indication that severity of dysexecutive disorder was asscociated with less use of proactive parental management strategies. Support for parents, in particular focused on effective management of dysexecutive problems, is recommended.	Univ Exeter, Ctr Clin Neuropsychol Res, Sch Psychol, Washington Singer Labs, Exeter EX4 4QG, Devon, England; Minist Community Dev Youth & Sports, Psychol Serv Unit, Singapore, Singapore	Hooper, L (corresponding author), Univ Exeter, Ctr Clin Neuropsychol Res, Sch Psychol, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	lucy.hooper@plymouth.ac.uk	; Chua, K/J-6249-2013	Chua, K/0000-0003-2713-5434; williams, huw/0000-0003-0670-2620; Chua, Kia-Chong/0000-0002-6693-6333; Chua, K/0000-0003-2922-3497			Anderson V, 2004, J PEDIATR PSYCHOL, V29, P67, DOI 10.1093/jpepsy/jsh011; Anderson V.A, 2001, DEV NEUROPSYCHOLOGY; Baker BL, 2005, J INTELL DISABIL RES, V49, P575, DOI 10.1111/j.1365-2788.2005.00691.x; BEAUMONT J, 1996, BLACKWELL DICT PSYCH; Boos J, 2003, VIRAL ENCEPHALITIS H; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CHONG KC, 2004, CAREGIVER DISTRESS P; CONNOLLY D, 2001, BR J OCCUP THER, V64, P41, DOI DOI 10.1177/030802260106400108; Cummings EM, 2005, J CHILD PSYCHOL PSYC, V46, P479, DOI 10.1111/j.1469-7610.2004.00368.x; CUMMINGS EM, 1999, INT NATURE DEPRESSIO; Deeken JF, 2003, J PAIN SYMPTOM MANAG, V26, P922, DOI 10.1016/S0885-3924(03)00327-0; DOWELL E, 2002, CONSEQUENCES ENCEPHA; Elliott TR, 2003, BRIT J HEALTH PSYCH, V8, P149, DOI 10.1348/135910703321649132; FLOYD FJ, 1993, AM J MENT RETARD, V97, P673; Garske GG, 1998, INT J REHABILITATION, V4, P29; Glozman Janna M., 2004, Neuropsychology Review, V14, P183, DOI 10.1007/s11065-004-8158-5; Goldstein G, 2002, HAEMOPHILIA, V8, P461, DOI 10.1046/j.1365-2516.2002.00642.x; Hassall R, 2005, J INTELL DISABIL RES, V49, P405, DOI 10.1111/j.1365-2788.2005.00673.x; Hastings RP, 2004, J CHILD PSYCHOL PSYC, V45, P1338, DOI 10.1111/j.1469-7610.2004.00357.x; Heiman T, 2002, J DEV PHYS DISABIL, V14, P159, DOI 10.1023/A:1015219514621; Jelalian E, 1997, CHILD HEALTH CARE, V26, P169, DOI 10.1207/s15326888chc2603_3; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Laszloffy TA, 2002, FAM RELAT, V51, P206, DOI 10.1111/j.1741-3729.2002.206098.x; Lazarus R.S., 1984, STRESS APPRAISAL COP; Lee S, 2003, FOOD SCI BIOTECHNOL, V12, P425; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1017/S0021963001006667; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Trute B, 2002, J PEDIATR PSYCHOL, V27, P271, DOI 10.1093/jpepsy/27.3.271; Vitaliano PP, 2004, CURR DIR PSYCHOL SCI, V13, P13, DOI 10.1111/j.0963-7214.2004.01301004.x; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1111/1469-7610.00302; WILGOSH L, 2004, INT J ADV COUNS, V26, P301, DOI DOI 10.1023/B:ADCO.0000035532.45759.FE; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Woolfson L, 2004, BRIT J HEALTH PSYCH, V9, P1, DOI 10.1348/135910704322778687; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	14	14	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG-OCT	2007	17	4-5					621	637		10.1080/09602010601137054			17	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	210AV	WOS:000249430000012	17676538				2021-06-18	
J	Hussein, MH; Daoud, GA; Kakita, H; Hattori, A; Murai, H; Yasuda, M; Mizuno, K; Goto, K; Ozaki, Y; Ito, T; Tanaka, T; Fukuda, S; Kato, I; Fujimoto, S; Suzuki, S; Sobajima, H; Togari, H				Hussein, Mohamed Hamed; Daoud, Ghada A.; Kakita, Hiroki; Hattori, Ayako; Murai, Hiroki; Yasuda, Mari; Mizuno, Keisuke; Goto, Kenji; Ozaki, Yasuhiko; Ito, Tetsuya; Tanaka, Taihei; Fukuda, Sumio; Kato, Ineko; Fujimoto, Shinji; Suzuki, Satoshi; Sobajima, Hisanori; Togari, Hajime			The sex differences of cerebrospinal fluid levels of interleukin 8 and antioxidants in asphyxiated newborns	SHOCK			English	Article						brain injury; neuron-specific enolase; total hydroperoxide; biological antioxidant potentials; cytokines	TRAUMATIC BRAIN-INJURY; RECEPTOR ANTAGONIST; OXIDATIVE STRESS; IMMUNE FUNCTION; INFANTS; HEMORRHAGE; GENDER; EXPRESSION; SURVIVAL; PROTEIN	Newborn males are more sensitive to brain injury than newborn females are. The aim of the present study was to find an explanation for this. We used the neuron-specific enolase (NSE) levels in the cerebrospinal fluid (CSF) for the classification of 32 newborns (19 males and 13 females) on their fifth postnatal day. The NSE levels were higher than normal (8.4 +/- 1.6 ng/mL) in 10 newborn males and 6 females and were, respectively, considered asphyxiated male and female groups. The remaining newborns, 9 males and 7 females, had normal CSF levels of NSE and were considered normal newborn male and female groups. The CSF samples were measured for 12 cytokines, using a cytokine array kit, and for total hydroperoxide and biological antioxidant potentials (BAPs), using the free radical analytic system. Among the 12 cytokines measured, only interleukin 8 (IL-8) was properly detected. The CSF levels of IL-8 were higher in the asphyxiated newborn females than in the other three groups. The mean CSF levels of BAPs in the asphyxiated newborn females were higher compared with the other three groups, but significance was detected only in comparison with the BAP levels in the CSF samples of the normal newborn males. There were no differences in total hydroperoxide levels among the groups. There are sex-related differences in the CSF levels of IL-8 and antioxidants in asphyxiated newborns, with higher levels in newborn females; this might contribute in the sexual dimorphism regarding the fact that females have better protection from brain injury than the males.	Nagoya City Univ, Grad Sch Med Sci, Dept Pediat Neonatol & Congenital Disorders, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Cairo Univ, Pediat Hosp, Neonatal Intens Care Unit, Cairo, Egypt; VACSERA, Dept Maternal & Child Hlth, Giza, Egypt; Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi 4678601, Japan	Hussein, MH (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Pediat Neonatol & Congenital Disorders, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	hamed@med.nagoya-cu.ac.jp	Murai, Hiroki/J-4030-2019	Murai, Hiroki/0000-0001-5291-8954; SOBAJIMA, HISANORI/0000-0002-7976-3945			Angele MK, 1999, SHOCK, V12, P316, DOI 10.1097/00024382-199910000-00011; ARAUJO DM, 1993, BRAIN RES, V600, P49, DOI 10.1016/0006-8993(93)90400-H; BAENZIGER O, 1994, PEDIATR NEUROL, V11, P319, DOI 10.1016/0887-8994(94)90009-4; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; BRY K, 1994, PEDIATR RES, V35, P130, DOI 10.1203/00006450-199401000-00029; Buonocore G, 2000, PEDIATR RES, V47, P221, DOI 10.1203/00006450-200002000-00012; Dammann O, 2001, PEDIATR RES, V49, P388, DOI 10.1203/00006450-200103000-00013; Dohi K, 2005, IN VIVO, V19, P855; Eikelenboom MJ, 2005, MULT SCLER, V11, P520, DOI 10.1191/1352458505ms1195oa; Elsmen E, 2004, ACTA PAEDIATR, V93, P529, DOI 10.1080/08035250410024998; Elsmen E, 2006, BIOL NEONATE, V89, P220, DOI 10.1159/000089838; Friel JK, 2004, PEDIATR RES, V56, P878, DOI 10.1203/01.PDR.0000146032.98120.43; GARCIAALIX A, 1994, PEDIATRICS, V93, P234; Guinsburg R, 2000, PAIN, V85, P127, DOI 10.1016/S0304-3959(99)00258-4; Gutteridge JMC, 1999, BRIT MED BULL, V55, P49, DOI 10.1258/0007142991902295; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; HOUDOU S, 1991, BRAIN RES, V556, P267, DOI 10.1016/0006-8993(91)90314-L; Kahlke V, 2002, SHOCK, V18, P24, DOI 10.1097/00024382-200207000-00005; Kahlke V, 2000, SHOCK, V14, P354, DOI 10.1097/00024382-200014030-00020; Lauterbach MD, 2001, NEUROPSYCHOLOGY, V15, P411, DOI 10.1037/0894-4105.15.3.411; Lecart C, 2000, BIOL NEONATE, V77, P217, DOI 10.1159/000014219; LEFER AM, 1991, BRIT J PHARMACOL, V103, P1153, DOI 10.1111/j.1476-5381.1991.tb12316.x; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Lieberman E, 1997, AM J OBSTET GYNECOL, V176, P667, DOI 10.1016/S0002-9378(97)70567-2; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Rennekampff HO, 2000, J SURG RES, V93, P41, DOI 10.1006/jsre.2000.5892; Saito M, 2004, PEDIATR RES, V55, P960, DOI 10.1203/01.PDR.0000125257.55596.97; SAMAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696; Savman K, 1998, PEDIATR RES, V43, P746; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; SOBAJIMA H, 1993, NAGOYA MED J, V37, P169; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116	34	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	AUG	2007	28	2					154	159		10.1097/shk.0b013e31803dcf55			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	193SV	WOS:000248295800005	17529906				2021-06-18	
J	Niendam, TA; Horwitz, J; Bearden, CE; Cannon, TD				Niendam, Tara A.; Horwitz, Jacqueline; Bearden, Carrie E.; Cannon, Tyrone D.			Ecological assessment of executive dysfunction in the psychosis prodrome: A pilot study	SCHIZOPHRENIA RESEARCH			English	Article						prodrome; psychosis; cognition; executive function; neuropsychology; functional outcome	TRAUMATIC BRAIN-INJURY; SCHIZOPHRENIA; PERFORMANCE; CHILDREN	Individuals with psychosis have prominent executive functioning (EF) deficits on neuropsychological tests, but their relationship to EF deficits in daily life is unclear. This study evaluates behavioral manifestations of EF deficits, assessed by the Behavioral Rating Inventory of Executive Functioning (BRIEF), and their clinical correlates in individuals at ultra-high-risk for psychosis (UHR). UHR subjects showed significantly elevated BRIEF scores, particularly on the Working Memory scale. BRIEF scores were associated with positive symptoms and functioning, but not with neuropsychological performance. The BRIEF appears to capture unique aspects of executive dysfunction, possibly associated with illness progression and functioning in the psychosis prodrome. (c) 2007 Elsevier B.V. All rights reserved.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	Niendam, TA (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	tniendam@ucla.edu	Niendam, Tara/K-8475-2015	Niendam, Tara/0000-0003-2285-5002; Sanz, Jacqueline/0000-0003-0465-0628; Bearden, Carrie/0000-0002-8516-923X	NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH014584, R01MH065079, P50MH066286] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50 MH066286, R01 MH065079, R01 MH065079-05, P50 MH066286-01A10002, P50 MH066286-01A19004, MH14584, R01 MH065079-03, R01 MH065079-02, R01 MH065079-04, MH65079, R01 MH065079-01A1] Funding Source: Medline		Addington J, 1999, SCHIZOPHRENIA BULL, V25, P173, DOI 10.1093/oxfordjournals.schbul.a033363; Auther AM, 2006, GLOBAL FUNCTIONING S; Bell MD, 2001, SCHIZOPHRENIA BULL, V27, P269, DOI 10.1093/oxfordjournals.schbul.a006873; Benton A., 1976, MULTILINGUAL APHASIA; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; Gioia G. A., 2000, J INT NEUROPSYCH SOC, V6; Gioia G.A., 2000, BEHAV RATING INVENTO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Hawkins KA, 2004, SCHIZOPHR RES, V67, P115, DOI 10.1016/j.schres.2003.08.007; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; McGlashan T.H., 2001, STRUCTURED INTERVIEW; Meyer SE, 2005, J CHILD ADOL PSYCHOP, V15, P434, DOI 10.1089/cap.2005.15.434; Niendam T. A., 2006, GLOBAL FUNCTIONING S; Niendam TA, 2006, SCHIZOPHR RES, V84, P100, DOI 10.1016/j.schres.2006.02.005; Reitan RM., 1985, HALSTEAD REITAN NEUR; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; WEEHSLER D, 1999, MANUAL WECHSLER ABBR	20	14	14	1	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964			SCHIZOPHR RES	Schizophr. Res.	JUL	2007	93	1-3					350	354		10.1016/j.schres.2007.03.009			5	Psychiatry	Psychiatry	184SU	WOS:000247663200040	17467957	Green Accepted			2021-06-18	
J	Radad, K; Gille, G; Jia, XJ; Durany, N; Rausch, WD				Radad, Khaled; Gille, Gabriele; Jia Xiaojing; Durany, Nuria; Rausch, Wolf-Dieter			CDP-choline reduces dopaminergic cell loss induced by MPP+ and glutamate in primary mesencephalic cell culture	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						citicoline; dopaminergic; glutamate; MPP+; neuroprotection; Parkinson's disease	HUMAN NEUROBLASTOMA-CELLS; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; PARKINSONS-DISEASE; CITICOLINE; CYTIDINE; DEATH; RAT; METABOLISM; ACTIVATION	Cytidine-5'-diphosphocholine (citicoline or CDP-choline) is an essential endogenous intermediate in the biosynthesis of phosphatidylcholine. In the present study, primary dopaminergic cultures from mouse mesencephala were treated with citicoline to investigate its neuroprotective potential on the survival of dopaminergic neurons exposed to MPP+ and glutamate. Treatment with citicoline alone significantly increased the survival of dopaminergic neurons compared to controls. MPP+ or glutamate decreased the total number of dopaminergic neurons whereas citicoline afforded significant protection against either toxicity. Moreover, citicoline significantly decreased propidium iodide uptake by cultured cells. The study concludes that citicoline exerts stimulant and neuroprotective actions on cultured dopaminergic neurons.	Tech Univ Dresden, Dept Neurol, D-01307 Dresden, Germany; Vet Med Univ, Inst Med Chem, Vienna, Austria; Univ Int Catalunya, Fac Hlth Sci, Barcelona, Spain; Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; Assiut Univ, Fac Med Vet, Dept Pathol, Assiut 71516, Egypt	Gille, G (corresponding author), Tech Univ Dresden, Dept Neurol, Fetscherstasse 74, D-01307 Dresden, Germany.	Gabriele.Gille@neuro.med.tu-dresden.de					Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Adibhatla RM, 2006, J BIOL CHEM, V281, P6718, DOI 10.1074/jbc.M512112200; Adibhatla RM, 2003, ANTIOXID REDOX SIGN, V5, P647, DOI 10.1089/152308603770310329; Adibhatla RM, 2002, J NEUROCHEM, V80, P12; Adibhatla RM, 2001, STROKE, V32, P2376, DOI 10.1161/hs1001.096010; AGNOLI A, 1982, NEUROPSYCHOBIOLOGY, V8, P289, DOI 10.1159/000117914; AGUT J, 1983, ARZNEIMITTEL-FORSCH, V33-2, P1045; Anderson CM, 2000, GLIA, V32, P1; Barrachina M, 2003, J NEUROL SCI, V215, P105, DOI 10.1016/S0022-510X(03)00204-1; Barrachina M, 2002, BRAIN RES, V957, P84, DOI 10.1016/S0006-8993(02)03605-3; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Brana C, 2002, BRAIN RES PROTOC, V10, P109, DOI 10.1016/S1385-299X(02)00201-5; Conant Richard, 2004, Altern Med Rev, V9, P17; Crespo D, 2004, ANN NY ACAD SCI, V1019, P41, DOI 10.1196/annals.1297.009; EBERHARDT R, 1990, CLIN THER, V12, P489; GALLETTI P, 1991, J NEUROL SCI, V103, pS19; Grieb P, 2002, J NEUROSCI RES, V67, P143, DOI 10.1002/jnr.10129; Grieb P, 2001, FOLIA NEUROPATHOL, V39, P141; Hurtado O, 2005, NEUROBIOL DIS, V18, P336, DOI 10.1016/j.nbd.2004.10.006; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; Krupinski J, 2005, NEUROCHEM RES, V30, P1067, DOI 10.1007/s11064-005-7201-0; Krupinski J, 2002, NEUROPHARMACOLOGY, V42, P846, DOI 10.1016/S0028-3908(02)00032-1; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LOPEZ G-COVIELLA I, 1992, Journal of Nutritional Biochemistry, V3, P313; McDaniel MA, 2003, NUTRITION, V19, P957, DOI 10.1016/S0899-9007(03)00024-8; Mehler-Wex C, 2006, J NEURAL TRANSM, V113, P1383, DOI 10.1007/s00702-005-0425-y; Meldrum BS, 1998, PROG BRAIN RES, V116, P441, DOI 10.1016/S0079-6123(08)60454-9; Mir C, 2003, J MOL NEUROSCI, V20, P53, DOI 10.1385/JMN:20:1:53; SAVCI V, 1995, J NEUROCHEM, V64, P378; SECADES JJ, 2002, METHODS FIND EXP SB, V24, P1; Teather LA, 2005, LEARN MEMORY, V12, P39, DOI 10.1101/lm.83905; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T	32	14	14	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	JUL	2007	117	7					985	998		10.1080/10623320600934341			14	Neurosciences	Neurosciences & Neurology	177NG	WOS:000247159200008	17613109				2021-06-18	
J	Bottlang, M; Sommers, MB; Lusardi, TA; Miesch, JJ; Simon, RP; Xiong, ZG				Bottlang, Michael; Sommers, Mark B.; Lusardi, Theresa A.; Miesch, Jennifer J.; Simon, Roger P.; Xiong, Zhi-Gang			Modeling neural injury in organotypic cultures by application of inertia-driven shear strain	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; hippocampus; organotypic; shear strain; TBI	IN-VITRO MODEL; HIPPOCAMPAL SLICE CULTURES; DIFFUSE AXONAL INJURY; MECHANICAL STRETCH; BRAIN-INJURY; CELLS; CALCIUM; TRAUMA; TISSUE; POLYSTYRENE	In vitro models of traumatic brain injury (TBI) are indispensable to explore the effects of mechanotrauma on neurological injury cascades and injury thresholds. This study characterizes a novel in vitro model of neural shear injury, which for the first time subjects organotypic cultures to inertia-driven shear strain. In this model, organotypic cultures preserved a high level of biological heterogeneity and spatial cytoarchitecture, while inertia-driven shear strain represented a tissue-level insult typical for closed head TBI in vivo. For neural injury simulation, organotypic hippocampal cultures derived from rats were inserted in an inertial loading module, which was subjected to impacts at five graded impact velocities ranging from 2 to 10 m/sec. The mechanical insult was quantified by measuring the transient shear deformation of the culture surface during impact with a high-speed camera. The resultant cell death was quantified with propidium iodide (PI) staining 24 hours following shear injury. Increasing impact velocities of 2, 4.6, 6.6, 8.1, and 10.4 m/sec caused graded peak shear elongation of 2.0 +/- 0.9%, 5.4 +/- 3.8%, 15.1 +/- 14.6%, 25.4 +/- 14.7%, and 56.3 +/- 51.3%, respectively. Cell death in response to impact velocities of 6.6 m/sec or less was not significantly higher than baseline cell death in sham cultures (4.4 +/- 1.5%). Higher impact velocities of 8.1 and 10.4 m/sec resulted in a significant increase in cell death to 19.9 +/- 12.9% and 36.7 +/- 14.2%, respectively (p < 0.001). The neural shear injury model delivered a gradable, defined mechanotrauma and thereby provides a novel tool for investigation of biological injury cascades in organotypic cultures.	Legacy Res Ctr, Biomech Lab, Portland, OR 97232 USA; Legacy Res Ctr, Robert S Dow Neurobiol Labs, Portland, OR USA	Bottlang, M (corresponding author), Legacy Res Ctr, Biomech Lab, 1225 NE 2nd Ave, Portland, OR 97232 USA.	mbottlang@biomechresearch.org	Augat, Peter/A-2051-2011	Augat, Peter/0000-0003-4805-2128; Lusardi, Theresa/0000-0003-0699-5662	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042946] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS42946] Funding Source: Medline		AbdelHamid KM, 1997, J NEUROSCI, V17, P3538; Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; CATER HL, 2004, ANN M SOC NEUR SAN D; CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500; DENNEYBROWN D, 1943, BRAIN, V64, P93; DERIDDER MN, 2001, 2001 BIOENG C SNOWB; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FINSEN BR, 1992, NEUROSCIENCE, V47, P105, DOI 10.1016/0306-4522(92)90125-L; Fung Y, 1994, 1 COURSE CONTINUUM M; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; King A. I., 2003, IRCOBI C; KING AI, 1995, J NEUROTRAUM, V12, P651, DOI 10.1089/neu.1995.12.651; Krimer LS, 1997, J NEUROSCI METH, V75, P55, DOI 10.1016/S0165-0270(97)02265-6; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LUCAS JH, 1991, BRAIN RES, V543, P181, DOI 10.1016/0006-8993(91)90027-S; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Mielke JG, 2005, DEV BRAIN RES, V160, P275, DOI 10.1016/j.devbrainres.2005.09.009; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Smith DH, 1999, J NEUROSCI, V19, P4263; STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stoppini L, 1997, J NEUROSCI METH, V72, P23, DOI 10.1016/S0165-0270(96)00151-3; Zhang Liying, 2002, Stapp Car Crash J, V46, P145	38	14	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2007	24	6					1068	1077		10.1089/neu.2006.3772			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	184EA	WOS:000247622700013	17600521				2021-06-18	
J	Hashimoto, K; Okumura, A; Shinoda, J; Abo, M; Nakamura, T				Hashimoto, Keiji; Okumura, Ayumi; Shinoda, Jun; Abo, Masahiro; Nakamura, Toshinori			Tensor magnetic resonance imaging in a case of mild traumatic brain injury with lowered verbal intelligence quotient	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; diffuse axonal injury; neuropsychological dysfunction; magnetic resonance imaging; diffusion tensor imaging		We report the case of a 31-year-old man who had mild traumatic brain injury as a result of an accident at the age of 24 years. Seven years after the trauma, at the age of 31 years, he had a lower verbal intelligence quotient than performance intelligence quotient by the Wechsler Adult Intelligence Scale - Revised, and frontal lobe dysfunction, for example, difficulty in maintaining or changing the set as revealed by the Wisconsin Card Sorting Test Keio Version. Conventional brain magnetic resonance imaging had not shown any abnormalities. Abnormal brain areas were detected on magnetic resonance diffusion tensor imaging. On tractography, some fibres from the corpus callosum towards the frontal cortex were noted to be lacking in the left hemisphere compared with the right. The tractography results may explain the patient's lowered verbal intelligence quotient and focal left frontal lobe dysfunction. Diffusion tensor imaging is therefore helpful in detecting lesions in mild traumatic brain injury with diffuse axonal injury.	Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo 1058461, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Neutrotraumatol, Tokyo, Japan; Kisawa Mem Hosp, Dept Neurosurg, Chubu Med Ctr Prolonged Taumat Brain Dysfunct, Gifu, Japan	Hashimoto, K (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	keiman@jikei.ac.jp		Abo, Masahiro/0000-0001-6701-4974			ABO M, 2006, J APPL RES, V6, P36; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kamikubo Takeshi, 2004, No To Shinkei, V56, P952; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Monchi O, 2001, J NEUROSCI, V21, P7733; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730	9	14	14	0	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2007	39	5					418	420		10.2340/16501977-0065			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	174SF	WOS:000246962400013	17549335	DOAJ Gold			2021-06-18	
J	Vungkhanching, M; Heinemann, AW; Langley, MJ; Ridgely, M; Kramer, KM				Vungkhanching, Martha; Heinemann, Allen W.; Langley, Mervin J.; Ridgely, Mary; Kramer, Karen M.			Feasibility of a skills-based substance abuse prevention program following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affect; alcohol; brain injury; drug use; coping skills; employment	HEAD-INJURY; ALCOHOLISM; OUTCOMES; MANAGEMENT; AMNESIA	Objective: To demonstrate the feasibility of a skills-based substance abuse prevention counseling program in a community setting for adults who sustained traumatic brain injury. Participants: Convenience sample of 117 participants (mean age = 35 years) with preinjury history of alcohol or other drug use. Intervention group participants (n = 36) from 3 vocational rehabilitation programs; a no-intervention comparison group (n = 81) from an outpatient rehabilitation service. Intervention: 12 individual counseling sessions featuring skills-based intervention. Main Outcome Measures: Changes in self-reported alcohol and other drug use, coping skillfulness, affect, and employment status from baseline to 9 months postintervention. Results: Significant differences were noted at baseline for the intervention and comparison groups on ethnicity, time postinjury, marital status, and employment (P < .05). At the 9-month follow-up, the intervention group participants achieved a statistically significant decrease in alcohol and drug use (P < .05), increase in coping skillfulness (P < .01), and increased likelihood of maintaining employment (P < .01) relative to the comparison group. Controlling for baseline-adjusted means for the intervention and comparison groups, a statistically significant group difference in adjusted change was noted; the intervention group participants reported lower negative affect at the 9-month follow-up assessment (P < .05). Conclusions: A skills-based intervention provides a promising approach to promoting abstinence from all substances and increasing readiness for employment for adults with traumatic brain injuries in outpatient settings.	Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; Dominican Univ, Grad Sch Social Work, River Forest, IL USA; Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; Clin Psychol Associates, Burlington, WI USA; Employment Psychol Associates, Madison, WI USA; Univ Kansas, Sch Med, Dept Prevent Med & Publ Hlth, Wichita, KS 67214 USA; Univ Kansas, Sch Med, Res Off, Wichita, KS 67214 USA	Heinemann, AW (corresponding author), Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, 345 E Super St, Chicago, IL 60611 USA.	a-heinemann@northwestern.edu	Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326			Blackerby W.F., 1990, J HEAD TRAUMA REHAB, V5, P47; BLOUNT JP, 1996, ALCOHOL DRUG INVENTO; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Hagenaars J.A., 1994, CATEGORICAL LONGITUD; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Heinemann AW, 2004, REHABIL PSYCHOL, V49, P156, DOI 10.1037/0090-5550.49.2.156; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JONES SL, 1982, ADDICT BEHAV, V7, P285, DOI 10.1016/0306-4603(82)90057-0; JONES SL, 1981, J STUD ALCOHOL, V42, P521, DOI 10.15288/jsa.1981.42.521; LANGLEY M, 1992, NEUROREHABILITATION, V2, P65; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; LANGLEY MJ, 1994, SKILL BASED SUBSTANC; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MILLER WR, 1985, PSYCHOL BULL, V98, P84, DOI 10.1037/0033-2909.98.1.84; Monti P. M., 2002, TREATING ALCOHOL DEP; Monti PM, 1999, ALCOHOL RES HEALTH, V23, P107; Panting A., 1972, REHABILITATION, V38, P33; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schmidt MF, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P211; Sherer M, 1999, BRAIN INJURY, V13, P973; Sisson R. W., 1989, HDB ALCOHOLISM TREAT, P242; SPARADEO F, 1993, STAFF DEV CLIN INTER, P189; WANBERG K, 1987, TREATMENT PREVENTION, P27; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	31	14	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2007	22	3					167	176		10.1097/01.HTR.0000271117.19652.98			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	174OH	WOS:000246951100003	17510592				2021-06-18	
J	Poca, MA; Sahuquillo, J; Vilalta, A; Garnacho, A				Poca, Maria A.; Sahuquillo, Juan; Vilalta, Anna; Garnacho, Angel			Lack of utility of arteriojugular venous differences of lactate as a reliable indicator of increased brain anaerobic metabolism in traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article; Proceedings Paper	7th Annual Conference of the Euroacademia Multidisciplinaria Neurotraumatologica	JUN, 2002	Newcastle upon Tyne, ENGLAND			traumatic brain injury; ischemia; brain metabolism; lactate; microdialysis	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL MICRODIALYSIS; GLUCOSE-METABOLISM; ISCHEMIA; BLOOD; STIMULATION; INFARCTION; TRANSPORT; EXISTENCE	Object. Ischemic lesions are highly prevalent in patients with traumatic brain injuries (TBIs) and are the single most important cause of secondary brain damage. The prevention and early treatment of these lesions is the primary aim in the modem treatment of these patients. One of the most widely used monitoring techniques at the bedside is quantification of brain extracellular level of lactate by using arteriojugular venous differences of lactate (AVDL). The purpose of this study was to determine the sensitivity, specificity, and predictive value of AVDL as an indicator of increases in brain lactate production in patients with TBIs. Methods. Artericjugular venous differences of lactate were calculated every 6 hours using samples obtained though a catheter placed in the jugular bulb in 45 patients with diffuse head injuries (57.8%) or evacuated brain lesions (42.2%). Cerebral lactate concentration obtained with a 20-kD inicrodialysis catheter implanted in undamaged tissue was used as the de facto gold standard. Six hundred seventy-three AVDL determinations and cerebral microdialysis samples were obtained simultaneously; 543 microdialysis samples (81%) showed lactate values greater than 2 mmol/L, but only 21 AVDL determinations (3.1%) showed an increase in brain lactate. No correlation was found between AVDL and cerebral lactate concentration (p = 0.014, p = 0.719). Arteriojugular venous differences of lactate had a sensitivity and specificity of 3.3 and 97.7%, respectively, with a false-negative rate of 96.7% and a false-positive rate of 2.3%. Conclusions. Arteriojugular venous differences of lactate do not reliably reflect increased cerebral lactate production and consequently are not reliable in ruling out brain ischemia in patients with TBIs. The clinical use of this monitoring method in neurocritical care should be reconsidered.	Ciudad Sanitaria & Univ Vall Hebron, Dept Neurosurg, E-08035 Barcelona, Spain	Sahuquillo, J (corresponding author), Ciudad Sanitaria & Univ Vall Hebron, Dept Neurosurg, Paseo Vall Hebron 119-129, E-08035 Barcelona, Spain.	sahuquillo@neurotraurna.net	Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Garnacho, Angel/A-9309-2013	Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Vilalta, Anna/0000-0002-2183-072X			Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; BAKKER EP, 1974, BIOCHIM BIOPHYS ACTA, V339, P285, DOI 10.1016/0005-2736(74)90325-3; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, ACT NEUR S, V76, P359; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; CRUZ J, 1993, J TRAUMA, V35, P805, DOI 10.1097/00005373-199311000-00026; FELLOWS LK, 1993, J NEUROCHEM, V60, P1258, DOI 10.1111/j.1471-4159.1993.tb03285.x; Gibbs EL, 1942, J BIOL CHEM, V144, P325; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; HILLERED L, 1995, NEUROCHEMICAL MONITO, P59; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJA, 1999, ACT NEUR S, V75, P57; Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kett-White R, 2002, ADV TECH STAND NEUR, V27, P87; Langemann H, 2001, NEUROL RES, V23, P531, DOI 10.1179/016164101101198785; LARRABEE MG, 1995, J NEUROCHEM, V64, P1734; LUTZ PL, 1997, BRAIN OXYGEN, P1; Magistretti PJ, 1997, NEUROSCIENTIST, V3, P361, DOI 10.1177/107385849700300608; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murr R, 1996, ACTA NEUROCHIR, V138, P928, DOI 10.1007/BF01411281; NEMOTO EM, 1974, STROKE, V5, P48, DOI 10.1161/01.STR.5.1.48; Oldendorf W H, 1971, Trans Am Neurol Assoc, V96, P46; OLDENDORF WH, 1973, AM J PHYSIOL, V224, P1450; PARDRIDGE W M, 1975, Critical Reviews in Toxicology, V3, P159, DOI 10.3109/10408447509079857; PARDRIDGE WM, 1977, J NEUROCHEM, V28, P5, DOI 10.1111/j.1471-4159.1977.tb07702.x; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; POOLE RC, 1993, AM J PHYSIOL, V264, pC761; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; Price NT, 1998, BIOCHEM J, V329, P321; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Robertson CS, 1998, NEUROL RES, V20, pS91; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; ROBERTSON CS, 1989, UPDTAE INTENSIVE CAR, P85; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82; Sarrafzadeh AS, 2001, ACT NEUR S, V77, P145; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; SOOD SC, 1980, ACTA NEUROCHIR, V53, P47, DOI 10.1007/BF02074520; Tofteng F, 2002, LIVER TRANSPLANT, V8, P302, DOI 10.1053/jlts.2002.32283; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; UNGERSTEDT U, 2000, MICRODIALYSIS NEUROM; Valadka A B, 2000, Neurosurg Focus, V9, pe3; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Weibel E. R, 1984, PATHWAY OXYGEN STRUC; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; 2000, J NEUROTRAUMA, V17, P457	59	14	14	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2007	106	4					530	537		10.3171/jns.2007.106.4.530			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	155OJ	WOS:000245586900004	17432701				2021-06-18	
J	Laskowski, A; Reiser, G; Reymann, KG				Laskowski, Alexandra; Reiser, Georg; Reymann, Klaus G.			Protease-activated receptor-1 induces generation of new microglia in the dentate gyrus of traumatised hippocampal slice cultures	NEUROSCIENCE LETTERS			English	Article						trauma; microglia; proliferation; microgliosis; organotypic hippocampal slice cultures; protease-activated receptor; PAR	CELL-PROLIFERATION; BRAIN-INJURY; FOCAL ISCHEMIA; THROMBIN; NEUROPROTECTION; NEUROGENESIS; MESOTRYPSIN; EXPRESSION; TRYPSIN	The protease thrombin is not only known as a major component in the blood coagulation cascade but is also involved in proinflammatory processes in the central nervous system (CNS). Here we used an in vitro model, to investigate the effect of thrombin and protease-activated receptor-1 (PAR-1) on proliferation and microgliosis after traumatic injury. A 5-day exposure to thrombin after cutting the Schaffer collaterals induced a proliferation and microgliosis in the dentate gyms of organotypic slice cultures. This effect is at least partially mediated by PAR-1 since the selective peptide agonist TRag shows similar effects. Thus, thrombin effects after injury might involve microglial proliferation. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; Univ Magdeburg, Inst Neurobiochem, D-39120 Magdeburg, Germany	Reymann, KG (corresponding author), Leibniz Inst Neurobiol, Brennecke Str 6, D-39118 Magdeburg, Germany.	reymann@ifn-magdeburg.de	Reymann, Klaus G/J-8507-2013				Balcaitis S, 2003, NEUROREPORT, V14, P2373, DOI 10.1097/00001756-200312190-00017; Chechneva O, 2006, NEUROBIOL DIS, V23, P247, DOI 10.1016/j.nbd.2006.02.015; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; GOINGS GE, 2006, GLIA; GRABHAM P, 1995, J NEUROCHEM, V64, P583; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Henrich-Noack P, 2006, BRAIN RES, V1070, P232, DOI 10.1016/j.brainres.2005.10.100; Henrich-Noack P, 2006, J NEUROSCI RES, V83, P469, DOI 10.1002/jnr.20746; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Laskowski A, 2005, BRAIN RES, V1037, P78, DOI 10.1016/j.brainres.2004.12.035; Moller T, 2006, SEMIN THROMB HEMOST, V32, P69, DOI 10.1055/s-2006-939556; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pforte C, 2005, NEUROSCIENCE, V136, P1133, DOI 10.1016/j.neuroscience.2005.08.043; QIU L, 2006, J CEREB BLOOD FLOW M; Sinnreich M, 2004, J NEUROCHEM, V88, P1380, DOI 10.1046/j.1471-4159.2003.02268.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Wang YF, 2006, J NEUROCHEM, V99, P759, DOI 10.1111/j.1471-4159.2006.04105.x; Weinstein JR, 2005, J NEUROCHEM, V95, P1177, DOI 10.1111/j.1471-4159.2005.03499.x; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x	30	14	16	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 19	2007	415	1					17	21		10.1016/j.neulet.2006.12.050			5	Neurosciences	Neurosciences & Neurology	153ZV	WOS:000245477500004	17324513				2021-06-18	
J	Gulino, R; Cataudella, T; Casamenti, F; Pepeu, G; Stanzani, S; Leanza, G				Gulino, Rosario; Cataudella, Tiziana; Casamenti, Fiorella; Pepeu, Giancarlo; Stanzani, Stefania; Leanza, Giampiero			Acetylcholine release from fetal tissue homotopically grafted to the motoneuron-depleted lumbar spinal cord. An in vivo microdialysis study in the awake rat	EXPERIMENTAL NEUROLOGY			English	Article						acetylcholine; neurotransmitter release; recovery; transplantation; volkensin; rat	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ADULT-RAT; CHOLINE-ACETYLTRANSFERASE; NORADRENALINE RELEASE; INVIVO MICRODIALYSIS; EVOKED RELEASE; DORSAL-HORN; DIRECTED DIFFERENTIATION; BEHAVIORAL ACTIVATION	Grafts of spinal cord (SC) tissue can survive and develop into the severed SC, but no conclusive data are available concerning the functional activity of transplanted neurons. In the present study, suspensions of prelabeled embryonic ventral SC tissue were grafted to the lumbar SC of rats with motoneuron loss induced by perinatal injection of volkensin. Eight to ten months post-grafting, acetylcholine (ACh) release was measured by microdialysis in awake rats, under either basal or stimulated conditions. In normal animals, baseline ACh output averaged 1.6 pmol/30 mu l, it exhibited a 4-fold increase after KCl-induced depolarization or handling, and it was completely inhibited by tetrodotoxin administration. Moreover, ACh levels did not change following acute SC transection performed under anesthesia during ongoing dialysis, suggesting an intrinsic source for spinal ACh. Treatment with volkensin produced a severe (> 85%) motoneuronal loss accompanied by a similar reduction in baseline ACh release and almost completely abolished effects of depolarization or handling. In transplanted animals, many motoneuron-like labeled cells were found within and just outside the graft area, but apparently in no case were they able to extend fibers towards the denervated muscle. However, the grafts restored baseline ACh output up to near-normal levels and responded with significantly increased release to depolarization, but not to handling. The present findings indicate that spinal neuroblasts can survive and develop within the motoneuron-depleted SC and release ACh in a near-normal, but apparently non-regulated, manner. This may be of importance for future studies involving intraspinal stem cell grafts. (c) 2006 Elsevier Inc. All rights reserved.	Univ Trieste, Dept Physiol & Pathol, BRAIN Ctr Neurosci, I-34127 Trieste, Italy; Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; Univ Catania, Dept Physiol Sci, I-95125 Catania, Italy	Leanza, G (corresponding author), Univ Trieste, Dept Physiol & Pathol, BRAIN Ctr Neurosci, Via Fleming 22, I-34127 Trieste, Italy.	gileanza@dfp.units.it		Gulino, Rosario/0000-0002-8067-697X; stanzani, stefania/0000-0003-3896-2523			ANDERSON DK, 1995, BRAIN PATHOL, V5, P451, DOI 10.1111/j.1750-3639.1995.tb00624.x; ARBUZOVADAVIS S, 2006, PROG BRAIN RES, V157, P207; BARBER RP, 1984, J COMP NEUROL, V229, P329, DOI 10.1002/cne.902290305; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BJORKLUND A, 1975, BRAIN RES, V83, P531, DOI 10.1016/0006-8993(75)90849-5; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; BJORKLUND A, 1983, ACTA PHYSIOL SCAND, P9; BORGES LF, 1986, BRAIN RES, V362, P140, DOI 10.1016/0006-8993(86)91407-1; Bouaziz H, 1996, ANESTHESIOLOGY, V84, P143, DOI 10.1097/00000542-199601000-00017; Bregman B. S., 1994, FUNCTIONAL NEURAL TR, P489; CAMPBELL K, 1993, NEUROSCIENCE, V53, P403, DOI 10.1016/0306-4522(93)90204-S; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; CENCI MA, 1994, BRAIN RES, V641, P225, DOI 10.1016/0006-8993(94)90150-3; CENCI MA, 1993, EXP NEUROL, V122, P73, DOI 10.1006/exnr.1993.1109; Cenci MA, 2000, EXP NEUROL, V164, P351, DOI 10.1006/exnr.2000.7433; CEVOLANI D, 1995, BRAIN RES, V689, P163, DOI 10.1016/0006-8993(95)00549-6; Christie SD, 2001, CAN J NEUROL SCI, V28, P6; CLOWRY GJ, 1992, EXP BRAIN RES, V91, P249; DAMSMA G, 1985, J NEUROCHEM, V45, P1649, DOI 10.1111/j.1471-4159.1985.tb07238.x; DEMIERRE B, 1990, BRAIN RES, V510, P355, DOI 10.1016/0006-8993(90)91391-S; Eisenach JC, 1996, ANESTH ANALG, V82, P621, DOI 10.1097/00000539-199603000-00034; Gao J, 2005, NEUROSCIENCE, V131, P257, DOI 10.1016/j.neuroscience.2004.10.033; GERIN C, 1994, J NEUROSCI METH, V52, P129, DOI 10.1016/0165-0270(94)90121-X; GIOVANNINI MG, 1994, J NEUROSCI, V14, P1358; Greensmith L, 1996, TRENDS NEUROSCI, V19, P450, DOI 10.1016/S0166-2236(96)20034-7; GWYN DG, 1966, SCIENCE, V153, P1543, DOI 10.1126/science.153.3743.1543; Hebel R., 1976, ANATOMY LAB RAT; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; Hoffman D R, 1997, Ann Health Law, V6, P147; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hoglund AU, 2000, J PHARMACOL EXP THER, V295, P100; IBRAHIM NA, 1989, NEUROPHARMACOLOGY, V28, P977, DOI 10.1016/0028-3908(89)90199-8; IWAMOTO ET, 1993, J PHARMACOL EXP THER, V265, P777; KALEN P, 1990, J NEUROSCI METH, V34, P107, DOI 10.1016/0165-0270(90)90048-K; KALEN P, 1988, BRAIN RES, V474, P374, DOI 10.1016/0006-8993(88)90454-4; KANAZAWA I, 1979, NEUROSCI LETT, V13, P325, DOI 10.1016/0304-3940(79)91514-3; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; Klimscha W, 1997, ANESTHESIOLOGY, V87, P110, DOI 10.1097/00000542-199707000-00015; KOBAYASHI N, 1991, NEUROSCIENCE, V45, P331, DOI 10.1016/0306-4522(91)90230-L; Kommalage M, 2005, EUR J PHARMACOL, V509, P127, DOI 10.1016/j.ejphar.2004.12.017; Kommalage M, 2003, PHARMACOL TOXICOL, V93, P169, DOI 10.1034/j.1600-0773.2003.930403.x; Kornmalage M, 2005, EUR J PHARMACOL, V525, P69, DOI 10.1016/j.ejphar.2005.08.035; LEANZA G, 1993, BRAIN RES, V615, P147, DOI 10.1016/0006-8993(93)91126-D; LEANZA G, 1993, BRAIN RES, V618, P47, DOI 10.1016/0006-8993(93)90427-O; Leanza G, 1996, BRAIN RES, V738, P281, DOI 10.1016/S0006-8993(96)00796-2; Leanza G, 1998, NEUROSCI LETT, V244, P89, DOI 10.1016/S0304-3940(98)00135-9; Leanza G, 1999, EUR J NEUROSCI, V11, P1789, DOI 10.1046/j.1460-9568.1999.00595.x; LINDEROTH B, 1994, NEUROSURGERY, V34, P484, DOI 10.1227/00006123-199403000-00014; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lindvall Olle, 2004, NeuroRx, V1, P382; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.0.CO;2-#; Martin LJ, 2000, INT J MOL MED, V5, P3; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; MATOS FF, 1992, PAIN, V48, P439, DOI 10.1016/0304-3959(92)90097-U; Murray M, 2004, J NEUROTRAUM, V21, P405, DOI 10.1089/089771504323004557; NAVARATNAM V, 1970, BRAIN RES, V18, P411, DOI 10.1016/0006-8993(70)90125-3; NILSSON OG, 1990, PROG BRAIN RES, V82, P321; NILSSON OG, 1992, BRAIN RES, V584, P132, DOI 10.1016/0006-8993(92)90886-E; NILSSON OG, 1992, NEUROSCIENCE, V49, P33, DOI 10.1016/0306-4522(92)90074-C; Nogradi A, 1996, EUR J NEUROSCI, V8, P2198, DOI 10.1111/j.1460-9568.1996.tb00741.x; NOGRADI A, 1992, NEUROSCIENCE, V50, P975, DOI 10.1016/0306-4522(92)90220-V; NOGRADI A, 1994, EXP NEUROL, V129, P130, DOI 10.1006/exnr.1994.1154; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PHELPS PE, 1984, J COMP NEUROL, V229, P347, DOI 10.1002/cne.902290306; Reier Paul J, 2004, NeuroRx, V1, P424, DOI 10.1007/BF03206629; ROSENBLAD C, 1993, NEUROSCIENCE, V55, P353, DOI 10.1016/0306-4522(93)90504-9; Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809; SATOH K, 1983, BRAIN RES BULL, V11, P693, DOI 10.1016/0361-9230(83)90013-8; Scali C, 2002, J NEURAL TRANSM, V109, P1067, DOI 10.1007/s007020200090; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; SHERRIFF FE, 1994, BRAIN RES, V634, P150, DOI 10.1016/0006-8993(94)90268-2; SHERRIFF FE, 1991, NEUROSCI LETT, V128, P52, DOI 10.1016/0304-3940(91)90758-L; SIERADZAN K, 1991, EXP NEUROL, V114, P286, DOI 10.1016/0014-4886(91)90154-5; SIERADZAN K, 1989, NEUROSCIENCE, V31, P115, DOI 10.1016/0306-4522(89)90034-1; STIRPE F, 1985, J BIOL CHEM, V260, P4589; SUNDSTROM E, 1995, NEUROCHEM INT, V27, P185, DOI 10.1016/0197-0186(95)00007-U; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WILEY RG, 1987, NEUROPATH APPL NEURO, V13, P39, DOI 10.1111/j.1365-2990.1987.tb00169.x; WILEY RG, 1988, BRAIN RES, V438, P145, DOI 10.1016/0006-8993(88)91333-9; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; YAKSH TL, 1980, BRAIN RES, V192, P133, DOI 10.1016/0006-8993(80)91014-8; YOSHIOKA K, 1990, NEUROSCIENCE, V38, P195, DOI 10.1016/0306-4522(90)90385-H; Zahn PK, 2002, PAIN, V100, P65, DOI 10.1016/S0304-3959(02)00241-5	85	14	14	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2007	204	1					326	338		10.1016/j.expneurol.2006.11.011			13	Neurosciences	Neurosciences & Neurology	148PC	WOS:000245086100034	17234186				2021-06-18	
J	Shohrati, M; Rouini, MR; Mojtahedzadeh, M; Firouzabadi, M; Ghaini, MR; Kanani, M				Shohrati, M.; Rouini, M. R.; Mojtahedzadeh, M.; Firouzabadi, M.; Ghaini, M. R.; Kanani, M.			Evaluation of phenytoin pharmacokinetics in neurotrauma patients	DARU-JOURNAL OF FACULTY OF PHARMACY			English	Article						phenytoin; pharmacokinetic; free fraction; neurotrauma	ILL TRAUMA PATIENTS; CRITICALLY ILL; HEAD-INJURY; SEIZURES; METABOLISM; DOSAGE	Previous studies have suggested that drug metabolism may be altered in patients with severe neurotrauma. The purpose of this prospective study was to observe the alteration of phenytoin pharmacokinetic and the resulting drug plasma level among these patients. Twenty pati ents with severe head injury (Glasgow Coma Scale: 8) requiring intravenous phenytoin were included in the study. Phenytoin sodium was diluted to a concentration of 25mg/ml and infused for 20 minutes at the rate of not faster than 25mg/min. Maintenance dose of phenytoin sodium was administered in the first day of head trauma and vital signs were monitored at hourly intervals while the patients remained in the neurosurgical intensive care unit. Blood samples were obtained for peak and trough concentrations. Free and total phenytoin levels were determined by both liquid chromatography and fluorescence polarization immunoassay (Eclair) of plasma samples after ultrafiltration and deproteinization respectively. Based on the reported Km (Km 5.4 mg/l), predicted population Vmax was calculated to be (7.3 +/- 0.4 mg/kg/d) which was significantly lower than calculated individual Vmax (9.3 +/- 3.2 mg/kg/d) (P=0.026). Moreover, significant differences was found between mean daily dose of phenytoin administered to patients (257 4 mg/d) and calculated mean daily dose based on individual Vmax (479 3 mg/d) (p=0.0015). Mean plasma concentrations determined by fluorescence polarization immunoassay (FPIA) (6.11 +/- 2.9 mg/l) and HPLC method (5.78 +/- 2.8 mg/l) were not statistically different Metabolic rate increased non-proportionally with increase in phenytoin concentration, and as a result decrease in clearance. Significant alteration in the metabolism of phenytoin occurred after severe neurotrauma. Based on our results, to keep phenytoin concentrations in the range of 10-20 mg/l, an increase in the phenytoin maintenance dose and more frequent monitoring of concentration is commonly required.	Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut, Tehran, Iran; Univ Tehran Med Sci, Fac Pharm, Dept Pharmacotherapy, Tehran, Iran; Univ Tehran Med Sci, Neurol Sina Hosp, Tehran, Iran; Baqiatallah Univ Med Sci, Res Ctr Chem Injuries, Tehran, Iran; Minist Hlth & Med Educ, Deputy Food & Drug Adm, Tehran, Iran	Rouini, MR (corresponding author), Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut, Tehran, Iran.	rouini@tums.ac.ir					ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; *APPL THER INC, 1992, APPL PHARM PRINC THE; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; DRISCOLL DF, 1988, CRIT CARE MED, V16, P1248, DOI 10.1097/00003246-198812000-00016; GOTTLIEB ME, 1983, J TRAUMA, V23, P836, DOI 10.1097/00005373-198309000-00009; GRASELA TH, 1983, CLIN PHARMACOKINET, V8, P355, DOI 10.2165/00003088-198308040-00006; LAMBIE DG, 1976, LANCET, V2, P386; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Markowsky SJ, 1996, ANN PHARMACOTHER, V30, P443, DOI 10.1177/106002809603000501; MAVER GE, 1974, BRIT J CLIN PHARMACO, V1, P163; McKindley DS, 1997, J CLIN PHARMACOL, V37, P129, DOI 10.1002/j.1552-4604.1997.tb04771.x; MICHAL J, 1997, J CHROMATO B, V693, P407; NEETA P, 1995, CRITICAL CARE MED, V23; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; VOZEH S, 1981, J PHARMACOKINET BIOP, V9, P131, DOI 10.1007/BF01068078; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; ZIELMAN S, 1994, THREA DRUG MONI, V19, P139; TXB PHARMACOTHERAPY, pCH57	21	14	15	0	4	TEHRAN UNIVERSITY OF MEDICAL SCIENCES	TEHRAN	P. O. BOX 14155-6451, TEHRAN, 00000, IRAN	1560-8115			DARU	Daru	SPR	2007	15	1					34	40					7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	178SI	WOS:000247240000007					2021-06-18	
J	Erol, FS; Topsakal, C; Kaplan, M; Yildirim, H; Ozveren, MF				Erol, Fatih Serhat; Topsakal, Cahide; Kaplan, Metin; Yildirim, Hanifi; Ozveren, Mehmet Faik			Collet-Sicard syndrome associated with occipital condyle fracture and epidural hematoma	YONSEI MEDICAL JOURNAL			English	Article						Collet-Sicard syndrome; cranial nerve palsy; epidural hematoma; occipital condyl fracture	CRANIAL NERVE PALSIES; CLOSED-HEAD-INJURY	A 31-year-old male was presented with a very rare case of ipsilateral palsies of the nerves IX through XII (Collet-Sicard syndrome) after a closed head injury. An occipital condyle fracture that was associated with epidural hematoma was diagnosed by computed tomography. The patient was conservatively managed, and following the treatment, partial neurological recovery ensued. The phenomenon of occipital condyle fracture involving the last four cranial nerve palsies is relatively rare. Although 3 cases of Collet-Sicard syndrome that were caused by an occipital condyle fracture has been reported, the association between condyle fracture and epidural hematoma has never been described before.	Firat Univ, Tip Fak, Norosirurji Anabilim Dali, Elazig, Turkey; Firat Univ, Sch Med, Dept Radiol, Elazig, Turkey	Erol, FS (corresponding author), Firat Univ, Tip Fak, Norosirurji Anabilim Dali, Elazig, Turkey.	fserol@yahoo.com	Yildirim, Hanefi/V-9722-2018				ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; BRIDGMAN SA, 1992, SURG NEUROL, V38, P152, DOI 10.1016/0090-3019(92)90094-4; BUCHOLZ RW, 1979, J TRAUMA, V19, P768, DOI 10.1097/00005373-197910000-00009; Collet FJ, 1915, LYON MED, V124, P121; Comacchio F, 1995, Ear Nose Throat J, V74, P845; Connolly B, 2000, SPINE, V25, P395, DOI 10.1097/00007632-200002010-00023; DICHIRO GD, 1964, J NEUROSURG, V21, P447, DOI 10.3171/jns.1964.21.6.0447; Fuentes S, 2000, NEUROCHIRURGIE, V46, P563; GRUNDY DJ, 1984, SPINE, V9, P339, DOI 10.1097/00007632-198405000-00002; HASHIMOTO T, 1988, NEUROSURGERY, V23, P367, DOI 10.1227/00006123-198809000-00015; Ide C, 1998, J NEUROSURG, V88, P773, DOI 10.3171/jns.1998.88.4.0773; JUNCOS JL, 1987, BRAIN, V110, P197, DOI 10.1093/brain/110.1.197; Miyazaki C, 2000, CLIN NEUROL NEUROSUR, V102, P255, DOI 10.1016/S0303-8467(00)00109-8; MOHANTY SK, 1973, J NEUROSURG, V38, P86, DOI 10.3171/jns.1973.38.1.0086; ORBAY T, 1989, SURG NEUROL, V31, P402, DOI 10.1016/0090-3019(89)90076-1; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; Rees JH, 1997, BRIT J RADIOL, V70, P856, DOI 10.1259/bjr.70.836.9486056; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; Sicard J, 1917, MARSEILLE MED, V53, P383; Silvestrini M, 1991, Riv Neurol, V61, P135; Tappin JA, 1996, J NEUROL NEUROSUR PS, V60, P14, DOI 10.1136/jnnp.60.1.14; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025	24	14	14	0	2	YONSEI UNIV COLLEGE MEDICINE	SEOUL	C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL 120-752, SOUTH KOREA	0513-5796			YONSEI MED J	Yonsei Med. J.	FEB 28	2007	48	1					120	123		10.3349/ymj.2007.48.1.120			4	Medicine, General & Internal	General & Internal Medicine	144RJ	WOS:000244813400016	17326254	DOAJ Gold, Green Published			2021-06-18	
J	Lichtveld, RA; Panhuizen, IF; Smit, RBJ; Holtslag, HR; van der Werken, C				Lichtveld, Rob A.; Panhuizen, Ivo F.; Smit, Ronald B. J.; Holtslag, Hermann R.; van der Werken, Christian			Predictors of death in trauma patients who are alive on arrival at hospital	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						scoring systems; polytrauma; traumatic brain injury; thorax and abdominal trauma; trauma registries; polytrauma managment including prehospital and shockroom; multiple trauma	BASE DEFICIT; DATA-BANK; PEDIATRIC TRAUMA; INJURY SEVERITY; RESUSCITATION; MORTALITY; SCORE; CARE; PH	Objective: To determine which factors predict death occurring in trauma patients who are alive on arrival at hospital Design Prospective cohort study Method Data were collected from 507 trauma patients with multiple injuries, with a Hospital Trauma Index-injury Severity Score of 16 or more, who were initially delivered by the Emergency Medical Services to the Emergency Department of the University Medical Centre Utrecht (UMCU) during the period 1999-2000. Results: Univariate analysis showed that every year of age increase resulted in a 2% greater risk of death. If the patient had been intubated at the scene of the accident, this risk was increased 4.3-fold. Every point of increase in the Triage Revised Trauma Score (T-RTS) reduced the risk of death by 30%. A similar (but inverse) tendency was found for the HTI-ISS score, with every point of increase resulting in a 5% greater risk of death. There was a clear relationship between the base excess (BE) and hemoglobin (Hb) levels and the risk of death, the latter being increased by 8% for each mmol/I drop in BE, and reduced by 22% for each mmol/I increase in Hb. The risk of death occurring was 2.6 times higher in cases with isolated neurotrauma. These associations hardly changed in the multivariate analysis; only the relation with having been intubated at the scene disappeared. Conclusion: The risk of severely injured accident patients dying after arriving in hospital is mainly determined by the T-RTS, age, presence of isolated neurological damage, BE and Hb level. Skull/brain damage and hemorrhage appear to be the most important causes of death in the first 24 h after the accident. The time interval between the accident and arrival at the hospital does not appear to affect the risk of death.	[Lichtveld, Rob A.] RAVU EMS, NL-3601 BE Utrecht, Netherlands; [Panhuizen, Ivo F.] Radboud Univ Nijmegen Med Ctr, Dept Anaesthesiol, Nijmegen, Netherlands; [Smit, Ronald B. J.] Municipal Hlth Author, Forens Med, Amsterdam, Netherlands; [van der Werken, Christian] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands	Lichtveld, RA (corresponding author), RAVU EMS, Nassaustr 127, NL-3601 BE Utrecht, Netherlands.	r.lichtveld@ravu.nl		Lichtveld, Robert/0000-0002-3957-7056			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Davis JW, 1998, J TRAUMA, V44, P114, DOI 10.1097/00005373-199801000-00014; Davis JW, 1998, J TRAUMA, V45, P873, DOI 10.1097/00005373-199811000-00005; Davis JW, 1997, J TRAUMA, V43, P507, DOI 10.1097/00005373-199709000-00020; DAVIS JW, 1991, ANN EMERG MED, V20, P842, DOI 10.1016/S0196-0644(05)81423-4; Guzzo JL, 2005, J AM COLL SURGEONS, V201, P891, DOI 10.1016/j.jamcollsurg.2005.07.013; HARTMAN JAM, 2005, LANDELIJK PROTOCOL A; Hopson LR, 2003, J AM COLL SURGEONS, V196, P106, DOI 10.1016/S1072-7515(02)01668-X; Huerta S, 2005, AM SURGEON, V71, P763; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; Kincaid EH, 2001, J TRAUMA, V51, P332, DOI 10.1097/00005373-200108000-00018; Lerner EB, 2003, ACAD EMERG MED, V10, P949, DOI 10.1197/S1069-6563(03)00313-0; Lerner EB, 2001, ACAD EMERG MED, V8, P758, DOI 10.1111/j.1553-2712.2001.tb00201.x; Martin MJ, 2005, AM J SURG, V190, P836, DOI 10.1016/j.amjsurg.2005.05.051; Nirula R, 2004, J TRAUMA, V57, P37, DOI 10.1097/01.TA.0000128236.45043.6A; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Peterson DL, 2004, AM SURGEON, V70, P326; Pickens JJ, 2005, J TRAUMA, V58, P951, DOI 10.1097/01.TA.0000162174.06448.5A; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Stockinger ZT, 2004, J AM COLL SURGEONS, V198, P227, DOI 10.1016/j.jamcollsurg.2003.10.012; TEASDALE G, 1974, LANCET, V2, P81; Tremblay LN, 2003, AM J SURG, V186, P597, DOI 10.1016/j.amjsurg.2003.09.003	26	14	14	0	8	URBAN & VOGEL	MUNICH	NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2007	33	1					46	51		10.1007/s00068-007-6097-6			6	Emergency Medicine	Emergency Medicine	313HV	WOS:000256732600008	26815974	Bronze			2021-06-18	
J	Hassett, LM; Harmer, AR; Moseley, AM; Mackey, MG				Hassett, L. M.; Harmer, A. R.; Moseley, A. M.; Mackey, M. G.			Validity of the modified 20-metre shuttle test: Assessment of cardiorespiratory fitness in people who have sustained a traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; effort tests; assessment	MAXIMAL OXYGEN-UPTAKE; FUNCTIONAL-CAPACITY; EXERCISE CAPACITY; AEROBIC CAPACITY; WALKING TEST; RUN TEST; RELIABILITY; RESPONSES; ADULTS; INDIVIDUALS	Primary objective: To validate the modified 20-metre shuttle test in adults who have sustained a traumatic brain injury (TBI). Design: Single-sample validity study. Setting: Brain injury rehabilitation unit. Participants: Twenty-four adults with severe TBI, discharged from hospital for at least 6-months. Protocol: Participants attended the facility for a familiarization session, followed by a symptom-limited treadmill test and a modified shuttle test on two separate days. The treadmill test was based on an individualised protocol which used a physiotherapist-selected speed and increments in gradient every minute until volitional fatigue. The modified shuttle test was externally-paced and commenced with a speed of 2.4 km h(-1) which increased every minute until volitional fatigue. Main measures: Four primary measures were taken from both tests: peak oxygen uptake, peak heart rate, maximal velocity and rating of perceived exertion. Results: All participants completed the study. There were no adverse events. A high correlation was observed between the modified shuttle test and the treadmill test for peak oxygen uptake, peak heart rate and maximal velocity ( r = 0.96, r = 0.80, r = 0.82, respectively; p<0.001), but not for rating of perceived exertion ( r = 0.013, p = 0.952). Conclusion: The modified shuttle test is a valid measure of cardiorespiratory fitness in people who have sustained a TBI.	Liverpool Hlth Serv, Brain Injury Rehabil Unit, Liverpool, NSW 1871, Australia; Univ Sydney, Discipline Physiotherapy, Lidcombe, NSW, Australia	Hassett, LM (corresponding author), Liverpool Hlth Serv, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool, NSW 1871, Australia.	leanne.hassett@sswahs.nsw.gov.au	Harmer, Alison/I-2593-2013	Harmer, Alison/0000-0003-4877-5801; Hassett, Leanne/0000-0002-3546-1822			AHMAIDI S, 1992, EUR J APPL PHYSIOL O, V65, P475, DOI 10.1007/BF00243517; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; *AM COLL SPORTS ME, 2005, HLTH REL PHYS FITN A; American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bhambhani Y, 2003, ARCH PHYS MED REHAB, V84, P1629, DOI 10.1053/S0003-9993(03)00343-5; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; DAWES H, 2003, PHYSIOTHERAPY, V89, P570; Dawes H, 2006, DISABIL REHABIL, V28, P1243, DOI 10.1080/09638280600554595; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Foster C, 1996, MED SCI SPORT EXER, V28, P752, DOI 10.1097/00005768-199606000-00014; Gayda M, 2003, ARCH PHYS MED REHAB, V84, P1012, DOI 10.1016/S0003-9993(03)00036-4; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; MacKay M, 2001, PHYS THER, V81, P1790, DOI 10.1093/ptj/81.11.1790; MacKay-Lyons MJ, 2002, ARCH PHYS MED REHAB, V83, P1697, DOI 10.1053/apmr.2002.36395; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; MONTGOMERY DL, 1992, CAN J SPORT SCI, V17, P309; Morales FJ, 1999, AM HEART J, V138, P291, DOI 10.1016/S0002-8703(99)70114-6; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2002, BRAIN INJURY, V16, P789, DOI 10.1080/02699050210131894; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; PALMERMCLEAN K, 2002, AM COLL SPORTS MED R, P98; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Wolman RL, 1994, CLIN REHABIL, V8, P253	35	14	14	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	10					1069	1077		10.1080/02699050701630375			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	222WU	WOS:000250329600010	17891570				2021-06-18	
J	Lippert-Gruener, M; Maegele, M; Garbe, J; Angelov, DN				Lippert-Gruener, Marcela; Maegele, Marc; Garbe, Janika; Angelov, Doychin N.			Late effects of enriched environment (EE) plus multimodal early onset stimulation (MEOS) after traumatic brain injury in rats: Ongoing improvement of neuromotor function despite sustained volume of the CNS lesion	EXPERIMENTAL NEUROLOGY			English	Article						rat; brain injury; enriched environment; stimulation; lesion volume; neurological recovery	FLUID PERCUSSION INJURY; MOTOR CORTEX; COGNITIVE FUNCTION; MESSENGER-RNA; SPATIAL MEMORY; CEREBRAL EDEMA; DENTATE GYRUS; UP-REGULATION; ADULT-RATS; IN-VITRO	Recently we showed that the combination between MEOS and EE applied to rats for 7-15 days after traumatic brain injury (TBI) was associated with reduced CNS lesion volume and enhanced reversal of neuromotor dysfunction. In a continuation of this work, we tested whether these effects persisted for longer post-operative periods, e.g. 30 days post-injury (dpi). Rats were subjected to lateral fluid percussion (LFP) or to sham injury. After LFP, one third of the animals (injured and sham) was placed under conditions of standard housing (SH), one third was kept in EE-only, and one third received EE+MEOS. Standardized composite neuroscore (NS) for neurological functions and computerized analysis of the vibrissal motor performance were used to assess post-traumatic neuromotor deficits. These were followed by evaluation of the cortical lesion volume (CLV) after immunostaining for neuron-specific enolase, caspase 3 active, and GEAR Finally, the volume of cortical lesion containing regeneration-associated proteins (CLV-RAP) was determined in sections stained for GAP-43, MAP2, and neuronal class III beta-tubulin. We found (i) no differences in the vibrissal motor performance; (ii) EE+MEOS rats performed significantly better than SH rats in NS; (iii) EE-only and EE+ MEOS animals, but not SH rats, showed better recovery at 30 dpi than at 15 dpi; (iv) no differences among all groups in CLV (larger than that at 15 dpi) and CLV-RAP, despite a clear tendency to reduction in the EE-only and EE+MEOS rats. We conclude that EE+MEOS retards, but cannot prevent the increase of lesion volume. This retardation is sufficient for a continuous restoration of neurological functions. (c) 2006 Elsevier Inc. All rights reserved.	Univ Cologne, Inst Anat 1, D-50931 Cologne, Germany; Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; Univ Witten Herdecke, Dept Surg, Merheim Med Ctr, Witten, Germany	Angelov, DN (corresponding author), Univ Cologne, Inst Anat 1, Joseph Stelzmann Str 9, D-50931 Cologne, Germany.	angelov.anatomie@uni-koeln.de					Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 1996, SOMATOSENS MOT RES, V13, P225, DOI 10.3109/08990229609052578; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brook GA, 1998, ACTA NEUROPATHOL, V95, P378, DOI 10.1007/s004010050814; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Czeh B, 1998, HIPPOCAMPUS, V8, P647, DOI 10.1002/(SICI)1098-1063(1998)8:6<647::AID-HIPO7>3.3.CO;2-C; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DORFL J, 1985, J ANAT, V142, P173; Emery DL, 2000, J COMP NEUROL, V424, P521; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P342, DOI 10.1097/01.WCB.0000046143.31247.FD; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GARNER CC, 1988, J CELL BIOL, V106, P779, DOI 10.1083/jcb.106.3.779; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Guntinas-Lichius O, 2002, J NEUROSCI, V22, P7121; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ikeda S, 1998, BRAIN RES, V792, P164, DOI 10.1016/S0006-8993(98)00213-3; INGLIS FM, 1995, NEUROSCIENCE, V66, P81, DOI 10.1016/0306-4522(94)00578-S; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; KOMISARU.BR, 1970, J COMP PHYSIOL PSYCH, V70, P482, DOI 10.1037/h0028709; Landgrebe M, 2000, EUR J NEUROSCI, V12, P3729, DOI 10.1046/j.1460-9568.2000.00264.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Laskawi R, 1997, EUR ARCH OTO-RHINO-L, V254, P81, DOI 10.1007/BF01526185; Laurer HL, 2000, EUR J TRAUMA, V26, P95, DOI DOI 10.1007/S000680050007; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Li SH, 2006, J NEUROSCI RES, V83, P292, DOI 10.1002/jnr.20720; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Lippert-Gruner M, 2002, ACT NEUR S, V79, P21; LIPPERTGRUENER ML, 2002, BRAIN INJURY, V14, P585; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pierce JES, 1996, J NEUROSCI, V16, P1083; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Popratiloff AS, 2001, J COMP NEUROL, V433, P364, DOI 10.1002/cne.1145; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; ROSENZWEIG M R, 1969, Developmental Psychobiology, V2, P87, DOI 10.1002/dev.420020208; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Sachdev RNS, 2003, SOMATOSENS MOT RES, V20, P163, DOI 10.1080/08990220311000405208; SANES JN, 1990, EXP BRAIN RES, V79, P479; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; SINSON G, 1995, J NEUROCHEM, V65, P2209; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; SULLIVAN H, 1976, J NEUROSURG, V45, P184; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tomov TL, 2002, EXP NEUROL, V178, P207, DOI 10.1006/exnr.2002.8040; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WINESKI LE, 1985, J MORPHOL, V183, P199, DOI 10.1002/jmor.1051830208; Young D, 1999, NAT MED, V5, P448; ZILLES K, 1985, CORTEX RAT SEREOTACT	92	14	16	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2007	203	1					82	94		10.1016/j.expneurol.2006.07.025			13	Neurosciences	Neurosciences & Neurology	123NU	WOS:000243303400010	16965773				2021-06-18	
J	Natale, JE; Guerguerian, AM; Joseph, JG; McCarter, R; Shao, C; Slomine, B; Christensen, J; Johnston, MV; Shaffner, DH				Natale, JoAnne E.; Guerguerian, Anne-Marie; Joseph, Jill G.; McCarter, Robert; Shao, Cheng; Slomine, Beth; Christensen, James; Johnston, Michael V.; Shaffner, Donald H.			Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						children; traumatic brain injury; magnesium sulfate; QT interval; hemodynamics	ANEURYSMAL SUBARACHNOID HEMORRHAGE; RANDOMIZED CONTROLLED-TRIAL; CLINICAL-TRIALS; SUDDEN-DEATH; HEAD TRAUMA; BLOOD-FLOW; RATS; THERAPY; DECLINE	Objective: Magnesium sulfate is neuroprotective in preclinical models, but there are limited safety data regarding its clinical use for pediatric traumatic brain injury. We conducted a pilot study in children with severe traumatic brain injury to a) examine if magnesium sulfate decreases mean arterial pressure, decreases cerebral perfusion pressure, increases intracranial pressure, or adversely effects cardiac conduction; and b) determine the feasibility of a multiple-center trial of magnesium sulfate. Design: Double-blinded, placebo-controlled, randomized pilot trial with repeated measurement of hemodynamic variables. Setting: Two pediatric trauma centers. Patients: Six children (3 months to 18 yrs) with severe traumatic brain injury. Interventions: Magnesium sulfate (50 mg/kg) bolus followed by (8.3 mg/kg/hr) infusion for 24 hr vs. equivolume placebo. Measurements and Main Results: We screened 96 patients with severe traumatic brain injury during 24 months; 20 were eligible for enrollment, six provided informed consent, four received magnesium sulfate, and two received placebo. Before and after study drug infusion, we repeatedly measured blood ionized magnesium concentration, mean arterial pressure, cerebral perfusion pressure, intracranial pressure, heart rate, and corrected QT interval. Mean age (7.9 yrs), mean highest Glasgow Coma Scale score (6), gender (33% boys), inflicted injury rate (17%), and case mortality rate (17%) did not differ between those enrolled and those not enrolled. Compared with baseline, magnesium sulfate did not change cerebral perfusion pressure, intracranial pressure, heart rate, or corrected QT interval. Mean arterial pressure was unchanged until the late phase of magnesium sulfate infusion, when mean arterial pressure rose (82 +/- 5 vs. 93 +/- 6 mm Hg, p <.05). Sixty-four percent of corrected QT interval determinations obtained in the first 6 days after injury exceeded 440 msecs; 12% were >600 msecs. Conclusions: In children with severe traumatic brain injury, magnesium sulfate administration did not decrease mean arterial pressure or cerebral perfusion pressure or adversely effect cardiac conduction. Our data suggest that enrollment of brain-injured children in a therapeutic trial remains challenging. These results provide information important for clinical trials of magnesium sulfate in children with severe traumatic brain injury.	Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; Childrens Natl Med Ctr, Ctr Hlth Serv & Community Res, Washington, DC 20010 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Kennedy Krieger Inst, Baltimore, MD USA; Johns Hopkins Univ, Baltimore, MD USA	Natale, JE (corresponding author), Univ Calif Davis, Med Ctr, Dept Pediat, 2516 Stockton Blvd, Sacramento, CA 95817 USA.	jnatale@cnmcresearch.org		SHAFFNER, DONALD/0000-0001-5530-0746	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR020359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS043146] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5-M01-RR-020359-01] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS43146] Funding Source: Medline		ALTURA BT, 1994, SCAND J CLIN LAB INV, V54, P21, DOI 10.3109/00365519409095208; Boet R, 2000, NEUROSURGERY, V47, P602, DOI 10.1097/00006123-200009000-00014; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Cheung RTF, 2000, ARCH NEUROL-CHICAGO, V57, P1685, DOI 10.1001/archneur.57.12.1685; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Fukui S, 2003, CRIT CARE, V7, pR7, DOI 10.1186/cc2160; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; HEINEN M, 2005, NATL TRENDS INJURY H, P53; LANGLOIS JA, 2006, 2004 TRAUMATIC BRAIN; Lees KR, 2004, LANCET, V363, P439; Mendez DR, 2005, PEDIATR RES, V57, P347, DOI 10.1203/01.PDR.0000150803.36315.FF; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; Ozdemir D, 2005, PEDIATR EMERG CARE, V21, P658, DOI 10.1097/01.pec.0000181427.25342.e0; Regan RF, 2001, BRAIN RES, V890, P177, DOI 10.1016/S0006-8993(00)03156-5; Sankar P, 2004, MED ANTHROPOL Q, V18, P429, DOI 10.1525/maq.2004.18.4.429; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; SORTEBERG W, 1989, ACTA NEUROCHIR, V97, P47, DOI 10.1007/BF01577739; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Bergh WM, 2004, STROKE, V35, P644, DOI 10.1161/01.STR.0000117092.38460.4F; Veyna RS, 2002, J NEUROSURG, V96, P510, DOI 10.3171/jns.2002.96.3.0510; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; VINK R, 1988, J BIOL CHEM, V263, P757; Wang T, 2004, J NEUROSURG ANESTH, V16, P201, DOI 10.1097/00008506-200407000-00004; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	33	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2007	8	1					1	9		10.1097/01.pcc.0000256620.55512.5f			9	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	124JM	WOS:000243364100001	17251875				2021-06-18	
J	Potter, EG; Cheng, Y; Knight, JB; Gordish-Dressman, H; Natale, JE				Potter, Emily G.; Cheng, Ying; Knight, Jay Brandon; Gordish-Dressman, Heather; Natale, Joanne E.			Metallothionein I and II attenuate the thalamic microglial response following traumatic axotomy in the immature brain	JOURNAL OF NEUROTRAUMA			English	Article						inflicted childhood neurotrauma; mice; microglial activation; negative binomial regression; secondary injury	FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; INFLICTED HEAD-INJURY; CELL-DEATH; RAT-BRAIN; DOPAMINERGIC-NEURONS; CEREBROSPINAL-FLUID; MOLECULAR-MECHANISMS; SENSORIMOTOR CORTEX; PARKINSONS-DISEASE	The clinical manifestations of inflicted traumatic brain injury in infancy most commonly result from intracranial hemorrhage, axonal stretch and disruption, and cerebral edema. Often hypoxia ischemia is superimposed, leading to early forebrain and later thalamic neurodegeneration. Such acute and delayed cellular injury activates microglia in the CNS. Although activated microglia provide important benefits in response to injury, microglial release of reactive oxygen species can be harmful to axotomized neurons. We have previously shown that the antioxidants metallothionein I and II (MT I & II) promote geniculocortical neuronal survival after visual cortex lesioning. The purpose of this investigation was to determine the influence of MT I & II on the density and rate of thalamic microglial activation and accumulation following in vivo axotomy. We ablated the visual cortex of 10-day-old and adult MT I & II knock out (MT-/-) and wild-type mice and then determined the density of microglia in the dorsal lateral geniculate nucleus (dLGN) over time. Compared to the wild-type strain, microglial activation occurred earlier in both young and adult MT-/- mice. Similarly, microglial density was significantly greater in young MT-/- mice 30, 36, and 48 hours after injury, and 3, 4, and 5 days after injury in MT-/- adults. In both younger and older mice, time and MT I & II deficiency each contributed significantly to greater microglial density. Only in younger mice did MT I & II expression significantly slow the rate (density X time) of microglial accumulation. These results suggest that augmentation of NIT I & II expression may provide therapeutic benefits to infants with inflicted brain injury.	Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC USA; George Washington Univ, Inst Biomed Sci, Neurosci Program, Washington, DC 20052 USA; Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA	Natale, JE (corresponding author), Univ Calif Davis, Med Ctr, Dept Pediat, 2516 Stockton Blvd, Sacramento, CA 95817 USA.	jnatale@cnmcresearch.org		Knight, Brandon/0000-0003-4953-7194; Gordish-Dressman, Heather/0000-0002-2330-5427	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [KO8 NS 41273] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS041273] Funding Source: NIH RePORTER		Acarin L, 1999, NEUROSCIENCE, V89, P549, DOI 10.1016/S0306-4522(98)00331-5; Acarin L, 1997, EXP NEUROL, V147, P410, DOI 10.1006/exnr.1997.6593; Agar J, 2003, AMYOTROPH LATERAL SC, V4, P232, DOI 10.1080/14660820310011278; Asanuma M, 2002, NEUROSCI LETT, V327, P61, DOI 10.1016/S0304-3940(02)00346-4; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Campagne MV, 2000, J NEUROSCI, V20, P5200, DOI 10.1523/JNEUROSCI.20-14-05200.2000; Cerutti SM, 2000, CELL BIOL INT, V24, P35, DOI 10.1006/cbir.1999.0451; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Dailey ME, 1999, METHODS, V18, P222, DOI 10.1006/meth.1999.0775; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Ebadi M, 2005, METHOD ENZYMOL, V396, P276, DOI 10.1016/S0076-6879(05)96024-2; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Gao HM, 2003, J NEUROSCI, V23, P6181; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Heese K, 1998, J NEUROCHEM, V70, P699; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hermann DM, 2000, ACTA NEUROPATHOL, V99, P147, DOI 10.1007/PL00007418; Hochman A, 2000, CELL MOL BIOL, V46, P41; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jensen MB, 1999, NEUROSCIENCE, V93, P507, DOI 10.1016/S0306-4522(99)00139-6; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kim D, 2003, NEUROREPORT, V14, P679, DOI 10.1097/00001756-200304150-00004; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; LEIBBRANDT MEI, 1994, TOXICOL APPL PHARM, V124, P72, DOI 10.1006/taap.1994.1010; Lu YZ, 2005, NEUROSCI LETT, V373, P159, DOI 10.1016/j.neulet.2004.10.004; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; Mischel RE, 1997, NEUROSCI LETT, V231, P17, DOI 10.1016/S0304-3940(97)00531-4; Morino T, 2003, NEUROSCI RES, V46, P309, DOI 10.1016/S0168-0102(03)00095-6; Muessel MJ, 2002, MOL BRAIN RES, V103, P12, DOI 10.1016/S0169-328X(02)00158-4; Munch G, 2003, EXP BRAIN RES, V150, P1, DOI 10.1007/s00221-003-1389-5; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Natale JE, 2002, NEUROSCIENCE, V112, P665, DOI 10.1016/S0306-4522(02)00098-2; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 2001, J NEUROTRAUM, V18, P447, DOI 10.1089/089771501750171056; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Potts Mathew B, 2006, NeuroRx, V3, P143; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Ruppel RA, 2002, NEUROSURG CLIN N AM, V13, P169, DOI 10.1016/S1042-3680(01)00005-5; Soltys Z, 2005, J NEUROSCI METH, V146, P50, DOI 10.1016/j.jneumeth.2005.01.009; Sorensen JC, 1996, EXP BRAIN RES, V112, P203; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; Vela JM, 2002, J NEUROTRAUM, V19, P1503, DOI 10.1089/089771502320914723; VERITY MA, 1994, NEUROTOXICOLOGY, V15, P81; Walsh DT, 2000, GLIA, V29, P392, DOI 10.1002/(SICI)1098-1136(20000215)29:4<392::AID-GLIA10>3.0.CO;2-C; Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x; Wang XJ, 2005, NEUROREPORT, V16, P267, DOI 10.1097/00001756-200502280-00013; West AK, 2004, REV NEUROSCIENCE, V15, P157; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	71	14	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					28	42		10.1089/neu.2006.0056.R1			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100004	17263668				2021-06-18	
J	Shapiro, SM; Sombati, S; Geiger, A; Rice, AC				Shapiro, Steven M.; Sombati, Sompong; Geiger, Angela; Rice, Ann C.			NMDA channel antagonist MK-801 does not protect against bilirubin neurotoxicity	NEONATOLOGY			English	Article						kernicterus; tissue culture; brainstem auditory evoked potentials; hyperbilirubinemia; jaundice; Gunn rat; free bilirubin	JAUNDICED GUNN-RATS; EVOKED-POTENTIAL ABNORMALITIES; HUMAN NT2-N NEURONS; TRAUMATIC BRAIN-INJURY; HUMAN SERUM-ALBUMIN; UNCONJUGATED BILIRUBIN; CELL-DEATH; RECEPTOR ANTAGONISTS; KINASE-II; IN-VITRO	Background: Bilirubin encephalopathy or kernicterus is a potentially serious complication of neonatal hyperbilirubinemia. The mechanism of bilirubin-induced neurotoxicity is not known. Many neurological insults are mediated through NMDA receptor activation. Objective: We assessed the effect of the NMDA channel antagonist, MK-801 on bilirubin neurotoxicity in vivo and in vitro. Methods: Bilirubin toxicity in vitro was assessed using trypan blue staining. Sulfadimethoxine injected ( i.p.) jaundiced Gunn rat pups exhibit many neurological sequelae observed in human hyperbilirubinemia. Brainstem auditory-evoked potentials ( BAEPs), a noninvasive sensitive tool to assess auditory dysfunction due to bilirubin neurotoxicity, were used to assess neuroprotection with MK-801 ( i.p.) in vivo. Results: In primary cultures of hippocampal neurons, 20 min exposure to 64: 32 mu M bilirubin: human serum albumin reduced the cell viability by approximately 50% ten hours later. MK-801 treatment did not protect the cells. MK-801 pretreatment doses ranging from 0.1-4.0 mg/kg did not protect against BAEP abnormalities in Gunn rat pups 6 h after sulfadimethoxine injection. Conclusion: Our findings suggest that bilirubin neurotoxicity is not mediated through NMDA receptor activation. Copyright (C) 2007 S. Karger AG, Basel.	Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pediat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Physiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Otolaryngol Head & Neck Surg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA	Rice, AC (corresponding author), Virginia Commonwealth Univ, Dept Neurol, POB 980599, Richmond, VA 23298 USA.	acrice@vcu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000369] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01 DC00369] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47151] Funding Source: Medline		AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Ahlfors CE, 2000, ANAL BIOCHEM, V279, P130, DOI 10.1006/abio.2000.4485; Ahlfors CE, 2001, BIOL NEONATE, V80, P158, DOI 10.1159/000047136; AMIT Y, 1993, EXP NEUROL, V121, P248, DOI 10.1006/exnr.1993.1092; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BLANC WA, 1959, J NEUROPATH EXP NEUR, V18, P165, DOI 10.1097/00005072-195901000-00011; BRODERSEN R, 1972, SCAND J CLIN LAB INV, V29, P433, DOI 10.3109/00365517209080263; Chihab R, 1998, J NEUROCHEM, V71, P1177; CHOI DW, 1992, SCIENCE, V258, P241, DOI 10.1126/science.1357748; Churn SB, 1995, ADV NEUROIMMUNOL, V5, P241, DOI 10.1016/0960-5428(95)00016-U; CHURN SB, 1995, PEDIATR RES, V38, P949, DOI 10.1203/00006450-199512000-00020; Conlee JW, 2000, ACTA NEUROPATHOL, V99, P393, DOI 10.1007/s004010051141; COULTER DA, 1992, J NEUROPHYSIOL, V68, P362; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; DELORENZO RJ, 2005, PHARMACOL THERAPEUT, V111, P288; Falcao AS, 2005, NEUROBIOL DIS, V20, P199, DOI 10.1016/j.nbd.2005.03.001; Fernandes A, 2004, J NEUROIMMUNOL, V153, P64, DOI 10.1016/j.jneuroim.2004.04.007; GEIGER AS, 2007, IN PRESS NEONATOLOGY; Grojean S, 2002, SEMIN PERINATOL, V26, P416, DOI 10.1053/sper.2002.37141; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; Hanko E, 2006, PEDIATR RES, V59, P72, DOI 10.1203/01.pdr.0000191135.63586.08; Hanko E, 2005, PEDIATR RES, V57, P179, DOI 10.1203/01.PDR.0000148711.11519.A5; Hanko E, 2006, BRAIN RES, V1103, P56, DOI 10.1016/j.brainres.2006.05.083; Hoffman DJ, 1996, PEDIATR RES, V40, P804, DOI 10.1203/00006450-199612000-00005; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; JACOBSEN J, 1969, FEBS LETT, V5, P112, DOI 10.1016/0014-5793(69)80307-8; JOHNSON L, 1961, AM J DIS CHILD, V101, P322, DOI 10.1001/archpedi.1961.04020040050007; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Keppel G, 1992, DESIGN ANAL RES HDB; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Malamud N., 1961, KERNICTERUS ITS IMPO, P230; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Meldrum BS, 2002, PROG BRAIN RES, V135, P487; NAGAOKA S, 1978, J BIOL CHEM, V253, P2005; Oakden WK, 2005, AM J NEURORADIOL, V26, P1571; ODELL GB, 1985, CEREBRAL ENERGY META, P229; Olney JW, 2002, NEUROTOXICOLOGY, V23, P659, DOI 10.1016/S0161-813X(01)00092-4; OLNEY JW, 1994, PSYCHOPHARMACOL BULL, V30, P533; Palmer GC, 2001, CURR DRUG TARGETS, V2, P241, DOI 10.2174/1389450013348335; Rice AC, 2006, BRAIN RES, V1107, P215, DOI 10.1016/j.brainres.2006.06.005; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Rodrigues CMP, 2002, PEDIATR RES, V51, P112, DOI 10.1203/00006450-200201000-00020; ROSE AL, 1979, J NEUROPATH EXP NEUR, V38, P152, DOI 10.1097/00005072-197903000-00006; SAWASAKI Y, 1976, J NEUROCHEM, V27, P577, DOI 10.1111/j.1471-4159.1976.tb12285.x; SCHUTTA HS, 1969, J PEDIATR-US, V75, P1070, DOI 10.1016/S0022-3476(69)80351-3; SHAPIRO SM, 1988, DEV BRAIN RES, V41, P147, DOI 10.1016/0165-3806(88)90178-2; SHAPIRO SM, 1988, PEDIATR RES, V23, P306, DOI 10.1203/00006450-198803000-00015; SHAPIRO SM, 1993, PEDIATR RES, V34, P629, DOI 10.1203/00006450-199311000-00014; Shapiro Steven M, 2005, J Perinatol, V25, P54, DOI 10.1038/sj.jp.7211157; Silva R, 1999, BIOCHEM BIOPH RES CO, V265, P67, DOI 10.1006/bbrc.1999.1646; Silva RFM, 2002, PEDIATR RES, V51, P535, DOI 10.1203/00006450-200204000-00022; SOMBATI S, 1991, BRAIN RES, V566, P316, DOI 10.1016/0006-8993(91)91716-E; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706; TURSKI L, 1993, EXPERIENTIA, V49, P1064, DOI 10.1007/BF01929915; Warr O, 2000, BRAIN RES, V879, P13, DOI 10.1016/S0006-8993(00)02676-7	57	14	14	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1661-7800			NEONATOLOGY	Neonatology		2007	92	4					248	257		10.1159/000103743			10	Pediatrics	Pediatrics	227KJ	WOS:000250655300006	17556843				2021-06-18	
J	Stablum, F; Umilta, C; Mazzoldi, M; Pastore, N; Magon, S				Stablum, Franca; Umilta, Carlo; Mazzoldi, Mariantonietta; Pastore, Nicole; Magon, Stefano			Rehabilitation of endogenous task shift processes in closed head injury patients	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							DYSEXECUTIVE SYNDROME; PRACTICAL SCALE; DEFICITS	This paper reports a study that was aimed to rehabilitate executive functions in CHI patients. When a subject is engaged in two speeded tasks, not simultaneously but with some form of alternation, the response is slower to an item of task A if it was preceded by an item of task B, than when it was preceded by an item of task A. This shift cost is small when subjects can prepare in advance for the new task (endogenous task shift), whereas the cost is much greater when preparation is not possible (exogenous task shift). The groups tested comprised 20 severe closed head injury (CHI) patients (10 who underwent treatment and 10 controls), 8 mild CHI patients, and 18 non-brain damaged (NBD) controls. In the present study, the shift cost was greater for severe CHI patients than for NBD controls. Treatment consisted of five sessions, in which an endogenous task shift paradigm was used. A significant reduction of the endogenous shift cost from assessment to retest was found. The reduction remained stable at the 4-month follow-up session. These results are not simply due to retesting, as the control patients did not show any improvement at retest. Interestingly, no reduction of exogenous task shift cost was found. The results showed also that the beneficial effect of the treatment generalises to other executive functions.	Univ Padua, Dipartimento Psicol Gen, I-35131 Padua, Italy	Stablum, F (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.			Magon, Stefano/0000-0003-1517-7581; Stablum, Franca/0000-0003-0123-5090			Beauchemin MJ, 2000, BRAIN COGNITION, V44, P63; BERNSTEIN DM, 1999, 27 M INT NEUR SOC BO; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Fuster J, 1989, PREFRONTAL CORTEX; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mateer CA, 1999, COGNITIVE NEUROREHAB; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; SCHNEIDER W, 1988, BEHAV RES METH INSTR, V20, P206, DOI 10.3758/BF03203833; SHALLICE T, 1994, ATTENTION PERFORM, pR15; Sohlberg M. M., 1989, INTRO COGNITIVE REHA; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; TEASDALE G, 1974, LANCET, V2, P81; UMILTA C, 1992, EUR J COGN PSYCHOL, V4, P21, DOI 10.1080/09541449208406241; UMILTA C, 1998, METACOGNITION COGNIT; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; Wilson B.A., 1996, BADS BEHAV ASSESSMEN	28	14	14	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN	2007	17	1					1	33		10.1080/13506280500411111			33	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	128GH	WOS:000243645700001	17178603				2021-06-18	
J	Young, TP; Hoaglin, HM; Burke, DT				Young, Timothy P.; Hoaglin, Heather M.; Burke, David T.			The role of serum testosterone and TBI in the in-patient rehabilitation setting	BRAIN INJURY			English	Article						brain injury; rehabilitation; testosterone; traumatic brain injury; acquired brain injury	TRAUMATIC BRAIN-INJURY; DYSFUNCTION; MEMORY; MEN	Objectives: To explore the relationship between serum testosterone levels, age, length of stay, admission, discharge and changes in functional capacity over time among patients with traumatic brain injury treated in a rehabilitation hospital. Design: This study used a nonrandomized chart review of 54 males, consecutively admitted to a brain injury rehabilitation hospital. Methods: The charts of 54 males consecutively admitted to a brain injury rehabilitation unit between the periods of December 2004 and May 2005 were included in this study. Individuals were included in this study if they were 18 years of age or older, had suffered a traumatic brain injury, undergone admission and discharge, functional independence measure (FIM) testing and had received a serum testosterone level check within one to seven days from admission. Main outcome and results: The main outcome measure of this study was the FIM changes over time, as compared with admission testosterone levels. Low serum testosterone levels on admission to the in-patient rehabilitation unit were associated with longer lengths of stay, lower average admission FIM scores, less improvement in FIM scores, and a lower FIM efficiency. Although not statistically significant, individuals presenting to our unit with low testosterone levels, on average, stayed 26 days longer than did those with normal levels. Age and the presence of multi- trauma did not appear to be factors associated with serum testosterone levels. Changes in discharge cognitive FIM scores between the two groups approached statistical significance (p = 0.06). Conclusion: This pilot study suggests that testosterone levels may be important in the recovery of patients with traumatic brain injury, treated at an in- patient rehabilitation hospital.	Harvard Univ, Sch Med, Dept Phys & Med Rehabil, Sch Spaulding Rehabil Hosp, Boston, MA 02115 USA	Burke, DT (corresponding author), Harvard Univ, Sch Med, Dept Phys & Med Rehabil, Sch Spaulding Rehabil Hosp, 125 Nashua St, Boston, MA 02115 USA.	dburke1@partners.org					Acuff ME, 2004, AM J PHYS MED REHAB, V83, P934, DOI 10.1097/01.PHM.0000143403.63328.C7; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cherrier MM, 2001, NEUROLOGY, V57, P80, DOI 10.1212/WNL.57.1.80; FLEISCHER AS, 1978, J NEUROSURG, V49, P650, DOI 10.3171/jns.1978.49.5.0650; FORGER NG, 1992, J NEUROBIOL, V23, P1192, DOI 10.1002/neu.480230910; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gregory CM, 2003, SPINAL CORD, V41, P23, DOI 10.1038/sj.sc.3101370; Janowsky JS, 2000, J COGNITIVE NEUROSCI, V12, P407, DOI 10.1162/089892900562228; LEE SC, 1994, BRAIN INJURY, V8, P571; Matsumoto A, 1997, BRAIN RES BULL, V44, P539, DOI 10.1016/S0361-9230(97)00240-2; Richard I., 2001, Annales de Readaptation et de Medecine Physique, V44, P19, DOI 10.1016/S0168-6054(00)00059-3	12	14	14	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	6					645	649		10.1080/02699050701210426			5	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	192LU	WOS:000248204100011	17577715				2021-06-18	
J	Shi, XY; Tang, ZQ; Sun, D; He, XJ				Shi Xiao-yan; Tang Zhong-quan; Sun Da; He Xiao-jun			Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury	CHINESE MEDICAL JOURNAL			English	Article						traumatic brain injury; hyperbaric oxygenation; computed tomography; single photon; emission computed tomography	CEREBRAL-BLOOD-FLOW; PHOTON EMISSION CT; SEVERE HEAD-INJURY; CORTICAL IMPACT; TIME-COURSE; RATS; VOLUME	Background. Improvement of clinical symptoms following hyperbaric oxygen (HBO) treatment of neuropsychiatric disorders arising from traumatic brain injury was proved by our previous study. This study was aim to obtain the evidence of other changes. Methods. Three hundred and ten patients with neuropsychiatric disorders arising from traumatic brain injury were treated twice with hyperbaric oxygen. Cerebral single photon emissions computed tomography (SPECT) images and computed tomography scans (CT) before and after hyperbaric oxygen treatment, were compared. Results. Before treatment, the proportion of abnormal cerebral changes detected by SPECT was 81.3% but only 15.2% by CT. After HBO treatment, 70.3% of SPECT scans showed no abnormalities and these patients were clinically improved. Treatment improved regional cerebral blood flow. Conclusion. SPECT was much more sensitive than CT in the diagnosis of neuropsychiatric disorders following hyperbaric oxygen treatment of neuropsychiatric disorders arising from traumatic brain injury.	Zhejiang Univ, Affiliated Hosp Zhejiang 2, Coll Med, Neurosci Care Unit, Hangzhou 310009, Peoples R China; Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Hyperbar Oxygen, Hangzhou 310009, Peoples R China; Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Nucl Med, Hangzhou 310009, Peoples R China; Chinese Journal Emergency Med, Editorial Board, Hangzhou 310009, Peoples R China	Shi, XY (corresponding author), Zhejiang Univ, Affiliated Hosp Zhejiang 2, Coll Med, Neurosci Care Unit, Hangzhou 310009, Peoples R China.	xys0571@hotmail.com					Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Badr AE, 2001, BRAIN RES, V916, P85, DOI 10.1016/S0006-8993(01)02867-0; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Deb S, 1999, AM J PSYCHIAT, V156, P374; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hattori N, 2003, ACTA NEUROCHIR SUPPL, V86, P49; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ren HJ, 2001, CHINESE MED J-PEKING, V114, P387; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Stamatakis EA, 2002, J NUCL MED, V43, P476; Steiner LA, 2003, J CEREBR BLOOD F MET, V23, P1371, DOI 10.1097/01.WCB.0000090861.67713.10; SUN D, 1997, RADIONUCLIDE BRAIN I, P239; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P143; Van Laere K, 2001, EUR J NUCL MED, V28, P862, DOI 10.1007/s002590100559	22	14	16	0	4	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	DEC 5	2006	119	23					1978	1982		10.1097/00029330-200612010-00007			5	Medicine, General & Internal	General & Internal Medicine	116QR	WOS:000242817900007	17199942	DOAJ Gold			2021-06-18	
J	Zink, BJ; Stern, SA; McBeth, BD; Wang, X; Mertz, M				Zink, Brian J.; Stern, Susan A.; McBeth, Brian D.; Wang, Xu; Mertz, Michelle			Effects of ethanol on limited resuscitation in a model of traumatic brain injury and hemorrhagic shock	JOURNAL OF NEUROSURGERY			English	Article						brain injury; hemorrhage; shock; ethanol; resuscitation; pig	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURIES; UNCONTROLLED HEMORRHAGE; INTRACRANIAL-PRESSURE; ALCOHOL-INTOXICATION; PERFUSION-PRESSURE; SWINE MODEL; RATS; ISOFLURANE; OUTCOMES	Object. Limited resuscitation following uncontrolled hemorrhagic shock (HS) has been associated with improved outcomes in various animal models, although it has not been previously studied in the setting of traumatic brain injury (TBI) and ethanol intoxication. The aim of the present study was to determine the effects of ethanol intoxication in a model of experimental TBI and HS treated with limited resuscitation. Methods. After induction of anesthesia and the placement of instruments, swine were subjected to a fluid-percussion injury of 3 atm. Simultaneously, hemorrhage was induced from an arterial catheter via a computerized roller pump to a mean arterial blood pressure (MABP) of 50 mm Hg, at which time uncontrolled hemorrhage was induced by the creation of an aortic tear. When the MABP decreased to 30 mm Hg, limited resuscitation to a MABP of 60 mm Hg was begun. After 60 minutes, animals were aggressively resuscitated to baseline MABP levels. Two groups of animals were studied: those receiving tap water by gastrostomy tube and those receiving ethanol (4 g/kg) by gastrostomy tube. Animals were monitored for 180 minutes after TBI. Hemorrhage volumes were significantly greater in ethanol-infused animals (mean +/- standard deviation, 41 +/- 34 mm Hg) compared with tap water-infused animals (17 +/- 18 mm Hg; p = 0.048). Resuscitation requirements were significantly higher and metabolic parameters significantly worse in the ethanol group. Survival time was also significantly decreased in the animals infused with ethanol (81 +/- 60 minutes) compared with those infused with tap water (130 +/- 51 minutes; p = 0.035). Conclusions. Ethanol intoxication led to increased hemorrhage volume and worsened hemodynamic and metabolic profiles in this model of limited resuscitation after TBI and HS. Ethanol-exposed animals had increased resuscitation requirements and decreased survival times.	Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI 48109 USA; Univ Minnesota, Reg Hosp, Dept Emergency Med, St Paul, MN 55455 USA	Zink, BJ (corresponding author), Brown Univ, Sch Med, Dept Emergency Med, 593 Eddy St,Potter 245, Providence, RI 02903 USA.	bzink@lifespan.org			NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA00184] Funding Source: Medline		Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Altura B M, 1984, Alcohol, V1, P325, DOI 10.1016/0741-8329(84)90056-9; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1993, NEUROSURGERY, V32, P547; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/neu.2004.21.1573; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; Ema M, 1998, ALCOHOL, V15, P95, DOI 10.1016/S0741-8329(97)00102-X; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; GABRIEL EJ, 2000, J NEUROTRAUM, V19, P125; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; GROSSLIGHT K, 1985, ANESTHESIOLOGY, V63, P533, DOI 10.1097/00000542-198511000-00011; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HANNON JP, 1981, DOMESTIC SWINE PHYSL; HONKANEN R, 1991, INJURY, V22, P225, DOI 10.1016/0020-1383(91)90047-I; HOVDA DA, 1992, J NEUROTRAUMA S1, V9, P47; KOWALENKO T, 1992, J TRAUMA, V33, P349, DOI 10.1097/00005373-199209000-00003; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Lacoste L, 2001, AM J CARDIOL, V87, P82, DOI 10.1016/S0002-9149(00)01277-7; Li WY, 2004, NEUROSCI LETT, V354, P221, DOI 10.1016/j.neulet.2003.10.047; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1991, J NEUROSURG S, V75, P59; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MURR R, 1993, ANESTH ANALG, V77, P898; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rubin R, 1999, ALCOHOL CLIN EXP RES, V23, P1114, DOI 10.1111/j.1530-0277.1999.tb04234.x; SCHELLER MS, 1987, ANESTHESIOLOGY, V67, P507, DOI 10.1097/00000542-198710000-00011; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Sinert R, 2005, ACAD EMERG MED, V12, P1141, DOI [10.1111/j.1553-2712.2005.tb01488.x, 10.1197/j.aem.2005.07.016]; STEM SA, 1993, ANN EMERG MED, V22, P155; Stern SA, 2001, SHOCK, V15, P16, DOI 10.1097/00024382-200115010-00003; STERN SA, 1995, ACAD EMERG MED, V2, P89, DOI 10.1111/j.1553-2712.1995.tb03167.x; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; THURMAN DJ, 1999, TRAUMATIC BRAIN  INJ; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; YUAN XQ, 1991, CIRC SHOCK, V35, P231; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zhang QH, 2000, ALCOHOL CLIN EXP RES, V24, P528; ZINK BJ, 1988, ANN EMERG MED, V17, P15, DOI 10.1016/S0196-0644(88)80496-7; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	58	14	14	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	DEC	2006	105	6					884	893		10.3171/jns.2006.105.6.884			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	111DJ	WOS:000242431300014	17405260				2021-06-18	
J	Darbin, O; Carre, E; Naritoku, D; Risso, JJ; Lonjon, M; Patrylo, PR				Darbin, Olivier; Carre, Emily; Naritoku, Dean; Risso, Jean Jacque; Lonjon, Michel; Patrylo, Peter R.			Glucose metabolites in the striatum of freely behaving rats following infusion of elevated potassium	BRAIN RESEARCH			English	Article						lactate; pyruvate; microdialysis; depolarization; injury	CORTICAL SPREADING DEPRESSION; CEREBRAL-ARTERY OCCLUSION; GAMMA-AMINOBUTYRIC-ACID; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; EXTRACELLULAR POTASSIUM; ENERGY-METABOLISM; INVIVO RELEASE	The outcome of patients with traumatic brain injury (TBI) can be predicted by the extracellular potassium concentration and the change in energy homeostasis. in this study, the authors investigated the effects of high potassium concentrations on extracellular levels of glucose, pyruvate and lactate in the rat striatum. Applying artificial cerebrospinal fluid (ACSF) enriched with 120 mM potassium by reverse microdialysis leads to an increase in lactate and reduction in glucose and pyruvate. Consequently, the lactate to pyruvate ratio was also increased. These data are discussed in the context of recent studies on lactate/pyruvate conversion and the potential mechanisms whereby high potassium could affect this equilibrium. We conclude that ischemic-like events are unlikely to explain these K+-induced changes. (c) 2006 Elsevier B.V. All rights reserved.	So Illinois Univ, Dept Physiol, Sch Med, Carbondale, IL 62901 USA; Hop Instruct Armees St Anne, IMNSAA, Dept Neurochem, F-83800 Toulon, France; So Illinois Univ, Sch Med, Dept Neurol & Pharmacol, Springfield, IL 62794 USA; CHU Pasteur, UNSA, Serv Neurochirurg, F-06002 Nice 01, France	Darbin, O (corresponding author), So Illinois Univ, Dept Physiol, Sch Med, Carbondale, IL 62901 USA.	olivier@darbin.com		Darbin, Olivier/0000-0003-1461-8517	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 00795] Funding Source: Medline		ADACHI K, 1995, J CEREBR BLOOD F MET, V15, P97, DOI 10.1038/jcbfm.1995.11; AMBERG G, 1989, J PHARMACOL METHOD, V22, P157, DOI 10.1016/0160-5402(89)90012-0; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; BURES J, 1984, AN ACAD BRAS CIENC, V56, P385; Darbin O, 2000, BRAIN RES, V881, P121, DOI 10.1016/S0006-8993(00)02633-0; Darbin O, 2003, EXP NEUROL, V181, P327, DOI 10.1016/S0014-4886(03)00112-2; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; DIETZEL I, 1982, EXP BRAIN RES, V46, P73; Doppenberg EMR, 1999, ACT NEUR S, V75, P31; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; FERNANDEZGALAZ C, 1993, J NEUROCHEM, V60, P1806, DOI 10.1111/j.1471-4159.1993.tb13407.x; GIRAULT JA, 1986, NEUROSCIENCE, V19, P1101, DOI 10.1016/0306-4522(86)90126-0; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Goodman JC, 1999, ACT NEUR S, V75, P35; GRANATA AR, 1983, BRAIN RES, V259, P77, DOI 10.1016/0006-8993(83)91068-5; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hashimoto M, 2000, BRAIN RES, V872, P294, DOI 10.1016/S0006-8993(00)02509-9; Hattori N, 2003, J NUCL MED, V44, P1709; HERTZ E, 1979, IN VITRO CELL DEV B, V15, P429; Hertz L, 1998, METHODS, V16, P293, DOI 10.1006/meth.1998.0686; HERTZ L, 1973, BRAIN RES, V60, P517, DOI 10.1016/0006-8993(73)90814-7; HERTZ L, 1966, J NEUROCHEM, V13, P1373, DOI 10.1111/j.1471-4159.1966.tb04300.x; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kett-White R, 2002, ACT NEUR S, V81, P363; KONIG JFR, 1963, RAT BRAIN; LEBOULCH NL, 1991, BRAIN RES, V559, P200, DOI 10.1016/0006-8993(91)90003-E; Lin JY, 2002, LIFE SCI, V71, P803, DOI 10.1016/S0024-3205(02)01738-1; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; Lonjon M, 2001, NEUROSCI LETT, V304, P21, DOI 10.1016/S0304-3940(01)01739-6; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; Mazel T, 2002, PHYSIOL RES, V51, pS85; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; NIELSEN EO, 1989, NEUROCHEM RES, V14, P321, DOI 10.1007/BF01000034; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; NOTO T, 1986, J NEUROCHEM, V46, P1877; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Pellerin L, 1996, DEV NEUROSCI-BASEL, V18, P336, DOI 10.1159/000111426; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PENG L, 1994, BRAIN RES, V663, P168, DOI 10.1016/0006-8993(94)90475-8; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; ROSENTHAL M, 1973, J NEUROPHYSIOL, V36, P739; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; SCHELLER D, 1992, NEUROSCI LETT, V135, P83, DOI 10.1016/0304-3940(92)90141-S; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Selman WR, 2004, BRAIN RES, V999, P167, DOI 10.1016/j.brainres.2003.11.016; Siesjo B K, 1978, Acta Anaesthesiol Scand Suppl, V70, P56; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Taylor DL, 1997, BRAIN RES, V764, P117, DOI 10.1016/S0006-8993(97)00434-4; Ungerstedt U, 1997, Acta Anaesthesiol Scand Suppl, V110, P123; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Yamamoto T, 1999, ACT NEUR S, V75, P17	59	14	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 20	2006	1116						127	131		10.1016/j.brainres.2006.06.095			5	Neurosciences	Neurosciences & Neurology	102EN	WOS:000241793900015	16979147				2021-06-18	
J	Eid, K; Labler, L; Ertel, W; Trentz, O; Keel, M				Eid, K.; Labler, L.; Ertel, W.; Trentz, O.; Keel, M.			Systemic effects of severe trauma on the function and apoptosis of human skeletal cells	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							3-DIMENSIONAL COLLAGEN SPONGES; COLONY-STIMULATING FACTOR; NERVE GROWTH-FACTOR; HETEROTOPIC OSSIFICATION; HEAD-INJURY; ENHANCED OSTEOGENESIS; NEUTROPHIL APOPTOSIS; BRAIN INJURY; SURVIVAL; BONE	Systemic factors are believed to be pivotal for the development of heterotopic ossification in severely-injured patients. In this study, cell cultures of putative target cells (human fibroblastic cells, osteoblastic cells (MG-63), and bone-marrow stromal cells (hBM)) were incubated with serum from ten consecutive polytraumatised patients taken from post-traumatic day 1 to day 21 and with serum from 12 healthy control subjects. The serum from the polytraumatised patients significantly stimulated the proliferation of fibroblasts, MG-63 and of hBM cells. The activity of alkaline phosphatase in MG-63 and hBM cells was significantly decreased when exposed to the serum of the severely-injured patient. After three weeks in 3D cell cultures, matrix production and osteogenic gene expression of hBM cells were equal in the patient and control groups. However, the serum from the polytraumatised patients significantly decreased apoptosis of hBM cells compared with the control serum (4.3% vs 19.1%, p = 0.031). Increased proliferation of osteoblastic cells and reduced apoptosis of osteoprogenitors may be responsible for increased osteogenesis in severely-injured patients.	Univ Zurich Hosp, Div Trauma Surg, CH-8091 Zurich, Switzerland	Eid, K (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Raemistr 100, CH-8091 Zurich, Switzerland.	karim.eid@usz.ch					Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; BRACH MA, 1992, BLOOD, V80, P2920; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; CLEMENTS NC, 1993, CHEST, V104, P1526, DOI 10.1378/chest.104.5.1526; COLLICOTT PE, 1980, JAMA-J AM MED ASSOC, V243, P1156; COLOTTA F, 1992, BLOOD, V80, P2012; Ertel W, 1999, J TRAUMA, V46, P784, DOI 10.1097/00005373-199905000-00005; Ertel W, 1998, J TRAUMA, V44, P767, DOI 10.1097/00005373-199805000-00005; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P38; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Keel M, 2000, UNFALLCHIRURG, V103, P243, DOI 10.1007/s001130050529; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; LARSON JM, 1981, RHEUMATOL REHABIL, V20, P193, DOI 10.1093/rheumatology/20.4.193; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253; Mogi M, 2000, LIFE SCI, V67, P1197, DOI 10.1016/S0024-3205(00)00705-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; Mueller SM, 1999, J BONE MINER RES, V14, P2118, DOI 10.1359/jbmr.1999.14.12.2118; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; ROBBINS JR, 1997, METHODS MOL MED, P173; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525; TRENTZ O, 2000, AO PRINCIPLES FRACTU, P661; Tumber A, 2000, J ENDOCRINOL, V167, P383, DOI 10.1677/joe.0.1670383; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319	44	14	16	0	1	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	OCT	2006	88B	10					1394	1400		10.1302/0301-620X.88B10.17139			7	Orthopedics; Surgery	Orthopedics; Surgery	102LQ	WOS:000241813000024	17012435				2021-06-18	
J	Ariza, M; Pueyo, R; Junque, C; Mataro, M; Poca, MA; Mena, MP; Sahuquillo, J				Ariza, Mar; Pueyo, Roser; Junque, Carme; Mataro, Maria; Antonia Poca, Maria; Pau Mena, Maria; Sahuquillo, Juan			Differences in visual vs. verbal memory impairments as a result of focal temporal lobe damage in patients with traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; temporal lesion; memory; laterality	SEVERE HEAD-INJURY; HIGH INTRACRANIAL-PRESSURE; RECOGNITION MEMORY; NEUROPSYCHOLOGICAL DEFICITS; HIPPOCAMPAL ATROPHY; NONVERBAL MEMORY; EPILEPSY; LOBECTOMY; RAT; RESECTION	Primary objective: The aim of the present study was to determine whether the type of lesion in a sample of moderate and severe traumatic brain injury (TBI) was related to material-specific memory impairment. Methods and procedures: Fifty-nine patients with TBI were classified into three groups according to whether the site of the lesion was right temporal, left temporal or diffuse. Six-months post-injury, visual (Warrington's Facial Recognition Memory Test and Rey's Complex Figure Test) and verbal (Rey's Auditory Verbal Learning Test) memories were assessed. Main outcome and results: Visual memory deficits assessed by facial memory were associated with right temporal lobe lesion, whereas verbal memory performance assessed with a list of words was related to left temporal lobe lesion. The group with diffuse injury showed both verbal and visual memory impairment. Conclusions: These results suggest a material-specific memory impairment in moderate and severe TBI after focal temporal lesions and a non-specific memory impairment after diffuse damage.	Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Barcelona, Spain; August Pi & Sunyer Biomed Res Inst, IDIBAPS, Barcelona, Spain; Dept Neurosurg, Barcelona, Spain; Vall Hebron Univ Hosp, Neurotraumatol Res Unit, Barcelona, Spain	Pueyo, R (corresponding author), Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, Passeig Vall Hebron 171, Barcelona, Spain.	rpueyo@ub.edu	Poca, Maria A./B-8475-2008; Benito, Roser Pueyo/G-3433-2011; Sahuquillo, Juan/B-3577-2008; Mena, Mari-Pau/AAC-7966-2020; Ariza, Mar/F-2754-2019; Mataro, Maria/B-4524-2011; Junque, Carme/B-4400-2011	Poca, Maria A./0000-0002-3831-0536; Benito, Roser Pueyo/0000-0002-8230-8409; Sahuquillo, Juan/0000-0003-0713-5875; Mataro, Maria/0000-0002-9946-2656; Junque, Carme/0000-0002-6381-3063; Ariza, Mar/0000-0003-1020-6945; Mena Jaramillo, Maria de la Paz/0000-0001-9248-5997			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Barr WB, 1997, BRAIN COGNITION, V35, P26, DOI 10.1006/brcg.1997.0925; Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; Baxendale SA, 1997, NEUROPSYCHOLOGIA, V35, P591, DOI 10.1016/S0028-3932(96)00123-6; BENSON DF, 1974, ACTA NEUROL SCAND, V50, P133; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BIGLER ED, 1996, HDB HUMAN BRAIN FUNC, V2; Breier J I, 1996, J Int Neuropsychol Soc, V2, P535; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cahn DA, 1998, J INT NEUROPSYCH SOC, V4, P106, DOI 10.1017/S1355617798001064; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; FORMISANO R, 1991, ACTA NEUROCHIR, V109, P1, DOI 10.1007/BF01405688; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Gennarelli T. A., 1998, SEM CLIN NEUR, V3, P160; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Gleissner U, 1998, J NEUROL NEUROSUR PS, V65, P665, DOI 10.1136/jnnp.65.5.665; Glosser G, 1998, J INT NEUROPSYCH SOC, V4, P502; Helmstaedter C, 1997, BRAIN COGNITION, V35, P110, DOI 10.1006/brcg.1997.0930; HERMANN BP, 1995, J EPILEPSY, V8, P139, DOI 10.1016/0896-6974(95)00022-6; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; JonesGotman M, 1997, NEUROPSYCHOLOGIA, V35, P963, DOI 10.1016/S0028-3932(97)00024-9; JONESGOTMAN M, 1986, NEUROPSYCHOLOGIA, V24, P659, DOI 10.1016/0028-3932(86)90005-9; Kilpatrick C, 1997, SEIZURE, V6, P213, DOI 10.1016/S1059-1311(97)80008-8; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Malina AC, 1998, PERCEPT MOTOR SKILL, V86, P1320, DOI 10.2466/pms.1998.86.3c.1320; MAPOU RL, 1992, HDB HEAD TRAUMA ACUT, P75; Martin RC, 1999, NEUROLOGY, V53, P2052, DOI 10.1212/WNL.53.9.2052; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Miller LA, 1998, NEUROPSYCHOLOGIA, V36, P1247, DOI 10.1016/S0028-3932(97)00139-5; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1958, Res Publ Assoc Res Nerv Ment Dis, V36, P244; MITCHELL DE, 1973, LANCET, V2, P215; Mitrushina M., 1999, HDB NORMATIVE DATA N; MORRIS RG, 1995, BRIT J CLIN PSYCHOL, V34, P571, DOI 10.1111/j.2044-8260.1995.tb01490.x; NAUGLE RI, 1994, ASSESSMENT, V1, P373; PHILLIPS NA, 1995, J CLIN EXP NEUROPSYC, V17, P713, DOI 10.1080/01688639508405161; Rey A., 1959, TEST COPIE REPROD ME; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Simons JS, 2001, NEUROPSYCHOLOGY, V15, P101, DOI 10.1037/0894-4105.15.1.101; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Taylor L B, 1969, Clin Neurosurg, V16, P269; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vaz SAM, 2004, SEIZURE-EUR J EPILEP, V13, P446, DOI 10.1016/j.seizure.2003.12.004; VONCRAMON DY, 1988, BRAIN, V111, P1061, DOI 10.1093/brain/111.5.1061; Walton NH, 1999, SEIZURE-EUR J EPILEP, V8, P241, DOI 10.1053/seiz.1999.0291; Warrington EK., 1984, RECOGNITION MEMORY T; White JR, 2002, EPILEPSY BEHAV, V3, P383, DOI 10.1016/S1525-5050(02)00051-3	59	14	14	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1053	1059		10.1080/02699050600909862			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100007	17060138				2021-06-18	
J	Celik, SE; Ozturk, H; Tolunay, S				Celik, Suat Erol; Ozturk, Hulya; Tolunay, Sahsine			Therapeutic effect of hypothermia and dizocilpine maleate on traumatic brain injury in neonatal rats	JOURNAL OF NEUROTRAUMA			English	Article						dizocilpine maleate; head injury; histopathology; hypothermia; newborn rat	SEVERE HEAD-INJURY; CEREBRAL BLOOD-FLOW; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; NEURONAL INJURY; MODEL; GLUTAMATE; ISCHEMIA; CHILDREN; RELEASE	This study was undertaken to evaluate the therapeutic effect of hypothermia and dizocilpine maleate in traumatic brain injury (TBI) on newborn rats. After induction of TBI, physiologic and histopathological assessments were performed on both the control and therapeutic groups to evaluate the effects of both agents. Rats were assigned into four groups as follows: normothermic (n = 23), hypothermic (n = 18), normothermia plus dizocilpine maleate (n = 18) and hypothermia plus dizocilpine maleate (n = 18). All the rats were injured using a weight-drop head injury model, artificially ventilated with a 33% O-2 and 66% NO2 Mixture, and physiological parameters, intracranial pressure, and brain and rectal temperatures were recorded. Mortality, physiological, neurological parameters, and histopathological changes were assessed after 24 h. As a result, intracranial pressure, cerebral perfusion pressure, morbidity, weight loss, and microscopic changes were significantly worse in the normothermic group (p < 0.05). There was no statistical difference between other groups (p > 0.05). Hypothermia and dizocilpine maleate displayed similar neuroprotective effects in TBI on newborn rats, but no additive effect was observed.	Beyoglu State Hosp, Dept Neurosurg, TR-34700 Istanbul, Turkey; Uludag Univ, Fac Med, Dept Pathol, Bursa, Turkey	Celik, SE (corresponding author), Beyoglu State Hosp, Dept Neurosurg, Goztepe Soyak Sitesi 58-1017, TR-34700 Istanbul, Turkey.	suaterolcelik@yahoo.com	Tolunay, Sahsine/AAI-1612-2021				Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BAKER CJ, 1995, NEUROSURGERY, V36, P994, DOI 10.1227/00006123-199505000-00016; BROWN AW, 1968, BRIT J EXP PATHOL, V49, P87; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; FREWEN TC, 1989, CRIT CARE MED, V17, P912, DOI 10.1097/00003246-198909000-00015; Hayashi N, 2000, No To Hattatsu, V32, P122; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LAPTOOK AR, 1995, STROKE, V26, P1240, DOI 10.1161/01.STR.26.7.1240; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Markarian GZ, 1996, NEUROSURGERY, V38, P542; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; POMERANZ S, 1993, J NEUROSURG, V79, P241, DOI 10.3171/jns.1993.79.2.0241; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; SADAMITSU D, 1997, CRIT CARE MED, V25, P8; Sherwood N.M., 1970, STEREOTAXIC ATLAS DE; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SLATER P, 1993, BRIT J PHARMACOL, V108, P1143, DOI 10.1111/j.1476-5381.1993.tb13518.x; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Takahashi I, 2000, NEUROL SURG TOKYO, V28, P983; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	28	14	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2006	23	9					1355	1365		10.1089/neu.2006.23.1355			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	085LP	WOS:000240605900007	16958587				2021-06-18	
J	Watt, SE; Shores, EA; Baguley, IJ; Dorsch, N; Fearnside, MR				Watt, Sharon E.; Shores, E. Arthur; Baguley, Ian J.; Dorsch, Nicholas; Fearnside, Michael R.			Protein S-100 and neuropsychological functioning following severe traumatic brain injury	BRAIN INJURY			English	Article						protein S-100; neuropsychological functioning; severe traumatic brain injury; Westmead PTA Scale	BIOCHEMICAL SERUM MARKERS; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; OUTCOME PREDICTION; DAMAGE; S100	Primary objective: To examine the relationship between serum concentrations of protein S-100 beta and neuropsychological functioning following severe traumatic brain injury. Design: Matched control group. Methods: Blood samples were taken within 12 hours of injury and then daily up to 7 days post-injury (n = 23). Within 2 weeks of emerging from post-traumatic amnesia (PTA), participants completed a battery of neuropsychological measures. These results were compared with a matched sample of healthy controls. Results: Early measurement of S-100 not only reflected overall brain injury severity, but also related to neuropsychological deficits, with higher serum concentrations associated with poorer performance across most cognitive domains. PTA duration, measured by the Westmead PTA Scale, was found to be the strongest predictor of S-100 concentration (R-2 = 0.59, p < 0.001). Conclusions: These findings show that measurement of serum protein S-100 may further aid in the identification of individuals with severe TBI who are likely to experience cognitive difficulties.	Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	Shores, EA (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	ashores@psy.mq.edu.au	Baguley, Ian J/K-6878-2013; Baguley, Ian/AAM-5828-2021	Baguley, Ian J/0000-0001-5650-3705; Shores, Edwin A/0000-0003-1553-5131			Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Carstairs JR, 2000, AUST PSYCHOL, V35, P36, DOI 10.1080/00050060008257466; CHOCA J, 1994, CAT COMPUTER CATEGOR; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; FANO G, 1993, NEUROSCIENCE, V53, P919, DOI 10.1016/0306-4522(93)90477-W; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gonzalez R, 2003, J INT NEUROPSYCH SOC, V9, P64, DOI 10.1017/S1355617703910071; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Haglid KG, 1997, BRAIN RES, V753, P196, DOI 10.1016/S0006-8993(96)01463-1; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; HARDEMARK HG, 1986, UPSALA J MED SCI, P29; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Hiscock Merrill, 2002, Appl Neuropsychol, V9, P129, DOI 10.1207/S15324826AN0903_1; Hutcheson G., 1999, MULTIVARIATE SOCIAL; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; LEZAK MD, 1996, NEUROPSYCHOLOGICAL A; Lovibond S.H., 1995, MANUAL DEPRESSION AN; Marchi N, 2003, J NEUROSCI, V23, P1949; MAROSSZECKY NEV, 1998, PTA PROTOCOL GUIDELI; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MILLER EN, 1996, CALIFORNIA COMPUTERI; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Shores Jr EAC, 2006, BRAIN IMPAIR, V7, P26; Stevens J., 1996, APPL MULTIVARIATE ST; SWAN N, 2003, NATL I DRUG ABUSE, V18, P1; Tabachnick B., 2001, USING MULTIVARIATE S; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Uomoto JM, 2004, REHABIL PSYCHOL, V49, P334, DOI 10.1037/0090-5550.49.4.334; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	51	14	15	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2006	20	10					1007	1017		10.1080/02699050600909698			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	093FA	WOS:000241152100002	17060133				2021-06-18	
J	Axelsson, V; Holback, S; Sjogren, M; Gustafsson, H; Forsby, A				Axelsson, V.; Holback, S.; Sjogren, M.; Gustafsson, H.; Forsby, A.			Gliotoxin induces caspase-dependent neurite degeneration and calpain-mediated general cytotoxicity in differentiated human neuroblastoma SH-SY5Y cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						gliotoxin; mycotoxin; caspase; calpain; neurite degeneration; cytotoxicity; SH-SY5Y cells	ACID-INDUCED DIFFERENTIATION; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; ASPERGILLUS-FUMIGATUS; BLASTOMA CELLS; II-SPECTRIN; APOPTOSIS; ACTIVATION; MYCOTOXINS; CLEAVAGE	In this study, a significant increase by 50% in intracellular free calcium concentration ([Ca2+](i)) was observed in differentiated human neuroblastoma (SH-SY5Y) cells after exposure to 0.25 mu M of the fungal metabolite gliotoxin for 72 h. Further, the involvement of caspases and calpains was demonstrated to underlie the gliotoxin-induced cytotoxic and neurite degenerative effects. The caspase inhibitor Z-VAD-fmk almost completely reduced the neurite degeneration from 40% degeneration of neurites to 5% as compared to control. Inhibition of calpains with calpeptin significantly attenuated gliotoxin-induced cytotoxicity, determined as reduction in total cellular protein content, from 43% to 14% as compared to control cells. Western blot analyses of alpha II-spectrin breakdown fragments confirmed activity of the proteases, and that all-spectrin was cleaved by caspases in gliotoxin-exposed cells. These results show that calpains and caspases have a role in the toxicity of gliotoxin in differentiated SH-SY5Y cells and that the process may be Ca2+-mediated. (c) 2006 Elsevier Inc. All rights reserved.	Stockholm Univ, Arrhenius Labs Nat Sci, Dept Neurochem, S-10691 Stockholm, Sweden	Axelsson, V (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Neurochem, S-10691 Stockholm, Sweden.	viktoria@neurochem.su.se		Forsby, Anna/0000-0001-6298-201X			Axelsson V, 2006, CELL BIOL TOXICOL, V22, P127, DOI 10.1007/s10565-006-0048-6; Banik NL, 1997, ANN NY ACAD SCI, V825, P120, DOI 10.1111/j.1749-6632.1997.tb48421.x; BAUER J, 1989, J MED VET MYCOL, V27, P45; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bizat N, 2003, J BIOL CHEM, V278, P43245, DOI 10.1074/jbc.M305057200; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; CICCARONE V, 1989, CANCER RES, V49, P219; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Forsby A, 1995, ATLA-ALTERN LAB ANIM, V23, P800; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GORDON KE, 1993, CAN J NEUROL SCI, V20, P237, DOI 10.1017/S0317167100048010; Green D, 2000, J MEMBRANE BIOL, V175, P223, DOI 10.1007/s002320001070; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hurne AM, 2002, J BIOL CHEM, V277, P31631, DOI 10.1074/jbc.M201699200; Ivins KJ, 1998, NEUROBIOL DIS, V5, P365, DOI 10.1006/nbdi.1998.0228; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kweon YO, 2003, J HEPATOL, V39, P38, DOI 10.1016/S0168-8278(03)00178-8; LAMBERT DG, 1990, BIOCHEM J, V265, P555, DOI 10.1042/bj2650555; LAND CJ, 1987, APPL ENVIRON MICROB, V53, P787, DOI 10.1128/AEM.53.4.787-790.1987; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LOPACHIN RM, 1994, NEUROTOXICOLOGY, V15, P247; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; MULLBACHER A, 1986, MOL IMMUNOL, V23, P231, DOI 10.1016/0161-5890(86)90047-7; Murray SS, 1997, EXP CELL RES, V233, P297, DOI 10.1006/excr.1997.3550; Nordin-Andersson M, 2003, CELL BIOL TOXICOL, V19, P43, DOI 10.1023/A:1022017731328; Nordin-Andersson M, 1998, TOXICOL IN VITRO, V12, P557, DOI 10.1016/S0887-2333(98)00035-6; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Rami A, 1997, NEUROSCI RES, V27, P93, DOI 10.1016/S0168-0102(96)01123-6; Richard JL, 1996, MYCOPATHOLOGIA, V134, P167, DOI 10.1007/BF00436725; RICHARD JL, 1994, J MED VET MYCOL, V32, P169; Rotter B, 2004, BIOCHEM J, V378, P161, DOI 10.1042/BJ20030955; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; SCHWEIZER M, 1994, BIOCHEMISTRY-US, V33, P13401, DOI 10.1021/bi00249a028; Scudamore KA, 1998, J SCI FOOD AGR, V77, P1, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;1::AID-JSFA9&gt;3.0.CO;2-4; Suen YK, 2001, FREE RADICAL RES, V35, P1, DOI 10.1080/10715760100300541; SUTTON P, 1994, INFECT IMMUN, V62, P1192, DOI 10.1128/IAI.62.4.1192-1198.1994; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; WARING P, 1988, J BIOL CHEM, V263, P18493; Waring P, 1996, GEN PHARMACOL, V27, P1311, DOI 10.1016/S0306-3623(96)00083-3; Wenehed V, 2003, FOOD CHEM TOXICOL, V41, P395, DOI 10.1016/S0278-6915(02)00250-8; Zhou XM, 2000, TOXICOL SCI, V54, P194, DOI 10.1093/toxsci/54.1.194	50	14	14	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	JUL 7	2006	345	3					1068	1074		10.1016/j.bbrc.2006.05.019			7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	054AA	WOS:000238346500025	16712786				2021-06-18	
